Citrus Sinensis ID: 019216

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340----
Protein Sequence
MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF
Secondary Structure (PSIPRED)
cccccccccccEEccEEEEEEEEccccEEEEEEEEcccccEEEEEEEEccccccccHHHHHHHHHHHHHHcccccEEEEEEEEEcccEEEEEEEEcccccHHHHHHHcccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEEccccccccccccccccEEcccccccccHHHHcccccccccccccHHHHHHHHHHHHcccccccccHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccHHcccccccccccccccccccccHHHHHHcccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccHHHEEEEEEEEEccccEEEEEEEcccccEEEEEEEEHHHHHHcccHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEccccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccccHHHccccccEEcccccHccccHHHHHcccccccccHHHHHHHHHHHHHHcccccccHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccccEEEHHHHHccHHHccccccccccccHcccccccHHcccccccccccccccccccccHEEEEEcccccccHHHHHcccccEEEEEcc
Coil and Loop (DISEMBL)
mviaekkqegmrlGRYELgrtlgegnfgkvkfaqdldsgLPFAVKILEKNRIIHLKITDQIKREIATLKllkhpnvvrLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVsychnkgvfhrdlKLENILldskgnikisdfglsalpqhfrddgllhttcgspnyvapevlanrgydgatsdiwsCGVILYVILtgylpfddrNLAVLYQKIFrgdfklpkwlspgaQNLLRkilepnpvkritiagikadewfeqdytpanpdddeedifvdneafsmhevpsdggrtpgspplinAFQLIGMsscldlsgffekevnvkvrnckf
Flexible Loop (DISEMBL)
mviaekkqegmrlgRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATlkllkhpnvvrlHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRgdfklpkwlSPGAQNLlrkilepnpvKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGffekevnvkvrnckf
Low Complexity Region (SEG)
MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF
Disordered region (IsUnstruct)
*************GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY************************************LINAFQLIGMSSCLDLSGFFEKEVNVKV*****
Disordered Region (DISOPRED)
***************YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP********************************INAFQLIGMSSCLDLSGFFEK********CKF
Disordered Region (DISEMBL)
********EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF
Disordered Region (DISPRO)
*********GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP*******************************SPPLINAFQLIGMSSCLDLSGFFEKEVNVKVR****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	344	2.2.26 [Sep-21-2011]
Q8RWC9	444	CBL-interacting serine/th	yes	no	0.985	0.763	0.724	1e-141
Q94C40	432	CBL-interacting serine/th	no	no	0.941	0.75	0.705	1e-138
Q0D4B2	525	CBL-interacting protein k	yes	no	0.965	0.632	0.701	1e-136
Q9LGV5	461	CBL-interacting protein k	no	no	0.962	0.718	0.703	1e-135
Q75L42	454	CBL-interacting protein k	no	no	0.956	0.724	0.684	1e-132
Q6ZLP5	450	CBL-interacting protein k	no	no	0.956	0.731	0.567	1e-112
Q2V452	441	CBL-interacting serine/th	no	no	0.950	0.741	0.564	1e-112
Q93VD3	482	CBL-interacting serine/th	no	no	0.965	0.688	0.545	1e-111
Q2QY53	438	CBL-interacting protein k	no	no	0.944	0.742	0.558	1e-109
Q2RAX3	454	CBL-interacting protein k	no	no	0.944	0.715	0.558	1e-109

>sp|Q8RWC9|CIPK1_ARATH CBL-interacting serine/threonine-protein kinase 1 OS=Arabidopsis thaliana GN=CIPK1 PE=1 SV=2

 Score =  501 bits (1291), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 247/341 (72%), Positives = 296/341 (86%), Gaps = 2/341 (0%)

Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           +K ++GMRLG+YELGRTLGEGNFGKVKFA+D  SG  FAVKI++K+RI  L  + QIKRE
Sbjct: 9   KKAEKGMRLGKYELGRTLGEGNFGKVKFAKDTVSGHSFAVKIIDKSRIADLNFSLQIKRE 68

Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           I TLK+LKHP++VRLHEVLASK+KI MV+E VTGGELFD+I S G+L E +GRK+FQQLI
Sbjct: 69  IRTLKMLKHPHIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQLI 128

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           DG+SYCH+KGVFHRDLKLEN+LLD+KG+IKI+DFGLSALPQHFRDDGLLHTTCGSPNYVA
Sbjct: 129 DGISYCHSKGVFHRDLKLENVLLDAKGHIKITDFGLSALPQHFRDDGLLHTTCGSPNYVA 188

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PEVLANRGYDGA SDIWSCGVILYVILTG LPFDDRNLAVLYQKI +GD  +P+WLSPGA
Sbjct: 189 PEVLANRGYDGAASDIWSCGVILYVILTGCLPFDDRNLAVLYQKICKGDPPIPRWLSPGA 248

Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP-DDDEEDIFVDNEAFSMHEVPSDG 303
           + +++++L+PNPV RIT+ GIKA EWF+ +Y P+ P DDDEE++  D++AFS+ E+ S+ 
Sbjct: 249 RTMIKRMLDPNPVTRITVVGIKASEWFKLEYIPSIPDDDDEEEVDTDDDAFSIQELGSEE 308

Query: 304 GRTPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
           G+   SP +INAFQLIGMSS LDLSGFFE+E NV  R  +F
Sbjct: 309 GKGSDSPTIINAFQLIGMSSFLDLSGFFEQE-NVSERRIRF 348

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q94C40|CIPKH_ARATH CBL-interacting serine/threonine-protein kinase 17 OS=Arabidopsis thaliana GN=CIPK17 PE=1 SV=1

 Score =  491 bits (1264), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 230/326 (70%), Positives = 278/326 (85%), Gaps = 2/326 (0%)

Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +GMR+G+YELGRTLGEGN  KVKFA D  +G  FA+KI+EK+ I  L ++ QIKREI TL
Sbjct: 4   KGMRVGKYELGRTLGEGNSAKVKFAIDTLTGESFAIKIIEKSCITRLNVSFQIKREIRTL 63

Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           K+LKHPN+VRLHEVLASK+KIYMVLE VTGG+LFD+I SKG+L E +GRK+FQQLIDGVS
Sbjct: 64  KVLKHPNIVRLHEVLASKTKIYMVLECVTGGDLFDRIVSKGKLSETQGRKMFQQLIDGVS 123

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           YCHNKGVFHRDLKLEN+LLD+KG+IKI+DFGLSAL QH+R+DGLLHTTCGSPNYVAPEVL
Sbjct: 124 YCHNKGVFHRDLKLENVLLDAKGHIKITDFGLSALSQHYREDGLLHTTCGSPNYVAPEVL 183

Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
           AN GYDGA SDIWSCGVILYVILTG LPFDD NLAV+ +KIF+GD  +P+W+S GA+ ++
Sbjct: 184 ANEGYDGAASDIWSCGVILYVILTGCLPFDDANLAVICRKIFKGDPPIPRWISLGAKTMI 243

Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPG 308
           +++L+PNPV R+TIAGIKA +WF+ DYTP+N DDD++   +  + F M E   +  ++P 
Sbjct: 244 KRMLDPNPVTRVTIAGIKAHDWFKHDYTPSNYDDDDDVYLIQEDVFMMKEYEEE--KSPD 301

Query: 309 SPPLINAFQLIGMSSCLDLSGFFEKE 334
           SP +INAFQLIGMSS LDLSGFFE E
Sbjct: 302 SPTIINAFQLIGMSSFLDLSGFFETE 327

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q0D4B2|CIPKL_ORYSJ CBL-interacting protein kinase 21 OS=Oryza sativa subsp. japonica GN=CIPK21 PE=2 SV=2

 Score =  483 bits (1244), Expect = e-136,   Method: Compositional matrix adjust.
 Identities = 235/335 (70%), Positives = 277/335 (82%), Gaps = 3/335 (0%)

Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
            MR+G+YE+GR LGEG+FGKVK A+  D+G  FA+KIL++ RI+ +KI +QIKREIATLK
Sbjct: 81  AMRMGKYEMGRALGEGHFGKVKLARHADTGAAFAIKILDRQRILAMKIDEQIKREIATLK 140

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           LLKHPNVVRLHEV ASK+KIYMVLEYV GGELFDKIA KG+L E EGRKLFQQL+D VSY
Sbjct: 141 LLKHPNVVRLHEVSASKTKIYMVLEYVNGGELFDKIALKGKLSEKEGRKLFQQLMDAVSY 200

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           CH KGV+HRDLK EN+L+D+KGNIK+SDFGLSALPQ+ R DGLLHTTCGSPNY+APEVL 
Sbjct: 201 CHEKGVYHRDLKPENVLVDAKGNIKVSDFGLSALPQNQRKDGLLHTTCGSPNYIAPEVLL 260

Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
           NRGYDG+ SDIWSCGVILYV+LTG LPFDD+N  VLYQKI +GD ++PKWLSPGAQ++LR
Sbjct: 261 NRGYDGSLSDIWSCGVILYVMLTGNLPFDDQNTVVLYQKILKGDARIPKWLSPGAQDILR 320

Query: 250 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGS 309
           KIL+PNP+ R+ I GI+A EWF QDYTPA P DD++D  + +    M E  +    T  +
Sbjct: 321 KILDPNPITRLDITGIRAHEWFRQDYTPAMPFDDDDDNNISDGNLHMTE--NQDIETSPA 378

Query: 310 PPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
              INAFQLIGMSSCLDLSGFFEKE +V  R  +F
Sbjct: 379 ISQINAFQLIGMSSCLDLSGFFEKE-DVSERKIRF 412

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LGV5|CIPK1_ORYSJ CBL-interacting protein kinase 1 OS=Oryza sativa subsp. japonica GN=CIPK1 PE=2 SV=1

 Score =  480 bits (1235), Expect = e-135,   Method: Compositional matrix adjust.
 Identities = 237/337 (70%), Positives = 280/337 (83%), Gaps = 6/337 (1%)

Query: 1   MVIAEKKQEGMR---LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI 57
           MV  E + E  R   LGRYE+GRTLGEGNFGKVK+A+ L +G  FA+KIL++N+I+ L+ 
Sbjct: 1   MVNGEAEAECTRASLLGRYEIGRTLGEGNFGKVKYARHLATGAHFAIKILDRNKILSLRF 60

Query: 58  TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR 117
            DQI+REI TLKLLKHPNVVRLHEV ASK+KIYMVLEYV GGELFDKIA KG+L E EGR
Sbjct: 61  DDQIRREIGTLKLLKHPNVVRLHEVAASKTKIYMVLEYVNGGELFDKIAVKGKLSEHEGR 120

Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
           +LFQQLID VSYCH+KGV+HRDLK EN+L+D +GNIKISDFGLSALPQH  +DGLLHTTC
Sbjct: 121 RLFQQLIDAVSYCHDKGVYHRDLKPENVLVDRRGNIKISDFGLSALPQHLGNDGLLHTTC 180

Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 237
           GSPNY+APEVL NRGYDG+ SDIWSCGVILYV+L GYLPFDDRNL VLYQKIF+GD ++P
Sbjct: 181 GSPNYIAPEVLQNRGYDGSLSDIWSCGVILYVMLVGYLPFDDRNLVVLYQKIFKGDTQIP 240

Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 297
           KWLSP A++LLR+ILEPNP+KRI IAGIK  EWF++DYTP  P DD++D ++D+    + 
Sbjct: 241 KWLSPSARDLLRRILEPNPMKRINIAGIKEHEWFQKDYTPVVPYDDDDDNYLDS-VLPIK 299

Query: 298 EVPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKE 334
           E   +  +    P  INAFQLIGM+S LDLSGFFE+E
Sbjct: 300 EQIDEAKQE--KPTHINAFQLIGMASALDLSGFFEEE 334

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q75L42|CIPKH_ORYSJ CBL-interacting protein kinase 17 OS=Oryza sativa subsp. japonica GN=CIPK17 PE=2 SV=1

 Score =  471 bits (1213), Expect = e-132,   Method: Compositional matrix adjust.
 Identities = 228/333 (68%), Positives = 275/333 (82%), Gaps = 4/333 (1%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           LG YE+GRTLGEGNFGKVK+A+ L +G  FAVKIL++ R++ L+  DQI+REIATLKLL+
Sbjct: 10  LGGYEMGRTLGEGNFGKVKYARHLATGGHFAVKILDRGRVVSLRAGDQIRREIATLKLLR 69

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP+VVRLHEV ASK+KIYMVLE+V GGELF++IA KG+L E EGR+LFQQLIDGVSYCH+
Sbjct: 70  HPHVVRLHEVAASKTKIYMVLEFVNGGELFERIAVKGKLSEKEGRRLFQQLIDGVSYCHD 129

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           +GV+HRDLK EN+L+D KGNIKISDFGLSALPQH  +DGLLHTTCGSPNY+APEVL N+G
Sbjct: 130 RGVYHRDLKPENVLVDQKGNIKISDFGLSALPQHLGNDGLLHTTCGSPNYIAPEVLQNKG 189

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
           YDG+ SDIWSCGVILYV+L GYLPFDDRN+ VLYQKIF+GD ++PKWLS  AQNLLR+IL
Sbjct: 190 YDGSLSDIWSCGVILYVMLIGYLPFDDRNIVVLYQKIFKGDTQIPKWLSHSAQNLLRRIL 249

Query: 253 EPNPVKRITIAGIKADEWFEQDYTPANP-DDDEEDIFVDNEAFSMHEVPSDGGRTPGSPP 311
           EPNP+KRI +AGIK+ EWF++DY P  P DDD+ED+       +  ++  + G    +  
Sbjct: 250 EPNPMKRIDMAGIKSHEWFQKDYIPVLPYDDDDEDVQFGARLPAKEQINDEPGDK--NSH 307

Query: 312 LINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
            INAFQLIGM+S LDLSGFFE E  V  R  +F
Sbjct: 308 QINAFQLIGMASSLDLSGFFEDE-EVSQRRIRF 339

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6ZLP5|CIPKN_ORYSJ CBL-interacting protein kinase 23 OS=Oryza sativa subsp. japonica GN=CIPK23 PE=2 SV=1

 Score =  406 bits (1044), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 193/340 (56%), Positives = 257/340 (75%), Gaps = 11/340 (3%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           R+GRYELGRTLGEG F KVKFA++ DSG   A+KIL+K++++  K+  QIKREI+T+KL+
Sbjct: 9   RVGRYELGRTLGEGTFAKVKFARNADSGENVAIKILDKDKVLKHKMIAQIKREISTMKLI 68

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           +HPNV+R+HEV+ASK+KIY+V+E VTGGELFDKIAS+GRL+E + RK FQQLI+ V YCH
Sbjct: 69  RHPNVIRMHEVMASKTKIYIVMELVTGGELFDKIASRGRLKEDDARKYFQQLINAVDYCH 128

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           ++GV+HRDLK EN+LLD+ G +K+SDFGLSAL Q  R+DGLLHTTCG+PNYVAPEV+ N+
Sbjct: 129 SRGVYHRDLKPENLLLDASGTLKVSDFGLSALSQQVREDGLLHTTCGTPNYVAPEVINNK 188

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
           GYDGA +D+WSCGVIL+V++ GYLPF+D NL  LY+KIF+ DF  P W S  A+ L++KI
Sbjct: 189 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLMSLYKKIFKADFSCPSWFSTSAKKLIKKI 248

Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD------NEAFSMHEVPSDGGR 305
           L+PNP  RITIA +  +EWF++ Y P  P  +  D+ +D      NE+    ++  +  R
Sbjct: 249 LDPNPSTRITIAELINNEWFKKGYQP--PRFETADVNLDDINSIFNESGDQTQLVVE--R 304

Query: 306 TPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVKV-RNCKF 344
               P ++NAF+LI  S  L+L   FEK+    V R  +F
Sbjct: 305 REERPSVMNAFELISTSQGLNLGTLFEKQSQGSVKRETRF 344

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2V452|CIPK3_ARATH CBL-interacting serine/threonine-protein kinase 3 OS=Arabidopsis thaliana GN=CIPK3 PE=1 SV=2

 Score =  405 bits (1041), Expect = e-112,   Method: Compositional matrix adjust.
 Identities = 192/340 (56%), Positives = 255/340 (75%), Gaps = 13/340 (3%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           ++Q   R+G+YE+GRT+GEG F KVKFA++ ++G P A+KIL+K +++  K+ +QI+REI
Sbjct: 4   RQQVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREI 63

Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
           AT+KL+KHPNVV+L+EV+ASK+KI+++LEYVTGGELFDKI + GR++E E R+ FQQLI 
Sbjct: 64  ATMKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIH 123

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
            V YCH++GV+HRDLK EN+LLDS GN+KISDFGLSAL Q  RDDGLLHT+CG+PNYVAP
Sbjct: 124 AVDYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAP 183

Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
           EVL +RGYDGAT+D+WSCGV+LYV+L GYLPFDD NL  LY+KI  G+F  P WLS GA 
Sbjct: 184 EVLNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAM 243

Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPA-------NPDDDEEDIFVDNEAFSMHE 298
            L+ +IL+PNP+ R+T   +  DEWF++DY P        +  DD + +F D+E   + E
Sbjct: 244 KLITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTE 303

Query: 299 VPSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVK 338
                 +    P  INAF++I MS  L+L   F+ E   K
Sbjct: 304 ------KREEQPAAINAFEIISMSRGLNLENLFDPEQEFK 337

Involved in the resistance to some abiotic stresses (e.g. high salt, hyperosmotic stress) in young seedlings, by regulating the expression of several stress-inducible genes (cold-and salt-induced genes but not drought-responsive genes). Required for the ABA response during germination. CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q93VD3|CIPKN_ARATH CBL-interacting serine/threonine-protein kinase 23 OS=Arabidopsis thaliana GN=CIPK23 PE=1 SV=1

 Score =  400 bits (1028), Expect = e-111,   Method: Compositional matrix adjust.
 Identities = 184/337 (54%), Positives = 251/337 (74%), Gaps = 5/337 (1%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +G+YELGRTLGEG F KVKFA+++++G   A+K+++K +++  K+  QIKREI+T+KL+K
Sbjct: 28  VGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLIK 87

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+R+ EV+ASK+KIY VLE+VTGGELFDKI+S GRL+E E RK FQQLI+ V YCH+
Sbjct: 88  HPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCHS 147

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           +GV+HRDLK EN+LLD+ G +K+SDFGLSALPQ  R+DGLLHTTCG+PNYVAPEV+ N+G
Sbjct: 148 RGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNKG 207

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
           YDGA +D+WSCGVIL+V++ GYLPF+D NL  LY+KIF+ +F  P W S  A+ L+++IL
Sbjct: 208 YDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRIL 267

Query: 253 EPNPVKRITIAGIKADEWFEQDYTP-----ANPDDDEEDIFVDNEAFSMHEVPSDGGRTP 307
           +PNP  RIT A +  +EWF++ Y       A+   D+ D   D+   S + V        
Sbjct: 268 DPNPATRITFAEVIENEWFKKGYKAPKFENADVSLDDVDAIFDDSGESKNLVVERREEGL 327

Query: 308 GSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
            +P  +NAF+LI  S  L+L   FEK++ +  R  +F
Sbjct: 328 KTPVTMNAFELISTSQGLNLGSLFEKQMGLVKRKTRF 364

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein leads to activation of the kinase in a calcium-dependent manner. Downstream of CBL1, CBL2, CBL3 and CBL9, regulates by phosphorylation the K(+) conductance and uptake of AKT1 in low K(+) condition, in response to calcium signaling and during the stomatal opening regulation by monitoring the turgor pressure in guard cells. In response to low nitrate concentration, phosphorylates NRT1.1, switching it from a low-affinity nitrate transporter to a high-affinity transporter. Confers tolerance to low potassium conditions. Involved in drought sensitivity and leaf transpiration.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2QY53|CIPKW_ORYSJ CBL-interacting protein kinase 32 OS=Oryza sativa subsp. japonica GN=CIPK32 PE=2 SV=2

 Score =  396 bits (1018), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 190/340 (55%), Positives = 250/340 (73%), Gaps = 15/340 (4%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           R+G+YELGRT+GEG F KVKFA+D ++G P A+KIL+K +++  K+ +QIKREI+T+KL+
Sbjct: 9   RVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTMKLI 68

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           KHPNVVR++EV+ SK+KIY+VLEYVTGGELFD I + GR++E E R+ FQQLI+ V YCH
Sbjct: 69  KHPNVVRIYEVMGSKTKIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVDYCH 128

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           ++GV+HRDLK EN+LLDS GN+K+SDFGLSAL Q  +DDGLLHTTCG+PNYVAPEVL ++
Sbjct: 129 SRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVLEDQ 188

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
           GYDGA +D+WSCGVIL+V+L GYLPF+D NL  LY+KI   +F  P W S  A+ LL +I
Sbjct: 189 GYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRLLTRI 248

Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPD-------DDEEDIFVDNEAFSMHEVPSDGG 304
           L+PNP+ R+TI  I  DEWF++ Y     D       DD   +F D+E   + E   +  
Sbjct: 249 LDPNPMTRVTIPEILEDEWFKKGYKRPEFDEKYDTTLDDVYAVFNDSEEHHVTEKKEE-- 306

Query: 305 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
                P  +NAF+LI MS+ L+L   F+ E   K R  +F
Sbjct: 307 -----PEALNAFELISMSAGLNLGNLFDSEQEFK-RETRF 340

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q2RAX3|CIPKX_ORYSJ CBL-interacting protein kinase 33 OS=Oryza sativa subsp. japonica GN=CIPK33 PE=2 SV=1

 Score =  396 bits (1017), Expect = e-109,   Method: Compositional matrix adjust.
 Identities = 190/340 (55%), Positives = 250/340 (73%), Gaps = 15/340 (4%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           R+G+YELGRT+GEG F KVKFA+D ++G P A+KIL+K +++  K+ +QIKREI+T+KL+
Sbjct: 9   RVGKYELGRTIGEGTFAKVKFARDTETGDPVAIKILDKEKVLKHKMVEQIKREISTMKLI 68

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           KHPNVVR++EV+ SK+ IY+VLEYVTGGELFD I + GR++E E R+ FQQLI+ V YCH
Sbjct: 69  KHPNVVRIYEVMGSKTNIYIVLEYVTGGELFDTIVNHGRMREDEARRYFQQLINAVDYCH 128

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           ++GV+HRDLK EN+LLDS GN+K+SDFGLSAL Q  +DDGLLHTTCG+PNYVAPEVL ++
Sbjct: 129 SRGVYHRDLKPENLLLDSYGNLKVSDFGLSALSQQIKDDGLLHTTCGTPNYVAPEVLEDQ 188

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
           GYDGA +D+WSCGVIL+V+L GYLPF+D NL  LY+KI   +F  P W S  A+ LL +I
Sbjct: 189 GYDGAMADLWSCGVILFVLLAGYLPFEDSNLMTLYKKISNAEFTFPPWTSFPAKRLLTRI 248

Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPD-------DDEEDIFVDNEAFSMHEVPSDGG 304
           L+PNP+ RITI  I  DEWF++ Y     D       DD + +F D+E   + E   +  
Sbjct: 249 LDPNPMTRITIPEILEDEWFKKGYKRPEFDEKYDTTLDDVDAVFNDSEEHHVTEKKEE-- 306

Query: 305 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
                P  +NAF+LI MS+ L+L   F+ E   K R  +F
Sbjct: 307 -----PEALNAFELISMSAGLNLGNLFDSEQEFK-RETRF 340

CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	344
255556588	436	CBL-interacting serine/threonine-protein	0.979	0.772	0.810	1e-164
224110276	474	predicted protein [Populus trichocarpa]	0.968	0.702	0.805	1e-161
356548027	446	PREDICTED: CBL-interacting serine/threon	0.979	0.755	0.777	1e-155
363807952	448	uncharacterized protein LOC100805710 [Gl	0.979	0.752	0.753	1e-151
356530499	447	PREDICTED: CBL-interacting serine/threon	0.991	0.762	0.731	1e-149
357450323	465	CBL-interacting protein kinase [Medicago	0.968	0.716	0.767	1e-146
356558505	437	PREDICTED: CBL-interacting serine/threon	0.970	0.764	0.735	1e-145
449441498	432	PREDICTED: CBL-interacting serine/threon	0.965	0.768	0.729	1e-142
357479181	446	CBL-interacting protein kinase [Medicago	0.973	0.751	0.718	1e-140
359477295	392	PREDICTED: CBL-interacting serine/threon	0.822	0.721	0.827	1e-139

>gi|255556588|ref|XP_002519328.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223541643|gb|EEF43192.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis]

 Score =  585 bits (1507), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 278/343 (81%), Positives = 309/343 (90%), Gaps = 6/343 (1%)

Query: 2   VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
           ++  +   GMRLG YELGRTLGEGNFGKVK A+++DSGLPFAVKILEKNRIIHL I+DQI
Sbjct: 1   MVTHQHHNGMRLGNYELGRTLGEGNFGKVKLAKNIDSGLPFAVKILEKNRIIHLNISDQI 60

Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
           KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV GGELFD+IASKG+L EA+GRKLFQ
Sbjct: 61  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVNGGELFDRIASKGKLPEAQGRKLFQ 120

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           QL+DGVSYCHNKGVFHRDLKLEN+L+D+KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN
Sbjct: 121 QLVDGVSYCHNKGVFHRDLKLENVLVDAKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 180

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 241
           YVAPE+L+NRGYDGATSD WSCGVILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWLS
Sbjct: 181 YVAPEILSNRGYDGATSDTWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQIPKWLS 240

Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPS 301
            GAQN++R+IL+PNPV RIT+A IK+DEWF+QDYTPA     EEDI +DNE FSMHE+P 
Sbjct: 241 SGAQNMIRRILDPNPVTRITMADIKSDEWFKQDYTPA-----EEDIHIDNEGFSMHELPP 295

Query: 302 DGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
           +G     SP LINAFQLIGMSSCLDLSGFFEKE +V  R  +F
Sbjct: 296 EGESILRSPTLINAFQLIGMSSCLDLSGFFEKE-DVSERKIRF 337

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224110276|ref|XP_002315469.1| predicted protein [Populus trichocarpa] gi|116265922|gb|ABJ91209.1| CBL-interacting protein kinase 1 [Populus trichocarpa] gi|222864509|gb|EEF01640.1| predicted protein [Populus trichocarpa]

 Score =  573 bits (1477), Expect = e-161,   Method: Compositional matrix adjust.
 Identities = 270/335 (80%), Positives = 310/335 (92%), Gaps = 2/335 (0%)

Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           GM+LG+YELGRTLGEGNFGKVK A+++++G PFAVKILEKNRII LKITDQIKREIATLK
Sbjct: 14  GMQLGKYELGRTLGEGNFGKVKLAKNIETGQPFAVKILEKNRIIDLKITDQIKREIATLK 73

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD+IASKG+L EAEGRK+FQQLIDGVSY
Sbjct: 74  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDRIASKGKLPEAEGRKMFQQLIDGVSY 133

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           CH+KGVFHRDLKLEN+L+D+KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE+L+
Sbjct: 134 CHSKGVFHRDLKLENVLVDAKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEILS 193

Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
           NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWLSPGA+N+++
Sbjct: 194 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQVPKWLSPGAKNMIK 253

Query: 250 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGS 309
           +IL+PNPV RIT A IKADEWF+ DYTP +  ++++D+++D+ AFS+ E PS+ G +P S
Sbjct: 254 RILDPNPVTRITTADIKADEWFKLDYTPMDSAEEQDDVYIDDAAFSIQEAPSEDG-SPKS 312

Query: 310 PPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
           P LINAFQLIGMSSCLDLSG FEKE +V  R  +F
Sbjct: 313 PNLINAFQLIGMSSCLDLSGLFEKE-DVSERKIRF 346

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356548027|ref|XP_003542405.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max]

 Score =  553 bits (1426), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 265/341 (77%), Positives = 302/341 (88%), Gaps = 4/341 (1%)

Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           + ++EGMRLG+YELGRTLGEGNFGKVKFA++ DSG  FAVKI+EKN+I+ L IT+QIKRE
Sbjct: 10  KSEREGMRLGKYELGRTLGEGNFGKVKFARNTDSGQAFAVKIIEKNKIVDLNITNQIKRE 69

Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           IATLKLL+HPNVVRL+EVLASK+KIYMVLEYV GGELFD IASKG+L E E RKLFQQLI
Sbjct: 70  IATLKLLRHPNVVRLYEVLASKTKIYMVLEYVNGGELFDIIASKGKLTEGECRKLFQQLI 129

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           DGVSYCH KGVFHRDLKLEN+L+D+KGNIK++DFGLSALPQH R+DGLLHTTCGSPNYVA
Sbjct: 130 DGVSYCHTKGVFHRDLKLENVLVDNKGNIKVTDFGLSALPQHLREDGLLHTTCGSPNYVA 189

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PEVLAN+GYDGATSD WSCGVILYV LTGYLPFDDRNL VLYQKIF+GD ++PKWLSPGA
Sbjct: 190 PEVLANKGYDGATSDTWSCGVILYVSLTGYLPFDDRNLVVLYQKIFKGDAQIPKWLSPGA 249

Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG- 303
           QN++R+IL+PNP  RIT+AGIK D WF++ Y PANP+D  ED+ VDNEAFS HE P++  
Sbjct: 250 QNMIRRILDPNPETRITMAGIKEDPWFKKGYIPANPED--EDVHVDNEAFSSHEEPNEAE 307

Query: 304 GRTPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
            R  GSP LINAFQLIGMSSCLDLSGFFEKE +V  R  +F
Sbjct: 308 QRNSGSPTLINAFQLIGMSSCLDLSGFFEKE-DVSERKIRF 347

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|363807952|ref|NP_001242199.1| uncharacterized protein LOC100805710 [Glycine max] gi|255644530|gb|ACU22768.1| unknown [Glycine max]

 Score =  540 bits (1391), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 257/341 (75%), Positives = 300/341 (87%), Gaps = 4/341 (1%)

Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           + ++EGMRLG+Y+LGRTLGEGNFGKVKFA++ DSG  FAVKI++KN I+ + IT+QI RE
Sbjct: 12  KSEREGMRLGKYDLGRTLGEGNFGKVKFARNTDSGQAFAVKIIDKNTIVDINITNQIIRE 71

Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           IATLKLL+HPNVVRL+EVLASK+KIYMVLEYV GGELFD IASKG+  E EGRKLFQQLI
Sbjct: 72  IATLKLLRHPNVVRLYEVLASKTKIYMVLEYVNGGELFDIIASKGKHIEGEGRKLFQQLI 131

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           DGVSYCH KGVFHRDLKLEN+L+D+KGNIKI+DFGLSALPQH R+DGLLHTTCGSPNYVA
Sbjct: 132 DGVSYCHTKGVFHRDLKLENVLVDNKGNIKITDFGLSALPQHLREDGLLHTTCGSPNYVA 191

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PEVLAN+GYDGATSD WSCGVILYVIL G+LPFDDRNL VLYQKIF+GD ++PKWL+PGA
Sbjct: 192 PEVLANKGYDGATSDTWSCGVILYVILPGHLPFDDRNLVVLYQKIFKGDVQIPKWLTPGA 251

Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG- 303
           +N++R+IL+PNP  RIT+AGIK D WF++ Y P NP+D  ED++VD EAFS+HE P++  
Sbjct: 252 RNMIRRILDPNPETRITMAGIKEDPWFKKGYIPVNPED--EDVYVDQEAFSIHEQPNEAE 309

Query: 304 GRTPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
            R  GSP LINAFQLIGMSSCLDLSGFFEKE +V  R  +F
Sbjct: 310 QRNSGSPSLINAFQLIGMSSCLDLSGFFEKE-DVSERKIRF 349

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356530499|ref|XP_003533818.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max]

 Score =  535 bits (1378), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 251/343 (73%), Positives = 304/343 (88%), Gaps = 2/343 (0%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           +  K+++G+RLG+YELG+TLGEGNFGKVK A+D  SG  FAVKIL+K++II L   DQIK
Sbjct: 6   LGRKEEQGVRLGKYELGKTLGEGNFGKVKLARDTHSGKLFAVKILDKSKIIDLNNIDQIK 65

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           REI+TLKLLKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKIASKG+L+EAEGRK+FQQ
Sbjct: 66  REISTLKLLKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKIASKGKLKEAEGRKIFQQ 125

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           LID VS+CHNKGVFHRDLKLEN+L+D+KGNIKI+DF LSALPQHFR+DGLLHTTCGSPNY
Sbjct: 126 LIDCVSFCHNKGVFHRDLKLENVLVDAKGNIKITDFNLSALPQHFREDGLLHTTCGSPNY 185

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
           VAPE+LAN+GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+G+ ++P+WLSP
Sbjct: 186 VAPEILANKGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGEVQIPRWLSP 245

Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSD 302
           G+QN+++++L+ NP  RIT+A IK DEWF++ YTPANP+D+EE +++D+E FS+H+V  +
Sbjct: 246 GSQNIIKRMLDANPKTRITMAMIKEDEWFKEGYTPANPEDEEESVYIDDEDFSIHDVSHE 305

Query: 303 GGR-TPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
             +  P SP LINAFQLI MSS LDLSG FE+E +V  R  +F
Sbjct: 306 ADQGCPRSPTLINAFQLISMSSSLDLSGLFEQE-DVSERKIRF 347

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357450323|ref|XP_003595438.1| CBL-interacting protein kinase [Medicago truncatula] gi|355484486|gb|AES65689.1| CBL-interacting protein kinase [Medicago truncatula]

 Score =  524 bits (1350), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 258/336 (76%), Positives = 299/336 (88%), Gaps = 3/336 (0%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           +RLG+YELG+TLGEGNFGKVK A+D D G  FAVKILEKN+I+ L  TDQIKREI+TLKL
Sbjct: 15  VRLGKYELGKTLGEGNFGKVKLARDTDCGQFFAVKILEKNKIVDLNNTDQIKREISTLKL 74

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           LKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKI+SKG+L EA GRK+FQQLIDGVSYC
Sbjct: 75  LKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKISSKGKLTEAHGRKMFQQLIDGVSYC 134

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           HNKGVFHRDLKLEN+L+D+KGNIKI+DF LSALPQH R DGLLHTTCGSPNYVAPE+LAN
Sbjct: 135 HNKGVFHRDLKLENVLVDAKGNIKITDFNLSALPQHCRADGLLHTTCGSPNYVAPEILAN 194

Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250
           RGYDGA SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+ D ++P+WLSPGAQN+++K
Sbjct: 195 RGYDGAKSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKADVQIPRWLSPGAQNIIKK 254

Query: 251 ILEPNPVKRITIAGIKADEWFEQDYTPAN--PDDDEEDIFVDNEAFSMHEVPSDGGRTPG 308
           IL+PNP  R+T+  IK DEWF++ Y PAN   +++EED+F+D+EAFS+HEV  DG ++P 
Sbjct: 255 ILDPNPKTRVTMDMIKEDEWFKEGYNPANLEDEEEEEDVFIDDEAFSIHEVSLDGDQSPK 314

Query: 309 SPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
           SP LINAFQLIGMSSCLDLSGFFE+E +V  R  +F
Sbjct: 315 SPALINAFQLIGMSSCLDLSGFFEQE-DVSERKIRF 349

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356558505|ref|XP_003547546.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Glycine max]

 Score =  519 bits (1336), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 248/337 (73%), Positives = 296/337 (87%), Gaps = 3/337 (0%)

Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +GMRLG+YELG+TLGEGNFGKVK A+D  SG  FAVKIL+K++II L  TDQIKREI TL
Sbjct: 12  QGMRLGKYELGKTLGEGNFGKVKLARDTHSGKLFAVKILDKSKIIDLNNTDQIKREIFTL 71

Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           KLLKHPNVVRL+EVLASK+KIYMVLEYV GGELFDKIASKG+L+EA GRK+FQQLID VS
Sbjct: 72  KLLKHPNVVRLYEVLASKTKIYMVLEYVNGGELFDKIASKGKLKEAVGRKIFQQLIDCVS 131

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +CHNKGVFHRDLKLEN+L+D+KGNIKI+DF LSALPQHFR DGLLHTTCGSPNYVAPE+L
Sbjct: 132 FCHNKGVFHRDLKLENVLVDAKGNIKITDFNLSALPQHFRADGLLHTTCGSPNYVAPEIL 191

Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
           AN+GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI +G+ ++P+WLSPG+QN++
Sbjct: 192 ANKGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKILKGEVQIPRWLSPGSQNII 251

Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGR-TP 307
           +++L+ N   RIT+A IK DEWF++ Y+PANP+D+EE +++D E FS+H+V  +  + +P
Sbjct: 252 KRMLDVNLKTRITMAMIKEDEWFKEGYSPANPEDEEESVYID-EDFSIHDVSLEADQGSP 310

Query: 308 GSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
            SP LINAFQLI MSS LDLSG FE+E +V  R  +F
Sbjct: 311 RSPTLINAFQLISMSSSLDLSGLFEQE-DVSERKIRF 346

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449441498|ref|XP_004138519.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Cucumis sativus]

 Score =  509 bits (1312), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 246/337 (72%), Positives = 284/337 (84%), Gaps = 5/337 (1%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           MRLG+YE+G+TLG GNFGKVK+A + ++  PFAVK L+K +II L IT Q KREI TLKL
Sbjct: 1   MRLGKYEIGKTLGHGNFGKVKYAINFETQQPFAVKELDKTKIIDLNITHQFKREIYTLKL 60

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           LKHPN+VRLHEVLASKSKIYMVLEYV GGELFD I+SKGRL EA+GRK+FQQL+DGVSYC
Sbjct: 61  LKHPNIVRLHEVLASKSKIYMVLEYVNGGELFDTISSKGRLSEAQGRKIFQQLLDGVSYC 120

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           H KGV+HRD+KLENIL+D+ GN+KI+DFGLSALP HFR DGLLHTTCGSPNYVAPE+LAN
Sbjct: 121 HRKGVYHRDIKLENILIDANGNVKITDFGLSALPDHFRGDGLLHTTCGSPNYVAPEILAN 180

Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250
           RGYDGA SDIWSCGVIL+VILTG LPFDDRNL+VLY KI +G+  LPKWLS GA+NL+R+
Sbjct: 181 RGYDGAASDIWSCGVILFVILTGSLPFDDRNLSVLYHKILKGEIHLPKWLSQGAKNLIRR 240

Query: 251 ILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA--FSMHEVPSD-GGRTP 307
           IL+PNP  RIT+A IK D+WF +DY PA  DD+EED    NEA  FSMH+VPS   G+  
Sbjct: 241 ILDPNPKSRITMASIKMDDWFRKDYRPAYLDDEEEDTHT-NEAISFSMHQVPSYLEGKCS 299

Query: 308 GSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
            SP  INAFQLIGMSSCLDLSGFFEKE ++  R  +F
Sbjct: 300 ESPTTINAFQLIGMSSCLDLSGFFEKE-DISERKVRF 335

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357479181|ref|XP_003609876.1| CBL-interacting protein kinase [Medicago truncatula] gi|355510931|gb|AES92073.1| CBL-interacting protein kinase [Medicago truncatula]

 Score =  503 bits (1294), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 242/337 (71%), Positives = 296/337 (87%), Gaps = 2/337 (0%)

Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           EG+RLG+YELGR LGEGNFGKVKFA++ DSG P+A+KI++KN+II L IT+QIKREI  L
Sbjct: 19  EGVRLGKYELGRILGEGNFGKVKFARNTDSGQPYAIKIIDKNKIIDLNITNQIKREICAL 78

Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           KLL+HPNVV+L+EVLASK+KIYMVLEYVTG ELFDKIASKG+L E EGRKLFQQLIDGVS
Sbjct: 79  KLLRHPNVVKLYEVLASKTKIYMVLEYVTGEELFDKIASKGKLPEGEGRKLFQQLIDGVS 138

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           YCH+KGVFHRDLKLEN+L+D+KGN+KI+DFGLSALPQ FR DGLLHTTCGS NYVAPE+L
Sbjct: 139 YCHSKGVFHRDLKLENVLVDAKGNLKITDFGLSALPQQFRADGLLHTTCGSANYVAPEIL 198

Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
           ANRGY+GA+SD+WSCGVILYV+LTG+LPFDDRNLAVLYQK+ +GDF+ PKWLS GAQN++
Sbjct: 199 ANRGYNGASSDVWSCGVILYVVLTGFLPFDDRNLAVLYQKVLKGDFQKPKWLSAGAQNII 258

Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPG 308
           ++IL+PNP  RIT+A IK D WF++ Y  A  +D+E+ ++VD++AF++HE+  +  ++  
Sbjct: 259 KRILDPNPKTRITMAEIKEDLWFKEGYNQAYHEDEEDGVYVDDQAFNIHELSHEEEKSSS 318

Query: 309 SPPL-INAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
             P+ INAFQLIGMSSCLDLSGFFEKE +V  R  +F
Sbjct: 319 QSPIRINAFQLIGMSSCLDLSGFFEKE-DVSERKIRF 354

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359477295|ref|XP_002275061.2| PREDICTED: CBL-interacting serine/threonine-protein kinase 1-like [Vitis vinifera] gi|229609839|gb|ACQ83535.1| CBL-interacting protein kinase 19 [Vitis vinifera]

 Score =  501 bits (1291), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 235/284 (82%), Positives = 264/284 (92%), Gaps = 1/284 (0%)

Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
           IKREIATLKLLKHPNVVRLHEVLASK+KIYMVLEYVTGGELFD+IAS G+L EAEGRKLF
Sbjct: 14  IKREIATLKLLKHPNVVRLHEVLASKTKIYMVLEYVTGGELFDRIASNGKLSEAEGRKLF 73

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
           QQLID VSYCHNKGVFHRDLKLEN+L+DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP
Sbjct: 74  QQLIDAVSYCHNKGVFHRDLKLENVLVDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 133

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
           NYVAPE+LANRGYDG+TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF+GD ++PKWL
Sbjct: 134 NYVAPEILANRGYDGSTSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFKGDAQMPKWL 193

Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVP 300
           S GA+N++++IL+P P  RIT+AGIKADEWF+Q YTPA P+++EEDI VD+EAFS++EVP
Sbjct: 194 SSGAKNIIKRILDPKPETRITMAGIKADEWFKQQYTPAYPEEEEEDIHVDDEAFSIYEVP 253

Query: 301 SDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
            +  ++PGSP LINAFQLIGMSSCLDLSGFFEKE +V  R  +F
Sbjct: 254 MEAKKSPGSPNLINAFQLIGMSSCLDLSGFFEKE-DVSERKIRF 296

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	344
TAIR|locus:2090537	444	CIPK1 "CBL-interacting protein	0.985	0.763	0.730	2.6e-134
TAIR|locus:2007685	432	CIPK17 "CBL-interacting protei	0.968	0.770	0.690	6.1e-126
TAIR|locus:2059279	451	CIPK3 "CBL-interacting protein	0.968	0.738	0.568	4.2e-102
TAIR|locus:2009812	482	CIPK23 "CBL-interacting protei	0.959	0.684	0.560	4.9e-101
TAIR|locus:1005716172	439	CIPK26 "calcineurin B-like pro	0.965	0.756	0.559	1.5e-99
TAIR|locus:2135962	445	CIPK8 "CBL-interacting protein	0.927	0.716	0.564	2.2e-96
TAIR|locus:2155233	446	SOS2 "SALT OVERLY SENSITIVE 2"	0.962	0.742	0.534	7.8e-94
TAIR|locus:2126749	441	SIP3 "SOS3-interacting protein	0.950	0.741	0.498	4.1e-88
TAIR|locus:2181047	421	CIPK15 "CBL-interacting protei	0.938	0.767	0.519	8.6e-88
TAIR|locus:2152380	439	CIPK20 "CBL-interacting protei	0.892	0.699	0.510	1.3e-86

TAIR|locus:2090537 CIPK1 "CBL-interacting protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1316 (468.3 bits), Expect = 2.6e-134, P = 2.6e-134
 Identities = 250/342 (73%), Positives = 296/342 (86%)

Query:     5 EKKQE-GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
             EKK E GMRLG+YELGRTLGEGNFGKVKFA+D  SG  FAVKI++K+RI  L  + QIKR
Sbjct:     8 EKKAEKGMRLGKYELGRTLGEGNFGKVKFAKDTVSGHSFAVKIIDKSRIADLNFSLQIKR 67

Query:    64 EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
             EI TLK+LKHP++VRLHEVLASK+KI MV+E VTGGELFD+I S G+L E +GRK+FQQL
Sbjct:    68 EIRTLKMLKHPHIVRLHEVLASKTKINMVMELVTGGELFDRIVSNGKLTETDGRKMFQQL 127

Query:   124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
             IDG+SYCH+KGVFHRDLKLEN+LLD+KG+IKI+DFGLSALPQHFRDDGLLHTTCGSPNYV
Sbjct:   128 IDGISYCHSKGVFHRDLKLENVLLDAKGHIKITDFGLSALPQHFRDDGLLHTTCGSPNYV 187

Query:   184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
             APEVLANRGYDGA SDIWSCGVILYVILTG LPFDDRNLAVLYQKI +GD  +P+WLSPG
Sbjct:   188 APEVLANRGYDGAASDIWSCGVILYVILTGCLPFDDRNLAVLYQKICKGDPPIPRWLSPG 247

Query:   244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD-EEDIFVDNEAFSMHEVPSD 302
             A+ +++++L+PNPV RIT+ GIKA EWF+ +Y P+ PDDD EE++  D++AFS+ E+ S+
Sbjct:   248 ARTMIKRMLDPNPVTRITVVGIKASEWFKLEYIPSIPDDDDEEEVDTDDDAFSIQELGSE 307

Query:   303 GGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
              G+   SP +INAFQLIGMSS LDLSGFFE+E NV  R  +F
Sbjct:   308 EGKGSDSPTIINAFQLIGMSSFLDLSGFFEQE-NVSERRIRF 348

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0006970 "response to osmotic stress" evidence=IMP

GO:0009651 "response to salt stress" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IMP

GO:0010118 "stomatal movement" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

TAIR|locus:2007685 CIPK17 "CBL-interacting protein kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 1237 (440.5 bits), Expect = 6.1e-126, P = 6.1e-126
 Identities = 232/336 (69%), Positives = 282/336 (83%)

Query:     9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
             +GMR+G+YELGRTLGEGN  KVKFA D  +G  FA+KI+EK+ I  L ++ QIKREI TL
Sbjct:     4 KGMRVGKYELGRTLGEGNSAKVKFAIDTLTGESFAIKIIEKSCITRLNVSFQIKREIRTL 63

Query:    69 KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
             K+LKHPN+VRLHEVLASK+KIYMVLE VTGG+LFD+I SKG+L E +GRK+FQQLIDGVS
Sbjct:    64 KVLKHPNIVRLHEVLASKTKIYMVLECVTGGDLFDRIVSKGKLSETQGRKMFQQLIDGVS 123

Query:   129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
             YCHNKGVFHRDLKLEN+LLD+KG+IKI+DFGLSAL QH+R+DGLLHTTCGSPNYVAPEVL
Sbjct:   124 YCHNKGVFHRDLKLENVLLDAKGHIKITDFGLSALSQHYREDGLLHTTCGSPNYVAPEVL 183

Query:   189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
             AN GYDGA SDIWSCGVILYVILTG LPFDD NLAV+ +KIF+GD  +P+W+S GA+ ++
Sbjct:   184 ANEGYDGAASDIWSCGVILYVILTGCLPFDDANLAVICRKIFKGDPPIPRWISLGAKTMI 243

Query:   249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPG 308
             +++L+PNPV R+TIAGIKA +WF+ DYTP+N DDD++   +  + F M E   +  ++P 
Sbjct:   244 KRMLDPNPVTRVTIAGIKAHDWFKHDYTPSNYDDDDDVYLIQEDVFMMKEYEEE--KSPD 301

Query:   309 SPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
             SP +INAFQLIGMSS LDLSGFFE E  +  R  +F
Sbjct:   302 SPTIINAFQLIGMSSFLDLSGFFETE-KLSERQIRF 336

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2059279 CIPK3 "CBL-interacting protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1012 (361.3 bits), Expect = 4.2e-102, P = 4.2e-102
 Identities = 190/334 (56%), Positives = 253/334 (75%)

Query:     6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
             ++Q   R+G+YE+GRT+GEG F KVKFA++ ++G P A+KIL+K +++  K+ +QI+REI
Sbjct:    14 RQQVKRRVGKYEVGRTIGEGTFAKVKFARNSETGEPVALKILDKEKVLKHKMAEQIRREI 73

Query:    66 ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
             AT+KL+KHPNVV+L+EV+ASK+KI+++LEYVTGGELFDKI + GR++E E R+ FQQLI 
Sbjct:    74 ATMKLIKHPNVVQLYEVMASKTKIFIILEYVTGGELFDKIVNDGRMKEDEARRYFQQLIH 133

Query:   126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
              V YCH++GV+HRDLK EN+LLDS GN+KISDFGLSAL Q  RDDGLLHT+CG+PNYVAP
Sbjct:   134 AVDYCHSRGVYHRDLKPENLLLDSYGNLKISDFGLSALSQQVRDDGLLHTSCGTPNYVAP 193

Query:   186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
             EVL +RGYDGAT+D+WSCGV+LYV+L GYLPFDD NL  LY+KI  G+F  P WLS GA 
Sbjct:   194 EVLNDRGYDGATADMWSCGVVLYVLLAGYLPFDDSNLMNLYKKISSGEFNCPPWLSLGAM 253

Query:   246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA-FSMHEVPSDGG 304
              L+ +IL+PNP+ R+T   +  DEWF++DY P   ++ ++    D +A F   E      
Sbjct:   254 KLITRILDPNPMTRVTPQEVFEDEWFKKDYKPPVFEERDDSNMDDIDAVFKDSEEHLVTE 313

Query:   305 RTPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVK 338
             +    P  INAF++I MS  L+L   F+ E   K
Sbjct:   314 KREEQPAAINAFEIISMSRGLNLENLFDPEQEFK 347

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0009735 "response to cytokinin stimulus" evidence=IEP

TAIR|locus:2009812 CIPK23 "CBL-interacting protein kinase 23" [Arabidopsis thaliana (taxid:3702)]

 Score = 1002 (357.8 bits), Expect = 4.9e-101, P = 4.9e-101
 Identities = 191/341 (56%), Positives = 261/341 (76%)

Query:    12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
             R+G+YELGRTLGEG F KVKFA+++++G   A+K+++K +++  K+  QIKREI+T+KL+
Sbjct:    27 RVGKYELGRTLGEGTFAKVKFARNVENGDNVAIKVIDKEKVLKNKMIAQIKREISTMKLI 86

Query:    72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
             KHPNV+R+ EV+ASK+KIY VLE+VTGGELFDKI+S GRL+E E RK FQQLI+ V YCH
Sbjct:    87 KHPNVIRMFEVMASKTKIYFVLEFVTGGELFDKISSNGRLKEDEARKYFQQLINAVDYCH 146

Query:   132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
             ++GV+HRDLK EN+LLD+ G +K+SDFGLSALPQ  R+DGLLHTTCG+PNYVAPEV+ N+
Sbjct:   147 SRGVYHRDLKPENLLLDANGALKVSDFGLSALPQQVREDGLLHTTCGTPNYVAPEVINNK 206

Query:   192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
             GYDGA +D+WSCGVIL+V++ GYLPF+D NL  LY+KIF+ +F  P W S  A+ L+++I
Sbjct:   207 GYDGAKADLWSCGVILFVLMAGYLPFEDSNLTSLYKKIFKAEFTCPPWFSASAKKLIKRI 266

Query:   252 LEPNPVKRITIAGIKADEWFEQDY-TPA--NPD---DDEEDIFVDN-EAFSMH-EVPSDG 303
             L+PNP  RIT A +  +EWF++ Y  P   N D   DD + IF D+ E+ ++  E   +G
Sbjct:   267 LDPNPATRITFAEVIENEWFKKGYKAPKFENADVSLDDVDAIFDDSGESKNLVVERREEG 326

Query:   304 GRTPGSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
              +TP +   +NAF+LI  S  L+L   FEK++ +  R  +F
Sbjct:   327 LKTPVT---MNAFELISTSQGLNLGSLFEKQMGLVKRKTRF 364

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IPI

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0010107 "potassium ion import" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007584 "response to nutrient" evidence=IMP

GO:0009414 "response to water deprivation" evidence=IMP

GO:0010118 "stomatal movement" evidence=RCA;IMP

GO:0009536 "plastid" evidence=IDA

GO:0000911 "cytokinesis by cell plate formation" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0016036 "cellular response to phosphate starvation" evidence=RCA

GO:0019375 "galactolipid biosynthetic process" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042631 "cellular response to water deprivation" evidence=RCA

TAIR|locus:1005716172 CIPK26 "calcineurin B-like protein (CBL)-interacting protein kinase 26" [Arabidopsis thaliana (taxid:3702)]

 Score = 988 (352.9 bits), Expect = 1.5e-99, P = 1.5e-99
 Identities = 187/334 (55%), Positives = 249/334 (74%)

Query:    12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
             R+G+YE+G+TLG+G F KV+ A + ++G   A+KIL+K +++  K+ +QI+REI T+KL+
Sbjct:     9 RVGKYEVGKTLGQGTFAKVRCAVNTETGERVALKILDKEKVLKHKMAEQIRREICTMKLI 68

Query:    72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
              HPNVVRL+EVLASK+KIY+VLE+ TGGELFDKI   GRL+E   RK FQQLI+ V YCH
Sbjct:    69 NHPNVVRLYEVLASKTKIYIVLEFGTGGELFDKIVHDGRLKEENARKYFQQLINAVDYCH 128

Query:   132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
             ++GV+HRDLK EN+LLD++GN+K+SDFGLSAL +  R DGLLHT CG+PNY APEVL ++
Sbjct:   129 SRGVYHRDLKPENLLLDAQGNLKVSDFGLSALSRQVRGDGLLHTACGTPNYAAPEVLNDQ 188

Query:   192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
             GYDGAT+D+WSCGVIL+V+L GYLPF+D NL  LY+KI  G++  P WLSPGA+NL+ +I
Sbjct:   189 GYDGATADLWSCGVILFVLLAGYLPFEDSNLMTLYKKIIAGEYHCPPWLSPGAKNLIVRI 248

Query:   252 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA-FSMHEVPSDGGRTPGSP 310
             L+PNP+ RITI  +  D WF+++Y PA  ++ EE    D +A F   E      +    P
Sbjct:   249 LDPNPMTRITIPEVLGDAWFKKNYKPAVFEEKEEANLDDVDAVFKDSEEHHVTEKKEEQP 308

Query:   311 PLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
               +NAF+LI MS  LDL   FE+E   K R  +F
Sbjct:   309 TSMNAFELISMSRALDLGNLFEEEEGFK-RETRF 341

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007165 "signal transduction" evidence=IEA;ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

TAIR|locus:2135962 CIPK8 "CBL-interacting protein kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 958 (342.3 bits), Expect = 2.2e-96, P = 2.2e-96
 Identities = 184/326 (56%), Positives = 247/326 (75%)

Query:    12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
             ++G+YELGRT+GEG F KVKFAQ+ ++G   A+KI++++ II  K+ DQIKREI+ +KL+
Sbjct:     5 KVGKYELGRTIGEGTFAKVKFAQNTETGESVAMKIVDRSTIIKRKMVDQIKREISIMKLV 64

Query:    72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
             +HP VVRL+EVLAS++KIY++LEY+TGGELFDKI   GRL E+E RK F QLIDGV YCH
Sbjct:    65 RHPCVVRLYEVLASRTKIYIILEYITGGELFDKIVRNGRLSESEARKYFHQLIDGVDYCH 124

Query:   132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
             +KGV+HRDLK EN+LLDS+GN+KISDFGLSALP+  +   +L TTCG+PNYVAPEVL+++
Sbjct:   125 SKGVYHRDLKPENLLLDSQGNLKISDFGLSALPE--QGVTILKTTCGTPNYVAPEVLSHK 182

Query:   192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
             GY+GA +DIWSCGVILYV++ GYLPFD+ +L  LY KI + +F  P + + GA++L+ +I
Sbjct:   183 GYNGAVADIWSCGVILYVLMAGYLPFDEMDLPTLYSKIDKAEFSCPSYFALGAKSLINRI 242

Query:   252 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDE----EDIFVDNEAFSMHEVPSDGGRTP 307
             L+PNP  RITIA I+ DEWF +DYTP    D E    +D++   +         DG R  
Sbjct:   243 LDPNPETRITIAEIRKDEWFLKDYTPVQLIDYEHVNLDDVYAAFDDPEEQTYAQDGTRDT 302

Query:   308 GSPPLINAFQLIGMSSCLDLSGFFEK 333
             G P  +NAF LI +S  L+L+  F++
Sbjct:   303 G-PLTLNAFDLIILSQGLNLATLFDR 327

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;TAS

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009749 "response to glucose stimulus" evidence=TAS

GO:0010167 "response to nitrate" evidence=IEP;IMP

GO:0048364 "root development" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2155233 SOS2 "SALT OVERLY SENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 934 (333.8 bits), Expect = 7.8e-94, P = 7.8e-94
 Identities = 180/337 (53%), Positives = 243/337 (72%)

Query:    12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
             R+G+YE+GRT+GEG F KVKFA++ D+G   A+KI+ K+ I+  ++ DQIKREI+ +K++
Sbjct:     7 RVGKYEVGRTIGEGTFAKVKFARNTDTGDNVAIKIMAKSTILKNRMVDQIKREISIMKIV 66

Query:    72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
             +HPN+VRL+EVLAS SKIY+VLE+VTGGELFD+I  KGRL+E+E RK FQQL+D V++CH
Sbjct:    67 RHPNIVRLYEVLASPSKIYIVLEFVTGGELFDRIVHKGRLEESESRKYFQQLVDAVAHCH 126

Query:   132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
              KGV+HRDLK EN+LLD+ GN+K+SDFGLSALPQ   +  LL TTCG+PNYVAPEVL+ +
Sbjct:   127 CKGVYHRDLKPENLLLDTNGNLKVSDFGLSALPQEGVE--LLRTTCGTPNYVAPEVLSGQ 184

Query:   192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
             GYDG+ +DIWSCGVIL+VIL GYLPF + +L  LY+KI   +F  P W S   + L+ +I
Sbjct:   185 GYDGSAADIWSCGVILFVILAGYLPFSETDLPGLYRKINAAEFSCPPWFSAEVKFLIHRI 244

Query:   252 LEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE----DIFVDNEAFSMHEVPSDGGRTP 307
             L+PNP  RI I GIK D WF  +Y P    ++EE    DI    +      V  +  R  
Sbjct:   245 LDPNPKTRIQIQGIKKDPWFRLNYVPIRAREEEEVNLDDIRAVFDGIEGSYVAENVERND 304

Query:   308 GSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
               P ++NAF++I +S  L+LS  F++  +   R  +F
Sbjct:   305 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRF 341

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0005515 "protein binding" evidence=IPI

GO:0004672 "protein kinase activity" evidence=IDA

GO:0042802 "identical protein binding" evidence=IPI

GO:0009705 "plant-type vacuole membrane" evidence=IDA

GO:0009651 "response to salt stress" evidence=IMP

TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 880 (314.8 bits), Expect = 4.1e-88, P = 4.1e-88
 Identities = 168/337 (49%), Positives = 231/337 (68%)

Query:    10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
             G+  GRYELGR LG G F KV  A+++ +G   A+K++ K +++ + + DQIKREI+ ++
Sbjct:    18 GLLHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMR 77

Query:    70 LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             ++KHPN+V LHEV+ASKSKIY  +E V GGELF K+A KGRL+E   R  FQQLI  V +
Sbjct:    78 MVKHPNIVELHEVMASKSKIYFAMELVRGGELFAKVA-KGRLREDVARVYFQQLISAVDF 136

Query:   130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
             CH++GV+HRDLK EN+LLD +GN+K++DFGLSA  +H + DGLLHTTCG+P YVAPEV+ 
Sbjct:   137 CHSRGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVIL 196

Query:   190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
              +GYDGA +D+WSCGVIL+V+L GYLPF D NL  +Y+KI+RGDFK P WLS  A+ L+ 
Sbjct:   197 KKGYDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVT 256

Query:   250 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEA--FSMHEVPSDGGRTP 307
             K+L+PNP  RITI  +    WF++  T +  +     I    E   F +H+   +     
Sbjct:   257 KLLDPNPNTRITIEKVMDSPWFKKQATRSRNEPVAATITTTEEDVDFLVHKSKEE----- 311

Query:   308 GSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
                  +NAF +I +S   DLS  FE++   + R  +F
Sbjct:   312 --TETLNAFHIIALSEGFDLSPLFEEKKKEEKREMRF 346

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0007275 "multicellular organismal development" evidence=IMP

GO:0009414 "response to water deprivation" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0010540 "basipetal auxin transport" evidence=IMP

GO:0042538 "hyperosmotic salinity response" evidence=IDA

GO:0010118 "stomatal movement" evidence=RCA

GO:0019722 "calcium-mediated signaling" evidence=RCA

TAIR|locus:2181047 CIPK15 "CBL-interacting protein kinase 15" [Arabidopsis thaliana (taxid:3702)]

 Score = 877 (313.8 bits), Expect = 8.6e-88, P = 8.6e-88
 Identities = 171/329 (51%), Positives = 230/329 (69%)

Query:     5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
             EKK   + L RYE+G+ LG+G F KV  A+ L +G   A+K+++K RI+ + +T+QIKRE
Sbjct:     2 EKKGSVLML-RYEVGKFLGQGTFAKVYHARHLKTGDSVAIKVIDKERILKVGMTEQIKRE 60

Query:    65 IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
             I+ ++LL+HPN+V LHEV+A+KSKIY V+E+V GGELF+K+ S G+L+E   RK FQQL+
Sbjct:    61 ISAMRLLRHPNIVELHEVMATKSKIYFVMEHVKGGELFNKV-STGKLREDVARKYFQQLV 119

Query:   125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
               V +CH++GV HRDLK EN+LLD  GN+KISDFGLSAL    R DGLLHTTCG+P YVA
Sbjct:   120 RAVDFCHSRGVCHRDLKPENLLLDEHGNLKISDFGLSALSDSRRQDGLLHTTCGTPAYVA 179

Query:   185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
             PEV++  GYDG  +D+WSCGVIL+V+L GYLPF D NL  LY+KI + + K P WL+PGA
Sbjct:   180 PEVISRNGYDGFKADVWSCGVILFVLLAGYLPFRDSNLMELYKKIGKAEVKFPNWLAPGA 239

Query:   245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGG 304
             + LL++IL+PNP  R++   I    WF +       +  EE+  VD EA        +  
Sbjct:   240 KRLLKRILDPNPNTRVSTEKIMKSSWFRKGLQEEVKESVEEETEVDAEAEGNASAEKEKK 299

Query:   305 RTPGSPPLINAFQLIGMSSCLDLSGFFEK 333
             R       +NAF++I +S+  DLSG FEK
Sbjct:   300 RCIN----LNAFEIISLSTGFDLSGLFEK 324

GO:0004672 "protein kinase activity" evidence=IEA;ISS;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0009788 "negative regulation of abscisic acid mediated signaling pathway" evidence=IMP

TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)]

 Score = 866 (309.9 bits), Expect = 1.3e-86, P = 1.3e-86
 Identities = 167/327 (51%), Positives = 230/327 (70%)

Query:    15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
             +YELGR LG+G F KV  A+++ +G   A+K+++K ++  + + DQIKREI+ ++L++HP
Sbjct:    11 KYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLVRHP 70

Query:    75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
             +VV LHEV+ASK+KIY  +EYV GGELFDK+ SKG+L+E   RK FQQLI  + YCH++G
Sbjct:    71 HVVFLHEVMASKTKIYFAMEYVKGGELFDKV-SKGKLKENIARKYFQQLIGAIDYCHSRG 129

Query:   135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
             V+HRDLK EN+LLD  G++KISDFGLSAL +  + DGLLHTTCG+P YVAPEV+  +GYD
Sbjct:   130 VYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKGYD 189

Query:   195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254
             GA +D+WSCGV+LYV+L G+LPF ++NL  +Y+KI +G+FK P W  P  + LL +IL+P
Sbjct:   190 GAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRILDP 249

Query:   255 NPVKRITIAGIKADEWFEQDY----TPANPDDDEEDIFVDN--EAFSMHEVPSDGGRTPG 308
             NP  RI I  I  + WF++ +    TP +P+  + D  + +   AFS+            
Sbjct:   250 NPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFSV------------ 297

Query:   309 SPPLINAFQLIG-MSSCLDLSGFFEKE 334
              P   NAF LI  +S   DLSG FEKE
Sbjct:   298 KPMSYNAFDLISSLSQGFDLSGLFEKE 324

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;TAS

GO:0005524 "ATP binding" evidence=IEA

GO:0005829 "cytosol" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0007165 "signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009737 "response to abscisic acid stimulus" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q0D4B2	CIPKL_ORYSJ	2, ., 7, ., 1, 1, ., 1	0.7014	0.9651	0.6323	yes	no
Q8RWC9	CIPK1_ARATH	2, ., 7, ., 1, 1, ., 1	0.7243	0.9854	0.7635	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.946
3rd Layer	2.7.11	0.963

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	344
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-107
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-92
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-78
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-75
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-70
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-69
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	2e-66
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-64
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-64
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-60
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-57
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-56
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-54
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	9e-52
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	4e-51
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-51
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-49
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-49
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	5e-49
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-49
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-48
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-48
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-47
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-47
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-47
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-47
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	7e-47
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	9e-47
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-46
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	7e-46
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	8e-46
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-46
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	1e-45
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-45
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-45
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-45
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-45
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-45
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	6e-45
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-43
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-43
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-43
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-43
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-43
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	4e-43
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-43
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-42
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-42
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-41
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-41
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	3e-41
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-40
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	3e-40
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	4e-40
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	5e-40
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	5e-40
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-39
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-39
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	2e-39
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	9e-39
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	2e-38
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-38
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	7e-38
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	9e-38
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-37
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-37
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	9e-37
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-36
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	1e-36
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-36
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-36
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-36
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-36
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	8e-36
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-35
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-35
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-35
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-35
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	4e-35
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-34
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-34
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-34
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-34
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-33
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-33
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	4e-33
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-33
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-33
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-33
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	8e-33
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-32
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-32
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-31
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-31
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-31
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-31
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	4e-31
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-31
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-31
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-31
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	7e-31
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-31
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-31
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	1e-30
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-30
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-30
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-30
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	8e-30
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-29
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-29
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-29
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	3e-29
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	4e-29
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-29
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-29
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-29
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-28
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-28
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-28
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-28
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-28
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-28
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	7e-28
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	8e-28
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-28
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	2e-27
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-27
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-27
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-27
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-27
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	6e-27
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-26
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-26
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-26
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-26
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-26
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-26
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	3e-26
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-26
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-25
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-25
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-25
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	1e-25
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-25
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-25
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	2e-25
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-25
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	4e-25
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	4e-25
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-25
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-25
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-24
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-24
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-24
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-24
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-24
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-24
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	3e-24
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-24
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	7e-24
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-23
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-23
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-23
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-23
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-23
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	5e-23
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-23
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-23
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-23
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	9e-23
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-22
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-22
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-22
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	6e-22
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-22
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	1e-21
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	1e-21
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-21
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-21
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-21
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-21
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	3e-21
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-21
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	9e-21
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-20
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-20
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-20
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-20
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-20
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-20
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-20
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	3e-20
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-20
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-20
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-20
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-20
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-20
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-20
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	6e-20
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-20
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	9e-20
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-19
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-19
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-19
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-19
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-19
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-19
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-19
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-19
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-19
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-19
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	5e-19
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	9e-19
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-18
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-18
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-18
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-18
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-18
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-18
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-17
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	4e-17
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	8e-17
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-16
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-16
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-16
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-16
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-16
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-15
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-15
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-15
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-15
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-15
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-15
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-15
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-15
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-15
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	3e-15
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	7e-15
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	7e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	1e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-14
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	4e-14
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-14
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	7e-14
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	7e-14
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	9e-14
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-13
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-13
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-13
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-13
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	1e-12
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-12
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-12
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-12
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-12
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	3e-12
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-12
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	7e-12
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	1e-11
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-11
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-11
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-10
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-10
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-09
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-09
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-09
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-09
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	4e-09
pfam03822	58	pfam03822, NAF, NAF domain	1e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	3e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	2e-07
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-07
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-06
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-06
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	6e-06
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	1e-05
cd12195	116	cd12195, CIPK_C, C-terminal regulatory domain of C	1e-05
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-05
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-04
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	2e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	5e-04
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	6e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	0.002
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.003

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  314 bits (807), Expect = e-107
 Identities = 115/260 (44%), Positives = 162/260 (62%), Gaps = 10/260 (3%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE+   LGEG+FGKV  A+D  +G   A+K+++K +I   K  ++I REI  LK LKHPN
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK--KDRERILREIKILKKLKHPN 58

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRL++V   + K+Y+V+EY  GG+LFD +  +GRL E E R   +Q++  + Y H+KG+
Sbjct: 59  IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILLD  G++K++DFGL+           L T  G+P Y+APEVL  +GY  
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175

Query: 196 ATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDFKLPKW---LSPGAQNLLRKI 251
           A  DIWS GVILY +LTG  PF     L  L++KI +     P     +SP A++L+RK+
Sbjct: 176 A-VDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234

Query: 252 LEPNPVKRITIAGIKADEWF 271
           L  +P KR+T        +F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  275 bits (705), Expect = 4e-92
 Identities = 107/263 (40%), Positives = 147/263 (55%), Gaps = 10/263 (3%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YEL R LG G+FG V  A+   +G   AVKIL+K      K     +REI  L+ L HPN
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKK-DQTARREIRILRRLSHPN 59

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRL +    K  +Y+V+EY  GG+LFD ++  G L E E +K+  Q++ G+ Y H+ G+
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILLD  G +KI+DFGL+   +  +    L T  G+P Y+APEVL      G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAK--KLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177

Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLA---VLYQKIFRGDFKLPKW----LSPGAQNLL 248
              D+WS GVILY +LTG  PF   N+     L ++I     +  +      S  A++L+
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237

Query: 249 RKILEPNPVKRITIAGIKADEWF 271
           +K L  +P KR T   I    WF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  239 bits (613), Expect = 2e-78
 Identities = 101/253 (39%), Positives = 156/253 (61%), Gaps = 6/253 (2%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G+FGKV   +  D+G  +A+K+L+K +II  K  +    E   L  + HP +V+LH 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
              ++ K+Y+VLEY  GGELF  ++ +GR  E   R    +++  + Y H+ G+ +RDLK
Sbjct: 61  AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ENILLD+ G+IK++DFGL+   +   +    +T CG+P Y+APEVL  +GY G   D W
Sbjct: 121 PENILLDADGHIKLTDFGLAK--ELSSEGSRTNTFCGTPEYLAPEVLLGKGY-GKAVDWW 177

Query: 202 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
           S GV+LY +LTG  PF   +   +Y+KI +   + P++LSP A++L+  +L+ +P KR+ 
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237

Query: 262 IAG---IKADEWF 271
             G   IKA  +F
Sbjct: 238 SGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  234 bits (599), Expect = 1e-75
 Identities = 100/262 (38%), Positives = 153/262 (58%), Gaps = 11/262 (4%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E  +TLG G+FG+V   +   SG  +A+KIL K +I+ LK  + +  E   L+ ++HP 
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V L+      S +Y+V+EYV GGELF  +   GR  E   R    Q++  + Y H+  +
Sbjct: 63  LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RDLK EN+LLDS G IKI+DFG +      R  G  +T CG+P Y+APE++ ++GY  
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGYGK 177

Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
           A  D W+ G+++Y +L GY PF D N   +Y+KI  G  + P + SP A++L+R +L+ +
Sbjct: 178 A-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236

Query: 256 PVKRI-----TIAGIKADEWFE 272
             KR+      +  IK   WF 
Sbjct: 237 LTKRLGNLKNGVNDIKNHPWFA 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  219 bits (560), Expect = 5e-70
 Identities = 91/279 (32%), Positives = 148/279 (53%), Gaps = 24/279 (8%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
           ++ G+ +GEG+F  V  A++ ++   +A+KIL+K ++I  K    +K E   L +L  HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
            +++L+     +  +Y VLEY   GEL   I   G L E   R    +++  + Y H+KG
Sbjct: 63  GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLS------ALPQHFRDDGLLHTT------------ 176
           + HRDLK ENILLD   +IKI+DFG +      + P+  + D     +            
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182

Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL 236
            G+  YV+PE+L N    G +SD+W+ G I+Y +LTG  PF   N  + +QKI + ++  
Sbjct: 183 VGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241

Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAG----IKADEWF 271
           P    P A++L+ K+L  +P  R+ +      +KA  +F
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  214 bits (548), Expect = 5e-69
 Identities = 96/247 (38%), Positives = 136/247 (55%), Gaps = 37/247 (14%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LGEG FG V  A+D  +G   A+KI++K     L   +++ REI  LK L HPN+V+L+ 
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLL--EELLREIEILKKLNHPNIVKLYG 58

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
           V   ++ +Y+V+EY  GG L D +    G+L E E  ++  Q+++G+ Y H+ G+ HRDL
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118

Query: 141 KLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           K ENILLDS  G +K++DFGLS       D  LL T  G+P Y+APEVL  +GY    SD
Sbjct: 119 KPENILLDSDNGKVKLADFGLSK--LLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176

Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
           IWS GVILY +                               P  ++L+RK+L+ +P KR
Sbjct: 177 IWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205

Query: 260 ITIAGIK 266
            +   I 
Sbjct: 206 PSAKEIL 212

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  209 bits (535), Expect = 2e-66
 Identities = 89/254 (35%), Positives = 140/254 (55%), Gaps = 7/254 (2%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +  G  LG G+FG V  A D D+G   AVK +E +     ++ + ++REI  L  L+HP
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEEL-EALEREIRILSSLQHP 59

Query: 75  NVVRL--HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           N+VR    E    K+ + + LEYV+GG L   +   G+L E   RK  +Q+++G++Y H+
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            G+ HRD+K  NIL+DS G +K++DFG +             +  G+P ++APEV+    
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVI-RGE 178

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDF-KLPKWLSPGAQNLLR 249
             G  +DIWS G  +  + TG  P+ +    +A LY+    G+  ++P+ LS  A++ LR
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238

Query: 250 KILEPNPVKRITIA 263
           K L  +P KR T  
Sbjct: 239 KCLRRDPKKRPTAD 252

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  205 bits (523), Expect = 1e-64
 Identities = 87/262 (33%), Positives = 139/262 (53%), Gaps = 21/262 (8%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL------EKNRIIHLKITDQIKREIATL 68
           +YE+ + +G+G+FGKV   +    G  + +K +      EK R       +    E+  L
Sbjct: 1   KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-------EDALNEVKIL 53

Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLI 124
           K L HPN+++ +E    K K+ +V+EY  GG+L  KI  + +      E +    F QL 
Sbjct: 54  KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
             + Y H++ + HRD+K +NI L S G +K+ DFG+S +        L  T  G+P Y++
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSS--TVDLAKTVVGTPYYLS 171

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPG 243
           PE+  N+ Y+   SDIWS G +LY + T   PF+  NL  L  KI +G +  +P   S  
Sbjct: 172 PELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSE 230

Query: 244 AQNLLRKILEPNPVKRITIAGI 265
            +NL+  +L+ +P +R +IA I
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQI 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  204 bits (520), Expect = 3e-64
 Identities = 93/260 (35%), Positives = 144/260 (55%), Gaps = 13/260 (5%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V+  +       FA+K ++K  I+     + I  E   L+   HP +V+L+ 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
               K  IYM++EY  GGEL+  +  +G   E   R     ++    Y HN+G+ +RDLK
Sbjct: 61  TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            EN+LLDS G +K+ DFG +   +  +      T CG+P YVAPE++ N+GYD +  D W
Sbjct: 121 PENLLLDSNGYVKLVDFGFA---KKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS-VDYW 176

Query: 202 SCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPV 257
           S G++LY +LTG  PF  DD +   +Y  I +G+ KL  P ++   A++L++++L  NP 
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236

Query: 258 KRI-----TIAGIKADEWFE 272
           +R+      I  IK  +WF 
Sbjct: 237 ERLGNLKGGIKDIKKHKWFN 256

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  195 bits (497), Expect = 5e-60
 Identities = 88/258 (34%), Positives = 147/258 (56%), Gaps = 6/258 (2%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
             +      +L  +E+G TLG G+FG+V+ A+   +G  +A+K L+K  I+ +K    + 
Sbjct: 7   FTKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVA 66

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           +E + L  L HP +V +      ++++Y +LE+V GGELF  +   GR      +    +
Sbjct: 67  QEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAE 126

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           L+    Y H+K + +RDLK EN+LLD+KG++K++DFG +      +      T CG+P Y
Sbjct: 127 LVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPEY 181

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
           +APEV+ ++G+  A  D W+ GV+LY  + GY PF D     +Y+KI  G  K P W   
Sbjct: 182 LAPEVIQSKGHGKAV-DWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDG 240

Query: 243 GAQNLLRKILEPNPVKRI 260
            A++L++ +L+ +  KR+
Sbjct: 241 RARDLVKGLLQTDHTKRL 258

Length = 329

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  187 bits (476), Expect = 3e-57
 Identities = 91/262 (34%), Positives = 150/262 (57%), Gaps = 11/262 (4%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
            E  +T+G G FG+V   +D  S   +A+K++    +I LK    +  E   LK + HP 
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL      +  +YM++EYV GGELF  + + GR   + G     +++  + Y H+K +
Sbjct: 63  IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RDLK ENILLD +G+IK++DFG +   +  RD     T CG+P Y+APEV+ ++G++ 
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFA---KKLRDR--TWTLCGTPEYLAPEVIQSKGHNK 177

Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
           A  D W+ G+++Y +L GY PF D N   +Y+KI  G  + P+ L   A++L++K+L  +
Sbjct: 178 AV-DWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD 236

Query: 256 PVKRI-----TIAGIKADEWFE 272
             +R+         +K   WF+
Sbjct: 237 RTRRLGNMKNGADDVKNHRWFK 258

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  183 bits (468), Expect = 2e-56
 Identities = 88/259 (33%), Positives = 142/259 (54%), Gaps = 12/259 (4%)

Query: 25  GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84
           G +G+V  A+   +G  +A+K+++K  +I     DQ+  E   L   + P VV+L+    
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63

Query: 85  SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 144
            K  +Y+V+EY+ GG+L   + + G L E   R    +++  + Y H+ G+ HRDLK +N
Sbjct: 64  GKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDN 123

Query: 145 ILLDSKGNIKISDFGLSAL----PQHFRDDGLLHT--TCGSPNYVAPEVLANRGYDGATS 198
           IL+DS G++K++DFGLS +     Q   +D         G+P+Y+APEV+  +G+   T 
Sbjct: 124 ILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-SKTV 182

Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--WLSPGAQNLLRKILEPNP 256
           D WS G ILY  L G  PF       ++Q I  G  + P+   +S  A +L+ K+L P+P
Sbjct: 183 DWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDP 242

Query: 257 VKRI---TIAGIKADEWFE 272
            KR+   +I  IK   +F+
Sbjct: 243 EKRLGAKSIEEIKNHPFFK 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  181 bits (458), Expect = 9e-54
 Identities = 98/292 (33%), Positives = 149/292 (51%), Gaps = 27/292 (9%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP- 74
           Y + R LGEG+FG+V  A+D       A+K+L K      K  ++  REI  L  L HP 
Sbjct: 2   YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFD---KIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+L++    +  +Y+V+EYV GG L D   KI  KG L E+E   +  Q++  + Y H
Sbjct: 59  NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118

Query: 132 NKGVFHRDLKLENILLDSKGN-IKISDFGLSAL----PQHFRDDGLLHTTCGSPNYVAPE 186
           +KG+ HRD+K ENILLD  G  +K+ DFGL+ L            L  T+ G+P Y+APE
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 187 VL--ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------ 232
           VL   +  Y  ++SDIWS G+ LY +LTG  PF+    +    +  +             
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238

Query: 233 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 283
                P+ +S  A +LL+K+L  +P  R++ +   + +         +   D
Sbjct: 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSD 290

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  171 bits (436), Expect = 9e-52
 Identities = 82/253 (32%), Positives = 139/253 (54%), Gaps = 13/253 (5%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   +G+G FG+V  A+   +G   A+K+++       +  ++I  EI  LK  KHPN
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLES---KEKKEKIINEIQILKKCKHPN 58

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
           +V+ +     K ++++V+E+ +GG L D + S  + L E++   + ++L+ G+ Y H+ G
Sbjct: 59  IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NILL S G +K+ DFGLSA      D    +T  G+P ++APEV+  + YD
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSA---QLSDTKARNTMVGTPYWMAPEVINGKPYD 175

Query: 195 GATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRK 250
              +DIWS G+    +  G  P+ +   +  L+ KI        + P+  S   ++ L+K
Sbjct: 176 YK-ADIWSLGITAIELAEGKPPYSELPPMKALF-KIATNGPPGLRNPEKWSDEFKDFLKK 233

Query: 251 ILEPNPVKRITIA 263
            L+ NP KR T  
Sbjct: 234 CLQKNPEKRPTAE 246

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  172 bits (437), Expect = 4e-51
 Identities = 91/245 (37%), Positives = 145/245 (59%), Gaps = 7/245 (2%)

Query: 20  RTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPN 75
           + LG+G +GKV   + +   D+G  FA+K+L+K  I+ + K T   K E   L+ +KHP 
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V L     +  K+Y++LEY++GGELF  +  +G   E        ++   + + H +G+
Sbjct: 62  IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RDLK ENILLD++G++K++DFGL    +   +  + HT CG+  Y+APE+L   G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGLCK--ESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178

Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
              D WS G ++Y +LTG  PF   N      KI +G   LP +L+P A++LL+K+L+ N
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238

Query: 256 PVKRI 260
           P  R+
Sbjct: 239 PSSRL 243

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  169 bits (431), Expect = 5e-51
 Identities = 83/259 (32%), Positives = 132/259 (50%), Gaps = 7/259 (2%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y+LG  +G G FG V    +L++G   A+K +   +I    +   I +EI  LK LKHP
Sbjct: 1   NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+V+    + +   +Y++LEY   G L   I   G   E+       Q++ G++Y H +G
Sbjct: 60  NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC-GSPNYVAPEVLANRGY 193
           V HRD+K  NIL    G +K++DFG++       D      +  G+P ++APEV+   G 
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVA---TKLNDVSKDDASVVGTPYWMAPEVIEMSGA 176

Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
             A SDIWS G  +  +LTG  P+ D N +A L++ +      LP+ +SP  ++ L +  
Sbjct: 177 STA-SDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCF 235

Query: 253 EPNPVKRITIAGIKADEWF 271
           + +P  R T   +    W 
Sbjct: 236 QKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  168 bits (426), Expect = 1e-49
 Identities = 107/324 (33%), Positives = 177/324 (54%), Gaps = 39/324 (12%)

Query: 20  RTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQI--KREIATLKLLKHP 74
           + LG+G+FGKV   + +   D+G  +A+K+L+K     LK+ D++  K E   L  + HP
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKAT---LKVRDRVRTKMERDILAEVNHP 58

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
            +V+LH    ++ K+Y++L+++ GG+LF +++ +    E + +    +L   + + H+ G
Sbjct: 59  FIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG 118

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + +RDLK ENILLD +G+IK++DFGLS        +   ++ CG+  Y+APEV+  RG+ 
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSFCGTVEYMAPEVVNRRGHT 176

Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254
            + +D WS GV+++ +LTG LPF  ++       I +    +P++LSP AQ+LLR + + 
Sbjct: 177 QS-ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKR 235

Query: 255 NPVKRI-----TIAGIKADEWF-------------EQDYTPA--NPDDDEEDIFVDNEAF 294
           NP  R+      +  IK   +F             +  + PA   PDD     + D E  
Sbjct: 236 NPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVGRPDD---TFYFDPEFT 292

Query: 295 SMHEVPSDGGRTPGSPPLINAFQL 318
           S    P D   +PG PP  NA QL
Sbjct: 293 S--RTPKD---SPGIPPSANAHQL 311

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  166 bits (423), Expect = 4e-49
 Identities = 90/242 (37%), Positives = 144/242 (59%), Gaps = 4/242 (1%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVR 78
           + LG+G+FGKV  A+   +   +AVK+L+K+ I+     +    E   L L  KHP + +
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    +K +++ V+EYV GG+L   I   GR  E   R    +++ G+ + H +G+ +R
Sbjct: 61  LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKL+N+LLDS+G+IKI+DFG+    +         T CG+P+Y+APE+L+ + Y G   
Sbjct: 121 DLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILSYQPY-GPAV 177

Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
           D W+ GV+LY +L G  PF+  +   L+Q I   + + P+WLS  A+++L+  L  NP K
Sbjct: 178 DWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237

Query: 259 RI 260
           R+
Sbjct: 238 RL 239

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  164 bits (418), Expect = 5e-49
 Identities = 79/248 (31%), Positives = 128/248 (51%), Gaps = 7/248 (2%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +EL R +G+G FGKV   Q  D+   FA+K + K + +       +  E   L+ L HP 
Sbjct: 2   FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V L      +  +Y+V++ + GG+L   ++ K +  E + +    +++  + Y H+KG+
Sbjct: 62  LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K +NILLD +G++ I+DF ++        D L  +T G+P Y+APEVL  +GY  
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177

Query: 196 ATSDIWSCGVILYVILTGYLPFD--DRNLAVLYQKIF-RGDFKLPKWLSPGAQNLLRKIL 252
              D WS GV  Y  L G  P+    R +    +      D   P   S  A + + K+L
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237

Query: 253 EPNPVKRI 260
           E +P KR+
Sbjct: 238 ERDPQKRL 245

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  164 bits (418), Expect = 6e-49
 Identities = 85/262 (32%), Positives = 132/262 (50%), Gaps = 16/262 (6%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE+  T+G+G+FG V+  +    G     K ++   +   K   Q+  E+  L+ LKHPN
Sbjct: 2   YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPN 60

Query: 76  VVRL--HEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSY 129
           +VR     +  S   +Y+V+EY  GG+L   I      +  ++E    ++  QL+  +  
Sbjct: 61  IVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120

Query: 130 CHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           CHN+      V HRDLK  NI LD+  N+K+ DFGL+ +  H  D     T  G+P Y++
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH--DSSFAKTYVGTPYYMS 178

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPG 243
           PE L +  YD   SDIWS G ++Y +     PF  RN   L  KI  G F ++P   S  
Sbjct: 179 PEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSE 237

Query: 244 AQNLLRKILEPNPVKRITIAGI 265
              +++ +L  +P KR +   +
Sbjct: 238 LNEVIKSMLNVDPDKRPSTEEL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  164 bits (417), Expect = 4e-48
 Identities = 84/241 (34%), Positives = 136/241 (56%), Gaps = 3/241 (1%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  +G  +A+KIL+K  II          E   L+  +HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H+  V +RD
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120

Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           LKLEN++LD  G+IKI+DFGL    +   D   + T CG+P Y+APEVL +  Y G   D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177

Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
            W  GV++Y ++ G LPF +++   L++ I   + + P+ LSP A++LL  +L+ +P +R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237

Query: 260 I 260
           +
Sbjct: 238 L 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  163 bits (414), Expect = 4e-48
 Identities = 94/297 (31%), Positives = 138/297 (46%), Gaps = 76/297 (25%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLL 71
           YE    LGEG +G V  A+D  +G   A+K     +I      + I     REI+ LK L
Sbjct: 1   YEKLEKLGEGTYGVVYKARDKKTGEIVALK-----KIRLDNEEEGIPSTALREISLLKEL 55

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGE-----LFDKIASKGRLQEAEGRKLFQQLIDG 126
           KHPN+V+L +V+ ++ K+Y+V EY    +       DK      L     + +  QL+ G
Sbjct: 56  KHPNIVKLLDVIHTERKLYLVFEYC---DMDLKKYLDKRPGP--LSPNLIKSIMYQLLRG 110

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----- 181
           ++YCH+  + HRDLK +NIL++  G +K++DFGL+                G P      
Sbjct: 111 LAYCHSHRILHRDLKPQNILINRDGVLKLADFGLA-------------RAFGIPLRTYTH 157

Query: 182 ------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR-- 231
                 Y APE+L  ++ Y  A  DIWS G I   ++TG   F  D  +  L+ KIF+  
Sbjct: 158 EVVTLWYRAPEILLGSKHYSTAV-DIWSVGCIFAEMITGKPLFPGDSEIDQLF-KIFQIL 215

Query: 232 --------------GDFK--LPKW-----------LSPGAQNLLRKILEPNPVKRIT 261
                          D+K   PK+           L P   +LL K+L+ NP KRI+
Sbjct: 216 GTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS 272

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  163 bits (413), Expect = 1e-47
 Identities = 97/267 (36%), Positives = 145/267 (54%), Gaps = 10/267 (3%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
           + +G+G+FGKV  A+    G  +AVK+L+K  I+  K  + I  E   L K LKHP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    +  K+Y VL+YV GGELF  +  +    E   R    ++   + Y H+  + +R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLK ENILLDS+G++ ++DFGL    +    +    T CG+P Y+APEVL    YD  T 
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVLRKEPYD-RTV 177

Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
           D W  G +LY +L G  PF  R+++ +Y  I     +LP   +  A +LL  +L  +  +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237

Query: 259 RITIAGIKADEWFEQD---YTPANPDD 282
           R+   G KAD    ++   ++P N DD
Sbjct: 238 RL---GAKADFLEIKNHVFFSPINWDD 261

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  160 bits (408), Expect = 1e-47
 Identities = 86/266 (32%), Positives = 136/266 (51%), Gaps = 13/266 (4%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
           R++ G  +G G FGKV  A +LD+G   AVK   ++ N     K   +I  E+  L+LLK
Sbjct: 1   RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND---PKTIKEIADEMKVLELLK 57

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPN+V+ + V   + K+Y+ +EY +GG L + +     L E   R    QL++G++Y H+
Sbjct: 58  HPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            G+ HRD+K  NI LD  G IK+ DFG +             + +  G+P Y+APEV+  
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITG 177

Query: 191 RGYDG--ATSDIWSCGVILYVILTGYLPFD--DRNLAVLYQKIFRGDFKLPK--WLSPGA 244
               G    +DIWS G ++  + TG  P+   D    +++         +P    LSP  
Sbjct: 178 GKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEG 237

Query: 245 QNLLRKILEPNPVKRITIAGIKADEW 270
           ++ L + LE +P KR T + +    +
Sbjct: 238 KDFLDRCLESDPKKRPTASELLQHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  161 bits (410), Expect = 1e-47
 Identities = 91/274 (33%), Positives = 158/274 (57%), Gaps = 22/274 (8%)

Query: 16  YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
           +EL R LG G +GKV   + +   D+G  +A+K+L+K  I+   K  +  + E   L+ +
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 72  KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           +  P +V LH    + +K++++L+YV GGELF  +  +    E+E R    +++  + + 
Sbjct: 62  RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTCGSPNYVAPEV 187
           H  G+ +RD+KLENILLDS+G++ ++DFGLS      +  R     ++ CG+  Y+APEV
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER----AYSFCGTIEYMAPEV 177

Query: 188 L--ANRGYDGATSDIWSCGVILYVILTGYLPF---DDRNL-AVLYQKIFRGDFKLPKWLS 241
           +   + G+D A  D WS GV+ + +LTG  PF    ++N  + + ++I +     PK +S
Sbjct: 178 IRGGSGGHDKAV-DWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMS 236

Query: 242 PGAQNLLRKILEPNPVKRITIAG---IKADEWFE 272
             A++ ++K+LE +P KR+   G   IK   +F+
Sbjct: 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  162 bits (411), Expect = 2e-47
 Identities = 85/240 (35%), Positives = 139/240 (57%), Gaps = 4/240 (1%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLH 80
           LG+G+FGKV  A+   +   +A+KIL+K+ II     +    E   L L   P  + +LH
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
               +  ++Y V+EYV GG+L   I   G+ +E        ++  G+ + H+KG+ +RDL
Sbjct: 68  SCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDL 127

Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 200
           KL+N++LD++G+IKI+DFG+    ++        T CG+P+Y+APE++A + Y G + D 
Sbjct: 128 KLDNVMLDAEGHIKIADFGMCK--ENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GKSVDW 184

Query: 201 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 260
           W+ GV+LY +L G  PFD  +   L+Q I   +   PK LS  A ++ + +L  +P KR+
Sbjct: 185 WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHPAKRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  161 bits (408), Expect = 7e-47
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 4/251 (1%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVR 78
           + LG+G+FGKV  A+   +   +A+K+L+K+ I+     D    E   L L  KHP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    +K +++ V+EYV GG+L  +I    +  E   R    ++   + + H  GV +R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKL+NILLD++G+ K++DFG+    +   +     T CG+P+Y+APE+L    Y G + 
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQELEY-GPSV 177

Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
           D W+ GV++Y ++ G  PF+  N   L++ I   D   P WLS  A ++L+  +  NP K
Sbjct: 178 DWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237

Query: 259 RITIAGIKADE 269
           R+     +  E
Sbjct: 238 RLGCVASQGGE 248

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  160 bits (407), Expect = 9e-47
 Identities = 93/250 (37%), Positives = 136/250 (54%), Gaps = 7/250 (2%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
           + +G+G+FGKV  A+    G  +AVK+L+K  I+  K    I  E   L K +KHP +V 
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    +  K+Y VL+YV GGELF  +  +    E   R    ++   + Y H+  + +R
Sbjct: 61  LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLK ENILLDS+G++ ++DFGL    +         T CG+P Y+APEVL  + YD  T 
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGIEHSKTTSTFCGTPEYLAPEVLRKQPYD-RTV 177

Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
           D W  G +LY +L G  PF  R+ A +Y  I     +L   +S  A++LL  +L+ +  K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237

Query: 259 RITIAGIKAD 268
           R+   G K D
Sbjct: 238 RL---GAKDD 244

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  159 bits (404), Expect = 3e-46
 Identities = 87/255 (34%), Positives = 144/255 (56%), Gaps = 7/255 (2%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVR 78
           R LG+G+FGKV  A+  +SG  +AVK+L+K+ I+     +    E   L L + HP + +
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           L+    +  +++ V+E+V GG+L   I    R  EA  R    ++   + + H+KG+ +R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKL+N+LLD +G+ K++DFG+    +   +     T CG+P+Y+APE+L    Y G + 
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177

Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
           D W+ GV+LY +L G+ PF+  N   L++ I   +   P WLS  A ++L+  +  NP  
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237

Query: 259 R---ITIAGIKADEW 270
           R   +T+ G +A   
Sbjct: 238 RLGSLTLGGEEAILR 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  158 bits (401), Expect = 7e-46
 Identities = 83/241 (34%), Positives = 136/241 (56%), Gaps = 3/241 (1%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H++ V +RD
Sbjct: 61  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120

Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           +KLEN++LD  G+IKI+DFGL    +   D   + T CG+P Y+APEVL +  Y G   D
Sbjct: 121 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177

Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
            W  GV++Y ++ G LPF +++   L++ I   + + P+ LSP A++LL  +L+ +P +R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237

Query: 260 I 260
           +
Sbjct: 238 L 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  158 bits (401), Expect = 8e-46
 Identities = 103/306 (33%), Positives = 158/306 (51%), Gaps = 19/306 (6%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVR 78
           + +G+G+FGKV  A+       +AVK+L+K  I+  K    I  E    LK +KHP +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    +  K+Y VL+Y+ GGELF  +  +    E   R    ++   + Y H+  + +R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLK ENILLDS+G+I ++DFGL    ++   +G   T CG+P Y+APEVL  + YD  T 
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177

Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
           D W  G +LY +L G  PF  RN A +Y  I     +L   ++  A++LL  +L+ +  K
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237

Query: 259 RIT-------------IAGIKADEWFEQDYTPA-NPD-DDEEDIFVDNEAFSMHEVPSDG 303
           R+               + I  D+   +  TP  NP+     D+   +  F+   VP+  
Sbjct: 238 RLGAKDDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPVPNSI 297

Query: 304 GRTPGS 309
           G++P S
Sbjct: 298 GQSPDS 303

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  158 bits (401), Expect = 9e-46
 Identities = 98/332 (29%), Positives = 174/332 (52%), Gaps = 31/332 (9%)

Query: 16  YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
           +EL + LG G +GKV   + +   D+G  +A+K+L+K  ++   K  +  + E   L+ +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 72  KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           +  P +V LH    +++K++++L+YV+GGE+F  +  +    E E R    ++I  + + 
Sbjct: 62  RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF--RDDGLLHTTCGSPNYVAPEVL 188
           H  G+ +RD+KLENILLDS+G++ ++DFGLS   + F   +    ++ CG+  Y+APE++
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLS---KEFLSEEKERTYSFCGTIEYMAPEII 178

Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFD---DRNL-AVLYQKIFRGDFKLPKWLSPGA 244
             +G  G   D WS G++++ +LTG  PF    +RN  + + ++I + D   P ++ P A
Sbjct: 179 RGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEA 238

Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDY---------------TPANPD-DDEEDIF 288
           Q+LL K+L  +P KR+      A E  E  +                P  P   +E D+ 
Sbjct: 239 QDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVNPPFRPSIRNELDVG 298

Query: 289 VDNEAFS-MHEVPSDGGRTPGSPPLINAFQLI 319
              E F+ +  V S  G  P    +   +  +
Sbjct: 299 NFAEEFTNLEPVYSPAGTPPSGARVFQGYSFV 330

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  156 bits (396), Expect = 1e-45
 Identities = 82/258 (31%), Positives = 134/258 (51%), Gaps = 21/258 (8%)

Query: 25  GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVL 83
           G FG V  A+   +G  FA+K+L+K+ +I       +K E A + +    P V +L+   
Sbjct: 7   GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66

Query: 84  ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLE 143
            SK  +Y+V+EY+ GG+    I + G L E   ++   +++ GV   H +G+ HRD+K E
Sbjct: 67  QSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPE 126

Query: 144 NILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDI 200
           N+L+D  G++K++DFGLS      + F          G+P+Y+APE +   G D   SD 
Sbjct: 127 NLLIDQTGHLKLTDFGLSRNGLENKKF---------VGTPDYLAPETILGVGDDKM-SDW 176

Query: 201 WSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNP 256
           WS G +++  L GY PF       ++  I       P+    + SP A +L+ ++L  +P
Sbjct: 177 WSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDP 236

Query: 257 VKRITIAG---IKADEWF 271
            KR+   G   IK+  +F
Sbjct: 237 AKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  157 bits (398), Expect = 2e-45
 Identities = 90/253 (35%), Positives = 142/253 (56%), Gaps = 4/253 (1%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVR 78
           + LG+G+FGKV  A+   +   FA+K L+K+ ++     +    E   L L  +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           L     +K  ++ V+EY+ GG+L   I S GR  EA  R    ++I G+ + H KG+ +R
Sbjct: 61  LFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKL+N+LLD  G+IKI+DFG+    ++   +G   T CG+P+Y+APE+L  + Y+ +  
Sbjct: 121 DLKLDNVLLDKDGHIKIADFGMCK--ENMNGEGKASTFCGTPDYIAPEILKGQKYNESV- 177

Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
           D WS GV+LY +L G  PF   +   L+  I       P+W+S  A++ L K+ E +P K
Sbjct: 178 DWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237

Query: 259 RITIAGIKADEWF 271
           R+ + G      F
Sbjct: 238 RLGVDGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  157 bits (399), Expect = 2e-45
 Identities = 89/241 (36%), Positives = 136/241 (56%), Gaps = 3/241 (1%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  SG  +A+KIL+K  II          E   LK  +HP +  L
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                +K ++  V+EYV GGELF  ++ +    E   R    +++  + Y H+  + +RD
Sbjct: 61  KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120

Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           LKLEN++LD  G+IKI+DFGL    +   D   + T CG+P Y+APEVL +  Y G   D
Sbjct: 121 LKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177

Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
            W  GV++Y ++ G LPF +++   L++ I   D K P+ LS  A++LL  +L  +P KR
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237

Query: 260 I 260
           +
Sbjct: 238 L 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  157 bits (398), Expect = 2e-45
 Identities = 87/242 (35%), Positives = 144/242 (59%), Gaps = 8/242 (3%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH---LKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FGKV  A+   +   +A+KIL+K+ +I    ++ T   KR +A     K P + +
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQD--KPPFLTQ 65

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    +  ++Y V+EYV GG+L   I   G+ +E +      ++  G+ + H +G+ +R
Sbjct: 66  LHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYR 125

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKL+N++LDS+G+IKI+DFG+    +H  D     T CG+P+Y+APE++A + Y G + 
Sbjct: 126 DLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSV 182

Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
           D W+ GV+LY +L G  PFD  +   L+Q I   +   PK LS  A ++ + ++  +P K
Sbjct: 183 DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSK 242

Query: 259 RI 260
           R+
Sbjct: 243 RL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  156 bits (396), Expect = 3e-45
 Identities = 91/255 (35%), Positives = 137/255 (53%), Gaps = 6/255 (2%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FGKV   +  D+   +A+K + K  I+          E   L  +  P +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
              S  K+Y+VL ++ GGELF  +  +GR   +  R    +L+  +   H   V +RDLK
Sbjct: 61  SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ENILLD +G+I + DFGL  L  + +DD   +T CG+P Y+APE+L   GY  A  D W
Sbjct: 121 PENILLDYQGHIALCDFGLCKL--NMKDDDKTNTFCGTPEYLAPELLLGHGYTKAV-DWW 177

Query: 202 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
           + GV+LY +LTG  PF D N+  +Y+KI +   + P      A++LL  +L  +P +R+ 
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237

Query: 262 IAG---IKADEWFEQ 273
             G   IK   +F Q
Sbjct: 238 YNGAQEIKNHPFFSQ 252

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  155 bits (395), Expect = 3e-45
 Identities = 86/282 (30%), Positives = 137/282 (48%), Gaps = 38/282 (13%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY++   +GEG  G V  A+D ++G   A+K +   R +   I +Q  REI  L+  +HP
Sbjct: 1   RYKILGRIGEGAHGIVFKAKDRETGETVALKKVA-LRRLEGGIPNQALREIKALQACQHP 59

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNK 133
            VV+L +V    S   +V+EY+    L + +  + R L EA+ +   + L+ GV+Y H  
Sbjct: 60  YVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT-TCGSPNYVAPEVL-ANR 191
           G+ HRDLK  N+L+ + G +KI+DFGL+ L     ++  L++    +  Y APE+L   R
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARL--FSEEEPRLYSHQVATRWYRAPELLYGAR 176

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL---YQKIFRGDFKLPKW- 239
            YD    D+W+ G I   +L G   F   N           L    ++ + G   LP + 
Sbjct: 177 KYDPGV-DLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235

Query: 240 ------------------LSPGAQNLLRKILEPNPVKRITIA 263
                              SP A +LL+ +L  +P KR++ A
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAA 277

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  156 bits (396), Expect = 6e-45
 Identities = 90/255 (35%), Positives = 136/255 (53%), Gaps = 7/255 (2%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKRE 64
           K++  M+   +   RTLG G+FG+V  A   +   P  A+K  EK++II  K  D +  E
Sbjct: 22  KRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSE 81

Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
              L  + HP  V L+     +S +Y+VLE+V GGE F  +    R     G     Q++
Sbjct: 82  RKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIV 141

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
               Y  +  + +RDLK EN+LLD  G IK++DFG + +      D   +T CG+P Y+A
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV-----DTRTYTLCGTPEYIA 196

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE+L N G+ G  +D W+ G+ +Y IL G  PF      ++YQKI  G    PK+L    
Sbjct: 197 PEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNC 255

Query: 245 QNLLRKILEPNPVKR 259
           ++L++K+L  +  KR
Sbjct: 256 KHLMKKLLSHDLTKR 270

Length = 340

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  152 bits (386), Expect = 1e-43
 Identities = 84/242 (34%), Positives = 138/242 (57%), Gaps = 4/242 (1%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  +G  +A+KIL+K  I+          E   L+  +HP +  L
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHR 138
                +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H+ K V +R
Sbjct: 61  KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKLEN++LD  G+IKI+DFGL    +  +D   + T CG+P Y+APEVL +  Y G   
Sbjct: 121 DLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177

Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
           D W  GV++Y ++ G LPF +++   L++ I   + + P+ LSP A++LL  +L+ +P +
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237

Query: 259 RI 260
           R+
Sbjct: 238 RL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  150 bits (381), Expect = 1e-43
 Identities = 84/256 (32%), Positives = 132/256 (51%), Gaps = 13/256 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLK 72
           R+  G  LG G+FG V    +LD G  FAVK   L  +     +   Q+++EIA L  L+
Sbjct: 1   RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ 60

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPN+V+       +  +Y+ LE V GG L   +   G   E   R   +Q++ G+ Y H+
Sbjct: 61  HPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHD 120

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           +   HRD+K  NIL+D+ G +K++DFG++   +   +     +  GSP ++APEV+A +G
Sbjct: 121 RNTVHRDIKGANILVDTNGVVKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIAQQG 177

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GDFK----LPKWLSPGAQNL 247
             G  +DIWS G  +  + TG  P+           +F+ G  K    +P  LS  A++ 
Sbjct: 178 GYGLAADIWSLGCTVLEMATGKPPWSQLE---GVAAVFKIGRSKELPPIPDHLSDEAKDF 234

Query: 248 LRKILEPNPVKRITIA 263
           + K L+ +P  R T A
Sbjct: 235 ILKCLQRDPSLRPTAA 250

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  150 bits (382), Expect = 1e-43
 Identities = 76/258 (29%), Positives = 124/258 (48%), Gaps = 25/258 (9%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLLK 72
           E  + LG+G+ G V   +   +G  +A+K       IH+   +    Q+ RE+ TL+  +
Sbjct: 4   ERVKVLGQGSSGVVYKVRHKPTGKIYALKK------IHVDGDEEFRKQLLRELKTLRSCE 57

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
            P VV+ +     + +I +VLEY+ GG L D +   G++ E     + +Q++ G+ Y H 
Sbjct: 58  SPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHT 117

Query: 133 K-GVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           K  + HRD+K  N+L++SKG +KI+DFG+S  L          +T  G+  Y++PE +  
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLEN---TLDQCNTFVGTVTYMSPERIQG 174

Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLPKW----LSPG 243
                  +DIWS G+ L     G  PF          L Q I  G    P       SP 
Sbjct: 175 E-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP--PPSLPAEEFSPE 231

Query: 244 AQNLLRKILEPNPVKRIT 261
            ++ +   L+ +P KR +
Sbjct: 232 FRDFISACLQKDPKKRPS 249

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  152 bits (385), Expect = 1e-43
 Identities = 84/243 (34%), Positives = 144/243 (59%), Gaps = 10/243 (4%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPNVV 77
           LG+G+FGKV  A+   +   +A+KIL+K+ +I     D ++  +   ++L    K P + 
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQ---DDDVECTMVEKRVLALSGKPPFLT 64

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           +LH    +  ++Y V+EYV GG+L  +I   GR +E        ++  G+ + H+KG+ +
Sbjct: 65  QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIY 124

Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
           RDLKL+N++LDS+G+IKI+DFG+    ++  D     T CG+P+Y+APE++A + Y G +
Sbjct: 125 RDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GKS 181

Query: 198 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPV 257
            D W+ GV+LY +L G  PF+  +   L+Q I   +   PK +S  A  + + ++  +P 
Sbjct: 182 VDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPG 241

Query: 258 KRI 260
           KR+
Sbjct: 242 KRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  150 bits (380), Expect = 2e-43
 Identities = 84/250 (33%), Positives = 138/250 (55%), Gaps = 8/250 (3%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHL-KITDQIKREIATLKLLKH 73
           +  G+ LG+G FG+V    D+D+G   AVK +  +       K  + ++ EI  LK L+H
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
             +V+ +  L     + + +EY+ GG + D++ + G L E   RK  +Q+++GV Y H+ 
Sbjct: 64  ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSN 123

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANRG 192
            + HRD+K  NIL DS GN+K+ DFG S   Q     G  + +  G+P +++PEV++  G
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFR--GDFKLPKWLSPGAQNLLR 249
           Y G  +D+WS G  +  +LT   P+ +   +A ++ KI     + +LP  +SP A+N LR
Sbjct: 184 Y-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF-KIATQPTNPQLPSHVSPDARNFLR 241

Query: 250 KILEPNPVKR 259
           +    N  KR
Sbjct: 242 RTFVENAKKR 251

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  150 bits (380), Expect = 4e-43
 Identities = 87/267 (32%), Positives = 161/267 (60%), Gaps = 17/267 (6%)

Query: 16  YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLL 71
           +EL + LG G +GKV   + +   DSG  +A+K+L+K  I+   K T+  + E   L+ +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 72  KH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           +  P +V LH    + +K++++L+Y+ GGELF  ++ + R +E E +    +++  + + 
Sbjct: 62  RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL--LHTTCGSPNYVAPEVL 188
           H  G+ +RD+KLENILLDS G++ ++DFGLS   + F +D +   ++ CG+  Y+AP+++
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLS---KEFHEDEVERAYSFCGTIEYMAPDIV 178

Query: 189 A--NRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSP 242
              + G+D A  D WS GV++Y +LTG  PF    +  + A + ++I + +   P+ +S 
Sbjct: 179 RGGDGGHDKAV-DWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 237

Query: 243 GAQNLLRKILEPNPVKRITIAGIKADE 269
            A+++++++L  +P KR+      ADE
Sbjct: 238 LAKDIIQRLLMKDPKKRLGCGPSDADE 264

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  150 bits (380), Expect = 6e-43
 Identities = 83/249 (33%), Positives = 143/249 (57%), Gaps = 10/249 (4%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPN 75
           + LG+G+FGKV  A+   +   FA+K L+K+ ++   + D ++  +   ++L    +HP 
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVL---MDDDVECTMVEKRVLSLAWEHPF 57

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +  L+    +K  ++ V+EY+ GG+L   I S  +           ++I G+ + H+KG+
Sbjct: 58  LTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI 117

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RDLKL+NILLD+ G+IKI+DFG+    ++   D    T CG+P+Y+APE+L  + Y  
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKY-N 174

Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            + D WS GV+LY +L G  PF   +   L+Q I   +   P+WL+  A+++L K+    
Sbjct: 175 TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVRE 234

Query: 256 PVKRITIAG 264
           P +R+ + G
Sbjct: 235 PERRLGVKG 243

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  149 bits (378), Expect = 1e-42
 Identities = 97/300 (32%), Positives = 142/300 (47%), Gaps = 57/300 (19%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKLL 71
           YE    +GEG +G+V  A++  +G   A+K   K R+ + K    IT    REI  L+ L
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALK---KIRMENEKEGFPIT--AIREIKLLQKL 55

Query: 72  KHPNVVRLHEVLASKSK--IYMVLEYV----TGGELFDKIASKG-RLQEAEGRKLFQQLI 124
           +HPN+VRL E++ SK K  IYMV EY+    TG      + S   +  E++ +   +QL+
Sbjct: 56  RHPNIVRLKEIVTSKGKGSIYMVFEYMDHDLTG-----LLDSPEVKFTESQIKCYMKQLL 110

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           +G+ Y H+ G+ HRD+K  NIL+++ G +K++DFGL A P   R+         +  Y  
Sbjct: 111 EGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL-ARPYTKRNSADYTNRVITLWYRP 169

Query: 185 PEVL--ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----------- 231
           PE+L  A R Y     D+WS G IL  +  G   F         +KIF            
Sbjct: 170 PELLLGATR-YGPE-VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWP 227

Query: 232 GDFKLP--------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
           G  KLP                      + P A +LL K+L  +P KRI+       E+F
Sbjct: 228 GVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  146 bits (371), Expect = 4e-42
 Identities = 85/268 (31%), Positives = 131/268 (48%), Gaps = 31/268 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD-----QIKR-----E 64
            +++ + LG+G++G V           + VK L  N+   LK  D     Q +R     E
Sbjct: 1   DFKVLKKLGKGSYGSV-----------YKVKRLSDNQFYALKEVDLGSMSQKEREDAVNE 49

Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLF 120
           I  L  + HPN++   E     +K+ +V+EY   G+L   I      +  + E E  ++F
Sbjct: 50  IRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIF 109

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            QL+ G+   H + + HRDLK  NILL +   +KI D G+S + +      +  T  G+P
Sbjct: 110 IQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLK----KNMAKTQIGTP 165

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW 239
           +Y+APEV   R Y    SDIWS G +LY + T   PF+ R++  L  K+ RG +  +P  
Sbjct: 166 HYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPI 224

Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKA 267
            S   QN +R +L+  P  R     I A
Sbjct: 225 YSQDLQNFIRSMLQVKPKLRPNCDKILA 252

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  147 bits (372), Expect = 1e-41
 Identities = 100/312 (32%), Positives = 158/312 (50%), Gaps = 20/312 (6%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVR 78
           + +G+G+FGKV  A+    G  +AVK+L+K  +++ K    I  E    LK +KHP +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    +  K+Y VL++V GGELF  +  +    E   R    ++   + Y H+  + +R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLK ENILLDS+G++ ++DFGL    +         T CG+P Y+APEV+  + YD  T 
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCK--EGIAQSDTTTTFCGTPEYLAPEVIRKQPYDN-TV 177

Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
           D W  G +LY +L G  PF  R++A +Y  I      L    S  A ++L ++LE +  +
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237

Query: 259 RI----TIAGIKADEWFEQ-DYT---------PANPD-DDEEDIFVDNEAFSMHEVPSDG 303
           R+        I+   +FE   +T         P NP+ +  +DI   +  F+   VP   
Sbjct: 238 RLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEGPDDISNFDAVFTEETVPYSV 297

Query: 304 GRTPGSPPLINA 315
             +     ++NA
Sbjct: 298 CFSSD-YSIVNA 308

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  146 bits (370), Expect = 2e-41
 Identities = 83/258 (32%), Positives = 148/258 (57%), Gaps = 11/258 (4%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL----KHPN 75
           + LG+G+FGKV  A+    G  FAVK L+K+ ++   I D ++  +   ++L    ++P 
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVL---IDDDVECTMVEKRVLALAWENPF 57

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +  L+    +K  ++ V+E++ GG+L   I  KGR           +++ G+ + H+KG+
Sbjct: 58  LTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI 117

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RDLKL+N++LD  G+IKI+DFG+    ++   D    T CG+P+Y+APE+L    Y  
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCK--ENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175

Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
           +  D WS GV+LY +L G  PF   +   L++ I       P+W++  ++++L K+ E +
Sbjct: 176 SV-DWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERD 234

Query: 256 PVKRITIAG-IKADEWFE 272
           P +R+ + G I+   +F+
Sbjct: 235 PTRRLGVVGNIRGHPFFK 252

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  146 bits (371), Expect = 3e-41
 Identities = 88/291 (30%), Positives = 143/291 (49%), Gaps = 34/291 (11%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             +E+ + +G G FG+V   +D D+G  +A+K+L K+ +I       ++ E   L     
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADS 60

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           P +V+L+     +  +Y+V+EY+ GG+L + +  K    E   R    +L+  +   H  
Sbjct: 61  PWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKL 120

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSA---------------LPQHFRDDGLLH---- 174
           G  HRD+K +NIL+D+ G+IK++DFGL                     FRD+ L+     
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDH 180

Query: 175 --------TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 226
                   +T G+P+Y+APEVL    Y     D WS GVILY +L G+ PF    L   Y
Sbjct: 181 KQRRVRANSTVGTPDYIAPEVLRGTPYGLE-CDWWSLGVILYEMLYGFPPFYSDTLQETY 239

Query: 227 QKI--FRGDFKLP--KWLSPGAQNLLRKILEPNPVKRITIA-GIKADEWFE 272
            KI  ++   + P    +SP A +L+ ++L   P  R+     IK+  +F+
Sbjct: 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLCD-PEDRLGSFEEIKSHPFFK 289

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  144 bits (364), Expect = 2e-40
 Identities = 81/242 (33%), Positives = 127/242 (52%), Gaps = 7/242 (2%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI---KREIATLKLLKHPNVVR 78
           LG G+FGKV  A+   +G  +A+K L+K  II     + +   KR   T    +HP +V 
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           L     ++  +  V+EY  GG+L   I       E         ++ G+ Y H   + +R
Sbjct: 67  LFACFQTEDHVCFVMEYAAGGDLMMHI-HTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKL+N+LLD++G +KI+DFGL      F D     T CG+P ++APEVL    Y  A  
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR--TSTFCGTPEFLAPEVLTETSYTRAV- 182

Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
           D W  GV++Y +L G  PF   +   ++  I   + + P++LS  A +++R++L  NP +
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPER 242

Query: 259 RI 260
           R+
Sbjct: 243 RL 244

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  144 bits (364), Expect = 3e-40
 Identities = 72/228 (31%), Positives = 116/228 (50%), Gaps = 14/228 (6%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G +G+V  A+  D+G   A+K ++K+ +  L     +  E   L   K   +V+L  
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                  +Y+ +EYV GG+    + + G L E   R    ++ + V   H  G  HRDLK
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLL---HTTCGSPNYVAPEVLANRGYDGATS 198
            EN L+D+ G+IK++DFGLS         G++   ++  GSP+Y+APEVL  +GYD  T 
Sbjct: 129 PENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGKGYD-FTV 179

Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLPKWLSPGA 244
           D WS G +LY  L G+ PF        ++ +  ++   + P +  P  
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRF 227

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  141 bits (358), Expect = 4e-40
 Identities = 73/257 (28%), Positives = 115/257 (44%), Gaps = 25/257 (9%)

Query: 17  ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
            LG+ LGEG FG+V   +         +  AVK L+++        ++  RE   ++ L 
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQI--EEFLREARIMRKLD 59

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
           HPNVV+L  V   +  +Y+V+EY+ GG+L         L++   +     L+        
Sbjct: 60  HPNVVKLLGVCTEEEPLYIVMEYMEGGDL------LSYLRKNRPKLSLSDLLSFALQIAR 113

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVA 184
           G+ Y  +K   HRDL   N L+     +KISDFGLS     + DD         P  ++A
Sbjct: 114 GMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYRKRGGKLPIRWMA 171

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPKWLSP 242
           PE L    +    SD+WS GV+L+ I T G  P+   +   + + +  G     P    P
Sbjct: 172 PESLKEGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPNCPP 230

Query: 243 GAQNLLRKILEPNPVKR 259
              +L+ +    +P  R
Sbjct: 231 ELYDLMLQCWAEDPEDR 247

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  141 bits (357), Expect = 5e-40
 Identities = 71/224 (31%), Positives = 106/224 (47%), Gaps = 13/224 (5%)

Query: 17  ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           ELG+ LGEG FG+V           +    AVK L K      +  +    E + +K L 
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTL-KEGASEEEREE-FLEEASIMKKLS 59

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
           HPN+VRL  V      +Y+V EY+ GG+L D +     +L   +  ++  Q+  G+ Y  
Sbjct: 60  HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG--SPNYVAPEVLA 189
           +K   HRDL   N L+     +KISDFGLS     + DD       G     ++APE L 
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLS--RDIYEDDYYRKRGGGKLPIKWMAPESLK 177

Query: 190 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
           +  +    SD+WS GV+L+ I T G  P+   +   + + +  G
Sbjct: 178 DGKFTSK-SDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG 220

Length = 258

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  141 bits (357), Expect = 5e-40
 Identities = 75/261 (28%), Positives = 117/261 (44%), Gaps = 32/261 (12%)

Query: 17  ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLK 69
            LG+ LGEG FG+V             +  AVK L+++         QI+   RE   ++
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED-----ASEQQIEEFLREARIMR 56

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID--- 125
            L HPN+V+L  V   +  + +V+EY+ GG+L         L++   ++L    L+    
Sbjct: 57  KLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDL------LDYLRKNRPKELSLSDLLSFAL 110

Query: 126 ----GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP- 180
               G+ Y  +K   HRDL   N L+     +KISDFGLS     + DD         P 
Sbjct: 111 QIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR--DLYDDDYYKVKGGKLPI 168

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-KLPK 238
            ++APE L    +    SD+WS GV+L+ I T G  P+   + A + + + +G     P 
Sbjct: 169 RWMAPESLKEGKFTSK-SDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPP 227

Query: 239 WLSPGAQNLLRKILEPNPVKR 259
              P    L+ +    +P  R
Sbjct: 228 NCPPELYKLMLQCWAEDPEDR 248

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  140 bits (354), Expect = 1e-39
 Identities = 79/254 (31%), Positives = 139/254 (54%), Gaps = 7/254 (2%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           +Y   + +GEG+FGK    +  + G  + +K +  +++   K  ++ ++E+A L  +KHP
Sbjct: 1   KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHP 59

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRL-QEAEGRKLFQQLIDGVSYCHN 132
           N+V+  E       +Y+V++Y  GG+L+ KI A +G L  E +    F Q+   + + H+
Sbjct: 60  NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           + + HRD+K +NI L   G IK+ DFG++ +     +  L  T  G+P Y++PE+  NR 
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRP 177

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKI 251
           Y+   SDIW+ G +LY + T    F+  N+  L  KI RG +  +    S   +NL+ ++
Sbjct: 178 YNN-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236

Query: 252 LEPNPVKRITIAGI 265
            + NP  R ++  I
Sbjct: 237 FKRNPRDRPSVNSI 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  140 bits (355), Expect = 1e-39
 Identities = 90/263 (34%), Positives = 131/263 (49%), Gaps = 26/263 (9%)

Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILE------KNRIIHLKITDQIKREIATLKLLK 72
           G  +G G+FG V    +  SG   AVK +E       ++     + D + REIA LK L+
Sbjct: 5   GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H N+V+          + + LEYV GG +   + + G  +E   R   +Q++ G++Y HN
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC--------GSPNYVA 184
           +G+ HRD+K  NIL+D+KG IKISDFG+S   +       L T          GS  ++A
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEA----NSLSTKTNGARPSLQGSVFWMA 180

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GDFKLPKW---L 240
           PEV+    Y     DIWS G ++  +LTG  PF D       Q IF+ G+   P+    +
Sbjct: 181 PEVVKQTSYTRKA-DIWSLGCLVVEMLTGKHPFPDCT---QLQAIFKIGENASPEIPSNI 236

Query: 241 SPGAQNLLRKILEPNPVKRITIA 263
           S  A + L K  E +  KR T A
Sbjct: 237 SSEAIDFLEKTFEIDHNKRPTAA 259

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  140 bits (356), Expect = 2e-39
 Identities = 97/317 (30%), Positives = 138/317 (43%), Gaps = 70/317 (22%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT-DQIK----REIATLK 69
           RYE G+ LGEG +  V  A+D ++G   A+K   K ++   K   D I     REI  L+
Sbjct: 1   RYEKGKKLGEGTYAVVYKARDKETGRIVAIK---KIKLGERKEAKDGINFTALREIKLLQ 57

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVS 128
            LKHPN++ L +V   KS I +V E++   +L   I  K   L  A+ +      + G+ 
Sbjct: 58  ELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLE 116

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 181
           Y H+  + HRDLK  N+L+ S G +K++DFGL+              + GSPN       
Sbjct: 117 YLHSNWILHRDLKPNNLLIASDGVLKLADFGLA-------------RSFGSPNRKMTHQV 163

Query: 182 ----YVAPEVLANRGYDGATSDIWSCGVILYVILTG--YLPFDD--RNLAVLYQKIFR-- 231
               Y APE+L    + G   D+WS G I   +L    +LP D     L     KIF   
Sbjct: 164 VTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG----KIFEAL 219

Query: 232 ---------GDFKLPKWL----SPG-------------AQNLLRKILEPNPVKRITIAGI 265
                    G   LP ++     P              A +LL+++L  NP KRIT    
Sbjct: 220 GTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQA 279

Query: 266 KADEWFEQDYTPANPDD 282
               +F  D  P  P  
Sbjct: 280 LEHPYFSNDPAPTPPSQ 296

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  139 bits (353), Expect = 9e-39
 Identities = 79/263 (30%), Positives = 146/263 (55%), Gaps = 18/263 (6%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVR 78
           R +G G++ KV   +   +   +A+K+++K  +   +  D ++ E    +    HP +V 
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    ++S+++ V+E+V+GG+L   +  + +L E   R    ++   +++ H +G+ +R
Sbjct: 61  LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GAT 197
           DLKL+N+LLD++G+IK++D+G+    +  R      T CG+PNY+APE+L  RG D G +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK--EGIRPGDTTSTFCGTPNYIAPEIL--RGEDYGFS 176

Query: 198 SDIWSCGVILYVILTGYLPFD--------DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLL 248
            D W+ GV+++ ++ G  PFD        D+N    L+Q I     ++P+ LS  A ++L
Sbjct: 177 VDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVL 236

Query: 249 RKILEPNPVKRITIAGIKADEWF 271
           +  L  +P +R+   G      F
Sbjct: 237 KGFLNKDPKERL---GCHPQTGF 256

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  138 bits (350), Expect = 2e-38
 Identities = 80/287 (27%), Positives = 131/287 (45%), Gaps = 36/287 (12%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G+ G+V   +   +G  FA+K+L+K  +I      ++  E   L  L HP +  L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 80  HEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           +    +++ + +V++Y  GGELF   +      L E   R    +++  + Y H  G+ +
Sbjct: 67  YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126

Query: 138 RDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPN------------- 181
           RDLK ENILL   G+I +SDF LS    +        L   +  S               
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186

Query: 182 -----------YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
                      Y+APEV++  G+  A  D W+ G++LY +L G  PF   N    +  I 
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSAV-DWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245

Query: 231 RGDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAG----IKADEWF 271
           + +   P    +S  A++L+RK+L  +P KR+        IK   +F
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  137 bits (346), Expect = 3e-38
 Identities = 83/259 (32%), Positives = 134/259 (51%), Gaps = 18/259 (6%)

Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-------HLKITDQIKREIATLKLL 71
           G  +G+G +G+V  A ++ +G   AVK +E    I          +   ++ EI TLK L
Sbjct: 6   GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            H N+V+      ++  + + LEYV GG +   + + GR +E   R   +Q+++G++Y H
Sbjct: 66  DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN- 190
           +KG+ HRDLK +N+L+D+ G  KISDFG+S       D+    +  GS  ++APEV+ + 
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185

Query: 191 -RGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGDFKLP------KWLSP 242
            +GY  A  DIWS G ++  +  G  P+ D+  +A ++ K+       P        LSP
Sbjct: 186 SQGYS-AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMF-KLGNKRSAPPIPPDVSMNLSP 243

Query: 243 GAQNLLRKILEPNPVKRIT 261
            A + L      NP  R T
Sbjct: 244 VALDFLNACFTINPDNRPT 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  137 bits (346), Expect = 7e-38
 Identities = 84/279 (30%), Positives = 138/279 (49%), Gaps = 28/279 (10%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E  + +  G +G V   +  ++   FA+K + K  +I      Q+  E   L   ++P 
Sbjct: 3   FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV +     +K  + MV+EYV GG+    + + G L     R  F + +  + Y HN G+
Sbjct: 63  VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSAL-----------------PQHFRDDGLLHTTCG 178
            HRDLK +N+L+ S G+IK++DFGLS +                  + F D  +    CG
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQV----CG 178

Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK 238
           +P Y+APEV+  +GY G   D W+ G+ILY  L G +PF       L+ ++   D + P+
Sbjct: 179 TPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237

Query: 239 W---LSPGAQNLLRKILEPNPVKRITIAG---IKADEWF 271
               L   AQ+L+ ++L  NP++R+   G   +K   +F
Sbjct: 238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFF 276

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  135 bits (341), Expect = 9e-38
 Identities = 83/248 (33%), Positives = 129/248 (52%), Gaps = 8/248 (3%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           +Y + R +GEG+FG+    Q ++S   +A+K +   +       +  ++E   L  +KHP
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSS--AVEDSRKEAVLLAKMKHP 58

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRL-QEAEGRKLFQQLIDGVSYCHN 132
           N+V   E   +   +Y+V+EY  GG+L  KI   +G+L  E    + F Q+  GV + H 
Sbjct: 59  NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           K V HRD+K +NI L   G +K+ DFG + L           T  G+P YV PE+  N  
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEIWENMP 176

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKI 251
           Y+   SDIWS G ILY + T   PF   +   L  K+ +G +K LP   S   ++L++++
Sbjct: 177 YNN-KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235

Query: 252 LEPNPVKR 259
            + NP  R
Sbjct: 236 FKRNPRSR 243

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  136 bits (343), Expect = 2e-37
 Identities = 78/251 (31%), Positives = 141/251 (56%), Gaps = 13/251 (5%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVR 78
           R +G G++ KV   +   +   +A+K+++K  +   +  D ++ E     +   HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    ++S+++ V+EYV GG+L   +  + +L E   R    ++   ++Y H +G+ +R
Sbjct: 61  LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKL+N+LLDS+G+IK++D+G+    +  R      T CG+PNY+APE+L    Y G + 
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177

Query: 199 DIWSCGVILYVILTGYLPFD--------DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLLR 249
           D W+ GV+++ ++ G  PFD        D+N    L+Q I     ++P+ LS  A ++L+
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237

Query: 250 KILEPNPVKRI 260
             L  +P +R+
Sbjct: 238 SFLNKDPKERL 248

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  134 bits (339), Expect = 2e-37
 Identities = 78/263 (29%), Positives = 121/263 (46%), Gaps = 23/263 (8%)

Query: 20  RTLGEGNFGKVKFA---QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           + LGEG FG+V               AVK L K      +  D   +E   +K L HPNV
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTL-KEDASEEERKD-FLKEARVMKKLGHPNV 58

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLID-------GV 127
           VRL  V   +  +Y+VLEY+ GG+L D +     +  +  +     + L+        G+
Sbjct: 59  VRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SPN-YVAP 185
            Y  +K   HRDL   N L+     +KISDFGLS     + DD     T G  P  ++AP
Sbjct: 119 EYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS--RDVYDDDYYRKKTGGKLPIRWMAP 176

Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSP 242
           E L +  +    SD+WS GV+L+ I T G  P+   +   + + + +G ++L  P++   
Sbjct: 177 ESLKDGIFTSK-SDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-YRLPKPEYCPD 234

Query: 243 GAQNLLRKILEPNPVKRITIAGI 265
               L+    + +P  R T + +
Sbjct: 235 ELYELMLSCWQLDPEDRPTFSEL 257

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 9e-37
 Identities = 77/283 (27%), Positives = 118/283 (41%), Gaps = 40/283 (14%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK---ILEKNRIIHLKITDQIKREIATLKL 70
            +YE+   +GEG +G V   ++  +G   A+K     E +  +         RE+  L+ 
Sbjct: 1   NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTAL----REVKVLRQ 56

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L+H N+V L E    K ++Y+V EYV    L    AS G L     R    QL+  ++YC
Sbjct: 57  LRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYC 116

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           H+  + HRD+K ENIL+   G +K+ DFG  A     R    L     +  Y APE+L  
Sbjct: 117 HSHNIIHRDIKPENILVSESGVLKLCDFGF-ARALRARPASPLTDYVATRWYRAPELLVG 175

Query: 191 RGYDGATSDIWSCGVI-------------------LYVILTGYLPFDDRNLAVLYQ-KIF 230
               G   D+W+ G I                   LY+I     P    +  +      F
Sbjct: 176 DTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF 235

Query: 231 RG------------DFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
            G            + + P  +S  A + L+  L  +P +R+T
Sbjct: 236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  133 bits (336), Expect = 1e-36
 Identities = 76/248 (30%), Positives = 129/248 (52%), Gaps = 19/248 (7%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           +GEG  G+V  A D  +G   A+K   L K         + I  EI  +K  KHPN+V  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNK------ELIINEILIMKDCKHPNIVDY 80

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           ++      ++++V+EY+ GG L D I  +  R+ E +   + ++++ G+ Y H++ V HR
Sbjct: 81  YDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR 140

Query: 139 DLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           D+K +NILL   G++K++DFG +A    +  +     ++  G+P ++APEV+  + Y   
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR----NSVVGTPYWMAPEVIKRKDYGPK 196

Query: 197 TSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILE 253
             DIWS G++   +  G  P   +  L  L+    +G    K P+  SP  ++ L K L 
Sbjct: 197 V-DIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLV 255

Query: 254 PNPVKRIT 261
            +P KR +
Sbjct: 256 KDPEKRPS 263

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  132 bits (333), Expect = 1e-36
 Identities = 72/248 (29%), Positives = 127/248 (51%), Gaps = 9/248 (3%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   +G+G+FG V           +A+K ++ +++   +  + I  E   L  L    
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSSY 60

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNK 133
           ++R +E    K K+ +V+EY   G+L   +       L E +  + F Q++ G+++ H+K
Sbjct: 61  IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL-HTTCGSPNYVAPEVLANRG 192
            + HRD+K  N+ LD+  N+KI D G++ L     D+    +T  G+P Y++PE+  ++ 
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKL---LSDNTNFANTIVGTPYYLSPELCEDKP 177

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKI 251
           Y+   SD+W+ GV+LY   TG  PFD  N   L  KI RG F  + +  S     L+ + 
Sbjct: 178 YN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236

Query: 252 LEPNPVKR 259
           L  +  +R
Sbjct: 237 LTKDYRQR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  132 bits (334), Expect = 2e-36
 Identities = 81/254 (31%), Positives = 126/254 (49%), Gaps = 10/254 (3%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V   Q   +G  +A K L+K R+   K       E   L+ +    +V L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRD 139
              +K  + +V+  + GG+L   I + G     E R +F   Q+I G+ + H + + +RD
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRD 120

Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           LK EN+LLD  GN++ISD GL+      +    +    G+P Y+APEVL    YD  + D
Sbjct: 121 LKPENVLLDDHGNVRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYD-FSVD 176

Query: 200 IWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            ++ G  LY ++ G  PF  R   V    L ++      + P   SP A++L   +L+ +
Sbjct: 177 WFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236

Query: 256 PVKRITIAGIKADE 269
           P KR+   G  ADE
Sbjct: 237 PEKRLGCRGGSADE 250

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 2e-36
 Identities = 82/244 (33%), Positives = 133/244 (54%), Gaps = 8/244 (3%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQI-KREIATLKLLKH-PNVVR 78
           +G+G FG+V   +  D+   +A+K+L K  I+  K +   I +R I    LL   P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           L     + S +Y+V +Y++GGELF  +  +GR  E   +    +L+  + + H   + +R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGAT 197
           DLK ENILLD+ G+I + DFGLS    +  D+   +T CG+  Y+APEVL + +GY    
Sbjct: 121 DLKPENILLDATGHIALCDFGLSK--ANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177

Query: 198 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-WLSPGAQNLLRKILEPNP 256
            D WS GV+++ +  G+ PF   +   +Y+ I  G  + PK  LS   +  ++ +L  NP
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237

Query: 257 VKRI 260
             R+
Sbjct: 238 QHRL 241

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  131 bits (332), Expect = 2e-36
 Identities = 78/258 (30%), Positives = 122/258 (47%), Gaps = 9/258 (3%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           +YE  R +G G FG V   +         +K +   ++         + E   LKLL HP
Sbjct: 1   KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHP 59

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHN 132
           N++  +E       + +V+EY  GG L + I  +    L E      F Q++  + + H 
Sbjct: 60  NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119

Query: 133 KGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           K + HRDLK +NILLD    + KI DFG+S +          +T  G+P Y++PE+   +
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYISPELCEGK 176

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRK 250
            Y+   SDIW+ G +LY + +    F+  NL  L  KI  G F  +    SP  + L+  
Sbjct: 177 PYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235

Query: 251 ILEPNPVKRITIAGIKAD 268
           +L  +P KR  ++ I A 
Sbjct: 236 MLNLDPSKRPQLSQIMAQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  132 bits (334), Expect = 4e-36
 Identities = 74/249 (29%), Positives = 139/249 (55%), Gaps = 11/249 (4%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVR 78
           R +G G++ KV   +   +   +A+K+++K  +   +  D ++ E    +    +P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LH    + S++++V+EYV GG+L   +  + +L E   R    ++   +++ H +G+ +R
Sbjct: 61  LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLKL+N+LLD+ G+IK++D+G+    +         T CG+PNY+APE+L    Y G + 
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCK--EGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177

Query: 199 DIWSCGVILYVILTGYLPFD------DRNLA-VLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
           D W+ GV+++ ++ G  PFD      D N    L+Q I     ++P++LS  A ++L+  
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237

Query: 252 LEPNPVKRI 260
           L  +P +R+
Sbjct: 238 LNKDPKERL 246

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  133 bits (336), Expect = 8e-36
 Identities = 85/300 (28%), Positives = 127/300 (42%), Gaps = 50/300 (16%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           +T+G G FG+V   + +D+   +A+K L K  ++       +K E   L    +  VV+L
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL 66

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           +     K  +Y V++Y+ GG++   +   G  +E   R    +L   +   H  G  HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRD 126

Query: 140 LKLENILLDSKGNIKISDFGLSA------------LPQHFRDDG---------------- 171
           +K +NIL+D  G+IK++DFGL                 H R D                 
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLK 186

Query: 172 -------------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 218
                        L H+  G+PNY+APEVL   GY     D WS GVILY +L G  PF 
Sbjct: 187 PLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQPPFL 245

Query: 219 DRNLAVLYQKI--FRGDFKLPKW--LSPGAQNLLRKILEPNPVKRI---TIAGIKADEWF 271
               A    K+  +     +P    LS  A +L+ + L      R+       IKA  +F
Sbjct: 246 ADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAHPFF 304

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 1e-35
 Identities = 81/280 (28%), Positives = 123/280 (43%), Gaps = 41/280 (14%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKH 73
           Y+    +GEG +G V  A+D  +G   A+K   K ++            REI  LK L H
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIK---KIKLRFESEGIPKTALREIKLLKELNH 57

Query: 74  PNVVRLHEVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           PN+++L +V   K  +Y+V E++ T      K   +G L E+  +    QL+ G+++CH+
Sbjct: 58  PNIIKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG-LPESLIKSYLYQLLQGLAFCHS 116

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-YVAPEVLANR 191
            G+ HRDLK EN+L++++G +K++DFGL+     F      +T       Y APE+L   
Sbjct: 117 HGILHRDLKPENLLINTEGVLKLADFGLARS---FGSPVRPYTHYVVTRWYRAPELLLGD 173

Query: 192 GYDGATSDIWSCGVILYVILTG--YLPFDD-----------------RNLAVLYQKIFRG 232
                  DIWS G I   +L+     P                                 
Sbjct: 174 KGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNY 233

Query: 233 DFKLPKW-----------LSPGAQNLLRKILEPNPVKRIT 261
            F  PK             SP A +LL ++L  +P KRIT
Sbjct: 234 KFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT 273

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  129 bits (327), Expect = 1e-35
 Identities = 71/252 (28%), Positives = 124/252 (49%), Gaps = 12/252 (4%)

Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVK---ILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           G+ LG G F     A+D+ +G   AVK    +        ++ + +++EI  +  L HP+
Sbjct: 5   GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++R+       S   + +E++ GG +   ++  G  +EA      +QL+ G+SY H   +
Sbjct: 65  IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124

Query: 136 FHRDLKLENILLDSKGN-IKISDFGLSA-LPQHFRDDGLLH-TTCGSPNYVAPEVLANRG 192
            HRD+K  N+L+DS G  ++I+DFG +A L       G       G+  ++APEVL    
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-----GDFKLPKWLSPGAQNL 247
           Y G + D+WS G ++  + T   P++    +     IF+         +P+ LSPG +++
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243

Query: 248 LRKILEPNPVKR 259
             + LE  P  R
Sbjct: 244 TLRCLELQPEDR 255

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  132 bits (333), Expect = 2e-35
 Identities = 91/300 (30%), Positives = 149/300 (49%), Gaps = 45/300 (15%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E  + +G G FG+V+  Q  D+G  +A+K L K+ ++  +    ++ E   L    +P 
Sbjct: 3   FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+L+     ++ +Y+++EY+ GG++   +  K    E E R    + I  +   H  G 
Sbjct: 63  VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122

Query: 136 FHRDLKLENILLDSKGNIKISDFGLS-----------------ALPQHFRDD-------- 170
            HRD+K +N+LLD+KG+IK+SDFGL                  ALP +F D         
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182

Query: 171 -----------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD 219
                       L ++T G+P+Y+APEV    GY     D WS GVI+Y +L GY PF  
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241

Query: 220 RNLAVLYQKI--FRGDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 272
            N    Y+KI  ++   + P    LSP A++L++++      +R+   G   IK+  +F+
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  128 bits (324), Expect = 3e-35
 Identities = 73/250 (29%), Positives = 125/250 (50%), Gaps = 16/250 (6%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +++   LGEG++G V  A   ++G   A+K++     +      +I +EI+ LK    P 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQ-----EIIKEISILKQCDSPY 59

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +V+ +      + +++V+EY   G + D  KI +K  L E E   +  Q + G+ Y H+ 
Sbjct: 60  IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNK-TLTEEEIAAILYQTLKGLEYLHSN 118

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
              HRD+K  NILL+ +G  K++DFG+S   Q        +T  G+P ++APEV+   GY
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 176

Query: 194 DGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
           +    DIWS G+    +  G  P+ D    R + ++  K        P+  SP   + ++
Sbjct: 177 NNKA-DIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT-LSDPEKWSPEFNDFVK 234

Query: 250 KILEPNPVKR 259
           K L  +P +R
Sbjct: 235 KCLVKDPEER 244

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  128 bits (322), Expect = 4e-35
 Identities = 83/259 (32%), Positives = 142/259 (54%), Gaps = 16/259 (6%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYE+ + +GEG+FGK+  A+         +K ++  ++  +K  +  K+E+  L  +KHP
Sbjct: 1   RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHP 59

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL--FQQLIDGVSYCHN 132
           N+V          ++++V+EY  GG+L  +I  +  +  +E + L  F Q+  G+ + H+
Sbjct: 60  NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119

Query: 133 KGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTC-GSPNYVAPEVLAN 190
           + + HRD+K +NI L   G + K+ DFG++   +   D   L  TC G+P Y++PE+  N
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIA---RQLNDSMELAYTCVGTPYYLSPEICQN 176

Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG----AQN 246
           R Y+  T DIWS G +LY + T   PF+  NL  L  KI +G F  P  +SP      ++
Sbjct: 177 RPYNNKT-DIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-P--ISPNFSRDLRS 232

Query: 247 LLRKILEPNPVKRITIAGI 265
           L+ ++ + +P  R +I  I
Sbjct: 233 LISQLFKVSPRDRPSITSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score =  131 bits (332), Expect = 1e-34
 Identities = 88/266 (33%), Positives = 134/266 (50%), Gaps = 31/266 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--------EKNRIIHLKITDQIKREIA 66
           +Y + R LG G  G V  A+ +  G PFAVK++        +KNR          + E+ 
Sbjct: 33  KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA---------QAEVC 83

Query: 67  TLKLLKHPNVVRLHEVLASK--------SKIYMVLEYVTGGELFDKIASKGR----LQEA 114
            L      ++V+ HE  A K          I +VL+Y   G+L  +I S+ +     +E 
Sbjct: 84  CLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREH 143

Query: 115 EGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174
           E   LF Q++  V + H+K + HRD+K  NILL S G +K+ DFG S +      D +  
Sbjct: 144 EAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR 203

Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234
           T CG+P YVAPE+   + Y    +D++S GV+LY +LT   PFD  N+  +  K   G +
Sbjct: 204 TFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY 262

Query: 235 K-LPKWLSPGAQNLLRKILEPNPVKR 259
             LP  +SP  Q ++  +L  +P +R
Sbjct: 263 DPLPPSISPEMQEIVTALLSSDPKRR 288

Length = 496

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  127 bits (322), Expect = 2e-34
 Identities = 91/318 (28%), Positives = 134/318 (42%), Gaps = 70/318 (22%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKL 70
           +L  YE+   LGEG FG+V  A+ + +G   A+K IL  N      IT    REI  LK 
Sbjct: 6   KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITAL--REIKILKK 63

Query: 71  LKHPNVVRLHEVLASKSK--------IYMVLEYVT---GGELFDKIASKGRLQEAEGRKL 119
           LKHPNVV L ++   +          +YMV  Y+     G L +      +L E++ +  
Sbjct: 64  LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP---SVKLTESQIKCY 120

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
             QL++G++Y H   + HRD+K  NIL+D++G +KI+DFGL+   + +          G 
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA---RPYDGPPPNPKGGGG 177

Query: 180 PN------------YVAPE-VLANRGYDGATSDIWSCGVILYVILTG--YLP-FDDRNLA 223
                         Y  PE +L  R Y  A  DIW  G +   + T    L    D +  
Sbjct: 178 GGTRKYTNLVVTRWYRPPELLLGERRYTTAV-DIWGIGCVFAEMFTRRPILQGKSDIDQL 236

Query: 224 VLYQKIFR-----GDFKLPKWLS-PGAQN------------------------LLRKILE 253
                IF+      +   P W S PG +                         LL K+L 
Sbjct: 237 ---HLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLS 293

Query: 254 PNPVKRITIAGIKADEWF 271
            +P KR+T +      +F
Sbjct: 294 LDPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  126 bits (319), Expect = 3e-34
 Identities = 81/262 (30%), Positives = 134/262 (51%), Gaps = 21/262 (8%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR---EIATLKLLKHPNVVR 78
           LG+G FGKV  AQ  ++GL  A KI      I ++  ++++    EI  L   KHPN+V 
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKI------IQIESEEELEDFMVEIDILSECKHPNIVG 66

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           L+E    ++K+++++E+  GG L   +    R L E + R + +Q+++ +++ H+  V H
Sbjct: 67  LYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIH 126

Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRG 192
           RDLK  NILL   G++K++DFG+SA  +         T  G+P ++APEV+A     +  
Sbjct: 127 RDLKAGNILLTLDGDVKLADFGVSAKNKS--TLQKRDTFIGTPYWMAPEVVACETFKDNP 184

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLR 249
           YD   +DIWS G+ L  +     P  + N   +  KI + +      P   S    + L+
Sbjct: 185 YD-YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLK 243

Query: 250 KILEPNPVKRITIAGIKADEWF 271
             L  +P  R T A +    + 
Sbjct: 244 SCLVKDPDDRPTAAELLKHPFV 265

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  125 bits (316), Expect = 5e-34
 Identities = 80/262 (30%), Positives = 130/262 (49%), Gaps = 13/262 (4%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           LG +++ + +G+G F  V  A  L  G   A+K ++   ++  K      +EI  LK L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGEL---FDKIASKGRL-QEAEGRKLFQQLIDGVS 128
           HPNV++        +++ +VLE    G+L         + RL  E    K F QL   + 
Sbjct: 61  HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 187
           + H+K + HRD+K  N+ + + G +K+ D GL    + F       H+  G+P Y++PE 
Sbjct: 121 HMHSKRIMHRDIKPANVFITATGVVKLGDLGLG---RFFSSKTTAAHSLVGTPYYMSPER 177

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFK-LPK-WLSPG 243
           +   GY+   SDIWS G +LY +     PF  D  NL  L +KI + D+  LP    S  
Sbjct: 178 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEE 236

Query: 244 AQNLLRKILEPNPVKRITIAGI 265
            ++L+ + + P+P KR  I+ +
Sbjct: 237 LRDLVSRCINPDPEKRPDISYV 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 3e-33
 Identities = 85/263 (32%), Positives = 135/263 (51%), Gaps = 29/263 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLK 69
            YEL + +G G +G V  A+D+ +G   A+K++        K+        I++EI+ LK
Sbjct: 4   DYELIQRIGSGTYGDVYKARDIATGELVAIKVI--------KLEPGDDFEIIQQEISMLK 55

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVS 128
             +HPN+V        + K+++V+EY  GG L D    ++G L E +   + ++ + G++
Sbjct: 56  ECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLA 115

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           Y H  G  HRD+K  NILL   G++K++DFG+SA  Q         +  G+P ++APEV 
Sbjct: 116 YLHETGKIHRDIKGANILLTEDGDVKLADFGVSA--QLTATIAKRKSFIGTPYWMAPEVA 173

Query: 189 ANR---GYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLP------K 238
           A     GYDG   DIW+ G+    +     P FD   +  L+  I + +F  P      K
Sbjct: 174 AVERKGGYDGK-CDIWALGITAIELAELQPPMFDLHPMRALFL-ISKSNFPPPKLKDKEK 231

Query: 239 WLSPGAQNLLRKILEPNPVKRIT 261
           W SP   + ++K L  +P KR T
Sbjct: 232 W-SPVFHDFIKKCLTKDPKKRPT 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  123 bits (311), Expect = 4e-33
 Identities = 89/291 (30%), Positives = 138/291 (47%), Gaps = 55/291 (18%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLLKHPNVV 77
           LGEG +  V   ++  +G   A+K       IHL   +       REI+ +K LKH N+V
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKE------IHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 78  RLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           RLH+V+ +++K+ +V EY+     +  D    +G L     +    QL+ G+++CH   V
Sbjct: 62  RLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRV 121

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVL-AN 190
            HRDLK +N+L++ +G +K++DFGL+      R  G+   T  +      Y AP+VL  +
Sbjct: 122 LHRDLKPQNLLINKRGELKLADFGLA------RAFGIPVNTFSNEVVTLWYRAPDVLLGS 175

Query: 191 RGYDGATS-DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-----------GDFKLPK 238
           R Y  +TS DIWS G I+  ++TG   F   N      KIFR           G  +LP+
Sbjct: 176 RTY--STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE 233

Query: 239 W------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
           +                    P   +LL ++L+ NP  RI+        WF
Sbjct: 234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  123 bits (312), Expect = 4e-33
 Identities = 87/301 (28%), Positives = 131/301 (43%), Gaps = 75/301 (24%)

Query: 24  EGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-------REIATLKLLKHPNV 76
           EG +G V  A+D  +G   A+K         LK+  + +       REI  L  L+HPN+
Sbjct: 15  EGTYGVVYRARDKKTGEIVALK--------KLKMEKEKEGFPITSLREINILLKLQHPNI 66

Query: 77  VRLHEVLASKS--KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNK 133
           V + EV+   +  KIYMV+EYV   +L   + + K    ++E + L  QL+ GV++ H+ 
Sbjct: 67  VTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDN 125

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-----------Y 182
            + HRDLK  N+LL+++G +KI DFGL+      R+        GSP            Y
Sbjct: 126 WILHRDLKTSNLLLNNRGILKICDFGLA------RE-------YGSPLKPYTQLVVTLWY 172

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----------- 231
            APE+L          D+WS G I   +LT    F  ++      KIF+           
Sbjct: 173 RAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWP 232

Query: 232 GDFKLPKW---------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEW 270
           G  +LP                       LS    +LL ++L  +P KRI+        +
Sbjct: 233 GFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Query: 271 F 271
           F
Sbjct: 293 F 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  123 bits (309), Expect = 5e-33
 Identities = 79/244 (32%), Positives = 130/244 (53%), Gaps = 8/244 (3%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--EKNRIIHLKITDQIKREIATLKLLKH 73
           + LG+ LG G FG+V    D D+G   AVK +  + +     K  + ++ EI  LK L+H
Sbjct: 4   WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRH 63

Query: 74  PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
             +V+ +  L    + K+ + +EY+ GG + D++ + G L E   R+  +Q++ GVSY H
Sbjct: 64  DRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLH 123

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLAN 190
           +  + HRD+K  NIL DS GN+K+ DFG S   Q     G  + +  G+P +++PEV++ 
Sbjct: 124 SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISG 183

Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNLL 248
            GY G  +D+WS    +  +LT   P+ +        KI     K  LP  +S   ++ L
Sbjct: 184 EGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFL 242

Query: 249 RKIL 252
           ++I 
Sbjct: 243 KQIF 246

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 5e-33
 Identities = 90/283 (31%), Positives = 134/283 (47%), Gaps = 59/283 (20%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ------IKREIATLKLLKHPN 75
           +GEG +G V  A+D  +G   A+K       I L+  D+      I REI+ LK L HPN
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKK------IRLETEDEGVPSTAI-REISLLKELNHPN 59

Query: 76  VVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +VRL +V+ S++K+Y+V E++     +  D     G L     +    QL+ G++YCH+ 
Sbjct: 60  IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-LDPPLIKSYLYQLLQGIAYCHSH 118

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-----LHTTCGSPNYVAPEVL 188
            V HRDLK +N+L+D +G +K++DFGL+      R  G+      H    +  Y APE+L
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLA------RAFGVPVRTYTHEVV-TLWYRAPEIL 171

Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR---------------- 231
                     DIWS G I   ++     F  D  +  L+ +IFR                
Sbjct: 172 LGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF-RIFRTLGTPDEDVWPGVTSL 230

Query: 232 GDFK--LPKW-----------LSPGAQNLLRKILEPNPVKRIT 261
            D+K   PKW           L     +LL K+L  +P KRI+
Sbjct: 231 PDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS 273

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  122 bits (309), Expect = 7e-33
 Identities = 66/210 (31%), Positives = 110/210 (52%), Gaps = 16/210 (7%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLK 69
            + L   +G+G+FG+V  A D  +    A+K+      I L+     I D I++EI  L 
Sbjct: 2   LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV------IDLEEAEDEIED-IQQEIQFLS 54

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             + P + + +      SK+++++EY  GG   D +   G+L E     + ++++ G+ Y
Sbjct: 55  QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEY 113

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H +G  HRD+K  NILL  +G++K++DFG+S   Q        +T  G+P ++APEV+ 
Sbjct: 114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSG--QLTSTMSKRNTFVGTPFWMAPEVIK 171

Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDD 219
             GYD   +DIWS G+    +  G  P  D
Sbjct: 172 QSGYDEK-ADIWSLGITAIELAKGEPPLSD 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  122 bits (307), Expect = 8e-33
 Identities = 77/241 (31%), Positives = 131/241 (54%), Gaps = 8/241 (3%)

Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILE--KNRIIHLKITDQIKREIATLKLLKHPNV 76
           G+ LG+G FG+V    D+D+G   A K ++         K    ++ EI  LK L+H  +
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 77  VRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V+ +  L  +++  + + +EY+ GG + D++ + G L E+  RK  +Q+++G+SY H+  
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLANRGY 193
           + HRD+K  NIL DS GN+K+ DFG S   Q     G  + +  G+P +++PEV++  GY
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186

Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRKI 251
            G  +D+WS G  +  +LT   P+ +        KI     + +LP  +S  A++ L  I
Sbjct: 187 -GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCI 245

Query: 252 L 252
            
Sbjct: 246 F 246

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  122 bits (306), Expect = 1e-32
 Identities = 79/244 (32%), Positives = 135/244 (55%), Gaps = 8/244 (3%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN--RIIHLKITDQIKREIATLKLLKH 73
           + LG+ LG+G FG+V    D D+G   AVK ++ +       K  + ++ EI  LK L H
Sbjct: 4   WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63

Query: 74  PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
             +V+ +  L    +  + + +E++ GG + D++ S G L E   RK  +Q+++GVSY H
Sbjct: 64  ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEVLAN 190
           +  + HRD+K  NIL DS GN+K+ DFG S   Q     G  + +  G+P +++PEV++ 
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183

Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFR-GDFKLPKWLSPGAQNLL 248
            GY G  +DIWS G  +  +LT   P+ +   +A +++   +  +  LP  +S   ++ L
Sbjct: 184 EGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242

Query: 249 RKIL 252
           ++I 
Sbjct: 243 KRIF 246

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  120 bits (302), Expect = 7e-32
 Identities = 83/284 (29%), Positives = 137/284 (48%), Gaps = 41/284 (14%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +       +  I REI+ LK L HPN+V+L +
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAI-REISLLKELNHPNIVKLLD 66

Query: 82  VLASKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
           V+ +++K+Y+V E++    + F   +    +     +    QL+ G+++CH+  V HRDL
Sbjct: 67  VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126

Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGA 196
           K +N+L++++G IK++DFGL+      R  G+   T         Y APE+L    Y   
Sbjct: 127 KPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYST 180

Query: 197 TSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LPK 238
             DIWS G I   ++T     P D          R L    + ++ G     D+K   PK
Sbjct: 181 AVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPK 240

Query: 239 W-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
           W           L    ++LL ++L  +P KRI+     A  +F
Sbjct: 241 WARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  119 bits (300), Expect = 1e-31
 Identities = 81/263 (30%), Positives = 129/263 (49%), Gaps = 25/263 (9%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKH 73
           YEL   +G G    V  A  L +    A+K   LEK +       D++++E+  +    H
Sbjct: 3   YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTS----VDELRKEVQAMSQCNH 58

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYC 130
           PNVV+ +       ++++V+ Y++GG L D + S    G L EA    + ++++ G+ Y 
Sbjct: 59  PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-----LLHTTCGSPNYVAP 185
           H+ G  HRD+K  NILL   G++KI+DFG+SA      D G     +  T  G+P ++AP
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSAS---LADGGDRTRKVRKTFVGTPCWMAP 175

Query: 186 EVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLP-----K 238
           EV+    GYD   +DIWS G+    + TG  P+     + VL   +      L      K
Sbjct: 176 EVMEQVHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYK 234

Query: 239 WLSPGAQNLLRKILEPNPVKRIT 261
             S   + ++   L+ +P KR T
Sbjct: 235 KYSKSFRKMISLCLQKDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  118 bits (297), Expect = 2e-31
 Identities = 86/259 (33%), Positives = 132/259 (50%), Gaps = 13/259 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI--TDQIKREIATLKLLK 72
           RY L + LG+G+FG V   +D  +     +K+L++  +  L    T Q  +E   L  L 
Sbjct: 1   RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVS 128
           HP +V+ H     +    ++ EY  G +L  K+     +   L E +  + F QL+ GV 
Sbjct: 61  HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120

Query: 129 YCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           Y H + + HRDLK +NI L  K N+ KI DFG+S L     D  L  T  G+P Y++PE 
Sbjct: 121 YMHQRRILHRDLKAKNIFL--KNNLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEA 176

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQN 246
           L ++GYD + SDIWS G ILY +      F+ +N   +  +I  G    LP+  S    +
Sbjct: 177 LKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNS 235

Query: 247 LLRKILEPNPVKRITIAGI 265
           +++ +L  +P  R + A I
Sbjct: 236 IMQSMLNKDPSLRPSAAEI 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  118 bits (297), Expect = 2e-31
 Identities = 68/257 (26%), Positives = 124/257 (48%), Gaps = 15/257 (5%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + L R LG G FG+V      +  +  A+KIL+ + ++        ++E+  LK L+H +
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQ---QDFQKEVQALKRLRHKH 63

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGR-LQEAEGRKLFQQLIDGVSYCHNK 133
           ++ L  V +    +Y++ E +  G L   + S +G+ L  A    +  Q+ +G++Y   +
Sbjct: 64  LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRG 192
              HRDL   NIL+      K++DFGL+ L    ++D  L +    P  + APE  A+ G
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEA-ASHG 179

Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLS--PGAQNLLR 249
                SD+WS G++LY + T G +P+   N   +Y +I  G +++P           ++ 
Sbjct: 180 TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMPCPAKCPQEIYKIML 238

Query: 250 KILEPNPVKRITIAGIK 266
           +     P  R +   ++
Sbjct: 239 ECWAAEPEDRPSFKALR 255

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  118 bits (299), Expect = 3e-31
 Identities = 65/204 (31%), Positives = 107/204 (52%), Gaps = 27/204 (13%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-REI-ATLKLLKH 73
           Y++ + LG+G FG V  A++ ++G   A+K + K +    +  + +  RE+ +  KL +H
Sbjct: 1   YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWE--ECMNLREVKSLRKLNEH 57

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGR-LQEAEGRKLFQQLIDGVSYCH 131
           PN+V+L EV     ++Y V EY+ G  L+  +   KG+   E+  R +  Q++ G+++ H
Sbjct: 58  PNIVKLKEVFRENDELYFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYV------ 183
             G FHRDLK EN+L+     +KI+DFGL+      R           P  +YV      
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLA------R-----EIRSRPPYTDYVSTRWYR 165

Query: 184 APEVLANRGYDGATSDIWSCGVIL 207
           APE+L       +  DIW+ G I+
Sbjct: 166 APEILLRSTSYSSPVDIWALGCIM 189

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  119 bits (299), Expect = 4e-31
 Identities = 97/324 (29%), Positives = 132/324 (40%), Gaps = 90/324 (27%)

Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--------REIATLK 69
           L R +GEG +G V  A+D  SG   A+K   K R       D  +        REI  L 
Sbjct: 12  LNR-IGEGTYGIVYRARDTTSGEIVALK---KVR------MDNERDGIPISSLREITLLL 61

Query: 70  LLKHPNVVRLHEVLASKS--KIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLID 125
            L+HPN+V L EV+  K    I++V+EY       L D + +     E++ + L  QL+ 
Sbjct: 62  NLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTP--FSESQVKCLMLQLLR 119

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPN- 181
           G+ Y H   + HRDLK+ N+LL  KG +KI+DFGL+    LP              +P  
Sbjct: 120 GLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM----------TPKV 169

Query: 182 ----YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLP------------------ 216
               Y APE+L     Y  A  D+W+ G IL  +L     LP                  
Sbjct: 170 VTLWYRAPELLLGCTTYTTAI-DMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228

Query: 217 -------FDDRNLAVLYQKIFRGDFKLPK-----------WLSPGAQNLLRKILEPNPVK 258
                  F D  L         G F LPK           WLS     LL  +L  +P K
Sbjct: 229 NESIWPGFSDLPLV--------GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKK 280

Query: 259 RITIAGIKADEWFEQDYTPANPDD 282
           R T        +F++   P  P+ 
Sbjct: 281 RATAEEALESSYFKEKPLPCEPEM 304

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  118 bits (297), Expect = 4e-31
 Identities = 76/259 (29%), Positives = 135/259 (52%), Gaps = 26/259 (10%)

Query: 15  RYELGR--TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IAT 67
           R  L     +GEG+ G V  A D  +G   AVK ++        +  Q +RE     +  
Sbjct: 18  RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD--------LRKQQRRELLFNEVVI 69

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           ++  +HPN+V ++       ++++V+E++ GG L D I +  R+ E +   +   ++  +
Sbjct: 70  MRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKAL 128

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           S+ H +GV HRD+K ++ILL S G +K+SDFG  A  Q  ++     +  G+P ++APEV
Sbjct: 129 SFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPEV 186

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGD----FKLPKWLSP 242
           ++   Y G   DIWS G+++  ++ G  P F++  L  +  K  R +     K    +SP
Sbjct: 187 ISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAM--KRIRDNLPPKLKNLHKVSP 243

Query: 243 GAQNLLRKILEPNPVKRIT 261
             ++ L ++L  +P +R T
Sbjct: 244 RLRSFLDRMLVRDPAQRAT 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  120 bits (302), Expect = 5e-31
 Identities = 95/312 (30%), Positives = 132/312 (42%), Gaps = 68/312 (21%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           +TLG G FG+V  A+ +D+   +A+K L K  ++       +K E   L    +  VVRL
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           +     K  +Y V++Y+ GG++   +   G   E   R    +L   V   H  G  HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126

Query: 140 LKLENILLDSKGNIKISDFGL---------SALPQ---HFRDDG---------------- 171
           +K +NIL+D  G+IK++DFGL         S   Q   H R D                 
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186

Query: 172 -----------------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 214
                            L H+  G+PNY+APEVL   GY     D WS GVILY +L G 
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245

Query: 215 LPFDDRNLAVLYQKIFRGDFKLPKW-----------LSPGAQNLLRKILEPNPVKRITIA 263
            PF       L Q       K+  W           LSP A +L+ K+    P  R+   
Sbjct: 246 PPF-------LAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCR-GPEDRLGKN 297

Query: 264 G---IKADEWFE 272
           G   IKA  +F+
Sbjct: 298 GADEIKAHPFFK 309

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  120 bits (302), Expect = 5e-31
 Identities = 85/282 (30%), Positives = 144/282 (51%), Gaps = 29/282 (10%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI----KREIA 66
           M+   +++ + +G G FG+V+  +   S   +A+K+L K  +I  K +D      +R+I 
Sbjct: 40  MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMI--KRSDSAFFWEERDI- 96

Query: 67  TLKLLKHPN---VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
               + H N   +V+LH        +YMV+EY+ GG+L + + S   + E   R    ++
Sbjct: 97  ----MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEKWARFYTAEV 151

Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPN 181
           +  +   H+ G  HRD+K +N+LLD  G++K++DFG          +G++   T  G+P+
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMDANGMVRCDTAVGTPD 208

Query: 182 YVAPEVLANRGYD---GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKL 236
           Y++PEVL ++G D   G   D WS GV LY +L G  PF   +L   Y KI   +     
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTF 268

Query: 237 PK--WLSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274
           P    +S  A++L+   L    V+  R  +  IK+  +F+ D
Sbjct: 269 PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  119 bits (300), Expect = 7e-31
 Identities = 75/247 (30%), Positives = 118/247 (47%), Gaps = 34/247 (13%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E  + +G G FG+V+  Q  D+G  +A+KIL K  ++  +    I+ E   L       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV++      K  +Y+++E++ GG++   +  K  L E E +    + +  +   H  G 
Sbjct: 63  VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122

Query: 136 FHRDLKLENILLDSKGNIKISDFGLS-----------------ALPQHFRDDG------- 171
            HRD+K +N+LLDSKG++K+SDFGL                  +LP  F           
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182

Query: 172 ---------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL 222
                    L  +T G+P+Y+APEV    GY+    D WS GVI+Y +L GY PF     
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 223 AVLYQKI 229
              Y+K+
Sbjct: 242 QETYKKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score =  123 bits (309), Expect = 7e-31
 Identities = 76/235 (32%), Positives = 117/235 (49%), Gaps = 14/235 (5%)

Query: 37  DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL-HEVLASKSKIYMVLEY 95
            +G   A+K+L  +         + +RE A    L HPN+V L     A    ++ V EY
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 96  VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---N 152
           V G  L + +A+ G L   E  +L  Q++D ++  HN+G+ HRDLK +NI++   G   +
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 153 IKISDFGLSALPQHFRDDGLLHTT-----CGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
            K+ DFG+  L    RD  +   T      G+P Y APE L         SD+++ G+I 
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVT-PNSDLYAWGLIF 179

Query: 208 YVILTGYLPFDDRNLA-VLYQKIFRGDFKLPKWLS--PGAQNLLRKILEPNPVKR 259
              LTG       ++A +LYQ++   D  LP W++  P  Q +LRK L  +P +R
Sbjct: 180 LECLTGQRVVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQ-VLRKALNKDPRQR 233

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  117 bits (296), Expect = 9e-31
 Identities = 86/293 (29%), Positives = 134/293 (45%), Gaps = 56/293 (19%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKH 73
           +++   +GEG +G+V  A+D D+G   A+K   K R+ + K    I   REI  L+ L H
Sbjct: 9   FDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQLNH 65

Query: 74  PNVVRLHEVLASKSK----------IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQ 122
            N+V L E++  K             Y+V EY+   +L   + S      E   +   +Q
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQ 124

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPN 181
           L++G++YCH K   HRD+K  NILL++KG IK++DFGL+ L  +  ++   +T    +  
Sbjct: 125 LLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL--YNSEESRPYTNKVITLW 182

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVL--------------- 225
           Y  PE+L      G   D+WSCG IL  + T    F  ++ LA L               
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242

Query: 226 -----------------YQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
                            Y++  R +F     +   A +LL  +L  +P KR T
Sbjct: 243 PDVIKLPYFNTMKPKKQYRRRLREEFSF---IPTPALDLLDHMLTLDPSKRCT 292

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  118 bits (298), Expect = 1e-30
 Identities = 72/247 (29%), Positives = 119/247 (48%), Gaps = 34/247 (13%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E  + +G G FG+V+  Q  D+G  +A+KIL K  ++  +    I+ E   L       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV++      K  +Y+++E++ GG++   +  K  L E   +    + +  +   H  G 
Sbjct: 63  VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122

Query: 136 FHRDLKLENILLDSKGNIKISDFGL-SALPQHFRDD------------------------ 170
            HRD+K +N+LLD+KG++K+SDFGL + L +  R +                        
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182

Query: 171 --------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL 222
                    L ++T G+P+Y+APEV    GY+    D WS GVI+Y +L GY PF     
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSETP 241

Query: 223 AVLYQKI 229
              Y+K+
Sbjct: 242 QETYRKV 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  117 bits (296), Expect = 1e-30
 Identities = 71/268 (26%), Positives = 134/268 (50%), Gaps = 16/268 (5%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +++   +G G+FG+V+  ++  +G  +A+K+++K+ ++  +     + E   L +   P 
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           + +L      K  +Y+V+EY  GG+L   +   + +  E   +    +L+  +   H  G
Sbjct: 63  IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVL-ANR 191
             HRD+K EN+L+D  G+IK++DFG +A       + ++++    G+P+Y+APEVL    
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAPEVLTTMN 179

Query: 192 GYDGATSDI----WSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLPKWL--SPG 243
           G    T  +    WS GVI Y ++ G  PF +   A  Y  I  F+   K P+    S  
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239

Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWF 271
             +L++ +L     +R+   G+    +F
Sbjct: 240 FLDLIQSLL-CGQKERLGYEGLCCHPFF 266

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  115 bits (290), Expect = 2e-30
 Identities = 86/258 (33%), Positives = 130/258 (50%), Gaps = 23/258 (8%)

Query: 15  RYELGRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR-----EIATL 68
            Y   R LG+G FG+   + +  D  L   V   E    ++L    + +R     EI  L
Sbjct: 1   HYIPIRVLGKGAFGEATLYRRTEDDSL---VVWKE----VNLTRLSEKERRDALNEIVIL 53

Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAE--GRKLFQQLID 125
            LL+HPN++  +      + + + +EY  GG L+DKI   KG+L E E     LFQ ++ 
Sbjct: 54  SLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ-IVS 112

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC-GSPNYVA 184
            VSY H  G+ HRD+K  NI L   G IK+ DFG+S   +    +  +  T  G+P Y++
Sbjct: 113 AVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS---KILGSEYSMAETVVGTPYYMS 169

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPG 243
           PE+     Y+   SDIW+ G +LY +LT    FD  N   L  KI +G++  +    S  
Sbjct: 170 PELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSE 228

Query: 244 AQNLLRKILEPNPVKRIT 261
             +L+  +L+ +P KR T
Sbjct: 229 LISLVHSLLQQDPEKRPT 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  114 bits (287), Expect = 8e-30
 Identities = 81/264 (30%), Positives = 125/264 (47%), Gaps = 18/264 (6%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
             LG GN G V       +G   AVK +     I+  I  QI RE+  L     P +V  
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLE--INEAIQKQILRELDILHKCNSPYIVGF 64

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
           +    +   I + +EY+ GG L DKI    +GR+ E    K+   ++ G++Y H K  + 
Sbjct: 65  YGAFYNNGDISICMEYMDGGSL-DKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123

Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           HRD+K  NIL++S+G IK+ DFG+S        + L  T  G+ +Y+APE +    Y   
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSG----QLVNSLAKTFVGTSSYMAPERIQGNDY-SV 178

Query: 197 TSDIWSCGVILYVILTGYLPF---DDRNLAV--LYQKIFRGDF-KLPK-WLSPGAQNLLR 249
            SDIWS G+ L  + TG  P+   +D    +  L Q I      +LP    SP  Q+ + 
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDFQDFVN 238

Query: 250 KILEPNPVKRITIAGIKADEWFEQ 273
             L  +P +R +   +    + ++
Sbjct: 239 LCLIKDPRERPSYKELLEHPFIKK 262

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  114 bits (288), Expect = 8e-30
 Identities = 71/208 (34%), Positives = 111/208 (53%), Gaps = 23/208 (11%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLK 72
           G +EL   +GEG +GKV  A+   +G   A+KI++   II  +  + IK E   L K   
Sbjct: 6   GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEE-IKEEYNILRKYSN 61

Query: 73  HPNVVRLHEVLASKS------KIYMVLEYVTGG---ELFDKIASKG-RLQEAEGRKLFQQ 122
           HPN+   +     K+      ++++V+E   GG   +L   +  KG RL+E     + ++
Sbjct: 62  HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
            + G++Y H   V HRD+K +NILL     +K+ DFG+SA  Q     G  +T  G+P +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPYW 179

Query: 183 VAPEVLA-----NRGYDGATSDIWSCGV 205
           +APEV+A     +  YD A SD+WS G+
Sbjct: 180 MAPEVIACDEQPDASYD-ARSDVWSLGI 206

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  115 bits (291), Expect = 1e-29
 Identities = 89/329 (27%), Positives = 133/329 (40%), Gaps = 67/329 (20%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKH 73
           RYEL + +G G +G V  A D  +G   A+K +  + +   L    +I REI  L+ L+H
Sbjct: 1   RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRILREIKLLRHLRH 58

Query: 74  PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
            N++ L ++L   S      +Y+V E +   +L   I S   L +   +    Q++ G+ 
Sbjct: 59  ENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLYQILRGLK 117

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYV--- 183
           Y H+  V HRDLK  NIL++S  ++KI DFGL+    P       L         YV   
Sbjct: 118 YLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE-------YVVTR 170

Query: 184 ---APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--------- 230
              APE+ L++  Y  A  DIWS G I   +LT    F  R+       I          
Sbjct: 171 WYRAPELLLSSSRYTKAI-DIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEE 229

Query: 231 ----------------RGDFKLPKW------LSPGAQNLLRKILEPNPVKRITIAGIKAD 268
                                           SP A +LL K+L  +P KRIT     A 
Sbjct: 230 DLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289

Query: 269 EWFEQDYTPA----------NPDDDEEDI 287
            +  Q + P               D++++
Sbjct: 290 PYLAQLHDPEDEPVAKPPFDFDFFDDDEL 318

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  116 bits (292), Expect = 1e-29
 Identities = 81/284 (28%), Positives = 143/284 (50%), Gaps = 15/284 (5%)

Query: 2   VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
           ++ + ++  M+   Y++ + +G G FG+V+  +   S   +A+K+L K  +I    +   
Sbjct: 31  IVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFF 90

Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
             E   +     P VV+L         +YMV+EY+ GG+L + + S   + E   +    
Sbjct: 91  WEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTA 149

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGS 179
           +++  +   H+ G+ HRD+K +N+LLD  G++K++DFG         + G++   T  G+
Sbjct: 150 EVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC---MKMDETGMVRCDTAVGT 206

Query: 180 PNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDF 234
           P+Y++PEVL ++   GY G   D WS GV L+ +L G  PF   +L   Y KI   +   
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 266

Query: 235 KLPK--WLSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274
             P+   +S  A+NL+   L    V+  R  +  IK   +F+ D
Sbjct: 267 NFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  114 bits (287), Expect = 1e-29
 Identities = 86/293 (29%), Positives = 137/293 (46%), Gaps = 65/293 (22%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK-------REIAT 67
           +YE    +GEG +G V  A++ ++    A+K         +++ D  +       REI  
Sbjct: 1   KYEKLEKIGEGTYGTVFKAKNRETHEIVALK--------RVRLDDDDEGVPSSALREICL 52

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLID 125
           LK LKH N+VRL++VL S  K+ +V EY      + FD  +  G +     +    QL+ 
Sbjct: 53  LKELKHKNIVRLYDVLHSDKKLTLVFEYCDQDLKKYFD--SCNGDIDPEIVKSFMFQLLK 110

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN---- 181
           G+++CH+  V HRDLK +N+L++  G +K++DFGL+      R  G +   C S      
Sbjct: 111 GLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA------RAFG-IPVRCYSAEVVTL 163

Query: 182 -YVAPEVL-ANRGYDGATS-DIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFR------ 231
            Y  P+VL   + Y   TS D+WS G I   +     P F   ++    ++IFR      
Sbjct: 164 WYRPPDVLFGAKLYS--TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPT 221

Query: 232 -----GDFKLPKW------------------LSPGAQNLLRKILEPNPVKRIT 261
                G  KLP +                  L+   ++LL+ +L  NPV+RI+
Sbjct: 222 EESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS 274

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  114 bits (288), Expect = 3e-29
 Identities = 67/206 (32%), Positives = 111/206 (53%), Gaps = 14/206 (6%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           E    +G G  G V       +G  +A+K++  N    ++   QI REI  L+ + HPNV
Sbjct: 77  ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRR--QICREIEILRDVNHPNV 134

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           V+ H++     +I ++LE++ GG L    IA +  L +     + +Q++ G++Y H + +
Sbjct: 135 VKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLAD-----VARQILSGIAYLHRRHI 189

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL---ANRG 192
            HRD+K  N+L++S  N+KI+DFG+S +     D    +++ G+  Y++PE +    N G
Sbjct: 190 VHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--CNSSVGTIAYMSPERINTDLNHG 247

Query: 193 -YDGATSDIWSCGVILYVILTGYLPF 217
            YDG   DIWS GV +     G  PF
Sbjct: 248 AYDGYAGDIWSLGVSILEFYLGRFPF 273

Length = 353

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  115 bits (288), Expect = 4e-29
 Identities = 73/243 (30%), Positives = 107/243 (44%), Gaps = 46/243 (18%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           +TLG G FG+V  A  +D+   +A+K L K  +++      +K E   L    +  VV+L
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           +     K  +Y V++Y+ GG++   +       E   R    +L   +   H  G  HRD
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126

Query: 140 LKLENILLDSKGNIKISDFGL----------------------SALPQHFRDD------- 170
           +K +NIL+D  G+IK++DFGL                      S  P    DD       
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186

Query: 171 ----------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 214
                            L H+  G+PNY+APEVL  +GY     D WS GVIL+ +L G 
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245

Query: 215 LPF 217
            PF
Sbjct: 246 PPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  112 bits (282), Expect = 6e-29
 Identities = 82/256 (32%), Positives = 126/256 (49%), Gaps = 10/256 (3%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG+G FG+V   Q   +G  +A K LEK RI   K       E   L+ +    VV L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
                +K  + +VL  + GG+L   I   G     EGR +F   ++  G+   H + + +
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125

Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
           RDLK ENILLD  G+I+ISD GL+    H  +   +    G+  Y+APEV+ N  Y   +
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYT-FS 181

Query: 198 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKILE 253
            D W+ G +LY ++ G  PF  R   +  +++ R       +  +  SP A++L + +L 
Sbjct: 182 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241

Query: 254 PNPVKRITIAGIKADE 269
            +P +R+   G  A E
Sbjct: 242 KDPKERLGCQGGGARE 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  112 bits (281), Expect = 7e-29
 Identities = 94/269 (34%), Positives = 144/269 (53%), Gaps = 37/269 (13%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
           LG+G +G V  A+DL + +  A+K I E++     +    +  EIA    LKH N+V+  
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDS----RYVQPLHEEIALHSYLKHRNIVQY- 70

Query: 81  EVLASKS-----KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLF--QQLIDGVSYCHN 132
             L S S     KI+M  E V GG L   + SK G L++ E   +F  +Q+++G+ Y H+
Sbjct: 71  --LGSDSENGFFKIFM--EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHD 126

Query: 133 KGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGL---LHTTCGSPNYVAPEVL 188
             + HRD+K +N+L+++  G +KISDFG S      R  G+     T  G+  Y+APEV+
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEVI 181

Query: 189 --ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-GDFK----LPKWLS 241
               RGY GA +DIWS G  +  + TG  PF +  L      +F+ G FK    +P+ LS
Sbjct: 182 DKGPRGY-GAPADIWSLGCTIVEMATGKPPFIE--LGEPQAAMFKVGMFKIHPEIPESLS 238

Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEW 270
             A+N + +  EP+P KR +   +  D +
Sbjct: 239 AEAKNFILRCFEPDPDKRASAHDLLQDPF 267

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  111 bits (280), Expect = 8e-29
 Identities = 82/244 (33%), Positives = 124/244 (50%), Gaps = 12/244 (4%)

Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILE---KNRIIHLKITDQIKREIATLKLLKHPN 75
           G  LG+G +G V +    + G   AVK +E    N +   K  ++++ E+  LK LKH N
Sbjct: 5   GEVLGKGAYGTV-YCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V+        + I + +E+V GG +   +   G L E    K  +Q++DGV+Y HN  V
Sbjct: 64  IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123

Query: 136 FHRDLKLENILLDSKGNIKISDFG----LSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            HRD+K  N++L   G IK+ DFG    L+ +  H     +L +  G+P ++APEV+   
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFD--DRNLAVLYQKIFRGDF-KLPKWLSPGAQNLL 248
           GY G  SDIWS G  ++ + TG  P    DR  A+ Y    RG   +LP   S  A + +
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFV 242

Query: 249 RKIL 252
              L
Sbjct: 243 TSCL 246

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  113 bits (283), Expect = 2e-28
 Identities = 83/275 (30%), Positives = 136/275 (49%), Gaps = 15/275 (5%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           M+   YE+ + +G G FG+V+  +   +   +A+K+L K  +I    +     E   +  
Sbjct: 40  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 99

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
              P VV+L         +YMV+EY+ GG+L + + S   + E   R    +++  +   
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 158

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVL 188
           H+ G  HRD+K +N+LLD  G++K++DFG          +G++   T  G+P+Y++PEVL
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMVRCDTAVGTPDYISPEVL 215

Query: 189 ANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLP--KWLS 241
            ++   GY G   D WS GV LY +L G  PF   +L   Y KI   +     P    +S
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 275

Query: 242 PGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274
             A+NL+   L    V+  R  +  IK   +F+ D
Sbjct: 276 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  111 bits (279), Expect = 2e-28
 Identities = 86/290 (29%), Positives = 137/290 (47%), Gaps = 57/290 (19%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKL 70
           YE    +GEG +G V  A+DL++G   A+K       + + ++++       REIA LK 
Sbjct: 1   YEELAEIGEGAYGTVYKARDLNTGRFVALKK------VRVPLSEEGIPLSTLREIALLKQ 54

Query: 71  LK---HPNVVRLHEVLA-----SKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLF 120
           L+   HPN+VRL +V        + K+ +V E+V         K    G L     + L 
Sbjct: 55  LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG-LPPETIKDLM 113

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
           +QL+ GV + H+  + HRDLK +NIL+ S G +KI+DFGL+ +   +  +  L +   + 
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI---YSFEMALTSVVVTL 170

Query: 181 NYVAPEVLANRGYDGATS-DIWSCGVILYVI---------------------LTGYLPFD 218
            Y APEVL    Y  AT  D+WS G I   +                     + G    +
Sbjct: 171 WYRAPEVLLQSSY--ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228

Query: 219 D--RNLAVL---YQKIFRGDFK--LPKWLSPGAQNLLRKILEPNPVKRIT 261
           +  RN+++    +       FK  +P+ +     +LL+K+L  NP KRI+
Sbjct: 229 EWPRNVSLPRSSFPSYTPRSFKSFVPE-ICEEGLDLLKKMLTFNPHKRIS 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  111 bits (278), Expect = 2e-28
 Identities = 79/256 (30%), Positives = 124/256 (48%), Gaps = 10/256 (3%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG+G FG+V   Q   +G  +A K LEK RI   K       E   L+ +    VV L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
                +K  + +VL  + GG+L   I + G     E R +F   ++  G+   H + + +
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125

Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
           RDLK ENILLD  G+I+ISD GL+       +   +    G+  Y+APEV+ N  Y   +
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181

Query: 198 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKILE 253
            D W  G ++Y ++ G  PF  R   V  +++ R       +  +  S  A+++ R++L 
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241

Query: 254 PNPVKRITIAGIKADE 269
            +P  R+   G  A+E
Sbjct: 242 KDPGFRLGCRGEGAEE 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 3e-28
 Identities = 75/282 (26%), Positives = 124/282 (43%), Gaps = 50/282 (17%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + +G+G FG+V+  Q  D+G  +A+K L K+ +        +K E   L     P VV L
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           +        +Y+++E++ GG+L   +       E   R    + +  +   H  G  HRD
Sbjct: 67  YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126

Query: 140 LKLENILLDSKGNIKISDFGL--------------------SALPQHFRDDGLL------ 173
           +K +NIL+D  G+IK+SDFGL                    S   +    + +       
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186

Query: 174 -------------------HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY 214
                              ++T G+P+Y+APE+   +GY G   D WS G I++  L G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245

Query: 215 LPFDDRNLAVLYQKI--FRGDFKLPK--WLSPGAQNLLRKIL 252
            PF   N    Y+KI  +R     P    LS  A++L+R+++
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI 287

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  110 bits (277), Expect = 3e-28
 Identities = 71/209 (33%), Positives = 110/209 (52%), Gaps = 18/209 (8%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL--EKNRIIHLKITDQIKREIATLKLLKHP 74
           EL R LGEG  G V   +  ++G+ FA+K +  + N  +      QI RE+   K  K P
Sbjct: 5   ELSR-LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQ----KQILRELEINKSCKSP 59

Query: 75  NVVRLHE--VLASKSKIYMVLEYVTGGEL---FDKIASKG-RLQEAEGRKLFQQLIDGVS 128
            +V+ +   +  S S I + +EY  GG L   + K+  +G R+ E    K+ + ++ G+S
Sbjct: 60  YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           Y H++ + HRD+K  NILL  KG +K+ DFG+S        + L  T  G+  Y+APE +
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV----NSLAGTFTGTSFYMAPERI 175

Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF 217
             + Y   TSD+WS G+ L  +     PF
Sbjct: 176 QGKPYS-ITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 5e-28
 Identities = 91/322 (28%), Positives = 137/322 (42%), Gaps = 71/322 (22%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +YE+   +G G +G+V  A+  +   G  +A+K  + ++  +  I+    REIA L+ LK
Sbjct: 1   KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60

Query: 73  HPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLID 125
           H NVV L EV    +   +Y++ +Y    +L+  I     A +  +  +  + L  Q+++
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119

Query: 126 GVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGL-----SALPQHFRDDGLLHTT 176
           GV Y H+  V HRDLK  NIL+      +G +KI D GL     + L      D ++ T 
Sbjct: 120 GVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI 179

Query: 177 CGSPNYVAPEV-LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQ---- 227
                Y APE+ L  R Y  A  DIW+ G I   +LT    F         +  +Q    
Sbjct: 180 W----YRAPELLLGARHYTKAI-DIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQL 234

Query: 228 -KIFR-----------------------GDFK--------LPKW------LSPGAQNLLR 249
            +IF                         DFK        L KW            +LLR
Sbjct: 235 ERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLR 294

Query: 250 KILEPNPVKRITIAGIKADEWF 271
           K+LE +P KRIT        +F
Sbjct: 295 KLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  110 bits (278), Expect = 7e-28
 Identities = 89/324 (27%), Positives = 142/324 (43%), Gaps = 50/324 (15%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G+V  A D  +G   A+K L +     IH K T    RE+  LK + 
Sbjct: 16  RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRT---YRELRLLKHMD 72

Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L     +Y+V   + G +L + +  + +L +   + L  Q++ G
Sbjct: 73  HENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ-KLSDDHIQFLVYQILRG 130

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+ G+ HRDLK  NI ++    +KI DFGL+        D  +     +  Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT-----DDEMTGYVATRWYRAPE 185

Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF----------------------------- 217
           ++ N  +   T DIWS G I+  +LTG   F                             
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 218 -DDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
              RN      ++ + DFK +    +P A +LL K+L  +P KRIT A   A  +  + +
Sbjct: 246 ESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305

Query: 276 TPAN-PDDDEEDIFVDNEAFSMHE 298
            P + P     D   ++   ++ E
Sbjct: 306 DPEDEPVAPPYDQSFESRDLTVDE 329

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  109 bits (275), Expect = 8e-28
 Identities = 84/282 (29%), Positives = 133/282 (47%), Gaps = 56/282 (19%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKLLKHPNV 76
           +GEG +G V   ++  +G   A+K       I L+  ++       REI+ LK L+HPN+
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKK------IRLESEEEGVPSTAIREISLLKELQHPNI 61

Query: 77  VRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V L +VL  +S++Y++ E+++    +  D +     +     +    Q++ G+ +CH++ 
Sbjct: 62  VCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-----LHTTCGSPNYVAPEVLA 189
           V HRDLK +N+L+D+KG IK++DFGL+      R  G+      H    +  Y APEVL 
Sbjct: 122 VLHRDLKPQNLLIDNKGVIKLADFGLA------RAFGIPVRVYTHEVV-TLWYRAPEVLL 174

Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFR----------------G 232
                    DIWS G I   + T    F  D  +  L+ +IFR                 
Sbjct: 175 GSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLF-RIFRILGTPTEDVWPGVTSLP 233

Query: 233 DFK--LPKW-----------LSPGAQNLLRKILEPNPVKRIT 261
           D+K   PKW           L     +LL K+L  +P KRI+
Sbjct: 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS 275

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 9e-28
 Identities = 81/275 (29%), Positives = 133/275 (48%), Gaps = 40/275 (14%)

Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           L R LG G FG+V +    +     AVK L+   +      +   +E   +K L+H  +V
Sbjct: 10  LERKLGAGQFGEV-WMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLV 64

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVSY 129
           +L+ V + +  IY+V EY++ G L D       L+  EG+KL   QL+D       G++Y
Sbjct: 65  QLYAVCSEEEPIYIVTEYMSKGSLLD------FLKSGEGKKLRLPQLVDMAAQIAEGMAY 118

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY----VAP 185
             ++   HRDL   NIL+      KI+DFGL+ L     DD   +T      +     AP
Sbjct: 119 LESRNYIHRDLAARNILVGENLVCKIADFGLARL---IEDD--EYTAREGAKFPIKWTAP 173

Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           E  AN G     SD+WS G++L  I+T G +P+       + +++ RG +++P+   P  
Sbjct: 174 EA-ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPR--PPNC 229

Query: 245 ----QNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                +L+ +  + +P +R T   ++    F +DY
Sbjct: 230 PEELYDLMLQCWDKDPEERPTFEYLQ---SFLEDY 261

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score =  108 bits (270), Expect = 2e-27
 Identities = 78/257 (30%), Positives = 124/257 (48%), Gaps = 15/257 (5%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L  + + + +G G F +V  A  L  G+P A+K ++   ++  K      +EI  LK L 
Sbjct: 1   LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVS 128
           HPNV++ +      +++ +VLE    G+L   I      K  + E    K F QL   + 
Sbjct: 61  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           + H++ V HRD+K  N+ + + G +K+ D GL             H+  G+P Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERI 178

Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
              GY+   SDIWS G +LY +     PF  D  NL  L +KI + D+  P   S     
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSE 235

Query: 247 LLRKILE----PNPVKR 259
            LR+++     P+P KR
Sbjct: 236 ELRQLVNMCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  107 bits (269), Expect = 2e-27
 Identities = 75/259 (28%), Positives = 133/259 (51%), Gaps = 18/259 (6%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-----LKL 70
           Y   R +G+G++G+V   +    G  + +K L      +L+   + +R+ A      L  
Sbjct: 2   YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKL------NLRNASRRERKAAEQEAQLLSQ 55

Query: 71  LKHPNVVRLHEVLASKS-KIYMVLEYVTGGELFDKIA-SKGRL-QEAEGRKLFQQLIDGV 127
           LKHPN+V   E    +   +Y+V+ +  GG+L+ K+   KG+L  E +  + F Q+   +
Sbjct: 56  LKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMAL 115

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H K + HRDLK +N+ L     IK+ D G++ + ++  D  +  T  G+P Y++PE+
Sbjct: 116 QYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYMSPEL 173

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQN 246
            +N+ Y+   SD+W+ G  +Y + T    F+ +++  L  +I  G    +PK  SP    
Sbjct: 174 FSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGE 232

Query: 247 LLRKILEPNPVKRITIAGI 265
           L+  +L   P KR ++  I
Sbjct: 233 LIATMLSKRPEKRPSVKSI 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  108 bits (271), Expect = 2e-27
 Identities = 85/285 (29%), Positives = 131/285 (45%), Gaps = 48/285 (16%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL---EKNRIIHLKITDQIKREIATLKLL 71
           +YE    +GEG++G V   ++ ++G   A+K     E + +I  KI     REI  LK L
Sbjct: 2   KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIK-KIA---LREIRMLKQL 57

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           KHPN+V L EV   K K+++V EY     L +   +   + E   +K+  Q +  V++CH
Sbjct: 58  KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCH 117

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-YVAPEVLAN 190
                HRD+K ENIL+  +G IK+ DFG + +     DD   +T   +   Y APE+L  
Sbjct: 118 KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD---YTDYVATRWYRAPELLVG 174

Query: 191 RGYDGATSDIWSCGVILYVILTG-------------YLPFDDRNLAVLY---QKIFR-GD 233
               G   D+W+ G +   +LTG             YL    + L  L    Q+IF    
Sbjct: 175 DTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLI--RKTLGDLIPRHQQIFSTNQ 232

Query: 234 F-----------------KLPKWLSPGAQNLLRKILEPNPVKRIT 261
           F                 K P  +S  A + L+  L+ +P +R++
Sbjct: 233 FFKGLSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  108 bits (270), Expect = 3e-27
 Identities = 77/248 (31%), Positives = 132/248 (53%), Gaps = 13/248 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYE    +G+G  G V  A D+ +G   A+K +   +    ++   I  EI  +K LK+P
Sbjct: 23  RYE---KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL---IINEILVMKELKNP 76

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+V   +      ++++V+EY+ GG L D + ++  + EA+   + ++ +  + + H   
Sbjct: 77  NIVNFLDSFLVGDELFVVMEYLAGGSLTD-VVTETCMDEAQIAAVCRECLQALEFLHANQ 135

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           V HRD+K +N+LL   G++K++DFG  A  Q   +     T  G+P ++APEV+  + Y 
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192

Query: 195 GATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKI 251
           G   DIWS G++   ++ G  P+ + N L  LY     G  +L  P+ LSP  ++ L + 
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252

Query: 252 LEPNPVKR 259
           LE +  KR
Sbjct: 253 LEMDVEKR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  108 bits (272), Expect = 4e-27
 Identities = 73/249 (29%), Positives = 130/249 (52%), Gaps = 15/249 (6%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+ + +G G FG+V   +  ++   FA+KIL K  ++    T   + E   L    +  
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           +  LH     ++ +Y+V++Y  GG+L   ++  + RL E   R    +++  +   H   
Sbjct: 63  ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLA--- 189
             HRD+K +NIL+D  G+I+++DFG S L     +DG + ++   G+P+Y++PE+L    
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPDYISPEILQAME 179

Query: 190 -NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLPKW---LSPG 243
             +G  G   D WS GV +Y +L G  PF   +L   Y KI   +  F+ P     +S  
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239

Query: 244 AQNLLRKIL 252
           A++L+R+++
Sbjct: 240 AKDLIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  107 bits (268), Expect = 6e-27
 Identities = 73/253 (28%), Positives = 129/253 (50%), Gaps = 20/253 (7%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IATLK 69
           +Y     +G+G  G V  A D+ +G   A+K         + +  Q K+E     I  ++
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDVATGQEVAIK--------QMNLQQQPKKELIINEILVMR 71

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             KHPN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + +
Sbjct: 72  ENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 130

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H+  V HRD+K +NILL   G++K++DFG  A  Q   +     T  G+P ++APEV+ 
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188

Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKLPKWLSPGAQN 246
            + Y G   DIWS G++   ++ G  P+ + N L  LY     G  + + P+ LS   ++
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 247

Query: 247 LLRKILEPNPVKR 259
            L + LE +  KR
Sbjct: 248 FLNRCLEMDVEKR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score =  106 bits (265), Expect = 1e-26
 Identities = 87/260 (33%), Positives = 134/260 (51%), Gaps = 26/260 (10%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ---IKREIATLKLLK 72
           YEL + +G G +G V  A++L +G   AVKI      I L+  D    I++EI  +K  K
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKI------IKLEPGDDFSLIQQEIFMVKECK 64

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H N+V       S+ K+++ +EY  GG L D     G L E +   + ++ + G++Y H+
Sbjct: 65  HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHS 124

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA--- 189
           KG  HRD+K  NILL   G++K++DFG++A  +         +  G+P ++APEV A   
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAA--KITATIAKRKSFIGTPYWMAPEVAAVEK 182

Query: 190 NRGYDGATSDIWSCGVILYVILTGYLP--FDDRNLAVLYQKIFRGDFKLP------KWLS 241
           N GY+    DIW+ G I  + L    P  FD   +  L+  + + +F+ P      KW S
Sbjct: 183 NGGYN-QLCDIWAVG-ITAIELAELQPPMFDLHPMRALFL-MSKSNFQPPKLKDKTKW-S 238

Query: 242 PGAQNLLRKILEPNPVKRIT 261
               N ++  L  NP KR T
Sbjct: 239 STFHNFVKISLTKNPKKRPT 258

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  106 bits (265), Expect = 2e-26
 Identities = 77/251 (30%), Positives = 135/251 (53%), Gaps = 26/251 (10%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE-----IATLKLLKHPNV 76
           +GEG+ G V  A++  SG   AVK+++        +  Q +RE     +  ++  +H NV
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMD--------LRKQQRRELLFNEVVIMRDYQHQNV 80

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
           V +++      ++++++E++ GG L D I S+ RL E +   + + ++  + Y H++GV 
Sbjct: 81  VEMYKSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIATVCESVLQALCYLHSQGVI 139

Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           HRD+K ++ILL   G +K+SDFG  A  Q  +D     +  G+P ++APEV++   Y G 
Sbjct: 140 HRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRTPY-GT 196

Query: 197 TSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKW-----LSPGAQNLLRK 250
             DIWS G+++  ++ G  P F D  +  +  K  R D   PK      +SP  ++ L +
Sbjct: 197 EVDIWSLGIMVIEMVDGEPPYFSDSPVQAM--KRLR-DSPPPKLKNAHKISPVLRDFLER 253

Query: 251 ILEPNPVKRIT 261
           +L   P +R T
Sbjct: 254 MLTREPQERAT 264

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  106 bits (267), Expect = 2e-26
 Identities = 88/322 (27%), Positives = 137/322 (42%), Gaps = 57/322 (17%)

Query: 15  RYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----------- 62
           RY   G  LGEG +GKV+ A D  +G   A+K ++   I +    D+             
Sbjct: 9   RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTL 68

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           RE+  +  +KH N++ L +V      I +V++ +   +L   +  K RL E++ + +  Q
Sbjct: 69  RELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQ 127

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGS 179
           +++G++  H     HRDL   NI ++SKG  KI+DFGL+     P +        T    
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187

Query: 180 PN---------YVAPEVL--ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK 228
                      Y APE+L  A + Y  A  D+WS G I   +LTG   F   N      +
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEK-YHFAV-DMWSVGCIFAELLTGKPLFPGENEIDQLGR 245

Query: 229 IF--RG-------------------DFKLPKWLSPGAQN-------LLRKILEPNPVKRI 260
           IF   G                     + PK L     N       LL+ +L+ NP++RI
Sbjct: 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305

Query: 261 TIAGIKADEWFEQDYTPANPDD 282
           +       E+F+ D  P +P  
Sbjct: 306 SAKEALKHEYFKSDPLPCDPSQ 327

Length = 335

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  105 bits (263), Expect = 2e-26
 Identities = 82/269 (30%), Positives = 124/269 (46%), Gaps = 39/269 (14%)

Query: 22  LGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FG V+  +   SG   +P AVK L+ +++    I D   +E A +  L H N++R
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL--SDIMDDFLKEAAIMHSLDHENLIR 60

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLIDGVSYCHNKGV 135
           L+ V+ +   + MV E    G L D++  K  L       L     Q+ +G+ Y  +K  
Sbjct: 61  LYGVVLTHP-LMMVTELAPLGSLLDRL-RKDALGHFLISTLCDYAVQIANGMRYLESKRF 118

Query: 136 FHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYV----------- 183
            HRDL   NILL S   +KI DFGL  ALPQ               +YV           
Sbjct: 119 IHRDLAARNILLASDDKVKIGDFGLMRALPQ------------NEDHYVMEEHLKVPFAW 166

Query: 184 -APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKW 239
            APE L  R +  A SD+W  GV L+ + T G  P+   + + + +KI +   +L  P+ 
Sbjct: 167 CAPESLRTRTFSHA-SDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA 225

Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKAD 268
                 N++ +    NP  R T A ++  
Sbjct: 226 CPQDIYNVMLQCWAHNPADRPTFAALREF 254

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score =  105 bits (262), Expect = 2e-26
 Identities = 79/259 (30%), Positives = 124/259 (47%), Gaps = 11/259 (4%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L  +++ + +G G F +V  A  L    P A+K ++   ++  K      +EI  LK L 
Sbjct: 1   LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVS 128
           HPNV++  +     +++ +VLE    G+L   I      K  + E    K F QL   V 
Sbjct: 61  HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           + H++ V HRD+K  N+ + + G +K+ D GL             H+  G+P Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERI 178

Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDF-KLPK-WLSPGA 244
              GY+   SDIWS G +LY +     PF  D  NL  L QKI + D+  LP    S   
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237

Query: 245 QNLLRKILEPNPVKRITIA 263
           + L+   + P+P +R  I 
Sbjct: 238 RELVSMCIYPDPDQRPDIG 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  105 bits (263), Expect = 3e-26
 Identities = 85/295 (28%), Positives = 135/295 (45%), Gaps = 48/295 (16%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL---EKNRIIHLKITDQIKREIATLKLL 71
           +YE    +GEG++G V   +  ++G   A+K     E ++++  KI     REI  LK L
Sbjct: 2   KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVK-KIA---MREIRMLKQL 57

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           +H N+V L EV   K ++Y+V E+V    L D       L E+  RK   Q++ G+ +CH
Sbjct: 58  RHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCH 117

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K ENIL+   G +K+ DFG +   A P     D +      +  Y APE+L
Sbjct: 118 SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYV-----ATRWYRAPELL 172

Query: 189 ANRGYDGATSDIWSCGVILYVILTG--YLPFDDR------------NLAVLYQKIFRG-- 232
                 G   DIW+ G ++  +LTG    P D              NL   +Q+IF+   
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232

Query: 233 ----------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
                           + + PK  S    +L ++ L  +P  R + + +   E+F
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKL-SGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score =  108 bits (270), Expect = 3e-26
 Identities = 71/210 (33%), Positives = 109/210 (51%), Gaps = 16/210 (7%)

Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL------QEAE 115
           + E+  L    H  +V+  +   S  K+ +++EY +GG+L  +I  K RL      QE E
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQI--KQRLKEHLPFQEYE 170

Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL-- 173
              LF Q++  +   H++ + HRDLK  NI L   G IK+ DFG S   + + D   L  
Sbjct: 171 VGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS---KQYSDSVSLDV 227

Query: 174 -HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 232
             + CG+P Y+APE+   + Y    +D+WS GVILY +LT + PF   +   + Q++  G
Sbjct: 228 ASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYG 286

Query: 233 DFK-LPKWLSPGAQNLLRKILEPNPVKRIT 261
            +   P  +S G + LL  +L  NP  R T
Sbjct: 287 KYDPFPCPVSSGMKALLDPLLSKNPALRPT 316

Length = 478

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  104 bits (262), Expect = 5e-26
 Identities = 65/204 (31%), Positives = 100/204 (49%), Gaps = 17/204 (8%)

Query: 20  RTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LGEG+FGKV+         ++G   AVK L  +       +D  +REI  L+ L H N
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL-NHSGEEQHRSD-FEREIEILRTLDHEN 67

Query: 76  VVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----QQLIDGVSY 129
           +V+   V        + +++EY+  G L D +    R ++    K       Q+  G+ Y
Sbjct: 68  IVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQ---RHRDQINLKRLLLFSSQICKGMDY 124

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVL 188
             ++   HRDL   NIL++S+  +KISDFGL+ +    +D   +     SP  + APE L
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184

Query: 189 ANRGYDGATSDIWSCGVILYVILT 212
               +  A SD+WS GV LY + T
Sbjct: 185 RTSKFSSA-SDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  104 bits (260), Expect = 1e-25
 Identities = 95/306 (31%), Positives = 139/306 (45%), Gaps = 62/306 (20%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLKL 70
           YE    +GEG +GKV  A+D ++G   A+K   K R   L++ ++       REI+ L++
Sbjct: 3   YEKLEKIGEGTYGKVYKARDKNTGKLVALK---KTR---LEMDEEGIPPTALREISLLQM 56

Query: 71  LKH-PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGR-----LQEAEGRKL 119
           L     +VRL +V   + K     +Y+V EY+   +L   + S GR     L     +  
Sbjct: 57  LSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSF 115

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLS---ALPQHFRDDGLLHT 175
             QL+ GV++CH  GV HRDLK +N+L+D  KG +KI+D GL    ++P         H 
Sbjct: 116 MYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV----KSYTHE 171

Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR--- 231
              +  Y APEVL    +     DIWS G I   +      F  D  L  L   IF+   
Sbjct: 172 IV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLL-HIFKLLG 229

Query: 232 --------GDFKL------PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIK 266
                   G  KL      P+W           LSP   +LL+K+L  +P KRI+     
Sbjct: 230 TPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAAL 289

Query: 267 ADEWFE 272
              +F+
Sbjct: 290 THPYFD 295

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  103 bits (258), Expect = 1e-25
 Identities = 78/261 (29%), Positives = 132/261 (50%), Gaps = 12/261 (4%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVR 78
           +G G FG+V   +  D+G  +A+K L+K RI   +       E   L L+     P +V 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           +     +  K+  +L+ + GG+L   ++  G   EAE R    ++I G+ + HN+ V +R
Sbjct: 62  MSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYR 121

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGAT 197
           DLK  NILLD  G+++ISD GL+      +     H + G+  Y+APEVL     YD ++
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYD-SS 176

Query: 198 SDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254
           +D +S G +L+ +L G+ PF     ++   + +       +LP   SP  ++LL  +L+ 
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236

Query: 255 NPVKRITIAGIKADEWFEQDY 275
           +  +R+   G  A E  E  +
Sbjct: 237 DVNRRLGCLGRGAQEVKEHPF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  103 bits (259), Expect = 1e-25
 Identities = 84/292 (28%), Positives = 130/292 (44%), Gaps = 66/292 (22%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLK- 72
           Y++   +GEG F +V  AQ   +G  +A+K ++K    H K  +Q+   REI  L+ L  
Sbjct: 1   YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKK----HFKSLEQVNNLREIQALRRLSP 56

Query: 73  HPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGV 127
           HPN++RL EVL  +   ++ +V E +    L++ I  KGR   L E   +    QL+  +
Sbjct: 57  HPNILRLIEVLFDRKTGRLALVFELMDM-NLYELI--KGRKRPLPEKRVKSYMYQLLKSL 113

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV---- 183
            + H  G+FHRD+K ENIL+     +K++DFG S                  P Y     
Sbjct: 114 DHMHRNGIFHRDIKPENILIK-DDILKLADFG-SC-----------RGIYSKPPYTEYIS 160

Query: 184 -----APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----------------- 221
                APE L   GY G   DIW+ G + + IL+ +  F   N                 
Sbjct: 161 TRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA 220

Query: 222 -LAVLYQKIFRGDFKLPK-------WL----SPGAQNLLRKILEPNPVKRIT 261
            +   ++K    ++  P         L    S    +LL+K+L  +P +RIT
Sbjct: 221 EVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT 272

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  103 bits (258), Expect = 1e-25
 Identities = 76/258 (29%), Positives = 133/258 (51%), Gaps = 21/258 (8%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR---EIATLKLLK 72
           +E+   LG+G FGKV  AQ+ ++G      +L   ++I  K  ++++    EI  L    
Sbjct: 7   WEIIGELGDGAFGKVYKAQNKETG------VLAAAKVIDTKSEEELEDYMVEIDILASCD 60

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCH 131
           HPN+V+L +    ++ +++++E+  GG +   +    R L E + R + +Q ++ ++Y H
Sbjct: 61  HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLH 120

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--- 188
              + HRDLK  NIL    G+IK++DFG+SA  ++ R      +  G+P ++APEV+   
Sbjct: 121 ENKIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCE 178

Query: 189 --ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPG 243
              +R YD   +D+WS G+ L  +     P  + N   +  KI + +      P   S  
Sbjct: 179 TSKDRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSE 237

Query: 244 AQNLLRKILEPNPVKRIT 261
            ++ L+K LE N   R T
Sbjct: 238 FKDFLKKCLEKNVDARWT 255

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score =  103 bits (257), Expect = 2e-25
 Identities = 76/260 (29%), Positives = 130/260 (50%), Gaps = 10/260 (3%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVR 78
           +G G FG+V   +  D+G  +A+K L+K RI   +       E   L L+     P +V 
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC 61

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           +     +  K+  +L+ + GG+L   ++  G   E E R    ++I G+ + HN+ V +R
Sbjct: 62  MTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYR 121

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATS 198
           DLK  NILLD  G+++ISD GL+      +     H + G+  Y+APEVL       +++
Sbjct: 122 DLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSSA 177

Query: 199 DIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
           D +S G +L+ +L G+ PF     ++   + +     + +LP   SP  ++LL  +L+ +
Sbjct: 178 DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQRD 237

Query: 256 PVKRITIAGIKADEWFEQDY 275
             KR+   G  A E  E  +
Sbjct: 238 VSKRLGCLGRGAQEVKEHVF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  102 bits (256), Expect = 2e-25
 Identities = 74/255 (29%), Positives = 131/255 (51%), Gaps = 16/255 (6%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +EL + +G G +G V  A+++++G   A+K++   ++   +    +++EI  +K  KH N
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHSN 67

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V        + K+++ +E+  GG L D     G L E++   + ++ + G+ Y H+KG 
Sbjct: 68  IVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGK 127

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA--NRGY 193
            HRD+K  NILL   G++K++DFG+SA  Q         +  G+P ++APEV A   +G 
Sbjct: 128 MHRDIKGANILLTDNGHVKLADFGVSA--QITATIAKRKSFIGTPYWMAPEVAAVERKGG 185

Query: 194 DGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLP------KWLSPGAQN 246
                DIW+ G+    +     P FD   +  L+  + + +F+ P      KW S    +
Sbjct: 186 YNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL-MTKSNFQPPKLKDKMKW-SNSFHH 243

Query: 247 LLRKILEPNPVKRIT 261
            ++  L  NP KR T
Sbjct: 244 FVKMALTKNPKKRPT 258

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 2e-25
 Identities = 66/213 (30%), Positives = 111/213 (52%), Gaps = 21/213 (9%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKL 70
           R EL   +G G +G V   + + +G   A+KI      I+L   D     I+RE+A L  
Sbjct: 5   RLEL---IGRGAYGAVYRGKHVPTGRVVALKI------INLDTPDDDVSDIQREVALLSQ 55

Query: 71  LKH---PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+    PN+ + +       ++++++EY  GG +   +   G + E     + ++++  +
Sbjct: 56  LRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSV-RTLMKAGPIAEKYISVIIREVLVAL 114

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H  GV HRD+K  NIL+ + GN+K+ DFG++AL           T  G+P ++APEV
Sbjct: 115 KYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEV 172

Query: 188 LAN-RGYDGATSDIWSCGVILYVILTGYLPFDD 219
           +   + YD   +DIWS G+ +Y + TG  P+ D
Sbjct: 173 ITEGKYYD-TKADIWSLGITIYEMATGNPPYSD 204

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  102 bits (256), Expect = 3e-25
 Identities = 74/259 (28%), Positives = 129/259 (49%), Gaps = 19/259 (7%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   LG+G FGKV  A++ ++G   A K++E      L   +    EI  L    HP 
Sbjct: 14  WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEEL---EDYMVEIEILATCNHPY 70

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
           +V+L        K+++++E+  GG +   +    R L E + + + +Q+++ + Y H+  
Sbjct: 71  IVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK 130

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV----- 187
           + HRDLK  N+LL   G+IK++DFG+SA  +    R D  +    G+P ++APEV     
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPYWMAPEVVMCET 186

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGA 244
           + +  YD   +DIWS G+ L  +     P  + N   +  KI + +      P   S   
Sbjct: 187 MKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245

Query: 245 QNLLRKILEPNPVKRITIA 263
           ++ L+  L+ +P  R + A
Sbjct: 246 RDFLKTALDKHPETRPSAA 264

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score =  101 bits (255), Expect = 4e-25
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 26/202 (12%)

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            +PN ++L+  + +     ++++Y+  G+LFD +  +G+L EAE +K+ +QL++ ++  H
Sbjct: 67  DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126

Query: 132 NKGVFHRDLKLENILLD-SKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEV 187
              + H D+KLEN+L D +K  I + D+GL      P  +  DG L       +Y +PE 
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY--DGTL-------DYFSPEK 177

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVLYQKIFRGDFKLPKW 239
           +    YD  + D W+ GV+ Y +LTG  PF +          L    QK         K 
Sbjct: 178 IKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK----KLPFIKN 232

Query: 240 LSPGAQNLLRKILEPNPVKRIT 261
           +S  A + ++ +L+ N   R+T
Sbjct: 233 VSKNANDFVQSMLKYNINYRLT 254

Length = 267

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  102 bits (255), Expect = 4e-25
 Identities = 73/215 (33%), Positives = 108/215 (50%), Gaps = 8/215 (3%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG+G FG+V   Q   +G  +A K LEK RI   K       E   L+ +    VV L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
                +K  + +VL  + GG+L   I + G     E R LF   +++ G+   H +   +
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125

Query: 138 RDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           RDLK ENILLD  G+I+ISD GL+  +P+       +    G+  Y+APEVL N+ Y   
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPE----GESIRGRVGTVGYMAPEVLNNQRY-TL 180

Query: 197 TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 231
           + D W  G ++Y ++ G  PF  R   V  +++ R
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDR 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  101 bits (252), Expect = 6e-25
 Identities = 67/202 (33%), Positives = 94/202 (46%), Gaps = 19/202 (9%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
             +G+GNFG V +   L      AVK         LK   +  +E   LK   HPN+V+L
Sbjct: 1   EKIGKGNFGDV-YKGVLKGNTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKL 57

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLID---GVSYCHNKGV 135
             V   K  IY+V+E V GG L   +   K RL     +KL Q  +D   G+ Y  +K  
Sbjct: 58  IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTV---KKLLQMSLDAAAGMEYLESKNC 114

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANR 191
            HRDL   N L+     +KISDFG+S       + G+   + G       + APE L N 
Sbjct: 115 IHRDLAARNCLVGENNVLKISDFGMS----REEEGGIYTVSDGLKQIPIKWTAPEAL-NY 169

Query: 192 GYDGATSDIWSCGVILYVILTG 213
           G   + SD+WS G++L+   + 
Sbjct: 170 GRYTSESDVWSYGILLWETFSL 191

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 6e-25
 Identities = 74/249 (29%), Positives = 128/249 (51%), Gaps = 15/249 (6%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+ + +G G FG+V   +  ++G  +A+KIL K  ++    T   + E   L       
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKG 134
           +  LH     ++ +Y+V++Y  GG+L   ++    RL E   R    +++  +   H  G
Sbjct: 63  ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLA--- 189
             HRD+K +N+LLD  G+I+++DFG S L      DG + +    G+P+Y++PE+L    
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFG-SCL--RLLADGTVQSNVAVGTPDYISPEILQAME 179

Query: 190 -NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDFKLP---KWLSPG 243
             +G  G   D WS GV +Y +L G  PF   +L   Y KI   +  F+ P     +S  
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239

Query: 244 AQNLLRKIL 252
           A++L+R+++
Sbjct: 240 AKDLIRRLI 248

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  100 bits (251), Expect = 1e-24
 Identities = 81/257 (31%), Positives = 125/257 (48%), Gaps = 12/257 (4%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG+G FG+V   Q   +G  +A K LEK RI   K       E   L+ +    VV L
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
                +K  + +VL  + GG+L   I + G     E R +F   +L  G+     + + +
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125

Query: 138 RDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           RDLK ENILLD +G+I+ISD GL+  +P+     G +    G+  Y+APEV+ N  Y   
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV----GTVGYMAPEVINNEKY-TF 180

Query: 197 TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKIL 252
           + D W  G ++Y ++ G  PF  R   V  +++ R       +  +  S  A+++ R +L
Sbjct: 181 SPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLL 240

Query: 253 EPNPVKRITIAGIKADE 269
             NP +R+   G  A  
Sbjct: 241 TKNPKERLGCRGNGAAG 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score =  104 bits (260), Expect = 1e-24
 Identities = 47/137 (34%), Positives = 81/137 (59%)

Query: 25  GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA 84
           G FGKV   +  ++   +AVK+++K  +I+  +  Q++ E   L L K P +V L+  L 
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQ 74

Query: 85  SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN 144
           S + +Y+V+EY+ GG++   +   G   E    K   ++   + Y H  G+ HRDLK +N
Sbjct: 75  SANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDN 134

Query: 145 ILLDSKGNIKISDFGLS 161
           +L+ ++G+IK++DFGLS
Sbjct: 135 MLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 99.7 bits (248), Expect = 2e-24
 Identities = 78/254 (30%), Positives = 124/254 (48%), Gaps = 14/254 (5%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G GNFG+V   +      P AVK   +     LK   +  +E   LK   HPN+VRL  
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLK--AKFLQEARILKQYSHPNIVRLIG 60

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
           V   K  IY+V+E V GG+    + ++G RL+  E  ++ +    G+ Y  +K   HRDL
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120

Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGA 196
              N L+  K  +KISDFG+S       +DG+  +T G       + APE L N G   +
Sbjct: 121 AARNCLVTEKNVLKISDFGMS----REEEDGVYASTGGMKQIPVKWTAPEAL-NYGRYSS 175

Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA-QNLLRKILEP 254
            SD+WS G++L+   + G +P+ + +     + I +G       L P A   L+ +  E 
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235

Query: 255 NPVKRITIAGIKAD 268
           +P +R + + +  +
Sbjct: 236 DPGQRPSFSTVHQE 249

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  101 bits (252), Expect = 2e-24
 Identities = 71/249 (28%), Positives = 127/249 (51%), Gaps = 15/249 (6%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+ + +G G FG+V   +   +   +A+KIL K  ++    T   + E   L       
Sbjct: 3   FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           +  LH     ++ +Y+V++Y  GG+L   ++  + RL E   R    +++  +   H   
Sbjct: 63  ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLA--- 189
             HRD+K +N+LLD  G+I+++DFG S L  +   DG + ++   G+P+Y++PE+L    
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCLKMN--QDGTVQSSVAVGTPDYISPEILQAME 179

Query: 190 -NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKWL---SPG 243
              G  G   D WS GV +Y +L G  PF   +L   Y KI   +  F+ P  +   S  
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239

Query: 244 AQNLLRKIL 252
           A++L+++++
Sbjct: 240 AKDLIQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  100 bits (250), Expect = 2e-24
 Identities = 72/253 (28%), Positives = 130/253 (51%), Gaps = 20/253 (7%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
           +Y     +G+G  G V  A D+ +G   A+K         + +  Q K+E+   ++L   
Sbjct: 20  KYTRFEKIGQGASGTVYTAIDIATGQEVAIK--------QMNLQQQPKKELIINEILVMR 71

Query: 72  --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K+PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + +
Sbjct: 72  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALDF 130

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H+  V HRD+K +NILL   G++K++DFG  A  Q   +     T  G+P ++APEV+ 
Sbjct: 131 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 188

Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQN 246
            + Y G   DIWS G++   ++ G  P+ + N L  LY     G  +L  P+ LS   ++
Sbjct: 189 RKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRD 247

Query: 247 LLRKILEPNPVKR 259
            L + LE +  +R
Sbjct: 248 FLNRCLEMDVDRR 260

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  100 bits (249), Expect = 3e-24
 Identities = 62/196 (31%), Positives = 110/196 (56%), Gaps = 7/196 (3%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A +  +G   AVK ++  +    +  + +  E+  ++   H NVV ++ 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYN 86

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +SY HN+GV HRD+K
Sbjct: 87  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 145

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL S G IK+SDFG  A  Q  ++     +  G+P ++APEV++   Y G   DIW
Sbjct: 146 SDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKSLVGTPYWMAPEVISRLPY-GTEVDIW 202

Query: 202 SCGVILYVILTGYLPF 217
           S G+++  ++ G  P+
Sbjct: 203 SLGIMVIEMIDGEPPY 218

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  100 bits (250), Expect = 3e-24
 Identities = 93/302 (30%), Positives = 142/302 (47%), Gaps = 60/302 (19%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-----IKREIATLK 69
           +YE    +GEG +G V  A+D  +    A+K       I L+  D+       REI+ LK
Sbjct: 3   QYEKVEKIGEGTYGVVYKARDRVTNETIALKK------IRLEQEDEGVPSTAIREISLLK 56

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----QLID 125
            ++H N+VRL +V+ S+ ++Y+V EY+   +L  K         A+  +L +    Q++ 
Sbjct: 57  EMQHGNIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILR 113

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPN--- 181
           G++YCH+  V HRDLK +N+L+D + N +K++DFGL+      R  G+   T        
Sbjct: 114 GIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLA------RAFGIPVRTFTHEVVTL 167

Query: 182 -YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR-------- 231
            Y APE+L    +     DIWS G I   ++     F  D  +  L+ KIFR        
Sbjct: 168 WYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF-KIFRILGTPNEE 226

Query: 232 --------GDFK--LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEW 270
                    D+K   PKW           L P   +LL K+L  +P KRIT       E+
Sbjct: 227 TWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Query: 271 FE 272
           F+
Sbjct: 287 FK 288

Length = 294

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 99.0 bits (247), Expect = 3e-24
 Identities = 70/251 (27%), Positives = 119/251 (47%), Gaps = 20/251 (7%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +LG T+G+G FG V        G   AVK L+               E + +  L+HPN+
Sbjct: 9   KLGATIGKGEFGDVM--LGDYRGQKVAVKCLKD----DSTAAQAFLAEASVMTTLRHPNL 62

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQ-QLIDGVSYCHNKG 134
           V+L  V+   + +Y+V EY+  G L D + S+GR +     +  F   + +G+ Y   K 
Sbjct: 63  VQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
             HRDL   N+L+      K+SDFGL+      ++      +   P  + APE L  + +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLA------KEASQGQDSGKLPVKWTAPEALREKKF 176

Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRK 250
               SD+WS G++L+ I + G +P+    L  +   + +G +++  P+   P    +++ 
Sbjct: 177 S-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPPEVYKVMKD 234

Query: 251 ILEPNPVKRIT 261
             E +P KR T
Sbjct: 235 CWELDPAKRPT 245

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 99.4 bits (248), Expect = 7e-24
 Identities = 66/209 (31%), Positives = 102/209 (48%), Gaps = 21/209 (10%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLK 72
            +YE    +G+G FG+V  A+   +    A+K +L +N      IT    REI  L+LLK
Sbjct: 12  SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITAL--REIKILQLLK 69

Query: 73  HPNVVRLHEVLASKSK--------IYMVLEYVT---GGELFDKIASKGRLQEAEGRKLFQ 121
           H NVV L E+  +K+          Y+V E+      G L +K     +   +E +K+ +
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNK---NVKFTLSEIKKVMK 126

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTT-CGS 179
            L++G+ Y H   + HRD+K  NIL+   G +K++DFGL+ A           +T    +
Sbjct: 127 MLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVT 186

Query: 180 PNYVAPEVLAN-RGYDGATSDIWSCGVIL 207
             Y  PE+L   R Y G   D+W  G I+
Sbjct: 187 LWYRPPELLLGERDY-GPPIDMWGAGCIM 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 98.6 bits (245), Expect = 1e-23
 Identities = 70/255 (27%), Positives = 132/255 (51%), Gaps = 24/255 (9%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
           +Y     +G+G  G V  A D+ +G   A++         + +  Q K+E+   ++L   
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMR 72

Query: 72  --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K+PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + +
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRD+K +NILL   G++K++DFG  A   P+  +   ++    G+P ++APEV
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV----GTPYWMAPEV 187

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGA 244
           +  + Y G   DIWS G++   ++ G  P+ + N L  LY     G  +L  P+ LS   
Sbjct: 188 VTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246

Query: 245 QNLLRKILEPNPVKR 259
           ++ L + L+ +  KR
Sbjct: 247 RDFLNRCLDMDVEKR 261

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 97.6 bits (243), Expect = 1e-23
 Identities = 77/268 (28%), Positives = 126/268 (47%), Gaps = 20/268 (7%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPF-AVK-------ILEKNRIIHLKITDQIKREIAT 67
           Y +   LG G FG V   +  ++G    A+K          K++    K    I  E+  
Sbjct: 2   YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61

Query: 68  LK-LLKHPNVVRLHEVLASKSKIYMVLEYVTG---GELFDKIASKG-RLQEAEGRKLFQQ 122
           +K  L+HPN+VR ++      ++Y+V++ + G   GE F+ +  K  R  E     +F Q
Sbjct: 62  IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121

Query: 123 LIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           ++  + Y H  K + HRDL   NI+L     + I+DFGL+   Q    +  L +  G+  
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ---PESKLTSVVGTIL 178

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWL 240
           Y  PE++ N  Y G  +D+W+ G ILY + T   PF   N+  L  KI    ++ LP+ +
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237

Query: 241 -SPGAQNLLRKILEPNPVKRITIAGIKA 267
            S    +++   L P+   R  I  + A
Sbjct: 238 YSEDVTDVITSCLTPDAEARPDIIQVSA 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 99.1 bits (247), Expect = 1e-23
 Identities = 84/296 (28%), Positives = 127/296 (42%), Gaps = 55/296 (18%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            RY   R LG G+ G V  A D D     AVK +       +K      REI  ++ L H
Sbjct: 5   SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVK---HALREIKIIRRLDH 61

Query: 74  PNVVRLHEVLASKSK--------------IYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
            N+V+++EVL                   +Y+V EY+        +  +G L E   R  
Sbjct: 62  DNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETD--LANVLEQGPLSEEHARLF 119

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLS-ALPQHFRDDGLLHTTC 177
             QL+ G+ Y H+  V HRDLK  N+ ++++  + KI DFGL+  +  H+   G L    
Sbjct: 120 MYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL 179

Query: 178 GSPNYVAPE-VLANRGYDGATSDIWSCGVILYVILTGYLPF------------------- 217
            +  Y +P  +L+   Y  A  D+W+ G I   +LTG   F                   
Sbjct: 180 VTKWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238

Query: 218 --DDRN--LAVLYQKIFRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRIT 261
             +DRN  L V+   + R D   P+         ++P A + L +IL  NP+ R+T
Sbjct: 239 REEDRNELLNVIPSFV-RNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 97.0 bits (241), Expect = 3e-23
 Identities = 84/270 (31%), Positives = 135/270 (50%), Gaps = 29/270 (10%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HP 74
           +E+  T+G+G +GKV    +  +G   AVKIL+    IH  I ++I+ E   LK L  HP
Sbjct: 20  WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDP---IH-DIDEEIEAEYNILKALSDHP 75

Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRK------LFQQL 123
           NVV+ + +   K      ++++VLE   GG + D +  KG L+  E  +      +  + 
Sbjct: 76  NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV--KGFLKRGERMEEPIIAYILHEA 133

Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           + G+ + H     HRD+K  NILL ++G +K+ DFG+SA     R     +T+ G+P ++
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWM 191

Query: 184 APEVLA-----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFK 235
           APEV+A     +  YD A  D+WS G+    +  G  P  D +      KI R       
Sbjct: 192 APEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLH 250

Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            P+  S    + +RK L  +  KR T++ +
Sbjct: 251 QPELWSNEFNDFIRKCLTKDYEKRPTVSDL 280

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 97.9 bits (244), Expect = 4e-23
 Identities = 88/304 (28%), Positives = 132/304 (43%), Gaps = 56/304 (18%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY++   +G+G++G V  A D  +G   A+K +  +   H+    +I REI  L+LL+HP
Sbjct: 1   RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLLRHP 59

Query: 75  NVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           ++V +  ++   S+     IY+V E +   +L   I +   L     +    QL+  + Y
Sbjct: 60  DIVEIKHIMLPPSRREFKDIYVVFE-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKY 118

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------ 183
            H   VFHRDLK +NIL ++   +KI DFGL+ +   F D     T     +YV      
Sbjct: 119 IHTANVFHRDLKPKNILANADCKLKICDFGLARV--AFNDTP---TAIFWTDYVATRWYR 173

Query: 184 APEVLANRGYDGATS--DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------- 234
           APE L    +   T   DIWS G I   +LTG   F  +N  V++Q     D        
Sbjct: 174 APE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN--VVHQLDLITDLLGTPSPE 230

Query: 235 -------------------KLPKWLS-------PGAQNLLRKILEPNPVKRITIAGIKAD 268
                              K P   S       P A  LL ++L  +P  R T     AD
Sbjct: 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290

Query: 269 EWFE 272
            +F+
Sbjct: 291 PYFK 294

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 96.1 bits (239), Expect = 5e-23
 Identities = 79/264 (29%), Positives = 126/264 (47%), Gaps = 23/264 (8%)

Query: 16  YELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A +
Sbjct: 1   WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVM 56

Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLID 125
           K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+  
Sbjct: 57  KEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQISS 115

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVA 184
            + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + A
Sbjct: 116 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWTA 173

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLS 241
           PE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ + +G +++  P+   
Sbjct: 174 PESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERPEGCP 231

Query: 242 PGAQNLLRKILEPNPVKRITIAGI 265
           P    L+R   + NP  R + A I
Sbjct: 232 PKVYELMRACWQWNPSDRPSFAEI 255

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 96.6 bits (240), Expect = 6e-23
 Identities = 77/245 (31%), Positives = 121/245 (49%), Gaps = 31/245 (12%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-K 72
             +E+  T+G+G +GKV    +   G   AVKIL+        + ++I+ E   L+ L  
Sbjct: 22  DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPN 77

Query: 73  HPNVVRLHEVL-----ASKSKIYMVLEYVTGG---ELFDKIASKG-RLQEAEGRKLFQQL 123
           HPNVV+ + +          ++++VLE   GG   EL   +   G RL EA    +    
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           + G+ + HN  + HRD+K  NILL ++G +K+ DFG+SA     R     +T+ G+P ++
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTSVGTPFWM 195

Query: 184 APEVLA-----NRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLP 237
           APEV+A     +  YD A  D+WS G+    +  G  P FD   +  L        FK+P
Sbjct: 196 APEVIACEQQYDYSYD-ARCDVWSLGITAIELGDGDPPLFDMHPVKTL--------FKIP 246

Query: 238 KWLSP 242
           +   P
Sbjct: 247 RNPPP 251

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 97.4 bits (242), Expect = 6e-23
 Identities = 95/310 (30%), Positives = 143/310 (46%), Gaps = 52/310 (16%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 18  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 74

Query: 73  HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V            +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 75  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 132

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 133 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 187

Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKIFR 231
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 247

Query: 232 GDFK--------LPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
              +        +PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 248 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307

Query: 276 TPANPDDDEE 285
              +PDD+  
Sbjct: 308 ---DPDDEPV 314

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 96.1 bits (239), Expect = 7e-23
 Identities = 79/267 (29%), Positives = 125/267 (46%), Gaps = 20/267 (7%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V   Q   +G  +A K L K R+   K  +    E   L  +    +V L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEA--EGRKLF--QQLIDGVSYCHNKGVFH 137
              +K+ + +V+  + GG+L   I +         E R  F   Q+I G+ + H + + +
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIY 120

Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRGYDG 195
           RDLK EN+LLD+ GN++ISD GL+   +    DG   T    G+P ++APE+L    YD 
Sbjct: 121 RDLKPENVLLDNDGNVRISDLGLAVELK----DGQSKTKGYAGTPGFMAPELLQGEEYDF 176

Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLLRKI 251
           +  D ++ GV LY ++    PF  R   V    L Q+I       P   SP +++    +
Sbjct: 177 SV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEAL 235

Query: 252 LEPNPVKRI-----TIAGIKADEWFEQ 273
           L  +P KR+        G++    F  
Sbjct: 236 LAKDPEKRLGFRDGNCDGLRTHPLFRD 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 95.9 bits (238), Expect = 9e-23
 Identities = 59/199 (29%), Positives = 106/199 (53%), Gaps = 8/199 (4%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++       +I D I++EI  L     P + R + 
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYITRYYG 69

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                +K+++++EY+ GG   D +   G L+E     + ++++ G+ Y H++   HRD+K
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 128

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL  +G++K++DFG++       D  +   T  G+P ++APEV+    YD   +DI
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-FKADI 184

Query: 201 WSCGVILYVILTGYLPFDD 219
           WS G+    +  G  P  D
Sbjct: 185 WSLGITAIELAKGEPPNSD 203

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 93.5 bits (232), Expect = 3e-22
 Identities = 68/204 (33%), Positives = 106/204 (51%), Gaps = 19/204 (9%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+GNFG+V F   L    P AVK  +++    LKI  +   E   LK   HPN+V+L  
Sbjct: 3   LGKGNFGEV-FKGTLKDKTPVAVKTCKEDLPQELKI--KFLSEARILKQYDHPNIVKLIG 59

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNKGVFHR 138
           V   +  IY+V+E V GG+    +  K    E + ++L +  +D   G++Y  +K   HR
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRKKK--DELKTKQLVKFALDAAAGMAYLESKNCIHR 117

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYD 194
           DL   N L+     +KISDFG+S      ++D  ++++ G       + APE L N G  
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEAL-NYGRY 171

Query: 195 GATSDIWSCGVILYVILT-GYLPF 217
            + SD+WS G++L+   + G  P+
Sbjct: 172 SSESDVWSYGILLWETFSLGVCPY 195

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 95.3 bits (237), Expect = 3e-22
 Identities = 67/201 (33%), Positives = 103/201 (51%), Gaps = 11/201 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY   + +G G FG V  A+D  +G   A+K + K     + +  +  RE+  LK L+H 
Sbjct: 11  RYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPV-LAKRTYRELKLLKHLRHE 69

Query: 75  NVVRLHEVLASKSK-IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           N++ L ++  S  + IY V E +  G    ++ +   L++   +    Q++ G+ Y H+ 
Sbjct: 70  NIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSA 127

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-LANRG 192
           GV HRDLK  NIL++   ++KI DFGL A  Q  +  G + T      Y APE+ L  + 
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGL-ARIQDPQMTGYVSTR----YYRAPEIMLTWQK 182

Query: 193 YDGATSDIWSCGVILYVILTG 213
           YD    DIWS G I   +L G
Sbjct: 183 YDVEV-DIWSAGCIFAEMLEG 202

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 95.4 bits (237), Expect = 3e-22
 Identities = 90/314 (28%), Positives = 135/314 (42%), Gaps = 50/314 (15%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY   + +G G +G V  A D  +G   A+K L +     L    +  RE+  LK +KH 
Sbjct: 16  RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMKHE 74

Query: 75  NVVRLHEVLASKSKI------YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           NV+ L +V      +      Y+V+ ++  G    K+    +L E   + L  Q++ G+ 
Sbjct: 75  NVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQMLKGLK 132

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           Y H  G+ HRDLK  N+ ++    +KI DFGL+      + D  +     +  Y APEV+
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEVI 187

Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF------------------------------D 218
            N  +   T DIWS G I+  +LTG   F                              D
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247

Query: 219 DRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ---- 273
            +N      +  + DF+ L    +P A N+L K+L  +   RIT A   A  +FE+    
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307

Query: 274 -DYTPANPDDDEED 286
            D T A P DD  D
Sbjct: 308 EDETEAPPYDDSFD 321

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 93.3 bits (232), Expect = 6e-22
 Identities = 75/204 (36%), Positives = 109/204 (53%), Gaps = 22/204 (10%)

Query: 22  LGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H N+
Sbjct: 12  LGKGNFGSVELCRYDPLQD-NTGEVVAVKKLQHSTAEHLR---DFEREIEILKSLQHDNI 67

Query: 77  VRLHEVLASKSK--IYMVLEYVTGGELFDK-IASKGRLQEAEGRKLFQ---QLIDGVSYC 130
           V+   V  S  +  + +V+EY+  G L D     + RL   + RKL     Q+  G+ Y 
Sbjct: 68  VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL---DHRKLLLYASQICKGMEYL 124

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNY-VAPEVL 188
            +K   HRDL   NIL++S+  +KI DFGL+  LPQ  ++   +     SP +  APE L
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD-KEYYKVREPGESPIFWYAPESL 183

Query: 189 ANRGYDGATSDIWSCGVILYVILT 212
               +  A SD+WS GV+LY + T
Sbjct: 184 TESKFSVA-SDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 93.9 bits (234), Expect = 9e-22
 Identities = 95/329 (28%), Positives = 144/329 (43%), Gaps = 65/329 (19%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+    +GEG +G V  A    +G+  A+K +      H     +  REI  L+  KH 
Sbjct: 6   RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISP--FEHQTFCQRTLREIKILRRFKHE 63

Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ + +++   S      +Y+V E +   +L+  I ++  L     +    Q++ G+ Y
Sbjct: 64  NIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKY 121

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGL--SALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL   A P+H    G L     +  Y APE+
Sbjct: 122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH-DHTGFLTEYVATRWYRAPEI 180

Query: 188 -LANRGYDGATSDIWSCGVILYVILTG--------Y------------------------ 214
            L ++GY  A  DIWS G IL  +L+         Y                        
Sbjct: 181 MLNSKGYTKAI-DIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239

Query: 215 ---------LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
                    LPF  +   V + K+F      P    P A +LL K+L  NP KRIT+   
Sbjct: 240 LRARNYIKSLPFKPK---VPWNKLF------PN-ADPKALDLLDKMLTFNPHKRITVEEA 289

Query: 266 KADEWFEQDYTPANPDDDEEDIFVDNEAF 294
            A  + EQ + P++    EE    D E F
Sbjct: 290 LAHPYLEQYHDPSDEPVAEEPFPFDFELF 318

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 92.7 bits (230), Expect = 1e-21
 Identities = 88/287 (30%), Positives = 130/287 (45%), Gaps = 49/287 (17%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLK- 72
           +YE    +G G +G V  A+D  SG   A+K +  +     L ++    RE+A LK L+ 
Sbjct: 1   QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLS--TVREVALLKRLEA 58

Query: 73  --HPNVVRLHEVLAS-----KSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQL 123
             HPN+VRL +V A+     ++K+ +V E+V        DK+   G L     + L +Q 
Sbjct: 59  FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPG-LPAETIKDLMRQF 117

Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ-HFRDDGLLHTTCGSPNY 182
           + G+ + H   + HRDLK ENIL+ S G +K++DFGL+ +         ++ T      Y
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----Y 173

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF------------ 230
            APEVL    Y     D+WS G I   +      F   + A    KIF            
Sbjct: 174 RAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP 232

Query: 231 ------RGDFK----------LPKWLSPGAQNLLRKILEPNPVKRIT 261
                 RG F           +P+    GAQ LL ++L  NP KRI+
Sbjct: 233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQ-LLLEMLTFNPHKRIS 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 92.8 bits (230), Expect = 1e-21
 Identities = 57/173 (32%), Positives = 94/173 (54%), Gaps = 10/173 (5%)

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
           RE++ LK LKH N+V LH+++ ++  + +V EY+   +L   + + G L      K+F  
Sbjct: 52  REVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGNLMSMHNVKIFMF 110

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
           QL+ G+SYCH + + HRDLK +N+L++ KG +K++DFGL+   ++P     + ++     
Sbjct: 111 QLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVV----- 165

Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 231
           +  Y  P+VL          D+W  G ILY + TG   F    +      IFR
Sbjct: 166 TLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 92.8 bits (230), Expect = 1e-21
 Identities = 72/248 (29%), Positives = 131/248 (52%), Gaps = 16/248 (6%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A    SG   AVK ++  +    +  + +  E+  ++  +H NVV ++ 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 84

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +S  H +GV HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIK 143

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL   G +K+SDFG  A  Q  ++     +  G+P ++APE+++   Y G   DIW
Sbjct: 144 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKSLVGTPYWMAPELISRLPY-GPEVDIW 200

Query: 202 SCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKW-----LSPGAQNLLRKILEPN 255
           S G+++  ++ G  P F++  L  +  K+ R +   PK      +SP  +  L ++L  +
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAM--KMIRDNLP-PKLKNLHKVSPSLKGFLDRLLVRD 257

Query: 256 PVKRITIA 263
           P +R T A
Sbjct: 258 PAQRATAA 265

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 92.3 bits (229), Expect = 2e-21
 Identities = 75/207 (36%), Positives = 108/207 (52%), Gaps = 25/207 (12%)

Query: 20  RTLGEGNFGKVKF-----AQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           R LGEG+FGKV       A D  +G   AVK L++        T   K+EI  LK L H 
Sbjct: 10  RVLGEGHFGKVSLYCYDPAND-GTGEMVAVKTLKRECGQQN--TSGWKKEINILKTLYHE 66

Query: 75  NVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           N+V+     + +    + +++EYV  G L D +  K +L  A+     QQ+ +G++Y H+
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYL-PKHKLNLAQLLLFAQQICEGMAYLHS 125

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPNY-VAP 185
           +   HRDL   N+LLD+   +KI DFGL+ A+P+       R+DG       SP +  A 
Sbjct: 126 QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAV 179

Query: 186 EVLANRGYDGATSDIWSCGVILYVILT 212
           E L    +  A SD+WS GV LY +LT
Sbjct: 180 ECLKENKFSYA-SDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 93.0 bits (232), Expect = 2e-21
 Identities = 105/346 (30%), Positives = 146/346 (42%), Gaps = 83/346 (23%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---------R 63
           L +YE+ + LG+G +G V  A D  +    A+K          KI D  +         R
Sbjct: 6   LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALK----------KIFDAFRNATDAQRTFR 55

Query: 64  EIATLK-LLKHPNVVRLHEVL-ASKSK-IYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
           EI  L+ L  HPN+V+L  V+ A   K IY+V EY+   +L   I     L++   R + 
Sbjct: 56  EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVI-RANILEDVHKRYIM 113

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS 179
            QL+  + Y H+  V HRDLK  NILL+S   +K++DFGL+ +L +   +      T   
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLT--- 170

Query: 180 PNYVA------PEVL-ANRGYDGATSDIWSCGVILYVILTG------------------- 213
            +YVA      PE+L  +  Y     D+WS G IL  +L G                   
Sbjct: 171 -DYVATRWYRAPEILLGSTRYTKGV-DMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEV 228

Query: 214 ------------YLPFDDRNLAVLYQ-KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI 260
                         PF    L  L        D  LPK  S  A +LL+K+L  NP KR+
Sbjct: 229 IGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPK-ASDDALDLLKKLLVFNPNKRL 287

Query: 261 TIAGIKADEWFEQDYTPA--NPDDDE---EDI---FVDNEAFSMHE 298
           T     A+E  E  Y     NP D+      I     DN   S+ E
Sbjct: 288 T-----AEEALEHPYVAQFHNPSDEPVLPYPITIPLDDNVKLSVAE 328

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 91.3 bits (227), Expect = 2e-21
 Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 13/205 (6%)

Query: 20  RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           + LG GNFG V     L      +  AVK L++  I   K   +  RE + +  L HP +
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK--KEFLREASVMAQLDHPCI 58

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
           VRL  V   +  + +V+E    G L   +  +  +  ++ ++L  Q+  G++Y  +K   
Sbjct: 59  VRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117

Query: 137 HRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGY 193
           HRDL   N+LL ++   KISDFG+S AL      D    TT G  P  + APE +    +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRAL--GAGSDYYRATTAGRWPLKWYAPECINYGKF 175

Query: 194 DGATSDIWSCGVILYVILT-GYLPF 217
               SD+WS GV L+   + G  P+
Sbjct: 176 SSK-SDVWSYGVTLWEAFSYGAKPY 199

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 95.2 bits (236), Expect = 2e-21
 Identities = 75/254 (29%), Positives = 127/254 (50%), Gaps = 38/254 (14%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           RL  YE+ + +G G FG+V   +   +   F  K +   R +  +   Q+  E+  ++ L
Sbjct: 11  RLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISY-RGLKEREKSQLVIEVNVMREL 69

Query: 72  KHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLID 125
           KH N+VR  +   +K+  K+Y+++E+   G+L   I       G+++E     + +QL+ 
Sbjct: 70  KHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH 129

Query: 126 GVSYCHN-------KGVFHRDLKLENILLDSK----GNI-------------KISDFGLS 161
            ++YCHN       + V HRDLK +NI L +     G I             KI DFGLS
Sbjct: 130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS 189

Query: 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD 219
              ++   + + H+  G+P Y +PE+L +  + YD   SD+W+ G I+Y + +G  PF  
Sbjct: 190 ---KNIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSGKTPFHK 245

Query: 220 -RNLAVLYQKIFRG 232
             N + L  ++ RG
Sbjct: 246 ANNFSQLISELKRG 259

Length = 1021

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 94.0 bits (233), Expect = 3e-21
 Identities = 66/230 (28%), Positives = 109/230 (47%), Gaps = 28/230 (12%)

Query: 13  LGRYELGRTLGEGNFGKV---------------KFAQDLDSGLPFAVKILEKNRIIHLKI 57
           L  + +   L  G FGK+               +     + G P   +++ K      + 
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206

Query: 58  TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV---LEYVTGGELFDK-IASKGRLQE 113
             Q++ EI  L  L H N++++ E+L S++  YM+    ++     ++D+    K R   
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLL 266

Query: 114 AEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDD 170
            + R + +QL+  V Y H+K + HRD+KLENI L+  G I + DFG +      +   D 
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY 326

Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 219
           G + T   +    +PE+LA  GY   T DIWSCG+IL  +L+  + P  D
Sbjct: 327 GWVGTVATN----SPEILAGDGYCEIT-DIWSCGLILLDMLSHDFCPIGD 371

Length = 501

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 90.7 bits (225), Expect = 6e-21
 Identities = 74/281 (26%), Positives = 124/281 (44%), Gaps = 34/281 (12%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLLKHPNVV 77
           LG+GN+G V       +G+  A+K       I L++ +    QI  E+  L     P +V
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKE------IRLELDESKFNQIIMELDILHKAVSPYIV 62

Query: 78  RLHEVLASKSKIYMVLEYVTGG---ELFDKIASKGRLQEAEGRKLFQQLIDGVSYC---H 131
             +     +  +YM +EY+  G   +L+    +   + E   R++   ++ G+ +    H
Sbjct: 63  DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           N  + HRD+K  N+L++  G +K+ DFG+S          L  T  G  +Y+APE + + 
Sbjct: 123 N--IIHRDVKPTNVLVNGNGQVKLCDFGVSGN----LVASLAKTNIGCQSYMAPERIKSG 176

Query: 192 GYDGA-----TSDIWSCGVILYVILTGYLPFDDRNLAVLY---QKIFRGD-FKLPKWLSP 242
           G +        SD+WS G+ +  +  G  P+     A ++     I  GD   LP   S 
Sbjct: 177 GPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSD 236

Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 283
            AQ+ + K L   P +R T A +    W  +     N D D
Sbjct: 237 DAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY---KNADVD 274

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 89.8 bits (223), Expect = 7e-21
 Identities = 62/250 (24%), Positives = 113/250 (45%), Gaps = 20/250 (8%)

Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
             + LG G FG V   +     +  A+K++ +  +      D    E   +  L HPN+V
Sbjct: 8   FLKELGSGQFGVVHLGKWRGK-IDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLV 62

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
           +L+ V   +  I++V EY+  G L + +   KG+L       +   + + + Y  + G  
Sbjct: 63  QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122

Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGY 193
           HRDL   N L+     +K+SDFGL+   ++  DD    +  G+     +  PEV  +   
Sbjct: 123 HRDLAARNCLVGEDNVVKVSDFGLA---RYVLDDQYTSSQ-GTKFPVKWAPPEVF-DYSR 177

Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDR-NLAVLYQKIFRGDFKL--PKWLSPGAQNLLR 249
             + SD+WS GV+++ + + G +P++   N  V+ + +  G ++L  PK        ++ 
Sbjct: 178 FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVV-ESVSAG-YRLYRPKLAPTEVYTIMY 235

Query: 250 KILEPNPVKR 259
                 P  R
Sbjct: 236 SCWHEKPEDR 245

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 89.6 bits (222), Expect = 9e-21
 Identities = 72/254 (28%), Positives = 121/254 (47%), Gaps = 20/254 (7%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-IKREIATLK 69
           + L +  LG  +GEG FG V   +    G   AVK       I   +T Q    E A + 
Sbjct: 3   LNLQKLTLGEIIGEGEFGAVLQGEYT--GQKVAVKN------IKCDVTAQAFLEETAVMT 54

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGV 127
            L H N+VRL  V+     +Y+V+E ++ G L + + ++GR  +   +  +    + +G+
Sbjct: 55  KLHHKNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y  +K + HRDL   NIL+   G  K+SDFGL+ +     D+  L        + APE 
Sbjct: 114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-----KWTAPEA 168

Query: 188 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ 245
           L ++ +  + SD+WS GV+L+ + + G  P+   +L  + + + +G   + P+       
Sbjct: 169 LKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVY 227

Query: 246 NLLRKILEPNPVKR 259
            L+    E  P KR
Sbjct: 228 VLMTSCWETEPKKR 241

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 89.6 bits (222), Expect = 9e-21
 Identities = 62/218 (28%), Positives = 117/218 (53%), Gaps = 15/218 (6%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  +V+L
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQL 64

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  IY+V EY++ G L + +   G R Q ++  ++ + + +G++Y  +K   HR
Sbjct: 65  YGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHR 124

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L+D +G +K+SDFGLS   ++  DD    ++ GS     +  PEVL    +  
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLLYSKFS- 179

Query: 196 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
           + SD+W+ GV+++ + + G +P++  N +   +K+ +G
Sbjct: 180 SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG 217

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 89.7 bits (222), Expect = 1e-20
 Identities = 64/223 (28%), Positives = 116/223 (52%), Gaps = 17/223 (7%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++       +I D I++EI  L     P V + + 
Sbjct: 12  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYVTKYYG 69

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                +K+++++EY+ GG   D + + G   E +   + ++++ G+ Y H++   HRD+K
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 128

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL  +G++K++DFG++       D  +   T  G+P ++APEV+    YD + +DI
Sbjct: 129 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADI 184

Query: 201 WSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKLPKWLSP 242
           WS G+    +  G  P  D + + VL        F +PK   P
Sbjct: 185 WSLGITAIELAKGEPPNSDMHPMRVL--------FLIPKNNPP 219

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 89.5 bits (222), Expect = 2e-20
 Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 33/274 (12%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL----KITDQIKREIATLKLLKHPN 75
             LG GN G V   + + +G   A K+      +H+     +  QI RE+  +   + P 
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKV------VHIGAKSSVRKQILRELQIMHECRSPY 64

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK- 133
           +V  +    +++ I M +E++  G L D+I  K G +      K+   +++G++Y +N  
Sbjct: 65  IVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            + HRD+K  NIL++S+G IK+ DFG+S  L     D     T  G+  Y++PE +    
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD-----TFVGTSTYMSPERIQGGK 178

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRN------------LAVLYQKIFRGDFKLPK-W 239
           Y    SD+WS G+ +  +  G  PF   N            L +L Q +     +LP   
Sbjct: 179 YT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237

Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
                ++ +   L  +P +R T   + A   F Q
Sbjct: 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ 271

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 89.0 bits (220), Expect = 2e-20
 Identities = 58/199 (29%), Positives = 105/199 (52%), Gaps = 8/199 (4%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++       +I D I++EI  L     P V + + 
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIED-IQQEITVLSQCDSPYVTKYYG 69

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                +K+++++EY+ GG   D +   G L E +   + ++++ G+ Y H++   HRD+K
Sbjct: 70  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 128

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL   G +K++DFG++       D  +   T  G+P ++APEV+    YD + +DI
Sbjct: 129 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADI 184

Query: 201 WSCGVILYVILTGYLPFDD 219
           WS G+    +  G  P  +
Sbjct: 185 WSLGITAIELAKGEPPHSE 203

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 60/208 (28%), Positives = 94/208 (45%), Gaps = 26/208 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH----LKITDQIKREIATLKL 70
           RY+    +G G +G V  A D  SG   A+K     +I H      +  +  RE+  L+ 
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRH 60

Query: 71  LKHPNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
            KH N++ + ++L         +Y+V++ +   +L   I S   L E   R    QL+ G
Sbjct: 61  FKHDNIIAIRDILRPPGADFKDVYVVMD-LMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
           + Y H+  V HRDLK  N+L++    ++I DFG++        +     T     YV   
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT----EYVATR 175

Query: 184 ---APEVL-ANRGYDGATSDIWSCGVIL 207
              APE+L +   Y  A  D+WS G I 
Sbjct: 176 WYRAPELLLSLPEYTTAI-DMWSVGCIF 202

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 89.3 bits (221), Expect = 2e-20
 Identities = 70/207 (33%), Positives = 104/207 (50%), Gaps = 23/207 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFA----VKILEKNRIIHLKITDQIKREIATLKL 70
           +YE    +GEG +GKV  A+DL +G  F     V++      + L       RE+A L+ 
Sbjct: 2   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTI----REVAVLRH 57

Query: 71  LK---HPNVVRLHEVLA-----SKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLF 120
           L+   HPNVVRL +V        ++K+ +V E+V        DK+   G   E   + + 
Sbjct: 58  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI-KDMM 116

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            QL+ G+ + H+  V HRDLK +NIL+ S G IK++DFGL+ +   +     L +   + 
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTL 173

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVIL 207
            Y APEVL    Y     D+WS G I 
Sbjct: 174 WYRAPEVLLQSSY-ATPVDLWSVGCIF 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 88.9 bits (220), Expect = 2e-20
 Identities = 66/219 (30%), Positives = 113/219 (51%), Gaps = 19/219 (8%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           G +EL   +G G +G+V   + + +G   A+K+++    +     ++IK EI  LK   H
Sbjct: 16  GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTEDEEEEIKLEINMLKKYSH 71

Query: 74  -PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIA-SKGR-LQEAEGRKLFQQLI 124
             N+   +     KS      ++++V+E+   G + D +  +KG  L+E     + ++++
Sbjct: 72  HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+++ H   V HRD+K +N+LL     +K+ DFG+SA  Q  R  G  +T  G+P ++A
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 189

Query: 185 PEVLANRGYDGAT----SDIWSCGVILYVILTGYLPFDD 219
           PEV+A      AT    SDIWS G+    +  G  P  D
Sbjct: 190 PEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD 228

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 90.1 bits (223), Expect = 2e-20
 Identities = 90/331 (27%), Positives = 147/331 (44%), Gaps = 64/331 (19%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D       AVK L +    +IH + T    RE+  LK +K
Sbjct: 16  RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRT---YRELRLLKHMK 72

Query: 73  HPNVVRLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V          +++Y+V   + G +L + I    +L +   + L  QL+ G
Sbjct: 73  HENVIGLLDVFTPATSIENFNEVYLVTN-LMGADL-NNIVKCQKLSDEHVQFLIYQLLRG 130

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+ G+ HRDLK  N+ ++    ++I DFGL+      + D  +     +  Y APE
Sbjct: 131 LKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPE 185

Query: 187 VLANRGYDGATSDIWSCGVILYVILTG--YLPFDD------RNLAVL------------- 225
           ++ N  +   T DIWS G I+  +L G    P +D      R + V+             
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245

Query: 226 -----------------YQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
                             +KIFRG        +P A +LL K+L  +  KRI+ +   A 
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIFRG-------ANPLAIDLLEKMLVLDSDKRISASEALAH 298

Query: 269 EWFEQDYTPAN-PDDDEEDIFVDNEAFSMHE 298
            +F Q + P + P+ +  D   +N+  ++ E
Sbjct: 299 PYFSQYHDPEDEPEAEPYDESPENKERTIEE 329

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 88.9 bits (221), Expect = 3e-20
 Identities = 61/224 (27%), Positives = 102/224 (45%), Gaps = 33/224 (14%)

Query: 17  ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
            L R LG+G+FG V     K     +     A+K + +N  +  +I  +   E + +K  
Sbjct: 9   TLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMKEF 66

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--------KLFQ-- 121
              +VVRL  V+++     +V+E +  G+L   + S+ R +             K  Q  
Sbjct: 67  NCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSR-RPEAENNPGLGPPTLQKFIQMA 125

Query: 122 -QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDG--LLHT 175
            ++ DG++Y   K   HRDL   N ++     +KI DFG++       ++R  G  LL  
Sbjct: 126 AEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL-- 183

Query: 176 TCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
               P  ++APE L + G     SD+WS GV+L+ + T    P+
Sbjct: 184 ----PVRWMAPESLKD-GVFTTKSDVWSFGVVLWEMATLAEQPY 222

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 60/190 (31%), Positives = 98/190 (51%), Gaps = 12/190 (6%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           R +G G+FG V FA+D+ +    A+K +    +  + K  D IK E+  L+ L+HPN ++
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK-EVRFLQKLRHPNTIQ 79

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
                  +   ++V+EY  G         K  LQE E   +    + G++Y H+  + HR
Sbjct: 80  YRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDG 195
           D+K  NILL   G +K+ DFG +++          +   G+P ++APEV+   + G YDG
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDG 193

Query: 196 ATSDIWSCGV 205
              D+WS G+
Sbjct: 194 KV-DVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 89.4 bits (222), Expect = 3e-20
 Identities = 86/313 (27%), Positives = 136/313 (43%), Gaps = 51/313 (16%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-- 72
           RYEL + LG+G +G V  A++ ++     V I +   +   KI    KR +  LKLL+  
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKIL--AKRALRELKLLRHF 58

Query: 73  --HPNVVRLHE---VLASK-SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
             H N+  L++   V     +++Y+  E +   +L   I S   L +A  +    Q++ G
Sbjct: 59  RGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCG 117

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVA 184
           + Y H+  V HRDLK  N+L+++   +KI DFGL+         + G +     +  Y A
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRA 177

Query: 185 PEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL---------- 225
           PE+ L+ + Y  A  D+WS G IL  +L     F  ++        L VL          
Sbjct: 178 PEIMLSFQSYTKAI-DVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSR 236

Query: 226 ------YQKIFRGDFKLPK---WLSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFE 272
                    I        K    + P A     +LL K+L  +P KRI++     +E  E
Sbjct: 237 IGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISV-----EEALE 291

Query: 273 QDYTPANPDDDEE 285
             Y     D D+E
Sbjct: 292 HPYLAIWHDPDDE 304

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 89.0 bits (221), Expect = 4e-20
 Identities = 68/201 (33%), Positives = 103/201 (51%), Gaps = 18/201 (8%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
           LG GN G V       SGL  A K+      IHL+I     +QI RE+  L     P +V
Sbjct: 9   LGAGNGGVVTKVLHRPSGLIMARKL------IHLEIKPAIRNQIIRELKVLHECNSPYIV 62

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK-GV 135
             +    S  +I + +E++ GG L D++  K GR+ E    K+   ++ G++Y   K  +
Sbjct: 63  GFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPENILGKISIAVLRGLTYLREKHKI 121

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y  
Sbjct: 122 MHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMANSFVGTRSYMSPERLQGTHY-T 176

Query: 196 ATSDIWSCGVILYVILTGYLP 216
             SDIWS G+ L  +  G  P
Sbjct: 177 VQSDIWSLGLSLVEMAIGRYP 197

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 89.2 bits (221), Expect = 4e-20
 Identities = 97/328 (29%), Positives = 144/328 (43%), Gaps = 59/328 (17%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-TDQIKREIATLKLLKH 73
           RY   + +G G +G V  A D  +G   A+K L  +R    +I   +  RE+  LK ++H
Sbjct: 16  RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKL--SRPFQSEIFAKRAYRELTLLKHMQH 73

Query: 74  PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
            NV+ L +V  S          Y+V+ Y+       KI     L E + + L  Q++ G+
Sbjct: 74  ENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGH-PLSEDKVQYLVYQMLCGL 130

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+ G+ HRDLK  N+ ++    +KI DFGL+   +H   D  +     +  Y APEV
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA---RH--ADAEMTGYVVTRWYRAPEV 185

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQ------------------- 227
           + N  +   T DIWS G I+  +LTG   F  ++ L  L Q                   
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245

Query: 228 ----------KIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ-- 273
                     K  R DF    PK  SP A +LL K+LE +  KR+T        +F+   
Sbjct: 246 AAKSYIKSLPKYPRKDFSTLFPK-ASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304

Query: 274 ---DYTPANPDDDEEDIFVDNEAFSMHE 298
              + T   P DD     ++NE  S+ E
Sbjct: 305 DADEETEQQPYDDS----LENEKLSVDE 328

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 87.8 bits (217), Expect = 5e-20
 Identities = 64/226 (28%), Positives = 113/226 (50%), Gaps = 13/226 (5%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V      ++    AVK L+   +           E   +K L+H  +
Sbjct: 9   KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKL 63

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKG 134
           VRL+ V+  +  IY++ EY+  G L D + S   G++   +      Q+ +G++Y   K 
Sbjct: 64  VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
             HRDL+  N+L+      KI+DFGL+ + +   ++         P  + APE + N G 
Sbjct: 124 YIHRDLRAANVLVSESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI-NFGS 180

Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
               SD+WS G++LY I+T G +P+   + + +   + RG +++P+
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPR 225

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 88.3 bits (219), Expect = 6e-20
 Identities = 64/199 (32%), Positives = 105/199 (52%), Gaps = 20/199 (10%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKN-RIIHLKITDQIKREIATLKLLKH 73
            +   R +G G+FG V FA+D+ +    A+K +  + +  + K  D IK E+  L+ L+H
Sbjct: 16  LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK-EVRFLQQLRH 74

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           PN +        +   ++V+EY  G   ++ +    K  LQE E   +    + G++Y H
Sbjct: 75  PNTIEYKGCYLREHTAWLVMEYCLGSASDILE--VHKKPLQEVEIAAICHGALQGLAYLH 132

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEV-L 188
           +    HRD+K  NILL   G +K++DFG ++L  P         ++  G+P ++APEV L
Sbjct: 133 SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--------NSFVGTPYWMAPEVIL 184

Query: 189 A-NRG-YDGATSDIWSCGV 205
           A + G YDG   D+WS G+
Sbjct: 185 AMDEGQYDGKV-DVWSLGI 202

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 88.9 bits (220), Expect = 6e-20
 Identities = 71/220 (32%), Positives = 108/220 (49%), Gaps = 19/220 (8%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
           LG GN G V       SGL  A K+      IHL+I     +QI RE+  L     P +V
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKL------IHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
             +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  + 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 126

Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y   
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-V 181

Query: 197 TSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGD 233
            SDIWS G+ L  +  G  P    D + L +++     GD
Sbjct: 182 QSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGD 221

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 87.5 bits (217), Expect = 7e-20
 Identities = 67/239 (28%), Positives = 113/239 (47%), Gaps = 27/239 (11%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLK 69
              E  + LG G FG V     +  G    +P A+K+L +      K   +I  E   + 
Sbjct: 7   TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMA 64

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELF-------DKIASKGRLQEAEGRKLFQQ 122
            + HP+VVRL  +  S S++ ++ + +  G L        D I S+  L          Q
Sbjct: 65  SVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCV------Q 117

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P- 180
           +  G+SY   K + HRDL   N+L+ +  ++KI+DFGL+ L     D+   H   G  P 
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYHAEGGKVPI 175

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
            ++A E + +R Y    SD+WS GV ++ ++T G  P++      +   + +G+ +LP+
Sbjct: 176 KWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RLPQ 232

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 88.2 bits (218), Expect = 9e-20
 Identities = 57/189 (30%), Positives = 97/189 (51%), Gaps = 10/189 (5%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R +G G+FG V FA+D+ +    A+K +  +     +    I +E+  L+ +KHPN +  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                 +   ++V+EY  G         K  LQE E   +    + G++Y H+  + HRD
Sbjct: 91  KGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150

Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGA 196
           +K  NILL   G +K++DFG +++          ++  G+P ++APEV+   + G YDG 
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGK 204

Query: 197 TSDIWSCGV 205
             D+WS G+
Sbjct: 205 V-DVWSLGI 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 87.1 bits (215), Expect = 1e-19
 Identities = 66/219 (30%), Positives = 114/219 (52%), Gaps = 19/219 (8%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           G +EL   +G G +G+V   + + +G   A+K+++    +     ++IK+EI  LK   H
Sbjct: 6   GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 61

Query: 74  -PNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIA-SKGR-LQEAEGRKLFQQLI 124
             N+   +     K+      ++++V+E+   G + D I  +KG  L+E     + ++++
Sbjct: 62  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+S+ H   V HRD+K +N+LL     +K+ DFG+SA  Q  R  G  +T  G+P ++A
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 179

Query: 185 PEVLANRGYDGAT----SDIWSCGVILYVILTGYLPFDD 219
           PEV+A      AT    SD+WS G+    +  G  P  D
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 87.4 bits (216), Expect = 1e-19
 Identities = 54/173 (31%), Positives = 91/173 (52%), Gaps = 10/173 (5%)

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
           RE++ LK LKH N+V LH+++ ++  + +V EY+   +L   +   G        KLF  
Sbjct: 53  REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLF 111

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
           QL+ G++YCH + V HRDLK +N+L++ +G +K++DFGL+   ++P     + ++     
Sbjct: 112 QLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVV----- 166

Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 231
           +  Y  P++L          D+W  G I Y + TG   F    +      IFR
Sbjct: 167 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFR 219

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 85.7 bits (212), Expect = 2e-19
 Identities = 65/256 (25%), Positives = 116/256 (45%), Gaps = 48/256 (18%)

Query: 29  KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK 88
           KV    D  +   F +K L K        + +  RE  T+     PN+V LH+ + S+  
Sbjct: 8   KVLLVMDTRTQQTFILKGLRK--------SSEYSRERLTIIPHCVPNMVCLHKYIVSEDS 59

Query: 89  IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD 148
           +++VL++  GG+L+  I+    + E   ++   +++  +   H +G+  RDL   NILLD
Sbjct: 60  VFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLD 119

Query: 149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGYDGATS------ 198
            +G+I+++ F        + +   +  +C        Y APEV       G  S      
Sbjct: 120 DRGHIQLTYFS------RWSE---VEDSCDGEAVENMYCAPEV-------GGISEETEAC 163

Query: 199 DIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-----DFKLPKWLSPGAQNLLRKILE 253
           D WS G IL+ +LTG           L +    G        +P+W+S  A++LL+++L+
Sbjct: 164 DWWSLGAILFELLTG---------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQ 214

Query: 254 PNPVKRITIAGIKADE 269
            NP +R+       ++
Sbjct: 215 FNPTERLGAGVAGVED 230

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 60/188 (31%), Positives = 95/188 (50%), Gaps = 12/188 (6%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
           +G G+FG V FA +  +    AVK +    +  + K  D IK E+  L+ LKHPN +   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIK-EVKFLQQLKHPNTIEYK 87

Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
                +   ++V+EY  G         K  LQE E   +    + G++Y H+  + HRD+
Sbjct: 88  GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147

Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGAT 197
           K  NILL   G +K++DFG ++           ++  G+P ++APEV+   + G YDG  
Sbjct: 148 KAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKV 201

Query: 198 SDIWSCGV 205
            D+WS G+
Sbjct: 202 -DVWSLGI 208

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 87.4 bits (216), Expect = 2e-19
 Identities = 73/230 (31%), Positives = 113/230 (49%), Gaps = 20/230 (8%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
           LG GN G V   Q   SGL  A K+      IHL+I     +QI RE+  L     P +V
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKL------IHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
             +    S  +I + +E++ GG L   +    R+ E    K+   ++ G++Y   K  + 
Sbjct: 67  GFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIM 126

Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y   
Sbjct: 127 HRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-V 181

Query: 197 TSDIWSCGVILYVILTGYLPF---DDRNL-AVLYQKIFRGDFKLPKWLSP 242
            SDIWS G+ L  +  G  P    D + L A+  + +  G+   P  +SP
Sbjct: 182 QSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISP 231

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 86.2 bits (213), Expect = 2e-19
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 6/212 (2%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V   Q  ++G  +A K L+K R+           E   L+ +  P +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFHRD 139
              SK+ + +V+  + GG+L   I + G       R +    Q+  G+ + H+  + +RD
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120

Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           +K EN+LLD +GN ++SD GL+      +D   +    G+  Y+APE+L    Y     D
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYSYPV-D 176

Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 231
            ++ G  +Y ++ G  PF D    V  +++ R
Sbjct: 177 WFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR 208

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 85.6 bits (212), Expect = 3e-19
 Identities = 78/275 (28%), Positives = 130/275 (47%), Gaps = 38/275 (13%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L R LG G FG+V +    ++  P AVK L+      +   D +  E   +K L+HP +
Sbjct: 9   QLLRKLGAGQFGEV-WEGLWNNTTPVAVKTLKPGT---MDPKDFL-AEAQIMKKLRHPKL 63

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           ++L+ V   +  IY+V E +  G L +       LQ   GR L   QLID       G++
Sbjct: 64  IQLYAVCTLEEPIYIVTELMKYGSLLE------YLQGGAGRALKLPQLIDMAAQVASGMA 117

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAP 185
           Y   +   HRDL   N+L+      K++DFGL+ +    ++D +     G+     + AP
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARV---IKED-IYEAREGAKFPIKWTAP 173

Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           E  A        SD+WS G++L  I+T G +P+     A + Q++ +G +++P    PG 
Sbjct: 174 EA-ALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPC--PPGC 229

Query: 245 QNLLRKIL----EPNPVKRITIAGIKADEWFEQDY 275
              L  I+    + +P  R T   ++   W  +D+
Sbjct: 230 PKELYDIMLDCWKEDPDDRPTFETLQ---WKLEDF 261

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 85.9 bits (213), Expect = 3e-19
 Identities = 73/260 (28%), Positives = 125/260 (48%), Gaps = 17/260 (6%)

Query: 17  ELGRTLGEGNFGKVK---FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            LGR +GEG FG V    +    +  +  AVK  +        + ++  +E   ++   H
Sbjct: 9   TLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDH 66

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           P++V+L  V+ +++ +++V+E    GEL   +  +K  L  A       QL   ++Y  +
Sbjct: 67  PHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES 125

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D+     + G  P  ++APE +  
Sbjct: 126 KRFVHRDIAARNVLVSSPDCVKLGDFGLS---RYLEDESYYKASKGKLPIKWMAPESINF 182

Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGD-FKLPKWLSPGAQNL 247
           R +  A SD+W  GV ++ IL  G  PF   +N  V+  +I  G+   +P    P   +L
Sbjct: 183 RRFTSA-SDVWMFGVCMWEILMLGVKPFQGVKNNDVI-GRIENGERLPMPPNCPPTLYSL 240

Query: 248 LRKILEPNPVKRITIAGIKA 267
           + K    +P KR     +KA
Sbjct: 241 MTKCWAYDPSKRPRFTELKA 260

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 88.7 bits (220), Expect = 3e-19
 Identities = 63/233 (27%), Positives = 109/233 (46%), Gaps = 30/233 (12%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + RY++ R +G+G  G+V  A D       A+K + ++   +  +  +  RE      L 
Sbjct: 1   MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGEL-------FDKIASKGRLQEAEGRK----LFQ 121
           HP +V ++ + +    +Y  + Y+ G  L       + K +    L E         +F 
Sbjct: 61  HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD---------GL 172
           ++   + Y H+KGV HRDLK +NILL   G + I D+G +   +   +D          +
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 173 LHTT-------CGSPNYVAPEVLANRGYDGATS-DIWSCGVILYVILTGYLPF 217
            +++        G+P+Y+APE L   G   + S DI++ GVILY +LT   P+
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPY 231

Length = 932

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 85.5 bits (212), Expect = 4e-19
 Identities = 71/239 (29%), Positives = 115/239 (48%), Gaps = 39/239 (16%)

Query: 20  RTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIATLKLL 71
           + +G G FG+V   +    G   +  A+K L     +K R+  L        E + +   
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL-------TEASIMGQF 62

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------ 125
            HPN++RL  V+     + ++ EY+  G L DK      L+E +G+    QL+       
Sbjct: 63  DHPNIIRLEGVVTKSRPVMIITEYMENGSL-DKF-----LRENDGKFTVGQLVGMLRGIA 116

Query: 126 -GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG--SP-N 181
            G+ Y       HRDL   NIL++S    K+SDFGLS   +   D    +TT G   P  
Sbjct: 117 SGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLS---RRLEDSEATYTTKGGKIPIR 173

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFKLPK 238
           + APE +A R +  A SD+WS G++++ +++ G  P+ D  N  V+ + +  G ++LP 
Sbjct: 174 WTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSYGERPYWDMSNQDVI-KAVEDG-YRLPP 229

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 85.9 bits (213), Expect = 4e-19
 Identities = 56/167 (33%), Positives = 86/167 (51%), Gaps = 34/167 (20%)

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
           RE + LK LKH N+V LH+++ +K  + +V EY+   +L   +   G        +LF  
Sbjct: 52  REASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLF 110

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQH----------FR 168
           QL+ G++YCH + V HRDLK +N+L+  +G +K++DFGL+   ++P            +R
Sbjct: 111 QLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYR 170

Query: 169 -DDGLLHTTCGSPNYVAPEVLANRGYDGATS-DIWSCGVILYVILTG 213
             D LL    GS  Y             +TS D+W  G I Y + TG
Sbjct: 171 PPDVLL----GSTEY-------------STSLDMWGVGCIFYEMATG 200

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 85.9 bits (212), Expect = 5e-19
 Identities = 62/207 (29%), Positives = 100/207 (48%), Gaps = 14/207 (6%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE    LGEG++  V   +   +G   A+K++          T    RE + LK LKH N
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFT--AIREASLLKGLKHAN 64

Query: 76  VVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +V LH+++ +K  + +V EYV     +  DK    G L     +    QL+ G+SY H +
Sbjct: 65  IVLLHDIIHTKETLTLVFEYVHTDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQR 122

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            + HRDLK +N+L+   G +K++DFGL+   ++P H   + ++     +  Y  P+VL  
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVV-----TLWYRPPDVLLG 177

Query: 191 RGYDGATSDIWSCGVILYVILTGYLPF 217
                   D+W  G I   ++ G   F
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 85.0 bits (210), Expect = 9e-19
 Identities = 82/287 (28%), Positives = 126/287 (43%), Gaps = 44/287 (15%)

Query: 18  LGRTLGEGNFGKV--KFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLL 71
           LG+TLGEG FGKV    A  L  G       AVK+L++N     ++ D +  E   LK +
Sbjct: 4   LGKTLGEGEFGKVVKATAFRL-KGRAGYTTVAVKMLKENAS-SSELRDLLS-EFNLLKQV 60

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASK------GRLQEAEGRKLFQ-- 121
            HP+V++L+   +    + +++EY   G L  F + + K      G         L    
Sbjct: 61  NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120

Query: 122 --------------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167
                         Q+  G+ Y     + HRDL   N+L+     +KISDFGLS     +
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR--DVY 178

Query: 168 RDDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD---RN 221
            +D  +  + G     ++A E L +  Y    SD+WS GV+L+ I+T G  P+       
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237

Query: 222 LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
           L  L +  +R +   P+  S    NL+    +  P KR T A I  +
Sbjct: 238 LFNLLKTGYRME--RPENCSEEMYNLMLTCWKQEPDKRPTFADISKE 282

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 84.7 bits (209), Expect = 1e-18
 Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 10/173 (5%)

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-Q 121
           RE++ LK LKH N+V LH+++ +   + +V EY+   +L   +   G +      K+F  
Sbjct: 53  REVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLY 111

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
           Q++ G++YCH + V HRDLK +N+L++ +G +K++DFGL+   ++P     + ++     
Sbjct: 112 QILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVV----- 166

Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 231
           +  Y  P+VL          D+W  G I + + +G   F    +      IFR
Sbjct: 167 TLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFR 219

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 83.4 bits (206), Expect = 2e-18
 Identities = 74/238 (31%), Positives = 116/238 (48%), Gaps = 26/238 (10%)

Query: 16  YELGRTLGEGNFGKVKFAQ---DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + LGR LG+G FG V+ AQ   +  S    AVK+L K  I      ++  RE A +K   
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59

Query: 73  HPNVVRLHEV-LASKSK----IYMV-LEYVTGGELFDKIASKGRLQE----AEGRKLFQQ 122
           HPNV++L  V L S++K    I MV L ++  G+L   +    R+ E       + L + 
Sbjct: 60  HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMS-RIGEEPFTLPLQTLVRF 118

Query: 123 LID---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
           +ID   G+ Y  +K   HRDL   N +L+    + ++DFGLS   +           C S
Sbjct: 119 MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS---KKIYSGDYYRQGCAS 175

Query: 180 P---NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 233
                ++A E LA+  Y    SD+W+ GV ++ I+T G  P+     + +Y  + +G+
Sbjct: 176 KLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 53/281 (18%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKLLKHPNVV 77
           LGEG++  V       +G   A+K+      I +K  + +     RE + LK LKH N+V
Sbjct: 13  LGEGSYATVYKGISRINGQLVALKV------ISMKTEEGVPFTAIREASLLKGLKHANIV 66

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
            LH+++ +K  +  V EY+        I   G L     R    QL+ G++Y H + + H
Sbjct: 67  LLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILH 126

Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----YVAPEVLANRGY 193
           RDLK +N+L+   G +K++DFGL+      R   +   T  S      Y  P+VL     
Sbjct: 127 RDLKPQNLLISYLGELKLADFGLA------RAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180

Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRN------------LAVLYQKIFRGDFKLPKW-- 239
             +  DIW  G I   +L G   F   +            L V  +  + G  KLP +  
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240

Query: 240 -----------------LS--PGAQNLLRKILEPNPVKRIT 261
                            LS  P A++L  ++L   P  RI+
Sbjct: 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS 281

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 84.2 bits (208), Expect = 3e-18
 Identities = 56/198 (28%), Positives = 98/198 (49%), Gaps = 17/198 (8%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y + +TL  G+ G+V  A       P  +KI +K   +          E   L+ + HP+
Sbjct: 68  YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTL---------IEAMLLQNVNHPS 118

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V+R+ + L S +   MVL + +  +L+  +  +   L   +   + +Q+++G+ Y H + 
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGY 193
           + HRD+K ENI ++    + I D G +  P       GL     G+    APEVLA   Y
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL----AGTVETNAPEVLARDKY 233

Query: 194 DGATSDIWSCGVILYVIL 211
           + + +DIWS G++L+ +L
Sbjct: 234 N-SKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 83.1 bits (205), Expect = 3e-18
 Identities = 79/278 (28%), Positives = 133/278 (47%), Gaps = 35/278 (12%)

Query: 20  RTLGEGNFGKVKFA----QDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLKLLKHP 74
           R LGEG+FGKV+      +  ++G   AVK L+ ++   H+     +K+EI  L+ L H 
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHI---ADLKKEIEILRNLYHE 66

Query: 75  NVVRLHEVLASK--SKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   +      + I +++E++  G L + +  +K ++   +  K   Q+  G+ Y  
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-VAPEVLAN 190
           ++   HRDL   N+L++S+  +KI DFGL+   +  ++   +     SP +  APE L  
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDF---KLPKWLSPGAQ 245
             +  A SD+WS GV LY +LT Y   +   + +  + I    G     +L + L  G +
Sbjct: 187 SKFYIA-SDVWSFGVTLYELLT-YCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKR 244

Query: 246 ------------NLLRKILEPNPVKRIT----IAGIKA 267
                        L+RK  E  P KR T    I G +A
Sbjct: 245 LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEA 282

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 82.3 bits (203), Expect = 3e-18
 Identities = 69/270 (25%), Positives = 123/270 (45%), Gaps = 24/270 (8%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           + +   +L +T+G+G FG V        G   AVK ++ +      +      E + +  
Sbjct: 3   LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMTQ 55

Query: 71  LKHPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---G 126
           L+H N+V+L  V+   K  +Y+V EY+  G L D + S+GR     G  L +  +D    
Sbjct: 56  LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEA 114

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y       HRDL   N+L+      K+SDFGL+      +D G L        + APE
Sbjct: 115 MEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPE 169

Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPG 243
            L  + +    SD+WS G++L+ I + G +P+    L  +  ++ +G +K+  P    P 
Sbjct: 170 ALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPV 227

Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
             +++++    +   R +   ++  E  E 
Sbjct: 228 VYDVMKQCWHLDAATRPSFLQLR--EQLEH 255

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 82.9 bits (205), Expect = 4e-18
 Identities = 70/259 (27%), Positives = 113/259 (43%), Gaps = 27/259 (10%)

Query: 21  TLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           TLG G FG+V     K  ++        VK L+K +  +L+   + +RE+   + L H N
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQS--EFRRELDMFRKLSHKN 69

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGR-------LQEAEGRKLFQQLIDG 126
           VVRL  +       YM+LEY   G+L  F +             L   +   L  Q+  G
Sbjct: 70  VVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAP 185
           + +  N    HRDL   N L+ S+  +K+S   LS     +  +         P  ++AP
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDV--YNSEYYKLRNALIPLRWLAP 187

Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           E +    +    SD+WS GV+++ + T G LPF   +   +  ++  G  +LP  +  G 
Sbjct: 188 EAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELP--VPEGC 244

Query: 245 QNLLRKILE----PNPVKR 259
            + L K++      NP  R
Sbjct: 245 PSRLYKLMTRCWAVNPKDR 263

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 82.6 bits (204), Expect = 4e-18
 Identities = 73/272 (26%), Positives = 121/272 (44%), Gaps = 27/272 (9%)

Query: 18  LGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           LG+ LGEG FG V   + +QD  S L  AVK ++ +   + +I + +  E A +K   HP
Sbjct: 3   LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-SEAACMKDFDHP 61

Query: 75  NVVRLHEV---LASKSKI---YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID--- 125
           NV++L  V    +S  KI    ++L ++  G+L   +    RL     +   Q L+    
Sbjct: 62  NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYS-RLGGLPEKLPLQTLLKFMV 120

Query: 126 ----GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP- 180
               G+ Y  N+   HRDL   N +L     + ++DFGLS   +             +  
Sbjct: 121 DIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS---KKIYSGDYYRQGRIAKM 177

Query: 181 --NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKL 236
              ++A E LA+R Y  + SD+W+ GV ++ I T G  P+       +Y  +  G+  K 
Sbjct: 178 PVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQ 236

Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
           P+       +L+      +P  R T   ++  
Sbjct: 237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 82.8 bits (205), Expect = 4e-18
 Identities = 71/226 (31%), Positives = 109/226 (48%), Gaps = 37/226 (16%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-----FAVKILEKNRIIHLKITDQIKREIATLK 69
           R  LG+ LGEG FG+V  A+ +    P      AVK+L+ +      ++D +  E+  +K
Sbjct: 13  RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK-DLSDLVS-EMEMMK 70

Query: 70  LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------GRKLF 120
           ++ KH N++ L  V   +  +Y+V+EY   G L D + ++    E             L 
Sbjct: 71  MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130

Query: 121 Q--------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--- 169
           Q        Q+  G+ +  +K   HRDL   N+L+     +KI+DFGL+      RD   
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA------RDIHH 184

Query: 170 -DGLLHTTCGS-P-NYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
            D    TT G  P  ++APE L +R Y    SD+WS GV+L+ I T
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 80.3 bits (198), Expect = 2e-17
 Identities = 70/232 (30%), Positives = 115/232 (49%), Gaps = 26/232 (11%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V      +     A+K L++  +      +    E   +K L+HP +
Sbjct: 9   KLVKKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRL 63

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           VRL+ V+ ++  IY++ EY+  G L D       L+  EG KL   +LID       G++
Sbjct: 64  VRLYAVV-TQEPIYIITEYMENGSLVD------FLKTPEGIKLTINKLIDMAAQIAEGMA 116

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEV 187
           +   K   HRDL+  NIL+      KI+DFGL+ L +   ++         P  + APE 
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEA 174

Query: 188 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           + N G     SD+WS G++L  I+T G +P+       + Q + RG +++P+
Sbjct: 175 I-NYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERG-YRMPR 224

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 79.9 bits (197), Expect = 3e-17
 Identities = 60/220 (27%), Positives = 109/220 (49%), Gaps = 17/220 (7%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG V   +   + +  A+K + +  +      +    E   +  L HP +V+L
Sbjct: 10  KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQL 64

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  +Y+V E++  G L + +  + G+L +     + Q + +G+ Y       HR
Sbjct: 65  YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124

Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L+ S G +K+SDFG++   ++  DD    ++ G+     +  PEV     Y  
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMT---RYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYS- 179

Query: 196 ATSDIWSCGVILYVILT-GYLPFDDR-NLAVLYQKIFRGD 233
           + SD+WS GV+++ + T G +PF+ + N  V+ + I RG 
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVV-EMISRGF 218

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.9 bits (197), Expect = 4e-17
 Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 19/201 (9%)

Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
            LG GN G V  A  L +    AVK++  +  I +++  QI  E+  L     P ++  +
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLD--ITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 81  EVLASKSKIYMVLEYVTGGEL--FDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
                +++I +  E++ GG L  + KI     GR+  A        ++ G++Y  +  + 
Sbjct: 66  GAFFVENRISICTEFMDGGSLDVYRKIPEHVLGRIAVA--------VVKGLTYLWSLKIL 117

Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           HRD+K  N+L++++G +K+ DFG+S        + +  T  G+  Y+APE ++   Y G 
Sbjct: 118 HRDVKPSNMLVNTRGQVKLCDFGVSTQLV----NSIAKTYVGTNAYMAPERISGEQY-GI 172

Query: 197 TSDIWSCGVILYVILTGYLPF 217
            SD+WS G+    +  G  P+
Sbjct: 173 HSDVWSLGISFMELALGRFPY 193

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 78.8 bits (194), Expect = 8e-17
 Identities = 63/217 (29%), Positives = 104/217 (47%), Gaps = 25/217 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIA 66
             ++ + +G G FG+V   +    G   +P A+K L     EK R   L        E +
Sbjct: 5   CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFL-------SEAS 57

Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLI 124
            +    HPN++ L  V+     + +V EY+  G L D    K  G+    +   + + + 
Sbjct: 58  IMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIA 116

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---N 181
            G+ Y  + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      
Sbjct: 117 SGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIR 174

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
           + APE +A R +  A SD+WS G++++ +++ G  P+
Sbjct: 175 WTAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPY 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 59/222 (26%), Positives = 110/222 (49%), Gaps = 16/222 (7%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G FG V     L+     A+K + +  +      +    E   +  L HP +V+L+ 
Sbjct: 12  IGSGQFGLVWLGYWLEKR-KVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYG 66

Query: 82  VLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
           V   +S I +V E++  G L D + A +G+  +     +   + +G++Y  +  V HRDL
Sbjct: 67  VCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDL 126

Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGAT 197
              N L+     +K+SDFG++     F  D    ++ G+     + +PEV +   Y  + 
Sbjct: 127 AARNCLVGENQVVKVSDFGMT----RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS-SK 181

Query: 198 SDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           SD+WS GV+++ + + G  P+++R+ + + + I  G F+L K
Sbjct: 182 SDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYK 222

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 77.8 bits (191), Expect = 2e-16
 Identities = 61/226 (26%), Positives = 112/226 (49%), Gaps = 14/226 (6%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V  A   +     AVK ++   +           E   +K L+H  +
Sbjct: 9   KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMSVEAFLA----EANVMKTLQHDKL 63

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V+LH V+ +K  IY++ E++  G L D + S    +    +      Q+ +G+++   + 
Sbjct: 64  VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
             HRDL+  NIL+ +    KI+DFGL+ + +   ++         P  + APE + N G 
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI-NFGS 179

Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
               SD+WS G++L  I+T G +P+   +   + + + RG +++P+
Sbjct: 180 FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPR 224

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 77.7 bits (191), Expect = 2e-16
 Identities = 57/195 (29%), Positives = 96/195 (49%), Gaps = 7/195 (3%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           ++E+   +GEG +G V   +  ++    A+K   K+   + ++ +   RE+  L+ LK  
Sbjct: 2   KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           N+V L E    + K+Y+V EYV     EL +++ + G   E + R    QLI  + +CH 
Sbjct: 61  NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN-GVPPE-KVRSYIYQLIKAIHWCHK 118

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             + HRD+K EN+L+     +K+ DFG +       +         +  Y +PE+L    
Sbjct: 119 NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPELLLGAP 177

Query: 193 YDGATSDIWSCGVIL 207
           Y G   D+WS G IL
Sbjct: 178 Y-GKAVDMWSVGCIL 191

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 64/213 (30%), Positives = 99/213 (46%), Gaps = 18/213 (8%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D   G+  AVK L +      H K   +  RE+  LK 
Sbjct: 20  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAK---RAYRELVLLKC 76

Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 77  VNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIHME--LDHERMSYLLYQML 133

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+        + ++     +  Y A
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYYRA 190

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
           PEV+   GY     DIWS G I+  ++ G + F
Sbjct: 191 PEVILGMGYK-ENVDIWSVGCIMGELVKGSVIF 222

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 76.5 bits (188), Expect = 5e-16
 Identities = 70/250 (28%), Positives = 113/250 (45%), Gaps = 8/250 (3%)

Query: 22  LGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           LG GNFG VK    +   S    AVKIL KN      + D++ RE   ++ L +P +VR+
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKIL-KNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
             +  ++S + +V+E    G L   +     + E    +L  Q+  G+ Y       HRD
Sbjct: 62  IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120

Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L   N+LL ++   KISDFGLS       +     T    P  + APE + N     + S
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECM-NYYKFSSKS 179

Query: 199 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNP 256
           D+WS GV+++   + G  P+       + Q I  G+  + P+   P   +L++       
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYGV 239

Query: 257 VKRITIAGIK 266
            +R   A ++
Sbjct: 240 DERPGFAVVE 249

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 77.0 bits (189), Expect = 6e-16
 Identities = 69/224 (30%), Positives = 108/224 (48%), Gaps = 31/224 (13%)

Query: 15  RYELGRTLGEGNFGKVKFAQ--DLDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 19  RLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 76

Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-------------GRLQE 113
           +K++ KH N++ L         +Y+++EY + G L + + ++                ++
Sbjct: 77  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQ 136

Query: 114 AEGRKLFQ---QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
              + L     Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 137 LSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 194

Query: 171 GLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
               TT G     ++APE L +R Y    SD+WS GV+L+ I T
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 49/162 (30%), Positives = 78/162 (48%), Gaps = 16/162 (9%)

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           REI  LK + H  ++ L      KS + MV+      +LF  +   G L   +   + ++
Sbjct: 135 REIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRR 193

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-------LPQHFRDDGLLHT 175
           L++ ++Y H +G+ HRD+K ENI LD   N  + DFG +         PQ +   G L T
Sbjct: 194 LLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253

Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
                   +PE+LA   Y  A +DIWS G++L+ +    +  
Sbjct: 254 N-------SPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTL 287

Length = 392

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 75.8 bits (186), Expect = 1e-15
 Identities = 75/262 (28%), Positives = 121/262 (46%), Gaps = 26/262 (9%)

Query: 18  LGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           LG+TLGEG FG V   +  QD DS L  AVK ++       ++ D +  E   +K   HP
Sbjct: 3   LGKTLGEGEFGSVMEGQLNQD-DSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHP 60

Query: 75  NVVRLHEVL--ASKSKIY----MVLEYVTGGEL-----FDKIASKGRLQEAEGR-KLFQQ 122
           NV+RL  V     +S+ Y    ++L ++  G+L     + ++    +    +   K    
Sbjct: 61  NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTCGS 179
           +  G+ Y  +K   HRDL   N +L+   N+ ++DFGLS       ++R   +       
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV-- 178

Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLP 237
             ++A E LA+R Y    SD+WS GV ++ I T G  P+     + +Y  + +G+  K P
Sbjct: 179 -KWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP 236

Query: 238 KWLSPGAQNLLRKILEPNPVKR 259
                G  +L+      NP  R
Sbjct: 237 PDCLDGLYSLMSSCWLLNPKDR 258

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 76.6 bits (189), Expect = 1e-15
 Identities = 77/293 (26%), Positives = 123/293 (41%), Gaps = 72/293 (24%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEK---NRIIHLKITDQIKREIATLKLLKHPNVVR 78
           +G G +G V  A++ ++    A+K +     NRI   +      REI  L+ L H NV+ 
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL----REIKLLRHLDHENVIA 68

Query: 79  LHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           + +++    +     +Y+V E +   +L   I S   L +   +    QL+ G+ Y H+ 
Sbjct: 69  IKDIMPPPHREAFNDVYIVYE-LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSA 127

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN----------YV 183
            V HRDLK  N+LL++  ++KI DFGL+             TT    +          Y 
Sbjct: 128 NVLHRDLKPSNLLLNANCDLKICDFGLA------------RTTSEKGDFMTEYVVTRWYR 175

Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTG--------YL------------PFDD---- 219
           APE+L N        D+WS G I   +L          Y+            P ++    
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGF 235

Query: 220 ----------RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI 262
                     R+L    ++ F   F  P   +P A +LL K+L  +P KRIT+
Sbjct: 236 IRNEKARRYIRSLPYTPRQSFARLF--PH-ANPLAIDLLEKMLVFDPSKRITV 285

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 75.4 bits (185), Expect = 1e-15
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 33/272 (12%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V +    +     AVK L+   +      +    E   +K L+H  +
Sbjct: 9   QLIKKLGNGQFGEV-WMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKL 63

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           V+L+ V+ S+  IY+V EY++ G L D       L++ EGR L    L+D       G++
Sbjct: 64  VQLYAVV-SEEPIYIVTEYMSKGSLLD------FLKDGEGRALKLPNLVDMAAQVAAGMA 116

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAP 185
           Y       HRDL+  NIL+      KI+DFGL+ L +    D       G+     + AP
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIE----DNEYTARQGAKFPIKWTAP 172

Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 243
           E  A  G     SD+WS G++L  ++T G +P+   N   + +++ RG     P+     
Sbjct: 173 EA-ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPIS 231

Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
              L+ +  + +P +R T   +++   F +DY
Sbjct: 232 LHELMLQCWKKDPEERPTFEYLQS---FLEDY 260

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 75.9 bits (187), Expect = 1e-15
 Identities = 71/255 (27%), Positives = 115/255 (45%), Gaps = 30/255 (11%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK--LLKH--PNVV 77
           +G G  G+V   +   +G   AVK + +         ++ KR +  L   L  H  P +V
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQMRRT-----GNKEENKRILMDLDVVLKSHDCPYIV 77

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNK-G 134
           + +    + S +++ +E +      DK+    +G + E    K+   ++  + Y   K G
Sbjct: 78  KCYGYFITDSDVFICMELM--STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT-TCGSPNYVAPEVL----A 189
           V HRD+K  NILLD+ GN+K+ DFG+S        D    T + G   Y+APE +     
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISG----RLVDSKAKTRSAGCAAYMAPERIDPPDP 191

Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD--DRNLAVLYQKIFRGDF-KLP--KWLSPGA 244
           N  YD   +D+WS G+ L  + TG  P+        VL  KI + +   LP  +  SP  
Sbjct: 192 NPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVL-TKILQEEPPSLPPNEGFSPDF 249

Query: 245 QNLLRKILEPNPVKR 259
            + +   L  +  KR
Sbjct: 250 CSFVDLCLTKDHRKR 264

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 74/279 (26%), Positives = 118/279 (42%), Gaps = 44/279 (15%)

Query: 18  LGRTLGEGNFGKVKFAQDLDSGLP------FAVKILEKNRIIHLKITDQIKREIATLKLL 71
           L R LGEG FGKV F  +     P       AVK L++      +     +RE   L   
Sbjct: 9   LKRELGEGAFGKV-FLGECYHLEPENDKELVAVKTLKETASNDAR--KDFEREAELLTNF 65

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--------------KGRLQEAEGR 117
           +H N+V+ + V        MV EY+  G+L   + S               G L  ++  
Sbjct: 66  QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125

Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT- 176
           ++  Q+  G+ Y  ++   HRDL   N L+     +KI DFG+S      RD   ++TT 
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS------RD---VYTTD 176

Query: 177 ----CGSP----NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 227
                G       ++ PE +  R +    SD+WS GV+L+ I T G  P+   +   + +
Sbjct: 177 YYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIE 235

Query: 228 KIFRGDFKL-PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            I +G     P+       +++    + +P +RI I  I
Sbjct: 236 CITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 75.9 bits (187), Expect = 2e-15
 Identities = 65/208 (31%), Positives = 102/208 (49%), Gaps = 12/208 (5%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           E  R +G G FG V    D   G   A+K +  N   +L    ++ RE+  L   KH NV
Sbjct: 3   EPDRPIGYGAFGVVWSVTDPRDGKRVALKKM-PNVFQNLVSCKRVFRELKMLCFFKHDNV 61

Query: 77  VRLHEVLASK-----SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYC 130
           +   ++L         +IY+V E +   +L   I S   L  ++  K+F  Q++ G+ Y 
Sbjct: 62  LSALDILQPPHIDPFEEIYVVTELMQS-DLHKIIVSPQPLS-SDHVKVFLYQILRGLKYL 119

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL-A 189
           H+ G+ HRD+K  N+L++S   +KI DFGL+ + +   +   +     +  Y APE+L  
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCVLKICDFGLARV-EEPDESKHMTQEVVTQYYRAPEILMG 178

Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPF 217
           +R Y  A  DIWS G I   +L   + F
Sbjct: 179 SRHYTSAV-DIWSVGCIFAELLGRRILF 205

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 74.9 bits (184), Expect = 2e-15
 Identities = 66/233 (28%), Positives = 104/233 (44%), Gaps = 19/233 (8%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
           +G G FGKV    +   G+  A V + E              +E+   + L HPNV++  
Sbjct: 3   IGNGWFGKV-LLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ-----LIDGVSYCHNKGV 135
                     +VLE+   G+L + + S   +     +K   Q     +  G+ + H    
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF 121

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPEVLANRGY 193
            H DL L N  L +  ++KI D+GL AL Q + +D  +   C + P  ++APE++  RG 
Sbjct: 122 IHSDLALRNCQLTADLSVKIGDYGL-ALEQ-YPEDYYITKDCHAVPLRWLAPELVEIRGQ 179

Query: 194 DGAT------SDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFKLPK 238
           D         S+IWS GV ++ + T    P+ D  +  VL Q +   D KLPK
Sbjct: 180 DLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK 232

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 75.5 bits (185), Expect = 2e-15
 Identities = 71/218 (32%), Positives = 105/218 (48%), Gaps = 25/218 (11%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           L  YE G  +G G +G V  A+  D      +A+K +E        I+    REIA L+ 
Sbjct: 1   LFEYE-GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGT-----GISMSACREIALLRE 54

Query: 71  LKHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI----ASKG-----RLQEAEGRKL 119
           LKHPNV+ L +V  S S  K++++ +Y    +L+  I    ASK      +L  +  + L
Sbjct: 55  LKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSL 113

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSAL-PQHFRDDGLLH 174
             Q++DG+ Y H   V HRDLK  NIL+      +G +KI+D G + L     +    L 
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173

Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
               +  Y APE+L    +     DIW+ G I   +LT
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 72/275 (26%), Positives = 121/275 (44%), Gaps = 40/275 (14%)

Query: 15  RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
               G+TLG G FGKV  A        D+ +  AVK+L+     H    + +  E+  + 
Sbjct: 36  NLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT--AHSSEREALMSELKIMS 93

Query: 70  LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ---QLID 125
            L  H N+V L         I ++ EY   G+L + +  K R        L     Q+  
Sbjct: 94  HLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAK 152

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV-- 183
           G+++  +K   HRDL   N+LL     +KI DFGL+      RD  +++ +    NYV  
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA------RD--IMNDS----NYVVK 200

Query: 184 ----------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
                     APE + N  Y    SD+WS G++L+ I + G  P+    +   + K+ + 
Sbjct: 201 GNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKE 259

Query: 233 DFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            +++  P+       ++++   + +P+KR T   I
Sbjct: 260 GYRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQI 294

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 74.8 bits (184), Expect = 3e-15
 Identities = 61/221 (27%), Positives = 98/221 (44%), Gaps = 31/221 (14%)

Query: 22  LGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           LGEG FGKV   +     +  S    A+K L++N     K+  + ++E   +  L+HPN+
Sbjct: 13  LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEP--KVQQEFRQEAELMSDLQHPNI 70

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIAS----------------KGRLQEAEGRKLF 120
           V L  V   +    M+ EY+  G+L + +                  K  L  ++   + 
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTC 177
            Q+  G+ Y  +    HRDL   N L+     +KISDFGLS       ++R   +   + 
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYR---VQSKSL 187

Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
               ++ PE +   G     SDIWS GV+L+ I + G  P+
Sbjct: 188 LPVRWMPPEAILY-GKFTTESDIWSFGVVLWEIFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 75.1 bits (184), Expect = 3e-15
 Identities = 70/218 (32%), Positives = 105/218 (48%), Gaps = 25/218 (11%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           L  YE G  +G G +G V  A+  D      +A+K +E        I+    REIA L+ 
Sbjct: 1   LFEYE-GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT-----GISMSACREIALLRE 54

Query: 71  LKHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI-------ASKGRLQEAEG--RKL 119
           LKHPNV+ L +V  S +  K++++ +Y    +L+  I       A+K  +Q   G  + L
Sbjct: 55  LKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSL 113

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSAL-PQHFRDDGLLH 174
             Q++DG+ Y H   V HRDLK  NIL+      +G +KI+D G + L     +    L 
Sbjct: 114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLD 173

Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
               +  Y APE+L    +     DIW+ G I   +LT
Sbjct: 174 PVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 75.0 bits (184), Expect = 3e-15
 Identities = 68/234 (29%), Positives = 107/234 (45%), Gaps = 51/234 (21%)

Query: 15  RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+         D  +  AVK+L+ N      + D I  E+  
Sbjct: 13  RLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLIS-EMEL 70

Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE------------- 113
           +KL+ KH N++ L  V   +  +Y+++EY          A+KG L+E             
Sbjct: 71  MKLIGKHKNIINLLGVCTQEGPLYVIVEY----------AAKGNLREFLRARRPPGPDYT 120

Query: 114 ------AEGRKLFQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL 160
                  E +  F+ L+        G+ Y  ++   HRDL   N+L+     +KI+DFGL
Sbjct: 121 FDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGL 180

Query: 161 SALPQHFRDDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           +        D    T+ G     ++APE L +R Y    SD+WS G++++ I T
Sbjct: 181 ARGVHDI--DYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 73.7 bits (181), Expect = 4e-15
 Identities = 75/273 (27%), Positives = 111/273 (40%), Gaps = 35/273 (12%)

Query: 20  RTLGEGNFGKVKFAQDLD-----SG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             LG G FG+V      D     SG +  AVK L K      K   +  +E   +    H
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKK--EFLKEAHLMSNFNH 58

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG-----RKLFQQLID--- 125
           PN+V+L  V       Y+++E + GG+L   +    R++         ++L    +D   
Sbjct: 59  PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYL-RDARVERFGPPLLTLKELLDICLDVAK 117

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGL-----SALPQHFRDDGLLHT 175
           G  Y       HRDL   N L+  KG      +KI DFGL      +       +GLL  
Sbjct: 118 GCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPV 177

Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR-NLAVLYQKIFRGD 233
                 ++APE L + G     SD+WS GV+++ ILT G  P+    N  VL      G 
Sbjct: 178 -----RWMAPESLLD-GKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGR 231

Query: 234 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 266
            + P+        L+      +P +R T   I+
Sbjct: 232 LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQ 264

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 73.5 bits (180), Expect = 7e-15
 Identities = 68/237 (28%), Positives = 110/237 (46%), Gaps = 36/237 (15%)

Query: 20  RTLGEGNFGKVKFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIATLKLL 71
           + +G G FG+V        G   +  A+K L     EK R   L        E + +   
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLS-------EASIMGQF 63

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------ 125
            H N++RL  V+       ++ EY+  G L DK      L++ +G     QL+       
Sbjct: 64  SHHNIIRLEGVVTKFKPAMIITEYMENGAL-DKY-----LRDHDGEFSSYQLVGMLRGIA 117

Query: 126 -GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---N 181
            G+ Y  +    HRDL   NIL++S    K+SDFGLS + +   +    +TT G      
Sbjct: 118 AGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG--TYTTSGGKIPIR 175

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           + APE +A R +  A SD+WS G++++ +++ G  P+ D +   + + I  G F+LP
Sbjct: 176 WTAPEAIAYRKFTSA-SDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLP 230

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 86/330 (26%), Positives = 145/330 (43%), Gaps = 59/330 (17%)

Query: 15  RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+ +       +  +  AVK+L K+      ++D +  E+  
Sbjct: 13  RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKML-KDDATDKDLSDLVS-EMEM 70

Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK---------GRLQEAEGR 117
           +K++ KH N++ L         +Y+++EY + G L + + ++            +  E +
Sbjct: 71  MKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQ 130

Query: 118 KLFQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 169
             F+ L+        G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD 
Sbjct: 131 LTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLA------RDV 184

Query: 170 ---DGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 223
              D    TT G     ++APE L +R Y    SD+WS GV+L+ I T G  P+    + 
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243

Query: 224 VLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI-----------KADEW- 270
            L++ +  G     P   +     ++R+     P +R T   +             DE+ 
Sbjct: 244 ELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTSTDEYL 303

Query: 271 -----FEQDYTPANPDDDEEDIFVDNEAFS 295
                FEQ Y+P  PD        D+  F+
Sbjct: 304 DLSVPFEQ-YSPGCPDSPSSCSSGDDSVFA 332

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 73.5 bits (180), Expect = 7e-15
 Identities = 76/270 (28%), Positives = 123/270 (45%), Gaps = 37/270 (13%)

Query: 22  LGEGNFGKVKFAQDLDSGLPF--AVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
           +GEGNFG+V  A     GL    A+K+L++  +   H     +++      KL  HPN++
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELE---VLCKLGHHPNII 66

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------------GRKLFQQL 123
            L     ++  +Y+ +EY   G L D +  K R+ E +               ++L Q  
Sbjct: 67  NLLGACENRGYLYIAIEYAPYGNLLDFL-RKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125

Query: 124 ID---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS- 179
            D   G+ Y   K   HRDL   N+L+      KI+DFGLS   + +     +  T G  
Sbjct: 126 SDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVY-----VKKTMGRL 180

Query: 180 -PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL- 236
              ++A E L    Y    SD+WS GV+L+ I++ G  P+     A LY+K+ +G +++ 
Sbjct: 181 PVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRME 238

Query: 237 -PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            P+        L+R+     P +R   A I
Sbjct: 239 KPRNCDDEVYELMRQCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 72.6 bits (178), Expect = 1e-14
 Identities = 62/235 (26%), Positives = 108/235 (45%), Gaps = 34/235 (14%)

Query: 22  LGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHP 74
           +G G FG+V   +    G   +  A+K L+         T++ +R    E + +    HP
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG------YTEKQRRDFLSEASIMGQFDHP 65

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------DGV 127
           N++ L  V+     + ++ E++  G L         L++ +G+    QL+        G+
Sbjct: 66  NIIHLEGVVTKSRPVMIITEFMENGAL------DSFLRQNDGQFTVIQLVGMLRGIAAGM 119

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVA 184
            Y       HRDL   NIL++S    K+SDFGLS   +    D    ++ G      + A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPF-DDRNLAVLYQKIFRGDFKLP 237
           PE +A R +  A SD+WS G++++ +++ G  P+ D  N  V+       D++LP
Sbjct: 180 PEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVI--NAIEQDYRLP 231

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 72.4 bits (177), Expect = 1e-14
 Identities = 75/269 (27%), Positives = 121/269 (44%), Gaps = 35/269 (13%)

Query: 22  LGEGNFGKVKFAQDLDSGLPF--AVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
           +GEGNFG+V  A+    GL    A+K +++  ++  H     +++      KL  HPN++
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE---VLCKLGHHPNII 59

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------------GRKLFQQL 123
            L      +  +Y+ +EY   G L D +  K R+ E +               ++L    
Sbjct: 60  NLLGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFA 118

Query: 124 ID---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS- 179
            D   G+ Y   K   HRDL   NIL+      KI+DFGLS   + +     +  T G  
Sbjct: 119 ADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRL 173

Query: 180 -PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKL 236
              ++A E L    Y    SD+WS GV+L+ I++ G  P+     A LY+K+ +G   + 
Sbjct: 174 PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232

Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
           P        +L+R+     P +R + A I
Sbjct: 233 PLNCDDEVYDLMRQCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 66/225 (29%), Positives = 109/225 (48%), Gaps = 39/225 (17%)

Query: 18  LGRTLGEGNFGKVKFAQDL--DSGLP-----FAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ L  D   P      AVK+L K+      ++D +  E+  +K+
Sbjct: 19  LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 76

Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL---------QEAEGRKLF 120
           + KH N++ L         +Y+++EY + G L + + ++            +  + +  F
Sbjct: 77  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF 136

Query: 121 QQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
           + L+        G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDVNNI 190

Query: 170 DGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           D    TT G     ++APE L +R Y    SD+WS GV+++ I T
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 72.3 bits (177), Expect = 2e-14
 Identities = 78/267 (29%), Positives = 118/267 (44%), Gaps = 31/267 (11%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLH 80
           +GEGNFG+V  A+    GL     I                 E+  L KL  HPN++ L 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----------QQLID----- 125
                +  +Y+ +EY   G L D +  K R+ E +               QQL+      
Sbjct: 75  GACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PN 181
             G+ Y   K   HRDL   NIL+      KI+DFGLS   + +     +  T G     
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRLPVR 188

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
           ++A E L    Y    SD+WS GV+L+ I++ G  P+     A LY+K+ +G ++L K L
Sbjct: 189 WMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPL 246

Query: 241 SPGAQ--NLLRKILEPNPVKRITIAGI 265
           +   +  +L+R+     P +R + A I
Sbjct: 247 NCDDEVYDLMRQCWREKPYERPSFAQI 273

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 32/210 (15%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D  +G   A+K L +    + H K   +  RE+  +KL
Sbjct: 15  LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAK---RAYRELVLMKL 71

Query: 71  LKHPNVVRLHEV------LASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQ 122
           + H N++ L  V      L     +Y+V+E +     ++        R+       L  Q
Sbjct: 72  VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMS-----YLLYQ 126

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN- 181
           ++ G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   +   +P  
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAG--TSFMMTPYV 178

Query: 182 ----YVAPEVLANRGYDGATSDIWSCGVIL 207
               Y APEV+   GY     DIWS G I+
Sbjct: 179 VTRYYRAPEVILGMGYK-ENVDIWSVGCIM 207

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 71.2 bits (174), Expect = 4e-14
 Identities = 64/219 (29%), Positives = 96/219 (43%), Gaps = 31/219 (14%)

Query: 18  LGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LGEG FGKV  A+          +  AVK L+      L      +RE   L  L+
Sbjct: 9   LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQ 65

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELF----------------DKIASKGRLQEAEG 116
           H ++V+ + V      + MV EY+  G+L                     +KG L  ++ 
Sbjct: 66  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125

Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLL 173
             +  Q+  G+ Y  ++   HRDL   N L+ +   +KI DFG+S       ++R  G  
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG-- 183

Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           HT      ++ PE +  R +    SD+WS GVIL+ I T
Sbjct: 184 HTML-PIRWMPPESIMYRKFT-TESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 70.5 bits (172), Expect = 6e-14
 Identities = 75/267 (28%), Positives = 127/267 (47%), Gaps = 33/267 (12%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   ++     +   +E   +K L+H  +V L+ 
Sbjct: 14  LGQGCFGEV-WMGTWNGTTKVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYA 68

Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--KLFQ------QLIDGVSYCHNK 133
           V+ S+  IY+V E++  G L D       L+E +G+  KL Q      Q+ DG++Y    
Sbjct: 69  VV-SEEPIYIVTEFMGKGSLLD------FLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLAN 190
              HRDL+  NIL+      KI+DFGL+ L +    D       G+     + APE  A 
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-AL 176

Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLL 248
            G     SD+WS G++L  ++T G +P+       + +++ RG     P+        L+
Sbjct: 177 YGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM 236

Query: 249 RKILEPNPVKRITIAGIKADEWFEQDY 275
           +   + +P +R T   I++   F +DY
Sbjct: 237 KLCWKKDPDERPTFEYIQS---FLEDY 260

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 71.6 bits (175), Expect = 7e-14
 Identities = 40/152 (26%), Positives = 76/152 (50%), Gaps = 5/152 (3%)

Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           E   L+ + HP++++L           ++L  Y T  +L+  +A+K  +   +   + + 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT--DLYCYLAAKRNIAICDILAIERS 190

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           ++  + Y H   + HRD+K ENI ++  G++ + DFG +  P     +   +   G+   
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK-YYGWAGTIAT 249

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGY 214
            APE+LA   Y G   DIWS G++L+ + T +
Sbjct: 250 NAPELLARDPY-GPAVDIWSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 70.9 bits (173), Expect = 7e-14
 Identities = 63/214 (29%), Positives = 98/214 (45%), Gaps = 24/214 (11%)

Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLLKHP 74
           L R LGEG FGKV F  +  +  P   KIL   + +     +  K   RE   L  L+H 
Sbjct: 9   LKRELGEGAFGKV-FLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 67

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------------RLQEAEGRKLFQ 121
           ++V+ + V      + MV EY+  G+L   + + G              L +++   + Q
Sbjct: 68  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQ 127

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCG 178
           Q+  G+ Y  ++   HRDL   N L+     +KI DFG+S       ++R  G  HT   
Sbjct: 128 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTML- 184

Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
              ++ PE +  R +    SD+WS GV+L+ I T
Sbjct: 185 PIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 58/209 (27%), Positives = 91/209 (43%), Gaps = 15/209 (7%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-KITDQIKREI-ATLKLLKHPNVVRL 79
           +G G FG V       SG   AVK   + R     K   ++  ++   ++    P +V+ 
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVK---RIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKF 68

Query: 80  HEVLASKSKIYMVLEYV-TGGELFDKIA---SKGRLQEAEGRKLFQQLIDGVSYCHNK-G 134
           +  L  +   ++ +E +    + F K      K  + E    K+    +  ++Y   +  
Sbjct: 69  YGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK 128

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NILLD  GNIK+ DFG+S       D        G   Y+APE +     D
Sbjct: 129 IIHRDVKPSNILLDRNGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDPSARD 185

Query: 195 G--ATSDIWSCGVILYVILTGYLPFDDRN 221
           G    SD+WS G+ LY + TG  P+   N
Sbjct: 186 GYDVRSDVWSLGITLYEVATGKFPYPKWN 214

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 71.5 bits (175), Expect = 8e-14
 Identities = 44/147 (29%), Positives = 78/147 (53%), Gaps = 5/147 (3%)

Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKGR-LQEAEGRKLFQ 121
           E   L+ L HP V+ L +V        +VL +Y +  +L+  + ++ R L  A+   + +
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS--DLYTYLGARLRPLGLAQVTAVAR 267

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           QL+  + Y H +G+ HRD+K EN+L++   +I + DFG +   +        +   G+ +
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILY 208
             APEVLA   Y   + DIWS G++++
Sbjct: 328 TNAPEVLAGDPYT-PSVDIWSAGLVIF 353

Length = 461

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 70.4 bits (172), Expect = 9e-14
 Identities = 75/272 (27%), Positives = 117/272 (43%), Gaps = 34/272 (12%)

Query: 22  LGEGNFGKVKFAQ------DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           LGEG FGKV  A+      + D  L  AVK L++            +RE   L +L+H +
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKML-VAVKALKE---ASESARQDFQREAELLTVLQHQH 68

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQ---------- 121
           +VR + V      + MV EY+  G+L   + S G     L   E     Q          
Sbjct: 69  IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128

Query: 122 -QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTC 177
            Q+  G+ Y  +    HRDL   N L+     +KI DFG+S       ++R  G    T 
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG---RTM 185

Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFK 235
               ++ PE +  R +    SDIWS GV+L+ I T G  P+   +     + I +G + +
Sbjct: 186 LPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELE 244

Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267
            P+   P    +++   +  P +R+ I  I +
Sbjct: 245 RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 69.6 bits (170), Expect = 1e-13
 Identities = 58/194 (29%), Positives = 95/194 (48%), Gaps = 14/194 (7%)

Query: 22  LGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           LG GNFG VK    +     +  A+K+L+        + D++ RE   +  L +P +VR+
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
             V  +++ + +V+E  +GG L   ++ K   +  +   +L  Q+  G+ Y   K   HR
Sbjct: 61  IGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119

Query: 139 DLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYD 194
           DL   N+LL ++   KISDFGLS AL     DD              + APE +  R + 
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLSKALGA---DDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 195 GATSDIWSCGVILY 208
            + SD+WS G+ ++
Sbjct: 177 -SRSDVWSYGITMW 189

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 59/236 (25%), Positives = 88/236 (37%), Gaps = 50/236 (21%)

Query: 14  GRYELGRTLGEGNFGKVKFA-----QDLDSGLP-----------FAVKILEKNRIIHLKI 57
                   LGEG FG+V        QD                  AVK+L  +   + + 
Sbjct: 5   QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64

Query: 58  TDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL---------FDKIASK 108
            D +K E+  L  L  PN+ RL  V      + M++EY+  G+L              + 
Sbjct: 65  -DFLK-EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLAC 122

Query: 109 GRLQEAEGRKLFQ--QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---L 163
                +    L+   Q+  G+ Y  +    HRDL   N L+     IKI+DFG+S     
Sbjct: 123 NSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182

Query: 164 PQHFRDDGLLHTTCGSPNYVAP-------EVLANRGYDGATSDIWSCGVILYVILT 212
             ++R  G             P        VL  + +    SD+W+ GV L+ ILT
Sbjct: 183 SDYYRVQG---------RAPLPIRWMAWESVLLGK-FTTK-SDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 77/259 (29%), Positives = 123/259 (47%), Gaps = 28/259 (10%)

Query: 20  RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           R +G+G+FG V     +DS    +  AVK L  NRI  L+  +Q  +E   +K   HPNV
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSL--NRITDLEEVEQFLKEGIIMKDFSHPNV 58

Query: 77  VRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHN 132
           + L  + L S+    +VL Y+  G+L + I S+     +++  G  L  Q+  G+ Y  +
Sbjct: 59  LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYLAS 116

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-------DGLLHTTCGSP-NYVA 184
           K   HRDL   N +LD    +K++DFGL+      RD           HT    P  ++A
Sbjct: 117 KKFVHRDLAARNCMLDESFTVKVADFGLA------RDIYDKEYYSVHNHTGAKLPVKWMA 170

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL-PKWLSP 242
            E L  + +    SD+WS GV+L+ ++T G  P+ D +   +   + +G   L P++   
Sbjct: 171 LESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPD 229

Query: 243 GAQNLLRKILEPNPVKRIT 261
               ++     P P  R T
Sbjct: 230 PLYEVMLSCWHPKPEMRPT 248

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 67.8 bits (166), Expect = 9e-13
 Identities = 55/231 (23%), Positives = 99/231 (42%), Gaps = 21/231 (9%)

Query: 17  ELGRTLGEGNFGK--VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           EL   +G+       V  A+   +    AVK +  +      +   +++EI T + L+HP
Sbjct: 1   ELLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLK-LLQQEIITSRQLQHP 59

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHN 132
           N++         S++Y+V   +  G   D + +     L E     + + +++ + Y H+
Sbjct: 60  NILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHS 119

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--------NYVA 184
           KG  HR +K  +ILL   G + +S  GL          G                  +++
Sbjct: 120 KGFIHRSVKASHILLSGDGKVVLS--GLRYS-VSMIKHGKRQRVVHDFPKSSVKNLPWLS 176

Query: 185 PEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY-QKIFRG 232
           PEVL    +GY+   SDI+S G+    +  G++PF D     +  +K+ RG
Sbjct: 177 PEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQMLLEKV-RG 225

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 67.1 bits (164), Expect = 1e-12
 Identities = 69/269 (25%), Positives = 120/269 (44%), Gaps = 24/269 (8%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI----ATLKLLKHPN 75
             LG G +G V   + + +G   AVK +       +   +Q KR +     +++ +  P 
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRAT----VNSQEQ-KRLLMDLDISMRSVDCPY 61

Query: 76  VVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHN 132
            V  +  L  +  +++ +E +     + + K+  KG  + E    K+   ++  + Y H+
Sbjct: 62  TVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121

Query: 133 K-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE----V 187
           K  V HRD+K  N+L++  G +K+ DFG+S    +  D        G   Y+APE     
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISG---YLVDSVAKTIDAGCKPYMAPERINPE 178

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDFKLPK-WLSPGA 244
           L  +GYD   SD+WS G+ +  + TG  P+D        L Q +     +LP    SP  
Sbjct: 179 LNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237

Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQ 273
           Q+ + K L+ N  +R     +    +FE 
Sbjct: 238 QDFVNKCLKKNYKERPNYPELLQHPFFEL 266

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 62/234 (26%), Positives = 93/234 (39%), Gaps = 47/234 (20%)

Query: 17  ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIA 66
            L R LG G FG+V              L  AVK L     E++    L        E  
Sbjct: 9   TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLM-------EAL 61

Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--------- 117
            +    H N+VRL  V   +   +++LE + GG+L      K  L+E   R         
Sbjct: 62  IMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDL------KSFLRENRPRPERPSSLTM 115

Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSA---LPQHF 167
                  + +  G  Y       HRD+   N LL  KG     KI+DFG++       ++
Sbjct: 116 KDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYY 175

Query: 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR 220
           R  G          ++ PE   + G   + +D+WS GV+L+ I + GY+P+  R
Sbjct: 176 RKGG---RAMLPIKWMPPEAFLD-GIFTSKTDVWSFGVLLWEIFSLGYMPYPGR 225

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 30/284 (10%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 72

Query: 71  LKHPNVVRLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 73  VNHKNIISLLNVFTPQKSLEEFQDVYLVME-LMDANLCQVIQME--LDHERMSYLLYQML 129

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 183

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWL 240
           Y APEV+   GY     DIWS G I+  ++   + F  R+    + K+        P+++
Sbjct: 184 YRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242

Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
               Q  +R  +E  P      AG+   + F     PA+ + ++
Sbjct: 243 KK-LQPTVRNYVENRP----KYAGLTFPKLFPDSLFPADSEHNK 281

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 18/225 (8%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D    +    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 229
           PEV+   GY     DIWS G I+  ++ G + F   +    + K+
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 66.4 bits (162), Expect = 2e-12
 Identities = 65/238 (27%), Positives = 102/238 (42%), Gaps = 47/238 (19%)

Query: 15  RYELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIKREIATLK 69
            Y   R +G+G FG+V    A  L    PF   AVK+L++     ++   Q  RE A + 
Sbjct: 8   EYV--RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQ--REAALMA 63

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS---------------------- 107
              HPN+V+L  V A    + ++ EY+  G+L + +                        
Sbjct: 64  EFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLN 123

Query: 108 KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167
              L   E   + +Q+  G++Y   +   HRDL   N L+     +KI+DFGLS      
Sbjct: 124 PLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS------ 177

Query: 168 RDDGLLHTTCGSPN------YVAPE-VLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
           R+         S N      ++ PE +  NR Y    SD+W+ GV+L+ I + G  P+
Sbjct: 178 RNIYSADYYKASENDAIPIRWMPPESIFYNR-YT-TESDVWAYGVVLWEIFSYGMQPY 233

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 14/207 (6%)

Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K+L +N     K   +I  E   +  +  P 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPY 70

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + +V + +  G L D +  +K R+   +      Q+  G+SY     
Sbjct: 71  VCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ S  ++KI+DFGL+ L     D+   H   G     ++A E + +R 
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLARLLD--IDETEYHADGGKVPIKWMALESILHRR 187

Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           +    SD+WS GV ++ ++T G  P+D
Sbjct: 188 FT-HQSDVWSYGVTVWELMTFGAKPYD 213

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 65.4 bits (159), Expect = 4e-12
 Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 39/225 (17%)

Query: 22  LGEGNFGKVKFAQDLDSGLP------FAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           LGE  FGKV +   L    P       A+K L+        + ++ K E      L+HPN
Sbjct: 13  LGEDRFGKV-YKGHLFGTAPGEQTQAVAIKTLKDK--AEGPLREEFKHEAMMRSRLQHPN 69

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELF----------------DKIASKGRLQEAEGRKL 119
           +V L  V+  +  + M+  Y +  +L                 D    K  L+ A+   +
Sbjct: 70  IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD------DGLL 173
             Q+  G+ +  +  V H+DL   N+L+  K N+KISD GL      FR+        L+
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL------FREVYAADYYKLM 183

Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
             +     +++PE +   G     SDIWS GV+L+ + + G  P+
Sbjct: 184 GNSLLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPY 227

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 64.9 bits (158), Expect = 5e-12
 Identities = 65/237 (27%), Positives = 111/237 (46%), Gaps = 34/237 (14%)

Query: 18  LGRTLGEGNFGKV-KFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKR----EIATLKL 70
           + R LG G FG++ +    L S   LP A+  L          +D+ +R    E  TL  
Sbjct: 9   IERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAG------CSDKQRRGFLAEALTLGQ 62

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
             H N+VRL  V+   + + +V EY++ G L         L++ EG+ +  QL+      
Sbjct: 63  FDHSNIVRLEGVITRGNTMMIVTEYMSNGAL------DSFLRKHEGQLVAGQLMGMLPGL 116

Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SPN- 181
             G+ Y    G  H+ L    +L++S    KIS F    L +  + + +  T  G SP  
Sbjct: 117 ASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQED-KSEAIYTTMSGKSPVL 173

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           + APE +    +  A SD+WS G++++ +++ G  P+ D +   + + +  G F+LP
Sbjct: 174 WAAPEAIQYHHFSSA-SDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLP 228

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 64.7 bits (158), Expect = 7e-12
 Identities = 60/225 (26%), Positives = 99/225 (44%), Gaps = 29/225 (12%)

Query: 15  RYELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           R  L   L EG FG++ +     +         VK + K+    +++T  ++ E   L  
Sbjct: 7   RVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTV-KDHASEIQVTLLLQ-ESCLLYG 64

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG------RKLFQ--- 121
           L H N++ +  V     +   VL              + RL EA        ++L     
Sbjct: 65  LSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAI 124

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           Q+  G+SY H +GV H+D+   N ++D +  +KI+D  LS      RD   +   C   N
Sbjct: 125 QIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS------RDLFPMDYHCLGDN 178

Query: 182 ------YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD 219
                 ++A E L N+ Y  A SD+WS GV+L+ ++T G  P+ +
Sbjct: 179 ENRPVKWMALESLVNKEYSSA-SDVWSFGVLLWELMTLGQTPYVE 222

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 75/284 (26%), Positives = 127/284 (44%), Gaps = 32/284 (11%)

Query: 20  RTLGEGNFGKV--KFAQDLDSGLP---FAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K     
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFTCH 69

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQLI 124
           +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  ++ 
Sbjct: 70  HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIA 129

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTCGS 179
           DG++Y + K   HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 130 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 185

Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFKLP 237
             ++APE L + G    +SD+WS GV+L+ I +    P+    N  VL   +  G    P
Sbjct: 186 -RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQP 243

Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 281
                   +L+R   + NP  R T   I      + D  P+ P+
Sbjct: 244 DNCPERVTDLMRMCWQFNPKMRPTFLEIV--NLLKDDLHPSFPE 285

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 64.2 bits (156), Expect = 1e-11
 Identities = 56/207 (27%), Positives = 98/207 (47%), Gaps = 14/207 (6%)

Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K L +      K   +I  E   +  + +P+
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE--ATSPKANKEILDEAYVMASVDNPH 70

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y   + 
Sbjct: 71  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR 129

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     D+   H   G     ++A E + +R 
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--ADEKEYHAEGGKVPIKWMALESILHRI 187

Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 188 YT-HQSDVWSYGVTVWELMTFGSKPYD 213

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 66/223 (29%), Positives = 109/223 (48%), Gaps = 20/223 (8%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 14  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 68

Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D  K      L+  +   +  Q+  G++Y       HRD
Sbjct: 69  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127

Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L +    D       G+     + APE  A  G    
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-ALYGRFTI 182

Query: 197 TSDIWSCGVILYVILT-GYLPFDDR-NLAVLYQKIFRGDFKLP 237
            SD+WS G++L  + T G +P+    N  VL Q + RG +++P
Sbjct: 183 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERG-YRMP 223

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 61/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)

Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+KIL  N     K   +   E   +  + HP+
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPH 70

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----QLIDGVSYCH 131
           +VRL  V  S + I +V + +  G L D +      ++  G +L      Q+  G+ Y  
Sbjct: 71  LVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLE 126

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSAL-----PQHFRDDGLLHTTCGSPNYVAPE 186
            + + HRDL   N+L+ S  ++KI+DFGL+ L      ++  D G +        ++A E
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI-----KWMALE 181

Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFD 218
            +  R +    SD+WS GV ++ ++T G  P+D
Sbjct: 182 CIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYD 213

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 63/266 (23%), Positives = 116/266 (43%), Gaps = 36/266 (13%)

Query: 22  LGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           LGE  FGK+     +   +D     A+K L+   I + +   + ++E + +  L HPN+V
Sbjct: 13  LGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD--INNPQQWGEFQQEASLMAELHHPNIV 70

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKI-----------------ASKGRLQEAEGRKLF 120
            L  V+  +  + M+ EY+  G+L + +                   K  L   +   + 
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTC 177
            Q+  G+ Y  +    H+DL   NIL+  + ++KISD GLS       ++R   +   + 
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYR---VQPKSL 187

Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVI----LTGYLPFDDRNLAVLYQKIFRGD 233
               ++ PE +    +  + SDIWS GV+L+ I    L  Y  F ++ +  + +K  R  
Sbjct: 188 LPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK--RQL 244

Query: 234 FKLPKWLSPGAQNLLRKILEPNPVKR 259
               +   P   +L+ +  +  P +R
Sbjct: 245 LPCSEDCPPRMYSLMTECWQEGPSRR 270

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 48/173 (27%), Positives = 72/173 (41%), Gaps = 28/173 (16%)

Query: 15  RYELGRTLGEGNFGKVKF------AQDLDSGLP--------FAVKILEKNRIIHLKITDQ 60
           +  L   LGEG FG+V        A+ L  G P         AVK+L  +  +     + 
Sbjct: 6   QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARND 63

Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG---------ELFDKIASKGRL 111
             +EI  +  LK+PN++RL  V  S   + M+ EY+  G         E+         +
Sbjct: 64  FLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNI 123

Query: 112 QEAEGRKLFQ---QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS 161
                  L     Q+  G+ Y  +    HRDL   N L+ +   IKI+DFG+S
Sbjct: 124 PSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 60.4 bits (146), Expect = 2e-10
 Identities = 58/217 (26%), Positives = 97/217 (44%), Gaps = 23/217 (10%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKHP 74
           E+GR  G  N   V  A+   +G    V+I  LE     HLK    ++ E+      +HP
Sbjct: 5   EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKA---LQNEVVLSHFFRHP 59

Query: 75  NVVRLHEVLASKSKIYMV---LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           N++    V  + S ++++   + Y +   L      +G + EA    +    + G++Y H
Sbjct: 60  NIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEG-MSEALIGNILFGALRGLNYLH 118

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-------VA 184
             G  HR++K  +IL+   G + +S  GLS L    R+          P +       ++
Sbjct: 119 QNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176

Query: 185 PEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD 219
           PE+L     GY+   SDI+S G+    + TG +PF D
Sbjct: 177 PELLRQDLYGYN-VKSDIYSVGITACELATGRVPFQD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 64/231 (27%), Positives = 96/231 (41%), Gaps = 56/231 (24%)

Query: 22  LGEGNFGKV---------KFAQD-------LDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           LGEG FG+V         KF           +  +  AVK+L ++   + +  D +K EI
Sbjct: 13  LGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNAR-NDFLK-EI 70

Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG--------- 116
             +  LK PN++RL  V  +   + M+ EY+  G+L ++  S+   QEA           
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEKADVVTISY 129

Query: 117 ---RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDD 170
                +  Q+  G+ Y  +    HRDL   N L+     IKI+DFG+S       ++R  
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 171 GLLHTTCGSPNYVAPEVLANR---------GYDGATSDIWSCGVILYVILT 212
           G               VL  R         G     SD+W+ GV L+ ILT
Sbjct: 190 G-------------RAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 59.1 bits (143), Expect = 4e-10
 Identities = 57/236 (24%), Positives = 103/236 (43%), Gaps = 26/236 (11%)

Query: 22  LGEGNFGKVKFAQ-DLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           +G G FGKV  ++   D+G+    VK L+ N     K  ++  ++    ++L+HPN+++ 
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKAN--ASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
                      +V EY   G+L   ++     +   Q    +++  ++  GV++ H    
Sbjct: 61  LGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNF 120

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCGSPNYVAPEVLANRGY 193
            H DL L N  L S   +K+ D+G+   P  +++D +      C    ++APE++    +
Sbjct: 121 LHSDLALRNCFLTSDLTVKVGDYGIG--PSRYKEDYIETEDDKCVPLRWLAPELVGEF-H 177

Query: 194 DGAT-------SDIWSCGVILYVILTG----YLPFDDRNLAVLYQKIFRGDFKLPK 238
            G         S++W+ GV L+ +       Y    DR   VL   I     KL K
Sbjct: 178 GGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE--VLNHVIKDQQVKLFK 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 37/119 (31%), Positives = 56/119 (47%), Gaps = 14/119 (11%)

Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 237
           G+P+Y+APE+L  + +  A  D W+ GV L+  LTG  PF+D     ++Q I   D   P
Sbjct: 542 GTPDYLAPELLLGKPHGPAV-DWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600

Query: 238 ---KWLSPGAQNLLRKILEPNPVKRITIAGIKAD------EWFEQDYTP----ANPDDD 283
              + LS  AQN +  +L  +P KR  +  +K        +W             PDD+
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWENLQNQTMPFIPQPDDE 659

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 19/204 (9%)

Query: 19  GRTLGEGNFGKVK---FAQDLDS-GLPFAVKILE--KNRIIHLKITDQIKREIATLKLLK 72
            + LG G FG V    +  + DS  +P A+K ++    R    +ITD +      +  L 
Sbjct: 12  LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHM----LAMGSLD 67

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
           H  +VRL  +    S + +V +    G L D +   +  L          Q+  G+ Y  
Sbjct: 68  HAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSP-NYVAPEVL 188
              + HR+L   NILL S   ++I+DFG++ L  P    D    ++   +P  ++A E +
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD---DKKYFYSEHKTPIKWMALESI 183

Query: 189 ANRGYDGATSDIWSCGVILYVILT 212
               Y    SD+WS GV ++ +++
Sbjct: 184 LFGRYT-HQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 77/303 (25%), Positives = 125/303 (41%), Gaps = 51/303 (16%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+LG  +G G+FG V  A  +D+    A+K +       L+      RE+  +K L H N
Sbjct: 68  YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKV-------LQDPQYKNRELLIMKNLNHIN 120

Query: 76  VVRLHEVLASKS------KIYM--VLEYV--TGGELFDKIASKGRLQEAEGRKLFQ-QLI 124
           ++ L +   ++        I++  V+E++  T  +     A           KL+  QL 
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLC 180

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
             ++Y H+K + HRDLK +N+L+D   + +K+ DFG  +          +   C S  Y 
Sbjct: 181 RALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG--SAKNLLAGQRSVSYIC-SRFYR 237

Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD--------RNLAVL---------- 225
           APE++          D+WS G I+  ++ GY  F          R + VL          
Sbjct: 238 APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKE 297

Query: 226 ----YQKIFRGDFK-------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
               Y  I   D K        PK     A N + + L+  P+KR+      AD +F+  
Sbjct: 298 MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL 357

Query: 275 YTP 277
             P
Sbjct: 358 RDP 360

Length = 440

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 45/167 (26%), Positives = 76/167 (45%), Gaps = 14/167 (8%)

Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQ 121
           E+   KL  HPN+V       + +++++V  ++  G   D I +     + E     + Q
Sbjct: 49  ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQ 108

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
            ++  + Y H+ G  HR +K  +IL+   G + +S  GL +          L      P 
Sbjct: 109 GVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPK 166

Query: 182 Y-------VAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD 219
           Y       ++PEVL    +GYD A SDI+S G+    +  G++PF D
Sbjct: 167 YSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD 212

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 58.0 bits (140), Expect = 1e-09
 Identities = 65/229 (28%), Positives = 98/229 (42%), Gaps = 46/229 (20%)

Query: 22  LGEGNFGKVKFA-----QDLDS-GLPF----------AVKILEKNRIIHLKITDQIKREI 65
           LGEG FG+V        QDL +   PF          AVKIL  +   + +  D +K E+
Sbjct: 13  LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNAR-NDFLK-EV 70

Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-------- 117
             L  LK PN++RL  V   +  + M+ EY+  G+L ++  S   L + E          
Sbjct: 71  KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDL-NQFLSSHHLDDKEENGNDAVPPA 129

Query: 118 ------------KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--- 162
                        +  Q+  G+ Y  +    HRDL   N L+     IKI+DFG+S    
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 211
              ++R  G          ++A E +    +  A SD+W+ GV L+ IL
Sbjct: 190 AGDYYRIQG---RAVLPIRWMAWECILMGKFTTA-SDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 56/215 (26%), Positives = 102/215 (47%), Gaps = 28/215 (13%)

Query: 18  LGRTLGEGNFGKV--KFAQDLDSGLP---FAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + R LG+G+FG V    A+ +    P    A+K + +   +  +I  +   E + +K   
Sbjct: 10  MSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEFN 67

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEG------RKLFQ---Q 122
             +VVRL  V++      +++E +T G+L   + S +  ++          +K+ Q   +
Sbjct: 68  CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGE 127

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRD--DGLLHTTC 177
           + DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL    
Sbjct: 128 IADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-- 185

Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
               +++PE L + G     SD+WS GV+L+ I T
Sbjct: 186 ---RWMSPESLKD-GVFTTYSDVWSFGVVLWEIAT 216

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|217748 pfam03822, NAF, NAF domain

 Score = 50.6 bits (122), Expect = 1e-08
 Identities = 17/32 (53%), Positives = 22/32 (68%)

Query: 313 INAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
           +NAF LI +SS LDLSG FE+E   K +  +F
Sbjct: 1   LNAFDLISLSSGLDLSGLFEEEKKSKKKETRF 32

Length = 58

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.8 bits (129), Expect = 3e-08
 Identities = 65/228 (28%), Positives = 98/228 (42%), Gaps = 36/228 (15%)

Query: 55  LKITDQIKREIA-----TLKLLK---HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI- 105
           LK+ D   R+IA     T  L+    H ++  +H V    S+  MV E+V  G L D   
Sbjct: 49  LKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPL-DVCL 107

Query: 106 -ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-------NIKISD 157
              KGR+  A    + QQL   +SY  +K + H ++  +NILL   G        IK+SD
Sbjct: 108 RKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSD 167

Query: 158 FGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI-LTGY 214
            G+S  AL +  R + +         ++APE +         +D WS G  L  I   G 
Sbjct: 168 PGVSFTALSREERVERI--------PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219

Query: 215 LPFDDRNLAV---LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
           +P  +R  +     Y+K  R    LP+        L+ + L   P +R
Sbjct: 220 VPLKERTPSEKERFYEKKHR----LPEPSCKELATLISQCLTYEPTQR 263

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 52.2 bits (125), Expect = 2e-07
 Identities = 70/279 (25%), Positives = 101/279 (36%), Gaps = 97/279 (34%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILE--------KNRIIHLKITDQI 61
           R +LG+ LG G FGKV  A         S    AVK+L+        K  +  LKI   I
Sbjct: 8   RLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHI 67

Query: 62  KREIATLKLL-----------------KHPNVVRLHEVLASKSKIYMV--LEYVTGGELF 102
              +  + LL                 K  N   L   L SK + +     +     E+ 
Sbjct: 68  GHHLNVVNLLGACTKPGGPLMVIVEYCKFGN---LSNYLRSKRECFSPYRNKSTRKREMK 124

Query: 103 DKIASKGRL------------------------QEAEGRKLFQ-------------QLID 125
            K   K RL                        ++ EG +L++             Q+  
Sbjct: 125 QKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVAR 184

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV-- 183
           G+ +  ++   HRDL   NILL     +KI DFGL+      RD          P+YV  
Sbjct: 185 GMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RD------IYKDPDYVRK 232

Query: 184 ----------APEVLANRGYDGATSDIWSCGVILYVILT 212
                     APE + ++ Y    SD+WS GV+L+ I +
Sbjct: 233 GDARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 57/228 (25%), Positives = 95/228 (41%), Gaps = 33/228 (14%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            R+++   LGEG FGKV  A D       AVKI+        K T   K EI  ++ ++ 
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQ 184

Query: 74  PNV------VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
            +       +++     +++    ++    G  L D I   G        ++  Q    +
Sbjct: 185 ADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVAL 244

Query: 128 SYCHNK-GVFHRDLKLENILLDSKGN----------------IKISDFGLSALPQHFRDD 170
            Y H +  + H DLK ENIL+++                   ++I D G     +H R  
Sbjct: 245 DYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRT- 303

Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 218
                   + +Y +PEV+   G+  +T D+WS G I+Y + TG L +D
Sbjct: 304 ----AIVSTRHYRSPEVVLGLGWMYST-DMWSMGCIIYELYTGKLLYD 346

Length = 467

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 54/216 (25%), Positives = 90/216 (41%), Gaps = 36/216 (16%)

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-- 120
              + +  L H ++V+L+ V      I MV EYV  G L D    + +   +   KL   
Sbjct: 50  ETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL-DVFLHREKNNVSLHWKLDVA 107

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILL----DSKGN---IKISDFG--LSALPQHFRDDG 171
           +QL   + Y  +K + H ++  +NIL+     ++G    IK+SD G  ++ L +  R + 
Sbjct: 108 KQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVE- 166

Query: 172 LLHTTCGSPNYVAPEVLANRGYDGATSDI----WSCGVILYVILT-GYLPFDDRNLA--- 223
                   P ++APE + N     A+  I    WS G  L  I + G  P    + +   
Sbjct: 167 ------RIP-WIAPECIRN---GQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE 216

Query: 224 VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
             YQ   +    +P        NL+ +    +P KR
Sbjct: 217 RFYQD--QHRLPMPDC--AELANLINQCWTYDPTKR 248

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 35/102 (34%), Positives = 52/102 (50%), Gaps = 12/102 (11%)

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS----ALPQHFRD-DGLLHTT 176
           Q+  G+ +  ++   HRDL   NILL     +KI DFGL+      P + R  D  L   
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL- 245

Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
                ++APE + +R Y    SD+WS GV+L+ I + G  P+
Sbjct: 246 ----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 282

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 44/159 (27%), Positives = 73/159 (45%), Gaps = 28/159 (17%)

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           Q+  G+S+  +K   HRDL   NILL      KI DFGL+   +  R+D          N
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIRNDS---------N 269

Query: 182 YV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228
           YV            APE + N  Y    SD+WS G++L+ I + G  P+    +   + K
Sbjct: 270 YVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYK 328

Query: 229 IFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
           + +  +++  P+       ++++   + +P+KR T   I
Sbjct: 329 MIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQI 367

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 37/115 (32%), Positives = 58/115 (50%), Gaps = 7/115 (6%)

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGS 179
           Q+ +G+ +  +K   HRDL   N+L+     +KI DFGL+      RD   +   +T   
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLAR--DIMRDSNYISKGSTFLP 304

Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNL-AVLYQKIFRG 232
             ++APE + N  Y    SD+WS G++L+ I T G  P+ +  +    Y  I RG
Sbjct: 305 LKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRG 358

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 58/243 (23%), Positives = 107/243 (44%), Gaps = 35/243 (14%)

Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHPNVV 77
           + +G G FGKV    +++SG   A +++ K   +   + +Q+K   E    + L+H N++
Sbjct: 1   KEIGNGWFGKV-ILGEVNSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLL 58

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLID---GVSYCHN 132
           +        +   +V+E+   G+L   + S  K  L   +   L +   +   G+ + H 
Sbjct: 59  QCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-------YVAP 185
               H DL L N LL +   +KI D+GLS     +++D  +     +P+       ++AP
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHN--KYKEDYYV-----TPDQLWVPLRWIAP 171

Query: 186 EVLANRGYD------GATSDIWSCGVILYVILT-GYLPF---DDRNLAVLYQKIFRGDFK 235
           E++     +         S++WS GV ++ +   G  P+    D    VL   +     K
Sbjct: 172 ELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQ--VLTYTVREQQLK 229

Query: 236 LPK 238
           LPK
Sbjct: 230 LPK 232

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 48.1 bits (114), Expect = 3e-06
 Identities = 40/153 (26%), Positives = 66/153 (43%), Gaps = 20/153 (13%)

Query: 99  GELFDKIASKGRLQEAEGRKLFQ-----------------QLIDGVSYCHNKGVFHRDLK 141
              +D+ AS     ++E + L                   Q+  G+ +  +K   HRDL 
Sbjct: 205 RSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLA 264

Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
             N+LL     +KI DFGL+    H  +     +T     ++APE + +  Y    SD+W
Sbjct: 265 ARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVW 323

Query: 202 SCGVILYVILT-GYLPFDDRNL-AVLYQKIFRG 232
           S G++L+ I + G  P+    + +  Y KI  G
Sbjct: 324 SYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSG 356

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 26/109 (23%)

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           Q+  G+ +  ++   HRDL   NILL     +KI DFGL+      RD          P+
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLA------RD------IYKDPD 229

Query: 182 YV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
           YV            APE + ++ Y    SD+WS GV+L+ I + G  P+
Sbjct: 230 YVRKGSARLPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPY 277

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 46.5 bits (110), Expect = 6e-06
 Identities = 52/196 (26%), Positives = 88/196 (44%), Gaps = 29/196 (14%)

Query: 48  EKNRIIHLKITDQIKREIA--------TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG 99
           EK   + LK+ D   R+I+         ++ + H ++V L+ V     +  MV E+V  G
Sbjct: 30  EKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFG 89

Query: 100 --ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL-----DSKGN 152
             +LF    S   L      K+ +QL   +SY  +K + H ++  +NILL     D +  
Sbjct: 90  PLDLFMHRKSD-VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECG 148

Query: 153 --IKISDFG--LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
             IK+SD G  ++ L +    + +         ++APE + +       +D WS G  L+
Sbjct: 149 PFIKLSDPGIPITVLSRQECVERI--------PWIAPECVEDSKNLSIAADKWSFGTTLW 200

Query: 209 VI-LTGYLPFDDRNLA 223
            I   G +P  D+ LA
Sbjct: 201 EICYNGEIPLKDKTLA 216

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 33/120 (27%), Positives = 53/120 (44%), Gaps = 26/120 (21%)

Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR---KLFQQLIDGVSYCHNKGV 135
           L +++ SK   Y V  Y     L  K+    +  E E +    + +Q++  +   H+ G+
Sbjct: 222 LADLMQSKEFPYNVEPY-----LLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGI 276

Query: 136 FHRDLKLENILLD-SKGNIKISDFGLSA--------LPQHFRDDGLLHTTCGSPNYVAPE 186
            HRD+K +NI+     G+ KI D G +A        +P+ F  D         P Y APE
Sbjct: 277 VHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLD---------PRYAAPE 327

Length = 566

>gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases

 Score = 43.7 bits (104), Expect = 1e-05
 Identities = 17/25 (68%), Positives = 19/25 (76%)

Query: 314 NAFQLIGMSSCLDLSGFFEKEVNVK 338
           NAF LI +SS LDLSG FE+E  VK
Sbjct: 1   NAFDLISLSSGLDLSGLFEEEDEVK 25

CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 44.1 bits (104), Expect = 8e-05
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 14/158 (8%)

Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           EIA +  L+HPN+V+L  +  S+   Y++ EY+ G  L + + +   L     RK+   +
Sbjct: 733 EIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN---LSWERRRKIAIGI 789

Query: 124 IDGVSYCH---NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
              + + H   +  V   +L  E I++D K    +      +LP     D        S 
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL----RLSLPGLLCTD---TKCFISS 842

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 218
            YVAPE    +      SDI+  G+IL  +LTG  P D
Sbjct: 843 AYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPAD 879

Length = 968

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 43.2 bits (102), Expect = 9e-05
 Identities = 44/241 (18%), Positives = 89/241 (36%), Gaps = 29/241 (12%)

Query: 41  PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH----EVLASKSKIYMVLEYV 96
              ++  +K    H  + D  + EI  L+ +   N+++++    +++    ++ ++LEY 
Sbjct: 45  EVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104

Query: 97  TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKI 155
           T G L + +  +  L       +      G+   +      +++L   + L+     +KI
Sbjct: 105 TRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKI 164

Query: 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT---------SDIWSCGVI 206
              GL                  SP +     +    Y              DI+S GV+
Sbjct: 165 ICHGL-------------EKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVV 211

Query: 207 LYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 264
           L+ I TG +PF++     +Y  I       KLP       + ++      + +KR  I  
Sbjct: 212 LWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKE 271

Query: 265 I 265
           I
Sbjct: 272 I 272

Length = 283

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 42.9 bits (101), Expect = 1e-04
 Identities = 40/139 (28%), Positives = 59/139 (42%), Gaps = 37/139 (26%)

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           Q+  G+ +  +K   HRD+   N+LL      KI DFGL+      RD           N
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA------RD------IMNDSN 267

Query: 182 YV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV---L 225
           YV            APE + +  Y    SD+WS G++L+ I + G  P+    + V    
Sbjct: 268 YVVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYP--GILVNSKF 324

Query: 226 YQKIFRG------DFKLPK 238
           Y+ + RG      DF  P+
Sbjct: 325 YKMVKRGYQMSRPDFAPPE 343

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 42.4 bits (99), Expect = 2e-04
 Identities = 17/43 (39%), Positives = 28/43 (65%)

Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159
           + + +Q++ G+   H  G+ HRD+K EN+L+   G +KI DFG
Sbjct: 312 KGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFG 354

Length = 507

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 40.6 bits (95), Expect = 5e-04
 Identities = 53/217 (24%), Positives = 91/217 (41%), Gaps = 41/217 (18%)

Query: 21  TLGEGNFGKVKFAQDLDSG-------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           +LG+G F K+      + G           +K+L+K+   H   ++      + +  L H
Sbjct: 2   SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSH 58

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGEL-------FDKIASKGRLQEAEGRKLFQQLIDG 126
            ++V  + V     +  MV EYV  G L        + I    +L+ A      +QL   
Sbjct: 59  KHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVA------KQLAWA 112

Query: 127 VSYCHNKGVFHRDLKLENILL-----DSKGN---IKISDFGLS--ALPQHFRDDGLLHTT 176
           + +  +KG+ H ++  +N+LL        GN   IK+SD G+S   LP+    + +    
Sbjct: 113 LHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERI---- 168

Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 213
                +V PE + N       +D WS G  L+ I +G
Sbjct: 169 ----PWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 39.3 bits (92), Expect = 6e-04
 Identities = 28/132 (21%), Positives = 52/132 (39%), Gaps = 17/132 (12%)

Query: 37  DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVV-RLHEVLASKSKIYMVLE 94
                + +KI               +RE+A L+LL +    V ++     S    Y+++E
Sbjct: 19  TKDEDYVLKINPSREKGA-----DREREVAILQLLARKGLPVPKVLASGESDGWSYLLME 73

Query: 95  YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN---KGVFHRDLKLENILLDSKG 151
           ++ G  L         + E E   + +QL + ++  H      + H DL   NIL+D   
Sbjct: 74  WIEGETL-------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK 126

Query: 152 NIKISDFGLSAL 163
            + I D+  +  
Sbjct: 127 ILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 38.7 bits (91), Expect = 0.002
 Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 7/87 (8%)

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           NV  ++ V      I  V+EY+ G  L D I S G  +    R++ +     V   H+ G
Sbjct: 62  NVPAVYFVDPENFII--VMEYIEGEPLKDLINSNGMEELELSREIGRL----VGKLHSAG 115

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLS 161
           + H DL   N++L S G I + DFGL+
Sbjct: 116 IIHGDLTTSNMIL-SGGKIYLIDFGLA 141

Length = 211

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 38.7 bits (90), Expect = 0.003
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 14/101 (13%)

Query: 17  ELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           + G+TLG G FGKV  A        D+ L  AVK+L+ +   H   TD+ +  ++ LK+L
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS--AH---TDEREALMSELKIL 95

Query: 72  ----KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK 108
               +H N+V L         + ++ EY   G+L + +  K
Sbjct: 96  SHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKK 136

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	344
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.98
PLN00181	793	protein SPA1-RELATED; Provisional	99.98
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
PRK09188	365	serine/threonine protein kinase; Provisional	99.96
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.94
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.93
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.93
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.93
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.92
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.9
PRK10345	210	hypothetical protein; Provisional	99.88
smart00090	237	RIO RIO-like kinase.	99.88
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.86
PRK14879	211	serine/threonine protein kinase; Provisional	99.85
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.84
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.83
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.82
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.81
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.79
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.77
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.74
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.73
KOG1243	690	consensus Protein kinase [General function predict	99.69
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.67
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.65
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.62
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.61
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.58
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.54
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.5
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.43
KOG3087	229	consensus Serine/threonine protein kinase [General	99.4
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.34
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.27
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.26
COG4248	637	Uncharacterized protein with protein kinase and he	99.26
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.26
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.26
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.2
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.99
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.94
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.88
PRK09902	216	hypothetical protein; Provisional	98.88
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.83
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.81
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.65
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.62
PF01636	239	APH: Phosphotransferase enzyme family This family	98.59
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.52
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.49
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.44
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.43
PLN02876	822	acyl-CoA dehydrogenase	98.37
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.36
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.27
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.18
KOG2270	520	consensus Serine/threonine protein kinase involved	98.17
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.13
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.08
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.08
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.99
PRK10593	297	hypothetical protein; Provisional	97.94
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.94
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.9
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.85
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.84
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.77
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.67
PRK05231	319	homoserine kinase; Provisional	97.65
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.49
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.42
PLN02236	344	choline kinase	97.42
PLN02756	418	S-methyl-5-thioribose kinase	97.41
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.24
PF03822	63	NAF: NAF domain; InterPro: IPR004041 The NAF domai	97.14
PRK12396	409	5-methylribose kinase; Reviewed	97.12
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.02
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.95
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.93
PTZ00384	383	choline kinase; Provisional	96.77
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.66
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.64
PRK11768	325	serine/threonine protein kinase; Provisional	96.53
COG2334	331	Putative homoserine kinase type II (protein kinase	96.38
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.3
PTZ00296	442	choline kinase; Provisional	95.83
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	95.81

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.9e-63  Score=455.05  Aligned_cols=264  Identities=37%  Similarity=0.698  Sum_probs=251.6

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      -+|...+.||+|||+.||.+++..+|..||+|++.+.........+++.+||++.+.|+|||||+++++|++..++|||.
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL   97 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL   97 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence            67999999999999999999999999999999999988888889999999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      |+|..++|.++++++++++|.+++.+++||+.||.|||+++|+|||||..|+|++++.+|||+|||+|.....  +....
T Consensus        98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~Erk  175 (592)
T KOG0575|consen   98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DGERK  175 (592)
T ss_pred             EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--ccccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999986543  44667


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcC
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE  253 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  253 (344)
                      .+.||||.|.|||++...++ +..+||||+||+||.||.|++||+..+..+++.+|....+.+|..++.++++||++||+
T Consensus       176 ~TlCGTPNYIAPEVl~k~gH-sfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~  254 (592)
T KOG0575|consen  176 KTLCGTPNYIAPEVLNKSGH-SFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR  254 (592)
T ss_pred             ceecCCCcccChhHhccCCC-CCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence            88999999999999997776 79999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCcCCCCCHhhhhcCccccccCCCCCC
Q 019216          254 PNPVKRITIAGIKADEWFEQDYTPANP  280 (344)
Q Consensus       254 ~dP~~Rps~~eil~~~~~~~~~~~~~~  280 (344)
                      +||.+|||++++|.|+||...+.|...
T Consensus       255 ~~P~~Rpsl~~vL~h~Ff~~g~~p~~l  281 (592)
T KOG0575|consen  255 PNPSERPSLDEVLDHPFFKSGFTPARL  281 (592)
T ss_pred             CCcccCCCHHHHhcCHhhhCCCcCCCC
Confidence            999999999999999999887777543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.2e-63  Score=435.08  Aligned_cols=261  Identities=39%  Similarity=0.701  Sum_probs=232.8

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchh----HHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      ..+.|.+.+.||+|+||.|-+|.++.+|+.||||++.+.......    ....+.+|+++|++|+|||||+++++|+..+
T Consensus       170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d  249 (475)
T KOG0615|consen  170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD  249 (475)
T ss_pred             hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence            456788999999999999999999999999999999876543311    2344679999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC---CCeEEeccccccCC
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALP  164 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~---~~vkl~Dfg~a~~~  164 (344)
                      ..|+||||++||+|++.+..++.+.+...+.+++|++.|+.|||++||+||||||+|||+..+   ..+||+|||+|+..
T Consensus       250 s~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  250 SSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             ceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            999999999999999999999999999999999999999999999999999999999999776   57999999999975


Q ss_pred             CcccCCCccccccCCCcccchhhhccCCC--CCccchhhhhhHHHHHHHhCCCCCCCccHHH-HHHHHhhCCCCCC----
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYVILTGYLPFDDRNLAV-LYQKIFRGDFKLP----  237 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslG~ll~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~----  237 (344)
                      +   ....+.+.|||+.|.|||++.+.+.  +..++|+|||||++|-+++|.+||.+..... ..++|.++.+.+-    
T Consensus       330 g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w  406 (475)
T KOG0615|consen  330 G---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQW  406 (475)
T ss_pred             c---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhh
Confidence            4   4667889999999999999986543  3457899999999999999999998876555 8889999977653    


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      ..++.++.+||.+||..||++|||+.|+|+||||+...
T Consensus       407 ~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~  444 (475)
T KOG0615|consen  407 DRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP  444 (475)
T ss_pred             hhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence            34899999999999999999999999999999998654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=8.9e-62  Score=423.74  Aligned_cols=261  Identities=38%  Similarity=0.713  Sum_probs=243.9

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      .....+|++++.||+|+||.||.++++.+++.+|+|+++|..+......+....|..+|.+++||+|++++..|++.+.+
T Consensus        21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL  100 (357)
T KOG0598|consen   21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL  100 (357)
T ss_pred             cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence            56788999999999999999999999999999999999998888877889999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      |+|+||+.||.|+.++++.+.+++..++.++..|+.||.|||+.||+||||||+|||++.+|+++|+|||+++..  ...
T Consensus       101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~--~~~  178 (357)
T KOG0598|consen  101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKED--LKD  178 (357)
T ss_pred             EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhc--ccC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999842  223


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-CCCCCCCHHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLL  248 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li  248 (344)
                      .....+.|||+.|||||++...++ +..+|+||||+++|+|++|.+||.+.+...+..+|..+.. ..|..++.++++++
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~~gy-~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll  257 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLGKGY-DKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL  257 (357)
T ss_pred             CCccccccCCccccChHHHhcCCC-CcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence            445567899999999999999988 5899999999999999999999999999999999999994 45555999999999


Q ss_pred             HHhcCCCcCCCC----CHhhhhcCccccc
Q 019216          249 RKILEPNPVKRI----TIAGIKADEWFEQ  273 (344)
Q Consensus       249 ~~~L~~dP~~Rp----s~~eil~~~~~~~  273 (344)
                      +++|+.||++|.    .+.+|.+||||..
T Consensus       258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~  286 (357)
T KOG0598|consen  258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKG  286 (357)
T ss_pred             HHHhccCHHHhcCCCCChHHhhcCccccc
Confidence            999999999995    6889999999974

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-60  Score=413.94  Aligned_cols=259  Identities=29%  Similarity=0.506  Sum_probs=235.6

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC-e
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-K   88 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~   88 (344)
                      +..+++.+.++.||+|+.|+||++.|+.+++.+|+|++..+  .+....+++.+|+++++..+|||||++|+.|.... .
T Consensus        75 ~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   75 GISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             ccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            45667889999999999999999999999999999999433  35667889999999999999999999999999988 4


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ++|+||||+||+|.+.+...++++|.....++.++++||.|||+ ++|+||||||+|||++..|+|||||||.+....  
T Consensus       153 isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv--  230 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV--  230 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh--
Confidence            99999999999999999988999999999999999999999996 899999999999999999999999999998543  


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc-----cHHHHHHHHhhC-CCCCCCC-C
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRG-DFKLPKW-L  240 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~-----~~~~~~~~i~~~-~~~~~~~-~  240 (344)
                        .+...+..||..|||||.+.+..| +.++||||||+.++||.+|+.||...     ...+++..|..+ .+.+|.. +
T Consensus       231 --nS~a~tfvGT~~YMsPERi~g~~Y-s~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~f  307 (364)
T KOG0581|consen  231 --NSIANTFVGTSAYMSPERISGESY-SVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEF  307 (364)
T ss_pred             --hhhcccccccccccChhhhcCCcC-CcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccC
Confidence              225678899999999999999887 68899999999999999999999774     677888888885 4567876 9


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      |+++++||..||++||.+|||+.|+++|||+.+..
T Consensus       308 S~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~  342 (364)
T KOG0581|consen  308 SPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE  342 (364)
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence            99999999999999999999999999999998653

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-60  Score=402.06  Aligned_cols=258  Identities=38%  Similarity=0.746  Sum_probs=246.4

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      ...+++|++++.||.|+||.|.+++++.+|..+|+|++.+......++.++..+|.++|+.+.||+++++++.+.+.+.+
T Consensus        40 ~~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~l  119 (355)
T KOG0616|consen   40 PYSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNL  119 (355)
T ss_pred             CcchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeE
Confidence            37899999999999999999999999999999999999999888889999999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      |+||||++||.|++++++.+++++..++.++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||.|+..     
T Consensus       120 ymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v-----  194 (355)
T KOG0616|consen  120 YMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRV-----  194 (355)
T ss_pred             EEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEe-----
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999843     


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR  249 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~  249 (344)
                      .....+.||||.|+|||++...++ +.++|+||||+++|||+.|.+||...+...++++|..++..+|..+++++++||+
T Consensus       195 ~~rT~TlCGTPeYLAPEii~sk~y-nkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~  273 (355)
T KOG0616|consen  195 SGRTWTLCGTPEYLAPEIIQSKGY-NKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLK  273 (355)
T ss_pred             cCcEEEecCCccccChHHhhcCCC-CcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHH
Confidence            334678899999999999999988 4899999999999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCcCCCC-----CHhhhhcCccccc
Q 019216          250 KILEPNPVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       250 ~~L~~dP~~Rp-----s~~eil~~~~~~~  273 (344)
                      ++|+.|-.+|.     ...+|..||||+.
T Consensus       274 ~LL~vD~t~R~gnlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  274 KLLQVDLTKRFGNLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             HHHhhhhHhhhcCcCCCccccccCccccc
Confidence            99999999994     4779999999984

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-59  Score=428.03  Aligned_cols=262  Identities=55%  Similarity=1.022  Sum_probs=244.5

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhCC-CCCccceeeEEeeC
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLK-HPNVVRLHEVLASK   86 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~   86 (344)
                      ....|+|.+.+.||+|+||.|++|.+..+|..||+|++.+.....  ....+.+.+|+.++++++ ||||+++++++...
T Consensus        13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~   92 (370)
T KOG0583|consen   13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP   92 (370)
T ss_pred             ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence            477899999999999999999999999999999999877652221  134567779999999999 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC-CCeEEeccccccCCC
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQ  165 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~-~~vkl~Dfg~a~~~~  165 (344)
                      ..+|+|||||.||+|++++.+.+++++..++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++....
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~  172 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP  172 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence            9999999999999999999999999999999999999999999999999999999999999999 999999999998653


Q ss_pred             cccCCCccccccCCCcccchhhhccCC-CCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCC-CHH
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL-SPG  243 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~  243 (344)
                        .......+.|||+.|+|||++.+.. |.+.++||||+|++||.|++|+.||+..+...++.++.++.+.+|.++ |++
T Consensus       173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~  250 (370)
T KOG0583|consen  173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE  250 (370)
T ss_pred             --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence              3456778899999999999999988 889999999999999999999999999999999999999999999999 999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      +++|+.+||..||.+|+|+.+++.||||+.
T Consensus       251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  251 ARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999999999997

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-59  Score=425.95  Aligned_cols=263  Identities=35%  Similarity=0.642  Sum_probs=244.8

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCe
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK   88 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~   88 (344)
                      .....+|.+++.||.|+|++|++|+++.+++.||||++.+..+......+.+.+|-.+|.+| .||+|+++|..|.++..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s  148 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES  148 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence            46778999999999999999999999999999999999888777777778889999999999 69999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +|+|+||+++|+|.++|++.+.+++..++.++.||+.||+|||++|||||||||+|||+++|+++||+|||.|+.+....
T Consensus       149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~  228 (604)
T KOG0592|consen  149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ  228 (604)
T ss_pred             eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998754322


Q ss_pred             CC---------C--ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC
Q 019216          169 DD---------G--LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP  237 (344)
Q Consensus       169 ~~---------~--~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  237 (344)
                      ..         .  ....++||..|++||++..... ++.+|+|+|||++|+|+.|++||.+.+...++++|+.-.+++|
T Consensus       229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp  307 (604)
T KOG0592|consen  229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP  307 (604)
T ss_pred             ccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence            11         1  1245799999999999988766 6899999999999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      ..+++.+++||+++|..||++|+|+.+|.+||||..
T Consensus       308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             CCCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence            999999999999999999999999999999999974

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-58  Score=403.91  Aligned_cols=261  Identities=39%  Similarity=0.654  Sum_probs=238.4

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      .-.+++|.+.+.||+|+||+||+|+++.++..||||.+.+... ..+..+.+..|+.+|+.++|||||.+++++..++++
T Consensus         6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i   84 (429)
T KOG0595|consen    6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI   84 (429)
T ss_pred             ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence            3568999999999999999999999999999999999987654 556778899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC------CCeEEeccccccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK------GNIKISDFGLSAL  163 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~------~~vkl~Dfg~a~~  163 (344)
                      |+|||||+||+|.+++++.+.+++..++.++.||+.||++||+++|+||||||.|||++..      -.+||+|||+|+.
T Consensus        85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~  164 (429)
T KOG0595|consen   85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF  164 (429)
T ss_pred             EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence            9999999999999999999999999999999999999999999999999999999999775      3589999999996


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC---CCCCCC
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWL  240 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~  240 (344)
                      ..   ......+.||++.|||||++....|+ .|+|+||+|+++|+|++|++||+..+..+.+..+.++..   .++..+
T Consensus       165 L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~  240 (429)
T KOG0595|consen  165 LQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL  240 (429)
T ss_pred             CC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence            54   45567788999999999999888885 899999999999999999999999999999988877753   345668


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      ++...+|+...|+.+|..|.+..+-+.|+++....
T Consensus       241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  241 SNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             cCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence            88889999999999999999999999999987654

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-58  Score=426.37  Aligned_cols=264  Identities=48%  Similarity=0.843  Sum_probs=249.6

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..-..|-|++++-||+|+-|.|.+|++..+|+.+|||++.+...........+.+||.+|+.+.|||++.+|+++++..+
T Consensus         7 ~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~   86 (786)
T KOG0588|consen    7 HKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH   86 (786)
T ss_pred             ccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence            44578999999999999999999999999999999999987654455567789999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +|+|.||++||.|++++.+.+++++.++.++++||+.|+.|+|..+|+|||+||+|+|++..+++||+|||+|.+.   .
T Consensus        87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe---~  163 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE---V  163 (786)
T ss_pred             EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc---c
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999853   3


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL  248 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  248 (344)
                      .+....+.||.+.|.|||++.+.+|++.++||||.|++||.||+|+.||++.+...++.++.+|.+.+|..+++++++||
T Consensus       164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLL  243 (786)
T KOG0588|consen  164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLL  243 (786)
T ss_pred             CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHH
Confidence            45677889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          249 RKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      ++||..||++|.|.+||++|||+....
T Consensus       244 r~ml~VDp~~RiT~~eI~kHP~l~g~~  270 (786)
T KOG0588|consen  244 RRMLDVDPSTRITTEEILKHPFLSGYT  270 (786)
T ss_pred             HHHhccCccccccHHHHhhCchhhcCC
Confidence            999999999999999999999997643

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.1e-57  Score=410.79  Aligned_cols=262  Identities=34%  Similarity=0.633  Sum_probs=238.2

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      .+.+++|++++.||+|+||.||+|+.+.+|+.+|+|++++.......+++.++.|-.+|...++|+||++|..|.+..++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L  216 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL  216 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence            56788999999999999999999999999999999999999888888999999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc---
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH---  166 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~---  166 (344)
                      |+||||++||++..+|.+.+.+++..++.++.+++.|+..+|+.|+|||||||+|+|||..|++||+||||+.....   
T Consensus       217 YLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  217 YLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             EEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999853110   


Q ss_pred             ----------------ccCCC--------------------------ccccccCCCcccchhhhccCCCCCccchhhhhh
Q 019216          167 ----------------FRDDG--------------------------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG  204 (344)
Q Consensus       167 ----------------~~~~~--------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG  204 (344)
                                      .....                          .....+|||.|+|||++.+.+| +..+|+||||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY-~~~cDwWSLG  375 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGY-GKECDWWSLG  375 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCC-CccccHHHHH
Confidence                            00000                          0112369999999999999997 6899999999


Q ss_pred             HHHHHHHhCCCCCCCccHHHHHHHHhhCC--CCCCC--CCCHHHHHHHHHhcCCCcCCCCC---HhhhhcCccccc
Q 019216          205 VILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ  273 (344)
Q Consensus       205 ~ll~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~--~~~~~~~~li~~~L~~dP~~Rps---~~eil~~~~~~~  273 (344)
                      |++||||.|.+||.+.+..+++.+|.+..  +.+|.  .+++++++||.+||. ||++|..   ++||.+||||+.
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~  450 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG  450 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence            99999999999999999999999999875  55664  478999999999999 9999985   899999999974

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=8.3e-58  Score=387.86  Aligned_cols=256  Identities=28%  Similarity=0.432  Sum_probs=222.5

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      |++|+.+.++|+|+||.||+++++.+|+.||||.+.. ...+....+-..+||++|++++|+|+|.++++|.....+++|
T Consensus         1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~E-sedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV   79 (396)
T KOG0593|consen    1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVE-SEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV   79 (396)
T ss_pred             CcHHhhhhccccCcceEEEEeccCCcccEEEEEeecc-CCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence            5789999999999999999999999999999999854 334556667789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~-~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      +|||+. ++.+.++ ....++...++.+++|++.|+.|+|+++++||||||+||||+.+|.+||||||+|+....  .+.
T Consensus        80 FE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd  156 (396)
T KOG0593|consen   80 FEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGD  156 (396)
T ss_pred             eeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccc
Confidence            999976 4445554 445689999999999999999999999999999999999999999999999999997653  344


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-----------------
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-----------------  234 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------  234 (344)
                      ....++.|.||+|||.+.+...++..+||||+||++.||++|.+.|.+.+..++...|....-                 
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            566788999999999999977778999999999999999999999999888777655543211                 


Q ss_pred             --CCC------------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccc
Q 019216          235 --KLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE  272 (344)
Q Consensus       235 --~~~------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~  272 (344)
                        .+|            ..++.-+.+|+++||+.||.+|++.+++|.|++|.
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd  288 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD  288 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence              111            11567889999999999999999999999999994

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-57  Score=402.56  Aligned_cols=262  Identities=30%  Similarity=0.498  Sum_probs=226.7

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCC
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS   87 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~   87 (344)
                      ....+.||.++++||.|+||.||+|+.+.+|..||||.+++.- ...+.. .-++|+..|++|+ ||||+++.+++.+.+
T Consensus         5 ~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf-~s~ee~-~nLREvksL~kln~hpniikL~Evi~d~~   82 (538)
T KOG0661|consen    5 QVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKF-YSWEEC-MNLREVKSLRKLNPHPNIIKLKEVIRDND   82 (538)
T ss_pred             ehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhh-ccHHHH-HHHHHHHHHHhcCCCCcchhhHHHhhccC
Confidence            3456789999999999999999999999999999999986533 222222 2357999999998 999999999998877


Q ss_pred             -eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           88 -KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        88 -~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                       .+|+||||| ..+|.++++. +..+++..++.|+.||++||+|+|++|+.|||+||+|||+..+..+||+|||+|+.. 
T Consensus        83 ~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev-  160 (538)
T KOG0661|consen   83 RILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV-  160 (538)
T ss_pred             ceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc-
Confidence             999999999 5699999975 456999999999999999999999999999999999999999999999999999953 


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC-------------
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------  232 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~-------------  232 (344)
                        ........++.|.||+|||++....+++.+.|||++||+++|+.+-++.|.|.+..+...+|..-             
T Consensus       161 --~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  161 --RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             --ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence              33444567889999999999999999999999999999999999999999999888777776531             


Q ss_pred             ------CCCCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          233 ------DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       233 ------~~~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                            ++.+|           ..+++++.+||.+||++||++||||.++|+||||+....
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~  299 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA  299 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence                  12222           226899999999999999999999999999999986544

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-55  Score=410.02  Aligned_cols=260  Identities=32%  Similarity=0.622  Sum_probs=242.6

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCe
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK   88 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~   88 (344)
                      .+.+.+|.++++||+|+||.|++|..+.+++.+|||+++|..+.....++..+.|.+|+.... ||.+++++..|.+.++
T Consensus       364 ~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~  443 (694)
T KOG0694|consen  364 PLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEH  443 (694)
T ss_pred             cccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCe
Confidence            577899999999999999999999999999999999999999888888999999999998886 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +|+||||+.||++ -.++..+.+++..++.|+..++.||.|||++||||||||.+|||+|.+|++||+|||+++..  ..
T Consensus       444 l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~--m~  520 (694)
T KOG0694|consen  444 LFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG--MG  520 (694)
T ss_pred             EEEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc--CC
Confidence            9999999999995 34455678999999999999999999999999999999999999999999999999999842  22


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL  248 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  248 (344)
                      .+....+.||||.|+|||++....| +.++|+||||++|||||.|.+||.+.+.++++..|...++.+|.++|.++.+++
T Consensus       521 ~g~~TsTfCGTpey~aPEil~e~~Y-t~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il  599 (694)
T KOG0694|consen  521 QGDRTSTFCGTPEFLAPEVLTEQSY-TRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIM  599 (694)
T ss_pred             CCCccccccCChhhcChhhhccCcc-cchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHH
Confidence            4456788999999999999999887 799999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCcCCCCC-----HhhhhcCccccc
Q 019216          249 RKILEPNPVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       249 ~~~L~~dP~~Rps-----~~eil~~~~~~~  273 (344)
                      +++|.++|.+|..     +.+|.+||||+.
T Consensus       600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~  629 (694)
T KOG0694|consen  600 RRLLRKNPEKRLGSGERDAEDIKKHPFFRS  629 (694)
T ss_pred             HHHhccCcccccCCCCCCchhhhhCCcccc
Confidence            9999999999986     578999999974

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-57  Score=382.61  Aligned_cols=249  Identities=32%  Similarity=0.540  Sum_probs=222.8

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceee-EEeeCC-
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE-VLASKS-   87 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-~~~~~~-   87 (344)
                      ..++..|+++++||+|+||+||++.+..+|..||.|.+.-. .-+.+..+.+..|+.+|++|+||||+++++ .+..+. 
T Consensus        15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e   93 (375)
T KOG0591|consen   15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE   93 (375)
T ss_pred             cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence            35677899999999999999999999999999999998633 345567788999999999999999999998 444444 


Q ss_pred             eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeecCCCCcEEEccCCCeEEeccc
Q 019216           88 KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHN--KG--VFHRDLKLENILLDSKGNIKISDFG  159 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~--~~--i~H~dikp~NILl~~~~~vkl~Dfg  159 (344)
                      -++||||+|.+|+|...++.    .+.+++..++.++.|++.||.++|.  .+  |+||||||.||+++.+|.|||+|||
T Consensus        94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG  173 (375)
T KOG0591|consen   94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG  173 (375)
T ss_pred             hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence            48999999999999998863    4569999999999999999999999  44  9999999999999999999999999


Q ss_pred             cccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC-CC-
Q 019216          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP-  237 (344)
Q Consensus       160 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~-  237 (344)
                      +++....  ......+.+|||.||+||++...+| ++++||||+||++|||+.-++||.+.+...+..+|.+++++ +| 
T Consensus       174 L~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y-~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~  250 (375)
T KOG0591|consen  174 LGRFLSS--KTTFAHSLVGTPYYMSPERIHESGY-NFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD  250 (375)
T ss_pred             hHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCC-CcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence            9997654  3344567899999999999999998 59999999999999999999999999999999999999876 67 


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCH
Q 019216          238 KWLSPGAQNLLRKILEPNPVKRITI  262 (344)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~  262 (344)
                      ..+|.++..||..|+..||..||+.
T Consensus       251 ~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  251 EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             HHhhhHHHHHHHHHccCCcccCCCc
Confidence            6799999999999999999999984

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-55  Score=387.11  Aligned_cols=261  Identities=34%  Similarity=0.555  Sum_probs=223.8

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC--eEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--KIY   90 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~~~   90 (344)
                      ..+|...+.||+|+||.||++.++.+|...|+|.+.....   ...+.+.+|+.+|.+++|||||++++......  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~---~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDS---PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccc---hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            4568899999999999999999999999999999865522   22677999999999999999999999754444  689


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc-CCCeEEeccccccCCCcc-
Q 019216           91 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHF-  167 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~-~~~vkl~Dfg~a~~~~~~-  167 (344)
                      +.|||+++|+|.+++.+.+ ++++..++.+.+|+++||+|||++||+||||||+|||++. ++.+||+|||++...... 
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            9999999999999999877 7999999999999999999999999999999999999999 799999999999865431 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhhCC--CCCCCCCCHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD--FKLPKWLSPGA  244 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~-~~~~~~~~~i~~~~--~~~~~~~~~~~  244 (344)
                      ..........||+.|||||++.......+++|||||||++.||+||+.||.. .........+....  +.+|..+|+++
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a  252 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA  252 (313)
T ss_pred             ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence            1122344678999999999998633333589999999999999999999987 44444444554443  67899999999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      ++||.+|+..||++||||.++|+|||..+...
T Consensus       253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~  284 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI  284 (313)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence            99999999999999999999999999987654

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=8.2e-54  Score=392.40  Aligned_cols=262  Identities=35%  Similarity=0.712  Sum_probs=239.2

Q ss_pred             hhccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216            6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus         6 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      .....+.+++|++.+.||+|+||.||+|.++.+++.||+|++.+.........+.+.+|+.++++++||||+++++++..
T Consensus        10 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~   89 (329)
T PTZ00263         10 PDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD   89 (329)
T ss_pred             cccCCCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc
Confidence            34577889999999999999999999999999999999999976554444556788999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      .+..|+||||+.|++|.+.+.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        90 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  169 (329)
T PTZ00263         90 ENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVP  169 (329)
T ss_pred             CCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcC
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999987432


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHH
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ  245 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  245 (344)
                      .     .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..+...+|.++++.++
T Consensus       170 ~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  243 (329)
T PTZ00263        170 D-----RTFTLCGTPEYLAPEVIQSKGH-GKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRAR  243 (329)
T ss_pred             C-----CcceecCChhhcCHHHHcCCCC-CCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHH
Confidence            2     2234679999999999987776 689999999999999999999999988888888898898999999999999


Q ss_pred             HHHHHhcCCCcCCCCC-----HhhhhcCccccc
Q 019216          246 NLLRKILEPNPVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps-----~~eil~~~~~~~  273 (344)
                      +||.+||+.||.+|++     ++++++||||.+
T Consensus       244 ~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        244 DLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            9999999999999997     799999999976

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-55  Score=379.87  Aligned_cols=262  Identities=31%  Similarity=0.473  Sum_probs=227.8

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee-----CCeE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-----KSKI   89 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~~~   89 (344)
                      +|..++.||+|+||.|+.|.++.+|+.||||.+. +.+.+....++..+|+.+|+.++|+||+.+.+++..     -..+
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~-~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKIL-NPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhh-hhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            4555799999999999999999999999999884 335566678899999999999999999999999865     3568


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      |+|+|+| +.+|...++.+..+++.+++.+++||+.||.|+|+.|++||||||.|+|++.+..+||||||+|+.......
T Consensus       102 YiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~  180 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFE  180 (359)
T ss_pred             EEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCc
Confidence            9999999 679999999888899999999999999999999999999999999999999999999999999997654434


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC----------------
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD----------------  233 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~----------------  233 (344)
                      .......+.|.+|+|||++.+...++.+.||||+||++.||++|++.|.|.+.....+.|..-.                
T Consensus       181 ~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~a  260 (359)
T KOG0660|consen  181 DGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKA  260 (359)
T ss_pred             ccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHH
Confidence            5556778899999999998877767899999999999999999999999987766665554311                


Q ss_pred             -------CCCC--------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCCC
Q 019216          234 -------FKLP--------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA  278 (344)
Q Consensus       234 -------~~~~--------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~~  278 (344)
                             ...|        +..++.+.+|+++||..||.+|+|++|+|+|||+.....+.
T Consensus       261 r~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~  320 (359)
T KOG0660|consen  261 RPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPE  320 (359)
T ss_pred             HHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCc
Confidence                   1111        23689999999999999999999999999999998876654

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.1e-55  Score=399.85  Aligned_cols=259  Identities=31%  Similarity=0.579  Sum_probs=241.5

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +++|-+.+.||+|+||.||+|+.+.+.+.||+|.+.|.... .+..+.+.+|+++++.++||||+.++++|++..++++|
T Consensus         1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV   79 (808)
T KOG0597|consen    1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV   79 (808)
T ss_pred             CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence            57899999999999999999999999999999999876653 45678899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      +|||.| +|+.++..++.++++.++.++.|++.||.|||+++|+|||+||.|||++..|.+|+||||+|+.++.  +...
T Consensus        80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v  156 (808)
T KOG0597|consen   80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV  156 (808)
T ss_pred             ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence            999976 9999999999999999999999999999999999999999999999999999999999999997654  4455


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhc
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL  252 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L  252 (344)
                      .....|||.|||||.+.+.+| +..+|+|||||++|||++|++||-..........|.......|...+..++.|++.+|
T Consensus       157 ltsikGtPlYmAPElv~e~py-d~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL  235 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPY-DHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL  235 (808)
T ss_pred             eeeccCcccccCHHHHcCCCc-cchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence            667789999999999998777 5889999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcCCCCCHhhhhcCccccccCC
Q 019216          253 EPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       253 ~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      .+||.+|.|-.+++.|||.+....
T Consensus       236 ~kdP~~RltW~~Ll~HpF~k~~~~  259 (808)
T KOG0597|consen  236 IKDPAQRLTWTDLLGHPFWKGKIN  259 (808)
T ss_pred             hcChhhcccHHHHhcChHHhhhhh
Confidence            999999999999999999975443

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.3e-54  Score=362.30  Aligned_cols=262  Identities=33%  Similarity=0.468  Sum_probs=227.6

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      .+|..+++||+|.||.||+|++..+|+.||||.++.... .........+||..|+.++|+||+.++++|...+.+.+|+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence            589999999999999999999999999999999976543 2234567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||++ .+|...++. ...++..+++.|+.+++.||+|||++.|+||||||+|+|++.+|.+||+|||+|+......  ..
T Consensus        81 Efm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~--~~  157 (318)
T KOG0659|consen   81 EFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN--RI  157 (318)
T ss_pred             Eecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC--cc
Confidence            9995 489888874 4579999999999999999999999999999999999999999999999999999765432  22


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--C---------CCC----
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--F---------KLP----  237 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--~---------~~~----  237 (344)
                      ....+.|.+|+|||.+.+...++..+||||.||++.||+.|.+-|.|.+..++...|.+..  +         .+|    
T Consensus       158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~  237 (318)
T KOG0659|consen  158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK  237 (318)
T ss_pred             cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence            3334789999999999998888999999999999999999999999999988888877521  0         011    


Q ss_pred             -------------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCCCC
Q 019216          238 -------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN  279 (344)
Q Consensus       238 -------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~~~  279 (344)
                                   ...+.++.+|+.+||..||.+|+|+.|+|+|+||.....+..
T Consensus       238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~  292 (318)
T KOG0659|consen  238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTP  292 (318)
T ss_pred             HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCC
Confidence                         114778899999999999999999999999999998655543

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-54  Score=382.06  Aligned_cols=264  Identities=31%  Similarity=0.505  Sum_probs=239.5

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..+.++.|+++++||+|.-|+||+|..+.++..+|+|++.+......+...++..|.+||+.++||.+..+|..|+.+..
T Consensus        72 ~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~  151 (459)
T KOG0610|consen   72 GSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKY  151 (459)
T ss_pred             CccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccce
Confidence            56788899999999999999999999999999999999999888877888899999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           89 IYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      .|++||||+||+|..+.+++  +.+++..++.++..++.||+|||-.|||+|||||+||||.++|++.|+||.++.....
T Consensus       152 ~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~  231 (459)
T KOG0610|consen  152 SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPV  231 (459)
T ss_pred             eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCC
Confidence            99999999999999988764  4699999999999999999999999999999999999999999999999998742100


Q ss_pred             -----------------------------c-----c--------------------CCCccccccCCCcccchhhhccCC
Q 019216          167 -----------------------------F-----R--------------------DDGLLHTTCGSPNYVAPEVLANRG  192 (344)
Q Consensus       167 -----------------------------~-----~--------------------~~~~~~~~~gt~~y~aPE~~~~~~  192 (344)
                                                   .     .                    ........+||-.|.|||++.+.+
T Consensus       232 ~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G  311 (459)
T KOG0610|consen  232 SPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG  311 (459)
T ss_pred             CCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCC
Confidence                                         0     0                    011223457999999999999999


Q ss_pred             CCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCC--CCHHHHHHHHHhcCCCcCCCCC----Hhhhh
Q 019216          193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRIT----IAGIK  266 (344)
Q Consensus       193 ~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rps----~~eil  266 (344)
                      . +.++|+|+||+++|||+.|..||.|.+..+++.+|+.....+|..  ++..+++||+++|.+||.+|..    +.||.
T Consensus       312 H-gsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK  390 (459)
T KOG0610|consen  312 H-GSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIK  390 (459)
T ss_pred             C-CchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhh
Confidence            8 589999999999999999999999999999999999999888864  6899999999999999999998    99999


Q ss_pred             cCccccc
Q 019216          267 ADEWFEQ  273 (344)
Q Consensus       267 ~~~~~~~  273 (344)
                      +||||+.
T Consensus       391 ~HpFF~g  397 (459)
T KOG0610|consen  391 RHPFFEG  397 (459)
T ss_pred             cCccccC
Confidence            9999985

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-54  Score=389.99  Aligned_cols=263  Identities=33%  Similarity=0.524  Sum_probs=228.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC--Ce
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SK   88 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~   88 (344)
                      ...+.|+.+++||+|+||.||+|++..+|+.||+|.++.... ......-..+||.||++|+||||+++.++....  ..
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence            456789999999999999999999999999999999976543 345567788999999999999999999998776  68


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      +|+|+|||+. +|.-++.+. -.|++.+++.+++||+.||+|+|.+||+|||||..|||||.+|.+||+|||+|+++...
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999999965 888888763 37999999999999999999999999999999999999999999999999999976543


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC----------CCCC
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD----------FKLP  237 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~----------~~~~  237 (344)
                      . .......+-|.||+|||.+.+...++.++|+||.||||.||++|++.|.+.+..++..+|++-.          ..+|
T Consensus       272 ~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP  350 (560)
T KOG0600|consen  272 G-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP  350 (560)
T ss_pred             C-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence            2 2235566789999999999998888999999999999999999999999999998888887521          1122


Q ss_pred             -------------------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          238 -------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       238 -------------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                                         ..+++.+.+|+..||..||.+|.||.++|+++||.....
T Consensus       351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~  408 (560)
T KOG0600|consen  351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPL  408 (560)
T ss_pred             cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCCC
Confidence                               126889999999999999999999999999999954433

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.6e-55  Score=360.05  Aligned_cols=264  Identities=35%  Similarity=0.686  Sum_probs=247.5

Q ss_pred             hhhccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe
Q 019216            5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA   84 (344)
Q Consensus         5 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~   84 (344)
                      ........+++|++++.||+|.||.||+|+.+.++..||+|++.++.+.......++.+|+++-..|+||||+++|++|.
T Consensus        13 ~~~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fh   92 (281)
T KOG0580|consen   13 SRATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFH   92 (281)
T ss_pred             cccccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhee
Confidence            34457799999999999999999999999999999999999999888777777889999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecccccc
Q 019216           85 SKSKIYMVLEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~--~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      +....|+++||..+|+++..++  ...++++..+..++.|++.||.|+|..+++||||||+|+|++.+|.+|++|||-+.
T Consensus        93 d~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV  172 (281)
T KOG0580|consen   93 DSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSV  172 (281)
T ss_pred             ccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCcee
Confidence            9999999999999999999998  66789999999999999999999999999999999999999999999999999987


Q ss_pred             CCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCH
Q 019216          163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP  242 (344)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  242 (344)
                      ..    +.....+.|||..|.+||+..+..++ ..+|+|++|++.||++.|.+||...+..+.+++|.+.+..+|..++.
T Consensus       173 ~~----p~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~  247 (281)
T KOG0580|consen  173 HA----PSNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISG  247 (281)
T ss_pred             ec----CCCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccCh
Confidence            42    24455788999999999999998885 88999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      ++.+||.+||.++|.+|.+..|++.|||...
T Consensus       248 ~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  248 GAADLISRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             hHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence            9999999999999999999999999999864

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-53  Score=383.14  Aligned_cols=254  Identities=35%  Similarity=0.661  Sum_probs=231.8

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++...........+.+.+|+.+++.++||||+++++++.+...+++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   80 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM   80 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence            47999999999999999999999999999999997654444445677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||+++++|.+++.+.+.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....     ..
T Consensus        81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~  155 (291)
T cd05612          81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT  155 (291)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence            9999999999999888999999999999999999999999999999999999999999999999999874321     12


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcC
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE  253 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  253 (344)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..+...+|..+++.+++||++||+
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~  234 (291)
T cd05612         156 WTLCGTPEYLAPEVIQSKGH-NKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV  234 (291)
T ss_pred             ccccCChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence            34578999999999987766 68999999999999999999999999888889999999999999999999999999999


Q ss_pred             CCcCCCCC-----HhhhhcCccccc
Q 019216          254 PNPVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       254 ~dP~~Rps-----~~eil~~~~~~~  273 (344)
                      .||.+||+     ++++++||||..
T Consensus       235 ~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         235 VDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             CCHHHccCCccCCHHHHhcCccccC
Confidence            99999995     999999999975

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.1e-52  Score=384.10  Aligned_cols=251  Identities=34%  Similarity=0.641  Sum_probs=227.2

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG   99 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~   99 (344)
                      +.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.++++++||||+++++++...+..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999997654444455667889999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCC
Q 019216          100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS  179 (344)
Q Consensus       100 ~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt  179 (344)
                      +|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....  ........+||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt  158 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence            9999998888999999999999999999999999999999999999999999999999999874211  22233456799


Q ss_pred             CcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCCC
Q 019216          180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR  259 (344)
Q Consensus       180 ~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  259 (344)
                      +.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..+...+|..+++++.+||++||+.||++|
T Consensus       159 ~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05571         159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             ccccChhhhcCCCC-CccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence            99999999987776 68999999999999999999999998888888888888889999999999999999999999999


Q ss_pred             C-----CHhhhhcCccccc
Q 019216          260 I-----TIAGIKADEWFEQ  273 (344)
Q Consensus       260 p-----s~~eil~~~~~~~  273 (344)
                      |     ++.++++||||..
T Consensus       238 ~~~~~~~~~~ll~h~~f~~  256 (323)
T cd05571         238 LGGGPEDAKEIMEHRFFAS  256 (323)
T ss_pred             CCCCCCCHHHHHcCCCcCC
Confidence            9     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-55  Score=364.14  Aligned_cols=260  Identities=38%  Similarity=0.720  Sum_probs=235.3

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      --+.|++-+.||+|.|+.||++.+..+|+.+|+|++....... ...+.+.+|+++-+.|+||||+++.+.+.+....|+
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~yl   87 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   87 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEE
Confidence            3458999999999999999999999999999999987554433 356889999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC---CCeEEeccccccCCCccc
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFR  168 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~---~~vkl~Dfg~a~~~~~~~  168 (344)
                      |+|++.|++|..-+..+-.+++..+..+++||+++|.|+|.+||+|||+||+|+|+...   .-+||+|||+|...+   
T Consensus        88 vFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---  164 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---  164 (355)
T ss_pred             EEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC---
Confidence            99999999998888777778999999999999999999999999999999999999654   359999999998543   


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCC----CCCHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGA  244 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~  244 (344)
                      .........|||.|+|||++...++ +..+|||+.|++||-|+.|.+||.+.+...++++|..+.+++|.    .+++++
T Consensus       165 ~g~~~~G~~GtP~fmaPEvvrkdpy-~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  165 DGEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             CccccccccCCCcccCHHHhhcCCC-CCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence            5556677899999999999998887 68899999999999999999999999999999999999887764    489999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      ++||++||..||++|+|+.|+|+|||+.+...
T Consensus       244 k~LvrrML~~dP~kRIta~EAL~HpWi~~r~~  275 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRITADEALKHPWICNRER  275 (355)
T ss_pred             HHHHHHHhccChhhhccHHHHhCCchhcchHH
Confidence            99999999999999999999999999987544

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1e-52  Score=386.50  Aligned_cols=261  Identities=35%  Similarity=0.628  Sum_probs=236.0

Q ss_pred             hccCccccCeEEeeeecccCceEEEEEEECCCC-ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216            7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus         7 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      +...+.+++|++.+.||+|+||.||+|.++.++ ..||+|.+.+...........+.+|+.+++.++||||+++++++..
T Consensus        23 ~~~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~  102 (340)
T PTZ00426         23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD  102 (340)
T ss_pred             cCCCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe
Confidence            346688899999999999999999999876654 6899999976554444556778899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      ....|+||||+.+++|.+++.+.+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~  182 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD  182 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999987532


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHH
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ  245 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  245 (344)
                      .     .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..+...+|..+++.+.
T Consensus       183 ~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~  256 (340)
T PTZ00426        183 T-----RTYTLCGTPEYIAPEILLNVGH-GKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCK  256 (340)
T ss_pred             C-----CcceecCChhhcCHHHHhCCCC-CccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence            1     2345679999999999987665 689999999999999999999999998888889999988889999999999


Q ss_pred             HHHHHhcCCCcCCCC-----CHhhhhcCccccc
Q 019216          246 NLLRKILEPNPVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       246 ~li~~~L~~dP~~Rp-----s~~eil~~~~~~~  273 (344)
                      ++|++||+.||.+|+     +++++++||||.+
T Consensus       257 ~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        257 HLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             HHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            999999999999995     8999999999975

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.5e-54  Score=377.79  Aligned_cols=258  Identities=44%  Similarity=0.792  Sum_probs=244.0

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      -||++.+.||+|.||.|-+|.+...|+.||||.+++..+.+....-++.+||++|..|+||||+.+|++|+..+.+.|||
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM  132 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM  132 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence            48999999999999999999999999999999999999988888899999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||..+|.|.+|+.+++.+++.+++++++||..|+.|+|+++++|||||.+|||++.|+++||+|||++..+   ......
T Consensus       133 EYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly---~~~kfL  209 (668)
T KOG0611|consen  133 EYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLY---ADKKFL  209 (668)
T ss_pred             EecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhh---ccccHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999998753   356677


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcC
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE  253 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  253 (344)
                      .++||++.|.+||++.+.+|.++.+|-||||++||.|..|..||++.+...+..+|.++.+.-|. -+..+.-||++||.
T Consensus       210 qTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-~PSdA~gLIRwmLm  288 (668)
T KOG0611|consen  210 QTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-TPSDASGLIRWMLM  288 (668)
T ss_pred             HHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-CCchHHHHHHHHHh
Confidence            89999999999999999999999999999999999999999999999999999999999877665 46788999999999


Q ss_pred             CCcCCCCCHhhhhcCccccccC
Q 019216          254 PNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       254 ~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      .+|.+|.|+.+|-.|=|.+-.+
T Consensus       289 VNP~RRATieDiAsHWWvNwgy  310 (668)
T KOG0611|consen  289 VNPERRATIEDIASHWWVNWGY  310 (668)
T ss_pred             cCcccchhHHHHhhhheeeccc
Confidence            9999999999999998887544

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-53  Score=378.34  Aligned_cols=271  Identities=39%  Similarity=0.670  Sum_probs=233.9

Q ss_pred             hhccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc-----------hhHHHHHHHHHHHHHhCCCC
Q 019216            6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----------LKITDQIKREIATLKLLKHP   74 (344)
Q Consensus         6 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-----------~~~~~~~~~E~~~l~~l~h~   74 (344)
                      ..+....+++|++++.||+|.||.|.+|.+..+++.||||++.+.....           ....+++.+||.+|+++.||
T Consensus        89 ~~~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~  168 (576)
T KOG0585|consen   89 DDQDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHP  168 (576)
T ss_pred             CcccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCc
Confidence            3445678999999999999999999999999999999999997643211           11246899999999999999


Q ss_pred             CccceeeEEee--CCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC
Q 019216           75 NVVRLHEVLAS--KSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG  151 (344)
Q Consensus        75 niv~l~~~~~~--~~~~~iv~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~  151 (344)
                      |||+++++..+  .+.+|+|+|||..|.+...- ...+ +++.+++.++++++.||+|||.+||+||||||+|+|++++|
T Consensus       169 nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g  247 (576)
T KOG0585|consen  169 NVVKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG  247 (576)
T ss_pred             CeeEEEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence            99999999875  46799999999988875432 3344 89999999999999999999999999999999999999999


Q ss_pred             CeEEeccccccCCCcc---cCCCccccccCCCcccchhhhcc---CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHH
Q 019216          152 NIKISDFGLSALPQHF---RDDGLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL  225 (344)
Q Consensus       152 ~vkl~Dfg~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~  225 (344)
                      +|||+|||.+......   ..........|||.|+|||.+..   ..+.+.+.||||+|++||.|+.|+.||-+....++
T Consensus       248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l  327 (576)
T KOG0585|consen  248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELEL  327 (576)
T ss_pred             cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHH
Confidence            9999999998744211   11222344689999999999876   45668899999999999999999999999999999


Q ss_pred             HHHHhhCCCCCCCC--CCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          226 YQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       226 ~~~i~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      +.+|....+.+|..  +...+++||.+||.+||.+|.+..+|..|||.......
T Consensus       328 ~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~  381 (576)
T KOG0585|consen  328 FDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS  381 (576)
T ss_pred             HHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence            99999999998876  79999999999999999999999999999999876443

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.2e-52  Score=360.81  Aligned_cols=265  Identities=31%  Similarity=0.410  Sum_probs=226.3

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee--CCeE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKI   89 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~   89 (344)
                      .++.|+.+.+|++|+||.||+|+++.+++.||+|.++... ......-.-.+||.+|.+++||||+.+-.+...  -+.+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence            4567999999999999999999999999999999997554 222333456789999999999999999988764  3579


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      |+|||||+ .+|.+++.+.+ ++...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.++.. 
T Consensus       153 y~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-  230 (419)
T KOG0663|consen  153 YIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-  230 (419)
T ss_pred             eeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence            99999995 49999998765 8999999999999999999999999999999999999999999999999999976543 


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC---------------
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---------------  233 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~---------------  233 (344)
                       .......+-|.+|+|||.+.+...++.+.|+||+||++.||+++++.|.|........+|.+..               
T Consensus       231 -~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp  309 (419)
T KOG0663|consen  231 -LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP  309 (419)
T ss_pred             -cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence             2224456789999999999998888899999999999999999999999999888888876421               


Q ss_pred             ----CCCC------------CC-CCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCCCCC
Q 019216          234 ----FKLP------------KW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP  280 (344)
Q Consensus       234 ----~~~~------------~~-~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~~~~  280 (344)
                          ..++            .. ++....+|++.+|..||.+|.|+.|.|+|.||.+...+..|
T Consensus       310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P  373 (419)
T KOG0663|consen  310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDP  373 (419)
T ss_pred             hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCCh
Confidence                0111            11 45888999999999999999999999999999986555433

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-52  Score=377.27  Aligned_cols=250  Identities=36%  Similarity=0.629  Sum_probs=225.8

Q ss_pred             ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCCCh
Q 019216           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL  101 (344)
Q Consensus        22 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~~L  101 (344)
                      ||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++||||+++++++......|+||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            79999999999999999999999999765444445567788999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCc
Q 019216          102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN  181 (344)
Q Consensus       102 ~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~  181 (344)
                      .+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  ........+||+.
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~  158 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE  158 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence            99998888899999999999999999999999999999999999999999999999999874321  1222345679999


Q ss_pred             ccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCCCC-
Q 019216          182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRI-  260 (344)
Q Consensus       182 y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp-  260 (344)
                      |+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..+++.+.+||.+||+.||++|| 
T Consensus       159 y~aPE~~~~~~~-~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~  237 (312)
T cd05585         159 YLAPELLLGHGY-TKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG  237 (312)
T ss_pred             cCCHHHHcCCCC-CCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence            999999987766 688999999999999999999999988888888999888899999999999999999999999997 


Q ss_pred             --CHhhhhcCcccccc
Q 019216          261 --TIAGIKADEWFEQD  274 (344)
Q Consensus       261 --s~~eil~~~~~~~~  274 (344)
                        ++.+++.||||.+.
T Consensus       238 ~~~~~e~l~hp~~~~~  253 (312)
T cd05585         238 YNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CCCHHHHHcCCCcCCC
Confidence              57999999999863

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-53  Score=384.95  Aligned_cols=258  Identities=26%  Similarity=0.512  Sum_probs=230.0

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      +-...+|+..++||+|+.|.||.|....+++.||||.+.......   .+-+.+|+.+|+..+|+|||++++.|.-.+.+
T Consensus       269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL  345 (550)
T KOG0578|consen  269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL  345 (550)
T ss_pred             CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence            456678999999999999999999999999999999997654333   45688999999999999999999999988999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      |+||||++||+|.+.+.. ..++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++.....  .
T Consensus       346 WVVMEym~ggsLTDvVt~-~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~--~  422 (550)
T KOG0578|consen  346 WVVMEYMEGGSLTDVVTK-TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE--E  422 (550)
T ss_pred             EEEEeecCCCchhhhhhc-ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc--c
Confidence            999999999999988765 4599999999999999999999999999999999999999999999999999885443  2


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC---CCCCCCCCCHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQN  246 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~  246 (344)
                      .....+.+||++|||||++....| +++.||||||++.+||+-|.+||-.++.......|...   .+..+..+|+.+++
T Consensus       423 ~~KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kd  501 (550)
T KOG0578|consen  423 QSKRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKD  501 (550)
T ss_pred             cCccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHH
Confidence            224567899999999999998887 69999999999999999999999988877776666654   34567789999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          247 LLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      |+.+||+.|+.+|+|+.|+|+||||+..
T Consensus       502 FL~~cL~~dv~~RasA~eLL~HpFl~~a  529 (550)
T KOG0578|consen  502 FLDRCLVVDVEQRASAKELLEHPFLKMA  529 (550)
T ss_pred             HHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence            9999999999999999999999999643

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.5e-51  Score=373.52  Aligned_cols=254  Identities=31%  Similarity=0.578  Sum_probs=224.4

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH---HhCCCCCccceeeEEeeCCeEEEE
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL---KLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l---~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      |++++.||+|+||.||+|.+..+|+.||+|++.+.........+.+.+|++++   +.++||||+++++++......|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            78999999999999999999999999999999765443344456677777665   456799999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |||++|++|...+.. +.+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.....  ....
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~  157 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDR  157 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCc
Confidence            999999999887754 5799999999999999999999999999999999999999999999999999864221  1222


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhc
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL  252 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L  252 (344)
                      ....+|++.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......|..+++.+.++|.+||
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L  236 (324)
T cd05589         158 TSTFCGTPEFLAPEVLTETSY-TRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLL  236 (324)
T ss_pred             ccccccCccccCHhHhcCCCC-CcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHh
Confidence            345679999999999987666 6889999999999999999999999888888888888888889999999999999999


Q ss_pred             CCCcCCCC-----CHhhhhcCccccc
Q 019216          253 EPNPVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       253 ~~dP~~Rp-----s~~eil~~~~~~~  273 (344)
                      +.||++||     ++.++++||||.+
T Consensus       237 ~~dP~~R~~~~~~~~~~l~~~~~f~~  262 (324)
T cd05589         237 RRNPERRLGSGEKDAEDVKKQPFFRD  262 (324)
T ss_pred             hcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence            99999999     6899999999975

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.4e-51  Score=377.34  Aligned_cols=251  Identities=36%  Similarity=0.639  Sum_probs=226.1

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG   99 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~   99 (344)
                      +.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+++||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g   80 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG   80 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence            46999999999999999999999999997655444455677889999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCC
Q 019216          100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS  179 (344)
Q Consensus       100 ~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt  179 (344)
                      +|.+.+...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+||
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt  158 (328)
T cd05593          81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT  158 (328)
T ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence            9999998888899999999999999999999999999999999999999999999999999874211  12223456799


Q ss_pred             CcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCCC
Q 019216          180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR  259 (344)
Q Consensus       180 ~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  259 (344)
                      +.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+||++||+.||++|
T Consensus       159 ~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (328)
T cd05593         159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR  237 (328)
T ss_pred             cCccChhhhcCCCC-CccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence            99999999987766 68999999999999999999999988888888888888888999999999999999999999999


Q ss_pred             C-----CHhhhhcCccccc
Q 019216          260 I-----TIAGIKADEWFEQ  273 (344)
Q Consensus       260 p-----s~~eil~~~~~~~  273 (344)
                      +     ++.++++|+||..
T Consensus       238 ~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         238 LGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             CCCCCCCHHHHhcCCCcCC
Confidence            7     8999999999965

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.1e-51  Score=375.50  Aligned_cols=251  Identities=33%  Similarity=0.642  Sum_probs=225.7

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG   99 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~   99 (344)
                      +.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            47999999999999999999999999997654444445667788999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCC
Q 019216          100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS  179 (344)
Q Consensus       100 ~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt  179 (344)
                      +|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  .........||
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt  158 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT  158 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence            9999998888899999999999999999999999999999999999999999999999999874211  12223446799


Q ss_pred             CcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCCC
Q 019216          180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR  259 (344)
Q Consensus       180 ~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  259 (344)
                      +.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+......+|..+++.+.+||.+||+.||++|
T Consensus       159 ~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R  237 (323)
T cd05595         159 PEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR  237 (323)
T ss_pred             cCcCCcccccCCCC-CchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence            99999999887766 68999999999999999999999998888888888888888999999999999999999999999


Q ss_pred             C-----CHhhhhcCccccc
Q 019216          260 I-----TIAGIKADEWFEQ  273 (344)
Q Consensus       260 p-----s~~eil~~~~~~~  273 (344)
                      +     ++.++++|+||..
T Consensus       238 ~~~~~~~~~~~l~h~~~~~  256 (323)
T cd05595         238 LGGGPSDAKEVMEHRFFLS  256 (323)
T ss_pred             CCCCCCCHHHHHcCCCcCC
Confidence            8     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-51  Score=377.29  Aligned_cols=258  Identities=41%  Similarity=0.741  Sum_probs=235.9

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~   90 (344)
                      .-..|++.+.||+|.||.||++.++.+|+.+|+|++.+...........+.+|+.+|+++. ||||+.++++|++...++
T Consensus        33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~  112 (382)
T KOG0032|consen   33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY  112 (382)
T ss_pred             ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence            3457999999999999999999999999999999998877665556778999999999998 999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC----CCeEEeccccccCCCc
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQH  166 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~----~~vkl~Dfg~a~~~~~  166 (344)
                      +|||+|.||.|++.+... .+++..+..+++|++.++.|||+.|++||||||+|+|+...    +.+|++|||++.....
T Consensus       113 lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~  191 (382)
T KOG0032|consen  113 LVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP  191 (382)
T ss_pred             EEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC
Confidence            999999999999999876 49999999999999999999999999999999999999643    4799999999986443


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCCCH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSP  242 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~  242 (344)
                         .......+||+.|+|||++...++ +..+||||+|+++|.|++|.+||.+.+......++..+.+.++    ..++.
T Consensus       192 ---~~~~~~~~Gtp~y~APEvl~~~~y-~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  192 ---GERLHTIVGTPEYVAPEVLGGRPY-GDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             ---CceEeeecCCccccCchhhcCCCC-CcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence               456778899999999999987777 6899999999999999999999999999999999999987665    33799


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .++++|++||..||.+|+|+.++|+|||+...
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            99999999999999999999999999999865

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-53  Score=363.62  Aligned_cols=263  Identities=33%  Similarity=0.638  Sum_probs=248.3

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      ...+++++|+.+++||+|.||.|-+++.+.+|+.+|+|++++.-+.......+...|-++|+..+||.+..+...|...+
T Consensus       162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d  241 (516)
T KOG0690|consen  162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD  241 (516)
T ss_pred             cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence            34579999999999999999999999999999999999999988888888899999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ++|+||||..||.|+-++.+...+++..++.+...|+.||.|||+++|++||||.+|+|++.+|++||+|||+++.  ..
T Consensus       242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE--~I  319 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKE--EI  319 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchh--cc
Confidence            9999999999999999999888999999999999999999999999999999999999999999999999999983  33


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL  247 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (344)
                      ..+....+.||||.|.|||++....| +.++|+|.+|++||||++|+.||.+.+...++..|+.+.+.+|..++++++.|
T Consensus       320 ~~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktL  398 (516)
T KOG0690|consen  320 KYGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTL  398 (516)
T ss_pred             cccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHH
Confidence            45566788999999999999999888 68999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCcCCCCC-----HhhhhcCccccc
Q 019216          248 LRKILEPNPVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       248 i~~~L~~dP~~Rps-----~~eil~~~~~~~  273 (344)
                      +..+|.+||++|..     +.||.+|+||..
T Consensus       399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             HHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            99999999999974     889999999963

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=4.8e-51  Score=379.02  Aligned_cols=258  Identities=31%  Similarity=0.551  Sum_probs=223.2

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++++.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+++.++|+||+++++.+.+...+|+||
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~   80 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM   80 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999997655444455677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC----
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD----  169 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~----  169 (344)
                      |||+|++|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......    
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~  160 (363)
T cd05628          81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY  160 (363)
T ss_pred             cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence            9999999999999888999999999999999999999999999999999999999999999999999874321100    


Q ss_pred             -----------------------------CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc
Q 019216          170 -----------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR  220 (344)
Q Consensus       170 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~  220 (344)
                                                   .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCC-CCchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                         001124589999999999988776 58999999999999999999999998


Q ss_pred             cHHHHHHHHhhC--CCCCCC--CCCHHHHHHHHHhcCCCcC---CCCCHhhhhcCccccc
Q 019216          221 NLAVLYQKIFRG--DFKLPK--WLSPGAQNLLRKILEPNPV---KRITIAGIKADEWFEQ  273 (344)
Q Consensus       221 ~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~L~~dP~---~Rps~~eil~~~~~~~  273 (344)
                      +......++...  ...+|.  .+++++++||.+|+. +|.   .||+++|+++||||+.
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~  298 (363)
T cd05628         240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEG  298 (363)
T ss_pred             CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCC
Confidence            888888887763  344554  378999999999775 444   4689999999999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-51  Score=375.60  Aligned_cols=254  Identities=30%  Similarity=0.530  Sum_probs=225.2

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++......|+||
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   80 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM   80 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence            58999999999999999999999999999999997654444445677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....     ..
T Consensus        81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~  155 (333)
T cd05600          81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA  155 (333)
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999874322     23


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--CCCCC------CCCHHHH
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK------WLSPGAQ  245 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~------~~~~~~~  245 (344)
                      ....||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+....  ...|.      .+++++.
T Consensus       156 ~~~~gt~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~  234 (333)
T cd05600         156 NSVVGSPDYMAPEVLRGKGY-DFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW  234 (333)
T ss_pred             CCcccCccccChhHhcCCCC-CCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence            45679999999999987766 689999999999999999999999888777766665432  22222      3589999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          246 NLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      +||.+||..+|.+||++.++++||||..
T Consensus       235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~  262 (333)
T cd05600         235 DLITKLINDPSRRFGSLEDIKNHPFFKE  262 (333)
T ss_pred             HHHHHHhhChhhhcCCHHHHHhCcccCC
Confidence            9999999999999999999999999985

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.8e-51  Score=374.18  Aligned_cols=251  Identities=34%  Similarity=0.649  Sum_probs=224.8

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEeccCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      +.||+|+||.||+|.++.+++.||+|++.+...........+..|..++..+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999765443444566777888888876 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      ++|.+++...+.+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g  158 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG  158 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence            99999998888899999999999999999999999999999999999999999999999999874211  2223345679


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCC
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK  258 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (344)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..+...+|..+++++.+||++||+.||++
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  237 (320)
T cd05590         159 TPDYIAPEILQEMLY-GPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM  237 (320)
T ss_pred             CccccCHHHHcCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence            999999999987666 6889999999999999999999999998888999998888899999999999999999999999


Q ss_pred             CCCH------hhhhcCccccc
Q 019216          259 RITI------AGIKADEWFEQ  273 (344)
Q Consensus       259 Rps~------~eil~~~~~~~  273 (344)
                      ||++      +++++||||..
T Consensus       238 R~~~~~~~~~~~~~~h~~f~~  258 (320)
T cd05590         238 RLGSLTLGGEEAILRHPFFKE  258 (320)
T ss_pred             CCCCCCCCCHHHHHcCCCcCC
Confidence            9998      89999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=5.9e-51  Score=372.73  Aligned_cols=256  Identities=34%  Similarity=0.630  Sum_probs=228.6

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CccceeeEEeeCCeEEEEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP-NVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~iv~   93 (344)
                      +|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+..|..+++.+.|+ +|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            589999999999999999999999999999999765443444566788899999999765 5888999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  .....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~  158 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT  158 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence            9999999999998888899999999999999999999999999999999999999999999999999863211  12233


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcC
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE  253 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  253 (344)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..+++.+.+++.+||+
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~  237 (324)
T cd05587         159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT  237 (324)
T ss_pred             eeecCCccccChhhhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence            45679999999999987766 68899999999999999999999999888888999888888999999999999999999


Q ss_pred             CCcCCCCCH-----hhhhcCccccc
Q 019216          254 PNPVKRITI-----AGIKADEWFEQ  273 (344)
Q Consensus       254 ~dP~~Rps~-----~eil~~~~~~~  273 (344)
                      .||++|++.     +++++||||..
T Consensus       238 ~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         238 KHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            999999986     89999999975

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.4e-53  Score=353.55  Aligned_cols=258  Identities=35%  Similarity=0.657  Sum_probs=231.0

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccc-----ccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeC
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR-----IIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK   86 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~-----~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~   86 (344)
                      +.+|...+.||+|..++|.++.++.+|+.+|+|++....     ....+..+...+|+.+|+++. ||+|+++.++|+++
T Consensus        16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~   95 (411)
T KOG0599|consen   16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD   95 (411)
T ss_pred             HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence            567888999999999999999999999999999986422     122345666788999999985 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ..+++|+|.|+.|.|+|++.+.-.+++...+.+++|+++|+.|||.++|+||||||+|||++++-++||+|||+++..  
T Consensus        96 sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l--  173 (411)
T KOG0599|consen   96 AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQL--  173 (411)
T ss_pred             chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeecc--
Confidence            999999999999999999999889999999999999999999999999999999999999999999999999999854  


Q ss_pred             ccCCCccccccCCCcccchhhhcc-----CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC--CC
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--KW  239 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--~~  239 (344)
                       ..+......||||+|.|||++..     .+.++...|+|++|++||.|+.|.+||-......+...|+.+++.+.  .|
T Consensus       174 -~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW  252 (411)
T KOG0599|consen  174 -EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW  252 (411)
T ss_pred             -CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence             34556778899999999999863     23346789999999999999999999998888889999999987763  33


Q ss_pred             --CCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          240 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       240 --~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                        ++..+++||.+||+.||.+|.|++|+|+||||.+
T Consensus       253 adis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q  288 (411)
T KOG0599|consen  253 ADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQ  288 (411)
T ss_pred             hhccccHHHHHHHHHeeCchhcccHHHHhcChHHHH
Confidence              7899999999999999999999999999999954

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-51  Score=362.52  Aligned_cols=262  Identities=28%  Similarity=0.464  Sum_probs=227.6

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      ...+.|++.+.||.|..++||+|+...++..||||++....+.+.  .+.+.+|+..++.++||||++++..|..+..+|
T Consensus        23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW  100 (516)
T KOG0582|consen   23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW  100 (516)
T ss_pred             CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence            567799999999999999999999999999999999987766443  788999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc-c
Q 019216           91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH-F  167 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~-~  167 (344)
                      +||.||.+|++.+++...  ..++|..+..++++++.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+-. .
T Consensus       101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G  180 (516)
T KOG0582|consen  101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG  180 (516)
T ss_pred             EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence            999999999999999863  3499999999999999999999999999999999999999999999999998653322 1


Q ss_pred             cCCC-ccccccCCCcccchhhhc-cCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC--------
Q 019216          168 RDDG-LLHTTCGSPNYVAPEVLA-NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP--------  237 (344)
Q Consensus       168 ~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~--------  237 (344)
                      .... ...+..||++|||||++. .-.-++.|+||||||++..||.+|..||....+..+...-+++.++.+        
T Consensus       181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d  260 (516)
T KOG0582|consen  181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKD  260 (516)
T ss_pred             ceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChH
Confidence            1111 125679999999999954 333346899999999999999999999999888777777677766532        


Q ss_pred             --CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          238 --KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       238 --~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                        ..++..++.+|..||++||.+|||++++|+|+||++.
T Consensus       261 ~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~  299 (516)
T KOG0582|consen  261 EDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKA  299 (516)
T ss_pred             HhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhc
Confidence              2267889999999999999999999999999999753

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.6e-50  Score=377.93  Aligned_cols=259  Identities=32%  Similarity=0.525  Sum_probs=221.6

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      +.|++++.||+|+||+||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence            46999999999999999999999999999999998765555556778999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC----
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD----  169 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~----  169 (344)
                      ||++|++|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+|||++.++++||+|||++........    
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999998753211000    


Q ss_pred             -----------------------------------------CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHH
Q 019216          170 -----------------------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY  208 (344)
Q Consensus       170 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~  208 (344)
                                                               .......+||+.|+|||++.+..+ +.++|||||||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlG~il~  239 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGY-TQLCDWWSVGVILF  239 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCC-CCccceeehhhHHH
Confidence                                                     001123579999999999987776 58999999999999


Q ss_pred             HHHhCCCCCCCccHHHHHHHHhhC--CCCCCC--CCCHHHHHHHHHhc--CCCcCCCCCHhhhhcCccccc
Q 019216          209 VILTGYLPFDDRNLAVLYQKIFRG--DFKLPK--WLSPGAQNLLRKIL--EPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       209 ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~L--~~dP~~Rps~~eil~~~~~~~  273 (344)
                      ||++|+.||...+.......+...  ...+|.  .+++++.+||.+|+  ..+|..|+++.++++||||.+
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~  310 (381)
T cd05626         240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE  310 (381)
T ss_pred             HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence            999999999887776666555532  334443  57999999999965  445556999999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-51  Score=377.54  Aligned_cols=258  Identities=33%  Similarity=0.618  Sum_probs=227.2

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+....++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM   80 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence            57999999999999999999999999999999997655444455677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc-----
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-----  168 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~-----  168 (344)
                      ||+++++|.+++.+.+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.......     
T Consensus        81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (350)
T cd05573          81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY  160 (350)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999987543221     


Q ss_pred             ----------------------CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHH
Q 019216          169 ----------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY  226 (344)
Q Consensus       169 ----------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~  226 (344)
                                            .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  239 (350)
T cd05573         161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPY-GLECDWWSLGVILYEMLYGFPPFYSDTLQETY  239 (350)
T ss_pred             ccccccccccccccccccccccccccccccccCccccCHHHHcCCCC-CCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence                                  0012234578999999999988766 68999999999999999999999998877777


Q ss_pred             HHHhh--CCCCCCCC--CCHHHHHHHHHhcCCCcCCCCC-HhhhhcCccccc
Q 019216          227 QKIFR--GDFKLPKW--LSPGAQNLLRKILEPNPVKRIT-IAGIKADEWFEQ  273 (344)
Q Consensus       227 ~~i~~--~~~~~~~~--~~~~~~~li~~~L~~dP~~Rps-~~eil~~~~~~~  273 (344)
                      .++..  ....+|..  +++.+.+||.+||. ||.+||+ ++++++||||..
T Consensus       240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~  290 (350)
T cd05573         240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKG  290 (350)
T ss_pred             HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCC
Confidence            77776  44444443  59999999999997 9999999 999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.2e-50  Score=370.36  Aligned_cols=251  Identities=35%  Similarity=0.642  Sum_probs=225.0

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEeccCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      +.||+|+||.||+|.++.+++.||+|++.+...........+..|..+++.+ +||||+++++++.....+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999999765444444556777899998866 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g  158 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG  158 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence            99999998888899999999999999999999999999999999999999999999999999874211  2222345679


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCC
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK  258 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (344)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.++|.+||+.||++
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~  237 (321)
T cd05591         159 TPDYIAPEILQELEY-GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK  237 (321)
T ss_pred             CccccCHHHHcCCCC-CCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence            999999999887766 6889999999999999999999999999999999999888889999999999999999999999


Q ss_pred             CC-------CHhhhhcCccccc
Q 019216          259 RI-------TIAGIKADEWFEQ  273 (344)
Q Consensus       259 Rp-------s~~eil~~~~~~~  273 (344)
                      |+       ++.++++||||..
T Consensus       238 R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         238 RLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             cCCCCCCCCCHHHHhcCCccCC
Confidence            99       8999999999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.2e-50  Score=369.74  Aligned_cols=251  Identities=37%  Similarity=0.706  Sum_probs=225.1

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEeccCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      +.||+|+||.||+|.++.+++.||+|++++...........+.+|..+++.+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999865544444566778899999888 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      ++|..++.+.+.+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++....  .........+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~--~~~~~~~~~~g  158 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGI--LGGVTTSTFCG  158 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecC--cCCCcccceec
Confidence            9999999888889999999999999999999999999999999999999999999999999986321  12222344679


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCC
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK  258 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (344)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..+++.+.+||++||+.||++
T Consensus       159 ~~~y~aPE~~~~~~~-~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~  237 (318)
T cd05570         159 TPDYIAPEILSYQPY-GPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK  237 (318)
T ss_pred             CccccCHHHhcCCCC-CcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence            999999999987776 5899999999999999999999999888888888888888889999999999999999999999


Q ss_pred             CCCH-----hhhhcCccccc
Q 019216          259 RITI-----AGIKADEWFEQ  273 (344)
Q Consensus       259 Rps~-----~eil~~~~~~~  273 (344)
                      |||+     .++++||||..
T Consensus       238 R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         238 RLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             cCCCCCCCHHHHhcCCCcCC
Confidence            9999     99999999976

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.8e-51  Score=379.51  Aligned_cols=258  Identities=31%  Similarity=0.553  Sum_probs=221.7

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++++.||+|+||.||+|.++.+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+...+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~   80 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM   80 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence            47999999999999999999999999999999987654444455678889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC---
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD---  170 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~---  170 (344)
                      ||++|++|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........   
T Consensus        81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  160 (377)
T cd05629          81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY  160 (377)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999998632110000   


Q ss_pred             ------------------------------------------CccccccCCCcccchhhhccCCCCCccchhhhhhHHHH
Q 019216          171 ------------------------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY  208 (344)
Q Consensus       171 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~  208 (344)
                                                                ......+||+.|+|||++.+..+ +.++|||||||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~  239 (377)
T cd05629         161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMF  239 (377)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCC-CCceeeEecchhhh
Confidence                                                      00012479999999999987766 68999999999999


Q ss_pred             HHHhCCCCCCCccHHHHHHHHhhC--CCCCCC--CCCHHHHHHHHHhcCCCcCCC---CCHhhhhcCccccc
Q 019216          209 VILTGYLPFDDRNLAVLYQKIFRG--DFKLPK--WLSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQ  273 (344)
Q Consensus       209 ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~L~~dP~~R---ps~~eil~~~~~~~  273 (344)
                      +|++|..||.+.+.......+...  ...+|.  .+++++.+||.+||. +|.+|   +|+.++++||||..
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            999999999988877777776653  344454  478999999999998 66664   69999999999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=3.3e-51  Score=374.60  Aligned_cols=251  Identities=34%  Similarity=0.647  Sum_probs=225.4

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG   99 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~   99 (344)
                      +.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.....+|+||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            47999999999999999999999999997655444445667788999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216          100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus       100 ~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      +|..++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++.....  .........|
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g  158 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG  158 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence            999999888889999999999999999999997 7999999999999999999999999999863211  1222345679


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCC
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK  258 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (344)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+||++||+.||++
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~  237 (325)
T cd05594         159 TPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ  237 (325)
T ss_pred             CcccCCHHHHccCCC-CCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence            999999999987766 6899999999999999999999999888888888888888899999999999999999999999


Q ss_pred             CC-----CHhhhhcCccccc
Q 019216          259 RI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       259 Rp-----s~~eil~~~~~~~  273 (344)
                      |+     ++.++++|+||..
T Consensus       238 R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         238 RLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             hCCCCCCCHHHHhcCCCcCC
Confidence            97     8999999999975

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-50  Score=375.81  Aligned_cols=258  Identities=33%  Similarity=0.613  Sum_probs=224.2

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++++.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+++.++||||+++++++.....+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM   80 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence            47999999999999999999999999999999997654444455677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC---
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD---  170 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~---  170 (344)
                      ||++|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........   
T Consensus        81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~  160 (364)
T cd05599          81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY  160 (364)
T ss_pred             CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999998643211000   


Q ss_pred             ---------------------------------CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCC
Q 019216          171 ---------------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF  217 (344)
Q Consensus       171 ---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf  217 (344)
                                                       ......+||+.|+|||++....+ +.++|||||||++|+|++|..||
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCC-CCeeeeecchhHHHHhhcCCCCC
Confidence                                             01113469999999999887776 68999999999999999999999


Q ss_pred             CCccHHHHHHHHhhCC--CCCCC--CCCHHHHHHHHHhcCCCcCCCCC---HhhhhcCccccc
Q 019216          218 DDRNLAVLYQKIFRGD--FKLPK--WLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ  273 (344)
Q Consensus       218 ~~~~~~~~~~~i~~~~--~~~~~--~~~~~~~~li~~~L~~dP~~Rps---~~eil~~~~~~~  273 (344)
                      .+.+.......+....  ..+|.  .+++.+.+||++||. +|.+|++   +.++++||||..
T Consensus       240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~  301 (364)
T cd05599         240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG  301 (364)
T ss_pred             CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCC
Confidence            9888777777776543  33343  478999999999996 9999998   999999999975

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=7.2e-51  Score=365.59  Aligned_cols=255  Identities=30%  Similarity=0.448  Sum_probs=219.4

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      .|++.+.||+|+||.||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|+||+++++++...+..++|||
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence            38899999999999999999999999999999876544333344567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        95 ~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |+++++|.+++..  ...+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.....   ...
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~  157 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET  157 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence            9999999887754  33689999999999999999999999999999999999999999999999999874321   222


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH----HHHHHHHhhCCCCCCCCCCHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKWLSPGAQNLL  248 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~li  248 (344)
                      .....||..|+|||++.+..+ +.++|||||||++|+|++|+.||.+...    ......+......++..+++.+.+|+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  236 (285)
T cd05631         158 VRGRVGTVGYMAPEVINNEKY-TFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC  236 (285)
T ss_pred             ecCCCCCCCccCHhhhcCCCC-CcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence            334578999999999987766 6889999999999999999999987543    23333444455667778999999999


Q ss_pred             HHhcCCCcCCCCC-----HhhhhcCccccc
Q 019216          249 RKILEPNPVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       249 ~~~L~~dP~~Rps-----~~eil~~~~~~~  273 (344)
                      ++||+.||++||+     ++++++||||.+
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~  266 (285)
T cd05631         237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKN  266 (285)
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHhcCHhhcC
Confidence            9999999999997     899999999976

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.3e-50  Score=370.21  Aligned_cols=252  Identities=37%  Similarity=0.681  Sum_probs=223.6

Q ss_pred             eeeecccCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           19 GRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      ++.||+|+||.||+|++.   .+++.||+|++.+.... .......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e   80 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE   80 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence            468999999999999864   57889999999764332 22344567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccc
Q 019216           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (344)
Q Consensus        95 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~  174 (344)
                      |+++++|.+.+.+.+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....  ......
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~  158 (323)
T cd05584          81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH  158 (323)
T ss_pred             CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence            999999999999888899999999999999999999999999999999999999999999999999863211  222234


Q ss_pred             cccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCC
Q 019216          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP  254 (344)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~  254 (344)
                      ..+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..+...+|..+++.+.+||.+||+.
T Consensus       159 ~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  237 (323)
T cd05584         159 TFCGTIEYMAPEILMRSGH-GKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR  237 (323)
T ss_pred             ccCCCccccChhhccCCCC-CCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence            4679999999999887665 588999999999999999999999988888888898888899999999999999999999


Q ss_pred             CcCCCC-----CHhhhhcCccccc
Q 019216          255 NPVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       255 dP~~Rp-----s~~eil~~~~~~~  273 (344)
                      ||++||     +++++++||||..
T Consensus       238 ~p~~R~~~~~~~~~~l~~h~~~~~  261 (323)
T cd05584         238 NPSSRLGAGPGDAAEVQSHPFFRH  261 (323)
T ss_pred             CHhHcCCCCCCCHHHHhcCCCcCC
Confidence            999999     8999999999975

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.1e-50  Score=369.22  Aligned_cols=259  Identities=33%  Similarity=0.617  Sum_probs=222.5

Q ss_pred             CeEEeeeecccCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKI   89 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~   89 (344)
                      +|++++.||+|+||.||+|.+.   .+++.||+|++.+.... .....+.+.+|+.+++.++ ||||+++++++.....+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5899999999999999999864   57899999999754322 2334567888999999995 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      ++||||+++++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~-~  159 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-E  159 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc-C
Confidence            999999999999999988888999999999999999999999999999999999999999999999999998743221 1


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc----cHHHHHHHHhhCCCCCCCCCCHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWLSPGAQ  245 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~~  245 (344)
                      .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||...    ........+......+|..+++.+.
T Consensus       160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (332)
T cd05614         160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ  239 (332)
T ss_pred             CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence            122334679999999999887654578899999999999999999999642    3344556666677788888999999


Q ss_pred             HHHHHhcCCCcCCCC-----CHhhhhcCcccccc
Q 019216          246 NLLRKILEPNPVKRI-----TIAGIKADEWFEQD  274 (344)
Q Consensus       246 ~li~~~L~~dP~~Rp-----s~~eil~~~~~~~~  274 (344)
                      +++.+||+.||++||     +++++++||||++.
T Consensus       240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999999999999     78899999999863

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.8e-50  Score=366.94  Aligned_cols=251  Identities=33%  Similarity=0.630  Sum_probs=221.2

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEeccCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      +.||+|+||.||+|.++.+|+.||+|++.+...........+..|..++..+ +||||+++++++...+.+|+||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4799999999999999999999999999765332223445667788888754 899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      ++|.+++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence            99999998888899999999999999999999999999999999999999999999999999863211  1223345679


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCC
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK  258 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (344)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|.+++.++++||++||+.||++
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~  237 (316)
T cd05620         159 TPDYIAPEILQGLKY-TFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR  237 (316)
T ss_pred             CcCccCHHHHcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            999999999987776 6889999999999999999999999888888888888888889999999999999999999999


Q ss_pred             CCCH-hhhhcCccccc
Q 019216          259 RITI-AGIKADEWFEQ  273 (344)
Q Consensus       259 Rps~-~eil~~~~~~~  273 (344)
                      ||++ +++++||||..
T Consensus       238 R~~~~~~~~~h~~f~~  253 (316)
T cd05620         238 RLGVVGNIRGHPFFKT  253 (316)
T ss_pred             cCCChHHHHcCCCcCC
Confidence            9998 58999999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-51  Score=370.95  Aligned_cols=251  Identities=30%  Similarity=0.504  Sum_probs=216.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCce-EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC-e
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-K   88 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~-vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~   88 (344)
                      .......+.+.||+|+||+||+|.+  .|+. ||+|++......... .+.+.+|+.+|.+++||||++++|++.... .
T Consensus        38 i~~~~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~  114 (362)
T KOG0192|consen   38 IDPDELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGS  114 (362)
T ss_pred             cChHHhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence            4455667778899999999999997  4455 999999765544444 789999999999999999999999998887 7


Q ss_pred             EEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeecCCCCcEEEccCC-CeEEeccccccCC
Q 019216           89 IYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKG-VFHRDLKLENILLDSKG-NIKISDFGLSALP  164 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~-i~H~dikp~NILl~~~~-~vkl~Dfg~a~~~  164 (344)
                      +++||||+++|+|.+++..  ...++...+..++.||+.|+.|||+++ ||||||||+|||++.++ ++||+|||+++..
T Consensus       115 ~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~  194 (362)
T KOG0192|consen  115 LCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREK  194 (362)
T ss_pred             eEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceee
Confidence            9999999999999999987  678999999999999999999999999 99999999999999998 9999999999854


Q ss_pred             CcccCCCccccccCCCcccchhhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CCCCCCCC
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWL  240 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~  240 (344)
                      ....  .......||..|||||++.+  ..+ +.++||||||+++|||+||+.||.+.........+...  .+.+|..+
T Consensus       195 ~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~-~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~  271 (362)
T KOG0192|consen  195 VISK--TSMTSVAGTYRWMAPEVLRGEKSPY-TEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKEC  271 (362)
T ss_pred             cccc--ccccCCCCCccccChhhhcCCCCcC-CccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccC
Confidence            3311  23334789999999999994  455 69999999999999999999999998875555555433  46678889


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ++.+..|+.+||+.||++||++.+++.
T Consensus       272 ~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  272 PPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            999999999999999999999999865

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.9e-50  Score=368.86  Aligned_cols=251  Identities=30%  Similarity=0.611  Sum_probs=220.0

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEeccCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      +.||+|+||.||+|.++.+++.||+|++++.........+.+.+|..+++.+ +||||+++++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4799999999999999999999999999876544455567788999999988 699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      ++|.+++.+.+++++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||+++...  .........+|
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~--~~~~~~~~~~g  158 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI--RPGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc--cCCCccccccC
Confidence            9999999888899999999999999999999999999999999999999999999999999986321  11223345689


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc---------cHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---------NLAVLYQKIFRGDFKLPKWLSPGAQNLLR  249 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~li~  249 (344)
                      |+.|+|||++.+..+ +.++|+|||||++|+|++|+.||...         ......+.+......+|..+++.+.++|+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~  237 (329)
T cd05588         159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK  237 (329)
T ss_pred             CccccCHHHHcCCCC-CCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            999999999987766 58999999999999999999999631         22335566677778889999999999999


Q ss_pred             HhcCCCcCCCCC------HhhhhcCccccc
Q 019216          250 KILEPNPVKRIT------IAGIKADEWFEQ  273 (344)
Q Consensus       250 ~~L~~dP~~Rps------~~eil~~~~~~~  273 (344)
                      +||+.||.+|+|      ++++++||||..
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            999999999997      789999999974

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.3e-50  Score=364.50  Aligned_cols=255  Identities=27%  Similarity=0.437  Sum_probs=213.6

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .+++|++.++||.|+||.||+|.+..+++.||+|+++....  ......+.+|+.++++++||||+++++++......++
T Consensus         3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l   80 (288)
T cd07871           3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTL   80 (288)
T ss_pred             ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence            47899999999999999999999999999999999864432  1223567789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      ||||+.+ +|.+++...+ .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ..
T Consensus        81 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~  157 (288)
T cd07871          81 VFEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PT  157 (288)
T ss_pred             EEeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CC
Confidence            9999975 8988887644 578999999999999999999999999999999999999999999999999874322  11


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-----------------
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-----------------  233 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-----------------  233 (344)
                      .......+++.|+|||++.+....+.++|||||||++|+|++|++||.+.+.......+....                 
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07871         158 KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEF  237 (288)
T ss_pred             ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhh
Confidence            122345788999999998765545789999999999999999999998877655544433210                 


Q ss_pred             --CCCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          234 --FKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       234 --~~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                        ..+|           ..+++++++||++||+.||.+|||++|+++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         238 RSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             hccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence              0011           2367899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=3.1e-50  Score=366.73  Aligned_cols=251  Identities=36%  Similarity=0.683  Sum_probs=220.6

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEeccCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      +.||+|+||.||+|.+..+++.||+|++++...........+..|..++..+ +||||+++++++.....+++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4799999999999999999999999999765433333445566677777654 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~g  158 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999874221  1223345679


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCC
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK  258 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (344)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..++.++.+||.+||+.||++
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~  237 (316)
T cd05592         159 TPDYIAPEILKGQKY-NESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK  237 (316)
T ss_pred             CccccCHHHHcCCCC-CCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence            999999999987766 6889999999999999999999999888888888888888888999999999999999999999


Q ss_pred             CCCHh-hhhcCccccc
Q 019216          259 RITIA-GIKADEWFEQ  273 (344)
Q Consensus       259 Rps~~-eil~~~~~~~  273 (344)
                      ||++. ++++||||..
T Consensus       238 R~~~~~~l~~h~~~~~  253 (316)
T cd05592         238 RLGVDGDIRQHPFFRG  253 (316)
T ss_pred             cCCChHHHHcCcccCC
Confidence            99864 8899999975

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2e-50  Score=369.07  Aligned_cols=256  Identities=34%  Similarity=0.626  Sum_probs=228.2

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      +|++++.||+|+||.||+|.+..+++.||+|++.+..............|..++..+ .|++|+++++++...+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            589999999999999999999999999999999765443344455677788888877 4899999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||+++++|.+.+...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  .....
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~  158 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT  158 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999874221  12233


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcC
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE  253 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  253 (344)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+++.+||+
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~  237 (323)
T cd05616         159 KTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT  237 (323)
T ss_pred             ccCCCChhhcCHHHhcCCCC-CCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence            45679999999999988776 68999999999999999999999999988889999988888999999999999999999


Q ss_pred             CCcCCCCCH-----hhhhcCccccc
Q 019216          254 PNPVKRITI-----AGIKADEWFEQ  273 (344)
Q Consensus       254 ~dP~~Rps~-----~eil~~~~~~~  273 (344)
                      .||.+|+++     .++++|+||..
T Consensus       238 ~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         238 KHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence            999999984     89999999974

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.1e-50  Score=377.32  Aligned_cols=258  Identities=34%  Similarity=0.556  Sum_probs=222.2

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus         1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence            47999999999999999999999999999999997655444456678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc-----
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-----  168 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~-----  168 (344)
                      |||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......     
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999975321000     


Q ss_pred             ----------------------------------------CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHH
Q 019216          169 ----------------------------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY  208 (344)
Q Consensus       169 ----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~  208 (344)
                                                              ........+||+.|+|||++.+..+ +.++|||||||++|
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvil~  239 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILY  239 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCC-CCeeeEEechHHHH
Confidence                                                    0001123479999999999988776 58999999999999


Q ss_pred             HHHhCCCCCCCccHHHHHHHHhhC--CCCCC--CCCCHHHHHHHHHhcCCCcCCCCC---HhhhhcCccccc
Q 019216          209 VILTGYLPFDDRNLAVLYQKIFRG--DFKLP--KWLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ  273 (344)
Q Consensus       209 ell~g~~pf~~~~~~~~~~~i~~~--~~~~~--~~~~~~~~~li~~~L~~dP~~Rps---~~eil~~~~~~~  273 (344)
                      ||++|++||.+.+......++...  ....|  ..+++++.++|.+|+ .+|.+|++   +.++++||||..
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~  310 (382)
T cd05625         240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKT  310 (382)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCC
Confidence            999999999988777666666543  23333  458999999999987 59999997   999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.8e-50  Score=367.28  Aligned_cols=251  Identities=37%  Similarity=0.625  Sum_probs=220.7

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCccceeeEEeeCCeEEEEEeccCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      +.||+|+||.||+|.++.+|+.||+|++.+...........+..|.. +++.++||||+++++.+......++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            47999999999999999999999999997654333333445555554 56789999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      ++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG  158 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999864211  1223345679


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCC
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK  258 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (344)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......++..+++.+.++|++||+.||.+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~  237 (323)
T cd05575         159 TPEYLAPEVLRKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK  237 (323)
T ss_pred             ChhhcChhhhcCCCC-CccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence            999999999987766 6889999999999999999999999888888888888888888889999999999999999999


Q ss_pred             CCCH----hhhhcCccccc
Q 019216          259 RITI----AGIKADEWFEQ  273 (344)
Q Consensus       259 Rps~----~eil~~~~~~~  273 (344)
                      ||++    .++++||||..
T Consensus       238 R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         238 RLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             CCCCCCCHHHHHcCCCcCC
Confidence            9997    59999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.4e-50  Score=375.03  Aligned_cols=264  Identities=29%  Similarity=0.514  Sum_probs=228.0

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      ...+..++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++....
T Consensus        37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~  116 (370)
T cd05596          37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK  116 (370)
T ss_pred             cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            34577889999999999999999999999999999999997654333344566788999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+|+||||++||+|.+++.+ ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++......
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~  195 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN  195 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence            99999999999999998865 46899999999999999999999999999999999999999999999999998743221


Q ss_pred             cCCCccccccCCCcccchhhhccCC---CCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--CCCCC--CC
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WL  240 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~--~~  240 (344)
                       ........+||+.|+|||++.+..   ..+.++|||||||++|+|++|+.||.+.+....+.++....  ..+|.  .+
T Consensus       196 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  274 (370)
T cd05596         196 -GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEI  274 (370)
T ss_pred             -CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCC
Confidence             111223567999999999987532   34689999999999999999999999988888888887643  44554  47


Q ss_pred             CHHHHHHHHHhcCCCcCC--CCCHhhhhcCccccc
Q 019216          241 SPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ  273 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~--Rps~~eil~~~~~~~  273 (344)
                      +..+.+||++||+.+|++  |+|++++++||||.+
T Consensus       275 s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~  309 (370)
T cd05596         275 SKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN  309 (370)
T ss_pred             CHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence            999999999999999988  999999999999975

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=7.7e-51  Score=354.78  Aligned_cols=261  Identities=32%  Similarity=0.475  Sum_probs=223.8

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-ccceeeEEeeCC----
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKS----   87 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~----   87 (344)
                      +..|+.+++||+|+||+||+|+++.+|+.||+|.++-.... +.......+|+.+|+.++|+| |+.+++++...+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence            66788899999999999999999999999999999755432 224456789999999999999 999999998877    


Q ss_pred             --eEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccc
Q 019216           88 --KIYMVLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus        88 --~~~iv~e~~~g~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a  161 (344)
                        .+++|+||+ ..+|..++....    .++...++.+++||+.||+|||+++|+||||||.||||+++|.+||+|||+|
T Consensus        89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence              899999999 569999998755    5788899999999999999999999999999999999999999999999999


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--------
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--------  233 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--------  233 (344)
                      +....  ........++|.+|+|||++.+...++...||||+||+++||+++++.|.+.+......+|.+-.        
T Consensus       168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            85432  22234566889999999999998777899999999999999999999999999888887776421        


Q ss_pred             ----------CCCCCC------------CCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          234 ----------FKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       234 ----------~~~~~~------------~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                ..++.+            .+++..+++.+||+.+|.+|.|++.+|.||||.+...+
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence                      111111            24588999999999999999999999999999876444

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.8e-50  Score=377.04  Aligned_cols=258  Identities=32%  Similarity=0.536  Sum_probs=221.4

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.++++++||||+++++.+...+.+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~   80 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM   80 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence            57999999999999999999999999999999997654434445677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC----
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD----  169 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~----  169 (344)
                      |||+|++|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........    
T Consensus        81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~  160 (376)
T cd05598          81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (376)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999752210000    


Q ss_pred             -------------------------------------CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh
Q 019216          170 -------------------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT  212 (344)
Q Consensus       170 -------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~  212 (344)
                                                           .......+||+.|+|||++.+..+ +.++|||||||++|+|++
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyell~  239 (376)
T cd05598         161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY-TQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCC-Ccceeeeeccceeeehhh
Confidence                                                 000123479999999999987776 689999999999999999


Q ss_pred             CCCCCCCccHHHHHHHHhhCC--CCCC--CCCCHHHHHHHHHhcCCCcCCCC---CHhhhhcCccccc
Q 019216          213 GYLPFDDRNLAVLYQKIFRGD--FKLP--KWLSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQ  273 (344)
Q Consensus       213 g~~pf~~~~~~~~~~~i~~~~--~~~~--~~~~~~~~~li~~~L~~dP~~Rp---s~~eil~~~~~~~  273 (344)
                      |+.||.+.+.......+....  ..+|  ..+++.+.++|.+|+ .+|.+|+   ++.++++||||..
T Consensus       240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~  306 (376)
T cd05598         240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG  306 (376)
T ss_pred             CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence            999999888766666655432  2333  358999999999987 5999999   9999999999975

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=3.9e-50  Score=360.91  Aligned_cols=255  Identities=25%  Similarity=0.394  Sum_probs=212.8

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++.+.||+|+||.||+|.++.+++.||+|++..... .....+.+.+|+.+++.++||||+++++++...+..++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence            579999999999999999999999999999999875432 2334567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||++++.+..+......+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++....... ....
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~  158 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANY  158 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cccc
Confidence            999887776555555679999999999999999999999999999999999999999999999999987543211 1122


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-------------------C
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------------F  234 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-------------------~  234 (344)
                      ....|++.|+|||++.+..+ +.++|||||||++|+|++|++||.+.+.......+....                   .
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         159 TEYVATRWYRSPELLLGAPY-GKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             cccccccccCCcHHHcCCCC-CCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            34578999999999987776 689999999999999999999998765443332222110                   0


Q ss_pred             CC-------------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          235 KL-------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       235 ~~-------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      ..             ...+|+.+.+||++||+.||++|||++++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            01             12367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=5.5e-50  Score=362.96  Aligned_cols=257  Identities=28%  Similarity=0.439  Sum_probs=209.9

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++......  .....+.+|+.+++.++||||+++++++......++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            47899999999999999999999999999999998654321  2234577899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |||+. ++|.+++.. .+.+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++.....  ...
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~  158 (303)
T cd07869          82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSH  158 (303)
T ss_pred             EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CCc
Confidence            99995 578777765 35689999999999999999999999999999999999999999999999999874322  112


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhh--CC---------------
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFR--GD---------------  233 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~-~~~~~~i~~--~~---------------  233 (344)
                      ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+... ......+..  +.               
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (303)
T cd07869         159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF  238 (303)
T ss_pred             cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence            233457899999999987655456889999999999999999999987432 222222211  00               


Q ss_pred             ----CC--CC---------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          234 ----FK--LP---------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       234 ----~~--~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                          ..  .+         ..+++.+.+|+.+||+.||++|||+.++++||||.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence                00  00         0145789999999999999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=6.5e-50  Score=366.54  Aligned_cols=251  Identities=31%  Similarity=0.617  Sum_probs=219.3

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEeccCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      +.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.++.++ +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999876544555567788899988876 799999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....  ........+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g  158 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG  158 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999874211  1222345679


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC---------ccHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---------RNLAVLYQKIFRGDFKLPKWLSPGAQNLLR  249 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~~~~li~  249 (344)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||..         .........+......+|..++..+.+||+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~  237 (329)
T cd05618         159 TPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK  237 (329)
T ss_pred             CccccCHHHHcCCCC-CCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence            999999999987766 5889999999999999999999952         123345566677778889999999999999


Q ss_pred             HhcCCCcCCCCC------HhhhhcCccccc
Q 019216          250 KILEPNPVKRIT------IAGIKADEWFEQ  273 (344)
Q Consensus       250 ~~L~~dP~~Rps------~~eil~~~~~~~  273 (344)
                      +||+.||++||+      +.++++||||.+
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~  267 (329)
T cd05618         238 SFLNKDPKERLGCHPQTGFADIQGHPFFRN  267 (329)
T ss_pred             HHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            999999999998      479999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=8.2e-50  Score=366.12  Aligned_cols=258  Identities=28%  Similarity=0.529  Sum_probs=222.7

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++++...........+.+|+.+++.++|+||+++++++......++||
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM   80 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence            47999999999999999999999999999999998654434445677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||+++++|.+++.+. ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....... ...
T Consensus        81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~  159 (330)
T cd05601          81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVN  159 (330)
T ss_pred             CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC-cee
Confidence            999999999999875 679999999999999999999999999999999999999999999999999987543211 112


Q ss_pred             cccccCCCcccchhhhcc-----CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--CCCC--CCCCHH
Q 019216          173 LHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP--KWLSPG  243 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~--~~~~~~  243 (344)
                      .....||+.|+|||++..     ....+.++|||||||++|+|++|+.||...+......++....  ..+|  ..+++.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD  239 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence            234578999999999863     2334688999999999999999999999888777777766542  2333  357999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      +.+||++||+ +|++|||++++++||||..
T Consensus       240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             HHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence            9999999998 9999999999999999975

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.3e-50  Score=364.21  Aligned_cols=252  Identities=34%  Similarity=0.611  Sum_probs=220.8

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCccceeeEEeeCCeEEEEEeccCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      +.||+|+||.||+|.+..+++.||+|++.+..............|..++.. ++||||+++++++.+.+.+++||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            479999999999999999999999999976543223334556678888876 4899999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      ++|.+++.+...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG  158 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence            99999998888899999999999999999999999999999999999999999999999999863211  1122345679


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCC
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK  258 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (344)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|.+++..+.++|.+||+.||++
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~  237 (316)
T cd05619         159 TPDYIAPEILLGQKY-NTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER  237 (316)
T ss_pred             CccccCHHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence            999999999987766 6899999999999999999999999888888888877777788889999999999999999999


Q ss_pred             CCCHh-hhhcCcccccc
Q 019216          259 RITIA-GIKADEWFEQD  274 (344)
Q Consensus       259 Rps~~-eil~~~~~~~~  274 (344)
                      ||++. ++++||||...
T Consensus       238 R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         238 RLGVKGDIRQHPFFREI  254 (316)
T ss_pred             cCCChHHHHcCcccCCC
Confidence            99996 89999999763

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=6.9e-50  Score=371.66  Aligned_cols=265  Identities=30%  Similarity=0.530  Sum_probs=226.5

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      ...+..++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++..+.
T Consensus        37 ~~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~  116 (370)
T cd05621          37 KLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDK  116 (370)
T ss_pred             hcCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCC
Confidence            34566789999999999999999999999999999999997644434444566889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+|+||||++|++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~  195 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDET  195 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccC
Confidence            99999999999999998865 46899999999999999999999999999999999999999999999999998754221


Q ss_pred             cCCCccccccCCCcccchhhhccCC---CCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--CCCCC--CC
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK--WL  240 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~--~~  240 (344)
                       ........+||+.|+|||++....   ..+.++|||||||++|+|++|+.||.+.+......++....  ..+|.  .+
T Consensus       196 -~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~  274 (370)
T cd05621         196 -GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEI  274 (370)
T ss_pred             -CceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccC
Confidence             111224567999999999987543   34688999999999999999999999988877777777643  44554  46


Q ss_pred             CHHHHHHHHHhcCCCcCC--CCCHhhhhcCcccccc
Q 019216          241 SPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD  274 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~--Rps~~eil~~~~~~~~  274 (344)
                      +..+++++.+||+.++.+  |+|+.++++||||+..
T Consensus       275 s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         275 SKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             CHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            999999999999866654  8999999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.1e-49  Score=364.24  Aligned_cols=256  Identities=34%  Similarity=0.627  Sum_probs=227.0

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv~   93 (344)
                      +|++.+.||+|+||.||+|.++.+|+.||+|++.+.........+.+..|..+++.+. |++|+++++++...+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            4789999999999999999999999999999997654433444566778999998886 577888999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||++|++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....  .....
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~  158 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT  158 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999874211  12223


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcC
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE  253 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  253 (344)
                      ...+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.....+.+......+|..+++.+.+++.+||+
T Consensus       159 ~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~  237 (323)
T cd05615         159 RTFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT  237 (323)
T ss_pred             cCccCCccccCHHHHcCCCC-CCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence            45679999999999987666 68999999999999999999999999888888899888888999999999999999999


Q ss_pred             CCcCCCCC-----HhhhhcCccccc
Q 019216          254 PNPVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       254 ~dP~~Rps-----~~eil~~~~~~~  273 (344)
                      .+|.+|++     .+++++||||..
T Consensus       238 ~~p~~R~~~~~~~~~~i~~h~~f~~  262 (323)
T cd05615         238 KHPSKRLGCGPEGERDIREHAFFRR  262 (323)
T ss_pred             cCHhhCCCCCCCCHHHHhcCcccCC
Confidence            99999997     478999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.1e-50  Score=372.37  Aligned_cols=258  Identities=31%  Similarity=0.575  Sum_probs=223.9

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.++..++||||+++++.+.....+|+||
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~   80 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM   80 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999997654444455678889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC----
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD----  169 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~----  169 (344)
                      ||++|++|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........    
T Consensus        81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~  160 (360)
T cd05627          81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY  160 (360)
T ss_pred             eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence            9999999999998888899999999999999999999999999999999999999999999999999864321100    


Q ss_pred             -----------------------------CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc
Q 019216          170 -----------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR  220 (344)
Q Consensus       170 -----------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~  220 (344)
                                                   .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGY-NKLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCC-CCcceeccccceeeecccCCCCCCCC
Confidence                                         001124579999999999988776 58999999999999999999999998


Q ss_pred             cHHHHHHHHhhC--CCCCCC--CCCHHHHHHHHHhcCCCcCCCCC---HhhhhcCccccc
Q 019216          221 NLAVLYQKIFRG--DFKLPK--WLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ  273 (344)
Q Consensus       221 ~~~~~~~~i~~~--~~~~~~--~~~~~~~~li~~~L~~dP~~Rps---~~eil~~~~~~~  273 (344)
                      +......++...  ...+|.  .+++.+++||.+|+. ||.+|++   +.++++||||..
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~  298 (360)
T cd05627         240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEG  298 (360)
T ss_pred             CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCC
Confidence            888877777653  334444  378999999999875 9999984   799999999985

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-51  Score=367.33  Aligned_cols=266  Identities=36%  Similarity=0.668  Sum_probs=245.2

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      ..|...|-|++.+-||+|-|+.|.+|++.-+|..||||++.+..... -...++.+|++.|+.++||||+++|++.....
T Consensus        12 ~DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQT   90 (864)
T KOG4717|consen   12 YDGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQT   90 (864)
T ss_pred             cccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccc
Confidence            45677889999999999999999999999999999999999876544 34568899999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc-CCCeEEeccccccCCC
Q 019216           88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQ  165 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~-~~~vkl~Dfg~a~~~~  165 (344)
                      .+|+|+|+=++|+|+++|-+ ...+.+..+++++.||+.|+.|+|+..++||||||+||.+.+ -|-|||.|||++... 
T Consensus        91 KlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf-  169 (864)
T KOG4717|consen   91 KLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKF-  169 (864)
T ss_pred             eEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccC-
Confidence            99999999999999999865 456999999999999999999999999999999999987754 589999999998743 


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHH
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ  245 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  245 (344)
                        ..+....+.||...|.|||++.+..|+.+++||||||++||-|.+|++||+..+..+.+..|+..++..|..++.+++
T Consensus       170 --~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCr  247 (864)
T KOG4717|consen  170 --QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECR  247 (864)
T ss_pred             --CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHH
Confidence              345567889999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      +||..||..||++|.+.++|..++|++....+
T Consensus       248 dLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~  279 (864)
T KOG4717|consen  248 DLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG  279 (864)
T ss_pred             HHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence            99999999999999999999999999865444

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9.2e-50  Score=363.94  Aligned_cols=251  Identities=34%  Similarity=0.656  Sum_probs=222.3

Q ss_pred             eeeecccCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 019216           19 GRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~   95 (344)
                      ++.||+|+||.||++.+.   .+|+.||+|++.+.... ......+.+|+.++++++||||+++++++......|+||||
T Consensus         1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~   79 (318)
T cd05582           1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF   79 (318)
T ss_pred             CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence            368999999999999863   57899999999764322 22345677899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcccc
Q 019216           96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT  175 (344)
Q Consensus        96 ~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~  175 (344)
                      +++++|.+++.+...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  .......
T Consensus        80 ~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~  157 (318)
T cd05582          80 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYS  157 (318)
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceec
Confidence            99999999998888899999999999999999999999999999999999999999999999999874322  1122345


Q ss_pred             ccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCC
Q 019216          176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN  255 (344)
Q Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d  255 (344)
                      .+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..+++.+.+||++||+.|
T Consensus       158 ~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~  236 (318)
T cd05582         158 FCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRN  236 (318)
T ss_pred             ccCChhhcCHHHHcCCCC-CCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcC
Confidence            679999999999987666 6889999999999999999999999888888888888888899999999999999999999


Q ss_pred             cCCCCC-----HhhhhcCccccc
Q 019216          256 PVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       256 P~~Rps-----~~eil~~~~~~~  273 (344)
                      |++||+     +.+++.|+||..
T Consensus       237 P~~R~~a~~~~~~~~~~~~~~~~  259 (318)
T cd05582         237 PANRLGAGPDGVEEIKRHPFFST  259 (318)
T ss_pred             HhHcCCCCCCCHHHHhCCCCcCC
Confidence            999999     677999999975

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.5e-49  Score=360.54  Aligned_cols=251  Identities=36%  Similarity=0.620  Sum_probs=220.1

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCccceeeEEeeCCeEEEEEeccCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+.+|.. +++.++||||+++++++...+..|+||||++|
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG   80 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            47999999999999999999999999997654433334455555654 67889999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      ++|...+.+...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (321)
T cd05603          81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG  158 (321)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999874211  1222345679


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCC
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK  258 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (344)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|...+..+.++|.+||+.||.+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~  237 (321)
T cd05603         159 TPEYLAPEVLRKEPY-DRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR  237 (321)
T ss_pred             CcccCCHHHhcCCCC-CCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence            999999999887666 5889999999999999999999999888888888888888888889999999999999999999


Q ss_pred             CCCH----hhhhcCccccc
Q 019216          259 RITI----AGIKADEWFEQ  273 (344)
Q Consensus       259 Rps~----~eil~~~~~~~  273 (344)
                      |+++    .++++|+||..
T Consensus       238 R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         238 RLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             cCCCCCCHHHHhCCCCcCC
Confidence            9976    49999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-52  Score=368.90  Aligned_cols=257  Identities=26%  Similarity=0.442  Sum_probs=228.2

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .-..|+.++.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+|..++++||.++|+.+..+..+++
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~--~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwi   88 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEA--EDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWI   88 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhc--chhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHH
Confidence            34578888999999999999999999999999999976543  3457889999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      +||||.||++.+.++....+++..+.-++++++.||.|||..+.+|||||+.|||+..+|.+||+|||++......  ..
T Consensus        89 iMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~--~~  166 (467)
T KOG0201|consen   89 IMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT--VK  166 (467)
T ss_pred             HHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech--hh
Confidence            9999999999999998888899999999999999999999999999999999999999999999999998755432  22


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-CCCCCCCHHHHHHHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRK  250 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~  250 (344)
                      ...+..||+.|||||++...+|+ .++||||||++.+||.+|.+|+....+......|-+..+ .+...+++.+++||..
T Consensus       167 rr~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~  245 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEA  245 (467)
T ss_pred             ccccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHH
Confidence            33788999999999999977874 799999999999999999999998877555544444433 3445689999999999


Q ss_pred             hcCCCcCCCCCHhhhhcCccccc
Q 019216          251 ILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       251 ~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      ||++||+.||||.++|+|+|.+.
T Consensus       246 CL~k~P~~RpsA~~LLKh~FIk~  268 (467)
T KOG0201|consen  246 CLDKNPEFRPSAKELLKHKFIKR  268 (467)
T ss_pred             HhhcCcccCcCHHHHhhhHHHHh
Confidence            99999999999999999999986

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.9e-49  Score=361.76  Aligned_cols=251  Identities=35%  Similarity=0.597  Sum_probs=220.2

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCccceeeEEeeCCeEEEEEeccCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      +.||+|+||.||+|.++.+|+.||+|++.+...........+..|.. +++.++||||+++++++...+..|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            46999999999999999999999999997654333334455556654 46778999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      ++|..++.+.+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g  158 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG  158 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence            99999998888999999999999999999999999999999999999999999999999999874211  1222345679


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCC
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK  258 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (344)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......+...+..+.++|++||+.||.+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~  237 (325)
T cd05604         159 TPEYLAPEVIRKQPY-DNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR  237 (325)
T ss_pred             ChhhCCHHHHcCCCC-CCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence            999999999987776 5889999999999999999999999888888888888877777789999999999999999999


Q ss_pred             CCCH----hhhhcCccccc
Q 019216          259 RITI----AGIKADEWFEQ  273 (344)
Q Consensus       259 Rps~----~eil~~~~~~~  273 (344)
                      ||++    .+++.||||..
T Consensus       238 R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         238 RLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             cCCCCCCHHHHhcCCCcCC
Confidence            9987    58999999975

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=3.1e-49  Score=363.21  Aligned_cols=259  Identities=29%  Similarity=0.441  Sum_probs=209.9

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC-----CeE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SKI   89 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~~   89 (344)
                      +|++.+.||+|+||.||+|.++.+|+.||+|.+.... ........+.+|+.+++.++||||+++++++...     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            6999999999999999999999999999999986432 2223345688999999999999999999987543     358


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      |+||||| +++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            9999999 569999998888899999999999999999999999999999999999999999999999999874322111


Q ss_pred             -CCccccccCCCcccchhhhccC-CCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhh----------------
Q 019216          170 -DGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----------------  231 (344)
Q Consensus       170 -~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~----------------  231 (344)
                       ........||+.|+|||++.+. ...+.++|||||||++|+|++|++||.+.+.......+..                
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence             1122345789999999998652 3346899999999999999999999987654332211110                


Q ss_pred             ----------CCCCC-----CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          232 ----------GDFKL-----PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       232 ----------~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                                .....     -..+++.+.+++.+||+.||++|||++++++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~  297 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA  297 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcC
Confidence                      00000     023678899999999999999999999999999997643

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.6e-50  Score=367.13  Aligned_cols=258  Identities=30%  Similarity=0.513  Sum_probs=237.1

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe-EE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK-IY   90 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~-~~   90 (344)
                      .+++|.+++++|+|+||.+++++++..++.+++|.+....... ...+...+|+.++.++.||||+.+.+.|..++. ++
T Consensus         2 ~m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~   80 (426)
T KOG0589|consen    2 EMDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLC   80 (426)
T ss_pred             ccchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEE
Confidence            5789999999999999999999999999999999997665443 345588999999999999999999999998887 99


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      |||+||+||++.+.+.+.+  -++++.+..|+.|++.|+.|||+++|+|||||+.||+++.++.|||+|||+|+....  
T Consensus        81 Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~--  158 (426)
T KOG0589|consen   81 IVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP--  158 (426)
T ss_pred             EEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC--
Confidence            9999999999999997543  589999999999999999999999999999999999999999999999999997654  


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL  247 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l  247 (344)
                      ......+..||+.|+.||++.+.+| +.++|||||||++|||++-+++|...+......+|.++. .++|..++.+++.+
T Consensus       159 ~~~~a~tvvGTp~YmcPEil~d~pY-n~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~l  237 (426)
T KOG0589|consen  159 EDSLASTVVGTPYYMCPEILSDIPY-NEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSL  237 (426)
T ss_pred             chhhhheecCCCcccCHHHhCCCCC-CccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHH
Confidence            2235677899999999999999988 589999999999999999999999999999999999987 77899999999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          248 LRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      |+.||..+|..||++.++|.+|.+..
T Consensus       238 v~~~l~~~P~~RPsa~~LL~~P~l~~  263 (426)
T KOG0589|consen  238 VKSMLRKNPEHRPSALELLRRPHLLR  263 (426)
T ss_pred             HHHHhhcCCccCCCHHHHhhChhhhh
Confidence            99999999999999999999998873

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=6.8e-49  Score=359.30  Aligned_cols=251  Identities=37%  Similarity=0.625  Sum_probs=218.7

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHH-HHHHhCCCCCccceeeEEeeCCeEEEEEeccCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~-~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      +.||+|+||.||+|.+..+++.||+|++.+...........+..|. .+++.++||||+++++++...+..|+||||++|
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING   80 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence            4799999999999999999999999999764433223334444444 456888999999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g  158 (325)
T cd05602          81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG  158 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence            99999998888899999999999999999999999999999999999999999999999999874221  2223345679


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCC
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVK  258 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (344)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......++..+++.+.++|.+||+.||.+
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~  237 (325)
T cd05602         159 TPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK  237 (325)
T ss_pred             CccccCHHHHcCCCC-CCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence            999999999987766 5889999999999999999999999888888888888877888889999999999999999999


Q ss_pred             CCCHh----hhhcCccccc
Q 019216          259 RITIA----GIKADEWFEQ  273 (344)
Q Consensus       259 Rps~~----eil~~~~~~~  273 (344)
                      |+++.    ++++|+||..
T Consensus       238 R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         238 RLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             CCCCCCCHHHHhcCcccCC
Confidence            99876    8999999964

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-50  Score=365.76  Aligned_cols=250  Identities=32%  Similarity=0.563  Sum_probs=218.5

Q ss_pred             ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccceeeEEeeCCeEEEEEeccCC
Q 019216           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        22 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      ||+|+||+||+|.++.+++.||+|++.+..............|..++...   .||||+++++++......|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            79999999999999999999999999765443334445566677777665   699999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      ++|.+.+.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g  158 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG  158 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence            99999998888999999999999999999999999999999999999999999999999999874221  2223345689


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCC-CCCHHHHHHHHHhcCCCcC
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-WLSPGAQNLLRKILEPNPV  257 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~li~~~L~~dP~  257 (344)
                      |..|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+..+...+|. .+++.+.+||++||+.||.
T Consensus       159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~  238 (330)
T cd05586         159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ  238 (330)
T ss_pred             CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence            999999999876554578999999999999999999999998888888888888777775 4799999999999999999


Q ss_pred             CCC----CHhhhhcCccccc
Q 019216          258 KRI----TIAGIKADEWFEQ  273 (344)
Q Consensus       258 ~Rp----s~~eil~~~~~~~  273 (344)
                      +||    ++.++++||||..
T Consensus       239 ~R~~~~~~~~~ll~h~~~~~  258 (330)
T cd05586         239 HRLGAHRDAVELKEHPFFAD  258 (330)
T ss_pred             HCCCCCCCHHHHhcCccccC
Confidence            998    6899999999975

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.6e-49  Score=366.36  Aligned_cols=266  Identities=30%  Similarity=0.528  Sum_probs=226.4

Q ss_pred             hccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216            7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus         7 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      +...+..++|++.+.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++.+...
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~  115 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD  115 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence            34567779999999999999999999999999999999998764433344456678899999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ..+|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~  194 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK  194 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCc
Confidence            999999999999999998865 4589999999999999999999999999999999999999999999999999875422


Q ss_pred             ccCCCccccccCCCcccchhhhccCC---CCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--CCCC--CC
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP--KW  239 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~--~~  239 (344)
                      . ........+||+.|+|||++....   ..+.++|||||||++|+|++|+.||.+.+......++....  ..+|  ..
T Consensus       195 ~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  273 (371)
T cd05622         195 E-GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDND  273 (371)
T ss_pred             C-CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCC
Confidence            1 111223567999999999987543   24689999999999999999999999988888888887643  3344  35


Q ss_pred             CCHHHHHHHHHhcCCCcCC--CCCHhhhhcCcccccc
Q 019216          240 LSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD  274 (344)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~--Rps~~eil~~~~~~~~  274 (344)
                      ++..++++|.+||..++.+  |++++++++|+||.+.
T Consensus       274 ~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~  310 (371)
T cd05622         274 ISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  310 (371)
T ss_pred             CCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence            8999999999999855543  7899999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.2e-48  Score=358.53  Aligned_cols=257  Identities=28%  Similarity=0.428  Sum_probs=218.6

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++++.||+|+||.||+|.+..+|..+|+|.+....  .......+.+|++++++++||||+++++++...+..+
T Consensus         2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   79 (331)
T cd06649           2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS   79 (331)
T ss_pred             CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence            34689999999999999999999999999999999986532  2345678999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~-~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +||||+++++|.+++.....+++..+..++.|++.||.|||+. +|+||||||+|||++.++.+||+|||++.....   
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~---  156 (331)
T cd06649          80 ICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---  156 (331)
T ss_pred             EEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc---
Confidence            9999999999999998888899999999999999999999986 699999999999999999999999999874322   


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh-------------------
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-------------------  230 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~-------------------  230 (344)
                       .......||..|+|||++.+..+ +.++|||||||++|+|++|+.||...+.......+.                   
T Consensus       157 -~~~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (331)
T cd06649         157 -SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPR  234 (331)
T ss_pred             -cccccCCCCcCcCCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccc
Confidence             22334578999999999987665 689999999999999999999997655443322111                   


Q ss_pred             ---------------------------hCC-CCC-CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          231 ---------------------------RGD-FKL-PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       231 ---------------------------~~~-~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                                                 ... ... ...+++++++||.+||+.||++|||+.++++||||+..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  307 (331)
T cd06649         235 PPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRS  307 (331)
T ss_pred             cccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhc
Confidence                                       000 111 12368899999999999999999999999999999753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.2e-49  Score=360.29  Aligned_cols=251  Identities=30%  Similarity=0.611  Sum_probs=219.9

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEeccCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      +.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++.++ .||||+++++++.....+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4799999999999999999999999999876554555667788999999888 599999999999999999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      ++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ........+|
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g  158 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG  158 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence            99999998888899999999999999999999999999999999999999999999999999873211  1223345689


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC-------ccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-------RNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI  251 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~-------~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  251 (344)
                      |+.|+|||++.+..+ +.++|||||||++|+|++|+.||..       .......+.+......+|..++..+.+++.+|
T Consensus       159 t~~y~aPE~~~~~~~-~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~  237 (327)
T cd05617         159 TPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF  237 (327)
T ss_pred             CcccCCHHHHCCCCC-CchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence            999999999987766 6899999999999999999999953       22344556666677788889999999999999


Q ss_pred             cCCCcCCCCC------HhhhhcCccccc
Q 019216          252 LEPNPVKRIT------IAGIKADEWFEQ  273 (344)
Q Consensus       252 L~~dP~~Rps------~~eil~~~~~~~  273 (344)
                      |+.||++|++      ++++++||||..
T Consensus       238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~  265 (327)
T cd05617         238 LNKDPKERLGCQPQTGFSDIKSHTFFRS  265 (327)
T ss_pred             hccCHHHcCCCCCCCCHHHHHcCCCCCC
Confidence            9999999998      469999999975

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-48  Score=356.59  Aligned_cols=259  Identities=29%  Similarity=0.534  Sum_probs=219.0

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++++.||+|+||.||++.++.+++.||+|++.+.........+.+.+|+.+++.++|+||+++++++.....+|+||
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM   80 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence            47999999999999999999999999999999997644434445567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||++|++|.+++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~  159 (331)
T cd05597          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQ  159 (331)
T ss_pred             ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Ccc
Confidence            99999999999976 4579999999999999999999999999999999999999999999999999986432211 111


Q ss_pred             cccccCCCcccchhhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--CCCC---CCCCHH
Q 019216          173 LHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP---KWLSPG  243 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~---~~~~~~  243 (344)
                      .....||+.|+|||++..    ....+.++|||||||++|+|++|+.||.+.+.......+....  ..++   ..+++.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  239 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE  239 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence            223568999999999863    2334678999999999999999999999888777777766532  3333   347999


Q ss_pred             HHHHHHHhcCCCcCC--CCCHhhhhcCccccc
Q 019216          244 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ  273 (344)
Q Consensus       244 ~~~li~~~L~~dP~~--Rps~~eil~~~~~~~  273 (344)
                      ++++|++||..++++  |+++.++++||||..
T Consensus       240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~  271 (331)
T cd05597         240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEG  271 (331)
T ss_pred             HHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence            999999999765544  889999999999975

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.3e-49  Score=366.21  Aligned_cols=255  Identities=20%  Similarity=0.329  Sum_probs=210.0

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      .+...++|++++.||+|+||.||+|.+..+++.||+|...         ...+.+|+.++++++||||+++++++.....
T Consensus        87 ~~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~---------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~  157 (391)
T PHA03212         87 AGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ---------RGGTATEAHILRAINHPSIIQLKGTFTYNKF  157 (391)
T ss_pred             cccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh---------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCe
Confidence            4566789999999999999999999999999999999653         2346789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      .+++||++ +++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus       158 ~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-  235 (391)
T PHA03212        158 TCLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-  235 (391)
T ss_pred             eEEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-
Confidence            99999999 5689999888788999999999999999999999999999999999999999999999999998743221 


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc-------HHHHHHHHh-----------
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-------LAVLYQKIF-----------  230 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~-------~~~~~~~i~-----------  230 (344)
                      ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||-...       .......+.           
T Consensus       236 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~  314 (391)
T PHA03212        236 NANKYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFP  314 (391)
T ss_pred             cccccccccCccCCCChhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcC
Confidence            1122345689999999999987666 689999999999999999998764311       111111111           


Q ss_pred             ---------------hCCCC----CC-----CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          231 ---------------RGDFK----LP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       231 ---------------~~~~~----~~-----~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                                     .....    .+     ..++.++.+||.+||+.||.+|||+.|+|+||||++..
T Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~  383 (391)
T PHA03212        315 IDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP  383 (391)
T ss_pred             cchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence                           00000    01     12466899999999999999999999999999998743

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=5.3e-49  Score=352.57  Aligned_cols=249  Identities=29%  Similarity=0.476  Sum_probs=213.3

Q ss_pred             ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCCCh
Q 019216           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL  101 (344)
Q Consensus        22 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~~L  101 (344)
                      ||+|+||+||++.++.+++.||+|.+.+.........+.+..|+.+++.++|+||+++++++......++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            79999999999999999999999998765443434456778899999999999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcccccc
Q 019216          102 FDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC  177 (344)
Q Consensus       102 ~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~  177 (344)
                      .+.+..    +..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......  ........
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~  158 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA  158 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccC
Confidence            887742    356899999999999999999999999999999999999999999999999998743321  12233457


Q ss_pred             CCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH----HHHHHHHhhCCCCCCCCCCHHHHHHHHHhcC
Q 019216          178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKWLSPGAQNLLRKILE  253 (344)
Q Consensus       178 gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  253 (344)
                      ||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....    ......+......++..+++.+.+++.+||+
T Consensus       159 g~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~  237 (280)
T cd05608         159 GTPGFMAPELLQGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA  237 (280)
T ss_pred             CCcCccCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence            8999999999987776 5889999999999999999999976432    3334444555566777899999999999999


Q ss_pred             CCcCCCC-----CHhhhhcCccccc
Q 019216          254 PNPVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       254 ~dP~~Rp-----s~~eil~~~~~~~  273 (344)
                      .||++||     +++++++||||+.
T Consensus       238 ~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         238 KDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             CCHHHhcCCCCCCHHHHhcChhhhc
Confidence            9999999     7899999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-49  Score=351.98  Aligned_cols=255  Identities=29%  Similarity=0.442  Sum_probs=218.9

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      .|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            48999999999999999999999999999999876544333344567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        95 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |+.+++|.+.+...  ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++.....   ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~  157 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET  157 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence            99999999887643  4589999999999999999999999999999999999999999999999999875321   122


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHH----HHHHHhhCCCCCCCCCCHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLL  248 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~li  248 (344)
                      .....|+..|+|||.+.+..+ +.++||||+||++|+|++|+.||.+.....    ....+......++..+++.+.+|+
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05605         158 IRGRVGTVGYMAPEVVKNERY-TFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC  236 (285)
T ss_pred             cccccCCCCccCcHHhcCCCC-CccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence            234578999999999987665 688999999999999999999998765432    233344445566777999999999


Q ss_pred             HHhcCCCcCCCC-----CHhhhhcCccccc
Q 019216          249 RKILEPNPVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       249 ~~~L~~dP~~Rp-----s~~eil~~~~~~~  273 (344)
                      .+||+.||++||     ++.++++||||..
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~  266 (285)
T cd05605         237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT  266 (285)
T ss_pred             HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence            999999999999     8999999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.5e-50  Score=349.22  Aligned_cols=256  Identities=31%  Similarity=0.458  Sum_probs=216.3

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC--C--
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--S--   87 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~--   87 (344)
                      ..=+|+-.+++|.|+||.||.|....+++.||||.+-....       --.+|+.+|+.++||||+++..+|...  .  
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            33468899999999999999999999999999998754432       223699999999999999998887532  2  


Q ss_pred             -eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC-CCeEEeccccc
Q 019216           88 -KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLS  161 (344)
Q Consensus        88 -~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~-~~vkl~Dfg~a  161 (344)
                       +..+||||++ .+|.+.++.    +.+++...++-+..||++||+|||+.||+||||||.|+|+|.+ |.+||||||.|
T Consensus        95 ~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSA  173 (364)
T KOG0658|consen   95 VYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSA  173 (364)
T ss_pred             hHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcc
Confidence             3568999995 599888874    5789999999999999999999999999999999999999987 89999999999


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC---------
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---------  232 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~---------  232 (344)
                      +....   +....++..|..|+|||.+.+...++.+.||||.||++.||+.|++.|.|.+...+...|.+-         
T Consensus       174 K~L~~---~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I  250 (364)
T KOG0658|consen  174 KVLVK---GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDI  250 (364)
T ss_pred             eeecc---CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHH
Confidence            96543   333456778999999999999888889999999999999999999999998877766655431         


Q ss_pred             --------CCC------------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCCC
Q 019216          233 --------DFK------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA  278 (344)
Q Consensus       233 --------~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~~  278 (344)
                              ...            +....++++.+|+.++|+.+|.+|.++.|++.||||.+...+.
T Consensus       251 ~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~~  316 (364)
T KOG0658|consen  251 KSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDPN  316 (364)
T ss_pred             hhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCcC
Confidence                    111            1233689999999999999999999999999999999876663

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.1e-48  Score=371.20  Aligned_cols=254  Identities=26%  Similarity=0.370  Sum_probs=208.1

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC-----
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----   86 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----   86 (344)
                      .-++|++++.||+|+||.||+|.+..+++.||||.+....       ....+|+.+++.++||||+++++++...     
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~  136 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKN  136 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccC
Confidence            4468999999999999999999999999999999885432       2345799999999999999999876432     


Q ss_pred             ---CeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC-CeEEecc
Q 019216           87 ---SKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDF  158 (344)
Q Consensus        87 ---~~~~iv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~-~vkl~Df  158 (344)
                         ..+++||||+++ +|.+++.    ....+++..++.++.||+.||+|||+.||+||||||+|||++.++ .+||+||
T Consensus       137 ~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF  215 (440)
T PTZ00036        137 EKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF  215 (440)
T ss_pred             CCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence               247799999964 7766664    346799999999999999999999999999999999999998765 6999999


Q ss_pred             ccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC------
Q 019216          159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------  232 (344)
Q Consensus       159 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~------  232 (344)
                      |+++....   ........||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+......++...      
T Consensus       216 Gla~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~  292 (440)
T PTZ00036        216 GSAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTE  292 (440)
T ss_pred             ccchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            99985322   222335678999999999877654578999999999999999999999987655444443321      


Q ss_pred             -----------CC------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          233 -----------DF------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       233 -----------~~------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                                 ..            .+|...++++.+||.+||+.||.+|||+.|+|+||||.+...
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        293 DQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             HHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence                       00            124456889999999999999999999999999999986543

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.1e-48  Score=348.51  Aligned_cols=255  Identities=38%  Similarity=0.738  Sum_probs=231.4

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++.+.||+|++|.||+|.+..+++.||+|++.+......+..+.+.+|+.++++++||||+++++++......++||
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM   80 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence            47999999999999999999999999999999997655545556778899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||+++++|.+++...+.+++..+..++.||+.||.|||+.|++||||+|.|||++.++.+||+|||++......     .
T Consensus        81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~  155 (290)
T cd05580          81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T  155 (290)
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence            99999999999998889999999999999999999999999999999999999999999999999998753321     3


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcC
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE  253 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~  253 (344)
                      ....+++.|+|||.+.+... +.++||||||+++|+|++|+.||...+......++..+...+|..+++.+.++|.+||+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  234 (290)
T cd05580         156 YTLCGTPEYLAPEIILSKGY-GKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ  234 (290)
T ss_pred             CCCCCCccccChhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence            34578999999999877655 68899999999999999999999888877777888888888899999999999999999


Q ss_pred             CCcCCCC-----CHhhhhcCcccccc
Q 019216          254 PNPVKRI-----TIAGIKADEWFEQD  274 (344)
Q Consensus       254 ~dP~~Rp-----s~~eil~~~~~~~~  274 (344)
                      .||.+|+     +++++++||||+..
T Consensus       235 ~~p~~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         235 VDLTKRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             CCHHHccCcccCCHHHHHcCcccccC
Confidence            9999999     89999999999753

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.1e-48  Score=361.80  Aligned_cols=260  Identities=28%  Similarity=0.447  Sum_probs=215.4

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ....+++|+++++||+|+||.||+|.+..+++.||+|++....  .......+.+|+.+++.++|+||+++++++...+.
T Consensus        69 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  146 (353)
T PLN00034         69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGE  146 (353)
T ss_pred             CCCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCe
Confidence            3456789999999999999999999999999999999986442  23445678999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +++||||+++++|.+.    ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus       147 ~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~-  221 (353)
T PLN00034        147 IQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT-  221 (353)
T ss_pred             EEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc-
Confidence            9999999999998643    34577888999999999999999999999999999999999999999999998754321 


Q ss_pred             CCCccccccCCCcccchhhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCCccH---HHHHHHH-hhCCCCCCCCC
Q 019216          169 DDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKI-FRGDFKLPKWL  240 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~---~~~~~~i-~~~~~~~~~~~  240 (344)
                       ........||..|+|||++..    ..+.+.++|||||||++|+|++|+.||.....   ......+ .......+..+
T Consensus       222 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (353)
T PLN00034        222 -MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA  300 (353)
T ss_pred             -cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCcc
Confidence             112234578999999998743    23445689999999999999999999974322   2222222 22344556778


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      ++++.+||.+||+.||++|||+.|+++||||.....
T Consensus       301 ~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        301 SREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCcccccCCc
Confidence            999999999999999999999999999999987533

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.9e-49  Score=365.12  Aligned_cols=251  Identities=31%  Similarity=0.433  Sum_probs=215.5

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-C-----CCccceeeEEeeCC
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H-----PNVVRLHEVLASKS   87 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----~niv~l~~~~~~~~   87 (344)
                      .+|.+++.||+|+||.|-+|.+..+++.||||+++...    ....+...|+.+|..|+ |     -|+|+++++|...+
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~  261 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN  261 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc
Confidence            48999999999999999999999999999999996543    45677888999999997 4     38999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC--CeEEeccccccC
Q 019216           88 KIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG--NIKISDFGLSAL  163 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~--~vkl~Dfg~a~~  163 (344)
                      ++|||+|.+ +.+|.++++.++  .++...++.++.||+.||.+||+.||||+||||+|||+.+-+  .|||+|||.|..
T Consensus       262 HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  262 HLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             ceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            999999999 679999998765  588999999999999999999999999999999999997665  699999999985


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC----------
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD----------  233 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~----------  233 (344)
                      ..     ....+++.+..|+|||++.+.+|. .+.||||||||++||++|.+.|.|.+..+++..|..-.          
T Consensus       341 ~~-----q~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  341 ES-----QRVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             cC-----CcceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            32     233478889999999999999985 78999999999999999999999988877776654210          


Q ss_pred             ------------------------------------------CCCCC-----------CCCHHHHHHHHHhcCCCcCCCC
Q 019216          234 ------------------------------------------FKLPK-----------WLSPGAQNLLRKILEPNPVKRI  260 (344)
Q Consensus       234 ------------------------------------------~~~~~-----------~~~~~~~~li~~~L~~dP~~Rp  260 (344)
                                                                ...|.           .-...+.+||.+||.+||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                                                      00110           0124568999999999999999


Q ss_pred             CHhhhhcCccccccC
Q 019216          261 TIAGIKADEWFEQDY  275 (344)
Q Consensus       261 s~~eil~~~~~~~~~  275 (344)
                      |+.++|+|||+....
T Consensus       495 tp~qal~Hpfl~~~~  509 (586)
T KOG0667|consen  495 TPAQALNHPFLTGTS  509 (586)
T ss_pred             CHHHHhcCccccccc
Confidence            999999999998543

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=6.9e-48  Score=353.64  Aligned_cols=259  Identities=28%  Similarity=0.508  Sum_probs=220.0

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++.++||+|+||.||++.++.+++.+|+|++.+...........+.+|+.++..++|+||+++++.+.....+|+||
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM   80 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999987544333344556888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||+++|+|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus        81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~  159 (332)
T cd05623          81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ  159 (332)
T ss_pred             eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence            99999999999976 467899999999999999999999999999999999999999999999999998643211 1112


Q ss_pred             cccccCCCcccchhhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--CCCC---CCCCHH
Q 019216          173 LHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP---KWLSPG  243 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~---~~~~~~  243 (344)
                      ....+||+.|+|||++..    ....+.++|||||||++|+|++|+.||.+.+......++....  ..+|   ..+++.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~  239 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED  239 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence            234579999999999863    2334688999999999999999999999988888888776653  2333   357999


Q ss_pred             HHHHHHHhcCCCcCC--CCCHhhhhcCccccc
Q 019216          244 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ  273 (344)
Q Consensus       244 ~~~li~~~L~~dP~~--Rps~~eil~~~~~~~  273 (344)
                      +++|+++||..++.+  |++++++++||||..
T Consensus       240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~  271 (332)
T cd05623         240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG  271 (332)
T ss_pred             HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence            999999999766554  789999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.8e-48  Score=363.04  Aligned_cols=258  Identities=28%  Similarity=0.423  Sum_probs=215.8

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC-----eE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KI   89 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~   89 (344)
                      +|++++.||+|+||.||+|.+..+|+.||+|.+... .......+++.+|+.+++.++||||+++++++....     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNV-FQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccc-ccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            478999999999999999999999999999988543 223334567889999999999999999999998766     78


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      |+||||+. ++|.+.+...+.+++..++.++.||+.||.|||+.|++||||||+|||++.++.+||+|||+++..... .
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~-~  157 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD-E  157 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC-c
Confidence            99999995 688888888788999999999999999999999999999999999999999999999999998753321 1


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhh------------------
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------------  231 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~------------------  231 (344)
                      ........+++.|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+..                  
T Consensus       158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  237 (372)
T cd07853         158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR  237 (372)
T ss_pred             cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence            12223456789999999988766557899999999999999999999988765544433321                  


Q ss_pred             -----CCC---------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          232 -----GDF---------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       232 -----~~~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                           ...         ......++++.+||.+||+.||++|||+.++++||||....
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence                 111         12334688999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=5.9e-48  Score=353.92  Aligned_cols=259  Identities=27%  Similarity=0.492  Sum_probs=219.7

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++++.||+|+||.||+++++.+++.||+|++.+...........+.+|+.++..++|+||+++++++...+..|+||
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~   80 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM   80 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence            47999999999999999999999999999999987644333344566888999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||++||+|.+++.+ ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus        81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~  159 (331)
T cd05624          81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ  159 (331)
T ss_pred             eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence            99999999999986 4679999999999999999999999999999999999999999999999999987432211 111


Q ss_pred             cccccCCCcccchhhhccC----CCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--CCCCC---CCCHH
Q 019216          173 LHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPK---WLSPG  243 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~~---~~~~~  243 (344)
                      ....+||+.|+|||++.+.    ...+.++|||||||++|+|++|+.||...+......++....  .++|.   .+++.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~  239 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE  239 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence            2335799999999998652    233678999999999999999999999888777777776543  33443   36899


Q ss_pred             HHHHHHHhcCCCcCC--CCCHhhhhcCccccc
Q 019216          244 AQNLLRKILEPNPVK--RITIAGIKADEWFEQ  273 (344)
Q Consensus       244 ~~~li~~~L~~dP~~--Rps~~eil~~~~~~~  273 (344)
                      ++++|.+||..++++  |++++++++|+||+.
T Consensus       240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence            999999999876655  578999999999975

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.4e-48  Score=370.90  Aligned_cols=257  Identities=28%  Similarity=0.439  Sum_probs=223.0

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCC-CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      ...|.+.+.||+|++|.||+|.+..+ +..||+|.+...   .......+.+|+.+++.++||||+++++++...+..|+
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~l  142 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLL  142 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEE
Confidence            44599999999999999999998877 788999976433   23445677889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           92 VLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ||||++|++|.+++..    ..++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       143 v~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~  222 (478)
T PTZ00267        143 IMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS  222 (478)
T ss_pred             EEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCc
Confidence            9999999999887753    456899999999999999999999999999999999999999999999999999854332


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-CCCCCCCHHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQN  246 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~  246 (344)
                      .........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..+.. +.|..+++.+.+
T Consensus       223 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  301 (478)
T PTZ00267        223 VSLDVASSFCGTPYYLAPELWERKRY-SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKA  301 (478)
T ss_pred             cccccccccCCCccccCHhHhCCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHHHH
Confidence            22222345679999999999887665 6899999999999999999999998888777777776654 456778999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          247 LLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      +|.+||+.||++||++.+++.|+|++.
T Consensus       302 li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        302 LLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            999999999999999999999999863

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=5e-48  Score=351.05  Aligned_cols=259  Identities=25%  Similarity=0.421  Sum_probs=214.4

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .+++|++.+.||+|+||.||+|.++.+++.||+|.+......  .....+.+|+.++++++||||+++++++..++..++
T Consensus         4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   81 (309)
T cd07872           4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTL   81 (309)
T ss_pred             CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEE
Confidence            467899999999999999999999999999999998654321  223457789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      ||||+.+ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....  ..
T Consensus        82 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~  158 (309)
T cd07872          82 VFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV--PT  158 (309)
T ss_pred             EEeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC--Cc
Confidence            9999965 888887654 4589999999999999999999999999999999999999999999999999874322  11


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC------------------
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------  232 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~------------------  232 (344)
                      .......++..|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...                  
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (309)
T cd07872         159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEF  238 (309)
T ss_pred             cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhh
Confidence            12234567899999999876554578999999999999999999999886654443333211                  


Q ss_pred             -CCCCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          233 -DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       233 -~~~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                       ....+           ..+++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         239 KNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence             01111           23688999999999999999999999999999998653

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5.8e-48  Score=357.90  Aligned_cols=259  Identities=29%  Similarity=0.443  Sum_probs=210.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC----
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----   86 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----   86 (344)
                      ..+++|++.+.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.+++.++||||+++++++...    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence            45789999999999999999999999999999999986542 2334456788999999999999999999998644    


Q ss_pred             --CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           87 --SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        87 --~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                        ..+|+||||+.+ +|.+.+.  ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence              357999999965 6666654  35889999999999999999999999999999999999999999999999998743


Q ss_pred             CcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhh-------------
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-------------  231 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~-------------  231 (344)
                      .   .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..             
T Consensus       174 ~---~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         174 C---TNFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             c---cCccCCCCcccCCCCCchhccCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            2   1222344678999999999987776 5789999999999999999999987654333222111             


Q ss_pred             ---------CCCC--------------------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          232 ---------GDFK--------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       232 ---------~~~~--------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                               ....                    .+...++.+++||.+||+.||++|||+.|+|+||||...+.+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~~  324 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDP  324 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcCc
Confidence                     1110                    111246789999999999999999999999999999865544

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=4.8e-48  Score=371.20  Aligned_cols=261  Identities=33%  Similarity=0.534  Sum_probs=225.5

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC---
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---   87 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---   87 (344)
                      ..-++|++.+.||+|+||+||+|.+..+|+.||+|++..... .......+.+|+.++..++|+|++++++.+....   
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~  107 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN  107 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence            455799999999999999999999999999999999876543 3345667889999999999999999987764322   


Q ss_pred             -----eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecc
Q 019216           88 -----KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF  158 (344)
Q Consensus        88 -----~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Df  158 (344)
                           .+++||||+++|+|.+++..    ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+||
T Consensus       108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF  187 (496)
T PTZ00283        108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF  187 (496)
T ss_pred             cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence                 36899999999999998864    346899999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-CCC
Q 019216          159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLP  237 (344)
Q Consensus       159 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~  237 (344)
                      |+++..............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..+.. ++|
T Consensus       188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~-s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~  266 (496)
T PTZ00283        188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPY-SKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP  266 (496)
T ss_pred             ccCeeccccccccccccccCCcceeCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence            99875443222233445689999999999987766 6899999999999999999999999888777777776543 467


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      ..+++.+.+++.+||+.||.+||++.++++|||+..
T Consensus       267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHH
Confidence            789999999999999999999999999999999864

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=5.1e-48  Score=347.63  Aligned_cols=252  Identities=31%  Similarity=0.436  Sum_probs=205.9

Q ss_pred             cCeEEeeeecccCceEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccceeeEEe-----
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLA-----   84 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~-----   84 (344)
                      .+|++++.||+|+||.||+|.+.. +++.||+|.++...... .....+.+|+.+++.+   +||||+++++++.     
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~   79 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   79 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence            479999999999999999999854 57889999986543222 2234556677777665   6999999999885     


Q ss_pred             eCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecccccc
Q 019216           85 SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      ....+++||||+. ++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            3456899999995 5898888753  458999999999999999999999999999999999999999999999999987


Q ss_pred             CCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-----C--
Q 019216          163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-----K--  235 (344)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-----~--  235 (344)
                      ....   ........||+.|+|||.+.+..+ +.++|||||||++|+|++|++||.+.+.......+.....     .  
T Consensus       159 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         159 IYSF---QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             eccC---CcccccccccccccChHHHhCCCC-CCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            5332   122345678999999999877665 5789999999999999999999998777666655543210     0  


Q ss_pred             --------------------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          236 --------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       236 --------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                                          +...+++.+.+|+.+||+.||++|||+.++|+||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                                112367888999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-48  Score=356.53  Aligned_cols=244  Identities=29%  Similarity=0.458  Sum_probs=212.6

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~   95 (344)
                      +++++.||+|-||.||+|.+.. ...||+|.++.....    .+.+.+|+.+|++|+|+|||++++++..+..+||||||
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~----~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~  282 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS----PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY  282 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC----hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence            4557889999999999999843 447999998754332    35677999999999999999999999998899999999


Q ss_pred             cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           96 VTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        96 ~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ++.|+|.++++.  .+.+...+...++.|||+|++||+++++|||||.+.||||++++.+||+|||+|+..... .....
T Consensus       283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~  361 (468)
T KOG0197|consen  283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTAS  361 (468)
T ss_pred             cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC-ceeec
Confidence            999999999986  456899999999999999999999999999999999999999999999999999943221 11111


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHh
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKI  251 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~  251 (344)
                      ....-...|.|||.+....+ +.+|||||||++||||+| |+.|+.+.+..+....+.++ ..+-|..+|+.+.+++..|
T Consensus       362 ~~~kfPIkWtAPEa~~~~~F-S~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C  440 (468)
T KOG0197|consen  362 EGGKFPIKWTAPEALNYGKF-SSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSC  440 (468)
T ss_pred             CCCCCCceecCHHHHhhCCc-ccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence            22233567999999998887 689999999999999999 99999999999999999887 6788999999999999999


Q ss_pred             cCCCcCCCCCHhhhh
Q 019216          252 LEPNPVKRITIAGIK  266 (344)
Q Consensus       252 L~~dP~~Rps~~eil  266 (344)
                      |..+|++|||++.+.
T Consensus       441 W~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  441 WHEDPEDRPTFETLR  455 (468)
T ss_pred             hhCCcccCCCHHHHH
Confidence            999999999998664

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.5e-48  Score=342.61  Aligned_cols=253  Identities=36%  Similarity=0.638  Sum_probs=214.0

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~   95 (344)
                      |++++.||+|+||+||+|.+..+++.||+|++........ ......+|+.++++++||||+++++++......+++||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEE-EREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHH-HHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccc-ccchhhhhhhccccccccccccccccccccccccccccc
Confidence            8999999999999999999999999999999976643322 233445699999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcccc
Q 019216           96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT  175 (344)
Q Consensus        96 ~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~  175 (344)
                      +.+++|.+++...+.+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+...  .........
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~  157 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP  157 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence            999999999998888999999999999999999999999999999999999999999999999998642  112334456


Q ss_pred             ccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc---cHHHHHHHHhhCCCCCC----CCCCHHHHHHH
Q 019216          176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLP----KWLSPGAQNLL  248 (344)
Q Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~----~~~~~~~~~li  248 (344)
                      ..++..|+|||++......+.++||||||+++|+|++|..||...   +......+........+    ...++.+.++|
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  237 (260)
T PF00069_consen  158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI  237 (260)
T ss_dssp             SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence            788999999999883344478999999999999999999999987   33333333333222111    12248999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCccc
Q 019216          249 RKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      .+||+.||++|||+.++++||||
T Consensus       238 ~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  238 KKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             HHHccCChhHCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=6.8e-49  Score=361.93  Aligned_cols=266  Identities=42%  Similarity=0.792  Sum_probs=249.2

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      ......+-|.+.+.||+|.|+.|.+|++..++..||||.+++..... ..+..+.+|++++..++||||++++.+.....
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~  128 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEA  128 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence            35678899999999999999999999999999999999998876544 44556999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+|+||||+.+|.+++++.+.+++.+..++.++.|+..|++|||+++|+|||||++|||++.+-++||+|||++....  
T Consensus       129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~--  206 (596)
T KOG0586|consen  129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD--  206 (596)
T ss_pred             eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999998654  


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL  247 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (344)
                       ......++||++.|.|||++.+..++++.+|+||+|+++|.|+.|..||++.+......+...+++.+|-.++-++.++
T Consensus       207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~l  285 (596)
T KOG0586|consen  207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDL  285 (596)
T ss_pred             -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHH
Confidence             4566789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          248 LRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      |+++|..+|.+|++.++++.|.|.......
T Consensus       286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             HHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            999999999999999999999999865443

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.8e-47  Score=351.02  Aligned_cols=256  Identities=29%  Similarity=0.441  Sum_probs=215.9

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      ..++|++.++||+|+||.||+|.+..++..+|+|.+....  .......+.+|+++++.++||||+++++++...+..++
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l   80 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   80 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence            4579999999999999999999999999999999886532  23345678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~-~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      ||||+++++|.+++.+.+.+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++.....    
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----  156 (333)
T cd06650          81 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----  156 (333)
T ss_pred             EEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----
Confidence            999999999999998888899999999999999999999985 799999999999999999999999999874321    


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH---------------------
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI---------------------  229 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i---------------------  229 (344)
                      .......|+..|+|||.+.+..+ +.++|||||||++|+|++|+.||...........+                     
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (333)
T cd06650         157 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG  235 (333)
T ss_pred             hccccCCCCccccCHHHhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence            12234578999999999877665 68899999999999999999999765433222111                     


Q ss_pred             -----------------------hhCC-CCCC-CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          230 -----------------------FRGD-FKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       230 -----------------------~~~~-~~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                                             .... ...+ ..+++++++||.+||+.||++|||+.|++.|+||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                                   1110 1111 1367889999999999999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.5e-48  Score=369.26  Aligned_cols=254  Identities=24%  Similarity=0.354  Sum_probs=204.4

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC------CCccceeeEEee
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH------PNVVRLHEVLAS   85 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------~niv~l~~~~~~   85 (344)
                      ..++|+++++||+|+||.||+|.+..+++.||||+++...    ........|+.+++.++|      .+++++++++..
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~  202 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN  202 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence            3478999999999999999999999999999999986432    223445667777776654      458888888865


Q ss_pred             C-CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEEccCC------------
Q 019216           86 K-SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKG------------  151 (344)
Q Consensus        86 ~-~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NILl~~~~------------  151 (344)
                      . ..+++|||++ |++|.+++.+.+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++            
T Consensus       203 ~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~  281 (467)
T PTZ00284        203 ETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP  281 (467)
T ss_pred             CCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccC
Confidence            4 5789999998 78999999888889999999999999999999998 5999999999999998765            


Q ss_pred             ----CeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHH
Q 019216          152 ----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ  227 (344)
Q Consensus       152 ----~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~  227 (344)
                          .+||+|||.+...     .......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.+......
T Consensus       282 ~~~~~vkl~DfG~~~~~-----~~~~~~~~gt~~Y~APE~~~~~~~-~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~  355 (467)
T PTZ00284        282 PDPCRVRICDLGGCCDE-----RHSRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLH  355 (467)
T ss_pred             CCCceEEECCCCccccC-----ccccccccCCccccCcHHhhcCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                4999999987632     122345689999999999988776 588999999999999999999998766544333


Q ss_pred             HHhhCCCCCC------------------------------------------CCCCHHHHHHHHHhcCCCcCCCCCHhhh
Q 019216          228 KIFRGDFKLP------------------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGI  265 (344)
Q Consensus       228 ~i~~~~~~~~------------------------------------------~~~~~~~~~li~~~L~~dP~~Rps~~ei  265 (344)
                      .+......+|                                          ...++.+.+||.+||+.||++|||++|+
T Consensus       356 ~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~  435 (467)
T PTZ00284        356 LMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQM  435 (467)
T ss_pred             HHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHH
Confidence            3221110000                                          0024567899999999999999999999


Q ss_pred             hcCccccccCC
Q 019216          266 KADEWFEQDYT  276 (344)
Q Consensus       266 l~~~~~~~~~~  276 (344)
                      |+||||.+.+.
T Consensus       436 L~Hp~~~~~~~  446 (467)
T PTZ00284        436 TTHPYVLKYYP  446 (467)
T ss_pred             hcCccccccCC
Confidence            99999987544

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.7e-47  Score=355.42  Aligned_cols=258  Identities=28%  Similarity=0.414  Sum_probs=212.0

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC-----
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----   86 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----   86 (344)
                      .+++|++.+.||+|+||.||+|.+..+++.||+|++.+.. ........+.+|+.+++.++||||+++++++...     
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~  100 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  100 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence            4789999999999999999999999999999999986432 2334456788999999999999999999987543     


Q ss_pred             -CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 -~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                       ...|+||||+.+ +|.+.+..  .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       101 ~~~~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         101 FQDVYIVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             cCeEEEEEeCCCC-CHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence             357999999954 77777643  47889999999999999999999999999999999999999999999999997532


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC------------
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------  233 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~------------  233 (344)
                      .   ........+|..|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......++....            
T Consensus       178 ~---~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         178 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             C---CCcccCCcccCCcCCHHHHhCCCC-CchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            2   222345678999999999988776 589999999999999999999998876655544443210            


Q ss_pred             ----------CC--------------------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          234 ----------FK--------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       234 ----------~~--------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                ..                    .....+..+++||.+||+.||.+|||+.++|+||||...+.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  327 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYDP  327 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccCc
Confidence                      00                    011135678999999999999999999999999999765444

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-47  Score=338.73  Aligned_cols=257  Identities=32%  Similarity=0.547  Sum_probs=220.7

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      +.|++.+.||+|++|.||.|.+..+++.||+|.+......  .......+.+|+.++++++||||+++++++......++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   81 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI   81 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence            4689999999999999999999999999999998754322  12235678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      ++||+++++|.+.+...+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..........
T Consensus        82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~  161 (263)
T cd06625          82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG  161 (263)
T ss_pred             EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999987443221111


Q ss_pred             -ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CCCCCCCCCHHHHHHH
Q 019216          172 -LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLL  248 (344)
Q Consensus       172 -~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li  248 (344)
                       ......++..|+|||.+.+..+ +.++||||||+++|+|++|+.||...+......++...  ...+|..++..+.++|
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (263)
T cd06625         162 TGMKSVTGTPYWMSPEVISGEGY-GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL  240 (263)
T ss_pred             ccccCCCcCccccCcceeccCCC-CchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence             1133567889999999887665 68999999999999999999999876655544444433  4456778999999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCccc
Q 019216          249 RKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      ++||..+|.+|||+.++++|+||
T Consensus       241 ~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         241 RRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHhhcCcccCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.7e-47  Score=343.64  Aligned_cols=255  Identities=30%  Similarity=0.447  Sum_probs=215.5

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.++++++|+|++.+++.+...+..++|||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence            47889999999999999999999999999999876544444445667889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        95 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |+.|++|.+++...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++.....   ...
T Consensus        81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~  157 (285)
T cd05630          81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT  157 (285)
T ss_pred             ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence            99999999888643  3589999999999999999999999999999999999999999999999999874321   112


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH---HHHHHH-hhCCCCCCCCCCHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---VLYQKI-FRGDFKLPKWLSPGAQNLL  248 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~---~~~~~i-~~~~~~~~~~~~~~~~~li  248 (344)
                      .....|+..|+|||.+.+..+ +.++||||||+++|+|++|+.||......   ...... .......+..+++++.+|+
T Consensus       158 ~~~~~g~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05630         158 IKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC  236 (285)
T ss_pred             ccCCCCCccccChHHHcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence            234578999999999987665 68899999999999999999999864321   111111 1123345677899999999


Q ss_pred             HHhcCCCcCCCCC-----HhhhhcCccccc
Q 019216          249 RKILEPNPVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       249 ~~~L~~dP~~Rps-----~~eil~~~~~~~  273 (344)
                      ++||+.||++|||     ++++++||||.+
T Consensus       237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence            9999999999999     899999999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.8e-47  Score=354.03  Aligned_cols=259  Identities=28%  Similarity=0.426  Sum_probs=210.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC----
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----   86 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----   86 (344)
                      ..+++|++++.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence            35789999999999999999999999999999999986432 2334456788899999999999999999988543    


Q ss_pred             --CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           87 --SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        87 --~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                        ...|+||||+++ ++.+.+.  ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence              357999999965 6766664  35889999999999999999999999999999999999999999999999999743


Q ss_pred             CcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC------------
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------  232 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~------------  232 (344)
                      .   .........||..|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+...            
T Consensus       170 ~---~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (355)
T cd07874         170 G---TSFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL  245 (355)
T ss_pred             C---CccccCCccccCCccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            2   2222345678999999999987766 58899999999999999999999876644333222110            


Q ss_pred             ----------CC--------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          233 ----------DF--------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       233 ----------~~--------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                ..                    ..+...+..+++||.+||+.||++|||+.|+|+||||...+.+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~~  320 (355)
T cd07874         246 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYDP  320 (355)
T ss_pred             cHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccCh
Confidence                      00                    0112245678999999999999999999999999999865443

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4.5e-47  Score=340.94  Aligned_cols=256  Identities=29%  Similarity=0.442  Sum_probs=218.9

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      .|+..+.||+|+||+||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+|++.+++.+..++..+++||
T Consensus         1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence            47889999999999999999999999999999876544443445567889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        95 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |+.+++|.+.+...  ..+++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.....   ...
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~  157 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES  157 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence            99999998887643  3699999999999999999999999999999999999999999999999999864321   112


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHH----HHHHhhCCCCCCCCCCHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL----YQKIFRGDFKLPKWLSPGAQNLL  248 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~~~li  248 (344)
                      .....|+..|+|||.+.+..+ +.++|+|||||++|+|++|+.||.+......    ...+......++..+++.+.+|+
T Consensus       158 ~~~~~g~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         158 IRGRVGTVGYMAPEVLNNQRY-TLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             ccCCCCCcCccChHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence            234578999999999977665 6889999999999999999999987654332    33333444556677899999999


Q ss_pred             HHhcCCCcCCCCC-----HhhhhcCcccccc
Q 019216          249 RKILEPNPVKRIT-----IAGIKADEWFEQD  274 (344)
Q Consensus       249 ~~~L~~dP~~Rps-----~~eil~~~~~~~~  274 (344)
                      .+||+.||++||+     +.+++.|+||.+.
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM  267 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence            9999999999999     8899999999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.5e-47  Score=352.31  Aligned_cols=254  Identities=26%  Similarity=0.400  Sum_probs=206.0

Q ss_pred             ccccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEe
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA   84 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~   84 (344)
                      +..++|++.+.||+|+||.||+|.+.     .++..||+|++....  .......+.+|+.+++.+ +||||+++++++.
T Consensus         4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (338)
T cd05102           4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACT   81 (338)
T ss_pred             cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence            45579999999999999999999752     445789999986432  233456788999999999 8999999999886


Q ss_pred             eC-CeEEEEEeccCCCChHHHHHhc-------------------------------------------------------
Q 019216           85 SK-SKIYMVLEYVTGGELFDKIASK-------------------------------------------------------  108 (344)
Q Consensus        85 ~~-~~~~iv~e~~~g~~L~~~l~~~-------------------------------------------------------  108 (344)
                      .. ..++++|||+++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence            54 4689999999999999988642                                                       


Q ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCc
Q 019216          109 -------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN  181 (344)
Q Consensus       109 -------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~  181 (344)
                             .++++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...............++..
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~  241 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK  241 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence                   2377888899999999999999999999999999999999999999999999975422111111223345678


Q ss_pred             ccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHH-HHHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCC
Q 019216          182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV-LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVK  258 (344)
Q Consensus       182 y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~-~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~  258 (344)
                      |+|||++.+..+ +.++|||||||++|||++ |..||.+..... ....+..+ ....|..+++.+.+++.+||+.||++
T Consensus       242 y~aPE~~~~~~~-~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~  320 (338)
T cd05102         242 WMAPESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKE  320 (338)
T ss_pred             ccCcHHhhcCCC-CcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhh
Confidence            999999887666 689999999999999997 999998755332 33333333 34456778999999999999999999


Q ss_pred             CCCHhhhhc
Q 019216          259 RITIAGIKA  267 (344)
Q Consensus       259 Rps~~eil~  267 (344)
                      |||+.++++
T Consensus       321 RPs~~el~~  329 (338)
T cd05102         321 RPTFSALVE  329 (338)
T ss_pred             CcCHHHHHH
Confidence            999999976

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2e-47  Score=352.15  Aligned_cols=257  Identities=29%  Similarity=0.423  Sum_probs=211.2

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC------
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------   86 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------   86 (344)
                      .++|++++.||+|+||.||+|.+..+++.||+|.+.+.. ........+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07878          14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF   92 (343)
T ss_pred             hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchh-hhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence            468999999999999999999999999999999986432 2223345677899999999999999999887533      


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ...|++++++ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        93 ~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878          93 NEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             CcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            3578999998 789987765 46799999999999999999999999999999999999999999999999999874322


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-------------
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------  233 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-------------  233 (344)
                           ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....             
T Consensus       171 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         171 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             -----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence                 23345789999999998775555789999999999999999999998766544433332110             


Q ss_pred             ----------CCC--------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          234 ----------FKL--------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       234 ----------~~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                ...        ....++.+.+||.+||+.||.+|||+.++++||||.+...+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             hhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence                      001        12356778999999999999999999999999999875433

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=5.3e-47  Score=343.05  Aligned_cols=258  Identities=26%  Similarity=0.434  Sum_probs=214.6

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .+++|++.+.||.|+||.||+|.+..+++.||+|.+.....  ......+.+|+.+++.++||||+++++++......++
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l   81 (301)
T cd07873           4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL   81 (301)
T ss_pred             cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence            57899999999999999999999999999999999864432  1223457789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      ||||+. ++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.....  ..
T Consensus        82 v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~--~~  158 (301)
T cd07873          82 VFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PT  158 (301)
T ss_pred             EEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC--CC
Confidence            999996 588888765 35689999999999999999999999999999999999999999999999999874322  11


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC------------------
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------  232 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~------------------  232 (344)
                      .......+++.|+|||++.+....+.++|||||||++|+|++|++||.+.+.......+...                  
T Consensus       159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (301)
T cd07873         159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF  238 (301)
T ss_pred             CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence            12233467889999999876555578899999999999999999999887655444333211                  


Q ss_pred             -CCCCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          233 -DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       233 -~~~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                       ....|           ..+++.+.+||.+||+.||.+|||++++++||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~  292 (301)
T cd07873         239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL  292 (301)
T ss_pred             cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence             00111           2468899999999999999999999999999999754

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.5e-47  Score=340.25  Aligned_cols=248  Identities=27%  Similarity=0.449  Sum_probs=207.1

Q ss_pred             ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCCCh
Q 019216           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL  101 (344)
Q Consensus        22 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~~L  101 (344)
                      ||+|+||.||++.++.+|+.||+|.+.............+..|+.++++++||||+++++++......++||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            79999999999999999999999998654433323344566799999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCC
Q 019216          102 FDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS  179 (344)
Q Consensus       102 ~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt  179 (344)
                      .+.+....  .+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.....   ........|+
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~  157 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT  157 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence            88876433  588999999999999999999999999999999999999999999999999874322   1222345789


Q ss_pred             CcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH----HHHHHHHhhCCCCCC-CCCCHHHHHHHHHhcCC
Q 019216          180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLP-KWLSPGAQNLLRKILEP  254 (344)
Q Consensus       180 ~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~-~~~~~~~~~li~~~L~~  254 (344)
                      ..|+|||++.+..+ +.++|||||||++|+|++|+.||.....    ..............+ ..+++++++|+.+||+.
T Consensus       158 ~~y~aPE~~~~~~~-~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         158 NGYMAPEILKEEPY-SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK  236 (277)
T ss_pred             CCccCHHHHccCCC-CCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence            99999999987775 6899999999999999999999976432    233333443333332 45899999999999999


Q ss_pred             CcCCCCCH----hhhhcCccccc
Q 019216          255 NPVKRITI----AGIKADEWFEQ  273 (344)
Q Consensus       255 dP~~Rps~----~eil~~~~~~~  273 (344)
                      ||++||++    ++++.|+||+.
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcC
Confidence            99999999    66889999975

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=3.9e-47  Score=341.47  Aligned_cols=251  Identities=31%  Similarity=0.434  Sum_probs=204.4

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccceeeEEee-----C
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLAS-----K   86 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~-----~   86 (344)
                      +|++.+.||+|+||.||+|.++.+++.||+|.+....... .....+.+|+.+++.+   +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            6999999999999999999999999999999986543221 2223455677776655   69999999998754     3


Q ss_pred             CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           87 SKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                      ...+++|||+. ++|.+++...  ..+++..++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||++...
T Consensus        80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            45899999996 4888888753  34899999999999999999999999999999999999999999999999998754


Q ss_pred             CcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-----------
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-----------  233 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-----------  233 (344)
                      ..   ........+|..|+|||++.+..+ +.++|||||||++|+|++|++||.+........++....           
T Consensus       159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (288)
T cd07863         159 SC---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  234 (288)
T ss_pred             cC---cccCCCccccccccCchHhhCCCC-CCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence            32   122234568899999999887665 689999999999999999999998776655544443210           


Q ss_pred             C----------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          234 F----------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       234 ~----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      .                .....++..+.+||.+||+.||++|||+.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0                0112367889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-48  Score=332.24  Aligned_cols=254  Identities=30%  Similarity=0.575  Sum_probs=221.8

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEeccC
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYVT   97 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv~e~~~   97 (344)
                      .+.||+|+|+.|-.+....+|..||||++.+..   ...+.++.+|++++.+.+ |+||++++++|+++..+|+|||.+.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~---gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP---GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCC---chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            478999999999999999999999999998773   345688999999999996 9999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC---eEEeccccccCCCccc-----C
Q 019216           98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFR-----D  169 (344)
Q Consensus        98 g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~---vkl~Dfg~a~~~~~~~-----~  169 (344)
                      ||+|...|+++..+++.++.++.++|+.||.|||++||.|||+||+|||...-+.   ||||||.++.-.....     .
T Consensus       160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spas  239 (463)
T KOG0607|consen  160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAS  239 (463)
T ss_pred             CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCC
Confidence            9999999999999999999999999999999999999999999999999976654   7999999876332211     2


Q ss_pred             CCccccccCCCcccchhhhc----cCCCCCccchhhhhhHHHHHHHhCCCCCCC---------------ccHHHHHHHHh
Q 019216          170 DGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDD---------------RNLAVLYQKIF  230 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~ll~ell~g~~pf~~---------------~~~~~~~~~i~  230 (344)
                      .....+.+|+..|||||++.    ...++..++|.||||+++|-|++|++||.+               .-...++..|.
T Consensus       240 tP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ  319 (463)
T KOG0607|consen  240 TPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQ  319 (463)
T ss_pred             CccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHh
Confidence            22344668999999999864    334556899999999999999999999965               12456778888


Q ss_pred             hCCCCCCCC----CCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          231 RGDFKLPKW----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       231 ~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      .+.+++|+.    +|.++++||..+|..|+.+|.++.++++|||++...
T Consensus       320 EGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~  368 (463)
T KOG0607|consen  320 EGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCA  368 (463)
T ss_pred             ccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccc
Confidence            999999964    899999999999999999999999999999998543

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.5e-47  Score=335.69  Aligned_cols=253  Identities=32%  Similarity=0.560  Sum_probs=223.6

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      +|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+......++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            58999999999999999999999999999999976655444567889999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccc
Q 019216           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (344)
Q Consensus        95 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~  174 (344)
                      |+.|++|.+++.+..++++..+..++.|+++||.|||++|++|+||+|+||++++++.++|+|||++.....   .....
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~---~~~~~  157 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTT  157 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC---Ccccc
Confidence            999999999998877899999999999999999999999999999999999999999999999999875332   11234


Q ss_pred             cccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 019216          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLPKWLSPGAQNLLRKI  251 (344)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  251 (344)
                      ...|+..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+   ...............|..++..+.++|.+|
T Consensus       158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (258)
T cd05578         158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL  236 (258)
T ss_pred             ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence            4568889999999887665 689999999999999999999998766   344444433356677788999999999999


Q ss_pred             cCCCcCCCCCH--hhhhcCccc
Q 019216          252 LEPNPVKRITI--AGIKADEWF  271 (344)
Q Consensus       252 L~~dP~~Rps~--~eil~~~~~  271 (344)
                      |+.||.+||++  .|+++||||
T Consensus       237 l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         237 LERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ccCChhHcCCccHHHHhcCCCC
Confidence            99999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-46  Score=342.41  Aligned_cols=260  Identities=31%  Similarity=0.528  Sum_probs=225.8

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      .+|++.+.||+|++|.||+|.+..+++.||+|.+.+...........+.+|+.+++.++|+||+++++.+......+++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   80 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM   80 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence            37999999999999999999999999999999997665444445678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC--
Q 019216           94 EYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--  169 (344)
Q Consensus        94 e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~--  169 (344)
                      ||+.|++|.+++...  ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.++|+|||++........  
T Consensus        81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            999999999998753  5689999999999999999999999999999999999999999999999998864322110  


Q ss_pred             -------------------------CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHH
Q 019216          170 -------------------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV  224 (344)
Q Consensus       170 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~  224 (344)
                                               ........|+..|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  239 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE  239 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence                                     001123467889999999987665 689999999999999999999999888777


Q ss_pred             HHHHHhhCCCCCCCC--CCHHHHHHHHHhcCCCcCCCCC----HhhhhcCcccccc
Q 019216          225 LYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRIT----IAGIKADEWFEQD  274 (344)
Q Consensus       225 ~~~~i~~~~~~~~~~--~~~~~~~li~~~L~~dP~~Rps----~~eil~~~~~~~~  274 (344)
                      ....+......++..  +++.+.++|.+||+.||++|||    ++++++||||++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence            777777666655554  6999999999999999999999    9999999999863

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-46  Score=334.13  Aligned_cols=256  Identities=34%  Similarity=0.520  Sum_probs=219.2

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc------hhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH------LKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      +|.+.+.||+|++|.||+|.+..+++.+|+|.+.......      .+..+.+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            5888999999999999999999999999999886543322      2344678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      .+++|||+++++|.+++.+.+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+.......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS  160 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence            99999999999999999888889999999999999999999999999999999999999999999999999987543211


Q ss_pred             C----CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC-CCCCCCCCCHH
Q 019216          169 D----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG  243 (344)
Q Consensus       169 ~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~  243 (344)
                      .    ........|+..|+|||.+.+..+ +.++|+|||||++|+|++|+.||...+.......+... ...+|..++..
T Consensus       161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06628         161 LSTKTNGARPSLQGSVFWMAPEVVKQTSY-TRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE  239 (267)
T ss_pred             ccCCccccccccCCCcCccChhHhccCCC-CchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence            1    111123467889999999887665 57899999999999999999999876655444444333 34567778999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      +.++|++||+.||.+||++.++++||||
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         240 AIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.9e-46  Score=330.07  Aligned_cols=253  Identities=28%  Similarity=0.537  Sum_probs=217.4

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee-CCeEEEEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIYMVL   93 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~iv~   93 (344)
                      +|++++.||+|++|.||++.++.+++.||+|.+..... .....+.+.+|+.++++++|+|++++++.+.. ...++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            59999999999999999999999999999999864332 23345678899999999999999999988764 44689999


Q ss_pred             eccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           94 EYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        94 e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      ||+++++|.+.+..  ...+++.+++.++.|++.||++||+.|++||||||+||+++.++.++|+|||++......  ..
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~--~~  157 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQ--CD  157 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEeccc--CC
Confidence            99999999998875  345899999999999999999999999999999999999999999999999998754321  12


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-CCCCCCCHHHHHHHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRK  250 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~  250 (344)
                      ......+++.|+|||++.+..+ +.++||||||+++++|++|+.||...+.......+..+.. ..+..+++.+.+++.+
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPY-NYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT  236 (257)
T ss_pred             ccccccCCcCccChhHhcCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence            2334568899999999887665 5789999999999999999999988776666666655543 4567789999999999


Q ss_pred             hcCCCcCCCCCHhhhhcCccc
Q 019216          251 ILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       251 ~L~~dP~~Rps~~eil~~~~~  271 (344)
                      ||+.||++|||+.++++||||
T Consensus       237 ~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         237 MLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HhccCcccCCCHHHHhcCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=3.9e-46  Score=328.90  Aligned_cols=253  Identities=28%  Similarity=0.477  Sum_probs=221.0

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      .|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+.+|+.+++.++|||++++++.+......++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            488999999999999999999999999999998654332 3456778899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        95 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |++|++|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......  ...
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~  157 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF  157 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence            99999999998764  56899999999999999999999999999999999999999999999999998754321  112


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-CCCCCCCHHHHHHHHHh
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKI  251 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~  251 (344)
                      .....+++.|+|||++.+..+ +.++|+||||+++|+|++|+.||...+.......+..+.. .++..+++.+.+++.+|
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd08529         158 ANTIVGTPYYLSPELCEDKPY-NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC  236 (256)
T ss_pred             hhccccCccccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence            234568899999999887765 5889999999999999999999998887776777666543 34557899999999999


Q ss_pred             cCCCcCCCCCHhhhhcCccc
Q 019216          252 LEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       252 L~~dP~~Rps~~eil~~~~~  271 (344)
                      |+.+|++||++.+++.|||+
T Consensus       237 l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         237 LTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ccCCcccCcCHHHHhhCCCC
Confidence            99999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.8e-46  Score=339.49  Aligned_cols=254  Identities=29%  Similarity=0.440  Sum_probs=214.5

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++.+.||+|+||.||+|.+..++..+|+|.+....  .......+.+|++++++++||||+++++.+..++.++++|
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM   78 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence            47999999999999999999999999999999886432  2344567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||+++++|.+++.+.+.+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.....    ..
T Consensus        79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~----~~  154 (308)
T cd06615          79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SM  154 (308)
T ss_pred             eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----cc
Confidence            999999999999888889999999999999999999997 5999999999999999999999999998864321    12


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--------------------
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--------------------  232 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--------------------  232 (344)
                      .....++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.......+...                    
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~-~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         155 ANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             cccCCCCcCccChhHhcCCCC-CccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            344578899999999876655 68899999999999999999999765533322222111                    


Q ss_pred             -----------------CCCCC-CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          233 -----------------DFKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       233 -----------------~~~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                                       ....| ..+++++.+|+.+||..||++|||+.++++||||...
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                             01111 1267889999999999999999999999999999764

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2e-46  Score=338.63  Aligned_cols=263  Identities=32%  Similarity=0.434  Sum_probs=219.6

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +|++.+.||+|++|.||+|.+..+|+.||+|.+......  .......+..|+.++++++|+||+++++++.+....++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            589999999999999999999999999999999765432  123445677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |||+ +++|.+++.... .+++..+..++.||++||.|||++|++||||+|+||+++.++.++|+|||++......  ..
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~  157 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NR  157 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC--Cc
Confidence            9999 899999998766 7999999999999999999999999999999999999999999999999998754321  11


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-----------------
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-----------------  234 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------  234 (344)
                      ......++..|+|||.+.+....+.++|||||||++|+|++|.+||.+.+......++.....                 
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV  237 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence            223345678899999986655557899999999999999999999987665554444432100                 


Q ss_pred             ------C-----CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCCCCC
Q 019216          235 ------K-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP  280 (344)
Q Consensus       235 ------~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~~~~  280 (344)
                            .     .....+..+.++|.+||++||++|||+.+++.|+||.+...+..+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~  294 (298)
T cd07841         238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPP  294 (298)
T ss_pred             cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCC
Confidence                  0     012357889999999999999999999999999999988776643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.6e-46  Score=339.22  Aligned_cols=259  Identities=32%  Similarity=0.581  Sum_probs=223.1

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      +.|++++.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+..+...++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   80 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM   80 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence            47999999999999999999999999999999987654434445677889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc-----
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-----  168 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~-----  168 (344)
                      ||++|++|.+++.+.+.+++..+..++.|++.||.|||++|++||||||.||+++.++.+||+|||+++......     
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (305)
T cd05609          81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY  160 (305)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence            999999999999888889999999999999999999999999999999999999999999999999886311000     


Q ss_pred             --------CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCC--
Q 019216          169 --------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--  238 (344)
Q Consensus       169 --------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--  238 (344)
                              .........++..|+|||.+....+ +.++|+|||||++|+|++|..||.+.........+.......|.  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (305)
T cd05609         161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD  239 (305)
T ss_pred             ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence                    0001112457889999999877665 68999999999999999999999988877777777766544433  


Q ss_pred             -CCCHHHHHHHHHhcCCCcCCCCC---HhhhhcCccccc
Q 019216          239 -WLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ  273 (344)
Q Consensus       239 -~~~~~~~~li~~~L~~dP~~Rps---~~eil~~~~~~~  273 (344)
                       .+++.+.++|.+||+.||++||+   +.++++||||..
T Consensus       240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~  278 (305)
T cd05609         240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLG  278 (305)
T ss_pred             ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccC
Confidence             57899999999999999999998   789999999965

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-48  Score=377.31  Aligned_cols=266  Identities=29%  Similarity=0.510  Sum_probs=234.9

Q ss_pred             hhccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216            6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus         6 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      -+.-.+..++|.+++.||+|+||.|.+++++.+++.||+|++.+-.........-|..|-.+|..-+.+.|+.++..|.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD  146 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD  146 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence            34445778899999999999999999999999999999999876433333445678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      +.++|+||||++||+|..++.+..++++..++.|+..|+.||..||+.|+|||||||+|||++..|++||+|||.+-.+.
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~  226 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMD  226 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcC
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999876543


Q ss_pred             cccCCCccccccCCCcccchhhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CCCCC--
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP--  237 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~--  237 (344)
                      . ...-.....+|||.|.+||++..    .+.+++.+|+||+|+.+|||+.|..||...+...++.+|++.  .+.+|  
T Consensus       227 ~-dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~  305 (1317)
T KOG0612|consen  227 A-DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE  305 (1317)
T ss_pred             C-CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc
Confidence            2 12234456799999999999863    245589999999999999999999999999999999999987  67778  


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCC---HhhhhcCccccc
Q 019216          238 KWLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ  273 (344)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps---~~eil~~~~~~~  273 (344)
                      ..+|.++++||++++. +|+.|..   ++++..||||.+
T Consensus       306 ~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g  343 (1317)
T KOG0612|consen  306 TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEG  343 (1317)
T ss_pred             cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence            4589999999999885 6788888   999999999974

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.7e-46  Score=335.44  Aligned_cols=253  Identities=30%  Similarity=0.441  Sum_probs=208.6

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      +|++++.||.|++|.||+|.+..+++.||+|.+..... .......+.+|+.++++++|||++++++++..+...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            58999999999999999999999999999999864322 22334677889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           95 YVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        95 ~~~g~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |+. ++|.+++...   ..+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......  ..
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~--~~  156 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP--VR  156 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCC--cc
Confidence            996 5888887642   46899999999999999999999999999999999999999999999999998743221  11


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC------------------
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------------  233 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~------------------  233 (344)
                      ......+++.|+|||++.+....+.++|||||||++|+|++|++||.+.+.......+....                  
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            12234568899999998765545688999999999999999999998765433322221100                  


Q ss_pred             -----------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          234 -----------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       234 -----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                                 ......+++++.++|++||+.||++|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                       00123478999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-48  Score=342.09  Aligned_cols=262  Identities=35%  Similarity=0.623  Sum_probs=240.4

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCC
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS   87 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~   87 (344)
                      ..+...+|.++..||+|+||.|-+|..+.+.+.+|||++++.-+......+--..|-++|... +-|.+++++..|.+-+
T Consensus       344 d~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD  423 (683)
T KOG0696|consen  344 DRIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD  423 (683)
T ss_pred             cceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh
Confidence            357788999999999999999999999999999999999887766555566666788888876 4788999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ++|+||||+.||+|.-.+++-+++.+..+..++..|+-||-|||++||++||||.+||+++.+|++||+|||+++.  +.
T Consensus       424 RLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKE--ni  501 (683)
T KOG0696|consen  424 RLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKE--NI  501 (683)
T ss_pred             heeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccc--cc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999873  33


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL  247 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (344)
                      .......+.||||.|+|||++...+| +.++|+||+|++||||+.|++||++.+..++++.|...+..+|+.+|.++.++
T Consensus       502 ~~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~i  580 (683)
T KOG0696|consen  502 FDGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAI  580 (683)
T ss_pred             cCCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHH
Confidence            45556778999999999999998887 78999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCcCCCCC-----HhhhhcCccccc
Q 019216          248 LRKILEPNPVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       248 i~~~L~~dP~~Rps-----~~eil~~~~~~~  273 (344)
                      .+.+|.+.|.+|..     -++|..||||+.
T Consensus       581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             HHHHhhcCCccccCCCCccccchhhCcchhh
Confidence            99999999999975     367999999973

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-46  Score=352.43  Aligned_cols=254  Identities=24%  Similarity=0.381  Sum_probs=207.8

Q ss_pred             ccccCeEEeeeecccCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      +...+|++++.||+|+||.||+|...  .++..||+|.+...        ....+|+.+++.++||||+++++++.....
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~  160 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKST  160 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCE
Confidence            34467999999999999999999764  45678999987543        234579999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      .+++||++. ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       161 ~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~  239 (392)
T PHA03207        161 VCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP  239 (392)
T ss_pred             EEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence            999999994 6898988777889999999999999999999999999999999999999999999999999987543322


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH---HHHHHHHhh--------------
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFR--------------  231 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~---~~~~~~i~~--------------  231 (344)
                      .........||+.|+|||++....+ +.++|||||||++|+|++|+.||.+...   ......+..              
T Consensus       240 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        240 DTPQCYGWSGTLETNSPELLALDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             ccccccccccccCccCHhHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            2222335679999999999987776 5889999999999999999999965431   111111110              


Q ss_pred             ---------------CCCCCC-----CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          232 ---------------GDFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       232 ---------------~~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                                     .....|     ..++.++.++|.+||..||++|||+.++|+||||.+.
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~  381 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE  381 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence                           001111     1246788999999999999999999999999999763

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.9e-46  Score=369.98  Aligned_cols=265  Identities=28%  Similarity=0.463  Sum_probs=218.1

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee--C
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--K   86 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~   86 (344)
                      ....+++|++++.||+|+||+||+|.++.++..||+|++..... .......+..|+.+++.++||||++++++|..  .
T Consensus         8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~   86 (1021)
T PTZ00266          8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN   86 (1021)
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence            34678999999999999999999999999999999999865433 33446778899999999999999999998854  4


Q ss_pred             CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeecCCCCcEEEccC-----
Q 019216           87 SKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK-------GVFHRDLKLENILLDSK-----  150 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~-------~i~H~dikp~NILl~~~-----  150 (344)
                      ..+|+||||+++++|.+++..    .+.+++..++.|+.||+.||.|||+.       +|+||||||+||||+.+     
T Consensus        87 ~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg  166 (1021)
T PTZ00266         87 QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIG  166 (1021)
T ss_pred             CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccc
Confidence            578999999999999998865    35799999999999999999999985       49999999999999642     


Q ss_pred             ------------CCeEEeccccccCCCcccCCCccccccCCCcccchhhhccC-CCCCccchhhhhhHHHHHHHhCCCCC
Q 019216          151 ------------GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPF  217 (344)
Q Consensus       151 ------------~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~ll~ell~g~~pf  217 (344)
                                  +.+||+|||++.....   ........||+.|+|||++.+. ...+.++|||||||++|+|++|+.||
T Consensus       167 ~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF  243 (1021)
T PTZ00266        167 KITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF  243 (1021)
T ss_pred             cccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCC
Confidence                        3489999999875422   2223445799999999998643 33468999999999999999999999


Q ss_pred             CCccHHHHHHHHhhCCCCCC-CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          218 DDRNLAVLYQKIFRGDFKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       218 ~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      ...+..............+| ...++++.+||..||+.+|.+||++.++|.|+|+.....+
T Consensus       244 ~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~p  304 (1021)
T PTZ00266        244 HKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGPP  304 (1021)
T ss_pred             CcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCCC
Confidence            86554433333333333333 4578999999999999999999999999999999865443

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-48  Score=344.37  Aligned_cols=261  Identities=30%  Similarity=0.466  Sum_probs=232.7

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..++.+.|+.-++||+|+||.||-+..+.+|+.+|+|.+.+.++....-....++|-.+|.+++.+.||.+-..|++.+.
T Consensus       180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~  259 (591)
T KOG0986|consen  180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA  259 (591)
T ss_pred             hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence            45778889999999999999999999999999999999877665544445567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           89 IYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      +++||..|+||+|.-+|.+.+  .+++..++.++.+|+.||.+||+.+||+||+||+|||+|+.|+++|+|+|+|...  
T Consensus       260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei--  337 (591)
T KOG0986|consen  260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEI--  337 (591)
T ss_pred             eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEec--
Confidence            999999999999988887655  7999999999999999999999999999999999999999999999999999843  


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc----HHHHHHHHhhCCCCCCCCCCH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSP  242 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~  242 (344)
                       .........+||.+|||||++.+..| +...|+|||||++|||+.|+.||....    .+++-+++......+|+.+|+
T Consensus       338 -~~g~~~~~rvGT~GYMAPEvl~ne~Y-~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~  415 (591)
T KOG0986|consen  338 -PEGKPIRGRVGTVGYMAPEVLQNEVY-DFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSE  415 (591)
T ss_pred             -CCCCccccccCcccccCHHHHcCCcc-cCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCH
Confidence             34445556699999999999998886 688999999999999999999997633    345666777778889999999


Q ss_pred             HHHHHHHHhcCCCcCCCCC-----HhhhhcCccccc
Q 019216          243 GAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps-----~~eil~~~~~~~  273 (344)
                      +++++.+.+|++||++|..     ++++.+||||+.
T Consensus       416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~  451 (591)
T KOG0986|consen  416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKD  451 (591)
T ss_pred             HHHHHHHHHHccCHHHhccCCCcCcchhhhCccccc
Confidence            9999999999999999975     678999999985

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.3e-46  Score=334.16  Aligned_cols=255  Identities=29%  Similarity=0.447  Sum_probs=212.2

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++.+.||+|++|.||+|.++.+|+.||+|.+..... .....+.+.+|+.+++.++|+|++++++++......++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence            579999999999999999999999999999998864421 2223456788999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||+++++|..++.....+++..++.++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........  ..
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~  157 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DY  157 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cc
Confidence            9999988887776667799999999999999999999999999999999999999999999999999875432111  12


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC-------------------CC
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------DF  234 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~-------------------~~  234 (344)
                      ....++..|+|||.+.+....+.++||||||+++|+|++|+.||.+.+.......+...                   ..
T Consensus       158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07847         158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL  237 (286)
T ss_pred             cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence            23457889999999876555578999999999999999999999876654333222110                   00


Q ss_pred             CCC------------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          235 KLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       235 ~~~------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      ..|            ..++..+.+|+.+||+.||++|||+.+++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            001            2357889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=6.8e-46  Score=335.07  Aligned_cols=260  Identities=25%  Similarity=0.447  Sum_probs=220.8

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      ..+....+|++++.||+|++|.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++|+|++++++.+....
T Consensus        14 ~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~   90 (296)
T cd06654          14 SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD   90 (296)
T ss_pred             ccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCC
Confidence            355677899999999999999999999999999999999865432   23467889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ..++||||+++++|.+++.+ ..+++.++..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus        91 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~  169 (296)
T cd06654          91 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  169 (296)
T ss_pred             EEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence            99999999999999998864 56899999999999999999999999999999999999999999999999988743221


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC---CCCCCCCCCHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGA  244 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~  244 (344)
                        ........+++.|+|||.+.+... +.++|||||||++|+|++|+.||...+.......+...   ....+..+++.+
T Consensus       170 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  246 (296)
T cd06654         170 --QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF  246 (296)
T ss_pred             --ccccCcccCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHH
Confidence              111233468899999999887665 68999999999999999999999877654433333222   223456688999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          245 QNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .+++.+||..||++|||+.++++|+||...
T Consensus       247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence            999999999999999999999999999764

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-46  Score=335.35  Aligned_cols=257  Identities=30%  Similarity=0.448  Sum_probs=220.2

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      .++|++++.||.|++|.||+|.+..++..+|+|.+...   .....+.+.+|+.++++++||||+++++.+......++|
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL   80 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence            45799999999999999999999889999999998543   334456788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |||+++++|.+++.+ ...+++..++.++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......  ..
T Consensus        81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~  158 (280)
T cd06611          81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ  158 (280)
T ss_pred             eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence            999999999998876 356999999999999999999999999999999999999999999999999987643221  11


Q ss_pred             ccccccCCCcccchhhhccC----CCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC---CCCCCCCHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGA  244 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~  244 (344)
                      ......++..|+|||.+...    ...+.++|+||||+++|+|++|+.||.+.+......++.....   ..+..++..+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSF  238 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHH
Confidence            22345688999999997532    2235689999999999999999999988776666666655532   3456689999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          245 QNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .++|.+||+.+|.+||++.++++|+||.+.
T Consensus       239 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         239 NDFLKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence            999999999999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.8e-46  Score=335.42  Aligned_cols=249  Identities=18%  Similarity=0.222  Sum_probs=212.2

Q ss_pred             ccCeEEe--eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee----C
Q 019216           13 LGRYELG--RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----K   86 (344)
Q Consensus        13 ~~~y~~~--~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~   86 (344)
                      ..+++..  ..||+|++|.||+|..  +|+.||+|.+.+.........+.+.+|+.+|++++||||+++++++.+    .
T Consensus        17 ~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~   94 (283)
T PHA02988         17 SDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL   94 (283)
T ss_pred             HHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCC
Confidence            3344444  6799999999999997  688999999976554444556788899999999999999999999876    4


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~-~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      ..+++||||+++|+|.+++.+.+.+++.....++.|++.||.|||+. +++||||||+|||++.++.+||+|||++....
T Consensus        95 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~  174 (283)
T PHA02988         95 PRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILS  174 (283)
T ss_pred             CceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhc
Confidence            57899999999999999999888899999999999999999999985 99999999999999999999999999987432


Q ss_pred             cccCCCccccccCCCcccchhhhccC-CCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CCCCCCCCCH
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSP  242 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~  242 (344)
                      .     ......++..|+|||++.+. ...+.++|||||||++|||++|+.||.+.+.......+...  .+.+|..+++
T Consensus       175 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  249 (283)
T PHA02988        175 S-----PPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPL  249 (283)
T ss_pred             c-----ccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcH
Confidence            2     12245688999999998752 23468999999999999999999999988877777777544  4455667899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+.+++.+||+.||++|||+.++++.
T Consensus       250 ~l~~li~~cl~~dp~~Rps~~ell~~  275 (283)
T PHA02988        250 EIKCIVEACTSHDSIKRPNIKEILYN  275 (283)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            99999999999999999999999863

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-48  Score=327.15  Aligned_cols=253  Identities=34%  Similarity=0.623  Sum_probs=217.7

Q ss_pred             cccCeEEe-eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEe----e
Q 019216           12 RLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA----S   85 (344)
Q Consensus        12 ~~~~y~~~-~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~----~   85 (344)
                      ..++|++- ++||-|-.|.|-.+.++.+|+.+|+|++.-.        ....+|+++--.. .|||||.++++|+    .
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~  130 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQG  130 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence            44566654 6799999999999999999999999998532        4566788775444 5999999999985    3


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC---CCeEEecccc
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGL  160 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~---~~vkl~Dfg~  160 (344)
                      ..++.+|||.++||.|++.++.++.  +++.++..|++||..|+.|||+.+|.||||||+|+|....   ..+||+|||+
T Consensus       131 rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGF  210 (400)
T KOG0604|consen  131 RKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGF  210 (400)
T ss_pred             ceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEeccccc
Confidence            4678899999999999999997665  9999999999999999999999999999999999999654   4699999999


Q ss_pred             ccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc----HHHHHHHHhhCCCCC
Q 019216          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKL  236 (344)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~----~~~~~~~i~~~~~~~  236 (344)
                      |+...   ......+.|-|++|.|||++....| +..+|+||+|+++|-|++|.+||....    ...+..+|..+.+.+
T Consensus       211 AK~t~---~~~~L~TPc~TPyYvaPevlg~eKy-dkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~F  286 (400)
T KOG0604|consen  211 AKETQ---EPGDLMTPCFTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEF  286 (400)
T ss_pred             ccccC---CCccccCCcccccccCHHHhCchhc-CCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccC
Confidence            98543   2445678899999999999887777 588999999999999999999996543    345678888898888


Q ss_pred             CCC----CCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          237 PKW----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       237 ~~~----~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      |..    +|..++++|+.+|..+|.+|.|+.++++|||..+...
T Consensus       287 P~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~  330 (400)
T KOG0604|consen  287 PEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEA  330 (400)
T ss_pred             CChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccccc
Confidence            743    7999999999999999999999999999999987543

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2e-46  Score=333.16  Aligned_cols=257  Identities=27%  Similarity=0.416  Sum_probs=214.8

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|+++...   ......+.+|+.+++.++||||+++++.+.....
T Consensus         4 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~   80 (267)
T cd06645           4 RRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDK   80 (267)
T ss_pred             ccCcHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCE
Confidence            3455678999999999999999999999999999999986542   2234567889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      .+++|||+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.....  
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--  158 (267)
T cd06645          81 LWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--  158 (267)
T ss_pred             EEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC--
Confidence            999999999999999998888999999999999999999999999999999999999999999999999999864322  


Q ss_pred             CCCccccccCCCcccchhhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC-----CCCC
Q 019216          169 DDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-----KWLS  241 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-----~~~~  241 (344)
                      .........|+..|+|||.+..  ....+.++|+|||||++|+|++|..||...................+     ..++
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06645         159 TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWS  238 (267)
T ss_pred             cccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCC
Confidence            1122234578999999999742  22236789999999999999999999866544333333322222211     2367


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcCcc
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKADEW  270 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~~~  270 (344)
                      ..+.++|.+||+.+|++|||++++++|||
T Consensus       239 ~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         239 NSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            89999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.4e-46  Score=337.27  Aligned_cols=253  Identities=29%  Similarity=0.472  Sum_probs=208.1

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      +|++.+.||+|++|.||+|.++.+|+.||+|.+..... .......+.+|+.++++++||||+++++++.+....++++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            69999999999999999999999999999999865422 22234567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        95 ~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      |+. ++|.+.+.+ .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......  ....
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~--~~~~  156 (284)
T cd07839          80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCY  156 (284)
T ss_pred             cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCC--CCCc
Confidence            996 578887764 567999999999999999999999999999999999999999999999999998743321  1122


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCC-CCccHHHHHHHHhhCC-------------------
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGD-------------------  233 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf-~~~~~~~~~~~i~~~~-------------------  233 (344)
                      ....++..|+|||.+.+....+.++|||||||++|+|++|..|| .+.+.......+....                   
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP  236 (284)
T ss_pred             CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence            33467889999999877655578999999999999999988875 4444444333332110                   


Q ss_pred             C----------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          234 F----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       234 ~----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      .          .....+++.+.+||.+||+.||.+|||+++++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            0          0112368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3e-46  Score=334.86  Aligned_cols=255  Identities=25%  Similarity=0.376  Sum_probs=217.0

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCC-----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      +.+++|++.+.||+|+||.||+|.+...+     ..||+|.+....  .......+.+|+.++++++||||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   79 (283)
T cd05048           2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK   79 (283)
T ss_pred             CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcC
Confidence            56789999999999999999999976555     689999886432  23445678899999999999999999999998


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc
Q 019216           86 KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS  149 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~  149 (344)
                      ....+++|||+++++|.+++...                ..+++..+..++.|++.||.|||++|++||||||+||++++
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~  159 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGE  159 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcC
Confidence            88999999999999999998754                45788999999999999999999999999999999999999


Q ss_pred             CCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHH
Q 019216          150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK  228 (344)
Q Consensus       150 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~  228 (344)
                      ++.+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|||++ |..||.+.+.......
T Consensus       160 ~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05048         160 GLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKF-TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcC-chhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999874322111112233456788999999877665 689999999999999998 9999998887777777


Q ss_pred             HhhCC-CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          229 IFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       229 i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +..+. ...|..+++++.+|+.+||+.||.+||++.+++++
T Consensus       239 i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         239 IRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            66553 34567799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.4e-46  Score=330.08  Aligned_cols=248  Identities=35%  Similarity=0.688  Sum_probs=219.8

Q ss_pred             ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCCCh
Q 019216           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL  101 (344)
Q Consensus        22 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~~L  101 (344)
                      ||.|++|.||+|.+..+++.+|+|++.+.........+.+.+|+.+++.++||||+++++.+..+...+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            79999999999999999999999999876555445567899999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCc
Q 019216          102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN  181 (344)
Q Consensus       102 ~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~  181 (344)
                      .+++.+...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++......   .......++..
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~---~~~~~~~~~~~  157 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSG---QKTWTFCGTPE  157 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcc---cccccccCCcC
Confidence            999988888999999999999999999999999999999999999999999999999998754321   12234578899


Q ss_pred             ccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc--HHHHHHHHh--hCCCCCCCCCCHHHHHHHHHhcCCCcC
Q 019216          182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIF--RGDFKLPKWLSPGAQNLLRKILEPNPV  257 (344)
Q Consensus       182 y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~--~~~~~~~i~--~~~~~~~~~~~~~~~~li~~~L~~dP~  257 (344)
                      |+|||.+.+..+ +.++|+||||+++|+|++|..||....  ......++.  ......|...++.+.++|.+||+.+|+
T Consensus       158 ~~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~  236 (262)
T cd05572         158 YVAPEIILNKGY-DFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE  236 (262)
T ss_pred             ccChhHhcCCCC-CChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence            999999877665 588999999999999999999998766  566666666  445667777899999999999999999


Q ss_pred             CCCC-----HhhhhcCccccc
Q 019216          258 KRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       258 ~Rps-----~~eil~~~~~~~  273 (344)
                      +||+     ++|+++||||.+
T Consensus       237 ~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         237 ERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             hCcCCcccCHHHHhcChhhhC
Confidence            9999     999999999975

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.2e-46  Score=331.87  Aligned_cols=255  Identities=29%  Similarity=0.414  Sum_probs=212.7

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      ...++|++.+.||+|+||.||+|.++.+++.||+|++.....   .....+.+|+.++++++||||+++++++......+
T Consensus         6 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~   82 (267)
T cd06646           6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLW   82 (267)
T ss_pred             CchhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEE
Confidence            345789999999999999999999999999999999864322   23456788999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      +||||+++++|.+++...+++++..+..++.|++.||.|||+.||+||||+|+||+++.++.+||+|||++.....  ..
T Consensus        83 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~--~~  160 (267)
T cd06646          83 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA--TI  160 (267)
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc--cc
Confidence            9999999999999998888899999999999999999999999999999999999999999999999999874321  11


Q ss_pred             CccccccCCCcccchhhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCC-----CCCCCHH
Q 019216          171 GLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL-----PKWLSPG  243 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~-----~~~~~~~  243 (344)
                      .......++..|+|||.+..  ....+.++|+|||||++|+|++|+.||...........+.......     +..++..
T Consensus       161 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (267)
T cd06646         161 AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST  240 (267)
T ss_pred             cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence            11234568889999998742  2223578999999999999999999997654433332222222221     2346889


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCcc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEW  270 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~  270 (344)
                      +.+|+++||+.+|++|||++++++|+|
T Consensus       241 ~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         241 FHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.4e-46  Score=333.50  Aligned_cols=257  Identities=34%  Similarity=0.638  Sum_probs=228.6

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv   92 (344)
                      ++|.+.+.||+|++|.||+|.+..+|+.||+|++.+...........+.+|..+++++. ||||+++++++......+++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            47999999999999999999999999999999997655544455677889999999998 99999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC--
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD--  170 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~--  170 (344)
                      ||++.+++|.+++.+.+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.........  
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            999999999999998888999999999999999999999999999999999999999999999999998754332110  


Q ss_pred             ----------------CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC
Q 019216          171 ----------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF  234 (344)
Q Consensus       171 ----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~  234 (344)
                                      .......++..|+|||.+..... +.++|+||||++++++++|+.||...+.....+.+.....
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~  239 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY  239 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence                            12223467889999999877654 6889999999999999999999998887777777777788


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCH----hhhhcCccc
Q 019216          235 KLPKWLSPGAQNLLRKILEPNPVKRITI----AGIKADEWF  271 (344)
Q Consensus       235 ~~~~~~~~~~~~li~~~L~~dP~~Rps~----~eil~~~~~  271 (344)
                      .+|..+++.+.++|.+||+.+|++|||+    +++++||||
T Consensus       240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            8888899999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=7e-46  Score=329.17  Aligned_cols=256  Identities=29%  Similarity=0.476  Sum_probs=218.3

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++.+.||.|++|+||+|.+..++..+|+|++.......  ....+.+|+.+++.++|+|++++++.+......+++|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   78 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM   78 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence            47999999999999999999998999999999986543322  5678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           94 EYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        94 e~~~g~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      |++++++|.+++.+.   ..+++..+..++.|++.||++||+.|++||||+|+||++++++.++|+|||++.........
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            999999999999764   45899999999999999999999999999999999999999999999999998754332221


Q ss_pred             --CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC-CC-----CCCCH
Q 019216          171 --GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP-----KWLSP  242 (344)
Q Consensus       171 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~-----~~~~~  242 (344)
                        .......++..|+|||++......+.++|+||||+++|+|++|+.||...+......+....... ++     ..+++
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK  238 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence              12234568899999999877644578999999999999999999999887665555555444321 11     24688


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      .+.+++.+||+.||++|||+.++++||||
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         239 SFRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            99999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.5e-46  Score=341.66  Aligned_cols=255  Identities=21%  Similarity=0.360  Sum_probs=206.0

Q ss_pred             Eeeeeccc--CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 019216           18 LGRTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (344)
Q Consensus        18 ~~~~Lg~G--~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~   95 (344)
                      ++++||+|  +|++||++.++.+|+.||+|.+..... .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            57889999  788999999999999999999865432 234456788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC----
Q 019216           96 VTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD----  169 (344)
Q Consensus        96 ~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~----  169 (344)
                      +++++|.+++..  ...+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+..........    
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            999999999865  34589999999999999999999999999999999999999999999999986542211100    


Q ss_pred             -CCccccccCCCcccchhhhccC-CCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC------------
Q 019216          170 -DGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------------  235 (344)
Q Consensus       170 -~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~------------  235 (344)
                       ........++..|+|||++.+. ...+.++|||||||++|+|++|+.||..............+..+            
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence             0011223567789999998753 23468899999999999999999999865543333222221110            


Q ss_pred             ----------------------------------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          236 ----------------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       236 ----------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                                                        ....+++.+.+||++||+.||++|||++++++||||++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence                                              11235778999999999999999999999999999976

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=9.6e-46  Score=328.82  Aligned_cols=256  Identities=30%  Similarity=0.506  Sum_probs=214.6

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCccceeeEEee--CCeEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIY   90 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~   90 (344)
                      .|++.+.||+|+||.||+|.+..++..||+|.+.....  ...+....+.+|+.+++.++||||+++++++..  ...++
T Consensus         3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (266)
T cd06651           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT   82 (266)
T ss_pred             CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence            68899999999999999999999999999998864432  123345678899999999999999999998865  46789


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc-C
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR-D  169 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~-~  169 (344)
                      +++||+++++|.+.+.+.+.+++..++.++.|++.||+|||+.+++||||+|+||+++.++.+||+|||++....... .
T Consensus        83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd06651          83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS  162 (266)
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence            999999999999999887889999999999999999999999999999999999999999999999999987543211 1


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CCCCCCCCCHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNL  247 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~l  247 (344)
                      ........++..|+|||.+.+..+ +.++|||||||++|+|++|+.||...............  ...+|..+++.+.++
T Consensus       163 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (266)
T cd06651         163 GTGIRSVTGTPYWMSPEVISGEGY-GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF  241 (266)
T ss_pred             CCccccCCccccccCHHHhCCCCC-CchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence            112233467889999999887665 68899999999999999999999876544444333322  345567789999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhcCcccc
Q 019216          248 LRKILEPNPVKRITIAGIKADEWFE  272 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~~~~~~  272 (344)
                      + +||..+|++||+++++++||||+
T Consensus       242 i-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         242 L-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             H-HHhcCChhhCcCHHHHhcCcccc
Confidence            9 67778999999999999999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.5e-46  Score=340.08  Aligned_cols=247  Identities=32%  Similarity=0.470  Sum_probs=193.6

Q ss_pred             eeeecccCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee--CCeEEEEEe
Q 019216           19 GRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIYMVLE   94 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~iv~e   94 (344)
                      .++||+|+||.||+|.++  .+++.||+|.+.....     ...+.+|+.++++++||||+++++++..  ...++++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            468999999999999975  4678999998864322     2456789999999999999999998854  457899999


Q ss_pred             ccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE----ccCCCeEEeccccc
Q 019216           95 YVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLS  161 (344)
Q Consensus        95 ~~~g~~L~~~l~~~---------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl----~~~~~vkl~Dfg~a  161 (344)
                      |+. ++|.+++...         ..+++..++.++.||+.||.|||+.||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07868          81 YAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             ccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence            994 5888877532         258999999999999999999999999999999999999    45578999999999


Q ss_pred             cCCCccc-CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH---------HHHHHHhh
Q 019216          162 ALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------VLYQKIFR  231 (344)
Q Consensus       162 ~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~---------~~~~~i~~  231 (344)
                      +...... .........||+.|+|||++.+....+.++||||+||++|+|++|++||.+....         .....+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07868         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN  239 (317)
T ss_pred             eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence            7543221 1122345678999999999887655578999999999999999999999653311         11111111


Q ss_pred             C----------------------------CCC----------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          232 G----------------------------DFK----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       232 ~----------------------------~~~----------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      .                            ...          .....+..+.+||.+||+.||.+|||++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0                            000          001135678999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=7.6e-46  Score=329.12  Aligned_cols=255  Identities=29%  Similarity=0.468  Sum_probs=215.9

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc---chhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      +|++.+.||+|+||.||+|.+ .+++.+|+|.+......   .......+.+|+.+++.++|+||+++++++......++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence            588999999999999999986 57889999988643221   22345678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc---
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR---  168 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~---  168 (344)
                      ++||+++++|.+++.+.+++++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++.......   
T Consensus        80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  159 (265)
T cd06631          80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG  159 (265)
T ss_pred             EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence            99999999999999887889999999999999999999999999999999999999999999999999887432111   


Q ss_pred             -CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC---CCCCCCCCCHHH
Q 019216          169 -DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGA  244 (344)
Q Consensus       169 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~  244 (344)
                       .........++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.......+...   ....+..++..+
T Consensus       160 ~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (265)
T cd06631         160 THSNMLKSMHGTPYWMAPEVINESGY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA  238 (265)
T ss_pred             cccccccccCCCccccChhhhcCCCC-cchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence             1112234568899999999877665 58899999999999999999999876554443333332   234667789999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          245 QNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      .++|++||+.+|++||++.++++||||
T Consensus       239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         239 IDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9.6e-46  Score=334.12  Aligned_cols=259  Identities=27%  Similarity=0.472  Sum_probs=221.1

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      .+....+|++.+.||.|++|.||+|.+..+++.||+|.+....   ....+.+.+|+.+++.++|||++++++++.....
T Consensus        14 ~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   90 (296)
T cd06655          14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGDE   90 (296)
T ss_pred             cCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCce
Confidence            3445567999999999999999999999999999999986433   2235678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      .++|+||+++++|.+++.. ..+++.++..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++...... 
T Consensus        91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~-  168 (296)
T cd06655          91 LFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE-  168 (296)
T ss_pred             EEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc-
Confidence            9999999999999988865 46899999999999999999999999999999999999999999999999988743321 


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC---CCCCCCCCCHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQ  245 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~  245 (344)
                       ........++..|+|||.+.+..+ +.++|||||||++|+|++|+.||.+.+.......+...   ....+..+++.+.
T Consensus       169 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (296)
T cd06655         169 -QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFR  246 (296)
T ss_pred             -cccCCCcCCCccccCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHH
Confidence             112233568889999999877665 58899999999999999999999887765544444333   2334566899999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          246 NLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ++|++||..||.+|||+.+++.||||+..
T Consensus       247 ~li~~~l~~dp~~Rpt~~~il~~~~~~~~  275 (296)
T cd06655         247 DFLNRCLEMDVEKRGSAKELLQHPFLKLA  275 (296)
T ss_pred             HHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence            99999999999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.1e-45  Score=326.29  Aligned_cols=253  Identities=30%  Similarity=0.593  Sum_probs=220.1

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+...... ......+.+|+.++++++||||+++++++......++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            699999999999999999999999999999998654332 2345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        95 ~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |+.+++|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......  ..
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~  157 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--EL  157 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hh
Confidence            999999999887543  57899999999999999999999999999999999999999999999999987543211  11


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-CCCCCCCHHHHHHHHHh
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKI  251 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~  251 (344)
                      .....|+..|+|||.+.+... +.++|+|||||++++|++|+.||...+.......+..+.. ..+..++.++.++|.+|
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  236 (256)
T cd08218         158 ARTCIGTPYYLSPEICENRPY-NNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL  236 (256)
T ss_pred             hhhccCCccccCHHHhCCCCC-CCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence            223457889999999877665 6789999999999999999999988777777766666543 46677899999999999


Q ss_pred             cCCCcCCCCCHhhhhcCccc
Q 019216          252 LEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       252 L~~dP~~Rps~~eil~~~~~  271 (344)
                      |+.+|++||++.++++||||
T Consensus       237 l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         237 FKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             hhCChhhCcCHHHHhhCcCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.5e-46  Score=334.84  Aligned_cols=255  Identities=29%  Similarity=0.431  Sum_probs=212.9

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.+.+..... ...+.+.+|+.+++.++||||+++++++......++||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence            47999999999999999999999999999999886543222 34567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||+++++|.++......+++..++.++.|++.||+|||+.|++||||+|+||++++++.++|+|||++......  ....
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~  157 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVY  157 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--cccc
Confidence            99999888887766667999999999999999999999999999999999999999999999999998753221  1222


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC-------------------CC
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------DF  234 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~-------------------~~  234 (344)
                      ....++..|+|||++.+....+.++||||||+++|+|++|++||...........+...                   ..
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07846         158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM  237 (286)
T ss_pred             CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence            33567889999999876555568899999999999999999999766543333222210                   00


Q ss_pred             C------------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          235 K------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       235 ~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      .            ....++..+.+|+.+||+.+|++||++.++++|+||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            0            123468899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-45  Score=329.27  Aligned_cols=257  Identities=31%  Similarity=0.500  Sum_probs=214.7

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc-------chhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-------HLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      +|.+.+.||.|++|.||+|.+..+|+.+|+|.++.....       .....+.+.+|+.+++.++|||++++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            688999999999999999999999999999988642211       1123457888999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ..++||||+++++|.+++.+.+.+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  161 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI  161 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999998754322


Q ss_pred             cCCCccccccCCCcccchhhhccCC-CCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CCCCC----CCC
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP----KWL  240 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~----~~~  240 (344)
                      ..........++..|+|||.+.... ..+.++|+||||+++|++++|..||...........+...  ...++    ..+
T Consensus       162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (272)
T cd06629         162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL  241 (272)
T ss_pred             ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence            2222233456888999999987654 2468899999999999999999999765554433333222  22223    236


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      +..+.++|.+||+.+|++|||++++++|||+
T Consensus       242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         242 SPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            8899999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.1e-45  Score=331.12  Aligned_cols=254  Identities=28%  Similarity=0.449  Sum_probs=216.3

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~   95 (344)
                      |++.+.||+|+||.||+|.+..++..+++|.+....   ....+.+.+|+.+++.++|||++++++.+..+...++||||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            788999999999999999999999999999885432   34456788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccc
Q 019216           96 VTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (344)
Q Consensus        96 ~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~  174 (344)
                      +++++|...+.+ ..++++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....  ......
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~~~~~~  161 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRRD  161 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc--cccccc
Confidence            999999887764 56799999999999999999999999999999999999999999999999999864322  112233


Q ss_pred             cccCCCcccchhhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC---CCCCCCCCHHHHHH
Q 019216          175 TTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNL  247 (344)
Q Consensus       175 ~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~l  247 (344)
                      ...++..|+|||.+..    ....+.++|||||||++|+|++|++||...+.......+....   ...|..++..+.++
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDF  241 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHH
Confidence            4578899999999742    2223578999999999999999999998877665555554432   23456689999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          248 LRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      |.+||+.||.+||++.++++||||...
T Consensus       242 i~~~l~~~p~~Rp~~~~il~~~~~~~~  268 (282)
T cd06643         242 LKKCLEKNVDARWTTTQLLQHPFVTVN  268 (282)
T ss_pred             HHHHccCChhhCcCHHHHhcCCCEecc
Confidence            999999999999999999999999864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.6e-46  Score=334.94  Aligned_cols=262  Identities=26%  Similarity=0.442  Sum_probs=220.6

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      ..+-..++|++++.||+|++|.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++|+|++++++.+....
T Consensus        13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~   89 (297)
T cd06656          13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGD   89 (297)
T ss_pred             ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            345566899999999999999999999999999999999865432   23466889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ..++||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~  168 (297)
T cd06656          90 ELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE  168 (297)
T ss_pred             EEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence            99999999999999998865 56899999999999999999999999999999999999999999999999998743221


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC---CCCCCCCCCHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGA  244 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~  244 (344)
                        ........+++.|+|||.+.+..+ +.++|+|||||++|+|++|+.||.+.+.......+...   ....+..+++.+
T Consensus       169 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (297)
T cd06656         169 --QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVF  245 (297)
T ss_pred             --ccCcCcccCCccccCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHH
Confidence              112234568889999999887665 68999999999999999999999876543332222222   223456688999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      .+|+.+||+.+|++||++.++++||||+....
T Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~  277 (297)
T cd06656         246 RDFLNRCLEMDVDRRGSAKELLQHPFLKLAKP  277 (297)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence            99999999999999999999999999986433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-46  Score=331.20  Aligned_cols=255  Identities=25%  Similarity=0.456  Sum_probs=220.5

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++.+.||.|++|.||+|.+..+++.||+|.+....  .......+.+|+.+++.++|+|++++++.+..+...++|+
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM   78 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence            57999999999999999999999999999999986442  2334567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||+++++|.+++... ++++..++.++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++.......  ...
T Consensus        79 e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~  155 (274)
T cd06609          79 EYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKR  155 (274)
T ss_pred             EeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--ccc
Confidence            999999999998765 78999999999999999999999999999999999999999999999999987543321  223


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-CCCCCC-CCHHHHHHHHHh
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKW-LSPGAQNLLRKI  251 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~-~~~~~~~li~~~  251 (344)
                      ....++..|+|||.+.+..+ +.++||||||+++|+|++|+.||...+.......+.... ...+.. +++.+.+++.+|
T Consensus       156 ~~~~~~~~y~~PE~~~~~~~-~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  234 (274)
T cd06609         156 NTFVGTPFWMAPEVIKQSGY-DEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLC  234 (274)
T ss_pred             ccccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHH
Confidence            34568889999999887665 689999999999999999999998776655555554443 333444 789999999999


Q ss_pred             cCCCcCCCCCHhhhhcCcccccc
Q 019216          252 LEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       252 L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      |..+|++|||++++++||||...
T Consensus       235 l~~~p~~Rpt~~~il~~~~~~~~  257 (274)
T cd06609         235 LNKDPKERPSAKELLKHKFIKKA  257 (274)
T ss_pred             hhCChhhCcCHHHHhhChhhcCC
Confidence            99999999999999999999764

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.9e-46  Score=351.21  Aligned_cols=250  Identities=24%  Similarity=0.324  Sum_probs=203.0

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|....         ..+.+|++++++++|+||+++++++...+..++|
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv  238 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV  238 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence            4589999999999999999999999999999996421         2356899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      ||++ .++|.+++... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus       239 ~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~  317 (461)
T PHA03211        239 LPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTP  317 (461)
T ss_pred             EEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccc
Confidence            9999 46888887653 469999999999999999999999999999999999999999999999999987543222222


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC-c-------cHHHHHHHHhhCCC---CC----
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-R-------NLAVLYQKIFRGDF---KL----  236 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~-~-------~~~~~~~~i~~~~~---~~----  236 (344)
                      ......||..|+|||++.+..+ +.++|||||||++|||++|..|+-. .       ....+...+.....   .+    
T Consensus       318 ~~~~~~GT~~Y~APE~~~~~~~-~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        318 FHYGIAGTVDTNAPEVLAGDPY-TPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             cccccCCCcCCcCHHHHcCCCC-CchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            2234579999999999988776 6899999999999999998755421 1       11222222221110   00    


Q ss_pred             ----------------------CC-----CCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          237 ----------------------PK-----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       237 ----------------------~~-----~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                                            +.     .+++.+.+||.+||+.||.+|||+.|+|+||||+.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence                                  00     24568999999999999999999999999999974

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-48  Score=355.33  Aligned_cols=255  Identities=27%  Similarity=0.434  Sum_probs=226.2

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      +-|.|+..||.|+||.||+|.++.++-..|.|++..   ...+.++.+.-||.||..++||+|+++++.|..++.++|+.
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIet---kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwili  108 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIET---KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILI  108 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcc---cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEE
Confidence            457899999999999999999999999999999853   34567889999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |||.||-....+-. ...+++.++..+++|++.||.|||+.+|||||||..|||++.+|.++|+|||.+.....  ....
T Consensus       109 EFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t~qk  186 (1187)
T KOG0579|consen  109 EFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--TRQK  186 (1187)
T ss_pred             eecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--HHhh
Confidence            99999988776654 56799999999999999999999999999999999999999999999999998764222  2233


Q ss_pred             cccccCCCcccchhhhcc-----CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC---CCCCCCHHH
Q 019216          173 LHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGA  244 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~  244 (344)
                      ..+++|||+|||||++..     .+| ..++||||||++|.||..+.+|....+.....-+|....++   -|+.++..+
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PY-DykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F  265 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSF  265 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCc-hhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHH
Confidence            467899999999998753     444 58999999999999999999999999999988888887655   367799999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          245 QNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .+++.+||.+||..||+++++|+|||+.+.
T Consensus       266 ~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~  295 (1187)
T KOG0579|consen  266 SDFLKRCLVKNPRNRPPAAQLLKHPFVQNA  295 (1187)
T ss_pred             HHHHHHHHhcCCccCCCHHHHhhCcccccC
Confidence            999999999999999999999999999854

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=9e-46  Score=331.48  Aligned_cols=249  Identities=29%  Similarity=0.459  Sum_probs=205.9

Q ss_pred             eecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHH---hCCCCCccceeeEEeeCCeEEEEEeccC
Q 019216           21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK---LLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (344)
Q Consensus        21 ~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~---~l~h~niv~l~~~~~~~~~~~iv~e~~~   97 (344)
                      .||+|+||.||+|.+..+++.+|+|.+.+.............+|..+++   ...|||++.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999987654332222233444544444   3479999999999998899999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcccccc
Q 019216           98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC  177 (344)
Q Consensus        98 g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~  177 (344)
                      +++|.+++...+.+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.....    .......
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~  156 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV  156 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc----cCccCcC
Confidence            999999998888899999999999999999999999999999999999999999999999999864322    1223357


Q ss_pred             CCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCC
Q 019216          178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP  254 (344)
Q Consensus       178 gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~  254 (344)
                      |+..|+|||.+......+.++||||+||++|+|++|..||....   ..............+|..+++++.++|.+||+.
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  236 (279)
T cd05633         157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR  236 (279)
T ss_pred             CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence            89999999998654434688999999999999999999996532   233333333445667788999999999999999


Q ss_pred             CcCCCC-----CHhhhhcCccccc
Q 019216          255 NPVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       255 dP~~Rp-----s~~eil~~~~~~~  273 (344)
                      ||++||     |+.++++||||+.
T Consensus       237 ~p~~R~~~~~~~~~~~~~h~~~~~  260 (279)
T cd05633         237 DVSKRLGCLGRGAQEVKEHVFFKG  260 (279)
T ss_pred             CHHHhcCCCCCCHHHHHhCccccC
Confidence            999999     6999999999976

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1.1e-45  Score=332.88  Aligned_cols=257  Identities=26%  Similarity=0.410  Sum_probs=217.2

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .-+.|+++++||+|+||.||+|.+..+++.+|+|.+...   .......+.+|+.+++.++|||++++++.+..+...++
T Consensus        10 ~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   86 (292)
T cd06644          10 PNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWI   86 (292)
T ss_pred             cchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEE
Confidence            346799999999999999999999999999999998643   34456778899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      ||||+++++|..++.+ ...+++..+..++.|++.+|.|||+.|++||||||+||+++.++.+||+|||++.....  ..
T Consensus        87 v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~--~~  164 (292)
T cd06644          87 MIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK--TL  164 (292)
T ss_pred             EEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc--cc
Confidence            9999999999887754 45789999999999999999999999999999999999999999999999998764221  11


Q ss_pred             CccccccCCCcccchhhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC---CCCCCCCHH
Q 019216          171 GLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPG  243 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~  243 (344)
                      .......++..|+|||.+..    ....+.++|||||||++|+|++|..||...+......++.....   ..+..++.+
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSME  244 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHH
Confidence            12234567889999998753    22235789999999999999999999987766555555544322   235568899


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      +.++|.+||+.||++||++.++++||||..
T Consensus       245 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~  274 (292)
T cd06644         245 FRDFLKTALDKHPETRPSAAQLLEHPFVSS  274 (292)
T ss_pred             HHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            999999999999999999999999999965

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.5e-45  Score=334.71  Aligned_cols=263  Identities=31%  Similarity=0.448  Sum_probs=215.8

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC--Ce
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SK   88 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~   88 (344)
                      ..+++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.++++++|+|++++++++...  +.
T Consensus         4 ~~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (309)
T cd07845           4 RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDS   82 (309)
T ss_pred             ccccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCe
Confidence            357899999999999999999999999999999999864432 122233566799999999999999999998654  56


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      +++||||+. ++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus        83 ~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          83 IFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            899999996 488888775 367899999999999999999999999999999999999999999999999998754321


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC---------------
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---------------  232 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~---------------  232 (344)
                      .  .......++..|+|||.+.+....+.++|||||||++|+|++|++||.+.+.......+...               
T Consensus       162 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07845         162 A--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL  239 (309)
T ss_pred             c--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc
Confidence            1  11223345788999999876555578999999999999999999999988776666555431               


Q ss_pred             ----CCCCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          233 ----DFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       233 ----~~~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                          ....+           ...++.+.+||.+||+.||++|||+.+++.||||++...+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         240 PLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             cccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence                11111           1258899999999999999999999999999999865554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.3e-45  Score=334.36  Aligned_cols=254  Identities=24%  Similarity=0.349  Sum_probs=205.0

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECC----------------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLD----------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP   74 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   74 (344)
                      +..++|++.++||+|+||.||+|.+..                ++..||+|++....  .......+.+|+.++++++||
T Consensus         2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~   79 (304)
T cd05096           2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDP   79 (304)
T ss_pred             CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCC
Confidence            456899999999999999999998532                34579999986532  233456788999999999999


Q ss_pred             CccceeeEEeeCCeEEEEEeccCCCChHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 019216           75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------------------RLQEAEGRKLFQQLIDGVSYCHNKGV  135 (344)
Q Consensus        75 niv~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~-------------------~~~~~~~~~i~~ql~~~L~~LH~~~i  135 (344)
                      ||+++++++......++||||+.+++|.+++....                   .+++..+..++.||+.||.|||+.||
T Consensus        80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i  159 (304)
T cd05096          80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNF  159 (304)
T ss_pred             CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCc
Confidence            99999999999999999999999999999886432                   35778899999999999999999999


Q ss_pred             eeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh--C
Q 019216          136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--G  213 (344)
Q Consensus       136 ~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~--g  213 (344)
                      +||||||+|||++.++.+||+|||++................++..|+|||++....+ +.++||||||+++|+|++  +
T Consensus       160 vH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         160 VHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKF-TTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             cccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCC-CchhhhHHHHHHHHHHHHccC
Confidence            9999999999999999999999999874322111111223345788999999877665 689999999999999986  6


Q ss_pred             CCCCCCccHHHHHHHHhh---C-----CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          214 YLPFDDRNLAVLYQKIFR---G-----DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       214 ~~pf~~~~~~~~~~~i~~---~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ..||.+.+.......+..   .     ....|..+++.+.+|+.+||+.||++|||+.++.+
T Consensus       239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            778877655444433221   1     12335568899999999999999999999999953

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.2e-45  Score=331.31  Aligned_cols=255  Identities=32%  Similarity=0.484  Sum_probs=214.4

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      +|++.+.||.|++|.||+|.+..+|+.||+|++...... ......+.+|+.++++++|||++++++++......++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            699999999999999999999999999999998754322 2345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           95 YVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        95 ~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      |+ +++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........ ...
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~  157 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLY  157 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-Ccc
Confidence            99 9999998864 45689999999999999999999999999999999999999999999999999875433211 123


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-------------------C
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------------F  234 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-------------------~  234 (344)
                      ....++..|+|||.+.+....+.++||||||+++|+|++|.+||.+.........+....                   .
T Consensus       158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T cd07832         158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI  237 (286)
T ss_pred             ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence            345788999999998766555789999999999999999999998766554443333210                   0


Q ss_pred             C-----------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccc
Q 019216          235 K-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE  272 (344)
Q Consensus       235 ~-----------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~  272 (344)
                      .           .....+..+.+||++||+.||.+|||++++++||||.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            0           0123578999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-47  Score=351.37  Aligned_cols=251  Identities=29%  Similarity=0.486  Sum_probs=216.9

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG   99 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~   99 (344)
                      -.||+|.||+||.|+|..+...+|||.+...   +.+..+-+..||.+-++|+|.||+++.|.+..++++-|.||-++||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            3699999999999999999999999998543   2345677899999999999999999999999999999999999999


Q ss_pred             ChHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc-CCCeEEeccccccCCCcccCCCcccc
Q 019216          100 ELFDKIAS-KGRL--QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHT  175 (344)
Q Consensus       100 ~L~~~l~~-~~~~--~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~  175 (344)
                      +|.++++. .+++  .+..+-.+.+||++||.|||++.|+|||||-+|+||+. .|.+||+|||-++.+..  ......+
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TET  735 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTET  735 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCccccc
Confidence            99999985 5777  78889999999999999999999999999999999975 58899999998886543  3345667


Q ss_pred             ccCCCcccchhhhcc-CCCCCccchhhhhhHHHHHHHhCCCCCCCc-cHHHHHHH--HhhCCCCCCCCCCHHHHHHHHHh
Q 019216          176 TCGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQK--IFRGDFKLPKWLSPGAQNLLRKI  251 (344)
Q Consensus       176 ~~gt~~y~aPE~~~~-~~~~~~~~DvwslG~ll~ell~g~~pf~~~-~~~~~~~~--i~~~~~~~~~~~~~~~~~li~~~  251 (344)
                      +.||.-|||||++.. ...++.++|||||||++.||.||++||... +......+  +++..+++|..++.+++.||.+|
T Consensus       736 FTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc  815 (1226)
T KOG4279|consen  736 FTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC  815 (1226)
T ss_pred             cccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence            889999999999864 334478999999999999999999999642 23332222  33456788999999999999999


Q ss_pred             cCCCcCCCCCHhhhhcCccccccC
Q 019216          252 LEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       252 L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      +.+||.+||++.++|.+||++...
T Consensus       816 Fepd~~~R~sA~~LL~DpFlq~~~  839 (1226)
T KOG4279|consen  816 FEPDPCDRPSAKDLLQDPFLQHNN  839 (1226)
T ss_pred             cCCCcccCccHHHhccCcccccCC
Confidence            999999999999999999998763

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.3e-45  Score=324.02  Aligned_cols=252  Identities=31%  Similarity=0.505  Sum_probs=219.2

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      +|++.+.||+|++|.||+|.+..+++.+|+|.+...... ......+.+|+.++++++|||++++++.+......++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            699999999999999999999999999999998765432 3446788999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC-CeEEeccccccCCCcccCCC
Q 019216           95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        95 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~-~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |+++++|.+++...  ..+++..+..++.|++.+|+|||++|++|+||+|+||+++.++ .+||+|||++.....   ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~---~~  156 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSS---KS  156 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCC---Cc
Confidence            99999999999763  3589999999999999999999999999999999999998655 579999999875432   12


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-CCCCCCCCHHHHHHHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRK  250 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~  250 (344)
                      ......++..|+|||.+.+... +.++||||||+++|+|++|+.||.+.+.......+.... .+++..+++.+.+++.+
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  235 (256)
T cd08220         157 KAYTVVGTPCYISPELCEGKPY-NQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS  235 (256)
T ss_pred             cccccccCCcccCchhccCCCC-CcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence            2234568889999999877655 688999999999999999999999887766666665543 45677789999999999


Q ss_pred             hcCCCcCCCCCHhhhhcCccc
Q 019216          251 ILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       251 ~L~~dP~~Rps~~eil~~~~~  271 (344)
                      ||+.+|++|||+.++++|||+
T Consensus       236 ~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         236 MLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HccCChhhCCCHHHHhhCCCC
Confidence            999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-45  Score=325.18  Aligned_cols=252  Identities=30%  Similarity=0.479  Sum_probs=215.9

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      .++|++.+.||.|++|.||+|.+..+++.+|+|++.....   ...+.+.+|+.++++++||||+++++.+.....++++
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~   78 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV   78 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence            4689999999999999999999999999999999865432   2467889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |||+.+++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......  ..
T Consensus        79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~  156 (262)
T cd06613          79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IA  156 (262)
T ss_pred             EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh--hh
Confidence            9999999999988765 78999999999999999999999999999999999999999999999999998743321  11


Q ss_pred             ccccccCCCcccchhhhccC---CCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC-----CCCCCCHH
Q 019216          172 LLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSPG  243 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~  243 (344)
                      ......++..|+|||.+...   .+ +.++|+||||+++|+|++|+.||.+.+.......+......     .+..++.+
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~~~~-~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (262)
T cd06613         157 KRKSFIGTPYWMAPEVAAVERKGGY-DGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV  235 (262)
T ss_pred             ccccccCCccccCchhhcccccCCc-CchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence            22345688899999998765   44 57899999999999999999999887655544444443222     23346788


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCcc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEW  270 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~  270 (344)
                      +.+++++||..+|.+|||+.+++.|+|
T Consensus       236 ~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         236 FHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=9.4e-46  Score=328.81  Aligned_cols=257  Identities=28%  Similarity=0.486  Sum_probs=215.9

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc---chhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~---~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      +|+..+.||+|++|.||+|.+..+++.||+|++......   .....+.+.+|+.++++++|+||+++++++...+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            588899999999999999999999999999998643321   12346788999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC-CeEEeccccccCCCcccC-
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRD-  169 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~-~vkl~Dfg~a~~~~~~~~-  169 (344)
                      ||||++|++|.+++.+.+++++..+..++.|++.||.|||++|++|+||+|+||+++.++ .+||+|||.+........ 
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~  160 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG  160 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence            999999999999998888899999999999999999999999999999999999998876 599999999875433211 


Q ss_pred             -CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHH---HHh--hCCCCCCCCCCHH
Q 019216          170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ---KIF--RGDFKLPKWLSPG  243 (344)
Q Consensus       170 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~---~i~--~~~~~~~~~~~~~  243 (344)
                       ........++..|+|||.+.+..+ +.++|+||||+++|+|++|..||..........   .+.  ......|..++++
T Consensus       161 ~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         161 AGEFQGQLLGTIAFMAPEVLRGEQY-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             CCccccccccccceeCHhHhccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence             111223467889999999877665 688999999999999999999997544322222   221  2234566778999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCcccc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWFE  272 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~~  272 (344)
                      +.+++.+||+.+|++|||+.++++||||+
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            99999999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.5e-45  Score=324.02  Aligned_cols=254  Identities=33%  Similarity=0.511  Sum_probs=218.5

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +|+..+.||+|++|.||+|.+..++..|++|.+.....  ...+..+.+.+|+.+++.++|+||+++++++.....++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            58888999999999999999988999999999865332  2234567889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      +||+++++|.+++.+.+.+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++.......   .
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~  157 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F  157 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence            9999999999999888889999999999999999999999999999999999999999999999999987543211   2


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhh--CCCCCCCCCCHHHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKWLSPGAQNLLRK  250 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~li~~  250 (344)
                      .....++..|+|||.+......+.++|+||||+++|+|++|+.||...........+..  ....++..+++.+.+++.+
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  237 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK  237 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence            34566889999999987655246889999999999999999999977654444444333  2344567789999999999


Q ss_pred             hcCCCcCCCCCHhhhhcCccc
Q 019216          251 ILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       251 ~L~~dP~~Rps~~eil~~~~~  271 (344)
                      ||+.+|++||++.+++.|||+
T Consensus       238 ~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         238 CLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.7e-45  Score=329.67  Aligned_cols=250  Identities=24%  Similarity=0.396  Sum_probs=209.7

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      .+|++++.||+|+||.||+|.+..+++.||+|.+....  .......+.+|+.++++++||||+++++.+......++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   78 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT   78 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence            36889999999999999999999999999999986542  2334567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||+++++|..+    ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++.....    ...
T Consensus        79 e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~  150 (279)
T cd06619          79 EFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIA  150 (279)
T ss_pred             ecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----ccc
Confidence            99999998644    3578999999999999999999999999999999999999999999999999874321    223


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH-------HHHHHHHhhCC-CCC-CCCCCHHH
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-------AVLYQKIFRGD-FKL-PKWLSPGA  244 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~-------~~~~~~i~~~~-~~~-~~~~~~~~  244 (344)
                      ....++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||.....       ......+.... ... ....++++
T Consensus       151 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (279)
T cd06619         151 KTYVGTNAYMAPERISGEQY-GIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF  229 (279)
T ss_pred             cCCCCChhhcCceeecCCCC-CCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence            34678999999999887665 6899999999999999999999965221       12222222222 122 23478899


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          245 QNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .+++.+||+.+|++||+++++++||||.+.
T Consensus       230 ~~li~~~l~~~P~~Rp~~~eil~~~~~~~~  259 (279)
T cd06619         230 VHFITQCMRKQPKERPAPENLMDHPFIVQY  259 (279)
T ss_pred             HHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence            999999999999999999999999999764

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.4e-45  Score=328.49  Aligned_cols=253  Identities=27%  Similarity=0.406  Sum_probs=210.4

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEee------
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS------   85 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~------   85 (344)
                      -|+|++.+.||+|+||.||+|.+..+++.||+|.+....    .....+.+|+.+++++ +|+|++++++.+..      
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~   80 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM   80 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence            478999999999999999999999999999999986543    2235678899999998 69999999999864      


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           86 KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      ...+|++|||+.+++|.+++...  ..+++..+..++.|++.||+|||+++|+||||||+||++++++.++|+|||++..
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~  160 (272)
T cd06637          81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ  160 (272)
T ss_pred             CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence            24689999999999999998763  4689999999999999999999999999999999999999999999999999875


Q ss_pred             CCcccCCCccccccCCCcccchhhhccC----CCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC--CCC
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--KLP  237 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~  237 (344)
                      ....  ........|+..|+|||++...    ...+.++|||||||++|+|++|+.||...........+.....  ..+
T Consensus       161 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd06637         161 LDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS  238 (272)
T ss_pred             cccc--cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCC
Confidence            4321  1223446789999999998632    2235789999999999999999999977655444444333221  123


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      ..++..+.+|+.+||..||.+|||+.+++.||||
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         239 KKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            4578999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.1e-46  Score=345.78  Aligned_cols=254  Identities=25%  Similarity=0.414  Sum_probs=207.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEe
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA   84 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~   84 (344)
                      ...++|++.+.||+|+||.||+|.+...     +..||+|.+....  .......+.+|+.+++.+ +|+||+++++.+.
T Consensus        35 ~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~  112 (374)
T cd05106          35 FPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACT  112 (374)
T ss_pred             ccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEec
Confidence            4566899999999999999999986443     4579999986543  223456788999999999 8999999999999


Q ss_pred             eCCeEEEEEeccCCCChHHHHHhc--------------------------------------------------------
Q 019216           85 SKSKIYMVLEYVTGGELFDKIASK--------------------------------------------------------  108 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~~--------------------------------------------------------  108 (344)
                      .....++|||||++|+|.+++...                                                        
T Consensus       113 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (374)
T cd05106         113 HGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSS  192 (374)
T ss_pred             CCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccc
Confidence            999999999999999999988542                                                        


Q ss_pred             --------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccc
Q 019216          109 --------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (344)
Q Consensus       109 --------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~  174 (344)
                                    .++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++............
T Consensus       193 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~  272 (374)
T cd05106         193 QSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKG  272 (374)
T ss_pred             ccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeecc
Confidence                          246788899999999999999999999999999999999999999999999987432211111111


Q ss_pred             cccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC--CCCCCCCCCHHHHHHHHHh
Q 019216          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKI  251 (344)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~  251 (344)
                      ...++..|+|||++.+..+ +.++|||||||++|+|++ |+.||...............  ....|..+++++.+++.+|
T Consensus       273 ~~~~~~~y~aPE~~~~~~~-~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  351 (374)
T cd05106         273 NARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC  351 (374)
T ss_pred             CCCCccceeCHHHhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence            2234567999999877665 689999999999999997 99999876544333333333  3445667899999999999


Q ss_pred             cCCCcCCCCCHhhhhc
Q 019216          252 LEPNPVKRITIAGIKA  267 (344)
Q Consensus       252 L~~dP~~Rps~~eil~  267 (344)
                      |+.||++|||+.++++
T Consensus       352 l~~dp~~RPs~~~l~~  367 (374)
T cd05106         352 WNLEPTERPTFSQISQ  367 (374)
T ss_pred             cCCChhhCcCHHHHHH
Confidence            9999999999999876

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=4.6e-45  Score=322.32  Aligned_cols=253  Identities=30%  Similarity=0.499  Sum_probs=221.2

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      +|++++.||.|+||.||.+++..+++.+++|.+...... ......+.+|+.++++++|+||+++++++......+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            699999999999999999999999999999998654332 3445678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           95 YVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        95 ~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |+++++|.+.+.+.  ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.......  ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~  157 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM  157 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence            99999999999764  468999999999999999999999999999999999999999999999999987543211  12


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC-CCCCCCHHHHHHHHHh
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKI  251 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~  251 (344)
                      .....+++.|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+..+... .+..++..+.+++.+|
T Consensus       158 ~~~~~~~~~y~ape~~~~~~~-~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  236 (256)
T cd08221         158 AETVVGTPYYMSPELCQGVKY-NFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL  236 (256)
T ss_pred             ccccCCCccccCHhhcCCCCC-CCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence            334568999999999877665 57899999999999999999999988877777777666443 3456789999999999


Q ss_pred             cCCCcCCCCCHhhhhcCccc
Q 019216          252 LEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       252 L~~dP~~Rps~~eil~~~~~  271 (344)
                      |..+|++|||+.++++|+|+
T Consensus       237 l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         237 LQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             cccCcccCCCHHHHhhCcCC
Confidence            99999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-45  Score=331.57  Aligned_cols=257  Identities=26%  Similarity=0.441  Sum_probs=216.6

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|.+....  .......+.+|+.++++++||||+++++.+......++||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM   78 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence            47899999999999999999999999999999886432  2334567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           94 EYVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        94 e~~~g~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      ||+++++|.+++...   ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.+||+|||++....    
T Consensus        79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~----  154 (286)
T cd06622          79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV----  154 (286)
T ss_pred             eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc----
Confidence            999999998888763   378999999999999999999997 599999999999999999999999999987432    


Q ss_pred             CCccccccCCCcccchhhhccCCC-----CCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHH---HhhC-CCCCCCCC
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGY-----DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK---IFRG-DFKLPKWL  240 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~---i~~~-~~~~~~~~  240 (344)
                      ........++..|+|||.+.+...     .+.++|+|||||++|+|++|+.||...........   +..+ ....+..+
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (286)
T cd06622         155 ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY  234 (286)
T ss_pred             CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence            122334568889999999865332     35789999999999999999999976554433322   2222 34566778


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      ++++.++|.+||+.+|++||++.++++||||.....
T Consensus       235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~  270 (286)
T cd06622         235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN  270 (286)
T ss_pred             CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence            999999999999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.1e-46  Score=343.92  Aligned_cols=249  Identities=27%  Similarity=0.398  Sum_probs=200.7

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      ....+|++++.||+|+||.||+|.+..++..||+|+..+.         ....|+.++++++||||+++++++......+
T Consensus        63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  133 (357)
T PHA03209         63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITC  133 (357)
T ss_pred             hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeE
Confidence            4456799999999999999999999999999999975432         2346899999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +|||++. ++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....   
T Consensus       134 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---  209 (357)
T PHA03209        134 MVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---  209 (357)
T ss_pred             EEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---
Confidence            9999995 588888764 45799999999999999999999999999999999999999999999999999874321   


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhC-CCCCCCccHH---------HHHHHHhhC----CCC
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLA---------VLYQKIFRG----DFK  235 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g-~~pf~~~~~~---------~~~~~i~~~----~~~  235 (344)
                      ........||..|+|||++.+..+ +.++|||||||++|+|+++ ..+|......         .....+...    ...
T Consensus       210 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  288 (357)
T PHA03209        210 APAFLGLAGTVETNAPEVLARDKY-NSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE  288 (357)
T ss_pred             CcccccccccccccCCeecCCCCC-CchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh
Confidence            122334578999999999887776 6899999999999999985 4444431110         011111110    000


Q ss_pred             CC------------------------------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          236 LP------------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       236 ~~------------------------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      ++                              ..++.++.+||.+||+.||++|||+.|+|+||||++
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        289 FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             cCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            11                              124667788999999999999999999999999975

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=8.3e-46  Score=345.10  Aligned_cols=254  Identities=28%  Similarity=0.431  Sum_probs=206.4

Q ss_pred             cccCeEEeeeecccCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEee
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS   85 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~   85 (344)
                      ..++|++.+.||+|+||.||+|++     ..++..||+|+++...  .....+.+.+|+.+++.+ +||||+++++++..
T Consensus        33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~  110 (375)
T cd05104          33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTV  110 (375)
T ss_pred             chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence            455899999999999999999974     3456789999986432  223456788999999999 79999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC--------------------------------------------------------
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKG--------------------------------------------------------  109 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~--------------------------------------------------------  109 (344)
                      ....++|||||++|+|.+++....                                                        
T Consensus       111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  190 (375)
T cd05104         111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR  190 (375)
T ss_pred             CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence            999999999999999999886421                                                        


Q ss_pred             -------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216          110 -------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus       110 -------------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                                         .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.........
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                               4678889999999999999999999999999999999999999999999998754321111


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHH-HHHHhhC-CCCCCCCCCHHHHHH
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL-YQKIFRG-DFKLPKWLSPGAQNL  247 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~-~~~i~~~-~~~~~~~~~~~~~~l  247 (344)
                      .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+...... ...+..+ ....|...+.++.+|
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~-~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  349 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDI  349 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCC-CCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHH
Confidence            11122334567999999887665 689999999999999998 9999987654333 3333332 233456678999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhcC
Q 019216          248 LRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~~  268 (344)
                      +.+||+.||++|||+.++++.
T Consensus       350 i~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         350 MKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5e-45  Score=323.93  Aligned_cols=257  Identities=31%  Similarity=0.501  Sum_probs=215.4

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCccceeeEEee--CCeE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKI   89 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~   89 (344)
                      ..|++.+.||+|+||.||.|.+..++..||+|.+.....  ......+.+.+|+.++++++||||+++++++.+  ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            479999999999999999999999999999998864322  223446788999999999999999999998865  3568


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +++|||+++++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~  161 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL  161 (265)
T ss_pred             EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence            89999999999999998877899999999999999999999999999999999999999999999999999875432111


Q ss_pred             -CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CCCCCCCCCHHHHH
Q 019216          170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQN  246 (344)
Q Consensus       170 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~  246 (344)
                       ........++..|+|||.+.+..+ +.++|||||||++|+|++|+.||...........+...  ....|..++..+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (265)
T cd06652         162 SGTGMKSVTGTPYWMSPEVISGEGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD  240 (265)
T ss_pred             cccccccCCCCccccChhhhcCCCC-CcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence             112233568889999999877665 68999999999999999999999876554444444332  23456678889999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhcCcccc
Q 019216          247 LLRKILEPNPVKRITIAGIKADEWFE  272 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~~~~~~  272 (344)
                      +|++||. +|++||+++++++|||+.
T Consensus       241 ~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         241 FLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            9999995 999999999999999974

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.7e-45  Score=322.23  Aligned_cols=249  Identities=33%  Similarity=0.569  Sum_probs=216.4

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      +|++.+.||+|+||.||++.++.+++.+|+|.++....  ....+.+.+|+.+++.++|+|++++++.+.....++++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            68999999999999999999999999999999864432  2345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        95 ~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |+++++|.+++..  ...+++..+..++.|++.||.+||++|++|+||||+||++++++.++|+|||++.....  ....
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~--~~~~  156 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS--PGAY  156 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecc--cccc
Confidence            9999999998864  34589999999999999999999999999999999999999999999999999874322  1112


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-CCCCCCCHHHHHHHHHh
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKI  251 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~  251 (344)
                      .....++..|+|||++.+..+ +.++|+||||+++|+|++|+.||...+.......+..+.. +.+..++..+.++|.+|
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  235 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPY-NNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM  235 (255)
T ss_pred             cccccCCccccCHHHHccCCc-CchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence            234568889999999877665 6899999999999999999999998887777666665543 45677899999999999


Q ss_pred             cCCCcCCCCCHhhhhcC
Q 019216          252 LEPNPVKRITIAGIKAD  268 (344)
Q Consensus       252 L~~dP~~Rps~~eil~~  268 (344)
                      |+.||++|||+.+++..
T Consensus       236 l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         236 FKRNPRSRPSATTILSR  252 (255)
T ss_pred             HhCCcccCCCHHHHhhc
Confidence            99999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.2e-45  Score=328.79  Aligned_cols=250  Identities=29%  Similarity=0.447  Sum_probs=209.3

Q ss_pred             eecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHH---HHHHhCCCCCccceeeEEeeCCeEEEEEeccC
Q 019216           21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI---ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (344)
Q Consensus        21 ~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~---~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~   97 (344)
                      .||+|+||.||+|.+..+++.||+|.+.+..............|.   ..++...||+|+.+++.+...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            489999999999999999999999998765433222222233343   34455679999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcccccc
Q 019216           98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC  177 (344)
Q Consensus        98 g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~  177 (344)
                      |++|.+++.+.+.+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||++.....    .......
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----~~~~~~~  156 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV  156 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----cCCcCcC
Confidence            999999998888899999999999999999999999999999999999999999999999999874322    1223457


Q ss_pred             CCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc---cHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCC
Q 019216          178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP  254 (344)
Q Consensus       178 gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~  254 (344)
                      |+..|+|||.+.+....+.++||||+|+++|+|++|+.||.+.   ...............+|..+++.+.+++.+||..
T Consensus       157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~  236 (278)
T cd05606         157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR  236 (278)
T ss_pred             CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence            8999999999875543468899999999999999999999875   3344444455556677888899999999999999


Q ss_pred             CcCCCC-----CHhhhhcCcccccc
Q 019216          255 NPVKRI-----TIAGIKADEWFEQD  274 (344)
Q Consensus       255 dP~~Rp-----s~~eil~~~~~~~~  274 (344)
                      +|++||     ++.++++||||...
T Consensus       237 ~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         237 DVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             CHHhccCCCCCCHHHHHhCccccCC
Confidence            999999     99999999999763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.5e-45  Score=325.36  Aligned_cols=252  Identities=22%  Similarity=0.320  Sum_probs=212.0

Q ss_pred             cccCeEEeeeecccCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ...+|++.+.||+|+||.||+|.++   ..+..||+|.++...  .......+.+|+.++++++||||+++++++.....
T Consensus         3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   80 (266)
T cd05064           3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT   80 (266)
T ss_pred             chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence            4568999999999999999999865   456789999986542  23345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .++||||+++++|.+++... ..+++..++.++.|++.||+|||++|++||||||+|||++.++.+|++|||.+......
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999999988763 57899999999999999999999999999999999999999999999999987642211


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ  245 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~  245 (344)
                       .........++..|+|||.+.+..+ +.++|||||||++|++++ |+.||.+.+.......+..+ ..+.|..++..+.
T Consensus       161 -~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (266)
T cd05064         161 -AIYTTMSGKSPVLWAAPEAIQYHHF-SSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH  238 (266)
T ss_pred             -chhcccCCCCceeecCHHHHhhCCc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence             1111112334678999999887666 689999999999999875 99999988777766666554 3456777899999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhc
Q 019216          246 NLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~  267 (344)
                      +++.+||+.+|.+|||++++++
T Consensus       239 ~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         239 QLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHcCCCchhCCCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.5e-45  Score=328.70  Aligned_cols=260  Identities=28%  Similarity=0.414  Sum_probs=215.1

Q ss_pred             hccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEee
Q 019216            7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS   85 (344)
Q Consensus         7 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~   85 (344)
                      ..-+...++|++.+.||+|+||.||+|.++.+++.+|+|++....    .....+.+|+.+++++ +|||++++++++..
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            344556789999999999999999999999999999999986432    2235677899999998 79999999999864


Q ss_pred             C-----CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEe
Q 019216           86 K-----SKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS  156 (344)
Q Consensus        86 ~-----~~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~  156 (344)
                      .     ...++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~  170 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV  170 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence            3     368999999999999988753    4568999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccCCCccccccCCCcccchhhhccCC----CCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC
Q 019216          157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG  232 (344)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~  232 (344)
                      |||++.......  .......++..|+|||.+....    ..+.++|||||||++|+|++|+.||...+.......+...
T Consensus       171 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~  248 (291)
T cd06639         171 DFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN  248 (291)
T ss_pred             ecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC
Confidence            999987533211  1123356888999999976433    1367899999999999999999999877665555555444


Q ss_pred             CC---CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccc
Q 019216          233 DF---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE  272 (344)
Q Consensus       233 ~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~  272 (344)
                      ..   ..+..++..+.++|.+||+.+|++||++.++++||||+
T Consensus       249 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         249 PPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             CCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            22   23455778999999999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.5e-45  Score=329.66  Aligned_cols=248  Identities=30%  Similarity=0.490  Sum_probs=212.2

Q ss_pred             ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCCCh
Q 019216           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL  101 (344)
Q Consensus        22 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~~L  101 (344)
                      ||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+++.++|||++++++++...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            69999999999999999999999998765433333455667899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCC
Q 019216          102 FDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS  179 (344)
Q Consensus       102 ~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt  179 (344)
                      .+++.+..  .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||.+.....   ........++
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~  157 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT  157 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence            99987655  689999999999999999999999999999999999999999999999998874322   2223345678


Q ss_pred             CcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH----HHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCC
Q 019216          180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN  255 (344)
Q Consensus       180 ~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~d  255 (344)
                      ..|+|||.+.+..+ +.++||||||+++|+|++|+.||.....    ......+.......+..+++.+.++|.+||+.|
T Consensus       158 ~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~  236 (277)
T cd05577         158 PGYMAPEVLQGEVY-DFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD  236 (277)
T ss_pred             CCcCCHHHhcCCCC-CchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence            89999999877664 6889999999999999999999976543    333333444455667778999999999999999


Q ss_pred             cCCCC-----CHhhhhcCccccc
Q 019216          256 PVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       256 P~~Rp-----s~~eil~~~~~~~  273 (344)
                      |++||     ++.++++||||..
T Consensus       237 p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         237 PEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             hhHccCCCcccHHHHHhChhhhc
Confidence            99999     8888999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.7e-45  Score=326.03  Aligned_cols=251  Identities=34%  Similarity=0.630  Sum_probs=220.8

Q ss_pred             ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCCCh
Q 019216           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL  101 (344)
Q Consensus        22 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~~L  101 (344)
                      ||+|+||.||+|.+..+|+.+|+|++.............+.+|++++++++||||+++++.+......|++|||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            68999999999999989999999998765544445667889999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC------CCcccc
Q 019216          102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD------DGLLHT  175 (344)
Q Consensus       102 ~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~------~~~~~~  175 (344)
                      .+++.+.+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++........      ......
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~  160 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR  160 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence            99998877899999999999999999999999999999999999999999999999999874322111      112233


Q ss_pred             ccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCC--CHHHHHHHHHhcC
Q 019216          176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL--SPGAQNLLRKILE  253 (344)
Q Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~li~~~L~  253 (344)
                      ..++..|+|||.+..... +.++||||||+++|++++|+.||...........+..+....+...  ++.+.+++++||+
T Consensus       161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  239 (265)
T cd05579         161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV  239 (265)
T ss_pred             cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence            467889999999877664 6889999999999999999999998888888888877777777665  9999999999999


Q ss_pred             CCcCCCCCH---hhhhcCccccc
Q 019216          254 PNPVKRITI---AGIKADEWFEQ  273 (344)
Q Consensus       254 ~dP~~Rps~---~eil~~~~~~~  273 (344)
                      .+|++|||+   .++++||||++
T Consensus       240 ~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         240 PDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             CCHhhcCCCccHHHHhcCccccC
Confidence            999999999   99999999974

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-49  Score=332.55  Aligned_cols=251  Identities=28%  Similarity=0.460  Sum_probs=219.7

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~   95 (344)
                      |+++++||+|+||.||+|.++.+|+.+|||.+...     ..+..+.+|+.++++++.|+++++|+.|.....+|+||||
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhh
Confidence            67899999999999999999999999999987543     3467899999999999999999999999999999999999


Q ss_pred             cCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccc
Q 019216           96 VTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (344)
Q Consensus        96 ~~g~~L~~~l~-~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~  174 (344)
                      |..|++.+.++ ++.++++.++..+++.-+.||+|||...-+|||||..|||++.+|.+||+|||.|.-+..  ......
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMAKRN  187 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMAKRN  187 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHHhhC
Confidence            99999999987 567899999999999999999999999999999999999999999999999999874322  122345


Q ss_pred             cccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC---CCCCCCCCHHHHHHHHHh
Q 019216          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRKI  251 (344)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~~  251 (344)
                      +..||+.|||||++..-+|+ .++||||||++..||..|++||.+-.+......|-...   +.-|..+|.++.++|+.|
T Consensus       188 TVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~C  266 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSC  266 (502)
T ss_pred             ccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHH
Confidence            67999999999999998886 67999999999999999999998766544333333222   234566899999999999


Q ss_pred             cCCCcCCCCCHhhhhcCcccccc
Q 019216          252 LEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       252 L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      |-+.|++|.|+.++++|+|.++.
T Consensus       267 LiK~PE~R~TA~~L~~H~FiknA  289 (502)
T KOG0574|consen  267 LIKKPEERKTALRLCEHTFIKNA  289 (502)
T ss_pred             hcCCHHHHHHHHHHhhhhhhcCC
Confidence            99999999999999999999753

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-48  Score=345.97  Aligned_cols=261  Identities=32%  Similarity=0.616  Sum_probs=244.9

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..+.+.+.+++.-||-|+||.|-++.-+.....+|+|++++..+.+.++.+++..|-++|..++.|+|+++|..|.+..+
T Consensus       415 a~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~ky  494 (732)
T KOG0614|consen  415 AQVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKY  494 (732)
T ss_pred             cccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchh
Confidence            56788899999999999999999999766666699999999888888899999999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +|+.||-|-||.|+..+..++.+.+..++.++..+++|++|||++|||+|||||+|.+++.+|.+||.|||+|+...   
T Consensus       495 vYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---  571 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---  571 (732)
T ss_pred             hhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc---
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999654   


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~  246 (344)
                      .+....++||||.|+|||++.+.+.+ .++|.||||+++|||++|++||.+.++..+++.|+++  .+.+|..++..+.+
T Consensus       572 ~g~KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~  650 (732)
T KOG0614|consen  572 SGRKTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATD  650 (732)
T ss_pred             cCCceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHH
Confidence            45567789999999999999999985 8999999999999999999999999999999999998  57889999999999


Q ss_pred             HHHHhcCCCcCCCCC-----HhhhhcCccccc
Q 019216          247 LLRKILEPNPVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       247 li~~~L~~dP~~Rps-----~~eil~~~~~~~  273 (344)
                      ||+++...+|.+|..     +.+|..|.||..
T Consensus       651 Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  651 LIKKLCRDNPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             HHHHHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence            999999999999986     889999999974

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.9e-45  Score=322.12  Aligned_cols=253  Identities=32%  Similarity=0.560  Sum_probs=218.9

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe--eCCeEEEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSKIYMV   92 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~iv   92 (344)
                      +|++++.||.|+||.||+|.+..+++.||+|.+..... .....+.+.+|+.+++.++||||+++++.+.  .....+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            58999999999999999999999999999999865433 3344577889999999999999999999775  34568999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCH-----NKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH-----~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      |||+++++|.+++..    ..++++..++.++.||+.||.+||     +.+++|+||+|+||+++.++.+||+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            999999999998875    457899999999999999999999     88999999999999999999999999999886


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-CCCCCCCH
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSP  242 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~  242 (344)
                      .....  .......++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.......+..+.. .++..++.
T Consensus       160 ~~~~~--~~~~~~~~~~~~~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (265)
T cd08217         160 LGHDS--SFAKTYVGTPYYMSPEQLNHMSY-DEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS  236 (265)
T ss_pred             ccCCc--ccccccccCCCccChhhhcCCCC-CchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence            43321  11234578999999999877665 6889999999999999999999998877766666666543 46677899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      .+.+++.+||+.+|++|||+.++++|||+
T Consensus       237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999995

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3.2e-45  Score=323.11  Aligned_cols=251  Identities=27%  Similarity=0.454  Sum_probs=215.1

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      -++|++.+.||.|++|.||+|.+..+++.+++|.+....     ....+.+|+.+++.++||||+++++.+......|++
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~   76 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE-----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIV   76 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH-----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEE
Confidence            368999999999999999999998889999999985432     157889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      +||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......  .
T Consensus        77 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~  154 (256)
T cd06612          77 MEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--A  154 (256)
T ss_pred             EecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--c
Confidence            999999999999875 4578999999999999999999999999999999999999999999999999987543211  1


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC---CCCCCCCCCHHHHHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLL  248 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li  248 (344)
                      ......++..|+|||++.+..+ +.++||||||+++|+|++|+.||...........+...   ....+..++..+.+++
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i  233 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGY-NNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFV  233 (256)
T ss_pred             ccccccCCccccCHHHHhcCCC-CchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHH
Confidence            2233457889999999887765 68899999999999999999999876554433333222   2233455788999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCccc
Q 019216          249 RKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      .+||+.||++|||+.++++||||
T Consensus       234 ~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         234 KKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             HHHHhcChhhCcCHHHHhcCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-45  Score=335.42  Aligned_cols=260  Identities=31%  Similarity=0.474  Sum_probs=209.6

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC-----Ce
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK   88 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~   88 (344)
                      ++|++.+.||+|++|.||+|.+..+|+.||+|.+...  ........+.+|+.++++++||||+++++++...     ..
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            6899999999999999999999999999999998532  2233456778899999999999999999887543     35


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      .++++||+. ++|.+.+.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus        83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~  160 (336)
T cd07849          83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH  160 (336)
T ss_pred             EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccc
Confidence            799999995 588777754 579999999999999999999999999999999999999999999999999987543221


Q ss_pred             C-CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhh---------------C
Q 019216          169 D-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR---------------G  232 (344)
Q Consensus       169 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~---------------~  232 (344)
                      . ........|+..|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+..               .
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (336)
T cd07849         161 DHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISL  240 (336)
T ss_pred             cccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhch
Confidence            1 11223457899999999876654447899999999999999999999977554332221110               0


Q ss_pred             -----------CCC-----CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          233 -----------DFK-----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       233 -----------~~~-----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                 ...     .....++.+.+++.+||+.||++|||+.++++||||++...+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         241 RARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             hhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCCC
Confidence                       000     012357889999999999999999999999999999976544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1e-44  Score=321.35  Aligned_cols=256  Identities=33%  Similarity=0.543  Sum_probs=216.7

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      ||++.+.||+|++|.||+|.+..+++.||+|.+...... ....+.+.+|+.+++.++|+||+++++++...+.+++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            699999999999999999999999999999998765432 3467889999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc--
Q 019216           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL--  172 (344)
Q Consensus        95 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~--  172 (344)
                      |+++++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++...........  
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            999999999998877799999999999999999999999999999999999999999999999999875433211111  


Q ss_pred             cccccCCCcccchhhhccCC--CCCccchhhhhhHHHHHHHhCCCCCCCcc-HHHHHHHHhh-CCCCCCCCC--CHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFR-GDFKLPKWL--SPGAQN  246 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~ll~ell~g~~pf~~~~-~~~~~~~i~~-~~~~~~~~~--~~~~~~  246 (344)
                      .....++..|+|||.+....  ..+.++||||||+++|++++|+.||.... .......+.. ....+|...  ++.+.+
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD  239 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence            22356788999999987654  23688999999999999999999997653 2222222222 233455544  899999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          247 LLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      +|++||+.+|.+|||+.+++.|||+
T Consensus       240 li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         240 FLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHccCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.8e-45  Score=326.41  Aligned_cols=254  Identities=30%  Similarity=0.464  Sum_probs=217.0

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++.+.||+|++|.||+|.++.+++.+|+|.+.....  ......+.+|+.++++++||||+++++.+......++++
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~   78 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM   78 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence            478899999999999999999999999999999865432  244567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        94 e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      ||+.+++|.+++... ..+++..+..++.|++.||+|||+ .|++|+||||+||+++.++.++|+|||.+......    
T Consensus        79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~----  154 (265)
T cd06605          79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS----  154 (265)
T ss_pred             EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH----
Confidence            999999999999875 789999999999999999999999 99999999999999999999999999988643221    


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc-----cHHHHHHHHhhC-CCCCCCC-CCHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRG-DFKLPKW-LSPGA  244 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~-----~~~~~~~~i~~~-~~~~~~~-~~~~~  244 (344)
                      ......++..|+|||.+.+..+ +.++||||||+++|+|++|+.||...     ......+.+... ....+.. +++.+
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06605         155 LAKTFVGTSSYMAPERIQGNDY-SVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF  233 (265)
T ss_pred             HhhcccCChhccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence            1112678889999999877665 68999999999999999999999654     233333444333 2334444 88999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          245 QNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .++|.+||..||++|||+.+++.||||+..
T Consensus       234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~  263 (265)
T cd06605         234 QDFVNLCLIKDPRERPSYKELLEHPFIKKY  263 (265)
T ss_pred             HHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence            999999999999999999999999999753

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.5e-45  Score=329.04  Aligned_cols=253  Identities=29%  Similarity=0.451  Sum_probs=209.4

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      .|++++.||.|++|.||+|.++.+|+.||+|.+..... .......+.+|++++++++||||+++++++......++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            48999999999999999999999999999998864332 22334578899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           95 YVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        95 ~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |+. ++|.+++..  ...+++..++.++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++......  ...
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~  156 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT  156 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence            995 588888864  356899999999999999999999999999999999999999999999999998743321  112


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC------------------C
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------------F  234 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~------------------~  234 (344)
                      .....++..|+|||.+.+....+.++||||||+++|+|+||+.||.+.+......++....                  .
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07860         157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP  236 (284)
T ss_pred             cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence            2334568899999988766655788999999999999999999998766544333322110                  0


Q ss_pred             C-----------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          235 K-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       235 ~-----------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      .           ....+++.++++|.+||+.||++|||++++++||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            0           112468899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-45  Score=324.90  Aligned_cols=254  Identities=30%  Similarity=0.444  Sum_probs=212.2

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCC---
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS---   87 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~---   87 (344)
                      ..++|++.+.||+|++|.||+|.++.+++.+++|++.....    ....+.+|+.+++++ .|+||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            35899999999999999999999999999999999865432    246788999999999 6999999999986543   


Q ss_pred             ---eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecccc
Q 019216           88 ---KIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (344)
Q Consensus        88 ---~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~  160 (344)
                         .++++|||+++++|.+++..    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||+
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~  159 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV  159 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence               58999999999999998864    35789999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCcccCCCccccccCCCcccchhhhccC----CCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC--
Q 019216          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--  234 (344)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~--  234 (344)
                      +......  ........++..|+|||.+...    ...+.++||||||+++|+|++|+.||...........+.....  
T Consensus       160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  237 (275)
T cd06608         160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT  237 (275)
T ss_pred             ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence            8643221  1222345688999999997542    2235789999999999999999999987665555555544422  


Q ss_pred             -CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          235 -KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       235 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                       ..+..++..+++||.+||..||++|||+.++++|||+
T Consensus       238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence             2233478899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-47  Score=345.32  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=224.6

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ..|.-++.||.|+||.||-|++..+.+.||||.+.-+.....+....+.+|++.|++++|||++.+.++|..+...|+||
T Consensus        26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM  105 (948)
T KOG0577|consen   26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM  105 (948)
T ss_pred             HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence            34666889999999999999999999999999998777777777889999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           94 EYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~-~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||| -|+-.|++. ...++-+.++..|+.+.+.||+|||+.+.||||||..|||+++.|.|||+|||.|.+...      
T Consensus       106 EYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------  178 (948)
T KOG0577|consen  106 EYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------  178 (948)
T ss_pred             HHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc------
Confidence            999 558888876 456799999999999999999999999999999999999999999999999999875433      


Q ss_pred             cccccCCCcccchhhhc--cCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC-CC-CCCCHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP-KWLSPGAQNLL  248 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~-~~~~~~~~~li  248 (344)
                      ..+++|||+|||||++.  ..+.++-++||||||++..||...++|+-+.+.......|..+..+ ++ ..+|..++.||
T Consensus       179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv  258 (948)
T KOG0577|consen  179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV  258 (948)
T ss_pred             hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence            46789999999999975  3333456899999999999999999998888877777777666543 33 34899999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          249 RKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      ..||++-|.+|||.+++|.|+|......
T Consensus       259 d~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  259 DSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             HHHHhhCcccCCcHHHHhhcchhccCCC
Confidence            9999999999999999999999865433

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-45  Score=328.29  Aligned_cols=256  Identities=29%  Similarity=0.455  Sum_probs=214.1

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++|++.+.||+|++|.||+|.+..+++.||+|.++.... .....+.+.+|+++++.++|+||+++++++...+..+++|
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence            589999999999999999999999999999998864322 2344578899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||++++.+..+..+...+++..++.++.|++.||.|||+.|++|+||+|+||++++++.+||+|||++........ ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~  158 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL  158 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence            9998877766666667799999999999999999999999999999999999999999999999999875433221 122


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC---------------------
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---------------------  232 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~---------------------  232 (344)
                      ....++..|+|||++.+....+.++||||||+++|+|++|+.||.+.+.......+...                     
T Consensus       159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07833         159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV  238 (288)
T ss_pred             cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence            34567889999999887744578999999999999999999999876544333222110                     


Q ss_pred             C-----------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          233 D-----------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       233 ~-----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      .           ...+..+++.+.+||++||..+|++|||++++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            0           01233458899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=6e-45  Score=330.44  Aligned_cols=261  Identities=27%  Similarity=0.405  Sum_probs=208.4

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC-
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-   87 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-   87 (344)
                      .+..+++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.++++++||||+++++++.... 
T Consensus         7 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   85 (310)
T cd07865           7 FCDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKAT   85 (310)
T ss_pred             ccchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEecccc
Confidence            34567899999999999999999999999999999998864332 2223345678999999999999999999886543 


Q ss_pred             -------eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccc
Q 019216           88 -------KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG  159 (344)
Q Consensus        88 -------~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg  159 (344)
                             ..++||||+. ++|.+.+... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg  164 (310)
T cd07865          86 PYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFG  164 (310)
T ss_pred             cccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCC
Confidence                   4599999995 5888877654 368999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccCC--CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--C--
Q 019216          160 LSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D--  233 (344)
Q Consensus       160 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~--  233 (344)
                      ++.........  .......++..|+|||.+.+....+.++||||||+++|+|++|+.||.+.+.......+..-  .  
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            98754322111  11223457888999999876554468899999999999999999999876654333222210  0  


Q ss_pred             ---------------CCCC-------------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          234 ---------------FKLP-------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       234 ---------------~~~~-------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                                     ..++             ...++.+.+||.+||..||.+|||++++++||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                           0111             1135778899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.8e-45  Score=327.45  Aligned_cols=259  Identities=27%  Similarity=0.428  Sum_probs=219.1

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++++.||+|+||+||+|.+..+|+.||+|++....  .....+.+.+|+++++.++||||+++++.+.....++
T Consensus         2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (284)
T cd06620           2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNIC   79 (284)
T ss_pred             ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEE
Confidence            45678999999999999999999999999999999886432  2344678899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++.....   
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~---  156 (284)
T cd06620          80 MCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN---  156 (284)
T ss_pred             EEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh---
Confidence            999999999999999887889999999999999999999997 5999999999999999999999999998764311   


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH-----------HHHHHHhhCC-CCCC
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-----------VLYQKIFRGD-FKLP  237 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~-----------~~~~~i~~~~-~~~~  237 (344)
                       .......|+..|+|||.+.+..+ +.++|+|||||++|++++|..||......           .....+.... ..++
T Consensus       157 -~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd06620         157 -SIADTFVGTSTYMSPERIQGGKY-TVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP  234 (284)
T ss_pred             -hccCccccCcccCCHHHHccCCC-CccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC
Confidence             11234578999999999877655 67899999999999999999999764431           2233333332 2233


Q ss_pred             CC-CCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          238 KW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       238 ~~-~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      .. ++..+.+|+.+||+.||++|||+.|+++|+||.+...
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~  274 (284)
T cd06620         235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR  274 (284)
T ss_pred             chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence            33 7889999999999999999999999999999977543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=7.6e-45  Score=325.94  Aligned_cols=255  Identities=23%  Similarity=0.364  Sum_probs=213.3

Q ss_pred             ccccCeEEeeeecccCceEEEEEEEC----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      +.+..|++.+.||+|+||.||+|.+.    ..+..+|+|.+....  .......+.+|+.++++++||||+++++++...
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~   79 (283)
T cd05090           2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE   79 (283)
T ss_pred             CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC
Confidence            56789999999999999999999853    456789999886432  234456788999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc
Q 019216           87 SKIYMVLEYVTGGELFDKIASK-----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS  149 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~-----------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~  149 (344)
                      ...|++|||+++++|.+++...                 ..+++..+..++.|++.||.|||++|++||||||+|||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~  159 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGE  159 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcC
Confidence            9999999999999999988532                 23788889999999999999999999999999999999999


Q ss_pred             CCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHH
Q 019216          150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK  228 (344)
Q Consensus       150 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~  228 (344)
                      ++.+||+|||+++...............++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.........
T Consensus       160 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05090         160 QLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKF-SSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM  238 (283)
T ss_pred             CCcEEeccccccccccCCcceecccCCCccceecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999875432211112233445678999999877665 689999999999999998 9999988776666655


Q ss_pred             HhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          229 IFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       229 i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +... ..+.+..+++.+.+++.+||+.||.+||++.+++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         239 VRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            5544 345677789999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=2.7e-45  Score=330.47  Aligned_cols=256  Identities=32%  Similarity=0.441  Sum_probs=212.7

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC--CeE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI   89 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~   89 (344)
                      .+++|++.+.||.|++|.||+|.+..+++.+|+|.++..... ......+.+|+.++++++||||+++++++...  ...
T Consensus         3 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~   81 (293)
T cd07843           3 SVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKI   81 (293)
T ss_pred             chhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcE
Confidence            356899999999999999999999999999999998654322 23345677899999999999999999998877  889


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      |+||||+. ++|.+++.... .+++..++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++.......
T Consensus        82 ~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          82 YMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             EEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99999996 49988887643 58999999999999999999999999999999999999999999999999987543211


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC---------------
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---------------  233 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~---------------  233 (344)
                        .......++..|+|||.+.+....+.++|+||||+++|+|++|..||..........++....               
T Consensus       161 --~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (293)
T cd07843         161 --KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP  238 (293)
T ss_pred             --cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccc
Confidence              122334578899999998766555688999999999999999999998776555444432210               


Q ss_pred             ----------------CCCCCC-CCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          234 ----------------FKLPKW-LSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       234 ----------------~~~~~~-~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                                      ..++.. +++.+.++|++||+.||++|||+.|++.|+||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         239 GAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             hhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence                            112222 58889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9e-45  Score=326.69  Aligned_cols=255  Identities=30%  Similarity=0.483  Sum_probs=206.4

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .+++|++.+.||+|++|.||+|.++.+++.||+|.+......  .....+.+|+.+++.++|+||+++++++......++
T Consensus         3 ~~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (291)
T cd07844           3 KLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTL   80 (291)
T ss_pred             CccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEE
Confidence            468999999999999999999999999999999998654321  122456789999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      ||||+.+ +|.+++... ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......  .
T Consensus        81 v~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~  157 (291)
T cd07844          81 VFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--S  157 (291)
T ss_pred             EEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC--C
Confidence            9999975 898888653 46899999999999999999999999999999999999999999999999998643211  1


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc-HHHHHHHHhhC-----------------
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG-----------------  232 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~-~~~~~~~i~~~-----------------  232 (344)
                      .......++..|+|||.+.+....+.++||||+|+++|+|++|+.||.+.. .......+...                 
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            111223467889999998765544688999999999999999999997654 22222222110                 


Q ss_pred             ----CCCC---------CCCCC--HHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          233 ----DFKL---------PKWLS--PGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       233 ----~~~~---------~~~~~--~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                          ....         ...++  ..+.+++.+||+.+|++|||+.++++||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                0000         01233  788999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.3e-44  Score=320.96  Aligned_cols=252  Identities=28%  Similarity=0.423  Sum_probs=215.1

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +...+|++.+.||+|++|.||+|.++.+++.||+|.+....    .....+.+|+.++++++|+||+++++++.....++
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   78 (263)
T cd05052           3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   78 (263)
T ss_pred             CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcE
Confidence            45678999999999999999999999999999999986432    23457889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ++|||+++++|.+++...  ..+++..++.++.|++.||+|||++|++||||||+||++++++.+||+|||++.......
T Consensus        79 lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~  158 (263)
T cd05052          79 IITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT  158 (263)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccce
Confidence            999999999999998753  358899999999999999999999999999999999999999999999999987543211


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                      . .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ....+..+++.+.+
T Consensus       159 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (263)
T cd05052         159 Y-TAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYE  236 (263)
T ss_pred             e-eccCCCCCccccCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence            1 11112234567999999877665 678999999999999998 99999988777776666654 45667789999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhcC
Q 019216          247 LLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ++.+||+.||++|||+.++++.
T Consensus       237 li~~cl~~~p~~Rp~~~~l~~~  258 (263)
T cd05052         237 LMRACWQWNPSDRPSFAEIHQA  258 (263)
T ss_pred             HHHHHccCCcccCCCHHHHHHH
Confidence            9999999999999999998763

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.9e-45  Score=329.78  Aligned_cols=263  Identities=25%  Similarity=0.378  Sum_probs=219.9

Q ss_pred             hhccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216            6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus         6 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      .......-.+|++.+.||+|+||.||+|.+..+++.||+|.+........+....+.+|+.+++.++|||++++++++..
T Consensus         7 ~~~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~   86 (307)
T cd06607           7 LFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR   86 (307)
T ss_pred             hhcCCCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe
Confidence            33445556789999999999999999999999999999999865544444556778999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           86 KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                      ....++||||+. +++.+.+.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...
T Consensus        87 ~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~  165 (307)
T cd06607          87 EHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLV  165 (307)
T ss_pred             CCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceec
Confidence            999999999996 577676653 457899999999999999999999999999999999999999999999999998743


Q ss_pred             CcccCCCccccccCCCcccchhhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-CCC-CCCC
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKL-PKWL  240 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-~~~-~~~~  240 (344)
                      ..      .....++..|+|||.+.+  ....+.++||||||+++|+|++|+.||.+.+.......+.... ... +..+
T Consensus       166 ~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (307)
T cd06607         166 SP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW  239 (307)
T ss_pred             CC------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhh
Confidence            22      223567889999998742  2334678999999999999999999998877655544444332 222 2347


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      +..+.++|.+||+.||++||++.+++.||||....
T Consensus       240 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  274 (307)
T cd06607         240 SDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER  274 (307)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence            88999999999999999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=8.1e-45  Score=336.08  Aligned_cols=258  Identities=29%  Similarity=0.460  Sum_probs=210.8

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC-----
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----   86 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----   86 (344)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|.+.+.. ........+.+|+.++++++||||+++++++...     
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            4678999999999999999999999999999999986432 2333456678899999999999999999988543     


Q ss_pred             -CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 -~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                       ...|+||||+. ++|.+.+...  +++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence             35799999995 5888877643  8999999999999999999999999999999999999999999999999987532


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC-------------
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------  232 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~-------------  232 (344)
                      .   ........++..|+|||.+.+..+ +.++|||||||++|+|++|+.||...+.......+...             
T Consensus       170 ~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         170 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             C---CCCCCCCcccccccCHHHHhCCCC-CCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            2   222334567889999999987776 58899999999999999999999876644433333210             


Q ss_pred             ---------CC-----C---------C-------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          233 ---------DF-----K---------L-------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       233 ---------~~-----~---------~-------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                               ..     .         +       +...++.+.++|.+||+.||++|||+.|+|.||||+..+.+
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~  320 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDP  320 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCC
Confidence                     00     0         0       11246678999999999999999999999999999865543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=296.29  Aligned_cols=257  Identities=31%  Similarity=0.505  Sum_probs=221.2

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      .+|+-.++||+|.||+||+|+++.+++.||+|.++.... ++.......+||-+|+.++|.||++++++...+..+-+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllkelkhknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence            567888999999999999999999999999999875432 3345677899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||| ..+|..+..+ ++.++.+.++.++.|++.||.|+|++++.|||+||.|.||+.+|++||+|||+++..+..  -..
T Consensus        81 e~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip--vrc  157 (292)
T KOG0662|consen   81 EFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP--VRC  157 (292)
T ss_pred             HHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--eEe
Confidence            999 5688888875 678999999999999999999999999999999999999999999999999999854331  122


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC-------C----CCCCC-
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-------F----KLPKW-  239 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~-------~----~~~~~-  239 (344)
                      ....+.|.+|++|.++.+...++...|+||-||++.|+.. |++.|.+.+......+|.+..       +    .+|+. 
T Consensus       158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk  237 (292)
T KOG0662|consen  158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK  237 (292)
T ss_pred             eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence            3445679999999999998888889999999999999987 899999999888888887521       1    11111 


Q ss_pred             -----------------CCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          240 -----------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       240 -----------------~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                                       ++..-++|++++|..+|.+|.+++++++||||.+.
T Consensus       238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence                             23455899999999999999999999999999764

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.3e-45  Score=326.01  Aligned_cols=256  Identities=24%  Similarity=0.423  Sum_probs=218.9

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      +.|+.++.||.|+||.||+|.+..++..||+|++.....  ......+.+|+.+++.+.||||+++++.+......++||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence            468889999999999999999999999999999865432  234578889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||++|++|.+++.. +++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......  ....
T Consensus        82 e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~~~~  158 (277)
T cd06640          82 EYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR  158 (277)
T ss_pred             ecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC--cccc
Confidence            99999999998865 57899999999999999999999999999999999999999999999999998743221  1122


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHhc
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKIL  252 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L  252 (344)
                      ....++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.......+... ....+..++..+.+++.+||
T Consensus       159 ~~~~~~~~y~apE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAY-DSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL  237 (277)
T ss_pred             ccccCcccccCHhHhccCCC-ccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence            33467889999999877665 68999999999999999999999877665555444333 23345567899999999999


Q ss_pred             CCCcCCCCCHhhhhcCccccccC
Q 019216          253 EPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       253 ~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      +.+|++||++.++++|+||.+..
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         238 NKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             ccCcccCcCHHHHHhChHhhhcc
Confidence            99999999999999999997643

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.7e-45  Score=325.95  Aligned_cols=254  Identities=27%  Similarity=0.385  Sum_probs=214.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      +..++|.+.+.||+|+||.||+|.+..     ++..||+|.+....  ..+....+.+|+++++.++|+||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   79 (280)
T cd05049           2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTE   79 (280)
T ss_pred             CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEec
Confidence            346789999999999999999998743     46789999986432  22345788999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKG--------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG  151 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~--------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~  151 (344)
                      ....+++|||+++++|.+++...+              .+++..+..++.|++.||.+||++|++||||||+||+++.++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~  159 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDL  159 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCC
Confidence            999999999999999999997542              378889999999999999999999999999999999999999


Q ss_pred             CeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHh
Q 019216          152 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIF  230 (344)
Q Consensus       152 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~  230 (344)
                      .+||+|||++................++..|+|||.+.+..+ +.++|||||||++|+|++ |+.||.+.+.......+.
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT  238 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCc-chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            999999999874322111111223345778999999887766 688999999999999998 999998877777777776


Q ss_pred             hCCC-CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          231 RGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       231 ~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .+.. ..+..++..+.+++.+||+.||++||++.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         239 QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            6654 345678999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-45  Score=321.78  Aligned_cols=248  Identities=31%  Similarity=0.577  Sum_probs=210.1

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCccceeeEEeeCCeEEEEEeccC
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~~~~~~iv~e~~~   97 (344)
                      ++.||.|++|.||+|.+..+|+.||+|++.+...........+..|..++ ...+|+|++++++++...+..|+++||++
T Consensus         1 ~~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (260)
T cd05611           1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN   80 (260)
T ss_pred             CccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC
Confidence            36799999999999999999999999998765433323333445555444 45589999999999999999999999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcccccc
Q 019216           98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC  177 (344)
Q Consensus        98 g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~  177 (344)
                      +++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.....      .....
T Consensus        81 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~  154 (260)
T cd05611          81 GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFV  154 (260)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCC
Confidence            999999998888899999999999999999999999999999999999999999999999998874321      23446


Q ss_pred             CCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCC----CCCCCHHHHHHHHHhcC
Q 019216          178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL----PKWLSPGAQNLLRKILE  253 (344)
Q Consensus       178 gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~~~~li~~~L~  253 (344)
                      ++..|+|||.+.+..+ +.++||||||+++|+|++|..||...+.......+.......    +..+++.+.+++.+||+
T Consensus       155 ~~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  233 (260)
T cd05611         155 GTPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC  233 (260)
T ss_pred             CCcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence            7889999999887664 689999999999999999999999888777776666554332    33578999999999999


Q ss_pred             CCcCCCCCH---hhhhcCccccc
Q 019216          254 PNPVKRITI---AGIKADEWFEQ  273 (344)
Q Consensus       254 ~dP~~Rps~---~eil~~~~~~~  273 (344)
                      .+|++||++   +|++.||||.+
T Consensus       234 ~~p~~R~~~~~~~~~l~~~~~~~  256 (260)
T cd05611         234 MDPAKRLGANGYQEIKSHPFFKS  256 (260)
T ss_pred             CCHHHccCCCcHHHHHcChHhhc
Confidence            999999954   79999999965

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-46  Score=321.60  Aligned_cols=265  Identities=30%  Similarity=0.605  Sum_probs=242.1

Q ss_pred             hhccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEe
Q 019216            6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA   84 (344)
Q Consensus         6 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~   84 (344)
                      +...++.+.+|++++.||+|+|+.|-+++.+.+.+.+|+|++++.-..+.+.++....|-.+..+. +||.++.++.+|.
T Consensus       242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq  321 (593)
T KOG0695|consen  242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ  321 (593)
T ss_pred             ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc
Confidence            355678899999999999999999999999999999999999988887888888899999988776 5999999999999


Q ss_pred             eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                      ++.++++|.||++||+|.-.++++.+++++.++.+...|+.||.|||++||++||||.+|+|++..|++||.|+|+++. 
T Consensus       322 tesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke-  400 (593)
T KOG0695|consen  322 TESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKE-  400 (593)
T ss_pred             ccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhc-
Confidence            9999999999999999988899999999999999999999999999999999999999999999999999999999873 


Q ss_pred             CcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC--------ccHHHHHHHHhhCCCCC
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD--------RNLAVLYQKIFRGDFKL  236 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~--------~~~~~~~~~i~~~~~~~  236 (344)
                       ....+....+.||||.|.|||++.+..| +..+|+|+||++|+||+.|+.||+-        .+...+++-|+...+.+
T Consensus       401 -~l~~gd~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiri  478 (593)
T KOG0695|consen  401 -GLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRI  478 (593)
T ss_pred             -CCCCCcccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccc
Confidence             3445566778999999999999999887 7999999999999999999999952        33455678888889999


Q ss_pred             CCCCCHHHHHHHHHhcCCCcCCCCC------HhhhhcCccccc
Q 019216          237 PKWLSPGAQNLLRKILEPNPVKRIT------IAGIKADEWFEQ  273 (344)
Q Consensus       237 ~~~~~~~~~~li~~~L~~dP~~Rps------~~eil~~~~~~~  273 (344)
                      |..+|-.+..+++..|++||.+|..      ++++..|+||+.
T Consensus       479 prslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  479 PRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             cceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            9999999999999999999999964      689999999973

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=9.6e-45  Score=325.59  Aligned_cols=256  Identities=30%  Similarity=0.445  Sum_probs=210.4

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEe----
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA----   84 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~----   84 (344)
                      ....++|++.+.||+|+||.||+|.+..+++.+|+|++....    .....+.+|+.+++.+ +||||+++++++.    
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~   89 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDV   89 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc
Confidence            346789999999999999999999999999999999875422    1235677899999999 6999999999873    


Q ss_pred             -eCCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccc
Q 019216           85 -SKSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG  159 (344)
Q Consensus        85 -~~~~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg  159 (344)
                       .+...++||||++|++|.+++..    ...+++..++.++.|++.||.|||+.+++||||||+||+++.++.+||+|||
T Consensus        90 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg  169 (286)
T cd06638          90 KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFG  169 (286)
T ss_pred             CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCC
Confidence             34578999999999999887752    3568899999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccCCCccccccCCCcccchhhhccC----CCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--
Q 019216          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--  233 (344)
Q Consensus       160 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--  233 (344)
                      ++.....  .........|+..|+|||++...    ...+.++|||||||++|+|++|+.||...........+....  
T Consensus       170 ~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~  247 (286)
T cd06638         170 VSAQLTS--TRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP  247 (286)
T ss_pred             ceeeccc--CCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC
Confidence            9874322  11122345689999999997532    223678999999999999999999998766544433333221  


Q ss_pred             -CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          234 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       234 -~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                       ...|..++..+.+++.+||+.||++|||+.++++|+||
T Consensus       248 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         248 TLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             cccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence             22345578899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.6e-44  Score=320.92  Aligned_cols=253  Identities=30%  Similarity=0.487  Sum_probs=212.5

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +++|++.+.||+|+||.||+|+++.+++.||+|.+........+....+.+|+.+++.++||||+++++++...+..+++
T Consensus         1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence            47899999999999999999999999999999988654444555567788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +||+++++|.+++..    ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~-  159 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-  159 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch-
Confidence            999999999888753    345899999999999999999999999999999999999999999999999998754321 


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc--HHHHHHHHhhCCC-CC-CCCCCHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDF-KL-PKWLSPGA  244 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~--~~~~~~~i~~~~~-~~-~~~~~~~~  244 (344)
                       ........++..|+|||.+.+... +.++|+||||+++|+|++|..||....  .......+..... +. +..++..+
T Consensus       160 -~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08228         160 -TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL  237 (267)
T ss_pred             -hHHHhcCCCCccccChhhhccCCC-CchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence             111233568889999999887665 578999999999999999999996543  2344444433222 22 23578899


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          245 QNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+++.+||+.+|++||++.++++.
T Consensus       238 ~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         238 RELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHCCCCcccCcCHHHHHHH
Confidence            999999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.3e-44  Score=325.80  Aligned_cols=254  Identities=27%  Similarity=0.385  Sum_probs=204.0

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      .++|++++.||+|+||.||+|.+..+|+.||+|.+.....  ......+.+|+.+++.++|+||+++++++......++|
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv   81 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV   81 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence            4689999999999999999999999999999999865432  12234567899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |||+. +++.+.+.. ...+++..++.++.|++.||.|||+.|++|+||||+|||++.++.+||+|||+++.....  ..
T Consensus        82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--~~  158 (291)
T cd07870          82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP--SQ  158 (291)
T ss_pred             Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCC--CC
Confidence            99995 677666654 456788999999999999999999999999999999999999999999999998743221  11


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHHhhC--------------C---
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRG--------------D---  233 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~-~~~~~i~~~--------------~---  233 (344)
                      ......++..|+|||.+.+....+.++||||||+++|+|++|+.||.+.+.. +....+...              .   
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (291)
T cd07870         159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY  238 (291)
T ss_pred             CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence            1233457889999999876443467899999999999999999999765432 111111100              0   


Q ss_pred             ------CCCC---------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          234 ------FKLP---------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       234 ------~~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                            ...+         -..++.+.+++.+||+.||++|||+.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                  0000         0135789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1e-44  Score=324.60  Aligned_cols=249  Identities=31%  Similarity=0.491  Sum_probs=204.4

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeC--CeEEEE
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK--SKIYMV   92 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~~~iv   92 (344)
                      |++++.||+|+||.||+|.+..+++.||+|.+.+..... . .....+|+.+++++. |+|++++++++.+.  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~-~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-E-QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-h-hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            788999999999999999999999999999986542211 2 223457888888885 99999999999877  889999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |||+. ++|.+.+.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++. +.+||+|||++.....   ..
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~---~~  153 (282)
T cd07831          79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYS---KP  153 (282)
T ss_pred             EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEeccccccccc---CC
Confidence            99996 588887765 357899999999999999999999999999999999999999 9999999999875422   11


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC------------------C
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------D  233 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~------------------~  233 (344)
                      ......++..|+|||.+......+.++|||||||++|+|++|+.||.+.+.......+...                  .
T Consensus       154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (282)
T cd07831         154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN  233 (282)
T ss_pred             CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence            2233467889999998766555578999999999999999999999887654443333210                  1


Q ss_pred             CCCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          234 FKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       234 ~~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      ..+|           ..++..+.++|.+||+.+|++|||+.++++||||
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            1111           2467899999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1e-46  Score=321.39  Aligned_cols=265  Identities=32%  Similarity=0.489  Sum_probs=214.5

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee-C
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-K   86 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~   86 (344)
                      .+..|++++.||+|+||.||+|..++++    +.+|||.++.+.. .........+|+.+++.++|||++.+..++.. +
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccC
Confidence            3568999999999999999999655443    3789999865432 22345678899999999999999999999877 7


Q ss_pred             CeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC----CCeEEec
Q 019216           87 SKIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK----GNIKISD  157 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~----~~vkl~D  157 (344)
                      ..+++++||.+. +|+..++-     ...++...++.++.||+.|+.|||++-|+||||||.||||..+    |+|||+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence            889999999965 88888852     2468999999999999999999999999999999999999888    8999999


Q ss_pred             cccccCCCcccC-CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH---------HHHHH
Q 019216          158 FGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---------AVLYQ  227 (344)
Q Consensus       158 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~---------~~~~~  227 (344)
                      ||+++.....-. -......+-|.+|+|||.+.+...++++.|||+.||++.||+|-++.|.+...         .....
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            999997543222 22344567899999999999999889999999999999999999998876332         12233


Q ss_pred             HHhhC-------CC----CCCCC--------------------------CCHHHHHHHHHhcCCCcCCCCCHhhhhcCcc
Q 019216          228 KIFRG-------DF----KLPKW--------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEW  270 (344)
Q Consensus       228 ~i~~~-------~~----~~~~~--------------------------~~~~~~~li~~~L~~dP~~Rps~~eil~~~~  270 (344)
                      +|+.-       .+    .+|.+                          -++.+.+|+.+||+.||.+|.|++++|+|+|
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            33321       00    01111                          2567899999999999999999999999999


Q ss_pred             ccccCCCC
Q 019216          271 FEQDYTPA  278 (344)
Q Consensus       271 ~~~~~~~~  278 (344)
                      |.+...+.
T Consensus       340 F~~d~lpp  347 (438)
T KOG0666|consen  340 FTEDPLPP  347 (438)
T ss_pred             cccCCCCC
Confidence            99886663

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9e-45  Score=324.30  Aligned_cols=256  Identities=26%  Similarity=0.489  Sum_probs=216.0

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCccceeeEEeeCCeEEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~i   91 (344)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+....  .......+.+|+.+++++.   |||++++++++......++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            5888999999999999999999999999999986432  2234567888999999986   9999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      +|||+++++|.+++.. +.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......  .
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~  156 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--S  156 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--c
Confidence            9999999999998865 578999999999999999999999999999999999999999999999999987543221  2


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-CCCCC-CCCHHHHHHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPK-WLSPGAQNLLR  249 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~-~~~~~~~~li~  249 (344)
                      ......|+..|+|||.+.+....+.++|+||||+++|+|++|..||.+.........+.... ..++. .++.++.+++.
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVA  236 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHH
Confidence            22344688899999998765545789999999999999999999998776554443332222 22333 27889999999


Q ss_pred             HhcCCCcCCCCCHhhhhcCccccccC
Q 019216          250 KILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       250 ~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      +||+.||++||++.+++.|+||++..
T Consensus       237 ~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         237 ACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             HHcCCCcccCcCHHHHhhChHhhccc
Confidence            99999999999999999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=9.3e-45  Score=328.76  Aligned_cols=254  Identities=27%  Similarity=0.412  Sum_probs=210.5

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCce--EEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEee
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS   85 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~   85 (344)
                      +.+.+++|++.+.||+|+||.||+|.++.++..  +|+|.+...  ........+.+|+.++.++ +||||+++++++..
T Consensus         2 ~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~   79 (303)
T cd05088           2 PVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   79 (303)
T ss_pred             CccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC
Confidence            356788999999999999999999998877765  466665432  2334456788999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS  149 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~  149 (344)
                      .+..|++|||+++++|.+++.+.+                .+++..++.++.|++.||+|||++|++||||||+|||++.
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~  159 (303)
T cd05088          80 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  159 (303)
T ss_pred             CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecC
Confidence            999999999999999999987532                4789999999999999999999999999999999999999


Q ss_pred             CCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHH
Q 019216          150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK  228 (344)
Q Consensus       150 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~  228 (344)
                      ++.+||+|||++......   .......++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......
T Consensus       160 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~  235 (303)
T cd05088         160 NYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  235 (303)
T ss_pred             CCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHH
Confidence            999999999998632111   01111233567999999876654 689999999999999998 9999988776666665


Q ss_pred             HhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          229 IFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       229 i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +... ....+..+++.+.+|+.+||+.+|++||++.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         236 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             HhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5443 234556688999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.7e-44  Score=319.83  Aligned_cols=255  Identities=29%  Similarity=0.495  Sum_probs=220.3

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      .+|++.+.||+|++|.||+|.+..+++.||+|.+......  .....+.+|+..+++++|+|++++++++......+++|
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~   78 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL   78 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence            3689999999999999999999999999999998654321  44678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||+++++|.+++.....+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++.......  ..
T Consensus        79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~  156 (264)
T cd06623          79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQ  156 (264)
T ss_pred             EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--Cc
Confidence            999999999999888889999999999999999999999 999999999999999999999999999987543211  11


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc---cHHHHHHHHhhC-CCCCCCC-CCHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRG-DFKLPKW-LSPGAQNL  247 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~---~~~~~~~~i~~~-~~~~~~~-~~~~~~~l  247 (344)
                      .....++..|+|||.+....+ +.++|+||||+++|+|++|+.||...   ........+... ....+.. ++..+.++
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  235 (264)
T cd06623         157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF  235 (264)
T ss_pred             ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence            224567889999999877654 68999999999999999999999776   344444444433 3344555 88999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          248 LRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      |.+||..+|++|||+.++++|||++.
T Consensus       236 i~~~l~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             HHHHccCChhhCCCHHHHHhCHHHHh
Confidence            99999999999999999999999975

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=329.75  Aligned_cols=256  Identities=32%  Similarity=0.477  Sum_probs=206.3

Q ss_pred             CeEEeeeecccCceEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC--CeEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIY   90 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~   90 (344)
                      +|++.+.||+|++|.||+|.+..  +++.||+|.+.............+.+|+.+++.++||||+++++++...  ..++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            68999999999999999999988  8999999998764323334456778899999999999999999999887  8899


Q ss_pred             EEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc----CCCeEEeccccc
Q 019216           91 MVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS----KGNIKISDFGLS  161 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~----~~~vkl~Dfg~a  161 (344)
                      +||||+.+ ++.+.+..     ...+++..++.++.|++.||.|||+.+|+||||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            99999964 77776642     136899999999999999999999999999999999999999    899999999998


Q ss_pred             cCCCcccC-CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHH---------HHHHHh-
Q 019216          162 ALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV---------LYQKIF-  230 (344)
Q Consensus       162 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~---------~~~~i~-  230 (344)
                      ........ ........++..|+|||.+.+....+.++|||||||++|+|++|++||.+.....         ....+. 
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            85433221 1122345778999999998765545688999999999999999999997644321         000000 


Q ss_pred             -------------------------hCCCCCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          231 -------------------------RGDFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       231 -------------------------~~~~~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                                               ......+           ...+..+.+++.+||+.||++|||+.++++||||
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence                                     0001111           1467789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.7e-44  Score=325.39  Aligned_cols=255  Identities=32%  Similarity=0.429  Sum_probs=207.6

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCe----
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK----   88 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~----   88 (344)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.+. ||||+++++++.....    
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~   79 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP   79 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence            479999999999999999999999999999998765322 2223456788999999995 6999999999876655    


Q ss_pred             -EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc-CCCeEEeccccc
Q 019216           89 -IYMVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLS  161 (344)
Q Consensus        89 -~~iv~e~~~g~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~-~~~vkl~Dfg~a  161 (344)
                       .|++|||+++ +|.+++...     ..+++..++.++.||+.||.|||+.|++||||+|+||+++. ++.+||+|||++
T Consensus        80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~  158 (295)
T cd07837          80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG  158 (295)
T ss_pred             eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence             8999999975 888887642     35799999999999999999999999999999999999998 889999999998


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-------
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-------  234 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-------  234 (344)
                      ......  ........+++.|+|||++.+....+.++||||||+++|+|++|..||.+.+......++.....       
T Consensus       159 ~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (295)
T cd07837         159 RAFSIP--VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW  236 (295)
T ss_pred             eecCCC--ccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence            743221  11122335688899999987655457899999999999999999999988765554444332100       


Q ss_pred             ----------CC-----------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccc
Q 019216          235 ----------KL-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE  272 (344)
Q Consensus       235 ----------~~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~  272 (344)
                                ..           ...+++.+.+||.+||+.||.+|||+.+++.||||+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                      00           123788999999999999999999999999999985

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.2e-44  Score=329.90  Aligned_cols=254  Identities=21%  Similarity=0.327  Sum_probs=210.2

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCce----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      +...+|++.+.||+|+||.||+|.+..++..    ||+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~   81 (316)
T cd05108           4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS   81 (316)
T ss_pred             cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC
Confidence            4567899999999999999999998766654    8999885432  234456788999999999999999999998765


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                       ..++++||+++|+|.+++... ..+++..+..++.|++.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~  160 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  160 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence             567999999999999999764 468899999999999999999999999999999999999999999999999998543


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHH
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG  243 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~  243 (344)
                      ............++..|+|||.+.+..+ +.++||||||+++|+|++ |+.||.+.........+..+ ..+.+..++.+
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd05108         161 ADEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTID  239 (316)
T ss_pred             CCCcceeccCCccceeecChHHhccCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence            3222111222344678999999887666 689999999999999998 99999887665554443333 34556678999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +.+++.+||..+|.+||++.+++.+
T Consensus       240 ~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         240 VYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.9e-46  Score=336.87  Aligned_cols=260  Identities=25%  Similarity=0.380  Sum_probs=213.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKI   89 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~   89 (344)
                      +.=..|+++++||+||.+.||++..... +.||+|.+.. ...+......+.+|+.+|.+|+ |.+|+++|++-..++.+
T Consensus       358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~-~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l  435 (677)
T KOG0596|consen  358 VKGREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVL-LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL  435 (677)
T ss_pred             ECcchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHH-hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence            3445799999999999999999997444 4455554422 2335567889999999999997 99999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           90 YMVLEYVTGGELFDKIASKGRL-QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~-~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      |+||||= ..+|...+++.... +.-.++.+..|++.|+.++|+.||||.||||.|+|+ -.|.+||+|||.|.......
T Consensus       436 YmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  436 YMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             EEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCccc
Confidence            9999986 56999999876653 336889999999999999999999999999999998 67899999999998766555


Q ss_pred             CCCccccccCCCcccchhhhccCCC----------CCccchhhhhhHHHHHHHhCCCCCCCcc-HHHHHHHHhhCC--CC
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGY----------DGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD--FK  235 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~----------~~~~~DvwslG~ll~ell~g~~pf~~~~-~~~~~~~i~~~~--~~  235 (344)
                      ..-.....+||+.||+||.+.....          .++++|||||||+||+|+.|++||..-. ....+..|...+  ++
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Ie  593 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIE  593 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccc
Confidence            5555667899999999999864322          2678999999999999999999997643 444455555543  46


Q ss_pred             CCCCCCHH-HHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          236 LPKWLSPG-AQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       236 ~~~~~~~~-~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +|..-+.. +.++++.||++||++|||+.++|+|||++-.
T Consensus       594 fp~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~  633 (677)
T KOG0596|consen  594 FPDIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ  633 (677)
T ss_pred             ccCCCCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence            66654444 9999999999999999999999999999753

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=5.1e-45  Score=332.22  Aligned_cols=247  Identities=32%  Similarity=0.468  Sum_probs=192.1

Q ss_pred             eeeecccCceEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe--eCCeEEEEEe
Q 019216           19 GRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSKIYMVLE   94 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~~iv~e   94 (344)
                      ..+||+|+||.||+|.++.  ++..||+|.+.....     ...+.+|+.++++++||||+++++++.  .....+++||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            4689999999999999754  568899998864321     245778999999999999999999885  3567899999


Q ss_pred             ccCCCChHHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE----ccCCCeEEeccccc
Q 019216           95 YVTGGELFDKIAS---------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLS  161 (344)
Q Consensus        95 ~~~g~~L~~~l~~---------~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl----~~~~~vkl~Dfg~a  161 (344)
                      |+. ++|.+++..         ...+++..++.++.||+.||.|||+.||+||||||+|||+    +.++.+||+|||++
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a  159 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA  159 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence            995 578777642         1248899999999999999999999999999999999999    45678999999999


Q ss_pred             cCCCcccC-CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH---------HHHHHHhh
Q 019216          162 ALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------VLYQKIFR  231 (344)
Q Consensus       162 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~---------~~~~~i~~  231 (344)
                      +....... ........+|..|+|||++.+....+.++|||||||++|+|++|++||......         ....++..
T Consensus       160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~  239 (317)
T cd07867         160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFS  239 (317)
T ss_pred             eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHH
Confidence            75432211 112334578999999999877555578999999999999999999999753211         00000000


Q ss_pred             ----------------------------CCC----------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          232 ----------------------------GDF----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       232 ----------------------------~~~----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                                                  ...          ......+..+.+|+.+||+.||.+|||++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         240 VMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                                        000          0011235678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.5e-44  Score=318.45  Aligned_cols=245  Identities=28%  Similarity=0.451  Sum_probs=204.5

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG   99 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~   99 (344)
                      +.||+|+||.||+|.++.+++.||+|.+....  ..+....+.+|++++++++||||+++++++......++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            47999999999999999999999999875432  2344567899999999999999999999999999999999999999


Q ss_pred             ChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216          100 ELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus       100 ~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      +|.+++.+.+ .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.................
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  158 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI  158 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence            9999987644 589999999999999999999999999999999999999999999999999874322111100111123


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCc
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNP  256 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP  256 (344)
                      +..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+... ....+..++..+.+++.+||+.+|
T Consensus       159 ~~~y~aPE~~~~~~~-~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  237 (252)
T cd05084         159 PVKWTAPEALNYGRY-SSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP  237 (252)
T ss_pred             ceeecCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence            456999999877665 688999999999999998 99999876665555555443 445667789999999999999999


Q ss_pred             CCCCCHhhhhc
Q 019216          257 VKRITIAGIKA  267 (344)
Q Consensus       257 ~~Rps~~eil~  267 (344)
                      ++|||+.++++
T Consensus       238 ~~Rps~~~~~~  248 (252)
T cd05084         238 GQRPSFSTVHQ  248 (252)
T ss_pred             hhCcCHHHHHH
Confidence            99999999875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.5e-44  Score=358.01  Aligned_cols=255  Identities=25%  Similarity=0.389  Sum_probs=208.6

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +++|++.++||+|+||.||+|.+..+|+.||+|++...........+++.+|+.++++++||||+++++++...+..+++
T Consensus         1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence            58999999999999999999999999999999999765444445567899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccc
Q 019216           93 LEYVTGGELFDKIASK-----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~-----------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a  161 (344)
                      |||++|++|.+++.+.           ..++...+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999988641           23456678899999999999999999999999999999999999999999999


Q ss_pred             cCCCcccC----------------CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHH
Q 019216          162 ALPQHFRD----------------DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL  225 (344)
Q Consensus       162 ~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~  225 (344)
                      ........                .......+||+.|+|||.+.+..+ +.++|||||||++|+|++|+.||........
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~-S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            75411100                011123469999999999887766 6899999999999999999999987554333


Q ss_pred             HHHHh-hCCCC--CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          226 YQKIF-RGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       226 ~~~i~-~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ..... .....  ....+++.+.+++.+||+.||++|++..+.+.+
T Consensus       240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            22211 11111  123578999999999999999999886665543

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.6e-44  Score=319.53  Aligned_cols=254  Identities=22%  Similarity=0.354  Sum_probs=213.6

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..++|++.+.||+|+||.||+|.++.+   ...||+|.++...  .......+.+|+.++++++||||+++++++.....
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (266)
T cd05033           2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP   79 (266)
T ss_pred             ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence            346899999999999999999998654   4589999886432  33445678889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+++|||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||+++++.++|+|||++......
T Consensus        80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            9999999999999999875 347899999999999999999999999999999999999999999999999999865321


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ  245 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~  245 (344)
                      ..........++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...........+... ..+.+..+++.+.
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  238 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALY  238 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCC-ccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHH
Confidence            11111122344578999999877665 689999999999999998 99999877766666666554 3455667899999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhcC
Q 019216          246 NLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +++.+||+.+|++||++.+++++
T Consensus       239 ~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         239 QLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHcCCCcccCcCHHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.2e-44  Score=324.41  Aligned_cols=255  Identities=26%  Similarity=0.392  Sum_probs=209.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEe-----
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA-----   84 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~-----   84 (344)
                      ...|.|++.+.||.|+||.||+|.+..+++.+|+|++....    .....+..|+.+++++ +|+|++++++++.     
T Consensus        13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   88 (282)
T cd06636          13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP   88 (282)
T ss_pred             ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence            45689999999999999999999999999999999985432    2345678899999998 6999999999884     


Q ss_pred             -eCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccc
Q 019216           85 -SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus        85 -~~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a  161 (344)
                       ....++++|||+.+++|.+++...  ..+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~  168 (282)
T cd06636          89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS  168 (282)
T ss_pred             CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence             246789999999999999988753  45888999999999999999999999999999999999999999999999998


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-CC-
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FK-  235 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-~~-  235 (344)
                      .....  .........|+..|+|||.+..    ....+.++|+|||||++|+|++|..||...........+.... .. 
T Consensus       169 ~~~~~--~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~  246 (282)
T cd06636         169 AQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL  246 (282)
T ss_pred             hhhhc--cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCC
Confidence            74322  1112334578899999999753    1223578999999999999999999997765444333333322 11 


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       236 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      .+..++..+.+||++||+.||.+|||+.++++||||
T Consensus       247 ~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         247 KSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             cccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            224578999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.8e-44  Score=322.54  Aligned_cols=254  Identities=22%  Similarity=0.309  Sum_probs=210.5

Q ss_pred             cccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      .-++|++.+.||+|+||.||+|.+.     .++..||+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            4568999999999999999999864     245679999875432  223456688999999999999999999999988


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEe
Q 019216           87 SKIYMVLEYVTGGELFDKIASKG----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS  156 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~----------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~  156 (344)
                      ...++||||+++++|.+++.+..          .++...+..++.|++.||.|||+.|++||||||+||++++++.++|+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~  161 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  161 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence            99999999999999999987532          25678889999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC-C
Q 019216          157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-F  234 (344)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~-~  234 (344)
                      |||++................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.......+.... .
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05062         162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL  240 (277)
T ss_pred             CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            9999874322111111122345778999999877665 689999999999999999 799998887776666655543 4


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       235 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ..+..+++.+.+++.+||+.||++|||+.+++++
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5677789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7e-45  Score=334.03  Aligned_cols=263  Identities=27%  Similarity=0.407  Sum_probs=214.5

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee----CCeE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKI   89 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~   89 (344)
                      ++|++.+.||+|++|.||+|.++.+|+.||+|.+..... .......+.+|+.++++++||||+++++++..    ....
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            689999999999999999999999999999999865322 22345677889999999999999999998753    3568


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      ++||||+. ++|.+.+...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........
T Consensus        84 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  162 (334)
T cd07855          84 YVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT  162 (334)
T ss_pred             EEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence            99999995 68999988778899999999999999999999999999999999999999999999999999874332111


Q ss_pred             --CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhh----------------
Q 019216          170 --DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR----------------  231 (344)
Q Consensus       170 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~----------------  231 (344)
                        ........++..|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+..                
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~  242 (334)
T cd07855         163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSD  242 (334)
T ss_pred             CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchh
Confidence              11223457889999999987644457899999999999999999999987654332222111                


Q ss_pred             ----------CCCCC-----CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCCC
Q 019216          232 ----------GDFKL-----PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA  278 (344)
Q Consensus       232 ----------~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~~  278 (344)
                                .....     ....++.+.++|++||+.+|.+|||+.+++.||||++...+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         243 RVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             hHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCCc
Confidence                      00011     133689999999999999999999999999999998655443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=2.5e-44  Score=324.36  Aligned_cols=258  Identities=30%  Similarity=0.442  Sum_probs=210.9

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +++|++.+.||+|++|.||+|.++.+|+.||+|.+..... .....+.+.+|+.++++++||||+++++++......++|
T Consensus         1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   79 (294)
T PLN00009          1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV   79 (294)
T ss_pred             CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence            5789999999999999999999999999999998865432 223446788899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc-CCCeEEeccccccCCCcccC
Q 019216           93 LEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~-~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      |||++ ++|.+.+.....  +++..++.++.||+.||+|||++|++||||+|+||+++. ++.+||+|||++......  
T Consensus        80 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~--  156 (294)
T PLN00009         80 FEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP--  156 (294)
T ss_pred             Eeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence            99995 588887765443  578889999999999999999999999999999999985 457999999998743221  


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC----------------
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD----------------  233 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~----------------  233 (344)
                      ........++..|+|||.+.+....+.++||||||+++|+|++|+.||...+......++....                
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            1112334678899999998765555689999999999999999999998766544444332110                


Q ss_pred             -----C--C------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          234 -----F--K------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       234 -----~--~------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                           .  .      ....+++.+.++|.+||+.+|++||++.++++||||.+.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence                 0  0      113468899999999999999999999999999999864

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.6e-44  Score=322.09  Aligned_cols=255  Identities=26%  Similarity=0.465  Sum_probs=217.5

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      .|...+.||+|++|.||++.+..+++.+++|.+....   ....+.+.+|+.+++.++|||++++++++...+..++++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            4566689999999999999999999999999885332   2334668899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccc
Q 019216           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (344)
Q Consensus        95 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~  174 (344)
                      |++|++|.+++.. +++++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||.+.....  ......
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~--~~~~~~  173 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK--EVPRRK  173 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhcc--CCcccc
Confidence            9999999998877 6789999999999999999999999999999999999999999999999998764322  111223


Q ss_pred             cccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCC---CCCCCHHHHHHHHHh
Q 019216          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL---PKWLSPGAQNLLRKI  251 (344)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~~~li~~~  251 (344)
                      ...|+..|+|||.+.+..+ +.++||||||+++|+|++|+.||...+.......+.......   +..++..+.+++++|
T Consensus       174 ~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  252 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRM  252 (285)
T ss_pred             cccCCccccCHHHhcCCCC-CCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHH
Confidence            4568899999999877665 688999999999999999999998877666666665543222   233789999999999


Q ss_pred             cCCCcCCCCCHhhhhcCccccccCC
Q 019216          252 LEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       252 L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      |+.+|++|||+.++++|+||.+...
T Consensus       253 l~~~p~~Rpt~~~il~~~~~~~~~~  277 (285)
T cd06648         253 LVRDPAQRATAAELLNHPFLAKAGP  277 (285)
T ss_pred             cccChhhCcCHHHHccCcccccCCC
Confidence            9999999999999999999987654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.5e-44  Score=323.90  Aligned_cols=252  Identities=31%  Similarity=0.486  Sum_probs=209.8

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      +|++.+.||.|++|.||+|.+..+|+.||+|.+......  .....+.+|+.+++.++|+||+++++.+...+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            589999999999999999999999999999998654321  224567789999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           95 YVTGGELFDKIASK---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        95 ~~~g~~L~~~l~~~---~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |+++ +|.+++...   ..+++..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||++......  ..
T Consensus        79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~  155 (284)
T cd07836          79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VN  155 (284)
T ss_pred             cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cc
Confidence            9975 888887653   35899999999999999999999999999999999999999999999999998743221  11


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC------------------
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------------  233 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~------------------  233 (344)
                      ......++..|++||.+.+....+.++||||||+++|+|++|+.||.+.+......++....                  
T Consensus       156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07836         156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK  235 (284)
T ss_pred             ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence            12334578899999998765555788999999999999999999998876555444433210                  


Q ss_pred             CC-----------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          234 FK-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       234 ~~-----------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      ..           +...+++.+.+++.+||+.||.+||++.++++||||
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            00           112357889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=8.1e-45  Score=327.45  Aligned_cols=257  Identities=27%  Similarity=0.451  Sum_probs=216.3

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ..|.....||+|+||.||++.+..++..||||.+....   ....+.+.+|+.+++.++|+|++++++.+...+..++||
T Consensus        22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence            34566788999999999999999999999999885432   234567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||+++++|.+++.. +.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....  .....
T Consensus        99 e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~--~~~~~  175 (292)
T cd06658          99 EFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVPKR  175 (292)
T ss_pred             eCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc--ccccC
Confidence            99999999888754 5689999999999999999999999999999999999999999999999999864322  11122


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC---CCCCCCCCHHHHHHHHH
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLRK  250 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li~~  250 (344)
                      ....++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.......+....   ......++..+.+++.+
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  254 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPY-GTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDL  254 (292)
T ss_pred             ceeecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHH
Confidence            34568899999999877665 678999999999999999999998877655554443322   22233578899999999


Q ss_pred             hcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          251 ILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       251 ~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      ||..||++|||++++++||||.....+
T Consensus       255 ~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         255 MLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             HccCChhHCcCHHHHhhChhhhccCCc
Confidence            999999999999999999999865444

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-44  Score=316.96  Aligned_cols=247  Identities=40%  Similarity=0.753  Sum_probs=221.8

Q ss_pred             ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCCCh
Q 019216           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL  101 (344)
Q Consensus        22 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~~L  101 (344)
                      ||+|+||.||++.+..+++.+|+|.+.+...........+..|+.+++.++|+|++++++.+..+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            79999999999999889999999999876555555677889999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCc
Q 019216          102 FDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN  181 (344)
Q Consensus       102 ~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~  181 (344)
                      .+++.....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++.......  .......++..
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~  158 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE  158 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence            9999888889999999999999999999999999999999999999999999999999987532211  12344567889


Q ss_pred             ccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCCCCC
Q 019216          182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT  261 (344)
Q Consensus       182 y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps  261 (344)
                      |+|||.+.+... +.++|+||||+++|++++|+.||...+.......+......+|...+..+.+++++||..||++||+
T Consensus       159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~  237 (250)
T cd05123         159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG  237 (250)
T ss_pred             ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence            999999877665 6789999999999999999999988887777777777888888889999999999999999999999


Q ss_pred             H---hhhhcCccc
Q 019216          262 I---AGIKADEWF  271 (344)
Q Consensus       262 ~---~eil~~~~~  271 (344)
                      +   .++++||||
T Consensus       238 ~~~~~~l~~~~~f  250 (250)
T cd05123         238 SGGAEEIKAHPFF  250 (250)
T ss_pred             cccHHHHHhCCCC
Confidence            9   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.3e-44  Score=318.05  Aligned_cols=249  Identities=25%  Similarity=0.430  Sum_probs=210.4

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      ..++|++.+.||+|+||.||+|.++ .+..+|+|.+.....    ....+.+|+.++++++||||+++++++......++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   76 (256)
T cd05114           2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYI   76 (256)
T ss_pred             CHHHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEE
Confidence            4578999999999999999999874 456799998764332    13568889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      +|||+++++|.+++.. .+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.+....... .
T Consensus        77 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~  155 (256)
T cd05114          77 VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-Y  155 (256)
T ss_pred             EEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-e
Confidence            9999999999999875 3568999999999999999999999999999999999999999999999999887432111 1


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL  248 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li  248 (344)
                      .......++..|+|||.+.+..+ +.++||||||+++|+|++ |+.||...+.......+..+. ...|...+..+.+++
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li  234 (256)
T cd05114         156 TSSSGAKFPVKWSPPEVFNFSKY-SSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVM  234 (256)
T ss_pred             eccCCCCCchhhCChhhcccCcc-chhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHH
Confidence            11112234568999999877665 589999999999999999 999999888777777776653 345666889999999


Q ss_pred             HHhcCCCcCCCCCHhhhhc
Q 019216          249 RKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~  267 (344)
                      .+||+.+|++|||+.++++
T Consensus       235 ~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         235 YSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHccCCcccCcCHHHHHH
Confidence            9999999999999999976

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-45  Score=352.33  Aligned_cols=254  Identities=31%  Similarity=0.528  Sum_probs=210.8

Q ss_pred             cccc--CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeE-Ee--
Q 019216           11 MRLG--RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEV-LA--   84 (344)
Q Consensus        11 ~~~~--~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~--   84 (344)
                      +.+|  +++|.+.|.+|||+.||+|.+...|..||+|.+...   +...++.+.+||.+|++|+ |+|||.+++. ..  
T Consensus        32 ~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~  108 (738)
T KOG1989|consen   32 FTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINR  108 (738)
T ss_pred             EEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccc
Confidence            4455  456889999999999999999888899999988544   5667889999999999998 9999999993 21  


Q ss_pred             -e---CCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEEccCCCeEEe
Q 019216           85 -S---KSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKIS  156 (344)
Q Consensus        85 -~---~~~~~iv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~--i~H~dikp~NILl~~~~~vkl~  156 (344)
                       .   .-.+++.||||.||.|.++++.  ...|++.++++|+.|+++|+++||..+  |||||||-+||||..+|..|||
T Consensus       109 ~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLC  188 (738)
T KOG1989|consen  109 SSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLC  188 (738)
T ss_pred             cCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeC
Confidence             1   1357899999999999999984  346999999999999999999999997  9999999999999999999999


Q ss_pred             ccccccCCCcccCC-Cc------cccccCCCcccchhhhc--cCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHH
Q 019216          157 DFGLSALPQHFRDD-GL------LHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ  227 (344)
Q Consensus       157 Dfg~a~~~~~~~~~-~~------~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~  227 (344)
                      |||.|...-..... ..      ......|+-|+|||++.  +...+++|+|||+|||+||-||....||+....    .
T Consensus       189 DFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----l  264 (738)
T KOG1989|consen  189 DFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----L  264 (738)
T ss_pred             cccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----e
Confidence            99998743221110 00      01124689999999964  344558999999999999999999999987643    2


Q ss_pred             HHhhCCCCCCC--CCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          228 KIFRGDFKLPK--WLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       228 ~i~~~~~~~~~--~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      .|..+++.+|.  .++..+.+||+.||+.||.+||++.+++.+-+.
T Consensus       265 aIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~  310 (738)
T KOG1989|consen  265 AILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFE  310 (738)
T ss_pred             eEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHH
Confidence            56778888875  589999999999999999999999999876443

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=3.1e-44  Score=322.90  Aligned_cols=259  Identities=24%  Similarity=0.323  Sum_probs=212.6

Q ss_pred             cccCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      ..++|++.+.||+|+||.||+|.++.     .+..||+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG   81 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            45799999999999999999997542     35689999875432  222345678899999999999999999999988


Q ss_pred             CeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEe
Q 019216           87 SKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS  156 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~----------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~  156 (344)
                      ...++||||+++++|.+++.+.          ...+...+..++.|++.||.|||++|++||||||+|||++.++.++|+
T Consensus        82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~  161 (288)
T cd05061          82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG  161 (288)
T ss_pred             CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence            8999999999999999999752          234567889999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CC
Q 019216          157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DF  234 (344)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~  234 (344)
                      |||+++...............++..|+|||.+.+..+ +.++|+|||||++|+|++ |..||.+.........+..+ ..
T Consensus       162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~  240 (288)
T cd05061         162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYL  240 (288)
T ss_pred             cCCccccccccccccccCCCcccccccCHHHhccCCC-ChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            9999874322111111122345678999999877665 689999999999999998 89999887777766666554 34


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc------Cccccc
Q 019216          235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA------DEWFEQ  273 (344)
Q Consensus       235 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~------~~~~~~  273 (344)
                      ..+...++.+.+++.+||+.||++|||+.++++      ||||..
T Consensus       241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         241 DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            566778899999999999999999999999987      777754

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.6e-44  Score=321.51  Aligned_cols=254  Identities=24%  Similarity=0.341  Sum_probs=211.2

Q ss_pred             cccCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      ..++|++.+.||+|++|.||+|.+..     ++..||+|.+....  .......+.+|+.+++.++|+||+++++++...
T Consensus         4 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   81 (277)
T cd05036           4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER   81 (277)
T ss_pred             CHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence            44789999999999999999999877     77899999875432  222345688899999999999999999999888


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC---CeEEe
Q 019216           87 SKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKIS  156 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~-------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~---~vkl~  156 (344)
                      ...+++|||++|++|.+++...+       .+++..+..++.||+.||+|||+++++||||||+|||++.++   .+||+
T Consensus        82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~  161 (277)
T cd05036          82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA  161 (277)
T ss_pred             CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence            88999999999999999987643       488999999999999999999999999999999999998765   58999


Q ss_pred             ccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CC
Q 019216          157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DF  234 (344)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~  234 (344)
                      |||+++................+..|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+... ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~  240 (277)
T cd05036         162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIF-TSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL  240 (277)
T ss_pred             cCccccccCCccceecCCCCCccHhhCCHHHHhcCCc-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            9999875421111111112233467999999877665 689999999999999997 99999987766666555443 45


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       235 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ..|..++..+.+++.+||+.+|++|||+.++++|
T Consensus       241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            5677789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-46  Score=342.03  Aligned_cols=243  Identities=26%  Similarity=0.418  Sum_probs=213.3

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +.+....-++-||.|+.|.||+|+.  .++.||||.++..          -..+|.-|++|+||||+.+.++|.....++
T Consensus       121 iPFe~IsELeWlGSGaQGAVF~Grl--~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyC  188 (904)
T KOG4721|consen  121 IPFEEISELEWLGSGAQGAVFLGRL--HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYC  188 (904)
T ss_pred             CCHHHhhhhhhhccCcccceeeeec--cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeE
Confidence            4555566678899999999999995  5678999977422          234788999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      ||||||..|.|...++...+++......|..+|+.|+.|||.++|||||||.-||||..+..|||+|||-++...   +.
T Consensus       189 IiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~---~~  265 (904)
T KOG4721|consen  189 IIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS---DK  265 (904)
T ss_pred             EeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh---hh
Confidence            999999999999999999999999999999999999999999999999999999999999999999999887432   33


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CCCCCCCCCHHHHHHH
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLL  248 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li  248 (344)
                      .....++||..|||||++.+.+. +.|+||||||+||||||||..||.+-+...+..-+-..  .++.|..++..++-||
T Consensus       266 STkMSFaGTVaWMAPEvIrnePc-sEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~  344 (904)
T KOG4721|consen  266 STKMSFAGTVAWMAPEVIRNEPC-SEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLL  344 (904)
T ss_pred             hhhhhhhhhHhhhCHHHhhcCCc-ccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHH
Confidence            45667899999999999988776 69999999999999999999999887665554444333  3567889999999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCc
Q 019216          249 RKILEPNPVKRITIAGIKADE  269 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~  269 (344)
                      +.||+..|..||++.+||.|-
T Consensus       345 Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  345 KQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             HHHHhcCCCCCccHHHHHHHH
Confidence            999999999999999999983

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=3.6e-44  Score=322.48  Aligned_cols=252  Identities=27%  Similarity=0.404  Sum_probs=212.4

Q ss_pred             cccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      ...+|.+.+.||+|+||.||++.+.     .++..+|+|.+....   ......+.+|+.++++++||||+++++++...
T Consensus         3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (288)
T cd05093           3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEG   79 (288)
T ss_pred             chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            3467999999999999999999853     345679999885432   33456789999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCe
Q 019216           87 SKIYMVLEYVTGGELFDKIASKG-------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNI  153 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~-------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~v  153 (344)
                      ...+++|||+++++|.+++...+             .+++..++.++.|++.||+|||++|++||||||+|||+++++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~  159 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV  159 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence            99999999999999999987543             38999999999999999999999999999999999999999999


Q ss_pred             EEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC
Q 019216          154 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG  232 (344)
Q Consensus       154 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~  232 (344)
                      ||+|||++................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+..+
T Consensus       160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~  238 (288)
T cd05093         160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQG  238 (288)
T ss_pred             EeccCCccccccCCceeecCCCCCccccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999874322111111223345678999999877665 689999999999999998 99999888777777777766


Q ss_pred             C-CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          233 D-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       233 ~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      . ...+..+++.+.+|+.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         239 RVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             CcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            5 3456678999999999999999999999999855

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.9e-44  Score=331.00  Aligned_cols=257  Identities=30%  Similarity=0.421  Sum_probs=208.0

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC------
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------   86 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------   86 (344)
                      -++|++.+.||.|+||.||+|.++.+|+.||+|.+.....   ...+.+.+|+.+++.++||||+++++++...      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            3799999999999999999999999999999999865432   3456788999999999999999999776543      


Q ss_pred             --------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc-CCCeEEec
Q 019216           87 --------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISD  157 (344)
Q Consensus        87 --------~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~-~~~vkl~D  157 (344)
                              ...+++|||+. ++|.+.+.. +.+++..++.++.||+.||.|||+.|++||||||+||+++. ++.+||+|
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d  158 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD  158 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence                    35789999996 588887754 56899999999999999999999999999999999999975 45789999


Q ss_pred             cccccCCCcccC-CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC---
Q 019216          158 FGLSALPQHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---  233 (344)
Q Consensus       158 fg~a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~---  233 (344)
                      ||++........ ........++..|+|||.+......+.++|||||||++|+|++|+.||.+.+.......+....   
T Consensus       159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~  238 (342)
T cd07854         159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV  238 (342)
T ss_pred             cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            999875432111 1112234678899999987664445688999999999999999999998766544443332210   


Q ss_pred             ----------------------C-----CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          234 ----------------------F-----KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       234 ----------------------~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                                            .     .+...++.++.+||.+||+.||++|||+.+++.||||+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence                                  0     0113467899999999999999999999999999999854

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.6e-44  Score=321.58  Aligned_cols=255  Identities=24%  Similarity=0.423  Sum_probs=218.2

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      -|++++.||+|+||.||+|.+..++..||+|.+.....  ......+.+|+.++++++||||+++++.+..+...++|||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   82 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME   82 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence            47789999999999999999989999999998754322  2345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccc
Q 019216           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (344)
Q Consensus        95 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~  174 (344)
                      |+++++|.+++.+ +.+++..+..++.|++.++.+||+.|++|+||+|+||+++.++.++|+|||++......  .....
T Consensus        83 ~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~--~~~~~  159 (277)
T cd06641          83 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QIKRN  159 (277)
T ss_pred             eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc--hhhhc
Confidence            9999999988864 56899999999999999999999999999999999999999999999999988643221  11123


Q ss_pred             cccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhcC
Q 019216          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILE  253 (344)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~  253 (344)
                      ...++..|+|||.+.+... +.++|+|||||++|+|++|..||...........+.... ..++..++.++.+++.+||+
T Consensus       160 ~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  238 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLN  238 (277)
T ss_pred             cccCCccccChhhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHcc
Confidence            3467889999999877665 578999999999999999999998776665555554443 33556789999999999999


Q ss_pred             CCcCCCCCHhhhhcCccccccC
Q 019216          254 PNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       254 ~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      .+|.+||++.++++||||.+..
T Consensus       239 ~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         239 KEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             CChhhCcCHHHHHhCHHHhhhh
Confidence            9999999999999999998753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.2e-44  Score=324.68  Aligned_cols=255  Identities=24%  Similarity=0.362  Sum_probs=214.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      +.+.+|++.+.||+|+||.||+|.+..     .++.||+|++....  .....+.+.+|+.++..++||||+++++++..
T Consensus         2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~   79 (283)
T cd05091           2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK   79 (283)
T ss_pred             CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            456789999999999999999998754     35789999986432  23345678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc
Q 019216           86 KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS  149 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~  149 (344)
                      ....++++||+.+++|.+++...                ..+++..+..++.|++.||.|||++|++||||||+|||+++
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~  159 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFD  159 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecC
Confidence            89999999999999999988531                34788889999999999999999999999999999999999


Q ss_pred             CCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHH
Q 019216          150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK  228 (344)
Q Consensus       150 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~  228 (344)
                      ++.+||+|||+++...............+++.|+|||.+.+..+ +.++|||||||++|||++ |..||.+.........
T Consensus       160 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  238 (283)
T cd05091         160 KLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEM  238 (283)
T ss_pred             CCceEecccccccccccchheeeccCccCCccccCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence            99999999999875432221122233445778999999877665 688999999999999998 9999998887777777


Q ss_pred             HhhCCC-CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          229 IFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       229 i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +..... ..+..++..+.+|+.+||+.+|.+||+++++++.
T Consensus       239 i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         239 IRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             HHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            776643 4577899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.9e-44  Score=331.46  Aligned_cols=258  Identities=27%  Similarity=0.402  Sum_probs=211.8

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC-----C
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----S   87 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~   87 (344)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++|+||+++++++...     .
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~   82 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN   82 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence            3589999999999999999999999999999999865322 223345677899999999999999999987543     3


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ..|+++||+. ++|.+++...+++++..++.++.|++.||.|||+++++||||||+||+++.++.+||+|||++......
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          83 DVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             cEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            5899999994 689999988888999999999999999999999999999999999999999999999999998754321


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC---------------
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---------------  232 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~---------------  232 (344)
                        ........++..|+|||.+......+.++|||||||++|+|++|+.||.+.+.......+...               
T Consensus       162 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07858         162 --GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNE  239 (337)
T ss_pred             --cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCch
Confidence              122334567889999999876444578999999999999999999999876543322211100               


Q ss_pred             -------------CC---CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          233 -------------DF---KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       233 -------------~~---~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                                   ..   .....+++.+.++|++||+.+|++|||++++++||||...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         240 KARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                         00   0123478999999999999999999999999999999764

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=3.3e-44  Score=316.77  Aligned_cols=253  Identities=30%  Similarity=0.571  Sum_probs=216.1

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      +|++.+.||+|+||.||+|.++.+|..+|+|.+..... .....+.+.+|+.+++.++|+|++++++.+......++++|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            68999999999999999999999999999999865432 22335677899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC-eEEeccccccCCCcccCCC
Q 019216           95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        95 ~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~-vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+.+++|+||+|+||++++++. +||+|||.+......  ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~--~~  157 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDS--ME  157 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCC--cc
Confidence            999999999887543  4789999999999999999999999999999999999998864 699999988754321  11


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-CCCCCCCHHHHHHHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRK  250 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~  250 (344)
                      ......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+..... ..+..++..+.++|.+
T Consensus       158 ~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  236 (257)
T cd08225         158 LAYTCVGTPYYLSPEICQNRPY-NNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ  236 (257)
T ss_pred             cccccCCCccccCHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence            2233468889999999877665 6899999999999999999999988776666655554433 3455678999999999


Q ss_pred             hcCCCcCCCCCHhhhhcCccc
Q 019216          251 ILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       251 ~L~~dP~~Rps~~eil~~~~~  271 (344)
                      ||+.+|++|||+.++++||||
T Consensus       237 ~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         237 LFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.9e-44  Score=314.68  Aligned_cols=255  Identities=34%  Similarity=0.539  Sum_probs=219.5

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC--CeEEEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIYMV   92 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~iv   92 (344)
                      +|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+.+|+.++++++||||+++++.+...  ...+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            588999999999999999999989999999998654432 34567889999999999999999999999888  889999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      +||+++++|.+++.+...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+...........
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            99999999999998877899999999999999999999999999999999999999999999999999875433221111


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc-HHHHHHHHh--hCCCCCCCCCCHHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIF--RGDFKLPKWLSPGAQNLLR  249 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~-~~~~~~~i~--~~~~~~~~~~~~~~~~li~  249 (344)
                      .....++..|+|||.+..... +.++||||||+++|+|++|..||.... .......+.  .....+|..++..+.++|.
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~  238 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR  238 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence            344678899999999877664 689999999999999999999998765 223333333  2345567778999999999


Q ss_pred             HhcCCCcCCCCCHhhhhcCccc
Q 019216          250 KILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       250 ~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      +||+.||++||++.+++.||||
T Consensus       239 ~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         239 KCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HhCcCChhhCCCHHHHhhCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.4e-45  Score=325.91  Aligned_cols=255  Identities=24%  Similarity=0.418  Sum_probs=216.0

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ..|+..+.||+|+||.||+|.+..+++.||+|.+.....  ....+.+.+|+.++++++||||+++++.+......++||
T Consensus         4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEE
Confidence            457788999999999999999999999999998864432  234567899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||+++++|.+++.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......  ....
T Consensus        82 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~  158 (277)
T cd06642          82 EYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR  158 (277)
T ss_pred             EccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--chhh
Confidence            99999999988864 56899999999999999999999999999999999999999999999999998754321  1112


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHhc
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKIL  252 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L  252 (344)
                      ....++..|+|||.+.+..+ +.++|+|||||++|+|++|+.||...........+... ....+..++..+.++|.+||
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  237 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAY-DFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL  237 (277)
T ss_pred             hcccCcccccCHHHhCcCCC-chhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence            23467889999999887665 58899999999999999999999876555444444333 23344567889999999999


Q ss_pred             CCCcCCCCCHhhhhcCcccccc
Q 019216          253 EPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       253 ~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +.+|++||++.++++||||...
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~  259 (277)
T cd06642         238 NKDPRFRPTAKELLKHKFITRY  259 (277)
T ss_pred             cCCcccCcCHHHHHHhHHHHHH
Confidence            9999999999999999999753

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-44  Score=320.32  Aligned_cols=255  Identities=24%  Similarity=0.327  Sum_probs=213.7

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      +..++|++.+.||+|+||.||+|.++..     +..||+|.+....  .......+.+|+.+++.++||||+++++++..
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   80 (277)
T cd05032           3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVST   80 (277)
T ss_pred             cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC
Confidence            4567999999999999999999997643     4789999975432  22345678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEE
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKG----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI  155 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~----------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl  155 (344)
                      ....++||||+++++|.+++....          .+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||
T Consensus        81 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          81 GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEE
Confidence            999999999999999999986432          3678899999999999999999999999999999999999999999


Q ss_pred             eccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-C
Q 019216          156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-D  233 (344)
Q Consensus       156 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~  233 (344)
                      +|||+++...............++..|+|||.+.+..+ +.++|||||||++|++++ |..||.+.+.......+..+ .
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~  239 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVF-TTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGH  239 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCC-CcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCC
Confidence            99999875432211112233456788999999876665 688999999999999998 99999887777766666644 3


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          234 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       234 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ...|..++..+.+++.+||+.+|++|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~  274 (277)
T cd05032         240 LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS  274 (277)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            45677789999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.7e-44  Score=314.36  Aligned_cols=253  Identities=34%  Similarity=0.587  Sum_probs=221.4

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+..... .......+.+|+++++.++|||++++++.+......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            68999999999999999999999999999999865432 23456678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           95 YVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        95 ~~~g~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      ++++++|.+++.+.    ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--  157 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV--  157 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence            99999999998763    679999999999999999999999999999999999999999999999999987543321  


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHH
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR  249 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~  249 (344)
                      .......|++.|+|||.+.+... +.++|+||+|+++++|++|+.||...+........... ...+|..++..+.++++
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  236 (258)
T cd08215         158 DLAKTVVGTPYYLSPELCQNKPY-NYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS  236 (258)
T ss_pred             ceecceeeeecccChhHhccCCC-CccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence            12334578899999999877665 68899999999999999999999888766666666554 34556678999999999


Q ss_pred             HhcCCCcCCCCCHhhhhcCccc
Q 019216          250 KILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       250 ~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      +||..+|++|||+.++++||||
T Consensus       237 ~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         237 SLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHcCCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-44  Score=322.99  Aligned_cols=252  Identities=31%  Similarity=0.459  Sum_probs=209.5

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~   95 (344)
                      |++.+.||.|++|.||+|.++.+|..||+|++..... .......+.+|+.+++.++|||++++++++......+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            6789999999999999999999999999999865432 223345678899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           96 VTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        96 ~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ++ ++|.+++....  .+++..+..++.|++.||+|||+.+++||||+|+||+++.++.++|+|||++......  ....
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~  156 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY  156 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence            94 68999887765  6899999999999999999999999999999999999999999999999998743321  1112


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--------------------
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--------------------  233 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--------------------  233 (344)
                      ....++..|+|||++.+....+.++||||||+++|+|++|+.||...+......++.+..                    
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            233568899999988765545688999999999999999999998766544433332210                    


Q ss_pred             ---------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          234 ---------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       234 ---------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                               ......++..+.++|.+||+.||.+|||+.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence                     01123467899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.9e-44  Score=320.90  Aligned_cols=246  Identities=27%  Similarity=0.480  Sum_probs=204.8

Q ss_pred             ccCeEEeeee--cccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeE
Q 019216           13 LGRYELGRTL--GEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        13 ~~~y~~~~~L--g~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~   89 (344)
                      .++|++.+.+  |.|+||.||++.++.++..+|+|.+.......        .|+.....+ +|||++++++.+...+..
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~   84 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGH   84 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCee
Confidence            4677787776  99999999999999999999999986543211        122222222 699999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC-CeEEeccccccCCCccc
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFR  168 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~-~vkl~Dfg~a~~~~~~~  168 (344)
                      ++||||+++++|.+++.++..+++..++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++.....  
T Consensus        85 ~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~--  162 (267)
T PHA03390         85 VLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT--  162 (267)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC--
Confidence            99999999999999998877899999999999999999999999999999999999999998 999999998874321  


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHH----HHHHhhCCCCCCCCCCHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL----YQKIFRGDFKLPKWLSPGA  244 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~  244 (344)
                          .....++..|+|||.+.+..+ +.++||||||+++|+|++|+.||........    ...........++.+++.+
T Consensus       163 ----~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T PHA03390        163 ----PSCYDGTLDYFSPEKIKGHNY-DVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNVSKNA  237 (267)
T ss_pred             ----CccCCCCCcccChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCcccccCHHH
Confidence                223468899999999987666 6889999999999999999999976443221    2222234445666799999


Q ss_pred             HHHHHHhcCCCcCCCCC-HhhhhcCccccc
Q 019216          245 QNLLRKILEPNPVKRIT-IAGIKADEWFEQ  273 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps-~~eil~~~~~~~  273 (344)
                      .+||.+||+.+|.+||+ ++++|+||||++
T Consensus       238 ~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        238 NDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            99999999999999996 699999999963

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-46  Score=336.38  Aligned_cols=260  Identities=33%  Similarity=0.626  Sum_probs=224.2

Q ss_pred             hccCcccc-CeEE--eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEE
Q 019216            7 KQEGMRLG-RYEL--GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL   83 (344)
Q Consensus         7 ~~~~~~~~-~y~~--~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~   83 (344)
                      .++.+.+. -|++  -+.||+|-||+||-|+++.+|+.||||++.+.++.... ...+.+|+.||+.+.||+|+.+--.|
T Consensus       554 iqe~vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~  632 (888)
T KOG4236|consen  554 IQENVDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMF  632 (888)
T ss_pred             hhhhhhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEee
Confidence            34444444 2554  47899999999999999999999999999988776543 47899999999999999999999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC---CeEEecc
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDF  158 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~--~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~---~vkl~Df  158 (344)
                      ++.+++++|||.+. |+..+.+-  +.+++++...+.++.||+.||.|||.+||+|+||||+|||+....   ++|||||
T Consensus       633 ET~ervFVVMEKl~-GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDF  711 (888)
T KOG4236|consen  633 ETPERVFVVMEKLH-GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDF  711 (888)
T ss_pred             cCCceEEEEehhhc-chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccc
Confidence            99999999999995 56666664  467899999999999999999999999999999999999997653   7999999


Q ss_pred             ccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC-
Q 019216          159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-  237 (344)
Q Consensus       159 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-  237 (344)
                      |+|++.+   ..+...+.+|||.|.|||++.+.+|+ ..-|+||+|+++|--++|..||...  +++..+|.+..+.+| 
T Consensus       712 GfARiIg---EksFRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp  785 (888)
T KOG4236|consen  712 GFARIIG---EKSFRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPP  785 (888)
T ss_pred             cceeecc---hhhhhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCC
Confidence            9999754   35556778999999999999999986 7899999999999999999999653  345566666665555 


Q ss_pred             ---CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          238 ---KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       238 ---~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                         +.+++.+.+||+.+|+..-.+|.|.+..|.|||+++.
T Consensus       786 ~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  786 NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence               3489999999999999999999999999999999864

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-44  Score=313.14  Aligned_cols=253  Identities=32%  Similarity=0.535  Sum_probs=220.8

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+...... ......+.+|++++++++|+|++++++++......+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            689999999999999999999999999999998765432 2456789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccc
Q 019216           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (344)
Q Consensus        95 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~  174 (344)
                      |+++++|.+++.+.+.+++..+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||++.......  ....
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~--~~~~  157 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVS--KDDA  157 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCc--cccc
Confidence            99999999999888889999999999999999999999999999999999999999999999999988543321  1123


Q ss_pred             cccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh-hCCCCCCCCCCHHHHHHHHHhcC
Q 019216          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-RGDFKLPKWLSPGAQNLLRKILE  253 (344)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~li~~~L~  253 (344)
                      ...++..|+|||.+.+... +.++||||||+++|+|++|..||............. .....++..++..+.+++.+||.
T Consensus       158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  236 (254)
T cd06627         158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ  236 (254)
T ss_pred             ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence            4568889999999877664 688999999999999999999998766544443433 34455677789999999999999


Q ss_pred             CCcCCCCCHhhhhcCccc
Q 019216          254 PNPVKRITIAGIKADEWF  271 (344)
Q Consensus       254 ~dP~~Rps~~eil~~~~~  271 (344)
                      .+|++|||+.+++.||||
T Consensus       237 ~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         237 KDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             CChhhCcCHHHHhcCCCC
Confidence            999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.8e-44  Score=323.76  Aligned_cols=257  Identities=28%  Similarity=0.450  Sum_probs=214.4

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeE
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV   82 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~   82 (344)
                      -.+..++|++.+.||+|+||.||++.++..     ...+|+|.+....  .......+.+|+.+++++ +|+||++++++
T Consensus         7 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   84 (293)
T cd05053           7 WELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGV   84 (293)
T ss_pred             cccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            345667999999999999999999997643     3789999886432  233456788999999999 79999999999


Q ss_pred             EeeCCeEEEEEeccCCCChHHHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEE
Q 019216           83 LASKSKIYMVLEYVTGGELFDKIAS----------------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL  146 (344)
Q Consensus        83 ~~~~~~~~iv~e~~~g~~L~~~l~~----------------~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NIL  146 (344)
                      +...+.++++|||+++++|.+++..                .+.+++..+..++.|++.||+|||+.||+||||||+|||
T Consensus        85 ~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil  164 (293)
T cd05053          85 CTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVL  164 (293)
T ss_pred             EcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEE
Confidence            9999999999999999999999864                245889999999999999999999999999999999999


Q ss_pred             EccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHH
Q 019216          147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL  225 (344)
Q Consensus       147 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~  225 (344)
                      ++.++.+||+|||+++...............++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+......
T Consensus       165 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  243 (293)
T cd05053         165 VTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  243 (293)
T ss_pred             EcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCc-CcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence            99999999999999885433211111122334567999999877665 688999999999999998 9999998877776


Q ss_pred             HHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          226 YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       226 ~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ...+..+ ....+..++..+.+|+.+||..||++|||+.+++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         244 FKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             HHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            6666554 345566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.9e-44  Score=328.98  Aligned_cols=257  Identities=30%  Similarity=0.405  Sum_probs=212.9

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC----
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----   87 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----   87 (344)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|.+.+.. ........+.+|+.+++.++||||+++++++....    
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR   91 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence            4578999999999999999999999999999999985432 23334567889999999999999999999986543    


Q ss_pred             --eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           88 --KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        88 --~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                        .+++||||+ |++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||+++.++.++|+|||++....
T Consensus        92 ~~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~  169 (343)
T cd07880          92 FHDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD  169 (343)
T ss_pred             cceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence              468999999 7799887764 679999999999999999999999999999999999999999999999999987432


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-----------
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-----------  234 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-----------  234 (344)
                      .     ......+++.|+|||.+.+....+.++|+||||+++|+|++|+.||.+.+.......+.....           
T Consensus       170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07880         170 S-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ  244 (343)
T ss_pred             c-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence            2     223446788999999987644457889999999999999999999987665444433322110           


Q ss_pred             --------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          235 --------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       235 --------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                                          .....+++.+.++|.+||+.||++|||+.+++.||||+....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~  306 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD  306 (343)
T ss_pred             chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence                                112357888999999999999999999999999999987544

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.4e-44  Score=324.54  Aligned_cols=260  Identities=27%  Similarity=0.444  Sum_probs=218.4

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      .+...++|++.+.||+|+||.||++.+..+++.||+|.+....   ....+.+.+|+.+++.++|||++++++.+.....
T Consensus        14 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~   90 (293)
T cd06647          14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDE   90 (293)
T ss_pred             ccCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCc
Confidence            3556789999999999999999999998899999999985432   2234678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      .|+|+||+++++|.+++.+ ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... 
T Consensus        91 ~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~-  168 (293)
T cd06647          91 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-  168 (293)
T ss_pred             EEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc-
Confidence            9999999999999998865 45889999999999999999999999999999999999999999999999987643321 


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC-C--CCCCCCCCHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-D--FKLPKWLSPGAQ  245 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~-~--~~~~~~~~~~~~  245 (344)
                       ........+++.|+|||.+....+ +.++|+||||+++|++++|+.||...+.......+... .  ...+..++..+.
T Consensus       169 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  246 (293)
T cd06647         169 -QSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR  246 (293)
T ss_pred             -ccccccccCChhhcCchhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHH
Confidence             112233468889999999877665 68899999999999999999999876654433322222 1  223345788999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          246 NLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      ++|++||+.+|++||++.+++.|+||+...
T Consensus       247 ~li~~~l~~~p~~Rp~~~~il~h~~~~~~~  276 (293)
T cd06647         247 DFLNRCLEMDVEKRGSAKELLQHPFLKIAK  276 (293)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence            999999999999999999999999998654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.4e-44  Score=319.72  Aligned_cols=252  Identities=30%  Similarity=0.501  Sum_probs=211.8

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +++|++.+.||+|++|.||+|.+..+++.+|+|.+.............+.+|+.+++.+.||||+++++++...+..+++
T Consensus         1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence            47899999999999999999999999999999988755444445567888999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...... 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-  159 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-  159 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC-
Confidence            999999999998863    346899999999999999999999999999999999999999999999999998754321 


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH--HHHHHHHhhCCC-CC-CCCCCHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL--AVLYQKIFRGDF-KL-PKWLSPGA  244 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~--~~~~~~i~~~~~-~~-~~~~~~~~  244 (344)
                       ........++..|+|||.+.+..+ +.++|+||||+++|+|++|..||.+...  ......+..... +. +..+++.+
T Consensus       160 -~~~~~~~~~~~~~~ape~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08229         160 -TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL  237 (267)
T ss_pred             -CcccccccCCcCccCHHHhcCCCc-cchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHH
Confidence             112234578899999999877665 5889999999999999999999976432  233333333222 22 24578999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhc
Q 019216          245 QNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .+++.+||+.||++|||+.++++
T Consensus       238 ~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         238 RQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHHhcCCCcccCCCHHHHHH
Confidence            99999999999999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-46  Score=340.63  Aligned_cols=252  Identities=25%  Similarity=0.395  Sum_probs=217.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++..+.+.||+|.||+||+|.+-.+   ||||++...... .+..+.|++|+.++++-+|.||+-+.|++..... .
T Consensus       389 Ip~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A  463 (678)
T KOG0193|consen  389 IPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPT-PEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A  463 (678)
T ss_pred             cCHHHhhccceeccccccceeecccccc---eEEEEEecCCCC-HHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence            5566778899999999999999998664   999999776554 4588999999999999999999999999988776 9


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      ||+.+|+|.+|+.++.- ...+.....+.|++|+++|+.|||.++|||||||..||++.++++|||+|||++........
T Consensus       464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g  543 (678)
T KOG0193|consen  464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG  543 (678)
T ss_pred             eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence            99999999999999863 45689999999999999999999999999999999999999999999999999987665544


Q ss_pred             CCccccccCCCcccchhhhccC--CCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC-----CCCCCCH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSP  242 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~~~  242 (344)
                      .......-|...|||||+++..  ..+++.+|||||||++|||++|..||...+.+.+...+-++-..     .-..++.
T Consensus       544 ~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk  623 (678)
T KOG0193|consen  544 EQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPK  623 (678)
T ss_pred             ccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHH
Confidence            4455566788899999998642  23478999999999999999999999987777777666666221     2244778


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ++++|+..||..++++||.+.+||.
T Consensus       624 ~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  624 AMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHHhcCcccCccHHHHHH
Confidence            9999999999999999999999987

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.3e-44  Score=325.23  Aligned_cols=258  Identities=26%  Similarity=0.464  Sum_probs=217.5

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      ..-|+....||+|+||.||+|.+..+++.||+|.+.....   ...+.+.+|+.+++.++|||++++++.+..+...+++
T Consensus        20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv   96 (297)
T cd06659          20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVL   96 (297)
T ss_pred             hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEE
Confidence            4455667789999999999999999999999999864332   2346688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++......  ...
T Consensus        97 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~  173 (297)
T cd06659          97 MEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPK  173 (297)
T ss_pred             EecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--ccc
Confidence            999999999887654 56899999999999999999999999999999999999999999999999998643221  112


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC---CCCCCCCHHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQNLLR  249 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li~  249 (344)
                      .....++..|+|||.+.+..+ +.++|||||||++|+|++|+.||...+.......+.....   ..+..+++.+.++|+
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~  252 (297)
T cd06659         174 RKSLVGTPYWMAPEVISRTPY-GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLE  252 (297)
T ss_pred             ccceecCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHH
Confidence            234578899999999987665 6899999999999999999999987776655555543322   223457889999999


Q ss_pred             HhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          250 KILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       250 ~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      +||+.+|++||++.++++|+||.+...+
T Consensus       253 ~~l~~~P~~Rps~~~ll~~~~~~~~~~~  280 (297)
T cd06659         253 RMLTREPQERATAQELLDHPFLLQTGLP  280 (297)
T ss_pred             HHhcCCcccCcCHHHHhhChhhccCCCc
Confidence            9999999999999999999999876544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-43  Score=314.86  Aligned_cols=256  Identities=31%  Similarity=0.502  Sum_probs=216.2

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccc--ccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC--CeE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR--IIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI   89 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~--~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~   89 (344)
                      .+|++.+.||+|++|.||+|.+..+++.||+|.+....  .........+.+|+.++++++|+||+++++.+...  ..+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            47999999999999999999999999999999875322  12234567889999999999999999999988653  568


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      ++++||+++++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  161 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM  161 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence            89999999999999998878899999999999999999999999999999999999999999999999999875432111


Q ss_pred             -CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CCCCCCCCCHHHHH
Q 019216          170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQN  246 (344)
Q Consensus       170 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~  246 (344)
                       ........++..|+|||.+.+... +.++|+|||||++|+|++|+.||..........++...  ...+|..+++.+.+
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~  240 (264)
T cd06653         162 SGTGIKSVTGTPYWMSPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD  240 (264)
T ss_pred             cCccccccCCcccccCHhhhcCCCC-CccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence             111234568899999999887665 58899999999999999999999876655544444433  34568889999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          247 LLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      ++.+||+ +|.+||++.+++.|||.
T Consensus       241 ~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         241 FLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHhc-CcccCccHHHHhcCCCC
Confidence            9999999 57999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1e-43  Score=315.37  Aligned_cols=252  Identities=31%  Similarity=0.496  Sum_probs=212.6

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      .++|++.+.||+|++|.||+|.+..+|+.||+|.++............+.+|+.++++++|+|++++++.+...+..+++
T Consensus         1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            37899999999999999999999989999999998754444455567899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      |||+++++|.+++.+    ...+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... 
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-  159 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-  159 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC-
Confidence            999999999998864    345899999999999999999999999999999999999999999999999998743221 


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc--HHHHHHHHhhCC-CCCCC-CCCHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGD-FKLPK-WLSPGA  244 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~--~~~~~~~i~~~~-~~~~~-~~~~~~  244 (344)
                       ........++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||....  .......+..+. .+.|. .++..+
T Consensus       160 -~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (267)
T cd08224         160 -TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL  237 (267)
T ss_pred             -CcccceecCCccccCHHHhccCCC-CchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHH
Confidence             112234568889999999887666 578999999999999999999996543  233334443332 23443 688899


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhc
Q 019216          245 QNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .++|.+||..+|++|||+.++++
T Consensus       238 ~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         238 RDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHHcCCCcccCCCHHHHHH
Confidence            99999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.5e-44  Score=322.85  Aligned_cols=254  Identities=23%  Similarity=0.294  Sum_probs=210.5

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCC----------------ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG----------------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP   74 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~----------------~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~   74 (344)
                      +..++|++++.||+|+||.||+|.+...+                ..||+|.+.....  ....+.+.+|++++++++||
T Consensus         2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~   79 (296)
T cd05051           2 FPRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDP   79 (296)
T ss_pred             CchhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCC
Confidence            46789999999999999999999876543                4689998864432  24567888999999999999


Q ss_pred             CccceeeEEeeCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCC
Q 019216           75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLE  143 (344)
Q Consensus        75 niv~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~-----------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~  143 (344)
                      ||+++++++..+...+++||++.+++|.+++.+..           .+++..++.++.|++.||+|||++|++||||||+
T Consensus        80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~  159 (296)
T cd05051          80 NIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATR  159 (296)
T ss_pred             CEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence            99999999999899999999999999999997655           6899999999999999999999999999999999


Q ss_pred             cEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh--CCCCCCCcc
Q 019216          144 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRN  221 (344)
Q Consensus       144 NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~--g~~pf~~~~  221 (344)
                      ||+++.++.++|+|||++................++..|+|||.+.+..+ +.++|||||||++|+|++  |..||...+
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         160 NCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             ceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            99999999999999999874322111112233456778999999877655 689999999999999998  788998766


Q ss_pred             HHHHHHHHhhC--------CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          222 LAVLYQKIFRG--------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       222 ~~~~~~~i~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ...........        ..+.+..++.++.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            55555444322        12334567899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.5e-44  Score=320.13  Aligned_cols=248  Identities=34%  Similarity=0.524  Sum_probs=204.7

Q ss_pred             EEeeeecccCceEEEEEEEC----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           17 ELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        17 ~~~~~Lg~G~~g~Vy~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      .+.+.||.|+||.||+|...    ..+..|+||.+..  ....+..+.+.+|++.+++++||||+++++++......++|
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~--~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv   79 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP--SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV   79 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST--TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc--ccccccceeeeeccccccccccccccccccccccccccccc
Confidence            56899999999999999987    4567899999843  22344578899999999999999999999999988889999


Q ss_pred             EeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           93 LEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      +||+++|+|.+++...  ..+++.....++.||+.||.|||+++++|+||++.|||++.++.+||+|||++.........
T Consensus        80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999876  67999999999999999999999999999999999999999999999999998754211111


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL  248 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li  248 (344)
                      ...........|+|||.+.+..+ +.++||||||+++||+++ |+.||.+.+......++..+. ...+..++..+.++|
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~-~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  238 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEY-TKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI  238 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEE-SHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred             ccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence            12233456678999999887765 689999999999999999 789999888877777775553 455677899999999


Q ss_pred             HHhcCCCcCCCCCHhhhhc
Q 019216          249 RKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~  267 (344)
                      .+||+.||++|||+.++++
T Consensus       239 ~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  239 QQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHT-SSGGGS--HHHHHH
T ss_pred             HHHcCCChhhCcCHHHHHh
Confidence            9999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.1e-44  Score=315.32  Aligned_cols=246  Identities=29%  Similarity=0.416  Sum_probs=213.6

Q ss_pred             eeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecc
Q 019216           20 RTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV   96 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~   96 (344)
                      +.||+|+||.||+|.+...   +..||+|.+.......  ..+.+.+|+.+++.++|+|++++++++......+++|||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            4799999999999998866   8999999986543222  4678899999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           97 TGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        97 ~g~~L~~~l~~~---------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ++++|.+++...         ..+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||.+......
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  158 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD  158 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence            999999999875         77999999999999999999999999999999999999999999999999999854432


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ  245 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~  245 (344)
                      ..........++..|+|||.+....+ +.++||||||+++|+|++ |..||...........+..+ ....+..+++++.
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (262)
T cd00192         159 DYYRKKTGGKLPIRWMAPESLKDGIF-TSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY  237 (262)
T ss_pred             cccccccCCCcCccccCHHHhccCCc-chhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence            21122334567889999999877654 689999999999999999 69999988877777777654 4456778899999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhcC
Q 019216          246 NLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +++.+||+.+|++|||+.+++++
T Consensus       238 ~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         238 ELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHccCCcccCcCHHHHHHh
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.6e-44  Score=321.24  Aligned_cols=253  Identities=27%  Similarity=0.403  Sum_probs=212.1

Q ss_pred             ccccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      +..++|.+.+.||+|+||.||+|.+.     .++..+++|.+....   ....+.+.+|+.++++++|+||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (291)
T cd05094           2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLTNLQHEHIVKFYGVCGD   78 (291)
T ss_pred             CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence            45678999999999999999999854     345678999875332   2334678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS  149 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~  149 (344)
                      ....++||||+++++|.+++...+                .+++..++.++.||+.||+|||++|++||||||+|||++.
T Consensus        79 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~  158 (291)
T cd05094          79 GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGA  158 (291)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEcc
Confidence            999999999999999999997532                3789999999999999999999999999999999999999


Q ss_pred             CCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHH
Q 019216          150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK  228 (344)
Q Consensus       150 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~  228 (344)
                      ++.++|+|||++................++..|+|||.+.+..+ +.++|||||||++|+|++ |+.||...+.......
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  237 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC  237 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999874332211112223456788999999887665 688999999999999999 9999988777666666


Q ss_pred             HhhCCC-CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          229 IFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       229 i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      +..+.. ..+..++..+.+++.+||+.||++|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         238 ITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             HhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            665543 345668899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=8.6e-44  Score=316.52  Aligned_cols=252  Identities=30%  Similarity=0.483  Sum_probs=208.1

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      .......||+|+||.||+|.+..++..||+|.+....   ....+.+.+|+.+++.++|+||+++++++..++..++++|
T Consensus         9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   85 (268)
T cd06624           9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD---SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME   85 (268)
T ss_pred             cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC---HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence            3344568999999999999999999999999876432   2345678899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc-CCCeEEeccccccCCCcccCC
Q 019216           95 YVTGGELFDKIASK-GRL--QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        95 ~~~g~~L~~~l~~~-~~~--~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~-~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      |+++++|.+.+... ..+  ++..+..++.|++.||+|||+.||+||||||+||+++. ++.++|+|||++......  .
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~  163 (268)
T cd06624          86 QVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--N  163 (268)
T ss_pred             cCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC--C
Confidence            99999999998754 455  78889999999999999999999999999999999976 679999999998744221  1


Q ss_pred             CccccccCCCcccchhhhccCC-CCCccchhhhhhHHHHHHHhCCCCCCCccHH--HHHH-HHhhCCCCCCCCCCHHHHH
Q 019216          171 GLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLA--VLYQ-KIFRGDFKLPKWLSPGAQN  246 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~ll~ell~g~~pf~~~~~~--~~~~-~i~~~~~~~~~~~~~~~~~  246 (344)
                      .......++..|+|||.+.... ..+.++|+||||+++|+|++|+.||......  .... ........+|..+++.+.+
T Consensus       164 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (268)
T cd06624         164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKN  243 (268)
T ss_pred             CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHH
Confidence            1223345788999999986533 2467899999999999999999999754321  1111 1223345567788999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          247 LLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      ++++||+.+|++|||+.+++.||||
T Consensus       244 li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         244 FILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             HHHHHcCCCchhCCCHHHHHhCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-43  Score=318.67  Aligned_cols=254  Identities=30%  Similarity=0.455  Sum_probs=210.0

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee--CCeEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKIYM   91 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~i   91 (344)
                      ++|+..+.||.|++|.||+|.+..+++.+|+|.+.....  ......+.+|++++++++||||+++++++..  ...+++
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l   78 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI   78 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence            579999999999999999999999999999999865432  2345778899999999999999999998854  347899


Q ss_pred             EEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           92 VLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ||||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..... 
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~-  157 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN-  157 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence            9999999999887653    34589999999999999999999999999999999999999999999999999864321 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc-----cHHHHHHHHhhCC-CCCC----
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRGD-FKLP----  237 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~-----~~~~~~~~i~~~~-~~~~----  237 (344)
                         .......++..|+|||.+.+..+ +.++|||||||++|+|++|+.||...     ........+.... ..++    
T Consensus       158 ---~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         158 ---SLAGTFTGTSFYMAPERIQGKPY-SITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             ---cccccccCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence               11223467889999999877665 57899999999999999999999765     2233333333321 1121    


Q ss_pred             --CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          238 --KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       238 --~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                        ..+++.+.+++.+||+.+|++|||+.|++.|+||...
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~  272 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQ  272 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccc
Confidence              2356789999999999999999999999999999654

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.2e-44  Score=330.00  Aligned_cols=258  Identities=30%  Similarity=0.423  Sum_probs=214.6

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe---
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK---   88 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---   88 (344)
                      .-++|++.+.||+|++|.||+|.+..+++.||+|++.... ........+.+|+.+++.++|||++++++++.....   
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLED   91 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccc
Confidence            4578999999999999999999999999999999886432 223345677889999999999999999988765544   


Q ss_pred             ---EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           89 ---IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        89 ---~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                         .++|+||+ +++|.+++.. .++++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++....
T Consensus        92 ~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~  169 (343)
T cd07851          92 FQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD  169 (343)
T ss_pred             cccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccccccc
Confidence               89999999 7799888865 579999999999999999999999999999999999999999999999999987432


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-----------
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-----------  234 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-----------  234 (344)
                      .     ......++..|+|||.+.+....+.++||||||+++|+|++|+.||.+.+.......+.....           
T Consensus       170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         170 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             c-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence            2     133456788999999987644457899999999999999999999987766555444432110           


Q ss_pred             --------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          235 --------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       235 --------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                          .....+++.+.++|.+||+.||++|||+.++++||||.+...+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             chhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence                                0112358899999999999999999999999999999875443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.7e-45  Score=339.91  Aligned_cols=259  Identities=27%  Similarity=0.481  Sum_probs=223.0

Q ss_pred             ccccCe-EEeeeecccCceEEEEEEECCCCceEEEEEeeccc-ccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216           11 MRLGRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR-IIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus        11 ~~~~~y-~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..=||| +....||+|+|-+||+|.|..+|..||.-.+.-.. ...++.++++..|+.+|+.|+||||+++|+++.+...
T Consensus        36 ~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n  115 (632)
T KOG0584|consen   36 DPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN  115 (632)
T ss_pred             CCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC
Confidence            344555 34588999999999999999999999875443222 2345667899999999999999999999999876554


Q ss_pred             --EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceeecCCCCcEEEccC-CCeEEeccccccC
Q 019216           89 --IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--GVFHRDLKLENILLDSK-GNIKISDFGLSAL  163 (344)
Q Consensus        89 --~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~--~i~H~dikp~NILl~~~-~~vkl~Dfg~a~~  163 (344)
                        +.+|+|.+.+|+|+.|+++.+.++...++.|++||+.||.|||++  .|+|||||-+||+|+.+ |.|||+|+|+|..
T Consensus       116 ~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  116 KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHH
Confidence              789999999999999999999999999999999999999999998  59999999999999876 8999999999985


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCC-CccHHHHHHHHhhCCCC--CCCCC
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDFK--LPKWL  240 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~-~~~~~~~~~~i~~~~~~--~~~~~  240 (344)
                      .    ........+|||.|||||++. ..| ...+||||||+.|.||.|+..||. +.+...+++++..|..+  +.+--
T Consensus       196 ~----r~s~aksvIGTPEFMAPEmYE-E~Y-nE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~  269 (632)
T KOG0584|consen  196 L----RKSHAKSVIGTPEFMAPEMYE-ENY-NELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVK  269 (632)
T ss_pred             h----hccccceeccCccccChHHHh-hhc-chhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccC
Confidence            4    334455689999999999986 455 589999999999999999999996 56788899999888543  44555


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      +|++++||.+||.. .+.|+|+.|+|.|+||..+-.
T Consensus       270 dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g  304 (632)
T KOG0584|consen  270 DPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGG  304 (632)
T ss_pred             CHHHHHHHHHHhcC-chhccCHHHHhhChhhccccc
Confidence            89999999999999 999999999999999987533

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=7.1e-44  Score=319.37  Aligned_cols=256  Identities=23%  Similarity=0.378  Sum_probs=205.7

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCccceeeEEeeCCeEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|.+.......  ....+..|+.+ ++.++||||+++++++......|++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv   78 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC   78 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence            47999999999999999999999999999999986543222  22345556654 6667899999999999999999999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~-~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      |||++ ++|.+++..    ...+++..++.++.|++.||.|||++ +++||||||+||+++.++.+||+|||++..... 
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~-  156 (283)
T cd06617          79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVD-  156 (283)
T ss_pred             hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccc-
Confidence            99996 588777653    34689999999999999999999997 999999999999999999999999999874322 


Q ss_pred             cCCCccccccCCCcccchhhhccC---CCCCccchhhhhhHHHHHHHhCCCCCCCc-cHHHHHHHHhhC-CCCCC-CCCC
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRG-DFKLP-KWLS  241 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DvwslG~ll~ell~g~~pf~~~-~~~~~~~~i~~~-~~~~~-~~~~  241 (344)
                        ........++..|+|||.+.+.   ...+.++|+|||||++|+|++|+.||... ........+... ...++ ..++
T Consensus       157 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd06617         157 --SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFS  234 (283)
T ss_pred             --ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCccccC
Confidence              1112234678899999988642   22367899999999999999999999753 222222233332 33333 3578


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      .++.++|.+||..+|++|||+.++++||||....
T Consensus       235 ~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  268 (283)
T cd06617         235 PEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL  268 (283)
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence            9999999999999999999999999999998753

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=9.4e-44  Score=318.22  Aligned_cols=253  Identities=24%  Similarity=0.346  Sum_probs=209.6

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      +...+|++++.||+|+||+||+|.+..+++    .||+|++....  .......+.+|+.+++.+.||||+++++++...
T Consensus         4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~   81 (279)
T cd05109           4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS   81 (279)
T ss_pred             cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence            345789999999999999999999877776    48999885432  233456788999999999999999999998754


Q ss_pred             CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                       ..++++||+++|+|.+.+.. .+.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++...
T Consensus        82 -~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          82 -TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             -CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecc
Confidence             57789999999999999876 4568999999999999999999999999999999999999999999999999987543


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHH
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG  243 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~  243 (344)
                      ............++..|+|||.+.+..+ +.++|||||||++|||++ |..||...........+..+ ..+.+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRF-THQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTID  239 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCC-CchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHH
Confidence            2211111222344678999999877665 589999999999999998 99999877666555555444 34456678999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      +.+++.+||+.||++||++.+++.
T Consensus       240 ~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         240 VYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=4.1e-44  Score=335.31  Aligned_cols=254  Identities=26%  Similarity=0.401  Sum_probs=206.7

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEe
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLA   84 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~   84 (344)
                      ...++|+++++||+|+||.||+|.+...     +..||+|++....  .....+.+.+|+.+++++. ||||+++++++.
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            4567888999999999999999987433     3579999986432  2334567899999999996 999999999999


Q ss_pred             eCCeEEEEEeccCCCChHHHHHhc--------------------------------------------------------
Q 019216           85 SKSKIYMVLEYVTGGELFDKIASK--------------------------------------------------------  108 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~~--------------------------------------------------------  108 (344)
                      .....|+|||||++|+|.+++..+                                                        
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            999999999999999999887542                                                        


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEc
Q 019216          109 ----------------------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD  148 (344)
Q Consensus       109 ----------------------------------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~  148 (344)
                                                              ..+++..+..++.|++.||.|||+.||+||||||+|||++
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~  271 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence                                                    1367788899999999999999999999999999999999


Q ss_pred             cCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHH-HH
Q 019216          149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV-LY  226 (344)
Q Consensus       149 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~-~~  226 (344)
                      .++.+||+|||+++...............++..|+|||.+.+..+ +.++|||||||++|+|++ |..||....... ..
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLY-TTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            999999999999875432211112223456788999999877665 689999999999999997 999998754333 33


Q ss_pred             HHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          227 QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       227 ~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ..+..+ ....+..+++.+.+++.+||+.||++|||+.++.+
T Consensus       351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            333333 34456678999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.5e-44  Score=328.71  Aligned_cols=265  Identities=30%  Similarity=0.385  Sum_probs=215.5

Q ss_pred             cccCeEE-eeeecccCceEEEEEEECCCCceEEEEEeecccccchh-----------HHHHHHHHHHHHHhCCCCCccce
Q 019216           12 RLGRYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----------ITDQIKREIATLKLLKHPNVVRL   79 (344)
Q Consensus        12 ~~~~y~~-~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~h~niv~l   79 (344)
                      .-++|.. .+.||+|+||.||+|.++.+++.||+|.+.........           ....+.+|+.+++.++|+||+++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~   85 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGL   85 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeee
Confidence            3468875 57799999999999999999999999998654322100           11247789999999999999999


Q ss_pred             eeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccc
Q 019216           80 HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG  159 (344)
Q Consensus        80 ~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg  159 (344)
                      ++++......+++|||+. ++|.+++.....+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||
T Consensus        86 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         86 VDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             eEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence            999999999999999996 5999999888889999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc------------cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHH
Q 019216          160 LSALPQHF------------RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ  227 (344)
Q Consensus       160 ~a~~~~~~------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~  227 (344)
                      ++......            ..........++..|+|||.+.+....+.++|+|||||++|+|++|+.||.+.+......
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~  244 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG  244 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            98754310            011112234568889999998765555789999999999999999999998877655554


Q ss_pred             HHhhCC--C--------------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          228 KIFRGD--F--------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       228 ~i~~~~--~--------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      .+....  .                          ......+..+.++|.+||+.+|++|||+++++.||||+....+
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~  322 (335)
T PTZ00024        245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP  322 (335)
T ss_pred             HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence            443210  0                          0012357889999999999999999999999999999876444

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=7.1e-44  Score=323.53  Aligned_cols=255  Identities=27%  Similarity=0.445  Sum_probs=211.5

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV   82 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~   82 (344)
                      ...++|.+.+.||+|+||.||+|.+..       ++..+|+|.+....  .......+.+|+.+++.+ +||||++++++
T Consensus        15 ~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          15 VPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             eehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            345899999999999999999998643       23579999986542  223356788899999999 79999999999


Q ss_pred             EeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEE
Q 019216           83 LASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL  146 (344)
Q Consensus        83 ~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NIL  146 (344)
                      +......|+||||+++++|.+++...+                .+++..+..++.|++.||+|||++|++||||||+||+
T Consensus        93 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nil  172 (307)
T cd05098          93 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  172 (307)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheE
Confidence            999999999999999999999997542                4788999999999999999999999999999999999


Q ss_pred             EccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHH
Q 019216          147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL  225 (344)
Q Consensus       147 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~  225 (344)
                      ++.++.+||+|||++................++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+......
T Consensus       173 l~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~  251 (307)
T cd05098         173 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  251 (307)
T ss_pred             EcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCC-CcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHH
Confidence            99999999999999874432111111112234568999999877665 689999999999999998 9999988777666


Q ss_pred             HHHHhhCC-CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          226 YQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       226 ~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ...+.... .+.|..++.++.+|+.+||..+|.+|||+.+++++
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         252 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            66665543 45677789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=8.3e-44  Score=314.72  Aligned_cols=250  Identities=24%  Similarity=0.416  Sum_probs=209.6

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      ..++|++++.||+|++|.||+|.+.. +..+|+|.+.....    ....+.+|+.++++++||||+++++++......++
T Consensus         2 ~~~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   76 (256)
T cd05113           2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYI   76 (256)
T ss_pred             ChHHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEE
Confidence            45689999999999999999998744 45699998864332    13568899999999999999999999998888999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      +|||+.+++|.+++... ..+++..++.++.|++.||+|||+.|++|+||||.||+++.++.+||+|||.+....... .
T Consensus        77 v~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~-~  155 (256)
T cd05113          77 VTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-Y  155 (256)
T ss_pred             EEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc-e
Confidence            99999999999998764 468999999999999999999999999999999999999999999999999887432211 0


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC-CCCCCCCCHHHHHHH
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL  248 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li  248 (344)
                      .......++..|+|||.+.+..+ +.++||||||+++|+|++ |+.||...+.......+..+. ...+...+..+.+++
T Consensus       156 ~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  234 (256)
T cd05113         156 TSSVGSKFPVRWSPPEVLLYSKF-SSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIM  234 (256)
T ss_pred             eecCCCccChhhCCHHHHhcCcc-cchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence            11112234567999999877665 578999999999999998 999998877766666666653 334566889999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcC
Q 019216          249 RKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+||+.||.+||++.+++.+
T Consensus       235 ~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         235 YSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHcCCCcccCCCHHHHHHh
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=9.1e-44  Score=321.31  Aligned_cols=250  Identities=28%  Similarity=0.422  Sum_probs=208.9

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCc--eEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~   89 (344)
                      +++|++.+.||+|+||.||+|.++.++.  .+++|.++..  ......+.+.+|+.++.++ +||||+++++++......
T Consensus         1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~   78 (297)
T cd05089           1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYL   78 (297)
T ss_pred             CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcc
Confidence            4689999999999999999999877765  4688877532  2233456788999999999 699999999999998999


Q ss_pred             EEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCe
Q 019216           90 YMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNI  153 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~v  153 (344)
                      +++|||+++++|.+++.+..                .+++..++.++.|++.||+|||++|++||||||+|||+++++.+
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~  158 (297)
T cd05089          79 YIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLAS  158 (297)
T ss_pred             eEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeE
Confidence            99999999999999986532                47889999999999999999999999999999999999999999


Q ss_pred             EEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC
Q 019216          154 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG  232 (344)
Q Consensus       154 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~  232 (344)
                      ||+|||++......   ........+..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+........++..+
T Consensus       159 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~  234 (297)
T cd05089         159 KIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVY-TTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  234 (297)
T ss_pred             EECCcCCCccccce---eccCCCCcCccccCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence            99999998632211   01111223457999999877665 689999999999999997 99999988877777766654


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          233 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       233 -~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                       ....+..+++.+.+|+.+||+.+|.+|||++++++.
T Consensus       235 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         235 YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence             345667789999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=8.7e-44  Score=320.19  Aligned_cols=259  Identities=32%  Similarity=0.596  Sum_probs=218.4

Q ss_pred             CeEEeeeecccCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~   89 (344)
                      .|++.+.||.|+||.||+|.+.   .+|..||+|++...... .....+.+.+|+.+++++ +|+||+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4899999999999999999975   47899999998754322 223456788899999999 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+.|++||||+|+|||++.++++||+|||++...... .
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-~  159 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED-E  159 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc-c
Confidence            999999999999999988888999999999999999999999999999999999999999999999999998754221 1


Q ss_pred             CCccccccCCCcccchhhhccC-CCCCccchhhhhhHHHHHHHhCCCCCCCc----cHHHHHHHHhhCCCCCCCCCCHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWLSPGA  244 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~ll~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~  244 (344)
                      ........|+..|+|||.+... ...+.++||||||+++|+|++|..||...    ........+.....+.|..+++.+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (290)
T cd05613         160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA  239 (290)
T ss_pred             ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence            1222345688999999998653 23367899999999999999999999643    234445555556667788899999


Q ss_pred             HHHHHHhcCCCcCCCC-----CHhhhhcCcccccc
Q 019216          245 QNLLRKILEPNPVKRI-----TIAGIKADEWFEQD  274 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rp-----s~~eil~~~~~~~~  274 (344)
                      .+++++||+.||++||     ++.+++.||||+..
T Consensus       240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~  274 (290)
T cd05613         240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI  274 (290)
T ss_pred             HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccC
Confidence            9999999999999997     89999999999764

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-44  Score=329.60  Aligned_cols=261  Identities=33%  Similarity=0.439  Sum_probs=218.3

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC-----eE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KI   89 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~   89 (344)
                      +|++.+.||.|++|.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.++|+||+++++++....     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            6999999999999999999999999999999986532 22344577889999999999999999999987764     78


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      |++|||+. ++|.+.+.+..++++..++.++.||+.||++||+.|++||||||.|||++.++.++|+|||++........
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            99999996 58999988877899999999999999999999999999999999999999999999999999885433211


Q ss_pred             -CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC-------------
Q 019216          170 -DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-------------  235 (344)
Q Consensus       170 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~-------------  235 (344)
                       ........++..|+|||.+.+....+.++|+||||+++|+|++|++||.+.+.......+......             
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence             012334567889999999887744578999999999999999999999887766555544432100             


Q ss_pred             ------------------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          236 ------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       236 ------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                        ....+++.+.++|.+||+++|++|||+++++.||||++...+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence                              112367889999999999999999999999999999875444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.7e-44  Score=330.28  Aligned_cols=254  Identities=27%  Similarity=0.407  Sum_probs=204.8

Q ss_pred             cccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEee
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS   85 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~   85 (344)
                      .-++|++.+.||+|+||.||+|.+.     .+++.||+|.+....  .....+.+.+|+.+++++ +|+||+++++++..
T Consensus         5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~   82 (337)
T cd05054           5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTK   82 (337)
T ss_pred             CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence            4468999999999999999999753     345789999886432  223456778899999999 79999999998764


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhc--------------------------------------------------------
Q 019216           86 -KSKIYMVLEYVTGGELFDKIASK--------------------------------------------------------  108 (344)
Q Consensus        86 -~~~~~iv~e~~~g~~L~~~l~~~--------------------------------------------------------  108 (344)
                       +..++++|||+++++|.+++...                                                        
T Consensus        83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             45788999999999999888542                                                        


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCccc
Q 019216          109 -----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV  183 (344)
Q Consensus       109 -----~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~  183 (344)
                           .++++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++................++..|+
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~  242 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM  242 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence                 257889999999999999999999999999999999999999999999999997543221111122334567899


Q ss_pred             chhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHH-HHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCC
Q 019216          184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY-QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRI  260 (344)
Q Consensus       184 aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~-~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rp  260 (344)
                      |||.+.+..+ +.++|||||||++|+|++ |..||.+....... ..+..+ ....|...++++.+++.+||+.+|++||
T Consensus       243 aPE~~~~~~~-~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP  321 (337)
T cd05054         243 APESIFDKVY-TTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP  321 (337)
T ss_pred             CcHHhcCCCC-CccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCc
Confidence            9999888776 688999999999999998 99999875433323 222222 3344667889999999999999999999


Q ss_pred             CHhhhhcC
Q 019216          261 TIAGIKAD  268 (344)
Q Consensus       261 s~~eil~~  268 (344)
                      ++.++++|
T Consensus       322 s~~ell~~  329 (337)
T cd05054         322 TFSELVEI  329 (337)
T ss_pred             CHHHHHHH
Confidence            99999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-44  Score=317.31  Aligned_cols=251  Identities=26%  Similarity=0.370  Sum_probs=207.3

Q ss_pred             eEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe----
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK----   88 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----   88 (344)
                      |++.+.||+|+||.||+|....+   +..||+|.+..... .......+.+|+..++.++||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            67889999999999999997653   47899999865432 23345678999999999999999999998865443    


Q ss_pred             --EEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecccc
Q 019216           89 --IYMVLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (344)
Q Consensus        89 --~~iv~e~~~g~~L~~~l~~~------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~  160 (344)
                        .+++|||+++++|..++...      ..+++..+..++.|++.||.|||+.|++||||||+||++++++.+||+|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence              79999999999999888532      3589999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCC
Q 019216          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK  238 (344)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~  238 (344)
                      ++...............++..|+|||.+.+..+ +.++|||||||++|||++ |..||.+.........+..+ ....|.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE  238 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCC-CcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            875432111111122334678999999876655 689999999999999999 99999887777776666654 455677


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          239 WLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+++.+.+++.+||+.||++|||+.+++.+
T Consensus       239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         239 DCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.9e-44  Score=315.12  Aligned_cols=249  Identities=23%  Similarity=0.422  Sum_probs=208.8

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      ..+|++.+.||+|++|.||+|.++ ++..+|+|.+.+...    ....+.+|+.+++.++||||+++++++......++|
T Consensus         3 ~~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   77 (256)
T cd05059           3 PSELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV   77 (256)
T ss_pred             hHHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence            457899999999999999999975 466899999864332    134677899999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |||++|++|.+++.. ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||+++...... ..
T Consensus        78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~-~~  156 (256)
T cd05059          78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ-YT  156 (256)
T ss_pred             EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceeccccc-cc
Confidence            999999999999875 3468999999999999999999999999999999999999999999999999987432111 00


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR  249 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~  249 (344)
                      ......++..|+|||.+.+..+ +.++||||||+++|+|++ |+.||...+.......+... ....|..+++.+.+++.
T Consensus       157 ~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  235 (256)
T cd05059         157 SSQGTKFPVKWAPPEVFDYSRF-SSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMY  235 (256)
T ss_pred             ccCCCCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHH
Confidence            1111223457999999887665 678999999999999999 89999887766666666544 34566778999999999


Q ss_pred             HhcCCCcCCCCCHhhhhcC
Q 019216          250 KILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       250 ~~L~~dP~~Rps~~eil~~  268 (344)
                      +||..+|++|||+.++++.
T Consensus       236 ~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         236 SCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHhcCChhhCcCHHHHHHH
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.2e-43  Score=313.85  Aligned_cols=245  Identities=26%  Similarity=0.372  Sum_probs=205.2

Q ss_pred             eeecccCceEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccC
Q 019216           20 RTLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~   97 (344)
                      +.||+|+||.||+|.+  +.++..+|+|++.... .+....+.+.+|+.+++.++||||+++++++.. ...++||||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~   78 (257)
T cd05116           1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAE   78 (257)
T ss_pred             CcCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCC
Confidence            3689999999999964  4677899999986432 334456788999999999999999999998754 46789999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC-Cccccc
Q 019216           98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTT  176 (344)
Q Consensus        98 g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~  176 (344)
                      +++|.+++.....+++..+..++.|++.||.|||++|++||||||.||+++.++.+||+|||++......... ......
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05116          79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHG  158 (257)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCC
Confidence            9999999988788999999999999999999999999999999999999999999999999998754321111 011122


Q ss_pred             cCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHhcCC
Q 019216          177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP  254 (344)
Q Consensus       177 ~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~  254 (344)
                      .++..|+|||.+....+ +.++|+|||||++|||++ |+.||...+.......+..+ ..+.|..+++++.++|.+||+.
T Consensus       159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~  237 (257)
T cd05116         159 KWPVKWYAPECMNYYKF-SSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTY  237 (257)
T ss_pred             CCCccccCHhHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhcc
Confidence            34578999999876554 678999999999999998 99999987777777666654 3567778999999999999999


Q ss_pred             CcCCCCCHhhhhc
Q 019216          255 NPVKRITIAGIKA  267 (344)
Q Consensus       255 dP~~Rps~~eil~  267 (344)
                      ||++||++++|..
T Consensus       238 ~p~~Rp~~~~i~~  250 (257)
T cd05116         238 GVDERPGFAVVEL  250 (257)
T ss_pred             CchhCcCHHHHHH
Confidence            9999999999864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=8.4e-44  Score=317.08  Aligned_cols=251  Identities=27%  Similarity=0.380  Sum_probs=205.6

Q ss_pred             eEEeeeecccCceEEEEEEECCCCc--eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee------CC
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------KS   87 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~   87 (344)
                      |.+.+.||+|+||.||+|.+..++.  .+|+|.+.... ......+.+.+|+.+++.++|+||+++++.+..      ..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   79 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP   79 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence            3577899999999999999877765  69999886532 233456788899999999999999999997642      23


Q ss_pred             eEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccc
Q 019216           88 KIYMVLEYVTGGELFDKIAS------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~------~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a  161 (344)
                      ..+++|||+.+++|.+.+..      ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus        80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  159 (272)
T cd05075          80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS  159 (272)
T ss_pred             CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence            56899999999999887742      234789999999999999999999999999999999999999999999999998


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC-CCCCCC
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKW  239 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~  239 (344)
                      ................+++.|+|||.+.+..+ +.++|||||||++|+|++ |+.||.+.........+..+. ...+..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd05075         160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVY-TTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD  238 (272)
T ss_pred             cccCcccceecCCcccCCcccCCHHHccCCCc-ChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence            85432111111122345678999999877665 689999999999999999 899998877777766666553 355667


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          240 LSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ++..+.++|.+||+.||++|||+.+++++
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            88999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-43  Score=314.45  Aligned_cols=250  Identities=24%  Similarity=0.368  Sum_probs=209.7

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++.+.||+|++|.||+|.+. +++.||+|.++....    ..+.+.+|+.++++++||||+++++++......+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05068           3 IDRTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY   77 (261)
T ss_pred             cchhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence            34578999999999999999999974 557899999865432    2456888999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ++|||+++++|.+++....  .+++..+..++.|++.||.+||+.|++||||||+||+++.++.+||+|||++.......
T Consensus        78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05068          78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI  157 (261)
T ss_pred             eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence            9999999999999997644  68999999999999999999999999999999999999999999999999987543211


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                      . ........+..|+|||.+.+..+ +.++||||||+++|+|++ |+.||.+.+.......+... ..+.+..++..+.+
T Consensus       158 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (261)
T cd05068         158 Y-EAREGAKFPIKWTAPEAALYNRF-SIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYD  235 (261)
T ss_pred             c-cccCCCcCceeccCccccccCCC-CchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence            0 01111223457999999877665 688999999999999999 99999987776666666544 34456678999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhc
Q 019216          247 LLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~  267 (344)
                      ++.+||+.+|.+||++.++++
T Consensus       236 li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         236 IMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHhhcCcccCCCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.3e-43  Score=312.59  Aligned_cols=251  Identities=32%  Similarity=0.531  Sum_probs=219.6

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      +|++.+.||+|++|.||++.+..+++.+|+|.+...... ......+.+|+.+++.++|+||+++++++......++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            589999999999999999999999999999998754432 2345677889999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           95 YVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        95 ~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      |+++++|.+++.+    ...+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.+||+|||++......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence            9999999998865    356899999999999999999999999999999999999999999999999998754332   


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-CCCCCCCHHHHHHHH
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLR  249 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~  249 (344)
                       ......++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.......+..... ..+..++.++.+++.
T Consensus       157 -~~~~~~~~~~~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  234 (256)
T cd08530         157 -MAKTQIGTPHYMAPEVWKGRPY-SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR  234 (256)
T ss_pred             -CcccccCCccccCHHHHCCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence             2234567889999999877665 5789999999999999999999998887766666665543 455678999999999


Q ss_pred             HhcCCCcCCCCCHhhhhcCccc
Q 019216          250 KILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       250 ~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      +||+.+|++|||+.++++||++
T Consensus       235 ~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         235 SMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHcCCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-43  Score=317.22  Aligned_cols=254  Identities=20%  Similarity=0.315  Sum_probs=208.3

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCce----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      +..++|++++.||+|+||.||+|.+..++..    +++|.+...  ........+..|+.++++++||||+++++++.. 
T Consensus         4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-   80 (279)
T cd05111           4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-   80 (279)
T ss_pred             CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-
Confidence            4567999999999999999999998877764    666766422  122344677888889999999999999998754 


Q ss_pred             CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      ...++++||+++++|.+++.. .+.+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~  160 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY  160 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence            457889999999999999975 4578999999999999999999999999999999999999999999999999987543


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC-CCCCCCCCHH
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPG  243 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~  243 (344)
                      ............++..|+|||.+.+..+ +.++||||||+++||+++ |+.||.+.........+..+. ...+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05111         161 PDDKKYFYSEHKTPIKWMALESILFGRY-THQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTID  239 (279)
T ss_pred             CCCcccccCCCCCcccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHH
Confidence            2211112233456778999999877665 689999999999999998 999998877666555554443 3445667889


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +.+++.+||..||++|||+.++++.
T Consensus       240 ~~~li~~c~~~~p~~Rps~~el~~~  264 (279)
T cd05111         240 VYMVMVKCWMIDENVRPTFKELANE  264 (279)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999998763

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-44  Score=319.74  Aligned_cols=253  Identities=32%  Similarity=0.500  Sum_probs=210.9

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC--CeEEEEE
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKIYMVL   93 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~~iv~   93 (344)
                      |++.+.||.|++|.||+|.+..+++.+|+|.+.... ........+.+|+.+++.++|+|++++++++...  ...++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            789999999999999999999999999999997653 2334456788999999999999999999999887  8899999


Q ss_pred             eccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           94 EYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||+++ +|.+++.+. ..+++..++.++.|++.||+|||+.|++|+||+|+||++++++.+||+|||++........ ..
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~  157 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD  157 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence            99964 888888764 5799999999999999999999999999999999999999999999999999875433211 11


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC------------------
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------------------  234 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~------------------  234 (344)
                      .....++..|+|||.+.+....+.++||||||+++|+|++|+.||...+.......+.....                  
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07840         158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN  237 (287)
T ss_pred             ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence            23345678899999877654457899999999999999999999988776555444432100                  


Q ss_pred             -----C--------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          235 -----K--------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       235 -----~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                           .        +...+++.+.+++++||+.+|.+||++++++.||||
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                 0        011138899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.2e-43  Score=314.23  Aligned_cols=250  Identities=25%  Similarity=0.404  Sum_probs=209.7

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|+++++||+|++|.||+|.+ .++..||+|.+....    ...+.+.+|+.+++.++|+||+++++.+......+
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05072           3 IPRESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY   77 (261)
T ss_pred             CchHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence            4567899999999999999999996 456779999875432    22467889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ++|||+++++|.+++.+  ...++...+..++.|++.||+|||+.+++||||||+||+++.++.++|+|||++.......
T Consensus        78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  157 (261)
T cd05072          78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE  157 (261)
T ss_pred             EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence            99999999999999865  3468889999999999999999999999999999999999999999999999997543211


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                      . .......++..|+|||.+....+ +.++|||||||++|+|++ |+.||...........+... ..+.+..++..+.+
T Consensus       158 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (261)
T cd05072         158 Y-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYD  235 (261)
T ss_pred             e-eccCCCccceecCCHHHhccCCC-ChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence            1 11122345678999999877665 688999999999999998 99999887776666665544 33444568899999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhc
Q 019216          247 LLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~  267 (344)
                      ++.+||+.+|++|||++++++
T Consensus       236 li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         236 IMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999865

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=6.5e-44  Score=315.90  Aligned_cols=249  Identities=26%  Similarity=0.422  Sum_probs=213.1

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      ..++|+++++||.|++|.||+|.+.. +..+|+|++....   ......+.+|+.+++.++|+||+++++++......++
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l   79 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI   79 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence            45679999999999999999999977 8899999986543   2235678899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +|||+++++|.+++.+.  ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||.+......  
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--  157 (261)
T cd05148          80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--  157 (261)
T ss_pred             EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc--
Confidence            99999999999999753  45899999999999999999999999999999999999999999999999998754221  


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL  247 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~l  247 (344)
                      ........++..|+|||.+....+ +.++||||||+++|+|++ |+.||.+.+.......+..+ ..+.+..+++.+.++
T Consensus       158 ~~~~~~~~~~~~~~~PE~~~~~~~-~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (261)
T cd05148         158 VYLSSDKKIPYKWTAPEAASHGTF-STKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKI  236 (261)
T ss_pred             cccccCCCCceEecCHHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHH
Confidence            111123345678999999877665 678999999999999998 89999888777676666654 345567789999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhc
Q 019216          248 LRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~  267 (344)
                      +.+||+.||.+|||+.++++
T Consensus       237 i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         237 MLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.2e-43  Score=320.14  Aligned_cols=254  Identities=25%  Similarity=0.393  Sum_probs=213.4

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      +.|...+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++|||++++++++.+....|+||
T Consensus        21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  100 (313)
T cd06633          21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM  100 (313)
T ss_pred             HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence            34777889999999999999999999999999987654444455567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||+. +++.+.+.. ..++++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....      .
T Consensus       101 e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------~  173 (313)
T cd06633         101 EYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------P  173 (313)
T ss_pred             ecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------C
Confidence            9995 577777754 4578999999999999999999999999999999999999999999999999886321      1


Q ss_pred             cccccCCCcccchhhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC--CCCCCCHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNLL  248 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li  248 (344)
                      .....|+..|+|||.+..  ....+.++||||||+++|+|++|..||...+.......+.....+  ....++..+.+|+
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  253 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFV  253 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHH
Confidence            234568889999999742  233467899999999999999999999877655555554443222  1234678899999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          249 RKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .+||+.+|.+||++.+++.||||+..
T Consensus       254 ~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         254 DYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             HHHccCChhhCcCHHHHhcCcccCCC
Confidence            99999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.9e-43  Score=350.42  Aligned_cols=151  Identities=31%  Similarity=0.588  Sum_probs=141.4

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .+++|+++++||+|+||.||+|.+..+++.||||++++...........+.+|+.+++.++||||+++++++.....+|+
T Consensus         2 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l   81 (669)
T cd05610           2 SIEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYL   81 (669)
T ss_pred             ccCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEE
Confidence            36899999999999999999999999999999999987655555667789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecccccc
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      ||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus        82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.8e-43  Score=326.00  Aligned_cols=258  Identities=31%  Similarity=0.431  Sum_probs=210.1

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC-----
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----   86 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----   86 (344)
                      .-++|++.+.||+|+||.||+|.+..+++.||+|.+.+.. ......+.+.+|+.++++++||||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcc-hhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            4489999999999999999999999999999999986532 2223356678899999999999999999988543     


Q ss_pred             -CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 -~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                       ...+++++++ |++|.+.+.. ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus        94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~  171 (345)
T cd07877          94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  171 (345)
T ss_pred             cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence             3478888887 7899877754 468999999999999999999999999999999999999999999999999987432


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC------------
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------------  233 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~------------  233 (344)
                      .     ......++..|+|||.+.+....+.++|||||||++|+|++|+.||...+.......+....            
T Consensus       172 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (345)
T cd07877         172 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  246 (345)
T ss_pred             c-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence            1     22345678899999998764445688999999999999999999998765444333222110            


Q ss_pred             -----------CCC--------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          234 -----------FKL--------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       234 -----------~~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                 ...        ....++.+.++|.+||+.||.+||++.++++||||.+...+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence                       001        11357889999999999999999999999999999875444

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=5e-44  Score=321.37  Aligned_cols=257  Identities=24%  Similarity=0.333  Sum_probs=207.4

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~   90 (344)
                      ...+|+..+.||+|+||.||++.+..+++.+|+|.+......  .....+.+|+.++.++. |+||+++++++..+...+
T Consensus         2 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~   79 (288)
T cd06616           2 TAEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCW   79 (288)
T ss_pred             cHHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEE
Confidence            345778889999999999999999999999999998654322  34567889999999996 999999999998888999


Q ss_pred             EEEeccCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           91 MVLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~-----~~~~~~~~~~~~i~~ql~~~L~~LH~~-~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                      ++|||+. +++.++..     ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++...
T Consensus        80 ~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             EEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            9999985 45544332     245799999999999999999999975 9999999999999999999999999998643


Q ss_pred             CcccCCCccccccCCCcccchhhhccC--CCCCccchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhhCC-CCC----
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGD-FKL----  236 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~ll~ell~g~~pf~~~~~-~~~~~~i~~~~-~~~----  236 (344)
                      ..   ........|+..|+|||.+...  ...+.++|||||||++|+|++|+.||..... .....++..+. ..+    
T Consensus       159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd06616         159 VD---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSE  235 (288)
T ss_pred             cc---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcC
Confidence            21   1122334678899999998765  2446899999999999999999999976542 12222222222 122    


Q ss_pred             CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       237 ~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +..+++.+.+|+.+||+.||++|||++++++||||+..
T Consensus       236 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         236 EREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             CCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhch
Confidence            22478999999999999999999999999999999763

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=3.4e-43  Score=308.55  Aligned_cols=249  Identities=32%  Similarity=0.529  Sum_probs=213.5

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      .|++.+.||+|++|.||++.+..+++.+++|.+.....   .....+.+|+.+++.++|+|++++++++......++++|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e   77 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME   77 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence            48899999999999999999998999999999865432   346788899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           95 YVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        95 ~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      |+++++|.+.+... ..+++..+..++.|++.||.+||+.|++||||+|+||+++.++.++|+|||.+........   .
T Consensus        78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~  154 (253)
T cd05122          78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R  154 (253)
T ss_pred             cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence            99999999998765 5799999999999999999999999999999999999999999999999999875433211   3


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC-CCCCCC--CCCHHHHHHHHH
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPK--WLSPGAQNLLRK  250 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~--~~~~~~~~li~~  250 (344)
                      ....++..|+|||.+..... +.++|+||||+++|+|++|+.||...+........... ....+.  .++..+.++|.+
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  233 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK  233 (253)
T ss_pred             cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence            45578899999999877664 68899999999999999999999877544433333322 222332  248999999999


Q ss_pred             hcCCCcCCCCCHhhhhcCcc
Q 019216          251 ILEPNPVKRITIAGIKADEW  270 (344)
Q Consensus       251 ~L~~dP~~Rps~~eil~~~~  270 (344)
                      ||+.||++|||+.++++|||
T Consensus       234 ~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         234 CLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HccCChhhCCCHHHHhcCCC
Confidence            99999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.5e-43  Score=313.68  Aligned_cols=254  Identities=22%  Similarity=0.359  Sum_probs=211.5

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      .++.|++.+.||+|+||.||+|.++.+++   .||+|.+....  .......+..|+.+++.++||||+++++++.....
T Consensus         2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~   79 (269)
T cd05065           2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRP   79 (269)
T ss_pred             ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCc
Confidence            46789999999999999999999887665   59999986432  34456789999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .++||||+++++|.+++.. .+.+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          80 VMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             eEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            9999999999999998875 456899999999999999999999999999999999999999999999999998754321


Q ss_pred             cCCCcccc-cc--CCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCH
Q 019216          168 RDDGLLHT-TC--GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP  242 (344)
Q Consensus       168 ~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~  242 (344)
                      ........ ..  .+..|+|||.+.+..+ +.++|||||||++||+++ |..||...+.......+... ..+.+..++.
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~  238 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPT  238 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcc-cchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCH
Confidence            11111111 11  2357999999887666 678999999999999886 99999887766666666443 3345567899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+.+++.+||+.+|++||++.+++..
T Consensus       239 ~~~~li~~~l~~~p~~Rp~~~~i~~~  264 (269)
T cd05065         239 ALHQLMLDCWQKDRNARPKFGQIVST  264 (269)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.5e-43  Score=317.12  Aligned_cols=252  Identities=28%  Similarity=0.408  Sum_probs=209.9

Q ss_pred             cccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      ...+|++.++||+|+||.||+|...     .++..+|+|.+...   .......+.+|+++++.++|+||+++++++...
T Consensus         3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   79 (280)
T cd05092           3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEG   79 (280)
T ss_pred             ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence            4568899999999999999999743     35678999987543   234456889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC
Q 019216           87 SKIYMVLEYVTGGELFDKIASKG---------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG  151 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~---------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~  151 (344)
                      ...+++|||+++++|.+++...+               .+++..+..++.|++.||+|||+.|++||||||+|||+++++
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~  159 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL  159 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence            99999999999999999987543               478899999999999999999999999999999999999999


Q ss_pred             CeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHh
Q 019216          152 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIF  230 (344)
Q Consensus       152 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~  230 (344)
                      .+||+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |++||...........+.
T Consensus       160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05092         160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT  238 (280)
T ss_pred             CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCc-CchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            999999999864322111111122334678999999887665 688999999999999998 999998777666666655


Q ss_pred             hC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          231 RG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       231 ~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .+ ....+..+++.+.+++.+||+.||.+||++.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         239 QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            54 34556778999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2.8e-43  Score=320.62  Aligned_cols=256  Identities=27%  Similarity=0.440  Sum_probs=211.8

Q ss_pred             CccccCeEEeeeecccCceEEEEEEEC-------CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceee
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE   81 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~   81 (344)
                      ....++|.+.+.||+|+||.||+|.+.       ..+..+|+|.+....  .......+.+|+.+++.+ +||||+++++
T Consensus         8 ~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~   85 (314)
T cd05099           8 EFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLG   85 (314)
T ss_pred             cccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEE
Confidence            355679999999999999999999863       234579999886432  233456788999999999 5999999999


Q ss_pred             EEeeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcE
Q 019216           82 VLASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI  145 (344)
Q Consensus        82 ~~~~~~~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NI  145 (344)
                      ++......+++|||+++++|.+++...                ..+++..+..++.|++.||.|||++|++||||||+||
T Consensus        86 ~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni  165 (314)
T cd05099          86 VCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV  165 (314)
T ss_pred             EEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeE
Confidence            999888999999999999999999653                2478889999999999999999999999999999999


Q ss_pred             EEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHH
Q 019216          146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV  224 (344)
Q Consensus       146 Ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~  224 (344)
                      |++.++.+||+|||+++...............++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.....
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~~l~el~~~g~~p~~~~~~~~  244 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVY-THQSDVWSFGILMWEIFTLGGSPYPGIPVEE  244 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCc-CccchhhHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999975432111111112234467999999877655 689999999999999999 999999887777


Q ss_pred             HHHHHhhCC-CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          225 LYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       225 ~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ....+..+. ...+..++.++.+++.+||+.||++|||+.++++.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~  289 (314)
T cd05099         245 LFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA  289 (314)
T ss_pred             HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            776666553 45567788999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=2.1e-43  Score=319.89  Aligned_cols=257  Identities=26%  Similarity=0.436  Sum_probs=214.7

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEEC-------CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCcccee
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLH   80 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~   80 (344)
                      ..+..++|++.+.||+|+||.||+|.+.       ..+..||+|.+....  .......+.+|+.+++.+ +||||++++
T Consensus        10 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~   87 (304)
T cd05101          10 WEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLL   87 (304)
T ss_pred             ccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhee
Confidence            4577889999999999999999999753       234579999886432  233456788999999999 799999999


Q ss_pred             eEEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCc
Q 019216           81 EVLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN  144 (344)
Q Consensus        81 ~~~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~N  144 (344)
                      +++......+++|||+.+++|.+++.+..                .++...+..++.|++.||.|||++|++||||||+|
T Consensus        88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N  167 (304)
T cd05101          88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN  167 (304)
T ss_pred             EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence            99999999999999999999999997532                46778899999999999999999999999999999


Q ss_pred             EEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHH
Q 019216          145 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA  223 (344)
Q Consensus       145 ILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~  223 (344)
                      ||++.++.+||+|||+++...............++..|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+..
T Consensus       168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            9999999999999999875433222222223445678999999877665 588999999999999998 89999888877


Q ss_pred             HHHHHHhhCC-CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          224 VLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       224 ~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .....+..+. ...+..++..+.+|+.+||+.+|++|||+.++++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         247 ELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            7777665543 34566789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=9.4e-44  Score=322.75  Aligned_cols=257  Identities=30%  Similarity=0.452  Sum_probs=206.3

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC------
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------   86 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------   86 (344)
                      +++|++.++||+|++|.||+|.++.+++.+|+|.+....... .....+.+|+.+++.++||||+++++++...      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            789999999999999999999999999999999886543211 2234567899999999999999999887433      


Q ss_pred             --CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           87 --SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        87 --~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                        ..+++||||+.+ ++...+.. ...+++..++.++.|+++||.|||+.|++||||||+||++++++.++|+|||++..
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence              357999999954 67676654 45799999999999999999999999999999999999999999999999999875


Q ss_pred             CCcccCCC---------ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC
Q 019216          164 PQHFRDDG---------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF  234 (344)
Q Consensus       164 ~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~  234 (344)
                      ........         ......+++.|+|||.+.+....+.++|||||||++|+|++|++||.+.+.......+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            43221111         112235678899999987655457889999999999999999999988776555444332100


Q ss_pred             -----------------------CCC-------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          235 -----------------------KLP-------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       235 -----------------------~~~-------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                                             ..+       ..+++.+.++|.+||+.||++|||+.+++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence                                   000       1245788999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-43  Score=314.59  Aligned_cols=253  Identities=25%  Similarity=0.361  Sum_probs=212.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      +..++|++.+.||+|+||.||+|.++.+|.    .+|+|.+.....  ......+.+|+.++++++|||++++++++.. 
T Consensus         4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-   80 (279)
T cd05057           4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-   80 (279)
T ss_pred             cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-
Confidence            456899999999999999999999876665    589998764432  3455778899999999999999999999887 


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      ...+++|||+++++|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++...
T Consensus        81 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          81 SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence            6889999999999999998764 468999999999999999999999999999999999999999999999999987543


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHH
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG  243 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~  243 (344)
                      ............++..|+|||.+....+ +.++|+||||+++|++++ |+.||.+.......+.+..+ ....|...+..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIY-THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTID  239 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCc-CchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHH
Confidence            2211111112233567999999876665 588999999999999998 99999988877777766655 34566778899


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      +.+++.+||..||+.||++.++++
T Consensus       240 ~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         240 VYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHH
Confidence            999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2e-43  Score=317.97  Aligned_cols=250  Identities=29%  Similarity=0.391  Sum_probs=207.8

Q ss_pred             CeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+....  .......+.+|+.+++.++||||+++++.+...+..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            58899999999999999998753     23578999875433  223456788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcE
Q 019216           90 YMVLEYVTGGELFDKIASK------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI  145 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~------------------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NI  145 (344)
                      +++|||+.+++|.+++...                        ..+++..+..++.|++.||.|||+.|++||||||+||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni  158 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV  158 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence            9999999999999988642                        2477889999999999999999999999999999999


Q ss_pred             EEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHH
Q 019216          146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV  224 (344)
Q Consensus       146 Ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~  224 (344)
                      |+++++.+||+|||+++...............++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.....
T Consensus       159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~  237 (290)
T cd05045         159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYPGIAPER  237 (290)
T ss_pred             EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCc-chHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999999874322111111223345678999999876665 688999999999999998 999999887777


Q ss_pred             HHHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          225 LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       225 ~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ....+... ....+..++..+.+++.+||+.+|++||++.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            66655443 34556778999999999999999999999999976

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.5e-43  Score=320.44  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=216.8

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ..|+..+.||+|+||.||+|.+..++..||+|.+........+....+.+|+.+++.++|||++++++++......++||
T Consensus        25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  104 (317)
T cd06635          25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM  104 (317)
T ss_pred             hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence            44888999999999999999999999999999987654444455678899999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||+.| +|.+.+.. ..++++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++.....      
T Consensus       105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~------  177 (317)
T cd06635         105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP------  177 (317)
T ss_pred             eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC------
Confidence            99965 77777653 56789999999999999999999999999999999999999999999999998864321      


Q ss_pred             cccccCCCcccchhhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC--CCCCCCHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNLL  248 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li  248 (344)
                      .....++..|+|||.+..  ....+.++|||||||++|+|++|+.||...+.......+......  .+..+++.+.+++
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  257 (317)
T cd06635         178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV  257 (317)
T ss_pred             cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHH
Confidence            234568889999999742  233468899999999999999999999887666655555554322  2345788999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          249 RKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      .+||+.+|.+||++.++++|+|+.....
T Consensus       258 ~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         258 DSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             HHHccCCcccCcCHHHHHhChhhhccCc
Confidence            9999999999999999999999976443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=2.3e-43  Score=319.48  Aligned_cols=255  Identities=26%  Similarity=0.410  Sum_probs=210.0

Q ss_pred             CccccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL   83 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~   83 (344)
                      .+..++|++.+.||+|+||.||+|.+.     .++..||+|.+....  .....+.+.+|+.+++++ +||||+++++++
T Consensus        31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  108 (302)
T cd05055          31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC  108 (302)
T ss_pred             cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence            466678999999999999999999853     345689999886432  233456789999999999 799999999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccc
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a  161 (344)
                      ...+..+++|||+.+++|.+++....  .+++.++..++.|++.||.|||+.+++|+||||+|||++.++.++|+|||++
T Consensus       109 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~  188 (302)
T cd05055         109 TIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA  188 (302)
T ss_pred             ecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccc
Confidence            99999999999999999999987543  3899999999999999999999999999999999999999999999999998


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC--CCCCC
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPK  238 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~  238 (344)
                      ................++..|+|||.+....+ +.++|||||||++|+|++ |..||..........+.....  ...+.
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  267 (302)
T cd05055         189 RDIMNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPE  267 (302)
T ss_pred             ccccCCCceeecCCCCcccccCCHhhhccCCC-CcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCC
Confidence            75432211111122345678999999877665 689999999999999998 999998766544444443332  33456


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          239 WLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ..++.+.+++.+||+.+|++|||+.++++
T Consensus       268 ~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         268 HAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            67899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-45  Score=305.42  Aligned_cols=262  Identities=24%  Similarity=0.368  Sum_probs=218.4

Q ss_pred             hccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEee
Q 019216            7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS   85 (344)
Q Consensus         7 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~   85 (344)
                      .+.....++.+.+..||.|+.|.||++..+.+|+..|||.+++..  +.+..++++..+.++.... +|+|++.+++|..
T Consensus        85 ~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   85 QRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             cccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            344456667788899999999999999999999999999997654  5566788888888877664 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           86 KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~-~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      +..+++.||.| +..+..++.+ .++++|..+-++...++.||.||.++ ||+|||+||+|||+|+.|++||||||.+..
T Consensus       163 n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGr  241 (391)
T KOG0983|consen  163 NTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGR  241 (391)
T ss_pred             CchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccce
Confidence            99999999998 4455555543 56799999999999999999999875 899999999999999999999999999874


Q ss_pred             CCcccCCCccccccCCCcccchhhhccC--CCCCccchhhhhhHHHHHHHhCCCCCCCc-cHHHHHHHHhhCCCCC-C--
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDFKL-P--  237 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~ll~ell~g~~pf~~~-~~~~~~~~i~~~~~~~-~--  237 (344)
                      +-   +........|.+.|||||.+.-.  .-+.-++||||||++++||.||+.||.+. ...+...++.+..++. |  
T Consensus       242 lv---dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~  318 (391)
T KOG0983|consen  242 LV---DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGH  318 (391)
T ss_pred             ee---cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcc
Confidence            32   22333455789999999998532  22357899999999999999999999984 4566777777765442 2  


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ..+|+.+++|+..||++|+.+||...++|+|||....
T Consensus       319 ~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y  355 (391)
T KOG0983|consen  319 MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY  355 (391)
T ss_pred             cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence            3389999999999999999999999999999998764

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2e-43  Score=317.25  Aligned_cols=256  Identities=29%  Similarity=0.471  Sum_probs=219.3

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      -....|++.+.||.|++|.||+|.+..++..|++|++.....    ....+.+|+.+++.++|+|++++++.+......+
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   91 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELW   91 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEE
Confidence            455678999999999999999999988899999999865432    3567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           91 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +++||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~--  169 (286)
T cd06614          92 VVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE--  169 (286)
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc--
Confidence            9999999999999998866 8999999999999999999999999999999999999999999999999987643221  


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-C--CCCCCCHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-K--LPKWLSPGAQN  246 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-~--~~~~~~~~~~~  246 (344)
                      ........++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.......+..... .  .+..++..+.+
T Consensus       170 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  248 (286)
T cd06614         170 KSKRNSVVGTPYWMAPEVIKRKDY-GPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKD  248 (286)
T ss_pred             hhhhccccCCcccCCHhHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHH
Confidence            112233457889999999877665 6889999999999999999999988766555444443322 2  22337899999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          247 LLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      +|.+||+.+|.+|||+.+++.|+||..
T Consensus       249 li~~~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         249 FLNKCLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HHHHHhccChhhCcCHHHHhhChHhhc
Confidence            999999999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.2e-43  Score=321.05  Aligned_cols=258  Identities=30%  Similarity=0.498  Sum_probs=209.3

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC---
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---   87 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---   87 (344)
                      ...++|++.+.||+|++|.||+|.++.+|+.||+|.++.... .......+.+|+.++++++|||++++++++....   
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~   82 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL   82 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence            456899999999999999999999999999999999865432 2223456778999999999999999999886654   


Q ss_pred             -------eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccc
Q 019216           88 -------KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG  159 (344)
Q Consensus        88 -------~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg  159 (344)
                             .+++++||+++ ++...+.+. ..+++..+..++.|++.||+|||+.||+||||||+||++++++.+||+|||
T Consensus        83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg  161 (302)
T cd07864          83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG  161 (302)
T ss_pred             hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence                   78999999976 777777653 468999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC---CC--
Q 019216          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DF--  234 (344)
Q Consensus       160 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~---~~--  234 (344)
                      ++........ .......++..|+|||.+.+....+.++|||||||++|+|++|++||...+.......+...   ..  
T Consensus       162 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         162 LARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             ccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            9875432111 11122345778999998876554578999999999999999999999876654444333221   00  


Q ss_pred             -------------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          235 -------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       235 -------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                                               .....+++.+.+++.+||+.||++|||+.+++.||||
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                     0112368899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.5e-44  Score=327.21  Aligned_cols=262  Identities=31%  Similarity=0.423  Sum_probs=212.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeC--C
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK--S   87 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~--~   87 (344)
                      ...++|++.+.||+|+||.||+|.+..+|+.+|+|.+.+.. ........+.+|+.+++++ +||||+++++++...  .
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~   82 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDK   82 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCc
Confidence            45679999999999999999999999899999999885432 2223345677899999999 999999999988643  4


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ..++||||+. ++|.+++.+. .+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......
T Consensus        83 ~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~  160 (337)
T cd07852          83 DIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL  160 (337)
T ss_pred             eEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence            6899999996 5998888765 7889999999999999999999999999999999999999999999999998754322


Q ss_pred             cCC---CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-----------
Q 019216          168 RDD---GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-----------  233 (344)
Q Consensus       168 ~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-----------  233 (344)
                      ...   .......|+..|+|||.+.+....+.++||||||+++|+|++|+.||.+........++....           
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07852         161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI  240 (337)
T ss_pred             cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence            211   223345688999999988765555788999999999999999999998765443333221110           


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          234 --------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       234 --------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                                          ......++..+.++|.+||+.||++|||+.++++|||+++..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~  302 (337)
T cd07852         241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFH  302 (337)
T ss_pred             HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhc
Confidence                                011123688999999999999999999999999999998753

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.8e-43  Score=312.41  Aligned_cols=248  Identities=25%  Similarity=0.387  Sum_probs=206.3

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      ..++|++.++||+|+||.||+|.+..+ ..||+|.+.....    ..+.+.+|+.+++.++||||+++++.+. ....++
T Consensus         4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l   77 (262)
T cd05071           4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYI   77 (262)
T ss_pred             ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEE
Confidence            457899999999999999999998655 4699999865332    2356888999999999999999999875 456789


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      ||||+++++|.+++.+.  ..+++..+..++.|++.||+|||+.+++||||||+||++++++.++|+|||.+....... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~-  156 (262)
T cd05071          78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-  156 (262)
T ss_pred             EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc-
Confidence            99999999999999753  357899999999999999999999999999999999999999999999999987543211 


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL  247 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~l  247 (344)
                      ........++..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.........+... ....+..++..+.++
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  235 (262)
T cd05071         157 YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL  235 (262)
T ss_pred             cccccCCcccceecCHhHhccCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence            111123345678999999877665 688999999999999999 89999887766666665544 344556789999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhc
Q 019216          248 LRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~  267 (344)
                      +.+||+.||++||++.++++
T Consensus       236 i~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         236 MCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHccCCcccCCCHHHHHH
Confidence            99999999999999999865

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=9.7e-44  Score=325.61  Aligned_cols=256  Identities=21%  Similarity=0.345  Sum_probs=204.4

Q ss_pred             eeeccc--CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccC
Q 019216           20 RTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (344)
Q Consensus        20 ~~Lg~G--~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~   97 (344)
                      ..||+|  +||+||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++..+...+++|||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            467777  999999999999999999999865433 23446788999999999999999999999999999999999999


Q ss_pred             CCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC----
Q 019216           98 GGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG----  171 (344)
Q Consensus        98 g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~----  171 (344)
                      +++|.+++.+.  ..+++..+..++.|++.||+|||++|++||||||+|||++.++.++++||+.+..........    
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            99999988764  348999999999999999999999999999999999999999999999998653221110000    


Q ss_pred             -ccccccCCCcccchhhhccCC-CCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC---------------
Q 019216          172 -LLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---------------  234 (344)
Q Consensus       172 -~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~---------------  234 (344)
                       ......++..|+|||++.+.. ..+.++|||||||++|+|++|+.||.................               
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR  242 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence             011123456799999987642 236889999999999999999999987654443333222111               


Q ss_pred             --------------------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          235 --------------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       235 --------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                                                      +.+..+++.+.+|+++||+.||++|||+.++++|+||++...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence                                            112235678999999999999999999999999999986544

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.6e-43  Score=320.03  Aligned_cols=260  Identities=25%  Similarity=0.369  Sum_probs=216.3

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      +...-..|+..+.||+|++|.||+|.++.++..+|+|.+.............+.+|+.+++.++|+|++++++++.....
T Consensus        10 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   89 (308)
T cd06634          10 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT   89 (308)
T ss_pred             cCCcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCe
Confidence            34455668889999999999999999999999999999865433344445678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .++||||+. +++.+.+.. ..++++..+..++.|++.||.|||+.+++||||+|+||+++.++.++|+|||++..... 
T Consensus        90 ~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~-  167 (308)
T cd06634          90 AWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-  167 (308)
T ss_pred             eEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-
Confidence            999999996 577776653 45689999999999999999999999999999999999999999999999999874321 


Q ss_pred             cCCCccccccCCCcccchhhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC--CCCCCCHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPG  243 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~  243 (344)
                           .....++..|+|||.+.+  ....+.++|||||||++|+|++|..||...+.......+.....+  .+..++..
T Consensus       168 -----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (308)
T cd06634         168 -----ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEY  242 (308)
T ss_pred             -----cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHH
Confidence                 234567889999999753  223367899999999999999999999876655444444443322  23458899


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      +.+||++||+.+|++||++.++++|+|+....
T Consensus       243 ~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         243 FRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             HHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence            99999999999999999999999999998743

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.3e-43  Score=322.67  Aligned_cols=261  Identities=26%  Similarity=0.386  Sum_probs=209.4

Q ss_pred             CeEEeeeecccCceEEEEEEECCC--CceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEee----CC
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS----KS   87 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----~~   87 (344)
                      +|++.+.||+|+||.||+|.+..+  +..||+|.+.... ........+.+|+.+++++ .||||+++++....    ..
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            589999999999999999999888  8999999886432 2223356678899999999 59999999987532    24


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .++++++++. ++|.+.+.....+++..++.++.||+.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus        80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~  158 (332)
T cd07857          80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN  158 (332)
T ss_pred             cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence            5789999984 699999988888999999999999999999999999999999999999999999999999998754321


Q ss_pred             cC--CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC-------------
Q 019216          168 RD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------  232 (344)
Q Consensus       168 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~-------------  232 (344)
                      ..  ........|+..|+|||.+.+....+.++||||||+++|+|++|++||...+.......+...             
T Consensus       159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (332)
T cd07857         159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG  238 (332)
T ss_pred             cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence            11  112234578999999998766444468999999999999999999999876543333222210             


Q ss_pred             ---------------CCC---CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          233 ---------------DFK---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       233 ---------------~~~---~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                     ...   .....+..+.+++.+||+.||++|||+.+++.|||+++...+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~~  301 (332)
T cd07857         239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHDP  301 (332)
T ss_pred             hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcCc
Confidence                           001   112357899999999999999999999999999999866443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-44  Score=331.91  Aligned_cols=249  Identities=28%  Similarity=0.442  Sum_probs=214.5

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCc---e-EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGL---P-FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~---~-vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..+.++||+|+||.||+|..+..+.   . ||+|..+............+.+|.++++.++||||+++||+......++
T Consensus       158 ~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~  237 (474)
T KOG0194|consen  158 DIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLM  237 (474)
T ss_pred             CccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccE
Confidence            34456899999999999998765322   3 8999887544455677889999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           91 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +|||+|+||+|.+++++.+ .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+++...... 
T Consensus       238 ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~-  316 (474)
T KOG0194|consen  238 LVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYV-  316 (474)
T ss_pred             EEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCccee-
Confidence            9999999999999999877 49999999999999999999999999999999999999999999999999988432111 


Q ss_pred             CCccc-cccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC--CCCCCCCCHHHH
Q 019216          170 DGLLH-TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLSPGAQ  245 (344)
Q Consensus       170 ~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~~  245 (344)
                        ... ...-...|+|||.+....+ +.++|||||||++||+++ |..||.+........++....  .+.|...+..+.
T Consensus       317 --~~~~~~klPirWLAPEtl~~~~~-s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~  393 (474)
T KOG0194|consen  317 --MKKFLKKLPIRWLAPETLNTGIF-SFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELA  393 (474)
T ss_pred             --eccccccCcceecChhhhccCcc-ccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHH
Confidence              111 1124578999999988755 799999999999999999 899999999999999996554  445667888999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhc
Q 019216          246 NLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .++.+|+..||++|||+.++.+
T Consensus       394 ~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  394 KVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHhccCChhhccCHHHHHH
Confidence            9999999999999999999865

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-43  Score=309.69  Aligned_cols=245  Identities=28%  Similarity=0.504  Sum_probs=211.2

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +...+|++.+.||.|++|.||+|..  .|+.||+|.+.....    ..+++.+|+.+++.++|+||+++++++......+
T Consensus         3 ~~~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   76 (256)
T cd05039           3 INSKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLY   76 (256)
T ss_pred             cChhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeE
Confidence            4567899999999999999999986  478999999864432    4577889999999999999999999999889999


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +||||+++++|.+++....  .+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||.+...... 
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~-  155 (256)
T cd05039          77 IVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-  155 (256)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc-
Confidence            9999999999999997655  6899999999999999999999999999999999999999999999999998754211 


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                          ......+..|+|||.+....+ +.++||||||+++|++++ |..||...........+... ....+..+++.+.+
T Consensus       156 ----~~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (256)
T cd05039         156 ----QDSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYK  230 (256)
T ss_pred             ----cccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHH
Confidence                112334567999999876665 578999999999999997 99999887776666655544 34556778999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhc
Q 019216          247 LLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~  267 (344)
                      +|.+||+.+|++|||+.++++
T Consensus       231 li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         231 VMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHHhccChhhCcCHHHHHH
Confidence            999999999999999999976

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.9e-43  Score=311.79  Aligned_cols=249  Identities=26%  Similarity=0.397  Sum_probs=207.7

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++.++||+|++|.||+|.+. .+..+|+|.+.....    ....+.+|+.++++++|+|++++++++. ....+
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~   76 (260)
T cd05070           3 IPRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY   76 (260)
T ss_pred             CchHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence            45678999999999999999999874 566799999865432    1356889999999999999999999875 45688


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ++|||+++++|.+++...  ..+++..++.++.|++.||.|||+.|++||||||+||++++++.++|+|||++.......
T Consensus        77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05070          77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence            999999999999998753  358999999999999999999999999999999999999999999999999987543211


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                      . .......++..|+|||.+.+..+ +.++|+||||+++|+|++ |..||.+.+.......+... ..+.+...+..+.+
T Consensus       157 ~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd05070         157 Y-TARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHE  234 (260)
T ss_pred             c-ccccCCCCCccccChHHHhcCCC-cchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence            1 11112234567999999876665 689999999999999999 99999887777766666554 45567778999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhc
Q 019216          247 LLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~  267 (344)
                      |+.+||..+|++|||++++.+
T Consensus       235 li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         235 LMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-46  Score=365.75  Aligned_cols=258  Identities=32%  Similarity=0.513  Sum_probs=222.5

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      ||+....||.|.||.||.|.+..+|...|+|.+.-+... ......+.+|..++..++|||++++|++=.+.+..+|.||
T Consensus      1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred             eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence            567788999999999999999999999999988765544 4567788999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc--CCCc
Q 019216           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR--DDGL  172 (344)
Q Consensus        95 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~--~~~~  172 (344)
                      ||.||+|.++++..+-.++...+.+..|++.|++|||+.|||||||||+|||++.+|.+|++|||.|.......  -...
T Consensus      1315 yC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~e 1394 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGE 1394 (1509)
T ss_pred             HhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHH
Confidence            99999999999887778888888899999999999999999999999999999999999999999998554321  1223


Q ss_pred             cccccCCCcccchhhhccCC--CCCccchhhhhhHHHHHHHhCCCCCCCcc-HHHHHHHHhh-CCCCCCCCCCHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFR-GDFKLPKWLSPGAQNLL  248 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~--~~~~~~DvwslG~ll~ell~g~~pf~~~~-~~~~~~~i~~-~~~~~~~~~~~~~~~li  248 (344)
                      .....||+.|||||++.+..  ..+.+.||||||||+.||+||+.||...+ .-.+..++.. ..+++|..++++.++||
T Consensus      1395 l~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~g~dFl 1474 (1509)
T KOG4645|consen 1395 LQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSEGRDFL 1474 (1509)
T ss_pred             HHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHhHHHHH
Confidence            45678999999999997643  23568999999999999999999998644 3333344444 46889999999999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCccccc
Q 019216          249 RKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      .+||+.||++|+++.|+++|.|-..
T Consensus      1475 e~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1475 EHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred             HHHHhcCchhhhHHHHHHHhhcccc
Confidence            9999999999999999999987654

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.9e-43  Score=311.56  Aligned_cols=253  Identities=23%  Similarity=0.393  Sum_probs=210.2

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..++|++.+.||+|+||.||+|.++.++.   .+|+|.++...  .......+.+|+.++++++||||+++++++...+.
T Consensus         2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   79 (267)
T cd05066           2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP   79 (267)
T ss_pred             CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence            35789999999999999999999865543   79999886432  23345688999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+++|||+++++|.+++.+. +.+++..+..++.|++.||++||+.|++||||||+|||++.++.++|+|||++......
T Consensus        80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999998764 46899999999999999999999999999999999999999999999999998754332


Q ss_pred             cCCCc-cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHH
Q 019216          168 RDDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA  244 (344)
Q Consensus       168 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~  244 (344)
                      ..... .....++..|+|||.+.+..+ +.++|+||||+++|++++ |..||.+.........+..+ ..+.+..+++.+
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAAL  238 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCcc-CchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHH
Confidence            11111 111223567999999877665 689999999999999887 99999887766666655544 234455678999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhc
Q 019216          245 QNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .+++.+||+.+|.+||++.++++
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         239 HQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHcccCchhCCCHHHHHH
Confidence            99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.7e-43  Score=309.85  Aligned_cols=250  Identities=26%  Similarity=0.409  Sum_probs=211.5

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++.+.||+|++|.||+|.+. +++.||+|.+.....    ..+.+.+|+.++++++|+|++++++++......+
T Consensus         3 ~~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   77 (261)
T cd05034           3 IPRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY   77 (261)
T ss_pred             cchhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence            45689999999999999999999975 557899999864432    2356889999999999999999999999888999


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ++|||+++++|.+++...  ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......
T Consensus        78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            999999999999999764  368999999999999999999999999999999999999999999999999987543211


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                       ........++..|+|||.+.+... +.++|+||||+++|+|++ |+.||.+.+.......+... ..+.+...+..+.+
T Consensus       158 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (261)
T cd05034         158 -YTAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYD  235 (261)
T ss_pred             -hhhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence             111112234567999999887665 689999999999999998 99999888777777776654 34556678999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhc
Q 019216          247 LLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~  267 (344)
                      ++.+||+.+|++||+++++++
T Consensus       236 ~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         236 LMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHcccCcccCCCHHHHHH
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.9e-43  Score=315.62  Aligned_cols=254  Identities=26%  Similarity=0.378  Sum_probs=211.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      +..++|++.+.||+|+||.||+|.+..     ++..||+|.+....  .......+.+|+.++++++||||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~   79 (288)
T cd05050           2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAV   79 (288)
T ss_pred             CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcC
Confidence            356789999999999999999998753     67899999886432  23345678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCC
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKG----------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLE  143 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~----------------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~  143 (344)
                      +...+++|||+++++|.+++....                      .+++..++.++.|++.||.|||++|++||||||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~  159 (288)
T cd05050          80 GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATR  159 (288)
T ss_pred             CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHh
Confidence            889999999999999999986432                      3678889999999999999999999999999999


Q ss_pred             cEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccH
Q 019216          144 NILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNL  222 (344)
Q Consensus       144 NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~  222 (344)
                      ||+++.++.++|+|||++.................+..|+|||.+.+..+ +.++|||||||++|+|++ |..||.+.+.
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~~~~~p~~~~~~  238 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGMQPYYGMAH  238 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            99999999999999999874322111111122334567999999877665 689999999999999998 8899988777


Q ss_pred             HHHHHHHhhCCC-CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          223 AVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       223 ~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ......+..+.. ..+..++..+.+|+.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         239 EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            777766665543 446678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=5.8e-43  Score=320.43  Aligned_cols=261  Identities=30%  Similarity=0.439  Sum_probs=211.8

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee-CCeEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIY   90 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~   90 (344)
                      .-++|++++.||.|+||.||+|.++.+++.||+|.+.+... .......+.+|+.+++.++||||+++++++.. ....+
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            34689999999999999999999999999999998865322 22345678899999999999999999999865 56789


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      +++||+ +++|.+++.. .++++..+..++.|++.||.|||+.|++||||+|.||++++++.++|+|||++.....    
T Consensus        87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~----  160 (328)
T cd07856          87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP----  160 (328)
T ss_pred             EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC----
Confidence            999999 6688877754 5688999999999999999999999999999999999999999999999999874321    


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhh-------------------
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-------------------  231 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~-------------------  231 (344)
                       ......++..|+|||.+.+....+.++|||||||++|+|++|+.||...+.......+..                   
T Consensus       161 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd07856         161 -QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL  239 (328)
T ss_pred             -CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence             223346788999999876644457899999999999999999999977554222111110                   


Q ss_pred             -------CCCCC-----CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCCCCC
Q 019216          232 -------GDFKL-----PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP  280 (344)
Q Consensus       232 -------~~~~~-----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~~~~  280 (344)
                             .....     ...+++.+.++|++||+.+|++|||+++++.|+||.....+...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~~~  300 (328)
T cd07856         240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE  300 (328)
T ss_pred             HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCccc
Confidence                   00011     12467899999999999999999999999999999876665433

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.8e-43  Score=309.32  Aligned_cols=244  Identities=26%  Similarity=0.389  Sum_probs=203.3

Q ss_pred             eeecccCceEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecc
Q 019216           20 RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV   96 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~   96 (344)
                      ++||+|+||.||+|....++   ..+|+|.+......  ...+.+.+|+.+++.++|+|++++++++. ....+++|||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence            47999999999999876554   78999998654432  34567889999999999999999999876 44679999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC-cccc
Q 019216           97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-LLHT  175 (344)
Q Consensus        97 ~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~-~~~~  175 (344)
                      ++++|.+++.+.+.+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||++.......... ....
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~  157 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA  157 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence            999999999887889999999999999999999999999999999999999999999999999987543211110 0111


Q ss_pred             ccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHhcC
Q 019216          176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILE  253 (344)
Q Consensus       176 ~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~  253 (344)
                      ..++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...+.......+... ....+..+++.+.+++.+||.
T Consensus       158 ~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~  236 (257)
T cd05060         158 GRWPLKWYAPECINYGKF-SSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK  236 (257)
T ss_pred             ccccccccCHHHhcCCCC-CccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence            123457999999877665 689999999999999998 99999887766666555544 345667789999999999999


Q ss_pred             CCcCCCCCHhhhhc
Q 019216          254 PNPVKRITIAGIKA  267 (344)
Q Consensus       254 ~dP~~Rps~~eil~  267 (344)
                      .+|++||++.++++
T Consensus       237 ~~p~~Rp~~~~l~~  250 (257)
T cd05060         237 YRPEDRPTFSELES  250 (257)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.1e-43  Score=317.54  Aligned_cols=253  Identities=23%  Similarity=0.304  Sum_probs=204.2

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCC--------------CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDS--------------GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV   77 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~--------------~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv   77 (344)
                      ..++|++.++||+|+||.||+|.+..+              ...||+|.+....  .......+.+|++++++++|+|++
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~   80 (295)
T cd05097           3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNII   80 (295)
T ss_pred             chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcC
Confidence            456999999999999999999987543              2358999986432  234456789999999999999999


Q ss_pred             ceeeEEeeCCeEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcE
Q 019216           78 RLHEVLASKSKIYMVLEYVTGGELFDKIASKG------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI  145 (344)
Q Consensus        78 ~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NI  145 (344)
                      ++++++......++||||+.+++|.+++....            .+++..+..++.|++.||+|||+.|++||||||+||
T Consensus        81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni  160 (295)
T cd05097          81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC  160 (295)
T ss_pred             eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence            99999999999999999999999999886432            367888999999999999999999999999999999


Q ss_pred             EEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh--CCCCCCCccHH
Q 019216          146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLA  223 (344)
Q Consensus       146 Ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~--g~~pf~~~~~~  223 (344)
                      +++.++.+||+|||++................++..|+|||.+....+ +.++|||||||++|+|++  |..||...+..
T Consensus       161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~  239 (295)
T cd05097         161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDE  239 (295)
T ss_pred             EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChH
Confidence            999999999999999874322111111122344678999999877665 689999999999999988  67888876554


Q ss_pred             HHHHHHhh--------CCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          224 VLYQKIFR--------GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       224 ~~~~~i~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .....+..        .....+..+++.+.+|+.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         240 QVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            44433321        112335567899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.4e-43  Score=308.85  Aligned_cols=244  Identities=25%  Similarity=0.469  Sum_probs=206.8

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe-eCCeE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SKSKI   89 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~   89 (344)
                      +.+.+|++.+.||+|+||.||++..  .|..+|+|.+....     ..+.+.+|+.++++++|+|++++++++. .....
T Consensus         3 ~~~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~   75 (256)
T cd05082           3 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   75 (256)
T ss_pred             ccHHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCce
Confidence            4677999999999999999999986  47789999885332     2457889999999999999999998754 55678


Q ss_pred             EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           90 YMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      +++|||+++++|.+++.+.+  .+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++..... 
T Consensus        76 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~-  154 (256)
T cd05082          76 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-  154 (256)
T ss_pred             EEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc-
Confidence            99999999999999987644  478999999999999999999999999999999999999999999999999874322 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ  245 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~  245 (344)
                          ......++..|+|||++....+ +.++|||||||++|+|++ |+.||...+.......+..+ ....+..+++.+.
T Consensus       155 ----~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (256)
T cd05082         155 ----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY  229 (256)
T ss_pred             ----cCCCCccceeecCHHHHccCCC-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence                1123344568999999877665 688999999999999998 99999887776666666544 3445677899999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhc
Q 019216          246 NLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~  267 (344)
                      +++.+||+.+|++|||+.++++
T Consensus       230 ~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         230 DVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-45  Score=300.56  Aligned_cols=255  Identities=27%  Similarity=0.415  Sum_probs=205.8

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee-----
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-----   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----   85 (344)
                      +.=.||++.++||.|||+-||++++..+++.||+|.+....   .+..+...+|++.-++++|||++++++....     
T Consensus        18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~   94 (302)
T KOG2345|consen   18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDG   94 (302)
T ss_pred             EcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccC
Confidence            34469999999999999999999999999999999986543   4567889999999999999999999887632     


Q ss_pred             CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEEccCCCeEEeccc
Q 019216           86 KSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFG  159 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~--i~H~dikp~NILl~~~~~vkl~Dfg  159 (344)
                      ....|++++|...|+|.+.++.    ...+++.++..|+.++++||.+||+..  ++||||||.|||+.+++.++|.|||
T Consensus        95 ~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~G  174 (302)
T KOG2345|consen   95 KHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLG  174 (302)
T ss_pred             ceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEecc
Confidence            3458999999999999999874    236999999999999999999999998  9999999999999999999999999


Q ss_pred             cccCCCcccCCC----c---cccccCCCcccchhhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCccH--HHHHHH
Q 019216          160 LSALPQHFRDDG----L---LHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNL--AVLYQK  228 (344)
Q Consensus       160 ~a~~~~~~~~~~----~---~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~--~~~~~~  228 (344)
                      .+......-.++    .   ......|..|+|||.+.-  ....+.++|||||||++|.|+.|..||+..-.  ..+.-.
T Consensus       175 S~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLA  254 (302)
T KOG2345|consen  175 SATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALA  254 (302)
T ss_pred             CccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEe
Confidence            987432211111    0   111245788999999753  23347899999999999999999999954211  001112


Q ss_pred             HhhCCCCCC--CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          229 IFRGDFKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       229 i~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +.++.+.+|  ..+|..+.++|+.||+.||.+||++.+++.+
T Consensus       255 v~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  255 VQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             eeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            233444555  3489999999999999999999999999875

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.9e-43  Score=316.46  Aligned_cols=254  Identities=26%  Similarity=0.457  Sum_probs=213.2

Q ss_pred             EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecc
Q 019216           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV   96 (344)
Q Consensus        17 ~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~   96 (344)
                      +...+||+|+||.||++.+..+++.||+|.+....   ......+.+|+.+++.++|+|++++++.+..++..+++|||+
T Consensus        23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence            33467999999999999999999999999875322   234567889999999999999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccc
Q 019216           97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT  176 (344)
Q Consensus        97 ~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~  176 (344)
                      ++++|.+++.. +.+++..+..++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.....  ........
T Consensus       100 ~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~--~~~~~~~~  176 (292)
T cd06657         100 EGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRRKSL  176 (292)
T ss_pred             CCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccc--cccccccc
Confidence            99999887654 5689999999999999999999999999999999999999999999999998764322  11122345


Q ss_pred             cCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC---CCCCCCCCCHHHHHHHHHhcC
Q 019216          177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLRKILE  253 (344)
Q Consensus       177 ~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~~~L~  253 (344)
                      .++..|+|||.+.+..+ +.++|+||+|+++|+|++|..||.+.........+...   .......+++.+.+++.+||+
T Consensus       177 ~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  255 (292)
T cd06657         177 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV  255 (292)
T ss_pred             ccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence            68899999999876665 68999999999999999999999887665544444332   222334578999999999999


Q ss_pred             CCcCCCCCHhhhhcCccccccCCC
Q 019216          254 PNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       254 ~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      .+|.+||++.++++||||.....+
T Consensus       256 ~~P~~R~~~~~ll~~~~~~~~~~~  279 (292)
T cd06657         256 RDPAQRATAAELLKHPFLAKAGPP  279 (292)
T ss_pred             CCcccCcCHHHHhcChHHhccCCC
Confidence            999999999999999999876543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=7e-43  Score=309.37  Aligned_cols=249  Identities=25%  Similarity=0.399  Sum_probs=206.3

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++.+.||+|++|.||+|.+..+ ..+|+|.+.....    ..+.+.+|+.++++++|+|++++++++. ....+
T Consensus         3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~   76 (260)
T cd05069           3 IPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIY   76 (260)
T ss_pred             CChHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcE
Confidence            3457899999999999999999997554 4699998754332    2356788999999999999999999875 45678


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ++|||+.+++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~  156 (260)
T cd05069          77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE  156 (260)
T ss_pred             EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence            999999999999999753  347899999999999999999999999999999999999999999999999987542211


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                       ........++..|+|||.+.+... +.++||||||+++|+|++ |+.||.+.........+... ..+.+...+..+.+
T Consensus       157 -~~~~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd05069         157 -YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHE  234 (260)
T ss_pred             -ccccCCCccchhhCCHHHhccCCc-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence             111122345678999998876665 689999999999999999 99999887776666666554 34456678999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhc
Q 019216          247 LLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~  267 (344)
                      ++++||+.||++||+++++++
T Consensus       235 li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         235 LMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHccCCcccCcCHHHHHH
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.2e-44  Score=343.56  Aligned_cols=254  Identities=27%  Similarity=0.397  Sum_probs=218.7

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEE
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL   83 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~   83 (344)
                      ..+..++.++.+.||+|+||.||+|+-.     ...+.||||.++...  +.....+|.+|++++..++|||||+++|+|
T Consensus       481 ~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC  558 (774)
T KOG1026|consen  481 LEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVC  558 (774)
T ss_pred             eEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEE
Confidence            4466778889999999999999999853     235689999986543  344678999999999999999999999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIASKG--------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS  149 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~~~~--------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~  149 (344)
                      ..++.+++|+|||..|+|.++|....              +++..+...|+.|||.|+.||-++.++||||-..|+||.+
T Consensus       559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge  638 (774)
T KOG1026|consen  559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGE  638 (774)
T ss_pred             ccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceecc
Confidence            99999999999999999999996422              2788899999999999999999999999999999999999


Q ss_pred             CCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHH
Q 019216          150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK  228 (344)
Q Consensus       150 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~  228 (344)
                      +-.|||+|||+++..-...-........-..+|||||.+....+ +.+|||||+|++|||+++ |+.||.+...++..+.
T Consensus       639 ~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kF-TteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~  717 (774)
T KOG1026|consen  639 NLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKF-TTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIEC  717 (774)
T ss_pred             ceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcc-cchhhhhhhhhhhhhhhccccCcccccchHHHHHH
Confidence            99999999999984322111111111223568999999999888 688999999999999999 9999999999888888


Q ss_pred             HhhCC-CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhh
Q 019216          229 IFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI  265 (344)
Q Consensus       229 i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ei  265 (344)
                      +..+. ++.|..+|.++.+|+..||+..|++||++.||
T Consensus       718 i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  718 IRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             HHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            88875 67789999999999999999999999999997

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.7e-43  Score=321.34  Aligned_cols=256  Identities=27%  Similarity=0.438  Sum_probs=211.5

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCC-------CceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-------GLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV   82 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~   82 (344)
                      +.-.+|++++.||+|+||.||+|.+...       +..||+|.+....  .......+.+|+.+++++ +||||++++++
T Consensus         9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~   86 (334)
T cd05100           9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGA   86 (334)
T ss_pred             cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence            3345899999999999999999986432       2368999876432  234467888999999999 79999999999


Q ss_pred             EeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEE
Q 019216           83 LASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL  146 (344)
Q Consensus        83 ~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NIL  146 (344)
                      +......+++|||+++++|.+++.+..                .++...+..++.|++.||.|||++|++||||||+|||
T Consensus        87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil  166 (334)
T cd05100          87 CTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVL  166 (334)
T ss_pred             EccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEE
Confidence            999899999999999999999987532                3677888999999999999999999999999999999


Q ss_pred             EccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHH
Q 019216          147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL  225 (344)
Q Consensus       147 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~  225 (344)
                      ++.++.+||+|||+++...............++..|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+....
T Consensus       167 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~  245 (334)
T cd05100         167 VTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL  245 (334)
T ss_pred             EcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCc-CchhhhHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999875432211111222334567999999877666 578999999999999998 8999998887777


Q ss_pred             HHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCc
Q 019216          226 YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE  269 (344)
Q Consensus       226 ~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~  269 (344)
                      ...+... ....+..++..+.+++.+||+.+|.+|||+.+++++-
T Consensus       246 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l  290 (334)
T cd05100         246 FKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDL  290 (334)
T ss_pred             HHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHH
Confidence            7766654 3456677899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.6e-43  Score=322.38  Aligned_cols=254  Identities=30%  Similarity=0.419  Sum_probs=207.2

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC------
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------   86 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------   86 (344)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++...      
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~   92 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF   92 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence            3699999999999999999999999999999999865322 223345688999999999999999999988644      


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ..+++|+||+. .+|.+..  ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus        93 ~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~  169 (342)
T cd07879          93 QDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA  169 (342)
T ss_pred             ceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC
Confidence            34689999995 4776654  34689999999999999999999999999999999999999999999999999874321


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--------------
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--------------  232 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--------------  232 (344)
                           ......++..|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+...              
T Consensus       170 -----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         170 -----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             -----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence                 1234567889999999876444468899999999999999999999887654443333221              


Q ss_pred             ---------CCCC--------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          233 ---------DFKL--------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       233 ---------~~~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                               ....        ....++.+.+||.+||+.||++||++.+++.||||+...
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                     0000        123678899999999999999999999999999998753

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.3e-43  Score=314.31  Aligned_cols=259  Identities=33%  Similarity=0.592  Sum_probs=216.1

Q ss_pred             CeEEeeeecccCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~   89 (344)
                      .|++.+.||+|++|.||+|.+.   .++..||+|++++.... .......+.+|+.+++++ .||||+++++.+......
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4899999999999999999864   46789999998754322 223456788999999999 599999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      ++||||+.+++|.+.+.....+++..++.++.|++.+|.|||+.|++||||+|.||+++.++.++|+|||++...... .
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~  159 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-E  159 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc-c
Confidence            999999999999999987778999999999999999999999999999999999999999999999999998753221 1


Q ss_pred             CCccccccCCCcccchhhhccCC-CCCccchhhhhhHHHHHHHhCCCCCCCcc----HHHHHHHHhhCCCCCCCCCCHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPGA  244 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~ll~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~  244 (344)
                      ........|+..|+|||.+.+.. ..+.++|+||||+++|+|++|..||....    .......+.....+.|..+++.+
T Consensus       160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  239 (288)
T cd05583         160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA  239 (288)
T ss_pred             ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence            11122346889999999986543 23578999999999999999999996432    33444555566677788899999


Q ss_pred             HHHHHHhcCCCcCCCCC---HhhhhcCcccccc
Q 019216          245 QNLLRKILEPNPVKRIT---IAGIKADEWFEQD  274 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps---~~eil~~~~~~~~  274 (344)
                      .+++.+||+.||++|||   +.++|+||||+..
T Consensus       240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             HHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence            99999999999999998   5677999999753

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-43  Score=313.89  Aligned_cols=250  Identities=33%  Similarity=0.454  Sum_probs=205.8

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccceeeEEeeCCe----
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLASKSK----   88 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~~~~----   88 (344)
                      |++.+.||+|++|.||+|.++.+++.||+|.++.... .......+.+|+.+++++   +|+|++++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            7899999999999999999988899999999864432 222345566788777666   59999999999987766    


Q ss_pred             -EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           89 -IYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        89 -~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                       .+++|||+. ++|.+++....  .+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....
T Consensus        80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~  158 (287)
T cd07838          80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS  158 (287)
T ss_pred             eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence             999999996 48988887643  58999999999999999999999999999999999999999999999999987543


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-----CC-----
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-----FK-----  235 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-----~~-----  235 (344)
                      ..   .......++..|+|||.+.+..+ +.++|+|||||++|+|++|++||.+.+..+...++....     ..     
T Consensus       159 ~~---~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (287)
T cd07838         159 FE---MALTSVVVTLWYRAPEVLLQSSY-ATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV  234 (287)
T ss_pred             CC---cccccccccccccChHHhccCCC-CCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence            21   12233457889999999887665 688999999999999999999999877666655554310     00     


Q ss_pred             ------C-----------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          236 ------L-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       236 ------~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                            +           ...+++.+.++|.+||+.||++||++.+++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence                  0           01246788999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-43  Score=341.11  Aligned_cols=261  Identities=28%  Similarity=0.397  Sum_probs=195.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCC-ceEEEEE--------------eecccccchhHHHHHHHHHHHHHhCCCCC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKI--------------LEKNRIIHLKITDQIKREIATLKLLKHPN   75 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~-~~vaiK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~h~n   75 (344)
                      ...++|++++.||+|+||.||+|..+... ...+.|.              +.+...........+.+|+.++++++|||
T Consensus       145 ~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        145 EFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCC
Confidence            34578999999999999999998764322 2222221              11111112234556889999999999999


Q ss_pred             ccceeeEEeeCCeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC
Q 019216           76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK  150 (344)
Q Consensus        76 iv~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~  150 (344)
                      |+++++++...+..|++++++ +++|.+++...     .......++.++.||+.||.|||++||+||||||+|||++.+
T Consensus       225 Iv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~  303 (501)
T PHA03210        225 ILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCD  303 (501)
T ss_pred             cCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCC
Confidence            999999999999999999999 55777776532     223466788999999999999999999999999999999999


Q ss_pred             CCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCC-CCCCc--cHHHHHH
Q 019216          151 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL-PFDDR--NLAVLYQ  227 (344)
Q Consensus       151 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~-pf~~~--~~~~~~~  227 (344)
                      +.+||+|||++...... .........||..|+|||++.+..+ +.++|||||||++|||++|.. ||...  .......
T Consensus       304 ~~vkL~DFGla~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKE-REAFDYGWVGTVATNSPEILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCEEEEeCCCceecCcc-cccccccccCCcCCCCchhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            99999999999754321 1112234679999999999988776 689999999999999999875 44322  1112221


Q ss_pred             HHhhC----CCCCC----------------------------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          228 KIFRG----DFKLP----------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       228 ~i~~~----~~~~~----------------------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ++...    ...+|                            ..++.++.++|.+||+.||.+|||+.|+|+||||...
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            11110    00010                            1246678889999999999999999999999999764

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=6.3e-43  Score=315.63  Aligned_cols=253  Identities=23%  Similarity=0.336  Sum_probs=204.0

Q ss_pred             cccCeEEeeeecccCceEEEEEEECC----------------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLD----------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN   75 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~----------------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n   75 (344)
                      ..++|++.+.||+|+||.||+|.+..                ++..+|+|.+....  .......+.+|+.+++.++|+|
T Consensus         3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~   80 (296)
T cd05095           3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPN   80 (296)
T ss_pred             ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCC
Confidence            45789999999999999999986432                34579999886432  2334567889999999999999


Q ss_pred             ccceeeEEeeCCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCc
Q 019216           76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-----------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN  144 (344)
Q Consensus        76 iv~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~-----------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~N  144 (344)
                      |+++++++...+..+++|||+++++|.+++....           .+++..+..++.|++.||+|||+.|++||||||+|
T Consensus        81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~N  160 (296)
T cd05095          81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRN  160 (296)
T ss_pred             cceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChhe
Confidence            9999999999999999999999999999987532           36677899999999999999999999999999999


Q ss_pred             EEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh--CCCCCCCccH
Q 019216          145 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNL  222 (344)
Q Consensus       145 ILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~--g~~pf~~~~~  222 (344)
                      ||++.++.++|+|||++................++..|+|||...+..+ +.++|||||||++|||++  |..||...+.
T Consensus       161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         161 CLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             EEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            9999999999999999874322111111122334678999998776665 689999999999999998  7889977655


Q ss_pred             HHHHHHHh--------hCCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          223 AVLYQKIF--------RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       223 ~~~~~~i~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ........        ....+.+..+++.+.+|+.+||+.||++||++.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            44433221        1123445668899999999999999999999999865

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.7e-43  Score=324.56  Aligned_cols=255  Identities=25%  Similarity=0.389  Sum_probs=204.6

Q ss_pred             ccccCeEEeeeecccCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEe
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA   84 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~   84 (344)
                      ...++|++.+.||+|+||.||+|.+     ..+++.||+|.++...  .......+.+|+.++.++ +||||+++++++.
T Consensus         4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~   81 (343)
T cd05103           4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT   81 (343)
T ss_pred             cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence            4567999999999999999999985     3567899999986433  223456788999999999 5899999999875


Q ss_pred             e-CCeEEEEEeccCCCChHHHHHhc-------------------------------------------------------
Q 019216           85 S-KSKIYMVLEYVTGGELFDKIASK-------------------------------------------------------  108 (344)
Q Consensus        85 ~-~~~~~iv~e~~~g~~L~~~l~~~-------------------------------------------------------  108 (344)
                      . +...+++||||++|+|.+++...                                                       
T Consensus        82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence            4 45688999999999999988642                                                       


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccc
Q 019216          109 ------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT  176 (344)
Q Consensus       109 ------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~  176 (344)
                                  ..++...+..++.|++.||+|||++||+||||||.|||++.++.+||+|||++...............
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  241 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA  241 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence                        13577788899999999999999999999999999999999999999999998753221111111223


Q ss_pred             cCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHH-HHHHHHhhC-CCCCCCCCCHHHHHHHHHhcC
Q 019216          177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA-VLYQKIFRG-DFKLPKWLSPGAQNLLRKILE  253 (344)
Q Consensus       177 ~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~-~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~  253 (344)
                      .++..|+|||.+.+..+ +.++||||||+++|+|++ |..||...... .....+..+ ....|...++.+.+++.+||+
T Consensus       242 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~  320 (343)
T cd05103         242 RLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  320 (343)
T ss_pred             CCCcceECcHHhcCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcc
Confidence            45677999999877665 689999999999999997 99999775432 222223222 345567788999999999999


Q ss_pred             CCcCCCCCHhhhhcC
Q 019216          254 PNPVKRITIAGIKAD  268 (344)
Q Consensus       254 ~dP~~Rps~~eil~~  268 (344)
                      .||++|||+.++++|
T Consensus       321 ~~p~~Rps~~eil~~  335 (343)
T cd05103         321 GEPSQRPTFSELVEH  335 (343)
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.7e-43  Score=328.83  Aligned_cols=257  Identities=27%  Similarity=0.366  Sum_probs=209.4

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeE
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEV   82 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~   82 (344)
                      -.+..++|.+.+.||+|+||.||+|++.     .++..||+|++....  .......+.+|+.++.++. ||||++++++
T Consensus        32 ~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~  109 (401)
T cd05107          32 WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGA  109 (401)
T ss_pred             ceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEE
Confidence            3466678899999999999999999964     345689999996532  2233457889999999997 9999999999


Q ss_pred             EeeCCeEEEEEeccCCCChHHHHHhcC-----------------------------------------------------
Q 019216           83 LASKSKIYMVLEYVTGGELFDKIASKG-----------------------------------------------------  109 (344)
Q Consensus        83 ~~~~~~~~iv~e~~~g~~L~~~l~~~~-----------------------------------------------------  109 (344)
                      +......++|||||.+|+|.+++...+                                                     
T Consensus       110 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         110 CTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             EccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence            999899999999999999999986432                                                     


Q ss_pred             ---------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCc
Q 019216          110 ---------------------------------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLEN  144 (344)
Q Consensus       110 ---------------------------------------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~N  144 (344)
                                                                   .+++..+..++.||+.||.|||+.+++||||||+|
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N  269 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN  269 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence                                                         25667788899999999999999999999999999


Q ss_pred             EEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHH
Q 019216          145 ILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA  223 (344)
Q Consensus       145 ILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~  223 (344)
                      ||++.++.+||+|||+++...............++..|+|||.+.+..+ +.++||||||+++|||++ |..||......
T Consensus       270 iLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslGvil~e~l~~g~~P~~~~~~~  348 (401)
T cd05107         270 VLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY-TTLSDVWSFGILLWEIFTLGGTPYPELPMN  348 (401)
T ss_pred             EEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC-CcHhHHHHHHHHHHHHHHcCCCCCCCCCch
Confidence            9999999999999999875322111111223456788999999887665 688999999999999998 89999875544


Q ss_pred             HHHHHH-hhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          224 VLYQKI-FRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       224 ~~~~~i-~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ...... ..+ ....|..++..+.+|+.+||..+|.+||++++++..
T Consensus       349 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         349 EQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            443333 333 345667789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-43  Score=314.55  Aligned_cols=252  Identities=33%  Similarity=0.500  Sum_probs=210.8

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~   95 (344)
                      |++.+.||+|++|.||+|.+..+++.||+|++.... ........+.+|+.++++++|+|++++++++......++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            678899999999999999999999999999987543 2233456778899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccc
Q 019216           96 VTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (344)
Q Consensus        96 ~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~  174 (344)
                      +. ++|.+++.+. ..+++..++.++.|++.||++||+.|++||||+|+||+++.++.++|+|||++......  .....
T Consensus        80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~  156 (282)
T cd07829          80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYT  156 (282)
T ss_pred             cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC--ccccC
Confidence            96 5999999876 57999999999999999999999999999999999999999999999999998754321  11223


Q ss_pred             cccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC------------------CCCC
Q 019216          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------DFKL  236 (344)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~------------------~~~~  236 (344)
                      ...++..|+|||.+.+....+.++||||||+++|++++|..||.+.+......++...                  ...+
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            3456778999999877644578999999999999999999999887655544433221                  0000


Q ss_pred             -----------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          237 -----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       237 -----------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                                 ...++..+.++|++||+.||++||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                       11247889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=1e-42  Score=311.62  Aligned_cols=254  Identities=22%  Similarity=0.310  Sum_probs=210.3

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECC----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee-
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLD----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-   85 (344)
                      +.-++|++.+.||+|+||.||+|.+..    ++..|++|.+...  ........+.+|+.+++.++|+||+++++++.. 
T Consensus         3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~   80 (280)
T cd05043           3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED   80 (280)
T ss_pred             cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence            455789999999999999999999875    3688999987533  234456778999999999999999999998765 


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEec
Q 019216           86 KSKIYMVLEYVTGGELFDKIASK--------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD  157 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~--------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~D  157 (344)
                      ....+++++|+++++|.+++...        ..+++..++.++.|++.||+|||+.+++||||||+||+++.++.+||+|
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d  160 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD  160 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence            56788999999999999998653        4588999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCC
Q 019216          158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFK  235 (344)
Q Consensus       158 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~  235 (344)
                      ||+++...............++..|+|||.+.+..+ +.++|||||||++|++++ |+.||...+.......+..+ .+.
T Consensus       161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  239 (280)
T cd05043         161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEY-SSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLA  239 (280)
T ss_pred             CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCC-CchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCC
Confidence            999874322111111122345678999999877665 688999999999999999 99999887776666555544 234


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       236 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .+..+++++.+++.+||..||++|||+.++++
T Consensus       240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         240 QPINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            45567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.5e-43  Score=310.41  Aligned_cols=253  Identities=32%  Similarity=0.523  Sum_probs=212.4

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      ||.+.+.||+|+||.||++.+...+..+++|+++.....  .......+..|+.+++.++||||+++++.+......+++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            699999999999999999999888888888877543321  122344577899999999999999999999988899999


Q ss_pred             EeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           93 LEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      |||+++++|.+.+..    ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.....  
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~--  157 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG--  157 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence            999999999888753    456899999999999999999999999999999999999964 6799999999875322  


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL  247 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l  247 (344)
                      .........++..|+|||.+.+..+ +.++|+||||+++|+|++|..||...........+..+. ...+..++.++.++
T Consensus       158 ~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (260)
T cd08222         158 SCDLATTFTGTPYYMSPEALKHQGY-DSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI  236 (260)
T ss_pred             CcccccCCCCCcCccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence            1122334567889999999876665 578999999999999999999998777666666665543 34566789999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhcCccc
Q 019216          248 LRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      |.+||+.+|++||++.++++||||
T Consensus       237 i~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         237 MQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHhcCChhhCcCHHHHhhCCCC
Confidence            999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1e-42  Score=308.18  Aligned_cols=248  Identities=27%  Similarity=0.424  Sum_probs=206.7

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .-.+|+++++||+|+||.||+|.. .+++.||+|.+.....    ....+.+|+.++++++|+|++++++++. ....++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~   77 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI   77 (260)
T ss_pred             chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence            456899999999999999999996 4577899999865432    2357888999999999999999999874 456899


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +|||+.+++|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++....... 
T Consensus        78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-  156 (260)
T cd05067          78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE-  156 (260)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-
Confidence            99999999999988653  468999999999999999999999999999999999999999999999999987433111 


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL  247 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~l  247 (344)
                      ........++..|+|||.+....+ +.++||||||+++|++++ |+.||.+.+.......+... ..+.+...+.++.++
T Consensus       157 ~~~~~~~~~~~~y~~pe~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (260)
T cd05067         157 YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL  235 (260)
T ss_pred             cccccCCcccccccCHHHhccCCc-CcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            111122345678999999876665 688999999999999999 99999887776666655444 345567788999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhc
Q 019216          248 LRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~  267 (344)
                      +.+||+.+|++|||++++++
T Consensus       236 i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         236 MRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHccCChhhCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.2e-42  Score=307.07  Aligned_cols=244  Identities=29%  Similarity=0.457  Sum_probs=205.0

Q ss_pred             eeecccCceEEEEEEECC-CCc--eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEecc
Q 019216           20 RTLGEGNFGKVKFAQDLD-SGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYV   96 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~   96 (344)
                      +.||+|++|.||+|.+.. +++  .||+|.+......  ...+.+.+|+.++++++||||+++++.+.. ...+++|||+
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA   77 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence            478999999999999765 333  6999998655432  556789999999999999999999999988 8899999999


Q ss_pred             CCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC-Ccc
Q 019216           97 TGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-GLL  173 (344)
Q Consensus        97 ~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~-~~~  173 (344)
                      ++++|.+.+.+..  .+++..++.++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++......... ...
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  157 (257)
T cd05040          78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME  157 (257)
T ss_pred             CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence            9999999997654  6899999999999999999999999999999999999999999999999998754332111 111


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC--CCCCCCCCCHHHHHHHHH
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRK  250 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~  250 (344)
                      ....++..|+|||.+.+..+ +.++|||||||++|+|++ |+.||...+.......+...  ....+..++..+.+++.+
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~-~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  236 (257)
T cd05040         158 EHLKVPFAWCAPESLRTRTF-SHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ  236 (257)
T ss_pred             cCCCCCceecCHHHhcccCc-CchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence            23456788999999877665 688999999999999999 99999887766666555532  334556688999999999


Q ss_pred             hcCCCcCCCCCHhhhhc
Q 019216          251 ILEPNPVKRITIAGIKA  267 (344)
Q Consensus       251 ~L~~dP~~Rps~~eil~  267 (344)
                      ||+.+|++|||+.++++
T Consensus       237 ~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         237 CWAHNPADRPTFAALRE  253 (257)
T ss_pred             HCCCCcccCCCHHHHHH
Confidence            99999999999999976

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-43  Score=313.07  Aligned_cols=250  Identities=30%  Similarity=0.476  Sum_probs=206.3

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEe
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      |++.+.||+|++|.||+|....+++.||+|.+......  .......+|+..+++++ |+|++++++++......++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            78899999999999999999889999999988643321  11233457899999999 9999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        95 ~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |+ +++|.+.+....  .+++..+..++.|++.+|.|||++|++|+||+|+||++++++.++|+|||++.....   ...
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~---~~~  154 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRS---RPP  154 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccC---CCC
Confidence            99 789999887654  789999999999999999999999999999999999999999999999999874322   112


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-------------------
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------------  233 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-------------------  233 (344)
                      .....++..|+|||++......+.++|+||||+++++|++|++||...+......++....                   
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            2345678899999988665545789999999999999999999998766544443332110                   


Q ss_pred             CC-----------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          234 FK-----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       234 ~~-----------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      ..           .....++.+.++|++||+.||++|||+.|++.||||
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            00           011236889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.5e-42  Score=306.91  Aligned_cols=243  Identities=26%  Similarity=0.389  Sum_probs=201.1

Q ss_pred             eecccCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCC
Q 019216           21 TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        21 ~Lg~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      .||+|+||.||+|.+.  ..+..||+|++....  .....+.+.+|+.++++++||||+++++++. ....++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence            4899999999999765  445679999886432  2344567899999999999999999999885 4578999999999


Q ss_pred             CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc-cccc
Q 019216           99 GELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-LHTT  176 (344)
Q Consensus        99 ~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~-~~~~  176 (344)
                      ++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++........... ....
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~  158 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG  158 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence            999998874 45789999999999999999999999999999999999999999999999999874332111111 1112


Q ss_pred             cCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHhcCC
Q 019216          177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP  254 (344)
Q Consensus       177 ~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~  254 (344)
                      .++..|+|||.+....+ +.++||||||+++|++++ |..||.+.........+..+ ....|..+++++.+++.+||..
T Consensus       159 ~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~  237 (257)
T cd05115         159 KWPLKWYAPECINFRKF-SSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY  237 (257)
T ss_pred             CCCcccCCHHHHccCCC-CchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence            33568999999877665 688999999999999996 99999887776666666554 3556778899999999999999


Q ss_pred             CcCCCCCHhhhhc
Q 019216          255 NPVKRITIAGIKA  267 (344)
Q Consensus       255 dP~~Rps~~eil~  267 (344)
                      ||++||++.++.+
T Consensus       238 ~~~~Rp~~~~i~~  250 (257)
T cd05115         238 KWEDRPNFAKVEE  250 (257)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.9e-42  Score=305.67  Aligned_cols=249  Identities=24%  Similarity=0.419  Sum_probs=209.8

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      .++|++.+.||+|+||.||+|.+. ++..+|+|.+......    ...+.+|++++++++|||++++++++......+++
T Consensus         3 ~~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   77 (256)
T cd05112           3 PSELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV   77 (256)
T ss_pred             hhHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence            468999999999999999999875 4678999988644322    34678899999999999999999999998999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |||+++++|.+++... +.+++..++.++.|++.||++||+.|++||||||+||+++.++.+||+|||++....... ..
T Consensus        78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-~~  156 (256)
T cd05112          78 FEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YT  156 (256)
T ss_pred             EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc-cc
Confidence            9999999999998753 568999999999999999999999999999999999999999999999999887432211 11


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR  249 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~  249 (344)
                      ......++..|+|||.+.+..+ +.++||||||+++|+|++ |+.||...........+..+ ....|...+..+.+|+.
T Consensus       157 ~~~~~~~~~~~~aPe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (256)
T cd05112         157 SSTGTKFPVKWSSPEVFSFSKY-SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQ  235 (256)
T ss_pred             ccCCCccchhhcCHhHhccCCc-ChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence            1122334568999999877665 678999999999999998 99999887777777666554 33446668999999999


Q ss_pred             HhcCCCcCCCCCHhhhhcC
Q 019216          250 KILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       250 ~~L~~dP~~Rps~~eil~~  268 (344)
                      +||+.+|++|||+.++++.
T Consensus       236 ~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         236 HCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHcccChhhCCCHHHHHHh
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.4e-42  Score=307.20  Aligned_cols=253  Identities=23%  Similarity=0.361  Sum_probs=210.2

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..++|+..+.||+|++|.||+|.++.++.   .+|+|.+....  .....+.+.+|+++++.++|||++++++++.....
T Consensus         3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (268)
T cd05063           3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP   80 (268)
T ss_pred             ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence            34688999999999999999999876654   79999885432  23345678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .++||||+++++|.+++.. .+.+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++......
T Consensus        81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            9999999999999999875 357899999999999999999999999999999999999999999999999998754322


Q ss_pred             cCCCcc-ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHH
Q 019216          168 RDDGLL-HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA  244 (344)
Q Consensus       168 ~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~  244 (344)
                      ...... .....+..|+|||.+.+..+ +.++|||||||++|+|++ |+.||...+.......+... ..+.+..++..+
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  239 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKF-TSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAV  239 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCc-ChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHH
Confidence            111111 11223457999999877665 689999999999999997 99999887776666666544 334445678999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhc
Q 019216          245 QNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .+++.+||+.+|++||++.++++
T Consensus       240 ~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         240 YQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999999976

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-42  Score=305.46  Aligned_cols=245  Identities=27%  Similarity=0.384  Sum_probs=205.5

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG   99 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~   99 (344)
                      ++||+|++|.||+|.+.. ++.||+|.+......  .....+.+|++++++++|+||+++++++......++||||++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   77 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG   77 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence            479999999999999877 999999988654322  34567899999999999999999999999999999999999999


Q ss_pred             ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216          100 ELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus       100 ~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      +|.+++.. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.................
T Consensus        78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~  157 (251)
T cd05041          78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI  157 (251)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence            99999865 34688999999999999999999999999999999999999999999999999874332111111112233


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCc
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNP  256 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP  256 (344)
                      +..|+|||.+.+..+ +.++|+||||+++|+|++ |..||...........+... ....+..++..+.+++.+||..+|
T Consensus       158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  236 (251)
T cd05041         158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP  236 (251)
T ss_pred             eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence            567999999877665 689999999999999999 89999887766666655543 345567789999999999999999


Q ss_pred             CCCCCHhhhhcC
Q 019216          257 VKRITIAGIKAD  268 (344)
Q Consensus       257 ~~Rps~~eil~~  268 (344)
                      ++|||+.++++.
T Consensus       237 ~~Rp~~~ell~~  248 (251)
T cd05041         237 ENRPSFSEIYNE  248 (251)
T ss_pred             hhCcCHHHHHHH
Confidence            999999999863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.9e-43  Score=311.58  Aligned_cols=239  Identities=23%  Similarity=0.308  Sum_probs=198.8

Q ss_pred             eeecccCceEEEEEEECCCCc-------eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           20 RTLGEGNFGKVKFAQDLDSGL-------PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~-------~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +.||+|+||.||+|.+...+.       .+|+|.+...   .....+.+.+|+.+++.++|||++++++++..+...++|
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv   77 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV   77 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence            479999999999999865443       4888877533   234456788899999999999999999999998899999


Q ss_pred             EeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC--------eEEeccccccC
Q 019216           93 LEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--------IKISDFGLSAL  163 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~--------vkl~Dfg~a~~  163 (344)
                      |||+++++|.+++..++ .+++..+..++.||+.||+|||+.||+||||||+||+++.++.        ++++|||++..
T Consensus        78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~  157 (258)
T cd05078          78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT  157 (258)
T ss_pred             EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence            99999999999997644 5899999999999999999999999999999999999988765        69999998864


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhC-CCCCCCccHHHHHHHHhhCCCCCCCCCCH
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGDFKLPKWLSP  242 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  242 (344)
                      ...      .....++..|+|||.+.+....+.++||||||+++|+|++| ..||...+..... ........+|...+.
T Consensus       158 ~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  230 (258)
T cd05078         158 VLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWT  230 (258)
T ss_pred             cCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcH
Confidence            321      23356788999999988755457889999999999999998 5677665544433 334455667777889


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+.+++.+||+.||++|||++++++.
T Consensus       231 ~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         231 ELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHHhccChhhCCCHHHHHHh
Confidence            99999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-43  Score=313.35  Aligned_cols=252  Identities=33%  Similarity=0.495  Sum_probs=210.0

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~   95 (344)
                      |++.+.||.|++|.||+|.+..+++.+++|.+..... .......+.+|+.++++++|+||+++++++......++++||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            6788999999999999999999999999999865432 223456788899999999999999999999999999999999


Q ss_pred             cCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccc
Q 019216           96 VTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (344)
Q Consensus        96 ~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~  174 (344)
                      +.+ +|.+.+.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......  ....
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~  156 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT  156 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence            965 88887765 4578999999999999999999999999999999999999999999999999987543221  1122


Q ss_pred             cccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-------------------CC
Q 019216          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------------FK  235 (344)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-------------------~~  235 (344)
                      ...++..|+|||.+.+....+.++|+||||+++|+|++|+.||.+.+......++....                   ..
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS  236 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence            34578899999998776445789999999999999999999998876655443332210                   00


Q ss_pred             -----------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          236 -----------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       236 -----------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                                 ....++..+.++|.+||+.||.+||++.+++.||||
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                       112367899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.8e-42  Score=312.65  Aligned_cols=261  Identities=23%  Similarity=0.361  Sum_probs=211.2

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK   86 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~   86 (344)
                      .....+++|++.+.||+|++|.||+|.+..+++.||+|.+.+...  ......+.+|+.++.++. ||||+++++++...
T Consensus         9 ~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~   86 (296)
T cd06618           9 KYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD   86 (296)
T ss_pred             eccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence            346788999999999999999999999998899999999875432  223455666777666664 99999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                      ...|++|||+. +++.+++.. ...+++..+..++.|++.||+|||+ .||+||||+|+||+++.++.+||+|||++...
T Consensus        87 ~~~~~v~e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~  165 (296)
T cd06618          87 SDVFICMELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL  165 (296)
T ss_pred             CeEEEEeeccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence            99999999984 577776654 4578999999999999999999997 59999999999999999999999999998743


Q ss_pred             CcccCCCccccccCCCcccchhhhccCC---CCCccchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhhCC-CCCC--
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANRG---YDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGD-FKLP--  237 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DvwslG~ll~ell~g~~pf~~~~~-~~~~~~i~~~~-~~~~--  237 (344)
                      ..   ........++..|+|||.+.+..   ..+.++||||||+++|+|++|+.||..... ......+.... ...+  
T Consensus       166 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  242 (296)
T cd06618         166 VD---SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPN  242 (296)
T ss_pred             cC---CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCC
Confidence            22   11122345778999999986542   236789999999999999999999976332 33344444332 2222  


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ..++.++.+|+.+||+.||.+||++.+++.|+||...
T Consensus       243 ~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         243 EGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             CCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            3478999999999999999999999999999999864

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-42  Score=308.41  Aligned_cols=243  Identities=28%  Similarity=0.431  Sum_probs=201.3

Q ss_pred             eeecccCceEEEEEEECCCCc--eEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEEEecc
Q 019216           20 RTLGEGNFGKVKFAQDLDSGL--PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYV   96 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~--~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv~e~~   96 (344)
                      +.||+|+||.||+|.++.++.  .+|+|.+....  .......+.+|+.+++++ +||||+++++++......+++|||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~   78 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA   78 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence            468999999999999988775  46888775322  233456788999999999 7999999999999999999999999


Q ss_pred             CCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecccc
Q 019216           97 TGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (344)
Q Consensus        97 ~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~  160 (344)
                      ++++|.+++....                .+++..+..++.|++.||+|||+.|++||||||+|||++.++.+||+|||+
T Consensus        79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl  158 (270)
T cd05047          79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL  158 (270)
T ss_pred             CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence            9999999987533                478899999999999999999999999999999999999999999999999


Q ss_pred             ccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCC
Q 019216          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK  238 (344)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~  238 (344)
                      +......   ........+..|+|||.+....+ +.++||||||+++|+|++ |..||.+.+.......+... ..+.+.
T Consensus       159 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  234 (270)
T cd05047         159 SRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL  234 (270)
T ss_pred             ccccchh---hhccCCCCccccCChHHHccCCC-CchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence            8632111   01111233567999999876665 689999999999999997 99999887776666666544 344566


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          239 WLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .++.++.+++.+||+.||.+|||+.++++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (270)
T cd05047         235 NCDDEVYDLMRQCWREKPYERPSFAQILVS  264 (270)
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            788999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.6e-42  Score=309.46  Aligned_cols=254  Identities=26%  Similarity=0.391  Sum_probs=212.8

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      +..++|++++.||+|+||.||+|+.+.     ..+.+++|.+....  .....+.+.+|++++++++|+||+++++++..
T Consensus         2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   79 (275)
T cd05046           2 FPRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCRE   79 (275)
T ss_pred             CChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECC
Confidence            345789999999999999999999753     35679999875432  22356788999999999999999999999988


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEe
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKG---------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS  156 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~---------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~  156 (344)
                      ....++||||+++++|.+++....         .+++..+..++.|++.||+|||+.||+||||||+||+++.++.++++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEc
Confidence            889999999999999999997655         68999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCCC-
Q 019216          157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF-  234 (344)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~-  234 (344)
                      |||++...... .........++..|+|||.+.+... +.++||||||+++|+|++ |..||...........+..+.. 
T Consensus       160 ~~~~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~  237 (275)
T cd05046         160 LLSLSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDF-STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLE  237 (275)
T ss_pred             ccccccccCcc-cccccCCceeEEeecChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcC
Confidence            99998643211 1111223345677999999877665 588999999999999998 8999987766666666665543 


Q ss_pred             -CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          235 -KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       235 -~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                       ..+..++..+.+++.+||+.+|++|||+.++++.
T Consensus       238 ~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         238 LPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence             3456689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2e-42  Score=305.25  Aligned_cols=248  Identities=28%  Similarity=0.436  Sum_probs=210.7

Q ss_pred             eEEeeeecccCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      +++.+.||.|+||.||++.+...+    ..||+|.+....  .....+.+.+|+.+++.++|+||+++++++...+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            467899999999999999998766    899999986443  22256788999999999999999999999999899999


Q ss_pred             EEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           92 VLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +|||+++++|.+.+.....  +++..+..++.|++.||++||+.|++||||+|+||+++.++.++|+|||++........
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999999999976544  89999999999999999999999999999999999999999999999999875433211


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC-CCCCCCCCHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNL  247 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~l  247 (344)
                      .. .....++..|+|||.+.+..+ +.++||||||+++|+|++ |.+||...+.......+.... ...+..++.++.++
T Consensus       159 ~~-~~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (258)
T smart00219      159 YK-KKGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL  236 (258)
T ss_pred             cc-cccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence            11 112236788999999866554 689999999999999998 899998877777776666543 44566689999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhc
Q 019216          248 LRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~  267 (344)
                      +.+||..||++|||+.++++
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      237 MLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHCcCChhhCcCHHHHHh
Confidence            99999999999999999976

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.9e-44  Score=328.27  Aligned_cols=261  Identities=32%  Similarity=0.520  Sum_probs=225.3

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      |.-+-|..++.||-|+||.|.++....+...||+|.+++.......+...++.|-.||...+.+.||++|..|.+.+.+|
T Consensus       626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY  705 (1034)
T KOG0608|consen  626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY  705 (1034)
T ss_pred             ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence            55567888999999999999999999999999999999888777778889999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      +||+|++||++..+|-+.+-|+|..++.++..+..|+++.|+.|+|||||||+|||||.+|++||.||||+.-..+..+.
T Consensus       706 FVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             EEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998642110000


Q ss_pred             ------------C----------------------------ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHH
Q 019216          171 ------------G----------------------------LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVI  210 (344)
Q Consensus       171 ------------~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~el  210 (344)
                                  +                            .....+||+.|+|||++...++ +..+|+||.|++||||
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~-~q~cdwws~gvil~em  864 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGY-TQLCDWWSVGVILYEM  864 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCc-cccchhhHhhHHHHHH
Confidence                        0                            0012369999999999999888 5889999999999999


Q ss_pred             HhCCCCCCCccHHHHHHHHhhCC----CCCCCCCCHHHHHHHHHhcCCCcCCCCC---HhhhhcCccccc
Q 019216          211 LTGYLPFDDRNLAVLYQKIFRGD----FKLPKWLSPGAQNLLRKILEPNPVKRIT---IAGIKADEWFEQ  273 (344)
Q Consensus       211 l~g~~pf~~~~~~~~~~~i~~~~----~~~~~~~~~~~~~li~~~L~~dP~~Rps---~~eil~~~~~~~  273 (344)
                      +.|++||...+..+...++.+..    +.....+++++.++|.++. .+++.|..   ++++..||||+.
T Consensus       865 ~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  865 LVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKG  933 (1034)
T ss_pred             hhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccc
Confidence            99999998887776666665542    3334669999999998866 45667764   678999999973

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-44  Score=330.09  Aligned_cols=244  Identities=36%  Similarity=0.599  Sum_probs=212.3

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~   90 (344)
                      ....|.+...+|.|+|+.|-.+.+..+++..++|++.+..       ....+|+.++... +||||+++++++.+....|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~  392 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY  392 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceee
Confidence            4678999999999999999999999999999999997652       2234577665555 6999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE-ccCCCeEEeccccccCCCcccC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL-DSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl-~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +|||.+.|+.+.+.+.....+. ..+..|+++|+.|+.|||++|++||||||+|||+ +..|+++|+|||.++....   
T Consensus       393 ~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~---  468 (612)
T KOG0603|consen  393 LVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER---  468 (612)
T ss_pred             eeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch---
Confidence            9999999999988888766555 7888999999999999999999999999999999 6889999999999884322   


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhhCCCCCCCCCCHHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKLPKWLSPGAQNLL  248 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~li  248 (344)
                        ...+.|-|..|.|||++...++ ++++||||||++||+||+|+.||..... .++..++..+.+.  .++|..+++||
T Consensus       469 --~~~tp~~t~~y~APEvl~~~~y-t~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl  543 (612)
T KOG0603|consen  469 --SCDTPALTLQYVAPEVLAIQEY-TEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL  543 (612)
T ss_pred             --hhcccchhhcccChhhhccCCC-CcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence              1445678899999999997777 6999999999999999999999986544 4666666555444  88999999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCccc
Q 019216          249 RKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      ++||+.||.+|+++.+++.|||+
T Consensus       544 ~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  544 QQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHhccCChhhCcChhhhccCcch
Confidence            99999999999999999999999

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-45  Score=305.56  Aligned_cols=264  Identities=28%  Similarity=0.422  Sum_probs=216.5

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee------
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------   85 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------   85 (344)
                      ..++|+-+.+||+|.||.||+|+.+++|+.||+|++-.... .........+|+.+|+.++|+|++.++++|..      
T Consensus        15 ~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~   93 (376)
T KOG0669|consen   15 EVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTN   93 (376)
T ss_pred             cchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcc
Confidence            46789999999999999999999999999999986543221 12234567789999999999999999988742      


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecccccc
Q 019216           86 --KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus        86 --~~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                        ...+|+||.+|+. +|..++.+. .+++..+++.++.+++.||.|+|...|+|||+||+|+||+.+|.+||+|||+++
T Consensus        94 r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   94 RDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             cccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence              2358999999954 888888654 579999999999999999999999999999999999999999999999999997


Q ss_pred             CCCcccCC--CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--C-----
Q 019216          163 LPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D-----  233 (344)
Q Consensus       163 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~-----  233 (344)
                      ......+.  ......+.|.+|++||.+.+...++++.|||+-||++.||++|.+.+.+.+.......|..-  .     
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            54432221  12233466999999999999888899999999999999999999999998777666555321  0     


Q ss_pred             ---------------CCCCCC-------------CCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          234 ---------------FKLPKW-------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       234 ---------------~~~~~~-------------~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                     .++|+.             -++.+.+|+.++|..||.+|+++.++++|.||.....|
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p  324 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP  324 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence                           011111             25688999999999999999999999999999876555

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.2e-42  Score=308.92  Aligned_cols=250  Identities=30%  Similarity=0.380  Sum_probs=199.2

Q ss_pred             cCe-EEeeeecccCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee--C
Q 019216           14 GRY-ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--K   86 (344)
Q Consensus        14 ~~y-~~~~~Lg~G~~g~Vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~   86 (344)
                      +|| ++++.||+|+||.||++.    ...++..||+|.+....  .......+.+|+.+++.++||||+++++++..  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   80 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGG   80 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            567 999999999999998765    34578899999986542  22345678899999999999999999998765  3


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ..++++|||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.....
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence            468999999999999998876 4599999999999999999999999999999999999999999999999999875432


Q ss_pred             ccCCCc-cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHH---------------HHHHHh
Q 019216          167 FRDDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV---------------LYQKIF  230 (344)
Q Consensus       167 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~---------------~~~~i~  230 (344)
                      ...... .....++..|+|||.+..... +.++||||||+++|+|++|..||.......               ....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKF-SYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCC-CcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence            111111 122345667999999877665 689999999999999999999986432110               001111


Q ss_pred             h-CCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          231 R-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       231 ~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      . ...+.+..++..+.+++.+||+.+|++|||++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            1 122345668899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=4.7e-42  Score=305.67  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=208.5

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      +.-.+|++.+.||+|+||.||+|.+...   ...||+|......  .....+.+.+|+.++++++||||+++++++.. .
T Consensus         3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~   79 (270)
T cd05056           3 IQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N   79 (270)
T ss_pred             echhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence            3456799999999999999999987544   3568999875432  23456788999999999999999999998875 4


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ..++||||+++++|.+++.+.. .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~  159 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED  159 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence            5789999999999999997644 589999999999999999999999999999999999999999999999999874322


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA  244 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~  244 (344)
                      ... .......++..|+|||.+....+ +.++||||||+++|++++ |..||...........+..+ ....+..+++.+
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (270)
T cd05056         160 ESY-YKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL  237 (270)
T ss_pred             ccc-eecCCCCccccccChhhhccCCC-CchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHH
Confidence            111 01112234467999999876665 688999999999999986 99999887766666665554 455677889999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          245 QNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+++.+||..+|++|||+.+++..
T Consensus       238 ~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         238 YSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.9e-42  Score=311.53  Aligned_cols=254  Identities=24%  Similarity=0.348  Sum_probs=207.3

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      +..++|++.+.||+|+||.||+|.+..+|.    .+|+|.+....  .......+.+|+.+++.++||||+++++++...
T Consensus         4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~   81 (303)
T cd05110           4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP   81 (303)
T ss_pred             cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC
Confidence            456789999999999999999999887776    46888775432  223345688999999999999999999998654


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 SKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                       ..++++||+++|+|.+++.... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~  160 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE  160 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence             4678999999999999987644 68999999999999999999999999999999999999999999999999997543


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHH
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG  243 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~  243 (344)
                      ............++..|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.........+..+ ..+.+..++..
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~-~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd05110         161 GDEKEYNADGGKMPIKWMALECIHYRKF-THQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTID  239 (303)
T ss_pred             CcccccccCCCccccccCCHHHhccCCC-ChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence            2211111223445678999999877665 688999999999999997 99999876655544444333 34445668899


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +.+++.+||..+|++||++.++++.
T Consensus       240 ~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         240 VYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=2e-42  Score=314.79  Aligned_cols=254  Identities=21%  Similarity=0.340  Sum_probs=200.5

Q ss_pred             eeccc--CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCC
Q 019216           21 TLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        21 ~Lg~G--~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      +||+|  ++|.||.+++..+++.||+|++.... ........+.+|+.+++.++|+||+++++++......+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            34444  45667777777799999999987542 2334567899999999999999999999999999999999999999


Q ss_pred             CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC-----CC
Q 019216           99 GELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----DG  171 (344)
Q Consensus        99 ~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~-----~~  171 (344)
                      ++|.+++.+.  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+........     ..
T Consensus        84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~  163 (314)
T cd08216          84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD  163 (314)
T ss_pred             CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence            9999998753  4589999999999999999999999999999999999999999999999998763321111     11


Q ss_pred             ccccccCCCcccchhhhccC-CCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC----------------
Q 019216          172 LLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF----------------  234 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~----------------  234 (344)
                      ......++..|+|||++... ...+.++|+||+||++|+|++|+.||..............+..                
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (314)
T cd08216         164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSM  243 (314)
T ss_pred             ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCc
Confidence            12334567789999998753 2236789999999999999999999987554332221111110                


Q ss_pred             ------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          235 ------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       235 ------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                                        ..+..++.++.+|+.+||+.||++|||+.++++||||+...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         244 SQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             CcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                              01112356789999999999999999999999999998765

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=8e-42  Score=302.59  Aligned_cols=249  Identities=25%  Similarity=0.419  Sum_probs=206.7

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++.++||+|+||.||+|.+ ..+..+|+|.+....    .....+.+|+.+++.++|+||+++++.+.. ...+
T Consensus         3 ~~~~~~~~~~~lg~g~~~~vy~~~~-~~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   76 (260)
T cd05073           3 IPRESLKLEKKLGAGQFGEVWMATY-NKHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY   76 (260)
T ss_pred             ccccceeEEeEecCccceEEEEEEe-cCCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence            4578999999999999999999986 455679999875432    234678889999999999999999999877 7789


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ++|||+++++|.+++.+.  ..++...+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+.......
T Consensus        77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999999753  357888999999999999999999999999999999999999999999999987432211


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                       ........++..|+|||.+....+ +.++|+||||+++|++++ |+.||.+.+.......+..+ ..+.+...+.++.+
T Consensus       157 -~~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (260)
T cd05073         157 -YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN  234 (260)
T ss_pred             -cccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHH
Confidence             111112334567999999876655 678999999999999999 99999987776666655544 33455678899999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhc
Q 019216          247 LLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~  267 (344)
                      ++.+||+.+|++||++.++++
T Consensus       235 ~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         235 IMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHcccCcccCcCHHHHHH
Confidence            999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2e-42  Score=309.06  Aligned_cols=238  Identities=25%  Similarity=0.327  Sum_probs=194.3

Q ss_pred             eecccCceEEEEEEECC------------------------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc
Q 019216           21 TLGEGNFGKVKFAQDLD------------------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV   76 (344)
Q Consensus        21 ~Lg~G~~g~Vy~a~~~~------------------------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni   76 (344)
                      +||+|+||.||+|....                        ....||+|++...   .......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence            69999999999997432                        2245888887543   22345678889999999999999


Q ss_pred             cceeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC----
Q 019216           77 VRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----  151 (344)
Q Consensus        77 v~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~----  151 (344)
                      +++++++......++||||+++++|..++.+ .+.+++..+..++.|++.||+|||++||+||||||+|||++.++    
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~  158 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG  158 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence            9999999999999999999999999888865 56789999999999999999999999999999999999997654    


Q ss_pred             ---CeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHH-hCCCCCCCccHHHHHH
Q 019216          152 ---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL-TGYLPFDDRNLAVLYQ  227 (344)
Q Consensus       152 ---~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell-~g~~pf~~~~~~~~~~  227 (344)
                         .+|++|||++.....      .....++..|+|||.+.+....+.++||||||+++|+|+ +|+.||.+....... 
T Consensus       159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~-  231 (274)
T cd05076         159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKE-  231 (274)
T ss_pred             ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHH-
Confidence               389999998753211      123356788999999876544478999999999999985 699999876554432 


Q ss_pred             HHhhCCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          228 KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       228 ~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .........|...++.+.++|.+||+.+|++|||+.+++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         232 RFYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            23334455666677899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.4e-42  Score=305.56  Aligned_cols=239  Identities=23%  Similarity=0.309  Sum_probs=194.6

Q ss_pred             eeecccCceEEEEEEECC------------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216           20 RTLGEGNFGKVKFAQDLD------------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      +.||+|+||.||+|+...            ....|++|++...   .......+.+|+.+++.++||||+++++++....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~   77 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV   77 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            479999999999998532            2336888887543   2334567888999999999999999999999888


Q ss_pred             eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC-------eEEeccc
Q 019216           88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-------IKISDFG  159 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~-------vkl~Dfg  159 (344)
                      ..+++|||+++++|..++.. ...+++..++.++.||+.||+|||+.||+||||||+|||++.++.       ++++|||
T Consensus        78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g  157 (262)
T cd05077          78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG  157 (262)
T ss_pred             CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence            99999999999999888765 456899999999999999999999999999999999999987664       8999999


Q ss_pred             cccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHH-hCCCCCCCccHHHHHHHHhhCCCCCCC
Q 019216          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL-TGYLPFDDRNLAVLYQKIFRGDFKLPK  238 (344)
Q Consensus       160 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell-~g~~pf~~~~~~~~~~~i~~~~~~~~~  238 (344)
                      ++.....      .....++..|+|||.+......+.++|||||||++|+|+ +|..||......... ...........
T Consensus       158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~  230 (262)
T cd05077         158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT  230 (262)
T ss_pred             CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence            8864321      223457888999999875554578999999999999998 589998776544332 33334444445


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          239 WLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ..++++.+|+.+||+.||.+||++.+++++
T Consensus       231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            567899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4e-42  Score=303.39  Aligned_cols=242  Identities=27%  Similarity=0.489  Sum_probs=204.6

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .+++|++.+.||+|+||.||++.  .+++.||+|.+....     ....+.+|+.++++++|||++++++++... ..++
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~--~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~   75 (254)
T cd05083           4 NLQKLTLGEIIGEGEFGAVLQGE--YTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI   75 (254)
T ss_pred             cHHHceeeeeeccCCCCceEecc--cCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence            56889999999999999999986  478889999885432     235788999999999999999999998654 5789


Q ss_pred             EEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           92 VLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +|||+.+++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....   
T Consensus        76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~---  152 (254)
T cd05083          76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM---  152 (254)
T ss_pred             EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccc---
Confidence            999999999999997643  578999999999999999999999999999999999999999999999999874221   


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL  247 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~l  247 (344)
                        .......+..|+|||.+.+..+ +.++|+||||+++|+|++ |+.||...+.......+..+ ....+..+++.+.++
T Consensus       153 --~~~~~~~~~~y~~pe~~~~~~~-~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  229 (254)
T cd05083         153 --GVDNSKLPVKWTAPEALKHKKF-SSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVL  229 (254)
T ss_pred             --cCCCCCCCceecCHHHhccCCc-CchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHH
Confidence              1122334567999999876665 688999999999999998 99999888777666666554 234456689999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhc
Q 019216          248 LRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~  267 (344)
                      +.+||+.+|.+||++++++.
T Consensus       230 i~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         230 MTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=8.9e-42  Score=300.28  Aligned_cols=244  Identities=26%  Similarity=0.426  Sum_probs=203.2

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG   99 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~   99 (344)
                      +.||+|+||.||+|.. .++..+|+|.+....  .......+.+|+.+++.++||||+++++++......++||||++++
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   77 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG   77 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence            4799999999999986 468899999886432  2233456889999999999999999999999999999999999999


Q ss_pred             ChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccC
Q 019216          100 ELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG  178 (344)
Q Consensus       100 ~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~g  178 (344)
                      +|.+++.. ...+++..+..++.|++.+|.|||++|++||||+|+||+++.++.+||+|||++....... ........+
T Consensus        78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~  156 (250)
T cd05085          78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI  156 (250)
T ss_pred             cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence            99998875 3468899999999999999999999999999999999999999999999999986422110 111112234


Q ss_pred             CCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCc
Q 019216          179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNP  256 (344)
Q Consensus       179 t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP  256 (344)
                      +..|+|||.+.+..+ +.++||||||+++|++++ |..||...........+... ....+..++..+.+++.+||+.+|
T Consensus       157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  235 (250)
T cd05085         157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP  235 (250)
T ss_pred             cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence            567999999876665 688999999999999998 99999887776666666544 345567789999999999999999


Q ss_pred             CCCCCHhhhhcC
Q 019216          257 VKRITIAGIKAD  268 (344)
Q Consensus       257 ~~Rps~~eil~~  268 (344)
                      ++||++.++++.
T Consensus       236 ~~Rp~~~~l~~~  247 (250)
T cd05085         236 ENRPKFSELQKE  247 (250)
T ss_pred             ccCCCHHHHHHH
Confidence            999999999763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-42  Score=341.55  Aligned_cols=252  Identities=26%  Similarity=0.397  Sum_probs=215.2

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCC-----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~-----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      +....-++.+.||+|+||.||.|.-....     ..||+|.+++.  .+.+....|.+|..+|+.++||||++++|++.+
T Consensus       689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~  766 (1025)
T KOG1095|consen  689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD  766 (1025)
T ss_pred             CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence            44556788999999999999999865332     34899988654  355667899999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecc
Q 019216           86 KSKIYMVLEYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF  158 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Df  158 (344)
                      ....+|++|||.||+|..+|++.       ..++..+...++.|||.|..||+++++|||||...|+|++....|||+||
T Consensus       767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF  846 (1025)
T KOG1095|consen  767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF  846 (1025)
T ss_pred             CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence            99999999999999999999865       34889999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccCCCcccc--ccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHH-hhCCC
Q 019216          159 GLSALPQHFRDDGLLHT--TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI-FRGDF  234 (344)
Q Consensus       159 g~a~~~~~~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i-~~~~~  234 (344)
                      |+|+..-.  .......  ..-...|||||.+....+ +.++||||||+++||++| |..||.+.+..++.... ..+.+
T Consensus       847 GlArDiy~--~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL  923 (1025)
T KOG1095|consen  847 GLARDIYD--KDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRL  923 (1025)
T ss_pred             chhHhhhh--chheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCcc
Confidence            99993211  1111111  122358999999998666 689999999999999999 99999998877777644 44578


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       235 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      +.|..++..+.+++..||+.+|++||++..|++
T Consensus       924 ~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  924 DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            889999999999999999999999999999987

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.5e-43  Score=346.55  Aligned_cols=255  Identities=32%  Similarity=0.526  Sum_probs=208.4

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe--------
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--------   84 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--------   84 (344)
                      +.+|+.++.||+||||.||+++++-+|+.||||.+....  .......+.+|+.+|.+|+|||||++|..+.        
T Consensus       478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~  555 (1351)
T KOG1035|consen  478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV  555 (1351)
T ss_pred             hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence            456678999999999999999999999999999996554  4566788999999999999999999885330        


Q ss_pred             ---------------------------------------------------e-------------------C--------
Q 019216           85 ---------------------------------------------------S-------------------K--------   86 (344)
Q Consensus        85 ---------------------------------------------------~-------------------~--------   86 (344)
                                                                         +                   .        
T Consensus       556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~  635 (1351)
T KOG1035|consen  556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD  635 (1351)
T ss_pred             ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence                                                               0                   0        


Q ss_pred             ---------------------------------CeEEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHh
Q 019216           87 ---------------------------------SKIYMVLEYVTGGELFDKIASKGRL-QEAEGRKLFQQLIDGVSYCHN  132 (344)
Q Consensus        87 ---------------------------------~~~~iv~e~~~g~~L~~~l~~~~~~-~~~~~~~i~~ql~~~L~~LH~  132 (344)
                                                       ..+||-||||+..++.+++.++... ....++++++||++||.|+|+
T Consensus       636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~  715 (1351)
T KOG1035|consen  636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD  715 (1351)
T ss_pred             cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh
Confidence                                             1268999999988888888776654 477899999999999999999


Q ss_pred             CCceeecCCCCcEEEccCCCeEEeccccccCCC-------------c---ccCCCccccccCCCcccchhhhccCC--CC
Q 019216          133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQ-------------H---FRDDGLLHTTCGSPNYVAPEVLANRG--YD  194 (344)
Q Consensus       133 ~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~-------------~---~~~~~~~~~~~gt~~y~aPE~~~~~~--~~  194 (344)
                      .|||||||||.||++++++.|||+|||+|+...             .   ..+.......+||..|+|||++.+..  .+
T Consensus       716 ~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Y  795 (1351)
T KOG1035|consen  716 QGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKY  795 (1351)
T ss_pred             CceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccc
Confidence            999999999999999999999999999998611             0   01112334568999999999998765  35


Q ss_pred             CccchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhhCCCCCCCC----CCHHHHHHHHHhcCCCcCCCCCHhhhhcCc
Q 019216          195 GATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPKW----LSPGAQNLLRKILEPNPVKRITIAGIKADE  269 (344)
Q Consensus       195 ~~~~DvwslG~ll~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~----~~~~~~~li~~~L~~dP~~Rps~~eil~~~  269 (344)
                      +.|+|+||||++++||+   .||.- .+...+...+.++.++.|..    --+.-..+|++||+.||++||||.|+|++.
T Consensus       796 n~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~  872 (1351)
T KOG1035|consen  796 NSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSE  872 (1351)
T ss_pred             cchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhcc
Confidence            68999999999999999   56754 44556667777666666522    234568999999999999999999999999


Q ss_pred             ccc
Q 019216          270 WFE  272 (344)
Q Consensus       270 ~~~  272 (344)
                      ||-
T Consensus       873 llp  875 (1351)
T KOG1035|consen  873 LLP  875 (1351)
T ss_pred             CCC
Confidence            986

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=5.8e-42  Score=304.95  Aligned_cols=246  Identities=23%  Similarity=0.300  Sum_probs=193.1

Q ss_pred             eeecccCceEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccC
Q 019216           20 RTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~   97 (344)
                      +.||+|+||.||+|....  ....+|+|.+....  .......+.+|+.+++.++|+||+++++.+......++||||++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP   78 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence            469999999999996432  44578888765332  23345678889999999999999999999999999999999999


Q ss_pred             CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           98 GGELFDKIASKG-----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        98 g~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      +++|.+++....     ..++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999999987643     246778899999999999999999999999999999999999999999999864321111111


Q ss_pred             cccccCCCcccchhhhccC------CCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCC-----CCCC
Q 019216          173 LHTTCGSPNYVAPEVLANR------GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFK-----LPKW  239 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~-----~~~~  239 (344)
                      .....++..|+|||++...      ...+.++|||||||++|+|++ |..||............... ...     .+..
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK  238 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence            1233456789999997532      233678999999999999999 88999877655554444332 222     3345


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          240 LSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +++.+.+++..|+ .||++|||++++++-
T Consensus       239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~  266 (269)
T cd05042         239 YSDRWYEVMQFCW-LDPETRPTAEEVHEL  266 (269)
T ss_pred             CCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence            7889999999999 599999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.2e-42  Score=306.85  Aligned_cols=250  Identities=27%  Similarity=0.409  Sum_probs=200.1

Q ss_pred             eEEeeeecccCceEEEEEEE----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC--CeE
Q 019216           16 YELGRTLGEGNFGKVKFAQD----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK--SKI   89 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~--~~~   89 (344)
                      |++++.||+|+||.||+|..    ..++..||+|.+....  .......+.+|+.+++.+.|||++++++++...  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence            68899999999999999974    4678899999986432  334457789999999999999999999988764  578


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ++||||++|++|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~  163 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  163 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence            9999999999999998764 358999999999999999999999999999999999999999999999999987543211


Q ss_pred             CC-CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc---------------HHHHHHHHhhC
Q 019216          169 DD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---------------LAVLYQKIFRG  232 (344)
Q Consensus       169 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~---------------~~~~~~~i~~~  232 (344)
                      .. .......++..|+|||.+.+..+ +.++||||||+++|+|+++..|+....               .......+..+
T Consensus       164 ~~~~~~~~~~~~~~y~apE~~~~~~~-~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05079         164 EYYTVKDDLDSPVFWYAPECLIQSKF-YIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG  242 (284)
T ss_pred             cceeecCCCCCCccccCHHHhccCCC-CccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence            11 11123456778999999877665 688999999999999999876642211               01111111111


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          233 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       233 -~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                       ..+.+..++..+.+|+.+||+.||++|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence             234456689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.9e-42  Score=305.83  Aligned_cols=245  Identities=27%  Similarity=0.394  Sum_probs=202.3

Q ss_pred             eeecccCceEEEEEEECCCC------ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           20 RTLGEGNFGKVKFAQDLDSG------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~------~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      +.||+|+||.||+|+++...      +.+|+|.+.+..  .......+.+|+.+++.++||||+++++++......+++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   78 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM   78 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence            46999999999999976543      689999875432  1233567889999999999999999999999888999999


Q ss_pred             eccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC-----CeEEeccccc
Q 019216           94 EYVTGGELFDKIASK-------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-----NIKISDFGLS  161 (344)
Q Consensus        94 e~~~g~~L~~~l~~~-------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~-----~vkl~Dfg~a  161 (344)
                      ||+++++|.+++.+.       ..+++..+..++.|++.||.|||+.+++|+||||+||+++.++     .++|+|||++
T Consensus        79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999998642       2378899999999999999999999999999999999999887     8999999998


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCC
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKW  239 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~  239 (344)
                      ................++..|+|||.+.+..+ +.++|||||||++|+|++ |+.||...+.......+..+ .+..+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  237 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN  237 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence            74322111111223345678999999877665 689999999999999998 99999877766666555443 4456677


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          240 LSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ++..+.+++.+||+.+|++||++.++++
T Consensus       238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         238 CPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            8999999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.1e-41  Score=303.26  Aligned_cols=245  Identities=20%  Similarity=0.266  Sum_probs=192.8

Q ss_pred             eeecccCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccC
Q 019216           20 RTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~   97 (344)
                      +.||+|+||.||+|...  .++..+|+|.++....  ......+.+|+.++++++||||+++++++.+....++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP   78 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence            46999999999999864  3556799998864432  2234578889999999999999999999998889999999999


Q ss_pred             CCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           98 GGELFDKIASKG-----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        98 g~~L~~~l~~~~-----~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      +++|.+++....     ..++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++...........
T Consensus        79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999999986432     356778889999999999999999999999999999999999999999999874322111111


Q ss_pred             cccccCCCcccchhhhccCC------CCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCC-----CCCC
Q 019216          173 LHTTCGSPNYVAPEVLANRG------YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFK-----LPKW  239 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~------~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~-----~~~~  239 (344)
                      .....++..|+|||++.+..      ..+.++||||||+++|+|++ |+.||............... ...     ....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP  238 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence            22345678899999986432      12578999999999999996 99999876554443332222 221     2234


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          240 LSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .++.+.+++++|+ .+|++|||+++++.
T Consensus       239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            6788999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.5e-41  Score=300.84  Aligned_cols=246  Identities=26%  Similarity=0.378  Sum_probs=198.6

Q ss_pred             eeecccCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe-eCCeEEEEEec
Q 019216           20 RTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SKSKIYMVLEY   95 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~~~iv~e~   95 (344)
                      +.||+|+||.||+|.+..   .+..+|+|.+...  ......+.+.+|+.+++.++|||++++++++. .+...+++|||
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   78 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY   78 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence            468999999999998653   3457999987432  22344677889999999999999999999765 45568899999


Q ss_pred             cCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc--CCCc
Q 019216           96 VTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR--DDGL  172 (344)
Q Consensus        96 ~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~--~~~~  172 (344)
                      +.+++|.+++.+. ...++..+..++.|++.||.|||+.+++||||||+|||+++++.+||+|||++.......  ....
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  158 (262)
T cd05058          79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN  158 (262)
T ss_pred             CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence            9999999998764 346778889999999999999999999999999999999999999999999987432111  0011


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC-CCCCCCCCHHHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRK  250 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~  250 (344)
                      .....++..|+|||.+....+ +.++|||||||++|+|++ |.+||...+.......+..+. ...+..+++.+.+++.+
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  237 (262)
T cd05058         159 HTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS  237 (262)
T ss_pred             cccCcCCccccChhHhccCcc-chHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence            123345678999999877665 689999999999999999 577888777666666665543 34456678999999999


Q ss_pred             hcCCCcCCCCCHhhhhcC
Q 019216          251 ILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       251 ~L~~dP~~Rps~~eil~~  268 (344)
                      ||+.+|++||++.+++..
T Consensus       238 cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         238 CWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HcCCChhhCCCHHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.5e-42  Score=301.84  Aligned_cols=229  Identities=28%  Similarity=0.446  Sum_probs=193.0

Q ss_pred             cCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCCChHHH
Q 019216           25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDK  104 (344)
Q Consensus        25 G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~~L~~~  104 (344)
                      |.+|.||+|.++.+++.||+|.+.+..        ...+|...+....||||+++++++......+++|||++|++|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            899999999999999999999986543        123344555556799999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccc
Q 019216          105 IASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA  184 (344)
Q Consensus       105 l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  184 (344)
                      +.+...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++++|||.+.....     ......++..|+|
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a  150 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA  150 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence            98877899999999999999999999999999999999999999999999999998764322     1223455778999


Q ss_pred             hhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCCCCCH--
Q 019216          185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI--  262 (344)
Q Consensus       185 PE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~--  262 (344)
                      ||.+....+ +.++|+||+|+++|+|++|+.|+.......    .......+|..+++.+.++|.+||+.||++||++  
T Consensus       151 PE~~~~~~~-~~~~DvwslG~il~el~~g~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~  225 (237)
T cd05576         151 PEVGGISEE-TEACDWWSLGAILFELLTGKTLVECHPSGI----NTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV  225 (237)
T ss_pred             CcccCCCCC-CchhhHHHHHHHHHHHHHCcchhhcCchhc----ccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence            999876655 688999999999999999998876432210    0112345678899999999999999999999996  


Q ss_pred             ---hhhhcCccc
Q 019216          263 ---AGIKADEWF  271 (344)
Q Consensus       263 ---~eil~~~~~  271 (344)
                         +++++||||
T Consensus       226 ~~~~~~~~h~~~  237 (237)
T cd05576         226 AGVEDIKSHPFF  237 (237)
T ss_pred             cchHHHHcCCCC
Confidence               999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-41  Score=312.64  Aligned_cols=247  Identities=30%  Similarity=0.417  Sum_probs=195.1

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC-eEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-KIYMV   92 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~~iv   92 (344)
                      +.|.-...||+|+||.||+|.- .+|..||||.+.......   ..+|.+|+.++.+++|||+++++|+|.+.+ ..++|
T Consensus        75 ~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LV  150 (361)
T KOG1187|consen   75 NNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLV  150 (361)
T ss_pred             hCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEE
Confidence            4566668999999999999996 445899999775543321   345999999999999999999999999888 59999


Q ss_pred             EeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC---CceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           93 LEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNK---GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~---~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      +||+++|+|.+.+....  +++|....+|+.++|.||+|||+.   .|+||||||+|||+|++.++||+|||+|+.....
T Consensus       151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence            99999999999998654  899999999999999999999985   3999999999999999999999999999743220


Q ss_pred             cCCCccccc-cCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc------HHHHH-HHHhhCC------
Q 019216          168 RDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN------LAVLY-QKIFRGD------  233 (344)
Q Consensus       168 ~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~------~~~~~-~~i~~~~------  233 (344)
                        ....... .||.+|+|||++..... +.++||||||+++.|++||+.+.+...      ..... ..+..+.      
T Consensus       231 --~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD  307 (361)
T KOG1187|consen  231 --DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVD  307 (361)
T ss_pred             --ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeC
Confidence              1222222 89999999999877554 789999999999999999998886432      11111 1222211      


Q ss_pred             CCCC-CCCC--H---HHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          234 FKLP-KWLS--P---GAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       234 ~~~~-~~~~--~---~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ..+. ...+  .   .+..+..+|++.+|..||++.++++
T Consensus       308 ~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  308 PRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             CCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            1111 2233  2   2457778999999999999999754

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=3e-41  Score=302.74  Aligned_cols=251  Identities=26%  Similarity=0.411  Sum_probs=199.1

Q ss_pred             cCeEEeeeecccCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee--CC
Q 019216           14 GRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KS   87 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~   87 (344)
                      .+|++++.||+|+||.||+|.    +..++..||+|.+....   ....+.+.+|++++++++||||+++++++..  ..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence            478999999999999999997    44678899999985432   3445678899999999999999999998643  34


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      .+++||||+++++|.+++.+. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            689999999999999998754 4689999999999999999999999999999999999999999999999999885432


Q ss_pred             ccCCCc-cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHH---------------HHHHh
Q 019216          167 FRDDGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL---------------YQKIF  230 (344)
Q Consensus       167 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~---------------~~~i~  230 (344)
                      ...... .....++..|+|||.+.+..+ +.++||||||+++|||++|..++........               .....
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL  239 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCc-ChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence            111100 111223456999999877665 6899999999999999998777543221100               01111


Q ss_pred             hC--CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          231 RG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       231 ~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ..  ..+.+..++..+.+|+.+||+.+|++|||+.++++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  279 (284)
T cd05081         240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ  279 (284)
T ss_pred             hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            11  234456688999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2e-41  Score=301.95  Aligned_cols=251  Identities=26%  Similarity=0.392  Sum_probs=203.7

Q ss_pred             eEEeeeecccCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC-----
Q 019216           16 YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----   87 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----   87 (344)
                      |++.+.||+|+||.||+|.++   .+++.||+|.+.... ......+.+.+|+.++++++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            678899999999999999865   357899999986433 33345677889999999999999999999875432     


Q ss_pred             -eEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecccc
Q 019216           88 -KIYMVLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (344)
Q Consensus        88 -~~~iv~e~~~g~~L~~~l~~~------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~  160 (344)
                       ..+++++|+.+++|.+++...      ..++...++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             247889999999998876431      2478899999999999999999999999999999999999999999999999


Q ss_pred             ccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCC
Q 019216          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK  238 (344)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~  238 (344)
                      ++...............++..|++||.+....+ +.++|||||||++|+|++ |++||.+.+.......+... ....+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  238 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVY-TTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP  238 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCcc-chhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence            875422111111122345578999999877665 578999999999999999 99999887776666655544 344556


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          239 WLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ..+..+.+++.+||+.+|++|||+.+++++
T Consensus       239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            688999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=308.87  Aligned_cols=251  Identities=29%  Similarity=0.465  Sum_probs=206.9

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC--CC----CccceeeEEeeC
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--HP----NVVRLHEVLASK   86 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~----niv~l~~~~~~~   86 (344)
                      -+||.++..+|+|.||.|-.+++..++..||||+++...    ...+...-|+++|+++.  -|    -++.+.++|+-.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~----kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD----KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH----HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            679999999999999999999999999999999986432    34566778999999994  22    267888889999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc---------------
Q 019216           87 SKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---------------  149 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~---------------  149 (344)
                      ++.+||+|.+ |.|+++.+.+++  +++..+++.+++||+++++|||+.+++|.||||+|||+..               
T Consensus       164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~  242 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF  242 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence            9999999999 889999998765  6889999999999999999999999999999999999932               


Q ss_pred             -----CCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH-
Q 019216          150 -----KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-  223 (344)
Q Consensus       150 -----~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~-  223 (344)
                           +..++|+|||.|+...     ....+.+.|..|+|||++.+-++ +..+||||+||+|+|+++|...|+.-+.. 
T Consensus       243 ~r~~ks~~I~vIDFGsAtf~~-----e~hs~iVsTRHYRAPEViLgLGw-S~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  243 IRPLKSTAIKVIDFGSATFDH-----EHHSTIVSTRHYRAPEVILGLGW-SQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             eccCCCcceEEEecCCcceec-----cCcceeeeccccCCchheeccCc-CCccCceeeeeEEEEeeccceecccCCcHH
Confidence                 2348999999998532     23366788999999999999999 58899999999999999999999764422 


Q ss_pred             --HHHHHHhhC------------------CCCCCCC-------------------------CCHHHHHHHHHhcCCCcCC
Q 019216          224 --VLYQKIFRG------------------DFKLPKW-------------------------LSPGAQNLLRKILEPNPVK  258 (344)
Q Consensus       224 --~~~~~i~~~------------------~~~~~~~-------------------------~~~~~~~li~~~L~~dP~~  258 (344)
                        ++.++|+..                  .++.|..                         -..++.+|+++||..||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence              244444321                  1111110                         1235789999999999999


Q ss_pred             CCCHhhhhcCcccccc
Q 019216          259 RITIAGIKADEWFEQD  274 (344)
Q Consensus       259 Rps~~eil~~~~~~~~  274 (344)
                      |+|+.|+|.||||...
T Consensus       397 RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  397 RITLREALSHPFFARL  412 (415)
T ss_pred             cccHHHHhcCHHhhcC
Confidence            9999999999999754

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.6e-41  Score=299.99  Aligned_cols=237  Identities=22%  Similarity=0.260  Sum_probs=193.6

Q ss_pred             eeecccCceEEEEEEECCCC----------ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           20 RTLGEGNFGKVKFAQDLDSG----------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~----------~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      +.||+|+||.||+|.+..++          ..+++|.+.....    ....+.+|+.+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            47999999999999998776          3578887643321    15678899999999999999999999887 778


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC-------CeEEeccccc
Q 019216           90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-------NIKISDFGLS  161 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~-------~vkl~Dfg~a  161 (344)
                      ++||||+++++|.+++...+ .++...+..++.||+.||.|||++||+||||||+|||++.++       .+||+|||++
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a  155 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP  155 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence            99999999999999998765 789999999999999999999999999999999999999888       7999999998


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhccC-CCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCCCCCCCC
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW  239 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~  239 (344)
                      .....      .....++..|+|||.+... ...+.++||||||+++|+|++ |..||...+........ ......+..
T Consensus       156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~  228 (259)
T cd05037         156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFY-QDQHRLPMP  228 (259)
T ss_pred             ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHH-hcCCCCCCC
Confidence            74322      2234567789999998765 344788999999999999999 68888766533332222 223333333


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          240 LSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ....+.+++.+||+.+|.+|||+.++++.
T Consensus       229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~  257 (259)
T cd05037         229 DCAELANLINQCWTYDPTKRPSFRAILRD  257 (259)
T ss_pred             CchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            45899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.9e-41  Score=300.35  Aligned_cols=250  Identities=30%  Similarity=0.497  Sum_probs=208.9

Q ss_pred             CeEEeeeecccCceEEEEEEECC-CCceEEEEEeecccc-------cchhHHHHHHHHHHHHHh-CCCCCccceeeEEee
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRI-------IHLKITDQIKREIATLKL-LKHPNVVRLHEVLAS   85 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~   85 (344)
                      .|++.+.||+|+||.||+|.+.. +++.+|+|.+.....       ........+.+|+.++.+ ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            48899999999999999999887 788999998764321       223345667788988875 789999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEEccCCCeEEecccc
Q 019216           86 KSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGL  160 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NILl~~~~~vkl~Dfg~  160 (344)
                      .+..+++|||++|++|.+++..    ...+++..++.++.|++.||.|||+ .|++|+||+|+||+++.++.+||+|||.
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999888743    3468999999999999999999996 6899999999999999999999999999


Q ss_pred             ccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC-CC-C
Q 019216          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LP-K  238 (344)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~-~  238 (344)
                      +.......   ......++..|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+.......+...... .+ .
T Consensus       161 ~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd08528         161 AKQKQPES---KLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG  236 (269)
T ss_pred             eeeccccc---ccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence            87543221   3345568889999999887665 68999999999999999999999887766666665554432 22 3


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          239 WLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+++.+.+++++||+.||++||++.|+.++
T Consensus       237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            578999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.2e-41  Score=302.08  Aligned_cols=252  Identities=26%  Similarity=0.400  Sum_probs=203.6

Q ss_pred             ccCeEEeeeecccCceEEEEEEEC----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee--C
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDL----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--K   86 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~   86 (344)
                      ...|++.+.||+|+||.||+|...    .++..+|+|++......  .....+.+|+.+++.++|+||+++++++..  .
T Consensus         3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~   80 (284)
T cd05038           3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG   80 (284)
T ss_pred             hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence            457889999999999999999864    34789999998654332  356789999999999999999999999876  5


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 SKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      ...+++|||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            67899999999999999997644 58999999999999999999999999999999999999999999999999988543


Q ss_pred             cccCCC-ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHH--------------HHHHHh
Q 019216          166 HFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV--------------LYQKIF  230 (344)
Q Consensus       166 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~--------------~~~~i~  230 (344)
                      ...... ......++..|+|||.+.+..+ +.++||||||+++|+|++|..|+.......              ......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKF-SSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELL  239 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCC-CcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHH
Confidence            211111 1112344567999999877665 688999999999999999999986532211              111122


Q ss_pred             hC--CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          231 RG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       231 ~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ..  ..+.+..++..+.+++.+||+.+|++|||+.++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         240 KEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             HcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            22  23345567899999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.6e-41  Score=301.84  Aligned_cols=254  Identities=14%  Similarity=0.155  Sum_probs=192.1

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccch-h-H------HHHHHHHHHHHHhCCCCCccce
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHL-K-I------TDQIKREIATLKLLKHPNVVRL   79 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~-~-~------~~~~~~E~~~l~~l~h~niv~l   79 (344)
                      ..-++|++.++||+|+||.||+|.+..+   +..+|+|+......... + .      ......+...++.+.|+|++++
T Consensus         9 i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~   88 (294)
T PHA02882          9 ITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKY   88 (294)
T ss_pred             cCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcE
Confidence            4446999999999999999999998777   67788886432221100 0 0      0112233445566789999999


Q ss_pred             eeEEeeCC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEE
Q 019216           80 HEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI  155 (344)
Q Consensus        80 ~~~~~~~~----~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl  155 (344)
                      ++.+....    ..+++++++ ..++.+.+......++..++.++.|++.||+|||+.+|+||||||+|||++.++.++|
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             EEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence            98765433    347788887 4477777766556788999999999999999999999999999999999999999999


Q ss_pred             eccccccCCCcccC-----CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH-H------
Q 019216          156 SDFGLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-A------  223 (344)
Q Consensus       156 ~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~-~------  223 (344)
                      +|||+++.......     ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+... .      
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~-~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~  246 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACV-TRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAA  246 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHh
Confidence            99999875421110     111223469999999999887766 6899999999999999999999987632 1      


Q ss_pred             --HHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          224 --VLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       224 --~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                        ....++..+...+ ...++.+.++++.|++.+|++||+++++++
T Consensus       247 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        247 KCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              1223333333333 346899999999999999999999999875

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8.3e-41  Score=297.52  Aligned_cols=245  Identities=21%  Similarity=0.313  Sum_probs=192.4

Q ss_pred             eeecccCceEEEEEEECCC--CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccC
Q 019216           20 RTLGEGNFGKVKFAQDLDS--GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~--~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~   97 (344)
                      +.||+|+||.||+|.....  ...+++|.+....  .....+.+.+|+.+++.++||||+++++.+......++||||++
T Consensus         1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   78 (268)
T cd05086           1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE   78 (268)
T ss_pred             CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence            3699999999999975433  2346667664332  22345788999999999999999999999999889999999999


Q ss_pred             CCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           98 GGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        98 g~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      +++|.+++.+.    ...++..++.++.||+.||+|||+.+++||||||+|||++.++.+||+|||++............
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  158 (268)
T cd05086          79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE  158 (268)
T ss_pred             CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence            99999998753    23567778899999999999999999999999999999999999999999987632111111122


Q ss_pred             ccccCCCcccchhhhccCC------CCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC------CCCCCCC
Q 019216          174 HTTCGSPNYVAPEVLANRG------YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD------FKLPKWL  240 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~------~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~------~~~~~~~  240 (344)
                      ...+++..|+|||++....      ..+.++||||||+++|+|++ |..||...+.......+..+.      ..++..+
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (268)
T cd05086         159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY  238 (268)
T ss_pred             cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence            3456788999999875321      12578999999999999997 688998766665555544332      2234457


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ++.+.+++..|| .+|++||++.++++
T Consensus       239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         239 SERWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence            899999999999 67999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=315.60  Aligned_cols=242  Identities=35%  Similarity=0.546  Sum_probs=196.2

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC------C
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------S   87 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------~   87 (344)
                      +-|..-+.||+|+||.||+++++.+|..||||.+++..  .....+...+|+++|++++|+|||+++++=++.      .
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            56777899999999999999999999999999987644  344567888999999999999999999886443      3


Q ss_pred             eEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEc--cCCC--eEEecccc
Q 019216           88 KIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD--SKGN--IKISDFGL  160 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~--~~~~--vkl~Dfg~  160 (344)
                      ...++||||.||||+..+++   ...+++.+.+.++..+..||.|||++||+||||||.||++.  .+|+  .||+|||.
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            46799999999999999974   45699999999999999999999999999999999999984  3343  69999999


Q ss_pred             ccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc-----cHHHHHHHHhhC---
Q 019216          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-----NLAVLYQKIFRG---  232 (344)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~-----~~~~~~~~i~~~---  232 (344)
                      |+..+   +++...+..||..|.+||.+....+++..+|.|||||++|++.||..||...     +...++..+.+.   
T Consensus       171 Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~  247 (732)
T KOG4250|consen  171 ARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSG  247 (732)
T ss_pred             cccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCc
Confidence            99543   4557788999999999999986566689999999999999999999999431     222333322211   


Q ss_pred             -----------------CCCCCCCCCHHH----HHHHHHhcCCCcCCCC
Q 019216          233 -----------------DFKLPKWLSPGA----QNLLRKILEPNPVKRI  260 (344)
Q Consensus       233 -----------------~~~~~~~~~~~~----~~li~~~L~~dP~~Rp  260 (344)
                                       .++.|..+++.+    ...+..+|..+|.+|.
T Consensus       248 v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  248 VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                             123334444443    4566778899999998

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-42  Score=287.16  Aligned_cols=260  Identities=25%  Similarity=0.350  Sum_probs=209.7

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCccceeeEEeeCCeE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~   89 (344)
                      ..-...+-+..||.|+||+|++..++.+|+..|||.++....  .....+++.|.....+ -++|||+++||....++..
T Consensus        61 F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdc  138 (361)
T KOG1006|consen   61 FTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDC  138 (361)
T ss_pred             cccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCce
Confidence            334455567889999999999999999999999999976553  3445678888876544 4699999999999999999


Q ss_pred             EEEEeccCCCChHHHH-----HhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           90 YMVLEYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l-----~~~~~~~~~~~~~i~~ql~~~L~~LH~~-~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      ||.||.| ..||..+-     ..+..++|+.+-.+....+.||.||.+. +|+|||+||+|||++..|.+||||||.+.-
T Consensus       139 WiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGq  217 (361)
T KOG1006|consen  139 WICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQ  217 (361)
T ss_pred             eeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHh
Confidence            9999999 44663322     2356799999999999999999999865 999999999999999999999999998863


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCC-CCccchhhhhhHHHHHHHhCCCCCCCcc-HHHHHHHHhhCCCCC---CC
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGY-DGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL---PK  238 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~~DvwslG~ll~ell~g~~pf~~~~-~~~~~~~i~~~~~~~---~~  238 (344)
                      +   .+.-......|...|||||.+....- +.-++||||||++|||+.||+.|+.+-+ ..+....+..+.++.   +.
T Consensus       218 L---v~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~  294 (361)
T KOG1006|consen  218 L---VDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDK  294 (361)
T ss_pred             H---HHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcc
Confidence            2   22222334578889999999864332 3578999999999999999999998744 455556666666543   22


Q ss_pred             C---CCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          239 W---LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       239 ~---~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      .   ++..++.+|.-||.+|-+.||...+++.+||++....
T Consensus       295 ~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  295 ECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             cccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence            2   7899999999999999999999999999999986543

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-40  Score=314.31  Aligned_cols=259  Identities=26%  Similarity=0.402  Sum_probs=223.4

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEe----
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLA----   84 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~----   84 (344)
                      ..+-+.|++.+.||.|.+|.||+++++.+++..|+|+......    .-+.+..|.++|+.+. |||++.+|++|.    
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~   90 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP   90 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence            3455789999999999999999999999999999999865432    3356788999999885 999999999985    


Q ss_pred             -eCCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccc
Q 019216           85 -SKSKIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus        85 -~~~~~~iv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a  161 (344)
                       .++.+|+|||||.|||..|++++  ..++.|..+..|++.++.||.+||++.++|||||-.|||++.+|.|||+|||++
T Consensus        91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence             45789999999999999999975  457999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhccCCC----CCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC--
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY----DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--  235 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~--  235 (344)
                      .-...  ......+..|||.|||||++...+.    ++..+|+||||++..||--|.+|+-+..+...+-.|-+..++  
T Consensus       171 aQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkL  248 (953)
T KOG0587|consen  171 AQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKL  248 (953)
T ss_pred             eeeec--ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccc
Confidence            74433  3344567899999999999864321    246799999999999999999999998887777777665433  


Q ss_pred             -CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          236 -LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       236 -~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                       -|+.++.++.++|..||.+|..+||+..++|.|||..+.
T Consensus       249 krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~  288 (953)
T KOG0587|consen  249 KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ  288 (953)
T ss_pred             cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence             356689999999999999999999999999999999743

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=305.65  Aligned_cols=246  Identities=27%  Similarity=0.417  Sum_probs=214.0

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      +.....+||.|-||.||.|.++...--||||.++...    -..+.|+.|..+|+.++|||+++++++|..+..+|||+|
T Consensus       268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTE  343 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITE  343 (1157)
T ss_pred             heeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEe
Confidence            4455789999999999999999988999999986443    346789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           95 YVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        95 ~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||..|+|.+|++++.  .++.....+++.||..|++||..+++|||||...|+|+.++..||++|||+++++..... ..
T Consensus       344 fM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTY-TA  422 (1157)
T KOG4278|consen  344 FMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTY-TA  422 (1157)
T ss_pred             cccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCce-ec
Confidence            999999999998754  367777888999999999999999999999999999999999999999999997543211 11


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK  250 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~  250 (344)
                      .....-..-|.|||-+..+.+ +.++|||+||++|||+.| |-.||.+-+....+..+.++ ..+-|..|++.+.+|++.
T Consensus       423 HAGAKFPIKWTAPEsLAyNtF-SiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMra  501 (1157)
T KOG4278|consen  423 HAGAKFPIKWTAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMRA  501 (1157)
T ss_pred             ccCccCcccccCccccccccc-ccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHHH
Confidence            112233567999999988887 689999999999999999 99999999888888777665 566789999999999999


Q ss_pred             hcCCCcCCCCCHhhhh
Q 019216          251 ILEPNPVKRITIAGIK  266 (344)
Q Consensus       251 ~L~~dP~~Rps~~eil  266 (344)
                      ||++.|++||+++|+-
T Consensus       502 CW~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  502 CWNWSPSDRPSFAEIH  517 (1157)
T ss_pred             HhcCCcccCccHHHHH
Confidence            9999999999999873

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.2e-39  Score=316.16  Aligned_cols=260  Identities=20%  Similarity=0.267  Sum_probs=181.1

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCC----CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeE-
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDS----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV-   82 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~----~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~-   82 (344)
                      ......++|++.+.||+|+||.||+|.+..+    +..||+|.+.....     .+....+  .++...+.++..++.. 
T Consensus       126 ~~~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~  198 (566)
T PLN03225        126 RPSFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGF  198 (566)
T ss_pred             CCCCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhh
Confidence            3456789999999999999999999999888    99999998753221     1111111  1122222222222211 


Q ss_pred             -----EeeCCeEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCcee
Q 019216           83 -----LASKSKIYMVLEYVTGGELFDKIASKGR--------------------LQEAEGRKLFQQLIDGVSYCHNKGVFH  137 (344)
Q Consensus        83 -----~~~~~~~~iv~e~~~g~~L~~~l~~~~~--------------------~~~~~~~~i~~ql~~~L~~LH~~~i~H  137 (344)
                           ...+...++|+||+.+++|.+++.....                    .....+..++.||+.||.|||++||+|
T Consensus       199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiH  278 (566)
T PLN03225        199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVH  278 (566)
T ss_pred             hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEe
Confidence                 2355678999999999999998865321                    123456789999999999999999999


Q ss_pred             ecCCCCcEEEcc-CCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCC---------------------CC
Q 019216          138 RDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY---------------------DG  195 (344)
Q Consensus       138 ~dikp~NILl~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---------------------~~  195 (344)
                      |||||+|||++. ++.+||+|||+++..... ........++++.|+|||.+.....                     .+
T Consensus       279 RDLKP~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~  357 (566)
T PLN03225        279 RDVKPQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP  357 (566)
T ss_pred             CcCCHHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence            999999999986 579999999999743221 1223345688999999997643221                     12


Q ss_pred             ccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC---------------------CCCCCCCHHHHHHHHHhcCC
Q 019216          196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---------------------KLPKWLSPGAQNLLRKILEP  254 (344)
Q Consensus       196 ~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~---------------------~~~~~~~~~~~~li~~~L~~  254 (344)
                      .++|||||||++|||+++..+++... ......+.....                     +..+..+....+||.+||+.
T Consensus       358 ~k~DVwSlGviL~el~~~~~~~~~~~-~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        358 DRFDIYSAGLIFLQMAFPNLRSDSNL-IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             CCcccHHHHHHHHHHHhCcCCCchHH-HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            35699999999999999777654321 111111111111                     01111233456899999999


Q ss_pred             CcCCCCCHhhhhcCccccccCC
Q 019216          255 NPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       255 dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      ||++|||+.++|+||||+....
T Consensus       437 dP~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        437 KGRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             CcccCCCHHHHhCCcCcCCCCc
Confidence            9999999999999999986443

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-41  Score=300.62  Aligned_cols=261  Identities=30%  Similarity=0.440  Sum_probs=216.1

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch----hHHHHHHHHHHHHHhCCCCCccceeeEEee-CC
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL----KITDQIKREIATLKLLKHPNVVRLHEVLAS-KS   87 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~   87 (344)
                      -.||-++.+||+|||+.||+|.+....+.||+|+-..+..+..    ...+...+|.+|-+.|+||.||++|++|.- .+
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            3588899999999999999999999999999998765554433    345678899999999999999999999964 46


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--CceeecCCCCcEEEccC---CCeEEecccccc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--GVFHRDLKLENILLDSK---GNIKISDFGLSA  162 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~--~i~H~dikp~NILl~~~---~~vkl~Dfg~a~  162 (344)
                      .+|-|+|||+|.+|.-+++....+++.+++.|+.||+.||.||.+.  .|||-||||.|||+-..   |.+||.|||+++
T Consensus       542 sFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             cceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence            7889999999999999999999999999999999999999999987  59999999999999443   679999999999


Q ss_pred             CCCcccCC-----CccccccCCCcccchhhhcc---CCCCCccchhhhhhHHHHHHHhCCCCCCCcc-HHHHHHH--Hhh
Q 019216          163 LPQHFRDD-----GLLHTTCGSPNYVAPEVLAN---RGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQK--IFR  231 (344)
Q Consensus       163 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~---~~~~~~~~DvwslG~ll~ell~g~~pf~~~~-~~~~~~~--i~~  231 (344)
                      +++.....     .......||.||++||.+.-   .+-.+.++||||+|+++|.++.|+.||.... ...+++.  |++
T Consensus       622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlk  701 (775)
T KOG1151|consen  622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILK  701 (775)
T ss_pred             hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhc
Confidence            76543322     12334579999999998652   3445789999999999999999999997643 2232221  222


Q ss_pred             -CCCCCC--CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          232 -GDFKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       232 -~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                       ....+|  +.+++++++||++||+..-++|....++..||+|..
T Consensus       702 AtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  702 ATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             ceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence             234444  458999999999999999999999999999999864

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=306.67  Aligned_cols=248  Identities=27%  Similarity=0.416  Sum_probs=208.0

Q ss_pred             cccCeEEeeeecccCceEEEEEEECC----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLD----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      .....++.++||.|-||.||.|....    ..-.||||..+.+..  .+..+.|.+|..+++.++||||++++|++... 
T Consensus       387 ~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t--~d~tekflqEa~iMrnfdHphIikLIGv~~e~-  463 (974)
T KOG4257|consen  387 RRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCT--PDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-  463 (974)
T ss_pred             ehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCC--hhhHHHHHHHHHHHHhCCCcchhheeeeeecc-
Confidence            33444557789999999999998532    234688898865443  33478999999999999999999999999754 


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ..|||||.++-|.|.++++.+. .++......++.||+.||+|||+.+++||||...|||+....-|||+|||+++-.+.
T Consensus       464 P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed  543 (974)
T KOG4257|consen  464 PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLED  543 (974)
T ss_pred             ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccc
Confidence            6899999999999999998654 689999999999999999999999999999999999999999999999999985432


Q ss_pred             ccCCCcccc--ccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCH
Q 019216          167 FRDDGLLHT--TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP  242 (344)
Q Consensus       167 ~~~~~~~~~--~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~  242 (344)
                         ......  ..-..-|||||.+.-..+ +.++|||.||+.+||++. |..||.+-...+....+.++ .++.|+.+++
T Consensus       544 ---~~yYkaS~~kLPIKWmaPESINfRrF-TtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp  619 (974)
T KOG4257|consen  544 ---DAYYKASRGKLPIKWMAPESINFRRF-TTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPP  619 (974)
T ss_pred             ---cchhhccccccceeecCccccchhcc-cchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCCh
Confidence               222222  223457999999887777 688999999999999887 99999987766666666666 6789999999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhh
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIK  266 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil  266 (344)
                      .+..|+.+||+.+|.+||++.++.
T Consensus       620 ~LYslmskcWayeP~kRPrftei~  643 (974)
T KOG4257|consen  620 ALYSLMSKCWAYEPSKRPRFTEIK  643 (974)
T ss_pred             HHHHHHHHHhccCcccCCcHHHHH
Confidence            999999999999999999988754

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=5.6e-39  Score=279.83  Aligned_cols=240  Identities=45%  Similarity=0.786  Sum_probs=207.3

Q ss_pred             CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCCChHHHH
Q 019216           26 NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI  105 (344)
Q Consensus        26 ~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~~L~~~l  105 (344)
                      +||.||+|.+..+|+.+|+|++........  .+.+.+|++.+++++|+|++++++.+......++++|++.+++|.+++
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~   78 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL   78 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence            589999999998999999999865443221  578899999999999999999999999989999999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccch
Q 019216          106 ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP  185 (344)
Q Consensus       106 ~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  185 (344)
                      .....++...+..++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+......   .......++..|++|
T Consensus        79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~p  155 (244)
T smart00220       79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---GLLTTFVGTPEYMAP  155 (244)
T ss_pred             HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc---cccccccCCcCCCCH
Confidence            87666899999999999999999999999999999999999999999999999998754321   133456788899999


Q ss_pred             hhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhhCCCCCCCC---CCHHHHHHHHHhcCCCcCCCCC
Q 019216          186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPKW---LSPGAQNLLRKILEPNPVKRIT  261 (344)
Q Consensus       186 E~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~-~~~~~~~~~i~~~~~~~~~~---~~~~~~~li~~~L~~dP~~Rps  261 (344)
                      |.+..... +.++||||||++++++++|..||.. .+..................   ++..+.+++.+||..+|++||+
T Consensus       156 E~~~~~~~-~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      156 EVLLGKGY-GKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             HHHccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence            99876666 5799999999999999999999987 55555555555554443332   8899999999999999999999


Q ss_pred             HhhhhcCccc
Q 019216          262 IAGIKADEWF  271 (344)
Q Consensus       262 ~~eil~~~~~  271 (344)
                      +.++++||||
T Consensus       235 ~~~~~~~~~~  244 (244)
T smart00220      235 AEEALQHPFF  244 (244)
T ss_pred             HHHHhhCCCC
Confidence            9999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-41  Score=286.46  Aligned_cols=253  Identities=28%  Similarity=0.441  Sum_probs=213.0

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC---
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---   87 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---   87 (344)
                      ....||.-+..+|.|+- .|..|.|...++.||+|.+-.. ..+....++..+|..++..+.|+||++++.+|....   
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence            44568999999999999 8889999999999999987554 444556778999999999999999999999996543   


Q ss_pred             ---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           88 ---KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        88 ---~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                         .+|+|||++ ..+|...+.  -.++...+..++.|++.|++|||+.||+||||||+||++..++.+||+|||+|+..
T Consensus        92 ~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   92 EFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence               479999999 568887776  34678899999999999999999999999999999999999999999999999853


Q ss_pred             CcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-----------
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-----------  233 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-----------  233 (344)
                      +.   .-.....+.|..|+|||++.+.++ .+.+||||+||++.||++|+..|.|.+....+.++....           
T Consensus       169 ~~---~~~mtpyVvtRyyrapevil~~~~-ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL  244 (369)
T KOG0665|consen  169 DT---DFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQL  244 (369)
T ss_pred             Cc---ccccCchhheeeccCchheeccCC-cccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHh
Confidence            22   235567789999999999999885 689999999999999999999999877766665554210           


Q ss_pred             ----------------CC----CCC-----------CCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccc
Q 019216          234 ----------------FK----LPK-----------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE  272 (344)
Q Consensus       234 ----------------~~----~~~-----------~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~  272 (344)
                                      ..    +|+           .-+..+++|+.+||..||++|.|++++|+|||++
T Consensus       245 ~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  245 QPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                            00    111           1245789999999999999999999999999998

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=309.17  Aligned_cols=257  Identities=29%  Similarity=0.422  Sum_probs=219.9

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCC-C--ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDS-G--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~-~--~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..++..+.++||+|.||.|++|.|+.. |  ..||||.++......  ....|.+|+.+|.+|+|+|++++|++..+ ..
T Consensus       108 pee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp  184 (1039)
T KOG0199|consen  108 PEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QP  184 (1039)
T ss_pred             cHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-ch
Confidence            445677889999999999999998753 3  468999997554322  67899999999999999999999999887 56


Q ss_pred             EEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           89 IYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ..+|||+++.|+|.+.+.+  ...+.......++.||+.|+.||..+++|||||...|+|+.....|||||||+.+.++.
T Consensus       185 ~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  185 AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            7899999999999999986  34577888999999999999999999999999999999999999999999999997665


Q ss_pred             ccCCCcccc-ccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHH
Q 019216          167 FRDDGLLHT-TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG  243 (344)
Q Consensus       167 ~~~~~~~~~-~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~  243 (344)
                      ..+...+.. ..-...|+|||.+....+ +.++|||++|+++|||++ |..||.+.....+++++-.+ .++-|+.++.+
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLrh~kF-ShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~csed  343 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLRHRKF-SHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSED  343 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhccccc-cccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChHH
Confidence            443322222 233457999999998887 689999999999999999 89999999999998888754 57788999999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCcccc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWFE  272 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~~  272 (344)
                      +.+++..||..+|.+|||+..|.+.-+..
T Consensus       344 IY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  344 IYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             HHHHHHHhccCCccccccHHHHHHhHHHH
Confidence            99999999999999999999997654443

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=310.87  Aligned_cols=254  Identities=24%  Similarity=0.398  Sum_probs=222.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      +.-+...|.+.||.|.||.||+|+.+..|   ..||||.++..  ..+++...|+.|..||-+.+||||+++.++.....
T Consensus       626 Id~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~  703 (996)
T KOG0196|consen  626 IDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSK  703 (996)
T ss_pred             cChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCc
Confidence            45567789999999999999999988666   46999999643  34567889999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      .+.||+|||++|+|..+|+. .++++..+...+++.|+.|++||-+.|++||||...||||+.+-.+|++|||+++.++.
T Consensus       704 PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvled  783 (996)
T KOG0196|consen  704 PVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  783 (996)
T ss_pred             eeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeeccc
Confidence            99999999999999999974 67899999999999999999999999999999999999999999999999999997654


Q ss_pred             ccCCCcccccc--CCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCH
Q 019216          167 FRDDGLLHTTC--GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP  242 (344)
Q Consensus       167 ~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~  242 (344)
                      ..... ..+.-  -..+|.|||.+...++ +.++||||+|++|||.++ |..||-+.+.++..+.|..+ .++.|-.++.
T Consensus       784 d~~~~-ytt~GGKIPiRWTAPEAIa~RKF-TsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~  861 (996)
T KOG0196|consen  784 DPEAA-YTTLGGKIPIRWTAPEAIAYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPA  861 (996)
T ss_pred             CCCcc-ccccCCccceeecChhHhhhccc-CchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcH
Confidence            33211 11222  2368999999998888 689999999999999988 99999888888888888776 6777788999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+.+|+..||++|-.+||.+.+|+++
T Consensus       862 aL~qLMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  862 ALYQLMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence            99999999999999999999999874

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=297.59  Aligned_cols=254  Identities=24%  Similarity=0.376  Sum_probs=209.1

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      ...-++..+.++||+|-||.|.++.- ..+..||+|.++....  ...++.|.+|+++|.+|+||||+.++++|..++.+
T Consensus       534 EfPRs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePi  610 (807)
T KOG1094|consen  534 EFPRSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPL  610 (807)
T ss_pred             hcchhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCch
Confidence            34556678899999999999999995 5579999999976553  33468999999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           90 YMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ++|+||++.|+|.+++....  ........+++.||+.|++||.+.+++||||.+.|+|++.++++||+|||+++.+-..
T Consensus       611 cmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg  690 (807)
T KOG1094|consen  611 CMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG  690 (807)
T ss_pred             HHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC
Confidence            99999999999999998753  2345566779999999999999999999999999999999999999999999843221


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh--CCCCCCCccHHHHHHHHh---hC-----CCCCC
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT--GYLPFDDRNLAVLYQKIF---RG-----DFKLP  237 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~--g~~pf~~~~~~~~~~~i~---~~-----~~~~~  237 (344)
                      .....-...+-..+|||||.+...++ +.++|+|+||+++||+++  ...||...+.+....+..   ..     -+..|
T Consensus       691 ~yy~vqgr~vlpiRwmawEsillgkF-ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P  769 (807)
T KOG1094|consen  691 DYYRVQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRP  769 (807)
T ss_pred             CceeeecceeeeeeehhHHHHHhccc-cchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCC
Confidence            11111122344579999999988887 689999999999999865  788998766655544332   22     13457


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          238 KWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .-++..+.+++-+||..|.++||+++++-.
T Consensus       770 ~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  770 PACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             CcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            779999999999999999999999999843

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-41  Score=283.18  Aligned_cols=258  Identities=28%  Similarity=0.414  Sum_probs=213.7

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC-----eE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----KI   89 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~~   89 (344)
                      +.+.-+.||.|+||.||.++|..+|+.||+|.+.. -..+....+++.+|+.+|...+|.|++..+++.....     .+
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            34556889999999999999999999999998843 3344455688999999999999999999998875433     36


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      |+++|.+ ..+|...+.+-..++...++-+++||++||.|||+.||.||||||.|.|++.|..+||||||+++..+.. .
T Consensus       133 YV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d-~  210 (449)
T KOG0664|consen  133 YVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR-D  210 (449)
T ss_pred             HHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchh-h
Confidence            7888888 4588888888888999999999999999999999999999999999999999999999999999965432 2


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhh------------------
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------------  231 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~------------------  231 (344)
                      ...+...+-|.+|+|||++.+...++.+.||||+||++.|++..+..|...+.....+.|..                  
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence            23344456689999999999988888999999999999999999999988776665554431                  


Q ss_pred             -----CCCCCC-----------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          232 -----GDFKLP-----------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       232 -----~~~~~~-----------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                           +...-|           ..-..+..+++..+|..||++|.+.++.+.|++..+..
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R  350 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR  350 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence                 211111           12345778999999999999999999999999987643

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=2e-40  Score=299.49  Aligned_cols=250  Identities=28%  Similarity=0.418  Sum_probs=209.9

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC------CCCccceeeEEeeCC
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK------HPNVVRLHEVLASKS   87 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~------h~niv~l~~~~~~~~   87 (344)
                      ++|.+..-.|+|=|++|..|.+...|+.||||+|+.+..    ..+.=++|+++|++|+      --++++++..|....
T Consensus       432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hkn  507 (752)
T KOG0670|consen  432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKN  507 (752)
T ss_pred             ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcc
Confidence            589999999999999999999999999999999976543    2344567999999996      247899999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC-CeEEeccccccC
Q 019216           88 KIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSAL  163 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~-~vkl~Dfg~a~~  163 (344)
                      ++|+|+|-+ ..+|.+.+++.+   .+....++.++.|+..||..|..+||+|.||||+||||++.. .+||||||.|..
T Consensus       508 HLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~  586 (752)
T KOG0670|consen  508 HLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASF  586 (752)
T ss_pred             eeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccc
Confidence            999999988 679999998755   478899999999999999999999999999999999999875 579999999875


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCC----
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW----  239 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~----  239 (344)
                      .+.    .....+..+..|+|||++.+.+|+ ...|+||+||+||||.||+..|.|.+...++...+...-++|..    
T Consensus       587 ~~e----neitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK  661 (752)
T KOG0670|consen  587 ASE----NEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK  661 (752)
T ss_pred             ccc----ccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence            432    233445567789999999999985 78999999999999999999999977666665544332222211    


Q ss_pred             --------------------------------------------------------CCHHHHHHHHHhcCCCcCCCCCHh
Q 019216          240 --------------------------------------------------------LSPGAQNLLRKILEPNPVKRITIA  263 (344)
Q Consensus       240 --------------------------------------------------------~~~~~~~li~~~L~~dP~~Rps~~  263 (344)
                                                                              .-.++++|+.+||..||++|.|..
T Consensus       662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n  741 (752)
T KOG0670|consen  662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN  741 (752)
T ss_pred             cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence                                                                    014678999999999999999999


Q ss_pred             hhhcCccccc
Q 019216          264 GIKADEWFEQ  273 (344)
Q Consensus       264 eil~~~~~~~  273 (344)
                      ++|+||||+.
T Consensus       742 qAL~HpFi~~  751 (752)
T KOG0670|consen  742 QALKHPFITE  751 (752)
T ss_pred             HHhcCCcccC
Confidence            9999999974

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-39  Score=287.93  Aligned_cols=131  Identities=31%  Similarity=0.471  Sum_probs=114.9

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-----C---CCccceeeEEe
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----H---PNVVRLHEVLA   84 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---~niv~l~~~~~   84 (344)
                      -+||-+.++||.|-|++||+|+|..+.+.||+|+.+..    ....+....||.+|++++     |   ..||++++.|.
T Consensus        77 ~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA----qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk  152 (590)
T KOG1290|consen   77 GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA----QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK  152 (590)
T ss_pred             CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh----hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence            37999999999999999999999999999999998643    245677889999999884     2   36999999985


Q ss_pred             ----eCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEEc
Q 019216           85 ----SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLD  148 (344)
Q Consensus        85 ----~~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~-~i~H~dikp~NILl~  148 (344)
                          .+.++++|+|++ |.+|..+|...  +.++...+++|++|++.||.|||.. ||||.||||+|||+.
T Consensus       153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence                456899999999 88999988753  4699999999999999999999975 999999999999994

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=9.8e-40  Score=267.91  Aligned_cols=251  Identities=25%  Similarity=0.449  Sum_probs=206.2

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeC--Ce
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASK--SK   88 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~--~~   88 (344)
                      ..++|++++++|+|.|+.||.|.+..+++.++||+++...      .+.+.+|+.+|+.|. ||||++++++..+.  ..
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt  109 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT  109 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence            4568999999999999999999999999999999996543      478999999999998 99999999998654  45


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC-CeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~-~vkl~Dfg~a~~~~~~  167 (344)
                      ..+|+||+++.+...+-   ..++.-.++.++.+++.||.|+|+.||+|||+||.|++|+... .++|+|+|+|.+... 
T Consensus       110 paLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp-  185 (338)
T KOG0668|consen  110 PSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP-  185 (338)
T ss_pred             chhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCC-
Confidence            67999999887776554   4588899999999999999999999999999999999998765 699999999986543 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCC-CCccHHHHHHHHhh-------------CC
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFR-------------GD  233 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf-~~~~~~~~~~~i~~-------------~~  233 (344)
                        .......+.+..|--||.+...+.+..+-|+|||||++..|+..+.|| .|.+...+..+|.+             -.
T Consensus       186 --~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~  263 (338)
T KOG0668|consen  186 --GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQ  263 (338)
T ss_pred             --CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHc
Confidence              222344566778899999988777778999999999999999999997 34333333323221             01


Q ss_pred             CCCC------------------------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          234 FKLP------------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       234 ~~~~------------------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ..++                        .-.++++.+|+.++|..|-.+|+|+.|++.||||...
T Consensus       264 i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~  328 (338)
T KOG0668|consen  264 IDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPV  328 (338)
T ss_pred             cCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHH
Confidence            1111                        1157999999999999999999999999999999754

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.3e-37  Score=295.24  Aligned_cols=265  Identities=19%  Similarity=0.231  Sum_probs=189.8

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEEC----------------CCCceEEEEEeecccccch-h----------HHHHH
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDL----------------DSGLPFAVKILEKNRIIHL-K----------ITDQI   61 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~----------------~~~~~vaiK~~~~~~~~~~-~----------~~~~~   61 (344)
                      .....++|++.++||+|+||.||+|.+.                ..++.||||.+........ +          ..+..
T Consensus       140 ~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~  219 (507)
T PLN03224        140 SRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETG  219 (507)
T ss_pred             CCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchh
Confidence            4567889999999999999999999752                3456799999854321100 0          01223


Q ss_pred             HHHHHHHHhCCCCCc-----cceeeEEee--------CCeEEEEEeccCCCChHHHHHhcC-------------------
Q 019216           62 KREIATLKLLKHPNV-----VRLHEVLAS--------KSKIYMVLEYVTGGELFDKIASKG-------------------  109 (344)
Q Consensus        62 ~~E~~~l~~l~h~ni-----v~l~~~~~~--------~~~~~iv~e~~~g~~L~~~l~~~~-------------------  109 (344)
                      ..|+.++.+++|.++     +++++++..        ....++||||+++++|.+++....                   
T Consensus       220 ~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~  299 (507)
T PLN03224        220 MVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD  299 (507)
T ss_pred             HHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence            346677777766544     566666542        346899999999999998886321                   


Q ss_pred             -----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccc
Q 019216          110 -----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA  184 (344)
Q Consensus       110 -----~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a  184 (344)
                           .+++..++.++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||++....... ........+|+.|+|
T Consensus       300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~a  378 (507)
T PLN03224        300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSP  378 (507)
T ss_pred             hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeC
Confidence                 23556788999999999999999999999999999999999999999999987432211 111112344789999


Q ss_pred             hhhhccCCC---------------------CCccchhhhhhHHHHHHHhCCC-CCCCccHH-----------HHHHHHhh
Q 019216          185 PEVLANRGY---------------------DGATSDIWSCGVILYVILTGYL-PFDDRNLA-----------VLYQKIFR  231 (344)
Q Consensus       185 PE~~~~~~~---------------------~~~~~DvwslG~ll~ell~g~~-pf~~~~~~-----------~~~~~i~~  231 (344)
                      ||.+.....                     ...+.||||+||++|+|++|.. ||.+....           ..+..+..
T Consensus       379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~  458 (507)
T PLN03224        379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG  458 (507)
T ss_pred             hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence            999754321                     0124799999999999999875 77542211           11111222


Q ss_pred             CCCCC--CCCCCHHHHHHHHHhcCCCc---CCCCCHhhhhcCcccccc
Q 019216          232 GDFKL--PKWLSPGAQNLLRKILEPNP---VKRITIAGIKADEWFEQD  274 (344)
Q Consensus       232 ~~~~~--~~~~~~~~~~li~~~L~~dP---~~Rps~~eil~~~~~~~~  274 (344)
                      ....+  ....++.+.+|+.+||..+|   .+|+|++|+|+||||...
T Consensus       459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~  506 (507)
T PLN03224        459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE  506 (507)
T ss_pred             cCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence            23333  34578999999999999876   689999999999999653

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-38  Score=301.96  Aligned_cols=244  Identities=31%  Similarity=0.428  Sum_probs=196.4

Q ss_pred             EeeeecccCceE-EEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEec
Q 019216           18 LGRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEY   95 (344)
Q Consensus        18 ~~~~Lg~G~~g~-Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv~e~   95 (344)
                      -.+.+|.|+.|+ ||+|.  ..|+.||||.+-.      +....+.+|+..|+..+ ||||+++|+.-.++.+.||..|.
T Consensus       513 ~~eilG~Gs~Gt~Vf~G~--ye~R~VAVKrll~------e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  513 PKEILGYGSNGTVVFRGV--YEGREVAVKRLLE------EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             cHHHcccCCCCcEEEEEe--eCCceehHHHHhh------HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            346789999985 88888  5788999997743      33567889999999985 99999999998899999999999


Q ss_pred             cCCCChHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc---CC--CeEEeccccccCCCc
Q 019216           96 VTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KG--NIKISDFGLSALPQH  166 (344)
Q Consensus        96 ~~g~~L~~~l~~~~~----~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~---~~--~vkl~Dfg~a~~~~~  166 (344)
                      | ..+|.++++..+.    ......+.++.|++.||++||+.+|+||||||.||||..   ++  +++|+|||+++....
T Consensus       585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~  663 (903)
T KOG1027|consen  585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG  663 (903)
T ss_pred             h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence            9 5699999986421    122456889999999999999999999999999999976   34  689999999987654


Q ss_pred             ccC-CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhC-CCCCCCccHHHHHHHHhhCCCCCCC---CCC
Q 019216          167 FRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGDFKLPK---WLS  241 (344)
Q Consensus       167 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g-~~pf~~~~~~~~~~~i~~~~~~~~~---~~~  241 (344)
                      ... -.......||-+|+|||++..... +.++||+||||++|+.++| +.||...-  ....+|.++...+-.   ...
T Consensus       664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~-~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~~~~d  740 (903)
T KOG1027|consen  664 GKSSFSRLSGGSGTSGWQAPEQLREDRK-TQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLEPLPD  740 (903)
T ss_pred             CcchhhcccCCCCcccccCHHHHhcccc-CcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccceeeeccCch
Confidence            322 123456689999999999987665 5789999999999999995 99997543  233456666554321   112


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      .++.+||.+|++++|..||+|.++|.||+|=.
T Consensus       741 ~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~  772 (903)
T KOG1027|consen  741 CEAKDLISRMLNPDPQLRPSATDVLNHPLFWD  772 (903)
T ss_pred             HHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence            28999999999999999999999999999954

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.1e-37  Score=321.23  Aligned_cols=237  Identities=23%  Similarity=0.332  Sum_probs=186.2

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ..|...+.||+|+||.||+|.++.++..||+|.+.....       ....|+..+++++||||+++++++......++||
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~  762 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH  762 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence            345667889999999999999999999999998854321       1124688899999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH---NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH---~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      ||+++++|.+++..   +++..+..++.|++.||+|||   +.+|+||||||+||+++.++..++. ||......     
T Consensus       763 Ey~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~-----  833 (968)
T PLN00113        763 EYIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC-----  833 (968)
T ss_pred             eCCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc-----
Confidence            99999999999863   889999999999999999999   6699999999999999999888775 66544211     


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc-----HHHHHHHHhhC-------CCCC--
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-----LAVLYQKIFRG-------DFKL--  236 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~-----~~~~~~~i~~~-------~~~~--  236 (344)
                       ......+|..|+|||++.+..+ +.++|||||||++|||++|+.||....     ...........       ....  
T Consensus       834 -~~~~~~~t~~y~aPE~~~~~~~-~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  911 (968)
T PLN00113        834 -TDTKCFISSAYVAPETRETKDI-TEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG  911 (968)
T ss_pred             -cCCCccccccccCcccccCCCC-CcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence             1123367899999999887666 689999999999999999999985421     11111111100       0001  


Q ss_pred             ----CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          237 ----PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       237 ----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                          +.....++.+++.+||+.||++|||+.|+++.
T Consensus       912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence                11112356789999999999999999999875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=292.91  Aligned_cols=259  Identities=29%  Similarity=0.427  Sum_probs=222.8

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      =...+|+++.++|.|+||.||+|+++.+++..|+|+++....   ....-+.+|+-+++..+||||+.+++.+.-...++
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr~dklw   88 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLW   88 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhhhcCcE
Confidence            356799999999999999999999999999999999975543   33567789999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      ++||||.||+|.+.-.--+++++.++..+++..+.||+|||+.|-+|||||-.|||+++.|.+|++|||.+.....  .-
T Consensus        89 icMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqita--ti  166 (829)
T KOG0576|consen   89 ICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA--TI  166 (829)
T ss_pred             EEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhh--hh
Confidence            9999999999998777778999999999999999999999999999999999999999999999999998764322  12


Q ss_pred             CccccccCCCcccchhhhc--cCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC-----CCCCHH
Q 019216          171 GLLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP-----KWLSPG  243 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~-----~~~~~~  243 (344)
                      .....+.||++|||||+-.  ..+.+...+|||++|+...|+-.-++|.-............+..+..|     ..+++.
T Consensus       167 ~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~  246 (829)
T KOG0576|consen  167 AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEF  246 (829)
T ss_pred             hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHH
Confidence            2345679999999999843  333335899999999999999988888766666666655555555443     448899


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +.+|++.+|.++|++|||++.+|.|||..+.
T Consensus       247 fh~fvK~altknpKkRptaeklL~h~fvs~~  277 (829)
T KOG0576|consen  247 FHNFVKGALTKNPKKRPTAEKLLQHPFVSQT  277 (829)
T ss_pred             HHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence            9999999999999999999999999998653

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=283.54  Aligned_cols=206  Identities=33%  Similarity=0.599  Sum_probs=185.0

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchh-----HHHHHHHHHHHHHhCC---CCCcccee
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLKLLK---HPNVVRLH   80 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~---h~niv~l~   80 (344)
                      +-..+..|..++.||.|+||.|++|.++.+...|+||.+.|.++....     .+..+..||+||.+++   |+||++++
T Consensus       556 ~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlL  635 (772)
T KOG1152|consen  556 EYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLL  635 (772)
T ss_pred             eecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhh
Confidence            345678899999999999999999999999999999999887654322     2334667999999997   99999999


Q ss_pred             eEEeeCCeEEEEEecc-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccc
Q 019216           81 EVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG  159 (344)
Q Consensus        81 ~~~~~~~~~~iv~e~~-~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg  159 (344)
                      ++|++++++|++||.- +|-+|+++++....++|.+++.|++|++.|+++||+.||+|||||-+|+.++.+|-+||+|||
T Consensus       636 dfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  636 DFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             heeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence            9999999999999975 567999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCC
Q 019216          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD  218 (344)
Q Consensus       160 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~  218 (344)
                      .|..    ...+......||..|.|||++.+.+|-+..-|||+||++||.++....||.
T Consensus       716 saa~----~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAY----TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhh----hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9874    344567788999999999999999999999999999999999998888874

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-36  Score=288.00  Aligned_cols=247  Identities=24%  Similarity=0.360  Sum_probs=212.9

Q ss_pred             EEeeeecccCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           17 ELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        17 ~~~~~Lg~G~~g~Vy~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +..++||+|+||+||+|.+...|+    +||+|++....  ..+....+.+|+-+|.+++|||++++++++.... +-||
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t--~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT--SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccC--CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHH
Confidence            346789999999999999876554    68888876443  3344678999999999999999999999997665 7789


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      ++|+++|+|.++++. +..+-......|..||++|+.|||+++++||||-..||||..-..+|+.|||+++........-
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            999999999999985 4578899999999999999999999999999999999999999999999999999876654443


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR  249 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~  249 (344)
                      ......-.+-|+|-|.+....+ +.++||||+|+++||++| |..|+.+....++-..+..+ +++-|..++-++..++-
T Consensus       856 ~~~~gK~pikwmale~i~~~~~-thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~mv  934 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKY-THQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVMV  934 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCC-CchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHHH
Confidence            3344455678999999888777 799999999999999999 99999998888887777665 56778889999999999


Q ss_pred             HhcCCCcCCCCCHhhhhc
Q 019216          250 KILEPNPVKRITIAGIKA  267 (344)
Q Consensus       250 ~~L~~dP~~Rps~~eil~  267 (344)
                      +||..|++.||+++++-.
T Consensus       935 kCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  935 KCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHhccCcccCccHHHHHH
Confidence            999999999999988643

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-35  Score=287.82  Aligned_cols=247  Identities=29%  Similarity=0.467  Sum_probs=205.8

Q ss_pred             EEeeeecccCceEEEEEEEC----C---CCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCe
Q 019216           17 ELGRTLGEGNFGKVKFAQDL----D---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK   88 (344)
Q Consensus        17 ~~~~~Lg~G~~g~Vy~a~~~----~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~   88 (344)
                      .+.+.||.|+||.|++|.-.    .   ....||+|.++....  ....+.+..|+.+|+.+ +|+||+.+++.+...+.
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~  376 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP  376 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence            45669999999999999733    1   246799998865443  25678899999999998 49999999999999899


Q ss_pred             EEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC
Q 019216           89 IYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN  152 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~  152 (344)
                      +++|+||+..|+|.++++.++                .++..+...++.||+.|++||++.+++||||-..|||+..+..
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~  456 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV  456 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence            999999999999999998755                3888999999999999999999999999999999999999999


Q ss_pred             eEEeccccccCCCcccCCCccccccC--CCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCcc-HHHHHHH
Q 019216          153 IKISDFGLSALPQHFRDDGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN-LAVLYQK  228 (344)
Q Consensus       153 vkl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~-~~~~~~~  228 (344)
                      +||+|||+|+........ ......+  ...|||||.+....+ +.++||||+|++|||+++ |..||.+-. .......
T Consensus       457 ~kIaDFGlar~~~~~~~y-~~~~~~~~LP~kWmApEsl~~~~f-t~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~  534 (609)
T KOG0200|consen  457 IKIADFGLARDHYNKDYY-RTKSSAGTLPVKWMAPESLFDRVF-TSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF  534 (609)
T ss_pred             EEEccccceeccCCCCce-EecCCCCccceeecCHHHhccCcc-cccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence            999999999843221111 1111122  345999999988665 789999999999999999 999999844 5555666


Q ss_pred             HhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          229 IFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       229 i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      +..+ ..+.|..+++++.++++.||+.+|++||++.++..
T Consensus       535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            6666 45788999999999999999999999999999865

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-36  Score=267.41  Aligned_cols=248  Identities=24%  Similarity=0.351  Sum_probs=195.2

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCccceeeEEeeCC-
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLASKS-   87 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~-   87 (344)
                      +.+...+++++||+|.||.||+|..  +++.||||++...      ..+.+..|-+|...  ++|+||+++++.-.... 
T Consensus       207 ~~l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~  278 (534)
T KOG3653|consen  207 LELDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA  278 (534)
T ss_pred             ccCCchhhHHHhhcCccceeehhhc--cCceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence            4456678899999999999999995  5589999998543      34667777777765  57999999998765444 


Q ss_pred             ---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------CCceeecCCCCcEEEccCCCeEE
Q 019216           88 ---KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN---------KGVFHRDLKLENILLDSKGNIKI  155 (344)
Q Consensus        88 ---~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~---------~~i~H~dikp~NILl~~~~~vkl  155 (344)
                         .+++|++|.+.|+|.+++.. ..+++....+++.-+++||+|||+         ..|+|||||..||||..|++.-|
T Consensus       279 ~~~eywLVt~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI  357 (534)
T KOG3653|consen  279 DRMEYWLVTEFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI  357 (534)
T ss_pred             cccceeEEeeeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence               78999999999999999976 568999999999999999999996         25999999999999999999999


Q ss_pred             eccccccCCCcccCCCccccccCCCcccchhhhccCCCC-----CccchhhhhhHHHHHHHhCC------------CCCC
Q 019216          156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-----GATSDIWSCGVILYVILTGY------------LPFD  218 (344)
Q Consensus       156 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DvwslG~ll~ell~g~------------~pf~  218 (344)
                      +|||+|...............+||.+|||||++.+.-..     -.+.||||+|.+||||++.-            .||.
T Consensus       358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe  437 (534)
T KOG3653|consen  358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE  437 (534)
T ss_pred             eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence            999999877655555555568999999999998763221     13589999999999999852            2332


Q ss_pred             -----CccHHHHHHHHhhC--CCCCCCC-----CCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          219 -----DRNLAVLYQKIFRG--DFKLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       219 -----~~~~~~~~~~i~~~--~~~~~~~-----~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                           ..+.+++...+.+.  .+.+|+.     ....+++.+..||+.||+-|.|+.=+.+
T Consensus       438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~e  498 (534)
T KOG3653|consen  438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEE  498 (534)
T ss_pred             HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHH
Confidence                 12334444444333  4445543     2457789999999999999999765433

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=240.53  Aligned_cols=212  Identities=23%  Similarity=0.406  Sum_probs=172.3

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +....+..||+|++|.|-+.++..+|+..|+|.++..-  +.+..+++++|+.+..+. .+|+++.+|+.+..+..+++.
T Consensus        46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc  123 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC  123 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence            34455788999999999999999999999999986432  344567788888876554 699999999999999999999


Q ss_pred             EeccCCCChHH----HHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           93 LEYVTGGELFD----KIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        93 ~e~~~g~~L~~----~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~-~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ||.|+ .||..    .+...+.++|..+-+++..+..||.|||++ .++|||+||.|||++.+|+||+||||.+..+.  
T Consensus       124 ME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~--  200 (282)
T KOG0984|consen  124 MELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV--  200 (282)
T ss_pred             HHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh--
Confidence            99994 46633    334567899999999999999999999987 89999999999999999999999999987432  


Q ss_pred             cCCCccccccCCCcccchhhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhhC
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG  232 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~ll~ell~g~~pf~~-~~~~~~~~~i~~~  232 (344)
                       +.-......|...|+|||.+..    .+| +-++||||||+++.||.+++.||+. .+...++.++...
T Consensus       201 -dSiAkt~daGCkpYmaPEri~~e~n~~gY-~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee  268 (282)
T KOG0984|consen  201 -DSIAKTMDAGCKPYMAPERINPELNQKGY-SVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE  268 (282)
T ss_pred             -hhhHHHHhcCCCccCChhhcCcccCcccc-eeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence             2222223568889999999753    344 6899999999999999999999975 4556666666554

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=249.03  Aligned_cols=252  Identities=28%  Similarity=0.456  Sum_probs=198.3

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeE-EeeCCeEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEV-LASKSKIY   90 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~-~~~~~~~~   90 (344)
                      .+.|.+.+.||.|-||.+-+|.++.+++.+++|.+.+..    ...+.+.+|...--.|. |.||+.-|++ |++.+.++
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~----tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQ----TTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcch----hhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            458999999999999999999999999999999986543    23567888887665664 9999998875 56677888


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC--CCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~--~~vkl~Dfg~a~~~~~~~  168 (344)
                      +++||++.|+|.+-+.. ..+.+...+.++.|+++||.|+|+.+++|||||.+||||-..  .+|||||||+.+..+   
T Consensus        99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g---  174 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG---  174 (378)
T ss_pred             EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC---
Confidence            99999999999988765 447899999999999999999999999999999999999433  489999999987432   


Q ss_pred             CCCccccccCCCcccchhhhccCC----CCCccchhhhhhHHHHHHHhCCCCCCCccH----HHHHHHHhh-CCCCCCC-
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRG----YDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFR-GDFKLPK-  238 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslG~ll~ell~g~~pf~~~~~----~~~~~~i~~-~~~~~~~-  238 (344)
                        ........+..|.+||......    ...+.+|+|.||+++|.++||++||+....    ...+.+... .....|+ 
T Consensus       175 --~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~  252 (378)
T KOG1345|consen  175 --TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK  252 (378)
T ss_pred             --ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchh
Confidence              2233334567799999864321    124678999999999999999999975321    122222222 2344553 


Q ss_pred             --CCCHHHHHHHHHhcCCCcCCC---CCHhhhhcCcccccc
Q 019216          239 --WLSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQD  274 (344)
Q Consensus       239 --~~~~~~~~li~~~L~~dP~~R---ps~~eil~~~~~~~~  274 (344)
                        .+++.+..+.++-|.++|++|   .++.......|.+..
T Consensus       253 F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~  293 (378)
T KOG1345|consen  253 FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKL  293 (378)
T ss_pred             hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhh
Confidence              478999999999999999999   566777777787643

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.1e-35  Score=263.59  Aligned_cols=254  Identities=28%  Similarity=0.418  Sum_probs=202.5

Q ss_pred             cccCeEEeeeecccCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCC
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS   87 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~   87 (344)
                      ....|.++++||.|+|++||+|++..   ..+.||+|.+....     ...++.+|+++|..+. +.||+++.+.+..++
T Consensus        34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd  108 (418)
T KOG1167|consen   34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNND  108 (418)
T ss_pred             hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence            34568899999999999999999877   78899999886443     2467999999999996 999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC-CCeEEeccccccCCCc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQH  166 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~-~~vkl~Dfg~a~~~~~  166 (344)
                      ...+|+||++..+..++...   ++...++.+++.++.||.++|.+||+||||||.|+|.+.. ++-.|+|||+|...+.
T Consensus       109 ~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~  185 (418)
T KOG1167|consen  109 QVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG  185 (418)
T ss_pred             eeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence            99999999999888887654   6789999999999999999999999999999999999865 6789999999861100


Q ss_pred             c------------------------------------------cCCCccccccCCCcccchhhhccCCCCCccchhhhhh
Q 019216          167 F------------------------------------------RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCG  204 (344)
Q Consensus       167 ~------------------------------------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG  204 (344)
                      .                                          ..........||++|+|||++...+..+.++||||.|
T Consensus       186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G  265 (418)
T KOG1167|consen  186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG  265 (418)
T ss_pred             hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence            0                                          0000111236999999999998877778999999999


Q ss_pred             HHHHHHHhCCCCCCCcc-HHHHHHHH--------------hhCC---------------------C------C-------
Q 019216          205 VILYVILTGYLPFDDRN-LAVLYQKI--------------FRGD---------------------F------K-------  235 (344)
Q Consensus       205 ~ll~ell~g~~pf~~~~-~~~~~~~i--------------~~~~---------------------~------~-------  235 (344)
                      +++..+++++.||-... .......+              ..+.                     .      +       
T Consensus       266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~  345 (418)
T KOG1167|consen  266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE  345 (418)
T ss_pred             ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence            99999999999983211 00000000              0000                     0      0       


Q ss_pred             ---CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          236 ---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       236 ---~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                         ..+.++..+.+|+.+||..||.+|.|++++|.||||.+
T Consensus       346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence               01224668999999999999999999999999999984

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-34  Score=257.50  Aligned_cols=247  Identities=26%  Similarity=0.401  Sum_probs=190.2

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCccceeeEEee----
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLAS----   85 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~----   85 (344)
                      .-.+.++.+.||+|.||.||+|.+  .|..||||++....      .....+|.++.+.  |+|+||+.+++.-..    
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs  280 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGS  280 (513)
T ss_pred             hhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence            446789999999999999999997  67889999995332      2456677777765  589999999987532    


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeecCCCCcEEEccCCCeEEec
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKLENILLDSKGNIKISD  157 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~--------~i~H~dikp~NILl~~~~~vkl~D  157 (344)
                      ...+|+|++|-+.|||+|++.+ ..++.+...+++..++.||++||..        .|.|||||..||||..+|..-|+|
T Consensus       281 ~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD  359 (513)
T KOG2052|consen  281 WTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD  359 (513)
T ss_pred             eEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence            2368999999999999999987 6789999999999999999999952        499999999999999999999999


Q ss_pred             cccccCCCcccC--CCccccccCCCcccchhhhccCC----CCC-ccchhhhhhHHHHHHHhC----------CCCCCC-
Q 019216          158 FGLSALPQHFRD--DGLLHTTCGSPNYVAPEVLANRG----YDG-ATSDIWSCGVILYVILTG----------YLPFDD-  219 (344)
Q Consensus       158 fg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~----~~~-~~~DvwslG~ll~ell~g----------~~pf~~-  219 (344)
                      +|+|....+..+  .......+||.+|||||++...-    +.+ ..+||||||.++||+...          ++||.+ 
T Consensus       360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~  439 (513)
T KOG2052|consen  360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV  439 (513)
T ss_pred             ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence            999986544322  22345679999999999986421    111 358999999999999863          667754 


Q ss_pred             ----ccHHHHHHHHhhC--CCCCCCCC-C----HHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          220 ----RNLAVLYQKIFRG--DFKLPKWL-S----PGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       220 ----~~~~~~~~~i~~~--~~~~~~~~-~----~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                          .+.+++.+-+...  .+.+|..+ +    ..+-.+++.||..+|.-|.|+--+.+
T Consensus       440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK  498 (513)
T KOG2052|consen  440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK  498 (513)
T ss_pred             CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence                3334443333222  33344332 2    24567899999999999999876643

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=4.2e-33  Score=236.94  Aligned_cols=213  Identities=45%  Similarity=0.786  Sum_probs=185.5

Q ss_pred             ecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCCCh
Q 019216           22 LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL  101 (344)
Q Consensus        22 Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~~L  101 (344)
                      ||+|++|.||++.+..+++.+++|++.......  ....+.+|+..++.++|++++++++++......++++|++.|++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            689999999999998889999999986544221  346789999999999999999999999988999999999998999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc-CCCeEEeccccccCCCcccCCCccccccCC
Q 019216          102 FDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGS  179 (344)
Q Consensus       102 ~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~-~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt  179 (344)
                      .+++... ..++...++.++.+++.+|.+||+.|++|+||+|.||+++. ++.++|+|||.+........  ......+.
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~  156 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT  156 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence            9998865 47899999999999999999999999999999999999999 89999999999874322110  13345678


Q ss_pred             CcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCCC
Q 019216          180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR  259 (344)
Q Consensus       180 ~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  259 (344)
                      ..|++||.+......+.++|+|++|++++++                               ..+.+++.+|++.||++|
T Consensus       157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R  205 (215)
T cd00180         157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR  205 (215)
T ss_pred             CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence            8999999987753446889999999999999                               788999999999999999


Q ss_pred             CCHhhhhcCc
Q 019216          260 ITIAGIKADE  269 (344)
Q Consensus       260 ps~~eil~~~  269 (344)
                      |++.++++++
T Consensus       206 ~~~~~l~~~~  215 (215)
T cd00180         206 PSAKEILEHL  215 (215)
T ss_pred             cCHHHHhhCC
Confidence            9999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=100.00  E-value=1.3e-32  Score=237.40  Aligned_cols=216  Identities=45%  Similarity=0.743  Sum_probs=183.4

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~   95 (344)
                      |.+.+.||.|++|.||++.+..+++.+|+|.+......  ...+.+.+|+..+++++|+|++++++.+......++++|+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            67889999999999999999888999999998754332  2467889999999999999999999999988999999999


Q ss_pred             cCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccc
Q 019216           96 VTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (344)
Q Consensus        96 ~~g~~L~~~l~~~~~-~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~  174 (344)
                      +++++|.+.+..... +++..+..++.|++.+|.+||+.+++|+||+|.||+++.++.++|+|||.+....... .....
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~-~~~~~  157 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL-AALLK  157 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-ccccc
Confidence            999999999987666 8999999999999999999999999999999999999999999999999887543221 01234


Q ss_pred             cccCCCcccchhhh-ccCCCCCccchhhhhhHHHHHHHhCCCCCCC--ccHHHHHHHHhhCCCC
Q 019216          175 TTCGSPNYVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPFDD--RNLAVLYQKIFRGDFK  235 (344)
Q Consensus       175 ~~~gt~~y~aPE~~-~~~~~~~~~~DvwslG~ll~ell~g~~pf~~--~~~~~~~~~i~~~~~~  235 (344)
                      ...++..|++||.+ ....+ +.++|+|+||+++++|++|+.||..  .+...+.+.+..+...
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~-~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  220 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGY-GEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPL  220 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCC-CchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcc
Confidence            45678899999998 44444 5689999999999999999999987  4444666777666543

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.98  E-value=4.8e-32  Score=238.06  Aligned_cols=254  Identities=20%  Similarity=0.242  Sum_probs=207.2

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      +...|++...++-+|.||.||.|++...     .+.|-+|.++.+.  ..-+...+.+|.-.+..+.|||+..+.+++..
T Consensus       281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie  358 (563)
T KOG1024|consen  281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIE  358 (563)
T ss_pred             hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence            4456788888999999999999976533     3456667664332  33457788999999999999999999998754


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEe
Q 019216           86 -KSKIYMVLEYVTGGELFDKIASK--------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS  156 (344)
Q Consensus        86 -~~~~~iv~e~~~g~~L~~~l~~~--------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~  156 (344)
                       ....++++.+..-|+|..++..+        +.++..+...++.|++.|++|||++|++|.||...|.+|++.-+|||+
T Consensus       359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt  438 (563)
T KOG1024|consen  359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT  438 (563)
T ss_pred             ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence             45678888999889999988732        236778888999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CC
Q 019216          157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DF  234 (344)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~  234 (344)
                      |=.+++..-...-.-.-........||+||.+.+..+ +.++|+||||++||||+| |+.|+..-++.++...+..+ .+
T Consensus       439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~y-ssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRl  517 (563)
T KOG1024|consen  439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHY-SSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRL  517 (563)
T ss_pred             cchhccccCcccccccCCCCCCcccccCHHHHhhhhh-cchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcccee
Confidence            9999884322111111111223567999999998887 588999999999999999 99999999999888888776 45


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       235 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .-|-.+|+++..++.-||+.+|++||+++|+..
T Consensus       518 aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  518 AQPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence            667889999999999999999999999999764

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.98  E-value=1.2e-32  Score=279.15  Aligned_cols=200  Identities=16%  Similarity=0.208  Sum_probs=146.1

Q ss_pred             CCC-CCccceeeEE-------eeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCC
Q 019216           71 LKH-PNVVRLHEVL-------ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK  141 (344)
Q Consensus        71 l~h-~niv~l~~~~-------~~~~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dik  141 (344)
                      ++| +||.++++++       .....++.++|++ +++|.+++.. ...+++.+++.+++||+.||+|||++||+|||||
T Consensus        29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK  107 (793)
T PLN00181         29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR  107 (793)
T ss_pred             hhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence            344 4777777766       2334677888988 6799999975 3469999999999999999999999999999999


Q ss_pred             CCcEEEccC-------------------CCeEEeccccccCCCcccC--------------CCccccccCCCcccchhhh
Q 019216          142 LENILLDSK-------------------GNIKISDFGLSALPQHFRD--------------DGLLHTTCGSPNYVAPEVL  188 (344)
Q Consensus       142 p~NILl~~~-------------------~~vkl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~aPE~~  188 (344)
                      |+||||+..                   +.+|++|||+++.......              .......+||++|+|||++
T Consensus       108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~  187 (793)
T PLN00181        108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED  187 (793)
T ss_pred             chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence            999999654                   4456666666553211000              0001124688999999998


Q ss_pred             ccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       189 ~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .+..+ +.++|||||||+||||++|.+|+.....  ....+..... +......+...+++.+||+++|.+||++.|+++
T Consensus       188 ~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        188 NGSSS-NCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             ccCCC-CchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence            88776 6899999999999999999998764321  1111111111 111112466789999999999999999999999


Q ss_pred             Ccccccc
Q 019216          268 DEWFEQD  274 (344)
Q Consensus       268 ~~~~~~~  274 (344)
                      ||||.+.
T Consensus       265 h~~~~~~  271 (793)
T PLN00181        265 SEFINEP  271 (793)
T ss_pred             chhhhhh
Confidence            9999763

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=4.9e-32  Score=262.52  Aligned_cols=261  Identities=31%  Similarity=0.534  Sum_probs=210.1

Q ss_pred             cCe-EEeeeecccCceEEEEEEECCCCceEEEEEeec---ccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           14 GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK---NRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        14 ~~y-~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      ..| ...+.+|.|++|.|+.+......+.++.|.++.   ...........+..|+.+-..+.|||++.....+......
T Consensus       317 ~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~  396 (601)
T KOG0590|consen  317 EKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI  396 (601)
T ss_pred             cccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc
Confidence            445 467889999999999888877777777776542   1122222333477788888889999998877777666656


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +-.||||++ +|+.++...+.++..++-.+++|++.|++|+|+.||.|||+|++|+++..+|.+||+|||.+........
T Consensus       397 ~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e  475 (601)
T KOG0590|consen  397 LQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE  475 (601)
T ss_pred             hhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence            666999999 9999999888899999999999999999999999999999999999999999999999999876544333


Q ss_pred             C--CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHH--HHHh-------hCCCCCCC
Q 019216          170 D--GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY--QKIF-------RGDFKLPK  238 (344)
Q Consensus       170 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~--~~i~-------~~~~~~~~  238 (344)
                      .  ......+|+..|+|||++....|+....||||.|++++.|.+|+.||.........  ....       .+...+-.
T Consensus       476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  555 (601)
T KOG0590|consen  476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLS  555 (601)
T ss_pred             hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHH
Confidence            3  45567799999999999999999999999999999999999999999765443221  1111       11112234


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      .++...+.+|.+||+.||.+|.|+++|++.+||+...
T Consensus       556 ~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~  592 (601)
T KOG0590|consen  556 LLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE  592 (601)
T ss_pred             hchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence            4788889999999999999999999999999998754

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=3.6e-30  Score=214.49  Aligned_cols=159  Identities=23%  Similarity=0.280  Sum_probs=128.2

Q ss_pred             CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcccccc
Q 019216           99 GELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC  177 (344)
Q Consensus        99 ~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~  177 (344)
                      |+|.+++.. ..++++..++.++.|++.||.|||+.+      ||+|||++.++.+|+  ||++.....       ....
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-------~~~~   65 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-------EQSR   65 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-------ccCC
Confidence            689999986 456999999999999999999999998      999999999999999  999875332       1236


Q ss_pred             CCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhhCCCCC-------CCCCCH--HHHHH
Q 019216          178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKL-------PKWLSP--GAQNL  247 (344)
Q Consensus       178 gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~-~~~~~~i~~~~~~~-------~~~~~~--~~~~l  247 (344)
                      ||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ......+.......       +..++.  .+.++
T Consensus        66 g~~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (176)
T smart00750       66 VDPYFMAPEVIQGQSY-TEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF  144 (176)
T ss_pred             CcccccChHHhcCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence            8999999999988776 5899999999999999999999976543 22233332221111       122333  69999


Q ss_pred             HHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          248 LRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      +.+||+.||.+||++.++++|+|+..
T Consensus       145 i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      145 MRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             HHHHHhcccccccCHHHHHHHHHHHH
Confidence            99999999999999999999999753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=242.04  Aligned_cols=239  Identities=33%  Similarity=0.630  Sum_probs=208.2

Q ss_pred             eecccCceEEEEEEE---CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEecc
Q 019216           21 TLGEGNFGKVKFAQD---LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYV   96 (344)
Q Consensus        21 ~Lg~G~~g~Vy~a~~---~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv~e~~   96 (344)
                      .+|.|+||.|+++..   ...|+.+|+|+..+......... ....|..++...+ ||.+++++..+..+...++++++.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence            379999999998763   35678899999876554332222 5667888888887 999999999999999999999999


Q ss_pred             CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccc
Q 019216           97 TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT  176 (344)
Q Consensus        97 ~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~  176 (344)
                      .||+|+..+.+...+.+..++.+...++.+++++|+.+|+|||+|++||+++.+|++++.|||+++..-.      ....
T Consensus        80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~------~~~~  153 (612)
T KOG0603|consen   80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK------EKIA  153 (612)
T ss_pred             ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHh------hhhc
Confidence            9999999888888889999999999999999999999999999999999999999999999999884321      1222


Q ss_pred             cCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCc
Q 019216          177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNP  256 (344)
Q Consensus       177 ~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP  256 (344)
                      |||..|||||++.  +. ..++|+||+|+++++|++|..||..    ++...|.+..+..|..+++.+++++..++..+|
T Consensus       154 cgt~eymApEI~~--gh-~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p  226 (612)
T KOG0603|consen  154 CGTYEYRAPEIIN--GH-LSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP  226 (612)
T ss_pred             ccchhhhhhHhhh--cc-CCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence            9999999999987  33 4679999999999999999999988    677888888999999999999999999999999


Q ss_pred             CCCCC-----HhhhhcCccccc
Q 019216          257 VKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       257 ~~Rps-----~~eil~~~~~~~  273 (344)
                      .+|.-     ..++++|+||+.
T Consensus       227 ~nrLg~~~~~~~eik~h~f~~~  248 (612)
T KOG0603|consen  227 ENRLGAGPDGVDEIKQHEFFQS  248 (612)
T ss_pred             HHHhccCcchhHHHhccchhee
Confidence            99986     478999999974

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.96  E-value=2.4e-27  Score=214.70  Aligned_cols=256  Identities=38%  Similarity=0.623  Sum_probs=211.0

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC-CccceeeEEeeCCeEEEEEe
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP-NVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~-niv~l~~~~~~~~~~~iv~e   94 (344)
                      |.+.+.||.|+||.||++.+.   ..+++|.+.............+.+|+.+++.+.|+ +++++++.+......+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence            789999999999999999986   78999998766544434577899999999999988 79999999977777899999


Q ss_pred             ccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC-CeEEeccccccCCCcccCC
Q 019216           95 YVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        95 ~~~g~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~-~vkl~Dfg~a~~~~~~~~~  170 (344)
                      ++.++++.+.+....   .++...+..++.|++.++.++|+.+++|||+||+||+++..+ .++++|||.+.........
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999999997777664   799999999999999999999999999999999999999998 7999999998743332211


Q ss_pred             C----ccccccCCCcccchhhhccC--CCCCccchhhhhhHHHHHHHhCCCCCCCccH----HHHHHHHhhCCCC-CCCC
Q 019216          171 G----LLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDFK-LPKW  239 (344)
Q Consensus       171 ~----~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~ll~ell~g~~pf~~~~~----~~~~~~i~~~~~~-~~~~  239 (344)
                      .    ......|+..|+|||.+...  ...+...|+|++|++++++++|..||.....    ......+...... ....
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence            1    34667899999999998874  3456889999999999999999999887653    4444444444433 2222


Q ss_pred             CC--------HHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          240 LS--------PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       240 ~~--------~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ..        ..+.+++.+++..+|..|.+..+...+++....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~  281 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL  281 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence            22        478999999999999999999998888666543

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=5.2e-28  Score=200.40  Aligned_cols=251  Identities=21%  Similarity=0.296  Sum_probs=199.6

Q ss_pred             hhccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEe
Q 019216            6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLA   84 (344)
Q Consensus         6 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~   84 (344)
                      +..+-+..|+|.++++||.|+||.+|+|....+|..||||+-.... .+    ..+..|..+.+.|+ ..+|..+..+..
T Consensus         7 s~~~~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-~h----pqL~yEskvY~iL~~g~GiP~i~~y~~   81 (341)
T KOG1163|consen    7 SLEELIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-KH----PQLLYESKVYRILQGGVGIPHIRHYGT   81 (341)
T ss_pred             chhhheeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-CC----cchhHHHHHHHHhccCCCCchhhhhcc
Confidence            3345578899999999999999999999999999999999864332 22    34667889999887 567888888888


Q ss_pred             eCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC---CCeEEecccc
Q 019216           85 SKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGL  160 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~---~~vkl~Dfg~  160 (344)
                      +..+-.+||+.+ |.+|.++++- ...++...+.-++-|++.-++|+|.++++||||||+|+|..-+   .++.|+|||+
T Consensus        82 e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGL  160 (341)
T KOG1163|consen   82 EKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGL  160 (341)
T ss_pred             ccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccc
Confidence            888899999999 9999998874 4569999999999999999999999999999999999999654   4689999999


Q ss_pred             ccCCCcccCCC-----ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHHhhC
Q 019216          161 SALPQHFRDDG-----LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRG  232 (344)
Q Consensus       161 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~---~~~~~~~i~~~  232 (344)
                      |+.........     ......||.+|.+--...+... +...|+-|+|.+|..+..|..||++..   ....+.+|...
T Consensus       161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~Ek  239 (341)
T KOG1163|consen  161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEK  239 (341)
T ss_pred             hhhhccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHh
Confidence            98654332211     1223478999998776665554 578999999999999999999998843   44445556555


Q ss_pred             CCCCC-----CCCCHHHHHHHHHhcCCCcCCCCCHh
Q 019216          233 DFKLP-----KWLSPGAQNLLRKILEPNPVKRITIA  263 (344)
Q Consensus       233 ~~~~~-----~~~~~~~~~li~~~L~~dP~~Rps~~  263 (344)
                      +...|     +.+|.++.-.+.-|-..--++-|...
T Consensus       240 K~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~  275 (341)
T KOG1163|consen  240 KMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYM  275 (341)
T ss_pred             hcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHH
Confidence            54443     56788888888888777777777643

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.96  E-value=2.4e-28  Score=222.96  Aligned_cols=173  Identities=21%  Similarity=0.167  Sum_probs=134.2

Q ss_pred             hccCccccCeEEeeeecccCceEEEEEEECC-CCceEEEEEeecccc--cchhHHHHHHHHHHHHHhCCCCCccc-eeeE
Q 019216            7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLKHPNVVR-LHEV   82 (344)
Q Consensus         7 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~   82 (344)
                      .+.....++|++.+.||+|+||.||+|.++. +++.+|||.+.....  ........+.+|+++|++++|+|++. +++.
T Consensus        11 ~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~   90 (365)
T PRK09188         11 DQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT   90 (365)
T ss_pred             cccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc
Confidence            3456778899999999999999999999876 678889998653211  12334567899999999999999985 4432


Q ss_pred             EeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecC-CCCcEEEccCCCeEEeccccc
Q 019216           83 LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL-KLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus        83 ~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~di-kp~NILl~~~~~vkl~Dfg~a  161 (344)
                          ...|+||||++|++|.. +.   ...   ...++.|++++|.|||+.||+|||| ||+|||++.++++||+|||+|
T Consensus        91 ----~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA  159 (365)
T PRK09188         91 ----GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLA  159 (365)
T ss_pred             ----CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccc
Confidence                45799999999999963 21   111   2568899999999999999999999 999999999999999999999


Q ss_pred             cCCCcccCCCc------cccccCCCcccchhhhcc
Q 019216          162 ALPQHFRDDGL------LHTTCGSPNYVAPEVLAN  190 (344)
Q Consensus       162 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  190 (344)
                      +..........      .....++..|+|||.+.-
T Consensus       160 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        160 SVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             eecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            86543221111      134577888999998753

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-27  Score=215.78  Aligned_cols=249  Identities=22%  Similarity=0.283  Sum_probs=193.9

Q ss_pred             CeEEeeeecccCceEEEEEEECCCC-ceEEEEEeecccccchhHHHHHHHHHHHHHhCC----CCCccceeeEE-eeCCe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLK----HPNVVRLHEVL-ASKSK   88 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~----h~niv~l~~~~-~~~~~   88 (344)
                      +|.+.++||+|+||.||+|.+..++ ..+|+|+........   ...+..|+.++..+.    .+++..+++.+ .....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            8999999999999999999987764 689999876543221   125777888888886    36899999998 57788


Q ss_pred             EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC-----CeEEeccccc
Q 019216           89 IYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-----NIKISDFGLS  161 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~-----~vkl~Dfg~a  161 (344)
                      .++||+.+ |.+|.++....  +.++...+..++.|++.+|.+||+.|++||||||.|+++....     .+.|.|||++
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla  174 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA  174 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence            99999999 99999988543  5799999999999999999999999999999999999998653     5899999999


Q ss_pred             cCCC--cccC-----CCc-cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhh--
Q 019216          162 ALPQ--HFRD-----DGL-LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--  231 (344)
Q Consensus       162 ~~~~--~~~~-----~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~--  231 (344)
                      +...  ....     ... .....||..|.++....+... +++.|+||++.++.+++.|..||.+........+...  
T Consensus       175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~  253 (322)
T KOG1164|consen  175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP  253 (322)
T ss_pred             ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence            8321  1111     111 233569999999999888776 6999999999999999999999977553222222221  


Q ss_pred             -C-CCC-CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          232 -G-DFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       232 -~-~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                       . ... .....+..+..+...+-..+...+|....+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence             1 111 234456778888888888899999998776553

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=5.8e-27  Score=202.41  Aligned_cols=243  Identities=22%  Similarity=0.316  Sum_probs=189.9

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~   90 (344)
                      .--.|+++++||.|+||.++.|.+..+++.||||.-....     ..-++..|.+..+.|. .++|..+|.+...+.+-.
T Consensus        26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni  100 (449)
T KOG1165|consen   26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI  100 (449)
T ss_pred             ecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence            3348999999999999999999999999999999754322     1345777888888875 899999999988888999


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC-----CeEEeccccccCC
Q 019216           91 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-----NIKISDFGLSALP  164 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~-----~vkl~Dfg~a~~~  164 (344)
                      +|+|++ |.||.|++.-+ ++++...+..++.|++.-++++|++.+|+|||||+|+||..-+     .+.++|||+|+.+
T Consensus       101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y  179 (449)
T KOG1165|consen  101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY  179 (449)
T ss_pred             hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence            999999 99999998854 4699999999999999999999999999999999999997644     4899999999854


Q ss_pred             CcccC-----CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhhCCCCC
Q 019216          165 QHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKL  236 (344)
Q Consensus       165 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~---~~~~~~~~~i~~~~~~~  236 (344)
                      -....     -...+...||.+||+--...+... +.+.|+=|||.++++.|.|..||.+   .+....+++|-..+-..
T Consensus       180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQ-SRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T  258 (449)
T KOG1165|consen  180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST  258 (449)
T ss_pred             cCccccccCccccccccccceeeeEeeccccchh-hhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence            32221     122345579999999887777766 6889999999999999999999987   34555566665443322


Q ss_pred             C-----CCCCHHHHHHHHHhcCCCcCCCCC
Q 019216          237 P-----KWLSPGAQNLLRKILEPNPVKRIT  261 (344)
Q Consensus       237 ~-----~~~~~~~~~li~~~L~~dP~~Rps  261 (344)
                      |     ..+|.++...++-.-..+-.+-|.
T Consensus       259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PD  288 (449)
T KOG1165|consen  259 PIEVLCEGFPEEFATYLRYVRRLDFFETPD  288 (449)
T ss_pred             CHHHHHhcCHHHHHHHHHHHHhcCcccCCC
Confidence            2     335555555444444444444444

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.94  E-value=9.7e-27  Score=226.70  Aligned_cols=221  Identities=33%  Similarity=0.600  Sum_probs=176.6

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .-++|..++.|..|+||.||.++|+.+.+.+|+|+ .++..        +.+-  ++.....|.++              
T Consensus        81 ~e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l--------ilRn--ilt~a~npfvv--------------  135 (1205)
T KOG0606|consen   81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL--------ILRN--ILTFAGNPFVV--------------  135 (1205)
T ss_pred             CccccceeEeeccCCCCceeeeeccccccchhhcc-cccch--------hhhc--cccccCCccee--------------
Confidence            34689999999999999999999999999999954 33321        1110  33333344443              


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc-----
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH-----  166 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~-----  166 (344)
                             |+-...++.-++++...        +.+++|||+.||+|||+||+|.+|+.-|++|+.|||+++..-.     
T Consensus       136 -------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn  200 (1205)
T KOG0606|consen  136 -------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN  200 (1205)
T ss_pred             -------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence                   45556666666666554        7889999999999999999999999999999999999864110     


Q ss_pred             --------ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCC
Q 019216          167 --------FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK  238 (344)
Q Consensus       167 --------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  238 (344)
                              ....-..+..|||+.|.|||++...+| +..+|+|++|+++|+.+-|..||.+.+.++++..+......+|.
T Consensus       201 l~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE  279 (1205)
T KOG0606|consen  201 LKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE  279 (1205)
T ss_pred             hhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccc
Confidence                    000112234599999999999999888 68999999999999999999999999999999999988777764


Q ss_pred             C---CCHHHHHHHHHhcCCCcCCCC---CHhhhhcCccccc
Q 019216          239 W---LSPGAQNLLRKILEPNPVKRI---TIAGIKADEWFEQ  273 (344)
Q Consensus       239 ~---~~~~~~~li~~~L~~dP~~Rp---s~~eil~~~~~~~  273 (344)
                      .   +++++++++.++|+.+|..|-   .+-++.+|+||+.
T Consensus       280 ~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~  320 (1205)
T KOG0606|consen  280 EDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQL  320 (1205)
T ss_pred             cCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceee
Confidence            4   789999999999999999996   5778999999974

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.6e-26  Score=194.85  Aligned_cols=249  Identities=20%  Similarity=0.342  Sum_probs=203.6

Q ss_pred             hhccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216            6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus         6 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      ++..|+.+++..++.+|...-.|..|+|++.  |..++.|++.... ......+.|..|.-.|+-..||||+.+++.|..
T Consensus       182 sr~~gid~~~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~-~t~risrdfneefp~lrifshpnilpvlgacns  258 (448)
T KOG0195|consen  182 SRYTGIDVSSLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVRE-VTARISRDFNEEFPALRIFSHPNILPVLGACNS  258 (448)
T ss_pred             ccccCcchhhhhhhhhhccCCCccccccccc--Ccchhhhhhhhhh-cchhhcchhhhhCcceeeecCCchhhhhhhccC
Confidence            3557888888899999999999999999984  4457778775433 334556778899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEEccCCCeEEe--ccc
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKIS--DFG  159 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~~--i~H~dikp~NILl~~~~~vkl~--Dfg  159 (344)
                      ...+.++..||+-|+|+..+.....  .+..++.+++.++++|++|||+..  |.--.|....++++++-+.+|+  |--
T Consensus       259 ppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~k  338 (448)
T KOG0195|consen  259 PPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTK  338 (448)
T ss_pred             CCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccce
Confidence            9999999999999999999986543  677899999999999999999973  4445689999999999776653  433


Q ss_pred             cccCCCcccCCCccccccCCCcccchhhhccCCCC--CccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CCC
Q 019216          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD--GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFK  235 (344)
Q Consensus       160 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~~  235 (344)
                      ++.     .    .....-.|.|++||.+...+.+  -.++|+|||++++|||.|...||......+.-.++.-.  ...
T Consensus       339 fsf-----q----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~  409 (448)
T KOG0195|consen  339 FSF-----Q----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVH  409 (448)
T ss_pred             eee-----e----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccccc
Confidence            322     1    1223457889999999876543  35789999999999999999999998887777776654  456


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhh
Q 019216          236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIK  266 (344)
Q Consensus       236 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eil  266 (344)
                      +|..+++....|++-|++.||.+||.+..++
T Consensus       410 ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  410 IPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             CCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            8999999999999999999999999988764

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.93  E-value=1.7e-25  Score=196.26  Aligned_cols=235  Identities=26%  Similarity=0.348  Sum_probs=153.9

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC----------CCccceeeEE-
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH----------PNVVRLHEVL-   83 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------~niv~l~~~~-   83 (344)
                      .+...+.||.|+++.||.+++..+|+.+|+|++...........+.+.+|.-....+.+          -.++--++.. 
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            44678899999999999999999999999999876554455567778777766655432          1222222222 


Q ss_pred             --------eeC---C-----eEEEEEeccCCCChHHHHH---hcCCC----CHHHHHHHHHHHHHHHHHHHhCCceeecC
Q 019216           84 --------ASK---S-----KIYMVLEYVTGGELFDKIA---SKGRL----QEAEGRKLFQQLIDGVSYCHNKGVFHRDL  140 (344)
Q Consensus        84 --------~~~---~-----~~~iv~e~~~g~~L~~~l~---~~~~~----~~~~~~~i~~ql~~~L~~LH~~~i~H~di  140 (344)
                              ...   .     ..+++|+-+ -++|.+.+.   .....    .......+..|+++.+++||..|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                    111   1     236677777 458877654   22222    22333555689999999999999999999


Q ss_pred             CCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccC-------CCCCccchhhhhhHHHHHHHhC
Q 019216          141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-------GYDGATSDIWSCGVILYVILTG  213 (344)
Q Consensus       141 kp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwslG~ll~ell~g  213 (344)
                      +|+|+|++++|.++|+||+.....+.     .......+..|.+||.....       -..+.+.|.|+||+++|.|++|
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~  246 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCG  246 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHS
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHc
Confidence            99999999999999999997763222     11213455779999986442       1236789999999999999999


Q ss_pred             CCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCCC
Q 019216          214 YLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR  259 (344)
Q Consensus       214 ~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  259 (344)
                      ..||...........    .+.....++..+++||+.+|++||.+|
T Consensus       247 ~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  247 RLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             S-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             cCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            999986543222111    233333689999999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.93  E-value=1.1e-25  Score=189.36  Aligned_cols=141  Identities=21%  Similarity=0.289  Sum_probs=112.0

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeecccccchh-----------------------HHHHHHHHHHHHHhCCCCC
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----------------------ITDQIKREIATLKLLKHPN   75 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~h~n   75 (344)
                      .+.||+|++|.||+|.+. +|+.||+|+++........                       ......+|+.++.++.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            578999999999999986 8999999999764321111                       0123356999999998887


Q ss_pred             ccceeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeecCCCCcEEEccCCCeE
Q 019216           76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENILLDSKGNIK  154 (344)
Q Consensus        76 iv~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~L-H~~~i~H~dikp~NILl~~~~~vk  154 (344)
                      +........ . ..++||||++|+++.......++++...+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus        81 v~~p~~~~~-~-~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~  157 (190)
T cd05147          81 IPCPEPILL-K-SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY  157 (190)
T ss_pred             CCCCcEEEe-c-CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence            744333322 2 2389999999887766544557899999999999999999999 799999999999999998 57899


Q ss_pred             EeccccccC
Q 019216          155 ISDFGLSAL  163 (344)
Q Consensus       155 l~Dfg~a~~  163 (344)
                      |+|||+|..
T Consensus       158 LiDFG~a~~  166 (190)
T cd05147         158 IIDVSQSVE  166 (190)
T ss_pred             EEEcccccc
Confidence            999999874

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.93  E-value=1.9e-25  Score=190.37  Aligned_cols=175  Identities=14%  Similarity=0.197  Sum_probs=134.8

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHH------HHHHHHHHHhCCCCCccceeeEEe
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ------IKREIATLKLLKHPNVVRLHEVLA   84 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~------~~~E~~~l~~l~h~niv~l~~~~~   84 (344)
                      ..-++|++++.||.|+||.||++.+  ++..+|+|+++............      +.+|+..+.++.|++|..+.+++.
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~  105 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL  105 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence            3468999999999999999999765  46689999997654444444444      578999999999999999988865


Q ss_pred             eC--------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEe
Q 019216           85 SK--------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS  156 (344)
Q Consensus        85 ~~--------~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~  156 (344)
                      ..        ...+++|||++|.+|.+...    +++    ....+++.+|..+|+.|++|||++|.||+++.+| ++|+
T Consensus       106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li  176 (232)
T PRK10359        106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII  176 (232)
T ss_pred             ecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence            33        35789999999999977632    333    3456999999999999999999999999999998 9999


Q ss_pred             ccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHH
Q 019216          157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL  211 (344)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell  211 (344)
                      |||.........              ....++....+. .++|+|+||+++..+.
T Consensus       177 Dfg~~~~~~e~~--------------a~d~~vler~y~-~~~di~~lg~~~~~~~  216 (232)
T PRK10359        177 DLSGKRCTAQRK--------------AKDRIDLERHYG-IKNEIKDLGYYLLIYK  216 (232)
T ss_pred             ECCCcccccchh--------------hHHHHHHHhHhc-ccccccceeEeehHHH
Confidence            999876321100              001123344454 7899999999887664

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=2.3e-25  Score=196.81  Aligned_cols=261  Identities=25%  Similarity=0.415  Sum_probs=182.1

Q ss_pred             hhhccCccccCeEEeeeecccCceEEEEEEECCCCc-----------------------------------eEEEEEeec
Q 019216            5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGL-----------------------------------PFAVKILEK   49 (344)
Q Consensus         5 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~-----------------------------------~vaiK~~~~   49 (344)
                      ..+.++.++++|++++.||+|..+.||.|.-+..|.                                   +.|||.+-.
T Consensus       148 ~r~dskFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN  227 (598)
T KOG4158|consen  148 NRIDSKFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFN  227 (598)
T ss_pred             chhhcccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcc
Confidence            345577899999999999999999999987554211                                   345564421


Q ss_pred             cc--ccchhHHHHHHHHHH------HH--------Hh--------CCCCCccceeeEEe---------------------
Q 019216           50 NR--IIHLKITDQIKREIA------TL--------KL--------LKHPNVVRLHEVLA---------------------   84 (344)
Q Consensus        50 ~~--~~~~~~~~~~~~E~~------~l--------~~--------l~h~niv~l~~~~~---------------------   84 (344)
                      -.  ..+....+.+.+|..      .+        +.        -+||||+++..+|.                     
T Consensus       228 ~~~~s~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~  307 (598)
T KOG4158|consen  228 FEHDSGDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARW  307 (598)
T ss_pred             cccCCchHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCccccccee
Confidence            11  112223333333321      00        11        25999999887762                     


Q ss_pred             ------eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEc--cCC--CeE
Q 019216           85 ------SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD--SKG--NIK  154 (344)
Q Consensus        85 ------~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~--~~~--~vk  154 (344)
                            ....+|+||... ..+|++++..+. .+.....-++.|+++|+.|||++|+.|||+|.+|||+.  +|+  .+.
T Consensus       308 ~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LV  385 (598)
T KOG4158|consen  308 YPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-RSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLV  385 (598)
T ss_pred             cccccCCCceEEEehhcc-hhhHHHHHhcCC-CchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEE
Confidence                  223589999887 459999998654 56777888999999999999999999999999999994  333  579


Q ss_pred             EeccccccCCCcc----cCCCccccccCCCcccchhhhccCC-----CCCccchhhhhhHHHHHHHhCCCCCCCccHHHH
Q 019216          155 ISDFGLSALPQHF----RDDGLLHTTCGSPNYVAPEVLANRG-----YDGATSDIWSCGVILYVILTGYLPFDDRNLAVL  225 (344)
Q Consensus       155 l~Dfg~a~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~  225 (344)
                      |+|||.+-.-+..    .-.+..-..-|....||||+....+     .+-.++|.|+.|.+.||++....||.+......
T Consensus       386 vaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L  465 (598)
T KOG4158|consen  386 VADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL  465 (598)
T ss_pred             EcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchhee
Confidence            9999986532110    0011112235677889999975432     123578999999999999999999977433222


Q ss_pred             HHH--HhhCCCCCCCCCCHHHHHHHHHhcCCCcCCCCCH---hhhhc
Q 019216          226 YQK--IFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI---AGIKA  267 (344)
Q Consensus       226 ~~~--i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~---~eil~  267 (344)
                      ..+  .....+.+|+.+++.+++++..+|+.||++|+++   +.+++
T Consensus       466 ~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  466 DTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             chhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccHHHhHHH
Confidence            111  1223567889999999999999999999999994   44554

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.92  E-value=2e-26  Score=224.92  Aligned_cols=246  Identities=27%  Similarity=0.380  Sum_probs=185.9

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeeccc-ccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR-IIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      .|...+.||++.|=.|.+|++ ..|. |++|++-+.. ........+..+|++ ...+++||++++..+...+...|+|-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~-~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKD-REGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccC-CCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence            788899999999999999997 4454 9999987654 223333344445555 66678999999998888888889999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc-ccCCCc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH-FRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~-~~~~~~  172 (344)
                      +|.. -+|+|.+..+..+...+.+.|+.||+.||.-+|+.||+|||||.+||||+..+-+.|+||-.-+-.-- ..+...
T Consensus       101 qyvk-hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad  179 (1431)
T KOG1240|consen  101 QYVK-HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD  179 (1431)
T ss_pred             HHHh-hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence            9994 59999998888888999999999999999999999999999999999999999999999976431100 011111


Q ss_pred             ----cccccCCCcccchhhhccCC----------CCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCCCCC-
Q 019216          173 ----LHTTCGSPNYVAPEVLANRG----------YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL-  236 (344)
Q Consensus       173 ----~~~~~gt~~y~aPE~~~~~~----------~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~-  236 (344)
                          ..+...-..|.|||.+....          .-+++.||||+||+++||++ |++||.-....    ...++.-.. 
T Consensus       180 f~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~----aYr~~~~~~~  255 (1431)
T KOG1240|consen  180 FTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLL----AYRSGNADDP  255 (1431)
T ss_pred             ceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHH----hHhccCccCH
Confidence                12223345799999976422          12578999999999999998 89999542211    111111111 


Q ss_pred             ----CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          237 ----PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       237 ----~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                          -+.-+..++.||..|++.||++|.++++.|+.
T Consensus       256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence                11235689999999999999999999999985

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.92  E-value=2.1e-24  Score=182.01  Aligned_cols=143  Identities=22%  Similarity=0.268  Sum_probs=114.0

Q ss_pred             EeeeecccCceEEEEEEECCCCceEEEEEeecccccch-----------------------hHHHHHHHHHHHHHhCCCC
Q 019216           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----------------------KITDQIKREIATLKLLKHP   74 (344)
Q Consensus        18 ~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~h~   74 (344)
                      +.+.||+|++|.||+|.+. +|+.||||+++.......                       .....+.+|...+.++.|+
T Consensus         1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~   79 (190)
T cd05145           1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA   79 (190)
T ss_pred             CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence            3578999999999999986 899999999976521100                       0122346799999999999


Q ss_pred             CccceeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEEccCCCe
Q 019216           75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNI  153 (344)
Q Consensus        75 niv~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NILl~~~~~v  153 (344)
                      ++.....+....  .++||||++|+++........+++...+..++.|++.++.++|+ .||+||||||+|||++ ++++
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            885544443332  47999999888664443345678899999999999999999999 9999999999999998 8999


Q ss_pred             EEeccccccCC
Q 019216          154 KISDFGLSALP  164 (344)
Q Consensus       154 kl~Dfg~a~~~  164 (344)
                      +|+|||++...
T Consensus       157 ~liDFG~a~~~  167 (190)
T cd05145         157 YIIDVSQAVEL  167 (190)
T ss_pred             EEEEcccceec
Confidence            99999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=5.8e-23  Score=171.61  Aligned_cols=190  Identities=18%  Similarity=0.184  Sum_probs=140.2

Q ss_pred             EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhH-HHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEe
Q 019216           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-TDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        17 ~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~-~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      .+...|++|+||+||.+..  .+.+++.+.+.......... ...+.+|+++|+++. |+++.+++++    ...+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            4678899999999997775  67788877765444322111 225789999999996 5889999886    34689999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecC-CCCcEEEccCCCeEEeccccccCCCcccCC---
Q 019216           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL-KLENILLDSKGNIKISDFGLSALPQHFRDD---  170 (344)
Q Consensus        95 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~di-kp~NILl~~~~~vkl~Dfg~a~~~~~~~~~---  170 (344)
                      |+.|.+|......      . ...++.|++.+|.++|++||+|||| ||+|||++.+|.++|+|||++.........   
T Consensus        79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~  151 (218)
T PRK12274         79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL  151 (218)
T ss_pred             eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence            9999988654321      1 2457889999999999999999999 799999999999999999999853321110   


Q ss_pred             -Cc-------cccccCCCcccchhhhccC-CCCCccchhhhhhHHHHHHHhCCCCCCC
Q 019216          171 -GL-------LHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDD  219 (344)
Q Consensus       171 -~~-------~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~ll~ell~g~~pf~~  219 (344)
                       ..       ..-...++.|++|+.-.-- ...-...++++.|+-+|.++|+..++-+
T Consensus       152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence             00       0112367888888864322 1112567999999999999999888643

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=2e-23  Score=206.95  Aligned_cols=238  Identities=19%  Similarity=0.270  Sum_probs=184.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +.-.+|.|-+.||+|+||.||.|.+.+ |+.||||+-+....+.-....++...+. ++  --+.|..+...+.-.+..+
T Consensus       695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~--~~~~~~~~~~a~~~~~~S~  770 (974)
T KOG1166|consen  695 VGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQ--MLPSIMHISSAHVFQNASV  770 (974)
T ss_pred             ecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hh--hhcchHHHHHHHccCCcce
Confidence            445689999999999999999999866 9999999987766555444444433333 11  1345666666666677788


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC-------CCeEEeccccccC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-------GNIKISDFGLSAL  163 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~-------~~vkl~Dfg~a~~  163 (344)
                      +|+||.+-|+|.++++..+.+++..+..++.|++..++.||..+||||||||+|.|+...       .-++|+|||.+..
T Consensus       771 lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siD  850 (974)
T KOG1166|consen  771 LVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSID  850 (974)
T ss_pred             eeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEeccccee
Confidence            999999999999999988899999999999999999999999999999999999999432       2489999999987


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-----CCCCC
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-----FKLPK  238 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-----~~~~~  238 (344)
                      +.-+.+.......++|..+-.+|+..+.+| +...|.|.|+.+++-||.|+.-=           ...+.     ..++.
T Consensus       851 m~lfp~~~~F~~~~~td~f~C~EM~~grpW-tYq~DyfGlAa~~h~mLFG~y~q-----------~~~g~~~~~~~~~~R  918 (974)
T KOG1166|consen  851 MKLFPDGTKFKAVWHTDLFDCIEMREGRPW-TYQIDYFGLAATVHVMLFGKYME-----------VKNGSSWMVKTNFPR  918 (974)
T ss_pred             eeEcCCCcEEeeeeccccchhHHHhcCCCC-chhhhhHHHHHHHHHHHHHHHHH-----------hcCCcceeccccchh
Confidence            777777777888999999999999999999 68999999999999999986431           22221     11233


Q ss_pred             CCC-HHHHHHHHHhcCCCcCCCCCHhh
Q 019216          239 WLS-PGAQNLLRKILEPNPVKRITIAG  264 (344)
Q Consensus       239 ~~~-~~~~~li~~~L~~dP~~Rps~~e  264 (344)
                      .+. .-+..++..+|+.|-..=|...+
T Consensus       919 y~~~~~W~~~F~~lLN~~~~~~p~l~~  945 (974)
T KOG1166|consen  919 YWKRDMWNKFFDLLLNPDCDTLPNLQE  945 (974)
T ss_pred             hhhHHHHHHHHHHHhCcCcccchhHHH
Confidence            322 34567888888833333333333

>PRK10345 hypothetical protein; Provisional

Probab=99.88  E-value=6.6e-22  Score=167.99  Aligned_cols=135  Identities=18%  Similarity=0.204  Sum_probs=107.7

Q ss_pred             EeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-----CCCCccceeeEEeeCC---eE
Q 019216           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-----KHPNVVRLHEVLASKS---KI   89 (344)
Q Consensus        18 ~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~h~niv~l~~~~~~~~---~~   89 (344)
                      -.+.||+|++|.||.  ++.++.. +||++.....   ...+.+.+|+.+++.+     +||||+++++++++..   .+
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v   79 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV   79 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence            357899999999995  6667665 6998865432   2346789999999999     5799999999998864   43


Q ss_pred             E-EEEec--cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCceeecCCCCcEEEccC----CCeEEeccccc
Q 019216           90 Y-MVLEY--VTGGELFDKIASKGRLQEAEGRKLFQQLIDGV-SYCHNKGVFHRDLKLENILLDSK----GNIKISDFGLS  161 (344)
Q Consensus        90 ~-iv~e~--~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L-~~LH~~~i~H~dikp~NILl~~~----~~vkl~Dfg~a  161 (344)
                      + +|+||  +.+++|.+++.+ +.+++.  ..++.|++.++ +|||+++|+||||||+|||++.+    ++++|+||+-+
T Consensus        80 ~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         80 YDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             EEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            4 78999  557999999976 456665  35678888777 99999999999999999999743    37999995433

>smart00090 RIO RIO-like kinase

Probab=99.88  E-value=3.4e-22  Score=173.70  Aligned_cols=144  Identities=22%  Similarity=0.251  Sum_probs=114.7

Q ss_pred             CeEEeeeecccCceEEEEEE-ECCCCceEEEEEeecccccc---------------------hhHHHHHHHHHHHHHhCC
Q 019216           15 RYELGRTLGEGNFGKVKFAQ-DLDSGLPFAVKILEKNRIIH---------------------LKITDQIKREIATLKLLK   72 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~-~~~~~~~vaiK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~   72 (344)
                      -|++.+.||+|++|.||+|. +..+|+.||+|+++......                     ......+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47889999999999999999 77899999999987543210                     001234678999999997


Q ss_pred             CCC--ccceeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeecCCCCcEEEcc
Q 019216           73 HPN--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG-VFHRDLKLENILLDS  149 (344)
Q Consensus        73 h~n--iv~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~-i~H~dikp~NILl~~  149 (344)
                      +.+  +.++++.    ...++||||++|.+|.........+....+..++.|++.+|.+||+.| ++||||||+||+++ 
T Consensus       109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-  183 (237)
T smart00090      109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-  183 (237)
T ss_pred             hcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence            533  3344432    235899999999888766544556777778899999999999999999 99999999999999 


Q ss_pred             CCCeEEeccccccC
Q 019216          150 KGNIKISDFGLSAL  163 (344)
Q Consensus       150 ~~~vkl~Dfg~a~~  163 (344)
                      +++++|+|||.+..
T Consensus       184 ~~~i~LiDFg~a~~  197 (237)
T smart00090      184 DGKVVIIDVSQSVE  197 (237)
T ss_pred             CCCEEEEEChhhhc
Confidence            88999999998874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.86  E-value=2.3e-23  Score=202.27  Aligned_cols=260  Identities=33%  Similarity=0.526  Sum_probs=213.5

Q ss_pred             ccCeEEeeeecccCceEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~   90 (344)
                      ...|.+.+.||+|+|+.|-++.... +...+|.|.+.... .......++..|..+-..+. |+|++.+++........+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            7789999999999999998888643 34456666654332 23344566777888888887 999999999999999999


Q ss_pred             EEEeccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCceeecCCCCcEEEccCC-CeEEeccccccCCCc
Q 019216           91 MVLEYVTGGELFDKI-ASKG-RLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQH  166 (344)
Q Consensus        91 iv~e~~~g~~L~~~l-~~~~-~~~~~~~~~i~~ql~~~L~~LH-~~~i~H~dikp~NILl~~~~-~vkl~Dfg~a~~~~~  166 (344)
                      +++++..|+++++.+ .... ..+...+..++.|+..++.|+| ..++.|+||||+|.+++..+ .++++|||+|.....
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~  177 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN  177 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence            999999999999988 5554 6788899999999999999999 99999999999999999999 999999999986655


Q ss_pred             -ccCCCccccccC-CCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHH-HhhC----CCCCCCC
Q 019216          167 -FRDDGLLHTTCG-SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK-IFRG----DFKLPKW  239 (344)
Q Consensus       167 -~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~-i~~~----~~~~~~~  239 (344)
                       ..........+| ++.|.|||...+..+.++..|+||.|+++..+++|..||........... ....    .......
T Consensus       178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (601)
T KOG0590|consen  178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS  257 (601)
T ss_pred             cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence             333444556788 99999999988877778899999999999999999999976544332111 1111    1334456


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      ++..+.+++.++|..+|..|.+.+++..++|+..
T Consensus       258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             CChhhhhcccccccCCchhccccccccccccccc
Confidence            8899999999999999999999999999999987

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.85  E-value=2.1e-20  Score=160.25  Aligned_cols=138  Identities=24%  Similarity=0.346  Sum_probs=114.9

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----KITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ++.||+|++|.||+|.+  .|..+++|+.........     .....+.+|+.++..+.|+++.....++......+++|
T Consensus         1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEE
Confidence            36799999999999986  677899998654322211     12346788999999999999887777766777889999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      ||++|++|.+.+.....    ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999998865332    7889999999999999999999999999999998 88999999998873

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.84  E-value=1.7e-20  Score=174.84  Aligned_cols=200  Identities=28%  Similarity=0.409  Sum_probs=157.0

Q ss_pred             HHhCCCCCccceeeEEeeCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeecCCCCcE
Q 019216           68 LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGV-FHRDLKLENI  145 (344)
Q Consensus        68 l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i-~H~dikp~NI  145 (344)
                      |+.+.|.|+.++++.+.++...++|.+||..|+|.|.+.. ...++..-...++++|+.||.|||...| .|+.++..|.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC   80 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC   80 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence            4568899999999999999999999999999999999986 4568888888999999999999999865 9999999999


Q ss_pred             EEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCC------CCccchhhhhhHHHHHHHhCCCCCCC
Q 019216          146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY------DGATSDIWSCGVILYVILTGYLPFDD  219 (344)
Q Consensus       146 Ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DvwslG~ll~ell~g~~pf~~  219 (344)
                      +++....+||+|||+.................-...|.|||.+.....      .+.+.|+||+|++++|+++.+.||..
T Consensus        81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~  160 (484)
T KOG1023|consen   81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL  160 (484)
T ss_pred             eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence            999999999999999875432111111111223456999999876421      25679999999999999999999976


Q ss_pred             c----cHHHHHHHHhh-CCC-CCCC-----CCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          220 R----NLAVLYQKIFR-GDF-KLPK-----WLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       220 ~----~~~~~~~~i~~-~~~-~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .    ...++..++.. +.. ..|.     ...+.+..+++.||..+|.+||+++++-.
T Consensus       161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            2    22345555555 221 1221     34567999999999999999999988744

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.83  E-value=6.1e-20  Score=155.98  Aligned_cols=133  Identities=21%  Similarity=0.277  Sum_probs=107.5

Q ss_pred             eecccCceEEEEEEECCCCceEEEEEeecccccc-----hhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEec
Q 019216           21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEY   95 (344)
Q Consensus        21 ~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~   95 (344)
                      .||+|++|.||+|..  +|..+++|.........     .....++.+|+++++.+.|+++.....++......+++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence            489999999999984  67889999865432211     11246678899999999988765554455556667899999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        96 ~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      ++|++|.+.+.....       .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999999888754321       7899999999999999999999999999999 88999999999874

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.82  E-value=5.3e-20  Score=156.27  Aligned_cols=137  Identities=26%  Similarity=0.352  Sum_probs=108.1

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch-------------------hHHHHHHHHHHHHHhCCCCC-
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-------------------KITDQIKREIATLKLLKHPN-   75 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~h~n-   75 (344)
                      |.+.+.||+|+||.||++.+. +|+.||||+++.......                   ........|+.++..+.+++ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            888999999999999999874 799999998764321000                   01123677899999887774 


Q ss_pred             -ccceeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeE
Q 019216           76 -VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK  154 (344)
Q Consensus        76 -iv~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vk  154 (344)
                       +...++    ....+++|||++|++|......      .....++.+++.++.++|+.|++||||+|.||++++++.++
T Consensus        96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~  165 (198)
T cd05144          96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY  165 (198)
T ss_pred             CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence             444443    2345899999999988665321      34677889999999999999999999999999999999999


Q ss_pred             EeccccccC
Q 019216          155 ISDFGLSAL  163 (344)
Q Consensus       155 l~Dfg~a~~  163 (344)
                      |+|||++..
T Consensus       166 liDfg~~~~  174 (198)
T cd05144         166 IIDWPQMVS  174 (198)
T ss_pred             EEECCcccc
Confidence            999999863

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.82  E-value=5.7e-21  Score=175.12  Aligned_cols=249  Identities=22%  Similarity=0.304  Sum_probs=166.4

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceee-------
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE-------   81 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~-------   81 (344)
                      ..+.+++.+..+..+++.+.......+   ...++-|..+..   +........+++-.+....|-+..-+.+       
T Consensus       242 ~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d---~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~  318 (516)
T KOG1033|consen  242 ESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD---SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLFE  318 (516)
T ss_pred             ccccccccccccccccCCchhhhhcccchhhhhccchhhhcc---chhhhhhhhhhhhheeccccCCcccccCCCCchhh
Confidence            344555666666666666665543332   222332322111   1122334445555555444333322222       


Q ss_pred             EE-----eeCCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCe
Q 019216           82 VL-----ASKSKIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNI  153 (344)
Q Consensus        82 ~~-----~~~~~~~iv~e~~~g~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~v  153 (344)
                      ..     ....++||.|++|.-.+|.+.+..+.   ..+....+.++.|++.|+.|   +|.+|+|+||.||+...+..+
T Consensus       319 ~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~  395 (516)
T KOG1033|consen  319 SSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQL  395 (516)
T ss_pred             hccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhh
Confidence            11     11235889999999999999997543   35677889999999999999   999999999999999999999


Q ss_pred             EEeccccccCCCccc----CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHH
Q 019216          154 KISDFGLSALPQHFR----DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK  228 (344)
Q Consensus       154 kl~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~  228 (344)
                      ||.|||+........    .........||.+||+||.+.+..+ +.++||||||++++|++. =...|   ........
T Consensus       396 kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y-~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d  471 (516)
T KOG1033|consen  396 KIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQY-SEKVDIYALGLILAELLIQFSTQF---ERIATLTD  471 (516)
T ss_pred             hhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhh-hhhcchhhHHHHHHHHHHHhccHH---HHHHhhhh
Confidence            999999987543322    1223455689999999999999887 699999999999999996 22222   22233333


Q ss_pred             HhhCCCC--CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          229 IFRGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       229 i~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      +..+.++  +-. =.|.-..|+.+||.+.|.+||++.+.--|.|.
T Consensus       472 ~r~g~ip~~~~~-d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  472 IRDGIIPPEFLQ-DYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hhcCCCChHHhh-cCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            4444433  111 13556799999999999999988777666664

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.81  E-value=2.8e-19  Score=173.81  Aligned_cols=138  Identities=20%  Similarity=0.260  Sum_probs=111.0

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      .|...+.||+|+||+||++.+...  .+++|+.......     .....+++.+|+++++.++|++++..+.++......
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~  411 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEK  411 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCC
Confidence            345678999999999999986443  4455543221111     112345688999999999999998877777666778


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      ++||||++|++|.+++.        ....++.|++.+|.+||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus       412 ~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        412 TIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            89999999999998875        357789999999999999999999999999999 678999999999874

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.79  E-value=8.2e-19  Score=147.48  Aligned_cols=137  Identities=26%  Similarity=0.387  Sum_probs=98.3

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHH---------------------HHHHHHHHHHhCCCCC--
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------------------QIKREIATLKLLKHPN--   75 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~h~n--   75 (344)
                      .+.||+|+||.||+|.+. +|+.||||+++...........                     ....|...+..+.+.+  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            578999999999999976 8999999998754322111111                     1135666666654332  


Q ss_pred             ccceeeEEeeCCeEEEEEeccCCCChHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEEccCCCe
Q 019216           76 VVRLHEVLASKSKIYMVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNI  153 (344)
Q Consensus        76 iv~l~~~~~~~~~~~iv~e~~~g~~L~~-~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NILl~~~~~v  153 (344)
                      +.+.++.    ...+++|||++|+.+.. .+.... .. ..+..++.+++.++.++|. .||+||||||+||+++ ++.+
T Consensus        81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~  153 (187)
T cd05119          81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV  153 (187)
T ss_pred             CCceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence            3444433    23589999999854321 121111 11 6788999999999999999 9999999999999999 8999


Q ss_pred             EEeccccccC
Q 019216          154 KISDFGLSAL  163 (344)
Q Consensus       154 kl~Dfg~a~~  163 (344)
                      +|+|||.+..
T Consensus       154 ~liDfg~a~~  163 (187)
T cd05119         154 YIIDVPQAVE  163 (187)
T ss_pred             EEEECccccc
Confidence            9999999863

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.77  E-value=7.7e-18  Score=146.68  Aligned_cols=137  Identities=23%  Similarity=0.369  Sum_probs=105.3

Q ss_pred             eeec-ccCceEEEEEEECCCCceEEEEEeecccc----------cchhHHHHHHHHHHHHHhCCCCCc--cceeeEEeeC
Q 019216           20 RTLG-EGNFGKVKFAQDLDSGLPFAVKILEKNRI----------IHLKITDQIKREIATLKLLKHPNV--VRLHEVLASK   86 (344)
Q Consensus        20 ~~Lg-~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~~   86 (344)
                      ..|| .||.|+||.+..  .+..++||.+.....          .......++.+|+.++..+.|+++  +..+++....
T Consensus        37 ~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             ceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            4677 888899998886  377899998854221          011234568889999999998875  5666654332


Q ss_pred             -C---eEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccc
Q 019216           87 -S---KIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus        87 -~---~~~iv~e~~~g-~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a  161 (344)
                       .   ..++|||+++| .+|.+++.. ..+++..    +.|++.+|.+||+.||+||||||.|||++.++.++|+|||.+
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~  189 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG  189 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence             2   23599999997 688888764 4555543    578999999999999999999999999999999999999988


Q ss_pred             cC
Q 019216          162 AL  163 (344)
Q Consensus       162 ~~  163 (344)
                      ..
T Consensus       190 ~~  191 (239)
T PRK01723        190 EL  191 (239)
T ss_pred             cc
Confidence            73

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.74  E-value=9.6e-18  Score=135.23  Aligned_cols=131  Identities=24%  Similarity=0.294  Sum_probs=111.2

Q ss_pred             EeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCccceeeEEeeCCeEEEEEec
Q 019216           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEY   95 (344)
Q Consensus        18 ~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~iv~e~   95 (344)
                      +++.||+|.++.||++....  ..+++|.......     ...+.+|+.+++.+.+  .++.+++.+....+..+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence            46889999999999999743  7899998754322     3568889999999976  5888998888877889999999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---CceeecCCCCcEEEccCCCeEEecccccc
Q 019216           96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---GVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus        96 ~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      +.|+++..+       +......++.+++.+|+.+|..   +++|+|++|.||+++..+.+++.|||.+.
T Consensus        75 ~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~  137 (155)
T cd05120          75 IEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG  137 (155)
T ss_pred             cCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence            988777543       5566778899999999999985   69999999999999998999999999886

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.73  E-value=9.9e-19  Score=171.30  Aligned_cols=264  Identities=25%  Similarity=0.411  Sum_probs=212.3

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      ......+.+.+-+-+|+++.++.+.-..+|...++|+..+.........+.+..+-.++-...+|-++...-.+......
T Consensus       800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~  879 (1205)
T KOG0606|consen  800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL  879 (1205)
T ss_pred             cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence            45677888999999999999999998888888888876654433332233344444444334456666554445566788


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc--
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF--  167 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~--  167 (344)
                      +++++|..|++|...+.+-+..+.+.++..+..+..++++||...+.|+|++|.|+|...+|..++.|||.....+..  
T Consensus       880 ~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p  959 (1205)
T KOG0606|consen  880 PLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPP  959 (1205)
T ss_pred             chhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccC
Confidence            999999999999999998888898999999999999999999999999999999999999999999999843211000  


Q ss_pred             -------------------------c--CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc
Q 019216          168 -------------------------R--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR  220 (344)
Q Consensus       168 -------------------------~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~  220 (344)
                                               .  +........+|+.|.+||.+.+... +..+|+|++|+.+++.++|.+||...
T Consensus       960 ~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen  960 TTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred             cCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCc
Confidence                                     0  0011233468999999999988877 57899999999999999999999999


Q ss_pred             cHHHHHHHHhhCCCCCC---CCCCHHHHHHHHHhcCCCcCCCCCHh---hhhcCcccccc
Q 019216          221 NLAVLYQKIFRGDFKLP---KWLSPGAQNLLRKILEPNPVKRITIA---GIKADEWFEQD  274 (344)
Q Consensus       221 ~~~~~~~~i~~~~~~~~---~~~~~~~~~li~~~L~~dP~~Rps~~---eil~~~~~~~~  274 (344)
                      ..+..++.+.+...+.|   ...++.+++++.++|..+|.+|..+.   ++-.|+||+..
T Consensus      1039 tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1039 TPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDV 1098 (1205)
T ss_pred             chhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCC
Confidence            99999999998887765   44799999999999999999999887   89999999853

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.69  E-value=8e-16  Score=145.34  Aligned_cols=234  Identities=18%  Similarity=0.292  Sum_probs=162.3

Q ss_pred             CeEEeeeecccCceEEE-EEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           15 RYELGRTLGEGNFGKVK-FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy-~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      -|++ ...+-++.+ +| .|..+.++.+|.+.+.+....   .....+.+.+.-|+.++||||+++++.++..+..|+|+
T Consensus        14 pY~l-e~~~~~~~a-~~~~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvT   88 (690)
T KOG1243|consen   14 PYDL-EETAFSSEA-LWPDGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVT   88 (690)
T ss_pred             Cccc-ccccCCCcc-cccccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEe
Confidence            3554 444444444 44 466778899999998865442   44567788889999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH-~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |.+.  .|..++++.+   ...+...+.||+.||.||| +.+++|++|.-..|+|+..|++||++|.++........  .
T Consensus        89 ErV~--Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~  161 (690)
T KOG1243|consen   89 ERVR--PLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--P  161 (690)
T ss_pred             eccc--cHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--c
Confidence            9984  5666776633   6777888999999999998 56899999999999999999999999998764322211  1


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhc
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL  252 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L  252 (344)
                      .....--..|..|+.+....   -..|.|.|||++++++.|..+  ..           .....+..++.....+-.+-+
T Consensus       162 ~~~~~~~~s~~~P~~~~~s~---~s~D~~~Lg~li~el~ng~~~--~~-----------~~~~~~~~ipk~~~~~~~k~~  225 (690)
T KOG1243|consen  162 AKSLYLIESFDDPEEIDPSE---WSIDSWGLGCLIEELFNGSLL--TK-----------TDLSNTGKIPKALIELYCKKL  225 (690)
T ss_pred             cccchhhhcccChhhcCccc---cchhhhhHHHHHHHHhCcccC--cc-----------hhhhccCccchhHHHHHHHHh
Confidence            11222233567777654333   246999999999999998332  11           112223334444455554555


Q ss_pred             CCCcCCCCCHhh-----hhcCccccccCC
Q 019216          253 EPNPVKRITIAG-----IKADEWFEQDYT  276 (344)
Q Consensus       253 ~~dP~~Rps~~e-----il~~~~~~~~~~  276 (344)
                      --.+..||....     .+-|.||++.+.
T Consensus       226 ~~~~~~r~n~~~~~~~~~~~~gff~n~fv  254 (690)
T KOG1243|consen  226 GATELKRPNKLRFILECRLLGGFFRNDFV  254 (690)
T ss_pred             ccccccccchhhHHHHHHhccccccchHH
Confidence            555666665322     234788876543

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=5.5e-17  Score=151.60  Aligned_cols=259  Identities=20%  Similarity=0.184  Sum_probs=193.9

Q ss_pred             ccccCeEEeeeecc--cCceEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEee
Q 019216           11 MRLGRYELGRTLGE--GNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~--G~~g~Vy~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~   85 (344)
                      ..-..+.+.+.+|.  |.+|.||.+..  ..++..+|+|.-+. .........+=.+|+.....++ |+|.++.+..++.
T Consensus       111 ~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~-p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~  189 (524)
T KOG0601|consen  111 FFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKI-PFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG  189 (524)
T ss_pred             hhhhhcccccccccCCCCCceeecccCCcccCCcccccccccC-CCCCccccccccchhhcccccCccccccccCccccc
Confidence            34456678899999  99999999998  78899999996321 1111222333445676666665 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHHhCCceeecCCCCcEEEccC-CCeEEeccc
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLID----GVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFG  159 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~ql~~----~L~~LH~~~i~H~dikp~NILl~~~-~~vkl~Dfg  159 (344)
                      .+..++-+|+| +.+|.+++..... +++..++..+.+...    ||.++|..+++|-|+||.||+...+ ...+++|||
T Consensus       190 ~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  190 SGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             CCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence            99999999999 6789888876554 889999999999999    9999999999999999999999999 789999999


Q ss_pred             cccCCCcccCCCc---cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc-cHHHHHHHHhhCCCC
Q 019216          160 LSALPQHFRDDGL---LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDFK  235 (344)
Q Consensus       160 ~a~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~-~~~~~~~~i~~~~~~  235 (344)
                      +........-...   .....|...|++||...+.  .+...|+|+||.++.+..++..+.... +.......-..-..+
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e  346 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLE  346 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchh
Confidence            9875443221111   1222577889999987654  367899999999999999886665432 110000000001112


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       236 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      +-...+.++...+..|++.+|-.|++++.++++.+...
T Consensus       347 ~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s  384 (524)
T KOG0601|consen  347 FCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS  384 (524)
T ss_pred             hhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence            23335667777999999999999999999999988863

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.65  E-value=3e-16  Score=149.94  Aligned_cols=145  Identities=23%  Similarity=0.388  Sum_probs=97.3

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc--------------------------c-----hhHHHHH
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--------------------------H-----LKITDQI   61 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--------------------------~-----~~~~~~~   61 (344)
                      +..|+. +.||+|++|.||+|+.+.+|+.||||+.++.-..                          +     .+..+.+
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            556776 8999999999999999888999999999754210                          0     0122233


Q ss_pred             HHHHHHHH------hCC----CCCccceeeEEee-CCeEEEEEeccCCCChHHH--HHhcC----CCCHHHHHHHHHHHH
Q 019216           62 KREIATLK------LLK----HPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDK--IASKG----RLQEAEGRKLFQQLI  124 (344)
Q Consensus        62 ~~E~~~l~------~l~----h~niv~l~~~~~~-~~~~~iv~e~~~g~~L~~~--l~~~~----~~~~~~~~~i~~ql~  124 (344)
                      .+|+...+      ++.    +.+.+.+-.++.+ ....++||||++|+++.+.  +...+    .+.+..+..++.|+ 
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-  276 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-  276 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence            33443333      331    2333333333322 3456799999999999764  33333    23344444555554 


Q ss_pred             HHHHHHHhCCceeecCCCCcEEEccCC----CeEEeccccccCCC
Q 019216          125 DGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQ  165 (344)
Q Consensus       125 ~~L~~LH~~~i~H~dikp~NILl~~~~----~vkl~Dfg~a~~~~  165 (344)
                            ...|++|+|+||.||+++.+|    +++++|||++...+
T Consensus       277 ------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 ------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             ------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence                  458999999999999999988    99999999987543

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.62  E-value=6.2e-15  Score=139.23  Aligned_cols=143  Identities=25%  Similarity=0.310  Sum_probs=96.6

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeecccccch-------------------------------hHHH------HH
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-------------------------------KITD------QI   61 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~-------------------------------~~~~------~~   61 (344)
                      .+.||.|++|.||+|+. .+|+.||||+.+......-                               +...      .+
T Consensus       122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            36799999999999996 5789999999865321000                               0001      23


Q ss_pred             HHHHHHHHhCC----CCCccceeeEEe-eCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 019216           62 KREIATLKLLK----HPNVVRLHEVLA-SKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLID-GVSYCHNKG  134 (344)
Q Consensus        62 ~~E~~~l~~l~----h~niv~l~~~~~-~~~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~-~L~~LH~~~  134 (344)
                      .+|...+.++.    +.+-+.+-.++. .....++||||++|++|.+..... ...   ....++.+++. .+..+|..|
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g  277 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDG  277 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence            34555544442    222222222222 234568999999999998776431 122   23445566655 467889999


Q ss_pred             ceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216          135 VFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus       135 i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      ++|+|++|.||+++.+++++++|||++...+
T Consensus       278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            9999999999999999999999999987543

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.61  E-value=1.3e-14  Score=121.36  Aligned_cols=141  Identities=16%  Similarity=0.213  Sum_probs=102.7

Q ss_pred             eeeecccCceEEEEEEECC------CCceEEEEEeeccccc-------------------chhHHH----HHHHHHHHHH
Q 019216           19 GRTLGEGNFGKVKFAQDLD------SGLPFAVKILEKNRII-------------------HLKITD----QIKREIATLK   69 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~------~~~~vaiK~~~~~~~~-------------------~~~~~~----~~~~E~~~l~   69 (344)
                      ...||.|.-+.||.|....      .+..+|||+.+.....                   ......    ...+|.+.|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999998643      3579999987632110                   011122    2348999999


Q ss_pred             hCCC--CCccceeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeecCCCCcEE
Q 019216           70 LLKH--PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENIL  146 (344)
Q Consensus        70 ~l~h--~niv~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~L-H~~~i~H~dikp~NIL  146 (344)
                      ++..  -++...+++    ...++||||+.+..+....-++..++...+..+..|++.+|..| |+.|++||||++.|||
T Consensus        82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL  157 (197)
T cd05146          82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNML  157 (197)
T ss_pred             HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            9863  455666654    45679999997654432222233456667788889999999998 8999999999999999


Q ss_pred             EccCCCeEEeccccccCC
Q 019216          147 LDSKGNIKISDFGLSALP  164 (344)
Q Consensus       147 l~~~~~vkl~Dfg~a~~~  164 (344)
                      +. ++.+.|+|||.+...
T Consensus       158 ~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         158 WH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             EE-CCcEEEEECCCceeC
Confidence            96 578999999998744

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.58  E-value=2.1e-15  Score=141.08  Aligned_cols=255  Identities=21%  Similarity=0.200  Sum_probs=189.5

Q ss_pred             ccccCeEEeeeecccCceEEEEEEEC-CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCe
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK   88 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~   88 (344)
                      ..+++|..+..||.|.|+.|+..... .++..|++|...+......... .-..|+.+...+. |.++++.+..+...+.
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQ  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence            45778999999999999999987755 6788999998765443332222 2345666666664 8899998888877778


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC-CCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~-~~vkl~Dfg~a~~~~~~  167 (344)
                      .|+-.|||+++++.....-...+.+...+.+..|++.++.++|+..++|+|++|.||++..+ +..++.|||.+....- 
T Consensus       341 ~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~-  419 (524)
T KOG0601|consen  341 GYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAF-  419 (524)
T ss_pred             ccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccce-
Confidence            88999999999886665444567888899999999999999999999999999999999886 6789999998762110 


Q ss_pred             cCCCccccccCCCccc-chhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHH
Q 019216          168 RDDGLLHTTCGSPNYV-APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN  246 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  246 (344)
                          .......+.++. .+|++........+.|++|||..+.+.+++...-..   ......+..+..+........+..
T Consensus       420 ----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~---~~~~~~i~~~~~p~~~~~~~~~q~  492 (524)
T KOG0601|consen  420 ----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES---GVQSLTIRSGDTPNLPGLKLQLQV  492 (524)
T ss_pred             ----ecccccccccccccchhhccccccccccccccccccccccccCcccCcc---cccceeeecccccCCCchHHhhhh
Confidence                111222334444 255544434346889999999999999998654221   112334555655555555688899


Q ss_pred             HHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          247 LLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +.+.++..++..||.+.++..|.-|...
T Consensus       493 ~~kv~~~~~~~~~~l~~~l~~~~~~~~~  520 (524)
T KOG0601|consen  493 LLKVMINPDRKRRPSAVELSLHSEFYRD  520 (524)
T ss_pred             hhhhhcCCccccchhhhhhcccchhhhh
Confidence            9999999999999999999888766543

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.54  E-value=4.4e-14  Score=116.63  Aligned_cols=127  Identities=18%  Similarity=0.222  Sum_probs=95.6

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-ceeeEEeeCCeEEEEEeccC
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV-RLHEVLASKSKIYMVLEYVT   97 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~~~iv~e~~~   97 (344)
                      ++.|+.|..+.||++...  +..|++|+......    ....+.+|+.+++.+.+.+++ +++....  ...++||||++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~   74 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE   74 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence            577899999999999863  77899998754321    122456789999888655544 4554432  33579999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeecCCCCcEEEccCCCeEEecccccc
Q 019216           98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV-----FHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus        98 g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i-----~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      |.++.+.        .......+.+++.+|+.||+.++     +|||++|.||+++ ++.++++|||.+.
T Consensus        75 G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          75 GSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             CCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            9887543        01123456899999999999885     9999999999998 6789999999876

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.50  E-value=4e-14  Score=123.24  Aligned_cols=202  Identities=19%  Similarity=0.267  Sum_probs=140.4

Q ss_pred             HHhCCCCCccceeeEEee-----CCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC--Cce
Q 019216           68 LKLLKHPNVVRLHEVLAS-----KSKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNK--GVF  136 (344)
Q Consensus        68 l~~l~h~niv~l~~~~~~-----~~~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~--~i~  136 (344)
                      |-++.|.|+++++.++.+     ..+..++.||+..|++...+++    ...+.....++|+-||+.||.|||+.  -|+
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii  200 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII  200 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence            444568999999988754     3457899999999999998874    34588889999999999999999998  499


Q ss_pred             eecCCCCcEEEccCCCeEEeccccccCCCccc--CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCC
Q 019216          137 HRDLKLENILLDSKGNIKISDFGLSALPQHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY  214 (344)
Q Consensus       137 H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~  214 (344)
                      |+++.-+-|++..+|-+|+.----........  .........+.++|.|||.=..... +.++|||++|....+|..+.
T Consensus       201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHhe
Confidence            99999999999999988875321111100000  0111122345688999986333333 45799999999999998775


Q ss_pred             CCC-CCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          215 LPF-DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       215 ~pf-~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      .-- .+.........+.+..+.+.   .+.-++++.+||+..|..||++++++.||.+-+
T Consensus       280 iq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe  336 (458)
T KOG1266|consen  280 IQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE  336 (458)
T ss_pred             eccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence            432 22222222222222211111   233467899999999999999999999998753

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.43  E-value=2.9e-12  Score=103.90  Aligned_cols=134  Identities=25%  Similarity=0.309  Sum_probs=98.2

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchh-----HHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      ..+++|+-+.+|.+..  -|..+++|.=.+...-+++     ...+..+|.+++.++.--+|.--+-+..+.....|+||
T Consensus         2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me   79 (204)
T COG3642           2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME   79 (204)
T ss_pred             chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence            4688999999998865  3445777753332222222     23466789999998875555444434445666789999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        95 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      |++|..|.+.+...       ...+++.+-.-+.-||..||+|+||.++||.+..++ +.++|||++..
T Consensus        80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            99999999888764       144556666667889999999999999999996655 99999999874

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.40  E-value=1e-11  Score=100.29  Aligned_cols=144  Identities=22%  Similarity=0.231  Sum_probs=105.5

Q ss_pred             EeeeecccCceEEEEEEECCCCceEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----KITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        18 ~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      .+..|-+|+-+.|+++..  .|+...||.-.....-++     -...+..+|+++|.++.--+|.--.-++.+...-.++
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~   88 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY   88 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence            678899999999999885  777888885322222222     2356788999999988754554333344445556789


Q ss_pred             EeccCC-CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC---CeEEeccccccC
Q 019216           93 LEYVTG-GELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSAL  163 (344)
Q Consensus        93 ~e~~~g-~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~---~vkl~Dfg~a~~  163 (344)
                      |||++| .++.+++....  .........++.+|-+.+.-||..+|+||||..+||++..++   .+.++|||++..
T Consensus        89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            999977 46777776422  233344478899999999999999999999999999998776   358999999864

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.34  E-value=7.8e-12  Score=107.63  Aligned_cols=140  Identities=21%  Similarity=0.324  Sum_probs=104.6

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC--CccceeeEEeeC---CeEEEEE
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP--NVVRLHEVLASK---SKIYMVL   93 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~~~~---~~~~iv~   93 (344)
                      .+.|+.|..+.||++... +|..+++|........  .....+.+|..+++.+.+.  ++.+++.+....   +..+++|
T Consensus         3 ~~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~   79 (223)
T cd05154           3 VRQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVM   79 (223)
T ss_pred             ceecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEE
Confidence            367899999999999864 3688999987543321  1245678899999998753  456777776553   2568999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-----------------------------------------  132 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-----------------------------------------  132 (344)
                      ||++|.++.+.+.. ..+++.....++.+++.+|..||+                                         
T Consensus        80 e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          80 ERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             EEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            99999888664422 346667777777777777777773                                         


Q ss_pred             ---------------CCceeecCCCCcEEEcc--CCCeEEecccccc
Q 019216          133 ---------------KGVFHRDLKLENILLDS--KGNIKISDFGLSA  162 (344)
Q Consensus       133 ---------------~~i~H~dikp~NILl~~--~~~vkl~Dfg~a~  162 (344)
                                     ..++|+|++|.||+++.  ++.+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~  205 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT  205 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence                           23699999999999998  5668999999876

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=2.2e-12  Score=122.70  Aligned_cols=157  Identities=22%  Similarity=0.335  Sum_probs=117.5

Q ss_pred             HHHHHHHHHHhC-CceeecCCCCcEEEccCCCeEEeccccccCCCcccC-------CCccccccCCCcccchhhhccCCC
Q 019216          122 QLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-------DGLLHTTCGSPNYVAPEVLANRGY  193 (344)
Q Consensus       122 ql~~~L~~LH~~-~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~  193 (344)
                      +.+.|+.|+|.. ++||++|.|++|.++.+|.+||+.|+.+........       ............|.|||++.... 
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~-  185 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT-  185 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc-
Confidence            344999999987 899999999999999999999999998764322111       11111123456799999988744 


Q ss_pred             CCccchhhhhhHHHHHHH-hCCCCCCCccHHHHHHHHhh----CCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          194 DGATSDIWSCGVILYVIL-TGYLPFDDRNLAVLYQKIFR----GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       194 ~~~~~DvwslG~ll~ell-~g~~pf~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+.++|+||+|+++|.+. .|+..+........+.....    +....+..+++++++=+.++|..++..||++.+++..
T Consensus       186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence            478999999999999999 57777765433222221111    1233457789999999999999999999999999999


Q ss_pred             ccccccCCCCC
Q 019216          269 EWFEQDYTPAN  279 (344)
Q Consensus       269 ~~~~~~~~~~~  279 (344)
                      +||.+...++.
T Consensus       266 ~ff~D~~~~aL  276 (700)
T KOG2137|consen  266 PFFSDPGLKAL  276 (700)
T ss_pred             cccCCchhhhh
Confidence            99998666553

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.26  E-value=4.8e-11  Score=99.47  Aligned_cols=127  Identities=29%  Similarity=0.383  Sum_probs=83.7

Q ss_pred             EEEEEEECCCCceEEEEEeecccc-----------------------cchhHHHHHHHHHHHHHhCCCC--CccceeeEE
Q 019216           29 KVKFAQDLDSGLPFAVKILEKNRI-----------------------IHLKITDQIKREIATLKLLKHP--NVVRLHEVL   83 (344)
Q Consensus        29 ~Vy~a~~~~~~~~vaiK~~~~~~~-----------------------~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~   83 (344)
                      .||.|.. .+|..+|+|+.+....                       ..........+|.+.|.++..-  ++.+++++.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899986 6678999998764211                       0111234678899999999865  456666542


Q ss_pred             eeCCeEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHhCCceeecCCCCcEEEccCCCeEEecccc
Q 019216           84 ASKSKIYMVLEYVT--GGELFDKIASKGRLQEAEGRKLFQQLIDGVSY-CHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (344)
Q Consensus        84 ~~~~~~~iv~e~~~--g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~-LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~  160 (344)
                          ..++||||+.  |..+..+...  .++......++.+++..+.. +|+.||+|||+++.|||++++ .+.++|||.
T Consensus        80 ----~~~ivME~I~~~G~~~~~l~~~--~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 ----RNVIVMEYIGEDGVPLPRLKDV--DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             ----TTEEEEE--EETTEEGGCHHHC--GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             ----CCEEEEEecCCCccchhhHHhc--cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence                3469999998  6555443322  12245567778888885555 579999999999999999877 999999998


Q ss_pred             ccC
Q 019216          161 SAL  163 (344)
Q Consensus       161 a~~  163 (344)
                      +..
T Consensus       153 av~  155 (188)
T PF01163_consen  153 AVD  155 (188)
T ss_dssp             EEE
T ss_pred             cee
Confidence            873

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.26  E-value=2.5e-10  Score=103.24  Aligned_cols=233  Identities=18%  Similarity=0.184  Sum_probs=151.5

Q ss_pred             EeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCccceeeEE-------eeCCeE
Q 019216           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEVL-------ASKSKI   89 (344)
Q Consensus        18 ~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~-------~~~~~~   89 (344)
                      ..+.||+|+-+.+|..-...  . -+.|++.+......      .+....|.. -.||-+-.-+.+-       ......
T Consensus        15 ~gr~LgqGgea~ly~l~e~~--d-~VAKIYh~Pppa~~------aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i   85 (637)
T COG4248          15 PGRPLGQGGEADLYTLGEVR--D-QVAKIYHAPPPAAQ------AQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI   85 (637)
T ss_pred             CCccccCCccceeeecchhh--c-hhheeecCCCchHH------HHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence            45789999999999655322  2 34488765443221      112222333 3466443312111       122337


Q ss_pred             EEEEeccCCCCh-HHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecccccc
Q 019216           90 YMVLEYVTGGEL-FDKIA------SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus        90 ~iv~e~~~g~~L-~~~l~------~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      .+.|..++|..- ..+..      +.....+.-..+.++.|+.+.+.||+.|.+-||+.++|+|+.+++.|.|.|=..-.
T Consensus        86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq  165 (637)
T COG4248          86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ  165 (637)
T ss_pred             EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence            788998877532 22221      12236778899999999999999999999999999999999999999999865433


Q ss_pred             CCCcccCCCccccccCCCcccchhhhc-----cCCCCCccchhhhhhHHHHHHHhC-CCCCCCcc-----HHHHHHHHhh
Q 019216          163 LPQHFRDDGLLHTTCGSPNYVAPEVLA-----NRGYDGATSDIWSCGVILYVILTG-YLPFDDRN-----LAVLYQKIFR  231 (344)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~DvwslG~ll~ell~g-~~pf~~~~-----~~~~~~~i~~  231 (344)
                      +   ..++......+|...|.+||.-.     +... +...|.|.||+++++++.| +.||.+-.     .......|..
T Consensus       166 i---~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~  241 (637)
T COG4248         166 I---NANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH  241 (637)
T ss_pred             e---ccCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence            2   12344455678999999999854     2222 4678999999999999986 99997611     0001112221


Q ss_pred             C-----------CCCCC-----CCCCHHHHHHHHHhcCCC--cCCCCCHh
Q 019216          232 G-----------DFKLP-----KWLSPGAQNLLRKILEPN--PVKRITIA  263 (344)
Q Consensus       232 ~-----------~~~~~-----~~~~~~~~~li~~~L~~d--P~~Rps~~  263 (344)
                      +           ..+.|     ..+++++..|..+|+...  +.-|||++
T Consensus       242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~  291 (637)
T COG4248         242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK  291 (637)
T ss_pred             ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence            1           11112     226899999999998753  56899965

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.26  E-value=2e-10  Score=106.14  Aligned_cols=212  Identities=21%  Similarity=0.221  Sum_probs=154.0

Q ss_pred             CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe----eCCeEEEEEeccCC-CC
Q 019216           26 NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA----SKSKIYMVLEYVTG-GE  100 (344)
Q Consensus        26 ~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~~~~~iv~e~~~g-~~  100 (344)
                      --.+.|+++...+|..|++|.++-.+...   ......-++.++++.|+|+|++.+++.    .+..+++|++|.++ ++
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~---~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T  364 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQS---TNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT  364 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccC---cccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence            34689999999999999999985433322   223334578899999999999999886    34568999999875 57


Q ss_pred             hHHHHHh---------------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216          101 LFDKIAS---------------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus       101 L~~~l~~---------------~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      |.++--.               +...++..+|.++.||..||.++|+.|+..+-|.|.+||++.+-+++|...|...+..
T Consensus       365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeec
Confidence            7665421               2346789999999999999999999999999999999999999899998888765433


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCC-CCCccHHHH-HHHHhhCCCCCCCCCCHH
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVL-YQKIFRGDFKLPKWLSPG  243 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~p-f~~~~~~~~-~~~i~~~~~~~~~~~~~~  243 (344)
                      ...              .  |.+.+.    .+-|.=.||.++..|.||..- +........ ...       +-..++.+
T Consensus       445 ~d~--------------~--~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~-------I~~~yS~D  497 (655)
T KOG3741|consen  445 EDP--------------T--EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR-------ITTTYSTD  497 (655)
T ss_pred             CCC--------------C--cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHH-------hhhhhhHH
Confidence            211              0  112221    356999999999999998543 111111111 111       22447888


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ++++|.-+...++.+ -++.+++.+
T Consensus       498 ~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  498 LRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHhcCccc-ccHHHHHHH
Confidence            999999998888876 566666553

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.26  E-value=5.4e-11  Score=102.18  Aligned_cols=137  Identities=26%  Similarity=0.385  Sum_probs=105.0

Q ss_pred             EEeeeecccCceEEEEEEECCCCceEEEEEeeccccc---------------c----hhHHHHHHHHHHHHHhCCCC--C
Q 019216           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---------------H----LKITDQIKREIATLKLLKHP--N   75 (344)
Q Consensus        17 ~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~---------------~----~~~~~~~~~E~~~l~~l~h~--n   75 (344)
                      .+..+||-|.-|.||.|.+ ..|.++|||.-+....+               +    .-......+|..+|++|...  .
T Consensus        94 ~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~  172 (304)
T COG0478          94 AIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK  172 (304)
T ss_pred             hhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence            4578899999999999997 47899999975432110               0    11234578899999999754  6


Q ss_pred             ccceeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEE
Q 019216           76 VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI  155 (344)
Q Consensus        76 iv~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl  155 (344)
                      +.+.+++    ++..+|||+++|..|...     +++.+....++..|++-+..+-..|++|||+++-||++++||.+.+
T Consensus       173 VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v  243 (304)
T COG0478         173 VPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV  243 (304)
T ss_pred             CCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence            6666654    567899999999776432     2245566667777777777777899999999999999999999999


Q ss_pred             eccccccC
Q 019216          156 SDFGLSAL  163 (344)
Q Consensus       156 ~Dfg~a~~  163 (344)
                      +||-.+..
T Consensus       244 IDwPQ~v~  251 (304)
T COG0478         244 IDWPQAVP  251 (304)
T ss_pred             EeCccccc
Confidence            99988763

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.20  E-value=6.9e-10  Score=97.94  Aligned_cols=132  Identities=16%  Similarity=0.116  Sum_probs=93.8

Q ss_pred             EEEEEEECCCCceEEEEEeecccccc-h-------hHHHHHHHHHHHHHhCCCCCc--cceeeEEee-----CCeEEEEE
Q 019216           29 KVKFAQDLDSGLPFAVKILEKNRIIH-L-------KITDQIKREIATLKLLKHPNV--VRLHEVLAS-----KSKIYMVL   93 (344)
Q Consensus        29 ~Vy~a~~~~~~~~vaiK~~~~~~~~~-~-------~~~~~~~~E~~~l~~l~h~ni--v~l~~~~~~-----~~~~~iv~   93 (344)
                      .|.++.  -.|+.|.||......... .       .-...+.+|.+.+.++..-+|  ...+.+++.     ....++||
T Consensus        37 rvvr~~--~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFE--LAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEE--ECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            355554  356789999663222100 0       001147789999888854343  334444432     23578999


Q ss_pred             eccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc-------CCCeEEecccccc
Q 019216           94 EYVTGG-ELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-------KGNIKISDFGLSA  162 (344)
Q Consensus        94 e~~~g~-~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~-------~~~vkl~Dfg~a~  162 (344)
                      |++++. +|.+++..  ..+.+......++.+++..+..||+.||+|+|+++.|||++.       ++.+.|+||+.+.
T Consensus       115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            999875 78888764  345667788899999999999999999999999999999975       4579999999875

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.99  E-value=2.7e-09  Score=90.98  Aligned_cols=105  Identities=23%  Similarity=0.378  Sum_probs=84.2

Q ss_pred             HHHHHHHHHHHhCCCCC--ccceeeEEeeC----CeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 019216           59 DQIKREIATLKLLKHPN--VVRLHEVLASK----SKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH  131 (344)
Q Consensus        59 ~~~~~E~~~l~~l~h~n--iv~l~~~~~~~----~~~~iv~e~~~g~-~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH  131 (344)
                      .+..+|...+..|..-+  +...+.+.+..    ...++|+|++++. +|.+++......+......++.+++..++-||
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH  135 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH  135 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence            46778888888775333  34455555432    2458999999874 79888887555778888999999999999999


Q ss_pred             hCCceeecCCCCcEEEccCC---CeEEeccccccC
Q 019216          132 NKGVFHRDLKLENILLDSKG---NIKISDFGLSAL  163 (344)
Q Consensus       132 ~~~i~H~dikp~NILl~~~~---~vkl~Dfg~a~~  163 (344)
                      +.||+|+|+++.|||++.++   .+.++||+.++.
T Consensus       136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            99999999999999999887   899999997763

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.94  E-value=1.3e-08  Score=86.75  Aligned_cols=140  Identities=20%  Similarity=0.226  Sum_probs=97.2

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeecccccch---------------------hHHHHHHHHHHHHHhCC--CCC
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---------------------KITDQIKREIATLKLLK--HPN   75 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---------------------~~~~~~~~E~~~l~~l~--h~n   75 (344)
                      ...|+.|.-+.||+|.. .++..+|+|+++.....-.                     .......+|..-|+++.  +-.
T Consensus        53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr  131 (268)
T COG1718          53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR  131 (268)
T ss_pred             EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence            45778888999999985 6788999999865322110                     11223456777777774  334


Q ss_pred             ccceeeEEeeCCeEEEEEeccCCCCh-HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEEccCCCe
Q 019216           76 VVRLHEVLASKSKIYMVLEYVTGGEL-FDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNI  153 (344)
Q Consensus        76 iv~l~~~~~~~~~~~iv~e~~~g~~L-~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NILl~~~~~v  153 (344)
                      +.+-+.+.    ...+||||+..... .-.| +.-++...++..+..++++.+.-|-. .+++|+||+.-|||+. ++.+
T Consensus       132 vP~Pi~~~----~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p  205 (268)
T COG1718         132 VPEPIAFR----NNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP  205 (268)
T ss_pred             CCCceeec----CCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence            44555443    45689999944311 1111 12234444788888999999988877 8999999999999998 8899


Q ss_pred             EEeccccccCCC
Q 019216          154 KISDFGLSALPQ  165 (344)
Q Consensus       154 kl~Dfg~a~~~~  165 (344)
                      .++|||.|....
T Consensus       206 ~iID~~QaV~~~  217 (268)
T COG1718         206 YIIDVSQAVTID  217 (268)
T ss_pred             EEEECccccccC
Confidence            999999988543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.88  E-value=2.4e-08  Score=84.20  Aligned_cols=141  Identities=17%  Similarity=0.234  Sum_probs=91.0

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHH------HHHHHHHHHhCC---CCCccceee
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ------IKREIATLKLLK---HPNVVRLHE   81 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~------~~~E~~~l~~l~---h~niv~l~~   81 (344)
                      ..-++|.+.+.+-.....-|.+..  .+|+.+++|..+............      ..+++..+.++.   ......++-
T Consensus        28 i~~~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl  105 (229)
T PF06176_consen   28 ILDNNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL  105 (229)
T ss_pred             HHhCCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence            345678888888888877776665  567889999875432211111111      223333333333   223333333


Q ss_pred             EEe-----eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEe
Q 019216           82 VLA-----SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS  156 (344)
Q Consensus        82 ~~~-----~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~  156 (344)
                      +..     -....+++|||++|..|.+...    +++    .+...+.+++.-||+.|+.|+|..|.|+++..+ .+++.
T Consensus       106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iI  176 (229)
T PF06176_consen  106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRII  176 (229)
T ss_pred             eeeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEE
Confidence            322     1234568999999988866532    233    244567778999999999999999999999855 59999


Q ss_pred             cccccc
Q 019216          157 DFGLSA  162 (344)
Q Consensus       157 Dfg~a~  162 (344)
                      ||+..+
T Consensus       177 D~~~k~  182 (229)
T PF06176_consen  177 DTQGKR  182 (229)
T ss_pred             ECcccc
Confidence            998655

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.88  E-value=4.3e-08  Score=82.41  Aligned_cols=137  Identities=16%  Similarity=0.167  Sum_probs=97.8

Q ss_pred             cccCceEEEEEEECCCCceEEEEEeeccc---ccchhHHHHHHHHHHHHHhCCCCC--ccceeeEEe-e----CCeEEEE
Q 019216           23 GEGNFGKVKFAQDLDSGLPFAVKILEKNR---IIHLKITDQIKREIATLKLLKHPN--VVRLHEVLA-S----KSKIYMV   92 (344)
Q Consensus        23 g~G~~g~Vy~a~~~~~~~~vaiK~~~~~~---~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~-~----~~~~~iv   92 (344)
                      |+||-+.|+....  .|+.+=+|.-....   ...+--...+.+|+..++++..-+  +.+.. ++. .    .-..+||
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            5689999998764  44467777543110   001223457889999998886332  44444 222 1    2246789


Q ss_pred             EeccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC--eEEecccccc
Q 019216           93 LEYVTG-GELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSA  162 (344)
Q Consensus        93 ~e~~~g-~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~--vkl~Dfg~a~  162 (344)
                      +|-+.| .+|.+.+.+.  .+.+......++.+++..++-||+.|+.|+|+.+.|||++.+|.  ++++||.-++
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            997754 5888877652  35677888899999999999999999999999999999987777  9999998665

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.83  E-value=9.3e-08  Score=96.51  Aligned_cols=207  Identities=18%  Similarity=0.197  Sum_probs=147.3

Q ss_pred             HHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE----EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 019216           58 TDQIKREIATLKLLKHPNVVRLHEVLASKSKIY----MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK  133 (344)
Q Consensus        58 ~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~----iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~  133 (344)
                      ......|+..+....|+|+..++.+........    +..++|...++...++.-+..+...++.+..++.+||.++|+.
T Consensus       226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~  305 (1351)
T KOG1035|consen  226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL  305 (1351)
T ss_pred             HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence            344556777788889999999998876544333    3457898999999999999999999999999999999999999


Q ss_pred             CceeecCCCC---cEEEccCCCeEEe--ccccccCCCcccCCCccccccCCCcccchhhhccCCCC-CccchhhhhhHHH
Q 019216          134 GVFHRDLKLE---NILLDSKGNIKIS--DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVIL  207 (344)
Q Consensus       134 ~i~H~dikp~---NILl~~~~~vkl~--Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~~DvwslG~ll  207 (344)
                      ...|.-+...   +-.++.++.+..+  ||+.+.....   ........-+..+.++|........ ....|+|++|.+.
T Consensus       306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d---~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~  382 (1351)
T KOG1035|consen  306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD---NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLL  382 (1351)
T ss_pred             ccceeEEecccccccccCccceeecchhhhcccccCCC---cccchhhcCccccccccccccccchhhhhhHHHHHHHHH
Confidence            7766666555   4445566666666  8887764322   2222333445667888876655442 2336999999999


Q ss_pred             HHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          208 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       208 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      ..+..|..+-....   ....+      ++........+++.+|+..++++|+++.+++.|+|......
T Consensus       383 ~~~~~~~~i~~~~~---~~~~~------l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~  442 (1351)
T KOG1035|consen  383 LQLSQGEDISEKSA---VPVSL------LDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTD  442 (1351)
T ss_pred             hhhhhcCccccccc---chhhh------hccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccc
Confidence            99998765522111   11111      11112226788999999999999999999999999875443

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.81  E-value=9.5e-08  Score=82.57  Aligned_cols=133  Identities=15%  Similarity=0.216  Sum_probs=83.8

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccceeeEEeeCCeEEEEEeccC
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEVLASKSKIYMVLEYVT   97 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~~iv~e~~~   97 (344)
                      ..||+|..+.||+.    .|..+++|......     ....+.+|.++++.+..-+  +.+.+++....+...++||+++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence            67899999999973    24568889875422     2345788999999886433  4677888777778889999998


Q ss_pred             CCC-hHHH--------------H-------Hhc--CCCCHHH-HHHHHHH----------HHH-HHHHHHh----CCcee
Q 019216           98 GGE-LFDK--------------I-------ASK--GRLQEAE-GRKLFQQ----------LID-GVSYCHN----KGVFH  137 (344)
Q Consensus        98 g~~-L~~~--------------l-------~~~--~~~~~~~-~~~i~~q----------l~~-~L~~LH~----~~i~H  137 (344)
                      |.+ +...              +       ...  ...+... ...+-.+          +.. ...+|..    ..++|
T Consensus        78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H  157 (226)
T TIGR02172        78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH  157 (226)
T ss_pred             CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence            863 1111              1       000  0011111 0111001          111 1222221    24789


Q ss_pred             ecCCCCcEEEccCCCeEEecccccc
Q 019216          138 RDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       138 ~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      +|+.|.||++++++ +.++||+.+.
T Consensus       158 gD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       158 GDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             cCCCCCcEEEcCCC-cEEEechhcC
Confidence            99999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.65  E-value=1.4e-07  Score=90.19  Aligned_cols=139  Identities=23%  Similarity=0.319  Sum_probs=88.7

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccc-------------------------------hhHHHH------HH
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-------------------------------LKITDQ------IK   62 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-------------------------------~~~~~~------~~   62 (344)
                      +.|+.++-|.||+|+. .+|+.||||+.+.+-...                               .+..+.      +.
T Consensus       131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            6789999999999997 459999999986532100                               111112      33


Q ss_pred             HHHHHHHhCC-----CCCccceeeEEe-eCCeEEEEEeccCCCChHHHH--HhcCCCCHHHHHHHHHHHHHH-HHHHHhC
Q 019216           63 REIATLKLLK-----HPNVVRLHEVLA-SKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDG-VSYCHNK  133 (344)
Q Consensus        63 ~E~~~l~~l~-----h~niv~l~~~~~-~~~~~~iv~e~~~g~~L~~~l--~~~~~~~~~~~~~i~~ql~~~-L~~LH~~  133 (344)
                      +|...+.++.     .+++ .+=.++. -.+.-.++|||++|..+.+..  +. ..++...+   +..++++ +..+=..
T Consensus       210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~~~~f~~q~~~d  284 (517)
T COG0661         210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHHHHHHHHHHHhc
Confidence            3444444332     2222 2222332 234567999999998887763  34 33453332   2222222 3334458


Q ss_pred             CceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216          134 GVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus       134 ~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                      |++|.|.+|.||+++.+|++.+.|||+....
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecC
Confidence            9999999999999999999999999998754

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.62  E-value=7.2e-09  Score=98.33  Aligned_cols=242  Identities=19%  Similarity=0.171  Sum_probs=162.7

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-ccceeeEEeeCCeEEEEEe
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~~iv~e   94 (344)
                      |.....+++|+++.+++.+...+...+ .+++...        ....-++++|.+++||| .+..++-++.+...++.++
T Consensus       244 s~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~  314 (829)
T KOG0576|consen  244 SEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR  314 (829)
T ss_pred             hHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence            345677899999999988875554444 5555322        34556899999999999 6777777778889999999


Q ss_pred             ccCCC-ChHHHH-HhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           95 YVTGG-ELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        95 ~~~g~-~L~~~l-~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ++.++ +-...+ ...-.+.+-+.....+.-+++++++|+.--+|+|    ||+..+ +..|..||+...-+..   ...
T Consensus       315 i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~---~~~  386 (829)
T KOG0576|consen  315 ICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR---TMK  386 (829)
T ss_pred             hhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc---ccc
Confidence            99776 222111 1111233334455566667889999998778888    777754 6799999998764332   223


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--CCCC--CCCCHHH-HHH
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP--KWLSPGA-QNL  247 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~--~~~~~~~-~~l  247 (344)
                      ..+..+++.++|||+...+.+. ...|.|++|.--.++--|.+|-...-  .....+-.+.  +.+-  ..+++.. .++
T Consensus       387 ~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~~~~~~  463 (829)
T KOG0576|consen  387 PRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPVFHRDF  463 (829)
T ss_pred             cccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCcccccCC
Confidence            4567899999999998887775 68899999987777777777643310  0000000000  0000  0011222 247


Q ss_pred             HHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          248 LRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      ...|+..-|..|+....++.|.+|+.....
T Consensus       464 ~~~~~~g~P~~pkv~mgacfsKvfngCpl~  493 (829)
T KOG0576|consen  464 PAPCLNGLPPTPKVHMGACFSKVFNGCPLR  493 (829)
T ss_pred             cccccCCCCCCCcchhhHHHHHHhccCccc
Confidence            788999999999999999999999876554

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.59  E-value=9.7e-07  Score=76.31  Aligned_cols=137  Identities=26%  Similarity=0.332  Sum_probs=81.5

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC--CccceeeEE---eeCCeEEEEE
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP--NVVRLHEVL---ASKSKIYMVL   93 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~--niv~l~~~~---~~~~~~~iv~   93 (344)
                      ++.|+.|..+.||++....  ..+++|.....     .....+.+|..+++.+...  .+.+++...   ......+++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~   74 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM   74 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence            5789999999999999754  48999986433     3356777888888887533  345666543   2334578999


Q ss_pred             eccCCCChHH----------------HHH---hc----CCCCHHH---H---HHH---------------HHHHHH-HHH
Q 019216           94 EYVTGGELFD----------------KIA---SK----GRLQEAE---G---RKL---------------FQQLID-GVS  128 (344)
Q Consensus        94 e~~~g~~L~~----------------~l~---~~----~~~~~~~---~---~~i---------------~~ql~~-~L~  128 (344)
                      ++++|..+..                .+.   +.    ..+....   .   ...               ...+.. .+.
T Consensus        75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  154 (239)
T PF01636_consen   75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ  154 (239)
T ss_dssp             EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence            9999987766                111   11    0111000   0   000               111222 233


Q ss_pred             HHHh-------CCceeecCCCCcEEEc-cCCCeEEecccccc
Q 019216          129 YCHN-------KGVFHRDLKLENILLD-SKGNIKISDFGLSA  162 (344)
Q Consensus       129 ~LH~-------~~i~H~dikp~NILl~-~~~~vkl~Dfg~a~  162 (344)
                      .+++       ..++|+|+.|.|||++ +++++-|+||+.+.
T Consensus       155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence            3332       3599999999999999 66667899998765

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.52  E-value=1.3e-06  Score=76.51  Aligned_cols=135  Identities=16%  Similarity=0.112  Sum_probs=82.4

Q ss_pred             eeecccCc-eEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEeccC
Q 019216           20 RTLGEGNF-GKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYVT   97 (344)
Q Consensus        20 ~~Lg~G~~-g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv~e~~~   97 (344)
                      +.|..|.. +.||+...  .+..+.+|......      ...+.+|+.+++.+. +--+.+++++....+..++|||+++
T Consensus         4 ~~~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~   75 (244)
T cd05150           4 ERVTEGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVP   75 (244)
T ss_pred             eecCCCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeC
Confidence            34555655 78998874  34678889764332      235667888888874 4445577777766667889999999


Q ss_pred             CCChHHHH----------------HhcC-------CCCHH--HHHHHHH--------------------HHHHHHHHHH-
Q 019216           98 GGELFDKI----------------ASKG-------RLQEA--EGRKLFQ--------------------QLIDGVSYCH-  131 (344)
Q Consensus        98 g~~L~~~l----------------~~~~-------~~~~~--~~~~i~~--------------------ql~~~L~~LH-  131 (344)
                      |.++....                .+-.       ++...  .......                    .+...+..|- 
T Consensus        76 G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  155 (244)
T cd05150          76 GVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEA  155 (244)
T ss_pred             CccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHh
Confidence            97765331                0000       11100  0000000                    0111122221 


Q ss_pred             ------hCCceeecCCCCcEEEccCCCeEEecccccc
Q 019216          132 ------NKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       132 ------~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                            ...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       156 ~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         156 TRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             hCCCcCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence                  1248999999999999987778899999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.49  E-value=1.4e-06  Score=70.68  Aligned_cols=129  Identities=16%  Similarity=0.228  Sum_probs=90.6

Q ss_pred             EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccc-eeeEEeeCCeEEEEEec
Q 019216           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR-LHEVLASKSKIYMVLEY   95 (344)
Q Consensus        17 ~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-l~~~~~~~~~~~iv~e~   95 (344)
                      ++.+.||+|..|.||++.+  .|..+|+|+-+...     ....+..|.++|..+.-.++.+ +|.+.    ..++.|||
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~   93 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEY   93 (201)
T ss_pred             hhhhhhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhh
Confidence            3467899999999999996  45589999865433     3577899999999998777654 44443    23355999


Q ss_pred             cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCC-CcEEEccCCCeEEeccccccC
Q 019216           96 VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKL-ENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        96 ~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp-~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      +.|..|.+.-...   +..    -+..+++.---|-..||-|+.|+- ..+++..++.+.|+||..|++
T Consensus        94 i~G~~L~~~~~~~---~rk----~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          94 IDGRPLGKLEIGG---DRK----HLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             hcCcchhhhhhcc---cHH----HHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            9998886654321   222    333455554446677999999874 444444555999999998874

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.44  E-value=3.8e-06  Score=70.21  Aligned_cols=128  Identities=25%  Similarity=0.287  Sum_probs=90.5

Q ss_pred             cCeEEeeeecccCc-eEEEEEEECCCCceEEEEEeecccc----------c-ch-------hHHHHHHHHHHHHHhCC--
Q 019216           14 GRYELGRTLGEGNF-GKVKFAQDLDSGLPFAVKILEKNRI----------I-HL-------KITDQIKREIATLKLLK--   72 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~-g~Vy~a~~~~~~~~vaiK~~~~~~~----------~-~~-------~~~~~~~~E~~~l~~l~--   72 (344)
                      .+++.++.||.|.- |.||++..  .|+.+|||+++.-..          . +.       .....+..|.+...+|+  
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            68899999999999 99999995  777999999432100          0 00       23346778998887775  


Q ss_pred             -CCCc--cceeeEEeeC------------------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 019216           73 -HPNV--VRLHEVLASK------------------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH  131 (344)
Q Consensus        73 -h~ni--v~l~~~~~~~------------------~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH  131 (344)
                       +.++  ++.+++..-.                  ....||.||.+...         .+...    -+.+|.+-+..+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence             4455  8888887321                  12467888776533         12223    3456677788899


Q ss_pred             hCCceeecCCCCcEEEccCCCeEEeccccc
Q 019216          132 NKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus       132 ~~~i~H~dikp~NILl~~~~~vkl~Dfg~a  161 (344)
                      ..||+-+|+++.|..   +  -||+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~---~--G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR---G--GKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc---C--CEEEecccC
Confidence            999999999999975   3  489999864

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.43  E-value=2.1e-06  Score=82.04  Aligned_cols=141  Identities=21%  Similarity=0.242  Sum_probs=87.4

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeeccccc----------------------------chhHHHHHH------HH
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII----------------------------HLKITDQIK------RE   64 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~----------------------------~~~~~~~~~------~E   64 (344)
                      -+.||..+.|.||+|+.+. |+.||||+-+..-..                            -.+..+.+.      +|
T Consensus       166 ~~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E  244 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE  244 (538)
T ss_pred             cchhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence            3679999999999999755 999999986542100                            011222222      33


Q ss_pred             HHHHH----hCCCCC------ccceeeEEeeCCeEEEEEeccCCCChHH--HHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 019216           65 IATLK----LLKHPN------VVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHN  132 (344)
Q Consensus        65 ~~~l~----~l~h~n------iv~l~~~~~~~~~~~iv~e~~~g~~L~~--~l~~~~~~~~~~~~~i~~ql~~~L~~LH~  132 (344)
                      .+-..    .+.|-+      |.++|-.+  .....++||||+|..+.|  .+.+. .++...+...+.+...  .-+=.
T Consensus       245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~-gi~~~~i~~~l~~~~~--~qIf~  319 (538)
T KOG1235|consen  245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR-GISPHDILNKLVEAYL--EQIFK  319 (538)
T ss_pred             HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc-CCCHHHHHHHHHHHHH--HHHHh
Confidence            33222    223444      33333222  235679999999987654  34443 3555544333333221  22335


Q ss_pred             CCceeecCCCCcEEEcc----CCCeEEeccccccCCC
Q 019216          133 KGVFHRDLKLENILLDS----KGNIKISDFGLSALPQ  165 (344)
Q Consensus       133 ~~i~H~dikp~NILl~~----~~~vkl~Dfg~a~~~~  165 (344)
                      .|++|+|=+|.||++..    ++.+.+.|||+.....
T Consensus       320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             cCCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            68999999999999984    5689999999987543

>PLN02876 acyl-CoA dehydrogenase

Probab=98.37  E-value=6.7e-06  Score=84.37  Aligned_cols=81  Identities=15%  Similarity=0.315  Sum_probs=57.0

Q ss_pred             EeeeecccCceEEEEEEECCCC--ceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCc--cceeeEEeeC---CeE
Q 019216           18 LGRTLGEGNFGKVKFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNV--VRLHEVLASK---SKI   89 (344)
Q Consensus        18 ~~~~Lg~G~~g~Vy~a~~~~~~--~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni--v~l~~~~~~~---~~~   89 (344)
                      .++.|+.|.++.+|+......+  ..+++|........  .....+.+|.++++.+. |.++  .+++.++.+.   +..
T Consensus        42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~  119 (822)
T PLN02876         42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA  119 (822)
T ss_pred             eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence            3678899999999998764432  46788865432211  12346889999999985 6665  6777776553   457


Q ss_pred             EEEEeccCCCC
Q 019216           90 YMVLEYVTGGE  100 (344)
Q Consensus        90 ~iv~e~~~g~~  100 (344)
                      |+||||++|..
T Consensus       120 flVME~v~G~~  130 (822)
T PLN02876        120 FYIMEYLEGRI  130 (822)
T ss_pred             eEEEEecCCcc
Confidence            89999998864

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.36  E-value=1.8e-05  Score=66.66  Aligned_cols=135  Identities=21%  Similarity=0.271  Sum_probs=94.4

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeeccccc-------------chhHHHHHHHHHHHHHhCC------CCCccce
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-------------HLKITDQIKREIATLKLLK------HPNVVRL   79 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-------------~~~~~~~~~~E~~~l~~l~------h~niv~l   79 (344)
                      ...||+|+.=.||.  | ......+||+.......             .....+...+|+.....+.      +.+|.++
T Consensus         6 ~~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~   82 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF   82 (199)
T ss_pred             CcccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence            35799999999983  3 34455799998765500             0112355666666665555      7889999


Q ss_pred             eeEEeeCCeEEEEEeccCC------CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC--
Q 019216           80 HEVLASKSKIYMVLEYVTG------GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG--  151 (344)
Q Consensus        80 ~~~~~~~~~~~iv~e~~~g------~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~--  151 (344)
                      +|+.++.....+|+|.+.+      .+|.+++.+ +.+++ .   +...+-+-..+|-+.+|+.+|++|.||++..++  
T Consensus        83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~  157 (199)
T PF10707_consen   83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG  157 (199)
T ss_pred             eEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence            9999999999999998742      468888754 44655 3   334444556778899999999999999996543  


Q ss_pred             --CeEEec-cccc
Q 019216          152 --NIKISD-FGLS  161 (344)
Q Consensus       152 --~vkl~D-fg~a  161 (344)
                        .+.|+| ||..
T Consensus       158 ~~~lvlIDG~G~~  170 (199)
T PF10707_consen  158 EFRLVLIDGLGEK  170 (199)
T ss_pred             ceEEEEEeCCCCc
Confidence              466666 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.27  E-value=6.1e-06  Score=71.83  Aligned_cols=73  Identities=12%  Similarity=0.043  Sum_probs=45.6

Q ss_pred             eeeecccCce-EEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC---CccceeeEEeeC---CeEEE
Q 019216           19 GRTLGEGNFG-KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP---NVVRLHEVLASK---SKIYM   91 (344)
Q Consensus        19 ~~~Lg~G~~g-~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~~~---~~~~i   91 (344)
                      ++.|+.|+.. .||+..     ..+++|+.....     ....+.+|..+++.+...   .+..+++.....   ...++
T Consensus         2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~   71 (235)
T cd05155           2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS   71 (235)
T ss_pred             ceeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence            4677877776 588652     347788754321     234788899999887532   234444443322   23578


Q ss_pred             EEeccCCCCh
Q 019216           92 VLEYVTGGEL  101 (344)
Q Consensus        92 v~e~~~g~~L  101 (344)
                      +|++++|.++
T Consensus        72 l~~~i~G~~l   81 (235)
T cd05155          72 VYRWLEGETA   81 (235)
T ss_pred             EEEeecCCCC
Confidence            9999998766

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.18  E-value=1.2e-06  Score=77.50  Aligned_cols=138  Identities=21%  Similarity=0.285  Sum_probs=97.3

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch-----------------h--HHHHHHHHHHHHHhCC-CC-
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----------------K--ITDQIKREIATLKLLK-HP-   74 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~-----------------~--~~~~~~~E~~~l~~l~-h~-   74 (344)
                      +.+++.||-|.-+.||.+-+ ..|++.++|.-+..+..-.                 -  .+-...+|...|+.|. |. 
T Consensus        94 ~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   94 ESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            56789999999999999997 6788999996543221100                 0  1123456777777774 32 


Q ss_pred             CccceeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeE
Q 019216           75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK  154 (344)
Q Consensus        75 niv~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vk  154 (344)
                      -+.+.++    .++.++|||++.|..|...-+      ...+..+...++.-+.-|-.+|+||||+.--||++.+++.++
T Consensus       173 pVPkpiD----~~RH~Vvmelv~g~Pl~~v~~------v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~  242 (465)
T KOG2268|consen  173 PVPKPID----HNRHCVVMELVDGYPLRQVRH------VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV  242 (465)
T ss_pred             CCCCccc----ccceeeHHHhhcccceeeeee------cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence            2344444    356789999999887754321      122334555666667778899999999999999999999999


Q ss_pred             EeccccccCC
Q 019216          155 ISDFGLSALP  164 (344)
Q Consensus       155 l~Dfg~a~~~  164 (344)
                      ++||-.....
T Consensus       243 vIDFPQmvS~  252 (465)
T KOG2268|consen  243 VIDFPQMVST  252 (465)
T ss_pred             EeechHhhcc
Confidence            9999876543

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.17  E-value=2.5e-05  Score=70.57  Aligned_cols=145  Identities=21%  Similarity=0.327  Sum_probs=99.3

Q ss_pred             EeeeecccCceEEEEEEECCCCceEEEEEeeccccc---------------------ch-h-HHHHHHHHHHHHHhCCCC
Q 019216           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---------------------HL-K-ITDQIKREIATLKLLKHP   74 (344)
Q Consensus        18 ~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~---------------------~~-~-~~~~~~~E~~~l~~l~h~   74 (344)
                      +-..|..|.-+.||.|.. .+|..+|||+++.+-..                     ++ . ..-....|++-|.++...
T Consensus       148 inGCiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  148 INGCISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             cccccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            456788899999999995 67888999987532110                     01 1 122456788888888755


Q ss_pred             CccceeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCceeecCCCCcEEEccCCCe
Q 019216           75 NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC-HNKGVFHRDLKLENILLDSKGNI  153 (344)
Q Consensus        75 niv~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~L-H~~~i~H~dikp~NILl~~~~~v  153 (344)
                      +|.-.--+. - ....+||+|+.......-.-++..++...+..+-.|++.-+.-| |.+++||.||+--|+|+ .+|.+
T Consensus       227 GIP~PePIl-L-k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~l  303 (520)
T KOG2270|consen  227 GIPCPEPIL-L-KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKL  303 (520)
T ss_pred             CCCCCCcee-e-ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEE
Confidence            543211111 1 23468999994322221122345678888888888888888887 46799999999999999 67889


Q ss_pred             EEeccccccCCCc
Q 019216          154 KISDFGLSALPQH  166 (344)
Q Consensus       154 kl~Dfg~a~~~~~  166 (344)
                      .++|.+.+...++
T Consensus       304 yiIDVSQSVE~DH  316 (520)
T KOG2270|consen  304 YIIDVSQSVEHDH  316 (520)
T ss_pred             EEEEccccccCCC
Confidence            9999998875433

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.13  E-value=3.9e-05  Score=66.65  Aligned_cols=75  Identities=16%  Similarity=0.235  Sum_probs=48.3

Q ss_pred             eeeecccCceEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceeeEEeeCCeEEEEEecc
Q 019216           19 GRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYV   96 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~iv~e~~   96 (344)
                      ++.|..|-...+|++.... .++.|++|+......    ..-...+|+.+++.+...++ .+++....  +  .++|||+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i   74 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI   74 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence            5678888889999997533 357899997653221    11223478888888854334 44444332  2  3799999


Q ss_pred             CCCCh
Q 019216           97 TGGEL  101 (344)
Q Consensus        97 ~g~~L  101 (344)
                      +|.++
T Consensus        75 ~G~~l   79 (235)
T cd05157          75 PGRTL   79 (235)
T ss_pred             CCCcC
Confidence            98765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.08  E-value=1.5e-05  Score=66.64  Aligned_cols=97  Identities=20%  Similarity=0.237  Sum_probs=77.8

Q ss_pred             HHHHHHHhCCC-CCccceeeEEeeCCeEEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Q 019216           63 REIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDK---IASKGRLQEAEGRKLFQQLIDGVSYCHN---KGV  135 (344)
Q Consensus        63 ~E~~~l~~l~h-~niv~l~~~~~~~~~~~iv~e~~~g~~L~~~---l~~~~~~~~~~~~~i~~ql~~~L~~LH~---~~i  135 (344)
                      .|.-+++.+.+ +++.+++|+|    ..+++.||...+++...   +..-...++....+++.++++.+.+|+.   ..+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            48888888875 6999999998    23568899976666421   1222346899999999999999999987   347


Q ss_pred             eeecCCCCcEEEccCCCeEEeccccccC
Q 019216          136 FHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus       136 ~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      .-.|++++|+-++++|++|++|...+..
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcch
Confidence            7799999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.08  E-value=0.00013  Score=68.04  Aligned_cols=80  Identities=20%  Similarity=0.211  Sum_probs=54.0

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeeccccc--c--hhHHHHHHHHHHHHHhCC---CCCccceeeEEeeCCeEEE
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--H--LKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~--~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~i   91 (344)
                      .+.||.|.++.||++.+...++.++||.-......  .  .-..++...|.+.|+.+.   ..++.+++.+  +....++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            47899999999999998544468999974311100  0  113456777888888763   3456677766  3355789


Q ss_pred             EEeccCCCC
Q 019216           92 VLEYVTGGE  100 (344)
Q Consensus        92 v~e~~~g~~  100 (344)
                      |||++++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999997643

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.99  E-value=3.6e-05  Score=67.89  Aligned_cols=133  Identities=16%  Similarity=0.188  Sum_probs=77.2

Q ss_pred             eecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceeeEEeeCCeEEEEEeccCCC
Q 019216           21 TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYVTGG   99 (344)
Q Consensus        21 ~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~iv~e~~~g~   99 (344)
                      .+..|-.+.+|+..  .++..+++|.......   ...-...+|..+++.+...++ .+++...  .  -++||||++|.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~   73 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE   73 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence            45668888999887  4567888997543211   110134678888888864433 3344432  2  36899999886


Q ss_pred             ChHH--------------HHHh---c----CCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCceeecC
Q 019216          100 ELFD--------------KIAS---K----GRLQE-AEGRKLFQQL---------IDGVSYCHN--------KGVFHRDL  140 (344)
Q Consensus       100 ~L~~--------------~l~~---~----~~~~~-~~~~~i~~ql---------~~~L~~LH~--------~~i~H~di  140 (344)
                      .+..              .+.+   .    .+++. ..+..+..++         ...+..+-.        ..++|+|+
T Consensus        74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl  153 (256)
T TIGR02721        74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV  153 (256)
T ss_pred             ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence            5421              1111   1    11121 1122222122         111222211        24899999


Q ss_pred             CCCcEEEccCCCeEEeccccccC
Q 019216          141 KLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus       141 kp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      .|.||++++++ +.|+||+.+..
T Consensus       154 ~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       154 HAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CcCcEEEeCCC-CEEEeccccCc
Confidence            99999999877 78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=97.94  E-value=0.00027  Score=63.77  Aligned_cols=80  Identities=13%  Similarity=0.117  Sum_probs=56.2

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC---CCccceeeEEee---CCe
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH---PNVVRLHEVLAS---KSK   88 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h---~niv~l~~~~~~---~~~   88 (344)
                      +..-.+.||.|..+.||.... .++ .+.+|..+...     ....+..|...|+.+.-   -.+.++++++..   .+.
T Consensus        15 ~~~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~-----~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~   87 (297)
T PRK10593         15 KLSRVECISEQPYAALWALYD-SQG-NPMPLMARSFS-----TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGP   87 (297)
T ss_pred             hhheeeecCCccceeEEEEEc-CCC-CEEEEEecccc-----cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCC
Confidence            444567899999999998864 223 47778753211     12467889999988853   357788877643   356


Q ss_pred             EEEEEeccCCCCh
Q 019216           89 IYMVLEYVTGGEL  101 (344)
Q Consensus        89 ~~iv~e~~~g~~L  101 (344)
                      .++|||+++|.++
T Consensus        88 ~~LVmE~i~G~~~  100 (297)
T PRK10593         88 DVLLLERLRGVSV  100 (297)
T ss_pred             eEEEEeccCCEec
Confidence            8999999998654

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.94  E-value=9.4e-05  Score=66.66  Aligned_cols=141  Identities=19%  Similarity=0.207  Sum_probs=83.8

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccceeeE------Eee
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEV------LAS   85 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~   85 (344)
                      ++..-++.|..|....+|+...  .+..+++|+....      ....+..|+.+++.+.+.+  +.+++..      ...
T Consensus        14 ~~~~~i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~   85 (296)
T cd05153          14 GELLSFEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSEL   85 (296)
T ss_pred             CchhheecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeee
Confidence            3444467788888899999864  3447899987531      1245667888777774322  3343331      123


Q ss_pred             CCeEEEEEeccCCCChHH----HH----------Hhc-CCC----------CHHH--HH--------HHHHHHHHHHHHH
Q 019216           86 KSKIYMVLEYVTGGELFD----KI----------ASK-GRL----------QEAE--GR--------KLFQQLIDGVSYC  130 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~----~l----------~~~-~~~----------~~~~--~~--------~i~~ql~~~L~~L  130 (344)
                      .+..++++++++|..+..    ..          ... ..+          .+..  ..        .....+..++.++
T Consensus        86 ~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  165 (296)
T cd05153          86 AGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQ  165 (296)
T ss_pred             CCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHH
Confidence            456789999998866421    01          100 000          0000  00        0111123344444


Q ss_pred             Hh-------CCceeecCCCCcEEEccCCCeEEecccccc
Q 019216          131 HN-------KGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       131 H~-------~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      .+       .+++|+|+.|.||++++++.+.|.||+.+.
T Consensus       166 ~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         166 DAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             HhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            43       369999999999999987777899999775

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.90  E-value=1.1e-06  Score=91.16  Aligned_cols=212  Identities=17%  Similarity=0.075  Sum_probs=145.0

Q ss_pred             HHHHHHHHHHHhCCCCCccceeeEEee--CCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh
Q 019216           59 DQIKREIATLKLLKHPNVVRLHEVLAS--KSKIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHN  132 (344)
Q Consensus        59 ~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~~iv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~  132 (344)
                      +....|..-++...|+++...+.-...  ....|..++|+.+|.+++.+-+.    .++...-+.....+...+..-+|.
T Consensus      1274 emll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls 1353 (2724)
T KOG1826|consen 1274 EMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILS 1353 (2724)
T ss_pred             HhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhh
Confidence            344455556667789988776655432  34568899999999999988642    234444444444454666677665


Q ss_pred             C-C----ceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHH
Q 019216          133 K-G----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL  207 (344)
Q Consensus       133 ~-~----i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll  207 (344)
                      . +    -+|+++|+.|.+|..+.++|+.++|+.+...+  .........+++.|++|++...-.+ +.++|+|..|+.+
T Consensus      1354 ~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~-t~rsdilr~s~~l 1430 (2724)
T KOG1826|consen 1354 LTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKF-TKRSDILRRSLSL 1430 (2724)
T ss_pred             cccCCccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhh-hhHHHHHHHHHHH
Confidence            4 2    68999999999999999999999999984322  2233445678889999999877666 4669999999999


Q ss_pred             HHHHhCCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          208 YVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       208 ~ell~g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      |....|..+|-..........+..+ ..+++...|.++......+|-+.-..||.-...+.-+.+..
T Consensus      1431 y~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1431 YLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred             HHHhcccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence            9999888776432222222222221 23445555666666677777777778998888777766643

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.85  E-value=0.00029  Score=63.87  Aligned_cols=144  Identities=18%  Similarity=0.233  Sum_probs=83.4

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccceeeEE------
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEVL------   83 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~------   83 (344)
                      .++....++.++.|....+|++.. .+| .+++|+.....  .   .+.+..|.++++.|...+  +.+++...      
T Consensus        20 ~~~~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~---~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~   92 (307)
T TIGR00938        20 DLGELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--K---AEELPFFLALTTHLAARGLPVPKPVKSRDGRQLS   92 (307)
T ss_pred             CCCCceeccccCCccccceEEEEe-CCC-cEEEEEecCCC--C---HHHHHHHHHHHHHHHHCCCCCCccccCCCCCeeh
Confidence            444455577888888889998874 334 68889875421  1   234455667776664222  33333321      


Q ss_pred             eeCCeEEEEEeccCCCChH----H-------HH---Hh-cCCC--------CHHH-----HH----------HHHHHHHH
Q 019216           84 ASKSKIYMVLEYVTGGELF----D-------KI---AS-KGRL--------QEAE-----GR----------KLFQQLID  125 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~----~-------~l---~~-~~~~--------~~~~-----~~----------~i~~ql~~  125 (344)
                      ...+..+++++|++|.++.    +       .+   .. ...+        ....     ..          .....+..
T Consensus        93 ~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~  172 (307)
T TIGR00938        93 TLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDK  172 (307)
T ss_pred             hcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHH
Confidence            2245678999999885431    1       11   10 0001        0000     00          00112233


Q ss_pred             HHHHHHh-------CCceeecCCCCcEEEccCCCeEEecccccc
Q 019216          126 GVSYCHN-------KGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       126 ~L~~LH~-------~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      .++++..       .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       173 ~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       173 ELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            4555532       579999999999999988877899999775

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.84  E-value=0.00018  Score=64.97  Aligned_cols=75  Identities=13%  Similarity=0.142  Sum_probs=48.6

Q ss_pred             eeeecccCceEEEEEEECC------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceeeEEeeCCeEEE
Q 019216           19 GRTLGEGNFGKVKFAQDLD------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYM   91 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~i   91 (344)
                      ++.|..|-...+|++....      .++.+++|+......    ......+|..+++.+...++ .+++.++. +   ..
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~   74 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFP-N---GR   74 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence            4567778888999987533      257899998754321    12345678888888763333 34555543 2   35


Q ss_pred             EEeccCCCCh
Q 019216           92 VLEYVTGGEL  101 (344)
Q Consensus        92 v~e~~~g~~L  101 (344)
                      |+||++|..+
T Consensus        75 v~e~i~G~~l   84 (302)
T cd05156          75 IEEFIPSRTL   84 (302)
T ss_pred             hhheeCCCcC
Confidence            8999988765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.77  E-value=0.00011  Score=69.21  Aligned_cols=161  Identities=22%  Similarity=0.262  Sum_probs=103.7

Q ss_pred             HHHHHHHHHHHhCCCCCccceeeEEee-CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 019216           59 DQIKREIATLKLLKHPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH  137 (344)
Q Consensus        59 ~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H  137 (344)
                      ..+.-....++.+.|+|....+++... ..+..+|||++ +.+|.+.+..+. +......              .+|+.|
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~~   90 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVLH   90 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccccce
Confidence            456677888999999999999988764 34578999999 779988876543 2211111              112222


Q ss_pred             ecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCC
Q 019216          138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF  217 (344)
Q Consensus       138 ~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf  217 (344)
                           -||       .+.+|- ++.       .           |        ....++++||||+|.++.++..|...+
T Consensus        91 -----~~~-------~~~td~-~~t-------~-----------~--------~~~~~pKsdVwsl~~i~~el~L~~~l~  131 (725)
T KOG1093|consen   91 -----LNI-------IYITDH-FLT-------K-----------Y--------PSPIGPKSDVWSLGFIILELYLGISLE  131 (725)
T ss_pred             -----ehh-------hhcccc-ccc-------c-----------C--------CCCCCcchhhhhHHHHHHHHHHhhHHH
Confidence                 122       233331 000       0           0        111235899999999999999998777


Q ss_pred             CCccHHHHHHHHhhCCC---C---------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          218 DDRNLAVLYQKIFRGDF---K---------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       218 ~~~~~~~~~~~i~~~~~---~---------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ......+....+.+-..   .         +-..++....++..+|+-..|..||...++.+++-|.+.
T Consensus       132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            65444333333322111   1         111256777899999999999999999999999888754

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.67  E-value=0.00053  Score=62.73  Aligned_cols=77  Identities=19%  Similarity=0.160  Sum_probs=48.7

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeec----ccccchhHHHHHHHHHHHHHhCC--CCC-ccceeeEEeeCCeEEEE
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEK----NRIIHLKITDQIKREIATLKLLK--HPN-VVRLHEVLASKSKIYMV   92 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~----~~~~~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~iv   92 (344)
                      +.||.|....||++.+...++.|+||--..    ....-+-..++..-|...|+...  .|. +.++|.+  +.....+|
T Consensus         1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v   78 (370)
T TIGR01767         1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV   78 (370)
T ss_pred             CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence            358999999999999754446899995321    11011223456667888887764  453 4445443  44456689


Q ss_pred             EeccCC
Q 019216           93 LEYVTG   98 (344)
Q Consensus        93 ~e~~~g   98 (344)
                      ||+++.
T Consensus        79 MEdL~~   84 (370)
T TIGR01767        79 MEDLSH   84 (370)
T ss_pred             HhhCcc
Confidence            999854

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PRK05231 homoserine kinase; Provisional

Probab=97.65  E-value=0.0018  Score=58.93  Aligned_cols=138  Identities=16%  Similarity=0.227  Sum_probs=74.7

Q ss_pred             EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccceee------EEeeCCe
Q 019216           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHE------VLASKSK   88 (344)
Q Consensus        17 ~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~------~~~~~~~   88 (344)
                      .-.+.|+.|....+|.... .+| .+++|++..  . .   .+.+..|+.+++.|...+  +.+.+.      +....+.
T Consensus        25 ~~~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~~--~-~---~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~   96 (319)
T PRK05231         25 LSLKGIAEGIENSNFFLTT-TQG-EYVLTLFER--L-T---AEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGK   96 (319)
T ss_pred             hccchhccccccceEEEEe-CCC-cEEEEEecc--C-C---hHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCE
Confidence            3456677888889998874 333 689998751  1 1   123334555555543111  223332      1123456


Q ss_pred             EEEEEeccCCCChH-----------HHHH---h-cCCC--------C--H-HH-HHH-----------HHHH-HHHHHHH
Q 019216           89 IYMVLEYVTGGELF-----------DKIA---S-KGRL--------Q--E-AE-GRK-----------LFQQ-LIDGVSY  129 (344)
Q Consensus        89 ~~iv~e~~~g~~L~-----------~~l~---~-~~~~--------~--~-~~-~~~-----------i~~q-l~~~L~~  129 (344)
                      .+++++|++|..+.           ..+.   . ...+        .  . .. ...           .+.+ +...+..
T Consensus        97 ~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  176 (319)
T PRK05231         97 PAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAF  176 (319)
T ss_pred             EEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHh
Confidence            78999999886431           1111   0 0000        0  0 00 000           1111 1112222


Q ss_pred             HH-------hCCceeecCCCCcEEEccCCCeEEecccccc
Q 019216          130 CH-------NKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       130 LH-------~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      +.       ..++||+|+.|.||+++.+...-|+||+.+.
T Consensus       177 ~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        177 LASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             hhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            22       2379999999999999866556899999875

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.49  E-value=0.0013  Score=58.70  Aligned_cols=30  Identities=23%  Similarity=0.422  Sum_probs=25.3

Q ss_pred             CceeecCCCCcEEEccCCCe-EEeccccccC
Q 019216          134 GVFHRDLKLENILLDSKGNI-KISDFGLSAL  163 (344)
Q Consensus       134 ~i~H~dikp~NILl~~~~~v-kl~Dfg~a~~  163 (344)
                      .++|+|++|.|||+++++++ -|.||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            38999999999999876664 6999998763

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.42  E-value=0.002  Score=58.21  Aligned_cols=144  Identities=16%  Similarity=0.199  Sum_probs=84.2

Q ss_pred             EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCccceeeEEeeCC--eEEEE
Q 019216           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKS--KIYMV   92 (344)
Q Consensus        17 ~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~--~~~iv   92 (344)
                      .+++.+..|....+|.....  ++.++++ .. .............+|..+++.+.-  --+...++.+..+.  ..+.|
T Consensus        28 ~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P-~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v  103 (321)
T COG3173          28 LIVEEISGGWSNDTFRLGDT--GQKYVLR-KP-PRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYV  103 (321)
T ss_pred             ceeeeccCCcccceEEEecC--CceEEEe-cC-CccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEE
Confidence            45555655555566666653  7788888 32 122233445667788888887752  23344556665544  67899


Q ss_pred             EeccCCCChHHH------------------HHhc-----------C---CCCHHHHHHHHHHH--------------HHH
Q 019216           93 LEYVTGGELFDK------------------IASK-----------G---RLQEAEGRKLFQQL--------------IDG  126 (344)
Q Consensus        93 ~e~~~g~~L~~~------------------l~~~-----------~---~~~~~~~~~i~~ql--------------~~~  126 (344)
                      |+|++|..+.+.                  +..-           +   .....++..+..+.              ..-
T Consensus       104 ~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~  183 (321)
T COG3173         104 MEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRL  183 (321)
T ss_pred             EEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHH
Confidence            999988432111                  1100           0   00111112222222              122


Q ss_pred             HHHHHhC--------CceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216          127 VSYCHNK--------GVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus       127 L~~LH~~--------~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                      ..+|+.+        .++|||+.+.||++++++-+-+.||+++..-
T Consensus       184 ~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         184 IKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            3444432        3799999999999999988999999998753

>PLN02236 choline kinase

Probab=97.42  E-value=0.0016  Score=60.08  Aligned_cols=137  Identities=20%  Similarity=0.191  Sum_probs=80.9

Q ss_pred             EeeeecccCceEEEEEEECC----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceeeEEeeCCeEEEE
Q 019216           18 LGRTLGEGNFGKVKFAQDLD----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMV   92 (344)
Q Consensus        18 ~~~~Lg~G~~g~Vy~a~~~~----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~iv   92 (344)
                      -++.|..|-...+|++....    .++.|++|+.....   ....+ ..+|..+++.+..-++ .++++.+..+    .|
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v  111 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RV  111 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eE
Confidence            34566668888999987432    34689999875432   12222 3678888888864444 3556655332    47


Q ss_pred             EeccCCCChHHH--------------HH---hcC------CCCHHHHHHHHHHH-----------------HHHHHHH--
Q 019216           93 LEYVTGGELFDK--------------IA---SKG------RLQEAEGRKLFQQL-----------------IDGVSYC--  130 (344)
Q Consensus        93 ~e~~~g~~L~~~--------------l~---~~~------~~~~~~~~~i~~ql-----------------~~~L~~L--  130 (344)
                      .+|++|.++...              +.   +..      ......+..+..++                 ...+..|  
T Consensus       112 ~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~  191 (344)
T PLN02236        112 EEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEK  191 (344)
T ss_pred             EEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHH
Confidence            899987665311              11   100      01122333333222                 1111122  


Q ss_pred             --H----hCCceeecCCCCcEEEcc-CCCeEEecccccc
Q 019216          131 --H----NKGVFHRDLKLENILLDS-KGNIKISDFGLSA  162 (344)
Q Consensus       131 --H----~~~i~H~dikp~NILl~~-~~~vkl~Dfg~a~  162 (344)
                        .    ...++|+|+++.||++++ ++.+.++||..+.
T Consensus       192 ~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        192 ELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             HhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence              1    125899999999999986 4689999999876

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.41  E-value=0.0027  Score=59.27  Aligned_cols=77  Identities=16%  Similarity=0.109  Sum_probs=50.9

Q ss_pred             EeeeecccCceEEEEEEECCCCceEEEEEeecccc-cch---hHHHHHHHHHHHHHhCC---CCCccceeeEEeeCCeEE
Q 019216           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHL---KITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        18 ~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~   90 (344)
                      ..+.||.|....||+..+  .+..++||.-..... ...   -...+...|...|+.+.   ..++.+++.++.  +..+
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v  111 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL  111 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence            477899999999999986  345699996541111 000   12344555677776654   347778888775  3457


Q ss_pred             EEEeccCC
Q 019216           91 MVLEYVTG   98 (344)
Q Consensus        91 iv~e~~~g   98 (344)
                      ++||++++
T Consensus       112 lvME~L~~  119 (418)
T PLN02756        112 IGMRYLEP  119 (418)
T ss_pred             EEEeecCC
Confidence            78999976

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.24  E-value=0.0025  Score=58.47  Aligned_cols=141  Identities=15%  Similarity=0.239  Sum_probs=79.9

Q ss_pred             cCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceeeEEeeCCeE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKI   89 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~   89 (344)
                      +..++ +.|..|-...+|++.....   +..|++|+......   . .-...+|..+++.+..-++ .++++++. .+  
T Consensus        15 ~~i~i-~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G--   86 (330)
T PLN02421         15 SDFSV-ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---Y-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG--   86 (330)
T ss_pred             CceEE-EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---e-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc--
Confidence            34444 4455477788998875432   34799998754321   1 1223568888888865555 35565553 22  


Q ss_pred             EEEEeccCCCChHH--------------HHHh--cCC------C-CHHHHHHHHHHH----------------------H
Q 019216           90 YMVLEYVTGGELFD--------------KIAS--KGR------L-QEAEGRKLFQQL----------------------I  124 (344)
Q Consensus        90 ~iv~e~~~g~~L~~--------------~l~~--~~~------~-~~~~~~~i~~ql----------------------~  124 (344)
                       +|.+|++|.++..              .+.+  ..+      . ....+..+..++                      .
T Consensus        87 -~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~  165 (330)
T PLN02421         87 -MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELR  165 (330)
T ss_pred             -EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHH
Confidence             4889987765421              1111  001      1 122233332222                      1


Q ss_pred             HHHHHHH----hCC----ceeecCCCCcEEEcc-CCCeEEeccccccC
Q 019216          125 DGVSYCH----NKG----VFHRDLKLENILLDS-KGNIKISDFGLSAL  163 (344)
Q Consensus       125 ~~L~~LH----~~~----i~H~dikp~NILl~~-~~~vkl~Dfg~a~~  163 (344)
                      .-+..+.    ..+    ++|+|+.+.|||+++ ++.++++||+.|..
T Consensus       166 ~~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        166 DEIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HHHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            1122221    112    799999999999975 47899999998864

>PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs)

Probab=97.14  E-value=9.7e-05  Score=49.21  Aligned_cols=28  Identities=46%  Similarity=0.781  Sum_probs=21.2

Q ss_pred             CCCcchHHHhHhhcCCCCCCCcccccce
Q 019216          310 PPLINAFQLIGMSSCLDLSGFFEKEVNV  337 (344)
Q Consensus       310 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (344)
                      |..++||++|++++++|||++|...+..
T Consensus         2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~   29 (63)
T PF03822_consen    2 PKSLNAFDIISLSSGFDLSGLFEEKDKS   29 (63)
T ss_dssp             -EE--HHHHHCTSTTTSCGGGGGCG-S-
T ss_pred             CccccHHHHHHhccCCChHHhcCccccc
Confidence            4568999999999999999999877664

Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.12  E-value=0.0042  Score=57.66  Aligned_cols=78  Identities=21%  Similarity=0.189  Sum_probs=51.0

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeec---ccccchhHHHHHHHHHHHHHhCC--CCC-ccceeeEEeeCCeEEEE
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEK---NRIIHLKITDQIKREIATLKLLK--HPN-VVRLHEVLASKSKIYMV   92 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~---~~~~~~~~~~~~~~E~~~l~~l~--h~n-iv~l~~~~~~~~~~~iv   92 (344)
                      .+.||.|....||++.+...++.|+||--..   ....=+-..++..-|..+|+...  .|. +.++|.+  +.....+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            6789999999999999854456799995321   11010123566777888888764  454 4445543  34456789


Q ss_pred             EeccCC
Q 019216           93 LEYVTG   98 (344)
Q Consensus        93 ~e~~~g   98 (344)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            998854

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.02  E-value=0.0072  Score=54.10  Aligned_cols=76  Identities=17%  Similarity=0.205  Sum_probs=48.0

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCccceeeEEeeCCeEEEE
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~iv   92 (344)
                      .+-.+.++.|.-..+|+..  .+++.+-+|+-...      ....+..|..-|+.|.   .-.+.+++.+....+..+++
T Consensus        19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~------~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl   90 (288)
T PF03881_consen   19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSES------GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL   90 (288)
T ss_dssp             --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGG------GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred             eeeeEecCCCChhheEEEE--CCCccEEEEecChh------hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence            4556789999999999888  67888999986522      1245777888888773   44567888888777777999


Q ss_pred             EeccCCC
Q 019216           93 LEYVTGG   99 (344)
Q Consensus        93 ~e~~~g~   99 (344)
                      |||++.+
T Consensus        91 le~l~~~   97 (288)
T PF03881_consen   91 LEFLEMG   97 (288)
T ss_dssp             EE-----
T ss_pred             EEeecCC
Confidence            9999765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.95  E-value=0.016  Score=52.39  Aligned_cols=29  Identities=31%  Similarity=0.618  Sum_probs=25.5

Q ss_pred             CCceeecCCCCcEEEccCCCeEEecccccc
Q 019216          133 KGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       133 ~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      .+++|||+.+.||+++. +.+.|.||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999999664

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.93  E-value=0.0046  Score=56.25  Aligned_cols=104  Identities=23%  Similarity=0.323  Sum_probs=70.6

Q ss_pred             eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~-~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      +..+.|++|++- |++|. .+   .....+++..++.+++..+.-+... ..-|||+.-.||||+ +|+|.|+||.+++.
T Consensus       297 e~~y~yl~~kdh-gt~is-~i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         297 ETLYLYLHFKDH-GTPIS-II---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             CceEEEEEEecC-Cceee-ee---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence            344667788876 55553 22   2235678888999988888888765 799999999999999 99999999999983


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCCCCccchhhhh
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSC  203 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Dvwsl  203 (344)
                      -..       .........--|-.+.+..  +..-+||-+
T Consensus       371 ~~~-------q~~isy~rldhp~lF~G~d--d~QFeIYrl  401 (488)
T COG5072         371 SYS-------QGIISYNRLDHPDLFNGVD--DYQFEIYRL  401 (488)
T ss_pred             ccC-------CceeeccccCchhhhcCcc--ceeeeHHHH
Confidence            211       1112222334455555433  456777764

>PTZ00384 choline kinase; Provisional

Probab=96.77  E-value=0.013  Score=54.75  Aligned_cols=75  Identities=16%  Similarity=0.171  Sum_probs=44.6

Q ss_pred             eeeecccCceEEEEEEECCC-Cce-----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceeeEEeeCCeEEE
Q 019216           19 GRTLGEGNFGKVKFAQDLDS-GLP-----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYM   91 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~-~~~-----vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~i   91 (344)
                      ++.|..|-.+.+|++..... +..     |.++....    .....-.-.+|+.+++.+...++ .++++.+..    ++
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~  126 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FT  126 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EE
Confidence            45565588889999975432 122     34343211    11111223568999999875555 456666532    58


Q ss_pred             EEeccCCCCh
Q 019216           92 VLEYVTGGEL  101 (344)
Q Consensus        92 v~e~~~g~~L  101 (344)
                      +.||++|.+|
T Consensus       127 l~efIeGr~l  136 (383)
T PTZ00384        127 IQEWVEGNTM  136 (383)
T ss_pred             EEEEeccccC
Confidence            8999988765

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.66  E-value=0.031  Score=50.73  Aligned_cols=29  Identities=21%  Similarity=0.279  Sum_probs=27.2

Q ss_pred             CceeecCCCCcEEEccCCCeEEecccccc
Q 019216          134 GVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       134 ~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      ++||+|+.++|+|+++++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            69999999999999999999999999876

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.64  E-value=0.0042  Score=52.98  Aligned_cols=29  Identities=34%  Similarity=0.614  Sum_probs=21.0

Q ss_pred             CceeecCCCCcEEE-ccCCCeEEecccccc
Q 019216          134 GVFHRDLKLENILL-DSKGNIKISDFGLSA  162 (344)
Q Consensus       134 ~i~H~dikp~NILl-~~~~~vkl~Dfg~a~  162 (344)
                      -++|+|+.+.|||+ +.++.++++||..|.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            48999999999999 888999999999875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.53  E-value=0.095  Score=47.91  Aligned_cols=71  Identities=18%  Similarity=0.141  Sum_probs=41.7

Q ss_pred             cCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccc---eee--EEeeCCeEEEEEeccC
Q 019216           25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVR---LHE--VLASKSKIYMVLEYVT   97 (344)
Q Consensus        25 G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~---l~~--~~~~~~~~~iv~e~~~   97 (344)
                      +.-..||.... .+|..+++|+.+....    ....+..|+..+..|....  ++.   .-+  +...++..+.++++++
T Consensus        36 s~eN~vy~v~~-~~~~~~vlKv~r~~~~----~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~  110 (325)
T PRK11768         36 SYENRVYQFGD-EDGRRVVAKFYRPERW----SDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRG  110 (325)
T ss_pred             cccceEEEEec-CCCCEEEEEEcCcccC----CHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeC
Confidence            44567898874 5567899998754322    2345666777776663211  121   111  2233456788999998


Q ss_pred             CCC
Q 019216           98 GGE  100 (344)
Q Consensus        98 g~~  100 (344)
                      |..
T Consensus       111 G~~  113 (325)
T PRK11768        111 GRA  113 (325)
T ss_pred             CCC
Confidence            754

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.38  E-value=0.06  Score=49.17  Aligned_cols=138  Identities=21%  Similarity=0.255  Sum_probs=80.2

Q ss_pred             EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC------ccceee----EEeeC
Q 019216           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN------VVRLHE----VLASK   86 (344)
Q Consensus        17 ~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~----~~~~~   86 (344)
                      .....|.+ .-..+|+... .+|. +++|+.+.. . .   ...+..|+..++.|.-.+      +..+-|    .....
T Consensus        29 ~~~~~l~s-~eN~~f~~~~-~~g~-~iLki~~~~-~-~---~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~  100 (331)
T COG2334          29 GSLRGLNS-EENSNFRVQT-EDGR-YILKIYRPG-W-T---RAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGG  100 (331)
T ss_pred             cccccccc-ccCceEEEEe-cCCC-eEEEEecCC-C-C---HHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCC
Confidence            33455665 6677898885 4444 499998654 2 1   345666777777764211      121111    11222


Q ss_pred             CeEEEEEeccCCCChHH-----HH----------Hh---cCC---------CCHH----HH---------HHHHHHHHHH
Q 019216           87 SKIYMVLEYVTGGELFD-----KI----------AS---KGR---------LQEA----EG---------RKLFQQLIDG  126 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~-----~l----------~~---~~~---------~~~~----~~---------~~i~~ql~~~  126 (344)
                      .+.+-+++|++|..+..     .+          ..   +-+         ..+.    ..         .....++...
T Consensus       101 ~r~a~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~  180 (331)
T COG2334         101 PRPAALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAA  180 (331)
T ss_pred             ceeEEEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHH
Confidence            47788999999877652     11          00   000         1111    00         1123344444


Q ss_pred             HHHHHh--------CC--ceeecCCCCcEEEccCCC-eEEecccccc
Q 019216          127 VSYCHN--------KG--VFHRDLKLENILLDSKGN-IKISDFGLSA  162 (344)
Q Consensus       127 L~~LH~--------~~--i~H~dikp~NILl~~~~~-vkl~Dfg~a~  162 (344)
                      +..+.+        .+  +||+|+.|.|||++.+.. +.+.||+-+.
T Consensus       181 ~~~~~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         181 LDRLLARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             HHHHHhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence            444443        23  999999999999999885 8999999775

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.30  E-value=0.018  Score=48.93  Aligned_cols=100  Identities=17%  Similarity=0.202  Sum_probs=64.4

Q ss_pred             eEEEEEeeccccc-chhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHH
Q 019216           41 PFAVKILEKNRII-HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL  119 (344)
Q Consensus        41 ~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i  119 (344)
                      ...+|.++..++. +   ...+..+.+++.++.  +|+++..  .....+.++.|+|.....            .. ..+
T Consensus        87 ~L~lKKi~slp~~~~---~~~y~nky~v~Armh--GilrL~N--Dn~~~yGvIlE~Cy~~~i------------~~-~N~  146 (308)
T PF07387_consen   87 PLFLKKIRSLPCCIN---DALYFNKYRVFARMH--GILRLKN--DNNYKYGVILERCYKIKI------------NF-SNF  146 (308)
T ss_pred             hhhhhhccCCCcccc---hhhhhhhhhHHHHhh--heeEeec--CCCceeEEEEeeccCccc------------ch-hHH
Confidence            3455666544433 2   234577888888764  5666652  234457799999943211            01 111


Q ss_pred             HHHHHHHHHHHHhC--CceeecCCCCcEEEccCCCeEEecccc
Q 019216          120 FQQLIDGVSYCHNK--GVFHRDLKLENILLDSKGNIKISDFGL  160 (344)
Q Consensus       120 ~~ql~~~L~~LH~~--~i~H~dikp~NILl~~~~~vkl~Dfg~  160 (344)
                      +..=+.+|.-.|+.  +.+|||-.|+||+-+..|.+||.|=+.
T Consensus       147 i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  147 ITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             HHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhh
Confidence            11123567778843  799999999999999999999998764

The function of this family is unknown.

>PTZ00296 choline kinase; Provisional

Probab=95.83  E-value=0.12  Score=49.37  Aligned_cols=79  Identities=11%  Similarity=0.049  Sum_probs=49.0

Q ss_pred             cCeEEeeeecccCceEEEEEEECCC--------CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-ceeeEEe
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDS--------GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV-RLHEVLA   84 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~--------~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~   84 (344)
                      ++. -++.|..|-...+|++.....        ++.|.+|+.-...   .... ...+|..+++.+...+|. ++++.+.
T Consensus       106 ~~I-~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~t---e~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~  180 (442)
T PTZ00296        106 DDV-RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDV---DELY-NPISEFEVYKTMSKYRIAPQLLNTFS  180 (442)
T ss_pred             ccE-EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCc---ccee-CHHHHHHHHHHHHHCCCCCceEEEeC
Confidence            344 466777788888999875421        5678999874321   1222 345688888877654553 4555543


Q ss_pred             eCCeEEEEEeccCCCCh
Q 019216           85 SKSKIYMVLEYVTGGEL  101 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L  101 (344)
                          -+.|.+|++|.+|
T Consensus       181 ----gg~I~efi~g~~l  193 (442)
T PTZ00296        181 ----GGRIEEWLYGDPL  193 (442)
T ss_pred             ----CCEEEEeeCCccC
Confidence                2357899987644

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=95.81  E-value=0.21  Score=42.89  Aligned_cols=79  Identities=27%  Similarity=0.330  Sum_probs=52.9

Q ss_pred             CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCccceeeEEeeCCeEEE
Q 019216           15 RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        15 ~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~i   91 (344)
                      +.+-.+.+..|.--..|...+  ....+-+|+-.      .+....+..|+.-|+.+.   .-.+.+++.+.....+.|+
T Consensus        17 ~i~er~~v~gG~inea~~v~d--g~~~~FvK~n~------~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~syl   88 (286)
T COG3001          17 EIKEREEVSGGDINEAWRLRD--GTDPFFVKCNQ------REQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYL   88 (286)
T ss_pred             hhhcccccCCccccceeEeec--CCcceEEEecc------hhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEE
Confidence            333445566666666665553  34567778532      234566777777766664   4567888888889999999


Q ss_pred             EEeccCCCCh
Q 019216           92 VLEYVTGGEL  101 (344)
Q Consensus        92 v~e~~~g~~L  101 (344)
                      ||||++-+.+
T Consensus        89 Vle~L~~~~~   98 (286)
T COG3001          89 VLEYLPTGPL   98 (286)
T ss_pred             EEeeccCCCC
Confidence            9999987554

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	344
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-75
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		4e-74
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-73
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-71
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-71
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-71
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-71
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-67
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-66
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		9e-66
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-65
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-64
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-64
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-64
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-64
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-63
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-63
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-62
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-61
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		8e-58
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		1e-57
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		6e-57
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		8e-57
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		7e-56
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-53
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-48
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-48
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-48
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-48
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-48
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		8e-48
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-48
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-47
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-47
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		7e-47
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-47
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		7e-47
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-46
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-46
3soa_A	444	Full-Length Human Camkii Length = 444		3e-46
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-46
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-46
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-46
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-46
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-46
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-46
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-46
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-46
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-46
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		5e-46
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-46
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-46
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-46
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		5e-46
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		5e-46
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		5e-46
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-46
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-46
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-45
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-45
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-45
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-45
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-45
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-45
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-45
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		8e-45
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		1e-44
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-44
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-44
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		1e-44
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-44
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-44
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-44
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-44
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		2e-44
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		2e-44
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-44
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-44
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-44
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-44
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-44
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-44
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-44
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-44
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		5e-44
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-44
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-44
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		6e-44
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-43
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-43
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-43
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-43
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-43
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-43
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-43
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-43
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-43
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-43
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-43
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-43
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-43
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-43
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-43
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		3e-43
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-43
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-43
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-43
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-43
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-43
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		5e-43
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-43
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		6e-43
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-43
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		7e-43
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		7e-43
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-43
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		8e-43
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		8e-43
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-43
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-43
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		9e-43
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		9e-43
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-42
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-42
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-42
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-42
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-42
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-42
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-42
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-42
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-42
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-42
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-42
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-42
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		2e-42
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-42
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-42
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-42
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-42
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-42
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		3e-42
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-42
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-42
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-42
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		3e-42
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-42
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-42
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-42
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-42
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		3e-42
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-42
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-42
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		3e-42
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-42
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-42
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-42
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		4e-42
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-42
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		4e-42
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-42
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-42
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		6e-42
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-42
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-41
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-41
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-41
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-41
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		3e-41
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		3e-41
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-41
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		5e-41
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		9e-41
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		5e-40
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		6e-40
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-40
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		6e-40
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		7e-40
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-40
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-39
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		2e-39
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-39
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-39
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-39
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-39
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-39
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		6e-39
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		6e-39
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		6e-39
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-39
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		7e-39
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-38
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-38
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-38
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-38
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-38
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-38
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-38
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		3e-38
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-38
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-38
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		3e-38
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		5e-38
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		5e-38
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-38
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-37
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-37
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-37
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-37
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-37
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-37
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-37
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-37
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-37
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		2e-37
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-37
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-37
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		3e-37
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-37
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-37
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-37
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-37
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-37
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		4e-37
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		4e-37
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-37
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-37
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-37
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-37
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-37
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-37
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-37
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		6e-37
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		6e-37
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-37
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		8e-37
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		8e-37
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		9e-37
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		9e-37
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-36
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-36
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-36
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-36
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-36
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-36
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-36
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-36
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-36
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-36
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-36
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-36
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-36
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-36
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-36
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-36
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-36
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-36
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		3e-36
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-36
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		5e-36
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-35
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-35
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		4e-35
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		5e-35
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		5e-35
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		1e-34
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-34
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-34
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-34
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-34
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		5e-34
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-33
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		7e-32
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-32
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		8e-32
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-31
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-31
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-31
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-30
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-30
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-30
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-30
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		4e-30
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-30
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		4e-30
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		4e-30
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-30
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-30
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		4e-30
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-30
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		4e-30
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-30
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-30
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		4e-30
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		4e-30
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		5e-30
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-30
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-30
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-29
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-29
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		1e-29
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-29
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-29
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-29
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		2e-29
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-29
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-29
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-29
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-29
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-28
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-28
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-27
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-27
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-27
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		5e-27
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		5e-27
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		5e-27
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-27
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-27
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-27
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		5e-27
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-27
2oza_A	356	Structure Of P38alpha Complex Length = 356		6e-27
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		6e-27
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		6e-27
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		6e-27
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-27
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-26
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-26
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		4e-26
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-25
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-25
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-25
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		8e-25
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-25
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		8e-25
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		1e-24
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-24
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		1e-24
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-24
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-24
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-24
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		6e-24
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-24
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		8e-24
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-24
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-24
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-24
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		9e-24
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-23
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-23
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-23
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-23
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-23
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-23
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-23
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		5e-23
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-23
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		6e-23
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-23
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		7e-23
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-23
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		1e-22
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-22
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-22
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-22
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-22
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-22
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-22
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-22
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-22
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-22
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-22
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-22
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-22
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-22
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-22
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		3e-22
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		3e-22
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		4e-22
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		4e-22
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		5e-22
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-22
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		5e-22
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-22
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		5e-22
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		5e-22
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-22
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		5e-22
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		5e-22
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		5e-22
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		5e-22
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-22
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		5e-22
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		5e-22
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		5e-22
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-22
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-22
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-22
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-22
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-22
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-22
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		6e-22
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		6e-22
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-22
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		6e-22
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-21
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-21
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-21
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		1e-21
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-21
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-21
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-21
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-21
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-21
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-21
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		2e-21
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-21
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		2e-21
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-21
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-21
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-21
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-21
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-21
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		2e-21
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-21
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		2e-21
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-21
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-21
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-21
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		2e-21
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-21
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-21
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-21
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-21
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-21
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-21
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-21
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-21
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-21
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-21
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-21
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-21
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-21
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-21
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-21
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-21
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-21
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-21
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-21
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-21
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-21
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-21
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-21
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		3e-21
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-21
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-21
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-21
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-21
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-21
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-21
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		5e-21
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-21
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-21
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		6e-21
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		7e-21
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		8e-21
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-21
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-20
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-20
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-20
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-20
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-20
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-20
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-20
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-20
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-20
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-20
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-20
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-20
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		2e-20
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-20
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-20
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-20
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-20
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-20
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-20
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-20
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		2e-20
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-20
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-20
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-20
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-20
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-20
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-20
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		2e-20
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-20
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-20
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-20
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-20
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-20
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-20
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-20
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-19
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-19
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-19
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-19
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-19
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-19
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-19
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-19
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-19
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-19
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-19
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-19
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-19
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-19
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-19
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-19
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-19
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-19
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-19
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-19
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-19
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-19
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		4e-19
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-19
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-19
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-19
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-19
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-19
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-19
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-19
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-19
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-19
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-19
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-19
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-19
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		7e-19
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		7e-19
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		9e-19
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-19
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		9e-19
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-19
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-19
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-19
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-18
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-18
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-18
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-18
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-18
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		1e-18
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-18
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		1e-18
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		2e-18
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-18
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		2e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		3e-18
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-18
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-18
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		4e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		4e-18
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-18
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		5e-18
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-18
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		6e-18
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-18
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-18
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-18
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-18
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-18
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-18
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-18
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-18
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-18
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-18
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		9e-18
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-18
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-18
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		9e-18
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		1e-17
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		1e-17
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-17
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-17
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-17
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-17
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		2e-17
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-17
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-17
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-17
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-17
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		3e-17
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		3e-17
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		3e-17
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-17
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-17
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-17
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-17
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-17
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-17
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-17
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		5e-17
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		5e-17
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-17
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-17
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-17
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-17
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-17
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		6e-17
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		6e-17
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-17
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		6e-17
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		6e-17
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-17
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		6e-17
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-17
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-17
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		6e-17
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-17
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		7e-17
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-17
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		7e-17
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		8e-17
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-16
4exu_A	371	Mapk13, Inactive Form Length = 371		1e-16
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-16
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-16
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-16
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-16
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-16
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-16
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-16
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-16
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		2e-16
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-16
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-16
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-16
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-16
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-16
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-16
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-16
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-16
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-16
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		5e-16
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		5e-16
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		5e-16
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-16
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		6e-16
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		6e-16
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		6e-16
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		6e-16
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		6e-16
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-16
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		6e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		6e-16
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-16
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		6e-16
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		7e-16
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		7e-16
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		7e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		8e-16
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		9e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		9e-16
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-15
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-15
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-15
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-15
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-15
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-15
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-15
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-15
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-15
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-15
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-15
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-15
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-15
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-15
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-15
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-15
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		2e-15
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-15
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-15
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-15
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-15
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-15
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		3e-15
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-15
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-15
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-15
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-15
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-15
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-15
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-15
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-15
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-15
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-15
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-15
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-15
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-15
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		5e-15
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-15
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		5e-15
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		6e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-15
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		6e-15
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		6e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		7e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		7e-15
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		7e-15
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		7e-15
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		7e-15
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-15
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		8e-15
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-15
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		8e-15
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-15
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-15
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		9e-15
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-14
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-14
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-14
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-14
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-14
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-14
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-14
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-14
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-14
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		2e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-14
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		3e-14
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		3e-14
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		3e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		3e-14
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-14
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-14
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		4e-14
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-14
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-14
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-14
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-14
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		5e-14
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-14
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		5e-14
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		6e-14
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-14
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		6e-14
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-14
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		6e-14
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		6e-14
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		6e-14
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-14
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		7e-14
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		7e-14
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-14
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		7e-14
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		7e-14
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		7e-14
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-14
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		9e-14
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		9e-14
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		9e-14
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		9e-14
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		9e-14
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-14
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		9e-14
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-13
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-13
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-13
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-13
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-13
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		1e-13
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-13
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-13
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		1e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-13
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-13
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-13
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		1e-13
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-13
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-13
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-13
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-13
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-13
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-13
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-13
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		2e-13
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-13
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-13
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		2e-13
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-13
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		2e-13
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-13
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		2e-13
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-13
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		2e-13
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		3e-13
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		3e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-13
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		5e-13
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-13
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		5e-13
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-13
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-13
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-13
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-13
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-13
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-13
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-13
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		7e-13
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		7e-13
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-13
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		8e-13
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-13
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		9e-13
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		9e-13
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-13
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		9e-13
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-12
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-12
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-12
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-12
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-12
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-12
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-12
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		1e-12
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-12
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-12
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		1e-12
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-12
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-12
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-12
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		1e-12
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		1e-12
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-12
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-12
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-12
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		1e-12
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		1e-12
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		1e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		1e-12
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		2e-12
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		2e-12
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-12
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-12
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		2e-12
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		2e-12
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-12
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-12
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		2e-12
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-12
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-12
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-12
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-12
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-12
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-12
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		3e-12
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		3e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-12
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		4e-12
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-12
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-12
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		4e-12
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-12
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-12
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		5e-12
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-12
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-12
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		9e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-12
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-11
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-11
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-11
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		1e-11
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		1e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-11
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-11
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-11
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		1e-11
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-11
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		2e-11
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		2e-11
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-11
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-11
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-11
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		3e-11
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-11
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		4e-11
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		5e-11
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-11
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		5e-11
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		6e-11
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-11
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		7e-11
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		7e-11
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		7e-11
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		9e-11
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		9e-11
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-11
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-10
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-10
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-10
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		2e-10
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-10
3gni_B	389	Structure Of Strad And Mo25 Length = 389		3e-10
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-10
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-10
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-10
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		4e-10
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		4e-10
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		4e-10
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-10
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-10
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		5e-10
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		5e-10
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		6e-10
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		6e-10
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		7e-10
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		7e-10
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		7e-10
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-10
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		8e-10
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		8e-10
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		8e-10
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		8e-10
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		8e-10
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-10
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		9e-10
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		9e-10
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		9e-10
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-09
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		1e-09
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-09
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-09
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-09
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-09
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-09
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		2e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-09
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		3e-09
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		3e-09
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		4e-09
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-09
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-09
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		4e-09
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		4e-09
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		4e-09
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-09
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		4e-09
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-09
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		4e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		4e-09
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		4e-09
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-09
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-09
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		5e-09
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		5e-09
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-09
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		6e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-09

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  277 bits (708), Expect = 6e-75,   Method: Compositional matrix adjust.
 Identities = 141/298 (47%), Positives = 196/298 (65%), Gaps = 11/298 (3%)
Query: 3   IAEKKQEG--MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
           +AEK++    +++G Y LG TLG G FGKVK  +   +G   AVKIL + +I  L +  +
Sbjct: 3   MAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK 62
Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
           I+REI  LKL +HP++++L++V+++ S I+MV+EYV+GGELFD I   GRL E E R+LF
Sbjct: 63  IRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF 122
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
           QQ++ GV YCH   V HRDLK EN+LLD+  N KI+DFGLS +     D   L  +CGSP
Sbjct: 123 QQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRXSCGSP 179
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
           NY APEV++ R Y G   DIWS GVILY +L G LPFDD ++  L++KI  G F  P++L
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL 239
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT----PANPDDDEEDIFVDNEAF 294
           +P   +LL+ +L+ +P+KR TI  I+  EWF+QD      P +P        +D+EA 
Sbjct: 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDP--SYSSTMIDDEAL 295

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  275 bits (702), Expect = 4e-74,   Method: Compositional matrix adjust.
 Identities = 133/269 (49%), Positives = 184/269 (68%), Gaps = 4/269 (1%)
Query: 7   KQEG-MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           K +G +++G Y LG TLG G FGKVK  +   +G   AVKIL + +I  L +  +IKREI
Sbjct: 3   KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62
Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
             LKL +HP++++L++V+++ +  +MV+EYV+GGELFD I   GR++E E R+LFQQ++ 
Sbjct: 63  QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
            V YCH   V HRDLK EN+LLD+  N KI+DFGLS +     D   L T+CGSPNY AP
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAP 179
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
           EV++ R Y G   DIWSCGVILY +L G LPFDD ++  L++KI  G F +P++L+    
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVA 239
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQD 274
            LL  +L+ +P+KR TI  I+  EWF+QD
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQD 268

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  272 bits (695), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 132/269 (49%), Positives = 183/269 (68%), Gaps = 4/269 (1%)
Query: 7   KQEG-MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           K +G +++G Y LG TLG G FGKVK  +   +G   AVKIL + +I  L +  +IKREI
Sbjct: 3   KHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREI 62
Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
             LKL +HP++++L++V+++ +  +MV+EYV+GGELFD I   GR++E E R+LFQQ++ 
Sbjct: 63  QNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
            V YCH   V HRDLK EN+LLD+  N KI+DFGLS +     D   L  +CGSPNY AP
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRDSCGSPNYAAP 179
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
           EV++ R Y G   DIWSCGVILY +L G LPFDD ++  L++KI  G F +P++L+    
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVA 239
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQD 274
            LL  +L+ +P+KR TI  I+  EWF+QD
Sbjct: 240 TLLMHMLQVDPLKRATIKDIREHEWFKQD 268

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  266 bits (680), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 127/266 (47%), Positives = 182/266 (68%), Gaps = 4/266 (1%)
Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +G  +G Y++ +TLGEG+FGKVK A    +G   A+KI+ K  +    +  +I+REI+ L
Sbjct: 9   DGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL 68
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           +LL+HP++++L++V+ SK +I MV+EY  G ELFD I  + ++ E E R+ FQQ+I  V 
Sbjct: 69  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 127
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           YCH   + HRDLK EN+LLD   N+KI+DFGLS +     D   L T+CGSPNY APEV+
Sbjct: 128 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVI 184
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
           + + Y G   D+WSCGVILYV+L   LPFDD ++ VL++ I  G + LPK+LSPGA  L+
Sbjct: 185 SGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLI 244
Query: 249 RKILEPNPVKRITIAGIKADEWFEQD 274
           +++L  NP+ RI+I  I  D+WF+ D
Sbjct: 245 KRMLIVNPLNRISIHEIMQDDWFKVD 270

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  266 bits (679), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 127/266 (47%), Positives = 182/266 (68%), Gaps = 4/266 (1%)
Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +G  +G Y++ +TLGEG+FGKVK A    +G   A+KI+ K  +    +  +I+REI+ L
Sbjct: 8   DGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL 67
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           +LL+HP++++L++V+ SK +I MV+EY  G ELFD I  + ++ E E R+ FQQ+I  V 
Sbjct: 68  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 126
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           YCH   + HRDLK EN+LLD   N+KI+DFGLS +     D   L T+CGSPNY APEV+
Sbjct: 127 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVI 183
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
           + + Y G   D+WSCGVILYV+L   LPFDD ++ VL++ I  G + LPK+LSPGA  L+
Sbjct: 184 SGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLI 243
Query: 249 RKILEPNPVKRITIAGIKADEWFEQD 274
           +++L  NP+ RI+I  I  D+WF+ D
Sbjct: 244 KRMLIVNPLNRISIHEIMQDDWFKVD 269

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  266 bits (679), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 127/266 (47%), Positives = 182/266 (68%), Gaps = 4/266 (1%)
Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +G  +G Y++ +TLGEG+FGKVK A    +G   A+KI+ K  +    +  +I+REI+ L
Sbjct: 3   DGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYL 62
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           +LL+HP++++L++V+ SK +I MV+EY  G ELFD I  + ++ E E R+ FQQ+I  V 
Sbjct: 63  RLLRHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVE 121
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           YCH   + HRDLK EN+LLD   N+KI+DFGLS +     D   L T+CGSPNY APEV+
Sbjct: 122 YCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVI 178
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
           + + Y G   D+WSCGVILYV+L   LPFDD ++ VL++ I  G + LPK+LSPGA  L+
Sbjct: 179 SGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLI 238
Query: 249 RKILEPNPVKRITIAGIKADEWFEQD 274
           +++L  NP+ RI+I  I  D+WF+ D
Sbjct: 239 KRMLIVNPLNRISIHEIMQDDWFKVD 264

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  263 bits (673), Expect = 8e-71,   Method: Compositional matrix adjust.
 Identities = 126/263 (47%), Positives = 180/263 (68%), Gaps = 4/263 (1%)
Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
            +G Y++ +TLGEG+FGKVK A    +G   A+KI+ K  +    +  +I+REI+ L+LL
Sbjct: 2   HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLL 61
Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           +HP++++L++V+ SK +I MV+EY  G ELFD I  + ++ E E R+ FQQ+I  V YCH
Sbjct: 62  RHPHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCH 120
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
              + HRDLK EN+LLD   N+KI+DFGLS +     D   L T+CGSPNY APEV++ +
Sbjct: 121 RHKIVHRDLKPENLLLDEHLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVISGK 177
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
            Y G   D+WSCGVILYV+L   LPFDD ++ VL++ I  G + LPK+LSPGA  L++++
Sbjct: 178 LYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 237
Query: 252 LEPNPVKRITIAGIKADEWFEQD 274
           L  NP+ RI+I  I  D+WF+ D
Sbjct: 238 LIVNPLNRISIHEIMQDDWFKVD 260

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  252 bits (643), Expect = 3e-67,   Method: Compositional matrix adjust.
 Identities = 119/259 (45%), Positives = 175/259 (67%), Gaps = 4/259 (1%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +G Y +  TLGEG+FGKVK A    +    A+K + +  +    +  +++REI+ LKLL+
Sbjct: 8   IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP++++L++V+ + + I MV+EY  GGELFD I  K R+ E EGR+ FQQ+I  + YCH 
Sbjct: 68  HPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHR 126
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             + HRDLK EN+LLD   N+KI+DFGLS +     D   L T+CGSPNY APEV+  + 
Sbjct: 127 HKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPEVINGKL 183
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
           Y G   D+WSCG++LYV+L G LPFDD  +  L++K+    + +P +LSPGAQ+L+R+++
Sbjct: 184 YAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLIRRMI 243
Query: 253 EPNPVKRITIAGIKADEWF 271
             +P++RITI  I+ D WF
Sbjct: 244 VADPMQRITIQEIRRDPWF 262

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  248 bits (634), Expect = 3e-66,   Method: Compositional matrix adjust.
 Identities = 119/280 (42%), Positives = 182/280 (65%), Gaps = 9/280 (3%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +G Y L +T+G+GNF KVK A+ + +G   A+KI++K ++    +  ++ RE+  +K+L 
Sbjct: 11  IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-QKLFREVRIMKILN 69
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPN+V+L EV+ ++  +Y+++EY +GGE+FD + + GR++E E R  F+Q++  V YCH 
Sbjct: 70  HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 129
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           K + HRDLK EN+LLD+  NIKI+DFG S     F   G L T CGSP Y APE+   + 
Sbjct: 130 KRIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDTFCGSPPYAAPELFQGKK 186
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
           YDG   D+WS GVILY +++G LPFD +NL  L +++ RG +++P ++S   +NLL++ L
Sbjct: 187 YDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFL 246
Query: 253 EPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNE 292
             NP+KR T+  I  D W       A  ++DE   FV+ E
Sbjct: 247 VLNPIKRGTLEQIMKDRWIN-----AGHEEDELKPFVEPE 281

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  246 bits (629), Expect = 9e-66,   Method: Compositional matrix adjust.
 Identities = 120/290 (41%), Positives = 184/290 (63%), Gaps = 9/290 (3%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           IA    E   +G Y L +T+G+GNF KVK A+ + +G   A+KI++K ++    +  ++ 
Sbjct: 4   IASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-QKLF 62
Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           RE+  +K+L HPN+V+L EV+ ++  +Y+++EY +GGE+FD + + GR++E E R  F+Q
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ 122
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           ++  V YCH K + HRDLK EN+LLD+  NIKI+DFG S     F   G L   CG+P Y
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS---NEFTVGGKLDAFCGAPPY 179
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
            APE+   + YDG   D+WS GVILY +++G LPFD +NL  L +++ RG +++P ++S 
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNE 292
             +NLL++ L  NP+KR T+  I  D W       A  ++DE   FV+ E
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWIN-----AGHEEDELKPFVEPE 284

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  243 bits (621), Expect = 8e-65,   Method: Compositional matrix adjust.
 Identities = 121/287 (42%), Positives = 181/287 (63%), Gaps = 9/287 (3%)
Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           A    E   +G Y L +T+G+GNF KVK A+ + +G   AVKI++K ++    +  ++ R
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL-QKLFR 62
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           E+  +K+L HPN+V+L EV+ ++  +Y+V+EY +GGE+FD + + GR++E E R  F+Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           +  V YCH K + HRDLK EN+LLD+  NIKI+DFG S     F     L T CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYA 179
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
           APE+   + YDG   D+WS GVILY +++G LPFD +NL  L +++ RG +++P ++S  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD 290
            +NLL+K L  NP KR T+  I  D W    +     +DDE   +V+
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIMKDRWMNVGH-----EDDELKPYVE 281

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  243 bits (620), Expect = 1e-64,   Method: Compositional matrix adjust.
 Identities = 117/268 (43%), Positives = 173/268 (64%), Gaps = 4/268 (1%)
Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           A    E   +G Y L +T+G+GNF KVK A+ + +G   AVKI++K ++    +  ++ R
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL-QKLFR 62
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           E+  +K+L HPN+V+L EV+ ++  +Y+V+EY +GGE+FD + + GR++E E R  F+Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           +  V YCH K + HRDLK EN+LLD+  NIKI+DFG S     F     L T CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYA 179
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
           APE+   + YDG   D+WS GVILY +++G LPFD +NL  L +++ RG +++P ++S  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWF 271
            +NLL+K L  NP KR T+  I  D W 
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIMKDRWM 267

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  243 bits (619), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 120/287 (41%), Positives = 181/287 (63%), Gaps = 9/287 (3%)
Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           A    E   +G Y L +T+G+GNF KVK A+ + +G   AV+I++K ++    +  ++ R
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSL-QKLFR 62
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           E+  +K+L HPN+V+L EV+ ++  +Y+V+EY +GGE+FD + + GR++E E R  F+Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           +  V YCH K + HRDLK EN+LLD+  NIKI+DFG S     F     L T CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYA 179
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
           APE+   + YDG   D+WS GVILY +++G LPFD +NL  L +++ RG +++P ++S  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD 290
            +NLL+K L  NP KR T+  I  D W    +     +DDE   +V+
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIMKDRWMNVGH-----EDDELKPYVE 281

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  240 bits (613), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 119/287 (41%), Positives = 180/287 (62%), Gaps = 9/287 (3%)
Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           A    E   +G Y L +T+G+GNF KVK A+ + +G   AVKI++K ++    +  ++ R
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL-QKLFR 62
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           E+  +K+L HPN+V+L EV+ ++  +Y+V+EY +GGE+FD + + GR++E E R  F+Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           +  V YCH K + HRDLK EN+LLD+  NIKI+DFG S     F     L   CG+P Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDAFCGAPPYA 179
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
           APE+   + YDG   D+WS GVILY +++G LPFD +NL  L +++ RG +++P ++S  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD 290
            +NLL+K L  NP KR T+  I  D W    +     +DDE   +V+
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIMKDRWMNVGH-----EDDELKPYVE 281

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  240 bits (612), Expect = 8e-64,   Method: Compositional matrix adjust.
 Identities = 119/287 (41%), Positives = 179/287 (62%), Gaps = 9/287 (3%)
Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           A    E   +G Y L +T+G+GNF KVK A+ + +G   AV+I++K ++    +  ++ R
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSL-QKLFR 62
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           E+  +K+L HPN+V+L EV+ ++  +Y+V+EY +GGE+FD + + GR++E E R  F+Q+
Sbjct: 63  EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQI 122
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           +  V YCH K + HRDLK EN+LLD+  NIKI+DFG S     F     L   CGSP Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDEFCGSPPYA 179
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
           APE+   + YDG   D+WS GVILY +++G LPFD +NL  L +++ RG +++P ++S  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 239
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD 290
            +NLL+K L  NP KR T+  I  D W          +DDE   +V+
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIMKDRWMN-----VGHEDDELKPYVE 281

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  239 bits (611), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 118/280 (42%), Positives = 178/280 (63%), Gaps = 9/280 (3%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           + +G Y L +T+G+GNF KVK A+ + +G   AVKI++K ++    +  ++ RE+  +K+
Sbjct: 4   LHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL-QKLFREVRIMKV 62
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HPN+V+L EV+ ++  +Y+V+EY +GGE+FD + + G ++E E R  F+Q++  V YC
Sbjct: 63  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYC 122
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           H K + HRDLK EN+LLD+  NIKI+DFG S     F     L T CGSP Y APE+   
Sbjct: 123 HQKFIVHRDLKAENLLLDADMNIKIADFGFS---NEFTFGNKLDTFCGSPPYAAPELFQG 179
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250
           + YDG   D+WS GVILY +++G LPFD +NL  L +++ RG +++P ++S   +NLL+K
Sbjct: 180 KKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKK 239
Query: 251 ILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD 290
            L  NP KR T+  I  D W          +DDE   +V+
Sbjct: 240 FLILNPSKRGTLEQIMKDRWMN-----VGHEDDELKPYVE 274

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  235 bits (599), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 115/267 (43%), Positives = 168/267 (62%), Gaps = 4/267 (1%)
Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           A    E   +G Y L +T+G+GNF KVK A+ + +G   AVKI++K ++    +  ++ R
Sbjct: 4   ATSADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSL-QKLFR 62
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           E+   K+L HPN+V+L EV+ ++  +Y+V EY +GGE+FD + + GR +E E R  F+Q+
Sbjct: 63  EVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQI 122
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           +  V YCH K + HRDLK EN+LLD+  NIKI+DFG S     F     L   CG+P Y 
Sbjct: 123 VSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFS---NEFTFGNKLDAFCGAPPYA 179
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
           APE+   + YDG   D+WS GVILY +++G LPFD +NL  L +++ RG +++P + S  
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTD 239
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
            +NLL+K L  NP KR T+  I  D W
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIXKDRW 266

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  232 bits (592), Expect = 2e-61,   Method: Compositional matrix adjust.
 Identities = 122/290 (42%), Positives = 182/290 (62%), Gaps = 10/290 (3%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           I     E   +G Y L +T+G+GNF KVK A+ + +G   AVKI++K ++    +  ++ 
Sbjct: 4   ITSATDEQPHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSL-QKLF 62
Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           RE+  +K+L HPN+V+L EV+ ++  +Y+V+EY +GGE+FD + + GR++E E R  F+Q
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQ 122
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           ++  V YCH K + HRDLK EN+LLD   NIKI+DFG S     F     L T CGSP Y
Sbjct: 123 IVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFS---NEFTVGNKLDTFCGSPPY 179
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
            APE+   + YDG   D+WS GVILY +++G LPFD +NL  L +++ RG +++P ++S 
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWF-----EQDYTP-ANPDDDEED 286
             +NLL+K+L  NP+KR ++  I  D W      E++  P   PD D  D
Sbjct: 240 DCENLLKKLLVLNPIKRGSLEQIMKDRWMNVGHEEEELKPYTEPDPDFND 289

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  220 bits (561), Expect = 8e-58,   Method: Compositional matrix adjust.
 Identities = 116/269 (43%), Positives = 160/269 (59%), Gaps = 23/269 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYEL + +G GNFG  +  +D  S    AVK +E+      KI + +KREI   + L+HP
Sbjct: 19  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHP 74
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VR  EV+ + + + +V+EY +GGELF++I + GR  E E R  FQQLI GVSYCH   
Sbjct: 75  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 134
Query: 135 VFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLH----TTCGSPNYVAPEVL 188
           V HRDLKLEN LLD      +KI DFG S          +LH    +T G+P Y+APEVL
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVL 187
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRGDFKLPKW--LSP 242
             + YDG  +D+WSCGV LYV+L G  PF+D    +N      +I    + +P +  +SP
Sbjct: 188 LKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISP 247
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWF 271
             ++L+ +I   +P KRI+I  I+  EWF
Sbjct: 248 ECRHLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  219 bits (559), Expect = 1e-57,   Method: Compositional matrix adjust.
 Identities = 116/269 (43%), Positives = 159/269 (59%), Gaps = 23/269 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYEL + +G GNFG  +  +D  S    AVK +E+      KI   +KREI   + L+HP
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIAANVKREIINHRSLRHP 75
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VR  EV+ + + + +V+EY +GGELF++I + GR  E E R  FQQLI GVSYCH   
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 135 VFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLH----TTCGSPNYVAPEVL 188
           V HRDLKLEN LLD      +KI DFG S          +LH    +T G+P Y+APEVL
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVL 188
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRGDFKLPKW--LSP 242
             + YDG  +D+WSCGV LYV+L G  PF+D    +N      +I    + +P +  +SP
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISP 248
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWF 271
             ++L+ +I   +P KRI+I  I+  EWF
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  217 bits (553), Expect = 6e-57,   Method: Compositional matrix adjust.
 Identities = 115/269 (42%), Positives = 159/269 (59%), Gaps = 23/269 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYEL + +G GNFG  +  +D  S    AVK +E+      KI + +KREI   + L+HP
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHP 75
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VR  EV+ + + + +V+EY +GGELF++I + GR  E E R  FQQLI GVSYCH   
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 135 VFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLH----TTCGSPNYVAPEVL 188
           V HRDLKLEN LLD      +KI  FG S          +LH    +T G+P Y+APEVL
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSK-------SSVLHSQPKSTVGTPAYIAPEVL 188
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRGDFKLPKW--LSP 242
             + YDG  +D+WSCGV LYV+L G  PF+D    +N      +I    + +P +  +SP
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISP 248
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWF 271
             ++L+ +I   +P KRI+I  I+  EWF
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  217 bits (552), Expect = 8e-57,   Method: Compositional matrix adjust.
 Identities = 115/269 (42%), Positives = 159/269 (59%), Gaps = 23/269 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYEL + +G GNFG  +  +D  S    AVK +E+      KI + +KREI   + L+HP
Sbjct: 20  RYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGE----KIDENVKREIINHRSLRHP 75
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VR  EV+ + + + +V+EY +GGELF++I + GR  E E R  FQQLI GVSYCH   
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ 135
Query: 135 VFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHT----TCGSPNYVAPEVL 188
           V HRDLKLEN LLD      +KI  FG S          +LH+    T G+P Y+APEVL
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSK-------SSVLHSQPKDTVGTPAYIAPEVL 188
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRGDFKLPKW--LSP 242
             + YDG  +D+WSCGV LYV+L G  PF+D    +N      +I    + +P +  +SP
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISP 248
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWF 271
             ++L+ +I   +P KRI+I  I+  EWF
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  214 bits (544), Expect = 7e-56,   Method: Compositional matrix adjust.
 Identities = 113/269 (42%), Positives = 159/269 (59%), Gaps = 23/269 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYEL + +G GNFG  +  +D  +    AVK +E+      KI + +KREI   + L+HP
Sbjct: 20  RYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGE----KIDENVKREIINHRSLRHP 75
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VR  EV+ + + + +V+EY +GGELF++I + GR  E E R  FQQLI GVSY H   
Sbjct: 76  NIVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQ 135
Query: 135 VFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLH----TTCGSPNYVAPEVL 188
           V HRDLKLEN LLD      +KI+DFG S          +LH    +  G+P Y+APEVL
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKA-------SVLHSQPKSAVGTPAYIAPEVL 188
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRGDFKLPKW--LSP 242
             + YDG  +D+WSCGV LYV+L G  PF+D    +N      +I    + +P +  +SP
Sbjct: 189 LKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISP 248
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWF 271
             ++L+ +I   +P KRI+I  I+  EWF
Sbjct: 249 ECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  204 bits (518), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 107/269 (39%), Positives = 156/269 (57%), Gaps = 23/269 (8%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  + +G GNFG  +  +D  +    AVK +E+       I + ++REI   + L+HP
Sbjct: 21  RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERG----AAIDENVQREIINHRSLRHP 76
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VR  EV+ + + + +++EY +GGEL+++I + GR  E E R  FQQL+ GVSYCH+  
Sbjct: 77  NIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ 136
Query: 135 VFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLH----TTCGSPNYVAPEVL 188
           + HRDLKLEN LLD      +KI DFG S          +LH    +T G+P Y+APEVL
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSK-------SSVLHSQPKSTVGTPAYIAPEVL 189
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRGDFKLPK--WLSP 242
             + YDG  +D+WSCGV LYV+L G  PF+D    R+     Q+I    + +P    +SP
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP 249
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWF 271
              +L+ +I   +P  RI+I  IK   WF
Sbjct: 250 ECCHLISRIFVADPATRISIPEIKTHSWF 278

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 107/279 (38%), Positives = 163/279 (58%), Gaps = 11/279 (3%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+L   LG+G F  V+    + +G  +A KI+   ++   +   +++RE    +LLKHPN
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL-SARDHQKLEREARICRLLKHPN 64
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ ++ +   Y+V + VTGGELF+ I ++    EA+     QQ+++ V++CH  G+
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGI 124
Query: 136 FHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN+LL SK     +K++DFGL+   Q   D        G+P Y++PEVL    
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQG--DQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLL 248
           Y G   D+W+CGVILY++L GY PF D +   LYQ+I  G  DF  P+W  ++P A++L+
Sbjct: 183 Y-GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 241
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
            K+L  NP KRIT +      W  Q  T A+    +E +
Sbjct: 242 NKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETV 280

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  189 bits (480), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 107/279 (38%), Positives = 163/279 (58%), Gaps = 11/279 (3%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+L   LG+G F  V+    + +G  +A KI+   ++   +   +++RE    +LLKHPN
Sbjct: 6   YQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKL-SARDHQKLEREARICRLLKHPN 64
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ ++ +   Y+V + VTGGELF+ I ++    EA+     QQ+++ V++CH  G+
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNGI 124
Query: 136 FHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN+LL SK     +K++DFGL+   Q   D        G+P Y++PEVL    
Sbjct: 125 VHRDLKPENLLLASKSKGAAVKLADFGLAIEVQ--GDQQAWFGFAGTPGYLSPEVLRKDP 182
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLL 248
           Y G   D+W+CGVILY++L GY PF D +   LYQ+I  G  DF  P+W  ++P A++L+
Sbjct: 183 Y-GKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 241
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
            K+L  NP KRIT +      W  Q  T A+    +E +
Sbjct: 242 NKMLTINPAKRITASEALKHPWICQRSTVASMMHRQETV 280

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  189 bits (479), Expect = 2e-48,   Method: Compositional matrix adjust.
 Identities = 104/266 (39%), Positives = 155/266 (58%), Gaps = 13/266 (4%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E   TLG G F +V  A++  +G  FAVK + K  +   + +  I+ EIA L+ +KH N
Sbjct: 24  FEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESS--IENEIAVLRKIKHEN 81
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V L ++  S + +Y+V++ V+GGELFD+I  KG   E +   L +Q++D V Y H  G+
Sbjct: 82  IVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGI 141
Query: 136 FHRDLKLENILL---DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN+L    D +  I ISDFGLS +        ++ T CG+P YVAPEVLA + 
Sbjct: 142 VHRDLKPENLLYYSQDEESKIMISDFGLSKMEGK---GDVMSTACGTPGYVAPEVLAQKP 198
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW--LSPGAQNLL 248
           Y  A  D WS GVI Y++L GY PF D N + L+++I + +++   P W  +S  A++ +
Sbjct: 199 YSKAV-DCWSIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFI 257
Query: 249 RKILEPNPVKRITIAGIKADEWFEQD 274
           R ++E +P KR T        W   D
Sbjct: 258 RNLMEKDPNKRYTCEQAARHPWIAGD 283

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  188 bits (478), Expect = 4e-48,   Method: Compositional matrix adjust.
 Identities = 108/279 (38%), Positives = 160/279 (57%), Gaps = 11/279 (3%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+L   +G+G F  V+    L +G  +A KI+   ++   +   +++RE    +LLKH N
Sbjct: 6   YQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKL-SARDHQKLEREARICRLLKHSN 64
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ ++ +   Y+V + VTGGELF+ I ++    EA+     QQ+++ V +CH  GV
Sbjct: 65  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 124
Query: 136 FHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN+LL SK     +K++DFGL+   Q   D        G+P Y++PEVL    
Sbjct: 125 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ--GDQQAWFGFAGTPGYLSPEVLRKEA 182
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLL 248
           Y G   DIW+CGVILY++L GY PF D +   LYQ+I  G  DF  P+W  ++P A+NL+
Sbjct: 183 Y-GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLI 241
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
            ++L  NP KRIT        W  Q  T A+    +E +
Sbjct: 242 NQMLTINPAKRITAHEALKHPWVCQRSTVASMMHRQETV 280

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  187 bits (476), Expect = 6e-48,   Method: Compositional matrix adjust.
 Identities = 106/269 (39%), Positives = 158/269 (58%), Gaps = 13/269 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  R LG+G+FG+V   +D  +G   AVK++ K ++      + + RE+  LK L HP
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L+E    K   Y+V E  TGGELFD+I S+ R  E +  ++ +Q++ G++Y H   
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146
Query: 135 VFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK    NI+I DFGLS    HF     +    G+  Y+APEVL   
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPEVL--H 201
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
           G      D+WS GVILY++L+G  PF+  N   + +K+ +G   F+LP+W  +S  A++L
Sbjct: 202 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYT 276
           +RK+L   P  RI+       EW  Q YT
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWI-QTYT 289

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  187 bits (475), Expect = 8e-48,   Method: Compositional matrix adjust.
 Identities = 106/269 (39%), Positives = 158/269 (58%), Gaps = 13/269 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  R LG+G+FG+V   +D  +G   AVK++ K ++      + + RE+  LK L HP
Sbjct: 50  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 109
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L+E    K   Y+V E  TGGELFD+I S+ R  E +  ++ +Q++ G++Y H   
Sbjct: 110 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 169
Query: 135 VFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK    NI+I DFGLS    HF     +    G+  Y+APEVL   
Sbjct: 170 IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPEVL--H 224
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
           G      D+WS GVILY++L+G  PF+  N   + +K+ +G   F+LP+W  +S  A++L
Sbjct: 225 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 284
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYT 276
           +RK+L   P  RI+       EW  Q YT
Sbjct: 285 IRKMLTYVPSMRISARDALDHEWI-QTYT 312

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  187 bits (474), Expect = 9e-48,   Method: Compositional matrix adjust.
 Identities = 106/269 (39%), Positives = 158/269 (58%), Gaps = 13/269 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  R LG+G+FG+V   +D  +G   AVK++ K ++      + + RE+  LK L HP
Sbjct: 51  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 110
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L+E    K   Y+V E  TGGELFD+I S+ R  E +  ++ +Q++ G++Y H   
Sbjct: 111 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 170
Query: 135 VFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK    NI+I DFGLS    HF     +    G+  Y+APEVL   
Sbjct: 171 IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPEVL--H 225
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
           G      D+WS GVILY++L+G  PF+  N   + +K+ +G   F+LP+W  +S  A++L
Sbjct: 226 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 285
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYT 276
           +RK+L   P  RI+       EW  Q YT
Sbjct: 286 IRKMLTYVPSMRISARDALDHEWI-QTYT 313

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  186 bits (472), Expect = 1e-47,   Method: Compositional matrix adjust.
 Identities = 106/269 (39%), Positives = 158/269 (58%), Gaps = 13/269 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  R LG+G+FG+V   +D  +G   AVK++ K ++      + + RE+  LK L HP
Sbjct: 33  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 92
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L+E    K   Y+V E  TGGELFD+I S+ R  E +  ++ +Q++ G++Y H   
Sbjct: 93  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 152
Query: 135 VFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK    NI+I DFGLS    HF     +    G+  Y+APEVL   
Sbjct: 153 IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKMKDKIGTAYYIAPEVL--H 207
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKW--LSPGAQNL 247
           G      D+WS GVILY++L+G  PF+  N   + +K+ +G   F+LP+W  +S  A++L
Sbjct: 208 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 267
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYT 276
           +RK+L   P  RI+       EW  Q YT
Sbjct: 268 IRKMLTYVPSMRISARDALDHEWI-QTYT 295

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  185 bits (470), Expect = 3e-47,   Method: Compositional matrix adjust.
 Identities = 105/279 (37%), Positives = 161/279 (57%), Gaps = 11/279 (3%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+L   LG+G F  V+    + +G  +A KI+   ++   +   +++RE    +LLKHPN
Sbjct: 24  YQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKL-SARDHQKLEREARICRLLKHPN 82
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ ++ +   Y++ + VTGGELF+ I ++    EA+     QQ+++ V +CH  GV
Sbjct: 83  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 142
Query: 136 FHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN+LL SK     +K++DFGL+   +   +        G+P Y++PEVL    
Sbjct: 143 VHRDLKPENLLLASKLKGAAVKLADFGLAIEVE--GEQQAWFGFAGTPGYLSPEVLRKDP 200
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLL 248
           Y G   D+W+CGVILY++L GY PF D +   LYQ+I  G  DF  P+W  ++P A++L+
Sbjct: 201 Y-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 259
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
            K+L  NP KRIT A      W     T A+    +E +
Sbjct: 260 NKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETV 298

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  184 bits (467), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 108/277 (38%), Positives = 159/277 (57%), Gaps = 16/277 (5%)
Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           K+ E +R   Y+    LG G F +V  A+D  +    A+K + K  +   + +  ++ EI
Sbjct: 11  KQAEDIR-DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGS--MENEI 67
Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
           A L  +KHPN+V L ++  S   +Y++++ V+GGELFD+I  KG   E +  +L  Q++D
Sbjct: 68  AVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 126 GVSYCHNKGVFHRDLKLENIL---LDSKGNIKISDFGLSALPQHFRDDG-LLHTTCGSPN 181
            V Y H+ G+ HRDLK EN+L   LD    I ISDFGLS +     D G +L T CG+P 
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPG 183
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW 239
           YVAPEVLA + Y  A  D WS GVI Y++L GY PF D N A L+++I + +++   P W
Sbjct: 184 YVAPEVLAQKPYSKAV-DCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW 242
Query: 240 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
             +S  A++ +R ++E +P KR T        W   D
Sbjct: 243 DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 279

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  184 bits (466), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 105/267 (39%), Positives = 153/267 (57%), Gaps = 15/267 (5%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+    LG G F +V  A+D  +    A+K + K  +   +    ++ EIA L  +KHPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V L ++  S   +Y++++ V+GGELFD+I  KG   E +  +L  Q++D V Y H+ G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 136 FHRDLKLENIL---LDSKGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANR 191
            HRDLK EN+L   LD    I ISDFGLS +     D G +L T CG+P YVAPEVLA +
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW--LSPGAQNL 247
            Y  A  D WS GVI Y++L GY PF D N A L+++I + +++   P W  +S  A++ 
Sbjct: 194 PYSKAV-DCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQD 274
           +R ++E +P KR T        W   D
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIAGD 279

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  184 bits (466), Expect = 7e-47,   Method: Compositional matrix adjust.
 Identities = 105/267 (39%), Positives = 153/267 (57%), Gaps = 15/267 (5%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+    LG G F +V  A+D  +    A+K + K  +   +    ++ EIA L  +KHPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKE--GSMENEIAVLHKIKHPN 77
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V L ++  S   +Y++++ V+GGELFD+I  KG   E +  +L  Q++D V Y H+ G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 136 FHRDLKLENIL---LDSKGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANR 191
            HRDLK EN+L   LD    I ISDFGLS +     D G +L T CG+P YVAPEVLA +
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW--LSPGAQNL 247
            Y  A  D WS GVI Y++L GY PF D N A L+++I + +++   P W  +S  A++ 
Sbjct: 194 PYSKAV-DCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQD 274
           +R ++E +P KR T        W   D
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIAGD 279

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 106/269 (39%), Positives = 155/269 (57%), Gaps = 13/269 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  R LG+G+FG+V   +D  +G   AVK++ K ++      + + RE+  LK L HP
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+ +L+E    K   Y+V E  TGGELFD+I S+ R  E +  ++ +Q++ G++Y H   
Sbjct: 87  NIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK 146
Query: 135 VFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK    NI+I DFGLS    HF          G+  Y+APEVL   
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLST---HFEASKKXKDKIGTAYYIAPEVL--H 201
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
           G      D+WS GVILY++L+G  PF+  N   + +K+ +G   F+LP+W  +S  A++L
Sbjct: 202 GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYT 276
           +RK L   P  RI+       EW  Q YT
Sbjct: 262 IRKXLTYVPSXRISARDALDHEWI-QTYT 289

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  183 bits (465), Expect = 1e-46,   Method: Compositional matrix adjust.
 Identities = 105/267 (39%), Positives = 154/267 (57%), Gaps = 15/267 (5%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+    LG G F +V  A+D  +    A+K + K  +   + +  ++ EIA L  +KHPN
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGS--MENEIAVLHKIKHPN 77
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +V L ++  S   +Y++++ V+GGELFD+I  KG   E +  +L  Q++D V Y H+ G+
Sbjct: 78  IVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 137
Query: 136 FHRDLKLENIL---LDSKGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLANR 191
            HRDLK EN+L   LD    I ISDFGLS +     D G +L T CG+P YVAPEVLA +
Sbjct: 138 VHRDLKPENLLYYSLDEDSKIMISDFGLSKM----EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW--LSPGAQNL 247
            Y  A  D WS GVI Y++L GY PF D N A L+++I + +++   P W  +S  A++ 
Sbjct: 194 PYSKAV-DCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 252
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQD 274
           +R ++E +P KR T        W   D
Sbjct: 253 IRHLMEKDPEKRFTCEQALQHPWIAGD 279

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  182 bits (461), Expect = 3e-46,   Method: Compositional matrix adjust.
 Identities = 103/279 (36%), Positives = 160/279 (57%), Gaps = 11/279 (3%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+L   LG+G F  V+    + +G  +A  I+   ++   +   +++RE    +LLKHPN
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPN 71
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ ++ +   Y++ + VTGGELF+ I ++    EA+     QQ+++ V +CH  GV
Sbjct: 72  IVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGV 131
Query: 136 FHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HR+LK EN+LL SK     +K++DFGL+   +   +        G+P Y++PEVL    
Sbjct: 132 VHRNLKPENLLLASKLKGAAVKLADFGLAIEVE--GEQQAWFGFAGTPGYLSPEVLRKDP 189
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLL 248
           Y G   D+W+CGVILY++L GY PF D +   LYQ+I  G  DF  P+W  ++P A++L+
Sbjct: 190 Y-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLI 248
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
            K+L  NP KRIT A      W     T A+    +E +
Sbjct: 249 NKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETV 287

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 98/253 (38%), Positives = 151/253 (59%), Gaps = 12/253 (4%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y++   LG+G F  V+      +GL FA KI+   ++   +   +++RE    + L+HPN
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPN 89
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ +  +S  Y+V + VTGGELF+ I ++    EA+     QQ+++ ++YCH+ G+
Sbjct: 90  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 149
Query: 136 FHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HR+LK EN+LL SK     +K++DFGL+       D    H   G+P Y++PEVL    
Sbjct: 150 VHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDP 206
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLL 248
           Y     DIW+CGVILY++L GY PF D +   LY +I  G  D+  P+W  ++P A++L+
Sbjct: 207 YSKPV-DIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 265
Query: 249 RKILEPNPVKRIT 261
             +L  NP KRIT
Sbjct: 266 DSMLTVNPKKRIT 278

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 150/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 150/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 150/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  181 bits (460), Expect = 4e-46,   Method: Compositional matrix adjust.
 Identities = 98/253 (38%), Positives = 151/253 (59%), Gaps = 12/253 (4%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y++   LG+G F  V+      +GL FA KI+   ++   +   +++RE    + L+HPN
Sbjct: 7   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ +  +S  Y+V + VTGGELF+ I ++    EA+     QQ+++ ++YCH+ G+
Sbjct: 66  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 125
Query: 136 FHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HR+LK EN+LL SK     +K++DFGL+       D    H   G+P Y++PEVL    
Sbjct: 126 VHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDP 182
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLL 248
           Y     DIW+CGVILY++L GY PF D +   LY +I  G  D+  P+W  ++P A++L+
Sbjct: 183 YSKPV-DIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 241
Query: 249 RKILEPNPVKRIT 261
             +L  NP KRIT
Sbjct: 242 DSMLTVNPKKRIT 254

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  181 bits (460), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 150/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 247 VENPSARITIPDIKKDRWYNK 267

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  181 bits (460), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 150/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 247 VENPSARITIPDIKKDRWYNK 267

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  181 bits (460), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 150/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 247 VENPSARITIPDIKKDRWYNK 267

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  181 bits (460), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 150/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 247 VENPSARITIPDIKKDRWYNK 267

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  181 bits (459), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 150/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 64
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 65  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 125 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 184
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 185 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 244
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 245 VENPSARITIPDIKKDRWYNK 265

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  181 bits (459), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 150/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 247 VENPSARITIPDIKKDRWYNK 267

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  181 bits (459), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 98/253 (38%), Positives = 151/253 (59%), Gaps = 12/253 (4%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y++   LG+G F  V+      +GL FA KI+   ++   +   +++RE    + L+HPN
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ +  +S  Y+V + VTGGELF+ I ++    EA+     QQ+++ ++YCH+ G+
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126
Query: 136 FHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HR+LK EN+LL SK     +K++DFGL+       D    H   G+P Y++PEVL    
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLL 248
           Y     DIW+CGVILY++L GY PF D +   LY +I  G  D+  P+W  ++P A++L+
Sbjct: 184 YSKPV-DIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242
Query: 249 RKILEPNPVKRIT 261
             +L  NP KRIT
Sbjct: 243 DSMLTVNPKKRIT 255

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  181 bits (459), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 150/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  181 bits (459), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 150/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  181 bits (459), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 150/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 247 VENPSARITIPDIKKDRWYNK 267

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  181 bits (459), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 98/253 (38%), Positives = 151/253 (59%), Gaps = 12/253 (4%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y++   LG+G F  V+      +GL FA KI+   ++   +   +++RE    + L+HPN
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ +  +S  Y+V + VTGGELF+ I ++    EA+     QQ+++ ++YCH+ G+
Sbjct: 67  IVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGI 126
Query: 136 FHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HR+LK EN+LL SK     +K++DFGL+       D    H   G+P Y++PEVL    
Sbjct: 127 VHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKDP 183
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLL 248
           Y     DIW+CGVILY++L GY PF D +   LY +I  G  D+  P+W  ++P A++L+
Sbjct: 184 YSKPV-DIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLI 242
Query: 249 RKILEPNPVKRIT 261
             +L  NP KRIT
Sbjct: 243 DSMLTVNPKKRIT 255

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  181 bits (459), Expect = 5e-46,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 150/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  181 bits (459), Expect = 6e-46,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 150/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 101/261 (38%), Positives = 149/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG  G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 108/279 (38%), Positives = 159/279 (56%), Gaps = 14/279 (5%)
Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +G    RY +   LG+G+FG+V   +D  +   +AVK++ K    + K T  I RE+  L
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELL 75
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           K L HPN+++L E+L   S  Y+V E  TGGELFD+I  + R  E +  ++ +Q+  G++
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 129 YCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
           Y H   + HRDLK ENILL+SK    +IKI DFGLS     F+ +  +    G+  Y+AP
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAP 192
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKW--LS 241
           EVL  RG      D+WS GVILY++L+G  PF  +N   + +++  G   F LP+W  +S
Sbjct: 193 EVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250
Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
             A++L+RK+L  +P  RIT        W  Q Y+   P
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWI-QKYSSETP 288

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 100/261 (38%), Positives = 149/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI    +L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINAMLNHEN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHA 186
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 247 VENPSARITIPDIKKDRWYNK 267

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  179 bits (454), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 151/269 (56%), Gaps = 5/269 (1%)
Query: 2   VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
            +AE  +    +  +++GR LG+G FG V  A++  +    A+K+L K+++    +  Q+
Sbjct: 3   ALAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 62
Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
           +REI     L+HPN++R++     + +IY++LE+   GEL+ ++   GR  E       +
Sbjct: 63  RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME 122
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           +L D + YCH + V HRD+K EN+L+  KG +KI+DFG S      R   +    CG+ +
Sbjct: 123 ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXM----CGTLD 178
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 241
           Y+ PE++  + +D    D+W  GV+ Y  L G  PFD  +    +++I   D K P +LS
Sbjct: 179 YLPPEMIEGKTHDEKV-DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLS 237
Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEW 270
            G+++L+ K+L  +P +R+ + G+    W
Sbjct: 238 DGSKDLISKLLRYHPPQRLPLKGVMEHPW 266

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  178 bits (452), Expect = 4e-45,   Method: Compositional matrix adjust.
 Identities = 92/281 (32%), Positives = 156/281 (55%), Gaps = 6/281 (2%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   GE++ ++    +  E        +L 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELA 123
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ 
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 179
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA
Sbjct: 180 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 239 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 279

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  177 bits (450), Expect = 5e-45,   Method: Compositional matrix adjust.
 Identities = 87/259 (33%), Positives = 149/259 (57%), Gaps = 5/259 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +++GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    R  E        +L + +SYCH+K V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRV 133
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R D    T CG+ +Y+ PE++  R +D 
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRD----TLCGTLDYLPPEMIEGRMHDE 189
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
              D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++L+ ++L+ N
Sbjct: 190 KV-DLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLLKHN 248
Query: 256 PVKRITIAGIKADEWFEQD 274
             +R+T+A +    W + +
Sbjct: 249 ASQRLTLAEVLEHPWIKAN 267

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  177 bits (449), Expect = 8e-45,   Method: Compositional matrix adjust.
 Identities = 93/282 (32%), Positives = 157/282 (55%), Gaps = 8/282 (2%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 25  ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 84
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 144
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYV 183
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S   P   RDD      CG+ +Y+
Sbjct: 145 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD-----LCGTLDYL 199
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
            PE++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ G
Sbjct: 200 PPEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEG 258
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           A++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 259 ARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 300

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 101/270 (37%), Positives = 156/270 (57%), Gaps = 15/270 (5%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y L  T+G G++G+VK A    + +  A K + K     ++  D+ K+EI  +K L HPN
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK---YFVEDVDRFKQEIEIMKSLDHPN 84
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+E     + IY+V+E  TGGELF+++  K   +E++  ++ + ++  V+YCH   V
Sbjct: 85  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 144
Query: 136 FHRDLKLENILL--DSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN L   DS  + +K+ DFGL+A    F+   ++ T  G+P YV+P+VL   G
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL--EG 199
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--WL--SPGAQNLL 248
             G   D WS GV++YV+L GY PF       +  KI  G F  P+  WL  SP A++L+
Sbjct: 200 LYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLI 259
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPA 278
           R++L  +P +RIT       EWFE+  + +
Sbjct: 260 RRLLTKSPKQRITSLQALEHEWFEKQLSSS 289

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 100/261 (38%), Positives = 149/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+   G+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 100/261 (38%), Positives = 149/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+   G+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  177 bits (448), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 101/270 (37%), Positives = 156/270 (57%), Gaps = 15/270 (5%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y L  T+G G++G+VK A    + +  A K + K     ++  D+ K+EI  +K L HPN
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPK---YFVEDVDRFKQEIEIMKSLDHPN 67
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+E     + IY+V+E  TGGELF+++  K   +E++  ++ + ++  V+YCH   V
Sbjct: 68  IIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127
Query: 136 FHRDLKLENILL--DSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN L   DS  + +K+ DFGL+A    F+   ++ T  G+P YV+P+VL   G
Sbjct: 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL--EG 182
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--WL--SPGAQNLL 248
             G   D WS GV++YV+L GY PF       +  KI  G F  P+  WL  SP A++L+
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLI 242
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPA 278
           R++L  +P +RIT       EWFE+  + +
Sbjct: 243 RRLLTKSPKQRITSLQALEHEWFEKQLSSS 272

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 100/261 (38%), Positives = 149/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+   G+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  176 bits (447), Expect = 1e-44,   Method: Compositional matrix adjust.
 Identities = 100/261 (38%), Positives = 149/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 8   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLNHEN 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 66  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 125
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+   G+  YVAPE+L  R +  
Sbjct: 126 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 186 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 245
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 246 VENPSARITIPDIKKDRWYNK 266

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 100/261 (38%), Positives = 149/261 (57%), Gaps = 5/261 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L H N
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEIXINKMLNHEN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           VV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H  G+
Sbjct: 67  VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+   G+  YVAPE+L  R +  
Sbjct: 127 THRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHA 186
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFKLPKW--LSPGAQNLLRKIL 252
              D+WSCG++L  +L G LP+D  + +   Y         L  W  +      LL KIL
Sbjct: 187 EPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKIL 246
Query: 253 EPNPVKRITIAGIKADEWFEQ 273
             NP  RITI  IK D W+ +
Sbjct: 247 VENPSARITIPDIKKDRWYNK 267

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 85/269 (31%), Positives = 150/269 (55%), Gaps = 5/269 (1%)
Query: 2   VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
            +AE  +    +  +++ R LG+G FG V  A++  +    A+K+L K+++    +  Q+
Sbjct: 2   ALAEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQL 61
Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
           +REI     L+HPN++R++     + +IY++LE+   GEL+ ++   GR  E       +
Sbjct: 62  RREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFME 121
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           +L D + YCH + V HRD+K EN+L+  KG +KI+DFG S      R   +    CG+ +
Sbjct: 122 ELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXM----CGTLD 177
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 241
           Y+ PE++  + +D    D+W  GV+ Y  L G  PFD  +    +++I   D K P +LS
Sbjct: 178 YLPPEMIEGKTHDEKV-DLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLS 236
Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEW 270
            G+++L+ K+L  +P +R+ + G+    W
Sbjct: 237 DGSKDLISKLLRYHPPQRLPLKGVMEHPW 265

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 105/272 (38%), Positives = 157/272 (57%), Gaps = 13/272 (4%)
Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +G    RY +   LG+G+FG+V   +D  +   +AVK++ K    + K T  I RE+  L
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELL 75
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           K L HPN+++L E+L   S  Y+V E  TGGELFD+I  + R  E +  ++ +Q+  G++
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 129 YCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
           Y H   + HRDLK ENILL+SK    +IKI DFGLS     F+ +  +    G+  Y+AP
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAP 192
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKW--LS 241
           EVL  RG      D+WS GVILY++L+G  PF  +N   + +++  G   F LP+W  +S
Sbjct: 193 EVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250
Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
             A++L+RK+L  +P  RIT        W ++
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 105/272 (38%), Positives = 157/272 (57%), Gaps = 13/272 (4%)
Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           +G    RY +   LG+G+FG+V   +D  +   +AVK++ K    + K T  I RE+  L
Sbjct: 17  QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELL 75
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           K L HPN+++L E+L   S  Y+V E  TGGELFD+I  + R  E +  ++ +Q+  G++
Sbjct: 76  KKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGIT 135
Query: 129 YCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
           Y H   + HRDLK ENILL+SK    +IKI DFGLS     F+ +  +    G+  Y+AP
Sbjct: 136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAYYIAP 192
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKW--LS 241
           EVL  RG      D+WS GVILY++L+G  PF  +N   + +++  G   F LP+W  +S
Sbjct: 193 EVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250
Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
             A++L+RK+L  +P  RIT        W ++
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  176 bits (445), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 91/279 (32%), Positives = 155/279 (55%), Gaps = 6/279 (2%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
               L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L + 
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R D    T CG+ +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRD----TLCGTLDYLPPE 177
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
           ++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++
Sbjct: 178 MIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 275

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 86/259 (33%), Positives = 148/259 (57%), Gaps = 5/259 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +++GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    R  E        +L + +SYCH+K V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRV 133
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ PE++  R +D 
Sbjct: 134 IHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHDE 189
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
              D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++L+ ++L+ N
Sbjct: 190 KV-DLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGARDLISRLLKHN 248
Query: 256 PVKRITIAGIKADEWFEQD 274
             +R+T+A +    W + +
Sbjct: 249 ASQRLTLAEVLEHPWIKAN 267

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  175 bits (444), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 155/281 (55%), Gaps = 6/281 (2%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ 
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 177
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA
Sbjct: 178 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 237 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 277

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  175 bits (443), Expect = 3e-44,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 155/281 (55%), Gaps = 6/281 (2%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ 
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 179
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA
Sbjct: 180 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 239 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 279

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 155/281 (55%), Gaps = 6/281 (2%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 25  ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 84
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 85  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 144
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ 
Sbjct: 145 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 200
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA
Sbjct: 201 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 259
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 260 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 300

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 155/281 (55%), Gaps = 6/281 (2%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 16  ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 75
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 76  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 135
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ 
Sbjct: 136 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 191
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA
Sbjct: 192 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 250
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 251 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 291

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 103/279 (36%), Positives = 156/279 (55%), Gaps = 11/279 (3%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y+L   LG+G F  V+          +A KI+   ++   +   +++RE    +LLKHPN
Sbjct: 33  YQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKL-SARDHQKLEREARICRLLKHPN 91
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VRLH+ ++ +   Y+V + VTGGELF+ I ++    EA+      Q+++ V++ H   +
Sbjct: 92  IVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQHDI 151
Query: 136 FHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN+LL SK     +K++DFGL+   Q   +        G+P Y++PEVL    
Sbjct: 152 VHRDLKPENLLLASKCKGAAVKLADFGLAIEVQ--GEQQAWFGFAGTPGYLSPEVLRKDP 209
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLL 248
           Y G   DIW+CGVILY++L GY PF D +   LYQ+I  G  DF  P+W  ++P A+NL+
Sbjct: 210 Y-GKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLI 268
Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
            ++L  NP KRIT        W  Q  T A+    +E +
Sbjct: 269 NQMLTINPAKRITADQALKHPWVCQRSTVASMMHRQETV 307

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 97/260 (37%), Positives = 148/260 (56%), Gaps = 15/260 (5%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
             LG G F +V   +   +G  FA+K ++K+          ++ EIA LK +KH N+V L
Sbjct: 15  EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTL 71
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
            ++  S +  Y+V++ V+GGELFD+I  +G   E +   + QQ++  V Y H  G+ HRD
Sbjct: 72  EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRD 131
Query: 140 LKLENILL---DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           LK EN+L    +    I I+DFGLS + Q    +G++ T CG+P YVAPEVLA + Y  A
Sbjct: 132 LKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQKPYSKA 187
Query: 197 TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKIL 252
             D WS GVI Y++L GY PF +   + L++KI  G  +F+ P W  +S  A++ +  +L
Sbjct: 188 V-DCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLL 246
Query: 253 EPNPVKRITIAGIKADEWFE 272
           E +P +R T     +  W +
Sbjct: 247 EKDPNERYTCEKALSHPWID 266

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 155/281 (55%), Gaps = 6/281 (2%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 1   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 120
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R   L    CG+ +Y+ 
Sbjct: 121 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL----CGTLDYLP 176
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA
Sbjct: 177 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 235
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 236 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 276

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 96/265 (36%), Positives = 144/265 (54%), Gaps = 3/265 (1%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + RY  GR LG+G F K     D+D+   FA K++ K+ ++     +++  EIA  K L 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +P+VV  H        +Y+VLE      L +    +  + E E R   +Q I GV Y HN
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             V HRDLKL N+ L+   ++KI DFGL+   +   D     T CG+PNY+APEVL  +G
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF--DGERKKTLCGTPNYIAPEVLCKKG 218
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
           +     DIWS G ILY +L G  PF+   L   Y +I + ++ +P+ ++P A  L+R++L
Sbjct: 219 HSFEV-DIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRML 277
Query: 253 EPNPVKRITIAGIKADEWFEQDYTP 277
             +P  R ++A +  DE+F   Y P
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  174 bits (442), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 97/254 (38%), Positives = 148/254 (58%), Gaps = 12/254 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  + LG G +G+V   +D  +G   A+KI++K+ +     +  +  E+A LK L HP
Sbjct: 5   RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 64
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L+E    K   Y+V+E   GGELFD+I  + +  E +   + +Q++ G +Y H   
Sbjct: 65  NIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN 124
Query: 135 VFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK     IKI DFGLSA   HF   G +    G+  Y+APEVL  +
Sbjct: 125 IVHRDLKPENLLLESKSRDALIKIVDFGLSA---HFEVGGKMKERLGTAYYIAPEVLRKK 181
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW--LSPGAQNL 247
            YD    D+WSCGVILY++L GY PF  +    + +++ +G F    P W  +S  A+ L
Sbjct: 182 -YD-EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQL 239
Query: 248 LRKILEPNPVKRIT 261
           ++ +L   P KRI+
Sbjct: 240 VKLMLTYEPSKRIS 253

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  174 bits (441), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 154/281 (54%), Gaps = 6/281 (2%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 123
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ 
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 179
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE +  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA
Sbjct: 180 PEXIEGRXHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 239 RDLISRLLKHNPSQRPXLREVLEHPWITANSSKPSNCQNKE 279

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 97/254 (38%), Positives = 148/254 (58%), Gaps = 12/254 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  + LG G +G+V   +D  +G   A+KI++K+ +     +  +  E+A LK L HP
Sbjct: 22  RYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHP 81
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L+E    K   Y+V+E   GGELFD+I  + +  E +   + +Q++ G +Y H   
Sbjct: 82  NIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN 141
Query: 135 VFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK     IKI DFGLSA   HF   G +    G+  Y+APEVL  +
Sbjct: 142 IVHRDLKPENLLLESKSRDALIKIVDFGLSA---HFEVGGKMKERLGTAYYIAPEVLRKK 198
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW--LSPGAQNL 247
            YD    D+WSCGVILY++L GY PF  +    + +++ +G F    P W  +S  A+ L
Sbjct: 199 -YD-EKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQL 256
Query: 248 LRKILEPNPVKRIT 261
           ++ +L   P KRI+
Sbjct: 257 VKLMLTYEPSKRIS 270

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 90/281 (32%), Positives = 155/281 (55%), Gaps = 6/281 (2%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 1   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 60
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 61  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 120
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI++FG S      R      T CG+ +Y+ 
Sbjct: 121 NALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT----TLCGTLDYLP 176
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA
Sbjct: 177 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 235
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 236 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 276

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 88/270 (32%), Positives = 151/270 (55%), Gaps = 6/270 (2%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R   L    CG+ +Y+ PE++  R +D 
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL----CGTLDYLPPEMIEGRMHDE 188
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
              D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++L+ ++L+ N
Sbjct: 189 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 247
Query: 256 PVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           P +R  +  +    W   + + P+N  + E
Sbjct: 248 PSQRPMLREVLEHPWITANSSKPSNCQNKE 277

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 155/280 (55%), Gaps = 8/280 (2%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+ 
Sbjct: 6   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 65
Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
               L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L + 
Sbjct: 66  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 125
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAP 185
           +SYCH+K V HRD+K EN+LL S G +KI+DFG S   P   R D      CG+ +Y+ P
Sbjct: 126 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLPP 180
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
           E++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA+
Sbjct: 181 EMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 239
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           +L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 240 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 279

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 155/280 (55%), Gaps = 8/280 (2%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+ 
Sbjct: 1   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
               L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L + 
Sbjct: 61  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 120
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAP 185
           +SYCH+K V HRD+K EN+LL S G +KI+DFG S   P   R D      CG+ +Y+ P
Sbjct: 121 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLPP 175
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
           E++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA+
Sbjct: 176 EMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 234
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           +L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 274

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 155/280 (55%), Gaps = 8/280 (2%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
               L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L + 
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAP 185
           +SYCH+K V HRD+K EN+LL S G +KI+DFG S   P   R D      CG+ +Y+ P
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLPP 176
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
           E++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA+
Sbjct: 177 EMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGAR 235
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           +L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 236 DLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 275

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 87/256 (33%), Positives = 146/256 (57%), Gaps = 7/256 (2%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 73  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 132
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
            HRD+K EN+LL S G +KI+DFG S   P   RDD      CG+ +Y+ PE++  R +D
Sbjct: 133 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDD-----LCGTLDYLPPEMIEGRMHD 187
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254
               D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++L+ ++L+ 
Sbjct: 188 EKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 246
Query: 255 NPVKRITIAGIKADEW 270
           NP +R  +  +    W
Sbjct: 247 NPSQRPMLREVLEHPW 262

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 149/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 21  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 80
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 81  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 140
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G   T CG+P Y+APE+
Sbjct: 141 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEI 195
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 196 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 254
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 255 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 283

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 91/281 (32%), Positives = 155/281 (55%), Gaps = 6/281 (2%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 4   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 63
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   GE++ ++    +  E        +L 
Sbjct: 64  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELA 123
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R   L     G+ +Y+ 
Sbjct: 124 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLX----GTLDYLP 179
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA
Sbjct: 180 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           ++L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 239 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKE 279

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 88/270 (32%), Positives = 151/270 (55%), Gaps = 6/270 (2%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ PE++  R +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHDE 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
              D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++L+ ++L+ N
Sbjct: 186 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           P +R  +  +    W   + + P+N  + E
Sbjct: 245 PSQRPMLREVLEHPWITANSSKPSNCQNKE 274

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 148/266 (55%), Gaps = 5/266 (1%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ 
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLP 177
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA
Sbjct: 178 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 245 QNLLRKILEPNPVKRITIAGIKADEW 270
           ++L+ ++L+ NP +R  +  +    W
Sbjct: 237 RDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 89/271 (32%), Positives = 152/271 (56%), Gaps = 8/271 (2%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
            HRD+K EN+LL S G +KI+DFG S   P   R D      CG+ +Y+ PE++  R +D
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD-----LCGTLDYLPPEMIEGRMHD 184
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254
               D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++L+ ++L+ 
Sbjct: 185 EKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 243
Query: 255 NPVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           NP +R  +  +    W   + + P+N  + E
Sbjct: 244 NPSQRPMLREVLEHPWITANSSKPSNCQNKE 274

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 149/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G   T CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 95/265 (35%), Positives = 143/265 (53%), Gaps = 3/265 (1%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + RY  GR LG+G F K     D+D+   FA K++ K+ ++     +++  EIA  K L 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +P+VV  H        +Y+VLE      L +    +  + E E R   +Q I GV Y HN
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             V HRDLKL N+ L+   ++KI DFGL+   +   D       CG+PNY+APEVL  +G
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF--DGERKKXLCGTPNYIAPEVLCKKG 218
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
           +     DIWS G ILY +L G  PF+   L   Y +I + ++ +P+ ++P A  L+R++L
Sbjct: 219 HSFEV-DIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRML 277
Query: 253 EPNPVKRITIAGIKADEWFEQDYTP 277
             +P  R ++A +  DE+F   Y P
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  172 bits (436), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 88/270 (32%), Positives = 151/270 (55%), Gaps = 6/270 (2%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R   L    CG+ +Y+ PE++  R +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTEL----CGTLDYLPPEMIEGRMHDE 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
              D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++L+ ++L+ N
Sbjct: 186 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           P +R  +  +    W   + + P+N  + E
Sbjct: 245 PSQRPMLREVLEHPWITANSSKPSNCQNKE 274

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 148/266 (55%), Gaps = 5/266 (1%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R   L    CG+ +Y+ 
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL----CGTLDYLP 177
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA
Sbjct: 178 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 245 QNLLRKILEPNPVKRITIAGIKADEW 270
           ++L+ ++L+ NP +R  +  +    W
Sbjct: 237 RDLISRLLKHNPSQRPMLREVLEHPW 262

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 95/265 (35%), Positives = 143/265 (53%), Gaps = 3/265 (1%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + RY  GR LG+G F K     D+D+   FA K++ K+ ++     +++  EIA  K L 
Sbjct: 41  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 100
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +P+VV  H        +Y+VLE      L +    +  + E E R   +Q I GV Y HN
Sbjct: 101 NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 160
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             V HRDLKL N+ L+   ++KI DFGL+   +   D       CG+PNY+APEVL  +G
Sbjct: 161 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF--DGERKKDLCGTPNYIAPEVLCKKG 218
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
           +     DIWS G ILY +L G  PF+   L   Y +I + ++ +P+ ++P A  L+R++L
Sbjct: 219 HSFEV-DIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRML 277
Query: 253 EPNPVKRITIAGIKADEWFEQDYTP 277
             +P  R ++A +  DE+F   Y P
Sbjct: 278 HADPTLRPSVAELLTDEFFTSGYAP 302

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 89/276 (32%), Positives = 153/276 (55%), Gaps = 6/276 (2%)
Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           E K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE
Sbjct: 2   ESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRRE 61
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           +     L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L 
Sbjct: 62  VEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + +SYCH+K V HRD+K EN+LL S G +KI++FG S      R      T CG+ +Y+ 
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRT----TLCGTLDYLP 177
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA
Sbjct: 178 PEMIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT-PAN 279
           ++L+ ++L+ NP +R  +  +    W   + + P+N
Sbjct: 237 RDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSN 272

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score =  172 bits (435), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 95/265 (35%), Positives = 143/265 (53%), Gaps = 3/265 (1%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + RY  GR LG+G F K     D+D+   FA K++ K+ ++     +++  EIA  K L 
Sbjct: 25  MKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD 84
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +P+VV  H        +Y+VLE      L +    +  + E E R   +Q I GV Y HN
Sbjct: 85  NPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHN 144
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             V HRDLKL N+ L+   ++KI DFGL+   +   D       CG+PNY+APEVL  +G
Sbjct: 145 NRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEF--DGERKKDLCGTPNYIAPEVLCKKG 202
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
           +     DIWS G ILY +L G  PF+   L   Y +I + ++ +P+ ++P A  L+R++L
Sbjct: 203 HSFEV-DIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSVPRHINPVASALIRRML 261
Query: 253 EPNPVKRITIAGIKADEWFEQDYTP 277
             +P  R ++A +  DE+F   Y P
Sbjct: 262 HADPTLRPSVAELLTDEFFTSGYAP 286

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  171 bits (434), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 149/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 175
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G   T CG+P Y+APE+
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGATWTLCGTPEYLAPEI 230
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 231 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 289
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 145/255 (56%), Gaps = 5/255 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++ +S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 70  ILRLYGYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKV 129
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R   L    CG+ +Y+ PE++  R +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL----CGTLDYLPPEMIEGRMHDE 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
              D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++L+ ++L+ N
Sbjct: 186 KV-DLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PVKRITIAGIKADEW 270
           P +R  +  +    W
Sbjct: 245 PSQRPMLREVLEHPW 259

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  171 bits (433), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 85/277 (30%), Positives = 155/277 (55%), Gaps = 10/277 (3%)
Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           G ++  +++G  LG+G+F  V  A+ + +GL  A+K+++K  +    +  +++ E+    
Sbjct: 7   GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVS 128
            LKHP+++ L+      + +Y+VLE    GE+   + ++ +   E E R    Q+I G+ 
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAP 185
           Y H+ G+ HRDL L N+LL    NIKI+DFGL+    +P         +T CG+PNY++P
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH-----YTLCGTPNYISP 181
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
           E+ A R   G  SD+WS G + Y +L G  PFD   +     K+   D+++P +LS  A+
Sbjct: 182 EI-ATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAK 240
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
           +L+ ++L  NP  R++++ +    +  ++ +  + D+
Sbjct: 241 DLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  171 bits (433), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 144/255 (56%), Gaps = 5/255 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R   L    CG+ +Y+ PE++  R +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAAL----CGTLDYLPPEMIEGRMHDE 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
              D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++L+ ++L+ N
Sbjct: 186 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PVKRITIAGIKADEW 270
           P +R  +  +    W
Sbjct: 245 PSQRPMLREVLEHPW 259

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  171 bits (432), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +T+G G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  171 bits (432), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 144/255 (56%), Gaps = 5/255 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 69  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 128
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ PE++  R +D 
Sbjct: 129 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHDE 184
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
              D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++L+ ++L+ N
Sbjct: 185 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 243
Query: 256 PVKRITIAGIKADEW 270
           P +R  +  +    W
Sbjct: 244 PSQRPMLREVLEHPW 258

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  171 bits (432), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G IK++DFGL+      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  171 bits (432), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 144/255 (56%), Gaps = 5/255 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 74  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 133
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ PE++  R +D 
Sbjct: 134 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHDE 189
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
              D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++L+ ++L+ N
Sbjct: 190 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 248
Query: 256 PVKRITIAGIKADEW 270
           P +R  +  +    W
Sbjct: 249 PSQRPMLREVLEHPW 263

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  170 bits (431), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  170 bits (431), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  170 bits (431), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  170 bits (431), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 147/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  FA+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 147/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  FA+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 147/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  FA+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 144/255 (56%), Gaps = 5/255 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R   L    CG+ +Y+ PE++  R +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXL----CGTLDYLPPEMIEGRMHDE 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
              D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++L+ ++L+ N
Sbjct: 186 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PVKRITIAGIKADEW 270
           P +R  +  +    W
Sbjct: 245 PSQRPMLREVLEHPW 259

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 89/279 (31%), Positives = 153/279 (54%), Gaps = 6/279 (2%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
               L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L + 
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R      T  G+ +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRT----TLSGTLDYLPPE 177
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
           ++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++
Sbjct: 178 MIEGRMHDEKV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDE 284
           L+ ++L+ NP +R  +  +    W   + + P+N  + E
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNSQNKE 275

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 85/255 (33%), Positives = 144/255 (56%), Gaps = 5/255 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 70  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 129
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R   L    CG+ +Y+ PE++  R +D 
Sbjct: 130 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXL----CGTLDYLPPEMIEGRMHDE 185
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
              D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++L+ ++L+ N
Sbjct: 186 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 244
Query: 256 PVKRITIAGIKADEW 270
           P +R  +  +    W
Sbjct: 245 PSQRPMLREVLEHPW 259

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 147/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 147/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 92/255 (36%), Positives = 145/255 (56%), Gaps = 5/255 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++  S    A+K+L K++I    +  Q++REI     L HPN
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+     + +IY++LEY   GEL+ ++       E     + ++L D + YCH K V
Sbjct: 85  ILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHGKKV 144
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL  KG +KI+DFG S      R      T CG+ +Y+ PE++  R ++ 
Sbjct: 145 IHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRK----TMCGTLDYLPPEMIEGRMHNE 200
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
              D+W  GV+ Y +L G  PF+  +    Y++I + D K P  +  GAQ+L+ K+L  N
Sbjct: 201 KV-DLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISKLLRHN 259
Query: 256 PVKRITIAGIKADEW 270
           P +R+ +A + A  W
Sbjct: 260 PSERLPLAQVSAHPW 274

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G I+++DFGL+      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLPNGVNDIKNHKWF 297

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 22  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 81
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 82  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 141
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 142 EYLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 196
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 197 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 255
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 256 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 284

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  169 bits (428), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  169 bits (427), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 147/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  +A+KIL+K +++ LK  +    E   
Sbjct: 28  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 87
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 147
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 202
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 203 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 261
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 262 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  169 bits (427), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 84/255 (32%), Positives = 143/255 (56%), Gaps = 5/255 (1%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+GR LG+G FG V  A++       A+K+L K ++    +  Q++RE+     L+HPN
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+K V
Sbjct: 67  ILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 126
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K EN+LL S G +KI+DFG S      R      T CG+ +Y+ PE++  R +D 
Sbjct: 127 IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT----TLCGTLDYLPPEMIEGRMHDE 182
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
              D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++L+ ++L+ N
Sbjct: 183 KV-DLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHN 241
Query: 256 PVKRITIAGIKADEW 270
           P +R  +  +    W
Sbjct: 242 PSQRPMLREVLEHPW 256

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 56  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 175
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 230
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 231 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 289
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 30  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 89
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 90  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 149
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 150 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 204
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 205 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 263
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 264 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 292

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  169 bits (427), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 147/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  +A+KIL+K +++ LK  +    E   
Sbjct: 28  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 87
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 88  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 147
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 148 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 202
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 203 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 261
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 262 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 IISKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 147/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 147/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 147/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 91/269 (33%), Positives = 147/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  +A+KIL+K +++ LK  +    E   
Sbjct: 56  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 115
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 116 LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 175
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 176 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 230
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 231 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 289
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 290 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 146/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P + +L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +T+G G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EY+ GG++F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 146/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P + +L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 100/268 (37%), Positives = 155/268 (57%), Gaps = 24/268 (8%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVR 78
           + LGEG+F   +      S   FAVKI+ K      ++    ++EI  LKL + HPN+V+
Sbjct: 17  KPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVK 70
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           LHEV   +   ++V+E + GGELF++I  K    E E   + ++L+  VS+ H+ GV HR
Sbjct: 71  LHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHR 130
Query: 139 DLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
           DLK EN+L   + +   IKI DFG + L     D+  L T C + +Y APE+L   GYD 
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKP--PDNQPLKTPCFTLHYAAPELLNQNGYD- 187
Query: 196 ATSDIWSCGVILYVILTGYLPFD--DRNLAV-----LYQKIFRGDFKLP----KWLSPGA 244
            + D+WS GVILY +L+G +PF   DR+L       + +KI +GDF       K +S  A
Sbjct: 188 ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEA 247
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFE 272
           ++L++ +L  +P KR+ ++G++ +EW +
Sbjct: 248 KDLIQGLLTVDPNKRLKMSGLRYNEWLQ 275

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 148/269 (55%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +T+G G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EY+ GG++F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 92/269 (34%), Positives = 145/269 (53%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  RTLG G+FG+V   +  ++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
            + +  P +V+L       S +YMVLEY  GGE+F  +   GR  E   R    Q++   
Sbjct: 96  QQAVNFPFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 89/269 (33%), Positives = 146/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   + +++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P + +L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  167 bits (424), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 146/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EY  GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+++D +G IK++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score =  167 bits (423), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 107/287 (37%), Positives = 162/287 (56%), Gaps = 15/287 (5%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD-QIKREIATLKLL 71
           +G+Y +G  LGEG++GKVK   D ++    AVKIL+K ++  +   +  +K+EI  L+ L
Sbjct: 4   IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL 63
Query: 72  KHPNVVRLHEVLAS--KSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +H NV++L +VL +  K K+YMV+EY   G  E+ D +  K R    +    F QLIDG+
Sbjct: 64  RHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK-RFPVCQAHGYFCQLIDGL 122
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H++G+ H+D+K  N+LL + G +KIS  G++     F  D    T+ GSP +  PE+
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 188 LAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
            AN    + G   DIWS GV LY I TG  PF+  N+  L++ I +G + +P    P   
Sbjct: 183 -ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN------PDDDEED 286
           +LL+ +LE  P KR +I  I+   WF + + PA       P  D +D
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKD 288

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 147/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+AP +
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPAI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 146/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q    L ++E  +TLG G+FG+V   +  ++G  +A+KIL+K +++ LK  +    E   
Sbjct: 36  QNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRI 95
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 96  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 155
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 156 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 210
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 211 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 269
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  I   +WF
Sbjct: 270 LRNLLQVDLTKRFGNLKNGVNDIXNHKWF 298

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 147/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  K        +  IK  +WF
Sbjct: 269 LRNLLQVDLTKAFGNLKNGVNDIKNHKWF 297

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 94/254 (37%), Positives = 150/254 (59%), Gaps = 17/254 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   LG G    V   +   +  P+A+K+L+K   +  KI   ++ EI  L  L HPN
Sbjct: 55  FEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKI---VRTEIGVLLRLSHPN 109
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +++L E+  + ++I +VLE VTGGELFD+I  KG   E +     +Q+++ V+Y H  G+
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGI 169
Query: 136 FHRDLKLENILLDS---KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            HRDLK EN+L  +      +KI+DFGLS + +H     L+ T CG+P Y APE+L    
Sbjct: 170 VHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVLMKTVCGTPGYCAPEILRGCA 226
Query: 193 YDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRGDFKL--PKW--LSPGAQNL 247
           Y G   D+WS G+I Y++L G+ PF D+R    ++++I   ++    P W  +S  A++L
Sbjct: 227 Y-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDL 285
Query: 248 LRKILEPNPVKRIT 261
           +RK++  +P KR+T
Sbjct: 286 VRKLIVLDPKKRLT 299

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 147/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G     CG+P  +APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLCGTPEALAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 147/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G      G+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLAGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 147/269 (54%), Gaps = 11/269 (4%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E   
Sbjct: 35  QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRI 94
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++   
Sbjct: 95  LQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTF 154
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G      G+P Y+APE+
Sbjct: 155 EYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWXLXGTPEYLAPEI 209
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           + ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   ++L
Sbjct: 210 ILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL 268
Query: 248 LRKILEPNPVKRI-----TIAGIKADEWF 271
           LR +L+ +  KR       +  IK  +WF
Sbjct: 269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  164 bits (416), Expect = 5e-41,   Method: Compositional matrix adjust.
 Identities = 97/280 (34%), Positives = 159/280 (56%), Gaps = 15/280 (5%)
Query: 1   MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
           M I  KK  G     Y+  + LG G +G+V   +D  + +  A+KI+ K  +       +
Sbjct: 26  MFITSKK--GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSK 82
Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
           +  E+A LKLL HPN+++L++    K   Y+V+E   GGELFD+I  + +  E +   + 
Sbjct: 83  LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVII 142
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTC 177
           +Q++ GV+Y H   + HRDLK EN+LL+SK     IKI DFGLSA+   F +   +    
Sbjct: 143 KQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERL 199
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL- 236
           G+  Y+APEVL  + YD    D+WS GVIL+++L GY PF  +    + +K+ +G +   
Sbjct: 200 GTAYYIAPEVLRKK-YD-EKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFD 257
Query: 237 -PKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
            P+W  +S GA++L++++L+ +  +RI+        W ++
Sbjct: 258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  164 bits (414), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 82/266 (30%), Positives = 150/266 (56%), Gaps = 11/266 (4%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L  +++ RTLG G+FG+V   +   +G  +A+K+L+K  ++ LK  +    E   L ++ 
Sbjct: 5   LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP ++R+        +I+M+++Y+ GGELF  +    R      +    ++   + Y H+
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 124
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           K + +RDLK ENILLD  G+IKI+DFG +   ++  D  + +  CG+P+Y+APEV++ + 
Sbjct: 125 KDIIYRDLKPENILLDKNGHIKITDFGFA---KYVPD--VTYXLCGTPDYIAPEVVSTKP 179
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
           Y+ +  D WS G+++Y +L GY PF D N    Y+KI   + + P + +   ++LL +++
Sbjct: 180 YNKSI-DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 238
Query: 253 EPNPVKRI-----TIAGIKADEWFEQ 273
             +  +R+         +K   WF++
Sbjct: 239 TRDLSQRLGNLQNGTEDVKNHPWFKE 264

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 98/294 (33%), Positives = 157/294 (53%), Gaps = 22/294 (7%)
Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD------ 59
           +K+EG     Y   R LG G +G+V   ++ +     A+K+++K++    + +D      
Sbjct: 28  RKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIE 87
Query: 60  ----QIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE 115
               +I  EI+ LK L HPN+++L +V   K   Y+V E+  GGELF++I ++ +  E +
Sbjct: 88  KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD 147
Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGL 172
              + +Q++ G+ Y H   + HRD+K ENILL++K    NIKI DFGLS+    F  D  
Sbjct: 148 AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF---FSKDYK 204
Query: 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 232
           L    G+  Y+APEVL  +       D+WSCGVI+Y++L GY PF  +N   + +K+ +G
Sbjct: 205 LRDRLGTAYYIAPEVLKKKY--NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG 262
Query: 233 ----DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
               DF   K +S  A+ L++ +L  +  KR T        W ++     N  D
Sbjct: 263 KYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSD 316

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 89/250 (35%), Positives = 154/250 (61%), Gaps = 11/250 (4%)
Query: 16  YELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQI--KREIATLKL 70
           +EL + LG+G+FGKV   + +   DSG  +A+K+L+K     LK+ D++  K E   L  
Sbjct: 30  FELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKAT---LKVRDRVRTKMERDILAD 86
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           + HP VV+LH    ++ K+Y++L+++ GG+LF +++ +    E + +    +L  G+ + 
Sbjct: 87  VNHPFVVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHL 146
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           H+ G+ +RDLK ENILLD +G+IK++DFGLS   +    +   ++ CG+  Y+APEV+  
Sbjct: 147 HSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEYMAPEVVNR 204
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250
           +G+   ++D WS GV+++ +LTG LPF  ++       I +    +P++LS  AQ+LLR 
Sbjct: 205 QGH-SHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMPQFLSTEAQSLLRA 263
Query: 251 ILEPNPVKRI 260
           + + NP  R+
Sbjct: 264 LFKRNPANRL 273

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 87/252 (34%), Positives = 154/252 (61%), Gaps = 11/252 (4%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQI--KREIATL 68
            ++EL + LG+G+FGKV   + +   D+   +A+K+L+K     LK+ D++  K E   L
Sbjct: 24  SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT---LKVRDRVRTKMERDIL 80
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
             + HP +V+LH    ++ K+Y++L+++ GG+LF +++ +    E + +    +L   + 
Sbjct: 81  VEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 140
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           + H+ G+ +RDLK ENILLD +G+IK++DFGLS   +    +   ++ CG+  Y+APEV+
Sbjct: 141 HLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVV 198
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
             RG+   ++D WS GV+++ +LTG LPF  ++       I +    +P++LSP AQ+LL
Sbjct: 199 NRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLL 257
Query: 249 RKILEPNPVKRI 260
           R + + NP  R+
Sbjct: 258 RMLFKRNPANRL 269

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  161 bits (407), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 87/251 (34%), Positives = 154/251 (61%), Gaps = 11/251 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQI--KREIATLK 69
           ++EL + LG+G+FGKV   + +   D+   +A+K+L+K     LK+ D++  K E   L 
Sbjct: 25  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT---LKVRDRVRTKMERDILV 81
Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            + HP +V+LH    ++ K+Y++L+++ GG+LF +++ +    E + +    +L   + +
Sbjct: 82  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 141
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H+ G+ +RDLK ENILLD +G+IK++DFGLS   +    +   ++ CG+  Y+APEV+ 
Sbjct: 142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVN 199
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
            RG+   ++D WS GV+++ +LTG LPF  ++       I +    +P++LSP AQ+LLR
Sbjct: 200 RRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 258
Query: 250 KILEPNPVKRI 260
            + + NP  R+
Sbjct: 259 MLFKRNPANRL 269

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  160 bits (406), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 87/251 (34%), Positives = 154/251 (61%), Gaps = 11/251 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQI--KREIATLK 69
           ++EL + LG+G+FGKV   + +   D+   +A+K+L+K     LK+ D++  K E   L 
Sbjct: 26  QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKAT---LKVRDRVRTKMERDILV 82
Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            + HP +V+LH    ++ K+Y++L+++ GG+LF +++ +    E + +    +L   + +
Sbjct: 83  EVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDH 142
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H+ G+ +RDLK ENILLD +G+IK++DFGLS   +    +   ++ CG+  Y+APEV+ 
Sbjct: 143 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVN 200
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
            RG+   ++D WS GV+++ +LTG LPF  ++       I +    +P++LSP AQ+LLR
Sbjct: 201 RRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLR 259
Query: 250 KILEPNPVKRI 260
            + + NP  R+
Sbjct: 260 MLFKRNPANRL 270

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  160 bits (406), Expect = 8e-40,   Method: Compositional matrix adjust.
 Identities = 93/256 (36%), Positives = 148/256 (57%), Gaps = 7/256 (2%)
Query: 9   EGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRII-HLKITDQIKRE 64
           E +R   +EL R LG+G +GKV   +     ++G  FA+K+L+K  I+ + K T   K E
Sbjct: 12  EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
              L+ +KHP +V L     +  K+Y++LEY++GGELF ++  +G   E        ++ 
Sbjct: 72  RNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEIS 131
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
             + + H KG+ +RDLK ENI+L+ +G++K++DFGL     H  D  + HT CG+  Y+A
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH--DGTVTHTFCGTIEYMA 189
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE+L   G++ A  D WS G ++Y +LTG  PF   N      KI +    LP +L+  A
Sbjct: 190 PEILMRSGHNRAV-DWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA 248
Query: 245 QNLLRKILEPNPVKRI 260
           ++LL+K+L+ N   R+
Sbjct: 249 RDLLKKLLKRNAASRL 264

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 89/257 (34%), Positives = 139/257 (54%), Gaps = 3/257 (1%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G F K     D D+   FA KI+ K+ ++     +++  EI+  + L H +VV  H 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                  +++VLE      L +    +  L E E R   +Q++ G  Y H   V HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
           L N+ L+    +KI DFGL+   ++  D     T CG+PNY+APEVL+ +G+     D+W
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEY--DGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 201
Query: 202 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
           S G I+Y +L G  PF+   L   Y +I + ++ +PK ++P A +L++K+L+ +P  R T
Sbjct: 202 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 261
Query: 262 IAGIKADEWFEQDYTPA 278
           I  +  DE+F   Y PA
Sbjct: 262 INELLNDEFFTSGYIPA 278

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 87/252 (34%), Positives = 141/252 (55%), Gaps = 6/252 (2%)
Query: 12  RLG--RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           RLG   +E  R LG+G+FGKV  A+  ++G  +AVK+L+K+ I+     +    E   L 
Sbjct: 19  RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILS 78
Query: 70  LLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           L + HP + +L     +  +++ V+E+V GG+L   I    R  EA  R    ++I  + 
Sbjct: 79  LARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALM 138
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           + H+KG+ +RDLKL+N+LLD +G+ K++DFG+    +   +     T CG+P+Y+APE+L
Sbjct: 139 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEIL 196
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
               Y G   D W+ GV+LY +L G+ PF+  N   L++ I   +   P WL   A  +L
Sbjct: 197 QEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL 255
Query: 249 RKILEPNPVKRI 260
           +  +  NP  R+
Sbjct: 256 KSFMTKNPTMRL 267

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 89/257 (34%), Positives = 139/257 (54%), Gaps = 3/257 (1%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G F K     D D+   FA KI+ K+ ++     +++  EI+  + L H +VV  H 
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 84
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                  +++VLE      L +    +  L E E R   +Q++ G  Y H   V HRDLK
Sbjct: 85  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 144
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
           L N+ L+    +KI DFGL+   ++  D     T CG+PNY+APEVL+ +G+     D+W
Sbjct: 145 LGNLFLNEDLEVKIGDFGLATKVEY--DGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 201
Query: 202 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
           S G I+Y +L G  PF+   L   Y +I + ++ +PK ++P A +L++K+L+ +P  R T
Sbjct: 202 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 261
Query: 262 IAGIKADEWFEQDYTPA 278
           I  +  DE+F   Y PA
Sbjct: 262 INELLNDEFFTSGYIPA 278

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 89/257 (34%), Positives = 139/257 (54%), Gaps = 3/257 (1%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G F K     D D+   FA KI+ K+ ++     +++  EI+  + L H +VV  H 
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 88
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                  +++VLE      L +    +  L E E R   +Q++ G  Y H   V HRDLK
Sbjct: 89  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 148
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
           L N+ L+    +KI DFGL+   ++  D     T CG+PNY+APEVL+ +G+     D+W
Sbjct: 149 LGNLFLNEDLEVKIGDFGLATKVEY--DGERKKTLCGTPNYIAPEVLSKKGHSFEV-DVW 205
Query: 202 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
           S G I+Y +L G  PF+   L   Y +I + ++ +PK ++P A +L++K+L+ +P  R T
Sbjct: 206 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 265
Query: 262 IAGIKADEWFEQDYTPA 278
           I  +  DE+F   Y PA
Sbjct: 266 INELLNDEFFTSGYIPA 282

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 149/266 (56%), Gaps = 9/266 (3%)
Query: 1   MVIAEKKQEGMRLGRYELG-----RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL 55
           M   ++KQ    L R +L        LG+G+FGKV  A    +   +A+KIL+K+ +I  
Sbjct: 1   MPSEDRKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQD 60
Query: 56  KITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEA 114
              +    E   L LL K P + +LH    +  ++Y V+EYV GG+L   I   G+ +E 
Sbjct: 61  DDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEP 120
Query: 115 EGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174
           +      ++  G+ + H +G+ +RDLKL+N++LDS+G+IKI+DFG+    +H  D     
Sbjct: 121 QAVFYAAEISIGLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTR 178
Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234
             CG+P+Y+APE++A + Y G + D W+ GV+LY +L G  PFD  +   L+Q I   + 
Sbjct: 179 EFCGTPDYIAPEIIAYQPY-GKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNV 237
Query: 235 KLPKWLSPGAQNLLRKILEPNPVKRI 260
             PK LS  A ++ + ++  +P KR+
Sbjct: 238 SYPKSLSKEAVSICKGLMTKHPAKRL 263

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 92/256 (35%), Positives = 147/256 (57%), Gaps = 7/256 (2%)
Query: 9   EGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRII-HLKITDQIKRE 64
           E +R   +EL R LG+G +GKV   +     ++G  FA+K+L+K  I+ + K T   K E
Sbjct: 12  EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
              L+ +KHP +V L     +  K+Y++LEY++GGELF ++  +G   E        ++ 
Sbjct: 72  RNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEIS 131
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
             + + H KG+ +RDLK ENI+L+ +G++K++DFGL     H  D  + H  CG+  Y+A
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH--DGTVTHXFCGTIEYMA 189
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE+L   G++ A  D WS G ++Y +LTG  PF   N      KI +    LP +L+  A
Sbjct: 190 PEILMRSGHNRAV-DWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA 248
Query: 245 QNLLRKILEPNPVKRI 260
           ++LL+K+L+ N   R+
Sbjct: 249 RDLLKKLLKRNAASRL 264

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 86/256 (33%), Positives = 140/256 (54%), Gaps = 3/256 (1%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +HP +  L
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 73
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H++ V +RD
Sbjct: 74  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 133
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           +KLEN++LD  G+IKI+DFGL    +   D   + T CG+P Y+APEVL +  Y G   D
Sbjct: 134 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 190
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
            W  GV++Y ++ G LPF +++   L++ I   + + P+ LSP A++LL  +L+ +P +R
Sbjct: 191 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 250
Query: 260 ITIAGIKADEWFEQDY 275
           +      A E  E  +
Sbjct: 251 LGGGPSDAKEVMEHRF 266

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 86/256 (33%), Positives = 140/256 (54%), Gaps = 3/256 (1%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +HP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H++ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           +KLEN++LD  G+IKI+DFGL    +   D   + T CG+P Y+APEVL +  Y G   D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 187
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
            W  GV++Y ++ G LPF +++   L++ I   + + P+ LSP A++LL  +L+ +P +R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 260 ITIAGIKADEWFEQDY 275
           +      A E  E  +
Sbjct: 248 LGGGPSDAKEVMEHRF 263

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 88/257 (34%), Positives = 138/257 (53%), Gaps = 3/257 (1%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G F K     D D+   FA KI+ K+ ++     +++  EI+  + L H +VV  H 
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                  +++VLE      L +    +  L E E R   +Q++ G  Y H   V HRDLK
Sbjct: 83  FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 142
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
           L N+ L+    +KI DFGL+   ++  D       CG+PNY+APEVL+ +G+     D+W
Sbjct: 143 LGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 199
Query: 202 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
           S G I+Y +L G  PF+   L   Y +I + ++ +PK ++P A +L++K+L+ +P  R T
Sbjct: 200 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 259
Query: 262 IAGIKADEWFEQDYTPA 278
           I  +  DE+F   Y PA
Sbjct: 260 INELLNDEFFTSGYIPA 276

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  157 bits (398), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 86/256 (33%), Positives = 140/256 (54%), Gaps = 3/256 (1%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +HP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H++ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           +KLEN++LD  G+IKI+DFGL    +   D   + T CG+P Y+APEVL +  Y G   D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 187
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
            W  GV++Y ++ G LPF +++   L++ I   + + P+ LSP A++LL  +L+ +P +R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 260 ITIAGIKADEWFEQDY 275
           +      A E  E  +
Sbjct: 248 LGGGPSDAKEVMEHRF 263

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score =  157 bits (398), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 88/257 (34%), Positives = 138/257 (53%), Gaps = 3/257 (1%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G F K     D D+   FA KI+ K+ ++     +++  EI+  + L H +VV  H 
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 106
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                  +++VLE      L +    +  L E E R   +Q++ G  Y H   V HRDLK
Sbjct: 107 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 166
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
           L N+ L+    +KI DFGL+   ++  D       CG+PNY+APEVL+ +G+     D+W
Sbjct: 167 LGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 223
Query: 202 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
           S G I+Y +L G  PF+   L   Y +I + ++ +PK ++P A +L++K+L+ +P  R T
Sbjct: 224 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 283
Query: 262 IAGIKADEWFEQDYTPA 278
           I  +  DE+F   Y PA
Sbjct: 284 INELLNDEFFTSGYIPA 300

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score =  157 bits (397), Expect = 7e-39,   Method: Compositional matrix adjust.
 Identities = 88/257 (34%), Positives = 138/257 (53%), Gaps = 3/257 (1%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G F K     D D+   FA KI+ K+ ++     +++  EI+  + L H +VV  H 
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                  +++VLE      L +    +  L E E R   +Q++ G  Y H   V HRDLK
Sbjct: 109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLK 168
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
           L N+ L+    +KI DFGL+   ++  D       CG+PNY+APEVL+ +G+     D+W
Sbjct: 169 LGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLSKKGHSFEV-DVW 225
Query: 202 SCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRIT 261
           S G I+Y +L G  PF+   L   Y +I + ++ +PK ++P A +L++K+L+ +P  R T
Sbjct: 226 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARPT 285
Query: 262 IAGIKADEWFEQDYTPA 278
           I  +  DE+F   Y PA
Sbjct: 286 INELLNDEFFTSGYIPA 302

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 110/315 (34%), Positives = 166/315 (52%), Gaps = 35/315 (11%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR--IIHLKITD---QIKREIATLKL 70
           Y + +TLG G  G+VK A +  +    A+KI+ K +  I   +  D    ++ EI  LK 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y 
Sbjct: 72  LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 131 HNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H  G+ HRDLK EN+LL S+     IKI+DFG S +     +  L+ T CG+P Y+APEV
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEV 187
Query: 188 LANRGYDGATS--DIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK-LPK-W--L 240
           L + G  G     D WS GVIL++ L+GY PF + R    L  +I  G +  +P+ W  +
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD-----NEAFS 295
           S  A +L++K+L  +P  R T        W +        D+D +  F D     NE+ +
Sbjct: 248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQ--------DEDMKRKFQDLLSEENESTA 299
Query: 296 MHEV---PSDGGRTP 307
           + +V   PS   + P
Sbjct: 300 LPQVLAQPSTSRKRP 314

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 110/315 (34%), Positives = 166/315 (52%), Gaps = 35/315 (11%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR--IIHLKITD---QIKREIATLKL 70
           Y + +TLG G  G+VK A +  +    A+KI+ K +  I   +  D    ++ EI  LK 
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 70
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y 
Sbjct: 71  LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 129
Query: 131 HNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H  G+ HRDLK EN+LL S+     IKI+DFG S +     +  L+ T CG+P Y+APEV
Sbjct: 130 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEV 186
Query: 188 LANRGYDGATS--DIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK-LPK-W--L 240
           L + G  G     D WS GVIL++ L+GY PF + R    L  +I  G +  +P+ W  +
Sbjct: 187 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 246
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD-----NEAFS 295
           S  A +L++K+L  +P  R T        W +        D+D +  F D     NE+ +
Sbjct: 247 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQ--------DEDMKRKFQDLLSEENESTA 298
Query: 296 MHEV---PSDGGRTP 307
           + +V   PS   + P
Sbjct: 299 LPQVLAQPSTSRKRP 313

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 110/315 (34%), Positives = 166/315 (52%), Gaps = 35/315 (11%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR--IIHLKITD---QIKREIATLKL 70
           Y + +TLG G  G+VK A +  +    A+KI+ K +  I   +  D    ++ EI  LK 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y 
Sbjct: 72  LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 131 HNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H  G+ HRDLK EN+LL S+     IKI+DFG S +     +  L+ T CG+P Y+APEV
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEV 187
Query: 188 LANRGYDGATS--DIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK-LPK-W--L 240
           L + G  G     D WS GVIL++ L+GY PF + R    L  +I  G +  +P+ W  +
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD-----NEAFS 295
           S  A +L++K+L  +P  R T        W +        D+D +  F D     NE+ +
Sbjct: 248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQ--------DEDMKRKFQDLLSEENESTA 299
Query: 296 MHEV---PSDGGRTP 307
           + +V   PS   + P
Sbjct: 300 LPQVLAQPSTSRKRP 314

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 110/315 (34%), Positives = 166/315 (52%), Gaps = 35/315 (11%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR--IIHLKITD---QIKREIATLKL 70
           Y + +TLG G  G+VK A +  +    A+KI+ K +  I   +  D    ++ EI  LK 
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 77
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y 
Sbjct: 78  LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 136
Query: 131 HNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H  G+ HRDLK EN+LL S+     IKI+DFG S +     +  L+ T CG+P Y+APEV
Sbjct: 137 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEV 193
Query: 188 LANRGYDGATS--DIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK-LPK-W--L 240
           L + G  G     D WS GVIL++ L+GY PF + R    L  +I  G +  +P+ W  +
Sbjct: 194 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 253
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD-----NEAFS 295
           S  A +L++K+L  +P  R T        W +        D+D +  F D     NE+ +
Sbjct: 254 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQ--------DEDMKRKFQDLLSEENESTA 305
Query: 296 MHEV---PSDGGRTP 307
           + +V   PS   + P
Sbjct: 306 LPQVLAQPSTSRKRP 320

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 139/256 (54%), Gaps = 3/256 (1%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +HP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H++ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           +KLEN++LD  G+IKI+DFGL    +   D   +   CG+P Y+APEVL +  Y G   D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVD 187
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
            W  GV++Y ++ G LPF +++   L++ I   + + P+ LSP A++LL  +L+ +P +R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 260 ITIAGIKADEWFEQDY 275
           +      A E  E  +
Sbjct: 248 LGGGPSDAKEVMEHRF 263

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 82/241 (34%), Positives = 135/241 (56%), Gaps = 3/241 (1%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +HP +  L
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 75
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H++ V +RD
Sbjct: 76  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 135
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           +KLEN++LD  G+IKI+DFGL    +   D   +   CG+P Y+APEVL +  Y G   D
Sbjct: 136 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVD 192
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
            W  GV++Y ++ G LPF +++   L++ I   + + P+ LSP A++LL  +L+ +P +R
Sbjct: 193 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 252
Query: 260 I 260
           +
Sbjct: 253 L 253

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 82/241 (34%), Positives = 135/241 (56%), Gaps = 3/241 (1%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +HP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H++ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           +KLEN++LD  G+IKI+DFGL    +   D   +   CG+P Y+APEVL +  Y G   D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVD 187
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
            W  GV++Y ++ G LPF +++   L++ I   + + P+ LSP A++LL  +L+ +P +R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 260 I 260
           +
Sbjct: 248 L 248

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 102/310 (32%), Positives = 158/310 (50%), Gaps = 19/310 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI-ATLKLLKHP 74
           +   + +G+G+FGKV  A+     + +AVK+L+K  I+  K    I  E    LK +KHP
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
            +V LH    +  K+Y VL+Y+ GGELF  +  +    E   R    ++   + Y H+  
Sbjct: 100 FLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 159
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + +RDLK ENILLDS+G+I ++DFGL    ++   +    T CG+P Y+APEVL  + YD
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQPYD 217
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP 254
             T D W  G +LY +L G  PF  RN A +Y  I     +L   ++  A++LL  +L+ 
Sbjct: 218 -RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQK 276
Query: 255 NPVKR-------------ITIAGIKADEWFEQDYTPA-NPD-DDEEDIFVDNEAFSMHEV 299
           +  KR             +  + I  D+   +  TP  NP+     D+   +  F+   V
Sbjct: 277 DRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPNVSGPNDLRHFDPEFTEEPV 336
Query: 300 PSDGGRTPGS 309
           P+  G+ P S
Sbjct: 337 PNAIGKAPDS 346

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 94/267 (35%), Positives = 150/267 (56%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y++G  LG G F  VK  ++  +GL +A K ++K +    +     ++I+RE++ L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPN++ LH+V  +++ + ++LE V+GGELFD +A K  L E E     +Q++DGV+Y H 
Sbjct: 74  HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 187
           K + H DLK ENI+L  K     +IK+ DFGL+    H  +DG+      G+P +VAPE+
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  D +     S  
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +RK+L     KR+TI       W
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 139/256 (54%), Gaps = 3/256 (1%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +HP +  L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H++ V +RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSD 199
           +KLEN++LD  G+IKI+DFGL    +   D   +   CG+P Y+APEVL +  Y G   D
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVLEDNDY-GRAVD 187
Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
            W  GV++Y ++ G LPF +++   L++ I   + + P+ LSP A++LL  +L+ +P +R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 260 ITIAGIKADEWFEQDY 275
           +      A E  E  +
Sbjct: 248 LGGGPSDAKEVMEHRF 263

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 100/274 (36%), Positives = 150/274 (54%), Gaps = 19/274 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR--IIHLKITD---QIKREIATLKL 70
           Y + +TLG G  G+VK A +  +    A+KI+ K +  I   +  D    ++ EI  LK 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y 
Sbjct: 72  LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 130
Query: 131 HNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H  G+ HRDLK EN+LL S+     IKI+DFG S +     +  L+ T CG+P Y+APEV
Sbjct: 131 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEV 187
Query: 188 LANRGYDGATS--DIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK-LPK-W--L 240
           L + G  G     D WS GVIL++ L+GY PF + R    L  +I  G +  +P+ W  +
Sbjct: 188 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 247
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
           S  A +L++K+L  +P  R T        W + +
Sbjct: 248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 143/256 (55%), Gaps = 4/256 (1%)
Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           K +  + +  +E  + LG+G FGKV   ++  +G  +A+KIL+K  I+          E 
Sbjct: 140 KPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 199
Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
             L+  +HP +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++ 
Sbjct: 200 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 259
Query: 126 GVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            + Y H+ K V +RDLKLEN++LD  G+IKI+DFGL    +  +D   + T CG+P Y+A
Sbjct: 260 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLA 317
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PEVL +  Y G   D W  GV++Y ++ G LPF +++   L++ I   + + P+ L P A
Sbjct: 318 PEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 376
Query: 245 QNLLRKILEPNPVKRI 260
           ++LL  +L+ +P +R+
Sbjct: 377 KSLLSGLLKKDPKQRL 392

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  154 bits (390), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 85/256 (33%), Positives = 143/256 (55%), Gaps = 4/256 (1%)
Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           K +  + +  +E  + LG+G FGKV   ++  +G  +A+KIL+K  I+          E 
Sbjct: 143 KPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTEN 202
Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
             L+  +HP +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++ 
Sbjct: 203 RVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVS 262
Query: 126 GVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            + Y H+ K V +RDLKLEN++LD  G+IKI+DFGL    +  +D   + T CG+P Y+A
Sbjct: 263 ALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLA 320
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PEVL +  Y G   D W  GV++Y ++ G LPF +++   L++ I   + + P+ L P A
Sbjct: 321 PEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEA 379
Query: 245 QNLLRKILEPNPVKRI 260
           ++LL  +L+ +P +R+
Sbjct: 380 KSLLSGLLKKDPKQRL 395

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  154 bits (388), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 97/267 (36%), Positives = 146/267 (54%), Gaps = 23/267 (8%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG G FG V   ++  SGL   +K + K+R       +QI+ EI  LK L HPN++++
Sbjct: 28  RKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKI 85
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS---KGR-LQEAEGRKLFQQLIDGVSYCHNKGV 135
            EV      +Y+V+E   GGEL ++I S   +G+ L E    +L +Q+++ ++Y H++ V
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHV 145
Query: 136 FHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            H+DLK ENIL         IKI DFGL+ L   F+ D       G+  Y+APEV     
Sbjct: 146 VHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAAGTALYMAPEVFKRDV 202
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW------LSPGAQN 246
                 DIWS GV++Y +LTG LPF   +L  + QK     +K P +      L+P A +
Sbjct: 203 --TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK---ATYKEPNYAVECRPLTPQAVD 257
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQ 273
           LL+++L  +P +R + A +   EWF+Q
Sbjct: 258 LLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 150/274 (54%), Gaps = 19/274 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR--IIHLKITD---QIKREIATLKL 70
           Y + +TLG G  G+VK A +  +    A++I+ K +  I   +  D    ++ EI  LK 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y 
Sbjct: 197 LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 255
Query: 131 HNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H  G+ HRDLK EN+LL S+     IKI+DFG S +     +  L+ T CG+P Y+APEV
Sbjct: 256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEV 312
Query: 188 LANRGYDGATS--DIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK-LPK-W--L 240
           L + G  G     D WS GVIL++ L+GY PF + R    L  +I  G +  +P+ W  +
Sbjct: 313 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 372
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
           S  A +L++K+L  +P  R T        W + +
Sbjct: 373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 90/272 (33%), Positives = 154/272 (56%), Gaps = 19/272 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKLLKH 73
           YEL   +G+G F  V+   + ++G  FAVKI++  +        T+ +KRE +   +LKH
Sbjct: 26  YELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSY 129
           P++V L E  +S   +YMV E++ G +L  +I  +        EA      +Q+++ + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 130 CHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLH-TTCGSPNYVAP 185
           CH+  + HRD+K EN+LL SK N   +K+ DFG++       + GL+     G+P+++AP
Sbjct: 146 CHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAI---QLGESGLVAGGRVGTPHFMAP 202
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW--LS 241
           EV+    Y G   D+W CGVIL+++L+G LPF       L++ I +G +K+   +W  +S
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS 260
Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
             A++L+R++L  +P +RIT+       W ++
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 99/274 (36%), Positives = 150/274 (54%), Gaps = 19/274 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNR--IIHLKITD---QIKREIATLKL 70
           Y + +TLG G  G+VK A +  +    A++I+ K +  I   +  D    ++ EI  LK 
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 210
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y 
Sbjct: 211 LNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYL 269
Query: 131 HNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H  G+ HRDLK EN+LL S+     IKI+DFG S +     +  L+ T CG+P Y+APEV
Sbjct: 270 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTYLAPEV 326
Query: 188 LANRGYDGATS--DIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK-LPK-W--L 240
           L + G  G     D WS GVIL++ L+GY PF + R    L  +I  G +  +P+ W  +
Sbjct: 327 LVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEV 386
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
           S  A +L++K+L  +P  R T        W + +
Sbjct: 387 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 420

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 95/290 (32%), Positives = 152/290 (52%), Gaps = 34/290 (11%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-------------- 56
           ++L +Y L   +G+G++G VK A + +    +A+K+L K ++I                 
Sbjct: 10  VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPA 69
Query: 57  ---------ITDQIKREIATLKLLKHPNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKI 105
                      +Q+ +EIA LK L HPNVV+L EVL   ++  +YMV E V  G + + +
Sbjct: 70  PGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-V 128
Query: 106 ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165
            +   L E + R  FQ LI G+ Y H + + HRD+K  N+L+   G+IKI+DFG+S    
Sbjct: 129 PTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVS---N 185
Query: 166 HFR-DDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNL 222
            F+  D LL  T G+P ++APE L+   + + G   D+W+ GV LY  + G  PF D  +
Sbjct: 186 EFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI 245
Query: 223 AVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEW 270
             L+ KI     + P    ++   ++L+ ++L+ NP  RI +  IK   W
Sbjct: 246 MCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPW 295

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 151/267 (56%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKIT-DQIKREIATLKLLK 72
           Y++G  LG G F  VK  ++  +GL +A K ++K  +R     ++ ++I+RE++ L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NV+ LH+V  +++ + ++LE V+GGELFD +A K  L E E     +Q++DGV+Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 187
           K + H DLK ENI+L  K     +IK+ DFGL+    H  +DG+      G+P +VAPE+
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  D +     S  
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +RK+L     KR+TI       W
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 151/267 (56%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKIT-DQIKREIATLKLLK 72
           Y++G  LG G F  VK  ++  +GL +A K ++K  +R     ++ ++I+RE++ L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NV+ LH+V  +++ + ++LE V+GGELFD +A K  L E E     +Q++DGV+Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 187
           K + H DLK ENI+L  K     +IK+ DFGL+    H  +DG+      G+P +VAPE+
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  D +     S  
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +RK+L     KR+TI       W
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 151/267 (56%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKIT-DQIKREIATLKLLK 72
           Y++G  LG G F  VK  ++  +GL +A K ++K  +R     ++ ++I+RE++ L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NV+ LH+V  +++ + ++LE V+GGELFD +A K  L E E     +Q++DGV+Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 187
           K + H DLK ENI+L  K     +IK+ DFGL+    H  +DG+      G+P +VAPE+
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  D +     S  
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +RK+L     KR+TI       W
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 83/249 (33%), Positives = 139/249 (55%), Gaps = 4/249 (1%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  +E  + LG+G FGKV   ++  +G  +A+KIL+K  I+          E   L+  +
Sbjct: 9   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 68
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H+
Sbjct: 69  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 128
Query: 133 -KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            K V +RDLKLEN++LD  G+IKI+DFGL    +  +D   +   CG+P Y+APEVL + 
Sbjct: 129 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDN 186
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
            Y G   D W  GV++Y ++ G LPF +++   L++ I   + + P+ L P A++LL  +
Sbjct: 187 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 245
Query: 252 LEPNPVKRI 260
           L+ +P +R+
Sbjct: 246 LKKDPKQRL 254

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 83/249 (33%), Positives = 139/249 (55%), Gaps = 4/249 (1%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  +E  + LG+G FGKV   ++  +G  +A+KIL+K  I+          E   L+  +
Sbjct: 8   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 67
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H+
Sbjct: 68  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 127
Query: 133 -KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            K V +RDLKLEN++LD  G+IKI+DFGL    +  +D   +   CG+P Y+APEVL + 
Sbjct: 128 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDN 185
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
            Y G   D W  GV++Y ++ G LPF +++   L++ I   + + P+ L P A++LL  +
Sbjct: 186 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 244
Query: 252 LEPNPVKRI 260
           L+ +P +R+
Sbjct: 245 LKKDPKQRL 253

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  152 bits (385), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 151/267 (56%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKIT-DQIKREIATLKLLK 72
           Y++G  LG G F  VK  ++  +GL +A K ++K  +R     ++ ++I+RE++ L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NV+ LH+V  +++ + ++LE V+GGELFD +A K  L E E     +Q++DGV+Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 187
           K + H DLK ENI+L  K     +IK+ DFGL+    H  +DG+      G+P +VAPE+
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  D +     S  
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +RK+L     KR+TI       W
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 104/302 (34%), Positives = 159/302 (52%), Gaps = 24/302 (7%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  + +     S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDG 303
           A++ +R++L  +P KR+TI       W +       P D ++ +     A +M +     
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK-------PKDTQQALSRKASAVNMEKFKKFA 300
Query: 304 GR 305
            R
Sbjct: 301 AR 302

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  152 bits (384), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 95/267 (35%), Positives = 151/267 (56%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKIT-DQIKREIATLKLLK 72
           Y++G  LG G F  VK  ++  +GL +A K ++K  +R     ++ ++I+RE++ L+ + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NV+ LH+V  +++ + ++LE V+GGELFD +A K  L E E     +Q++DGV+Y H 
Sbjct: 74  HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHT 133
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGL-LHTTCGSPNYVAPEV 187
           K + H DLK ENI+L  K     +IK+ DFGL+    H  +DG+      G+P +VAPE+
Sbjct: 134 KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA----HEIEDGVEFKNIFGTPEFVAPEI 189
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  D +     S  
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +RK+L     KR+TI       W
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPW 275

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  152 bits (384), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 83/249 (33%), Positives = 139/249 (55%), Gaps = 4/249 (1%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  +E  + LG+G FGKV   ++  +G  +A+KIL+K  I+          E   L+  +
Sbjct: 7   MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 66
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H+
Sbjct: 67  HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHS 126
Query: 133 -KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            K V +RDLKLEN++LD  G+IKI+DFGL    +  +D   +   CG+P Y+APEVL + 
Sbjct: 127 EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVLEDN 184
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
            Y G   D W  GV++Y ++ G LPF +++   L++ I   + + P+ L P A++LL  +
Sbjct: 185 DY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGL 243
Query: 252 LEPNPVKRI 260
           L+ +P +R+
Sbjct: 244 LKKDPKQRL 252

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 99/267 (37%), Positives = 148/267 (55%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  + +     S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 149/269 (55%), Gaps = 17/269 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  + +     S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFE 272
           A++ +R++L  +P KR+TI       W +
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 99/267 (37%), Positives = 148/267 (55%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  + +     S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  152 bits (383), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 89/266 (33%), Positives = 146/266 (54%), Gaps = 15/266 (5%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           YE+G  LG G F  V+  +   +G  +A K ++K R+   +     ++I+RE+  L+ ++
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPN++ LH++  +K+ + ++LE V+GGELFD +A K  L E E  +  +Q++DGV Y H+
Sbjct: 67  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 126
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           K + H DLK ENI+L  K      IK+ DFG++                G+P +VAPE++
Sbjct: 127 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPGA 244
            N    G  +D+WS GVI Y++L+G  PF        L  +    +  D +     S  A
Sbjct: 184 -NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 242
Query: 245 QNLLRKILEPNPVKRITIAGIKADEW 270
           ++ +R++L  +P +R+TIA      W
Sbjct: 243 KDFIRRLLVKDPKRRMTIAQSLEHSW 268

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 99/267 (37%), Positives = 148/267 (55%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  + +     S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 99/267 (37%), Positives = 148/267 (55%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  + +     S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 99/267 (37%), Positives = 148/267 (55%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  + +     S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 99/267 (37%), Positives = 148/267 (55%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 187
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  + +     S  
Sbjct: 188 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +R++L  +P KR+TI       W
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  152 bits (383), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 99/267 (37%), Positives = 148/267 (55%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 12  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 71
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 72  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 187
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  + +     S  
Sbjct: 188 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +R++L  +P KR+TI       W
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPW 273

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 99/269 (36%), Positives = 149/269 (55%), Gaps = 17/269 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPAFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  + +     S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFE 272
           A++ +R++L  +P KR+TI       W +
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 142/251 (56%), Gaps = 4/251 (1%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           M+L  +     LG+G+FGKV  ++   +   +AVKIL+K+ +I     +    E   L L
Sbjct: 17  MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K P + +LH    +  ++Y V+EYV GG+L   I   GR +E        ++  G+ +
Sbjct: 77  PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 136
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
             +KG+ +RDLKL+N++LDS+G+IKI+DFG+    ++  D       CG+P+Y+APE++A
Sbjct: 137 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIA 194
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
            + Y G + D W+ GV+LY +L G  PF+  +   L+Q I   +   PK +S  A  + +
Sbjct: 195 YQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 253
Query: 250 KILEPNPVKRI 260
            ++  +P KR+
Sbjct: 254 GLMTKHPGKRL 264

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 99/267 (37%), Positives = 148/267 (55%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  + +     S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 99/267 (37%), Positives = 148/267 (55%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  + +     S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  151 bits (381), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 131/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          ++  G+  YV+PE+L  +    
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-AC 213
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 273
Query: 256 PVKRI 260
             KR+
Sbjct: 274 ATKRL 278

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 149/261 (57%), Gaps = 10/261 (3%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q  +++  +EL + LG+G+FGKV  A+   +   FA+K L+K+ ++   + D ++  +  
Sbjct: 12  QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL---MDDDVECTMVE 68
Query: 68  LKLL----KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
            ++L    +HP +  +     +K  ++ V+EY+ GG+L   I S  +   +       ++
Sbjct: 69  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 128
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           I G+ + H+KG+ +RDLKL+NILLD  G+IKI+DFG+    ++   D   +  CG+P+Y+
Sbjct: 129 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGTPDYI 186
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
           APE+L  + Y+ +  D WS GV+LY +L G  PF  ++   L+  I   +   P+WL   
Sbjct: 187 APEILLGQKYNHSV-DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 245
Query: 244 AQNLLRKILEPNPVKRITIAG 264
           A++LL K+    P KR+ + G
Sbjct: 246 AKDLLVKLFVREPEKRLGVRG 266

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 142/251 (56%), Gaps = 4/251 (1%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           M+L  +     LG+G+FGKV  ++   +   +AVKIL+K+ +I     +    E   L L
Sbjct: 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 397
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K P + +LH    +  ++Y V+EYV GG+L   I   GR +E        ++  G+ +
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFF 457
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
             +KG+ +RDLKL+N++LDS+G+IKI+DFG+    ++  D       CG+P+Y+APE++A
Sbjct: 458 LQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEIIA 515
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
            + Y G + D W+ GV+LY +L G  PF+  +   L+Q I   +   PK +S  A  + +
Sbjct: 516 YQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574
Query: 250 KILEPNPVKRI 260
            ++  +P KR+
Sbjct: 575 GLMTKHPGKRL 585

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  150 bits (380), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 131/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          ++  G+  YV+PE+L  +    
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-AC 209
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 269
Query: 256 PVKRI 260
             KR+
Sbjct: 270 ATKRL 274

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 130/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKS-AC 210
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 256 PVKRI 260
             KR+
Sbjct: 271 ATKRL 275

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  150 bits (380), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 99/267 (37%), Positives = 148/267 (55%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  + +     S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  150 bits (379), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 130/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 95  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 154
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 155 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 213
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 214 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 273
Query: 256 PVKRI 260
             KR+
Sbjct: 274 ATKRL 278

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  150 bits (379), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 130/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 210
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 256 PVKRI 260
             KR+
Sbjct: 271 ATKRL 275

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 130/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 76  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 135
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 136 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 194
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 195 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 254
Query: 256 PVKRI 260
             KR+
Sbjct: 255 ATKRL 259

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 130/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 210
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 256 PVKRI 260
             KR+
Sbjct: 271 ATKRL 275

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 130/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 212
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 256 PVKRI 260
             KR+
Sbjct: 273 ATKRL 277

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 130/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 212
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 256 PVKRI 260
             KR+
Sbjct: 273 ATKRL 277

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 145/266 (54%), Gaps = 15/266 (5%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           YE+G  LG G F  V+  +   +G  +A K ++K R+   +     ++I+RE+  L+ ++
Sbjct: 28  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIR 87
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPN++ LH++  +K+ + ++LE V+GGELFD +A K  L E E  +  +Q++DGV Y H+
Sbjct: 88  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 147
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           K + H DLK ENI+L  K      IK+ DFG++                G+P +VAPE++
Sbjct: 148 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEIV 204
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPGA 244
            N    G  +D+WS GVI Y++L+G  PF        L  +    +  D +     S  A
Sbjct: 205 -NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 263
Query: 245 QNLLRKILEPNPVKRITIAGIKADEW 270
           ++ +R++L  +P +R+ IA      W
Sbjct: 264 KDFIRRLLVKDPKRRMXIAQSLEHSW 289

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 130/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 71  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 130
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 131 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 189
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 190 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 249
Query: 256 PVKRI 260
             KR+
Sbjct: 250 ATKRL 254

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 145/266 (54%), Gaps = 15/266 (5%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           YE+G  LG G F  V+  +   +G  +A K ++K R+   +     ++I+RE+  L+ ++
Sbjct: 14  YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 73
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPN++ LH++  +K+ + ++LE V+GGELFD +A K  L E E  +  +Q++DGV Y H+
Sbjct: 74  HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHS 133
Query: 133 KGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           K + H DLK ENI+L  K      IK+ DFG++                G+P +VAPE++
Sbjct: 134 KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEIV 190
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPGA 244
            N    G  +D+WS GVI Y++L+G  PF        L  +    +  D +     S  A
Sbjct: 191 -NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA 249
Query: 245 QNLLRKILEPNPVKRITIAGIKADEW 270
           ++ +R++L  +P +R+ IA      W
Sbjct: 250 KDFIRRLLVKDPKRRMXIAQSLEHSW 275

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 130/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 70  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 188
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 189 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 248
Query: 256 PVKRI 260
             KR+
Sbjct: 249 ATKRL 253

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 130/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 99  FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 158
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 159 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 217
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 218 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 277
Query: 256 PVKRI 260
             KR+
Sbjct: 278 ATKRL 282

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 130/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 69  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 128
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 129 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 187
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 188 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 247
Query: 256 PVKRI 260
             KR+
Sbjct: 248 ATKRL 252

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 130/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 212
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 256 PVKRI 260
             KR+
Sbjct: 273 ATKRL 277

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 100/268 (37%), Positives = 144/268 (53%), Gaps = 22/268 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE+   +G G++   K      + + FAVKI++K++       D  +     L+  +HPN
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSK------RDPTEEIEILLRYGQHPN 77
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++ L +V      +Y+V E + GGEL DKI  +    E E   +   +   V Y H +GV
Sbjct: 78  IITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 136 FHRDLKLENIL-LDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            HRDLK  NIL +D  GN   I+I DFG +   Q   ++GLL T C + N+VAPEVL  +
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLERQ 195
Query: 192 GYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLP--KW--LSPG 243
           GYD A  DIWS GV+LY +LTGY PF    DD    +L  +I  G F L    W  +S  
Sbjct: 196 GYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL-ARIGSGKFSLSGGYWNSVSDT 253
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWF 271
           A++L+ K+L  +P +R+T A +    W 
Sbjct: 254 AKDLVSKMLHVDPHQRLTAALVLRHPWI 281

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 130/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 91  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 150
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 151 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 209
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 210 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 269
Query: 256 PVKRI 260
             KR+
Sbjct: 270 ATKRL 274

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 130/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 72  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 131
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 132 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 190
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 191 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 250
Query: 256 PVKRI 260
             KR+
Sbjct: 251 ATKRL 255

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 81/245 (33%), Positives = 129/245 (52%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 97  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 156
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 157 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 215
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P    P A++L+ K+L  +
Sbjct: 216 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPKARDLVEKLLVLD 275
Query: 256 PVKRI 260
             KR+
Sbjct: 276 ATKRL 280

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 80/245 (32%), Positives = 129/245 (52%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F     A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 92  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 210
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 211 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 256 PVKRI 260
             KR+
Sbjct: 271 ATKRL 275

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 80/245 (32%), Positives = 130/245 (53%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   G L   I   G   E   R    +++  + Y H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          ++  G+  YV+PE+L  +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS-AS 212
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K+L  +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 256 PVKRI 260
             KR+
Sbjct: 273 ATKRL 277

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  149 bits (375), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 98/267 (36%), Positives = 147/267 (55%), Gaps = 17/267 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLLK 72
           Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK ++
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPNV+ LHEV  +K+ + ++ E V GGELFD +A K  L E E  +  +Q+++GV Y H+
Sbjct: 73  HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHS 132
Query: 133 KGVFHRDLKLENI-LLDS---KGNIKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEV 187
             + H DLK ENI LLD    K  IKI DFGL+    H  D G       G+P +VAPE+
Sbjct: 133 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA----HKIDFGNEFKNIFGTPEFVAPEI 188
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPG 243
           + N    G  +D+WS GVI Y++L+G  PF        LA +    +  + +     S  
Sbjct: 189 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEW 270
           A++ +R++L  +P KR+TI       W
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPW 274

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  148 bits (374), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 80/245 (32%), Positives = 129/245 (52%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AX 212
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++ KI + ++  P+   P A++L+ K+L  +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 256 PVKRI 260
             KR+
Sbjct: 273 ATKRL 277

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 80/245 (32%), Positives = 129/245 (52%), Gaps = 1/245 (0%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  L HP 
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y H KG+
Sbjct: 94  FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 153
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK ENILL+   +I+I+DFG + +          +   G+  YV+PE+L  +    
Sbjct: 154 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS-AC 212
Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +SD+W+ G I+Y ++ G  PF   N  +++ KI + ++  P+   P A++L+ K+L  +
Sbjct: 213 KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKLLVLD 272
Query: 256 PVKRI 260
             KR+
Sbjct: 273 ATKRL 277

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  148 bits (373), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 148/261 (56%), Gaps = 10/261 (3%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           Q  +++  + L + LG+G+FGKV  A+   +   FA+K L+K+ ++   + D ++  +  
Sbjct: 11  QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVL---MDDDVECTMVE 67
Query: 68  LKLL----KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
            ++L    +HP +  +     +K  ++ V+EY+ GG+L   I S  +   +       ++
Sbjct: 68  KRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI 127
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           I G+ + H+KG+ +RDLKL+NILLD  G+IKI+DFG+    ++   D   +  CG+P+Y+
Sbjct: 128 ILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTPDYI 185
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
           APE+L  + Y+ +  D WS GV+LY +L G  PF  ++   L+  I   +   P+WL   
Sbjct: 186 APEILLGQKYNHSV-DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKE 244
Query: 244 AQNLLRKILEPNPVKRITIAG 264
           A++LL K+    P KR+ + G
Sbjct: 245 AKDLLVKLFVREPEKRLGVRG 265

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  145 bits (367), Expect = 2e-35,   Method: Compositional matrix adjust.
 Identities = 100/268 (37%), Positives = 140/268 (52%), Gaps = 22/268 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE+   +G G++   K      +   FAVKI++K++       D  +     L+  +HPN
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSK------RDPTEEIEILLRYGQHPN 77
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++ L +V      +Y+V E   GGEL DKI  +    E E   +   +   V Y H +GV
Sbjct: 78  IITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGV 137
Query: 136 FHRDLKLENIL-LDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            HRDLK  NIL +D  GN   I+I DFG +   Q   ++GLL T C + N+VAPEVL  +
Sbjct: 138 VHRDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLLXTPCYTANFVAPEVLERQ 195
Query: 192 GYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLP--KW--LSPG 243
           GYD A  DIWS GV+LY  LTGY PF    DD    +L  +I  G F L    W  +S  
Sbjct: 196 GYDAA-CDIWSLGVLLYTXLTGYTPFANGPDDTPEEIL-ARIGSGKFSLSGGYWNSVSDT 253
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWF 271
           A++L+ K L  +P +R+T A +    W 
Sbjct: 254 AKDLVSKXLHVDPHQRLTAALVLRHPWI 281

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  145 bits (366), Expect = 3e-35,   Method: Compositional matrix adjust.
 Identities = 88/274 (32%), Positives = 161/274 (58%), Gaps = 17/274 (6%)
Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQIKRE 64
           E + +  +EL + LG G +GKV   + +   D+G  +A+K+L+K  I+   K T+  + E
Sbjct: 49  EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTE 108
Query: 65  IATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
              L+ ++  P +V LH    +++K++++L+Y+ GGELF  ++ + R  E E +    ++
Sbjct: 109 RQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEI 168
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL--LHTTCGSPN 181
           +  + + H  G+ +RD+KLENILLDS G++ ++DFGLS   + F  D     +  CG+  
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS---KEFVADETERAYDFCGTIE 225
Query: 182 YVAPEVL--ANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFK 235
           Y+AP+++   + G+D A  D WS GV++Y +LTG  PF    +  + A + ++I + +  
Sbjct: 226 YMAPDIVRGGDSGHDKAV-DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 269
            P+ +S  A++L++++L  +P KR+      ADE
Sbjct: 285 YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADE 318

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  145 bits (365), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 87/272 (31%), Positives = 151/272 (55%), Gaps = 19/272 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKLLKH 73
           YEL   +G+G F  V+   + ++G  FAVKI++  +        T+ +KRE +   +LKH
Sbjct: 28  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 87
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSY 129
           P++V L E  +S   +YMV E++ G +L  +I  +        EA      +Q+++ + Y
Sbjct: 88  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 147
Query: 130 CHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLH-TTCGSPNYVAP 185
           CH+  + HRD+K   +LL SK N   +K+  FG++       + GL+     G+P+++AP
Sbjct: 148 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---QLGESGLVAGGRVGTPHFMAP 204
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW--LS 241
           EV+    Y G   D+W CGVIL+++L+G LPF       L++ I +G +K+   +W  +S
Sbjct: 205 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS 262
Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
             A++L+R++L  +P +RIT+       W ++
Sbjct: 263 ESAKDLVRRMLMLDPAERITVYEALNHPWLKE 294

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  144 bits (364), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 87/272 (31%), Positives = 151/272 (55%), Gaps = 19/272 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKLLKH 73
           YEL   +G+G F  V+   + ++G  FAVKI++  +        T+ +KRE +   +LKH
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSY 129
           P++V L E  +S   +YMV E++ G +L  +I  +        EA      +Q+++ + Y
Sbjct: 86  PHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRY 145
Query: 130 CHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLH-TTCGSPNYVAP 185
           CH+  + HRD+K   +LL SK N   +K+  FG++       + GL+     G+P+++AP
Sbjct: 146 CHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI---QLGESGLVAGGRVGTPHFMAP 202
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW--LS 241
           EV+    Y G   D+W CGVIL+++L+G LPF       L++ I +G +K+   +W  +S
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHIS 260
Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
             A++L+R++L  +P +RIT+       W ++
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKE 292

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  144 bits (364), Expect = 5e-35,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 147/265 (55%), Gaps = 13/265 (4%)
Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           K    + L  ++L R +G G++ KV   +   +   +A+++++K  +   +  D ++ E 
Sbjct: 44  KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK 103
Query: 66  ATL-KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
               +   HP +V LH    ++S+++ V+EYV GG+L   +  + +L E   R    ++ 
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
             ++Y H +G+ +RDLKL+N+LLDS+G+IK++D+G+    +  R      T CG+PNY+A
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIA 221
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFD--------DRNLA-VLYQKIFRGDFK 235
           PE+L    Y G + D W+ GV+++ ++ G  PFD        D+N    L+Q I     +
Sbjct: 222 PEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRI 260
           +P+ LS  A ++L+  L  +P +R+
Sbjct: 281 IPRSLSVKAASVLKSFLNKDPKERL 305

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 89/275 (32%), Positives = 144/275 (52%), Gaps = 20/275 (7%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE--KNRIIHLK---ITDQIKREIATLK 69
           +Y+    +G G    V+      +G  FAVKI+E    R+   +   + +  +RE   L+
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 70  LLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
            +  HP+++ L +   S S +++V + +  GELFD +  K  L E E R + + L++ VS
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           + H   + HRDLK ENILLD    I++SDFG S    H      L   CG+P Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEIL 271
Query: 189 ------ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW- 239
                  + GY G   D+W+CGVIL+ +L G  PF  R   ++ + I  G ++   P+W 
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330
Query: 240 -LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
             S   ++L+ ++L+ +P  R+T        +FE+
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/270 (34%), Positives = 143/270 (52%), Gaps = 22/270 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y +  T+G G++ + K      + + +AVK+++K++       D  +     L+  +HPN
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK------RDPSEEIEILLRYGQHPN 82
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++ L +V      +Y+V E + GGEL DKI  +    E E   +   +   V Y H++GV
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 136 FHRDLKLENIL-LDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            HRDLK  NIL +D  GN   ++I DFG +   Q   ++GLL T C + N+VAPEVL  +
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLKRQ 200
Query: 192 GYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLP--KW--LSPG 243
           GYD    DIWS G++LY +L GY PF     D    +L  +I  G F L    W  +S  
Sbjct: 201 GYDEG-CDIWSLGILLYTMLAGYTPFANGPSDTPEEIL-TRIGSGKFTLSGGNWNTVSET 258
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
           A++L+ K+L  +P +R+T   +    W  Q
Sbjct: 259 AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQ 288

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 99/310 (31%), Positives = 156/310 (50%), Gaps = 23/310 (7%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y +  T+G G++ + K      + + +AVK+++K++       D  +     L+  +HPN
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSK------RDPSEEIEILLRYGQHPN 82
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++ L +V      +Y+V E + GGEL DKI  +    E E   +   +   V Y H++GV
Sbjct: 83  IITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGV 142
Query: 136 FHRDLKLENIL-LDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            HRDLK  NIL +D  GN   ++I DFG +   Q   ++GLL T C + N+VAPEVL  +
Sbjct: 143 VHRDLKPSNILYVDESGNPECLRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLKRQ 200
Query: 192 GYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLP--KW--LSPG 243
           GYD    DIWS G++LY +L GY PF     D    +L  +I  G F L    W  +S  
Sbjct: 201 GYDEG-CDIWSLGILLYTMLAGYTPFANGPSDTPEEIL-TRIGSGKFTLSGGNWNTVSET 258
Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ-DYTPANPDDDEEDIFVDNEAFSMHEVPSD 302
           A++L+ K+L  +P +R+T   +    W  Q D  P +    ++   V     + +   + 
Sbjct: 259 AKDLVSKMLHVDPHQRLTAKQVLQHPWVTQKDKLPQSQLSHQDLQLVKGAMAATYSALNS 318
Query: 303 GGRTPGSPPL 312
              TP   P+
Sbjct: 319 SKPTPQLKPI 328

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 146/265 (55%), Gaps = 13/265 (4%)
Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           K    + L  ++L R +G G++ KV   +   +   +A+K+++K  +   +  D ++ E 
Sbjct: 12  KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEK 71
Query: 66  ATL-KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
               +   HP +V LH    ++S+++ V+EYV GG+L   +  + +L E   R    ++ 
Sbjct: 72  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 131
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
             ++Y H +G+ +RDLKL+N+LLDS+G+IK++D+G+    +  R        CG+PNY+A
Sbjct: 132 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIA 189
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFD--------DRNLA-VLYQKIFRGDFK 235
           PE+L    Y G + D W+ GV+++ ++ G  PFD        D+N    L+Q I     +
Sbjct: 190 PEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 248
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRI 260
           +P+ +S  A ++L+  L  +P +R+
Sbjct: 249 IPRSMSVKAASVLKSFLNKDPKERL 273

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 144/258 (55%), Gaps = 13/258 (5%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLL 71
           L  ++L R +G G++ KV   +   +   +A+K+++K  +   +  D ++ E     +  
Sbjct: 4   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 63
Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            HP +V LH    ++S+++ V+EYV GG+L   +  + +L E   R    ++   ++Y H
Sbjct: 64  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 123
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            +G+ +RDLKL+N+LLDS+G+IK++D+G+    +  R        CG+PNY+APE+L   
Sbjct: 124 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGE 181
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFD--------DRNLA-VLYQKIFRGDFKLPKWLSP 242
            Y G + D W+ GV+++ ++ G  PFD        D+N    L+Q I     ++P+ LS 
Sbjct: 182 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 240
Query: 243 GAQNLLRKILEPNPVKRI 260
            A ++L+  L  +P +R+
Sbjct: 241 KAASVLKSFLNKDPKERL 258

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 144/258 (55%), Gaps = 13/258 (5%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLL 71
           L  ++L R +G G++ KV   +   +   +A+K+++K  +   +  D ++ E     +  
Sbjct: 8   LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQAS 67
Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            HP +V LH    ++S+++ V+EYV GG+L   +  + +L E   R    ++   ++Y H
Sbjct: 68  NHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLH 127
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            +G+ +RDLKL+N+LLDS+G+IK++D+G+    +  R        CG+PNY+APE+L   
Sbjct: 128 ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGE 185
Query: 192 GYDGATSDIWSCGVILYVILTGYLPFD--------DRNLA-VLYQKIFRGDFKLPKWLSP 242
            Y G + D W+ GV+++ ++ G  PFD        D+N    L+Q I     ++P+ LS 
Sbjct: 186 DY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSV 244
Query: 243 GAQNLLRKILEPNPVKRI 260
            A ++L+  L  +P +R+
Sbjct: 245 KAASVLKSFLNKDPKERL 262

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score =  139 bits (351), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 95/303 (31%), Positives = 146/303 (48%), Gaps = 37/303 (12%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQIKREIATLKLLK 72
             Y LG  LG+G FG V     L   L  A+K++ +NR++    ++D +   +    L K
Sbjct: 31  AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWK 90
Query: 73  ------HPNVVRLHEVLASKSKIYMVLEY-VTGGELFDKIASKGRLQEAEGRKLFQQLID 125
                 HP V+RL +   ++    +VLE  +   +LFD I  KG L E   R  F Q++ 
Sbjct: 91  VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA 150
Query: 126 GVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            + +CH++GV HRD+K ENIL+D  +G  K+ DFG  AL     D+       G+  Y  
Sbjct: 151 AIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGAL---LHDEPYTDFD-GTRVYSP 206
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE ++   Y    + +WS G++LY ++ G +PF+        Q+I   +   P  +SP  
Sbjct: 207 PEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAHVSPDC 260
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPSDGG 304
             L+R+ L P P  R ++  I  D W +   TPA      ED+ ++         PS GG
Sbjct: 261 CALIRRCLAPKPSSRPSLEEILLDPWMQ---TPA------EDVPLN---------PSKGG 302
Query: 305 RTP 307
             P
Sbjct: 303 PAP 305

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  134 bits (337), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 139/274 (50%), Gaps = 18/274 (6%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L  Y++   LG G FG V    +  +G  FA K +      H    + +++EI T+ +L+
Sbjct: 50  LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMSVLR 106
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCH 131
           HP +V LH+     +++ M+ E+++GGELF+K+A +  ++ E E  +  +Q+  G+ + H
Sbjct: 107 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 166
Query: 132 NKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
                H DLK ENI+  +K    +K+ DFGL+A   H      +  T G+  + APEV  
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAE 223
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
            +   G  +D+WS GV+ Y++L+G  PF    DD  L  +    +  D      +S   +
Sbjct: 224 GKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 282
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
           + +RK+L  +P  R+TI       W     TP N
Sbjct: 283 DFIRKLLLADPNTRMTIHQALEHPWL----TPGN 312

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  134 bits (337), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 84/274 (30%), Positives = 139/274 (50%), Gaps = 18/274 (6%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L  Y++   LG G FG V    +  +G  FA K +      H    + +++EI T+ +L+
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFV---MTPHESDKETVRKEIQTMSVLR 212
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCH 131
           HP +V LH+     +++ M+ E+++GGELF+K+A +  ++ E E  +  +Q+  G+ + H
Sbjct: 213 HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMH 272
Query: 132 NKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
                H DLK ENI+  +K    +K+ DFGL+A   H      +  T G+  + APEV  
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAAPEVAE 329
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
            +   G  +D+WS GV+ Y++L+G  PF    DD  L  +    +  D      +S   +
Sbjct: 330 GKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK 388
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
           + +RK+L  +P  R+TI       W     TP N
Sbjct: 389 DFIRKLLLADPNTRMTIHQALEHPWL----TPGN 418

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  134 bits (336), Expect = 8e-32,   Method: Compositional matrix adjust.
 Identities = 81/276 (29%), Positives = 149/276 (53%), Gaps = 14/276 (5%)
Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++G     Y++   LG G FG V    +  +G  F  K +     +  K T  +K EI+ 
Sbjct: 45  KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD-KYT--VKNEISI 101
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDG 126
           +  L HP ++ LH+    K ++ ++LE+++GGELFD+IA++  ++ EAE     +Q  +G
Sbjct: 102 MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 161
Query: 127 VSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + + H   + H D+K ENI+ ++K   ++KI DFGL+        D ++  T  +  + A
Sbjct: 162 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFAA 218
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WL 240
           PE++ +R   G  +D+W+ GV+ YV+L+G  PF   +     Q + R D++  +     +
Sbjct: 219 PEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 277
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT 276
           SP A++ ++ +L+  P KR+T+       W + D++
Sbjct: 278 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  134 bits (336), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 81/249 (32%), Positives = 132/249 (53%), Gaps = 20/249 (8%)
Query: 35  DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94
           D+  G  F+ + +++ R   LK  D ++      K+  HPN+++L +   + +  ++V +
Sbjct: 51  DVTGGGSFSAEEVQELREATLKEVDILR------KVSGHPNIIQLKDTYETNTFFFLVFD 104
Query: 95  YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154
            +  GELFD +  K  L E E RK+ + L++ +   H   + HRDLK ENILLD   NIK
Sbjct: 105 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 164
Query: 155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA------NRGYDGATSDIWSCGVILY 208
           ++DFG S           L + CG+P+Y+APE++       + GY G   D+WS GVI+Y
Sbjct: 165 LTDFGFSC---QLDPGEKLRSVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMY 220
Query: 209 VILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW--LSPGAQNLLRKILEPNPVKRITIAG 264
            +L G  PF  R   ++ + I  G+++   P+W   S   ++L+ + L   P KR T   
Sbjct: 221 TLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 280
Query: 265 IKADEWFEQ 273
             A  +F+Q
Sbjct: 281 ALAHPFFQQ 289

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/249 (32%), Positives = 131/249 (52%), Gaps = 20/249 (8%)
Query: 35  DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94
           D+  G  F+ + +++ R   LK  D ++      K+  HPN+++L +   + +  ++V +
Sbjct: 38  DVTGGGSFSAEEVQELREATLKEVDILR------KVSGHPNIIQLKDTYETNTFFFLVFD 91
Query: 95  YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154
            +  GELFD +  K  L E E RK+ + L++ +   H   + HRDLK ENILLD   NIK
Sbjct: 92  LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 151
Query: 155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA------NRGYDGATSDIWSCGVILY 208
           ++DFG S           L   CG+P+Y+APE++       + GY G   D+WS GVI+Y
Sbjct: 152 LTDFGFSC---QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMY 207
Query: 209 VILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW--LSPGAQNLLRKILEPNPVKRITIAG 264
            +L G  PF  R   ++ + I  G+++   P+W   S   ++L+ + L   P KR T   
Sbjct: 208 TLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 267
Query: 265 IKADEWFEQ 273
             A  +F+Q
Sbjct: 268 ALAHPFFQQ 276

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  132 bits (333), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 81/249 (32%), Positives = 131/249 (52%), Gaps = 20/249 (8%)
Query: 35  DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE 94
           D+  G  F+ + +++ R   LK  D ++      K+  HPN+++L +   + +  ++V +
Sbjct: 51  DVTGGGSFSAEEVQELREATLKEVDILR------KVSGHPNIIQLKDTYETNTFFFLVFD 104
Query: 95  YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK 154
            +  GELFD +  K  L E E RK+ + L++ +   H   + HRDLK ENILLD   NIK
Sbjct: 105 LMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIK 164
Query: 155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA------NRGYDGATSDIWSCGVILY 208
           ++DFG S           L   CG+P+Y+APE++       + GY G   D+WS GVI+Y
Sbjct: 165 LTDFGFSC---QLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMY 220
Query: 209 VILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW--LSPGAQNLLRKILEPNPVKRITIAG 264
            +L G  PF  R   ++ + I  G+++   P+W   S   ++L+ + L   P KR T   
Sbjct: 221 TLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEE 280
Query: 265 IKADEWFEQ 273
             A  +F+Q
Sbjct: 281 ALAHPFFQQ 289

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 136/271 (50%), Gaps = 17/271 (6%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKL 70
            +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK 
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 71  LKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +      V+RL +         ++LE +    +LFD I  +G LQE   R  F Q+++ V
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 128 SYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
            +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPE 183
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
            +    Y G ++ +WS G++LY ++ G +PF+        ++I RG     + +S   Q+
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQH 237
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
           L+R  L   P  R T   I+   W +    P
Sbjct: 238 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 268

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 139/256 (54%), Gaps = 7/256 (2%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + +Y   + +GEG+FGK    +  + G  + +K +  +R+   K  ++ +RE+A L  +K
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMK 81
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRL-QEAEGRKLFQQLIDGVSYC 130
           HPN+V+  E       +Y+V++Y  GG+LF +I A KG L QE +    F Q+   + + 
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           H++ + HRD+K +NI L   G +++ DFG++ +     +  L     G+P Y++PE+  N
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLSPEICEN 199
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLR 249
           + Y+   SDIW+ G +LY + T    F+  ++  L  KI  G F  +    S   ++L+ 
Sbjct: 200 KPYNN-KSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258
Query: 250 KILEPNPVKRITIAGI 265
           ++ + NP  R ++  I
Sbjct: 259 QLFKRNPRDRPSVNSI 274

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 135/271 (49%), Gaps = 17/271 (6%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKL 70
            +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK 
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 71  LKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +      V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 128
Query: 128 SYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
            +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPE 184
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
            +    Y G ++ +WS G++LY ++ G +PF+        ++I RG     + +S   Q+
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQH 238
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
           L+R  L   P  R T   I+   W +    P
Sbjct: 239 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 269

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 135/271 (49%), Gaps = 17/271 (6%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKL 70
            +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 71  LKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +      V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 128 SYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
            +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE
Sbjct: 124 RHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPE 179
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
            +    Y G ++ +WS G++LY ++ G +PF+        ++I RG     + +S   Q+
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSXECQH 233
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
           L+R  L   P  R T   I+   W +    P
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 140/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 12  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 71
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 72  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 131
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 132 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 187
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+        ++I RG   
Sbjct: 188 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 241
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 242 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 283

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 140/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 40  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 99
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 100 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 159
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 160 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 215
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+        ++I RG   
Sbjct: 216 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 269
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 270 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 311

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 135/271 (49%), Gaps = 17/271 (6%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKL 70
            +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK 
Sbjct: 9   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 68
Query: 71  LKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +      V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V
Sbjct: 69  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 128
Query: 128 SYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
            +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE
Sbjct: 129 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPE 184
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
            +    Y G ++ +WS G++LY ++ G +PF+        ++I RG     + +S   Q+
Sbjct: 185 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQH 238
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
           L+R  L   P  R T   I+   W +    P
Sbjct: 239 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 269

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 140/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 13  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 72
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 73  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 132
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 133 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 188
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+        ++I RG   
Sbjct: 189 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 242
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 243 FRQRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWMQDVLLP 284

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 135/271 (49%), Gaps = 17/271 (6%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKL 70
            +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK 
Sbjct: 8   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 67
Query: 71  LKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +      V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V
Sbjct: 68  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 128 SYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
            +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE
Sbjct: 128 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPE 183
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
            +    Y G ++ +WS G++LY ++ G +PF+        ++I RG     + +S   Q+
Sbjct: 184 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQH 237
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
           L+R  L   P  R T   I+   W +    P
Sbjct: 238 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 268

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 135/271 (49%), Gaps = 17/271 (6%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKL 70
            +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK 
Sbjct: 7   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 66
Query: 71  LKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +      V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V
Sbjct: 67  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 126
Query: 128 SYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
            +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE
Sbjct: 127 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPE 182
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
            +    Y G ++ +WS G++LY ++ G +PF+        ++I RG     + +S   Q+
Sbjct: 183 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQH 236
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
           L+R  L   P  R T   I+   W +    P
Sbjct: 237 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 267

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 140/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 13  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 72
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 73  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 132
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 133 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 188
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+        ++I RG   
Sbjct: 189 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 242
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 243 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 284

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 140/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 32  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 91
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 92  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 151
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 152 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 207
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+        ++I RG   
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 261
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 140/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 25  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 84
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 85  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 144
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 145 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 200
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+        ++I RG   
Sbjct: 201 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 254
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 255 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 296

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 87/271 (32%), Positives = 135/271 (49%), Gaps = 17/271 (6%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKL 70
            +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 71  LKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +      V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 128 SYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
            +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPE 179
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
            +    Y G ++ +WS G++LY ++ G +PF+        ++I RG     + +S   Q+
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQH 233
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
           L+R  L   P  R T   I+   W +    P
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 135/270 (50%), Gaps = 17/270 (6%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 10  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 69
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 70  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 185
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           +    Y G ++ +WS G++LY ++ G +PF+        ++I RG     + +S   Q+L
Sbjct: 186 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSSECQHL 239
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTP 277
           +R  L   P  R T   I+   W +    P
Sbjct: 240 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 269

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 140/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 12  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 71
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 72  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 131
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 132 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 187
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+        ++I RG   
Sbjct: 188 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 241
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 242 FRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 283

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score =  128 bits (322), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 140/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 13  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 72
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 73  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 132
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 133 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 188
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+        ++I RG   
Sbjct: 189 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 242
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 243 FRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 284

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 140/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 40  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 99
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 100 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 159
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 160 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 215
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+        ++I RG   
Sbjct: 216 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 269
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 270 FRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 311

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 135/270 (50%), Gaps = 17/270 (6%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 32  QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 91
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 92  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 151
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 152 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 207
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           +    Y G ++ +WS G++LY ++ G +PF+        ++I RG     + +S   Q+L
Sbjct: 208 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQRVSXECQHL 261
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTP 277
           +R  L   P  R T   I+   W +    P
Sbjct: 262 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 291

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 140/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 45  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 104
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 105 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 164
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 165 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 220
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+        ++I RG   
Sbjct: 221 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 274
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 275 FRQRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 316

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 140/262 (53%), Gaps = 12/262 (4%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           + E +    +E+ R +G+G+FGKV   Q  D+   +A+K + K + +       + +E+ 
Sbjct: 8   ENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQ 67
Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
            ++ L+HP +V L      +  ++MV++ + GG+L   +      +E   +    +L+  
Sbjct: 68  IMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMA 127
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAP 185
           + Y  N+ + HRD+K +NILLD  G++ I+DF ++A LP+    +  + T  G+  Y+AP
Sbjct: 128 LDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR----ETQITTMAGTKPYMAP 183
Query: 186 EVLANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
           E+ ++R   GY  A  D WS GV  Y +L G  P+  R+     + +   +  +  + S 
Sbjct: 184 EMFSSRKGAGYSFAV-DWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSA 242
Query: 243 GAQ---NLLRKILEPNPVKRIT 261
            +Q   +LL+K+LEPNP +R +
Sbjct: 243 WSQEMVSLLKKLLEPNPDQRFS 264

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 90/266 (33%), Positives = 144/266 (54%), Gaps = 18/266 (6%)
Query: 16  YELGRT--LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           Y + +T  LG G FG+V   ++  +GL  A KI+ K R   +K  +++K EI+ +  L H
Sbjct: 89  YTVSKTEILGGGRFGQVHKCEETATGLKLAAKII-KTR--GMKDKEEVKNEISVMNQLDH 145
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHN 132
            N+++L++   SK+ I +V+EYV GGELFD+I  +   L E +     +Q+ +G+ + H 
Sbjct: 146 ANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ 205
Query: 133 KGVFHRDLKLENILL---DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
             + H DLK ENIL    D+K  IKI DFGL+   + ++    L    G+P ++APEV+ 
Sbjct: 206 MYILHLDLKPENILCVNRDAK-QIKIIDFGLA---RRYKPREKLKVNFGTPEFLAPEVV- 260
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLPKW--LSPGAQ 245
           N  +    +D+WS GVI Y++L+G  PF   N A     I   R D +  ++  +S  A+
Sbjct: 261 NYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320
Query: 246 NLLRKILEPNPVKRITIAGIKADEWF 271
             + K+L      RI+ +      W 
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWL 346

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 139/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 25  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 84
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 85  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 144
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 145 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 200
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+     +  Q  FR    
Sbjct: 201 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR---- 256
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 257 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 296

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 139/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 25  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 84
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 85  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 144
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 145 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 200
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+     +  Q  FR    
Sbjct: 201 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR---- 256
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 257 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 296

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 139/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 26  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 85
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 86  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 145
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 146 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 201
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+     +  Q  FR    
Sbjct: 202 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR---- 257
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 258 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 297

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 139/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 26  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 85
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 86  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 145
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 146 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 201
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+     +  Q  FR    
Sbjct: 202 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR---- 257
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 258 --QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 297

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 134/270 (49%), Gaps = 17/270 (6%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
           +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK +
Sbjct: 5   QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 72  KH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
                 V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V 
Sbjct: 65  SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 129 YCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +     G+  Y  PE 
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPEW 180
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           +    Y G ++ +WS G++LY ++ G +PF+     +  Q  FR      + +S   Q+L
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR------QRVSSECQHL 234
Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTP 277
           +R  L   P  R T   I+   W +    P
Sbjct: 235 IRWCLALRPSDRPTFEEIQNHPWMQDVLLP 264

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 139/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 25  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 84
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 85  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 144
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 145 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 200
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+     +  Q  FR    
Sbjct: 201 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR---- 256
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 257 --QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 296

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 139/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 26  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 85
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 86  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 145
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 146 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 201
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+     +  Q  FR    
Sbjct: 202 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR---- 257
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 258 --QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 297

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 89/282 (31%), Positives = 139/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 26  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 85
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 86  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 145
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 146 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 201
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+     +  Q  FR    
Sbjct: 202 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIGGQVFFR---- 257
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 258 --QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 297

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  125 bits (313), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 91/267 (34%), Positives = 136/267 (50%), Gaps = 19/267 (7%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVV 77
            + LG G F  V+      +G  +A K L+K R        +I  EIA L+L K  P V+
Sbjct: 34  SKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVI 92
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGV 135
            LHEV  + S+I ++LEY  GGE+F     +    + E +  +L +Q+++GV Y H   +
Sbjct: 93  NLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNI 152
Query: 136 FHRDLKLENILLDS---KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            H DLK +NILL S    G+IKI DFG+S    H  +   L    G+P Y+APE+L    
Sbjct: 153 VHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTPEYLAPEIL---N 206
Query: 193 YDGAT--SDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFKLPKW--LSPGAQN 246
           YD  T  +D+W+ G+I Y++LT   PF  +D     L       D+    +  +S  A +
Sbjct: 207 YDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATD 266
Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQ 273
            ++ +L  NP KR T     +  W +Q
Sbjct: 267 FIQSLLVKNPEKRPTAEICLSHSWLQQ 293

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  122 bits (307), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 94/311 (30%), Positives = 145/311 (46%), Gaps = 53/311 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--IHLKITDQIKREIATLKLLK 72
           +Y L   +G+G++G V+ A +  +    A+KI+ KN+I  I+ K  ++IK E+  +K L 
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-----SKGRL---------------- 111
           HPN+ RL+EV   +  I +V+E   GG L DK+      S G+                 
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 112 -------------------QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152
                              +E     + +Q+   + Y HN+G+ HRD+K EN L  +  +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 153 --IKISDFGLSALPQHFRDDGL--LHTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGVI 206
             IK+ DFGLS       +     + T  G+P +VAPEVL   N  Y G   D WS GV+
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GPKCDAWSAGVL 265
Query: 207 LYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKW--LSPGAQNLLRKILEPNPVKRITI 262
           L+++L G +PF   N A    ++      F+ P +  LSP A++LL  +L  N  +R   
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325
Query: 263 AGIKADEWFEQ 273
                  W  Q
Sbjct: 326 MRALQHPWISQ 336

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score =  122 bits (306), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 87/290 (30%), Positives = 140/290 (48%), Gaps = 19/290 (6%)
Query: 9   EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITD----QIKR 63
           EG    +Y     LG G FG V  A D +      VK ++K +++    I D    ++  
Sbjct: 19  EGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTL 78
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLE-YVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           EIA L  ++H N++++ ++  ++    +V+E + +G +LF  I    RL E     +F+Q
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           L+  V Y   K + HRD+K ENI++     IK+ DFG +A   +     L +T CG+  Y
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA---YLERGKLFYTFCGTIEY 195
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
            APEVL    Y G   ++WS GV LY ++    PF +       ++        P  +S 
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLVSK 249
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN-PDDDEEDIFVDN 291
              +L+  +L+P P +R T+  +  D W  Q   P N  D   E++F  N
Sbjct: 250 ELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ---PVNLADYTWEEVFRVN 296

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 82/275 (29%), Positives = 139/275 (50%), Gaps = 15/275 (5%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           M+   Y++ + +G G FG+V+  +   S   +A+K+L K  +I    +     E   +  
Sbjct: 72  MKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 131
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
              P VV+L         +YMV+EY+ GG+L + + S   + E   +    +++  +   
Sbjct: 132 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN-LMSNYDVPEKWAKFYTAEVVLALDAI 190
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVL 188
           H+ G+ HRD+K +N+LLD  G++K++DFG         + G++H  T  G+P+Y++PEVL
Sbjct: 191 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTC---MKMDETGMVHCDTAVGTPDYISPEVL 247
Query: 189 ANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLPK--WLS 241
            ++   GY G   D WS GV L+ +L G  PF   +L   Y KI   +     P+   +S
Sbjct: 248 KSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEIS 307
Query: 242 PGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274
             A+NL+   L    V+  R  +  IK   +F+ D
Sbjct: 308 KHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 342

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 91/287 (31%), Positives = 143/287 (49%), Gaps = 43/287 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLH 80
           LGEG + KV+ A  L +G  +AVKI+EK +  H +   ++ RE+ TL +   + N++ L 
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEK-QAGHSR--SRVFREVETLYQCQGNKNILELI 77
Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL 140
           E     ++ Y+V E + GG +   I  +    E E  ++ + +   + + H KG+ HRDL
Sbjct: 78  EFFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDL 137
Query: 141 KLENILLDSK---GNIKISDFGL--------SALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           K ENIL +S      +KI DF L        S  P    +   L T CGS  Y+APEV+ 
Sbjct: 138 KPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPE---LTTPCGSAEYMAPEVV- 193
Query: 190 NRGYDGAT-----SDIWSCGVILYVILTGYLPFD---------DRNLAV------LYQKI 229
               D AT      D+WS GV+LY++L+GY PF          DR          L++ I
Sbjct: 194 EVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESI 253
Query: 230 FRGDFKLP--KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272
             G ++ P   W  +S  A++L+ K+L  +  +R++ A +    W +
Sbjct: 254 QEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWVQ 300

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  118 bits (296), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 136/275 (49%), Gaps = 15/275 (5%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           M+   YE+ + +G G FG+V+  +   +   +A+K+L K  +I    +     E   +  
Sbjct: 71  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 130
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
              P VV+L         +YMV+EY+ GG+L + + S   + E   R    +++  +   
Sbjct: 131 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 189
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVL 188
           H+ G  HRD+K +N+LLD  G++K++DFG          +G++   T  G+P+Y++PEVL
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 189 ANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLP--KWLS 241
            ++   GY G   D WS GV LY +L G  PF   +L   Y KI   +     P    +S
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 306
Query: 242 PGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274
             A+NL+   L    V+  R  +  IK   +F+ D
Sbjct: 307 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 341

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 143/281 (50%), Gaps = 31/281 (11%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 27  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 78
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 79  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 138
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 139 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 195
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAV---LYQKIFRGDFKL--PKW--L 240
               YD  + D+WS GVI+Y++L GY PF  +  LA+   +  +I  G ++   P+W  +
Sbjct: 196 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 254
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 280
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 255 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 295

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 143/281 (50%), Gaps = 31/281 (11%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 28  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 79
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 80  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 139
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 140 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 196
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAV---LYQKIFRGDFKL--PKW--L 240
               YD  + D+WS GVI+Y++L GY PF  +  LA+   +  +I  G ++   P+W  +
Sbjct: 197 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 255
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 280
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 256 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 296

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  118 bits (296), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 136/275 (49%), Gaps = 15/275 (5%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           M+   YE+ + +G G FG+V+  +   +   +A+K+L K  +I    +     E   +  
Sbjct: 66  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 125
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
              P VV+L         +YMV+EY+ GG+L + + S   + E   R    +++  +   
Sbjct: 126 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 184
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVL 188
           H+ G  HRD+K +N+LLD  G++K++DFG          +G++   T  G+P+Y++PEVL
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMVRCDTAVGTPDYISPEVL 241
Query: 189 ANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLP--KWLS 241
            ++   GY G   D WS GV LY +L G  PF   +L   Y KI   +     P    +S
Sbjct: 242 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 301
Query: 242 PGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274
             A+NL+   L    V+  R  +  IK   +F+ D
Sbjct: 302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 83/275 (30%), Positives = 136/275 (49%), Gaps = 15/275 (5%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           M+   YE+ + +G G FG+V+  +   +   +A+K+L K  +I    +     E   +  
Sbjct: 71  MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 130
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
              P VV+L         +YMV+EY+ GG+L + + S   + E   R    +++  +   
Sbjct: 131 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEKWARFYTAEVVLALDAI 189
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVL 188
           H+ G  HRD+K +N+LLD  G++K++DFG          +G++   T  G+P+Y++PEVL
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMNKEGMVRCDTAVGTPDYISPEVL 246
Query: 189 ANR---GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLP--KWLS 241
            ++   GY G   D WS GV LY +L G  PF   +L   Y KI   +     P    +S
Sbjct: 247 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS 306
Query: 242 PGAQNLLRKILEPNPVK--RITIAGIKADEWFEQD 274
             A+NL+   L    V+  R  +  IK   +F+ D
Sbjct: 307 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 341

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 143/281 (50%), Gaps = 31/281 (11%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 37  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 88
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 89  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 148
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 149 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 205
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAV---LYQKIFRGDFKL--PKW--L 240
               YD  + D+WS GVI+Y++L GY PF  +  LA+   +  +I  G ++   P+W  +
Sbjct: 206 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 264
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 280
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 265 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 305

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 143/281 (50%), Gaps = 31/281 (11%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 29  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 80
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 81  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 140
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 141 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 197
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAV---LYQKIFRGDFKL--PKW--L 240
               YD  + D+WS GVI+Y++L GY PF  +  LA+   +  +I  G ++   P+W  +
Sbjct: 198 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 256
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 280
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 257 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 297

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  118 bits (295), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 143/281 (50%), Gaps = 31/281 (11%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 22  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 73
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 74  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 133
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 134 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 190
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAV---LYQKIFRGDFKL--PKW--L 240
               YD  + D+WS GVI+Y++L GY PF  +  LA+   +  +I  G ++   P+W  +
Sbjct: 191 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 249
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 280
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 250 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 290

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 143/281 (50%), Gaps = 31/281 (11%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 74
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 191
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAV---LYQKIFRGDFKL--PKW--L 240
               YD  + D+WS GVI+Y++L GY PF  +  LA+   +  +I  G ++   P+W  +
Sbjct: 192 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 250
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 280
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 251 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 291

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 143/281 (50%), Gaps = 31/281 (11%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 74
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 191
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAV---LYQKIFRGDFKL--PKW--L 240
               YD  + D+WS GVI+Y++L GY PF  +  LA+   +  +I  G ++   P+W  +
Sbjct: 192 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 250
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 280
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 251 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 291

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 143/281 (50%), Gaps = 31/281 (11%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 21  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 72
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 73  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 132
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 133 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 189
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAV---LYQKIFRGDFKL--PKW--L 240
               YD  + D+WS GVI+Y++L GY PF  +  LA+   +  +I  G ++   P+W  +
Sbjct: 190 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 248
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 280
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 249 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 289

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 143/281 (50%), Gaps = 31/281 (11%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 67  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 118
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 119 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 235
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAV---LYQKIFRGDFKL--PKW--L 240
               YD  + D+WS GVI+Y++L GY PF  +  LA+   +  +I  G ++   P+W  +
Sbjct: 236 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 280
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 335

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  118 bits (295), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 143/281 (50%), Gaps = 31/281 (11%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 73  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 124
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 125 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 184
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAPEVL
Sbjct: 185 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVL 241
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAV---LYQKIFRGDFKL--PKW--L 240
               YD  + D+WS GVI+Y++L GY PF  +  LA+   +  +I  G ++   P+W  +
Sbjct: 242 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 300
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 280
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 301 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 341

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  117 bits (294), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 92/291 (31%), Positives = 141/291 (48%), Gaps = 36/291 (12%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRL 79
            LGEG   +V+   +L +   +AVKI+EK       I  ++ RE+  L +   H NV+ L
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
            E    + + Y+V E + GG +   I  +    E E   + Q +   + + HNKG+ HRD
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 140 LKLENILLDSKGN---IKISDFGLSALPQHFRDDGL-----LHTTCGSPNYVAPEVLANR 191
           LK ENIL +       +KI DFGL +  +   D        L T CGS  Y+APEV+   
Sbjct: 137 LKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 192 GYDGAT----SDIWSCGVILYVILTGYLPFD---------DRNLA------VLYQKIFRG 232
             + +      D+WS GVILY++L+GY PF          DR  A      +L++ I  G
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256
Query: 233 DFKLP--KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
            ++ P   W  +S  A++L+ K+L  +  +R++ A +    W  Q   P N
Sbjct: 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV-QGCAPEN 306

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 142/281 (50%), Gaps = 31/281 (11%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 21  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 72
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 73  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 132
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG +   +       L   C +P YVAPEVL
Sbjct: 133 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTEPCYTPYYVAPEVL 189
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAV---LYQKIFRGDFKL--PKW--L 240
               YD  + D+WS GVI+Y++L GY PF  +  LA+   +  +I  G ++   P+W  +
Sbjct: 190 GPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 248
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 280
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 249 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 289

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 88/282 (31%), Positives = 139/282 (49%), Gaps = 17/282 (6%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITD 59
           +A  K++     +Y++G  LG G  G V     +   LP A+K +EK+RI     L    
Sbjct: 40  LAPGKEKEPLESQYQVGPLLGSGGSGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 99
Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 100 RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 159
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D ++G +K+ DFG  AL +    D +   
Sbjct: 160 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 215
Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+        ++I RG   
Sbjct: 216 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 269
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
             + +S   Q+L+R  L   P  R T   I+   W +    P
Sbjct: 270 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 311

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  115 bits (287), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 91/291 (31%), Positives = 140/291 (48%), Gaps = 36/291 (12%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRL 79
            LGEG   +V+   +L +   +AVKI+EK       I  ++ RE+  L +   H NV+ L
Sbjct: 20  VLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
            E    + + Y+V E + GG +   I  +    E E   + Q +   + + HNKG+ HRD
Sbjct: 77  IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRD 136
Query: 140 LKLENILLDSKGN---IKISDFGLSALPQHFRDDGL-----LHTTCGSPNYVAPEVLANR 191
           LK ENIL +       +KI DF L +  +   D        L T CGS  Y+APEV+   
Sbjct: 137 LKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAF 196
Query: 192 GYDGAT----SDIWSCGVILYVILTGYLPFD---------DRNLA------VLYQKIFRG 232
             + +      D+WS GVILY++L+GY PF          DR  A      +L++ I  G
Sbjct: 197 SEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEG 256
Query: 233 DFKLP--KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
            ++ P   W  +S  A++L+ K+L  +  +R++ A +    W  Q   P N
Sbjct: 257 KYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV-QGCAPEN 306

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 134/260 (51%), Gaps = 17/260 (6%)
Query: 7   KQEGMRLGR--YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
           K + MRL R  +E+ + +G G FG+V   +  ++   FA+KIL K  ++    T   + E
Sbjct: 65  KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREE 124
Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQL 123
              L       +  LH      + +Y+V++Y  GG+L   ++  + RL E   R    ++
Sbjct: 125 RDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEM 184
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPN 181
           +  +   H     HRD+K +NIL+D  G+I+++DFG S L     +DG + ++   G+P+
Sbjct: 185 VIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFG-SCL--KLMEDGTVQSSVAVGTPD 241
Query: 182 YVAPEVL----ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFK 235
           Y++PE+L      +G  G   D WS GV +Y +L G  PF   +L   Y KI   +  F+
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301
Query: 236 LPKW---LSPGAQNLLRKIL 252
            P     +S  A++L+R+++
Sbjct: 302 FPTQVTDVSENAKDLIRRLI 321

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 80/265 (30%), Positives = 128/265 (48%), Gaps = 13/265 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYELG  LG G   +V  A+DL      AVK+L  +         + +RE      L HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 75  NVVRLHEVLASKSKI----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
            +V +++   +++      Y+V+EYV G  L D + ++G +      ++       +++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           H  G+ HRD+K  NIL+ +   +K+ DFG++ A+              G+  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQAR 192
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDFKLP----KWLSPGA 244
               D A SD++S G +LY +LTG  PF  D  ++V YQ + R D   P    + LS   
Sbjct: 193 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDPIPPSARHEGLSADL 250
Query: 245 QNLLRKILEPNPVKRI-TIAGIKAD 268
             ++ K L  NP  R  T A ++AD
Sbjct: 251 DAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 128/265 (48%), Gaps = 13/265 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYELG  LG G   +V  A+DL      AVK+L  +         + +RE      L HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 75  NVVRLHEVLASKSKI----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
            +V +++   +++      Y+V+EYV G  L D + ++G +      ++       +++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           H  G+ HRD+K  NI++ +   +K+ DFG++ A+              G+  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDFKLP----KWLSPGA 244
               D A SD++S G +LY +LTG  PF  D  ++V YQ + R D   P    + LS   
Sbjct: 193 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDPIPPSARHEGLSADL 250
Query: 245 QNLLRKILEPNPVKRI-TIAGIKAD 268
             ++ K L  NP  R  T A ++AD
Sbjct: 251 DAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 78/261 (29%), Positives = 126/261 (48%), Gaps = 11/261 (4%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L  + + + +G G F +V  A  L  G+P A+K ++   ++  K      +EI  LK L 
Sbjct: 31  LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVS 128
           HPNV++ +      +++ +VLE    G+L   I      K  + E    K F QL   + 
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           + H++ V HRD+K  N+ + + G +K+ D GL             H+  G+P Y++PE +
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPERI 208
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDF-KLPK-WLSPGA 244
              GY+   SDIWS G +LY +     PF  D  NL  L +KI + D+  LP    S   
Sbjct: 209 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEEL 267
Query: 245 QNLLRKILEPNPVKRITIAGI 265
           + L+   + P+P KR  +  +
Sbjct: 268 RQLVNMCINPDPEKRPDVTYV 288

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 128/265 (48%), Gaps = 13/265 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYELG  LG G   +V  A+DL      AVK+L  +         + +RE      L HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 75  NVVRLHEVLASKSKI----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
            +V +++   +++      Y+V+EYV G  L D + ++G +      ++       +++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           H  G+ HRD+K  NI++ +   +K+ DFG++ A+              G+  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDFKLP----KWLSPGA 244
               D A SD++S G +LY +LTG  PF  D  ++V YQ + R D   P    + LS   
Sbjct: 193 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDPIPPSARHEGLSADL 250
Query: 245 QNLLRKILEPNPVKRI-TIAGIKAD 268
             ++ K L  NP  R  T A ++AD
Sbjct: 251 DAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  110 bits (276), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 80/258 (31%), Positives = 129/258 (50%), Gaps = 23/258 (8%)
Query: 42  FAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVVRLHEVL----ASKSKIYMVLEYV 96
           F  +  EK  +  L+   + +RE+    +  + P++VR+ +V     A +  + +V E +
Sbjct: 82  FNKRTQEKFALKXLQDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVXECL 141
Query: 97  TGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---G 151
            GGELF +I  +G     E E  ++ + + + + Y H+  + HRD+K EN+L  SK    
Sbjct: 142 DGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNA 201
Query: 152 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 211
            +K++DFG +   +       L T C +P YVAPEVL    YD  + D WS GVI Y++L
Sbjct: 202 ILKLTDFGFA---KETTSHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDXWSLGVIXYILL 257
Query: 212 TGYLPF-DDRNLAV---LYQKIFRGDFKL--PKW--LSPGAQNLLRKILEPNPVKRITIA 263
            GY PF  +  LA+      +I  G ++   P+W  +S   + L+R +L+  P +R TI 
Sbjct: 258 CGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSEVSEEVKXLIRNLLKTEPTQRXTIT 317
Query: 264 GIKADEWFEQDY-TPANP 280
                 W  Q    P  P
Sbjct: 318 EFXNHPWIXQSTKVPQTP 335

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 128/265 (48%), Gaps = 13/265 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYELG  LG G   +V  A+DL      AVK+L  +         + +RE      L HP
Sbjct: 30  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 89
Query: 75  NVVRLHEVLASKSKI----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
            +V +++   +++      Y+V+EYV G  L D + ++G +      ++       +++ 
Sbjct: 90  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 149
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           H  G+ HRD+K  NI++ +   +K+ DFG++ A+              G+  Y++PE   
Sbjct: 150 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 209
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDFKLP----KWLSPGA 244
               D A SD++S G +LY +LTG  PF  D  ++V YQ + R D   P    + LS   
Sbjct: 210 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDPIPPSARHEGLSADL 267
Query: 245 QNLLRKILEPNPVKRI-TIAGIKAD 268
             ++ K L  NP  R  T A ++AD
Sbjct: 268 DAVVLKALAKNPENRYQTAAEMRAD 292

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 127/265 (47%), Gaps = 13/265 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYELG  LG G   +V  A+DL      AVK+L  +         + +RE      L HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 75  NVVRLHEVLASKSKI----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
            +V +++   +++      Y+V+EYV G  L D + ++G +      ++       +++ 
Sbjct: 73  AIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           H  G+ HRD+K  NI++ +   +K+ DFG++ A+              G+  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDFKLP----KWLSPGA 244
               D A SD++S G +LY +LTG  PF  D   +V YQ + R D   P    + LS   
Sbjct: 193 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPDSVAYQHV-REDPIPPSARHEGLSADL 250
Query: 245 QNLLRKILEPNPVKRI-TIAGIKAD 268
             ++ K L  NP  R  T A ++AD
Sbjct: 251 DAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score =  110 bits (274), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 127/265 (47%), Gaps = 13/265 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYELG  LG G   +V  A+DL      AVK+L  +         + +RE      L HP
Sbjct: 13  RYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHP 72
Query: 75  NVVRLHEVLASKSKI----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
            +V ++    +++      Y+V+EYV G  L D + ++G +      ++       +++ 
Sbjct: 73  AIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           H  G+ HRD+K  NI++ +   +K+ DFG++ A+              G+  Y++PE   
Sbjct: 133 HQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQAR 192
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDFKLP----KWLSPGA 244
               D A SD++S G +LY +LTG  PF  D  ++V YQ + R D   P    + LS   
Sbjct: 193 GDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDPIPPSARHEGLSADL 250
Query: 245 QNLLRKILEPNPVKRI-TIAGIKAD 268
             ++ K L  NP  R  T A ++AD
Sbjct: 251 DAVVLKALAKNPENRYQTAAEMRAD 275

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score =  108 bits (271), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 79/262 (30%), Positives = 128/262 (48%), Gaps = 16/262 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE+  T+G G++G+ +  +    G     K L+   +   +    +  E+  L+ LKHPN
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHPN 66
Query: 76  VVRLHEVLASKSK--IYMVLEYVTGGELFDKIA--SKGR--LQEAEGRKLFQQLIDGVSY 129
           +VR ++ +  ++   +Y+V+EY  GG+L   I   +K R  L E    ++  QL   +  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 130 CHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           CH +      V HRDLK  N+ LD K N+K+ DFGL+ +  H  D     T  G+P Y++
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTPYYMS 184
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPG 243
           PE +    Y+   SDIWS G +LY +     PF   +   L  KI  G F ++P   S  
Sbjct: 185 PEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243
Query: 244 AQNLLRKILEPNPVKRITIAGI 265
              ++ ++L      R ++  I
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEI 265

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 78/253 (30%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G+FG V  A+   S +  AVKIL +    H +  ++  RE+A +K L+HPN+V    
Sbjct: 45  IGAGSFGTVHRAEWHGSDV--AVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNKG--VF 136
            +     + +V EY++ G L+  +   G  ++ + R+      D   G++Y HN+   + 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--TCGSPNYVAPEVLANRGYD 194
           HRDLK  N+L+D K  +K+ DFGLS L    +    L +    G+P ++APEVL +    
Sbjct: 162 HRDLKSPNLLVDKKYTVKVCDFGLSRL----KASXFLXSKXAAGTPEWMAPEVLRDEP-S 216
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI-FRGD-FKLPKWLSPGAQNLLRKIL 252
              SD++S GVIL+ + T   P+ + N A +   + F+    ++P+ L+P    ++    
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCW 276
Query: 253 EPNPVKRITIAGI 265
              P KR + A I
Sbjct: 277 TNEPWKRPSFATI 289

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score =  108 bits (269), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 139/265 (52%), Gaps = 23/265 (8%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
            LG+G +G V   +DL + +  A+K I E++     + +  +  EIA  K LKH N+V+ 
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS----RYSQPLHEEIALHKHLKHKNIVQY 84
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLF--QQLIDGVSYCHNKGVF 136
               +    I + +E V GG L   + SK G L++ E    F  +Q+++G+ Y H+  + 
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 137 HRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGL---LHTTCGSPNYVAPEVL--AN 190
           HRD+K +N+L+++  G +KISDFG S      R  G+     T  G+  Y+APE++    
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           RGY G  +DIWS G  +  + TG  PF    +   A+    +F+   ++P+ +S  A+  
Sbjct: 200 RGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 258
Query: 248 LRKILEPNPVKRITIAGIKADEWFE 272
           + K  EP+P KR     +  DE+ +
Sbjct: 259 ILKCFEPDPDKRACANDLLVDEFLK 283

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score =  108 bits (269), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 84/265 (31%), Positives = 139/265 (52%), Gaps = 23/265 (8%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
            LG+G +G V   +DL + +  A+K I E++     + +  +  EIA  K LKH N+V+ 
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS----RYSQPLHEEIALHKHLKHKNIVQY 70
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLF--QQLIDGVSYCHNKGVF 136
               +    I + +E V GG L   + SK G L++ E    F  +Q+++G+ Y H+  + 
Sbjct: 71  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 130
Query: 137 HRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGL---LHTTCGSPNYVAPEVL--AN 190
           HRD+K +N+L+++  G +KISDFG S      R  G+     T  G+  Y+APE++    
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSK-----RLAGINPCTETFTGTLQYMAPEIIDKGP 185
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           RGY G  +DIWS G  +  + TG  PF    +   A+    +F+   ++P+ +S  A+  
Sbjct: 186 RGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAF 244
Query: 248 LRKILEPNPVKRITIAGIKADEWFE 272
           + K  EP+P KR     +  DE+ +
Sbjct: 245 ILKCFEPDPDKRACANDLLVDEFLK 269

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score =  107 bits (268), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 133/265 (50%), Gaps = 10/265 (3%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           + +  + + R +G G FG+V   +  D+G  +A+K L+K RI   +       E   L L
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 71  LKH---PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +     P +V +     +  K+  +L+ + GG+L   ++  G   EA+ R    ++I G+
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            + HN+ V +RDLK  NILLD  G+++ISD GL+      +     H + G+  Y+APEV
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEV 361
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           L       +++D +S G +L+ +L G+ PF     ++   + +       +LP   SP  
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 421
Query: 245 QNLLRKILEPNPVKRITIAGIKADE 269
           ++LL  +L+ +  +R+   G  A E
Sbjct: 422 RSLLEGLLQRDVNRRLGCLGRGAQE 446

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 118/225 (52%), Gaps = 23/225 (10%)
Query: 74  PNVVRLHEVLAS----KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGV 127
           P++V + +V  +    K  + +++E + GGELF +I  +G     E E  ++ + +   +
Sbjct: 82  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 141
Query: 128 SYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            + H+  + HRD+K EN+L  SK     +K++DFG +           L T C +P YVA
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE----TTQNALQTPCYTPYYVA 197
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAV---LYQKIFRGDFKL--PK 238
           PEVL    YD  + D+WS GVI+Y++L G+ PF  +   A+   + ++I  G +    P+
Sbjct: 198 PEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 256
Query: 239 W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 280
           W  +S  A+ L+R +L+ +P +R+TI       W  Q    P  P
Sbjct: 257 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 70/225 (31%), Positives = 118/225 (52%), Gaps = 23/225 (10%)
Query: 74  PNVVRLHEVLAS----KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGV 127
           P++V + +V  +    K  + +++E + GGELF +I  +G     E E  ++ + +   +
Sbjct: 63  PHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAI 122
Query: 128 SYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            + H+  + HRD+K EN+L  SK     +K++DFG +           L T C +P YVA
Sbjct: 123 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE----TTQNALQTPCYTPYYVA 178
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAV---LYQKIFRGDFKL--PK 238
           PEVL    YD  + D+WS GVI+Y++L G+ PF  +   A+   + ++I  G +    P+
Sbjct: 179 PEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPE 237
Query: 239 W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 280
           W  +S  A+ L+R +L+ +P +R+TI       W  Q    P  P
Sbjct: 238 WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 282

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 133/265 (50%), Gaps = 10/265 (3%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           + +  + + R +G G FG+V   +  D+G  +A+K L+K RI   +       E   L L
Sbjct: 185 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 244
Query: 71  LKH---PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +     P +V +     +  K+  +L+ + GG+L   ++  G   EA+ R    ++I G+
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 304
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            + HN+ V +RDLK  NILLD  G+++ISD GL+      +     H + G+  Y+APEV
Sbjct: 305 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEV 360
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           L       +++D +S G +L+ +L G+ PF     ++   + +       +LP   SP  
Sbjct: 361 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 420
Query: 245 QNLLRKILEPNPVKRITIAGIKADE 269
           ++LL  +L+ +  +R+   G  A E
Sbjct: 421 RSLLEGLLQRDVNRRLGCLGRGAQE 445

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 77/253 (30%), Positives = 131/253 (51%), Gaps = 17/253 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G+FG V  A+   S +  AVKIL +    H +  ++  RE+A +K L+HPN+V    
Sbjct: 45  IGAGSFGTVHRAEWHGSDV--AVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNKG--VF 136
            +     + +V EY++ G L+  +   G  ++ + R+      D   G++Y HN+   + 
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIV 161
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH--TTCGSPNYVAPEVLANRGYD 194
           HR+LK  N+L+D K  +K+ DFGLS L    +    L   +  G+P ++APEVL +    
Sbjct: 162 HRNLKSPNLLVDKKYTVKVCDFGLSRL----KASTFLSSKSAAGTPEWMAPEVLRDEP-S 216
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI-FRGD-FKLPKWLSPGAQNLLRKIL 252
              SD++S GVIL+ + T   P+ + N A +   + F+    ++P+ L+P    ++    
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCW 276
Query: 253 EPNPVKRITIAGI 265
              P KR + A I
Sbjct: 277 TNEPWKRPSFATI 289

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score =  107 bits (267), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 128/262 (48%), Gaps = 16/262 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE+  T+G G++G+ +  +    G     K L+   +   +    +  E+  L+ LKHPN
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHPN 66
Query: 76  VVRLHEVLASKSK--IYMVLEYVTGGELFDKIA--SKGR--LQEAEGRKLFQQLIDGVSY 129
           +VR ++ +  ++   +Y+V+EY  GG+L   I   +K R  L E    ++  QL   +  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 130 CHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           CH +      V HRDLK  N+ LD K N+K+ DFGL+ +  H  D+       G+P Y++
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DEDFAKEFVGTPYYMS 184
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPG 243
           PE +    Y+   SDIWS G +LY +     PF   +   L  KI  G F ++P   S  
Sbjct: 185 PEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243
Query: 244 AQNLLRKILEPNPVKRITIAGI 265
              ++ ++L      R ++  I
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEI 265

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 133/265 (50%), Gaps = 10/265 (3%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           + +  + + R +G G FG+V   +  D+G  +A+K L+K RI   +       E   L L
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 71  LKH---PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +     P +V +     +  K+  +L+ + GG+L   ++  G   EA+ R    ++I G+
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            + HN+ V +RDLK  NILLD  G+++ISD GL+      +     H + G+  Y+APEV
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEV 361
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           L       +++D +S G +L+ +L G+ PF     ++   + +       +LP   SP  
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 421
Query: 245 QNLLRKILEPNPVKRITIAGIKADE 269
           ++LL  +L+ +  +R+   G  A E
Sbjct: 422 RSLLEGLLQRDVNRRLGCLGRGAQE 446

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 133/265 (50%), Gaps = 10/265 (3%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           + +  + + R +G G FG+V   +  D+G  +A+K L+K RI   +       E   L L
Sbjct: 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 245
Query: 71  LKH---PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +     P +V +     +  K+  +L+ + GG+L   ++  G   EA+ R    ++I G+
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 305
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            + HN+ V +RDLK  NILLD  G+++ISD GL+      +     H + G+  Y+APEV
Sbjct: 306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEV 361
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           L       +++D +S G +L+ +L G+ PF     ++   + +       +LP   SP  
Sbjct: 362 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 421
Query: 245 QNLLRKILEPNPVKRITIAGIKADE 269
           ++LL  +L+ +  +R+   G  A E
Sbjct: 422 RSLLEGLLQRDVNRRLGCLGRGAQE 446

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 78/262 (29%), Positives = 127/262 (48%), Gaps = 16/262 (6%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE+  T+G G++G+ +  +    G     K L+   +   +    +  E+  L+ LKHPN
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAE-KQMLVSEVNLLRELKHPN 66
Query: 76  VVRLHEVLASKSK--IYMVLEYVTGGELFDKIA--SKGR--LQEAEGRKLFQQLIDGVSY 129
           +VR ++ +  ++   +Y+V+EY  GG+L   I   +K R  L E    ++  QL   +  
Sbjct: 67  IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 126
Query: 130 CHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           CH +      V HRDLK  N+ LD K N+K+ DFGL+ +  H  D        G+P Y++
Sbjct: 127 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTPYYMS 184
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPG 243
           PE +    Y+   SDIWS G +LY +     PF   +   L  KI  G F ++P   S  
Sbjct: 185 PEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSDE 243
Query: 244 AQNLLRKILEPNPVKRITIAGI 265
              ++ ++L      R ++  I
Sbjct: 244 LNEIITRMLNLKDYHRPSVEEI 265

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 133/256 (51%), Gaps = 17/256 (6%)
Query: 11  MRLGR--YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           M+L R  +E+ + +G G FG+V   +  ++   +A+KIL K  ++    T   + E   L
Sbjct: 69  MQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVL 128
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGV 127
                  +  LH     ++ +Y+V++Y  GG+L   ++  + +L E   R    +++  +
Sbjct: 129 VNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI 188
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAP 185
              H     HRD+K +N+LLD  G+I+++DFG S L  +  DDG + ++   G+P+Y++P
Sbjct: 189 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMN--DDGTVQSSVAVGTPDYISP 245
Query: 186 EVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKW 239
           E+L       G  G   D WS GV +Y +L G  PF   +L   Y KI   +  F+ P  
Sbjct: 246 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSH 305
Query: 240 ---LSPGAQNLLRKIL 252
              +S  A++L+++++
Sbjct: 306 VTDVSEEAKDLIQRLI 321

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 133/256 (51%), Gaps = 17/256 (6%)
Query: 11  MRLGR--YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           M+L R  +E+ + +G G FG+V   +  ++   +A+KIL K  ++    T   + E   L
Sbjct: 85  MQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFREERDVL 144
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGV 127
                  +  LH     ++ +Y+V++Y  GG+L   ++  + +L E   R    +++  +
Sbjct: 145 VNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAI 204
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAP 185
              H     HRD+K +N+LLD  G+I+++DFG S L  +  DDG + ++   G+P+Y++P
Sbjct: 205 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFG-SCLKMN--DDGTVQSSVAVGTPDYISP 261
Query: 186 EVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLPKW 239
           E+L       G  G   D WS GV +Y +L G  PF   +L   Y KI   +  F+ P  
Sbjct: 262 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSH 321
Query: 240 ---LSPGAQNLLRKIL 252
              +S  A++L+++++
Sbjct: 322 VTDVSEEAKDLIQRLI 337

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 88/298 (29%), Positives = 145/298 (48%), Gaps = 47/298 (15%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKL 70
           + +Y     +GEG +G V  AQ+ + G  FA+K   LEK       I     REI+ LK 
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE---DEGIPSTTIREISILKE 56
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           LKH N+V+L++V+ +K ++ +V E++     +L D    +G L+    +    QL++G++
Sbjct: 57  LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIA 114
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAP 185
           YCH++ V HRDLK +N+L++ +G +KI+DFGL+    +P       ++     +  Y AP
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIV-----TLWYRAP 169
Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-----------GDF 234
           +VL        T DIWS G I   ++ G   F   + A    +IFR              
Sbjct: 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVT 229
Query: 235 KLPKW------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
           +LPK+                  L     +LL K+L+ +P +RIT        +F+++
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 144/296 (48%), Gaps = 43/296 (14%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + +Y     +GEG +G V  AQ+ + G  FA+K +   +     I     REI+ LK LK
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-GIPSTTIREISILKELK 58
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           H N+V+L++V+ +K ++ +V E++     +L D    +G L+    +    QL++G++YC
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H++ V HRDLK +N+L++ +G +KI+DFGL+    +P       ++     +  Y AP+V
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-----TLWYRAPDV 171
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-----------GDFKL 236
           L        T DIWS G I   ++ G   F   + A    +IFR              +L
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 237 PKW------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
           PK+                  L     +LL K+L+ +P +RIT        +F+++
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 132/268 (49%), Gaps = 19/268 (7%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI--KREIATLKLLK 72
           +Y +   LG G FG V    +  S   +  K ++      +K TDQ+  K+EI+ L + +
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVK------VKGTDQVLVKKEISILNIAR 59
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
           H N++ LHE   S  ++ M+ E+++G ++F++I  S   L E E      Q+ + + + H
Sbjct: 60  HRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLH 119
Query: 132 NKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           +  + H D++ ENI+  ++    IKI +FG +   +   +  LL T   +P Y APEV  
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---APEYYAPEVHQ 176
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQ 245
           +     AT D+WS G ++YV+L+G  PF       + + I   ++       K +S  A 
Sbjct: 177 HDVVSTAT-DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM 235
Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQ 273
           + + ++L      R+T +      W +Q
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQ 263

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  105 bits (261), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 85/296 (28%), Positives = 144/296 (48%), Gaps = 43/296 (14%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + +Y     +GEG +G V  AQ+ + G  FA+K +   +     I     REI+ LK LK
Sbjct: 1   MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-GIPSTTIREISILKELK 58
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           H N+V+L++V+ +K ++ +V E++     +L D    +G L+    +    QL++G++YC
Sbjct: 59  HSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLD--VCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H++ V HRDLK +N+L++ +G +KI+DFGL+    +P       ++     +  Y AP+V
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVV-----TLWYRAPDV 171
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR-----------GDFKL 236
           L        T DIWS G I   ++ G   F   + A    +IFR              +L
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 237 PKW------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
           PK+                  L     +LL K+L+ +P +RIT        +F+++
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 134/259 (51%), Gaps = 15/259 (5%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   LG+G FGKV  AQ+ ++ +  A K+++      L   +    EI  L    HPN
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDILASCDHPN 95
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
           +V+L +    ++ +++++E+  GG +   +    R L E++ + + +Q +D ++Y H+  
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA----- 189
           + HRDLK  NIL    G+IK++DFG+SA  ++ R      +  G+P ++APEV+      
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQN 246
           +R YD   +D+WS G+ L  +     P  + N   +  KI + +      P   S   ++
Sbjct: 214 DRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 272
Query: 247 LLRKILEPNPVKRITIAGI 265
            L+K LE N   R T + +
Sbjct: 273 FLKKCLEKNVDARWTTSQL 291

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score =  104 bits (260), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 134/259 (51%), Gaps = 15/259 (5%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   LG+G FGKV  AQ+ ++ +  A K+++      L   +    EI  L    HPN
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDILASCDHPN 95
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
           +V+L +    ++ +++++E+  GG +   +    R L E++ + + +Q +D ++Y H+  
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA----- 189
           + HRDLK  NIL    G+IK++DFG+SA  ++ R      +  G+P ++APEV+      
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDSFIGTPYWMAPEVVMCETSK 213
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQN 246
           +R YD   +D+WS G+ L  +     P  + N   +  KI + +      P   S   ++
Sbjct: 214 DRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 272
Query: 247 LLRKILEPNPVKRITIAGI 265
            L+K LE N   R T + +
Sbjct: 273 FLKKCLEKNVDARWTTSQL 291

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  104 bits (259), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 74/246 (30%), Positives = 134/246 (54%), Gaps = 16/246 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A++  SG   AVK+++  +    ++   +  E+  ++  +H NVV +++
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL---LFNEVVIMRDYQHFNVVEMYK 109
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++++E++ GG L D I S+ RL E +   + + ++  ++Y H +GV HRD+K
Sbjct: 110 SYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIK 168
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL   G +K+SDFG  A  Q  +D        G+P ++APEV++   Y     DIW
Sbjct: 169 SDSILLTLDGRVKLSDFGFCA--QISKDVPKRKXLVGTPYWMAPEVISRSLY-ATEVDIW 225
Query: 202 SCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKW-----LSPGAQNLLRKILEPN 255
           S G+++  ++ G  P F D  +  +  K  R D   PK      +SP  ++ L ++L  +
Sbjct: 226 SLGIMVIEMVDGEPPYFSDSPVQAM--KRLR-DSPPPKLKNSHKVSPVLRDFLERMLVRD 282
Query: 256 PVKRIT 261
           P +R T
Sbjct: 283 PQERAT 288

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 138/285 (48%), Gaps = 35/285 (12%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKH 73
           YEL   +G G    V+ A         A+K   LEK +       D++ +EI  +    H
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS----MDELLKEIQAMSQCHH 72
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFD---KIASKGR-----LQEAEGRKLFQQLID 125
           PN+V  +     K ++++V++ ++GG + D    I +KG      L E+    + +++++
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---DGLLHTTCGSPNY 182
           G+ Y H  G  HRD+K  NILL   G+++I+DFG+SA      D   + +  T  G+P +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 183 VAPEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 241
           +APEV+   RGYD   +DIWS G+    + TG  P+       +     + D   P  L 
Sbjct: 193 MAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND---PPSLE 248
Query: 242 PGAQN--LLRK-----------ILEPNPVKRITIAGIKADEWFEQ 273
            G Q+  +L+K            L+ +P KR T A +   ++F++
Sbjct: 249 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 293

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 138/285 (48%), Gaps = 35/285 (12%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLKH 73
           YEL   +G G    V+ A         A+K   LEK +       D++ +EI  +    H
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS----MDELLKEIQAMSQCHH 67
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFD---KIASKGR-----LQEAEGRKLFQQLID 125
           PN+V  +     K ++++V++ ++GG + D    I +KG      L E+    + +++++
Sbjct: 68  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---DGLLHTTCGSPNY 182
           G+ Y H  G  HRD+K  NILL   G+++I+DFG+SA      D   + +  T  G+P +
Sbjct: 128 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 187
Query: 183 VAPEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 241
           +APEV+   RGYD   +DIWS G+    + TG  P+       +     + D   P  L 
Sbjct: 188 MAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND---PPSLE 243
Query: 242 PGAQN--LLRK-----------ILEPNPVKRITIAGIKADEWFEQ 273
            G Q+  +L+K            L+ +P KR T A +   ++F++
Sbjct: 244 TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQK 288

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 143/294 (48%), Gaps = 44/294 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 72
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E+++    +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 73  VIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 131
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK EN+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 132 LKPENLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 196 ATSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LP 237
              DIWS G I   ++T     P D          R L    + ++ G     D+K   P
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 238 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           KW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 298

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 143/294 (48%), Gaps = 44/294 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 70
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E+++    +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 71  VIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 129
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK EN+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 130 LKPENLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 196 ATSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LP 237
              DIWS G I   ++T     P D          R L    + ++ G     D+K   P
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 238 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           KW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 296

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 75/259 (28%), Positives = 133/259 (51%), Gaps = 15/259 (5%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   LG+G FGKV  AQ+ ++ +  A K+++      L   +    EI  L    HPN
Sbjct: 39  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEEL---EDYMVEIDILASCDHPN 95
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
           +V+L +    ++ +++++E+  GG +   +    R L E++ + + +Q +D ++Y H+  
Sbjct: 96  IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK 155
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA----- 189
           + HRDLK  NIL    G+IK++DFG+SA  ++ R         G+P ++APEV+      
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRXIQRRDXFIGTPYWMAPEVVMCETSK 213
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQN 246
           +R YD   +D+WS G+ L  +     P  + N   +  KI + +      P   S   ++
Sbjct: 214 DRPYD-YKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 272
Query: 247 LLRKILEPNPVKRITIAGI 265
            L+K LE N   R T + +
Sbjct: 273 FLKKCLEKNVDARWTTSQL 291

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 132/255 (51%), Gaps = 24/255 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
           +Y     +G+G  G V  A D+ +G   A++         + +  Q K+E+   ++L   
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMR 73
Query: 72  --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K+PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + +
Sbjct: 74  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 132
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRD+K +NILL   G++K++DFG  A   P+  +   ++    G+P ++APEV
Sbjct: 133 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV----GTPYWMAPEV 188
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGA 244
           +  + Y G   DIWS G++   ++ G  P+ + N L  LY     G  +L  P+ LS   
Sbjct: 189 VTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 247
Query: 245 QNLLRKILEPNPVKR 259
           ++ L + LE +  KR
Sbjct: 248 RDFLNRCLEMDVEKR 262

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 130/253 (51%), Gaps = 20/253 (7%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
           +Y     +G+G  G V  A D+ +G   A++         + +  Q K+E+   ++L   
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMR 72
Query: 72  --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K+PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + +
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H+  V HRD+K +NILL   G++K++DFG  A  Q   +     T  G+P ++APEV+ 
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 189
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQN 246
            + Y G   DIWS G++   ++ G  P+ + N L  LY     G  +L  P+ LS   ++
Sbjct: 190 RKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 248
Query: 247 LLRKILEPNPVKR 259
            L + L+ +  KR
Sbjct: 249 FLNRCLDMDVEKR 261

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 132/255 (51%), Gaps = 24/255 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
           +Y     +G+G  G V  A D+ +G   A++         + +  Q K+E+   ++L   
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMR 72
Query: 72  --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K+PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + +
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRD+K +NILL   G++K++DFG  A   P+  +   ++    G+P ++APEV
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV----GTPYWMAPEV 187
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGA 244
           +  + Y G   DIWS G++   ++ G  P+ + N L  LY     G  +L  P+ LS   
Sbjct: 188 VTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 245 QNLLRKILEPNPVKR 259
           ++ L + LE +  KR
Sbjct: 247 RDFLNRCLEMDVEKR 261

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/253 (28%), Positives = 130/253 (51%), Gaps = 20/253 (7%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
           +Y     +G+G  G V  A D+ +G   A++         + +  Q K+E+   ++L   
Sbjct: 22  KYTRFEKIGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMR 73
Query: 72  --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K+PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + +
Sbjct: 74  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 132
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H+  V HR++K +NILL   G++K++DFG  A  Q   +     T  G+P ++APEV+ 
Sbjct: 133 LHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVT 190
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGAQN 246
            + Y G   DIWS G++   ++ G  P+ + N L  LY     G  +L  P+ LS   ++
Sbjct: 191 RKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRD 249
Query: 247 LLRKILEPNPVKR 259
            L + LE +  KR
Sbjct: 250 FLNRCLEMDVEKR 262

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK EN+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPENLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 295

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 143/294 (48%), Gaps = 44/294 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 72
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E+++    +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 73  VIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 131
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 132 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 196 ATSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LP 237
              DIWS G I   ++T     P D          R L    + ++ G     D+K   P
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 238 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           KW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 298

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 142/294 (48%), Gaps = 44/294 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 70
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 129
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK EN+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 130 LKPENLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 196 ATSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LP 237
              DIWS G I   ++T     P D          R L    + ++ G     D+K   P
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 238 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           KW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 296

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 143/294 (48%), Gaps = 44/294 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 71
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E+++    +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 72  VIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 131 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 196 ATSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LP 237
              DIWS G I   ++T     P D          R L    + ++ G     D+K   P
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 238 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           KW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 297

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 142/294 (48%), Gaps = 44/294 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 71
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK EN+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 131 LKPENLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 196 ATSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LP 237
              DIWS G I   ++T     P D          R L    + ++ G     D+K   P
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 238 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           KW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 297

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 91/294 (30%), Positives = 142/294 (48%), Gaps = 44/294 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 72
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E+V     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 73  VIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 131
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 132 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 196 ATSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LP 237
              DIWS G I   ++T     P D          R L    + ++ G     D+K   P
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 238 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           KW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 298

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+S+CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLSFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG----SPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 295

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 142/294 (48%), Gaps = 44/294 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 76
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 77  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 135
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 136 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 189
Query: 196 ATSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LP 237
              DIWS G I   ++T     P D          R L    + ++ G     D+K   P
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 249
Query: 238 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           KW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 250 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 302

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGXKYYS 182
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 295

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 91/310 (29%), Positives = 142/310 (45%), Gaps = 52/310 (16%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  + D+ SGL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 52  RYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 108
Query: 73  HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V    +       +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 109 HENVIGLLDVFTPATSLEEFNDVYLVT-HLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 166
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 167 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 221
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL------ 240
           ++ N  +   T DIWS G I+  +LTG   F   +     Q+I R     P  +      
Sbjct: 222 IMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPS 281
Query: 241 -------------------------SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                                    +P A +LL K+L  +  KRIT +   A  +F Q +
Sbjct: 282 HEARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYH 341
Query: 276 TPANPDDDEE 285
              +PDD+ E
Sbjct: 342 ---DPDDEPE 348

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 92/295 (31%), Positives = 142/295 (48%), Gaps = 46/295 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 68
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E+V        D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 69  VIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 127
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 128 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 294

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 68
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 127
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 128 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 294

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 73
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 132
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG----SPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 133 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 186
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 245
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 246 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 299

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 295

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 62/196 (31%), Positives = 109/196 (55%), Gaps = 7/196 (3%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A +  +G   AVK ++  +    +  + +  E+  ++   H NVV ++ 
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHDNVVDMYS 109
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +SY HN+GV HRD+K
Sbjct: 110 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIK 168
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL S G IK+SDFG  A  Q  ++        G+P ++APEV++   Y G   DIW
Sbjct: 169 SDSILLTSDGRIKLSDFGFCA--QVSKEVPKRKXLVGTPYWMAPEVISRLPY-GTEVDIW 225
Query: 202 SCGVILYVILTGYLPF 217
           S G+++  ++ G  P+
Sbjct: 226 SLGIMVIEMIDGEPPY 241

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 295

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 142/294 (48%), Gaps = 44/294 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 70
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 129
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 130 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 196 ATSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LP 237
              DIWS G I   ++T     P D          R L    + ++ G     D+K   P
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 243
Query: 238 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           KW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 244 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 296

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 142/294 (48%), Gaps = 44/294 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 71
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 131 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 196 ATSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LP 237
              DIWS G I   ++T     P D          R L    + ++ G     D+K   P
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 238 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           KW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 297

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 142/294 (48%), Gaps = 44/294 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 72
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 131
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 132 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 196 ATSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LP 237
              DIWS G I   ++T     P D          R L    + ++ G     D+K   P
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 238 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           KW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 298

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 142/294 (48%), Gaps = 44/294 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 71
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 72  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 131 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 184
Query: 196 ATSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LP 237
              DIWS G I   ++T     P D          R L    + ++ G     D+K   P
Sbjct: 185 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 244
Query: 238 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           KW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 245 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 297

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 70
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 129
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 130 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 183
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 242
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 296

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 70
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 71  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 129
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 130 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 183
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 184 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 242
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 243 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 296

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 68
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 127
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 128 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 181
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 294

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 68
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 127
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 128 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 294

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 142/294 (48%), Gaps = 44/294 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 72
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 131
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 132 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 196 ATSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LP 237
              DIWS G I   ++T     P D          R L    + ++ G     D+K   P
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 238 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           KW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 298

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 142/294 (48%), Gaps = 44/294 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 73
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 74  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 132
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 133 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 186
Query: 196 ATSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LP 237
              DIWS G I   ++T     P D          R L    + ++ G     D+K   P
Sbjct: 187 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 246
Query: 238 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           KW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 247 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 299

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 295

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 142/294 (48%), Gaps = 44/294 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 18  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 76
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 77  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 135
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG----SPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 136 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 189
Query: 196 ATSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LP 237
              DIWS G I   ++T     P D          R L    + ++ G     D+K   P
Sbjct: 190 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 249
Query: 238 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           KW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 250 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 302

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 295

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 88/282 (31%), Positives = 133/282 (47%), Gaps = 42/282 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIATLK 69
           R  + R L EG F  V  AQD+ SG  +A+K L     EKNR I       I+      K
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAI-------IQEVCFMKK 81
Query: 70  LLKHPNVVRL--------HEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKL 119
           L  HPN+V+          E    +++  ++ E   G   E   K+ S+G L      K+
Sbjct: 82  LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141
Query: 120 FQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-------D 170
           F Q    V + H +   + HRDLK+EN+LL ++G IK+ DFG +    H+ D        
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRR 201
Query: 171 GLLH---TTCGSPNYVAPEV--LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL 225
            L+    T   +P Y  PE+  L +    G   DIW+ G ILY++     PF+D   A L
Sbjct: 202 ALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG--AKL 259
Query: 226 YQKIFRGDFKLPKWLSPGA--QNLLRKILEPNPVKRITIAGI 265
             +I  G + +P   +      +L+R +L+ NP +R++IA +
Sbjct: 260 --RIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEV 299

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 82/256 (32%), Positives = 128/256 (50%), Gaps = 10/256 (3%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG+G FG+V   Q   +G  +A K LEK RI   K       E   L+ +    VV L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
                +K  + +VL  + GG+L   I   G+    E R +F   ++  G+   H + + +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
           RDLK ENILLD  G+I+ISD GL+    H  +   +    G+  Y+APEV+ N  Y   +
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYT-FS 365
Query: 198 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILE 253
            D W+ G +LY ++ G  PF  R   +  +++ R   ++P    +  SP A++L  ++L 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 254 PNPVKRITIAGIKADE 269
            +P +R+   G  A E
Sbjct: 426 KDPAERLGCRGGSARE 441

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 82/256 (32%), Positives = 128/256 (50%), Gaps = 10/256 (3%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG+G FG+V   Q   +G  +A K LEK RI   K       E   L+ +    VV L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNKGVFH 137
                +K  + +VL  + GG+L   I   G+    E R +F   ++  G+   H + + +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
           RDLK ENILLD  G+I+ISD GL+    H  +   +    G+  Y+APEV+ N  Y   +
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYT-FS 365
Query: 198 SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILE 253
            D W+ G +LY ++ G  PF  R   +  +++ R   ++P    +  SP A++L  ++L 
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 254 PNPVKRITIAGIKADE 269
            +P +R+   G  A E
Sbjct: 426 KDPAERLGCRGGSARE 441

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 182
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 295

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 91/295 (30%), Positives = 143/295 (48%), Gaps = 46/295 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 68
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 69  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 127
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 128 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKYYS 181
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 182 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 294

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 90/294 (30%), Positives = 141/294 (47%), Gaps = 44/294 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 72
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++        D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 73  VIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 131
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 132 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 185
Query: 196 ATSDIWSCGVILYVILT--GYLPFDD---------RNLAVLYQKIFRG-----DFK--LP 237
              DIWS G I   ++T     P D          R L    + ++ G     D+K   P
Sbjct: 186 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFP 245
Query: 238 KW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           KW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 246 KWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 298

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  101 bits (251), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 70/255 (27%), Positives = 132/255 (51%), Gaps = 24/255 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--- 71
           +Y     +G+G  G V  A D+ +G   A++         + +  Q K+E+   ++L   
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIR--------QMNLQQQPKKELIINEILVMR 72
Query: 72  --KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             K+PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + +
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEF 131
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA--LPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRD+K +NILL   G++K++DFG  A   P+  +   ++    G+P ++APEV
Sbjct: 132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV----GTPYWMAPEV 187
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--PKWLSPGA 244
           +  + Y G   DIWS G++   ++ G  P+ + N L  LY     G  +L  P+ LS   
Sbjct: 188 VTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246
Query: 245 QNLLRKILEPNPVKR 259
           ++ L + L+ +  KR
Sbjct: 247 RDFLNRCLDMDVEKR 261

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 103/211 (48%), Gaps = 16/211 (7%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIATLK 69
           RY++   LG G    V  A+D    +  A+K +     EK   +      + +RE+    
Sbjct: 12  RYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLK-----RFEREVHNSS 66
Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            L H N+V + +V       Y+V+EY+ G  L + I S G L          Q++DG+ +
Sbjct: 67  QLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKH 126
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--TCGSPNYVAPEV 187
            H+  + HRD+K +NIL+DS   +KI DFG++   +   +  L  T    G+  Y +PE 
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIA---KALSETSLTQTNHVLGTVQYFSPEQ 183
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFD 218
                 D  T DI+S G++LY +L G  PF+
Sbjct: 184 AKGEATDECT-DIYSIGIVLYEMLVGEPPFN 213

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPQDQSFESRDLLID 335

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 140/287 (48%), Gaps = 45/287 (15%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HPN+V+L +
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHPNIVKLLD 69
Query: 82  VLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V HRD
Sbjct: 70  VIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGYDG 195
           LK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y  
Sbjct: 129 LKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYXHEVVTLWYRAPEILLGCKYYS 182
Query: 196 ATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK--L 236
              DIWS G I   ++T    F  D  +  L+ +IFR                 D+K   
Sbjct: 183 TAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKPSF 241
Query: 237 PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272
           PKW           L    ++LL ++L  +P KRI+     A  +F+
Sbjct: 242 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQ 288

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 150/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKSQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL    +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLC---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPYDQSLESRDLLID 335

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPTDQSFESRDLLID 335

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 100/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L K    IIH K T    RE+  LK +K
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRT---YRELRLLKHMK 91
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 149
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 204
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 264
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 265 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 324
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 325 DPDDEPVADPYDQSFESRDLLID 347

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKXQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPYDQSFESRDLLID 335

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKXQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPYDQSFESRDLLID 335

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPRDQSFESRDLLID 335

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 143/297 (48%), Gaps = 50/297 (16%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKLLKHPNVVRL 79
           +GEG +G V  A++  +G    V  L K R+      +     REI+ LK L HPN+V+L
Sbjct: 11  IGEGTYGVVYKARNKLTG---EVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 67
Query: 80  HEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
            +V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V H
Sbjct: 68  LDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLH 126
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGY 193
           RDLK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y
Sbjct: 127 RDLKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 194 DGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK- 235
                DIWS G I   ++T    F  D  +  L+ +IFR                 D+K 
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKP 239
Query: 236 -LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
             PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 240 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 295

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 93/297 (31%), Positives = 143/297 (48%), Gaps = 50/297 (16%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKLLKHPNVVRL 79
           +GEG +G V  A++  +G    V  L K R+      +     REI+ LK L HPN+V+L
Sbjct: 10  IGEGTYGVVYKARNKLTG---EVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKL 66
Query: 80  HEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
            +V+ +++K+Y+V E++     +  D  A  G         LFQ L+ G+++CH+  V H
Sbjct: 67  LDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCHSHRVLH 125
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT----CGSPNYVAPEVLANRGY 193
           RDLK +N+L++++G IK++DFGL+      R  G+   T      +  Y APE+L    Y
Sbjct: 126 RDLKPQNLLINTEGAIKLADFGLA------RAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 194 DGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRG----------------DFK- 235
                DIWS G I   ++T    F  D  +  L+ +IFR                 D+K 
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF-RIFRTLGTPDEVVWPGVTSMPDYKP 238
Query: 236 -LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
             PKW           L    ++LL ++L  +P KRI+     A  +F QD T   P
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF-QDVTKPVP 294

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 85
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 143
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 198
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 258
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 259 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 319 DPDDEPVADPYDQSFESRDLLID 341

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPYDQSFESRDLLID 335

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 136/265 (51%), Gaps = 18/265 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A    SG   AVK ++  +    +  + +  E+  ++  +H NVV ++ 
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 138
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +S  H +GV HRD+K
Sbjct: 139 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 197
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL   G +K+SDFG  A  Q  ++        G+P ++APE+++   Y G   DIW
Sbjct: 198 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 254
Query: 202 SCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKWL------SPGAQNLLRKILEP 254
           S G+++  ++ G  P F++  L  +  K+ R +  LP  L      SP  +  L ++L  
Sbjct: 255 SLGIMVIEMVDGEPPYFNEPPLKAM--KMIRDN--LPPRLKNLHKVSPSLKGFLDRLLVR 310
Query: 255 NPVKRITIAGIKADEWFEQDYTPAN 279
           +P +R T A +    +  +   PA+
Sbjct: 311 DPAQRATAAELLKHPFLAKAGPPAS 335

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 136/265 (51%), Gaps = 18/265 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A    SG   AVK ++  +    +  + +  E+  ++  +H NVV ++ 
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 95
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +S  H +GV HRD+K
Sbjct: 96  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 154
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL   G +K+SDFG  A  Q  ++        G+P ++APE+++   Y G   DIW
Sbjct: 155 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 211
Query: 202 SCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKWL------SPGAQNLLRKILEP 254
           S G+++  ++ G  P F++  L  +  K+ R +  LP  L      SP  +  L ++L  
Sbjct: 212 SLGIMVIEMVDGEPPYFNEPPLKAM--KMIRDN--LPPRLKNLHKVSPSLKGFLDRLLVR 267
Query: 255 NPVKRITIAGIKADEWFEQDYTPAN 279
           +P +R T A +    +  +   PA+
Sbjct: 268 DPAQRATAAELLKHPFLAKAGPPAS 292

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 86
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 144
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADE--MTGYVATRWYRAPE 199
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 320 DPDDEPVADPYDQSFESRDLLID 342

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 81
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 139
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 194
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 254
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 255 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 315 DPDDEPVADPYDQSFESRDLLID 337

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 86
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 144
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADE--MTGYVATRWYRAPE 199
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 320 DPDDEPVADPYDQSLESRDLLID 342

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 88/312 (28%), Positives = 136/312 (43%), Gaps = 68/312 (21%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----------ITDQIK 62
           + +YE    +GEG +G V           F  K  E + I+ LK          +     
Sbjct: 1   MQKYEKLEKIGEGTYGTV-----------FKAKNRETHEIVALKRVRLDDDDEGVPSSAL 49
Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLF 120
           REI  LK LKH N+VRLH+VL S  K+ +V E+      + FD  +  G L     +   
Sbjct: 50  REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFL 107
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            QL+ G+ +CH++ V HRDLK +N+L++  G +K++DFGL+      R  G +   C S 
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLA------RAFG-IPVRCYSA 160
Query: 181 N-----YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFR--- 231
                 Y  P+VL        + D+WS G I   +     P F   ++    ++IFR   
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLG 220
Query: 232 --------GDFKLPKW------------------LSPGAQNLLRKILEPNPVKRITIAGI 265
                      KLP +                  L+   ++LL+ +L+ NPV+RI+    
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
Query: 266 KADEWFEQDYTP 277
               +F  D+ P
Sbjct: 281 LQHPYF-SDFCP 291

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 136/265 (51%), Gaps = 18/265 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A    SG   AVK ++  +    +  + +  E+  ++  +H NVV ++ 
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 93
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +S  H +GV HRD+K
Sbjct: 94  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 152
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL   G +K+SDFG  A  Q  ++        G+P ++APE+++   Y G   DIW
Sbjct: 153 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 209
Query: 202 SCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKWL------SPGAQNLLRKILEP 254
           S G+++  ++ G  P F++  L  +  K+ R +  LP  L      SP  +  L ++L  
Sbjct: 210 SLGIMVIEMVDGEPPYFNEPPLKAM--KMIRDN--LPPRLKNLHKVSPSLKGFLDRLLVR 265
Query: 255 NPVKRITIAGIKADEWFEQDYTPAN 279
           +P +R T A +    +  +   PA+
Sbjct: 266 DPAQRATAAELLKHPFLAKAGPPAS 290

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 86
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 144
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTADE--MTGYVATRWYRAPE 199
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 320 DPDDEPVADPYDQSSESRDLLID 342

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 136/265 (51%), Gaps = 18/265 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A    SG   AVK ++  +    ++   +  E+  ++  +H NVV ++ 
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYN 215
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +S  H +GV HRD+K
Sbjct: 216 SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 274
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL   G +K+SDFG  A  Q  ++        G+P ++APE+++   Y G   DIW
Sbjct: 275 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 331
Query: 202 SCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKWL------SPGAQNLLRKILEP 254
           S G+++  ++ G  P F++  L  +  K+ R +  LP  L      SP  +  L ++L  
Sbjct: 332 SLGIMVIEMVDGEPPYFNEPPLKAM--KMIRDN--LPPRLKNLHKVSPSLKGFLDRLLVR 387
Query: 255 NPVKRITIAGIKADEWFEQDYTPAN 279
           +P +R T A +    +  +   PA+
Sbjct: 388 DPAQRATAAELLKHPFLAKAGPPAS 412

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 86
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 144
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 199
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 200 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 259
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 320 DPDDEPVADPYDQSFESRDLLID 342

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGXVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPYDQSFESRDLLID 335

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 28  RYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 84
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 142
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 197
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 258 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 317
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 318 DPDDEPVADPYDQSFESRDLLID 340

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 136/265 (51%), Gaps = 18/265 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A    SG   AVK ++  +    +  + +  E+  ++  +H NVV ++ 
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 84
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +S  H +GV HRD+K
Sbjct: 85  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 143
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL   G +K+SDFG  A  Q  ++        G+P ++APE+++   Y G   DIW
Sbjct: 144 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 200
Query: 202 SCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKWL------SPGAQNLLRKILEP 254
           S G+++  ++ G  P F++  L  +  K+ R +  LP  L      SP  +  L ++L  
Sbjct: 201 SLGIMVIEMVDGEPPYFNEPPLKAM--KMIRDN--LPPRLKNLHKVSPSLKGFLDRLLVR 256
Query: 255 NPVKRITIAGIKADEWFEQDYTPAN 279
           +P +R T A +    +  +   PA+
Sbjct: 257 DPAQRATAAELLKHPFLAKAGPPAS 281

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPYDQSFESRDLLID 335

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 136/265 (51%), Gaps = 18/265 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +GEG+ G V  A    SG   AVK ++  +    +  + +  E+  ++  +H NVV ++ 
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYN 88
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                 ++++V+E++ GG L D I +  R+ E +   +   ++  +S  H +GV HRD+K
Sbjct: 89  SYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIK 147
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIW 201
            ++ILL   G +K+SDFG  A  Q  ++        G+P ++APE+++   Y G   DIW
Sbjct: 148 SDSILLTHDGRVKLSDFGFCA--QVSKEVPRRKXLVGTPYWMAPELISRLPY-GPEVDIW 204
Query: 202 SCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDFKLPKWL------SPGAQNLLRKILEP 254
           S G+++  ++ G  P F++  L  +  K+ R +  LP  L      SP  +  L ++L  
Sbjct: 205 SLGIMVIEMVDGEPPYFNEPPLKAM--KMIRDN--LPPRLKNLHKVSPSLKGFLDRLLVR 260
Query: 255 NPVKRITIAGIKADEWFEQDYTPAN 279
           +P +R T A +    +  +   PA+
Sbjct: 261 DPAQRATAAELLKHPFLAKAGPPAS 285

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 81
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 139
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 194
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 254
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 255 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 315 DPDDEPVADPYDQSFESRDLLID 337

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 85
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 143
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 198
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 258
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 259 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 319 DPDDEPVADPYDQSFESRDLLID 341

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPFDQSFESRDLLID 335

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 102
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 160
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 215
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 275
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 276 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 335
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 336 DPDDEPVADPYDQSFESRDLLID 358

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 46  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 102
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 103 HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 160
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 161 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MXGYVATRWYRAPE 215
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 216 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 275
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 276 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 335
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 336 DPDDEPVADPYDQSFESRDLLID 358

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 118/217 (54%), Gaps = 31/217 (14%)
Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDK--IASKGRLQEAEGRK 118
           REI+ +K LKH N+VRL++V+ +++K+ +V E++     +  D   + +  R  E    K
Sbjct: 52  REISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVK 111
Query: 119 LFQ-QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
            FQ QL+ G+++CH   + HRDLK +N+L++ +G +K+ DFGL+      R  G+   T 
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA------RAFGIPVNTF 165
Query: 178 GSPN----YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLY--- 226
            S      Y AP+VL        + DIWSCG IL  ++TG   F    D+  L +++   
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225
Query: 227 ----QKIFRGDFKLPKWLSPGAQNL----LRKILEPN 255
               + ++    KLPK+ +P  Q      LR++L+P+
Sbjct: 226 GTPNESLWPSVTKLPKY-NPNIQQRPPRDLRQVLQPH 261

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 84
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 142
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 197
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 258 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 317
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 318 DPDDEPVADPYDQSFESRDLLID 340

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPYDQSFESRDLLID 335

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 90
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 148
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 203
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 263
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 264 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 323
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 324 DPDDEPVADPYDQSFESRDLLID 346

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 84
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 142
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 197
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 258 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 317
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 318 DPDDEPVADPYDQSFESRDLLID 340

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 28  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 84
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 85  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 142
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 143 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 197
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 198 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 257
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 258 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 317
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 318 DPDDEPVADPYDQSFESRDLLID 340

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 91
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 149
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 204
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 264
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 265 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 324
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 325 DPDDEPVADPYDQSFESRDLLID 347

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 22  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 78
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 79  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 136
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 137 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 191
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 192 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 251
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 252 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 311
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 312 DPDDEPVADPYDQSFESRDLLID 334

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 35  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 91
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 92  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 149
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 150 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 204
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 205 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 264
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 265 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 324
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 325 DPDDEPVADPYDQSFESRDLLID 347

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 81
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 139
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 194
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 254
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 255 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 315 DPDDEPVADPYDQSFESRDLLID 337

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 25  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 81
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 82  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 139
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 140 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 194
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 195 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 254
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 255 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 314
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 315 DPDDEPVADPYDQSFESRDLLID 337

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPYDQSFESRDLLID 335

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 99
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 157
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 212
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 272
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 273 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 332
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 333 DPDDEPVADPYDQSFESRDLLID 355

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 76
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 134
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 189
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 249
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 250 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 309
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 310 DPDDEPVADPYDQSFESRDLLID 332

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 85
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 143
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 198
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 258
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 259 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 319 DPDDEPVADPYDQSFESRDLLID 341

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 21  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 77
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 78  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 135
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 136 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 190
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 191 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 250
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 251 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 310
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 311 DPDDEPVADPYDQSFESRDLLID 333

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 34  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 90
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 91  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 148
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 149 LKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 203
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 204 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 263
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 264 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 323
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 324 DPDDEPVADPYDQSFESRDLLID 346

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 98
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 156
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 211
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 271
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 272 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 331
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 332 DPDDEPVADPYDQSFESRDLLID 354

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 20  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 76
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 77  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 134
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 135 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 189
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 190 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 249
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 250 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 309
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 310 DPDDEPVADPYDQSFESRDLLID 332

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 99.0 bits (245), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/289 (29%), Positives = 134/289 (46%), Gaps = 25/289 (8%)
Query: 11  MRLGRYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           M L ++E+ RT       LG G FG+V         L  AVK L+++ +      ++  +
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLK 56
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--- 120
           E A +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L    
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 115
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            Q+   + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTXTAHAGAKFP 173
Query: 181 -NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL-- 236
             + APE LA   +    SD+W+ GV+L+ I T G  P+   + + +Y+ +   D+++  
Sbjct: 174 IKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE-LLEKDYRMER 231
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
           P+        L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 232 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 278

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 99/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 75
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 133
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 188
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 309 DPDDEPVADPYDQSFESRDLLID 331

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 98.2 bits (243), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 134/285 (47%), Gaps = 25/285 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 63
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y+++E++T G L D +    R QE     L     Q+ 
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 122
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 123 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTXTAHAGAKFPIKWT 180
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 181 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 238
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
                 L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 239 PEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 281

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 98/323 (30%), Positives = 151/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI D+GL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPYDQSFESRDLLID 335

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 134/285 (47%), Gaps = 25/285 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y+++E++T G L D +    R QE     L     Q+ 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 179
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 180 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 237
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
                 L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 280

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 98.2 bits (243), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 137/261 (52%), Gaps = 19/261 (7%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   LG+G FGKV  A++ ++G   A K++E       ++ D I  EI  L    HP 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIV-EIEILATCDHPY 77
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
           +V+L        K+++++E+  GG +   +    R L E + + + +Q+++ +++ H+K 
Sbjct: 78  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 137
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-----LA 189
           + HRDLK  N+L+  +G+I+++DFG+SA  ++ +      +  G+P ++APEV     + 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA----- 244
           +  YD   +DIWS G+ L  +     P  + N   +  KI + D   P  L+P       
Sbjct: 196 DTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--PPTLLTPSKWSVEF 252
Query: 245 QNLLRKILEPNPVKRITIAGI 265
           ++ L+  L+ NP  R + A +
Sbjct: 253 RDFLKIALDKNPETRPSAAQL 273

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 74/261 (28%), Positives = 137/261 (52%), Gaps = 19/261 (7%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E+   LG+G FGKV  A++ ++G   A K++E       ++ D I  EI  L    HP 
Sbjct: 13  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYI-VEIEILATCDHPY 69
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
           +V+L        K+++++E+  GG +   +    R L E + + + +Q+++ +++ H+K 
Sbjct: 70  IVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR 129
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-----LA 189
           + HRDLK  N+L+  +G+I+++DFG+SA  ++ +      +  G+P ++APEV     + 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETMK 187
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA----- 244
           +  YD   +DIWS G+ L  +     P  + N   +  KI + D   P  L+P       
Sbjct: 188 DTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD--PPTLLTPSKWSVEF 244
Query: 245 QNLLRKILEPNPVKRITIAGI 265
           ++ L+  L+ NP  R + A +
Sbjct: 245 RDFLKIALDKNPETRPSAAQL 265

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 134/285 (47%), Gaps = 25/285 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y+++E++T G L D +    R QE     L     Q+ 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 179
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 180 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 237
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
                 L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 280

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 126/265 (47%), Gaps = 23/265 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y+++E++T G L D +    R QE     L     Q+ 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 126
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 184
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 185 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 242
Query: 241 SPGAQNLLRKILEPNPVKRITIAGI 265
                 L+R   + NP  R + A I
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 86/271 (31%), Positives = 130/271 (47%), Gaps = 26/271 (9%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIK-REIATLKL 70
           + +YE    +GEG++G V   ++ D+G   A+K  LE +     K+  +I  REI  LK 
Sbjct: 24  MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD---KMVKKIAMREIKLLKQ 80
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L+H N+V L EV   K + Y+V E+V    L D       L     +K   Q+I+G+ +C
Sbjct: 81  LRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC 140
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H+  + HRD+K ENIL+   G +K+ DFG +   A P    DD +      +  Y APE+
Sbjct: 141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEV-----ATRWYRAPEL 195
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIF-RGDFKLPKWLSPGAQ 245
           L      G   D+W+ G ++  +  G   F  D ++  LY  +   G+      L P  Q
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGN------LIPRHQ 249
Query: 246 NLLRKILEPNPV-KRITIAGIKADEWFEQDY 275
            L  K    NPV   + +  IK  E  E+ Y
Sbjct: 250 ELFNK----NPVFAGVRLPEIKEREPLERRY 276

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 98/323 (30%), Positives = 150/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 75
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCAKLTDDHVQFLIYQILRG 133
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 188
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 249 ESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 309 DPDDEPVADPYDQSFESRDLLID 331

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 87/312 (27%), Positives = 136/312 (43%), Gaps = 68/312 (21%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----------ITDQIK 62
           + +YE    +GEG +G V           F  K  E + I+ LK          +     
Sbjct: 1   MQKYEKLEKIGEGTYGTV-----------FKAKNRETHEIVALKRVRLDDDDEGVPSSAL 49
Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLF 120
           REI  LK LKH N+VRLH+VL S  K+ +V E+      + FD  +  G L     +   
Sbjct: 50  REICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFD--SCNGDLDPEIVKSFL 107
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            QL+ G+ +CH++ V HRDLK +N+L++  G +K+++FGL+      R  G +   C S 
Sbjct: 108 FQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA------RAFG-IPVRCYSA 160
Query: 181 N-----YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFR--- 231
                 Y  P+VL        + D+WS G I   +     P F   ++    ++IFR   
Sbjct: 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG 220
Query: 232 --------GDFKLPKW------------------LSPGAQNLLRKILEPNPVKRITIAGI 265
                      KLP +                  L+   ++LL+ +L+ NPV+RI+    
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280
Query: 266 KADEWFEQDYTP 277
               +F  D+ P
Sbjct: 281 LQHPYF-SDFCP 291

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 134/289 (46%), Gaps = 25/289 (8%)
Query: 11  MRLGRYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           M L ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +
Sbjct: 1   MSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLK 56
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--- 120
           E A +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L    
Sbjct: 57  EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMA 115
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            Q+   + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P
Sbjct: 116 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTFTAHAGAKFP 173
Query: 181 -NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL-- 236
             + APE LA   +    SD+W+ GV+L+ I T G  P+   + + +Y+ +   D+++  
Sbjct: 174 IKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE-LLEKDYRMER 231
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
           P+        L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 232 PEGCPEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 278

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 25/285 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 179
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 180 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 237
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
                 L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 280

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 98/323 (30%), Positives = 150/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 99
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 157
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MXGXVATRWYRAPE 212
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 272
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 273 ESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 332
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 333 DPDDEPVADPYDQSFESRDLLID 355

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 25/285 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 179
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 180 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 237
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
                 L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 280

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 25/285 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 126
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 184
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 185 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 242
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
                 L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 285

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 25/285 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 126
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 184
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 185 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 242
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
                 L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 285

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 125/265 (47%), Gaps = 23/265 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 126
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTXTAHAGAKFPIKWT 184
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 185 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 242
Query: 241 SPGAQNLLRKILEPNPVKRITIAGI 265
                 L+R   + NP  R + A I
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 25/285 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 20  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 75
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 76  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 134
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 135 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 192
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 193 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 250
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
                 L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 251 PEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 293

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 25/285 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 64
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 123
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 181
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 182 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 239
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
                 L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 240 PEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 282

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 82/285 (28%), Positives = 133/285 (46%), Gaps = 25/285 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 64
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 123
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 181
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 182 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 239
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
                 L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 240 PEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 282

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 66/207 (31%), Positives = 104/207 (50%), Gaps = 15/207 (7%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL---EKNRIIHLKITDQIKREIATLK 69
           + +YE    +GEG++G V   ++ D+G   A+K     E + +I  KI     REI  LK
Sbjct: 2   MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIK-KIA---LREIRMLK 57
Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            LKHPN+V L EV   K ++++V EY     L +    +  + E   + +  Q +  V++
Sbjct: 58  QLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL---PQHFRDDGLLHTTCGSPNYVAPE 186
           CH     HRD+K ENIL+     IK+ DFG + L   P  + DD +      +  Y +PE
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEV-----ATRWYRSPE 172
Query: 187 VLANRGYDGATSDIWSCGVILYVILTG 213
           +L      G   D+W+ G +   +L+G
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 98/323 (30%), Positives = 150/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPYDQSFESRDLLID 335

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 98/323 (30%), Positives = 150/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 33  RYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 89
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 90  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 147
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 148 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 202
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 203 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 262
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 263 ESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 322
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 323 DPDDEPVADPYDQSFESRDLLID 345

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 98/323 (30%), Positives = 150/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI  FGL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPYDQSFESRDLLID 335

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 100/325 (30%), Positives = 151/325 (46%), Gaps = 61/325 (18%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVA 184
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  G + T      Y A
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMAGFVATRW----YRA 190
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI 229
           PE++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 230 --------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
                    +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q
Sbjct: 251 SSESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 274 DYTP-----ANPDD---DEEDIFVD 290
            + P     A+P D   +  D+ +D
Sbjct: 311 YHDPDDEPVADPYDQSFESRDLLID 335

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 125/265 (47%), Gaps = 23/265 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 12  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 67
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 68  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 126
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 127 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 184
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 185 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 242
Query: 241 SPGAQNLLRKILEPNPVKRITIAGI 265
                 L+R   + NP  R + A I
Sbjct: 243 PEKVYELMRACWQWNPSDRPSFAEI 267

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 100/325 (30%), Positives = 151/325 (46%), Gaps = 61/325 (18%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVA 184
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  G + T      Y A
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDEMAGFVATRW----YRA 190
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI 229
           PE++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 250
Query: 230 --------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
                    +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q
Sbjct: 251 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 310
Query: 274 DYTP-----ANPDD---DEEDIFVD 290
            + P     A+P D   +  D+ +D
Sbjct: 311 YHDPDDEPVADPYDQSFESRDLLID 335

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 125/265 (47%), Gaps = 23/265 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 11  KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 66
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 67  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 125
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 126 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 183
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 184 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 241
Query: 241 SPGAQNLLRKILEPNPVKRITIAGI 265
                 L+R   + NP  R + A I
Sbjct: 242 PEKVYELMRACWQWNPSDRPSFAEI 266

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 98/323 (30%), Positives = 150/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 43  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 99
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 100 HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 157
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 158 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 212
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 213 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 272
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 273 ESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 332
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 333 DPDDEPVADPYDQSFESRDLLID 355

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 134/277 (48%), Gaps = 18/277 (6%)
Query: 2   VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
           ++   K+  ++   +E+ + +G G F +V   +   +G  +A+KI+ K  ++        
Sbjct: 49  IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF 108
Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE-GRKLF 120
           + E   L       + +LH     ++ +Y+V+EY  GG+L   ++  G    AE  R   
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--TCG 178
            +++  +   H  G  HRD+K +NILLD  G+I+++DFG S L    R DG + +    G
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG-SCL--KLRADGTVRSLVAVG 225
Query: 179 SPNYVAPEVL------ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--F 230
           +P+Y++PE+L         G  G   D W+ GV  Y +  G  PF   + A  Y KI  +
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285
Query: 231 RGDFKLP---KWLSPGAQNLLRKILEPNPVKRITIAG 264
           +    LP   + +   A++ ++++L P P  R+   G
Sbjct: 286 KEHLSLPLVDEGVPEEARDFIQRLLCP-PETRLGRGG 321

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 98/323 (30%), Positives = 150/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 29  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 85
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 86  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 143
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 144 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 198
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 199 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 258
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 259 ESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 318
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 319 DPDDEPVADPYDQSFESRDLLID 341

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 98/323 (30%), Positives = 150/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 42  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 98
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 99  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 156
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 157 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 211
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 212 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 271
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 272 ESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 331
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 332 DPDDEPVADPYDQSFESRDLLID 354

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 98/323 (30%), Positives = 150/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 75
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 133
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MTGYVATRWYRAPE 188
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 249 ESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 309 DPDDEPVADPYDQSFESRDLLID 331

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/267 (29%), Positives = 126/267 (47%), Gaps = 23/267 (8%)
Query: 13  LGRYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           L ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E 
Sbjct: 3   LDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEA 58
Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQ 122
           A +K +KHPN+V+L  V   +   Y+++E++T G L D +    R QE     L     Q
Sbjct: 59  AVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQ 117
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-N 181
           +   + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  
Sbjct: 118 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTXTAHAGAKFPIK 175
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PK 238
           + APE LA   +    SD+W+ GV+L+ I T G  P+   + + +Y+ +   D+++  P+
Sbjct: 176 WTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYE-LLEKDYRMERPE 233
Query: 239 WLSPGAQNLLRKILEPNPVKRITIAGI 265
                   L+R   + NP  R + A I
Sbjct: 234 GCPEKVYELMRACWQWNPSDRPSFAEI 260

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 125/265 (47%), Gaps = 23/265 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 179
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 180 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 237
Query: 241 SPGAQNLLRKILEPNPVKRITIAGI 265
                 L+R   + NP  R + A I
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/265 (29%), Positives = 125/265 (47%), Gaps = 23/265 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 7   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 62
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 63  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 121
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG--DTYTAHAGAKFPIKWT 179
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 180 APESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 237
Query: 241 SPGAQNLLRKILEPNPVKRITIAGI 265
                 L+R   + NP  R + A I
Sbjct: 238 PEKVYELMRACWQWNPSDRPSFAEI 262

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 98/323 (30%), Positives = 150/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI D GL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPYDQSFESRDLLID 335

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 98/323 (30%), Positives = 150/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 75
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 76  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 133
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DFGL+   +H  D+  +     +  Y APE
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA---RHTDDE--MAGFVATRWYRAPE 188
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 189 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 248
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 249 ESARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 309 DPDDEPVADPYDQSFESRDLLID 331

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 98/323 (30%), Positives = 150/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI D GL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPYDQSFESRDLLID 335

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 95.5 bits (236), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 123/263 (46%), Gaps = 19/263 (7%)
Query: 13  LGRYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           + ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E 
Sbjct: 24  MDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME----VEEFLKEA 79
Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ--QL 123
           A +K +KHPN+V+L  V   +   Y+V EY+  G L D +    R +      L+   Q+
Sbjct: 80  AVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQI 139
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 182
              + Y   K   HRDL   N L+     +K++DFGLS L     D    H     P  +
Sbjct: 140 SSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT--GDTYTAHAGAKFPIKW 197
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWL 240
            APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y  + +G   + P+  
Sbjct: 198 TAPESLAYNTF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLEKGYRMEQPEGC 256
Query: 241 SPGAQNLLRKILEPNPVKRITIA 263
            P    L+R   + +P  R + A
Sbjct: 257 PPKVYELMRACWKWSPADRPSFA 279

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 98/323 (30%), Positives = 150/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI D GL+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPYDQSFESRDLLID 335

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 94.4 bits (233), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 133/285 (46%), Gaps = 25/285 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 214 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 269
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 270 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLLYMATQIS 328
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HR+L   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 329 SAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWT 386
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 387 APESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 444
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
                 L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 445 PEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 487

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 108/222 (48%), Gaps = 11/222 (4%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E    LG GN G V       SGL  A K++     I   I +QI RE+  L     P 
Sbjct: 70  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 127
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-G 134
           +V  +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 187
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y 
Sbjct: 188 IMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS 243
Query: 195 GATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGD 233
              SDIWS G+ L  +  G  P    D + L +++     GD
Sbjct: 244 -VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 284

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/285 (28%), Positives = 134/285 (47%), Gaps = 25/285 (8%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 253 KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 308
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 309 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 367
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYV 183
             + Y   K   HR+L   N L+     +K++DFGLS L     D    H     P  + 
Sbjct: 368 SAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT--GDTYTAHAGAKFPIKWT 425
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWL 240
           APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++  P+  
Sbjct: 426 APESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRMERPEGC 483
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
                 L+R   + NP  R + A I   + FE  +  ++  D+ E
Sbjct: 484 PEKVYELMRACWQWNPSDRPSFAEIH--QAFETMFQESSISDEVE 526

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 97/323 (30%), Positives = 149/323 (46%), Gaps = 57/323 (17%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +G   AVK L +    IIH K T    RE+  LK +K
Sbjct: 23  RYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRT---YRELRLLKHMK 79
Query: 73  HPNVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V      L   + +Y+V  ++ G +L + I    +L +   + L  Q++ G
Sbjct: 80  HENVIGLLDVFTPARSLEEFNDVYLV-THLMGADL-NNIVKCQKLTDDHVQFLIYQILRG 137
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H+  + HRDLK  N+ ++    +KI DF L+   +H  D+  +     +  Y APE
Sbjct: 138 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLA---RHTDDE--MTGYVATRWYRAPE 192
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF------DDRNL---------AVLYQKI-- 229
           ++ N  +   T DIWS G I+  +LTG   F      D   L         A L +KI  
Sbjct: 193 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS 252
Query: 230 ------FRGDFKLPKW--------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                  +   ++PK          +P A +LL K+L  +  KRIT A   A  +F Q +
Sbjct: 253 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 312
Query: 276 TP-----ANPDD---DEEDIFVD 290
            P     A+P D   +  D+ +D
Sbjct: 313 DPDDEPVADPYDQSFESRDLLID 335

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 108/222 (48%), Gaps = 11/222 (4%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E    LG GN G V       SGL  A K++     I   I +QI RE+  L     P 
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 92
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-G 134
           +V  +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  
Sbjct: 93  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y 
Sbjct: 153 IMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS 208
Query: 195 GATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGD 233
              SDIWS G+ L  +  G  P    D + L +++     GD
Sbjct: 209 -VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 249

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 68/253 (26%), Positives = 126/253 (49%), Gaps = 18/253 (7%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +++   LGEG++G V  A   ++G   A+K +     +      +I +EI+ ++    P+
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-----EIIKEISIMQQCDSPH 85
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKG 134
           VV+ +      + +++V+EY   G + D I  + + L E E   + Q  + G+ Y H   
Sbjct: 86  VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR 145
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
             HRD+K  NILL+++G+ K++DFG++   Q        +   G+P ++APEV+   GY+
Sbjct: 146 KIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDXMAKRNXVIGTPFWMAPEVIQEIGYN 203
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------GDFKLPKWLSPGAQNLL 248
              +DIWS G+    +  G  P+ D +     + IF         F+ P+  S    + +
Sbjct: 204 -CVADIWSLGITAIEMAEGKPPYADIH---PMRAIFMIPTNPPPTFRKPELWSDNFTDFV 259
Query: 249 RKILEPNPVKRIT 261
           ++ L  +P +R T
Sbjct: 260 KQCLVKSPEQRAT 272

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 108/222 (48%), Gaps = 11/222 (4%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E    LG GN G V       SGL  A K++     I   I +QI RE+  L     P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-G 134
           +V  +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 195 GATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGD 233
              SDIWS G+ L  +  G  P    D + L +++     GD
Sbjct: 182 -VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 9   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 64
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 65  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 123
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---- 180
             + Y   K   HRDL   N L+     +K++DFGLS L        +   T  +P    
Sbjct: 124 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAPAGAK 175
Query: 181 ---NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL 236
               + APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++
Sbjct: 176 FPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRM 233
Query: 237 --PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
             P+        L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 234 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 282

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 134/291 (46%), Gaps = 37/291 (12%)
Query: 15  RYELGRT-------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++E+ RT       LG G +G+V         L  AVK L+++ +      ++  +E A 
Sbjct: 8   KWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAV 63
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF---QQLI 124
           +K +KHPN+V+L  V   +   Y++ E++T G L D +    R QE     L     Q+ 
Sbjct: 64  MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVLLYMATQIS 122
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---- 180
             + Y   K   HRDL   N L+     +K++DFGLS L        +   T  +P    
Sbjct: 123 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL--------MTGDTYTAPAGAK 174
Query: 181 ---NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL 236
               + APE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ +   D+++
Sbjct: 175 FPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE-LLEKDYRM 232
Query: 237 --PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
             P+        L+R   + NP  R + A I     FE  +  ++  D+ E
Sbjct: 233 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQA--FETMFQESSISDEVE 281

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 108/222 (48%), Gaps = 11/222 (4%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E    LG GN G V       SGL  A K++     I   I +QI RE+  L     P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-G 134
           +V  +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 195 GATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGD 233
              SDIWS G+ L  +  G  P    D + L +++     GD
Sbjct: 182 -VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 108/222 (48%), Gaps = 11/222 (4%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E    LG GN G V       SGL  A K++     I   I +QI RE+  L     P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-G 134
           +V  +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 195 GATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGD 233
              SDIWS G+ L  +  G  P    D + L +++     GD
Sbjct: 182 -VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 70/222 (31%), Positives = 108/222 (48%), Gaps = 11/222 (4%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E    LG GN G V       SGL  A K++     I   I +QI RE+  L     P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-G 134
           +V  +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 195 GATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGD 233
              SDIWS G+ L  +  G  P    D + L +++     GD
Sbjct: 182 -VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGD 222

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 8/199 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++           Q  +EI  L     P V + + 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 72
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                +K+++++EY+ GG   D +   G L E +   + ++++ G+ Y H++   HRD+K
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL   G +K++DFG++       D  +   T  G+P ++APEV+    YD + +DI
Sbjct: 132 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADI 187
Query: 201 WSCGVILYVILTGYLPFDD 219
           WS G+    +  G  P  +
Sbjct: 188 WSLGITAIELARGEPPHSE 206

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 101/199 (50%), Gaps = 8/199 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++           Q  +EI  L     P V + + 
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 92
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                +K+++++EY+ GG   D +   G L E +   + ++++ G+ Y H++   HRD+K
Sbjct: 93  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 151
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL   G +K++DFG++       D  +   T  G+P ++APEV+    YD + +DI
Sbjct: 152 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIKQSAYD-SKADI 207
Query: 201 WSCGVILYVILTGYLPFDD 219
           WS G+    +  G  P  +
Sbjct: 208 WSLGITAIELARGEPPHSE 226

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 34/216 (15%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----------ITDQIK 62
           + +Y+    +GEG +G V  A+D             + RI+ LK          I     
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKD------------SQGRIVALKRIRLDAEDEGIPSTAI 67
Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLF 120
           REI+ LK L HPN+V L +V+ S+  + +V E++     ++ D+  +K  LQ+++ +   
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYL 125
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTC 177
            QL+ GV++CH   + HRDLK +N+L++S G +K++DFGL+    +P       ++    
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW- 184
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 213
               Y AP+VL        + DIWS G I   ++TG
Sbjct: 185 ----YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 110/216 (50%), Gaps = 34/216 (15%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----------ITDQIK 62
           + +Y+    +GEG +G V  A+D             + RI+ LK          I     
Sbjct: 20  MEKYQKLEKVGEGTYGVVYKAKD------------SQGRIVALKRIRLDAEDEGIPSTAI 67
Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLF 120
           REI+ LK L HPN+V L +V+ S+  + +V E++     ++ D+  +K  LQ+++ +   
Sbjct: 68  REISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDE--NKTGLQDSQIKIYL 125
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTC 177
            QL+ GV++CH   + HRDLK +N+L++S G +K++DFGL+    +P       ++    
Sbjct: 126 YQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLW- 184
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 213
               Y AP+VL        + DIWS G I   ++TG
Sbjct: 185 ----YRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 70/218 (32%), Positives = 107/218 (49%), Gaps = 32/218 (14%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
            LG+G FG+V  A++      +A+K   K R    K++  I  E+  L  L H  VVR +
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIK---KIRHTEEKLS-TILSEVMLLASLNHQYVVRYY 68
Query: 81  -------------EVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDG 126
                          +  KS +++ +EY   G L+D I S+    Q  E  +LF+Q+++ 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-------------L 173
           +SY H++G+ HRDLK  NI +D   N+KI DFGL A   H   D L             L
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL-AKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 211
            +  G+  YVA EVL   G+     D++S G+I + ++
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/257 (29%), Positives = 119/257 (46%), Gaps = 20/257 (7%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E    LG GN G V       SGL  A K++     I   I +QI RE+  L     P 
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 65
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-G 134
           +V  +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  
Sbjct: 66  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 125
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y 
Sbjct: 126 IMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS 181
Query: 195 GATSDIWSCGVILYVILTGYLPF-------DDRNLAVLYQKIFRGDFKLPKWLSPGA--- 244
              SDIWS G+ L  +  G  P        D R    +++ +     + P  L  G    
Sbjct: 182 -VQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSL 240
Query: 245 --QNLLRKILEPNPVKR 259
             Q+ + K L  NP +R
Sbjct: 241 EFQDFVNKCLIKNPAER 257

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 102
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 103 NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 163 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 222
Query: 191 RGYDGATSDIWSCGVILYVILT 212
             +  A SD+WS GV+LY + T
Sbjct: 223 SKFSVA-SDVWSFGVVLYELFT 243

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 75
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 76  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 135
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 136 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 195
Query: 191 RGYDGATSDIWSCGVILYVILT 212
             +  A SD+WS GV+LY + T
Sbjct: 196 SKFSVA-SDVWSFGVVLYELFT 216

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 71
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 191 RGYDGATSDIWSCGVILYVILT 212
             +  A SD+WS GV+LY + T
Sbjct: 192 SKFSVA-SDVWSFGVVLYELFT 212

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 77
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 78  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 137
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 138 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 197
Query: 191 RGYDGATSDIWSCGVILYVILT 212
             +  A SD+WS GV+LY + T
Sbjct: 198 SKFSVA-SDVWSFGVVLYELFT 218

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/217 (31%), Positives = 106/217 (48%), Gaps = 11/217 (5%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E    LG GN G V   Q   SGL  A K++     I   I +QI RE+  L     P 
Sbjct: 18  FERISELGAGNGGVVTKVQHRPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 75
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-G 134
           +V  +    S  +I + +E++ GG L   +    R+ E    K+   ++ G++Y   K  
Sbjct: 76  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQ 135
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y+APE L    Y 
Sbjct: 136 IMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMAPERLQGTHYS 191
Query: 195 GATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQK 228
              SDIWS G+ L  +  G  P    D + L  ++ +
Sbjct: 192 -VQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIFGR 227

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 76
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 77  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 136
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 137 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 196
Query: 191 RGYDGATSDIWSCGVILYVILT 212
             +  A SD+WS GV+LY + T
Sbjct: 197 SKFSVA-SDVWSFGVVLYELFT 217

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 71
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 191
Query: 191 RGYDGATSDIWSCGVILYVILT 212
             +  A SD+WS GV+LY + T
Sbjct: 192 SKFSVA-SDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 69
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 70  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 129
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 130 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 189
Query: 191 RGYDGATSDIWSCGVILYVILT 212
             +  A SD+WS GV+LY + T
Sbjct: 190 SKFSVA-SDVWSFGVVLYELFT 210

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 78
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 79  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 138
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 139 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 198
Query: 191 RGYDGATSDIWSCGVILYVILT 212
             +  A SD+WS GV+LY + T
Sbjct: 199 SKFSVA-SDVWSFGVVLYELFT 219

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 74
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 191 RGYDGATSDIWSCGVILYVILT 212
             +  A SD+WS GV+LY + T
Sbjct: 195 SKFSVA-SDVWSFGVVLYELFT 215

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 70
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 71  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 130
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 131 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 190
Query: 191 RGYDGATSDIWSCGVILYVILT 212
             +  A SD+WS GV+LY + T
Sbjct: 191 SKFSVA-SDVWSFGVVLYELFT 211

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 74
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D + A   R+   +  +   Q+  G+ Y  
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLG 134
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 191 RGYDGATSDIWSCGVILYVILT 212
             +  A SD+WS GV+LY + T
Sbjct: 195 SKFSVA-SDVWSFGVVLYELFT 215

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-- 72
           +YE    +GEG +GKV  A+DL +G  F      + +     +     RE+A L+ L+  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 73  -HPNVVRLHEVLA-----SKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLI 124
            HPNVVRL +V        ++K+ +V E+V        DK+   G   E     +FQ L+
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 130
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ + H+  V HRDLK +NIL+ S G IK++DFGL+ +   +     L +   +  Y A
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRA 187
Query: 185 PEVLANRGYDGATSDIWSCGVIL 207
           PEVL    Y     D+WS G I 
Sbjct: 188 PEVLLQSSY-ATPVDLWSVGCIF 209

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-- 72
           +YE    +GEG +GKV  A+DL +G  F      + +     +     RE+A L+ L+  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 73  -HPNVVRLHEVLA-----SKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLI 124
            HPNVVRL +V        ++K+ +V E+V        DK+   G   E     +FQ L+
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 130
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ + H+  V HRDLK +NIL+ S G IK++DFGL+ +   +     L +   +  Y A
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRA 187
Query: 185 PEVLANRGYDGATSDIWSCGVIL 207
           PEVL    Y     D+WS G I 
Sbjct: 188 PEVLLQSSY-ATPVDLWSVGCIF 209

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 69/203 (33%), Positives = 102/203 (50%), Gaps = 15/203 (7%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-- 72
           +YE    +GEG +GKV  A+DL +G  F      + +     +     RE+A L+ L+  
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF 71
Query: 73  -HPNVVRLHEVLA-----SKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLI 124
            HPNVVRL +V        ++K+ +V E+V        DK+   G   E     +FQ L+
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LL 130
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ + H+  V HRDLK +NIL+ S G IK++DFGL+ +   +     L +   +  Y A
Sbjct: 131 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRA 187
Query: 185 PEVLANRGYDGATSDIWSCGVIL 207
           PEVL    Y     D+WS G I 
Sbjct: 188 PEVLLQSSY-ATPVDLWSVGCIF 209

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 89
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 149
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 191 RGYDGATSDIWSCGVILYVILT 212
             +  A SD+WS GV+LY + T
Sbjct: 210 SKFSVA-SDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 89
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 90  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 149
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 150 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 209
Query: 191 RGYDGATSDIWSCGVILYVILT 212
             +  A SD+WS GV+LY + T
Sbjct: 210 SKFSVA-SDVWSFGVVLYELFT 230

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 107/207 (51%), Gaps = 9/207 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++           Q  +EI  L       V + + 
Sbjct: 31  IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSSYVTKYYG 88
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                SK+++++EY+ GG   D + + G   E +   + ++++ G+ Y H++   HRD+K
Sbjct: 89  SYLKGSKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIK 147
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL  +G++K++DFG++       D  +   T  G+P ++APEV+    YD + +DI
Sbjct: 148 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNTFVGTPFWMAPEVIQQSAYD-SKADI 203
Query: 201 WSCGVILYVILTGYLPFDDRN-LAVLY 226
           WS G+    +  G  P  D + + VL+
Sbjct: 204 WSLGITAIELAKGEPPNSDMHPMRVLF 230

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 8/199 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++           Q  +EI  L     P + R   
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYITRYFG 84
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                +K+++++EY+ GG   D +   G L+E     + ++++ G+ Y H++   HRD+K
Sbjct: 85  SYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSERKIHRDIK 143
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL  +G++K++DFG++       D  +      G+P ++APEV+    YD   +DI
Sbjct: 144 AANVLLSEQGDVKLADFGVAG---QLTDTQIKRNXFVGTPFWMAPEVIKQSAYD-FKADI 199
Query: 201 WSCGVILYVILTGYLPFDD 219
           WS G+    +  G  P  D
Sbjct: 200 WSLGITAIELAKGEPPNSD 218

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/208 (32%), Positives = 100/208 (48%), Gaps = 13/208 (6%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           LG  +G GNFG+V   +        AVK   +     LK   +  +E   LK   HPN+V
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA--KFLQEARILKQYSHPNIV 175
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVF 136
           RL  V   K  IY+V+E V GG+    + ++G RL+     ++      G+ Y  +K   
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG----SPNYVAPEVLANRG 192
           HRDL   N L+  K  +KISDFG+S        DG+   + G       + APE L N G
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMS----REEADGVXAASGGLRQVPVKWTAPEAL-NYG 290
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDD 219
              + SD+WS G++L+   + G  P+ +
Sbjct: 291 RYSSESDVWSFGILLWETFSLGASPYPN 318

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 77/251 (30%), Positives = 121/251 (48%), Gaps = 26/251 (10%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----DQIKREIATLKLLKHPNVV 77
           LG GN G V       SGL  A       ++IHL+I     +QI RE+  L     P +V
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMA------RKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 86
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVF 136
             +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  + 
Sbjct: 87  GFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIM 146
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L    Y   
Sbjct: 147 HRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDSMANSFVGTRSYMSPERLQGTHYS-V 201
Query: 197 TSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-------KLPKWL-SPGAQNLL 248
            SDIWS G+ L  +  G  P    + ++   ++   D+       KLP  + S   Q+ +
Sbjct: 202 QSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELL--DYIVNEPPPKLPSGVFSLEFQDFV 259
Query: 249 RKILEPNPVKR 259
            K L  NP +R
Sbjct: 260 NKCLIKNPAER 270

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 66/196 (33%), Positives = 95/196 (48%), Gaps = 12/196 (6%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           LG  +G GNFG+V   +        AVK   +     LK   +  +E   LK   HPN+V
Sbjct: 118 LGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA--KFLQEARILKQYSHPNIV 175
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVF 136
           RL  V   K  IY+V+E V GG+    + ++G RL+     ++      G+ Y  +K   
Sbjct: 176 RLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG----SPNYVAPEVLANRG 192
           HRDL   N L+  K  +KISDFG+S        DG+   + G       + APE L N G
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMS----REEADGVYAASGGLRQVPVKWTAPEAL-NYG 290
Query: 193 YDGATSDIWSCGVILY 208
              + SD+WS G++L+
Sbjct: 291 RYSSESDVWSFGILLW 306

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 118/251 (47%), Gaps = 15/251 (5%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG G FG+V   Q   +G  +A K L K R+   K       E   L  +    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSYCHNKGV 135
                +K+ + +V+  + GG++   I +        QE        Q++ G+ + H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRGY 193
            +RDLK EN+LLD  GN++ISD GL+   +     G   T    G+P ++APE+L    Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKA----GQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLLR 249
           D +  D ++ GV LY ++    PF  R   V    L Q++       P   SP +++   
Sbjct: 367 DFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 250 KILEPNPVKRI 260
            +L+ +P KR+
Sbjct: 426 ALLQKDPEKRL 436

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 8/199 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++           Q  +EI  L     P V + + 
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 87
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                +K+++++EY+ GG   D +   G L E +   + ++++ G+ Y H++   HRD+K
Sbjct: 88  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 146
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL   G +K++DFG++       D  +      G+P ++APEV+    YD + +DI
Sbjct: 147 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNXFVGTPFWMAPEVIKQSAYD-SKADI 202
Query: 201 WSCGVILYVILTGYLPFDD 219
           WS G+    +  G  P  +
Sbjct: 203 WSLGITAIELARGEPPHSE 221

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 90.9 bits (224), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 55/199 (27%), Positives = 100/199 (50%), Gaps = 8/199 (4%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G+G+FG+V    D  +    A+KI++           Q  +EI  L     P V + + 
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ--QEITVLSQCDSPYVTKYYG 72
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
                +K+++++EY+ GG   D +   G L E +   + ++++ G+ Y H++   HRD+K
Sbjct: 73  SYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIK 131
Query: 142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLANRGYDGATSDI 200
             N+LL   G +K++DFG++       D  +      G+P ++APEV+    YD + +DI
Sbjct: 132 AANVLLSEHGEVKLADFGVAG---QLTDTQIKRNXFVGTPFWMAPEVIKQSAYD-SKADI 187
Query: 201 WSCGVILYVILTGYLPFDD 219
           WS G+    +  G  P  +
Sbjct: 188 WSLGITAIELARGEPPHSE 206

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 104/202 (51%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           R LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 74
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++E++  G L + +   K R+   +  +   Q+  G+ Y  
Sbjct: 75  NIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLG 134
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+  LPQ      +         + APE L  
Sbjct: 135 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTE 194
Query: 191 RGYDGATSDIWSCGVILYVILT 212
             +  A SD+WS GV+LY + T
Sbjct: 195 SKFSVA-SDVWSFGVVLYELFT 215

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 111/214 (51%), Gaps = 14/214 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 12  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 64
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  + AS+ + +  +   + +Q   G+ Y
Sbjct: 65  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 123
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV+ 
Sbjct: 124 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 183
Query: 190 NRGYDGAT--SDIWSCGVILYVILTGYLPFDDRN 221
            +  +  +  SD+++ G++LY ++TG LP+ + N
Sbjct: 184 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 217

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 78/247 (31%), Positives = 116/247 (46%), Gaps = 10/247 (4%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E    LG GN G V       SGL  A K++     I   I +QI RE+  L     P 
Sbjct: 11  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPY 68
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-G 134
           +V  +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y   K  
Sbjct: 69  IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 128
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NIL++S+G IK+ DFG+S        D + +   G+ +Y++PE L    Y 
Sbjct: 129 IMHRDVKPSNILVNSRGEIKLCDFGVSGQ----LIDEMANEFVGTRSYMSPERLQGTHYS 184
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF-RGDFKLPKWL-SPGAQNLLRKIL 252
              SDIWS G+ L  +  G  P     +  L   I      KLP  + S   Q+ + K L
Sbjct: 185 -VQSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCL 243
Query: 253 EPNPVKR 259
             NP +R
Sbjct: 244 IKNPAER 250

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 118/251 (47%), Gaps = 15/251 (5%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG G FG+V   Q   +G  +A K L K R+   K       E   L  +    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSYCHNKGV 135
                +K+ + +V+  + GG++   I +        QE        Q++ G+ + H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRGY 193
            +RDLK EN+LLD  GN++ISD GL+   +     G   T    G+P ++APE+L    Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKA----GQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLLR 249
           D +  D ++ GV LY ++    PF  R   V    L Q++       P   SP +++   
Sbjct: 367 DFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 250 KILEPNPVKRI 260
            +L+ +P KR+
Sbjct: 426 ALLQKDPEKRL 436

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 118/251 (47%), Gaps = 15/251 (5%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG G FG+V   Q   +G  +A K L K R+   K       E   L  +    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSYCHNKGV 135
                +K+ + +V+  + GG++   I +        QE        Q++ G+ + H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRGY 193
            +RDLK EN+LLD  GN++ISD GL+   +     G   T    G+P ++APE+L    Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKA----GQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLLR 249
           D +  D ++ GV LY ++    PF  R   V    L Q++       P   SP +++   
Sbjct: 367 DFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 250 KILEPNPVKRI 260
            +L+ +P KR+
Sbjct: 426 ALLQKDPEKRL 436

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 73/251 (29%), Positives = 118/251 (47%), Gaps = 15/251 (5%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R LG G FG+V   Q   +G  +A K L K R+   K       E   L  +    +V L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGR----LQEAEGRKLFQQLIDGVSYCHNKGV 135
                +K+ + +V+  + GG++   I +        QE        Q++ G+ + H + +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRGY 193
            +RDLK EN+LLD  GN++ISD GL+   +     G   T    G+P ++APE+L    Y
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLAVELKA----GQTKTKGYAGTPGFMAPELLLGEEY 366
Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFKLPKWLSPGAQNLLR 249
           D +  D ++ GV LY ++    PF  R   V    L Q++       P   SP +++   
Sbjct: 367 DFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425
Query: 250 KILEPNPVKRI 260
            +L+ +P KR+
Sbjct: 426 ALLQKDPEKRL 436

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/173 (31%), Positives = 93/173 (53%), Gaps = 10/173 (5%)
Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
           RE++ LK LKH N+V LH+++ ++  + +V EY+   +L   +   G +      KLF  
Sbjct: 49  REVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLFLF 107
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
           QL+ G++YCH + V HRDLK +N+L++ +G +K++DFGL+   ++P    D+ ++     
Sbjct: 108 QLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVV----- 162
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR 231
           +  Y  P++L          D+W  G I Y + TG   F    +      IFR
Sbjct: 163 TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR 215

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 139/308 (45%), Gaps = 50/308 (16%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-----ILEKNRIIHLKITDQI 61
           K++   +  Y + RTL +G F K+   +  D+   +A+K     +LEK R       D+I
Sbjct: 24  KEKDKYINDYRIIRTLNQGKFNKIILCEK-DNKF-YALKKYEKSLLEKKRDFTKSNNDKI 81
Query: 62  ---------KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDK---IAS 107
                    K E+  +  +K+   +    ++ +  ++Y++ EY+    +  FD+   +  
Sbjct: 82  SIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLD 141
Query: 108 KGR---LQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSAL 163
           K     +     + + + +++  SY HN K + HRD+K  NIL+D  G +K+SDFG S  
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-- 199
Query: 164 PQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDR-N 221
              +  D  +  + G+  ++ PE  +N   Y+GA  DIWS G+ LYV+    +PF  + +
Sbjct: 200 --EYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257
Query: 222 LAVLYQKIFRGDFKLP-------------------KWLSPGAQNLLRKILEPNPVKRITI 262
           L  L+  I   + + P                    +LS    + L+  L  NP +RIT 
Sbjct: 258 LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317
Query: 263 AGIKADEW 270
                 EW
Sbjct: 318 EDALKHEW 325

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/202 (33%), Positives = 106/202 (52%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 71
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 72  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 131
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLAN 190
            K   HRDL   NIL++++  +KI DFGL+ +    ++   +     SP  + APE L  
Sbjct: 132 TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE 191
Query: 191 RGYDGATSDIWSCGVILYVILT 212
             +  A SD+WS GV+LY + T
Sbjct: 192 SKFSVA-SDVWSFGVVLYELFT 212

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 132/281 (46%), Gaps = 52/281 (18%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVV 77
            + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P++V
Sbjct: 23  SQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCPHIV 74
Query: 78  RLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCH 131
           R+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + Y H
Sbjct: 75  RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 134
Query: 132 NKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           +  + HRD+K EN+L  SK     +K++DFG                        A E  
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AKETT 171
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAV---LYQKIFRGDFKL--PKW--L 240
             + YD  + D+WS GVI+Y++L GY PF  +  LA+   +  +I  G ++   P+W  +
Sbjct: 172 GEK-YD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY-TPANP 280
           S   + L+R +L+  P +R+TI       W  Q    P  P
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTP 270

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 106/218 (48%), Gaps = 32/218 (14%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
            LG+G FG+V  A++      +A+K   K R    K++  I  E+  L  L H  VVR +
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIK---KIRHTEEKLS-TILSEVMLLASLNHQYVVRYY 68
Query: 81  -------------EVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDG 126
                          +  KS +++ +EY     L+D I S+    Q  E  +LF+Q+++ 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-------------L 173
           +SY H++G+ HRDLK  NI +D   N+KI DFGL A   H   D L             L
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL-AKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 211
            +  G+  YVA EVL   G+     D++S G+I + ++
Sbjct: 188 TSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI 225

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 88/305 (28%), Positives = 138/305 (45%), Gaps = 47/305 (15%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 101
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N++ +++++ + +      +Y+V  ++ G +L+ K+     L          Q++ G+ Y
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYLV-THLMGADLY-KLLKTQHLSNDHICYFLYQILRGLKY 159
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE+
Sbjct: 160 IHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEI 218
Query: 188 LAN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL------------- 225
           + N +GY  +  DIWS G IL  +L+         YL   +  L +L             
Sbjct: 219 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 226 -----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQD 274
                Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ 
Sbjct: 278 LKARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 336
Query: 275 YTPAN 279
           Y P++
Sbjct: 337 YDPSD 341

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/219 (30%), Positives = 114/219 (52%), Gaps = 19/219 (8%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           G +EL   +G G +G+V   + + +G   A+K+++    +     ++IK+EI  LK   H
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 74  P-NVVRLHEVLASKS------KIYMVLEYVTGGELFDKIA-SKGR-LQEAEGRKLFQQLI 124
             N+   +     K+      ++++V+E+   G + D I  +KG  L+E     + ++++
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+S+ H   V HRD+K +N+LL     +K+ DFG+SA  Q  R  G  +T  G+P ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 197
Query: 185 PEVLANRGYDGAT----SDIWSCGVILYVILTGYLPFDD 219
           PEV+A      AT    SD+WS G+    +  G  P  D
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 236

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R +G G+FG V FA+D+ +    A+K +  +     +    I +E+  L+ L+HPN ++ 
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                 +   ++V+EY  G         K  LQE E   +    + G++Y H+  + HRD
Sbjct: 120 RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 179
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGA 196
           +K  NILL   G +K+ DFG +++          +   G+P ++APEV+   + G YDG 
Sbjct: 180 VKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEGQYDGK 233
Query: 197 TSDIWSCGVILYVILTGYLP-FDDRNLAVLYQ 227
             D+WS G+    +     P F+   ++ LY 
Sbjct: 234 V-DVWSLGITCIELAERKPPLFNMNAMSALYH 264

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/202 (32%), Positives = 106/202 (52%), Gaps = 14/202 (6%)
Query: 20  RTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + LG+GNFG V+       QD ++G   AVK L+ +   HL+     +REI  LK L+H 
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQD-NTGEVVAVKKLQHSTEEHLR---DFEREIEILKSLQHD 72
Query: 75  NVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH 131
           N+V+   V   A +  + +++EY+  G L D +   K R+   +  +   Q+  G+ Y  
Sbjct: 73  NIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 132
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLAN 190
            K   HR+L   NIL++++  +KI DFGL+ +    ++   +     SP  + APE L  
Sbjct: 133 TKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE 192
Query: 191 RGYDGATSDIWSCGVILYVILT 212
             +  A SD+WS GV+LY + T
Sbjct: 193 SKFSVA-SDVWSFGVVLYELFT 213

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 60/214 (28%), Positives = 110/214 (51%), Gaps = 14/214 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 76
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  + AS+ + +  +   + +Q   G+ Y
Sbjct: 77  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H K + HRDLK  NI L     +KI DFGL+     +          GS  ++APEV+ 
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 190 NRGYDGAT--SDIWSCGVILYVILTGYLPFDDRN 221
            +  +  +  SD+++ G++LY ++TG LP+ + N
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 18/202 (8%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
           R +G G +G V  A D       AVK L +    +IH + T    RE+  LK LKH NV+
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRT---YRELRLLKHLKHENVI 90
Query: 78  RLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            L +V          S++Y+V   + G +L + + S+  L +   + L  QL+ G+ Y H
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTT-LMGADLNNIVKSQA-LSDEHVQFLVYQLLRGLKYIH 148
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + G+ HRDLK  N+ ++    ++I DFGL+      + D  +     +  Y APE++ N 
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNW 203
Query: 192 GYDGATSDIWSCGVILYVILTG 213
            +   T DIWS G I+  +L G
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQG 225

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 104/212 (49%), Gaps = 11/212 (5%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           R +G G+FG V FA+D+ +    A+K +  +     +    I +E+  L+ L+HPN ++ 
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
                 +   ++V+EY  G         K  LQE E   +    + G++Y H+  + HRD
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL--ANRG-YDGA 196
           +K  NILL   G +K+ DFG +++          +   G+P ++APEV+   + G YDG 
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIM------APANXFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 197 TSDIWSCGVILYVILTGYLP-FDDRNLAVLYQ 227
             D+WS G+    +     P F+   ++ LY 
Sbjct: 195 V-DVWSLGITCIELAERKPPLFNMNAMSALYH 225

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 114/224 (50%), Gaps = 10/224 (4%)
Query: 22  LGEGNFGKVKFAQ-DLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FG V+  + D  SG  +  AVK L+ + +   +  D   RE+  +  L H N++R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           L+ V+ +   + MV E    G L D++   +G        +   Q+ +G+ Y  +K   H
Sbjct: 86  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 138 RDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDG 195
           RDL   N+LL ++  +KI DFGL  ALPQ+  D  ++      P  + APE L  R +  
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHXVMQEHRKVPFAWCAPESLKTRTFSH 203
Query: 196 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           A SD W  GV L+ + T G  P+   N + +  KI +   +LP+
Sbjct: 204 A-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 130/260 (50%), Gaps = 18/260 (6%)
Query: 11  MRLGRYE--LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           M L R E  L + LG G FG VK  +        AVK++++  +      D+  +E  T+
Sbjct: 3   MELKREEITLLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSE----DEFFQEAQTM 57
Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGV 127
             L HP +V+ + V + +  IY+V EY++ G L + + S G+ L+ ++  ++   + +G+
Sbjct: 58  MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVA 184
           ++  +    HRDL   N L+D    +K+SDFG++   ++  DD  + ++ G+     + A
Sbjct: 118 AFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT---RYVLDDQYV-SSVGTKFPVKWSA 173
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSP 242
           PEV     Y  + SD+W+ G++++ + + G +P+D    + +  K+ +G     P   S 
Sbjct: 174 PEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASD 232
Query: 243 GAQNLLRKILEPNPVKRITI 262
               ++       P KR T 
Sbjct: 233 TIYQIMYSCWHELPEKRPTF 252

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 70/210 (33%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIAT 67
            M   RYE    +G G +G V  A+D  SG   A+K +             I   RE+A 
Sbjct: 5   SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVAL 64
Query: 68  LKLLK---HPNVVRLHEVLASKS-----KIYMVLEYVTGG--ELFDKIASKGRLQEAEGR 117
           L+ L+   HPNVVRL +V A+       K+ +V E+V        DK    G L     +
Sbjct: 65  LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIK 123
Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
            L +Q + G+ + H   + HRDLK ENIL+ S G +K++DFGL+ +   +     L    
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALTPVV 180
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
            +  Y APEVL    Y     D+WS G I 
Sbjct: 181 VTLWYRAPEVLLQSTY-ATPVDMWSVGCIF 209

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 114/224 (50%), Gaps = 10/224 (4%)
Query: 22  LGEGNFGKVKFAQ-DLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FG V+  + D  SG  +  AVK L+ + +   +  D   RE+  +  L H N++R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           L+ V+ +   + MV E    G L D++   +G        +   Q+ +G+ Y  +K   H
Sbjct: 76  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 138 RDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDG 195
           RDL   N+LL ++  +KI DFGL  ALPQ+  D  ++      P  + APE L  R +  
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHXVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 196 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           A SD W  GV L+ + T G  P+   N + +  KI +   +LP+
Sbjct: 194 A-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 88/311 (28%), Positives = 139/311 (44%), Gaps = 47/311 (15%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY   + +GEG +G V  A D       A+K +      H     +  REI  L   +H 
Sbjct: 44  RYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFE--HQTYCQRTLREIQILLRFRHE 101
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           NV+ + ++L + +      +Y+V + +   +L+ K+    +L          Q++ G+ Y
Sbjct: 102 NVIGIRDILRASTLEAMRDVYIVQD-LMETDLY-KLLKSQQLSNDHICYFLYQILRGLKY 159
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEV 187
            H+  V HRDLK  N+L+++  ++KI DFGL+ +  P+H    G L     +  Y APE+
Sbjct: 160 IHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEH-DHTGFLTEXVATRWYRAPEI 218
Query: 188 LAN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL------------- 225
           + N +GY  +  DIWS G IL  +L+         YL   +  L +L             
Sbjct: 219 MLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 226 -----YQKIFRGDFKL------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
                Y +      K+      PK  S  A +LL ++L  NP KRIT+    A  + EQ 
Sbjct: 278 MKARNYLQSLPSKTKVAWAKLFPKSDS-KALDLLDRMLTFNPNKRITVEEALAHPYLEQY 336
Query: 275 YTPANPDDDEE 285
           Y P +    EE
Sbjct: 337 YDPTDEPVAEE 347

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 114/224 (50%), Gaps = 10/224 (4%)
Query: 22  LGEGNFGKVKFAQ-DLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FG V+  + D  SG  +  AVK L+ + +   +  D   RE+  +  L H N++R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           L+ V+ +   + MV E    G L D++   +G        +   Q+ +G+ Y  +K   H
Sbjct: 80  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 138 RDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDG 195
           RDL   N+LL ++  +KI DFGL  ALPQ+  D  ++      P  + APE L  R +  
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESLKTRTFSH 197
Query: 196 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           A SD W  GV L+ + T G  P+   N + +  KI +   +LP+
Sbjct: 198 A-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 240

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLK 69
           M   RYE    +G G +G V  A+D  SG   A+K +   N    L I+    RE+A L+
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIS--TVREVALLR 58
Query: 70  LLK---HPNVVRLHEVLASKS-----KIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKL 119
            L+   HPNVVRL +V A+       K+ +V E+V        DK    G L     + L
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDL 117
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
            +Q + G+ + H   + HRDLK ENIL+ S G +K++DFGL+ +   +     L     +
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALDPVVVT 174
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVIL 207
             Y APEVL    Y     D+WS G I 
Sbjct: 175 LWYRAPEVLLQSTY-ATPVDMWSVGCIF 201

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 114/224 (50%), Gaps = 10/224 (4%)
Query: 22  LGEGNFGKVKFAQ-DLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FG V+  + D  SG  +  AVK L+ + +   +  D   RE+  +  L H N++R
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           L+ V+ +   + MV E    G L D++   +G        +   Q+ +G+ Y  +K   H
Sbjct: 86  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 144
Query: 138 RDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDG 195
           RDL   N+LL ++  +KI DFGL  ALPQ+  D  ++      P  + APE L  R +  
Sbjct: 145 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESLKTRTFSH 203
Query: 196 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           A SD W  GV L+ + T G  P+   N + +  KI +   +LP+
Sbjct: 204 A-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLK 69
           M   RYE    +G G +G V  A+D  SG   A+K +   N    L I+    RE+A L+
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIS--TVREVALLR 58
Query: 70  LLK---HPNVVRLHEVLASKS-----KIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKL 119
            L+   HPNVVRL +V A+       K+ +V E+V        DK    G L     + L
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDL 117
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
            +Q + G+ + H   + HRDLK ENIL+ S G +K++DFGL+ +   +     L     +
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALAPVVVT 174
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVIL 207
             Y APEVL    Y     D+WS G I 
Sbjct: 175 LWYRAPEVLLQSTY-ATPVDMWSVGCIF 201

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 122/260 (46%), Gaps = 11/260 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 39  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 98
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 99  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 157
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 158 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 214
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 248
           R +  A SD+W  GV ++ IL  G  PF       +  +I  G+   +P    P   +L+
Sbjct: 215 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 273
Query: 249 RKILEPNPVKRITIAGIKAD 268
            K    +P +R     +KA 
Sbjct: 274 TKCWAYDPSRRPRFTELKAQ 293

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 122/259 (47%), Gaps = 11/259 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 68  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 183
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 248
           R +  A SD+W  GV ++ IL  G  PF       +  +I  G+   +P    P   +L+
Sbjct: 184 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 242
Query: 249 RKILEPNPVKRITIAGIKA 267
            K    +P +R     +KA
Sbjct: 243 TKCWAYDPSRRPRFTELKA 261

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 72/208 (34%), Positives = 101/208 (48%), Gaps = 18/208 (8%)
Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE-KNRIIHLKITDQIKREIATLK 69
           M   RYE    +G G +G V  A+D  SG   A+K +   N    L I+    RE+A L+
Sbjct: 1   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPIS--TVREVALLR 58
Query: 70  LLK---HPNVVRLHEVLASKS-----KIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKL 119
            L+   HPNVVRL +V A+       K+ +V E+V        DK    G L     + L
Sbjct: 59  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDL 117
Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
            +Q + G+ + H   + HRDLK ENIL+ S G +K++DFGL+ +   +     L     +
Sbjct: 118 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARI---YSYQMALFPVVVT 174
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVIL 207
             Y APEVL    Y     D+WS G I 
Sbjct: 175 LWYRAPEVLLQSTY-ATPVDMWSVGCIF 201

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 122/260 (46%), Gaps = 11/260 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 71  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 248
           R +  A SD+W  GV ++ IL  G  PF       +  +I  G+   +P    P   +L+
Sbjct: 187 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 245
Query: 249 RKILEPNPVKRITIAGIKAD 268
            K    +P +R     +KA 
Sbjct: 246 TKCWAYDPSRRPRFTELKAQ 265

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 122/260 (46%), Gaps = 11/260 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 16  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 75
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 76  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 134
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 191
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 248
           R +  A SD+W  GV ++ IL  G  PF       +  +I  G+   +P    P   +L+
Sbjct: 192 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 250
Query: 249 RKILEPNPVKRITIAGIKAD 268
            K    +P +R     +KA 
Sbjct: 251 TKCWAYDPSRRPRFTELKAQ 270

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 122/260 (46%), Gaps = 11/260 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 71  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 129
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 248
           R +  A SD+W  GV ++ IL  G  PF       +  +I  G+   +P    P   +L+
Sbjct: 187 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 245
Query: 249 RKILEPNPVKRITIAGIKAD 268
            K    +P +R     +KA 
Sbjct: 246 TKCWAYDPSRRPRFTELKAQ 265

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 122/260 (46%), Gaps = 11/260 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 14  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 73
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 74  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 132
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 189
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 248
           R +  A SD+W  GV ++ IL  G  PF       +  +I  G+   +P    P   +L+
Sbjct: 190 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 248
Query: 249 RKILEPNPVKRITIAGIKAD 268
            K    +P +R     +KA 
Sbjct: 249 TKCWAYDPSRRPRFTELKAQ 268

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 114/224 (50%), Gaps = 10/224 (4%)
Query: 22  LGEGNFGKVKFAQ-DLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FG V+  + D  SG  +  AVK L+ + +   +  D   RE+  +  L H N++R
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           L+ V+ +   + MV E    G L D++   +G        +   Q+ +G+ Y  +K   H
Sbjct: 80  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 138
Query: 138 RDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDG 195
           RDL   N+LL ++  +KI DFGL  ALPQ+  D  ++      P  + APE L  R +  
Sbjct: 139 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESLKTRTFSH 197
Query: 196 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           A SD W  GV L+ + T G  P+   N + +  KI +   +LP+
Sbjct: 198 A-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 240

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 87.4 bits (215), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 122/260 (46%), Gaps = 11/260 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 13  RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 72
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 73  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 131
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 188
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 248
           R +  A SD+W  GV ++ IL  G  PF       +  +I  G+   +P    P   +L+
Sbjct: 189 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 247
Query: 249 RKILEPNPVKRITIAGIKAD 268
            K    +P +R     +KA 
Sbjct: 248 TKCWAYDPSRRPRFTELKAQ 267

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 114/224 (50%), Gaps = 10/224 (4%)
Query: 22  LGEGNFGKVKFAQ-DLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FG V+  + D  SG  +  AVK L+ + +   +  D   RE+  +  L H N++R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           L+ V+ +   + MV E    G L D++   +G        +   Q+ +G+ Y  +K   H
Sbjct: 76  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 138 RDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDG 195
           RDL   N+LL ++  +KI DFGL  ALPQ+  D  ++      P  + APE L  R +  
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 196 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           A SD W  GV L+ + T G  P+   N + +  KI +   +LP+
Sbjct: 194 A-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 72/224 (32%), Positives = 114/224 (50%), Gaps = 10/224 (4%)
Query: 22  LGEGNFGKVKFAQ-DLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           LG+G+FG V+  + D  SG  +  AVK L+ + +   +  D   RE+  +  L H N++R
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           L+ V+ +   + MV E    G L D++   +G        +   Q+ +G+ Y  +K   H
Sbjct: 76  LYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIH 134
Query: 138 RDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDG 195
           RDL   N+LL ++  +KI DFGL  ALPQ+  D  ++      P  + APE L  R +  
Sbjct: 135 RDLAARNLLLATRDLVKIGDFGLMRALPQN-DDHYVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 196 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           A SD W  GV L+ + T G  P+   N + +  KI +   +LP+
Sbjct: 194 A-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 236

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 27/233 (11%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V      ++    AVK L+   +           E   +K L+H  +
Sbjct: 16  KLVKRLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKL 70
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSY 129
           VRL+ V+  +  IY++ EY+  G L D + S     +  G+ L  +LID       G++Y
Sbjct: 71  VRLYAVVTREEPIYIITEYMAKGSLLDFLKS-----DEGGKVLLPKLIDFSAQIAEGMAY 125
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPE 186
              K   HRDL+  N+L+      KI+DFGL+ + +    D       G+     + APE
Sbjct: 126 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIE----DNEYTAREGAKFPIKWTAPE 181
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
            + N G     SD+WS G++LY I+T G +P+  R  A +   + +G +++P+
Sbjct: 182 AI-NFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTALSQG-YRMPR 232

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 122/260 (46%), Gaps = 11/260 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 71  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTXXKASKGKLPIKWMAPESINF 186
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 248
           R +  A SD+W  GV ++ IL  G  PF       +  +I  G+   +P    P   +L+
Sbjct: 187 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 245
Query: 249 RKILEPNPVKRITIAGIKAD 268
            K    +P +R     +KA 
Sbjct: 246 TKCWAYDPSRRPRFTELKAQ 265

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 109/214 (50%), Gaps = 14/214 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 24  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 76
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++  ++ +V ++  G  L+  + AS+ + +  +   + +Q   G+ Y
Sbjct: 77  TRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY 135
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H K + HRDLK  NI L     +KI DFGL+     +          GS  ++APEV+ 
Sbjct: 136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 195
Query: 190 NRGYDGAT--SDIWSCGVILYVILTGYLPFDDRN 221
            +  +  +  SD+++ G++LY ++TG LP+ + N
Sbjct: 196 MQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
           R +G G +G V  A D       AVK L +    +IH + T    RE+  LK LKH NV+
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRT---YRELRLLKHLKHENVI 90
Query: 78  RLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            L +V          S++Y+V   + G +L + +  +  L +   + L  QL+ G+ Y H
Sbjct: 91  GLLDVFTPATSIEDFSEVYLVTT-LMGADLNNIVKCQA-LSDEHVQFLVYQLLRGLKYIH 148
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + G+ HRDLK  N+ ++    ++I DFGL+      + D  +     +  Y APE++ N 
Sbjct: 149 SAGIIHRDLKPSNVAVNEDSELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNW 203
Query: 192 GYDGATSDIWSCGVILYVILTG 213
            +   T DIWS G I+  +L G
Sbjct: 204 MHYNQTVDIWSVGCIMAELLQG 225

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 122/259 (47%), Gaps = 11/259 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 248
           R +  A SD+W  GV ++ IL  G  PF       +  +I  G+   +P    P   +L+
Sbjct: 567 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 625
Query: 249 RKILEPNPVKRITIAGIKA 267
            K    +P +R     +KA
Sbjct: 626 TKCWAYDPSRRPRFTELKA 644

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 18/202 (8%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKHPNVV 77
           R +G G +G V  A D       AVK L +    +IH + T    RE+  LK LKH NV+
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRT---YRELRLLKHLKHENVI 82
Query: 78  RLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            L +V          S++Y+V   + G +L + +  +  L +   + L  QL+ G+ Y H
Sbjct: 83  GLLDVFTPATSIEDFSEVYLVTT-LMGADLNNIVKCQA-LSDEHVQFLVYQLLRGLKYIH 140
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + G+ HRDLK  N+ ++    ++I DFGL+      + D  +     +  Y APE++ N 
Sbjct: 141 SAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADEEMTGYVATRWYRAPEIMLNW 195
Query: 192 GYDGATSDIWSCGVILYVILTG 213
            +   T DIWS G I+  +L G
Sbjct: 196 MHYNQTVDIWSVGCIMAELLQG 217

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 71/223 (31%), Positives = 102/223 (45%), Gaps = 30/223 (13%)
Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLK 69
           R  RYE    LGEG F  V  A+D ++    A+K ++       K  I     REI  L+
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ 67
Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
            L HPN++ L +    KS I +V +++ T  E+  K  S   L  +  +      + G+ 
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL-VLTPSHIKAYMLMTLQGLE 126
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 181
           Y H   + HRDLK  N+LLD  G +K++DFGL+              + GSPN       
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-------------KSFGSPNRAYXHQV 173
Query: 182 ----YVAPEVLANRGYDGATSDIWSCGVILYVIL--TGYLPFD 218
               Y APE+L      G   D+W+ G IL  +L    +LP D
Sbjct: 174 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 216

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 25/210 (11%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHP 74
           G  LG+G FG+       ++G    +K L       ++  ++ +R    E+  ++ L+HP
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKEL-------IRFDEETQRTFLKEVKVMRCLEHP 67
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYCHNK 133
           NV++   VL    ++  + EY+ GG L   I S         R  F + +  G++Y H+ 
Sbjct: 68  NVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSM 127
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSAL-------PQHFR-----DDGLLHTTCGSPN 181
            + HRDL   N L+    N+ ++DFGL+ L       P+  R     D    +T  G+P 
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVIL 211
           ++APE++  R YD    D++S G++L  I+
Sbjct: 188 WMAPEMINGRSYDEKV-DVFSFGIVLCEII 216

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 102/215 (47%), Gaps = 32/215 (14%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
            LG+G FG+V  A++      +A+K   K R    K++  I  E+  L  L H  VVR +
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIK---KIRHTEEKLS-TILSEVXLLASLNHQYVVRYY 68
Query: 81  -------------EVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDG 126
                          +  KS +++  EY     L+D I S+    Q  E  +LF+Q+++ 
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEA 128
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL-------------L 173
           +SY H++G+ HR+LK  NI +D   N+KI DFGL A   H   D L             L
Sbjct: 129 LSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGL-AKNVHRSLDILKLDSQNLPGSSDNL 187
Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY 208
            +  G+  YVA EVL   G+     D +S G+I +
Sbjct: 188 TSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFF 222

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 122/260 (46%), Gaps = 11/260 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 11  RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 70
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 71  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 129
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ +   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 186
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 248
           R +  A SD+W  GV ++ IL  G  PF       +  +I  G+   +P    P   +L+
Sbjct: 187 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 245
Query: 249 RKILEPNPVKRITIAGIKAD 268
            K    +P +R     +KA 
Sbjct: 246 TKCWAYDPSRRPRFTELKAQ 265

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 99/217 (45%), Gaps = 20/217 (9%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           G +E+   LG G FG V      D+G   A+K   +   +  K  ++   EI  +K L H
Sbjct: 15  GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNH 72
Query: 74  PNVVRLHEV------LASKSKIYMVLEYVTGGEL---FDKIASKGRLQEAEGRKLFQQLI 124
           PNVV   EV      LA      + +EY  GG+L    ++  +   L+E   R L   + 
Sbjct: 73  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 132
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNI---KISDFGLSALPQHFRDDGLLHTT-CGSP 180
             + Y H   + HRDLK ENI+L         KI D G +       D G L T   G+ 
Sbjct: 133 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK----ELDQGELCTEFVGTL 188
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
            Y+APE+L  + Y   T D WS G + +  +TG+ PF
Sbjct: 189 QYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPF 224

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 99/217 (45%), Gaps = 20/217 (9%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           G +E+   LG G FG V      D+G   A+K   +   +  K  ++   EI  +K L H
Sbjct: 14  GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNH 71
Query: 74  PNVVRLHEV------LASKSKIYMVLEYVTGGEL---FDKIASKGRLQEAEGRKLFQQLI 124
           PNVV   EV      LA      + +EY  GG+L    ++  +   L+E   R L   + 
Sbjct: 72  PNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNI---KISDFGLSALPQHFRDDGLLHTT-CGSP 180
             + Y H   + HRDLK ENI+L         KI D G +       D G L T   G+ 
Sbjct: 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK----ELDQGELCTEFVGTL 187
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
            Y+APE+L  + Y   T D WS G + +  +TG+ PF
Sbjct: 188 QYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPF 223

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 70/259 (27%), Positives = 122/259 (47%), Gaps = 11/259 (4%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 450
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +    +     L+  QL   ++Y  +
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLAN 190
           K   HRD+   N+L+ +   +K+ DFGLS   ++  D      + G     ++APE +  
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 566
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 248
           R +  A SD+W  GV ++ IL  G  PF       +  +I  G+   +P    P   +L+
Sbjct: 567 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 625
Query: 249 RKILEPNPVKRITIAGIKA 267
            K    +P +R     +KA
Sbjct: 626 TKCWAYDPSRRPRFTELKA 644

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 6/205 (2%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           G  +GEG FG V +   +++      K+     I   ++  Q  +EI  +   +H N+V 
Sbjct: 36  GNKMGEGGFGVV-YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           L    +    + +V  Y+  G L D+++       L      K+ Q   +G+++ H    
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K  NILLD     KISDFGL+   + F    +     G+  Y+APE L  RG   
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEAL--RGEIT 212
Query: 196 ATSDIWSCGVILYVILTGYLPFDDR 220
             SDI+S GV+L  I+TG    D+ 
Sbjct: 213 PKSDIYSFGVVLLEIITGLPAVDEH 237

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 6/205 (2%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           G  +GEG FG V +   +++      K+     I   ++  Q  +EI  +   +H N+V 
Sbjct: 36  GNKMGEGGFGVV-YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           L    +    + +V  Y+  G L D+++       L      K+ Q   +G+++ H    
Sbjct: 95  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K  NILLD     KISDFGL+   + F    +     G+  Y+APE L  RG   
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEAL--RGEIT 212
Query: 196 ATSDIWSCGVILYVILTGYLPFDDR 220
             SDI+S GV+L  I+TG    D+ 
Sbjct: 213 PKSDIYSFGVVLLEIITGLPAVDEH 237

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 85
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLXEXVATRWYRAPEIM 203
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 204 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 263 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 276 TPAN 279
            P++
Sbjct: 322 DPSD 325

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 86
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 145
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 146 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLXEXVATRWYRAPEIM 204
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 205 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 263
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 264 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 322
Query: 276 TPAN 279
            P++
Sbjct: 323 DPSD 326

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 83
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 143 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 201
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 202 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 260
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 261 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 319
Query: 276 TPAN 279
            P++
Sbjct: 320 DPSD 323

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 96/205 (46%), Gaps = 6/205 (2%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           G  +GEG FG V +   +++      K+     I   ++  Q  +EI  +   +H N+V 
Sbjct: 30  GNKMGEGGFGVV-YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVE 88
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           L    +    + +V  Y+  G L D+++       L      K+ Q   +G+++ H    
Sbjct: 89  LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 148
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K  NILLD     KISDFGL+   + F    +     G+  Y+APE L  RG   
Sbjct: 149 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEAL--RGEIT 206
Query: 196 ATSDIWSCGVILYVILTGYLPFDDR 220
             SDI+S GV+L  I+TG    D+ 
Sbjct: 207 PKSDIYSFGVVLLEIITGLPAVDEH 231

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 32  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 89
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 90  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 148
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 149 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 207
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 208 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 266
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 267 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 325
Query: 276 TPAN 279
            P++
Sbjct: 326 DPSD 329

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 81
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 141 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 199
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 200 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 258
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 259 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 276 TPAN 279
            P++
Sbjct: 318 DPSD 321

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 81
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 141 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 199
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 200 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 258
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 259 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 276 TPAN 279
            P++
Sbjct: 318 DPSD 321

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 60
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 61  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV  
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
           + ++      SD+++ G++LY ++TG LP+ + N
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 13  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 65
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 66  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 124
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV  
Sbjct: 125 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
           + ++      SD+++ G++LY ++TG LP+ + N
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 13  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 65
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 66  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 124
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV  
Sbjct: 125 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 184
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
           + ++      SD+++ G++LY ++TG LP+ + N
Sbjct: 185 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 218

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 79
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 138
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 139 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 197
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 198 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 256
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 257 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 315
Query: 276 TPAN 279
            P++
Sbjct: 316 DPSD 319

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 81
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 199
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 200 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 258
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 259 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 276 TPAN 279
            P++
Sbjct: 318 DPSD 321

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 29  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 86
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 87  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 145
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 146 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 204
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 205 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 263
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 264 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 322
Query: 276 TPAN 279
            P++
Sbjct: 323 DPSD 326

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 22  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 79
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 80  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 138
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 139 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 197
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 198 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINL 256
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 257 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 315
Query: 276 TPAN 279
            P++
Sbjct: 316 DPSD 319

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 30  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 87
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 88  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 146
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 147 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 205
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 206 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 264
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 265 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 323
Query: 276 TPAN 279
            P++
Sbjct: 324 DPSD 327

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 21  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 78
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 79  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 137
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 138 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 196
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 197 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 255
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 256 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 314
Query: 276 TPAN 279
            P++
Sbjct: 315 DPSD 318

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 44  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 101
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 102 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 160
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 161 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 219
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 220 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 278
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 279 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 337
Query: 276 TPAN 279
            P++
Sbjct: 338 DPSD 341

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 85
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 203
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 204 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 263 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 276 TPAN 279
            P++
Sbjct: 322 DPSD 325

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 81
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 199
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 200 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINL 258
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 259 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 276 TPAN 279
            P++
Sbjct: 318 DPSD 321

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 10  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 62
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 63  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 121
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV  
Sbjct: 122 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 181
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
           + ++      SD+++ G++LY ++TG LP+ + N
Sbjct: 182 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 215

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 24  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 81
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 82  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 140
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 141 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 199
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 200 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINL 258
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 259 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 317
Query: 276 TPAN 279
            P++
Sbjct: 318 DPSD 321

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 35  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 87
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 88  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 146
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV  
Sbjct: 147 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 206
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
           + ++      SD+++ G++LY ++TG LP+ + N
Sbjct: 207 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 240

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 85
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 145 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 203
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 204 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 263 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 276 TPAN 279
            P++
Sbjct: 322 DPSD 325

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 66/231 (28%), Positives = 114/231 (49%), Gaps = 23/231 (9%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V      ++    AVK L+   +           E   +K L+H  +
Sbjct: 15  KLVKKLGAGQFGEVWMGY-YNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKL 69
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVSY 129
           VRL+ V+  +  IY++ E++  G L D + S     +  G+ L  +LID       G++Y
Sbjct: 70  VRLYAVVTKEEPIYIITEFMAKGSLLDFLKS-----DEGGKVLLPKLIDFSAQIAEGMAY 124
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVL 188
              K   HRDL+  N+L+      KI+DFGL+ + +   ++         P  + APE +
Sbjct: 125 IERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED--NEYTAREGAKFPIKWTAPEAI 182
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
            N G     S++WS G++LY I+T G +P+  R  A +   + +G +++P+
Sbjct: 183 -NFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSALSQG-YRMPR 231

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 108/214 (50%), Gaps = 14/214 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 88
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 89  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 147
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV  
Sbjct: 148 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
           + ++      SD+++ G++LY ++TG LP+ + N
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 84.3 bits (207), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYXQRTLREIKILLRFRHE 85
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 145 HSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 203
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 204 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 263 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 276 TPAN 279
            P++
Sbjct: 322 DPSD 325

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/304 (28%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHE 85
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKCQHLSNDHICYFLYQILRGLKYI 144
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 203
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 204 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 263 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 276 TPAN 279
            P++
Sbjct: 322 DPSD 325

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 131/301 (43%), Gaps = 54/301 (17%)
Query: 16  YELGRT------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-TDQIKREIATL 68
           +EL +T      +G G +G V  A D  SG   A+K L  +R    +I   +  RE+  L
Sbjct: 38  WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLL 95
Query: 69  KLLKHPNVVRLHEVLASKSKI------YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           K ++H NV+ L +V    S +      Y+V+ ++       KI       E + + L  Q
Sbjct: 96  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGM-EFSEEKIQYLVYQ 152
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           ++ G+ Y H+ GV HRDLK  N+ ++    +KI DFGL+        D  +     +  Y
Sbjct: 153 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWY 207
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF------------ 230
            APEV+ +  +   T DIWS G I+  +LTG   F  ++      +I             
Sbjct: 208 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 267
Query: 231 ------------------RGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
                             R DF +L    SP A +LL K+LE +  KR+T A      +F
Sbjct: 268 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 327
Query: 272 E 272
           E
Sbjct: 328 E 328

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 136/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A++ +      H     +  REI  L   +H 
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFE--HQTYCQRTLREIKILLRFRHE 85
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 86  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 144
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 203
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 204 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  + EQ Y
Sbjct: 263 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
Query: 276 TPAN 279
            P++
Sbjct: 322 DPSD 325

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 132/301 (43%), Gaps = 54/301 (17%)
Query: 16  YELGRT------LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI-TDQIKREIATL 68
           +EL +T      +G G +G V  A D  SG   A+K L  +R    +I   +  RE+  L
Sbjct: 20  WELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKL--SRPFQSEIFAKRAYRELLLL 77
Query: 69  KLLKHPNVVRLHEVLASKSKI------YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           K ++H NV+ L +V    S +      Y+V+ ++       KI    +  E + + L  Q
Sbjct: 78  KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTD--LQKIMGL-KFSEEKIQYLVYQ 134
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           ++ G+ Y H+ GV HRDLK  N+ ++    +KI DFGL+        D  +     +  Y
Sbjct: 135 MLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWY 189
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF------------ 230
            APEV+ +  +   T DIWS G I+  +LTG   F  ++      +I             
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQ 249
Query: 231 ------------------RGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
                             R DF +L    SP A +LL K+LE +  KR+T A      +F
Sbjct: 250 KLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309
Query: 272 E 272
           E
Sbjct: 310 E 310

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 135/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLAFRHE 83
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 143 HSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 201
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 202 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINL 260
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  +  Q Y
Sbjct: 261 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYY 319
Query: 276 TPAN 279
            P++
Sbjct: 320 DPSD 323

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 83.6 bits (205), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 20  RTLGEGNFGKVKF----AQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           R LGEG+FGKV        +  +G   AVK L+ +     +     K+EI  L+ L H +
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHR--SGWKQEIDILRTLYHEH 94
Query: 76  VVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +++       A  + + +V+EYV  G L D +  +  +  A+     QQ+ +G++Y H +
Sbjct: 95  IIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYLHAQ 153
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPN-YVAPE 186
              HRDL   N+LLD+   +KI DFGL+ A+P+       R+DG       SP  + APE
Sbjct: 154 HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDG------DSPVFWYAPE 207
Query: 187 VLANRGYDGATSDIWSCGVILYVILT 212
            L    +  A SD+WS GV LY +LT
Sbjct: 208 CLKEYKFYYA-SDVWSFGVTLYELLT 232

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 60
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 61  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+     +          GS  ++APEV  
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
           + ++      SD+++ G++LY ++TG LP+ + N
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 85/304 (27%), Positives = 135/304 (44%), Gaps = 45/304 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H 
Sbjct: 26  RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLAFRHE 83
Query: 75  NVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           N++ +++++ + +    K   +++ +   +L+ K+     L          Q++ G+ Y 
Sbjct: 84  NIIGINDIIRAPTIEQMKDVYIVQDLMETDLY-KLLKTQHLSNDHICYFLYQILRGLKYI 142
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           H+  V HRDLK  N+LL++  ++KI DFGL+  A P H    G L     +  Y APE++
Sbjct: 143 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTGFLTEYVATRWYRAPEIM 201
Query: 189 AN-RGYDGATSDIWSCGVILYVILTG--------YLPFDDRNLAVL-------------- 225
            N +GY  +  DIWS G IL  +L+         YL   +  L +L              
Sbjct: 202 LNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 260
Query: 226 ----YQKIFRGDFKLPKW--LSPGAQ----NLLRKILEPNPVKRITIAGIKADEWFEQDY 275
               Y        K+P W  L P A     +LL K+L  NP KRI +    A  +  Q Y
Sbjct: 261 KARNYLLSLPHKNKVP-WNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYY 319
Query: 276 TPAN 279
            P++
Sbjct: 320 DPSD 323

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 28/217 (12%)
Query: 18  LGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITD-------QIKREIAT 67
           L   +G G+FG V   K+  D+      AVKIL        K+ D         + E+A 
Sbjct: 40  LSTRIGSGSFGTVYKGKWHGDV------AVKIL--------KVVDPTPEQFQAFRNEVAV 85
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDG 126
           L+  +H N++ L     +K  + +V ++  G  L+  +   + + Q  +   + +Q   G
Sbjct: 86  LRKTRHVNIL-LFMGYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQG 144
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H K + HRD+K  NI L     +KI DFGL+ +   +     +    GS  ++APE
Sbjct: 145 MDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPE 204
Query: 187 VLANRGYD--GATSDIWSCGVILYVILTGYLPFDDRN 221
           V+  +  +     SD++S G++LY ++TG LP+   N
Sbjct: 205 VIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 241

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 57/214 (26%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 60
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++  ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 61  TRHVNIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 119
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV  
Sbjct: 120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
           + ++      SD+++ G++LY ++TG LP+ + N
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/261 (27%), Positives = 123/261 (47%), Gaps = 20/261 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           L   +G G FGKV  A  +   +       + +  I   I + +++E     +LKHPN++
Sbjct: 11  LEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTI-ENVRQEAKLFAMLKHPNII 69
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--- 134
            L  V   +  + +V+E+  GG L +++ S  R+          Q+  G++Y H++    
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 135 VFHRDLKLENILLDSKGN--------IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + HRDLK  NIL+  K          +KI+DFGL+   +  R   +  +  G+  ++APE
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR--EWHRTTKM--SAAGAYAWMAPE 184
Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLY-QKIFRGDFKLPKWLSPGA 244
           V+    +    SD+WS GV+L+ +LTG +PF   + LAV Y   + +    +P       
Sbjct: 185 VIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPEPF 243
Query: 245 QNLLRKILEPNPVKRITIAGI 265
             L+     P+P  R +   I
Sbjct: 244 AKLMEDCWNPDPHSRPSFTNI 264

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 28  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 80
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 81  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 139
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+     +          GS  ++APEV  
Sbjct: 140 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 199
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
           + ++      SD+++ G++LY ++TG LP+ + N
Sbjct: 200 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 233

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 107/214 (50%), Gaps = 14/214 (6%)
Query: 14  GRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           G+  +G+ +G G+FG V   K+  D+      AVK+L        ++    K E+  L+ 
Sbjct: 36  GQITVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAPTPQQL-QAFKNEVGVLRK 88
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSY 129
            +H N++ L    ++K ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y
Sbjct: 89  TRHVNIL-LFMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY 147
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV-- 187
            H K + HRDLK  NI L     +KI DFGL+     +          GS  ++APEV  
Sbjct: 148 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIR 207
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
           + ++      SD+++ G++LY ++TG LP+ + N
Sbjct: 208 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 241

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 15  RYELGRTLGEGNFGKVKFAQD--LDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 86
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK----------------GR 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQ 146
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 204
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
               TT G     ++APE L +R Y    SD+WS GV+L+ I T
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFT 247

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 19/214 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLL 71
           + +YE    +G+G FG+V  A+   +G   A+K +L +N      IT    REI  L+LL
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT--ALREIKILQLL 74
Query: 72  KHPNVVRLHEVLASKSK--------IYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQ 121
           KH NVV L E+  +K+         IY+V ++       L   +  K  L E   +++ Q
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQ 132
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
            L++G+ Y H   + HRD+K  N+L+   G +K++DFGL+   +L ++ + +   +    
Sbjct: 133 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 191
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           +  Y  PE+L      G   D+W  G I+  + T
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 19/214 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLL 71
           + +YE    +G+G FG+V  A+   +G   A+K +L +N      IT    REI  L+LL
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT--ALREIKILQLL 74
Query: 72  KHPNVVRLHEVLASKSK--------IYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQ 121
           KH NVV L E+  +K+         IY+V ++       L   +  K  L E   +++ Q
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQ 132
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
            L++G+ Y H   + HRD+K  N+L+   G +K++DFGL+   +L ++ + +   +    
Sbjct: 133 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 191
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           +  Y  PE+L      G   D+W  G I+  + T
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 19/214 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLL 71
           + +YE    +G+G FG+V  A+   +G   A+K +L +N      IT    REI  L+LL
Sbjct: 16  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITAL--REIKILQLL 73
Query: 72  KHPNVVRLHEVLASKSK--------IYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQ 121
           KH NVV L E+  +K+         IY+V ++       L   +  K  L E   +++ Q
Sbjct: 74  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQ 131
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
            L++G+ Y H   + HRD+K  N+L+   G +K++DFGL+   +L ++ + +   +    
Sbjct: 132 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 190
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           +  Y  PE+L      G   D+W  G I+  + T
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 224

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 107/214 (50%), Gaps = 19/214 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLL 71
           + +YE    +G+G FG+V  A+   +G   A+K +L +N      IT    REI  L+LL
Sbjct: 17  VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPIT--ALREIKILQLL 74
Query: 72  KHPNVVRLHEVLASKSK--------IYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQ 121
           KH NVV L E+  +K+         IY+V ++       L   +  K  L E   +++ Q
Sbjct: 75  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEI--KRVMQ 132
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCG 178
            L++G+ Y H   + HRD+K  N+L+   G +K++DFGL+   +L ++ + +   +    
Sbjct: 133 MLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV- 191
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           +  Y  PE+L      G   D+W  G I+  + T
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWT 225

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 115/238 (48%), Gaps = 37/238 (15%)
Query: 20  RTLGEGNFGKV-KFAQDLDSG---LPFAVKIL-----EKNRIIHLKITDQIKREIATLKL 70
           + +G G FG+V K      SG   +P A+K L     EK R+  L        E   +  
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG-------EAGIMGQ 102
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
             H N++RL  V++    + ++ EY+  G L DK      L+E +G     QL+      
Sbjct: 103 FSHHNIIRLEGVISKYKPMMIITEYMENGAL-DKF-----LREKDGEFSVLQLVGMLRGI 156
Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--- 180
             G+ Y  N    HRDL   NIL++S    K+SDFGLS + +   D    +TT G     
Sbjct: 157 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED--DPEATYTTSGGKIPI 214
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
            + APE ++ R +  A SD+WS G++++ ++T G  P+ + +   + + I  G F+LP
Sbjct: 215 RWTAPEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLP 270

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 20  RTLGEGNFGKVKF----AQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           R LGEG+FGKV        +  +G   AVK L++     L+   Q  REI  L+ L H +
Sbjct: 15  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQ--REIEILRTLYHEH 72
Query: 76  VVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +V+       + +  + +V+EYV  G L D +  +  +  A+     QQ+ +G++Y H +
Sbjct: 73  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLP-RHCVGLAQLLLFAQQICEGMAYLHAQ 131
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPN-YVAPE 186
              HR L   N+LLD+   +KI DFGL+ A+P+       R+DG       SP  + APE
Sbjct: 132 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAPE 185
Query: 187 VLANRGYDGATSDIWSCGVILYVILT 212
            L    +  A SD+WS GV LY +LT
Sbjct: 186 CLKECKFYYA-SDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 71/206 (34%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 20  RTLGEGNFGKVKF----AQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           R LGEG+FGKV        +  +G   AVK L++     L+   Q  REI  L+ L H +
Sbjct: 14  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQ--REIEILRTLYHEH 71
Query: 76  VVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +V+       + +  + +V+EYV  G L D +  +  +  A+     QQ+ +G++Y H +
Sbjct: 72  IVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL-PRHCVGLAQLLLFAQQICEGMAYLHAQ 130
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPN-YVAPE 186
              HR L   N+LLD+   +KI DFGL+ A+P+       R+DG       SP  + APE
Sbjct: 131 HYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAPE 184
Query: 187 VLANRGYDGATSDIWSCGVILYVILT 212
            L    +  A SD+WS GV LY +LT
Sbjct: 185 CLKECKFYYA-SDVWSFGVTLYELLT 209

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 122/280 (43%), Gaps = 22/280 (7%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D   G+  AVK L +      H K   +  RE+  LK 
Sbjct: 23  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAK---RAYRELVLLKC 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIHME--LDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+   +    + ++     +  Y A
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTACTNFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PEV+   GY  A  DIWS G I+  ++ G + F   +    + K+               
Sbjct: 194 PEVILGMGY-AANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAAL 252
Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
           Q  +R  +E  P       GIK +E F     P+  + D+
Sbjct: 253 QPTVRNYVENRP----KYPGIKFEELFPDWIFPSESERDK 288

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 115/254 (45%), Gaps = 26/254 (10%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR--EIATLKLLKHPNVVRL 79
           LG G+FG+V   +D  +G   AVK          K+  ++ R  E+     L  P +V L
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVK----------KVRLEVFRAEELMACAGLTSPRIVPL 150
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           +  +     + + +E + GG L   +  +G L E        Q ++G+ Y H++ + H D
Sbjct: 151 YGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGD 210
Query: 140 LKLENILLDSKG-NIKISDFGLSALPQHFRDDGLLHTTC------GSPNYVAPEVLANRG 192
           +K +N+LL S G +  + DFG +      + DGL  +        G+  ++APEV+  R 
Sbjct: 211 VKADNVLLSSDGSHAALCDFGHAVC---LQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS 267
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLR 249
            D A  D+WS   ++  +L G  P+       L  KI        ++P   +P     ++
Sbjct: 268 CD-AKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQ 326
Query: 250 KILEPNPVKRITIA 263
           + L   P+ R++ A
Sbjct: 327 EGLRKEPIHRVSAA 340

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 15  RYELGRTLGEGNFGKVKFAQD--LDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 21  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 78
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK----------------GR 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 79  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 138
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 139 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 196
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
               TT G     ++APE L +R Y    SD+WS GV+L+ I T
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFT 239

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 113/231 (48%), Gaps = 24/231 (10%)
Query: 20  RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKR----EIATLKLLK 72
           R +G G FG+V   +    G   LP A+K L+      +  T++ +R    E + +    
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLK------VGYTEKQRRDFLGEASIMGQFD 81
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYC 130
           HPN++ L  V+     + +V EY+  G L D    K  G+    +   + + +  G+ Y 
Sbjct: 82  HPNIIHLEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGISAGMKYL 140
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEV 187
            + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + APE 
Sbjct: 141 SDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTAPEA 198
Query: 188 LANRGYDGATSDIWSCGVILY-VILTGYLPFDDRNLAVLYQKIFRGDFKLP 237
           +A R +  A SD+WS G++++ V+  G  P+ +     + + +  G ++LP
Sbjct: 199 IAFRKFTSA-SDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEG-YRLP 247

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 106/204 (51%), Gaps = 15/204 (7%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  +V+L
Sbjct: 14  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 68
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  I+++ EY+  G L + +   + R Q  +  ++ + + + + Y  +K   HR
Sbjct: 69  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 128
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L++ +G +K+SDFGLS   ++  DD    ++ GS     +  PEVL    +  
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKF-S 183
Query: 196 ATSDIWSCGVILYVILT-GYLPFD 218
           + SDIW+ GV+++ I + G +P++
Sbjct: 184 SKSDIWAFGVLMWEIYSLGKMPYE 207

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 15  RYELGRTLGEGNFGKVKFAQD--LDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 71
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK----------------GR 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 131
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 189
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
               TT G     ++APE L +R Y    SD+WS GV+L+ I T
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFT 232

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 15  RYELGRTLGEGNFGKVKFAQD--LDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 18  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 75
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK----------------GR 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 76  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 135
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 136 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 193
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
               TT G     ++APE L +R Y    SD+WS GV+L+ I T
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFT 236

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 15  RYELGRTLGEGNFGKVKFAQD--LDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 86
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK----------------GR 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQ 146
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 204
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
               TT G     ++APE L +R Y    SD+WS GV+L+ I T
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFT 247

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 15  RYELGRTLGEGNFGKVKFAQD--LDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 86
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG----------------R 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQ 146
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 204
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
               TT G     ++APE L +R Y    SD+WS GV+L+ I T
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFT 247

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 106/204 (51%), Gaps = 15/204 (7%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  +V+L
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 64
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  I+++ EY+  G L + +   + R Q  +  ++ + + + + Y  +K   HR
Sbjct: 65  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 124
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L++ +G +K+SDFGLS   ++  DD    ++ GS     +  PEVL    +  
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKF-S 179
Query: 196 ATSDIWSCGVILYVILT-GYLPFD 218
           + SDIW+ GV+++ I + G +P++
Sbjct: 180 SKSDIWAFGVLMWEIYSLGKMPYE 203

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 106/204 (51%), Gaps = 15/204 (7%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  +V+L
Sbjct: 15  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 69
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  I+++ EY+  G L + +   + R Q  +  ++ + + + + Y  +K   HR
Sbjct: 70  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L++ +G +K+SDFGLS   ++  DD    ++ GS     +  PEVL    +  
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKF-S 184
Query: 196 ATSDIWSCGVILYVILT-GYLPFD 218
           + SDIW+ GV+++ I + G +P++
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 66/221 (29%), Positives = 107/221 (48%), Gaps = 33/221 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKR----EIAT 67
           R  + + +G G+ G+V + +    G   +P A+K L+         T++ +R    E + 
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG------YTERQRRDFLSEASI 103
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-- 125
           +    HPN++RL  V+       +V EY+  G L D       L+  +G+    QL+   
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTF-----LRTHDGQFTIMQLVGML 157
Query: 126 -----GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
                G+ Y  + G  HRDL   N+L+DS    K+SDFGLS + +   D    +TT G  
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED--DPDAAYTTTGGK 215
Query: 181 ---NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
               + APE +A R +  A SD+WS GV+++ +L  G  P+
Sbjct: 216 IPIRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPY 255

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 15  RYELGRTLGEGNFGKVKFAQD--LDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 22  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 79
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK----------------GR 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 80  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 139
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 140 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 197
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
               TT G     ++APE L +R Y    SD+WS GV+L+ I T
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFT 240

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 15  RYELGRTLGEGNFGKVKFAQD--LDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 29  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 86
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK----------------GR 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 87  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 146
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 147 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 204
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
               TT G     ++APE L +R Y    SD+WS GV+L+ I T
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFT 247

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 106/204 (51%), Gaps = 15/204 (7%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  +V+L
Sbjct: 21  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 75
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  I+++ EY+  G L + +   + R Q  +  ++ + + + + Y  +K   HR
Sbjct: 76  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 135
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L++ +G +K+SDFGLS   ++  DD    ++ GS     +  PEVL    +  
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKF-S 190
Query: 196 ATSDIWSCGVILYVILT-GYLPFD 218
           + SDIW+ GV+++ I + G +P++
Sbjct: 191 SKSDIWAFGVLMWEIYSLGKMPYE 214

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 106/204 (51%), Gaps = 15/204 (7%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  +V+L
Sbjct: 30  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 84
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  I+++ EY+  G L + +   + R Q  +  ++ + + + + Y  +K   HR
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L++ +G +K+SDFGLS   ++  DD    ++ GS     +  PEVL    +  
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKF-S 199
Query: 196 ATSDIWSCGVILYVILT-GYLPFD 218
           + SDIW+ GV+++ I + G +P++
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 69/224 (30%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 15  RYELGRTLGEGNFGKVKFAQ--DLDSGLP-----FAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+   LD   P      AVK+L K+      ++D I  E+  
Sbjct: 70  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKML-KSDATEKDLSDLIS-EMEM 127
Query: 68  LKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK----------------GR 110
           +K++ KH N++ L         +Y+++EY + G L + + ++                 +
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H   D
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--D 245
Query: 171 GLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
               TT G     ++APE L +R Y    SD+WS GV+L+ I T
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFT 288

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 64/231 (27%), Positives = 115/231 (49%), Gaps = 18/231 (7%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLK 72
           ++ R +G G FG+V   +     LP    +    + + +  T++ +R    E + +    
Sbjct: 46  KIERVIGAGEFGEVCSGR---LKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFD 102
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYC 130
           HPNVV L  V+     + +V+E++  G L D    K  G+    +   + + +  G+ Y 
Sbjct: 103 HPNVVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYL 161
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEV 187
            + G  HRDL   NIL++S    K+SDFGLS + +   D   ++TT G      + APE 
Sbjct: 162 ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIED--DPEAVYTTTGGKIPVRWTAPEA 219
Query: 188 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           +  R +  A SD+WS G++++ +++ G  P+ D +   + + I  G ++LP
Sbjct: 220 IQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLP 268

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 20/222 (9%)
Query: 20  RTLGEGNFGKVKFA----QDLDSGLPFAVKILEK----NRIIHLKITDQIKREIATLKLL 71
           R LGEG+FGKV+      +  ++G   AVK L+     N I  LK      +EI  L+ L
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK------KEIEILRNL 80
Query: 72  KHPNVVRLHEVLASK--SKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVS 128
            H N+V+   +      + I +++E++  G L + +  +K ++   +  K   Q+  G+ 
Sbjct: 81  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 140
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-VAPEV 187
           Y  ++   HRDL   N+L++S+  +KI DFGL+   +  ++   +     SP +  APE 
Sbjct: 141 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 200
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 229
           L    +  A SD+WS GV L+ +LT Y   D   +A+  + I
Sbjct: 201 LMQSKFYIA-SDVWSFGVTLHELLT-YCDSDSSPMALFLKMI 240

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 103/199 (51%), Gaps = 12/199 (6%)
Query: 22  LGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           LG+GNFG V+  +      ++G   AVK L+ +     +     +REI  LK L    +V
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKALHSDFIV 71
Query: 78  RLHEVL--ASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           +   V     + ++ +V+EY+  G L D +   + RL  +       Q+  G+ Y  ++ 
Sbjct: 72  KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 131
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
             HRDL   NIL++S+ ++KI+DFGL+ L    +D  ++     SP  + APE L++  +
Sbjct: 132 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIF 191
Query: 194 DGATSDIWSCGVILYVILT 212
               SD+WS GV+LY + T
Sbjct: 192 -SRQSDVWSFGVVLYELFT 209

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 80.9 bits (198), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 112/222 (50%), Gaps = 20/222 (9%)
Query: 20  RTLGEGNFGKVKFA----QDLDSGLPFAVKILEK----NRIIHLKITDQIKREIATLKLL 71
           R LGEG+FGKV+      +  ++G   AVK L+     N I  LK      +EI  L+ L
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK------KEIEILRNL 68
Query: 72  KHPNVVRLHEVLASK--SKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVS 128
            H N+V+   +      + I +++E++  G L + +  +K ++   +  K   Q+  G+ 
Sbjct: 69  YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMD 128
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY-VAPEV 187
           Y  ++   HRDL   N+L++S+  +KI DFGL+   +  ++   +     SP +  APE 
Sbjct: 129 YLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPEC 188
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 229
           L    +  A SD+WS GV L+ +LT Y   D   +A+  + I
Sbjct: 189 LMQSKFYIA-SDVWSFGVTLHELLT-YCDSDSSPMALFLKMI 228

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 122/277 (44%), Gaps = 48/277 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           L   LG+G    V   +   +G  FA+K+   N I  L+  D   RE   LK L H N+V
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 78  RL---HEVLASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           +L    E   ++ K+ +++E+   G L+  +        L E+E   + + ++ G+++  
Sbjct: 71  KLFAIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 132 NKGVFHRDLKLENILL----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
             G+ HR++K  NI+     D +   K++DFG +   +   DD    +  G+  Y+ P++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---RELEDDEQFVSLYGTEEYLHPDM 186
Query: 188 LA-------NRGYDGATSDIWSCGVILYVILTGYLPFD-----DRNLAVLYQKI------ 229
                    ++   GAT D+WS GV  Y   TG LPF       RN  V+Y+ I      
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 230 --------------FRGDFKLPKWLSPGAQNLLRKIL 252
                         + GD  +   LS G Q LL  +L
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 105/219 (47%), Gaps = 29/219 (13%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKR----EIAT 67
           R  + + +G G+ G+V + +    G   +P A+K L+         T++ +R    E + 
Sbjct: 50  RIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG------YTERQRRDFLSEASI 103
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-- 125
           +    HPN++RL  V+       +V EY+  G L D       L+  +G+    QL+   
Sbjct: 104 MGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTF-----LRTHDGQFTIMQLVGML 157
Query: 126 -----GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
                G+ Y  + G  HRDL   N+L+DS    K+SDFGLS + +   D     T    P
Sbjct: 158 RGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIP 217
Query: 181 -NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
             + APE +A R +  A SD+WS GV+++ +L  G  P+
Sbjct: 218 IRWTAPEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPY 255

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 107/206 (51%), Gaps = 23/206 (11%)
Query: 20  RTLGEGNFGKVKF----AQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           R LGEG+FGKV        +  +G   AVK L+ +     +     K+EI  L+ L H +
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLYHEH 77
Query: 76  VVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +++       + +  + +V+EYV  G L D +  +  +  A+     QQ+ +G++Y H++
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHSQ 136
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPN-YVAPE 186
              HR+L   N+LLD+   +KI DFGL+ A+P+       R+DG       SP  + APE
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAPE 190
Query: 187 VLANRGYDGATSDIWSCGVILYVILT 212
            L    +  A SD+WS GV LY +LT
Sbjct: 191 CLKEYKFYYA-SDVWSFGVTLYELLT 215

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/198 (30%), Positives = 95/198 (47%), Gaps = 14/198 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL-- 79
           +G G +G V  A D  +G   A+K L +     L    +  RE+  LK ++H NV+ L  
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL-FAKRAYRELRLLKHMRHENVIGLLD 91
Query: 80  ----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
                E L   +  Y+V+ ++  G    K+    +L E   + L  Q++ G+ Y H  G+
Sbjct: 92  VFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI 149
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRDLK  N+ ++    +KI DFGL+      + D  +     +  Y APEV+ N     
Sbjct: 150 IHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMXGXVVTRWYRAPEVILNWMRYT 204
Query: 196 ATSDIWSCGVILYVILTG 213
            T DIWS G I+  ++TG
Sbjct: 205 QTVDIWSVGCIMAEMITG 222

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/254 (26%), Positives = 116/254 (45%), Gaps = 26/254 (10%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR--EIATLKLLKHPNVVRL 79
           LG G+FG+V   +D  +G   AVK          K+  ++ R  E+     L  P +V L
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVK----------KVRLEVFRAEELMACAGLTSPRIVPL 131
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           +  +     + + +E + GG L   +  +G L E        Q ++G+ Y H++ + H D
Sbjct: 132 YGAVREGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGD 191
Query: 140 LKLENILLDSKG-NIKISDFGLSALPQHFRDDGL---LHT---TCGSPNYVAPEVLANRG 192
           +K +N+LL S G +  + DFG +      + DGL   L T     G+  ++APEV+  R 
Sbjct: 192 VKADNVLLSSDGSHAALCDFGHAVC---LQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS 248
Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLLR 249
            D A  D+WS   ++  +L G  P+       L  KI        ++P   +P     ++
Sbjct: 249 CD-AKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPPVREIPPSCAPLTAQAIQ 307
Query: 250 KILEPNPVKRITIA 263
           + L   P+ R++ A
Sbjct: 308 EGLRKEPIHRVSAA 321

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 106/204 (51%), Gaps = 15/204 (7%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  +V+L
Sbjct: 30  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 84
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  I+++ EY+  G L + +   + R Q  +  ++ + + + + Y  +K   HR
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L++ +G +K+SDFGLS   ++  DD    ++ GS     +  PEVL    +  
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEET-SSVGSKFPVRWSPPEVLMYSKF-S 199
Query: 196 ATSDIWSCGVILYVILT-GYLPFD 218
           + SDIW+ GV+++ I + G +P++
Sbjct: 200 SKSDIWAFGVLMWEIYSLGKMPYE 223

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 105/204 (51%), Gaps = 15/204 (7%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  +V+L
Sbjct: 15  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQL 69
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
           + V   +  I+++ EY+  G L + +   + R Q  +  ++ + + + + Y  +K   HR
Sbjct: 70  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L++ +G +K+SDFGLS   ++  DD    +  GS     +  PEVL    +  
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYTSSR-GSKFPVRWSPPEVLMYSKF-S 184
Query: 196 ATSDIWSCGVILYVILT-GYLPFD 218
           + SDIW+ GV+++ I + G +P++
Sbjct: 185 SKSDIWAFGVLMWEIYSLGKMPYE 208

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 91/205 (44%), Gaps = 6/205 (2%)
Query: 19  GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR 78
           G   GEG FG V +   +++      K+     I   ++  Q  +EI      +H N+V 
Sbjct: 27  GNKXGEGGFGVV-YKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVE 85
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           L    +    + +V  Y   G L D+++       L      K+ Q   +G+++ H    
Sbjct: 86  LLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH 145
Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            HRD+K  NILLD     KISDFGL+   + F          G+  Y APE L  RG   
Sbjct: 146 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEAL--RGEIT 203
Query: 196 ATSDIWSCGVILYVILTGYLPFDDR 220
             SDI+S GV+L  I+TG    D+ 
Sbjct: 204 PKSDIYSFGVVLLEIITGLPAVDEH 228

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/247 (25%), Positives = 119/247 (48%), Gaps = 18/247 (7%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + +G G FG V     L+     A+K +++  +      D    E   +  L HP +V+L
Sbjct: 33  QEIGSGQFGLVHLGYWLNKD-KVAIKTIKEGSMSE----DDFIEEAEVMMKLSHPKLVQL 87
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-KLFQQLIDGVSYCHNKGVFHR 138
           + V   ++ I +V E++  G L D + ++  L  AE    +   + +G++Y     V HR
Sbjct: 88  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 147
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L+     IK+SDFG++     F  D    ++ G+     + +PEV +   Y  
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMT----RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS- 202
Query: 196 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKIL 252
           + SD+WS GV+++ + + G +P+++R+ + + + I  G F+L  P+  S     ++    
Sbjct: 203 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCW 261
Query: 253 EPNPVKR 259
           +  P  R
Sbjct: 262 KERPEDR 268

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 106/206 (51%), Gaps = 23/206 (11%)
Query: 20  RTLGEGNFGKVKF----AQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           R LGEG+FGKV        +  +G   AVK L+ +     +     K+EI  L+ L H +
Sbjct: 20  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--CGPQHRSGWKQEIDILRTLYHEH 77
Query: 76  VVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +++       + +  + +V+EYV  G L D +  +  +  A+     QQ+ +G++Y H +
Sbjct: 78  IIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLP-RHSIGLAQLLLFAQQICEGMAYLHAQ 136
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPN-YVAPE 186
              HR+L   N+LLD+   +KI DFGL+ A+P+       R+DG       SP  + APE
Sbjct: 137 HYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAPE 190
Query: 187 VLANRGYDGATSDIWSCGVILYVILT 212
            L    +  A SD+WS GV LY +LT
Sbjct: 191 CLKEYKFYYA-SDVWSFGVTLYELLT 215

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 121/277 (43%), Gaps = 48/277 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           L   LG+G    V   +   +G  FA+K+   N I  L+  D   RE   LK L H N+V
Sbjct: 13  LSDILGQGATANVFRGRHKKTGDLFAIKVF--NNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 78  RL---HEVLASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           +L    E   ++ K+ +++E+   G L+  +        L E+E   + + ++ G+++  
Sbjct: 71  KLFAIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129
Query: 132 NKGVFHRDLKLENILL----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
             G+ HR++K  NI+     D +   K++DFG +   +   DD       G+  Y+ P++
Sbjct: 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---RELEDDEQFVXLYGTEEYLHPDM 186
Query: 188 LA-------NRGYDGATSDIWSCGVILYVILTGYLPFD-----DRNLAVLYQKI------ 229
                    ++   GAT D+WS GV  Y   TG LPF       RN  V+Y+ I      
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 230 --------------FRGDFKLPKWLSPGAQNLLRKIL 252
                         + GD  +   LS G Q LL  +L
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 112/225 (49%), Gaps = 22/225 (9%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V  A   +     AVK ++   +      +    E   +K L+H  +
Sbjct: 185 KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKL 239
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQ-QLIDGVSYCHNKG 134
           V+LH V+ +K  IY++ E++  G L D + S +G  Q       F  Q+ +G+++   + 
Sbjct: 240 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 298
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
             HRDL+  NIL+ +    KI+DFGL+ +   F              + APE + N G  
Sbjct: 299 YIHRDLRAANILVSASLVCKIADFGLARVGAKF-----------PIKWTAPEAI-NFGSF 346
Query: 195 GATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
              SD+WS G++L  I+T G +P+   +   + + + RG +++P+
Sbjct: 347 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPR 390

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 114/230 (49%), Gaps = 18/230 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 20  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 135
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 193
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           A R +  A SD+WS G++L+ +++ G  P+ + +   + + +  G ++LP
Sbjct: 194 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 241

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 114/230 (49%), Gaps = 18/230 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 165 DMGFVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           A R +  A SD+WS G++L+ +++ G  P+ + +   + + +  G ++LP
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 114/230 (49%), Gaps = 18/230 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 37  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 93
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 94  PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 152
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 153 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 210
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           A R +  A SD+WS G++L+ +++ G  P+ + +   + + +  G ++LP
Sbjct: 211 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 258

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 114/230 (49%), Gaps = 18/230 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           A R +  A SD+WS G++L+ +++ G  P+ + +   + + +  G ++LP
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 114/230 (49%), Gaps = 18/230 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           A R +  A SD+WS G++L+ +++ G  P+ + +   + + +  G ++LP
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 114/230 (49%), Gaps = 18/230 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           A R +  A SD+WS G++L+ +++ G  P+ + +   + + +  G ++LP
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/292 (26%), Positives = 131/292 (44%), Gaps = 37/292 (12%)
Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATL 68
           G  L  +E  + LG G FG V  A++      +A+K I   NR +     +++ RE+  L
Sbjct: 1   GRYLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNREL---AREKVMREVKAL 57
Query: 69  KLLKHPNVVRLHEVLASKSK------------IYMVLEYVTGGELFDKIASKGRLQEAEG 116
             L+HP +VR       K+             +Y+ ++      L D +  +  ++E E 
Sbjct: 58  AKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERER 117
Query: 117 R---KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGL 172
                +F Q+ + V + H+KG+ HRDLK  NI       +K+ DFGL +A+ Q   +  +
Sbjct: 118 SVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
Query: 173 L--------HT-TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 223
           L        HT   G+  Y++PE +    Y     DI+S G+IL+ +L    PF  +   
Sbjct: 178 LTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKV-DIFSLGLILFELL---YPFSTQMER 233
Query: 224 VLYQKIFRGDFKLPKWLS---PGAQNLLRKILEPNPVKRITIAGIKADEWFE 272
           V      R + K P   +   P    +++ +L P+P++R     I  +  FE
Sbjct: 234 VRTLTDVR-NLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFE 284

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 114/230 (49%), Gaps = 18/230 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 47  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 103
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 104 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 162
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 163 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 220
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           A R +  A SD+WS G++L+ +++ G  P+ + +   + + +  G ++LP
Sbjct: 221 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 268

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 114/230 (49%), Gaps = 18/230 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           A R +  A SD+WS G++L+ +++ G  P+ + +   + + +  G ++LP
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/232 (30%), Positives = 107/232 (46%), Gaps = 43/232 (18%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---------R 63
           L +YEL + LG+G +G V  + D  +G   AVK          KI D  +         R
Sbjct: 8   LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVK----------KIFDAFQNSTDAQRTFR 57
Query: 64  EIATLKLLK-HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
           EI  L  L  H N+V L  VL + +   +Y+V +Y+        +     L+    + + 
Sbjct: 58  EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYMETD--LHAVIRANILEPVHKQYVV 115
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-----------LP----- 164
            QLI  + Y H+ G+ HRD+K  NILL+++ ++K++DFGLS            +P     
Sbjct: 116 YQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 165 --QHFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 213
             ++F DD  +L     +  Y APE+L          D+WS G IL  IL G
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCG 227

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 115/228 (50%), Gaps = 18/228 (7%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V  A   +     AVK ++   +      +    E   +K L+H  +
Sbjct: 18  KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKL 72
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQ-QLIDGVSYCHNKG 134
           V+LH V+ +K  IY++ E++  G L D + S +G  Q       F  Q+ +G+++   + 
Sbjct: 73  VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 131
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANR 191
             HRDL+  NIL+ +    KI+DFGL+ +     +D       G+     + APE + N 
Sbjct: 132 YIHRDLRAANILVSASLVCKIADFGLARV----IEDNEYTAREGAKFPIKWTAPEAI-NF 186
Query: 192 GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           G     SD+WS G++L  I+T G +P+   +   + + + RG +++P+
Sbjct: 187 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPR 233

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/263 (25%), Positives = 119/263 (45%), Gaps = 20/263 (7%)
Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
            + +   +L +T+G+G FG V        G   AVK ++ +      +      E + + 
Sbjct: 189 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMT 241
Query: 70  LLKHPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDG 126
            L+H N+V+L  V+   K  +Y+V EY+  G L D + S+GR  L      K    + + 
Sbjct: 242 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 301
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y       HRDL   N+L+      K+SDFGL+      +D G L        + APE
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPE 356
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPG 243
            L  + +    SD+WS G++L+ I + G +P+    L  +  ++ +G +K+  P    P 
Sbjct: 357 ALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPA 414
Query: 244 AQNLLRKILEPNPVKRITIAGIK 266
             ++++     +   R T   ++
Sbjct: 415 VYDVMKNCWHLDAATRPTFLQLR 437

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 30  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 84
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 85  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 143
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIKS 200
Query: 199 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
           D+WS G++L  I+T G +P+       + Q + RG
Sbjct: 201 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 235

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 12/199 (6%)
Query: 22  LGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           LG+GNFG V+  +      ++G   AVK L+ +     +     +REI  LK L    +V
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKALHSDFIV 74
Query: 78  RLHEVL--ASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           +   V     +  + +V+EY+  G L D +   + RL  +       Q+  G+ Y  ++ 
Sbjct: 75  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 134
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
             HRDL   NIL++S+ ++KI+DFGL+ L    +D  ++     SP  + APE L++  +
Sbjct: 135 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 194
Query: 194 DGATSDIWSCGVILYVILT 212
               SD+WS GV+LY + T
Sbjct: 195 -SRQSDVWSFGVVLYELFT 212

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 23  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 77
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 78  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 136
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIKS 193
Query: 199 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
           D+WS G++L  I+T G +P+       + Q + RG
Sbjct: 194 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 228

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 29  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 83
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 84  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 142
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIKS 199
Query: 199 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
           D+WS G++L  I+T G +P+       + Q + RG
Sbjct: 200 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 234

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 12/199 (6%)
Query: 22  LGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           LG+GNFG V+  +      ++G   AVK L+ +     +     +REI  LK L    +V
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKALHSDFIV 75
Query: 78  RLHEVL--ASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           +   V     +  + +V+EY+  G L D +   + RL  +       Q+  G+ Y  ++ 
Sbjct: 76  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 135
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
             HRDL   NIL++S+ ++KI+DFGL+ L    +D  ++     SP  + APE L++  +
Sbjct: 136 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 195
Query: 194 DGATSDIWSCGVILYVILT 212
               SD+WS GV+LY + T
Sbjct: 196 -SRQSDVWSFGVVLYELFT 213

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 27  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 81
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 82  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIKS 197
Query: 199 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
           D+WS G++L  I+T G +P+       + Q + RG
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 232

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 21  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 75
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIKS 191
Query: 199 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
           D+WS G++L  I+T G +P+       + Q + RG
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 21  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 75
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIKS 191
Query: 199 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
           D+WS G++L  I+T G +P+       + Q + RG
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 22  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 76
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 77  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 135
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIED--NEXTAREGAKFPIKWTAPEAI-NYGTFTIKS 192
Query: 199 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
           D+WS G++L  I+T G +P+       + Q + RG
Sbjct: 193 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 227

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 84/319 (26%), Positives = 133/319 (41%), Gaps = 60/319 (18%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKH 73
           ++L   LGEG +G V  A    +G   A+K +E     +  L+      REI  LK  KH
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKH 68
Query: 74  PNVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
            N++ +  +    S     ++Y++ E +       ++ S   L +   +    Q +  V 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--TCGSPNYV--- 183
             H   V HRDLK  N+L++S  ++K+ DFGL+ +      D    T    G   YV   
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR 186
Query: 184 ---APEVLANRGYDGATSDIWSCGVIL------------------YVILTGYL--PFDDR 220
              APEV+          D+WSCG IL                   +++ G +  P  D 
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 221 NLAVLYQKIFRGDFK-LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKAD 268
           +L  +     R   K LP +           ++P   +LL+++L  +P KRIT     A 
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT-----AK 301
Query: 269 EWFEQDY--TPANPDDDEE 285
           E  E  Y  T  +P+D+ E
Sbjct: 302 EALEHPYLQTYHDPNDEPE 320

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/199 (31%), Positives = 102/199 (51%), Gaps = 12/199 (6%)
Query: 22  LGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           LG+GNFG V+  +      ++G   AVK L+ +     +     +REI  LK L    +V
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQR---DFQREIQILKALHSDFIV 87
Query: 78  RLHEVL--ASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           +   V     +  + +V+EY+  G L D +   + RL  +       Q+  G+ Y  ++ 
Sbjct: 88  KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR 147
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGY 193
             HRDL   NIL++S+ ++KI+DFGL+ L    +D  ++     SP  + APE L++  +
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 194 DGATSDIWSCGVILYVILT 212
               SD+WS GV+LY + T
Sbjct: 208 -SRQSDVWSFGVVLYELFT 225

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 114/236 (48%), Gaps = 28/236 (11%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLK 72
           ++ + +G G FG+V   +     +P   +I    + +    TD+ +R    E + +    
Sbjct: 32  KIEKVIGVGEFGEVCSGR---LKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD 88
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------D 125
           HPN++ L  V+     + ++ EY+  G L         L++ +GR    QL+        
Sbjct: 89  HPNIIHLEGVVTKCKPVMIITEYMENGSL------DAFLRKNDGRFTVIQLVGMLRGIGS 142
Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NY 182
           G+ Y  +    HRDL   NIL++S    K+SDFG+S + +   D    +TT G      +
Sbjct: 143 GMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLED--DPEAAYTTRGGKIPIRW 200
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
            APE +A R +  A SD+WS G++++ +++ G  P+ D +   + + I  G ++LP
Sbjct: 201 TAPEAIAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLP 254

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 114/230 (49%), Gaps = 18/230 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGL+ + +   D    +TT G      + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLARVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           A R +  A SD+WS G++L+ +++ G  P+ + +   + + +  G ++LP
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 17/217 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 31  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 85
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 86  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 144
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+    + KI+DFGL+ L     +D       G+     + APE + N G    
Sbjct: 145 LRAANILVSDTLSCKIADFGLARL----IEDNEYTAREGAKFPIKWTAPEAI-NYGTFTI 199
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
            SD+WS G++L  I+T G +P+       + Q + RG
Sbjct: 200 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 236

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 118/247 (47%), Gaps = 18/247 (7%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + +G G FG V     L+     A+K + +  +      +    E   +  L HP +V+L
Sbjct: 13  QEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQL 67
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-KLFQQLIDGVSYCHNKGVFHR 138
           + V   ++ I +V E++  G L D + ++  L  AE    +   + +G++Y     V HR
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHR 127
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L+     IK+SDFG++     F  D    ++ G+     + +PEV +   Y  
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMT----RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS- 182
Query: 196 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKIL 252
           + SD+WS GV+++ + + G +P+++R+ + + + I  G F+L  P+  S     ++    
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCW 241
Query: 253 EPNPVKR 259
           +  P  R
Sbjct: 242 KERPEDR 248

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 17/217 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 26  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 81  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+    + KI+DFGL+ L     +D       G+     + APE + N G    
Sbjct: 140 LRAANILVSDTLSCKIADFGLARL----IEDNEYTAREGAKFPIKWTAPEAI-NYGTFTI 194
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
            SD+WS G++L  I+T G +P+       + Q + RG
Sbjct: 195 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 231

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 115/228 (50%), Gaps = 18/228 (7%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V  A   +     AVK ++   +      +    E   +K L+H  +
Sbjct: 191 KLEKKLGAGQFGEVWMAT-YNKHTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKL 245
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQ-QLIDGVSYCHNKG 134
           V+LH V+ +K  IY++ E++  G L D + S +G  Q       F  Q+ +G+++   + 
Sbjct: 246 VKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANR 191
             HRDL+  NIL+ +    KI+DFGL+ + +    D       G+     + APE + N 
Sbjct: 305 YIHRDLRAANILVSASLVCKIADFGLARVIE----DNEYTAREGAKFPIKWTAPEAI-NF 359
Query: 192 GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           G     SD+WS G++L  I+T G +P+   +   + + + RG +++P+
Sbjct: 360 GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPR 406

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 17/217 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 27  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 81
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 82  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+    + KI+DFGL+ L     +D       G+     + APE + N G    
Sbjct: 141 LRAANILVSDTLSCKIADFGLARL----IEDNEYTAREGAKFPIKWTAPEAI-NYGTFTI 195
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
            SD+WS G++L  I+T G +P+       + Q + RG
Sbjct: 196 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 232

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 17/217 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 21  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 75
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+    + KI+DFGL+ L +    D       G+     + APE + N G    
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIE----DNEYTAREGAKFPIKWTAPEAI-NYGTFTI 189
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
            SD+WS G++L  I+T G +P+       + Q + RG
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 82/319 (25%), Positives = 132/319 (41%), Gaps = 60/319 (18%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKH 73
           ++L   LGEG +G V  A    +G   A+K +E     +  L+      REI  LK  KH
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKH 68
Query: 74  PNVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
            N++ +  +    S     ++Y++ E +       ++ S   L +   +    Q +  V 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--------TCGSP 180
             H   V HRDLK  N+L++S  ++K+ DFGL+ +      D    T           + 
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR 186
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVIL------------------YVILTGYL--PFDDR 220
            Y APEV+          D+WSCG IL                   +++ G +  P  D 
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 221 NLAVLYQKIFRGDFK-LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKAD 268
           +L  +     R   K LP +           ++P   +LL+++L  +P KRIT     A 
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT-----AK 301
Query: 269 EWFEQDY--TPANPDDDEE 285
           E  E  Y  T  +P+D+ E
Sbjct: 302 EALEHPYLQTYHDPNDEPE 320

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 126/260 (48%), Gaps = 24/260 (9%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKLLK 72
           E  + +G+G FG V   + +      A+K L     +     ++   + +RE+  +  L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCH 131
           HPN+V+L+ ++ +  +  MV+E+V  G+L+ ++  K   ++ +   +L   +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 132 NKG--VFHRDLKLENILLDSKGN-----IKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           N+   + HRDL+  NI L S         K++DFGLS    H    GLL    G+  ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-SVSGLL----GNFQWMA 194
Query: 185 PEVL-ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDF---KLPKW 239
           PE + A        +D +S  +ILY ILTG  PFD+ +   + +  + R +     +P+ 
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254
Query: 240 LSPGAQNLLRKILEPNPVKR 259
             P  +N++      +P KR
Sbjct: 255 CPPRLRNVIELCWSGDPKKR 274

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 118/247 (47%), Gaps = 18/247 (7%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + +G G FG V     L+     A+K + +  +      +    E   +  L HP +V+L
Sbjct: 13  QEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQL 67
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-KLFQQLIDGVSYCHNKGVFHR 138
           + V   ++ I +V E++  G L D + ++  L  AE    +   + +G++Y     V HR
Sbjct: 68  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 127
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L+     IK+SDFG++     F  D    ++ G+     + +PEV +   Y  
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMT----RFVLDDQYTSSTGTKFPVKWASPEVFSFSRY-S 182
Query: 196 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKIL 252
           + SD+WS GV+++ + + G +P+++R+ + + + I  G F+L  P+  S     ++    
Sbjct: 183 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCW 241
Query: 253 EPNPVKR 259
           +  P  R
Sbjct: 242 KERPEDR 248

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 118/247 (47%), Gaps = 18/247 (7%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + +G G FG V     L+     A+K + +  +      +    E   +  L HP +V+L
Sbjct: 11  QEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQL 65
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-KLFQQLIDGVSYCHNKGVFHR 138
           + V   ++ I +V E++  G L D + ++  L  AE    +   + +G++Y     V HR
Sbjct: 66  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 125
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L+     IK+SDFG++     F  D    ++ G+     + +PEV +   Y  
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMT----RFVLDDQYTSSTGTKFPVKWASPEVFSFSRY-S 180
Query: 196 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKIL 252
           + SD+WS GV+++ + + G +P+++R+ + + + I  G F+L  P+  S     ++    
Sbjct: 181 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCW 239
Query: 253 EPNPVKR 259
           +  P  R
Sbjct: 240 KERPEDR 246

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 113/231 (48%), Gaps = 18/231 (7%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLK 72
           ++ + +G G FG+V   +     +P   +I    + +    TD+ +R    E + +    
Sbjct: 17  KIEKVIGVGEFGEVCSGR---LKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD 73
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYC 130
           HPN++ L  V+     + ++ EY+  G L D    K  GR    +   + + +  G+ Y 
Sbjct: 74  HPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL 132
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEV 187
            +    HRDL   NIL++S    K+SDFG+S + +   D    +TT G      + APE 
Sbjct: 133 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED--DPEAAYTTRGGKIPIRWTAPEA 190
Query: 188 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           +A R +  A SD+WS G++++ +++ G  P+ D +   + + I  G ++LP
Sbjct: 191 IAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLP 239

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 17/212 (8%)
Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
            + +   +L +T+G+G FG V        G   AVK ++ +      +      E + + 
Sbjct: 2   ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMT 54
Query: 70  LLKHPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDG 126
            L+H N+V+L  V+   K  +Y+V EY+  G L D + S+GR  L      K    + + 
Sbjct: 55  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 114
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y       HRDL   N+L+      K+SDFGL+      +D G L        + APE
Sbjct: 115 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPE 169
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
            L  + +    SD+WS G++L+ I + G +P+
Sbjct: 170 ALREKKF-STKSDVWSFGILLWEIYSFGRVPY 200

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 99/212 (46%), Gaps = 17/212 (8%)
Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
            + +   +L +T+G+G FG V        G   AVK ++ +      +      E + + 
Sbjct: 17  ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMT 69
Query: 70  LLKHPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDG 126
            L+H N+V+L  V+   K  +Y+V EY+  G L D + S+GR  L      K    + + 
Sbjct: 70  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y       HRDL   N+L+      K+SDFGL+      +D G L        + APE
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPE 184
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
            L  + +    SD+WS G++L+ I + G +P+
Sbjct: 185 ALREKKFS-TKSDVWSFGILLWEIYSFGRVPY 215

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 82/326 (25%), Positives = 132/326 (40%), Gaps = 60/326 (18%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D   G+  AVK L +      H K   +  RE+  LK 
Sbjct: 21  LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAK---RAYRELVLLKC 77
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 78  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVIHME--LDHERMSYLLYQML 134
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+   +    + ++     +  Y A
Sbjct: 135 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTASTNFMMTPYVVTRYYRA 191
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------GDFK--- 235
           PEV+   GY     DIWS G I+  ++ G + F   +    + K+         +F    
Sbjct: 192 PEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAAL 250
Query: 236 ----------------------LPKWLSPG-----------AQNLLRKILEPNPVKRITI 262
                                  P W+ P            A++LL K+L  +P KRI++
Sbjct: 251 QPTVRNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISV 310
Query: 263 AGIKADEWFEQDYTPANPDDDEEDIF 288
                  +    Y PA  +     I+
Sbjct: 311 DEALRHPYITVWYDPAEAEAPPPQIY 336

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           E+   +G G FG V  A+     +  A+K +E        I      E+  L  + HPN+
Sbjct: 11  EVEEVVGRGAFGVVCKAKWRAKDV--AIKQIESESERKAFIV-----ELRQLSRVNHPNI 63
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL---QEAEGRKLFQQLIDGVSYCHN- 132
           V+L+   A  + + +V+EY  GG L++ +     L     A       Q   GV+Y H+ 
Sbjct: 64  VKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121
Query: 133 --KGVFHRDLKLENILLDSKGNI-KISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVL 188
             K + HRDLK  N+LL + G + KI DFG +  +  H  ++       GS  ++APEV 
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK------GSAAWMAPEVF 175
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDD 219
               Y     D++S G+IL+ ++T   PFD+
Sbjct: 176 EGSNYS-EKCDVFSWGIILWEVITRRKPFDE 205

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 113/230 (49%), Gaps = 18/230 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V EY+  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGL  + +   D    +TT G      + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           A R +  A SD+WS G++L+ +++ G  P+ + +   + + +  G ++LP
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 17/217 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 16  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 70
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 71  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 129
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+    + KI+DFGL+ L +    D       G+     + APE + N G    
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLIE----DNEYTAREGAKFPIKWTAPEAI-NYGTFTI 184
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
            SD+WS G++L  I+T G +P+       + Q + RG
Sbjct: 185 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 221

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 24/211 (11%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           E+   +G G FG V  A+     +  A+K +E        I      E+  L  + HPN+
Sbjct: 12  EVEEVVGRGAFGVVCKAKWRAKDV--AIKQIESESERKAFIV-----ELRQLSRVNHPNI 64
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL---QEAEGRKLFQQLIDGVSYCHN- 132
           V+L+   A  + + +V+EY  GG L++ +     L     A       Q   GV+Y H+ 
Sbjct: 65  VKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 122
Query: 133 --KGVFHRDLKLENILLDSKGNI-KISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVL 188
             K + HRDLK  N+LL + G + KI DFG +  +  H  ++       GS  ++APEV 
Sbjct: 123 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK------GSAAWMAPEVF 176
Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDD 219
               Y     D++S G+IL+ ++T   PFD+
Sbjct: 177 EGSNYS-EKCDVFSWGIILWEVITRRKPFDE 206

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 39/225 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINNI 210
Query: 170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           D    TT G     ++APE L +R Y    SD+WS GV+++ I T
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFT 254

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 113/231 (48%), Gaps = 18/231 (7%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLK 72
           ++ + +G G FG+V   +     +P   +I    + +    TD+ +R    E + +    
Sbjct: 11  KIEKVIGVGEFGEVCSGR---LKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFD 67
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYC 130
           HPN++ L  V+     + ++ EY+  G L D    K  GR    +   + + +  G+ Y 
Sbjct: 68  HPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYL 126
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEV 187
            +    HRDL   NIL++S    K+SDFG+S + +   D    +TT G      + APE 
Sbjct: 127 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLED--DPEAAYTTRGGKIPIRWTAPEA 184
Query: 188 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           +A R +  A SD+WS G++++ +++ G  P+ D +   + + I  G ++LP
Sbjct: 185 IAYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEG-YRLP 233

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/247 (25%), Positives = 117/247 (47%), Gaps = 18/247 (7%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           + +G G FG V     L+     A+K + +  +      +    E   +  L HP +V+L
Sbjct: 16  QEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQL 70
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-KLFQQLIDGVSYCHNKGVFHR 138
           + V   ++ I +V E++  G L D + ++  L  AE    +   + +G++Y     V HR
Sbjct: 71  YGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 130
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDG 195
           DL   N L+     IK+SDFG++     F  D    ++ G+     + +PEV +   Y  
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMT----RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS- 185
Query: 196 ATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKIL 252
           + SD+WS GV+++ + + G +P+++R+ + + + I  G F+L  P+  S     ++    
Sbjct: 186 SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCW 244
Query: 253 EPNPVKR 259
              P  R
Sbjct: 245 RERPEDR 251

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 82/319 (25%), Positives = 132/319 (41%), Gaps = 60/319 (18%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKH 73
           ++L   LGEG +G V  A    +G   A+K +E     +  L+      REI  LK  KH
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL----REIKILKHFKH 68
Query: 74  PNVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
            N++ +  +    S     ++Y++ E +       ++ S   L +   +    Q +  V 
Sbjct: 69  ENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAVK 126
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--------TCGSP 180
             H   V HRDLK  N+L++S  ++K+ DFGL+ +      D    T           + 
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVIL------------------YVILTGYL--PFDDR 220
            Y APEV+          D+WSCG IL                   +++ G +  P  D 
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 221 NLAVLYQKIFRGDFK-LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKAD 268
           +L  +     R   K LP +           ++P   +LL+++L  +P KRIT     A 
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT-----AK 301
Query: 269 EWFEQDY--TPANPDDDEE 285
           E  E  Y  T  +P+D+ E
Sbjct: 302 EALEHPYLQTYHDPNDEPE 320

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 39/225 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINNI 210
Query: 170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           D    TT G     ++APE L +R Y    SD+WS GV+++ I T
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFT 254

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 108/225 (48%), Gaps = 39/225 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINNI 210
Query: 170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           D   +TT G     ++APE L +R Y    SD+WS GV+++ I T
Sbjct: 211 DYYKNTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFT 254

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 17/212 (8%)
Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
            + +   +L +T+G+G FG V        G   AVK ++ +      +      E + + 
Sbjct: 8   ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMT 60
Query: 70  LLKHPNVVRLHEVLAS-KSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDG 126
            L+H N+V+L  V+   K  +Y+V EY+  G L D + S+GR  L      K    + + 
Sbjct: 61  QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 120
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y       HRDL   N+L+      K+SDFGL+      +D G L        + APE
Sbjct: 121 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPE 175
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
            L    +    SD+WS G++L+ I + G +P+
Sbjct: 176 ALREAAFS-TKSDVWSFGILLWEIYSFGRVPY 206

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYE+ + +G+G+FG+V  A D       A+K++   +  H     Q   EI  L+ L+  
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAEEIRILEHLRKQ 153
Query: 75  ------NVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDG 126
                 NV+ + E    ++ I M  E ++    EL  K   +G       RK    ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQC 212
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           +   H   + H DLK ENILL  +G   IK+ DFG S+  +H R    ++T   S  Y A
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQR----VYTXIQSRFYRA 267
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGY--LPFDD 219
           PEV+    Y G   D+WS G IL  +LTGY  LP +D
Sbjct: 268 PEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGED 303

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 113/230 (49%), Gaps = 18/230 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V E +  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 165 DMGAVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           A R +  A SD+WS G++L+ +++ G  P+ + +   + + +  G ++LP
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/245 (25%), Positives = 116/245 (47%), Gaps = 18/245 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G FG V     L+     A+K + +  +      +    E   +  L HP +V+L+ 
Sbjct: 16  IGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYG 70
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR-KLFQQLIDGVSYCHNKGVFHRDL 140
           V   ++ I +V E++  G L D + ++  L  AE    +   + +G++Y     V HRDL
Sbjct: 71  VCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 130
Query: 141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGAT 197
              N L+     IK+SDFG++     F  D    ++ G+     + +PEV +   Y  + 
Sbjct: 131 AARNCLVGENQVIKVSDFGMT----RFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS-SK 185
Query: 198 SDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEP 254
           SD+WS GV+++ + + G +P+++R+ + + + I  G F+L  P+  S     ++      
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCWRE 244
Query: 255 NPVKR 259
            P  R
Sbjct: 245 RPEDR 249

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/217 (32%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYE+ + +G+G+FG+V  A D       A+K++   +  H     Q   EI  L+ L+  
Sbjct: 98  RYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAEEIRILEHLRKQ 153
Query: 75  ------NVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDG 126
                 NV+ + E    ++ I M  E ++    EL  K   +G       RK    ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQC 212
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           +   H   + H DLK ENILL  +G   IK+ DFG S+  +H R    ++T   S  Y A
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQR----VYTXIQSRFYRA 267
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGY--LPFDD 219
           PEV+    Y G   D+WS G IL  +LTGY  LP +D
Sbjct: 268 PEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGED 303

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 109/223 (48%), Gaps = 32/223 (14%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           K+ GM     EL   +G G FG+V  A+    G  + +K ++ N        ++ +RE+ 
Sbjct: 7   KRFGMDFKEIEL---IGSGGFGQVFKAKHRIDGKTYVIKRVKYN-------NEKAEREVK 56
Query: 67  TLKLLKHPNVVRLHEVL-------------ASKSK---IYMVLEYVTGGELFDKIASK-- 108
            L  L H N+V  +                +S+SK   +++ +E+   G L   I  +  
Sbjct: 57  ALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRG 116
Query: 109 GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
            +L +    +LF+Q+  GV Y H+K + +RDLK  NI L     +KI DFGL       +
Sbjct: 117 EKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT---SLK 173
Query: 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 211
           +DG    + G+  Y++PE ++++ Y G   D+++ G+IL  +L
Sbjct: 174 NDGKRXRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELL 215

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 39/225 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINNI 210
Query: 170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           D    TT G     ++APE L +R Y    SD+WS GV+++ I T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFT 254

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 104/209 (49%), Gaps = 12/209 (5%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FGKV +   L  G   AVK L++ R    ++  Q + E+  + +  H N++RL  
Sbjct: 46  LGRGGFGKV-YKGRLADGTLVAVKRLKEERXQGGEL--QFQTEVEMISMAVHRNLLRLRG 102
Query: 82  VLASKSKIYMVLEYVTGGE----LFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---G 134
              + ++  +V  Y+  G     L ++  S+  L   + +++      G++Y H+     
Sbjct: 103 FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 162
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NILLD +    + DFGL+ L   ++D  +     G+  ++APE L+  G  
Sbjct: 163 IIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDXHVXXAVRGTIGHIAPEYLST-GKS 220
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLA 223
              +D++  GV+L  ++TG   FD   LA
Sbjct: 221 SEKTDVFGYGVMLLELITGQRAFDLARLA 249

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 39/225 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEEDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINNI 210
Query: 170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           D    TT G     ++APE L +R Y    SD+WS GV+++ I T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFT 254

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 39/225 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINNI 210
Query: 170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           D    TT G     ++APE L +R Y    SD+WS GV+++ I T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFT 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 39/225 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 26  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 83
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 84  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 143
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 144 KDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLA------RDINNI 197
Query: 170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           D    TT G     ++APE L +R Y    SD+WS GV+++ I T
Sbjct: 198 DYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFT 241

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 39/225 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 28  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 85
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 86  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 145
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 146 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINNI 199
Query: 170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           D    TT G     ++APE L +R Y    SD+WS GV+++ I T
Sbjct: 200 DYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFT 243

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 39/225 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 85  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 142
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 143 IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 203 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINNI 256
Query: 170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           D    TT G     ++APE L +R Y    SD+WS GV+++ I T
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFT 300

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 113/230 (49%), Gaps = 18/230 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 20  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 76
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V E +  G L D    K   +    +   + + +  G+ Y  
Sbjct: 77  PNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 135
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 136 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 193
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           A R +  A SD+WS G++L+ +++ G  P+ + +   + + +  G ++LP
Sbjct: 194 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 241

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/225 (28%), Positives = 107/225 (47%), Gaps = 39/225 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 31  LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 88
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 89  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 148
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 149 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINNI 202
Query: 170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           D    TT G     ++APE L +R Y    SD+WS GV+++ I T
Sbjct: 203 DYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFT 246

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 113/231 (48%), Gaps = 26/231 (11%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V +    +     A+K L+   +      +    E   +K LKH  +
Sbjct: 12  QLIKRLGNGQFGEV-WMGTWNGNTKVAIKTLKPGTMS----PESFLEEAQIMKKLKHDKL 66
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL--------FQQLIDGVS 128
           V+L+ V+ S+  IY+V EY+  G L D       L++ EGR L          Q+  G++
Sbjct: 67  VQLYAVV-SEEPIYIVTEYMNKGSLLD------FLKDGEGRALKLPNLVDMAAQVAAGMA 119
Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEV 187
           Y       HRDL+  NIL+ +    KI+DFGL+ L +   ++         P  + APE 
Sbjct: 120 YIERMNYIHRDLRSANILVGNGLICKIADFGLARLIED--NEXTARQGAKFPIKWTAPEA 177
Query: 188 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
            A  G     SD+WS G++L  ++T G +P+   N   + +++ RG +++P
Sbjct: 178 -ALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMP 226

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 13/215 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FG+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 17  LGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 71
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HR+
Sbjct: 72  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRN 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+    + KI+DFGL+ L +   ++         P  + APE + N G     S
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLIED--NEYTAREGAKFPIKWTAPEAI-NYGTFTIKS 187
Query: 199 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
           D+WS G++L  I+T G +P+       + Q + RG
Sbjct: 188 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 222

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/230 (26%), Positives = 113/230 (49%), Gaps = 18/230 (7%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKH 73
           + + +G G FG+V   +     LP   +I    + + +  T++ +R    E + +    H
Sbjct: 49  IDKVVGAGEFGEVCSGR---LKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDH 105
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH 131
           PN++RL  V+     + +V E +  G L D    K   +    +   + + +  G+ Y  
Sbjct: 106 PNIIRLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS 164
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           + G  HRDL   NIL++S    K+SDFGLS + +   D    +TT G      + +PE +
Sbjct: 165 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLED--DPEAAYTTRGGKIPIRWTSPEAI 222
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
           A R +  A SD+WS G++L+ +++ G  P+ + +   + + +  G ++LP
Sbjct: 223 AYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLP 270

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 125/260 (48%), Gaps = 24/260 (9%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKLLK 72
           E  + +G+G FG V   + +      A+K L     +     ++   + +RE+  +  L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCH 131
           HPN+V+L+ ++ +  +  MV+E+V  G+L+ ++  K   ++ +   +L   +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 132 NKG--VFHRDLKLENILLDSKGN-----IKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           N+   + HRDL+  NI L S         K++DFG S    H    GLL    G+  ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH-SVSGLL----GNFQWMA 194
Query: 185 PEVL-ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDF---KLPKW 239
           PE + A        +D +S  +ILY ILTG  PFD+ +   + +  + R +     +P+ 
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254
Query: 240 LSPGAQNLLRKILEPNPVKR 259
             P  +N++      +P KR
Sbjct: 255 CPPRLRNVIELCWSGDPKKR 274

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 21/210 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKL 70
           + RY     LGEG +G+V  A D  +    A+K   + R+ H +  +     RE++ LK 
Sbjct: 33  IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRLEHEEEGVPGTAIREVSLLKE 89
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L+H N++ L  V+    +++++ EY    +L   +     +     +    QLI+GV++C
Sbjct: 90  LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFC 148
Query: 131 HNKGVFHRDLKLENILLDSKGN-----IKISDFGLS---ALP-QHFRDDGLLHTTCGSPN 181
           H++   HRDLK +N+LL          +KI DFGL+    +P + F  + +      +  
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEII------TLW 202
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVIL 211
           Y  PE+L    +   + DIWS   I   +L
Sbjct: 203 YRPPEILLGSRHYSTSVDIWSIACIWAEML 232

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 107/225 (47%), Gaps = 39/225 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++EY + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
                   QL  G+ Y  ++   HRDL   N+L+     ++I+DFGL+      RD    
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLA------RDINNI 210
Query: 170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           D    TT G     ++APE L +R Y    SD+WS GV+++ I T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFT 254

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 125/260 (48%), Gaps = 24/260 (9%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKLLK 72
           E  + +G+G FG V   + +      A+K L     +     ++   + +RE+  +  L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCH 131
           HPN+V+L+ ++ +  +  MV+E+V  G+L+ ++  K   ++ +   +L   +  G+ Y  
Sbjct: 82  HPNIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQ 139
Query: 132 NKG--VFHRDLKLENILLDSKGN-----IKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           N+   + HRDL+  NI L S         K++DF LS    H    GLL    G+  ++A
Sbjct: 140 NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH-SVSGLL----GNFQWMA 194
Query: 185 PEVL-ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDF---KLPKW 239
           PE + A        +D +S  +ILY ILTG  PFD+ +   + +  + R +     +P+ 
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254
Query: 240 LSPGAQNLLRKILEPNPVKR 259
             P  +N++      +P KR
Sbjct: 255 CPPRLRNVIELCWSGDPKKR 274

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 103/209 (49%), Gaps = 12/209 (5%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FGKV +   L  G   AVK L++ R    ++  Q + E+  + +  H N++RL  
Sbjct: 38  LGRGGFGKV-YKGRLADGXLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRG 94
Query: 82  VLASKSKIYMVLEYVTGGE----LFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---G 134
              + ++  +V  Y+  G     L ++  S+  L   + +++      G++Y H+     
Sbjct: 95  FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK 154
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NILLD +    + DFGL+ L   ++D  +     G   ++APE L+  G  
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKL-MDYKDXHVXXAVRGXIGHIAPEYLST-GKS 212
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLA 223
              +D++  GV+L  ++TG   FD   LA
Sbjct: 213 SEKTDVFGYGVMLLELITGQRAFDLARLA 241

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/275 (28%), Positives = 128/275 (46%), Gaps = 27/275 (9%)
Query: 15  RYELGRTLGEGNFGKVKFAQ---DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           ++ LGR LG+G FG V+ AQ   +  S +  AVK+L K  II     ++  RE A +K  
Sbjct: 24  QFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEF 82
Query: 72  KHPNVVRLHEV-LASKSK----IYMV-LEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
            HP+V +L  V L S++K    I MV L ++  G+L   + +  R+ E       Q L+ 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLA-SRIGENPFNLPLQTLVR 141
Query: 126 -------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG 178
                  G+ Y  ++   HRDL   N +L     + ++DFGLS   +           C 
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS---RKIYSGDYYRQGCA 198
Query: 179 SP---NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD- 233
           S     ++A E LA+  Y    SD+W+ GV ++ I+T G  P+     A +Y  +  G+ 
Sbjct: 199 SKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR 257
Query: 234 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
            K P        +L+ +    +P +R +   ++ +
Sbjct: 258 LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME 292

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G+FG+V   +D  +G   AVK   K R+   ++      E+     L  P +V L+ 
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRV-----EELVACAGLSSPRIVPLYG 131
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
            +     + + +E + GG L   I   G L E        Q ++G+ Y H + + H D+K
Sbjct: 132 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 191
Query: 142 LENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTC------GSPNYVAPEVLANRGYD 194
            +N+LL S G+   + DFG +      + DGL  +        G+  ++APEV+  +  D
Sbjct: 192 ADNVLLSSDGSRAALCDFGHALC---LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 248
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL 236
            A  DIWS   ++  +L G  P         + + FRG   L
Sbjct: 249 -AKVDIWSSCCMMLHMLNGCHP---------WTQYFRGPLCL 280

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 78/268 (29%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRL 79
            +GEGNFG+V  A+    GL     I                 E+  L KL  HPN++ L
Sbjct: 22  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 81
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----------QQLID---- 125
                 +  +Y+ +EY   G L D +  K R+ E +               QQL+     
Sbjct: 82  LGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 126 ---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--P 180
              G+ Y   K   HRDL   NIL+      KI+DFGLS   + +     +  T G    
Sbjct: 141 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRLPV 195
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW 239
            ++A E L N       SD+WS GV+L+ I++ G  P+     A LY+K+ +G ++L K 
Sbjct: 196 RWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP 253
Query: 240 LSPGAQ--NLLRKILEPNPVKRITIAGI 265
           L+   +  +L+R+     P +R + A I
Sbjct: 254 LNCDDEVYDLMRQCWREKPYERPSFAQI 281

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRL 79
            +GEGNFG+V  A+    GL     I                 E+  L KL  HPN++ L
Sbjct: 32  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 91
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------------GRKLFQQLID 125
                 +  +Y+ +EY   G L D +  K R+ E +               ++L     D
Sbjct: 92  LGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 126 ---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--P 180
              G+ Y   K   HRDL   NIL+      KI+DFGLS   + +     +  T G    
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRLPV 205
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW 239
            ++A E L N       SD+WS GV+L+ I++ G  P+     A LY+K+ +G ++L K 
Sbjct: 206 RWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP 263
Query: 240 LSPGAQ--NLLRKILEPNPVKRITIAGI 265
           L+   +  +L+R+     P +R + A I
Sbjct: 264 LNCDDEVYDLMRQCWREKPYERPSFAQI 291

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 17/217 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G  G+V      +     AVK L++  +      D    E   +K L+H  +VRL+ 
Sbjct: 21  LGAGQAGEVWMGY-YNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYA 75
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ ++  IY++ EY+  G L D  K  S  +L   +   +  Q+ +G+++   +   HRD
Sbjct: 76  VV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+    + KI+DFGL+ L     +D       G+     + APE + N G    
Sbjct: 135 LRAANILVSDTLSCKIADFGLARL----IEDAEXTAREGAKFPIKWTAPEAI-NYGTFTI 189
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
            SD+WS G++L  I+T G +P+       + Q + RG
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG 226

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/229 (30%), Positives = 109/229 (47%), Gaps = 25/229 (10%)
Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKV--KFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
           ++ +++    L  YE G  +G G +G V     +D      +A+K +E        I+  
Sbjct: 11  LSSERERVEDLFEYE-GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT-----GISMS 64
Query: 61  IKREIATLKLLKHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKI-------ASKGRL 111
             REIA L+ LKHPNV+ L +V  S +  K++++ +Y    +L+  I       A+K  +
Sbjct: 65  ACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPV 123
Query: 112 QEAEG--RKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSAL-P 164
           Q   G  + L  Q++DG+ Y H   V HRDLK  NIL+      +G +KI+D G + L  
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 183
Query: 165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 213
              +    L     +  Y APE+L    +     DIW+ G I   +LT 
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/263 (24%), Positives = 119/263 (45%), Gaps = 17/263 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G+F  V    D ++ +  A   L+  ++   +   + K E   LK L+HPN+VR ++
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSE-RQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 82  VLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--V 135
              S  K    I +V E  T G L   +      +    R   +Q++ G+ + H +   +
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 136 FHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
            HRDLK +NI +    G++KI D GL+ L +            G+P + APE    + YD
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFXAPEXYEEK-YD 207
Query: 195 GATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKI 251
            +  D+++ G       T   P+ + +N A +Y+++  G       K   P  + ++   
Sbjct: 208 ESV-DVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGC 266
Query: 252 LEPNPVKRITIAGIKADEWFEQD 274
           +  N  +R +I  +    +F+++
Sbjct: 267 IRQNKDERYSIKDLLNHAFFQEE 289

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 18/209 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K+
Sbjct: 23  LKRYQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKV 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D   S+    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTG 213
           PEV+   GY     DIWS GVI+  ++ G
Sbjct: 194 PEVILGMGYK-ENVDIWSVGVIMGEMIKG 221

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 99/221 (44%), Gaps = 22/221 (9%)
Query: 10  GMRLG-RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL 68
           G  LG RY   + LG G  G V  A D D     A+K   K  +   +      REI  +
Sbjct: 6   GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK---KIVLTDPQSVKHALREIKII 62
Query: 69  KLLKHPNVVRLHEVLASK--------------SKIYMVLEYVTGGELFDKIASKGRLQEA 114
           + L H N+V++ E+L                 + +Y+V EY+        +  +G L E 
Sbjct: 63  RRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETD--LANVLEQGPLLEE 120
Query: 115 EGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLS-ALPQHFRDDGL 172
             R    QL+ G+ Y H+  V HRDLK  N+ ++++  + KI DFGL+  +  H+   G 
Sbjct: 121 HARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG 213
           L     +  Y +P +L +        D+W+ G I   +LTG
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/230 (24%), Positives = 107/230 (46%), Gaps = 14/230 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLK 72
           ++ + +G G FG+V         LP   +I    + +    T++ +R    E + +    
Sbjct: 36  KIEQVIGAGEFGEVCSGH---LKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 92
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
           HPNV+ L  V+   + + ++ E++  G L   +  + G+    +   + + +  G+ Y  
Sbjct: 93  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 152
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +    HRDL   NIL++S    K+SDFGLS   +    D    +  G      + APE +
Sbjct: 153 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 212
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
             R +  A SD+WS G++++ +++ G  P+ D     +   I   D++LP
Sbjct: 213 QYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-EQDYRLP 260

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGRLQEAEGRKLFQ 121
           E + +   +HPN++RL  V+ +   + ++ E++  G L  F ++ + G+    +   + +
Sbjct: 65  EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLR 123
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP- 180
            +  G+ Y       HRDL   NIL++S    K+SDFGLS   +    D    ++ G   
Sbjct: 124 GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKI 183
Query: 181 --NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
              + APE +A R +  A SD WS G++++ +++ G  P+ D +   +   I   D++LP
Sbjct: 184 PIRWTAPEAIAFRKFTSA-SDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI-EQDYRLP 241

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 129/286 (45%), Gaps = 48/286 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 23  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 74
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 75  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 132
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 133 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 189
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------FKL 236
            APE++       ++ D+WS G +L  +L G             Q IF GD       ++
Sbjct: 190 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGDSGVDQLVEI 236
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
            K L    +  +R+ + PN         IKA  W  + + P  P +
Sbjct: 237 IKVLGTPTREQIRE-MNPN-YTEFKFPQIKAHPW-TKVFRPRTPPE 279

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 129/286 (45%), Gaps = 48/286 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 26  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 77
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 78  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 135
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 136 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 192
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------FKL 236
            APE++       ++ D+WS G +L  +L G             Q IF GD       ++
Sbjct: 193 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGDSGVDQLVEI 239
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
            K L    +  +R+ + PN         IKA  W  + + P  P +
Sbjct: 240 IKVLGTPTREQIRE-MNPN-YTEFKFPQIKAHPW-TKVFRPRTPPE 282

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 101/228 (44%), Gaps = 20/228 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE+  T+G G +G V  A+   +G   A+K +  N    +    +  RE+  LK  KH N
Sbjct: 57  YEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHDN 115
Query: 76  VVRLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           ++ + ++L           +Y+VL+ +   +L   I S   L     R    QL+ G+ Y
Sbjct: 116 IIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 174
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS-------ALPQHFRDDGLLHTTCGSPNY 182
            H+  V HRDLK  N+L++    +KI DFG++       A  Q+F     +     +  Y
Sbjct: 175 MHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF-----MTEYVATRWY 229
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
            APE++ +        D+WS G I   +L     F  +N     Q I 
Sbjct: 230 RAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIM 277

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 39/231 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 85
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 144 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 200
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 233
            APE++       ++ D+WS G +L  +L G             Q IF GD
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGD 238

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 18/213 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKV 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D   S+    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
           PEV+   GY     DIWS GVI+  ++ G + F
Sbjct: 194 PEVILGMGYK-ENVDIWSVGVIMGEMIKGGVLF 225

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 20/219 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           YE+  T+G G +G V  A+   +G   A+K +  N    +    +  RE+  LK  KH N
Sbjct: 56  YEIIETIGNGAYGVVSSARRRLTGQQVAIKKI-PNAFDVVTNAKRTLRELKILKHFKHDN 114
Query: 76  VVRLHEVLASK------SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           ++ + ++L           +Y+VL+ +   +L   I S   L     R    QL+ G+ Y
Sbjct: 115 IIAIKDILRPTVPYGEFKSVYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKY 173
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS-------ALPQHFRDDGLLHTTCGSPNY 182
            H+  V HRDLK  N+L++    +KI DFG++       A  Q+F     +     +  Y
Sbjct: 174 MHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYF-----MTEYVATRWY 228
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
            APE++ +        D+WS G I   +L     F  +N
Sbjct: 229 RAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKN 267

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 129/286 (45%), Gaps = 48/286 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 73
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 188
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------FKL 236
            APE++       ++ D+WS G +L  +L G             Q IF GD       ++
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGDSGVDQLVEI 235
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
            K L    +  +R+ + PN         IKA  W  + + P  P +
Sbjct: 236 IKVLGTPTREQIRE-MNPN-YTEFKFPQIKAHPW-TKVFRPRTPPE 278

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 39/231 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 30  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 81
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 82  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 139
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 140 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 196
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 233
            APE++       ++ D+WS G +L  +L G             Q IF GD
Sbjct: 197 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGD 234

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 39/231 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 41  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 92
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 93  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 150
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 151 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 207
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 233
            APE++       ++ D+WS G +L  +L G             Q IF GD
Sbjct: 208 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGD 245

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 39/231 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 73
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 188
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 233
            APE++       ++ D+WS G +L  +L G             Q IF GD
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGD 226

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 39/225 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++ Y + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINNI 210
Query: 170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           D    TT G     ++APE L +R Y    SD+WS GV+++ I T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFT 254

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 39/231 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 34  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 85
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 86  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 143
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 144 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 200
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 233
            APE++       ++ D+WS G +L  +L G             Q IF GD
Sbjct: 201 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGD 238

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 106/224 (47%), Gaps = 18/224 (8%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           E+G  +G+G FG+V +       +   +  +E++    LK     KRE+   +  +H NV
Sbjct: 36  EIGELIGKGRFGQV-YHGRWHGEVAIRLIDIERDNEDQLK---AFKREVMAYRQTRHENV 91
Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           V       S   + ++     G  L+  +  +K  L   + R++ Q+++ G+ Y H KG+
Sbjct: 92  VLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 136 FHRDLKLENILLDSKGNIKISDFGL---SALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            H+DLK +N+  D+ G + I+DFGL   S + Q  R +  L    G   ++APE++    
Sbjct: 152 LHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210
Query: 193 YD--------GATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQ 227
            D           SD+++ G I Y +     PF  +   A+++Q
Sbjct: 211 PDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G+FG+V   +D  +G   AVK   K R+   ++      E+     L  P +V L+ 
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRV-----EELVACAGLSSPRIVPLYG 117
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
            +     + + +E + GG L   I   G L E        Q ++G+ Y H + + H D+K
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 177
Query: 142 LENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTC------GSPNYVAPEVLANRGYD 194
            +N+LL S G+   + DFG +      + DGL  +        G+  ++APEV+  +  D
Sbjct: 178 ADNVLLSSDGSRAALCDFGHALC---LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 234
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL 236
            A  DIWS   ++  +L G  P         + + FRG   L
Sbjct: 235 -AKVDIWSSCCMMLHMLNGCHP---------WTQYFRGPLCL 266

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 39/231 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 107
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 222
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 233
            APE++       ++ D+WS G +L  +L G             Q IF GD
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGD 260

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 129/286 (45%), Gaps = 48/286 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 73
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYY 188
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------FKL 236
            APE++       ++ D+WS G +L  +L G             Q IF GD       ++
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGDSGVDQLVEI 235
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
            K L    +  +R+ + PN         IKA  W  + + P  P +
Sbjct: 236 IKVLGTPTREQIRE-MNPN-YTEFKFPQIKAHPW-TKVFRPRTPPE 278

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 100/222 (45%), Gaps = 28/222 (12%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G+FG+V   +D  +G   AVK   K R+   ++      E+     L  P +V L+ 
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVK---KVRLEVFRV-----EELVACAGLSSPRIVPLYG 133
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK 141
            +     + + +E + GG L   I   G L E        Q ++G+ Y H + + H D+K
Sbjct: 134 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVK 193
Query: 142 LENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTC------GSPNYVAPEVLANRGYD 194
            +N+LL S G+   + DFG +      + DGL  +        G+  ++APEV+  +  D
Sbjct: 194 ADNVLLSSDGSRAALCDFGHALC---LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCD 250
Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL 236
            A  DIWS   ++  +L G  P         + + FRG   L
Sbjct: 251 -AKVDIWSSCCMMLHMLNGCHP---------WTQYFRGPLCL 282

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 39/231 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 35  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 86
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 87  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 144
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 145 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYY 201
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 233
            APE++       ++ D+WS G +L  +L G             Q IF GD
Sbjct: 202 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGD 239

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 107/231 (46%), Gaps = 38/231 (16%)
Query: 15  RYELGRTLGEGNFGKVKFAQD-LDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLK 72
           RYE+   +G G++G V  A D L+  +    KIL   R+   L    +I REIA L  L 
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKIL---RVFEDLIDCKRILREIAILNRLN 110
Query: 73  HPNVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           H +VV++ +++  K      ++Y+VLE +   +      +   L E   + L   L+ GV
Sbjct: 111 HDHVVKVLDIVIPKDVEKFDELYVVLE-IADSDFKKLFRTPVYLTELHIKTLLYNLLVGV 169
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGL-----------SALPQHFRDDGL-LHT 175
            Y H+ G+ HRDLK  N L++   ++K+ DFGL           S LP   R+D + L T
Sbjct: 170 KYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVT 229
Query: 176 TCGSPN-------------YVAPE-VLANRGYDGATSDIWSCGVILYVILT 212
              + N             Y APE +L    Y  A  D+WS G I   +L 
Sbjct: 230 FPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIGCIFAELLN 279

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 122/281 (43%), Gaps = 36/281 (12%)
Query: 15  RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           R   G+TLG G FGKV  A        D+ +  AVK+L+ +   HL   + +  E+  L 
Sbjct: 47  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 104
Query: 70  LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK------------------GR 110
            L  H N+V L           ++ EY   G+L + +  K                    
Sbjct: 105 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 164
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+++  +K   HRDL   NILL      KI DFGL+   +H ++D
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RHIKND 221
Query: 171 G--LLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
              ++      P  ++APE + N  Y    SD+WS G+ L+ + + G  P+    +   +
Sbjct: 222 SNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 280
Query: 227 QKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            K+ +  F++  P+       ++++   + +P+KR T   I
Sbjct: 281 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 321

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/252 (27%), Positives = 114/252 (45%), Gaps = 18/252 (7%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL----KLLKHPNVV 77
           LG G++G+V   +  + G  +AVK      +   +      R++A +    K+ +HP  V
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVK----RSMSPFRGPKDRARKLAEVGSHEKVGQHPCCV 120
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVF 136
           RL +       +Y+  E + G  L     + G  L EA+     +  +  +++ H++G+ 
Sbjct: 121 RLEQAWEEGGILYLQTE-LCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLV 179
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           H D+K  NI L  +G  K+ DFGL          G      G P Y+APE+L  +G  G 
Sbjct: 180 HLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELL--QGSYGT 234
Query: 197 TSDIWSCGV-ILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            +D++S G+ IL V     LP        L Q     +F     LS   +++L  +LEP+
Sbjct: 235 AADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFT--AGLSSELRSVLVMMLEPD 292
Query: 256 PVKRITIAGIKA 267
           P  R T   + A
Sbjct: 293 PKLRATAEALLA 304

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 39/231 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 27  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 78
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 79  NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 136
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 137 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYY 193
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 233
            APE++       ++ D+WS G +L  +L G             Q IF GD
Sbjct: 194 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGD 231

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 39/231 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 58  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 109
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 110 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 167
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 168 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYY 224
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 233
            APE++       ++ D+WS G +L  +L G             Q IF GD
Sbjct: 225 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGD 262

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 39/231 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 50  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 101
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 102 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 159
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 160 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYY 216
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 233
            APE++       ++ D+WS G +L  +L G             Q IF GD
Sbjct: 217 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGD 254

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 109/236 (46%), Gaps = 17/236 (7%)
Query: 59  DQIKREIATL-KLLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG 116
           D  + EIA L KL +H + ++RL++   +   IYMV+E     +L   +  K  +   E 
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 157
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +  ++ +++ V   H  G+ H DLK  N L+   G +K+ DFG++   Q      +  + 
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 177 CGSPNYVAPEVLANRGYD----------GATSDIWSCGVILYVILTGYLPFDD--RNLAV 224
            G+ NY+ PE + +                 SD+WS G ILY +  G  PF      ++ 
Sbjct: 217 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 225 LYQKIF-RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
           L+  I    + + P       Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 332

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 39/231 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 107
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 165
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 166 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYY 222
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 233
            APE++       ++ D+WS G +L  +L G             Q IF GD
Sbjct: 223 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGD 260

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/217 (32%), Positives = 102/217 (47%), Gaps = 23/217 (10%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RYE+ + +G+G FG+V  A D       A+K++   +  H     Q   EI  L+ L+  
Sbjct: 98  RYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFH----RQAAEEIRILEHLRKQ 153
Query: 75  ------NVVRLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDG 126
                 NV+ + E    ++ I M  E ++    EL  K   +G       RK    ++  
Sbjct: 154 DKDNTMNVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQC 212
Query: 127 VSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           +   H   + H DLK ENILL  +G   IK+ DFG S+  +H R    ++    S  Y A
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG-SSCYEHQR----VYXXIQSRFYRA 267
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGY--LPFDD 219
           PEV+    Y G   D+WS G IL  +LTGY  LP +D
Sbjct: 268 PEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGED 303

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 149
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
             + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 209 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 241

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 109/236 (46%), Gaps = 17/236 (7%)
Query: 59  DQIKREIATL-KLLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG 116
           D  + EIA L KL +H + ++RL++   +   IYMV+E     +L   +  K  +   E 
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 129
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +  ++ +++ V   H  G+ H DLK  N L+   G +K+ DFG++   Q      +  + 
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 177 CGSPNYVAPEVLANRGYD----------GATSDIWSCGVILYVILTGYLPFDD--RNLAV 224
            G+ NY+ PE + +                 SD+WS G ILY +  G  PF      ++ 
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248
Query: 225 LYQKIF-RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
           L+  I    + + P       Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 249 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 39/231 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 60  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 111
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 112 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 169
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 170 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYY 226
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 233
            APE++       ++ D+WS G +L  +L G             Q IF GD
Sbjct: 227 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGD 264

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 109/236 (46%), Gaps = 17/236 (7%)
Query: 59  DQIKREIATL-KLLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG 116
           D  + EIA L KL +H + ++RL++   +   IYMV+E     +L   +  K  +   E 
Sbjct: 55  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 113
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +  ++ +++ V   H  G+ H DLK  N L+   G +K+ DFG++   Q      +  + 
Sbjct: 114 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 172
Query: 177 CGSPNYVAPEVLANRGYD----------GATSDIWSCGVILYVILTGYLPFDD--RNLAV 224
            G+ NY+ PE + +                 SD+WS G ILY +  G  PF      ++ 
Sbjct: 173 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 232
Query: 225 LYQKI-FRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
           L+  I    + + P       Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 233 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 288

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 109/236 (46%), Gaps = 17/236 (7%)
Query: 59  DQIKREIATL-KLLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG 116
           D  + EIA L KL +H + ++RL++   +   IYMV+E     +L   +  K  +   E 
Sbjct: 51  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 109
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +  ++ +++ V   H  G+ H DLK  N L+   G +K+ DFG++   Q      +  + 
Sbjct: 110 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 168
Query: 177 CGSPNYVAPEVLANRGYD----------GATSDIWSCGVILYVILTGYLPFDD--RNLAV 224
            G+ NY+ PE + +                 SD+WS G ILY +  G  PF      ++ 
Sbjct: 169 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 228
Query: 225 LYQKI-FRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
           L+  I    + + P       Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 229 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 284

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 49/180 (27%), Positives = 91/180 (50%), Gaps = 9/180 (5%)
Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGRLQEAEGRKLFQ 121
           E + +   +HPN++RL  V+ +   + ++ E++  G L  F ++ + G+    +   + +
Sbjct: 67  EASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRL-NDGQFTVIQLVGMLR 125
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP- 180
            +  G+ Y       HRDL   NIL++S    K+SDFGLS   +    D    ++ G   
Sbjct: 126 GIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 181 --NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
              + APE +A R +  A SD WS G++++ +++ G  P+ D +   +   I   D++LP
Sbjct: 186 PIRWTAPEAIAFRKFTSA-SDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI-EQDYRLP 243

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/231 (30%), Positives = 109/231 (47%), Gaps = 39/231 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 152
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 153 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 210
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 211 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYY 267
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD 233
            APE++       ++ D+WS G +L  +L G             Q IF GD
Sbjct: 268 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGD 305

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 106/225 (47%), Gaps = 39/225 (17%)
Query: 18  LGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           LG+ LGEG FG+V  A+ +          +  AVK+L K+      ++D +  E+  +K+
Sbjct: 39  LGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKML-KDDATEKDLSDLVS-EMEMMKM 96
Query: 71  L-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-----------GRLQEAEGR- 117
           + KH N++ L         +Y+++ Y + G L + + ++            R+ E +   
Sbjct: 97  IGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 156
Query: 118 ----KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD---- 169
                   QL  G+ Y  ++   HRDL   N+L+     +KI+DFGL+      RD    
Sbjct: 157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------RDINNI 210
Query: 170 DGLLHTTCG--SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           D    TT G     ++APE L +R Y    SD+WS GV+++ I T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFT 254

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 109/236 (46%), Gaps = 17/236 (7%)
Query: 59  DQIKREIATL-KLLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG 116
           D  + EIA L KL +H + ++RL++   +   IYMV+E     +L   +  K  +   E 
Sbjct: 52  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 110
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +  ++ +++ V   H  G+ H DLK  N L+   G +K+ DFG++   Q      +  + 
Sbjct: 111 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 177 CGSPNYVAPEVLANRGYD----------GATSDIWSCGVILYVILTGYLPFDD--RNLAV 224
            G+ NY+ PE + +                 SD+WS G ILY +  G  PF      ++ 
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229
Query: 225 LYQKIF-RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
           L+  I    + + P       Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 230 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 285

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 45/236 (19%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           K+ GM     EL   +G G FG+V  A+    G  + ++ ++ N        ++ +RE+ 
Sbjct: 8   KRFGMDFKEIEL---IGSGGFGQVFKAKHRIDGKTYVIRRVKYN-------NEKAEREVK 57
Query: 67  TLKLLKHPNVVRLHEVL--------------------------ASKSK---IYMVLEYVT 97
            L  L H N+V  +                             +S+SK   +++ +E+  
Sbjct: 58  ALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCD 117
Query: 98  GGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI 155
            G L   I  +   +L +    +LF+Q+  GV Y H+K + HRDLK  NI L     +KI
Sbjct: 118 KGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKI 177
Query: 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 211
            DFGL       ++DG    + G+  Y++PE ++++ Y G   D+++ G+IL  +L
Sbjct: 178 GDFGLVT---SLKNDGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELL 229

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/268 (28%), Positives = 118/268 (44%), Gaps = 31/268 (11%)
Query: 21  TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRL 79
            +GEGNFG+V  A+    GL     I                 E+  L KL  HPN++ L
Sbjct: 29  VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINL 88
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE--------------GRKLFQQLID 125
                 +  +Y+ +EY   G L D +  K R+ E +               ++L     D
Sbjct: 89  LGACEHRGYLYLAIEYAPHGNLLDFL-RKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 126 ---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--P 180
              G+ Y   K   HR+L   NIL+      KI+DFGLS   + +     +  T G    
Sbjct: 148 VARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRLPV 202
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW 239
            ++A E L N       SD+WS GV+L+ I++ G  P+     A LY+K+ +G ++L K 
Sbjct: 203 RWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKP 260
Query: 240 LSPGAQ--NLLRKILEPNPVKRITIAGI 265
           L+   +  +L+R+     P +R + A I
Sbjct: 261 LNCDDEVYDLMRQCWREKPYERPSFAQI 288

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 127/285 (44%), Gaps = 46/285 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y   + +G G+FG V  A+  DSG   A+K + + +           RE+  ++ L H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQIMRKLDHCN 74
Query: 76  VVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQLI 124
           +VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL 
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
             ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y 
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYYR 189
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------FKLP 237
           APE++       ++ D+WS G +L  +L G             Q IF GD       ++ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGDSGVDQLVEII 236
Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
           K L    +  +R+ + PN         IKA  W  + + P  P +
Sbjct: 237 KVLGTPTREQIRE-MNPN-YTEFAFPQIKAHPW-TKVFRPRTPPE 278

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 81/286 (28%), Positives = 128/286 (44%), Gaps = 48/286 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKHP 74
           Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDHC 73
Query: 75  NVVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQL 123
           N+VRL     S    K  +Y+  VL+YV   E   ++A     +K  L     +    QL
Sbjct: 74  NIVRLRYFFYSSGEKKDVVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQL 131
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYY 188
Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------FKL 236
            APE++       ++ D+WS G +L  +L G             Q IF GD       ++
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGDSGVDQLVEI 235
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
            K L    +  +R+ + PN         IKA  W  + + P  P +
Sbjct: 236 IKVLGTPTREQIRE-MNPN-YTEFKFPQIKAHPW-TKVFRPRTPPE 278

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 109/236 (46%), Gaps = 17/236 (7%)
Query: 59  DQIKREIATL-KLLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG 116
           D  + EIA L KL +H + ++RL++   +   IYMV+E     +L   +  K  +   E 
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 157
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +  ++ +++ V   H  G+ H DLK  N L+   G +K+ DFG++   Q      +  + 
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 177 CGSPNYVAPEVLANRGYD----------GATSDIWSCGVILYVILTGYLPFDD--RNLAV 224
            G+ NY+ PE + +                 SD+WS G ILY +  G  PF      ++ 
Sbjct: 217 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 225 LYQKIF-RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
           L+  I    + + P       Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 332

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 109/236 (46%), Gaps = 17/236 (7%)
Query: 59  DQIKREIATL-KLLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG 116
           D  + EIA L KL +H + ++RL++   +   IYMV+E     +L   +  K  +   E 
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 129
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +  ++ +++ V   H  G+ H DLK  N L+   G +K+ DFG++   Q      +  + 
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQ 188
Query: 177 CGSPNYVAPEVLANRGYD----------GATSDIWSCGVILYVILTGYLPFDD--RNLAV 224
            G+ NY+ PE + +                 SD+WS G ILY +  G  PF      ++ 
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248
Query: 225 LYQKIF-RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
           L+  I    + + P       Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 249 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 109/236 (46%), Gaps = 17/236 (7%)
Query: 59  DQIKREIATL-KLLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG 116
           D  + EIA L KL +H + ++RL++   +   IYMV+E     +L   +  K  +   E 
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 157
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +  ++ +++ V   H  G+ H DLK  N L+   G +K+ DFG++   Q      +  + 
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 177 CGSPNYVAPEVLANRGYD----------GATSDIWSCGVILYVILTGYLPFDD--RNLAV 224
            G+ NY+ PE + +                 SD+WS G ILY +  G  PF      ++ 
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 225 LYQKIF-RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
           L+  I    + + P       Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 277 LHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 332

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 127/285 (44%), Gaps = 46/285 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y   + +G G+FG V  A+  DSG   A+K + + +           RE+  ++ L H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQIMRKLDHCN 74
Query: 76  VVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQLI 124
           +VRL     S    K ++Y+  VL+YV   E   ++A     +K  L     +    QL 
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVP--ETVYRVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
             ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y 
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSYIC-SRYYR 189
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------FKLP 237
           APE++       ++ D+WS G +L  +L G             Q IF GD       ++ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGDSGVDQLVEII 236
Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
           K L    +  +R+ + PN         IKA  W  + + P  P +
Sbjct: 237 KVLGTPTREQIRE-MNPN-YTEFKFPQIKAHPW-TKVFRPRTPPE 278

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 118/269 (43%), Gaps = 26/269 (9%)
Query: 18  LGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           LG+ LGEG FG V      Q+  + L  AVK ++ +     +I ++   E A +K   HP
Sbjct: 38  LGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREI-EEFLSEAACMKDFSHP 96
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---- 125
           NV+RL  V    S     K  ++L ++  G+L   +    RL+        Q L+     
Sbjct: 97  NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLY-SRLETGPKHIPLQTLLKFMVD 155
Query: 126 ---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGS 179
              G+ Y  N+   HRDL   N +L     + ++DFGLS       ++R   +       
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV-- 213
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLP 237
             ++A E LA+R Y  + SD+W+ GV ++ I T G  P+       +Y  +  G   K P
Sbjct: 214 -KWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQP 271
Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIK 266
           +        ++      +P+ R T + ++
Sbjct: 272 EDCLDELYEIMYSCWRTDPLDRPTFSVLR 300

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 25  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 84
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 85  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 142
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 143 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 201
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
             + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 202 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 234

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 51  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 110
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 111 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 168
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 169 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 227
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
             + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 228 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 260

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKV 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D   S+    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
           PEV+   GY     DIWS G I+  ++ G + F
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 98/213 (46%), Gaps = 18/213 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K+
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKV 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D   S+    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
           PEV+   GY     DIWS G I+  ++ G + F
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLF 225

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 30  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 90  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 147
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 148 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 206
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
             + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 207 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 239

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 126/285 (44%), Gaps = 46/285 (16%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y   + +G G+FG V  A+  DSG   A+K + + +           RE+  ++ L H N
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFK-------NRELQIMRKLDHCN 74
Query: 76  VVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIA-----SKGRLQEAEGRKLFQQLI 124
           +VRL     S    K ++Y+  VL+YV       ++A     +K  L     +    QL 
Sbjct: 75  IVRLRYFFYSSGEKKDEVYLNLVLDYVPATVY--RVARHYSRAKQTLPVIYVKLYMYQLF 132
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
             ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   Q  R +  +   C S  Y 
Sbjct: 133 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK--QLVRGEPNVSXIC-SRYYR 189
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD------FKLP 237
           APE++       ++ D+WS G +L  +L G             Q IF GD       ++ 
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLG-------------QPIFPGDSGVDQLVEII 236
Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
           K L    +  +R+ + PN         IKA  W  + + P  P +
Sbjct: 237 KVLGTPTREQIRE-MNPN-YTEFAFPQIKAHPW-TKVFRPRTPPE 278

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 32  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 91
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 92  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 149
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 150 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 208
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
             + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 209 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 241

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 61/207 (29%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K+L +N     K   +I  E   +  +  P 
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLREN--TSPKANKEILDEAYVMAGVGSPY 80
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + +V + +  G L D +  ++GRL   +      Q+  G+SY  +  
Sbjct: 81  VSRLLGICLT-STVQLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLEDVR 139
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ S  ++KI+DFGL+ L     D+   H   G     ++A E +  R 
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDI--DETEYHADGGKVPIKWMALESILRRR 197
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           +    SD+WS GV ++ ++T G  P+D
Sbjct: 198 FT-HQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 150
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
             + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 210 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 52  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 111
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 112 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 169
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 170 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 228
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
             + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 229 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 261

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 150
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 209
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
             + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 210 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 88  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 145
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 146 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 204
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
             + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 205 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 237

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ Y  
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKYLA 148
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEYYSVHNKTGAKLPVKWMALESL 207
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
             + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 208 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 240

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 34/227 (14%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLKHP 74
           YE+   +G G++G V  A D ++    A+K  + NR+   L    +I REI  L  LK  
Sbjct: 30  YEIKHLIGRGSYGYVYLAYDKNANKNVAIK--KVNRMFEDLIDCKRILREITILNRLKSD 87
Query: 75  NVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            ++RLH+++  +      ++Y+VLE +   +L     +   L E   + +   L+ G  +
Sbjct: 88  YIIRLHDLIIPEDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKF 146
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ-----HFRDDGLLHTTCGSPN--- 181
            H  G+ HRDLK  N LL+   ++KI DFGL+         H  +D         P    
Sbjct: 147 IHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHN 206
Query: 182 ---------------YVAPE-VLANRGYDGATSDIWSCGVILYVILT 212
                          Y APE +L    Y  +  DIWS G I   +L 
Sbjct: 207 KNLKKQLTSHVVTRWYRAPELILLQENYTNSI-DIWSTGCIFAELLN 252

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 18/213 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D   S+    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
           PEV+   GY     DIWS G I+  ++ G + F
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLF 225

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 77/284 (27%), Positives = 123/284 (43%), Gaps = 29/284 (10%)
Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLLKHP 74
           L R LGEG FGKV F  +  +  P   KIL   + +     +  K   RE   L  L+H 
Sbjct: 17  LKRELGEGAFGKV-FLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHE 75
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------------RLQEAEGRKLFQ 121
           ++V+ + V      + MV EY+  G+L   + + G              L +++   + Q
Sbjct: 76  HIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQ 135
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCG 178
           Q+  G+ Y  ++   HRDL   N L+     +KI DFG+S       ++R  G  HT   
Sbjct: 136 QIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG--HTML- 192
Query: 179 SPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKL 236
              ++ PE +  R +    SD+WS GV+L+ I T G  P+   +   + + I +G   + 
Sbjct: 193 PIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR 251
Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           P+        L+    +  P  R  I GI       Q+   A+P
Sbjct: 252 PRTCPQEVYELMLGCWQREPHMRKNIKGIHT---LLQNLAKASP 292

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 106/230 (46%), Gaps = 14/230 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLK 72
           ++ + +G G FG+V         LP   +I    + +    T++ +R    E + +    
Sbjct: 10  KIEQVIGAGEFGEVCSGH---LKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 66
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCH 131
           HPNV+ L  V+   + + ++ E++  G L   +  + G+    +   + + +  G+ Y  
Sbjct: 67  HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA 126
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +    HR L   NIL++S    K+SDFGLS   +    D    +  G      + APE +
Sbjct: 127 DMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 186
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLP 237
             R +  A SD+WS G++++ +++ G  P+ D     +   I   D++LP
Sbjct: 187 QYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI-EQDYRLP 234

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ +  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFLA 150
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
             + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 210 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA------RTAGTSFMMTPYVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
           Y APEV+   GY     DIWS G I+  ++   + F  R+    + K+ 
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 101/212 (47%), Gaps = 9/212 (4%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHNK 133
           V+ L  + L S+    +VL Y+  G+L + I ++      +    F  Q+  G+ +  +K
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 211
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLAN 190
              HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L  
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEFDSVHNKTGAKLPVKWMALESLQT 270
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
           + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 271 QKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 301

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKX 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA------RTAGTSFMMTPYVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVIL 207
           Y APEV+   GY     DIWS G I+
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIM 215

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 38  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 97
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ +  
Sbjct: 98  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFLA 155
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 156 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
             + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 215 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 247

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 72
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVI--QMELDHERMSYLLYQML 129
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 130 XGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA------RTAGTSFMMTPYVVTRY 183
Query: 182 YVAPEVLANRGYDGATSDIWSCGVIL 207
           Y APEV+   GY     DIWS G I+
Sbjct: 184 YRAPEVILGMGY-KENVDIWSVGCIM 208

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 31  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 90
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ +  
Sbjct: 91  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFLA 148
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 149 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
             + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 208 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 240

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 33  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 92
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ +  
Sbjct: 93  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFLA 150
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 151 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
             + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 210 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 242

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 124/259 (47%), Gaps = 17/259 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 26  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V+EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 81  VV-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+      K++DFGL+ L +   ++         P  + APE  A  G     S
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIED--NEXTARQGAKFPIKWTAPEA-ALYGRFTIKS 196
Query: 199 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNP 256
           D+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    +P
Sbjct: 197 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKDP 256
Query: 257 VKRITIAGIKADEWFEQDY 275
            +R T   ++A   F +DY
Sbjct: 257 EERPTFEYLQA---FLEDY 272

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 13/214 (6%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ +  
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFLA 151
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVL 188
           +K   HRDL   N +LD K  +K++DFGL A   + ++   +H   G+     ++A E L
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGL-ARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
             + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 211 QTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 243

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 69/275 (25%), Positives = 122/275 (44%), Gaps = 32/275 (11%)
Query: 17  ELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           + G+TLG G FGKV  A        D+ L  AVK+L+     H    + +  E+  +  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE-----------AEGRKL 119
            +H N+V L         + ++ EY   G+L + +  K R+ E           A  R L
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166
Query: 120 FQ---QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG--LLH 174
                Q+  G+++  +K   HRD+   N+LL +    KI DFGL+   +   +D   ++ 
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDIMNDSNYIVK 223
Query: 175 TTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
                P  ++APE + +  Y    SD+WS G++L+ I + G  P+    +   + K+ + 
Sbjct: 224 GNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 233 DFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            +++  P +      ++++      P  R T   I
Sbjct: 283 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 97/213 (45%), Gaps = 18/213 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D   S+    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
           PEV+   GY     DIWS G I+  ++ G + F
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLF 225

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 124/261 (47%), Gaps = 21/261 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 26  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V+EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 81  VV-SEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 140 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 194
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254
            SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 254
Query: 255 NPVKRITIAGIKADEWFEQDY 275
           +P +R T   ++A   F +DY
Sbjct: 255 DPEERPTFEYLQA---FLEDY 272

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/219 (29%), Positives = 99/219 (45%), Gaps = 31/219 (14%)
Query: 18  LGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LGEG FGKV  A+  +       +  AVK L+   +   K     +RE   L  L+
Sbjct: 19  LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARK---DFQREAELLTNLQ 75
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----------------ASKGRLQEAEG 116
           H ++V+ + V      + MV EY+  G+L   +                 +KG L  ++ 
Sbjct: 76  HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 135
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLL 173
             +  Q+  G+ Y  ++   HRDL   N L+ +   +KI DFG+S       ++R  G  
Sbjct: 136 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG-- 193
Query: 174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
           HT      ++ PE +  R +    SD+WS GVIL+ I T
Sbjct: 194 HTML-PIRWMPPESIMYRKFT-TESDVWSFGVILWEIFT 230

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 17/216 (7%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
                +G G+FG V     LD+ G      +   NRI  +    Q   E   +K   HPN
Sbjct: 34  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 93
Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCH 131
           V+ L  + L S+    +VL Y+  G+L + I ++     +++  G  L  Q+  G+ +  
Sbjct: 94  VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL--QVAKGMKFLA 151
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSP---NYVAPE 186
           +K   HRDL   N +LD K  +K++DFGL+   L + F     +H   G+     ++A E
Sbjct: 152 SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDS---VHNKTGAKLPVKWMALE 208
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
            L  + +    SD+WS GV+L+ ++T G  P+ D N
Sbjct: 209 SLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVN 243

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 102/217 (47%), Gaps = 39/217 (17%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           Y   + +G G+FG V  A+ ++S      K+L+  R  +        RE+  ++++KHPN
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKN--------RELQIMRIVKHPN 93
Query: 76  VVRLHEVLAS----KSKIYM--VLEYVTGGELFDKIASKGRLQEAEGRKLFQ----QLID 125
           VV L     S    K ++++  VLEYV    ++       +L++     L +    QL+ 
Sbjct: 94  VVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLR 152
Query: 126 GVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN--- 181
            ++Y H+ G+ HRD+K +N+LLD   G +K+ DFG + +              G PN   
Sbjct: 153 SLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI-----------LIAGEPNVSX 201
Query: 182 -----YVAPEVLANRGYDGATSDIWSCGVILYVILTG 213
                Y APE++          DIWS G ++  ++ G
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQG 238

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 30/284 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 117
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 174
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 228
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWL 240
           Y APEV+   GY     DIWS G I+  ++   + F  R+    + K+        P+++
Sbjct: 229 YRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
               Q  +R  +E  P      AG+   + F     PA+ + ++
Sbjct: 288 K-KLQPTVRNYVENRP----KYAGLTFPKLFPDSLFPADSEHNK 326

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 123/284 (43%), Gaps = 30/284 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 61  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 117
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 174
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 175 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 228
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-DFKLPKWL 240
           Y APEV+   GY     DIWS G I+  ++   + F  R+    + K+        P+++
Sbjct: 229 YRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 287
Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
               Q  +R  +E  P      AG+   + F     PA+ + ++
Sbjct: 288 K-KLQPTVRNYVENRP----KYAGLTFPKLFPDSLFPADSEHNK 326

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 80
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 137
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 191
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
           Y APEV+   GY     DIWS G I+  ++   + F  R+    + K+ 
Sbjct: 192 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 239

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
           Y APEV+   GY     DIWS G I+  ++   + F  R+    + K+ 
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 70.9 bits (172), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 80
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 137
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 191
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
           Y APEV+   GY     DIWS G I+  ++   + F  R+    + K+ 
Sbjct: 192 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 239

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 73
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 130
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 184
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
           Y APEV+   GY     DIWS G I+  ++   + F  R+    + K+ 
Sbjct: 185 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 232

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 72
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 129
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 130 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 183
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
           Y APEV+   GY     DIWS G I+  ++   + F  R+    + K+ 
Sbjct: 184 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 22  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 78
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 79  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 135
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 136 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 189
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
           Y APEV+   GY     DIWS G I+  ++   + F  R+    + K+ 
Sbjct: 190 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 237

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
           Y APEV+   GY     DIWS G I+  ++   + F  R+    + K+ 
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 73
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 130
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 184
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
           Y APEV+   GY     DIWS G I+  ++   + F  R+    + K+ 
Sbjct: 185 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 232

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 121/281 (43%), Gaps = 36/281 (12%)
Query: 15  RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           R   G+TLG G FGKV  A        D+ +  AVK+L+ +   HL   + +  E+  L 
Sbjct: 40  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 97
Query: 70  LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK------------------GR 110
            L  H N+V L           ++ EY   G+L + +  K                    
Sbjct: 98  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 157
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+++  +K   HRDL   NILL      KI DFGL+   +  ++D
Sbjct: 158 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIKND 214
Query: 171 G--LLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
              ++      P  ++APE + N  Y    SD+WS G+ L+ + + G  P+    +   +
Sbjct: 215 SNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 273
Query: 227 QKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            K+ +  F++  P+       ++++   + +P+KR T   I
Sbjct: 274 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 314

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 100/226 (44%), Gaps = 18/226 (7%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D    +    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMEPEVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
           PEV+   GY     DIWS G I+  ++   + F  R+    + K+ 
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 238

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 121/281 (43%), Gaps = 36/281 (12%)
Query: 15  RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           R   G+TLG G FGKV  A        D+ +  AVK+L+ +   HL   + +  E+  L 
Sbjct: 47  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 104
Query: 70  LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK------------------GR 110
            L  H N+V L           ++ EY   G+L + +  K                    
Sbjct: 105 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 164
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+++  +K   HRDL   NILL      KI DFGL+   +  ++D
Sbjct: 165 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIKND 221
Query: 171 G--LLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
              ++      P  ++APE + N  Y    SD+WS G+ L+ + + G  P+    +   +
Sbjct: 222 SNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 280
Query: 227 QKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            K+ +  F++  P+       ++++   + +P+KR T   I
Sbjct: 281 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 321

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 122/271 (45%), Gaps = 28/271 (10%)
Query: 17  ELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           + G+TLG G FGKV  A        D+ L  AVK+L+     H    + +  E+  +  L
Sbjct: 41  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 98
Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKL--------F 120
            +H N+V L         + ++ EY   G+L + +  K    L + +GR L         
Sbjct: 99  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 158
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG--LLHTTCG 178
            Q+  G+++  +K   HRD+   N+LL +    KI DFGL+   +   +D   ++     
Sbjct: 159 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDIMNDSNYIVKGNAR 215
Query: 179 SP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL 236
            P  ++APE + +  Y    SD+WS G++L+ I + G  P+    +   + K+ +  +++
Sbjct: 216 LPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 274
Query: 237 --PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
             P +      ++++      P  R T   I
Sbjct: 275 AQPAFAPKNIYSIMQACWALEPTHRPTFQQI 305

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 21/261 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 19  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 73
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D  K  +   L+  +   +  Q+  G++Y       HRD
Sbjct: 74  VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 132
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 133 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 187
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254
            SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    
Sbjct: 188 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 247
Query: 255 NPVKRITIAGIKADEWFEQDY 275
            P +R T   ++A   F +DY
Sbjct: 248 EPEERPTFEYLQA---FLEDY 265

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 121/281 (43%), Gaps = 36/281 (12%)
Query: 15  RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           R   G+TLG G FGKV  A        D+ +  AVK+L+ +   HL   + +  E+  L 
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 81
Query: 70  LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK------------------GR 110
            L  H N+V L           ++ EY   G+L + +  K                    
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+++  +K   HRDL   NILL      KI DFGL+   +  ++D
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIKND 198
Query: 171 G--LLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
              ++      P  ++APE + N  Y    SD+WS G+ L+ + + G  P+    +   +
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257
Query: 227 QKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            K+ +  F++  P+       ++++   + +P+KR T   I
Sbjct: 258 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 124/261 (47%), Gaps = 21/261 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 26  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V+EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 81  VV-SEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 140 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 194
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254
            SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 254
Query: 255 NPVKRITIAGIKADEWFEQDY 275
           +P +R T   ++A   F +DY
Sbjct: 255 DPEERPTFEYLQA---FLEDY 272

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKX 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLXQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA------RTAGTSFMMTPYVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
           Y APEV+   GY     DIWS G I+  ++   + F  R+    + K+ 
Sbjct: 191 YRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 99/204 (48%), Gaps = 15/204 (7%)
Query: 22  LGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           LG GNFG V+    +     +  A+K+L++        T+++ RE   +  L +P +VRL
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
             V  +++ + +V+E   GG L   +  K   +  +   +L  Q+  G+ Y   K   HR
Sbjct: 76  IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 139 DLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYD 194
           DL   N+LL ++   KISDFGLS AL     DD              + APE +  R + 
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYTARSAGKWPLKWYAPECINFRKF- 190
Query: 195 GATSDIWSCGVILYVILT-GYLPF 217
            + SD+WS GV ++  L+ G  P+
Sbjct: 191 SSRSDVWSYGVTMWEALSYGQKPY 214

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 123/261 (47%), Gaps = 21/261 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 26  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 81  VV-SEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 140 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 194
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254
            SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 254
Query: 255 NPVKRITIAGIKADEWFEQDY 275
           +P +R T   ++A   F +DY
Sbjct: 255 DPEERPTFEYLQA---FLEDY 272

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 121/261 (46%), Gaps = 21/261 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 17  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 71
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D +  +    L+  +   +  Q+  G++Y       HRD
Sbjct: 72  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 130
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 131 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 185
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254
            SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    
Sbjct: 186 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 245
Query: 255 NPVKRITIAGIKADEWFEQDY 275
           +P +R T   ++A   F +DY
Sbjct: 246 DPEERPTFEYLQA---FLEDY 263

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 18  LGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           LG+TLGEG FGKV  A              AVK+L++N     ++ D +  E   LK + 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS-ELRDLLS-EFNVLKQVN 84
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASK--------------GRLQEAEG 116
           HP+V++L+   +    + +++EY   G L  F + + K                L   + 
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 117 RKLFQ--------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
           R L          Q+  G+ Y     + HRDL   NIL+     +KISDFGLS     + 
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSR--DVYE 202
Query: 169 DDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 225
           +D  +  + G     ++A E L +  Y    SD+WS GV+L+ I+T G  P+       L
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
Query: 226 YQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
           +  +  G   + P   S     L+ +  +  P KR   A I  D
Sbjct: 262 FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKX 79
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVME-LMDANLCQVI--QMELDHERMSYLLYQML 136
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 137 CGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLA------RTAGTSFMMTPYVVTRY 190
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
           Y APEV+   GY     DIWS G I+  ++   + F  R+    + K+ 
Sbjct: 191 YRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/271 (25%), Positives = 122/271 (45%), Gaps = 28/271 (10%)
Query: 17  ELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           + G+TLG G FGKV  A        D+ L  AVK+L+     H    + +  E+  +  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKL--------F 120
            +H N+V L         + ++ EY   G+L + +  K    L + +GR L         
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLLHFS 166
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG--LLHTTCG 178
            Q+  G+++  +K   HRD+   N+LL +    KI DFGL+   +   +D   ++     
Sbjct: 167 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDIMNDSNYIVKGNAR 223
Query: 179 SP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL 236
            P  ++APE + +  Y    SD+WS G++L+ I + G  P+    +   + K+ +  +++
Sbjct: 224 LPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 282
Query: 237 --PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
             P +      ++++      P  R T   I
Sbjct: 283 AQPAFAPKNIYSIMQACWALEPTHRPTFQQI 313

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 71/281 (25%), Positives = 121/281 (43%), Gaps = 36/281 (12%)
Query: 15  RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           R   G+TLG G FGKV  A        D+ +  AVK+L+ +   HL   + +  E+  L 
Sbjct: 42  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 99
Query: 70  LL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK------------------GR 110
            L  H N+V L           ++ EY   G+L + +  K                    
Sbjct: 100 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 159
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+++  +K   HRDL   NILL      KI DFGL+   +  ++D
Sbjct: 160 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIKND 216
Query: 171 G--LLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
              ++      P  ++APE + N  Y    SD+WS G+ L+ + + G  P+    +   +
Sbjct: 217 SNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 275
Query: 227 QKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            K+ +  F++  P+       ++++   + +P+KR T   I
Sbjct: 276 YKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 316

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 106/238 (44%), Gaps = 33/238 (13%)
Query: 1   MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD- 59
           MVI + K        Y   + LGEG F  V   + L  G  +A+K     RI+  +  D 
Sbjct: 23  MVIIDNKH-------YLFIQKLGEGGFSYVDLVEGLHDGHFYALK-----RILCHEQQDR 70
Query: 60  -QIKREIATLKLLKHPNVVRLHEVL----ASKSKIYMVLEYVTGGELFDKIA---SKGR- 110
            + +RE    +L  HPN++RL         +K + +++L +   G L+++I     KG  
Sbjct: 71  EEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF 130
Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG--------LSA 162
           L E +   L   +  G+   H KG  HRDLK  NILL  +G   + D G        +  
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD--GATSDIWSCGVILYVILTGYLPFD 218
             Q           C + +Y APE+ + + +      +D+WS G +LY ++ G  P+D
Sbjct: 191 SRQALTLQDWAAQRC-TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYD 247

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 123/261 (47%), Gaps = 21/261 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 26  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 81  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 140 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 194
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254
            SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 254
Query: 255 NPVKRITIAGIKADEWFEQDY 275
           +P +R T   ++A   F +DY
Sbjct: 255 DPEERPTFEYLQA---FLEDY 272

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D    +    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPEVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
           PEV+   GY     DIWS G I+  ++ G + F
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLF 225

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 119/259 (45%), Gaps = 17/259 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 23  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY+  G L D  K  +   L+  +   +  Q+  G++Y       HRD
Sbjct: 78  VV-SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+      K++DFGL+ L +   ++         P  + APE  A  G     S
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIED--NEWTARQGAKFPIKWTAPEA-ALYGRFTIKS 193
Query: 199 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNP 256
           D+WS G++L  + T G +P+       +  ++ RG     P        +L+ +     P
Sbjct: 194 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 253
Query: 257 VKRITIAGIKADEWFEQDY 275
            +R T   ++A   F +DY
Sbjct: 254 EERPTFEYLQA---FLEDY 269

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 122/275 (44%), Gaps = 32/275 (11%)
Query: 17  ELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           + G+TLG G FGKV  A        D+ L  AVK+L+     H    + +  E+  +  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAE-----------GRKL 119
            +H N+V L         + ++ EY   G+L + +  K R+ E +            R L
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTLSTRDL 166
Query: 120 FQ---QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG--LLH 174
                Q+  G+++  +K   HRD+   N+LL +    KI DFGL+   +   +D   ++ 
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDIMNDSNYIVK 223
Query: 175 TTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
                P  ++APE + +  Y    SD+WS G++L+ I + G  P+    +   + K+ + 
Sbjct: 224 GNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKD 282
Query: 233 DFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            +++  P +      ++++      P  R T   I
Sbjct: 283 GYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 317

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 121/261 (46%), Gaps = 21/261 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 15  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 69
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D +  +    L+  +   +  Q+  G++Y       HRD
Sbjct: 70  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 128
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 129 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 183
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254
            SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    
Sbjct: 184 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 243
Query: 255 NPVKRITIAGIKADEWFEQDY 275
           +P +R T   ++A   F +DY
Sbjct: 244 DPEERPTFEYLQA---FLEDY 261

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 21/261 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 192 LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D  K  +   L+  +   +  Q+  G++Y       HRD
Sbjct: 247 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 360
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254
            SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 420
Query: 255 NPVKRITIAGIKADEWFEQDY 275
            P +R T   ++A   F +DY
Sbjct: 421 EPEERPTFEYLQA---FLEDY 438

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 21/261 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 275 LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D  K  +   L+  +   +  Q+  G++Y       HRD
Sbjct: 330 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 389 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 443
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254
            SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 503
Query: 255 NPVKRITIAGIKADEWFEQDY 275
            P +R T   ++A   F +DY
Sbjct: 504 EPEERPTFEYLQA---FLEDY 521

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 21/261 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 192 LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D  K  +   L+  +   +  Q+  G++Y       HRD
Sbjct: 247 VV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 360
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254
            SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 420
Query: 255 NPVKRITIAGIKADEWFEQDY 275
            P +R T   ++A   F +DY
Sbjct: 421 EPEERPTFEYLQA---FLEDY 438

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 125/284 (44%), Gaps = 53/284 (18%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK----HPN 75
           + LG G+ G V F      G P AVK +         + D     +  +KLL     HPN
Sbjct: 39  KILGYGSSGTVVFQGSF-QGRPVAVKRM---------LIDFCDIALMEIKLLTESDDHPN 88
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG------RLQ-EAEGRKLFQQLIDGVS 128
           V+R +    +   +Y+ LE +    L D + SK       +LQ E     L +Q+  GV+
Sbjct: 89  VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 147
Query: 129 YCHNKGVFHRDLKLENILLDSKG-------------NIKISDFGLS----ALPQHFRDDG 171
           + H+  + HRDLK +NIL+ +                I ISDFGL     +    FR + 
Sbjct: 148 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXN- 206
Query: 172 LLHTTCGSPNYVAPEVLANRGYDGATS--DIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228
            L+   G+  + APE+L        T   DI+S G + Y IL+ G  PF D+        
Sbjct: 207 -LNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK--YSRESN 263
Query: 229 IFRGDFKL-------PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
           I RG F L        + L   A +L+ ++++ +P+KR T   +
Sbjct: 264 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 307

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 119/261 (45%), Gaps = 21/261 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 23  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 77
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY+  G L D  K  +   L+  +   +  Q+  G++Y       HRD
Sbjct: 78  VV-SEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 137 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 191
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254
            SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    
Sbjct: 192 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 251
Query: 255 NPVKRITIAGIKADEWFEQDY 275
            P +R T   ++A   F +DY
Sbjct: 252 EPEERPTFEYLQA---FLEDY 269

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D    +    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
           PEV+   GY     DIWS G I+  ++ G + F
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLF 225

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 24  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 80
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D    +    E +  +   L  Q++ G+
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 141 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 194
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
           PEV+   GY     DIWS G I+  ++ G + F
Sbjct: 195 PEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLF 226

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 82/284 (28%), Positives = 125/284 (44%), Gaps = 53/284 (18%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK----HPN 75
           + LG G+ G V F      G P AVK +         + D     +  +KLL     HPN
Sbjct: 39  KILGYGSSGTVVFQGSF-QGRPVAVKRM---------LIDFCDIALMEIKLLTESDDHPN 88
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG------RLQ-EAEGRKLFQQLIDGVS 128
           V+R +    +   +Y+ LE +    L D + SK       +LQ E     L +Q+  GV+
Sbjct: 89  VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 147
Query: 129 YCHNKGVFHRDLKLENILLDSKG-------------NIKISDFGLS----ALPQHFRDDG 171
           + H+  + HRDLK +NIL+ +                I ISDFGL     +    FR + 
Sbjct: 148 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXN- 206
Query: 172 LLHTTCGSPNYVAPEVLANRGYDGATS--DIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228
            L+   G+  + APE+L        T   DI+S G + Y IL+ G  PF D+        
Sbjct: 207 -LNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK--YSRESN 263
Query: 229 IFRGDFKL-------PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
           I RG F L        + L   A +L+ ++++ +P+KR T   +
Sbjct: 264 IIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 307

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 18/226 (7%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D    +    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMEPEVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
           PEV+   GY     D+WS G I+  ++   + F  R+    + K+ 
Sbjct: 194 PEVILGMGYK-ENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 238

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 23  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 79
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D    +    E +  +   L  Q++ G+
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 193
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
           PEV+   GY     DIWS G I+  ++ G + F
Sbjct: 194 PEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLF 225

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 18  LGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           LG+TLGEG FGKV  A              AVK+L++N     ++ D +  E   LK + 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS-ELRDLLS-EFNVLKQVN 84
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASK--------------GRLQEAEG 116
           HP+V++L+   +    + +++EY   G L  F + + K                L   + 
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 117 RKLFQ--------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
           R L          Q+  G+ Y     + HRDL   NIL+     +KISDFGLS     + 
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR--DVYE 202
Query: 169 DDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 225
           +D  +  + G     ++A E L +  Y    SD+WS GV+L+ I+T G  P+       L
Sbjct: 203 EDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
Query: 226 YQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
           +  +  G   + P   S     L+ +  +  P KR   A I  D
Sbjct: 262 FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 123/284 (43%), Gaps = 38/284 (13%)
Query: 18  LGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           LG+TLGEG FGKV  A              AVK+L++N     ++ D +  E   LK + 
Sbjct: 27  LGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPS-ELRDLLS-EFNVLKQVN 84
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASK--------------GRLQEAEG 116
           HP+V++L+   +    + +++EY   G L  F + + K                L   + 
Sbjct: 85  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 117 RKLFQ--------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
           R L          Q+  G+ Y     + HRDL   NIL+     +KISDFGLS     + 
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR--DVYE 202
Query: 169 DDGLLHTTCGS--PNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 225
           +D  +  + G     ++A E L +  Y    SD+WS GV+L+ I+T G  P+       L
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261
Query: 226 YQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
           +  +  G   + P   S     L+ +  +  P KR   A I  D
Sbjct: 262 FNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 123/261 (47%), Gaps = 21/261 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K ++H  +V+L+ 
Sbjct: 26  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKIRHEKLVQLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 81  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 140 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 194
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254
            SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 254
Query: 255 NPVKRITIAGIKADEWFEQDY 275
           +P +R T   ++A   F +DY
Sbjct: 255 DPEERPTFEYLQA---FLEDY 272

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 122/261 (46%), Gaps = 21/261 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 193 LGQGCFGEV-WMGTWNGTTRVAIKTLKPGNMS----PEAFLQEAQVMKKLRHEKLVQLYA 247
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 248 VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 306
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL  L     +D       G+     + APE  A  G    
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLI----EDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 361
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254
            SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    
Sbjct: 362 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 421
Query: 255 NPVKRITIAGIKADEWFEQDY 275
           +P +R T   ++A   F +DY
Sbjct: 422 DPEERPTFEYLQA---FLEDY 439

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 123/261 (47%), Gaps = 21/261 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 26  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 81  VV-SEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 140 LRAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 194
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254
            SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 254
Query: 255 NPVKRITIAGIKADEWFEQDY 275
           +P +R T   ++A   F +DY
Sbjct: 255 DPEERPTFEYLQA---FLEDY 272

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 122/261 (46%), Gaps = 21/261 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 26  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 80
Query: 82  VLASKSKIYMVLEYVTGGELFDKIASK-GR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D +  + G+ L+  +   +  Q+  G++Y       HRD
Sbjct: 81  VV-SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L   NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 140 LAAANILVGENLVCKVADFGLARL----IEDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 194
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254
            SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 254
Query: 255 NPVKRITIAGIKADEWFEQDY 275
           +P +R T   ++A   F +DY
Sbjct: 255 DPEERPTFEYLQA---FLEDY 272

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 113/269 (42%), Gaps = 28/269 (10%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVR 78
           LGEG FGKV F  +  + LP   K+L   + +           +RE   L +L+H ++VR
Sbjct: 49  LGEGAFGKV-FLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASK---------------GRLQEAEGRKLFQQL 123
              V      + MV EY+  G+L   + S                G L   +   +  Q+
Sbjct: 108 FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 167
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSP 180
             G+ Y       HRDL   N L+     +KI DFG+S       ++R  G    T    
Sbjct: 168 AAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG---RTMLPI 224
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK 238
            ++ PE +  R +    SD+WS GV+L+ I T G  P+   +       I +G + + P+
Sbjct: 225 RWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR 283
Query: 239 WLSPGAQNLLRKILEPNPVKRITIAGIKA 267
              P    ++R   +  P +R +I  + A
Sbjct: 284 ACPPEVYAIMRGCWQREPQQRHSIKDVHA 312

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 18/213 (8%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 25  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 81
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D    +    E +  +   L  Q++ G+
Sbjct: 82  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 141
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 142 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMVPFVVTRYYRA 195
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
           PEV+   GY     DIWS G I+  ++ G + F
Sbjct: 196 PEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLF 227

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 113/269 (42%), Gaps = 28/269 (10%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVR 78
           LGEG FGKV F  +  + LP   K+L   + +           +RE   L +L+H ++VR
Sbjct: 26  LGEGAFGKV-FLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASK---------------GRLQEAEGRKLFQQL 123
              V      + MV EY+  G+L   + S                G L   +   +  Q+
Sbjct: 85  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 144
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSP 180
             G+ Y       HRDL   N L+     +KI DFG+S       ++R  G    T    
Sbjct: 145 AAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG---RTMLPI 201
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK 238
            ++ PE +  R +    SD+WS GV+L+ I T G  P+   +       I +G + + P+
Sbjct: 202 RWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR 260
Query: 239 WLSPGAQNLLRKILEPNPVKRITIAGIKA 267
              P    ++R   +  P +R +I  + A
Sbjct: 261 ACPPEVYAIMRGCWQREPQQRHSIKDVHA 289

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 102/229 (44%), Gaps = 24/229 (10%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 17  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 73
Query: 71  LKHPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           + H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++
Sbjct: 74  VNHKNIIGLLNVFTPQKSLEEFQDVYIVME-LMDANLCQVI--QMELDHERMSYLLYQML 130
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPN 181
            G+ + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  
Sbjct: 131 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRY 184
Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
           Y APEV+   GY     D+WS G I+  ++   + F  R+    + K+ 
Sbjct: 185 YRAPEVILGMGYK-ENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 232

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/226 (26%), Positives = 100/226 (44%), Gaps = 18/226 (7%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKL 70
           L RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K 
Sbjct: 28  LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKC 84
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK---LFQQLIDGV 127
           + H N++ L  V   +  +    +     EL D    +    E +  +   L  Q++ G+
Sbjct: 85  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 144
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG---LLHTTCGSPNYVA 184
            + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   ++     +  Y A
Sbjct: 145 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYYRA 198
Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
           PEV+   GY     D+WS G I+  ++   + F  R+    + K+ 
Sbjct: 199 PEVILGMGYK-ENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 243

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 71/269 (26%), Positives = 113/269 (42%), Gaps = 28/269 (10%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLLKHPNVVR 78
           LGEG FGKV F  +  + LP   K+L   + +           +RE   L +L+H ++VR
Sbjct: 20  LGEGAFGKV-FLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 79  LHEVLASKSKIYMVLEYVTGGELFDKIASK---------------GRLQEAEGRKLFQQL 123
              V      + MV EY+  G+L   + S                G L   +   +  Q+
Sbjct: 79  FFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQV 138
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRDDGLLHTTCGSP 180
             G+ Y       HRDL   N L+     +KI DFG+S       ++R  G    T    
Sbjct: 139 AAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGG---RTMLPI 195
Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPK 238
            ++ PE +  R +    SD+WS GV+L+ I T G  P+   +       I +G + + P+
Sbjct: 196 RWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR 254
Query: 239 WLSPGAQNLLRKILEPNPVKRITIAGIKA 267
              P    ++R   +  P +R +I  + A
Sbjct: 255 ACPPEVYAIMRGCWQREPQQRHSIKDVHA 283

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 105/207 (50%), Gaps = 18/207 (8%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-P 74
           Y+L R LG G + +V  A ++ +     VKIL+  +       ++IKREI  L+ L+  P
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KNKIKREIKILENLRGGP 92
Query: 75  NVVRLHEVL---ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           N++ L +++    S++   +V E+V   + F ++     L + + R    +++  + YCH
Sbjct: 93  NIITLADIVKDPVSRTPA-LVFEHVNNTD-FKQLYQT--LTDYDIRFYMYEILKALDYCH 148
Query: 132 NKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           + G+ HRD+K  N+++D +   +++ D+GL+     +      +    S  +  PE+L +
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF---YHPGQEYNVRVASRYFKGPELLVD 205
Query: 191 RGYDGATSDIWSCGVILYVILTGYLPF 217
                 + D+WS G +L  ++    PF
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPF 232

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 65/251 (25%), Positives = 115/251 (45%), Gaps = 12/251 (4%)
Query: 20  RTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           R +G+G+FG V   + +D     +  A+K L  +RI  ++  +   RE   ++ L HPNV
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 77  VRLHEVLASKSKI-YMVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYCHNKG 134
           + L  ++     + +++L Y+  G+L   I S  R    +    F  Q+  G+ Y   + 
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK 144
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLS--ALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             HRDL   N +LD    +K++DFGL+   L + +              + A E L    
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR 204
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250
           +    SD+WS GV+L+ +LT G  P+   +   L   + +G     P++       ++++
Sbjct: 205 FT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQVMQQ 263
Query: 251 ILEPNPVKRIT 261
             E +P  R T
Sbjct: 264 CWEADPAVRPT 274

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 120/261 (45%), Gaps = 21/261 (8%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 192 LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  IY+V EY++ G L D  K  +   L+  +   +  Q+  G++Y       HRD
Sbjct: 247 VV-SEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP---NYVAPEVLANRGYDGA 196
           L+  NIL+      K++DFGL+ L     +D       G+     + APE  A  G    
Sbjct: 306 LRAANILVGENLVCKVADFGLARLI----EDNEYTARQGAKFPIKWTAPEA-ALYGRFTI 360
Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP 254
            SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +    
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRK 420
Query: 255 NPVKRITIAGIKADEWFEQDY 275
            P +R T   ++A   F +DY
Sbjct: 421 EPEERPTFEYLQA---FLEDY 438

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/245 (27%), Positives = 116/245 (47%), Gaps = 37/245 (15%)
Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAV-KILEKNRIIHLKITDQIK 62
           A  ++    + R+++ R  G+G FG V+  ++  +G+  A+ K+++  R  + ++  QI 
Sbjct: 13  AADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL--QIM 70
Query: 63  REIATLKLLKHPNVVRLHEVLAS-----KSKIYM--VLEYVTGGELFDKIASKGRLQEAE 115
           +++A   +L HPN+V+L     +     +  IY+  V+EYV    L     +  R Q A 
Sbjct: 71  QDLA---VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAP 126
Query: 116 GRKLFQ----QLIDGVSYCH--NKGVFHRDLKLENILL-DSKGNIKISDFGLSALPQHFR 168
              L +    QLI  +   H  +  V HRD+K  N+L+ ++ G +K+ DFG SA      
Sbjct: 127 PPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFG-SAKKLSPS 185
Query: 169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK 228
           +  + +    S  Y APE++    +     DIWS G I   ++ G             + 
Sbjct: 186 EPNVAYIC--SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG-------------EP 230
Query: 229 IFRGD 233
           IFRGD
Sbjct: 231 IFRGD 235

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 15/204 (7%)
Query: 22  LGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           LG GNFG V+    +     +  A+K+L++        T+++ RE   +  L +P +VRL
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
             V  +++ + +V+E   GG L   +  K   +  +   +L  Q+  G+ Y   K   HR
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP----NYVAPEVLANRGYD 194
           +L   N+LL ++   KISDFGLS   +    D   +T   +      + APE +  R + 
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLS---KALGADDSYYTARSAGKWPLKWYAPECINFRKF- 516
Query: 195 GATSDIWSCGVILYVILT-GYLPF 217
            + SD+WS GV ++  L+ G  P+
Sbjct: 517 SSRSDVWSYGVTMWEALSYGQKPY 540

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 100/223 (44%), Gaps = 29/223 (13%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLKHP 74
           Y +   +G G++G V  A D ++    A+K  + NR+   L    +I REI  L  LK  
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 75  NVVRLHEV-----LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            ++RL+++     L    ++Y+VLE +   +L     +   L E   + +   L+ G ++
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYIVLE-IADSDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL----------------- 172
            H  G+ HRDLK  N LL+   ++K+ DFGL+      +D  +                 
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNL 204
Query: 173 ---LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
              L +   +  Y APE++  +     + DIWS G I   +L 
Sbjct: 205 KKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 41/235 (17%)
Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPF------AVKILEKNRIIHLKITDQIKREIATLKL 70
           E  R +GEG FG+V F       LP+      AVK+L++     ++     +RE A +  
Sbjct: 50  EYVRDIGEGAFGRV-FQARAPGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALMAE 106
Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD----------------------KIASK 108
             +PN+V+L  V A    + ++ EY+  G+L +                      +++S 
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 109 GR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---L 163
           G   L  AE   + +Q+  G++Y   +   HRDL   N L+     +KI+DFGLS     
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
             +++ DG          ++ PE +    Y    SD+W+ GV+L+ I + G  P+
Sbjct: 227 ADYYKADG---NDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPY 277

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 122/292 (41%), Gaps = 63/292 (21%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKIL------EKNRIIHLKITDQIKREIATLKLLKHPN 75
           +G G  G+V   +   +G   AVK +      E+N+ I + +          LK    P 
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLD-------VVLKSHDCPY 85
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK 133
           +V+      + + +++ +E +  G   +K+  +  G + E    K+   ++  + Y   K
Sbjct: 86  IVQCFGTFITNTDVFIAMELM--GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 134 -GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL---- 188
            GV HRD+K  NILLD +G IK+ DFG+S       DD     + G   Y+APE +    
Sbjct: 144 HGVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPD 200
Query: 189 -ANRGYDGATSDIWSCGVILYVILTGYLPFDD--RNLAVLYQKI------------FRGD 233
                YD   +D+WS G+ L  + TG  P+ +   +  VL + +            F GD
Sbjct: 201 PTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGD 259
Query: 234 F-------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272
           F             K PK+          K+LE + +KR     +    WF+
Sbjct: 260 FQSFVKDCLTKDHRKRPKY---------NKLLEHSFIKRYETLEVDVASWFK 302

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 65/245 (26%), Positives = 101/245 (41%), Gaps = 36/245 (14%)
Query: 2   VIAEKKQEGMR---LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-- 56
           +I + KQ  ++   L        LGE  FGKV        G  F     E+ + + +K  
Sbjct: 11  LINQHKQAKLKEISLSAVRFMEELGEDRFGKVY------KGHLFGPAPGEQTQAVAIKTL 64
Query: 57  -------ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELF------- 102
                  + ++ + E      L+HPNVV L  V+     + M+  Y + G+L        
Sbjct: 65  KDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRS 124
Query: 103 ---------DKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNI 153
                    D    K  L+  +   L  Q+  G+ Y  +  V H+DL   N+L+  K N+
Sbjct: 125 PHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV 184
Query: 154 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT- 212
           KISD GL           LL  +     ++APE +   G     SDIWS GV+L+ + + 
Sbjct: 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIM-YGKFSIDSDIWSYGVVLWEVFSY 243
Query: 213 GYLPF 217
           G  P+
Sbjct: 244 GLQPY 248

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 128/291 (43%), Gaps = 63/291 (21%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK----HPN 75
           + LG G+ G V F      G P AVK +         + D     +  +KLL     HPN
Sbjct: 21  KILGYGSSGTVVFQGSF-QGRPVAVKRM---------LIDFCDIALMEIKLLTESDDHPN 70
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG------RLQ-EAEGRKLFQQLIDGVS 128
           V+R +    +   +Y+ LE +    L D + SK       +LQ E     L +Q+  GV+
Sbjct: 71  VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 129 YCHNKGVFHRDLKLENILLDSKG-------------NIKISDFGLS----ALPQHFRDDG 171
           + H+  + HRDLK +NIL+ +                I ISDFGL     +    FR + 
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTN- 188
Query: 172 LLHTTCGSPNYVAPEV------LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 224
            L+   G+  + APE+      L  +     + DI+S G + Y IL+ G  PF D+    
Sbjct: 189 -LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK---- 243
Query: 225 LYQK---IFRGDFKL-------PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            Y +   I RG F L        + L   A +L+ ++++ +P+KR T   +
Sbjct: 244 -YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/259 (26%), Positives = 119/259 (45%), Gaps = 17/259 (6%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG+G FG+V +    +     A+K L+   +      +   +E   +K L+H  +V+L+ 
Sbjct: 16  LGQGCFGEV-WMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA 70
Query: 82  VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRD 139
           V+ S+  I +V EY++ G L D  K  +   L+  +   +  Q+  G++Y       HRD
Sbjct: 71  VV-SEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 129
Query: 140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGATS 198
           L+  NIL+      K++DFGL+ L +   ++         P  + APE  A  G     S
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIED--NEXTARQGAKFPIKWTAPEA-ALYGRFTIKS 186
Query: 199 DIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNP 256
           D+WS G++L  + T G +P+       +  ++ RG     P        +L+ +     P
Sbjct: 187 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEP 246
Query: 257 VKRITIAGIKADEWFEQDY 275
            +R T   ++A   F +DY
Sbjct: 247 EERPTFEYLQA---FLEDY 262

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 76  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 134
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 135 RDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYKF-SS 193
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 194 KSDVWSFGVLMW 205

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 106/224 (47%), Gaps = 18/224 (8%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILE--KNRIIHLKITDQIKREIATLKLLKH 73
           + LG G FG V     +  G    +P  +K++E    R     +TD +      +  L H
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHM----LAIGSLDH 92
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
            ++VRL   L   S + +V +Y+  G L D +   +G L          Q+  G+ Y   
Sbjct: 93  AHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 151
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSP-NYVAPEVLAN 190
            G+ HR+L   N+LL S   ++++DFG++  LP    D  LL++   +P  ++A E +  
Sbjct: 152 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD--DKQLLYSEAKTPIKWMALESIHF 209
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD 233
             Y    SD+WS GV ++ ++T G  P+    LA +   + +G+
Sbjct: 210 GKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE 252

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 92  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 150
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 151 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SS 209
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 210 KSDVWSFGVLMW 221

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 91
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 92  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 150
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 151 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SS 209
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 210 KSDVWSFGVLMW 221

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 93/222 (41%), Gaps = 33/222 (14%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---------ITDQIKREIATLKLLK 72
           LGE  FGKV        G  F     E+ + + +K         + ++ + E      L+
Sbjct: 17  LGEDRFGKVY------KGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ 70
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELF----------------DKIASKGRLQEAEG 116
           HPNVV L  V+     + M+  Y + G+L                 D    K  L+  + 
Sbjct: 71  HPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDF 130
Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
             L  Q+  G+ Y  +  V H+DL   N+L+  K N+KISD GL           LL  +
Sbjct: 131 VHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNS 190
Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
                ++APE +   G     SDIWS GV+L+ + + G  P+
Sbjct: 191 LLPIRWMAPEAIMY-GKFSIDSDIWSYGVVLWEVFSYGLQPY 231

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 70/261 (26%), Positives = 111/261 (42%), Gaps = 55/261 (21%)
Query: 17  ELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKRE--IATLK 69
           E G+ LG G FGKV  A           +  AVK+L++         D  +RE  ++ LK
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-------ADSSEREALMSELK 100
Query: 70  LL----KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--------------GRL 111
           ++     H N+V L         IY++ EY   G+L + + SK               RL
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 112 QEAEGRKLFQ---------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162
           +E E   +           Q+  G+ +   K   HRDL   N+L+     +KI DFGL+ 
Sbjct: 161 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA- 219
Query: 163 LPQHFRD-----DGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYL 215
                RD     + ++      P  ++APE L   G     SD+WS G++L+ I + G  
Sbjct: 220 -----RDIMSDSNYVVRGNARLPVKWMAPESLF-EGIYTIKSDVWSYGILLWEIFSLGVN 273
Query: 216 PFDDRNLAVLYQKIFRGDFKL 236
           P+    +   + K+ +  FK+
Sbjct: 274 PYPGIPVDANFYKLIQNGFKM 294

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 82/291 (28%), Positives = 128/291 (43%), Gaps = 63/291 (21%)
Query: 20  RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK----HPN 75
           + LG G+ G V F      G P AVK +         + D     +  +KLL     HPN
Sbjct: 21  KILGYGSSGTVVFQGSF-QGRPVAVKRM---------LIDFCDIALMEIKLLTESDDHPN 70
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG------RLQ-EAEGRKLFQQLIDGVS 128
           V+R +    +   +Y+ LE +    L D + SK       +LQ E     L +Q+  GV+
Sbjct: 71  VIRYYCSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVA 129
Query: 129 YCHNKGVFHRDLKLENILLDSKG-------------NIKISDFGLS----ALPQHFRDDG 171
           + H+  + HRDLK +NIL+ +                I ISDFGL     +    FR + 
Sbjct: 130 HLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXN- 188
Query: 172 LLHTTCGSPNYVAPEV------LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 224
            L+   G+  + APE+      L  +     + DI+S G + Y IL+ G  PF D+    
Sbjct: 189 -LNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK---- 243
Query: 225 LYQK---IFRGDFKL-------PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            Y +   I RG F L        + L   A +L+ ++++ +P+KR T   +
Sbjct: 244 -YSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/214 (28%), Positives = 101/214 (47%), Gaps = 18/214 (8%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILE--KNRIIHLKITDQIKREIATLKLLKH 73
           + LG G FG V     +  G    +P  +K++E    R     +TD +      +  L H
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHM----LAIGSLDH 74
Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
            ++VRL   L   S + +V +Y+  G L D +   +G L          Q+  G+ Y   
Sbjct: 75  AHIVRLLG-LCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSP-NYVAPEVLAN 190
            G+ HR+L   N+LL S   ++++DFG++  LP    D  LL++   +P  ++A E +  
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD--DKQLLYSEAKTPIKWMALESIHF 191
Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 223
             Y    SD+WS GV ++ ++T G  P+    LA
Sbjct: 192 GKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLA 224

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 89
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 90  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 148
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 149 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SS 207
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 208 KSDVWSFGVLMW 219

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 81
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 82  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 140
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 141 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SS 199
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 200 KSDVWSFGVLMW 211

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 72  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SS 189
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 190 KSDVWSFGVLMW 201

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 69
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 70  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 128
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 129 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SS 187
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 188 KSDVWSFGVLMW 199

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 75
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 76  RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 134
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 135 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKF-SS 193
Query: 197 TSDIWSCGVILY 208
            SD+WS GV+++
Sbjct: 194 KSDVWSFGVLMW 205

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/209 (26%), Positives = 100/209 (47%), Gaps = 21/209 (10%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA----TLKLLKHPNVV 77
           LG G +G V+  + + SG   AVK     RI     + + KR +     +++ +  P  V
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVK-----RIRATVNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 78  RLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNK- 133
             +  L  +  +++ +E +     + + ++  KG+ + E    K+   ++  + + H+K 
Sbjct: 70  TFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE----VLA 189
            V HRD+K  N+L+++ G +K+ DFG+S    +  DD       G   Y+APE     L 
Sbjct: 130 SVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPERINPELN 186
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD 218
            +GY    SDIWS G+ +  +     P+D
Sbjct: 187 QKGY-SVKSDIWSLGITMIELAILRFPYD 214

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 7/202 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 433
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 434 RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 492
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 493 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-S 551
Query: 197 TSDIWSCGVILYVILT-GYLPF 217
            SD+WS GV+++   + G  P+
Sbjct: 552 KSDVWSFGVLMWEAFSYGQKPY 573

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/109 (38%), Positives = 58/109 (53%), Gaps = 11/109 (10%)
Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL-- 188
            N  + HRD+K  NILLD  GNIK+ DFG+S       D        G   Y+APE +  
Sbjct: 143 ENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYMAPERIDP 199
Query: 189 --ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ--KIFRGD 233
             + +GYD   SD+WS G+ LY + TG  P+   N +V  Q  ++ +GD
Sbjct: 200 SASRQGYD-VRSDVWSLGITLYELATGRFPYPKWN-SVFDQLTQVVKGD 246

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+KIL  N     K   +   E   +  + HP+
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPH 101
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----QQLIDGVSYCH 131
           +VRL  V  S + I +V + +  G L + +      ++  G +L      Q+  G+ Y  
Sbjct: 102 LVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEH---KDNIGSQLLLNWCVQIAKGMMYLE 157
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSAL-----PQHFRDDGLLHTTCGSPNYVAPE 186
            + + HRDL   N+L+ S  ++KI+DFGL+ L      ++  D G +        ++A E
Sbjct: 158 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI-----KWMALE 212
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFD 218
            +  R +    SD+WS GV ++ ++T G  P+D
Sbjct: 213 CIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYD 244

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/284 (23%), Positives = 122/284 (42%), Gaps = 41/284 (14%)
Query: 17  ELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           + G+TLG G FGKV  A        D+ L  AVK+L+     H    + +  E+  +  L
Sbjct: 34  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 91
Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR---------------LQEAE 115
            +H N+V L         + ++ EY   G+L + +  K                 L + +
Sbjct: 92  GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEGLDKED 151
Query: 116 GRKL--------FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167
           GR L          Q+  G+++  +K   HRD+   N+LL +    KI DFGL+   +  
Sbjct: 152 GRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDI 208
Query: 168 RDDG--LLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 223
            +D   ++      P  ++APE + +  Y    SD+WS G++L+ I + G  P+    + 
Sbjct: 209 MNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVN 267
Query: 224 VLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
             + K+ +  +++  P +      ++++      P  R T   I
Sbjct: 268 SKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 311

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 97/202 (48%), Gaps = 7/202 (3%)
Query: 20  RTLGEGNFGKVK--FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK  + Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 434
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +  ++S + +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 435 RMIGICEAESWM-LVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 493
Query: 138 RDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS   +   +     T    P  + APE +    +  +
Sbjct: 494 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-S 552
Query: 197 TSDIWSCGVILYVILT-GYLPF 217
            SD+WS GV+++   + G  P+
Sbjct: 553 KSDVWSFGVLMWEAFSYGQKPY 574

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 26/213 (12%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+KIL  N     K   +   E   +  + HP+
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKIL--NETTGPKANVEFMDEALIMASMDHPH 78
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF----QQLIDGVSYCH 131
           +VRL  V  S + I +V + +  G L + +      ++  G +L      Q+  G+ Y  
Sbjct: 79  LVRLLGVCLSPT-IQLVTQLMPHGCLLEYVHEH---KDNIGSQLLLNWCVQIAKGMMYLE 134
Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSAL-----PQHFRDDGLLHTTCGSPNYVAPE 186
            + + HRDL   N+L+ S  ++KI+DFGL+ L      ++  D G +        ++A E
Sbjct: 135 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI-----KWMALE 189
Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFD 218
            +  R +    SD+WS GV ++ ++T G  P+D
Sbjct: 190 CIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYD 221

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 108/242 (44%), Gaps = 54/242 (22%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
           +Y LG+TLG G+FG V    D++SG  FA+K +L+  R  +        RE+  +K+L H
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKN--------RELDIMKVLDH 59
Query: 74  PNVVRL--------------------HEVLASKSK------------------IYMVLEY 95
            N+++L                    H  L  K+                   + +++EY
Sbjct: 60  VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 96  V--TGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152
           V  T  ++       GR        ++  QL   V + H+ G+ HRD+K +N+L++SK N
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 153 -IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVIL 211
            +K+ DFG +   +    +  +   C S  Y APE++        + D+WS G +   ++
Sbjct: 180 TLKLCDFGSAK--KLIPSEPSVAXIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 212 TG 213
            G
Sbjct: 237 LG 238

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 121/254 (47%), Gaps = 23/254 (9%)
Query: 18  LGRTLGEGNFGKVK---FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           L R LGEG FG+V    +       +  AVK  +K+  +  K  ++   E   +K L HP
Sbjct: 12  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHP 69
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHNK 133
           ++V+L  ++  +   ++++E    GEL   +       +     L+  Q+   ++Y  + 
Sbjct: 70  HIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 128
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLANR 191
              HRD+ + NIL+ S   +K+ DFGLS   ++  D+     +       +++PE +  R
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLS---RYIEDEDYYKASVTRLPIKWMSPESINFR 185
Query: 192 GYDGATSDIWSCGVILYVILT-GYLPF---DDRNLAVLYQKIFRGDFKLPK--WLSPGAQ 245
            +  A SD+W   V ++ IL+ G  PF   +++++  + +K   GD +LPK     P   
Sbjct: 186 RFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---GD-RLPKPDLCPPVLY 240
Query: 246 NLLRKILEPNPVKR 259
            L+ +  + +P  R
Sbjct: 241 TLMTRCWDYDPSDR 254

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 100/232 (43%), Gaps = 39/232 (16%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
            RYE+  TLGEG FGKV    D  +G    AVKI++       +  +  + EI  L+ L 
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN 69
Query: 73  --HPN----VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL--QEAEGRKLFQQLI 124
              PN     V++ E       I +V E + G   +D I   G L  +    RK+  Q+ 
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 125 DGVSYCHNKGVFHRDLKLENILL---------------DSKG----NIKISDFGLSALPQ 165
             V++ H+  + H DLK ENIL                D +     +IK+ DFG +    
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY-- 186
Query: 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
              DD    T   + +Y APEV+   G+     D+WS G IL     G+  F
Sbjct: 187 ---DDEHHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVF 234

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 72/256 (28%), Positives = 122/256 (47%), Gaps = 25/256 (9%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           G+YE+   +  G  G +  A D + +G P  +K L  +     +     +R+   L  + 
Sbjct: 80  GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQF--LAEVV 137
Query: 73  HPNVVRLHEVLASKSKI-----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           HP++V++   +    +      Y+V+EYV G  L  K +   +L  AE      +++  +
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL--KRSKGQKLPVAEAIAYLLEILPAL 195
Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           SY H+ G+ + DLK ENI+L ++  +K+ D G  +    F   G L+   G+P + APE+
Sbjct: 196 SYLHSIGLVYNDLKPENIML-TEEQLKLIDLGAVSRINSF---GYLY---GTPGFQAPEI 248
Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL 247
           +  R      +DI++ G  L   LT  LP   RN       +   D  L  + S G   L
Sbjct: 249 V--RTGPTVATDIYTVGRTL-AALTLDLP--TRN-GRYVDGLPEDDPVLKTYDSYG--RL 300
Query: 248 LRKILEPNPVKRITIA 263
           LR+ ++P+P +R T A
Sbjct: 301 LRRAIDPDPRQRFTTA 316

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 121/254 (47%), Gaps = 23/254 (9%)
Query: 18  LGRTLGEGNFGKVK---FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           L R LGEG FG+V    +       +  AVK  +K+  +  K  ++   E   +K L HP
Sbjct: 28  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHP 85
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHNK 133
           ++V+L  ++  +   ++++E    GEL   +       +     L+  Q+   ++Y  + 
Sbjct: 86  HIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 144
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLANR 191
              HRD+ + NIL+ S   +K+ DFGLS   ++  D+     +       +++PE +  R
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLS---RYIEDEDYYKASVTRLPIKWMSPESINFR 201
Query: 192 GYDGATSDIWSCGVILYVILT-GYLPF---DDRNLAVLYQKIFRGDFKLPK--WLSPGAQ 245
            +  A SD+W   V ++ IL+ G  PF   +++++  + +K   GD +LPK     P   
Sbjct: 202 RFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---GD-RLPKPDLCPPVLY 256
Query: 246 NLLRKILEPNPVKR 259
            L+ +  + +P  R
Sbjct: 257 TLMTRCWDYDPSDR 270

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/209 (25%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA----TLKLLKHPNVV 77
           LG G +G V+  + + SG   AVK     RI     + + KR +     +++ +  P  V
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVK-----RIRATVNSQEQKRLLMDLDISMRTVDCPFTV 113
Query: 78  RLHEVLASKSKIYMVLEYVTGG--ELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNK- 133
             +  L  +  +++ +E +     + + ++  KG+ + E    K+   ++  + + H+K 
Sbjct: 114 TFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV----LA 189
            V HRD+K  N+L+++ G +K+ DFG+S    +  D        G   Y+APE     L 
Sbjct: 174 SVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDSVAKTIDAGCKPYMAPERINPELN 230
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD 218
            +GY    SDIWS G+ +  +     P+D
Sbjct: 231 QKGY-SVKSDIWSLGITMIELAILRFPYD 258

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 121/254 (47%), Gaps = 23/254 (9%)
Query: 18  LGRTLGEGNFGKVK---FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           L R LGEG FG+V    +       +  AVK  +K+  +  K  ++   E   +K L HP
Sbjct: 16  LNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDHP 73
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ-QLIDGVSYCHNK 133
           ++V+L  ++  +   ++++E    GEL   +       +     L+  Q+   ++Y  + 
Sbjct: 74  HIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS--PNYVAPEVLANR 191
              HRD+ + NIL+ S   +K+ DFGLS   ++  D+     +       +++PE +  R
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLS---RYIEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 192 GYDGATSDIWSCGVILYVILT-GYLPF---DDRNLAVLYQKIFRGDFKLPK--WLSPGAQ 245
            +  A SD+W   V ++ IL+ G  PF   +++++  + +K   GD +LPK     P   
Sbjct: 190 RFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---GD-RLPKPDLCPPVLY 244
Query: 246 NLLRKILEPNPVKR 259
            L+ +  + +P  R
Sbjct: 245 TLMTRCWDYDPSDR 258

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 66/277 (23%), Positives = 120/277 (43%), Gaps = 34/277 (12%)
Query: 17  ELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           + G+TLG G FGKV  A        D+ L  AVK+L+     H    + +  E+  +  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106
Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-------------ASKGRLQEAEGR 117
            +H N+V L         + ++ EY   G+L + +              S    ++   R
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSR 166
Query: 118 KLFQ---QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG--L 172
            L     Q+  G+++  +K   HRD+   N+LL +    KI DFGL+   +   +D   +
Sbjct: 167 DLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA---RDIMNDSNYI 223
Query: 173 LHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIF 230
           +      P  ++APE + +  Y    SD+WS G++L+ I + G  P+    +   + K+ 
Sbjct: 224 VKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLV 282
Query: 231 RGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
           +  +++  P +      ++++      P  R T   I
Sbjct: 283 KDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQI 319

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 114/240 (47%), Gaps = 43/240 (17%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---- 62
           K E  +  RY L R LG G+F  V  A+D+ +    A+KI+  +++      D+IK    
Sbjct: 12  KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQR 71
Query: 63  -------REIAT-----LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGE----LFDKIA 106
                  +E +      LKLL H N           + +++V+ +   GE    L  K  
Sbjct: 72  VNDADNTKEDSMGANHILKLLDHFN-------HKGPNGVHVVMVFEVLGENLLALIKKYE 124
Query: 107 SKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILL---DSKGN---IKISDFG 159
            +G +     +++ +QL+ G+ Y H + G+ H D+K EN+L+   DS  N   IKI+D G
Sbjct: 125 HRG-IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 183
Query: 160 LSAL-PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 218
            +    +H+ +      +  +  Y +PEVL    + G  +DIWS   +++ ++TG   F+
Sbjct: 184 NACWYDEHYTN------SIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFE 236

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 114/240 (47%), Gaps = 43/240 (17%)
Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---- 62
           K E  +  RY L R LG G+F  V  A+D+ +    A+KI+  +++      D+IK    
Sbjct: 12  KGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQR 71
Query: 63  -------REIAT-----LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGE----LFDKIA 106
                  +E +      LKLL H N           + +++V+ +   GE    L  K  
Sbjct: 72  VNDADNTKEDSMGANHILKLLDHFN-------HKGPNGVHVVMVFEVLGENLLALIKKYE 124
Query: 107 SKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILL---DSKGN---IKISDFG 159
            +G +     +++ +QL+ G+ Y H + G+ H D+K EN+L+   DS  N   IKI+D G
Sbjct: 125 HRG-IPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLG 183
Query: 160 LSAL-PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD 218
            +    +H+ +      +  +  Y +PEVL    + G  +DIWS   +++ ++TG   F+
Sbjct: 184 NACWYDEHYTN------SIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFE 236

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG----ELFDKIASKGRLQEAEGRKLFQQL 123
           L   +HP++V L      ++++ ++ +Y+  G     L+        +   +  ++    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
             G+ Y H + + HRD+K  NILLD     KI+DFG+S          L     G+  Y+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYI 208
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
            PE    +G     SD++S GV+L+ +L           + + Q + R    L +W    
Sbjct: 209 DPEYFI-KGRLTEKSDVYSFGVVLFEVLCAR--------SAIVQSLPREMVNLAEWAVES 259
Query: 244 AQN-LLRKILEPNPVKRI 260
             N  L +I++PN   +I
Sbjct: 260 HNNGQLEQIVDPNLADKI 277

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 87/198 (43%), Gaps = 14/198 (7%)
Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGG----ELFDKIASKGRLQEAEGRKLFQQL 123
           L   +HP++V L      ++++ ++ +Y+  G     L+        +   +  ++    
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
             G+ Y H + + HRD+K  NILLD     KI+DFG+S          L     G+  Y+
Sbjct: 149 ARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYI 208
Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
            PE    +G     SD++S GV+L+ +L           + + Q + R    L +W    
Sbjct: 209 DPEYFI-KGRLTEKSDVYSFGVVLFEVLCAR--------SAIVQSLPREMVNLAEWAVES 259
Query: 244 AQN-LLRKILEPNPVKRI 260
             N  L +I++PN   +I
Sbjct: 260 HNNGQLEQIVDPNLADKI 277

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 70/232 (30%), Positives = 99/232 (42%), Gaps = 39/232 (16%)
Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
            RYE+  TLGEG FGKV    D  +G    AVKI++       +  +  + EI  L+ L 
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLN 69
Query: 73  --HPN----VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL--QEAEGRKLFQQLI 124
              PN     V++ E       I +V E + G   +D I   G L  +    RK+  Q+ 
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128
Query: 125 DGVSYCHNKGVFHRDLKLENILL---------------DSKG----NIKISDFGLSALPQ 165
             V++ H+  + H DLK ENIL                D +     +IK+ DFG +    
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATY-- 186
Query: 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
              DD    T     +Y APEV+   G+     D+WS G IL     G+  F
Sbjct: 187 ---DDEHHSTLVXXRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVF 234

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 79
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 80  VCRLLGICLT-STVQLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 138
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 139 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 197 YT-HQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K   
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 78
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQ 122
             +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  +
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTC 177
           + DG++Y + K   HRDL   N ++     +KI DFG++       ++R    GLL    
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPV-- 196
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFK 235
               ++APE L + G    +SD+WS GV+L+ I +    P+    N  VL   +  G   
Sbjct: 197 ---RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 252
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            P        +L+R   + NP  R T   I
Sbjct: 253 QPDNCPERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K   
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 78
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQ 122
             +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  +
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTC 177
           + DG++Y + K   HRDL   N ++     +KI DFG++       ++R    GLL    
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-- 196
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFK 235
               ++APE L + G    +SD+WS GV+L+ I +    P+    N  VL   +  G   
Sbjct: 197 ---RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 252
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            P        +L+R   + NP  R T   I
Sbjct: 253 QPDNCPERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 18  LGRTLGEGNFGKV--KFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K   
Sbjct: 20  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 77
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQ 122
             +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  +
Sbjct: 78  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 137
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTC 177
           + DG++Y + K   HRDL   N ++     +KI DFG++       ++R    GLL    
Sbjct: 138 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-- 195
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFK 235
               ++APE L + G    +SD+WS GV+L+ I +    P+    N  VL   +  G   
Sbjct: 196 ---RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 251
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            P        +L+R   + NP  R T   I
Sbjct: 252 QPDNCPERVTDLMRMCWQFNPKMRPTFLEI 281

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 102/217 (47%), Gaps = 13/217 (5%)
Query: 14  GRYELGRTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           G YEL   +G+G  +   V  A+   +G    V+ +      +  +T  ++ E+   KL 
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLF 83
Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSY 129
            HPN+V       + +++++V  ++  G   D I +     + E     + Q ++  + Y
Sbjct: 84  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLH----TTCGSPNYVA 184
            H+ G  HR +K  +IL+   G + +S    + ++  H +   ++H     +     +++
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 185 PEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD 219
           PEVL    +GYD A SDI+S G+    +  G++PF D
Sbjct: 204 PEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD 239

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 80
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 81  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 198 YT-HQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 82
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 83  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 141
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 142 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 199
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 200 YT-HQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 79
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 80  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 138
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 139 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 196
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 197 YT-HQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 81
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 82  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 199 YT-HQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 78
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 79  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 196 YT-HQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/205 (26%), Positives = 97/205 (47%), Gaps = 10/205 (4%)
Query: 20  RTLGEGNFGKVKFAQDLDSG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG G FG V     +  G  +   V I+E       K   +I  E   +  + +P+V 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
           RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ + 
Sbjct: 115 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLV 173
Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRGYD 194
           HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R Y 
Sbjct: 174 HRDLAARNVLVKTPQHVKITDFGLAKLLGA--EEKEYHAEGGKVPIKWMALESILHRIYT 231
Query: 195 GATSDIWSCGVILYVILT-GYLPFD 218
              SD+WS GV ++ ++T G  P+D
Sbjct: 232 -HQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 102/217 (47%), Gaps = 13/217 (5%)
Query: 14  GRYELGRTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           G YEL   +G+G  +   V  A+   +G    V+ +      +  +T  ++ E+   KL 
Sbjct: 9   GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLF 67
Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSY 129
            HPN+V       + +++++V  ++  G   D I +     + E     + Q ++  + Y
Sbjct: 68  NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 127
Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLH----TTCGSPNYVA 184
            H+ G  HR +K  +IL+   G + +S    + ++  H +   ++H     +     +++
Sbjct: 128 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 187
Query: 185 PEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDD 219
           PEVL    +GYD A SDI+S G+    +  G++PF D
Sbjct: 188 PEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKD 223

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 78
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 196 YT-HQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 99/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 75
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+ +G++Y  ++ 
Sbjct: 76  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRR 134
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 135 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 192
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 193 YT-HQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 121/276 (43%), Gaps = 42/276 (15%)
Query: 18  LGRTLGEGNFGKV--KFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K   
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 78
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQ 122
             +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  +
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------DG 171
           + DG++Y + K   HRDL   N ++     +KI DFG++      RD            G
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT------RDIXETDXXRKGGKG 192
Query: 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKI 229
           LL        ++APE L + G    +SD+WS GV+L+ I +    P+    N  VL   +
Sbjct: 193 LLPV-----RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 246
Query: 230 FRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
             G    P        +L+R   + NP  R T   I
Sbjct: 247 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 282

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 121/276 (43%), Gaps = 42/276 (15%)
Query: 18  LGRTLGEGNFGKV--KFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K   
Sbjct: 18  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 75
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQ 122
             +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  +
Sbjct: 76  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 135
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------DG 171
           + DG++Y + K   HRDL   N ++     +KI DFG++      RD            G
Sbjct: 136 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT------RDIXETDXXRKGGKG 189
Query: 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKI 229
           LL        ++APE L + G    +SD+WS GV+L+ I +    P+    N  VL   +
Sbjct: 190 LLPV-----RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 243
Query: 230 FRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
             G    P        +L+R   + NP  R T   I
Sbjct: 244 DGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEI 279

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 74/276 (26%), Positives = 121/276 (43%), Gaps = 42/276 (15%)
Query: 18  LGRTLGEGNFGKV--KFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K   
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 78
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQ 122
             +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  +
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------DG 171
           + DG++Y + K   HRDL   N ++     +KI DFG++      RD            G
Sbjct: 139 IADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT------RDIXETDXXRKGGKG 192
Query: 172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKI 229
           LL        ++APE L + G    +SD+WS GV+L+ I +    P+    N  VL   +
Sbjct: 193 LLPV-----RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 246
Query: 230 FRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
             G    P        +L+R   + NP  R T   I
Sbjct: 247 DGGYLDQPDNCPERVTDLMRMCWQFNPNMRPTFLEI 282

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 18/208 (8%)
Query: 49  KNRIIHLKITDQI-----------KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT 97
           + RI+ LK+  +            +RE  T   L+ P+VV +H+      ++Y+    + 
Sbjct: 58  RERIVALKLXSETLSSDPVFRTRXQREARTAGRLQEPHVVPIHDFGEIDGQLYVDXRLIN 117
Query: 98  GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 157
           G +L   +  +G L       + +Q+   +   H  G  HRD+K ENIL+ +     + D
Sbjct: 118 GVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVD 177
Query: 158 FGLSALPQHFRDDGL--LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 215
           FG+++      D+ L  L  T G+  Y APE  +   +    +DI++   +LY  LTG  
Sbjct: 178 FGIASATT---DEKLTQLGNTVGTLYYXAPERFSE-SHATYRADIYALTCVLYECLTGSP 233
Query: 216 PFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
           P+    L+V    I +     P  + PG
Sbjct: 234 PYQGDQLSVXGAHINQA-IPRPSTVRPG 260

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K   
Sbjct: 22  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 79
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQ 122
             +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  +
Sbjct: 80  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 139
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTC 177
           + DG++Y + K   HR+L   N ++     +KI DFG++       ++R    GLL    
Sbjct: 140 IADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-- 197
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFK 235
               ++APE L + G    +SD+WS GV+L+ I +    P+    N  VL   +  G   
Sbjct: 198 ---RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 253
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            P        +L+R   + NP  R T   I
Sbjct: 254 QPDNCPERVTDLMRMCWQFNPNMRPTFLEI 283

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 61.2 bits (147), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 122/270 (45%), Gaps = 30/270 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L R LG+G+FG V    A+D+  G      AVK + ++  +  +I  +   E + +K   
Sbjct: 21  LLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI--EFLNEASVMKGFT 78
Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGR---------KLFQQ 122
             +VVRL  V++      +V+E +  G+L   + S +   +   GR         ++  +
Sbjct: 79  CHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAE 138
Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTC 177
           + DG++Y + K   HR+L   N ++     +KI DFG++       ++R    GLL    
Sbjct: 139 IADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV-- 196
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD-RNLAVLYQKIFRGDFK 235
               ++APE L + G    +SD+WS GV+L+ I +    P+    N  VL   +  G   
Sbjct: 197 ---RWMAPESLKD-GVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 252
Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            P        +L+R   + NP  R T   I
Sbjct: 253 QPDNCPERVTDLMRMCWQFNPNMRPTFLEI 282

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 85
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 86  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 203 YT-HQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 81
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 82  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 199 YT-HQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 81
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 82  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 199 YT-HQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 81
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 82  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 140
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 141 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 198
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 199 YT-HQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 103
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 104 VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 162
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 163 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 220
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 221 YT-HQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 78
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 196 YT-HQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 78
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 196 YT-HQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 80
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 81  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 198 YT-HQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 88
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 89  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 147
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 148 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 205
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 206 YT-HQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 84
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 85  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 143
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 144 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 201
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 202 YT-HQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 72
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 73  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 131
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 132 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 190 YTH-QSDVWSYGVTVWELMTFGSKPYD 215

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL----KLLKHPNVV 77
           LG G +G V+  + + SG   AVK     RI     + + KR +  L    + +  P  V
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVK-----RIRATVNSQEQKRLLXDLDISXRTVDCPFTV 96
Query: 78  RLHEVLASKSKIYMVLEY--VTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNK- 133
             +  L  +  +++  E    +  + + ++  KG+ + E    K+   ++  + + H+K 
Sbjct: 97  TFYGALFREGDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 156
Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE----VLA 189
            V HRD+K  N+L+++ G +K  DFG+S    +  DD       G   Y APE     L 
Sbjct: 157 SVIHRDVKPSNVLINALGQVKXCDFGISG---YLVDDVAKDIDAGCKPYXAPERINPELN 213
Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD 218
            +GY    SDIWS G+    +     P+D
Sbjct: 214 QKGY-SVKSDIWSLGITXIELAILRFPYD 241

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFD-------KIASKGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L          +A+   L      K+ Q   ++ 
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 204
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
             +++PE L + G     SD+WS GV+L+ I T
Sbjct: 205 -RWMSPESLKD-GVFTTYSDVWSFGVVLWEIAT 235

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + L  G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 85
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 86  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 203 YT-HQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 105/242 (43%), Gaps = 42/242 (17%)
Query: 8   QEGMRLGR-YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           ++GM L   + + R +G+G FG+V   Q +D+   +AVK++   +    K T   K E  
Sbjct: 28  KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEAD 83
Query: 67  TLKLLKHPNVVRLHEVLASKSKIY---MVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQ 121
            LK +++ ++   + V      +Y   M L +   G    +I ++        E  KL+ 
Sbjct: 84  ILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYC 143
Query: 122 -QLIDGVSYCHNKGVFHRDLKLENILLD-------------------------SKGNIKI 155
            +++  ++Y     + H DLK ENILLD                             IK+
Sbjct: 144 IEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKL 203
Query: 156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL 215
            DFG +     +       +   +  Y APEV+ N G+D  +SD+WS G +L  + TG L
Sbjct: 204 IDFGCATFKSDYHG-----SIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYTGSL 257
Query: 216 PF 217
            F
Sbjct: 258 LF 259

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 80
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 81  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFG + L     ++   H   G     ++A E + +R 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGRAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 198 YT-HQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 80
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 81  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFG + L     ++   H   G     ++A E + +R 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGRAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 198 YT-HQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 114/273 (41%), Gaps = 26/273 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK----ILEKNRIIHLK----ITDQIKREIAT 67
           Y + R +  G++G V    D   G+P A+K     +   R +++     +  ++ REI  
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 68  LKLLKHPNVVRLHEVLA-----SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
           L    HPN++ L ++       +  K+Y+V E +   +L   I  +  +   +  + F  
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE-LMRTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
            ++ G+   H  GV HRDL   NILL    +I I DF L+   +   D    H       
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTHRW- 198
Query: 182 YVAPE-VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPK 238
           Y APE V+  +G+     D+WS G ++  +      F          KI    G  K+  
Sbjct: 199 YRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257
Query: 239 ---WLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
              + SP A++ LR  L   P +  T     AD
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTAD 290

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 70/273 (25%), Positives = 114/273 (41%), Gaps = 26/273 (9%)
Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVK----ILEKNRIIHLK----ITDQIKREIAT 67
           Y + R +  G++G V    D   G+P A+K     +   R +++     +  ++ REI  
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 68  LKLLKHPNVVRLHEVLA-----SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ- 121
           L    HPN++ L ++       +  K+Y+V E +   +L   I  +  +   +  + F  
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTE-LMRTDLAQVIHDQRIVISPQHIQYFMY 141
Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
            ++ G+   H  GV HRDL   NILL    +I I DF L+   +   D    H       
Sbjct: 142 HILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANKTHYVTHRW- 198
Query: 182 YVAPE-VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPK 238
           Y APE V+  +G+     D+WS G ++  +      F          KI    G  K+  
Sbjct: 199 YRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIED 257
Query: 239 ---WLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
              + SP A++ LR  L   P +  T     AD
Sbjct: 258 VVMFSSPSARDYLRNSLSNVPARAWTAVVPTAD 290

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 24/213 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 19  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 78
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFD-------KIASKGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L          +A+   L      K+ Q   ++ 
Sbjct: 79  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 138
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 139 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 194
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
             +++PE L + G     SD+WS GV+L+ I T
Sbjct: 195 -RWMSPESLKD-GVFTTYSDVWSFGVVLWEIAT 225

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 82
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++++ +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 83  VCRLLGICLT-STVQLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 141
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFG + L     ++   H   G     ++A E + +R 
Sbjct: 142 LVHRDLAARNVLVKTPQHVKITDFGRAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 199
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 200 YT-HQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 31/210 (14%)
Query: 84  ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG---RKLFQQLIDGVSYCHNKGVFHRDL 140
           + K  +Y+ ++      L D +  +  L++ E      +F Q+ + V + H+KG+ HRDL
Sbjct: 131 SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDL 190
Query: 141 KLENILLDSKGNIKISDFGL-SALPQHFRDDGLLHTT---------CGSPNYVAPEVLAN 190
           K  NI       +K+ DFGL +A+ Q   +  +L             G+  Y++PE +  
Sbjct: 191 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHG 250
Query: 191 RGYDGATSDIWSCGVILYVILTGY--------LPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
             Y     DI+S G+IL+ +L  +        +  D RNL   +  +F   +       P
Sbjct: 251 NNYSHKV-DIFSLGLILFELLYSFSTQMERVRIITDVRNLK--FPLLFTQKY-------P 300
Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFE 272
               +++ +L P+P +R     I  +  FE
Sbjct: 301 QEHMMVQDMLSPSPTERPEATDIIENAIFE 330

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 29  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 88
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 148
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 204
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
             +++PE L + G     SD+WS GV+L+ I T
Sbjct: 205 -RWMSPESLKD-GVFTTYSDVWSFGVVLWEIAT 235

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 110/263 (41%), Gaps = 35/263 (13%)
Query: 22  LGEGNFGKV-KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
           +G G FG V K  + LD G  +A+K  +K     +   + ++   A   L +H +VVR  
Sbjct: 19  IGSGEFGSVFKCVKRLD-GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 77
Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRL----QEAEGRKLFQQLIDGVSYCHNKGVF 136
              A    + +  EY  GG L D I+   R+    +EAE + L  Q+  G+ Y H+  + 
Sbjct: 78  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 137
Query: 137 HRDLKLENILL-------------------DSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
           H D+K  NI +                    +K   KI D G      H           
Sbjct: 138 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG------HVTRISSPQVEE 191
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KL 236
           G   ++A EVL         +DI++  + + V   G  P   RN    + +I +G   ++
Sbjct: 192 GDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL-PRN-GDQWHEIRQGRLPRI 248
Query: 237 PKWLSPGAQNLLRKILEPNPVKR 259
           P+ LS     LL+ ++ P+P +R
Sbjct: 249 PQVLSQEFTELLKVMIHPDPERR 271

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 110/263 (41%), Gaps = 35/263 (13%)
Query: 22  LGEGNFGKV-KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
           +G G FG V K  + LD G  +A+K  +K     +   + ++   A   L +H +VVR  
Sbjct: 17  IGSGEFGSVFKCVKRLD-GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 75
Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRL----QEAEGRKLFQQLIDGVSYCHNKGVF 136
              A    + +  EY  GG L D I+   R+    +EAE + L  Q+  G+ Y H+  + 
Sbjct: 76  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 135
Query: 137 HRDLKLENILL-------------------DSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
           H D+K  NI +                    +K   KI D G      H           
Sbjct: 136 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG------HVTRISSPQVEE 189
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KL 236
           G   ++A EVL         +DI++  + + V   G  P   RN    + +I +G   ++
Sbjct: 190 GDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL-PRN-GDQWHEIRQGRLPRI 246
Query: 237 PKWLSPGAQNLLRKILEPNPVKR 259
           P+ LS     LL+ ++ P+P +R
Sbjct: 247 PQVLSQEFTELLKVMIHPDPERR 269

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + L  G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 78
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 196 YTH-QSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/227 (28%), Positives = 103/227 (45%), Gaps = 23/227 (10%)
Query: 63  REIATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEA-EGRKLF 120
           RE+  L+   +HPNV+R       +   Y+ +E +    L + +  K       E   L 
Sbjct: 66  REVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLL 124
Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIK--ISDFGLS---ALPQH--FRDD 170
           QQ   G+++ H+  + HRDLK  NIL+   ++ G IK  ISDFGL    A+ +H   R  
Sbjct: 125 QQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRS 184
Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATS--DIWSCGVIL-YVILTGYLPFD---DRNLAV 224
           G+     G+  ++APE+L+    +  T   DI+S G +  YVI  G  PF     R   +
Sbjct: 185 GVP----GTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI 240
Query: 225 LYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
           L            K     A+ L+ K++  +P KR +   +    +F
Sbjct: 241 LLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 110/263 (41%), Gaps = 35/263 (13%)
Query: 22  LGEGNFGKV-KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
           +G G FG V K  + LD G  +A+K  +K     +   + ++   A   L +H +VVR  
Sbjct: 17  IGSGEFGSVFKCVKRLD-GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 75
Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRL----QEAEGRKLFQQLIDGVSYCHNKGVF 136
              A    + +  EY  GG L D I+   R+    +EAE + L  Q+  G+ Y H+  + 
Sbjct: 76  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 135
Query: 137 HRDLKLENILL-------------------DSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
           H D+K  NI +                    +K   KI D G      H           
Sbjct: 136 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG------HVTRISSPQVEE 189
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KL 236
           G   ++A EVL         +DI++  + + V   G  P   RN    + +I +G   ++
Sbjct: 190 GDSRFLANEVLQENYTHLPKADIFALALTV-VCAAGAEPL-PRN-GDQWHEIRQGRLPRI 246
Query: 237 PKWLSPGAQNLLRKILEPNPVKR 259
           P+ LS     LL+ ++ P+P +R
Sbjct: 247 PQVLSQEFTELLKVMIHPDPERR 269

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 78
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 79  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 137
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFG + L     ++   H   G     ++A E + +R 
Sbjct: 138 LVHRDLAARNVLVKTPQHVKITDFGRAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 195
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 196 YT-HQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 22  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 142 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 197
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
             +++PE L + G     SD+WS GV+L+ I T
Sbjct: 198 -RWMSPESLKD-GVFTTYSDVWSFGVVLWEIAT 228

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 16  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 75
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 76  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 135
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 136 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 191
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
             +++PE L + G     SD+WS GV+L+ I T
Sbjct: 192 -RWMSPESLKD-GVFTTYSDVWSFGVVLWEIAT 222

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + L  G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 28  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 85
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 86  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFGL+ L     ++   H   G     ++A E + +R 
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 203 YT-HQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 22  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 81
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 82  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 141
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 142 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 197
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
             +++PE L + G     SD+WS GV+L+ I T
Sbjct: 198 -RWMSPESLKD-GVFTTYSDVWSFGVVLWEIAT 228

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 80
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 81  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 139
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFG + L     ++   H   G     ++A E + +R 
Sbjct: 140 LVHRDLAARNVLVKTPQHVKITDFGRAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 197
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 198 YT-HQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 14/207 (6%)
Query: 20  RTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           + LG G FG V     +  G    +P A+K  E       K   +I  E   +  + +P+
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 85
Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           V RL  +  + S + ++ + +  G L D +   K  +          Q+  G++Y  ++ 
Sbjct: 86  VCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR 144
Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP--NYVAPEVLANRG 192
           + HRDL   N+L+ +  ++KI+DFG + L     ++   H   G     ++A E + +R 
Sbjct: 145 LVHRDLAARNVLVKTPQHVKITDFGRAKLLG--AEEKEYHAEGGKVPIKWMALESILHRI 202
Query: 193 YDGATSDIWSCGVILYVILT-GYLPFD 218
           Y    SD+WS GV ++ ++T G  P+D
Sbjct: 203 YT-HQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL- 71
           + RYE+   +G+G+FG+V  A D       A+KI++  +       +Q + E+  L+L+ 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMN 108
Query: 72  KHPN-----VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLI 124
           KH       +V L      ++ + +V E ++   L+D + +     +     RK  QQ+ 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 125 DGVSYCHNK--GVFHRDLKLENILL--DSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGS 179
             + +       + H DLK ENILL    +  IKI DFG S  L Q       ++    S
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR------IYQXIQS 221
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
             Y +PEVL    YD A  D+WS G IL  + TG   F   N
Sbjct: 222 RFYRSPEVLLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGAN 262

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 23  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 82
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 83  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 142
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 143 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 198
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
             +++PE L + G     SD+WS GV+L+ I T
Sbjct: 199 -RWMSPESLKD-GVFTTYSDVWSFGVVLWEIAT 229

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 20  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 79
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 80  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 139
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 140 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 195
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
             +++PE L + G     SD+WS GV+L+ I T
Sbjct: 196 -RWMSPESLKD-GVFTTYSDVWSFGVVLWEIAT 226

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/222 (31%), Positives = 104/222 (46%), Gaps = 25/222 (11%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL- 71
           + RYE+   +G+G+FG+V  A D       A+KI+ KN+   L   +Q + E+  L+L+ 
Sbjct: 34  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFL---NQAQIEVRLLELMN 89
Query: 72  KHPN-----VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLI 124
           KH       +V L      ++ + +V E ++   L+D + +     +     RK  QQ+ 
Sbjct: 90  KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMC 148
Query: 125 DGVSYCHNK--GVFHRDLKLENILL--DSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGS 179
             + +       + H DLK ENILL    +  IKI DFG S  L Q       ++    S
Sbjct: 149 TALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR------IYQXIQS 202
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
             Y +PEVL    YD A  D+WS G IL  + TG   F   N
Sbjct: 203 RFYRSPEVLLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGAN 243

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 68/263 (25%), Positives = 110/263 (41%), Gaps = 35/263 (13%)
Query: 22  LGEGNFGKV-KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH 80
           +G G FG V K  + LD G  +A+K  +K     +   + ++   A   L +H +VVR  
Sbjct: 15  IGSGEFGSVFKCVKRLD-GCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF 73
Query: 81  EVLASKSKIYMVLEYVTGGELFDKIASKGRL----QEAEGRKLFQQLIDGVSYCHNKGVF 136
              A    + +  EY  GG L D I+   R+    +EAE + L  Q+  G+ Y H+  + 
Sbjct: 74  SAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLV 133
Query: 137 HRDLKLENILL-------------------DSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
           H D+K  NI +                    +K   KI D G      H           
Sbjct: 134 HMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG------HVTRISSPQVEE 187
Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KL 236
           G   ++A EVL         +DI++  + + V   G  P   RN    + +I +G   ++
Sbjct: 188 GDSRFLANEVLQENYTHLPKADIFALALTV-VXAAGAEPL-PRN-GDQWHEIRQGRLPRI 244
Query: 237 PKWLSPGAQNLLRKILEPNPVKR 259
           P+ LS     LL+ ++ P+P +R
Sbjct: 245 PQVLSQEFTELLKVMIHPDPERR 267

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 24/213 (11%)
Query: 18  LGRTLGEGNFGKVK--FAQDLDSGLPFA-VKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + R LG+G+FG V    A+ +    P   V I   N    ++   +   E + +K     
Sbjct: 51  MSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCH 110
Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQ---QLI 124
           +VVRL  V++      +++E +T G+L   + S          L      K+ Q   ++ 
Sbjct: 111 HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMIQMAGEIA 170
Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA---LPQHFRD--DGLLHTTCGS 179
           DG++Y +     HRDL   N ++     +KI DFG++       ++R    GLL      
Sbjct: 171 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV---- 226
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILT 212
             +++PE L + G     SD+WS GV+L+ I T
Sbjct: 227 -RWMSPESLKD-GVFTTYSDVWSFGVVLWEIAT 257

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 25/222 (11%)
Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL- 71
           + RYE+   +G+G+FG+V  A D       A+KI++  +       +Q + E+  L+L+ 
Sbjct: 53  MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMN 108
Query: 72  KHPN-----VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLI 124
           KH       +V L      ++ + +V E ++   L+D + +     +     RK  QQ+ 
Sbjct: 109 KHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMC 167
Query: 125 DGVSYCHNK--GVFHRDLKLENILL--DSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGS 179
             + +       + H DLK ENILL    +  IKI DFG S  L Q       ++    S
Sbjct: 168 TALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQLGQR------IYQXIQS 221
Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
             Y +PEVL    YD A  D+WS G IL  + TG   F   N
Sbjct: 222 RFYRSPEVLLGMPYDLAI-DMWSLGCILVEMHTGEPLFSGAN 262

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 101/233 (43%), Gaps = 43/233 (18%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT------DQIKREIATL 68
           R  LG+ LG G FG+V  A        F +      R + +K+        + +  ++ L
Sbjct: 28  RLNLGKPLGRGAFGQVIEAD------AFGIDKTATXRTVAVKMLKEGATHSEHRALMSEL 81
Query: 69  KLL----KHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKGRLQEAEGRKLFQ-- 121
           K+L     H NVV L           MV+ E+   G L   + SK R +    + L++  
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYKDLYKDF 140
Query: 122 -----------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS----ALPQH 166
                      Q+  G+ +  ++   HRDL   NILL  K  +KI DFGL+      P +
Sbjct: 141 LTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 200
Query: 167 FRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
            R  D  L        ++APE + +R Y    SD+WS GV+L+ I + G  P+
Sbjct: 201 VRKGDARLPL-----KWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY 247

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 70/278 (25%), Positives = 118/278 (42%), Gaps = 39/278 (14%)
Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT------DQIKREIATL 68
           R  LG+ LG G FG+V  A        F +      R + +K+        + +  ++ L
Sbjct: 28  RLNLGKPLGRGAFGQVIEAD------AFGIDKTATXRTVAVKMLKEGATHSEHRALMSEL 81
Query: 69  KLL----KHPNVVRLHEVLASKSKIYMVL-EYVTGGELFDKIASKGRLQEAEGRKLFQ-- 121
           K+L     H NVV L           MV+ E+   G L   + SK R +    + L++  
Sbjct: 82  KILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSK-RNEFVPYKDLYKDF 140
Query: 122 -----------QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD- 169
                      Q+  G+ +  ++   HRDL   NILL  K  +KI DFGL+     ++D 
Sbjct: 141 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLAR--DIYKDP 198
Query: 170 DGLLHTTCGSP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 227
           D +       P  ++APE + +R Y    SD+WS GV+L+ I + G  P+    +   + 
Sbjct: 199 DYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFX 257
Query: 228 KIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIA 263
           +  +   ++  P + +P     +       P +R T +
Sbjct: 258 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFS 295
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	344
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-170
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-169
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	1e-168
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	1e-167
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-166
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-166
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-166
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-165
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	1e-160
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-159
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-157
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-155
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-152
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-152
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-148
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-148
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-145
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-144
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-135
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-114
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-111
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-111
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-110
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-109
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-108
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-108
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-108
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-107
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-107
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-106
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-104
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-104
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-102
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-102
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-102
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-102
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-102
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-102
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-102
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-102
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-101
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-101
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-101
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-100
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-100
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-100
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-100
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-100
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	1e-100
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-98
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-97
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-96
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-95
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-95
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	3e-94
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	4e-94
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-94
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-93
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	4e-89
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-88
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	1e-83
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-83
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-83
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-82
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	6e-81
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-80
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-80
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-80
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-79
2a19_B	284	Interferon-induced, double-stranded RNA-activated	5e-78
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-76
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-75
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-74
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-74
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	6e-73
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-72
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-72
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-71
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-71
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-71
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-71
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-70
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-70
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	8e-70
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-68
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-68
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-67
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-67
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-67
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-66
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-66
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	4e-66
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-64
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-64
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-63
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-60
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-59
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-59
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-54
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-52
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	2e-08
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-51
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-49
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-49
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	8e-49
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-48
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-48
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-48
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	7e-48
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-47
3niz_A	311	Rhodanese family protein; structural genomics, str	4e-47
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	9e-47
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-46
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-46
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-46
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	9e-46
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-45
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-44
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-44
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	3e-44
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	4e-44
3ork_A	311	Serine/threonine protein kinase; structural genomi	5e-44
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	6e-44
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-44
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-43
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-43
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-43
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-43
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-41
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-41
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-41
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-41
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-40
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-40
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-40
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-39
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-39
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-38
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-38
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-37
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-37
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-36
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-36
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	1e-35
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	2e-35
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-35
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-34
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-34
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	4e-34
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-33
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-33
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-33
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-33
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	6e-33
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-32
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-32
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-32
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	1e-32
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-32
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-32
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-32
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	5e-32
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-31
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-31
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-31
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-31
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-31
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-31
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-31
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-31
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-31
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-31
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-31
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-31
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	5e-31
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-31
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-31
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-31
3rp9_A	458	Mitogen-activated protein kinase; structural genom	8e-31
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	9e-31
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-30
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-30
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-30
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-30
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-30
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-30
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-30
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	4e-30
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	7e-30
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-29
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-29
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-29
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-29
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-29
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-29
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	8e-29
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-28
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-28
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-28
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-27
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	4e-27
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-27
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-26
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-26
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-26
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-26
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-26
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	7e-26
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-25
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-25
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-25
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-25
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-24
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-24
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-24
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-24
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-24
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-23
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-23
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-23
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-23
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-23
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-22
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-21
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-21
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	5e-19
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	8e-18
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-17
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	8e-16
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-15
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-13
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	6e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	8e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-07
2ehb_D	143	CBL-interacting serine/threonine-protein kinase 2;	2e-06
2zfd_B	123	Putative uncharacterized protein T20L15_90; calciu	4e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-04
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	6e-04

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  480 bits (1238), Expect = e-170
 Identities = 140/295 (47%), Positives = 192/295 (65%), Gaps = 5/295 (1%)

Query: 1   MVIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
           M   +K    +++G Y LG TLG G FGKVK  +   +G   AVKIL + +I  L +  +
Sbjct: 3   MAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGK 62

Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
           I+REI  LKL +HP++++L++V+++ S I+MV+EYV+GGELFD I   GRL E E R+LF
Sbjct: 63  IRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLF 122

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
           QQ++ GV YCH   V HRDLK EN+LLD+  N KI+DFGLS +     D   L T+CGSP
Sbjct: 123 QQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSP 179

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
           NY APEV++ R Y G   DIWS GVILY +L G LPFDD ++  L++KI  G F  P++L
Sbjct: 180 NYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYL 239

Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP--ANPDDDEEDIFVDNEA 293
           +P   +LL+ +L+ +P+KR TI  I+  EWF+QD        D       +D+EA
Sbjct: 240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEA 294

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  471 bits (1214), Expect = e-169
 Identities = 132/274 (48%), Positives = 182/274 (66%), Gaps = 3/274 (1%)

Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
             K    +++G Y LG TLG G FGKVK  +   +G   AVKIL + +I  L +  +IKR
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           EI  LKL +HP++++L++V+++ +  +MV+EYV+GGELFD I   GR++E E R+LFQQ+
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120

Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           +  V YCH   V HRDLK EN+LLD+  N KI+DFGLS +     D   L T+CGSPNY 
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYA 177

Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG 243
           APEV++ R Y G   DIWSCGVILY +L G LPFDD ++  L++KI  G F +P++L+  
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRS 237

Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
              LL  +L+ +P+KR TI  I+  EWF+QD   
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  469 bits (1208), Expect = e-167
 Identities = 112/333 (33%), Positives = 167/333 (50%), Gaps = 17/333 (5%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
              RY+  + +G GNFG  +  +D  +    AVK +E+   I     + ++REI   + L
Sbjct: 18  DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSL 73

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           +HPN+VR  EV+ + + + +++EY +GGEL+++I + GR  E E R  FQQL+ GVSYCH
Sbjct: 74  RHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCH 133

Query: 132 NKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           +  + HRDLKLEN LLD      +KI DFG S             +T G+P Y+APEVL 
Sbjct: 134 SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAPEVLL 190

Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK----IFRGDFKLPK--WLSPG 243
            + YDG  +D+WSCGV LYV+L G  PF+D      Y+K    I    + +P    +SP 
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250

Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP--ANPDDDEEDIFVDNEAFSMHEVPS 301
             +L+ +I   +P  RI+I  IK   WF ++      N  +         +     +   
Sbjct: 251 CCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIM 310

Query: 302 DGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKE 334
                   P + N      M+  LDL    +  
Sbjct: 311 QIISEATIPAVRNRCLDDFMTDNLDLDDDMDDF 343

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  465 bits (1200), Expect = e-166
 Identities = 122/290 (42%), Positives = 184/290 (63%), Gaps = 5/290 (1%)

Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
                 +G Y +  TLGEG+FGKVK A    +    A+K + +  +    +  +++REI+
Sbjct: 2   AISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREIS 61

Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
            LKLL+HP++++L++V+ + + I MV+EY  GGELFD I  K R+ E EGR+ FQQ+I  
Sbjct: 62  YLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICA 120

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + YCH   + HRDLK EN+LLD   N+KI+DFGLS +     D   L T+CGSPNY APE
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAPE 177

Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
           V+  + Y G   D+WSCG++LYV+L G LPFDD  +  L++K+    + +P +LSPGAQ+
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQS 237

Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYT-PANPDDDEEDIFVDNEAFS 295
           L+R+++  +P++RITI  I+ D WF  +      P ++ +  + D+   S
Sbjct: 238 LIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVS 287

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  465 bits (1199), Expect = e-166
 Identities = 108/309 (34%), Positives = 163/309 (52%), Gaps = 14/309 (4%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NVV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            G+ HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPKW--LSPGAQNLLR 249
           +     D+WSCG++L  +L G LP+D   +    Y         L  W  +      LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 250 KILEPNPVKRITIAGIKADEWFEQDYTP--------ANPDDDEEDIFVDNEAFSMHEVPS 301
           KIL  NP  RITI  IK D W+ +            +    +    F  +   ++   P 
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPV 303

Query: 302 DGG-RTPGS 309
           +   RTPGS
Sbjct: 304 NSASRTPGS 312

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  462 bits (1192), Expect = e-166
 Identities = 101/266 (37%), Positives = 150/266 (56%), Gaps = 5/266 (1%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L 
Sbjct: 6   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 63

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NVV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H 
Sbjct: 64  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 123

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            G+ HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R 
Sbjct: 124 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 183

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFKLPKW--LSPGAQNLLR 249
           +     D+WSCG++L  +L G LP+D   +    Y         L  W  +      LL 
Sbjct: 184 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 243

Query: 250 KILEPNPVKRITIAGIKADEWFEQDY 275
           KIL  NP  RITI  IK D W+ +  
Sbjct: 244 KILVENPSARITIPDIKKDRWYNKPL 269

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  462 bits (1191), Expect = e-165
 Identities = 104/289 (35%), Positives = 159/289 (55%), Gaps = 13/289 (4%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK-ITDQIKREIATLKL 70
            +G+Y +G  LGEG++GKVK   D ++    AVKIL+K ++  +      +K+EI  L+ 
Sbjct: 3   LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62

Query: 71  LKHPNVVRLHEVL--ASKSKIYMVLEYVTGG--ELFDKIASKGRLQEAEGRKLFQQLIDG 126
           L+H NV++L +VL    K K+YMV+EY   G  E+ D +  + R    +    F QLIDG
Sbjct: 63  LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVP-EKRFPVCQAHGYFCQLIDG 121

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H++G+ H+D+K  N+LL + G +KIS  G++     F  D    T+ GSP +  PE
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181

Query: 187 VLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
           +      + G   DIWS GV LY I TG  PF+  N+  L++ I +G + +P    P   
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241

Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN------PDDDEEDIF 288
           +LL+ +LE  P KR +I  I+   WF + + PA       P  D +D +
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPPSPDTKDRW 290

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  449 bits (1158), Expect = e-160
 Identities = 94/276 (34%), Positives = 145/276 (52%), Gaps = 3/276 (1%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           I E   +     RY  GR LG+G F K     D D+   FA KI+ K+ ++     +++ 
Sbjct: 4   IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS 63

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
            EI+  + L H +VV  H        +++VLE      L +    +  L E E R   +Q
Sbjct: 64  MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 123

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           ++ G  Y H   V HRDLKL N+ L+    +KI DFGL+   ++  D       CG+PNY
Sbjct: 124 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNY 181

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
           +APEVL+ +G+     D+WS G I+Y +L G  PF+   L   Y +I + ++ +PK ++P
Sbjct: 182 IAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 240

Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278
            A +L++K+L+ +P  R TI  +  DE+F   Y PA
Sbjct: 241 VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  448 bits (1155), Expect = e-159
 Identities = 94/276 (34%), Positives = 145/276 (52%), Gaps = 3/276 (1%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           I E   +     RY  GR LG+G F K     D D+   FA KI+ K+ ++     +++ 
Sbjct: 30  IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMS 89

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
            EI+  + L H +VV  H        +++VLE      L +    +  L E E R   +Q
Sbjct: 90  MEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQ 149

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           ++ G  Y H   V HRDLKL N+ L+    +KI DFGL+   ++  D       CG+PNY
Sbjct: 150 IVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNY 207

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
           +APEVL+ +G+     D+WS G I+Y +L G  PF+   L   Y +I + ++ +PK ++P
Sbjct: 208 IAPEVLSKKGHSFE-VDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 266

Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278
            A +L++K+L+ +P  R TI  +  DE+F   Y PA
Sbjct: 267 VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  442 bits (1138), Expect = e-157
 Identities = 115/283 (40%), Positives = 177/283 (62%), Gaps = 4/283 (1%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           IA    E   +G Y L +T+G+GNF KVK A+ + +G   A+KI++K ++    +  ++ 
Sbjct: 4   IASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-QKLF 62

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           RE+  +K+L HPN+V+L EV+ ++  +Y+++EY +GGE+FD + + GR++E E R  F+Q
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQ 122

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           ++  V YCH K + HRDLK EN+LLD+  NIKI+DFG S     F   G L   CG+P Y
Sbjct: 123 IVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNE---FTVGGKLDAFCGAPPY 179

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
            APE+   + YDG   D+WS GVILY +++G LPFD +NL  L +++ RG +++P ++S 
Sbjct: 180 AAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMST 239

Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
             +NLL++ L  NP+KR T+  I  D W    +         E
Sbjct: 240 DCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVE 282

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  436 bits (1124), Expect = e-155
 Identities = 82/274 (29%), Positives = 152/274 (55%), Gaps = 4/274 (1%)

Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           G ++  +++G  LG+G+F  V  A+ + +GL  A+K+++K  +    +  +++ E+    
Sbjct: 7   GEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVS 128
            LKHP+++ L+      + +Y+VLE    GE+   + ++     E E R    Q+I G+ 
Sbjct: 67  QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           Y H+ G+ HRDL L N+LL    NIKI+DFGL+   +        +T CG+PNY++PE+ 
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIA 184

Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL 248
               + G  SD+WS G + Y +L G  PFD   +     K+   D+++P +LS  A++L+
Sbjct: 185 TRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLI 243

Query: 249 RKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
            ++L  NP  R++++ +    +  ++ +  + D+
Sbjct: 244 HQLLRRNPADRLSLSSVLDHPFMSRNSSTKSKDE 277

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  429 bits (1105), Expect = e-152
 Identities = 94/298 (31%), Positives = 153/298 (51%), Gaps = 32/298 (10%)

Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT------ 58
               + ++L +Y L   +G+G++G VK A + +    +A+K+L K ++I           
Sbjct: 4   GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPP 63

Query: 59  -----------------DQIKREIATLKLLKHPNVVRLHEVL--ASKSKIYMVLEYVTGG 99
                            +Q+ +EIA LK L HPNVV+L EVL   ++  +YMV E V  G
Sbjct: 64  RGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQG 123

Query: 100 ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFG 159
            + + + +   L E + R  FQ LI G+ Y H + + HRD+K  N+L+   G+IKI+DFG
Sbjct: 124 PVME-VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPF 217
           +S   +    D LL  T G+P ++APE L+   + + G   D+W+ GV LY  + G  PF
Sbjct: 183 VSNEFK--GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240

Query: 218 DDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
            D  +  L+ KI     + P    ++   ++L+ ++L+ NP  RI +  IK   W  +
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  427 bits (1100), Expect = e-152
 Identities = 88/278 (31%), Positives = 154/278 (55%), Gaps = 5/278 (1%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           +AE  +    +  +++GR LG+G FG V  A++  +    A+K+L K+++    +  Q++
Sbjct: 3   LAEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR 62

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           REI     L+HPN++R++     + +IY++LE+   GEL+ ++   GR  E       ++
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           L D + YCH + V HRD+K EN+L+  KG +KI+DFG S      R      T CG+ +Y
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDY 178

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
           + PE++  + +D    D+W  GV+ Y  L G  PFD  +    +++I   D K P +LS 
Sbjct: 179 LPPEMIEGKTHDEK-VDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSD 237

Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           G+++L+ K+L  +P +R+ + G+    W + +     P
Sbjct: 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLP 275

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  420 bits (1081), Expect = e-148
 Identities = 84/312 (26%), Positives = 140/312 (44%), Gaps = 15/312 (4%)

Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---- 59
                EG    +Y     LG G FG V  A D +      VK ++K +++     +    
Sbjct: 14  GLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKL 73

Query: 60  -QIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE-YVTGGELFDKIASKGRLQEAEGR 117
            ++  EIA L  ++H N++++ ++  ++    +V+E + +G +LF  I    RL E    
Sbjct: 74  GKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLAS 133

Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
            +F+QL+  V Y   K + HRD+K ENI++     IK+ DFG +A         L +T C
Sbjct: 134 YIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFC 190

Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP 237
           G+  Y APEVL    Y G   ++WS GV LY ++    PF +       ++        P
Sbjct: 191 GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPP 244

Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 297
             +S    +L+  +L+P P +R T+  +  D W  Q    A+   +E       E+  + 
Sbjct: 245 YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLS 304

Query: 298 EVPSDGGRTPGS 309
               + G    S
Sbjct: 305 AASLEMGNRSLS 316

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  417 bits (1075), Expect = e-148
 Identities = 87/281 (30%), Positives = 152/281 (54%), Gaps = 5/281 (1%)

Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           K+    L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+ 
Sbjct: 2   KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61

Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
               L+HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L + 
Sbjct: 62  IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANA 121

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           +SYCH+K V HRD+K EN+LL S G +KI+DFG S      R        CG+ +Y+ PE
Sbjct: 122 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPE 177

Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
           ++  R +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++
Sbjct: 178 MIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD 236

Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
           L+ ++L+ NP +R  +  +    W   + +  +   ++E  
Sbjct: 237 LISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESA 277

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  411 bits (1059), Expect = e-145
 Identities = 86/292 (29%), Positives = 133/292 (45%), Gaps = 19/292 (6%)

Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--- 60
              K        Y LG  LG+G FG V     L   L  A+K++ +NR++          
Sbjct: 21  PGGKDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVT 80

Query: 61  IKREIATLKLL----KHPNVVRLHEVLASKSKIYMVLEY-VTGGELFDKIASKGRLQEAE 115
              E+A L  +     HP V+RL +   ++    +VLE  +   +LFD I  KG L E  
Sbjct: 81  CPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGP 140

Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLH 174
            R  F Q++  + +CH++GV HRD+K ENIL+D + G  K+ DFG  AL      D    
Sbjct: 141 SRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLH----DEPYT 196

Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234
              G+  Y  PE ++   Y    + +WS G++LY ++ G +PF+        Q+I   + 
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAEL 250

Query: 235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEED 286
             P  +SP    L+R+ L P P  R ++  I  D W +        +  +  
Sbjct: 251 HFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKGG 302

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  410 bits (1055), Expect = e-144
 Identities = 89/291 (30%), Positives = 140/291 (48%), Gaps = 17/291 (5%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI---IHLKITD 59
           +A  K++     +Y++G  LG G FG V     +   LP A+K +EK+RI     L    
Sbjct: 32  LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGT 91

Query: 60  QIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEG 116
           ++  E+  LK +      V+RL +         ++LE      +LFD I  +G LQE   
Sbjct: 92  RVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELA 151

Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHT 175
           R  F Q+++ V +CHN GV HRD+K ENIL+D  +G +K+ DFG  AL +    D +   
Sbjct: 152 RSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTD 207

Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK 235
             G+  Y  PE +    Y G ++ +WS G++LY ++ G +PF+        ++I RG   
Sbjct: 208 FDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVF 261

Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEED 286
             + +S   Q+L+R  L   P  R T   I+   W +    P    +    
Sbjct: 262 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLH 312

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  389 bits (1000), Expect = e-135
 Identities = 74/324 (22%), Positives = 132/324 (40%), Gaps = 50/324 (15%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--------- 56
            K++   +  Y + RTL +G F K+   +       +A+K  EK+ +   +         
Sbjct: 23  VKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDK 80

Query: 57  -----ITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRL 111
                  D  K E+  +  +K+   +    ++ +  ++Y++ EY+    +         L
Sbjct: 81  ISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVL 140

Query: 112 Q--------EAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSA 162
                        + + + +++  SY HN K + HRD+K  NIL+D  G +K+SDFG S 
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESE 200

Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDD-R 220
               +  D  +  + G+  ++ PE  +N   Y+GA  DIWS G+ LYV+    +PF    
Sbjct: 201 ----YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKI 256

Query: 221 NLAVLYQKIFRGDFKLP-------------------KWLSPGAQNLLRKILEPNPVKRIT 261
           +L  L+  I   + + P                    +LS    + L+  L  NP +RIT
Sbjct: 257 SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT 316

Query: 262 IAGIKADEWFEQDYTPANPDDDEE 285
                  EW          +  +E
Sbjct: 317 SEDALKHEWLADTNIEDLREFSKE 340

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  332 bits (853), Expect = e-114
 Identities = 98/283 (34%), Positives = 145/283 (51%), Gaps = 19/283 (6%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLK 69
            Y + +TLG G  G+VK A +  +    A+KI+ K +              ++ EI  LK
Sbjct: 11  EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y
Sbjct: 71  KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 129

Query: 130 CHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
            H  G+ HRDLK EN+LL S+     IKI+DFG S   +   +  L+ T CG+P Y+APE
Sbjct: 130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS---KILGETSLMRTLCGTPTYLAPE 186

Query: 187 VLANRGYDGATS--DIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRG--DFKLPKW-- 239
           VL + G  G     D WS GVIL++ L+GY PF +      L  +I  G  +F    W  
Sbjct: 187 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 246

Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
           +S  A +L++K+L  +P  R T        W + +       D
Sbjct: 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 289

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  324 bits (832), Expect = e-111
 Identities = 97/275 (35%), Positives = 154/275 (56%), Gaps = 16/275 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y L  T+G G++G+VK A    + +  A K + K     ++  D+ K+EI  +K L HP
Sbjct: 10  YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIMKSLDHP 66

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N++RL+E     + IY+V+E  TGGELF+++  K   +E++  ++ + ++  V+YCH   
Sbjct: 67  NIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN 126

Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           V HRDLK EN L  +      +K+ DFGL+A    F+   ++ T  G+P YV+P+VL   
Sbjct: 127 VAHRDLKPENFLFLTDSPDSPLKLIDFGLAA---RFKPGKMMRTKVGTPYYVSPQVL-EG 182

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
            Y G   D WS GV++YV+L GY PF     + +  KI  G   F    W  +SP A++L
Sbjct: 183 LY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241

Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
           +R++L  +P +RIT       EWF +    ++P +
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWF-EKQLSSSPRN 275

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  323 bits (831), Expect = e-111
 Identities = 100/280 (35%), Positives = 156/280 (55%), Gaps = 12/280 (4%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y++   LG+G F  V+      +GL FA KI+   ++       +++RE    + L+HP
Sbjct: 7   NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDF-QKLEREARICRKLQHP 65

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VRLH+ +  +S  Y+V + VTGGELF+ I ++    EA+     QQ+++ ++YCH+ G
Sbjct: 66  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125

Query: 135 VFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HR+LK EN+LL SK     +K++DFGL+       D    H   G+P Y++PEVL   
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLA---IEVNDSEAWHGFAGTPGYLSPEVLKKD 182

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
            Y     DIW+CGVILY++L GY PF D +   LY +I  G  D+  P+W  ++P A++L
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241

Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
           +  +L  NP KRIT        W       A+    ++ +
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQDTV 281

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  325 bits (836), Expect = e-110
 Identities = 98/283 (34%), Positives = 146/283 (51%), Gaps = 19/283 (6%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLK 69
            Y + +TLG G  G+VK A +  +    A++I+ K +              ++ EI  LK
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            L HP ++++     ++   Y+VLE + GGELFDK+    RL+EA  +  F Q++  V Y
Sbjct: 196 KLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQY 254

Query: 130 CHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
            H  G+ HRDLK EN+LL S+     IKI+DFG S   +   +  L+ T CG+P Y+APE
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS---KILGETSLMRTLCGTPTYLAPE 311

Query: 187 VLANRGYDGATS--DIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRG--DFKLPKW-- 239
           VL + G  G     D WS GVIL++ L+GY PF + R    L  +I  G  +F    W  
Sbjct: 312 VLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAE 371

Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
           +S  A +L++K+L  +P  R T        W + +       D
Sbjct: 372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQD 414

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  323 bits (829), Expect = e-109
 Identities = 89/275 (32%), Positives = 141/275 (51%), Gaps = 20/275 (7%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-----IHLKITDQIKREIATLK 69
           +Y+    +G G    V+      +G  FAVKI+E            ++ +  +RE   L+
Sbjct: 95  KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILR 154

Query: 70  LLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
            +  HP+++ L +   S S +++V + +  GELFD +  K  L E E R + + L++ VS
Sbjct: 155 QVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVS 214

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           + H   + HRDLK ENILLD    I++SDFG S    H      L   CG+P Y+APE+L
Sbjct: 215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYLAPEIL 271

Query: 189 ------ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW- 239
                  + GY G   D+W+CGVIL+ +L G  PF  R   ++ + I  G   F  P+W 
Sbjct: 272 KCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD 330

Query: 240 -LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
             S   ++L+ ++L+ +P  R+T        +FE+
Sbjct: 331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  318 bits (816), Expect = e-108
 Identities = 86/283 (30%), Positives = 134/283 (47%), Gaps = 21/283 (7%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD------QIKREIATL 68
            YE    LG G    V+      +   +AVKI++          +         +E+  L
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77

Query: 69  KLLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           + +  HPN+++L +   + +  ++V + +  GELFD +  K  L E E RK+ + L++ +
Sbjct: 78  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
              H   + HRDLK ENILLD   NIK++DFG S           L   CG+P+Y+APE+
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDPGEKLREVCGTPSYLAPEI 194

Query: 188 LA------NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW 239
           +       + GY G   D+WS GVI+Y +L G  PF  R   ++ + I  G   F  P+W
Sbjct: 195 IECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253

Query: 240 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
              S   ++L+ + L   P KR T     A  +F+Q       
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  319 bits (820), Expect = e-108
 Identities = 100/278 (35%), Positives = 154/278 (55%), Gaps = 12/278 (4%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y++   LG+G F  V+      +GL FA KI+   ++        ++RE    + L+HP
Sbjct: 30  NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQK-LEREARICRKLQHP 88

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VRLH+ +  +S  Y+V + VTGGELF+ I ++    EA+     QQ+++ ++YCH+ G
Sbjct: 89  NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 148

Query: 135 VFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HR+LK EN+LL SK     +K++DFGL+       D    H   G+P Y++PEVL   
Sbjct: 149 IVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHGFAGTPGYLSPEVLKKD 205

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
            Y     DIW+CGVILY++L GY PF D +   LY +I  G  D+  P+W  ++P A++L
Sbjct: 206 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 264

Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
           +  +L  NP KRIT        W       A+    ++
Sbjct: 265 IDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQD 302

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  316 bits (813), Expect = e-108
 Identities = 95/277 (34%), Positives = 147/277 (53%), Gaps = 15/277 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +     LG G F +V   +   +G  FA+K ++K+          ++ EIA LK +KH 
Sbjct: 10  TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHE 66

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+V L ++  S +  Y+V++ V+GGELFD+I  +G   E +   + QQ++  V Y H  G
Sbjct: 67  NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126

Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+L  +      I I+DFGLS        +G++ T CG+P YVAPEVLA +
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLS----KMEQNGIMSTACGTPGYVAPEVLAQK 182

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
            Y     D WS GVI Y++L GY PF +   + L++KI  G  +F+ P W  +S  A++ 
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241

Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
           +  +LE +P +R T     +  W + +          
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGNTALHRDIYPS 278

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  313 bits (804), Expect = e-107
 Identities = 94/269 (34%), Positives = 142/269 (52%), Gaps = 17/269 (6%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +   R LG G FG V   ++  SGL   +K + K+R       +QI+ EI  LK L HP
Sbjct: 23  LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPM--EQIEAEIEVLKSLDHP 80

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYC 130
           N++++ EV      +Y+V+E   GGEL ++I S       L E    +L +Q+++ ++Y 
Sbjct: 81  NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140

Query: 131 HNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H++ V H+DLK ENIL         IKI DFGL+     F+ D       G+  Y+APEV
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE---LFKSDEHSTNAAGTALYMAPEV 197

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL---PKWLSPGA 244
              R       DIWS GV++Y +LTG LPF   +L  + QK    +       + L+P A
Sbjct: 198 F-KRDVTFKC-DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQA 255

Query: 245 QNLLRKILEPNPVKRITIAGIKADEWFEQ 273
            +LL+++L  +P +R + A +   EWF+Q
Sbjct: 256 VDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  313 bits (805), Expect = e-107
 Identities = 72/290 (24%), Positives = 124/290 (42%), Gaps = 36/290 (12%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +E    LG+G FG+V  A++      +A+K +        +    I  E+  L  L H  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQY 63

Query: 76  VVRLHEV-------------LASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQ 121
           VVR +               +  KS +++ +EY   G L+D I S+    Q  E  +LF+
Sbjct: 64  VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFR 123

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH------------FRD 169
           Q+++ +SY H++G+ HRDLK  NI +D   N+KI DFGL+                    
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 229
              L +  G+  YVA EVL   G+     D++S G+I + ++  Y          + +K+
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKKL 241

Query: 230 FRGDFKLPKWL----SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                + P           + ++R +++ +P KR     +    W    +
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  311 bits (798), Expect = e-106
 Identities = 104/267 (38%), Positives = 155/267 (58%), Gaps = 13/267 (4%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY +   LG+G+FG+V   +D  +   +AVK++ K    + K T  I RE+  LK L HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L E+L   S  Y+V E  TGGELFD+I  + R  E +  ++ +Q+  G++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK ENILL+SK    +IKI DFGLS     F+ +  +    G+  Y+APEVL   
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLST---CFQQNTKMKDRIGTAYYIAPEVL-RG 197

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
            YD    D+WS GVILY++L+G  PF  +N   + +++  G   F LP+W  +S  A++L
Sbjct: 198 TYDEK-CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 248 LRKILEPNPVKRITIAGIKADEWFEQD 274
           +RK+L  +P  RIT        W ++ 
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKY 283

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  311 bits (800), Expect = e-104
 Identities = 103/279 (36%), Positives = 156/279 (55%), Gaps = 13/279 (4%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y+L   LG+G F  V+    + +G  +A  I+   ++        ++RE    +LLKHP
Sbjct: 12  EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQK-LEREARICRLLKHP 70

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+VRLH+ ++ +   Y++ + VTGGELF+ I ++    EA+     QQ+++ V +CH  G
Sbjct: 71  NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130

Query: 135 VFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDG-LLHTTCGSPNYVAPEVLAN 190
           V HR+LK EN+LL SK     +K++DFGL+        +        G+P Y++PEVL  
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLAI---EVEGEQQAWFGFAGTPGYLSPEVLRK 187

Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQN 246
             Y G   D+W+CGVILY++L GY PF D +   LYQ+I  G  DF  P+W  ++P A++
Sbjct: 188 DPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246

Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
           L+ K+L  NP KRIT A      W     T A+    +E
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQE 285

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  306 bits (787), Expect = e-104
 Identities = 67/280 (23%), Positives = 124/280 (44%), Gaps = 19/280 (6%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y + + +G G   KV    +    + +A+K +      + +  D  + EIA L  L+  
Sbjct: 29  IYSILKQIGSGGSSKVFQVLNEKKQI-YAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 86

Query: 75  N--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +  ++RL++   +   IYMV+E     +L   +  K  +   E +  ++ +++ V   H 
Sbjct: 87  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            G+ H DLK  N L+   G +K+ DFG++   Q      +  +  G+ NY+ PE + +  
Sbjct: 146 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204

Query: 193 YD----------GATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKI-FRGDFKLPKW 239
                          SD+WS G ILY +  G  PF      ++ L+  I    + + P  
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264

Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
                Q++L+  L+ +P +RI+I  + A  + +    P N
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  302 bits (776), Expect = e-102
 Identities = 88/271 (32%), Positives = 142/271 (52%), Gaps = 15/271 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
            YE+G  LG G F  V+  +   +G  +A K ++K R+         ++I+RE+  L+ +
Sbjct: 6   HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           +HPN++ LH++  +K+ + ++LE V+GGELFD +A K  L E E  +  +Q++DGV Y H
Sbjct: 66  RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125

Query: 132 NKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +K + H DLK ENI+L  K      IK+ DFG++                G+P +VAPE+
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA---HKIEAGNEFKNIFGTPEFVAPEI 182

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 243
           +          D+WS GVI Y++L+G  PF           I     DF    +   S  
Sbjct: 183 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241

Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
           A++ +R++L  +P +R+TIA      W +  
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  305 bits (782), Expect = e-102
 Identities = 93/288 (32%), Positives = 146/288 (50%), Gaps = 15/288 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKLL 71
            Y++G  LG G F  VK  ++  +GL +A K ++K +          ++I+RE++ L+ +
Sbjct: 13  FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            HPN++ LH+V  +++ + ++LE V+GGELFD +A K  L E E     +Q++DGV+Y H
Sbjct: 73  LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132

Query: 132 NKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            K + H DLK ENI+L  K     +IK+ DFGL+       D        G+P +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEI 189

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 243
           +          D+WS GVI Y++L+G  PF           I     DF    +   S  
Sbjct: 190 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSEL 248

Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 291
           A++ +RK+L     KR+TI       W     T       E  + ++N
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLEN 296

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  309 bits (793), Expect = e-102
 Identities = 104/276 (37%), Positives = 156/276 (56%), Gaps = 13/276 (4%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY +   LG+G+FG+V   +D  +   +AVK++ K    + K T  I RE+  LK L HP
Sbjct: 23  RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L E+L   S  Y+V E  TGGELFD+I  + R  E +  ++ +Q+  G++Y H   
Sbjct: 82  NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN 141

Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK ENILL+SK    +IKI DFGLS     F+ +  +    G+  Y+APEVL   
Sbjct: 142 IVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAYYIAPEVL-RG 197

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
            Y     D+WS GVILY++L+G  PF  +N   + +++  G   F LP+W  +S  A++L
Sbjct: 198 TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL 256

Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 283
           +RK+L  +P  RIT        W ++  +      D
Sbjct: 257 IRKMLTFHPSLRITATQCLEHPWIQKYSSETPTISD 292

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  303 bits (777), Expect = e-102
 Identities = 92/288 (31%), Positives = 145/288 (50%), Gaps = 15/288 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT---DQIKREIATLKLL 71
            Y++G  LG G F  VK  ++  +GL +A K ++K +    +     ++I+RE++ L+ +
Sbjct: 13  FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            H NV+ LH+V  +++ + ++LE V+GGELFD +A K  L E E     +Q++DGV+Y H
Sbjct: 73  LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLH 132

Query: 132 NKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            K + H DLK ENI+L  K     +IK+ DFGL+       D        G+P +VAPE+
Sbjct: 133 TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA---HEIEDGVEFKNIFGTPEFVAPEI 189

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 243
           +          D+WS GVI Y++L+G  PF           I     DF    +   S  
Sbjct: 190 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSEL 248

Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 291
           A++ +RK+L     KR+TI       W             E  + ++N
Sbjct: 249 AKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLEN 296

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  303 bits (778), Expect = e-102
 Identities = 90/312 (28%), Positives = 138/312 (44%), Gaps = 53/312 (16%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--IKREIATLKLLK 72
           +Y L   +G+G++G V+ A +  +    A+KI+ KN+I  +   D   IK E+  +K L 
Sbjct: 27  KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ-------------------- 112
           HPN+ RL+EV   +  I +V+E   GG L DK+                           
Sbjct: 87  HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146

Query: 113 --------------------EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152
                               E     + +Q+   + Y HN+G+ HRD+K EN L  +  +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206

Query: 153 --IKISDFGLSAL--PQHFRDDGLLHTTCGSPNYVAPEVL--ANRGYDGATSDIWSCGVI 206
             IK+ DFGLS      +  +   + T  G+P +VAPEVL   N  Y     D WS GV+
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC-DAWSAGVL 265

Query: 207 LYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITI 262
           L+++L G +PF   N A    ++      F+ P +  LSP A++LL  +L  N  +R   
Sbjct: 266 LHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDA 325

Query: 263 AGIKADEWFEQD 274
                  W  Q 
Sbjct: 326 MRALQHPWISQF 337

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  302 bits (776), Expect = e-102
 Identities = 94/278 (33%), Positives = 146/278 (52%), Gaps = 18/278 (6%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +E+   LG G    V   +   +  P+A+K+L+K           ++ EI  L  L HP
Sbjct: 54  FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT-----VDKKIVRTEIGVLLRLSHP 108

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L E+  + ++I +VLE VTGGELFD+I  KG   E +     +Q+++ V+Y H  G
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG 168

Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+L  +      +KI+DFGLS   +      L+ T CG+P Y APE+L   
Sbjct: 169 IVHRDLKPENLLYATPAPDAPLKIADFGLS---KIVEHQVLMKTVCGTPGYCAPEILRGC 225

Query: 192 GYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRG--DFKLPKW--LSPGAQN 246
            Y G   D+WS G+I Y++L G+ PF D+R    ++++I      F  P W  +S  A++
Sbjct: 226 AY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKD 284

Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
           L+RK++  +P KR+T        W            D 
Sbjct: 285 LVRKLIVLDPKKRLTTFQALQHPWV-TGKAANFVHMDT 321

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  308 bits (790), Expect = e-102
 Identities = 94/292 (32%), Positives = 152/292 (52%), Gaps = 22/292 (7%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT----------DQIKRE 64
            Y   R LG G +G+V   ++ +     A+K+++K++    + +          ++I  E
Sbjct: 37  SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96

Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
           I+ LK L HPN+++L +V   K   Y+V E+  GGELF++I ++ +  E +   + +Q++
Sbjct: 97  ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQIL 156

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
            G+ Y H   + HRD+K ENILL++K    NIKI DFGLS     F  D  L    G+  
Sbjct: 157 SGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS---SFFSKDYKLRDRLGTAY 213

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW 239
           Y+APEVL  + Y     D+WSCGVI+Y++L GY PF  +N   + +K+ +G   F    W
Sbjct: 214 YIAPEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW 271

Query: 240 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFV 289
             +S  A+ L++ +L  +  KR T        W ++     N  D +     
Sbjct: 272 KNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGA 323

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  301 bits (773), Expect = e-102
 Identities = 72/309 (23%), Positives = 116/309 (37%), Gaps = 50/309 (16%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             + L   LG+G    V   +   +G  FA+K+        L+  D   RE   LK L H
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNH 66

Query: 74  PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVS 128
            N+V+L  +    +     +++E+   G L+  +        L E+E   + + ++ G++
Sbjct: 67  KNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMN 126

Query: 129 YCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           +    G+ HR++K  NI+     D +   K++DFG +       DD    +  G+  Y+ 
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLH 183

Query: 185 PEVLANRGYD-------GATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRG- 232
           P++              GAT D+WS GV  Y   TG LPF      R    +  KI  G 
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243

Query: 233 ------------------DFKLPKW--LSPGAQN----LLRKILEPNPVKRITIAGIKAD 268
                                +P    LS G Q     +L  ILE +  K        A+
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303

Query: 269 EWFEQDYTP 277
                    
Sbjct: 304 TSDILHRGN 312

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  306 bits (786), Expect = e-101
 Identities = 104/282 (36%), Positives = 158/282 (56%), Gaps = 12/282 (4%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+  R LG+G+FG+V   +D  +G   AVK++ K ++      + + RE+  LK L HP
Sbjct: 27  RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L+E    K   Y+V E  TGGELFD+I S+ R  E +  ++ +Q++ G++Y H   
Sbjct: 87  NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK 146

Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK    NI+I DFGLS    HF     +    G+  Y+APEVL + 
Sbjct: 147 IVHRDLKPENLLLESKSKDANIRIIDFGLS---THFEASKKMKDKIGTAYYIAPEVL-HG 202

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
            Y     D+WS GVILY++L+G  PF+  N   + +K+ +G   F+LP+W  +S  A++L
Sbjct: 203 TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDL 261

Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFV 289
           +RK+L   P  RI+       EW +         D       
Sbjct: 262 IRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNA 303

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  302 bits (775), Expect = e-101
 Identities = 87/284 (30%), Positives = 146/284 (51%), Gaps = 18/284 (6%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ--IKREIATLKLLK 72
            YEL   +G+G F  V+   + ++G  FAVKI++  +           +KRE +   +LK
Sbjct: 25  VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ----EAEGRKLFQQLIDGVS 128
           HP++V L E  +S   +YMV E++ G +L  +I  +        EA      +Q+++ + 
Sbjct: 85  HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144

Query: 129 YCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
           YCH+  + HRD+K   +LL SK N   +K+  FG++   Q      +     G+P+++AP
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI--QLGESGLVAGGRVGTPHFMAP 202

Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LS 241
           EV+    Y G   D+W CGVIL+++L+G LPF       L++ I +G       +W  +S
Sbjct: 203 EVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNPRQWSHIS 260

Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEWF-EQDYTPANPDDDE 284
             A++L+R++L  +P +RIT+       W  E+D         E
Sbjct: 261 ESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPE 304

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  310 bits (795), Expect = e-101
 Identities = 76/298 (25%), Positives = 110/298 (36%), Gaps = 42/298 (14%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
             G +E+   LG G FG V      D+G   A+K   +      K  ++   EI  +K L
Sbjct: 12  TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSP--KNRERWCLEIQIMKKL 69

Query: 72  KHPNVVRLHEVLASKSKI------YMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQ 122
            HPNVV   EV     K+       + +EY  GG+L   +        L+E   R L   
Sbjct: 70  NHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSD 129

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDDGLLHTTCGS 179
           +   + Y H   + HRDLK ENI+L         KI D G +   +      L     G+
Sbjct: 130 ISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA---KELDQGELCTEFVGT 186

Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI---------- 229
             Y+APE+L  + Y   T D WS G + +  +TG+ PF      V +             
Sbjct: 187 LQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIV 245

Query: 230 ----------FRGDFKLPKWLSPGAQNL----LRKILEPNPVKRITIAGIKADEWFEQ 273
                     F      P  LS          L+ +L  +  +R T         F+ 
Sbjct: 246 VYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  301 bits (772), Expect = e-100
 Identities = 67/286 (23%), Positives = 124/286 (43%), Gaps = 19/286 (6%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             Y + + +G G   KV    + +    +A+K +      + +  D  + EIA L  L+ 
Sbjct: 56  RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQ 113

Query: 74  PN--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            +  ++RL++   +   IYMV+E     +L   +  K  +   E +  ++ +++ V   H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
             G+ H DLK  N L+   G +K+ DFG++   Q      +  +  G+ NY+ PE + + 
Sbjct: 173 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 192 GYD----------GATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKIFRG-DFKLPK 238
                           SD+WS G ILY +  G  PF      ++ L+  I    + + P 
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291

Query: 239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
                 Q++L+  L+ +P +RI+I  + A  + +    P N     
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 337

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  298 bits (766), Expect = e-100
 Identities = 91/288 (31%), Positives = 145/288 (50%), Gaps = 15/288 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKIT---DQIKREIATLKLL 71
            Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK +
Sbjct: 12  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           +HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H
Sbjct: 72  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 131

Query: 132 NKGVFHRDLKLENILLDSK----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +  + H DLK ENI+L  +      IKI DFGL+                G+P +VAPE+
Sbjct: 132 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 188

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 243
           +          D+WS GVI Y++L+G  PF           +     +F+   +   S  
Sbjct: 189 VNYEPLGLEA-DMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 247

Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 291
           A++ +R++L  +P KR+TI       W +   T          + ++ 
Sbjct: 248 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEK 295

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  298 bits (765), Expect = e-100
 Identities = 67/285 (23%), Positives = 124/285 (43%), Gaps = 19/285 (6%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y + + +G G   KV    + +    +A+K +      + +  D  + EIA L  L+  
Sbjct: 10  IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 67

Query: 75  N--VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +  ++RL++   +   IYMV+E     +L   +  K  +   E +  ++ +++ V   H 
Sbjct: 68  SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            G+ H DLK  N L+   G +K+ DFG++   Q      +  +  G+ NY+ PE + +  
Sbjct: 127 HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185

Query: 193 YD----------GATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKI-FRGDFKLPKW 239
                          SD+WS G ILY +  G  PF      ++ L+  I    + + P  
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245

Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
                Q++L+  L+ +P +RI+I  + A  + +    P N     
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKG 290

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  303 bits (777), Expect = e-100
 Identities = 91/276 (32%), Positives = 153/276 (55%), Gaps = 13/276 (4%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y+  + LG G +G+V   +D  + +  A+KI+ K  +     +  +  E+A LKLL HP
Sbjct: 38  MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHP 96

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+++L++    K   Y+V+E   GGELFD+I  + +  E +   + +Q++ GV+Y H   
Sbjct: 97  NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156

Query: 135 VFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+LL+SK     IKI DFGLS     F +   +    G+  Y+APEVL  +
Sbjct: 157 IVHRDLKPENLLLESKEKDALIKIVDFGLS---AVFENQKKMKERLGTAYYIAPEVL-RK 212

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
            Y     D+WS GVIL+++L GY PF  +    + +K+ +G   F  P+W  +S GA++L
Sbjct: 213 KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDL 271

Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDD 283
           ++++L+ +  +RI+        W ++  +      +
Sbjct: 272 IKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIE 307

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  297 bits (762), Expect = e-100
 Identities = 95/284 (33%), Positives = 141/284 (49%), Gaps = 22/284 (7%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
            YE+   +G G++   K      + + FAVKI++K++            EI  L +  +H
Sbjct: 23  GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQH 75

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           PN++ L +V      +Y+V E + GGEL DKI  +    E E   +   +   V Y H +
Sbjct: 76  PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQ 135

Query: 134 GVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           GV HRDLK  NIL   +     +I+I DFG +   Q   ++GLL T C + N+VAPEVL 
Sbjct: 136 GVVHRDLKPSNILYVDESGNPESIRICDFGFAK--QLRAENGLLMTPCYTANFVAPEVLE 193

Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFD---DRNLAVLYQKIFRG--DFKLPKW--LSP 242
            +GYD A  DIWS GV+LY +LTGY PF    D     +  +I  G        W  +S 
Sbjct: 194 RQGYDAA-CDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252

Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEED 286
            A++L+ K+L  +P +R+T A +    W            + +D
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQD 296

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  299 bits (766), Expect = e-100
 Identities = 70/312 (22%), Positives = 117/312 (37%), Gaps = 55/312 (17%)

Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
             +      + L   LG+G    V   +   +G  FA+K+        L+  D   RE  
Sbjct: 2   GSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFE 59

Query: 67  TLKLLKHPNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQ 121
            LK L H N+V+L  +    +     +++E+   G L+  +        L E+E   + +
Sbjct: 60  VLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
            ++ G+++    G+ HR++K  NI+     D +   K++DFG +       DD    +  
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLY 176

Query: 178 GSPNYVAPEVLANRGYD-------GATSDIWSCGVILYVILTGYLPFDD----RNLAVLY 226
           G+  Y+ P++              GAT D+WS GV  Y   TG LPF      R    + 
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236

Query: 227 QKIFRGDF-------------------------KLPKWLSPGAQNLLRKILEPNPVKRIT 261
            KI  G                            L + L      +L  ILE +  K   
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296

Query: 262 IAGIKADEWFEQ 273
                 D++F +
Sbjct: 297 F-----DQFFAE 303

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  292 bits (749), Expect = 4e-98
 Identities = 66/274 (24%), Positives = 125/274 (45%), Gaps = 15/274 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           +Y +   LG G FG V    +  S   +  K ++            +K+EI+ L + +H 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
           N++ LHE   S  ++ M+ E+++G ++F++I +    L E E      Q+ + + + H+ 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 134 GVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            + H D++ ENI+  ++ +  IKI +FG +   +  +          +P Y APEV  + 
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVHQHD 178

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
               AT D+WS G ++YV+L+G  PF       + + I      F    +  +S  A + 
Sbjct: 179 VVSTAT-DMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237

Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 281
           + ++L      R+T +      W +Q     +  
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  290 bits (744), Expect = 3e-97
 Identities = 101/298 (33%), Positives = 158/298 (53%), Gaps = 28/298 (9%)

Query: 15  RYELG---RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
            Y+L    + LGEG+F   +      S   FAVKI+ K            ++EI  LKL 
Sbjct: 9   HYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLC 62

Query: 72  K-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           + HPN+V+LHEV   +   ++V+E + GGELF++I  K    E E   + ++L+  VS+ 
Sbjct: 63  EGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHM 122

Query: 131 HNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H+ GV HRDLK EN+L   +     IKI DFG + L     D+  L T C + +Y APE+
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP--DNQPLKTPCFTLHYAAPEL 180

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-------LAVLYQKIFRG--DFKLPK 238
           L   GYD +  D+WS GVILY +L+G +PF   +          + +KI +G   F+   
Sbjct: 181 LNQNGYDES-CDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEA 239

Query: 239 W--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEA 293
           W  +S  A++L++ +L  +P KR+ ++G++ +EW +      +NP    + +     A
Sbjct: 240 WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGSSGAA 297

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  286 bits (735), Expect = 6e-96
 Identities = 94/282 (33%), Positives = 139/282 (49%), Gaps = 17/282 (6%)

Query: 15  RYEL-GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            Y L  + LG G F  V+      +G  +A K L+K R       + I  EIA L+L K 
Sbjct: 29  FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE-ILHEIAVLELAKS 87

Query: 74  -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYC 130
            P V+ LHEV  + S+I ++LEY  GGE+F     +    + E +  +L +Q+++GV Y 
Sbjct: 88  CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYL 147

Query: 131 HNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           H   + H DLK +NILL S    G+IKI DFG+S   +       L    G+P Y+APE+
Sbjct: 148 HQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMS---RKIGHACELREIMGTPEYLAPEI 204

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPG 243
           L       AT D+W+ G+I Y++LT   PF   +    Y  I +   D+    +  +S  
Sbjct: 205 LNYDPITTAT-DMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQL 263

Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
           A + ++ +L  NP KR T     +  W  Q +   N    EE
Sbjct: 264 ATDFIQSLLVKNPEKRPTAEICLSHSWL-QQWDFENLFHPEE 304

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  288 bits (739), Expect = 1e-95
 Identities = 77/278 (27%), Positives = 138/278 (49%), Gaps = 14/278 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y++   LG G FG V    +  +G  F  K +             +K EI+ +  L HP
Sbjct: 52  YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHP 108

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
            ++ LH+    K ++ ++LE+++GGELFD+IA++  ++ EAE     +Q  +G+ + H  
Sbjct: 109 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 168

Query: 134 GVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            + H D+K ENI+ ++K    +KI DFGL+        D ++  T  +  + APE++   
Sbjct: 169 SIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAAPEIVDRE 225

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
                T D+W+ GV+ YV+L+G  PF   +     Q + R   +F    +  +SP A++ 
Sbjct: 226 PVGFYT-DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDF 284

Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
           ++ +L+  P KR+T+       W + D++         
Sbjct: 285 IKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSS 322

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  285 bits (731), Expect = 2e-95
 Identities = 92/300 (30%), Positives = 138/300 (46%), Gaps = 39/300 (13%)

Query: 15  RYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
            Y+L    LGEG   +V+   +L +   +AVKI+EK       I  ++ RE+  L   + 
Sbjct: 13  VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQG 69

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NV+ L E    + + Y+V E + GG +   I  +    E E   + Q +   + + HN
Sbjct: 70  HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHN 129

Query: 133 KGVFHRDLKLENILLDSKGN---IKISDFGLSAL-----PQHFRDDGLLHTTCGSPNYVA 184
           KG+ HRDLK ENIL +       +KI DF L +               L T CGS  Y+A
Sbjct: 130 KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA 189

Query: 185 PEVL-----ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV--------------- 224
           PEV+         YD    D+WS GVILY++L+GY PF  R  +                
Sbjct: 190 PEVVEAFSEEASIYDKR-CDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248

Query: 225 LYQKIFRG--DFKLPKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           L++ I  G  +F    W  +S  A++L+ K+L  +  +R++ A +    W  Q   P N 
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV-QGCAPENT 307

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  284 bits (728), Expect = 3e-94
 Identities = 85/269 (31%), Positives = 139/269 (51%), Gaps = 16/269 (5%)

Query: 15  RYELGRT--LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
            Y + +T  LG G FG+V   ++  +GL  A KI++      +K  +++K EI+ +  L 
Sbjct: 88  FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMNQLD 144

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCH 131
           H N+++L++   SK+ I +V+EYV GGELFD+I  +   L E +     +Q+ +G+ + H
Sbjct: 145 HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMH 204

Query: 132 NKGVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
              + H DLK ENIL  ++    IKI DFGL+   + ++    L    G+P ++APEV+ 
Sbjct: 205 QMYILHLDLKPENILCVNRDAKQIKIIDFGLA---RRYKPREKLKVNFGTPEFLAPEVVN 261

Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQ 245
                  T D+WS GVI Y++L+G  PF   N A     I     D +  ++  +S  A+
Sbjct: 262 YDFVSFPT-DMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAK 320

Query: 246 NLLRKILEPNPVKRITIAGIKADEWFEQD 274
             + K+L      RI+ +      W    
Sbjct: 321 EFISKLLIKEKSWRISASEALKHPWLSDH 349

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  290 bits (744), Expect = 4e-94
 Identities = 76/272 (27%), Positives = 132/272 (48%), Gaps = 14/272 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y++   LG G FG V    +  +G  FA K +           + +++EI T+ +L+HP
Sbjct: 158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHP 214

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNK 133
            +V LH+     +++ M+ E+++GGELF+K+A +  ++ E E  +  +Q+  G+ + H  
Sbjct: 215 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHEN 274

Query: 134 GVFHRDLKLENILLDSKG--NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
              H DLK ENI+  +K    +K+ DFGL+    H      +  T G+  + APEV   +
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLT---AHLDPKQSVKVTTGTAEFAAPEVAEGK 331

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPKW--LSPGAQNL 247
                T D+WS GV+ Y++L+G  PF   N     + +     +     +  +S   ++ 
Sbjct: 332 PVGYYT-DMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDF 390

Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPAN 279
           +RK+L  +P  R+TI       W      P  
Sbjct: 391 IRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  281 bits (722), Expect = 9e-94
 Identities = 84/301 (27%), Positives = 142/301 (47%), Gaps = 33/301 (10%)

Query: 15  RYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLK 72
            Y+L +  LG G  GKV       +G   A+K+L  +         + ++E+    +   
Sbjct: 29  DYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASG 80

Query: 73  HPNVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDG 126
            P++V + +V       K  + +++E + GGELF +I  +G     E E  ++ + +   
Sbjct: 81  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140

Query: 127 VSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
           + + H+  + HRD+K EN+L  SK     +K++DFG +           L T C +P YV
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK----ETTQNALQTPCYTPYYV 196

Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRG--DFKLP 237
           APEVL    YD +  D+WS GVI+Y++L G+ PF           + ++I  G   F  P
Sbjct: 197 APEVLGPEKYDKS-CDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNP 255

Query: 238 KW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEAF 294
           +W  +S  A+ L+R +L+ +P +R+TI       W  Q    P  P      +  D + +
Sbjct: 256 EWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDHW 315

Query: 295 S 295
            
Sbjct: 316 D 316

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  283 bits (727), Expect = 1e-93
 Identities = 83/300 (27%), Positives = 141/300 (47%), Gaps = 30/300 (10%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKHP 74
               + LG G  GKV    +  +   FA+K+L+           + +RE+       + P
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 115

Query: 75  NVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDGVS 128
           ++VR+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + 
Sbjct: 116 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175

Query: 129 YCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
           Y H+  + HRD+K EN+L  SK     +K++DFG +   +       L T C +P YVAP
Sbjct: 176 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA---KETTSHNSLTTPCYTPYYVAP 232

Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRG--DFKLPKW 239
           EVL    YD +  D+WS GVI+Y++L GY PF   +       +  +I  G  +F  P+W
Sbjct: 233 EVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 291

Query: 240 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMH 297
             +S   + L+R +L+  P +R+TI       W  Q             +  +++     
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWED 351

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  269 bits (689), Expect = 4e-89
 Identities = 86/272 (31%), Positives = 139/272 (51%), Gaps = 7/272 (2%)

Query: 7   KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           +    R   ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE  
Sbjct: 23  QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 82

Query: 67  TLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
            +  L HP  V+L+       K+Y  L Y   GEL   I   G   E   R    +++  
Sbjct: 83  VMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSA 142

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + Y H KG+ HRDLK ENILL+   +I+I+DFG + +          ++  G+  YV+PE
Sbjct: 143 LEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 202

Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
           +L  +     +SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++
Sbjct: 203 LLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD 261

Query: 247 LLRKILEPNPVKRITI------AGIKADEWFE 272
           L+ K+L  +  KR+          +KA  +FE
Sbjct: 262 LVEKLLVLDATKRLGCEEMEGYGPLKAHPFFE 293

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  270 bits (691), Expect = 1e-88
 Identities = 57/311 (18%), Positives = 100/311 (32%), Gaps = 53/311 (17%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           + + G R      G  LG+ +      A D ++G  F V +             Q+K E+
Sbjct: 65  ESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEV 124

Query: 66  ATLKLLK-------------------------HPNVVRLHEVLASKSKIYMVLEY----- 95
             L+LL+                            ++R+         +     Y     
Sbjct: 125 LRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQS 184

Query: 96  ---VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN 152
                G  L    ++   L      +L  Q+I  ++  H+ G+ H  L+  +I+LD +G 
Sbjct: 185 NLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGG 244

Query: 153 IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----------YDGATSDIWS 202
           + ++ F           DG    +  S  +  PE+ A R               + D W+
Sbjct: 245 VFLTGFEHL------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWA 298

Query: 203 CGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITI 262
            G+++Y I    LP          + IFR      K +    + LL   L      R+  
Sbjct: 299 LGLVIYWIWCADLPITKDAALGGSEWIFRS----CKNIPQPVRALLEGFLRYPKEDRLLP 354

Query: 263 AGIKADEWFEQ 273
                   +EQ
Sbjct: 355 LQAMETPEYEQ 365

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  254 bits (652), Expect = 1e-83
 Identities = 65/286 (22%), Positives = 112/286 (39%), Gaps = 23/286 (8%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y   + LGEG F  V   + L  G  +A+K +  +     +   + +RE    +L  HP
Sbjct: 30  HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDRE---EAQREADMHRLFNHP 86

Query: 75  NVVRLHEV----LASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDG 126
           N++RL         +K + +++L +   G L+++I         L E +   L   +  G
Sbjct: 87  NILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRG 146

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH-------FRDDGLLHTTCGS 179
           +   H KG  HRDLK  NILL  +G   + D G                          +
Sbjct: 147 LEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 180 PNYVAPEVLANRGYDGAT--SDIWSCGVILYVILTGYLPFDDRNLAV-LYQKIFRGDFKL 236
            +Y APE+ + + +      +D+WS G +LY ++ G  P+D             +    +
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSI 266

Query: 237 PKW--LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           P+    S     LL  ++  +P +R  I  + +     Q   P   
Sbjct: 267 PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAPGQH 312

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  255 bits (653), Expect = 2e-83
 Identities = 84/308 (27%), Positives = 135/308 (43%), Gaps = 34/308 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
           R  + R L EG F  V  AQD+ SG  +A+K L  N     +    I +E+  +K L  H
Sbjct: 29  RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNR---AIIQEVCFMKKLSGH 85

Query: 74  PNVVRLH-------EVLASKSKIYMVLEYVTGGELFDKI---ASKGRLQEAEGRKLFQQL 123
           PN+V+         E   +    +++L  +  G+L + +    S+G L      K+F Q 
Sbjct: 86  PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145

Query: 124 IDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH------- 174
              V + H +   + HRDLK+EN+LL ++G IK+ DFG +    H+ D            
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 175 ---TTCGSPNYVAPEV--LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI 229
              T   +P Y  PE+  L +    G   DIW+ G ILY++     PF+D        +I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK----LRI 261

Query: 230 FRGDFKLPKWL--SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
             G + +P          +L+R +L+ NP +R++IA +             NP     ++
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITEL 321

Query: 288 FVDNEAFS 295
              N  + 
Sbjct: 322 LEQNGGYG 329

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  258 bits (661), Expect = 2e-83
 Identities = 79/295 (26%), Positives = 119/295 (40%), Gaps = 49/295 (16%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
                + LG G+ G V F      G P AVK +  +        D    EI  L +   H
Sbjct: 16  LVVSEKILGYGSSGTVVFQGSFQ-GRPVAVKRMLIDFC------DIALMEIKLLTESDDH 68

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDG 126
           PNV+R +    +   +Y+ LE      L D + SK          +E     L +Q+  G
Sbjct: 69  PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127

Query: 127 VSYCHNKGVFHRDLKLENILLDSKG-------------NIKISDFGLSAL--PQHFRDDG 171
           V++ H+  + HRDLK +NIL+ +                I ISDFGL             
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 172 LLHTTCGSPNYVAPEVL-------ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA 223
            L+   G+  + APE+L         R    +  DI+S G + Y IL+ G  PF D+   
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRS-IDIFSMGCVFYYILSKGKHPFGDKYSR 246

Query: 224 VLYQKIFRGDFKLP-------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
                I RG F L        + L   A +L+ ++++ +P+KR T   +     F
Sbjct: 247 E--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLF 299

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  249 bits (637), Expect = 8e-82
 Identities = 78/274 (28%), Positives = 128/274 (46%), Gaps = 16/274 (5%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           R   YE+  T+G G++G+ +  +    G     K L+   +        +  E+  L+ L
Sbjct: 4   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLREL 62

Query: 72  KHPNVVRLHE--VLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLID 125
           KHPN+VR ++  +  + + +Y+V+EY  GG+L   I      +  L E    ++  QL  
Sbjct: 63  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 122

Query: 126 GVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            +  CH +      V HRDLK  N+ LD K N+K+ DFGL+ +  H  D     T  G+P
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTP 180

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW 239
            Y++PE +    Y+   SDIWS G +LY +     PF   +   L  KI  G F ++P  
Sbjct: 181 YYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239

Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
            S     ++ ++L      R ++  I  +    +
Sbjct: 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  249 bits (638), Expect = 6e-81
 Identities = 73/264 (27%), Positives = 136/264 (51%), Gaps = 7/264 (2%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + +Y   + +GEG+FGK    +  + G  + +K +  +R+   K  ++ +RE+A L  +K
Sbjct: 23  MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMK 81

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEGRKLFQQLIDGVSYC 130
           HPN+V+  E       +Y+V++Y  GG+LF +I        QE +    F Q+   + + 
Sbjct: 82  HPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHV 141

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           H++ + HRD+K +NI L   G +++ DFG++ +        L     G+P Y++PE+  N
Sbjct: 142 HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICEN 199

Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLR 249
           + Y+   SDIW+ G +LY + T    F+  ++  L  KI  G F  +    S   ++L+ 
Sbjct: 200 KPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258

Query: 250 KILEPNPVKRITIAGIKADEWFEQ 273
           ++ + NP  R ++  I    +  +
Sbjct: 259 QLFKRNPRDRPSVNSILEKGFIAK 282

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  247 bits (632), Expect = 1e-80
 Identities = 78/298 (26%), Positives = 132/298 (44%), Gaps = 52/298 (17%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
               + LG G  GKV    +  +   FA+K+L+           + +RE+    +  + P
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRASQCP 71

Query: 75  NVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQ--EAEGRKLFQQLIDGVS 128
           ++VR+ +V     A +  + +V+E + GGELF +I  +G     E E  ++ + + + + 
Sbjct: 72  HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131

Query: 129 YCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
           Y H+  + HRD+K EN+L  SK     +K++DFG                        A 
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AK 168

Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRG--DFKLPKW 239
           E      YD +  D+WS GVI+Y++L GY PF   +       +  +I  G  +F  P+W
Sbjct: 169 ETTG-EKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226

Query: 240 --LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD-YTPANPDDDEEDIFVDNEAF 294
             +S   + L+R +L+  P +R+TI       W  Q    P  P      +  D E +
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERW 284

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  250 bits (641), Expect = 2e-80
 Identities = 61/272 (22%), Positives = 98/272 (36%), Gaps = 24/272 (8%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKH 73
            +     LG G  G + +    D     AVK +               RE+  L+   +H
Sbjct: 25  SFCPKDVLGHGAEGTIVYRGMFD-NRDVAVKRILPECF------SFADREVQLLRESDEH 77

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHN 132
           PNV+R       +   Y+ +E      L + +  K       E   L QQ   G+++ H+
Sbjct: 78  PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136

Query: 133 KGVFHRDLKLENILLDSKGN-----IKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPE 186
             + HRDLK  NIL+            ISDFGL   L              G+  ++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 187 VL---ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW--- 239
           +L             DI+S G + Y +++ G  PF           +             
Sbjct: 197 MLSEDCKENPTYT-VDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255

Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
               A+ L+ K++  +P KR +   +    +F
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFF 287

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  246 bits (631), Expect = 7e-80
 Identities = 91/272 (33%), Positives = 148/272 (54%), Gaps = 11/272 (4%)

Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE 64
              Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E
Sbjct: 32  TPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNE 91

Query: 65  IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
              L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++
Sbjct: 92  KRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIV 151

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
               Y H+  + +RDLK EN+L+D +G I+++DFG +      R  G   T CG+P  +A
Sbjct: 152 LTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALA 206

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE++ ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   
Sbjct: 207 PEIILSKGYNKAV-DWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDL 265

Query: 245 QNLLRKILEPNPVKRI-----TIAGIKADEWF 271
           ++LLR +L+ +  KR       +  IK  +WF
Sbjct: 266 KDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  243 bits (622), Expect = 5e-79
 Identities = 81/262 (30%), Positives = 145/262 (55%), Gaps = 11/262 (4%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +++ RTLG G+FG+V   +   +G  +A+K+L+K  ++ LK  +    E   L ++ HP 
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++R+        +I+M+++Y+ GGELF  +    R      +    ++   + Y H+K +
Sbjct: 68  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RDLK ENILLD  G+IKI+DFG +          + +T CG+P+Y+APEV++ + Y  
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPY-N 181

Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
            + D WS G+++Y +L GY PF D N    Y+KI   + + P + +   ++LL +++  +
Sbjct: 182 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241

Query: 256 PVKRI-----TIAGIKADEWFE 272
             +R+         +K   WF+
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFK 263

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  239 bits (613), Expect = 5e-78
 Identities = 62/277 (22%), Positives = 117/277 (42%), Gaps = 33/277 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            ++    +G G FG+V  A+    G  + +K ++ N        ++ +RE+  L  L H 
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHV 64

Query: 75  NVVRLHE----------------VLASKSKIYMVLEYVTGGELFDKI--ASKGRLQEAEG 116
           N+V  +                   +    +++ +E+   G L   I      +L +   
Sbjct: 65  NIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA 124

Query: 117 RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
            +LF+Q+  GV Y H+K + +RDLK  NI L     +KI DFGL       ++DG    +
Sbjct: 125 LELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTRS 181

Query: 177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL 236
            G+  Y++PE ++++ Y     D+++ G+IL  +L       + +    +  +  G   +
Sbjct: 182 KGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETS--KFFTDLRDG--II 236

Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
                   + LL+K+L   P  R   + I       +
Sbjct: 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  236 bits (603), Expect = 3e-76
 Identities = 66/261 (25%), Positives = 110/261 (42%), Gaps = 10/261 (3%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            ++    LG G++G+V   +  + G  +AVK              ++    +  K+ +HP
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
             VRL +       +Y+  E   G  L     + G  L EA+     +  +  +++ H++
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
           G+ H D+K  NI L  +G  K+ DFGL          G      G P Y+APE+L    Y
Sbjct: 177 GLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELLQG-SY 232

Query: 194 DGATSDIWSCGVILYVILTGY-LPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
             A +D++S G+ +  +     LP        L Q     +F     LS   +++L  +L
Sbjct: 233 GTA-ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMML 289

Query: 253 EPNPVKRITIAGIKADEWFEQ 273
           EP+P  R T   + A     Q
Sbjct: 290 EPDPKLRATAEALLALPVLRQ 310

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  232 bits (595), Expect = 4e-75
 Identities = 78/262 (29%), Positives = 126/262 (48%), Gaps = 11/262 (4%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
            L  + + + +G G F +V  A  L  G+P A+K ++   ++  K      +EI  LK L
Sbjct: 30  TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQL 89

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGV 127
            HPNV++ +      +++ +VLE    G+L   I      K  + E    K F QL   +
Sbjct: 90  NHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSAL 149

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            + H++ V HRD+K  N+ + + G +K+ D GL             H+  G+P Y++PE 
Sbjct: 150 EHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPER 207

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFRGDFK-LPKW-LSPG 243
           +   GY+   SDIWS G +LY +     PF  D  NL  L +KI + D+  LP    S  
Sbjct: 208 IHENGYNFK-SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEE 266

Query: 244 AQNLLRKILEPNPVKRITIAGI 265
            + L+   + P+P KR  +  +
Sbjct: 267 LRQLVNMCINPDPEKRPDVTYV 288

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  233 bits (595), Expect = 2e-74
 Identities = 37/301 (12%), Positives = 82/301 (27%), Gaps = 47/301 (15%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           + +L   L  G+   V   +D++    FA+K+            +++         L   
Sbjct: 63  KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122

Query: 75  NVVRLHEVL--------------------------ASKSKIYMVLEYVTG------GELF 102
           +     +                             + +   +++   +         L 
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182

Query: 103 DKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA 162
                +G         L  QLI   +   +KG+ H     +N+ +   G + + D     
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242

Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLPFDDRN 221
                +       +     Y   E L           + W  G+ +Y +   +LPF    
Sbjct: 243 -----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297

Query: 222 LAV--LYQKIFRG-------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272
             +   +++            F     L    + L+ + L  +  +R+          F 
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357

Query: 273 Q 273
           Q
Sbjct: 358 Q 358

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  233 bits (595), Expect = 6e-74
 Identities = 61/346 (17%), Positives = 105/346 (30%), Gaps = 49/346 (14%)

Query: 10  GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           G R      G  LG+ +      A D ++G  F V +             Q+K E+  L+
Sbjct: 74  GERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR 133

Query: 70  LL----------------------KHPNVVRLHEVLASKSKIYMVLEYVT---------- 97
           LL                      K P   ++  V   +  ++++  +            
Sbjct: 134 LLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT 193

Query: 98  -GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS 156
            G  L    ++   L      +L  Q+I  ++  H+ G+ H  L+  +I+LD +G + ++
Sbjct: 194 FGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLT 253

Query: 157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT----SDIWSCGVILYVILT 212
            F              +      P   A  +L    +         D W+ G+ +Y I  
Sbjct: 254 GFEHLVRDGASAVS-PIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC 312

Query: 213 GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272
             LP  D       + IFR    +P       + LL   L      R+          +E
Sbjct: 313 ADLPNTDDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368

Query: 273 Q------DYTPANPDDDEEDIFVDNEAFSMHEVPSDGGRTPGSPPL 312
           Q         P    D E          S    P + G       +
Sbjct: 369 QLRTELSAALPLYQTDGEPTREGGAPP-SGTSQPDEAGAAEAVTAI 413

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  227 bits (580), Expect = 6e-73
 Identities = 68/293 (23%), Positives = 117/293 (39%), Gaps = 33/293 (11%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L  +E  + LG G FG V  A++      +A+K +        +  +++ RE+  L  L+
Sbjct: 4   LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLE 61

Query: 73  HPNVVRLHEV------------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR--- 117
           HP +VR                 + K  +Y+ ++      L D +  +  ++E E     
Sbjct: 62  HPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL 121

Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL----------PQHF 167
            +F Q+ + V + H+KG+ HRDLK  NI       +K+ DFGL                 
Sbjct: 122 HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181

Query: 168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLY 226
                     G+  Y++PE +    Y     DI+S G+IL+ +L    PF  +       
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRTL 237

Query: 227 QKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278
             +    F  L     P    +++ +L P+P++R     I  +  FE    P 
Sbjct: 238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  227 bits (580), Expect = 1e-72
 Identities = 91/259 (35%), Positives = 146/259 (56%), Gaps = 7/259 (2%)

Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRII-HLKITDQ 60
            +  E +R   +EL R LG+G +GKV   +     ++G  FA+K+L+K  I+ + K T  
Sbjct: 8   NRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAH 67

Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
            K E   L+ +KHP +V L     +  K+Y++LEY++GGELF ++  +G   E       
Sbjct: 68  TKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYL 127

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            ++   + + H KG+ +RDLK ENI+L+ +G++K++DFGL    +   D  + HT CG+ 
Sbjct: 128 AEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVTHTFCGTI 185

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
            Y+APE+L   G+     D WS G ++Y +LTG  PF   N      KI +    LP +L
Sbjct: 186 EYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYL 244

Query: 241 SPGAQNLLRKILEPNPVKR 259
           +  A++LL+K+L+ N   R
Sbjct: 245 TQEARDLLKKLLKRNAASR 263

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  228 bits (584), Expect = 2e-72
 Identities = 72/262 (27%), Positives = 131/262 (50%), Gaps = 11/262 (4%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           E+ R +G+G+FGKV   Q  D+   +A+K + K + +       + +E+  ++ L+HP +
Sbjct: 18  EILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFL 77

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVF 136
           V L      +  ++MV++ + GG+L   +      +E   +    +L+  + Y  N+ + 
Sbjct: 78  VNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRII 137

Query: 137 HRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR---GY 193
           HRD+K +NILLD  G++ I+DF ++A       +  + T  G+  Y+APE+ ++R   GY
Sbjct: 138 HRDMKPDNILLDEHGHVHITDFNIAA---MLPRETQITTMAGTKPYMAPEMFSSRKGAGY 194

Query: 194 DGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250
                D WS GV  Y +L G  P+  R   +   +           P   S    +LL+K
Sbjct: 195 -SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKK 253

Query: 251 ILEPNPVKRI-TIAGIKADEWF 271
           +LEPNP +R   ++ ++   + 
Sbjct: 254 LLEPNPDQRFSQLSDVQNFPYM 275

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  224 bits (573), Expect = 3e-71
 Identities = 88/268 (32%), Positives = 147/268 (54%), Gaps = 5/268 (1%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
             Q  +++  + L + LG+G+FGKV  A+   +   FA+K L+K+ ++     +    E 
Sbjct: 9   SLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEK 68

Query: 66  ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
             L L  +HP +  +     +K  ++ V+EY+ GG+L   I S  +   +       ++I
Sbjct: 69  RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEII 128

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ + H+KG+ +RDLKL+NILLD  G+IKI+DFG+    ++   D   +T CG+P+Y+A
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIA 186

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE+L  + Y   + D WS GV+LY +L G  PF  ++   L+  I   +   P+WL   A
Sbjct: 187 PEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEA 245

Query: 245 QNLLRKILEPNPVKRITIAG-IKADEWF 271
           ++LL K+    P KR+ + G I+    F
Sbjct: 246 KDLLVKLFVREPEKRLGVRGDIRQHPLF 273

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  224 bits (573), Expect = 4e-71
 Identities = 52/298 (17%), Positives = 104/298 (34%), Gaps = 36/298 (12%)

Query: 6   KKQEGMRLG--RYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKIT 58
           K +   +LG     +   LGEG F +V  A      D  +   F +K+ +        I 
Sbjct: 55  KPKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIG 114

Query: 59  DQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-----ASKGRLQE 113
            Q+      LK       ++ +     ++   +V E  + G L + I       +  + +
Sbjct: 115 TQLMER---LKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQ 171

Query: 114 AEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL-----------DSKGNIKISDFGLSA 162
                   +++  +   H+  + H D+K +N +L           D    + + D G S 
Sbjct: 172 GLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231

Query: 163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRN 221
             + F    +    C +  +   E+L+N+ ++    D +     +Y +L G Y+   +  
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQI-DYFGVAATVYCMLFGTYMKVKNEG 290

Query: 222 LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGI---KADEWFEQDYT 276
                + +FR    L  W           +L       +    +   K  + F+Q YT
Sbjct: 291 GECKPEGLFRRLPHLDMW-----NEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYT 343

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  223 bits (571), Expect = 5e-71
 Identities = 83/244 (34%), Positives = 137/244 (56%), Gaps = 3/244 (1%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           ++  + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +HP 
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H++ V
Sbjct: 67  LTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RD+KLEN++LD  G+IKI+DFGL    +   D   + T CG+P Y+APEVL +  Y G
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVLEDNDY-G 183

Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
              D W  GV++Y ++ G LPF +++   L++ I   + + P+ LSP A++LL  +L+ +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKD 243

Query: 256 PVKR 259
           P +R
Sbjct: 244 PKQR 247

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  224 bits (573), Expect = 5e-71
 Identities = 91/274 (33%), Positives = 142/274 (51%), Gaps = 8/274 (2%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           +        +   +   + +G+G+FGKV  A+     + +AVK+L+K  I+  K    I 
Sbjct: 27  LGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIM 86

Query: 63  REIATL-KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
            E   L K +KHP +V LH    +  K+Y VL+Y+ GGELF  +  +    E   R    
Sbjct: 87  SERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA 146

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           ++   + Y H+  + +RDLK ENILLDS+G+I ++DFGL    ++   +    T CG+P 
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPE 204

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 241
           Y+APEVL  + Y   T D W  G +LY +L G  PF  RN A +Y  I     +L   ++
Sbjct: 205 YLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNIT 263

Query: 242 PGAQNLLRKILEPNPVKRITIAG----IKADEWF 271
             A++LL  +L+ +  KR+        IK+  +F
Sbjct: 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFF 297

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  222 bits (567), Expect = 1e-70
 Identities = 86/259 (33%), Positives = 152/259 (58%), Gaps = 7/259 (2%)

Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQ 60
            ++  E     ++EL + LG+G+FGKV   K     D+   +A+K+L+K  +   +   +
Sbjct: 14  VKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKV-RDRVR 72

Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
            K E   L  + HP +V+LH    ++ K+Y++L+++ GG+LF +++ +    E + +   
Sbjct: 73  TKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYL 132

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            +L   + + H+ G+ +RDLK ENILLD +G+IK++DFGLS   +    +   ++ CG+ 
Sbjct: 133 AELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTV 190

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL 240
            Y+APEV+  RG+   ++D WS GV+++ +LTG LPF  ++       I +    +P++L
Sbjct: 191 EYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFL 249

Query: 241 SPGAQNLLRKILEPNPVKR 259
           SP AQ+LLR + + NP  R
Sbjct: 250 SPEAQSLLRMLFKRNPANR 268

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  221 bits (565), Expect = 6e-70
 Identities = 88/286 (30%), Positives = 144/286 (50%), Gaps = 20/286 (6%)

Query: 3   IAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK 62
           I       + +  +E  R LG+G+FGKV  A+  ++G  +AVK+L+K+ I+     +   
Sbjct: 12  IGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTM 71

Query: 63  REIATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
            E   L L   HP + +L     +  +++ V+E+V GG+L   I    R  EA  R    
Sbjct: 72  TEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAA 131

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           ++I  + + H+KG+ +RDLKL+N+LLD +G+ K++DFG+    +   +     T CG+P+
Sbjct: 132 EIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPD 189

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS 241
           Y+APE+L    Y G   D W+ GV+LY +L G+ PF+  N   L++ I   +   P WL 
Sbjct: 190 YIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLH 248

Query: 242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
             A  +L+  +  NP  R+   G             +     E  I
Sbjct: 249 EDATGILKSFMTKNPTMRL---G-------------SLTQGGEHAI 278

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  220 bits (564), Expect = 8e-70
 Identities = 86/255 (33%), Positives = 144/255 (56%), Gaps = 4/255 (1%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
             ++ M+L  +     LG+G+FGKV  ++   +   +AVKIL+K+ +I     +    E 
Sbjct: 12  GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK 71

Query: 66  ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
             L L  K P + +LH    +  ++Y V+EYV GG+L   I   GR +E        ++ 
Sbjct: 72  RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 131

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ +  +KG+ +RDLKL+N++LDS+G+IKI+DFG+    ++  D     T CG+P+Y+A
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIA 189

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE++A + Y G + D W+ GV+LY +L G  PF+  +   L+Q I   +   PK +S  A
Sbjct: 190 PEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 248

Query: 245 QNLLRKILEPNPVKR 259
             + + ++  +P KR
Sbjct: 249 VAICKGLMTKHPGKR 263

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  221 bits (564), Expect = 1e-68
 Identities = 85/257 (33%), Positives = 142/257 (55%), Gaps = 4/257 (1%)

Query: 4   AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
             K +  + +  +E  + LG+G FGKV   ++  +G  +A+KIL+K  I+          
Sbjct: 138 LAKPKHRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLT 197

Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           E   L+  +HP +  L     +  ++  V+EY  GGELF  ++ +    E   R    ++
Sbjct: 198 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 257

Query: 124 IDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           +  + Y H+ K V +RDLKLEN++LD  G+IKI+DFGL    +  +D   + T CG+P Y
Sbjct: 258 VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEY 315

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
           +APEVL +  Y G   D W  GV++Y ++ G LPF +++   L++ I   + + P+ L P
Sbjct: 316 LAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGP 374

Query: 243 GAQNLLRKILEPNPVKR 259
            A++LL  +L+ +P +R
Sbjct: 375 EAKSLLSGLLKKDPKQR 391

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  216 bits (552), Expect = 4e-68
 Identities = 82/290 (28%), Positives = 149/290 (51%), Gaps = 29/290 (10%)

Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
            + + L  ++L R +G G++ KV   +   +   +A+K+++K  +   +  D ++ E   
Sbjct: 3   MDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV 62

Query: 68  LKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
            +    HP +V LH    ++S+++ V+EYV GG+L   +  + +L E   R    ++   
Sbjct: 63  FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 122

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           ++Y H +G+ +RDLKL+N+LLDS+G+IK++D+G+    +  R      T CG+PNY+APE
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIAPE 180

Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPF---------DDRNLAVLYQKIFRGDFKLP 237
           +L    Y G + D W+ GV+++ ++ G  PF         D      L+Q I     ++P
Sbjct: 181 ILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 239

Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
           + LS  A ++L+  L  +P +R+   G              +P     DI
Sbjct: 240 RSLSVKAASVLKSFLNKDPKERL---G-------------CHPQTGFADI 273

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  216 bits (553), Expect = 1e-67
 Identities = 82/292 (28%), Positives = 149/292 (51%), Gaps = 29/292 (9%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
           K    + L  ++L R +G G++ KV   +   +   +A+++++K  +   +  D ++ E 
Sbjct: 44  KASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEK 103

Query: 66  ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
              +    HP +V LH    ++S+++ V+EYV GG+L   +  + +L E   R    ++ 
Sbjct: 104 HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 163

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
             ++Y H +G+ +RDLKL+N+LLDS+G+IK++D+G+    +  R      T CG+PNY+A
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCGTPNYIA 221

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPF---------DDRNLAVLYQKIFRGDFK 235
           PE+L    Y G + D W+ GV+++ ++ G  PF         D      L+Q I     +
Sbjct: 222 PEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR 280

Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI 287
           +P+ LS  A ++L+  L  +P +R+   G              +P     DI
Sbjct: 281 IPRSLSVKAASVLKSFLNKDPKERL---G-------------CHPQTGFADI 316

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  222 bits (568), Expect = 2e-67
 Identities = 86/255 (33%), Positives = 144/255 (56%), Gaps = 4/255 (1%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
             ++ M+L  +     LG+G+FGKV  ++   +   +AVKIL+K+ +I     +    E 
Sbjct: 333 GNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEK 392

Query: 66  ATLKL-LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI 124
             L L  K P + +LH    +  ++Y V+EYV GG+L   I   GR +E        ++ 
Sbjct: 393 RVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIA 452

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ +  +KG+ +RDLKL+N++LDS+G+IKI+DFG+    ++  D     T CG+P+Y+A
Sbjct: 453 IGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKTFCGTPDYIA 510

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA 244
           PE++A + Y G + D W+ GV+LY +L G  PF+  +   L+Q I   +   PK +S  A
Sbjct: 511 PEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEA 569

Query: 245 QNLLRKILEPNPVKR 259
             + + ++  +P KR
Sbjct: 570 VAICKGLMTKHPGKR 584

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  220 bits (562), Expect = 3e-67
 Identities = 80/267 (29%), Positives = 128/267 (47%), Gaps = 15/267 (5%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +   R LG+G FG+V   Q   +G  +A K LEK RI   K       E   L+ +    
Sbjct: 186 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 245

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF--QQLIDGVSYCHNK 133
           VV L     +K  + +VL  + GG+L   I   G+    E R +F   ++  G+   H +
Sbjct: 246 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE 305

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
            + +RDLK ENILLD  G+I+ISD GL+    H  +   +    G+  Y+APEV+ N  Y
Sbjct: 306 RIVYRDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIKGRVGTVGYMAPEVVKNERY 362

Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----DFKLPKWLSPGAQNLLR 249
             +  D W+ G +LY ++ G  PF  R   +  +++ R       +  +  SP A++L  
Sbjct: 363 TFSP-DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCS 421

Query: 250 KILEPNPVKRI-----TIAGIKADEWF 271
           ++L  +P +R+     +   +K    F
Sbjct: 422 QLLCKDPAERLGCRGGSAREVKEHPLF 448

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  217 bits (555), Expect = 2e-66
 Identities = 76/281 (27%), Positives = 126/281 (44%), Gaps = 18/281 (6%)

Query: 6   KKQEGMRLGR--YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR 63
           K  E   +G   +   R LG G FG+V   Q   +G  +A K L K R+   K       
Sbjct: 175 KWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMV 234

Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE--AEGRKLF- 120
           E   L  +    +V L     +K+ + +V+  + GG++   I +         E R +F 
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294

Query: 121 -QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
             Q++ G+ + H + + +RDLK EN+LLD  GN++ISD GL+   +            G+
Sbjct: 295 TAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV--ELKAGQTKTKGYAGT 352

Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV----LYQKIFRGDFK 235
           P ++APE+L    YD +  D ++ GV LY ++    PF  R   V    L Q++      
Sbjct: 353 PGFMAPELLLGEEYDFSV-DYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411

Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAG-----IKADEWF 271
            P   SP +++    +L+ +P KR+         ++    F
Sbjct: 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  214 bits (546), Expect = 2e-66
 Identities = 83/283 (29%), Positives = 137/283 (48%), Gaps = 17/283 (6%)

Query: 2   VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
            I + +   M+   YE+ + +G G FG+V+  +   +   +A+K+L K  +I    +   
Sbjct: 57  TINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF 116

Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ 121
             E   +     P VV+L         +YMV+EY+ GG+L   + S   + E   R    
Sbjct: 117 WEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEKWARFYTA 175

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCGS 179
           +++  +   H+ G  HRD+K +N+LLD  G++K++DFG          +G++   T  G+
Sbjct: 176 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGT 232

Query: 180 PNYVAPEVLANRGYD---GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FRGDF 234
           P+Y++PEVL ++G D   G   D WS GV LY +L G  PF   +L   Y KI   +   
Sbjct: 233 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL 292

Query: 235 KLPK--WLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 272
             P    +S  A+NL+   L  +   R+   G   IK   +F+
Sbjct: 293 TFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHLFFK 334

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  211 bits (539), Expect = 4e-66
 Identities = 83/266 (31%), Positives = 154/266 (57%), Gaps = 13/266 (4%)

Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRII-HLKITDQ 60
               E + +  +EL + LG G +GKV   +     D+G  +A+K+L+K  I+   K T+ 
Sbjct: 45  TGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEH 104

Query: 61  IKREIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
            + E   L+ ++  P +V LH    +++K++++L+Y+ GGELF  ++ + R  E E +  
Sbjct: 105 TRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIY 164

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
             +++  + + H  G+ +RD+KLENILLDS G++ ++DFGLS        +   +  CG+
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGT 223

Query: 180 PNYVAPEVL--ANRGYDGATSDIWSCGVILYVILTGYLPF----DDRNLAVLYQKIFRGD 233
             Y+AP+++   + G+D A  D WS GV++Y +LTG  PF    +  + A + ++I + +
Sbjct: 224 IEYMAPDIVRGGDSGHDKAV-DWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282

Query: 234 FKLPKWLSPGAQNLLRKILEPNPVKR 259
              P+ +S  A++L++++L  +P KR
Sbjct: 283 PPYPQEMSALAKDLIQRLLMKDPKKR 308

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  216 bits (551), Expect = 1e-64
 Identities = 74/278 (26%), Positives = 132/278 (47%), Gaps = 17/278 (6%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE- 64
           +    + +  + + R +G G FG+V   +  D+G  +A+K L+K RI   +       E 
Sbjct: 181 ELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER 240

Query: 65  --IATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
             ++ +     P +V +     +  K+  +L+ + GG+L   ++  G   EA+ R    +
Sbjct: 241 IMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAE 300

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
           +I G+ + HN+ V +RDLK  NILLD  G+++ISD GL+            H + G+  Y
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD----FSKKKPHASVGTHGY 356

Query: 183 VAPEVLA-NRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLPK 238
           +APEVL     YD +  D +S G +L+ +L G+ PF          + +       +LP 
Sbjct: 357 MAPEVLQKGVAYDSSA-DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415

Query: 239 WLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWF 271
             SP  ++LL  +L+ +  +R+         +K   +F
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  209 bits (534), Expect = 2e-64
 Identities = 77/287 (26%), Positives = 134/287 (46%), Gaps = 21/287 (7%)

Query: 2   VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
             ++ KQ  +    +E+ + +G G FG+V   +  ++   FA+KIL K  ++    T   
Sbjct: 62  FTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACF 121

Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLF 120
           + E   L       +  LH      + +Y+V++Y  GG+L   ++  + RL E   R   
Sbjct: 122 REERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCG 178
            +++  +   H     HRD+K +NIL+D  G+I+++DFG         +DG +      G
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCL---KLMEDGTVQSSVAVG 238

Query: 179 SPNYVAPEVL-----ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI--FR 231
           +P+Y++PE+L         Y G   D WS GV +Y +L G  PF   +L   Y KI   +
Sbjct: 239 TPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK 297

Query: 232 GDFKLPKW---LSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 272
             F+ P     +S  A++L+R+++      R+   G    K   +F 
Sbjct: 298 ERFQFPTQVTDVSENAKDLIRRLICSRE-HRLGQNGIEDFKKHPFFS 343

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  206 bits (527), Expect = 1e-63
 Identities = 71/288 (24%), Positives = 130/288 (45%), Gaps = 21/288 (7%)

Query: 2   VIAEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI 61
           ++   K+  ++   +E+ + +G G F +V   +   +G  +A+KI+ K  ++        
Sbjct: 49  IVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCF 108

Query: 62  KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLF 120
           + E   L       + +LH     ++ +Y+V+EY  GG+L   ++  G R+     R   
Sbjct: 109 REERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYL 168

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL--HTTCG 178
            +++  +   H  G  HRD+K +NILLD  G+I+++DFG        R DG +      G
Sbjct: 169 AEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVG 225

Query: 179 SPNYVAPEVLANRGYD------GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG 232
           +P+Y++PE+L   G        G   D W+ GV  Y +  G  PF   + A  Y KI   
Sbjct: 226 TPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285

Query: 233 DFKLP-----KWLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFE 272
              L      + +   A++ ++++L   P  R+   G    +   +F 
Sbjct: 286 KEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFF 332

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  195 bits (497), Expect = 1e-60
 Identities = 58/274 (21%), Positives = 101/274 (36%), Gaps = 35/274 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +     +G G FG V        G  +A+K  +K     +   + ++   A   L +H 
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYC 130
           +VVR     A    + +  EY  GG L D I          +EAE + L  Q+  G+ Y 
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 131 HNKGVFHRDLKLENILLDSKGNI-------------------KISDFGLSALPQHFRDDG 171
           H+  + H D+K  NI +                         KI D G            
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTR------IS 185

Query: 172 LLHTTCGSPNYVAPEVLA-NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF 230
                 G   ++A EVL  N  +    +DI++  + +           + +    + +I 
Sbjct: 186 SPQVEEGDSRFLANEVLQENYTHLPK-ADIFALALTVVCAAGAEPLPRNGD---QWHEIR 241

Query: 231 RGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIA 263
           +G   ++P+ LS     LL+ ++ P+P +R +  
Sbjct: 242 QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAM 275

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  193 bits (492), Expect = 3e-59
 Identities = 59/255 (23%), Positives = 103/255 (40%), Gaps = 18/255 (7%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
                  +G G+FG+V   +D  +G   AVK +         +      E+     L  P
Sbjct: 59  WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVR--------LEVFRVEELVACAGLSSP 110

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
            +V L+  +     + + +E + GG L   I   G L E        Q ++G+ Y H + 
Sbjct: 111 RIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR 170

Query: 135 VFHRDLKLENILLDSKGN-IKISDFGLSA---LPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           + H D+K +N+LL S G+   + DFG +         +         G+  ++APEV+  
Sbjct: 171 ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG 230

Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQN 246
           +  D    DIWS   ++  +L G  P+       +   KI        ++P   +P    
Sbjct: 231 KPCDAK-VDIWSSCCMMLHMLNGCHPWTQYFRGPLCL-KIASEPPPIREIPPSCAPLTAQ 288

Query: 247 LLRKILEPNPVKRIT 261
            +++ L   PV R +
Sbjct: 289 AIQEGLRKEPVHRAS 303

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  191 bits (488), Expect = 3e-59
 Identities = 77/259 (29%), Positives = 128/259 (49%), Gaps = 17/259 (6%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
                    LG+G +G V   +DL + +  A+K + +    + +    +  EIA  K LK
Sbjct: 21  YDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQ---PLHEEIALHKHLK 77

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEG--RKLFQQLIDGVSY 129
           H N+V+     +    I + +E V GG L   + SK G L++ E       +Q+++G+ Y
Sbjct: 78  HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKY 137

Query: 130 CHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
            H+  + HRD+K +N+L+++  G +KISDFG S             T  G+  Y+APE++
Sbjct: 138 LHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQYMAPEII 195

Query: 189 --ANRGYDGATSDIWSCGVILYVILTGYLPFDD--RNLAVLYQKIFRGDF--KLPKWLSP 242
               RGY  A +DIWS G  +  + TG  PF +     A ++ K+       ++P+ +S 
Sbjct: 196 DKGPRGYGKA-ADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGMFKVHPEIPESMSA 253

Query: 243 GAQNLLRKILEPNPVKRIT 261
            A+  + K  EP+P KR  
Sbjct: 254 EAKAFILKCFEPDPDKRAC 272

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  178 bits (453), Expect = 5e-54
 Identities = 65/272 (23%), Positives = 127/272 (46%), Gaps = 18/272 (6%)

Query: 14  GRYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           GR+      +G G+F  V    D ++ +  A   L+  ++   +   + K E   LK L+
Sbjct: 25  GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQ 83

Query: 73  HPNVVRLH----EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           HPN+VR +      +  K  I +V E +T G L   +     ++    R   +Q++ G+ 
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143

Query: 129 YCHNKG--VFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
           + H +   + HRDLK +NI +    G++KI D GL+ L +            G+P ++AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPEFMAP 199

Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD--FKLPKWLSP 242
           E+     YD +  D+++ G+ +  + T   P+ + +N A +Y+++  G       K   P
Sbjct: 200 EMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257

Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD 274
             + ++   +  N  +R +I  +    +F+++
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  175 bits (445), Expect = 2e-52
 Identities = 51/246 (20%), Positives = 93/246 (37%), Gaps = 17/246 (6%)

Query: 41  PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGE 100
            +         +      D    +I  +      N V   +  + K  +Y+ ++      
Sbjct: 88  IWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKEN 147

Query: 101 LFDKIASKGRLQEAEG---RKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD 157
           L D +  +  L++ E      +F Q+ + V + H+KG+ HRDLK  NI       +K+ D
Sbjct: 148 LKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD 207

Query: 158 FGLSA----------LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVIL 207
           FGL            +              G+  Y++PE +    Y     DI+S G+IL
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK-VDIFSLGLIL 266

Query: 208 YVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGIK 266
           + +L  +    +R    +   +    F  L     P    +++ +L P+P +R     I 
Sbjct: 267 FELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDII 324

Query: 267 ADEWFE 272
            +  FE
Sbjct: 325 ENAIFE 330

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 53.7 bits (129), Expect = 2e-08
 Identities = 17/66 (25%), Positives = 32/66 (48%), Gaps = 2/66 (3%)

Query: 16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
          +E  + +G G FG V  A++      +A+K +        +  +++ RE+  L  L+HP 
Sbjct: 8  FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAR--EKVMREVKALAKLEHPG 65

Query: 76 VVRLHE 81
          +VR   
Sbjct: 66 IVRYFN 71

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  172 bits (439), Expect = 2e-51
 Identities = 84/323 (26%), Positives = 123/323 (38%), Gaps = 76/323 (23%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--------R 63
           R  RYE    LGEG F  V  A+D ++    A+K   K   I L    + K        R
Sbjct: 8   RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIK---K---IKLGHRSEAKDGINRTALR 61

Query: 64  EIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQ 121
           EI  L+ L HPN++ L +    KS I +V +++      +     +   L  +  +    
Sbjct: 62  EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYML 119

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
             + G+ Y H   + HRDLK  N+LLD  G +K++DFGL+              + GSPN
Sbjct: 120 MTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-------------KSFGSPN 166

Query: 182 -----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQ 227
                      Y APE+L   R Y     D+W+ G IL  +L    +LP D  +L  L  
Sbjct: 167 RAYTHQVVTRWYRAPELLFGARMYGVGV-DMWAVGCILAELLLRVPFLPGDS-DLDQLT- 223

Query: 228 KIFR-----------GDFKLP-----------------KWLSPGAQNLLRKILEPNPVKR 259
           +IF                LP                         +L++ +   NP  R
Sbjct: 224 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCAR 283

Query: 260 ITIAGIKADEWFEQDYTPANPDD 282
           IT       ++F     P     
Sbjct: 284 ITATQALKMKYFSNRPGPTPGCQ 306

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  167 bits (425), Expect = 1e-49
 Identities = 79/314 (25%), Positives = 126/314 (40%), Gaps = 68/314 (21%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
           +YE    +GEG++G V   ++ D+G   A+K  LE      +K      REI  LK LKH
Sbjct: 4   KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIAL--REIRMLKQLKH 61

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           PN+V L EV   K ++++V EY         D+   +  + E   + +  Q +  V++CH
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-----NYV--- 183
                HRD+K ENIL+     IK+ DFG +      R           P     + V   
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFA------R-------LLTGPSDYYDDEVATR 166

Query: 184 ---APEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR------ 231
              +PE+L  +  Y     D+W+ G +   +L+G    P    ++  LY  I +      
Sbjct: 167 WYRSPELLVGDTQYGPPV-DVWAIGCVFAELLSGVPLWPGKS-DVDQLY-LIRKTLGDLI 223

Query: 232 -------------GDFKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIK 266
                           K+P              +S  A  LL+  L  +P +R+T   + 
Sbjct: 224 PRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLL 283

Query: 267 ADEWFEQDYTPANP 280
              +FE      + 
Sbjct: 284 HHPYFENIREIEDL 297

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  165 bits (421), Expect = 8e-49
 Identities = 81/312 (25%), Positives = 133/312 (42%), Gaps = 58/312 (18%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
           +YE    +GEG++G V   ++ D+G   A+K  LE +    +K      REI  LK L+H
Sbjct: 26  KYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKI--AMREIKLLKQLRH 83

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
            N+V L EV   K + Y+V E+V     +  +       L     +K   Q+I+G+ +CH
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCH 141

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV------AP 185
           +  + HRD+K ENIL+   G +K+ DFG +   +     G ++      + V      AP
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFA---RTLAAPGEVYD-----DEVATRWYRAP 193

Query: 186 EVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR----------- 231
           E+L  +  Y  A  D+W+ G ++  +  G    P D  ++  LY  I             
Sbjct: 194 ELLVGDVKYGKAV-DVWAIGCLVTEMFMGEPLFPGDS-DIDQLY-HIMMCLGNLIPRHQE 250

Query: 232 --------GDFKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
                      +LP+             LS    +L +K L  +P KR   A +   ++F
Sbjct: 251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

Query: 272 EQDYTPANPDDD 283
           + D        +
Sbjct: 311 QMDGFAERFSQE 322

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  163 bits (416), Expect = 2e-48
 Identities = 82/296 (27%), Positives = 130/296 (43%), Gaps = 71/296 (23%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIATLKL 70
           +YE    +GEG +G V  A++ ++    A+K   + R+         +    REI  LK 
Sbjct: 3   KYEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSS--ALREICLLKE 57

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           LKH N+VRLH+VL S  K+ +V E+      + FD     G L     +    QL+ G+ 
Sbjct: 58  LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLG 115

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 181
           +CH++ V HRDLK +N+L++  G +K+++FGL+      R         G P        
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLA------R-------AFGIPVRCYSAEV 162

Query: 182 ----YVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPF--DDRNLAVLYQKIFR--- 231
               Y  P+VL   + Y  +  D+WS G I   +     P    +     L  +IFR   
Sbjct: 163 VTLWYRPPDVLFGAKLYSTSI-DMWSAGCIFAELANAGRPLFPGNDVDDQLK-RIFRLLG 220

Query: 232 --------GDFKLPKW------------------LSPGAQNLLRKILEPNPVKRIT 261
                      KLP +                  L+   ++LL+ +L+ NPV+RI+
Sbjct: 221 TPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  163 bits (416), Expect = 3e-48
 Identities = 76/324 (23%), Positives = 124/324 (38%), Gaps = 74/324 (22%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKL 70
            Y     LGEG +  V   +   +    A+K   +   I L+  +       RE++ LK 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALK---E---IRLEHEEGAPCTAIREVSLLKD 56

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           LKH N+V LH+++ ++  + +V EY+     +  D       +     +    QL+ G++
Sbjct: 57  LKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDD--CGNIINMHNVKLFLFQLLRGLA 114

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN------- 181
           YCH + V HRDLK +N+L++ +G +K++DFGL+      R           P        
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLA------R-------AKSIPTKTYDNEV 161

Query: 182 ----YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR--- 231
               Y  P++L  +  Y     D+W  G I Y + TG    P        L+  IFR   
Sbjct: 162 VTLWYRPPDILLGSTDYSTQI-DMWGVGCIFYEMATGRPLFPGST-VEEQLH-FIFRILG 218

Query: 232 ----------------GDFKLPKW-----------LSPGAQNLLRKILEPNPVKRITIAG 264
                             +  PK+           L     +LL K+L+     RI+   
Sbjct: 219 TPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAED 278

Query: 265 IKADEWFEQDYTPANPDDDEEDIF 288
                +F       +   D   IF
Sbjct: 279 AMKHPFFLSLGERIHKLPDTTSIF 302

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  163 bits (414), Expect = 5e-48
 Identities = 80/323 (24%), Positives = 135/323 (41%), Gaps = 79/323 (24%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLKL 70
           +++    LG G +  V    +  +G+  A+K       + L   +       REI+ +K 
Sbjct: 6   QFKQLEKLGNGTYATVYKGLNKTTGVYVALKE------VKLDSEEGTPSTAIREISLMKE 59

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGG-----ELFDKIASKGRLQEAEGRKLFQQLID 125
           LKH N+VRL++V+ +++K+ +V E++        +      +   L+    +    QL+ 
Sbjct: 60  LKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQ 119

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN---- 181
           G+++CH   + HRDLK +N+L++ +G +K+ DFGL+      R         G P     
Sbjct: 120 GLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA------R-------AFGIPVNTFS 166

Query: 182 -------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQKIFR 231
                  Y AP+VL  +R Y  +  DIWSCG IL  ++TG    P  + +   L   IF 
Sbjct: 167 SEVVTLWYRAPDVLMGSRTYSTSI-DIWSCGCILAEMITGKPLFPGTN-DEEQLK-LIFD 223

Query: 232 -----------GDFKLPKW-----------------------LSPGAQNLLRKILEPNPV 257
                         KLPK+                       L     + L  +L+ NP 
Sbjct: 224 IMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPD 283

Query: 258 KRITIAGIKADEWFEQDYTPANP 280
            R++        WF + Y  A+ 
Sbjct: 284 MRLSAKQALHHPWFAEYYHHASM 306

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  162 bits (413), Expect = 7e-48
 Identities = 74/250 (29%), Positives = 126/250 (50%), Gaps = 13/250 (5%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
            +   +G G+FG V  A+    G   AVKIL +    H +  ++  RE+A +K L+HPN+
Sbjct: 40  NIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNI 96

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHNK 133
           V     +     + +V EY++ G L+  +   G  ++ + R+      D   G++Y HN+
Sbjct: 97  VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR 156

Query: 134 G--VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
              + HR+LK  N+L+D K  +K+ DFGLS L           +  G+P ++APEVL + 
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS--TFLSSKSAAGTPEWMAPEVLRDE 214

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD-FKLPKWLSPGAQNLLR 249
             +   SD++S GVIL+ + T   P+ + N   V+    F+    ++P+ L+P    ++ 
Sbjct: 215 PSNEK-SDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIE 273

Query: 250 KILEPNPVKR 259
                 P KR
Sbjct: 274 GCWTNEPWKR 283

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  160 bits (408), Expect = 2e-47
 Identities = 85/318 (26%), Positives = 138/318 (43%), Gaps = 91/318 (28%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
           +Y     +GEG +G V  AQ+                   LK   +I+            
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN------------NYGETFALK---KIRLEKEDEGIPSTT 47

Query: 63  -REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKL 119
            REI+ LK LKH N+V+L++V+ +K ++ +V E++     +L D    +G L+    +  
Sbjct: 48  IREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV--CEGGLESVTAKSF 105

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
             QL++G++YCH++ V HRDLK +N+L++ +G +KI+DFGL+      R         G 
Sbjct: 106 LLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLA------R-------AFGI 152

Query: 180 PN-----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVL 225
           P            Y AP+VL  ++ Y     DIWS G I   ++ G    P        L
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTI-DIWSVGCIFAEMVNGTPLFPGVS-EADQL 210

Query: 226 YQKIFR-----------GDFKLPKW------------------LSPGAQNLLRKILEPNP 256
             +IFR              +LPK+                  L     +LL K+L+ +P
Sbjct: 211 M-RIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDP 269

Query: 257 VKRITIAGIKADEWFEQD 274
            +RIT        +F+++
Sbjct: 270 NQRITAKQALEHAYFKEN 287

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  160 bits (408), Expect = 4e-47
 Identities = 83/306 (27%), Positives = 132/306 (43%), Gaps = 92/306 (30%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
           +Y+    +GEG +G V  A+D             + RI+ LK   +I+            
Sbjct: 22  KYQKLEKVGEGTYGVVYKAKD------------SQGRIVALK---RIRLDAEDEGIPSTA 66

Query: 63  -REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTG--GELFDKIASKGRLQEAEGRKL 119
            REI+ LK L HPN+V L +V+ S+  + +V E++     ++ D+   K  LQ+++ +  
Sbjct: 67  IREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN--KTGLQDSQIKIY 124

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
             QL+ GV++CH   + HRDLK +N+L++S G +K++DFGL+      R         G 
Sbjct: 125 LYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA------R-------AFGI 171

Query: 180 PN-----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVL 225
           P            Y AP+VL  ++ Y  +  DIWS G I   ++TG    P    +   L
Sbjct: 172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSV-DIWSIGCIFAEMITGKPLFPGVT-DDDQL 229

Query: 226 YQKIFR-----------GDFKLP-------------------KWLSPGAQNLLRKILEPN 255
             KIF               +LP                           +LL  +L  +
Sbjct: 230 P-KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFD 288

Query: 256 PVKRIT 261
           P KRI+
Sbjct: 289 PNKRIS 294

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  160 bits (407), Expect = 9e-47
 Identities = 87/320 (27%), Positives = 132/320 (41%), Gaps = 76/320 (23%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIAT 67
            + RY     LGEG +G+V  A D  +    A+K   + R+ H +     T  I RE++ 
Sbjct: 32  SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRLEHEEEGVPGT-AI-REVSL 86

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           LK L+H N++ L  V+    +++++ EY    +L   +     +     +    QLI+GV
Sbjct: 87  LKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGV 145

Query: 128 SYCHNKGVFHRDLKLENILLDS-----KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN- 181
           ++CH++   HRDLK +N+LL          +KI DFGL+      R         G P  
Sbjct: 146 NFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA------R-------AFGIPIR 192

Query: 182 ----------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQK 228
                     Y  PE+L  +R Y  +  DIWS   I   +L      P D   +  L+ K
Sbjct: 193 QFTHEIITLWYRPPEILLGSRHYSTSV-DIWSIACIWAEMLMKTPLFPGDS-EIDQLF-K 249

Query: 229 IFR--G--------------DFK--------------LPKWLSPGAQNLLRKILEPNPVK 258
           IF   G              D+K              L   L     +LL  +LE +PVK
Sbjct: 250 IFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVK 309

Query: 259 RITIAGIKADEWF-EQDYTP 277
           RI+        +F   D+ P
Sbjct: 310 RISAKNALEHPYFSHNDFDP 329

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  158 bits (403), Expect = 1e-46
 Identities = 62/255 (24%), Positives = 119/255 (46%), Gaps = 20/255 (7%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            +G+ +G G+FG V   K+  D+      AVK+L        +     K E+  L+  +H
Sbjct: 27  TVGQRIGSGSFGTVYKGKWHGDV------AVKMLNVTAP-TPQQLQAFKNEVGVLRKTRH 79

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
            N++      ++  ++ +V ++  G  L+  + AS+ + +  +   + +Q   G+ Y H 
Sbjct: 80  VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           K + HRDLK  NI L     +KI DFGL+     +          GS  ++APEV+  + 
Sbjct: 139 KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 193 YDGAT--SDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK-----LPKWLSPGA 244
            +  +  SD+++ G++LY ++TG LP+ +  N   + + + RG        +        
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRM 258

Query: 245 QNLLRKILEPNPVKR 259
           + L+ + L+    +R
Sbjct: 259 KRLMAECLKKKRDER 273

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  159 bits (403), Expect = 2e-46
 Identities = 73/305 (23%), Positives = 121/305 (39%), Gaps = 45/305 (14%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           E+   +G G FG V  A+        A+K +E               E+  L  + HPN+
Sbjct: 11  EVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNI 63

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSYCHN- 132
           V+L    A  + + +V+EY  GG L++ +     L            +    GV+Y H+ 
Sbjct: 64  VKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSM 121

Query: 133 --KGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRD-DGLLHTTCGSPNYVAPEVL 188
             K + HRDLK  N+LL + G  +KI DFG +       D    +    GS  ++APEV 
Sbjct: 122 QPKALIHRDLKPPNLLLVAGGTVLKICDFGTA------CDIQTHMTNNKGSAAWMAPEVF 175

Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSPG 243
               Y     D++S G+IL+ ++T   PFD+  +     +I           L K L   
Sbjct: 176 EGSNYSEK-CDVFSWGIILWEVITRRKPFDE--IGGPAFRIMWAVHNGTRPPLIKNLPKP 232

Query: 244 AQNLLRKILEPNPVKR--------------ITIAGIKADEWFEQDYTPANPDDDEEDIFV 289
            ++L+ +    +P +R                  G      +   ++    +D   + +V
Sbjct: 233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQHSLPPGEDGRVEPYV 292

Query: 290 DNEAF 294
           D   F
Sbjct: 293 DFAEF 297

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  157 bits (399), Expect = 6e-46
 Identities = 69/255 (27%), Positives = 119/255 (46%), Gaps = 15/255 (5%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            RY++   LG G    V  A+D    +  A+K +        +   + +RE+     L H
Sbjct: 11  ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
            N+V + +V       Y+V+EY+ G  L + I S G L          Q++DG+ + H+ 
Sbjct: 71  QNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTC--GSPNYVAPEVLAN 190
            + HRD+K +NIL+DS   +KI DFG++ AL     +  L  T    G+  Y +PE  A 
Sbjct: 131 RIVHRDIKPQNILIDSNKTLKIFDFGIAKAL----SETSLTQTNHVLGTVQYFSPE-QAK 185

Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDF-----KLPKWLSPGA 244
                  +DI+S G++LY +L G  PF+ +  +++  + I +         + K +    
Sbjct: 186 GEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHI-QDSVPNVTTDVRKDIPQSL 244

Query: 245 QNLLRKILEPNPVKR 259
            N++ +  E +   R
Sbjct: 245 SNVILRATEKDKANR 259

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  157 bits (399), Expect = 9e-46
 Identities = 86/313 (27%), Positives = 121/313 (38%), Gaps = 72/313 (23%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKL 70
           RYE    +G G +G V  A+D  SG   A+K +           L I+    RE+A L+ 
Sbjct: 10  RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIS--TVREVALLRR 67

Query: 71  LK---HPNVVRLHEVLASKS-----KIYMVLEYVTG--GELFDKIASKGRLQEAEGRKLF 120
           L+   HPNVVRL +V A+       K+ +V E+V        DK    G L     + L 
Sbjct: 68  LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPG-LPAETIKDLM 126

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
           +Q + G+ + H   + HRDLK ENIL+ S G +K++DFGL+      R            
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA------R-------IYSYQ 173

Query: 181 N----------YVAPEVLANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVLYQK 228
                      Y APEVL    Y     D+WS G I   +         +      L  K
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPV-DMWSVGCIFAEMFRRKPLFCGNS-EADQLG-K 230

Query: 229 IFR-----------GDFKLPKW----------------LSPGAQNLLRKILEPNPVKRIT 261
           IF             D  LP+                 +      LL ++L  NP KRI+
Sbjct: 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290

Query: 262 IAGIKADEWFEQD 274
                   +  +D
Sbjct: 291 AFRALQHSYLHKD 303

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  156 bits (396), Expect = 6e-45
 Identities = 78/281 (27%), Positives = 120/281 (42%), Gaps = 18/281 (6%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIATLKLL 71
           +E    LG GN G V       SGL  A K+      IHL+I      QI RE+  L   
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKL------IHLEIKPAIRNQIIRELQVLHEC 88

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
             P +V  +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y  
Sbjct: 89  NSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLR 148

Query: 132 NKG-VFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            K  + HRD+K  NIL++S+G IK+ DFG+S  L      D + ++  G+ +Y++PE L 
Sbjct: 149 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSMANSFVGTRSYMSPERLQ 203

Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR 249
              Y    SDIWS G+ L  +  G  P    +   L                P  +   R
Sbjct: 204 GTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 262

Query: 250 KILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVD 290
            + +     R  +A  +  ++   +  P  P       F D
Sbjct: 263 PLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD 303

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  154 bits (391), Expect = 1e-44
 Identities = 66/263 (25%), Positives = 115/263 (43%), Gaps = 21/263 (7%)

Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI-----K 62
           +EG + G Y L R +G G  G V  A+D       A+K++ +     L  +D +     +
Sbjct: 28  REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSE----TLS-SDPVFRTRMQ 82

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           RE  T   L+ P+VV +H+      ++Y+ +  + G +L   +  +G L       + +Q
Sbjct: 83  REARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQ 142

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHT--TCGSP 180
           +   +   H  G  HRD+K ENIL+ +     + DFG++       D+ L     T G+ 
Sbjct: 143 IGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIA---SATTDEKLTQLGNTVGTL 199

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK-- 238
            Y+APE  +        +DI++   +LY  LTG  P+    L+V+   I       P   
Sbjct: 200 YYMAPERFSESHATYR-ADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTV 257

Query: 239 --WLSPGAQNLLRKILEPNPVKR 259
              +      ++ + +  NP  R
Sbjct: 258 RPGIPVAFDAVIARGMAKNPEDR 280

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  154 bits (392), Expect = 2e-44
 Identities = 81/331 (24%), Positives = 134/331 (40%), Gaps = 79/331 (23%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK----ITDQIKREIAT 67
            + +YE    +G+G FG+V  A+   +G   A+K   K  + + K    IT    REI  
Sbjct: 15  EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITAL--REIKI 69

Query: 68  LKLLKHPNVVRLHEVLASKS--------KIYMVLEYV----TGGELFDKIASKGRLQEAE 115
           L+LLKH NVV L E+  +K+         IY+V ++      G  L   +    +   +E
Sbjct: 70  LQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG--LLSNV--LVKFTLSE 125

Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLH 174
            +++ Q L++G+ Y H   + HRD+K  N+L+   G +K++DFGL+ A           +
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185

Query: 175 TTCGSPN------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTG--YLPFDDRNLAVL 225
           T     N      Y  PE+L   R Y     D+W  G I+  + T    +  +       
Sbjct: 186 T-----NRVVTLWYRPPELLLGERDYGPPI-DLWGAGCIMAEMWTRSPIMQGNT----EQ 235

Query: 226 YQ--KIFR-------------------GDFKLPKW-------------LSPGAQNLLRKI 251
           +Q   I +                      +L K                P A +L+ K+
Sbjct: 236 HQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKL 295

Query: 252 LEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
           L  +P +RI        ++F  D  P++   
Sbjct: 296 LVLDPAQRIDSDDALNHDFFWSDPMPSDLKG 326

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  153 bits (389), Expect = 3e-44
 Identities = 84/309 (27%), Positives = 124/309 (40%), Gaps = 92/309 (29%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK------------ 62
           +YE    +GEG +GKV  A+DL +G           R + LK   +++            
Sbjct: 12  QYECVAEIGEGAYGKVFKARDLKNG----------GRFVALK---RVRVQTGEEGMPLST 58

Query: 63  -REIATLKLLK---HPNVVRLHEVL-----ASKSKIYMVLEYVTG--GELFDKIASKGRL 111
            RE+A L+ L+   HPNVVRL +V        ++K+ +V E+V        DK+   G +
Sbjct: 59  IREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPG-V 117

Query: 112 QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG 171
                + +  QL+ G+ + H+  V HRDLK +NIL+ S G IK++DFGL+      R   
Sbjct: 118 PTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------R--- 168

Query: 172 LLHTTCGSPN----------YVAPEVLANRGYDGATSDIWSCGVILYVILTG--YLPFDD 219
                               Y APEVL    Y     D+WS G I   +           
Sbjct: 169 ----IYSFQMALTSVVVTLWYRAPEVLLQSSYATPV-DLWSVGCIFAEMFRRKPLFRGSS 223

Query: 220 RNLAVLYQKIFR-----------GDFKLPKW----------------LSPGAQNLLRKIL 252
            ++  L  KI              D  LP+                 +    ++LL K L
Sbjct: 224 -DVDQLG-KILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCL 281

Query: 253 EPNPVKRIT 261
             NP KRI+
Sbjct: 282 TFNPAKRIS 290

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  152 bits (387), Expect = 4e-44
 Identities = 63/262 (24%), Positives = 108/262 (41%), Gaps = 26/262 (9%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
             G  LG+G FG+       ++G    +K L +      +      +E+  ++ L+HPNV
Sbjct: 13  IHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNV 69

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLID---GVSYCHN 132
           ++   VL    ++  + EY+ GG L   I S           +      D   G++Y H+
Sbjct: 70  LKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPW---SQRVSFAKDIASGMAYLHS 126

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQH------------FRDDGLLHTTCGSP 180
             + HRDL   N L+    N+ ++DFGL+ L                 D    +T  G+P
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKL--P 237
            ++APE++  R YD    D++S G++L  I+       D     + +    RG      P
Sbjct: 187 YWMAPEMINGRSYDEK-VDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245

Query: 238 KWLSPGAQNLLRKILEPNPVKR 259
               P    +  +  + +P KR
Sbjct: 246 PNCPPSFFPITVRCCDLDPEKR 267

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  152 bits (387), Expect = 5e-44
 Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 25/269 (9%)

Query: 8   QEGMRL-GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI----- 61
                L  RYELG  LG G   +V  A+DL      AVK+L       L   D       
Sbjct: 5   TTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRA----DLA-RDPSFYLRF 59

Query: 62  KREIATLKLLKHPNVVRLHEV----LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGR 117
           +RE      L HP +V +++       +    Y+V+EYV G  L D + ++G +      
Sbjct: 60  RREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAI 119

Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
           ++       +++ H  G+ HRD+K  NI++ +   +K+ DFG+ A       + +  T  
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGI-ARAIADSGNSVTQTAA 178

Query: 178 --GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDF 234
             G+  Y++PE  A      A SD++S G +LY +LTG  PF  D  ++V YQ + R D 
Sbjct: 179 VIGTAQYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHV-REDP 236

Query: 235 KLPK----WLSPGAQNLLRKILEPNPVKR 259
             P      LS     ++ K L  NP  R
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENR 265

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  152 bits (386), Expect = 6e-44
 Identities = 67/248 (27%), Positives = 118/248 (47%), Gaps = 11/248 (4%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
            +     +G+G+FG+V    D  +    A+KI  LE+      +I D I++EI  L    
Sbjct: 23  LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA---EDEIED-IQQEITVLSQCD 78

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
            P V + +      +K+++++EY+ GG   D +   G L E +   + ++++ G+ Y H+
Sbjct: 79  SPYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHS 137

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           +   HRD+K  N+LL   G +K++DFG++   Q        +T  G+P ++APEV+    
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAG--QLTDTQIKRNTFVGTPFWMAPEVIKQSA 195

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGDFKLPKWLSPGAQNLLRKI 251
           YD   +DIWS G+    +  G  P  + + + VL+         L    S   +  +   
Sbjct: 196 YDSK-ADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEAC 254

Query: 252 LEPNPVKR 259
           L   P  R
Sbjct: 255 LNKEPSFR 262

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  150 bits (382), Expect = 9e-44
 Identities = 52/259 (20%), Positives = 99/259 (38%), Gaps = 32/259 (12%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
                L E + G++        G    VK+L K R    + +     E   L++  HPNV
Sbjct: 13  NFLTKLNENHSGELWKG--RWQGNDIVVKVL-KVRDWSTRKSRDFNEECPRLRIFSHPNV 69

Query: 77  VRLHEVLAS--KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
           + +     S       ++  ++  G L++       L E     +   Q +        G
Sbjct: 70  LPVLGACQSPPAPHPTLITHWMPYGSLYN------VLHEGTNFVVDQSQAVKFALDMARG 123

Query: 127 VSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           +++ H     +    L   ++++D     +IS   +                  +P +VA
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK----FSFQSP---GRMYAPAWVA 176

Query: 185 PEVLANRGYDGAT--SDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD-FKLPKWL 240
           PE L  +  D     +D+WS  V+L+ ++T  +PF D  N+ +  +    G    +P  +
Sbjct: 177 PEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGI 236

Query: 241 SPGAQNLLRKILEPNPVKR 259
           SP    L++  +  +P KR
Sbjct: 237 SPHVSKLMKICMNEDPAKR 255

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  150 bits (382), Expect = 1e-43
 Identities = 66/263 (25%), Positives = 116/263 (44%), Gaps = 30/263 (11%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL----EKNRIIHLKITDQIKREIATLKLLK 72
           E  + +G+G FG V   + +      A+K L     +     ++   + +RE+  +  L 
Sbjct: 22  EYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN 81

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---GVSY 129
           HPN+V+L       +   MV+E+V  G+L+ ++  K      +     + ++D   G+ Y
Sbjct: 82  HPNIVKL--YGLMHNPPRMVMEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEY 137

Query: 130 CHNKG--VFHRDLKLENILLDSKG-----NIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
             N+   + HRDL+  NI L S         K++DFGLS           +    G+  +
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLGNFQW 192

Query: 183 VAPEVLANRG--YDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGD-FKL 236
           +APE +      Y    +D +S  +ILY ILTG  PFD+ +   +  +      G    +
Sbjct: 193 MAPETIGAEEESYTEK-ADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTI 251

Query: 237 PKWLSPGAQNLLRKILEPNPVKR 259
           P+   P  +N++      +P KR
Sbjct: 252 PEDCPPRLRNVIELCWSGDPKKR 274

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  149 bits (379), Expect = 3e-43
 Identities = 72/257 (28%), Positives = 115/257 (44%), Gaps = 22/257 (8%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-KITDQIKREIATLKLLKHPN 75
            L   +G G FGKV  A     G   AVK    +    + +  + +++E     +LKHPN
Sbjct: 10  TLEEIIGIGGFGKVYRA--FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG- 134
           ++ L  V   +  + +V+E+  GG L   ++ K R+          Q+  G++Y H++  
Sbjct: 68  IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYLHDEAI 126

Query: 135 --VFHRDLKLENILLDSKG--------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
             + HRDLK  NIL+  K          +KI+DFGL+             +  G+  ++A
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMA 182

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGD-FKLPKWLSP 242
           PEV+    +    SD+WS GV+L+ +LTG +PF     LAV Y          +P     
Sbjct: 183 PEVIRASMFSKG-SDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCPE 241

Query: 243 GAQNLLRKILEPNPVKR 259
               L+     P+P  R
Sbjct: 242 PFAKLMEDCWNPDPHSR 258

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  150 bits (382), Expect = 3e-43
 Identities = 58/260 (22%), Positives = 110/260 (42%), Gaps = 25/260 (9%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           E+G  +G+G FG+V   ++  ++      A+++++  R          KRE+   +  +H
Sbjct: 36  EIGELIGKGRFGQVYHGRWHGEV------AIRLIDIERDNE-DQLKAFKREVMAYRQTRH 88

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHN 132
            NVV       S   + ++     G  L+  +   K  L   + R++ Q+++ G+ Y H 
Sbjct: 89  ENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHA 148

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLS---ALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
           KG+ H+DLK +N+  D  G + I+DFGL     + Q  R +  L    G   ++APE++ 
Sbjct: 149 KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207

Query: 190 NRGYDGAT--------SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW 239
               D           SD+++ G I Y +     PF  +    +  ++  G         
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIG 267

Query: 240 LSPGAQNLLRKILEPNPVKR 259
           +     ++L         +R
Sbjct: 268 MGKEISDILLFCWAFEQEER 287

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  146 bits (370), Expect = 1e-41
 Identities = 72/255 (28%), Positives = 131/255 (51%), Gaps = 17/255 (6%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +E+   LG+G FGKV  A++ ++G   A K++E       ++ D    EI  L    HP
Sbjct: 20  VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELED-YIVEIEILATCDHP 76

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
            +V+L        K+++++E+  GG +   +      L E + + + +Q+++ +++ H+K
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-- 191
            + HRDLK  N+L+  +G+I+++DFG+SA  ++ +      +  G+P ++APEV+     
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSA--KNLKTLQKRDSFIGTPYWMAPEVVMCETM 194

Query: 192 ---GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGA 244
               YD   +DIWS G+ L  +     P  + N + VL  KI + D      P   S   
Sbjct: 195 KDTPYDYK-ADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSDPPTLLTPSKWSVEF 252

Query: 245 QNLLRKILEPNPVKR 259
           ++ L+  L+ NP  R
Sbjct: 253 RDFLKIALDKNPETR 267

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  145 bits (368), Expect = 3e-41
 Identities = 68/252 (26%), Positives = 126/252 (50%), Gaps = 14/252 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +++   LGEG++G V  A   ++G   A+K +     +      +I +EI+ ++    P
Sbjct: 30  VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSP 84

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           +VV+ +      + +++V+EY   G + D I      L E E   + Q  + G+ Y H  
Sbjct: 85  HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
              HRD+K  NILL+++G+ K++DFG++   Q        +T  G+P ++APEV+   GY
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGY 202

Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLLR 249
           +   +DIWS G+    +  G  P+ D + +  ++  I       F+ P+  S    + ++
Sbjct: 203 NCV-ADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELWSDNFTDFVK 260

Query: 250 KILEPNPVKRIT 261
           + L  +P +R T
Sbjct: 261 QCLVKSPEQRAT 272

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  144 bits (366), Expect = 4e-41
 Identities = 71/252 (28%), Positives = 129/252 (51%), Gaps = 14/252 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
           +Y     +G+G  G V  A D+ +G   A++   L++     L     I  EI  ++  K
Sbjct: 21  KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL-----IINEILVMRENK 75

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + + H+
Sbjct: 76  NPNIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHS 134

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
             V HRD+K +NILL   G++K++DFG  A  Q   +     T  G+P ++APEV+  + 
Sbjct: 135 NQVIHRDIKSDNILLGMDGSVKLTDFGFCA--QITPEQSKRSTMVGTPYWMAPEVVTRKA 192

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKLPKWLSPGAQNLLR 249
           Y     DIWS G++   ++ G  P+ + N L  LY     G  + + P+ LS   ++ L 
Sbjct: 193 YGPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251

Query: 250 KILEPNPVKRIT 261
           + LE +  KR +
Sbjct: 252 RCLEMDVEKRGS 263

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  145 bits (367), Expect = 4e-41
 Identities = 71/253 (28%), Positives = 133/253 (52%), Gaps = 16/253 (6%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
             +    +GEG+ G V  A++  SG   AVK+  L K +   L     +  E+  ++  +
Sbjct: 46  LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL-----LFNEVVIMRDYQ 100

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NVV +++      ++++++E++ GG L D I S+ RL E +   + + ++  ++Y H 
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHA 159

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           +GV HRD+K ++ILL   G +K+SDFG  A  Q  +D     +  G+P ++APEV++   
Sbjct: 160 QGVIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPEVISRSL 217

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQNLL 248
           Y     DIWS G+++  ++ G  P+   + +  +  ++        K    +SP  ++ L
Sbjct: 218 YA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK-RLRDSPPPKLKNSHKVSPVLRDFL 275

Query: 249 RKILEPNPVKRIT 261
            ++L  +P +R T
Sbjct: 276 ERMLVRDPQERAT 288

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  142 bits (361), Expect = 2e-40
 Identities = 75/270 (27%), Positives = 121/270 (44%), Gaps = 31/270 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLKLLK 72
            YEL   +G G    V+ A         A+K   LEK +       D++ +EI  +    
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ----TSMDELLKEIQAMSQCH 71

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------- 124
           HPN+V  +     K ++++V++ ++GG + D I       E +   L +  I        
Sbjct: 72  HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL---HTTCGSPN 181
           +G+ Y H  G  HRD+K  NILL   G+++I+DFG+SA      D        T  G+P 
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 182 YVAPEVLA-NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLY----------QKI 229
           ++APEV+   RGYD   +DIWS G+    + TG  P+     + VL           +  
Sbjct: 192 WMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG 250

Query: 230 FRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
            +    L K+     + ++   L+ +P KR
Sbjct: 251 VQDKEMLKKY-GKSFRKMISLCLQKDPEKR 279

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  143 bits (362), Expect = 2e-40
 Identities = 61/255 (23%), Positives = 109/255 (42%), Gaps = 17/255 (6%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHP 74
            E    +G G  G+V   +   +G   AVK + ++   + +   +I  ++  + K    P
Sbjct: 27  LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS--GNKEENKRILMDLDVVLKSHDCP 84

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK- 133
            +V+      + + +++ +E +       K   +G + E    K+   ++  + Y   K 
Sbjct: 85  YIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
           GV HRD+K  NILLD +G IK+ DFG+S       DD     + G   Y+APE +     
Sbjct: 145 GVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDPPDP 201

Query: 194 DGAT----SDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGD---FKLPKWLSPGA 244
                   +D+WS G+ L  + TG  P+ +      VL  K+ + +          S   
Sbjct: 202 TKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVL-TKVLQEEPPLLPGHMGFSGDF 260

Query: 245 QNLLRKILEPNPVKR 259
           Q+ ++  L  +  KR
Sbjct: 261 QSFVKDCLTKDHRKR 275

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  144 bits (365), Expect = 4e-40
 Identities = 94/371 (25%), Positives = 136/371 (36%), Gaps = 98/371 (26%)

Query: 15  RYE-LGRTLGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
            +E  G  +G G +G V  A+  D      +A+K +E   I          REIA L+ L
Sbjct: 21  LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSAC-----REIALLREL 75

Query: 72  KHPNVVRLHEVLASKS--KIYMVLEYV--------TGGELFDKIASKGRLQEAEGRKLFQ 121
           KHPNV+ L +V  S +  K++++ +Y                      +L     + L  
Sbjct: 76  KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDS----KGNIKISDFGLSALPQHFRDDGLLHTTC 177
           Q++DG+ Y H   V HRDLK  NIL+      +G +KI+D G +      R         
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------R-------LF 182

Query: 178 GSPN--------------YVAPEVL-ANRGYDGATSDIWSCGVILYVILTGYLPF----D 218
            SP               Y APE+L   R Y  A  DIW+ G I   +LT    F    +
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI-DIWAIGCIFAELLTSEPIFHCRQE 241

Query: 219 DRNLAVLYQ-----KIFR-----------GDFKLPKW----------------------- 239
           D   +  Y      +IF               K+P+                        
Sbjct: 242 DIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEK 301

Query: 240 ----LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFS 295
                   A +LL+K+L  +P+KRIT      D +F +D  P +       I      F 
Sbjct: 302 HKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFL 361

Query: 296 MHEVPSDGGRT 306
             E P D G  
Sbjct: 362 TEEEPDDKGDK 372

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  141 bits (357), Expect = 3e-39
 Identities = 67/253 (26%), Positives = 117/253 (46%), Gaps = 18/253 (7%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +   R +G G+FG V FA+D+ +    A+K +  +     +    I +E+  L+ L+HP
Sbjct: 55  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N ++       +   ++V+EY  G         K  LQE E   +    + G++Y H+  
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVLANR-- 191
           + HRD+K  NILL   G +K+ DFG ++ +          ++  G+P ++APEV+     
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-------NSFVGTPYWMAPEVILAMDE 227

Query: 192 -GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FKLPKWLSPGAQN 246
             YDG   D+WS G+    +     P  + N ++ LY  I + +    +   W S   +N
Sbjct: 228 GQYDGK-VDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHW-SEYFRN 284

Query: 247 LLRKILEPNPVKR 259
            +   L+  P  R
Sbjct: 285 FVDSCLQKIPQDR 297

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  141 bits (358), Expect = 3e-39
 Identities = 54/230 (23%), Positives = 101/230 (43%), Gaps = 18/230 (7%)

Query: 14  GRYELGRTLGEG--NFGKVKFAQDLDSGLPFAVKI--LEKNRIIHLKITDQIKREIATLK 69
           G YEL   +G+G  +   V  A+   +G    V+   LE      +     ++ E+   K
Sbjct: 25  GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMV---TFLQGELHVSK 81

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLIDGV 127
           L  HPN+V       + +++++V  ++  G   D         + E     + Q ++  +
Sbjct: 82  LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTC----GSPNY 182
            Y H+ G  HR +K  +IL+   G + +S    +  +  H +   ++H           +
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPW 201

Query: 183 VAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKI 229
           ++PEVL    +GYD   SDI+S G+    +  G++PF D     +L +K+
Sbjct: 202 LSPEVLQQNLQGYDAK-SDIYSVGITACELANGHVPFKDMPATQMLLEKL 250

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  137 bits (348), Expect = 4e-38
 Identities = 74/264 (28%), Positives = 126/264 (47%), Gaps = 27/264 (10%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLK 72
           G +EL   +G G +G+V   + + +G   A+K+++   +   +  + IK+EI  LK    
Sbjct: 24  GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEE-IKQEINMLKKYSH 79

Query: 73  HPNVVRLHE------VLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLI 124
           H N+   +             ++++V+E+   G + D  K      L+E     + ++++
Sbjct: 80  HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+S+ H   V HRD+K +N+LL     +K+ DFG+SA  Q  R  G  +T  G+P ++A
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA--QLDRTVGRRNTFIGTPYWMA 197

Query: 185 PEVLANR-----GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD---FK 235
           PEV+A        YD   SD+WS G+    +  G  P  D + +  L+  I R      K
Sbjct: 198 PEVIACDENPDATYDFK-SDLWSLGITAIEMAEGAPPLCDMHPMRALF-LIPRNPAPRLK 255

Query: 236 LPKWLSPGAQNLLRKILEPNPVKR 259
             KW S   Q+ +   L  N  +R
Sbjct: 256 SKKW-SKKFQSFIESCLVKNHSQR 278

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  137 bits (347), Expect = 5e-38
 Identities = 67/268 (25%), Positives = 111/268 (41%), Gaps = 38/268 (14%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIAT-LKL 70
            +    +G G +G V       SG   AVK       I   + +    Q+  ++   ++ 
Sbjct: 24  LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR------IRSTVDEKEQKQLLMDLDVVMRS 77

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI------ASKGRLQEAEGRKLFQQLI 124
              P +V+ +  L  +   ++ +E ++    FDK            + E    K+    +
Sbjct: 78  SDCPYIVQFYGALFREGDCWICMELMSTS--FDKFYKYVYSVLDDVIPEEILGKITLATV 135

Query: 125 DGVSYCHNKG-VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV 183
             +++      + HRD+K  NILLD  GNIK+ DFG+S       D        G   Y+
Sbjct: 136 KALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLVDSIAKTRDAGCRPYM 192

Query: 184 APEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGD-FKL 236
           APE +      +GYD   SD+WS G+ LY + TG  P+   N     L  ++ +GD  +L
Sbjct: 193 APERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPYPKWNSVFDQL-TQVVKGDPPQL 250

Query: 237 P-----KWLSPGAQNLLRKILEPNPVKR 259
                 ++ SP   N +   L  +  KR
Sbjct: 251 SNSEEREF-SPSFINFVNLCLTKDESKR 277

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  141 bits (358), Expect = 1e-37
 Identities = 63/265 (23%), Positives = 108/265 (40%), Gaps = 38/265 (14%)

Query: 8   QEGMRL-GRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQI---- 61
             G  + G+YE+   +  G  G +  A D + +G P  +K L  +        D      
Sbjct: 73  NPGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-------DAEAQAM 125

Query: 62  -KREIATLKLLKHPNVVRLHEV-----LASKSKIYMVLEYVTGGELFDKIASKGRLQEAE 115
              E   L  + HP++V++               Y+V+EYV G  L        +L  AE
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK--GQKLPVAE 183

Query: 116 GRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL-SALPQHFRDDGLLH 174
                 +++  +SY H+ G+ + DLK ENI+L  +  +K+ D G  S +       G L 
Sbjct: 184 AIAYLLEILPALSYLHSIGLVYNDLKPENIMLT-EEQLKLIDLGAVSRINS----FGYL- 237

Query: 175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF 234
              G+P + APE++  R      +DI++ G  L  +       + R +  L +       
Sbjct: 238 --YGTPGFQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGLPEDD----- 288

Query: 235 KLPKWLSPGAQNLLRKILEPNPVKR 259
                       LLR+ ++P+P +R
Sbjct: 289 -PVLKTYDSYGRLLRRAIDPDPRQR 312

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  135 bits (342), Expect = 1e-37
 Identities = 63/277 (22%), Positives = 114/277 (41%), Gaps = 32/277 (11%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD----QIKREIA-TLKL 70
            E    LG G +G V+  + + SG   AVK       I   +      ++  ++  +++ 
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKR------IRATVNSQEQKRLLMDLDISMRT 62

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-----ASKGRLQEAEGRKLFQQLID 125
           +  P  V  +  L  +  +++ +E +      DK           + E    K+   ++ 
Sbjct: 63  VDCPFTVTFYGALFREGDVWICMELMDTS--LDKFYKQVIDKGQTIPEDILGKIAVSIVK 120

Query: 126 GVSYCHNKG-VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            + + H+K  V HRD+K  N+L+++ G +K+ DFG+S    +  DD       G   Y+A
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMA 177

Query: 185 PEVLANR----GYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFRGDFKLP- 237
           PE +       GY    SDIWS G+ +  +     P+D        L Q +     +LP 
Sbjct: 178 PERINPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA 236

Query: 238 -KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
            K+ S    +   + L+ N  +R T   +    +F  
Sbjct: 237 DKF-SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  135 bits (342), Expect = 1e-36
 Identities = 84/353 (23%), Positives = 131/353 (37%), Gaps = 100/353 (28%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
            Y   + +G G+FG V  A+  DSG   A+K +L+  R  +        RE+  ++ L H
Sbjct: 55  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKN--------RELQIMRKLDH 106

Query: 74  PNVVRLHEVLASKS------KIYMVLEYVTG---GELFDKIASKGRLQEAEGRKLFQQLI 124
            N+VRL     S         + +VL+YV             +K  L     +    QL 
Sbjct: 107 CNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF 166

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPN-- 181
             ++Y H+ G+ HRD+K +N+LLD     +K+ DFG +                G PN  
Sbjct: 167 RSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA-----------KQLVRGEPNVS 215

Query: 182 YV------APEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD- 233
           Y+      APE++     Y  +  D+WS G +L  +L G             Q IF GD 
Sbjct: 216 YICSRYYRAPELIFGATDYTSSI-DVWSAGCVLAELLLG-------------QPIFPGDS 261

Query: 234 -----------------------------FKLPKW------------LSPGAQNLLRKIL 252
                                        FK P+               P A  L  ++L
Sbjct: 262 GVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLL 321

Query: 253 EPNPVKRITIAGIKADEWFEQDYTPAN--PDDDEEDIFVDNEAFSMHEVPSDG 303
           E  P  R+T     A  +F++   P    P+  +     +   F+  E+ S+ 
Sbjct: 322 EYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFN---FTTQELSSNP 371

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  130 bits (328), Expect = 1e-35
 Identities = 72/237 (30%), Positives = 106/237 (44%), Gaps = 26/237 (10%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            L   LG+G+FG V   ++       +  AVK L+ + +   +  D   RE+  +  L H
Sbjct: 21  RLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDH 80

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
            N++RL+ V      + MV E    G L D      RL++ +G  L   L         G
Sbjct: 81  RNLIRLYGV-VLTPPMKMVTELAPLGSLLD------RLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYV-- 183
           + Y  +K   HRDL   N+LL ++  +KI DFGL  ALPQ   +D               
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ---NDDHYVMQEHRKVPFAW 190

Query: 184 -APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
            APE L  R +  A SD W  GV L+ + T G  P+   N + +  KI +   +LP+
Sbjct: 191 CAPESLKTRTFSHA-SDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR 246

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  132 bits (333), Expect = 2e-35
 Identities = 73/310 (23%), Positives = 126/310 (40%), Gaps = 74/310 (23%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK--ILEKNRIIHLKITDQIKREIATLKLLK 72
            Y   + +G G+FG V  A+ ++S    A+K  + +K             RE+  ++++K
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKN---------RELQIMRIVK 90

Query: 73  HPNVVRLHEVLASKS------KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQ----Q 122
           HPNVV L     S         + +VLEYV    ++       +L++     L +    Q
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPMLLIKLYMYQ 149

Query: 123 LIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           L+  ++Y H+ G+ HRD+K +N+LLD   G +K+ DFG +                G PN
Sbjct: 150 LLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA-----------KILIAGEPN 198

Query: 182 --YV------APEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR- 231
             Y+      APE++     Y     DIWS G ++  ++ G   F   +      +I + 
Sbjct: 199 VSYICSRYYRAPELIFGATNYTTNI-DIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257

Query: 232 ----------------GDFKLPKW------------LSPGAQNLLRKILEPNPVKRITIA 263
                            + K P+               P A +L+ ++LE  P  R+T  
Sbjct: 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317

Query: 264 GIKADEWFEQ 273
                 +F++
Sbjct: 318 EALCHPFFDE 327

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  128 bits (324), Expect = 4e-35
 Identities = 38/260 (14%), Positives = 75/260 (28%), Gaps = 43/260 (16%)

Query: 10  GMRL--GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           G R+  GRY L    G     +   A D       A+  ++   ++   +  +       
Sbjct: 25  GARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLR 84

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           L  +  P V R+ +V+ +++   +V E++ GG L +              +  Q L    
Sbjct: 85  LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD--TSPSPVGAIRAMQSLAAAA 142

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
              H  GV         + +   G++ ++                          +    
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMPDA- 179

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPKWLSPG 243
                      DI   G  LY +L    P  +      LA   +    G    P  +   
Sbjct: 180 -------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT-AGQPIEPADIDRD 231

Query: 244 A----QNLLRKILEPNPVKR 259
                  +  + ++ +   R
Sbjct: 232 IPFQISAVAARSVQGDGGIR 251

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  128 bits (324), Expect = 2e-34
 Identities = 80/344 (23%), Positives = 130/344 (37%), Gaps = 75/344 (21%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K + 
Sbjct: 26  RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVN 82

Query: 73  HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++ G
Sbjct: 83  HKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANLCQVI--QMELDHERMSYLLYQMLCG 139

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
           + + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G          YV   
Sbjct: 140 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTP---YVVTR 190

Query: 184 ---APEVLANRGYDGATSDIWSCGVILYVILTG--------------------------- 213
              APEV+   GY     DIWS G I+  ++ G                           
Sbjct: 191 YYRAPEVILGMGYKENV-DIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEF 249

Query: 214 ----------YL----PFDDRNLAVLYQK-IFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
                     Y+     +   +   L+   +F  D +  K  +  A++LL K+L  +  K
Sbjct: 250 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASK 309

Query: 259 RITIAGIKADEWFEQDYTPANPDDDEEDIF---VDNEAFSMHEV 299
           RI++       +    Y P+  +     I    +D    ++ E 
Sbjct: 310 RISVDEALQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEW 353

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  126 bits (319), Expect = 3e-34
 Identities = 63/293 (21%), Positives = 112/293 (38%), Gaps = 52/293 (17%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
            L   +G+G +G+V        G   AVKI         + +   + E+    +L+H N+
Sbjct: 11  TLLECVGKGRYGEVWRGSW--QGENVAVKIFSS----RDEKSWFRETELYNTVMLRHENI 64

Query: 77  VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +           S ++++++  Y   G L+D +     L      ++   +  G+++ H 
Sbjct: 65  LGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHI 123

Query: 133 K--------GVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNY 182
           +         + HRDLK +NIL+   G   I+D GL+ +      + D   +   G+  Y
Sbjct: 124 EIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRY 183

Query: 183 VAPEVLANRGYDGAT-----SDIWSCGVILYVILTGY----------LPFDDRN------ 221
           +APEVL               DIW+ G++L+ +               PF D        
Sbjct: 184 MAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243

Query: 222 ----LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE----PNPVKRITIAGIK 266
                 V   +  R +    +W S      L K+++     NP  R+T   IK
Sbjct: 244 EDMRKVVCVDQQ-RPNIP-NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK 294

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  129 bits (326), Expect = 4e-34
 Identities = 82/344 (23%), Positives = 132/344 (38%), Gaps = 75/344 (21%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+  + +G G  G V  A D       A+K L +      H K   +  RE+  +K + 
Sbjct: 63  RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK---RAYRELVLMKCVN 119

Query: 73  HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H N++ L  V   +        +Y+V+E +    L   I  +  L       L  Q++ G
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVI--QMELDHERMSYLLYQMLCG 176

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
           + + H+ G+ HRDLK  NI++ S   +KI DFGL+      R  G   T+     YV   
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAG---TSFMMTPYVVTR 227

Query: 184 ---APEVLANRGYDGATSDIWSCGVILYVILTG--------------------------- 213
              APEV+   GY     DIWS G I+  ++                             
Sbjct: 228 YYRAPEVILGMGYKENV-DIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 286

Query: 214 ----------YL----PFDDRNLAVLYQK-IFRGDFKLPKWLSPGAQNLLRKILEPNPVK 258
                     Y+     +       L+   +F  D +  K  +  A++LL K+L  +P K
Sbjct: 287 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 346

Query: 259 RITIAGIKADEWFEQDYTPANPDDDEEDIF---VDNEAFSMHEV 299
           RI++       +    Y PA  +     I+   +D    ++ E 
Sbjct: 347 RISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW 390

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  126 bits (319), Expect = 1e-33
 Identities = 73/260 (28%), Positives = 113/260 (43%), Gaps = 20/260 (7%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
            LG  +G GNFG+V   +        AVK   +     LK   +  +E   LK   HPN+
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA--KFLQEARILKQYSHPNI 174

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF-QQLIDGVSYCHNKGV 135
           VRL  V   K  IY+V+E V GG+    + ++G     +           G+ Y  +K  
Sbjct: 175 VRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNY----VAPEVLA 189
            HRDL   N L+  K  +KISDFG+S      R+  DG+   + G         APE L 
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMS------REEADGVYAASGGLRQVPVKWTAPEALN 288

Query: 190 NRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQN 246
              Y    SD+WS G++L+   + G  P+ + +     + + +G  +L  P+        
Sbjct: 289 YGRYSSE-SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPCPELCPDAVFR 346

Query: 247 LLRKILEPNPVKRITIAGIK 266
           L+ +     P +R + + I 
Sbjct: 347 LMEQCWAYEPGQRPSFSTIY 366

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  128 bits (323), Expect = 1e-33
 Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 26/233 (11%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
            +   LG G +G+V         L  AVK L+++ +      ++  +E A +K +KHPN+
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKHPNL 278

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           V+L  V   +   Y++ E++T G L D       L+E   +++    L+         + 
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLD------YLRECNRQEVSAVVLLYMATQISSAME 332

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY--VAPE 186
           Y   K   HR+L   N L+     +K++DFGLS   +    D               APE
Sbjct: 333 YLEKKNFIHRNLAARNCLVGENHLVKVADFGLS---RLMTGDTYTAHAGAKFPIKWTAPE 389

Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
            LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ + +  +++ +
Sbjct: 390 SLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMER 440

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  125 bits (317), Expect = 2e-33
 Identities = 79/340 (23%), Positives = 127/340 (37%), Gaps = 63/340 (18%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD--QIKREIATLKLLK 72
            ++L   LGEG +G V  A    +G   A+K   K      K     +  REI  LK  K
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIK---KIEPFD-KPLFALRTLREIKILKHFK 67

Query: 73  HPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           H N++ +  +    S      +Y++ E +   +L  ++ S   L +   +    Q +  V
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELM-QTDL-HRVISTQMLSDDHIQYFIYQTLRAV 125

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGL--SALPQHFRDDGLLHTTCGSPNYV-- 183
              H   V HRDLK  N+L++S  ++K+ DFGL          +        G   +V  
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT 185

Query: 184 ----APEV-LANRGYDGATSDIWSCGVILYVILTG--------YL------------PFD 218
               APEV L +  Y  A  D+WSCG IL  +           Y             P  
Sbjct: 186 RWYRAPEVMLTSAKYSRAM-DVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244

Query: 219 DRNLAVL-----------YQKIFRGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
           D +L  +                    +   P+ ++P   +LL+++L  +P KRIT    
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITAKEA 303

Query: 266 KADEWFEQDYTP-----ANPDDDEEDIF-VDNEAFSMHEV 299
               + +  + P       P       F    EA +  ++
Sbjct: 304 LEHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDL 343

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  125 bits (315), Expect = 2e-33
 Identities = 66/291 (22%), Positives = 120/291 (41%), Gaps = 58/291 (19%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
            Y+L R LG G + +V  A ++ +     VKI      +      +IKREI  L+ L+  
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKI------LKPVKKKKIKREIKILENLRGG 90

Query: 74  PNVVRLHEVL--ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           PN++ L +++         +V E+V   +      +   L + + R    +++  + YCH
Sbjct: 91  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCH 147

Query: 132 NKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVLA 189
           + G+ HRD+K  N+++D +   +++ D+GL+     F   G  +     S  +  PE+L 
Sbjct: 148 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA----EFYHPGQEYNVRVASRYFKGPELLV 203

Query: 190 N-RGYDGATSDIWSCGVILYVILTGYLPF--------------------DDRNLAVLYQK 228
           + + YD +  D+WS G +L  ++    PF                    D  +    Y  
Sbjct: 204 DYQMYDYSL-DMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262

Query: 229 IFRGDFK--LPKW----------------LSPGAQNLLRKILEPNPVKRIT 261
                F   L +                 +SP A + L K+L  +   R+T
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  123 bits (312), Expect = 6e-33
 Identities = 58/237 (24%), Positives = 110/237 (46%), Gaps = 29/237 (12%)

Query: 17  ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  + LG G FG V       +     +P A+K L +          +I  E   +  + 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVD 75

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
           +P+V RL  +    S + ++ + +  G L D       ++E +     Q L++       
Sbjct: 76  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLD------YVREHKDNIGSQYLLNWCVQIAK 128

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NY 182
           G++Y  ++ + HRDL   N+L+ +  ++KI+DFGL+  L     ++   H   G  P  +
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---EEKEYHAEGGKVPIKW 185

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           +A E + +R Y    SD+WS GV ++ ++T G  P+D    + +   + +G  +LP+
Sbjct: 186 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQ 240

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  126 bits (318), Expect = 1e-32
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 32/285 (11%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
            L   LG+G FG+V       +    A+K L+   +      +   +E   +K L+H  +
Sbjct: 270 RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 324

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           V+L+ V  S+  IY+V EY++ G L D       L+   G+ L   QL+D       G++
Sbjct: 325 VQLYAV-VSEEPIYIVTEYMSKGSLLD------FLKGETGKYLRLPQLVDMAAQIASGMA 377

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPE 186
           Y       HRDL+  NIL+      K++DFGL+   +   D+          P  + APE
Sbjct: 378 YVERMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKWTAPE 434

Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPG 243
                 +    SD+WS G++L  + T G +P+       +  ++ RG +++  P      
Sbjct: 435 AALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPES 492

Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIF 288
             +L+ +     P +R T   ++   + E  +T   P     +  
Sbjct: 493 LHDLMCQCWRKEPEERPTFEYLQ--AFLEDYFTSTEPQYQPGENL 535

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  122 bits (308), Expect = 1e-32
 Identities = 63/235 (26%), Positives = 108/235 (45%), Gaps = 30/235 (12%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
            +   LG G +G+V         L  AVK L+++        +  +  +E A +K +KHP
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT------MEVEEFLKEAAVMKEIKHP 69

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
           N+V+L  V   +   Y++ E++T G L D       L+E   +++    L+         
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLD------YLRECNRQEVSAVVLLYMATQISSA 123

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVA 184
           + Y   K   HRDL   N L+     +K++DFGLS L      D          P  + A
Sbjct: 124 MEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL---MTGDTYTAHAGAKFPIKWTA 180

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           PE LA   +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ + +  +++ +
Sbjct: 181 PESLAYNKFSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMER 233

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  125 bits (316), Expect = 1e-32
 Identities = 70/285 (24%), Positives = 122/285 (42%), Gaps = 32/285 (11%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
            L   LG+G FG+V       +    A+K L+   +      +   +E   +K L+H  +
Sbjct: 187 RLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKL 241

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           V+L+ V  S+  IY+V EY++ G L D       L+   G+ L   QL+D       G++
Sbjct: 242 VQLYAV-VSEEPIYIVTEYMSKGSLLD------FLKGETGKYLRLPQLVDMAAQIASGMA 294

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPE 186
           Y       HRDL+  NIL+      K++DFGL+   +   D+          P  + APE
Sbjct: 295 YVERMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKWTAPE 351

Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL--PKWLSPG 243
                 +    SD+WS G++L  + T G +P+       +  ++ RG +++  P      
Sbjct: 352 AALYGRFTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPES 409

Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIF 288
             +L+ +     P +R T   ++   + E  +T   P     +  
Sbjct: 410 LHDLMCQCWRKEPEERPTFEYLQ--AFLEDYFTSTEPQYQPGENL 452

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  122 bits (308), Expect = 2e-32
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 26/236 (11%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            + + +G G+ G+V   +        +P A+K L+       +       E + +    H
Sbjct: 52  HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQR--RDFLSEASIMGQFDH 109

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
           PN++RL  V+       +V EY+  G L         L+  +G+    QL+        G
Sbjct: 110 PNIIRLEGVVTRGRLAMIVTEYMENGSLDT------FLRTHDGQFTIMQLVGMLRGVGAG 163

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
           + Y  + G  HRDL   N+L+DS    K+SDFGLS + +   D    +TT G    +   
Sbjct: 164 MRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE--DDPDAAYTTTGGKIPIRWT 221

Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           APE +A R +  A SD+WS GV+++ +L  G  P+ +     +   +  G ++LP 
Sbjct: 222 APEAIAFRTFSSA-SDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPA 275

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  121 bits (306), Expect = 2e-32
 Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 14/228 (6%)

Query: 18  LGRTLGEGNFGKVKFA--QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
             + LG GNFG VK    Q        AVKIL KN      + D++  E   ++ L +P 
Sbjct: 21  EDKELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPY 79

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           +VR+  +        +V+E    G L   +     +++    +L  Q+  G+ Y      
Sbjct: 80  IVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138

Query: 136 FHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS--P-NYVAPEVLANR 191
            HRDL   N+LL ++   KISDFGLS AL     D+           P  + APE +   
Sbjct: 139 VHRDLAARNVLLVTQHYAKISDFGLSKALRA---DENYYKAQTHGKWPVKWYAPECINYY 195

Query: 192 GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
            +    SD+WS GV+++   + G  P+     + +   + +G  ++  
Sbjct: 196 KFSSK-SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGC 241

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  122 bits (308), Expect = 3e-32
 Identities = 89/332 (26%), Positives = 138/332 (41%), Gaps = 64/332 (19%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           RY+    +G G +G V  A D  +GL  AVK L +    IIH K   +  RE+  LK +K
Sbjct: 30  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK---RTYRELRLLKHMK 86

Query: 73  HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V            +Y+V   + G +L + +  + +L +   + L  Q++ G
Sbjct: 87  HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRG 144

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
           + Y H+  + HRDLK  N+ ++    +KI DFGL+                    YV   
Sbjct: 145 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTG-----------YVATR 193

Query: 184 ---APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------GD 233
              APE+ L    Y+    DIWS G I+  +LTG   F   +     + I R       +
Sbjct: 194 WYRAPEIMLNWMHYNQTV-DIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAE 252

Query: 234 F--------------KLPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKAD 268
                           L +             +P A +LL K+L  +  KRIT A   A 
Sbjct: 253 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312

Query: 269 EWFEQDYTPAN-PDDDEEDIFVDNEAFSMHEV 299
            +F Q + P + P  D  D  +++    + E 
Sbjct: 313 AYFAQYHDPDDEPVADPYDQSLESRDLLIDEW 344

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  122 bits (307), Expect = 5e-32
 Identities = 91/360 (25%), Positives = 137/360 (38%), Gaps = 80/360 (22%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
            Y   + +G G +G V  A D  +G   A+K L +     +  K   +  RE+  LK ++
Sbjct: 26  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK---RAYRELRLLKHMR 82

Query: 73  HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V             Y+V+ ++ G +L  K+    +L E   + L  Q++ G
Sbjct: 83  HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDL-GKLMKHEKLGEDRIQFLVYQMLKG 140

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
           + Y H  G+ HRDLK  N+ ++    +KI DFGL+      R      T      YV   
Sbjct: 141 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMT-----GYVVTR 189

Query: 184 ---APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--------- 230
              APEV L    Y     DIWS G I+  ++TG   F   +     ++I          
Sbjct: 190 WYRAPEVILNWMRYTQTV-DIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAE 248

Query: 231 ---------------------RGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267
                                + DF   L    SP A NLL K+L  +  +R+T     A
Sbjct: 249 FVQRLQSDEAKNYMKGLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVTAGEALA 307

Query: 268 DEWFEQDYTPA--------NPDDDEEDIFVD-------NEAFSMHEVPSDGGRTPGSPPL 312
             +FE  +           +   D+ D  +D        E  S       G R     PL
Sbjct: 308 HPYFESLHDTEDEPQVQKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLGARVSKETPL 367

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  120 bits (302), Expect = 1e-31
 Identities = 77/325 (23%), Positives = 122/325 (37%), Gaps = 73/325 (22%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD--QIKREIATLKLLK 72
           RY   + LG G  G V  A D D     A+K     +I+           REI  ++ L 
Sbjct: 12  RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK-----KIVLTDPQSVKHALREIKIIRRLD 66

Query: 73  HPNVVRLHEVLASKSK--------------IYMVLEYVTGGELFDKIASKGRLQEAEGRK 118
           H N+V++ E+L                   +Y+V EY+   +L   +  +G L E   R 
Sbjct: 67  HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDL-ANVLEQGPLLEEHARL 124

Query: 119 LFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLS-ALPQHFRDDGLLHTT 176
              QL+ G+ Y H+  V HRDLK  N+ ++++   +KI DFGL+  +  H+   G L   
Sbjct: 125 FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHL--- 181

Query: 177 CGSPNYV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLPF------------ 217
                 +      +P + L+   Y  A  D+W+ G I   +LTG   F            
Sbjct: 182 ---SEGLVTKWYRSPRLLLSPNNYTKAI-DMWAAGCIFAEMLTGKTLFAGAHELEQMQLI 237

Query: 218 -------DDRNLAVLYQKIFRGDFKLPKW-----------LSPGAQNLLRKILEPNPVKR 259
                   + +   L   I                     +S  A + L +IL  +P+ R
Sbjct: 238 LESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDR 297

Query: 260 ITIAGIKADEWFEQDYTPANPDDDE 284
           +T     +  +      P     DE
Sbjct: 298 LTAEEALSHPYMSIYSFP----MDE 318

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  119 bits (300), Expect = 1e-31
 Identities = 65/238 (27%), Positives = 109/238 (45%), Gaps = 33/238 (13%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           ELGR +GEG FG V    +    +  L  A+K  +      ++  ++  +E  T++   H
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 75

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
           P++V+L  V+ +++ +++++E  T GEL         LQ  +       LI         
Sbjct: 76  PHIVKLIGVI-TENPVWIIMELCTLGELRS------FLQVRKYSLDLASLILYAYQLSTA 128

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-N 181
           ++Y  +K   HRD+   N+L+ S   +K+ DFGLS      R   D   +       P  
Sbjct: 129 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS------RYMEDSTYYKASKGKLPIK 182

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           ++APE +  R +  A SD+W  GV ++ IL  G  PF       +  +I  G  +LP 
Sbjct: 183 WMAPESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPM 238

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  120 bits (303), Expect = 1e-31
 Identities = 64/236 (27%), Positives = 107/236 (45%), Gaps = 27/236 (11%)

Query: 18  LGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             + +G G FG+V             +P A+K L+       +       E   +    H
Sbjct: 48  RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR--VDFLGEAGIMGQFSH 105

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
            N++RL  V++    + ++ EY+  G L         L+E +G     QL+        G
Sbjct: 106 HNIIRLEGVISKYKPMMIITEYMENGALDK------FLREKDGEFSVLQLVGMLRGIAAG 159

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
           + Y  N    HRDL   NIL++S    K+SDFGLS + +   D    +TT G    +   
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE--DDPEATYTTSGGKIPIRWT 217

Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           APE ++ R +  A SD+WS G++++ ++T G  P+ + +   + + I  G F+LP 
Sbjct: 218 APEAISYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPT 271

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  120 bits (302), Expect = 2e-31
 Identities = 58/237 (24%), Positives = 106/237 (44%), Gaps = 29/237 (12%)

Query: 17  ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
              + LG G FG V       +     +P  +K++E       +    +   +  +  L 
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLD 73

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
           H ++VRL  +    S + +V +Y+  G L D       +++  G    Q L++       
Sbjct: 74  HAHIVRLLGLC-PGSSLQLVTQYLPLGSLLD------HVRQHRGALGPQLLLNWGVQIAK 126

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCG-SP-NY 182
           G+ Y    G+ HR+L   N+LL S   ++++DFG++  LP    DD  L  +   +P  +
Sbjct: 127 GMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP---DDKQLLYSEAKTPIKW 183

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           +A E +    Y    SD+WS GV ++ ++T G  P+    LA +   + +G  +L +
Sbjct: 184 MALESIHFGKYTHQ-SDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQ 238

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  120 bits (303), Expect = 2e-31
 Identities = 80/332 (24%), Positives = 140/332 (42%), Gaps = 59/332 (17%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILEKNRIIHLKITDQIKREIATLKLLKH 73
           RY     +GEG +G V  A D  + +  A+K I       + +   +  REI  L   +H
Sbjct: 28  RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQ---RTLREIKILLRFRH 84

Query: 74  PNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
            N++ +++++ + +      +Y+V + +   +L+  + ++  L          Q++ G+ 
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQ-HLSNDHICYFLYQILRGLK 142

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV----- 183
           Y H+  V HRDLK  N+LL++  ++KI DFGL+ +     D     T      YV     
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT-----EYVATRWY 197

Query: 184 -APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL-------Y 226
            APE+ L ++GY  +  DIWS G IL  +L+    F  ++        L +L        
Sbjct: 198 RAPEIMLNSKGYTKSI-DIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 256

Query: 227 QKIF---------------RGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE 269
             I                +  +    P      A +LL K+L  NP KRI +    A  
Sbjct: 257 NCIINLKARNYLLSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEVEQALAHP 315

Query: 270 WFEQDYTPANPDDDEE--DIFVDNEAFSMHEV 299
           + EQ Y P++    E      ++ +     ++
Sbjct: 316 YLEQYYDPSDEPIAEAPFKFDMELDDLPKEKL 347

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  120 bits (303), Expect = 2e-31
 Identities = 76/348 (21%), Positives = 135/348 (38%), Gaps = 90/348 (25%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVK-ILE----KNRIIHLKITDQIKREIATLK 69
           R+++ R  G+G FG V+  ++  +G+  A+K +++    +NR +         + +  L 
Sbjct: 24  RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL---------QIMQDLA 74

Query: 70  LLKHPNVVRLHEVLASKSK-------IYMVLEYV--TGGELFDKIASKGRLQEAEGRKLF 120
           +L HPN+V+L     +  +       + +V+EYV  T          +         K+F
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVF 134

Query: 121 Q-QLIDGVSYCHNK--GVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTT 176
             QLI  +   H     V HRD+K  N+L++ + G +K+ DFG +   +    +  +   
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK--KLSPSEPNVAYI 192

Query: 177 CGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-- 233
           C S  Y APE++   + Y  A  DIWS G I   ++ G             + IFRGD  
Sbjct: 193 C-SRYYRAPELIFGNQHYTTAV-DIWSVGCIFAEMMLG-------------EPIFRGDNS 237

Query: 234 ----------------------------FKLPKW---------------LSPGAQNLLRK 250
                                         L                   +  A +LL  
Sbjct: 238 AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSA 297

Query: 251 ILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHE 298
           +L+  P +R+         +F++ + PA    + +D+  D   F  +E
Sbjct: 298 LLQYLPEERMKPYEALCHPYFDELHDPATKLPNNKDLPEDLFRFLPNE 345

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  120 bits (302), Expect = 2e-31
 Identities = 90/334 (26%), Positives = 139/334 (41%), Gaps = 68/334 (20%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
            Y     +G G +G V  A D  SG   A+K L +     I  K   +  RE+  LK ++
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAK---RAYRELLLLKHMQ 81

Query: 73  HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H NV+ L +V    S        Y+V+ ++   +L   +    +  E + + L  Q++ G
Sbjct: 82  HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDLQKIM--GLKFSEEKIQYLVYQMLKG 138

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV--- 183
           + Y H+ GV HRDLK  N+ ++    +KI DFGL+      R      T      YV   
Sbjct: 139 LKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA------RHADAEMT-----GYVVTR 187

Query: 184 ---APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--------- 230
              APEV L+   Y+    DIWS G I+  +LTG   F  ++      +I          
Sbjct: 188 WYRAPEVILSWMHYNQTV-DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTE 246

Query: 231 ---------------------RGDFK--LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA 267
                                R DF    P+  SP A +LL K+LE +  KR+T A    
Sbjct: 247 FVQKLNDKAAKSYIQSLPQTPRKDFTQLFPR-ASPQAADLLEKMLELDVDKRLTAAQALT 305

Query: 268 DEWFEQDYTPANPDDDEE--DIFVDNEAFSMHEV 299
             +FE    P    + ++  D  +++E  ++ E 
Sbjct: 306 HPFFEPFRDPEEETEAQQPFDDSLEHEKLTVDEW 339

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  119 bits (301), Expect = 3e-31
 Identities = 69/293 (23%), Positives = 118/293 (40%), Gaps = 52/293 (17%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
            L  ++G+G FG+V   +    G   AVKI         + +   + EI    +L+H N+
Sbjct: 45  VLQESIGKGRFGEVWRGKW--RGEEVAVKIFSS----REERSWFREAEIYQTVMLRHENI 98

Query: 77  VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH- 131
           +      ++   + +++++V +Y   G LFD +     +      KL      G+++ H 
Sbjct: 99  LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHM 157

Query: 132 -------NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGSPNY 182
                     + HRDLK +NIL+   G   I+D GL+       D  D   +   G+  Y
Sbjct: 158 EIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRY 217

Query: 183 VAPEVLANRGYDGAT-----SDIWSCGVILYVILTGY----------LPFDDRN------ 221
           +APEVL +            +DI++ G++ + I              LP+ D        
Sbjct: 218 MAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277

Query: 222 ----LAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE----PNPVKRITIAGIK 266
                 V  QK+ R +    +W S  A  ++ KI+      N   R+T   IK
Sbjct: 278 EEMRKVVCEQKL-RPNIP-NRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  120 bits (302), Expect = 3e-31
 Identities = 64/240 (26%), Positives = 111/240 (46%), Gaps = 36/240 (15%)

Query: 18  LGRTLGEGNFGKV---KFAQDLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIATLK 69
           + + +G G FG+V   +        +  A+K L     EK R   L        E + + 
Sbjct: 49  IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFL-------GEASIMG 101

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---- 125
              HPN++RL  V+     + +V EY+  G L         L++ + +    QL+     
Sbjct: 102 QFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF------LRKHDAQFTVIQLVGMLRG 155

Query: 126 ---GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY 182
              G+ Y  + G  HRDL   NIL++S    K+SDFGL  + +   D    +TT G    
Sbjct: 156 IASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE--DDPEAAYTTRGGKIP 213

Query: 183 V---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           +   +PE +A R +  A SD+WS G++L+ +++ G  P+ + +   + + +  G ++LP 
Sbjct: 214 IRWTSPEAIAYRKFTSA-SDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 271

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  119 bits (300), Expect = 3e-31
 Identities = 58/237 (24%), Positives = 110/237 (46%), Gaps = 29/237 (12%)

Query: 17  ELGRTLGEGNFGKVK----FAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  + LG G FG V       +     +P A+K L +          +I  E   +  + 
Sbjct: 18  KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMASVD 75

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
           +P+V RL  +    S + ++ + +  G L D       ++E +     Q L++       
Sbjct: 76  NPHVCRLLGIC-LTSTVQLITQLMPFGCLLD------YVREHKDNIGSQYLLNWCVQIAK 128

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGS-P-NY 182
           G++Y  ++ + HRDL   N+L+ +  ++KI+DFGL+  L     ++   H   G  P  +
Sbjct: 129 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA---EEKEYHAEGGKVPIKW 185

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           +A E + +R Y    SD+WS GV ++ ++T G  P+D    + +   + +G  +LP+
Sbjct: 186 MALESILHRIYTHQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQ 240

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  117 bits (296), Expect = 3e-31
 Identities = 60/237 (25%), Positives = 106/237 (44%), Gaps = 36/237 (15%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
              + +G G FG V       +    A+K + +          +     E   +  L HP
Sbjct: 11  TFVQEIGSGQFGLVHLGY-WLNKDKVAIKTIREGA------MSEEDFIEEAEVMMKLSHP 63

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GV 127
            +V+L+ V   ++ I +V E++  G L D       L+   G    + L+        G+
Sbjct: 64  KLVQLYGVCLEQAPICLVTEFMEHGCLSD------YLRTQRGLFAAETLLGMCLDVCEGM 117

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NY 182
           +Y     V HRDL   N L+     IK+SDFG++      R   D    ++ G+  P  +
Sbjct: 118 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMT------RFVLDDQYTSSTGTKFPVKW 171

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
            +PEV +   Y    SD+WS GV+++ + + G +P+++R+ + + + I  G F+L K
Sbjct: 172 ASPEVFSFSRYSSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYK 226

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  119 bits (299), Expect = 4e-31
 Identities = 57/299 (19%), Positives = 110/299 (36%), Gaps = 54/299 (18%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           +    +L      G FG V  AQ        AVKI         K + Q + E+ +L  +
Sbjct: 22  QSMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQD----KQSWQNEYEVYSLPGM 75

Query: 72  KHPNVVRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           KH N+++         +    ++++  +   G L D +     +   E   + + +  G+
Sbjct: 76  KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGL 134

Query: 128 SYCHNK----------GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
           +Y H             + HRD+K +N+LL +     I+DFGL+   +  +  G  H   
Sbjct: 135 AYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQV 194

Query: 178 GSPNYVAPEVLANRGYDGAT----SDIWSCGVILYVILTGYLP----------------- 216
           G+  Y+APEVL              D+++ G++L+ + +                     
Sbjct: 195 GTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254

Query: 217 ----FDDRNLAVLYQKIFRGDFKLPK-WLSPGAQNLLRKILE----PNPVKRITIAGIK 266
                +D    V+++K       L   W       +L + +E     +   R++   + 
Sbjct: 255 QHPSLEDMQEVVVHKKK---RPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVG 310

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  117 bits (296), Expect = 5e-31
 Identities = 64/248 (25%), Positives = 101/248 (40%), Gaps = 32/248 (12%)

Query: 5   EKKQEGMRLGRYELGRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITDQIK 62
             K++ + +   ELG     GNFG V+          +  A+K+L++         +++ 
Sbjct: 5   FLKRDNLLIADIELG----CGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--EEMM 58

Query: 63  REIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQ 122
           RE   +  L +P +VRL  V      + +V+E   GG L         L           
Sbjct: 59  REAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK------FLVGKREEIPVSN 111

Query: 123 LID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLH 174
           + +       G+ Y   K   HRDL   N+LL ++   KISDFGLS AL     DD    
Sbjct: 112 VAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA---DDSYYT 168

Query: 175 TTCGS--P-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIF 230
                  P  + APE +  R +    SD+WS GV ++  L+ G  P+       +   I 
Sbjct: 169 ARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

Query: 231 RGDFKLPK 238
           +G  ++  
Sbjct: 228 QG-KRMEC 234

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  117 bits (295), Expect = 5e-31
 Identities = 63/237 (26%), Positives = 110/237 (46%), Gaps = 36/237 (15%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHP 74
              + LG G FG VK+ +        A+K++++          + +   E   +  L H 
Sbjct: 27  TFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEG------SMSEDEFIEEAKVMMNLSHE 79

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GV 127
            +V+L+ V   +  I+++ EY+  G L +       L+E   R   QQL++        +
Sbjct: 80  KLVQLYGVCTKQRPIFIITEYMANGCLLN------YLREMRHRFQTQQLLEMCKDVCEAM 133

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NY 182
            Y  +K   HRDL   N L++ +G +K+SDFGLS      R   D    ++ GS  P  +
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLS------RYVLDDEYTSSVGSKFPVRW 187

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
             PEVL    +    SDIW+ GV+++ I + G +P++    +   + I +G  +L +
Sbjct: 188 SPPEVLMYSKFSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYR 242

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  117 bits (295), Expect = 6e-31
 Identities = 61/240 (25%), Positives = 105/240 (43%), Gaps = 37/240 (15%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            L R LGEG FG+V    +       +  AVK  +K+  +  K  ++   E   +K L H
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK--EKFMSEAVIMKNLDH 72

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
           P++V+L  ++  +   ++++E    GEL         L+  +       L+         
Sbjct: 73  PHIVKLIGII-EEEPTWIIMELYPYGELGH------YLERNKNSLKVLTLVLYSLQICKA 125

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--PNY 182
           ++Y  +    HRD+ + NIL+ S   +K+ DFGLS      R   D   +    +  P  
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLS------RYIEDEDYYKASVTRLP-- 177

Query: 183 V---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           +   +PE +  R +  A SD+W   V ++ IL+ G  PF       +   + +G  +LPK
Sbjct: 178 IKWMSPESINFRRFTTA-SDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLPK 235

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  117 bits (295), Expect = 7e-31
 Identities = 65/243 (26%), Positives = 108/243 (44%), Gaps = 48/243 (19%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L   LG G FG+V      +     AVK L++  +      D    E   +K L+H  +
Sbjct: 16  KLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRL 70

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           VRL+ V  ++  IY++ EY+  G L D       L+   G KL   +L+D       G++
Sbjct: 71  VRLYAV-VTQEPIYIITEYMENGSLVD------FLKTPSGIKLTINKLLDMAAQIAEGMA 123

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV----- 183
           +   +   HRDL+  NIL+    + KI+DFGL+   +   D+           Y      
Sbjct: 124 FIEERNYIHRDLRAANILVSDTLSCKIADFGLA---RLIEDN----------EYTAREGA 170

Query: 184 -------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFK 235
                  APE +    +    SD+WS G++L  I+T G +P+       + Q + RG ++
Sbjct: 171 KFPIKWTAPEAINYGTFTIK-SDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YR 228

Query: 236 LPK 238
           + +
Sbjct: 229 MVR 231

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  120 bits (302), Expect = 8e-31
 Identities = 66/233 (28%), Positives = 98/233 (42%), Gaps = 52/233 (22%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------QIKREI 65
           RYE+   +G G++G V  A D       A+K          KI           +I REI
Sbjct: 54  RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK----------KILRVFEDLIDCKRILREI 103

Query: 66  ATLKLLKHPNVVRLHEVLASKS-----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
           A L  L H +VV++ +++  K      ++Y+VLE     +      +   L E   + L 
Sbjct: 104 AILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLL 162

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-----------ALPQHFRD 169
             L+ GV Y H+ G+ HRDLK  N L++   ++K+ DFGL+            LP   R+
Sbjct: 163 YNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRE 222

Query: 170 DGLLHTTCGSPN--------YV------APEV-LANRGYDGATSDIWSCGVIL 207
           D +   T             +V      APE+ L    Y  A  D+WS G I 
Sbjct: 223 DDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI-DVWSIGCIF 274

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  116 bits (293), Expect = 9e-31
 Identities = 68/279 (24%), Positives = 127/279 (45%), Gaps = 44/279 (15%)

Query: 18  LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLLKHPN 75
           L + LG G FG VK  +        AVK++++          + +  +E  T+  L HP 
Sbjct: 12  LLKELGSGQFGVVKLGK-WKGQYDVAVKMIKEG------SMSEDEFFQEAQTMMKLSHPK 64

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------GVS 128
           +V+ + V + +  IY+V EY++ G L +       L+         QL++       G++
Sbjct: 65  LVKFYGVCSKEYPIYIVTEYISNGCLLN------YLRSHGKGLEPSQLLEMCYDVCEGMA 118

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS--P-NYV 183
           +  +    HRDL   N L+D    +K+SDFG++      R   D    ++ G+  P  + 
Sbjct: 119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFGMT------RYVLDDQYVSSVGTKFPVKWS 172

Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSP 242
           APEV     Y    SD+W+ G++++ + + G +P+D    + +  K+ +G  +L +    
Sbjct: 173 APEVFHYFKYSSK-SDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRLYR--PH 228

Query: 243 GAQNLLRKIL----EPNPVKRITIAGIKA--DEWFEQDY 275
            A + + +I+       P KR T   + +  +   E+D 
Sbjct: 229 LASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKDK 267

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  116 bits (293), Expect = 1e-30
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)

Query: 17  ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  + LG+GNFG V+         ++G   AVK L+ +     +     +REI  LK L+
Sbjct: 13  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ 69

Query: 73  HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
           H N+V+   V  S  +  + +++EY+  G L D       LQ+ + R    +L+      
Sbjct: 70  HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD------YLQKHKERIDHIKLLQYTSQI 123

Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 182
             G+ Y   K   HRDL   NIL++++  +KI DFGL+ +    ++   +     SP  +
Sbjct: 124 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW 183

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT 212
            APE L    +  A SD+WS GV+LY + T
Sbjct: 184 YAPESLTESKFSVA-SDVWSFGVVLYELFT 212

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  117 bits (295), Expect = 1e-30
 Identities = 67/221 (30%), Positives = 102/221 (46%), Gaps = 35/221 (15%)

Query: 17  ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLK 69
           +    LG+GNFG V+         ++G   AVK L+ +        DQ +   REI  LK
Sbjct: 26  KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG------PDQQRDFQREIQILK 79

Query: 70  LLKHPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-- 125
            L    +V+   V     +  + +V+EY+  G L D       LQ    R    +L+   
Sbjct: 80  ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD------FLQRHRARLDASRLLLYS 133

Query: 126 -----GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCG- 178
                G+ Y  ++   HRDL   NIL++S+ ++KI+DFGL+  LP     D  +    G 
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD--KDYYVVREPGQ 191

Query: 179 SP-NYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
           SP  + APE L++  +    SD+WS GV+LY + T      
Sbjct: 192 SPIFWYAPESLSDNIFSRQ-SDVWSFGVVLYELFTYCDKSC 231

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  117 bits (296), Expect = 2e-30
 Identities = 70/339 (20%), Positives = 123/339 (36%), Gaps = 66/339 (19%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL------KITD--QIKREIA 66
            Y + R +  G++G V    D   G+P A+K +                    ++ REI 
Sbjct: 23  PYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81

Query: 67  TLKLLKHPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLF 120
            L    HPN++ L ++     +     +Y+V E +   +L   I   +  +     +   
Sbjct: 82  LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQRIVISPQHIQYFM 140

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
             ++ G+   H  GV HRDL   NILL    +I I DF L+   +    D          
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANK------T 191

Query: 181 NYV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--------LAVL 225
           +YV      APE+ +  +G+     D+WS G ++  +      F            + V+
Sbjct: 192 HYVTHRWYRAPELVMQFKGFTKLV-DMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVV 250

Query: 226 ------------------YQKIFRGDFKLPKW------LSPGAQNLLRKILEPNPVKRIT 261
                             Y +    +     W        P A +L+ K+LE NP +RI+
Sbjct: 251 GTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS 310

Query: 262 IAGIKADEWFEQDYTPAN-PDDDEEDIFVDNEAFSMHEV 299
                   +FE  + P +  +   E    D     ++++
Sbjct: 311 TEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDVYDM 349

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  117 bits (294), Expect = 2e-30
 Identities = 64/293 (21%), Positives = 118/293 (40%), Gaps = 52/293 (17%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           ++ + +G+G +G+V   +    G   AVK+         + +   + EI    L++H N+
Sbjct: 40  QMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFT----TEEASWFRETEIYQTVLMRHENI 93

Query: 77  VRL----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           +       +   S +++Y++ +Y   G L+D + S   L      KL    + G+ + H 
Sbjct: 94  LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHT 152

Query: 133 K--------GVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPNY 182
           +         + HRDLK +NIL+   G   I+D GL+          D   +T  G+  Y
Sbjct: 153 EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRY 212

Query: 183 VAPEVLANRGYDGAT-----SDIWSCGVILYVILTGYLP--------------------F 217
           + PEVL              +D++S G+IL+ +    +                     +
Sbjct: 213 MPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272

Query: 218 DDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE----PNPVKRITIAGIK 266
           +D    V  +K+ R  F   +W S      + K++      NP  R+T   +K
Sbjct: 273 EDMREIVCIKKL-RPSFP-NRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  115 bits (291), Expect = 2e-30
 Identities = 59/236 (25%), Positives = 101/236 (42%), Gaps = 38/236 (16%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L +T+G+G FG V        G   AVK ++ +             E + +  L+H N+
Sbjct: 24  KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNL 76

Query: 77  VRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GV 127
           V+L  V +  K  +Y+V EY+  G L D       L+      L    L+         +
Sbjct: 77  VQLLGVIVEEKGGLYIVTEYMAKGSLVD------YLRSRGRSVLGGDCLLKFSLDVCEAM 130

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNY----V 183
            Y       HRDL   N+L+      K+SDFGL+      ++     +T  +        
Sbjct: 131 EYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT------KEA---SSTQDTGKLPVKWT 181

Query: 184 APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           APE L  + +    SD+WS G++L+ I + G +P+    L  +  ++ +G +K+  
Sbjct: 182 APEALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA 235

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  119 bits (299), Expect = 3e-30
 Identities = 65/233 (27%), Positives = 111/233 (47%), Gaps = 28/233 (12%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV 76
           +L + LG G FG+V  A         AVK ++   +      +    E   +K L+H  +
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSV----EAFLAEANVMKTLQHDKL 245

Query: 77  VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------GVS 128
           V+LH V  +K  IY++ E++  G L D       L+  EG K    +LID       G++
Sbjct: 246 VKLHAV-VTKEPIYIITEFMAKGSLLD------FLKSDEGSKQPLPKLIDFSAQIAEGMA 298

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS-P-NYVAPE 186
           +   +   HRDL+  NIL+ +    KI+DFGL+   +   D+          P  + APE
Sbjct: 299 FIEQRNYIHRDLRAANILVSASLVCKIADFGLA---RVIEDNEYTAREGAKFPIKWTAPE 355

Query: 187 VLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
            +    +    SD+WS G++L  I+T G +P+   +   + + + RG +++P+
Sbjct: 356 AINFGSFTIK-SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPR 406

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  118 bits (297), Expect = 3e-30
 Identities = 63/275 (22%), Positives = 107/275 (38%), Gaps = 43/275 (15%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
            Y +   +G G++G V  A D ++    A+K + +    +I  K   +I REI  L  LK
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCK---RILREITILNRLK 83

Query: 73  HPNVVRLHEVLASKSK-----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
              ++RL++++          +Y+VLE     +L     +   L E   + +   L+ G 
Sbjct: 84  SDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILYNLLLGE 142

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-----------ALPQHFRDDGLLHTT 176
           ++ H  G+ HRDLK  N LL+   ++K+ DFGL+                  ++   H  
Sbjct: 143 NFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNK 202

Query: 177 CGSP---NYV------APEV-LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY 226
                  ++V      APE+ L    Y  +  DIWS G I   +L       +       
Sbjct: 203 NLKKQLTSHVVTRWYRAPELILLQENYTKSI-DIWSTGCIFAELLNMLQSHINDPTN--R 259

Query: 227 QKIFRGDFKLPKWLSPGAQNL--------LRKILE 253
             +F G    P      ++ +        L  I  
Sbjct: 260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFN 294

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  115 bits (291), Expect = 4e-30
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 24/210 (11%)

Query: 17  ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  + LG+GNFG V+         ++G   AVK L+ +     +     +REI  LK L+
Sbjct: 44  KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQ 100

Query: 73  HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
           H N+V+   V  S  +  + +++EY+  G L D       LQ+ + R    +L+      
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD------YLQKHKERIDHIKLLQYTSQI 154

Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 182
             G+ Y   K   HRDL   NIL++++  +KI DFGL+ +    ++   +     SP  +
Sbjct: 155 CKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW 214

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT 212
            APE L    +  A SD+WS GV+LY + T
Sbjct: 215 YAPESLTESKFSVA-SDVWSFGVVLYELFT 243

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  119 bits (299), Expect = 7e-30
 Identities = 64/235 (27%), Positives = 109/235 (46%), Gaps = 27/235 (11%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           ELGR +GEG FG V    +    +  +  A+K  +      ++  ++  +E  T++   H
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVR--EKFLQEALTMRQFDH 450

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID-------G 126
           P++V+L  V+ +++ +++++E  T GEL         LQ  +       LI         
Sbjct: 451 PHIVKLIGVI-TENPVWIIMELCTLGELRS------FLQVRKFSLDLASLILYAYQLSTA 503

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCG-SP-NYVA 184
           ++Y  +K   HRD+   N+L+ S   +K+ DFGLS       D      + G  P  ++A
Sbjct: 504 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY---MEDSTYYKASKGKLPIKWMA 560

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           PE +  R +  A SD+W  GV ++ IL  G  PF       +  +I  G  +LP 
Sbjct: 561 PESINFRRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPM 613

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  116 bits (293), Expect = 2e-29
 Identities = 62/234 (26%), Positives = 103/234 (44%), Gaps = 34/234 (14%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQ-IKREIATLKLLKHPN 75
           +L +T+G+G FG V        G   AVK ++ +       T Q    E + +  L+H N
Sbjct: 196 KLLQTIGKGEFGDVMLG--DYRGNKVAVKCIKND------ATAQAFLAEASVMTQLRHSN 247

Query: 76  VVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLID-------G 126
           +V+L  V +  K  +Y+V EY+  G L D       L+      L    L+         
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVD------YLRSRGRSVLGGDCLLKFSLDVCEA 301

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NYVAP 185
           + Y       HRDL   N+L+      K+SDFGL+      ++      T   P  + AP
Sbjct: 302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT------KEASSTQDTGKLPVKWTAP 355

Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPK 238
           E L  + +    SD+WS G++L+ I + G +P+    L  +  ++ +G +K+  
Sbjct: 356 EALREKKFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA 407

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  113 bits (286), Expect = 2e-29
 Identities = 62/210 (29%), Positives = 103/210 (49%), Gaps = 23/210 (10%)

Query: 17  ELGRTLGEGNFGKVKFA----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  R LGEG+FGKV+      +  ++G   AVK L K       I D +K+EI  L+ L 
Sbjct: 24  KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSL-KPESGGNHIAD-LKKEIEILRNLY 81

Query: 73  HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID----- 125
           H N+V+   +        I +++E++  G L +       L + + +   +Q +      
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE------YLPKNKNKINLKQQLKYAVQI 135

Query: 126 --GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP-NY 182
             G+ Y  ++   HRDL   N+L++S+  +KI DFGL+   +  ++   +     SP  +
Sbjct: 136 CKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFW 195

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILT 212
            APE L    +  A SD+WS GV L+ +LT
Sbjct: 196 YAPECLMQSKFYIA-SDVWSFGVTLHELLT 224

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  113 bits (284), Expect = 2e-29
 Identities = 53/293 (18%), Positives = 97/293 (33%), Gaps = 55/293 (18%)

Query: 17  ELGRTLGEGNFGKV-------KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
               +LG+G F K+                    +K+L+K    H   ++      + + 
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMS 67

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID---- 125
            L H ++V  + V     +  +V E+V  G L         L++ +        ++    
Sbjct: 68  KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY------LKKNKNCINILWKLEVAKQ 121

Query: 126 ---GVSYCHNKGVFHRDLKLENILLDSKGN--------IKISDFGLSALPQHFRDDGLLH 174
               + +     + H ++  +NILL  + +        IK+SD G+S             
Sbjct: 122 LAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS------IT----- 170

Query: 175 TTCGSPNY-------VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
                 +        V PE + N       +D WS G  L+ I + G  P    +     
Sbjct: 171 --VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL 228

Query: 227 QKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTP 277
           Q       +LP   +    NL+   ++  P  R +   I    +  F  D  P
Sbjct: 229 QFYEDR-HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVP 280

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  114 bits (288), Expect = 3e-29
 Identities = 83/360 (23%), Positives = 135/360 (37%), Gaps = 81/360 (22%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLK 72
           +YEL + LG+G +G V  + D  +G   AVK +          +   +  REI  L  L 
Sbjct: 10  KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQ---RTFREIMILTELS 66

Query: 73  -HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            H N+V L  VL + +   +Y+V +Y+   +L   I +   L+    + +  QLI  + Y
Sbjct: 67  GHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRAN-ILEPVHKQYVVYQLIKVIKY 124

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPN------- 181
            H+ G+ HRD+K  NILL+++ ++K++DFGLS +     R    +  +            
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184

Query: 182 -----YV------APEV-LANRGYDGATSDIWSCGVILYVILTG---------------- 213
                YV      APE+ L +  Y     D+WS G IL  IL G                
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGI-DMWSLGCILGEILCGKPIFPGSSTMNQLERI 243

Query: 214 ----------------------YL---------PFDDRNLAVLYQKIFRGDFKLPKWLSP 242
                                  +            ++       K            + 
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303

Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDI---FVDNEAFSMHEV 299
            A +LL K+L+ NP KRI+        +    + P    + +  I     DN   S+ + 
Sbjct: 304 EALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDY 363

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  117 bits (294), Expect = 3e-29
 Identities = 65/251 (25%), Positives = 101/251 (40%), Gaps = 31/251 (12%)

Query: 5   EKKQEGMRLGRYEL---GRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITD 59
           E K + + L R  L      LG GNFG V+          +  A+K+L++         +
Sbjct: 324 ELKDKKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT--E 381

Query: 60  QIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL 119
           ++ RE   +  L +P +VRL  V      + +V+E   GG L         L        
Sbjct: 382 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK------FLVGKREEIP 434

Query: 120 FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDG 171
              + +       G+ Y   K   HR+L   N+LL ++   KISDFGLS AL     DD 
Sbjct: 435 VSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGA---DDS 491

Query: 172 LLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ 227
                      +   APE +  R +    SD+WS GV ++  L+ G  P+       +  
Sbjct: 492 YYTARSAGKWPLKWYAPECINFRKFSSR-SDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 550

Query: 228 KIFRGDFKLPK 238
            I +G  ++  
Sbjct: 551 FIEQG-KRMEC 560

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  113 bits (284), Expect = 4e-29
 Identities = 69/211 (32%), Positives = 104/211 (49%), Gaps = 27/211 (12%)

Query: 17  ELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  R LGEG+FGKV        +  +G   AVK L+ +     +     K+EI  L+ L 
Sbjct: 34  KKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLY 91

Query: 73  HPNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           H ++++            + +V+EYV  G L D +  +  +  A+     QQ+ +G++Y 
Sbjct: 92  HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQQICEGMAYL 150

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLS-ALPQ-----HFRDDGLLHTTCGSPNYV- 183
           H +   HRDL   N+LLD+   +KI DFGL+ A+P+       R+DG        P  V 
Sbjct: 151 HAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------P--VF 202

Query: 184 --APEVLANRGYDGATSDIWSCGVILYVILT 212
             APE L    +  A SD+WS GV LY +LT
Sbjct: 203 WYAPECLKEYKFYYA-SDVWSFGVTLYELLT 232

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  112 bits (282), Expect = 8e-29
 Identities = 54/225 (24%), Positives = 86/225 (38%), Gaps = 37/225 (16%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKRE--IATLKLLKHP 74
           +L   +G G +G V     LD   P AVK+                 E  I  + L++H 
Sbjct: 16  KLLELIGRGRYGAVYKGS-LD-ERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHD 67

Query: 75  NVVRL-----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           N+ R            + +  +V+EY   G L   + S          +L   +  G++Y
Sbjct: 68  NIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAY 126

Query: 130 CH---------NKGVFHRDLKLENILLDSKGNIKISDFGLS------ALPQHFRDDGLLH 174
            H            + HRDL   N+L+ + G   ISDFGLS       L +   +D    
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186

Query: 175 TTCGSPNYVAPEVL------ANRGYDGATSDIWSCGVILYVILTG 213
           +  G+  Y+APEVL       +        D+++ G+I + I   
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  112 bits (282), Expect = 1e-28
 Identities = 73/314 (23%), Positives = 130/314 (41%), Gaps = 50/314 (15%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            LGR LG+G FG V   +  Q+  S +  AVK+L+ + I    I +   RE A +K   H
Sbjct: 26  TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEE-FLREAACMKEFDH 84

Query: 74  PNVVRL------HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI--- 124
           P+V +L                 ++L ++  G+L   + +  R+ E       Q L+   
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFNLPLQTLVRFM 143

Query: 125 ----DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
                G+ Y  ++   HRDL   N +L     + ++DFGLS      R    +++     
Sbjct: 144 VDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS------RK---IYSG---- 190

Query: 181 NY-------------VAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
           +Y             +A E LA+  Y    SD+W+ GV ++ I+T G  P+     A +Y
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVH-SDVWAFGVTMWEIMTRGQTPYAGIENAEIY 249

Query: 227 QKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
             +  G+  K P        +L+ +    +P +R +   ++ +   E      +     +
Sbjct: 250 NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRME--LENILGHLSVLSTSQ 307

Query: 286 D-IFVDNEAFSMHE 298
           D ++++ E    H 
Sbjct: 308 DPLYINIERAHHHH 321

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  111 bits (280), Expect = 4e-28
 Identities = 70/343 (20%), Positives = 120/343 (34%), Gaps = 107/343 (31%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLL 71
           +Y LG+TLG G+FG V    D++SG  FA+K          K+    +   RE+  +K+L
Sbjct: 8   KYSLGKTLGTGSFGIVCEVFDIESGKRFALK----------KVLQDPRYKNRELDIMKVL 57

Query: 72  KHPNVVRLHEVLASKSK--------------------------------------IYMVL 93
            H N+++L +   +                                         + +++
Sbjct: 58  DHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIM 117

Query: 94  EYVTGGELFDKI----ASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS 149
           EYV    L   +     S   +          QL   V + H+ G+ HRD+K +N+L++S
Sbjct: 118 EYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 150 K-GNIKISDFGLSALPQHFRDDGLLHTTCGSPN--YV------APEVLAN-RGYDGATSD 199
           K   +K+ DFG +      +           P+  Y+      APE++     Y  +  D
Sbjct: 177 KDNTLKLCDFGSA------K-----KLIPSEPSVAYICSRFYRAPELMLGATEYTPSI-D 224

Query: 200 IWSCGVILYVILTGYLPFDDRNLAVLYQKIF-----------------RGDFKLPKW--- 239
           +WS G +   ++ G   F          +I                    + + P     
Sbjct: 225 LWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAK 284

Query: 240 ---------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
                        A +LL +IL   P  RI      A  +F+ 
Sbjct: 285 DWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH 327

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  109 bits (275), Expect = 6e-28
 Identities = 63/246 (25%), Positives = 102/246 (41%), Gaps = 44/246 (17%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK--REIATLKLL 71
                +G G+FG V       +    +  AVK L +       I +  +   E   +K  
Sbjct: 28  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI----TDIGEVSQFLTEGIIMKDF 83

Query: 72  KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI------ 124
            HPNV+ L  + L S+    +VL Y+  G+L      +  ++        + LI      
Sbjct: 84  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQV 137

Query: 125 -DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL-------PQHFRDDGLLHTT 176
             G+ Y  +K   HRDL   N +LD K  +K++DFGL+           H +    L   
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL--- 194

Query: 177 CGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG 232
              P  V   A E L  + +    SD+WS GV+L+ ++T G  P+ D N   +   + +G
Sbjct: 195 ---P--VKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG 248

Query: 233 DFKLPK 238
             +L +
Sbjct: 249 -RRLLQ 253

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  110 bits (276), Expect = 1e-27
 Identities = 63/249 (25%), Positives = 103/249 (41%), Gaps = 50/249 (20%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
                +G G+FG V       +    +  AVK L  NRI  +    Q   E   +K   H
Sbjct: 92  HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDFSH 149

Query: 74  PNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI-------D 125
           PNV+ L  + L S+    +VL Y+  G+L      +  ++        + LI        
Sbjct: 150 PNVLSLLGICLRSEGSPLVVLPYMKHGDL------RNFIRNETHNPTVKDLIGFGLQVAK 203

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYV-- 183
           G+ +  +K   HRDL   N +LD K  +K++DFGL+      RD   ++       +   
Sbjct: 204 GMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA------RD---MYDK----EFDSV 250

Query: 184 -------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 229
                        A E L  + +    SD+WS GV+L+ ++T G  P+ D N   +   +
Sbjct: 251 HNKTGAKLPVKWMALESLQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 309

Query: 230 FRGDFKLPK 238
            +G  +L +
Sbjct: 310 LQG-RRLLQ 317

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  107 bits (270), Expect = 4e-27
 Identities = 71/312 (22%), Positives = 123/312 (39%), Gaps = 52/312 (16%)

Query: 17  ELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIKREIATLKLL 71
            + R LG+G+FG V    A+ +    P    A+K + +   +  +I  +   E + +K  
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMKEF 85

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGEL--FDKIASKGRLQEAEGRKL-FQQLI---- 124
              +VVRL  V++      +++E +T G+L  + +                  ++I    
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 125 ---DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------D 170
              DG++Y +     HRDL   N ++     +KI DFG++      RD            
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT------RDIYETDYYRKGGK 199

Query: 171 GLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
           GLL      P  V   +PE L +  +    SD+WS GV+L+ I T    P+   +   + 
Sbjct: 200 GLL------P--VRWMSPESLKDGVFTTY-SDVWSFGVVLWEIATLAEQPYQGLSNEQVL 250

Query: 227 QKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTPANPDD 282
           + +  G   L  P         L+R   + NP  R +   I +   E  E  +   +   
Sbjct: 251 RFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYY 309

Query: 283 DEEDIFVDNEAF 294
            EE+   + E  
Sbjct: 310 SEENKLPEPEEL 321

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  108 bits (272), Expect = 9e-27
 Identities = 65/222 (29%), Positives = 99/222 (44%), Gaps = 29/222 (13%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            RYE+ + +G+G+FG+V  A D       A+K++ +N     +   Q   EI  L+ L+ 
Sbjct: 97  YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV-RN---EKRFHRQAAEEIRILEHLRK 152

Query: 74  ------PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEG------RKLFQ 121
                  NV+ + E    ++ I M  E +    L++ I  K + Q   G      RK   
Sbjct: 153 QDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELI-KKNKFQ---GFSLPLVRKFAH 207

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILL--DSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
            ++  +   H   + H DLK ENILL    +  IK+ DFG S       +   ++T   S
Sbjct: 208 SILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-----CYEHQRVYTYIQS 262

Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN 221
             Y APEV+    Y     D+WS G IL  +LTGY      +
Sbjct: 263 RFYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGED 303

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  106 bits (266), Expect = 1e-26
 Identities = 61/244 (25%), Positives = 105/244 (43%), Gaps = 40/244 (16%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
              R +G+G+FG V   ++     + +  A+K L  +RI  ++  +   RE   ++ L H
Sbjct: 24  HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSL--SRITEMQQVEAFLREGLLMRGLNH 81

Query: 74  PNVVRLHEV-LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID------- 125
           PNV+ L  + L  +   +++L Y+  G+L         ++  +     + LI        
Sbjct: 82  PNVLALIGIMLPPEGLPHVLLPYMCHGDL------LQFIRSPQRNPTVKDLISFGLQVAR 135

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL-------PQHFRDDGLLHTTCG 178
           G+ Y   +   HRDL   N +LD    +K++DFGL+                  L     
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL----- 190

Query: 179 SPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDF 234
            P  V   A E L    +    SD+WS GV+L+ +LT G  P+   +   L   + +G  
Sbjct: 191 -P--VKWTALESLQTYRFTTK-SDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-R 245

Query: 235 KLPK 238
           +LP+
Sbjct: 246 RLPQ 249

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  105 bits (265), Expect = 2e-26
 Identities = 68/250 (27%), Positives = 103/250 (41%), Gaps = 45/250 (18%)

Query: 18  LGRTLGEGNFGKVKFAQ--DLDSGLPFAVKILEKNRIIHLKITDQIK----REIATLK-L 70
               +GEGNFG+V  A+       +  A+K +++        +         E+  L  L
Sbjct: 29  FQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY------ASKDDHRDFAGELEVLCKL 82

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEGRKL-FQ 121
             HPN++ L      +  +Y+ +EY   G L D        +      +  +    L  Q
Sbjct: 83  GHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142

Query: 122 QLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH 174
           QL+        G+ Y   K   HRDL   NIL+      KI+DFGLS      R   +  
Sbjct: 143 QLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS------RGQEVYV 196

Query: 175 TTCGS--PNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK 228
                  P  V   A E L    Y    SD+WS GV+L+ I++ G  P+     A LY+K
Sbjct: 197 KKTMGRLP--VRWMAIESLNYSVYTTN-SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 253

Query: 229 IFRGDFKLPK 238
           + +G ++L K
Sbjct: 254 LPQG-YRLEK 262

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  105 bits (264), Expect = 3e-26
 Identities = 65/246 (26%), Positives = 98/246 (39%), Gaps = 47/246 (19%)

Query: 17  ELGRTLGEGNFGKV---KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            LG+ LGEG FG V      Q+  + L  AVK + K      +  ++   E A +K   H
Sbjct: 37  ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95

Query: 74  PNVVRL-----HEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLI---- 124
           PNV+RL             K  ++L ++  G+L   +    RL+        Q L+    
Sbjct: 96  PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYS-RLETGPKHIPLQTLLKFMV 154

Query: 125 ---DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-----------D 170
               G+ Y  N+   HRDL   N +L     + ++DFGLS      +             
Sbjct: 155 DIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLS------KKIYSGDYYRQGRI 208

Query: 171 GLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY 226
             +      P  V   A E LA+R Y    SD+W+ GV ++ I T G  P+       +Y
Sbjct: 209 AKM------P--VKWIAIESLADRVYTSK-SDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259

Query: 227 QKIFRG 232
             +  G
Sbjct: 260 DYLLHG 265

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  105 bits (264), Expect = 3e-26
 Identities = 67/313 (21%), Positives = 113/313 (36%), Gaps = 64/313 (20%)

Query: 17  ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
            L R LG G FG+V         +  S L  AVK L +      ++      E   +   
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDEL--DFLMEALIISKF 90

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLI------ 124
            H N+VR   V       ++++E + GG+L   +    R + ++   L    L+      
Sbjct: 91  NHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHVARDI 149

Query: 125 -DGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRD----------- 169
             G  Y       HRD+   N LL   G     KI DFG++      RD           
Sbjct: 150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRASYYRKGG 203

Query: 170 DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL 225
             +L      P  V    PE      +    +D WS GV+L+ I + GY+P+  ++   +
Sbjct: 204 CAML------P--VKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKSNQEV 254

Query: 226 YQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKA------------DEWF 271
            + +  G  ++  PK        ++ +  +  P  R   A I              +   
Sbjct: 255 LEFVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTAL 313

Query: 272 EQDYTPANPDDDE 284
             +Y P   ++++
Sbjct: 314 PIEYGPLVEEEEK 326

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  104 bits (261), Expect = 5e-26
 Identities = 60/262 (22%), Positives = 95/262 (36%), Gaps = 62/262 (23%)

Query: 17  ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
                LGE  FGKV           +     A+K L+            ++     E   
Sbjct: 12  RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDK------AEGPLREEFRHEAML 65

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD---------KIASKGRLQEAEGRK 118
              L+HPNVV L  V+     + M+  Y + G+L +          + S    +  +   
Sbjct: 66  RARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125

Query: 119 LFQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-- 169
                +        G+ Y  +  V H+DL   N+L+  K N+KISD GL       R+  
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF------REVY 179

Query: 170 ---------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
                    + LL      P  +   APE +    +    SDIWS GV+L+ + + G  P
Sbjct: 180 AADYYKLLGNSLL------P--IRWMAPEAIMYGKFSID-SDIWSYGVVLWEVFSYGLQP 230

Query: 217 FDDRNLAVLYQKIFRGDFKLPK 238
           +   +   + + I      LP 
Sbjct: 231 YCGYSNQDVVEMIRNR-QVLPC 251

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  105 bits (263), Expect = 7e-26
 Identities = 69/317 (21%), Positives = 115/317 (36%), Gaps = 72/317 (22%)

Query: 17  ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
            L R LG G FG+V         +  S L  AVK L +        ++Q +     E   
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV------CSEQDELDFLMEALI 127

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKL-FQQLI-- 124
           +    H N+VR   V       +++LE + GG+L   +    R + ++   L    L+  
Sbjct: 128 ISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRET-RPRPSQPSSLAMLDLLHV 186

Query: 125 -----DGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRD------- 169
                 G  Y       HRD+   N LL   G     KI DFG++      RD       
Sbjct: 187 ARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA------RDIYRAGYY 240

Query: 170 ----DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN 221
                 +L      P  V    PE      +    +D WS GV+L+ I + GY+P+  ++
Sbjct: 241 RKGGCAML------P--VKWMPPEAFMEGIFTSK-TDTWSFGVLLWEIFSLGYMPYPSKS 291

Query: 222 LAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKA------------ 267
              + + +  G  ++  PK        ++ +  +  P  R   A I              
Sbjct: 292 NQEVLEFVTSG-GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVI 350

Query: 268 DEWFEQDYTPANPDDDE 284
           +     +Y P   ++++
Sbjct: 351 NTALPIEYGPLVEEEEK 367

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  104 bits (262), Expect = 1e-25
 Identities = 64/216 (29%), Positives = 97/216 (44%), Gaps = 23/216 (10%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            RYE+   +G+G+FG+V  A D       A+KI+ KN        +Q + E+  L+L+  
Sbjct: 54  DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII-KN---KKAFLNQAQIEVRLLELMNK 109

Query: 74  P------NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLID 125
                   +V L      ++ + +V E +    L+D + +     +     RK  QQ+  
Sbjct: 110 HDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCT 168

Query: 126 GVSYCHNK--GVFHRDLKLENILL--DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
            + +       + H DLK ENILL    +  IKI DFG S+     R    ++    S  
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQR----IYQYIQSRF 223

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
           Y +PEVL    YD A  D+WS G IL  + TG   F
Sbjct: 224 YRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLF 258

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  104 bits (261), Expect = 2e-25
 Identities = 73/368 (19%), Positives = 131/368 (35%), Gaps = 95/368 (25%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
            RY L R LG G+F  V  A+D+ +    A+KI+  ++      T+  + EI  L+ +  
Sbjct: 19  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVND 74

Query: 73  ----------HPNVVRLHEVLASKSKIY----MVLEYVTGGELFD--KIASKGRLQEAEG 116
                       ++++L +    K        MV E V G  L    K      +     
Sbjct: 75  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE-VLGENLLALIKKYEHRGIPLIYV 133

Query: 117 RKLFQQLIDGVSYCHNK-GVFHRDLKLENILLD------SKGNIKISDFGLSALPQHFRD 169
           +++ +QL+ G+ Y H + G+ H D+K EN+L++      +   IKI+D G +        
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW-----Y 188

Query: 170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY--- 226
           D     +  +  Y +PEVL    +     DIWS   +++ ++TG   F+           
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAPWGCGA-DIWSTACLIFELITGDFLFEPDEGHSYTKDD 247

Query: 227 ------------------------QKIF--RGDFK---------LPKWLSPGAQ------ 245
                                   +  F  RG  +         L   L+   +      
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307

Query: 246 ----NLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDNEAFSMHEVPS 301
               + L  +L+ +P KR    G+    W             ++ + ++       E+  
Sbjct: 308 KEISDFLSPMLQLDPRKRADAGGLVNHPWL------------KDTLGMEEIRVPDRELYG 355

Query: 302 DGGRTPGS 309
            G   PG 
Sbjct: 356 SGSDIPGW 363

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  103 bits (258), Expect = 4e-25
 Identities = 76/331 (22%), Positives = 134/331 (40%), Gaps = 72/331 (21%)

Query: 17  ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
            LG+ LGEG FG+V  A          +     AVK+L+ +       T++       E+
Sbjct: 72  VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD------ATEKDLSDLISEM 125

Query: 66  ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
             +K++ KH N++ L         +Y+++EY + G L +         +           
Sbjct: 126 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 185

Query: 117 RKL-FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
            +L  + L+        G+ Y  +K   HRDL   N+L+     +KI+DFGL+      R
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA------R 239

Query: 169 D-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-G 213
           D           +G L      P  V   APE L +R Y    SD+WS GV+L+ I T G
Sbjct: 240 DIHHIDYYKKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLG 290

Query: 214 YLPFDDRNLAVLYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
             P+    +  L++ +  G  ++  P   +     ++R      P +R T   +   E  
Sbjct: 291 GSPYPGVPVEELFKLLKEG-HRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLV--EDL 347

Query: 272 EQDYTPANPDDDEEDIFVDNEAFSMHEVPSD 302
           ++         ++E  +  +     +++P+ 
Sbjct: 348 DRIVALT---SNQEMGYYHHHHHHDYDIPTT 375

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  101 bits (253), Expect = 9e-25
 Identities = 72/262 (27%), Positives = 105/262 (40%), Gaps = 65/262 (24%)

Query: 17  ELGRTLGEGNFGKVK--FAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
            LG+TLGEG FGKV    A  L     +   AVK+L++N       +         E   
Sbjct: 26  VLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN------ASPSELRDLLSEFNV 79

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL----------------FDKIASKGRL 111
           LK + HP+V++L+   +    + +++EY   G L                     +   L
Sbjct: 80  LKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSL 139

Query: 112 QEAEGRKL-FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163
              + R L    LI        G+ Y     + HRDL   NIL+     +KISDFGLS  
Sbjct: 140 DHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS-- 197

Query: 164 PQHFRDDGLLHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVIL 211
               RD   ++      +YV            A E L +  Y    SD+WS GV+L+ I+
Sbjct: 198 ----RD---VYEE---DSYVKRSQGRIPVKWMAIESLFDHIYTTQ-SDVWSFGVLLWEIV 246

Query: 212 T-GYLPFDDRNLAVLYQKIFRG 232
           T G  P+       L+  +  G
Sbjct: 247 TLGGNPYPGIPPERLFNLLKTG 268

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  101 bits (254), Expect = 1e-24
 Identities = 67/265 (25%), Positives = 114/265 (43%), Gaps = 65/265 (24%)

Query: 17  ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
            LG+ LGEG FG+V  A             +  AVK+L+ +       T++       E+
Sbjct: 38  TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD------ATEKDLSDLVSEM 91

Query: 66  ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
             +K++ KH N++ L         +Y+++EY + G L +         +     +     
Sbjct: 92  EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151

Query: 117 RKL-FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
            ++ F+ L+        G+ Y  ++   HRDL   N+L+     +KI+DFGL+      R
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------R 205

Query: 169 D-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-G 213
           D           +G L      P  V   APE L +R Y    SD+WS GV+++ I T G
Sbjct: 206 DINNIDYYKKTTNGRL------P--VKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLG 256

Query: 214 YLPFDDRNLAVLYQKIFRGDFKLPK 238
             P+    +  L++ +  G  ++ K
Sbjct: 257 GSPYPGIPVEELFKLLKEG-HRMDK 280

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  102 bits (255), Expect = 1e-24
 Identities = 67/265 (25%), Positives = 114/265 (43%), Gaps = 65/265 (24%)

Query: 17  ELGRTLGEGNFGKVKFA-------QDLDSGLPFAVKILEKNRIIHLKITDQIK----REI 65
            LG+ LGEG FG+V  A             +  AVK+L+ +       T++       E+
Sbjct: 84  TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD------ATEKDLSDLVSEM 137

Query: 66  ATLKLL-KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEG 116
             +K++ KH N++ L         +Y+++EY + G L +         +     +     
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197

Query: 117 RKL-FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR 168
            ++ F+ L+        G+ Y  ++   HRDL   N+L+     +KI+DFGL+      R
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA------R 251

Query: 169 D-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-G 213
           D           +G L      P  V   APE L +R Y    SD+WS GV+++ I T G
Sbjct: 252 DINNIDYYKKTTNGRL------P--VKWMAPEALFDRVYTHQ-SDVWSFGVLMWEIFTLG 302

Query: 214 YLPFDDRNLAVLYQKIFRGDFKLPK 238
             P+    +  L++ +  G  ++ K
Sbjct: 303 GSPYPGIPVEELFKLLKEG-HRMDK 326

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  101 bits (253), Expect = 1e-24
 Identities = 59/233 (25%), Positives = 96/233 (41%), Gaps = 48/233 (20%)

Query: 17  ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           + G+TLG G FGKV  A        D+ L  AVK+L+     H    + +  E+  +  L
Sbjct: 49  QFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKEALMSELKIMSHL 106

Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGELFD------KIASKGRLQEAEGRKL-FQQL 123
            +H N+V L         + ++ EY   G+L +      ++                + L
Sbjct: 107 GQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDL 166

Query: 124 ID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT 176
           +        G+++  +K   HRD+   N+LL +    KI DFGL+      RD   +   
Sbjct: 167 LHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA------RD---IMND 217

Query: 177 CGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
               NY+            APE + +  Y    SD+WS G++L+ I + G  P
Sbjct: 218 ---SNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNP 266

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =   99 bits (250), Expect = 2e-24
 Identities = 69/262 (26%), Positives = 105/262 (40%), Gaps = 63/262 (24%)

Query: 17  ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
            L R LGEG FGKV              +  AVK L+         T   +    RE   
Sbjct: 18  VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP-------TLAARKDFQREAEL 70

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFD---------KIASKGRLQEAEGRK 118
           L  L+H ++V+ + V      + MV EY+  G+L            I   G+ ++A+G  
Sbjct: 71  LTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGEL 130

Query: 119 LFQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-- 169
              Q++        G+ Y  ++   HRDL   N L+ +   +KI DFG+S      RD  
Sbjct: 131 GLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS------RDVY 184

Query: 170 ---------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
                      +L      P  +    PE +  R +    SD+WS GVIL+ I T G  P
Sbjct: 185 STDYYRVGGHTML------P--IRWMPPESIMYRKFTTE-SDVWSFGVILWEIFTYGKQP 235

Query: 217 FDDRNLAVLYQKIFRGDFKLPK 238
           +   +   + + I +G   L +
Sbjct: 236 WFQLSNTEVIECITQG-RVLER 256

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  100 bits (251), Expect = 2e-24
 Identities = 65/237 (27%), Positives = 95/237 (40%), Gaps = 52/237 (21%)

Query: 17  ELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
             G+TLG G FGKV  A        D+ +  AVK+L+ +   HL   + +  E+  L  L
Sbjct: 26  SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYL 83

Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGEL-----------FDKIASKGRLQEAEGRKL 119
             H N+V L           ++ EY   G+L                S   +++ E    
Sbjct: 84  GNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALD 143

Query: 120 FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172
            + L+        G+++  +K   HRDL   NILL      KI DFGL+      RD   
Sbjct: 144 LEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA------RD--- 194

Query: 173 LHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
           +       NYV            APE + N  Y    SD+WS G+ L+ + + G  P
Sbjct: 195 IKND---SNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSP 247

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  100 bits (252), Expect = 2e-24
 Identities = 61/264 (23%), Positives = 104/264 (39%), Gaps = 69/264 (26%)

Query: 17  ELGRTLGEGNFGKV--KFAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
           E  R +GEG FG+V    A  L    PF   AVK+L++        +  ++    RE A 
Sbjct: 50  EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE------ASADMQADFQREAAL 103

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL----------------FDKIASKGRL 111
           +    +PN+V+L  V A    + ++ EY+  G+L                   ++++ R+
Sbjct: 104 MAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARV 163

Query: 112 QEAEGRKL-FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL 163
                  L   + +        G++Y   +   HRDL   N L+     +KI+DFGLS  
Sbjct: 164 SSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS-- 221

Query: 164 PQHFRD-----------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYV 209
               R+           +  +      P  +    PE +    Y    SD+W+ GV+L+ 
Sbjct: 222 ----RNIYSADYYKADGNDAI------P--IRWMPPESIFYNRYTTE-SDVWAYGVVLWE 268

Query: 210 ILT-GYLPFDDRNLAVLYQKIFRG 232
           I + G  P+       +   +  G
Sbjct: 269 IFSYGLQPYYGMAHEEVIYYVRDG 292

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  100 bits (251), Expect = 3e-24
 Identities = 68/261 (26%), Positives = 98/261 (37%), Gaps = 62/261 (23%)

Query: 17  ELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIK----REIAT 67
            L   LGEG FGKV              +  AVK L++        ++  +    RE   
Sbjct: 44  VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA-------SESARQDFQREAEL 96

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGEL--------FDKIASKGRLQEAEGRKL 119
           L +L+H ++VR   V      + MV EY+  G+L         D     G    A G   
Sbjct: 97  LTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLG 156

Query: 120 FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--- 169
             QL+        G+ Y       HRDL   N L+     +KI DFG+S      RD   
Sbjct: 157 LGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS------RDIYS 210

Query: 170 --------DGLLHTTCGSPNYV---APEVLANRGYDGATSDIWSCGVILYVILT-GYLPF 217
                     +L      P  +    PE +  R +    SD+WS GV+L+ I T G  P+
Sbjct: 211 TDYYRVGGRTML------P--IRWMPPESILYRKFTTE-SDVWSFGVVLWEIFTYGKQPW 261

Query: 218 DDRNLAVLYQKIFRGDFKLPK 238
              +       I +G  +L +
Sbjct: 262 YQLSNTEAIDCITQG-RELER 281

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 98.9 bits (247), Expect = 1e-23
 Identities = 60/236 (25%), Positives = 99/236 (41%), Gaps = 43/236 (18%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             + + R +G+G FG+V   Q +D+   +AVK++ +N     K T   K E   LK +++
Sbjct: 35  NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV-RN---IKKYTRSAKIEADILKKIQN 90

Query: 74  -----PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDG 126
                 N+V+ H        + ++ E   G  L++ I           + +    +++  
Sbjct: 91  DDINNNNIVKYHGKFMYYDHMCLIFE-PLGPSLYEIITRNNYNGFHIEDIKLYCIEILKA 149

Query: 127 VSYCHNKGVFHRDLKLENILLDS-------------------------KGNIKISDFGLS 161
           ++Y     + H DLK ENILLD                             IK+ DFG  
Sbjct: 150 LNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-C 208

Query: 162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
           A  +         +   +  Y APEV+ N G+D + SD+WS G +L  + TG L F
Sbjct: 209 ATFKSDY----HGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGSLLF 259

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 98.4 bits (246), Expect = 1e-23
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 37/223 (16%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           +G G FGKV +   L  G   A+K         ++   + + EI TL   +HP++V L  
Sbjct: 47  IGHGVFGKV-YKGVLRDGAKVALKRRTPESSQGIE---EFETEIETLSFCRHPHLVSLIG 102

Query: 82  VLASKSKIYMVLEYVTGGE----LFDKIASKG------RLQEAEG--RKLFQQLIDGVSY 129
               ++++ ++ +Y+  G     L+             RL+   G  R        G+ Y
Sbjct: 103 FCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR--------GLHY 154

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYVAPE 186
            H + + HRD+K  NILLD     KI+DFG+S       +    H +    G+  Y+ PE
Sbjct: 155 LHTRAIIHRDVKSINILLDENFVPKITDFGISKK---GTELDQTHLSTVVKGTLGYIDPE 211

Query: 187 VLANRGYDGATSDIWSCGVILYVILTG------YLPFDDRNLA 223
               +G     SD++S GV+L+ +L         LP +  NLA
Sbjct: 212 -YFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 98.0 bits (245), Expect = 1e-23
 Identities = 64/225 (28%), Positives = 91/225 (40%), Gaps = 52/225 (23%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKR----EIATLKLLKHPNVV 77
           +GEG FG V +   ++     AVK L     I  +   ++K+    EI  +   +H N+V
Sbjct: 39  MGEGGFGVV-YKGYVN-NTTVAVKKLAAMVDITTE---ELKQQFDQEIKVMAKCQHENLV 93

Query: 78  RL--------HEVLASKSKIYMVLEYVTGG----ELFDKIASKG-----RLQEAEG--RK 118
            L           L     +Y    Y+  G     L     +       R + A+G    
Sbjct: 94  ELLGFSSDGDDLCL-----VY---VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN- 144

Query: 119 LFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-- 176
                  G+++ H     HRD+K  NILLD     KISDFGL+              T  
Sbjct: 145 -------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA---SEKFAQTVMTSR 194

Query: 177 -CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR 220
             G+  Y+APE L  RG     SDI+S GV+L  I+TG    D+ 
Sbjct: 195 IVGTTAYMAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEH 237

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 97.3 bits (243), Expect = 3e-23
 Identities = 65/241 (26%), Positives = 99/241 (41%), Gaps = 59/241 (24%)

Query: 17  ELGRTLGEGNFGKVK--FAQDLDSGLPF---AVKILEKNRIIHLKITDQIK----REIAT 67
           +LG+ LG G FG+V    A  +D        AVK+L++        T         E+  
Sbjct: 30  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG------ATHSEHRALMSELKI 83

Query: 68  LKLL-KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFD--------KIASKGRLQEAEGR 117
           L  +  H NVV L          + +++E+   G L           +  K   ++    
Sbjct: 84  LIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 143

Query: 118 KL-FQQLID-------GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD 169
            L  + LI        G+ +  ++   HRDL   NILL  K  +KI DFGL+      RD
Sbjct: 144 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD 197

Query: 170 DGLLHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
              ++     P+YV            APE + +R Y    SD+WS GV+L+ I + G  P
Sbjct: 198 ---IYKD---PDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASP 250

Query: 217 F 217
           +
Sbjct: 251 Y 251

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 96.6 bits (241), Expect = 7e-23
 Identities = 64/242 (26%), Positives = 95/242 (39%), Gaps = 57/242 (23%)

Query: 17  ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           E G+ LG G FGKV  A           +  AVK+L++         + +  E+  +  L
Sbjct: 48  EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQL 105

Query: 72  -KHPNVVRLHEVLASKSKIYMVLEYVTGGEL---------------FDKIASKGRLQEAE 115
             H N+V L         IY++ EY   G+L                +    K   +E +
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEED 165

Query: 116 GRKL-FQQLI-------DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF 167
              L F+ L+        G+ +   K   HRDL   N+L+     +KI DFGL+      
Sbjct: 166 LNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA------ 219

Query: 168 RDDGLLHTTCGSPNYV------------APEVLANRGYDGATSDIWSCGVILYVILT-GY 214
           RD   + +     NYV            APE L    Y    SD+WS G++L+ I + G 
Sbjct: 220 RD---IMSD---SNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGV 272

Query: 215 LP 216
            P
Sbjct: 273 NP 274

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 69/238 (28%), Positives = 94/238 (39%), Gaps = 51/238 (21%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPF-AVKILEKNRIIHLKITDQIKREIATLKLLK 72
            RYE+  TLGEG FGKV    D  +G    AVKI+ KN     +  +  + EI  L+ L 
Sbjct: 14  ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIV-KN---VDRYCEAARSEIQVLEHLN 69

Query: 73  HP------NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLI 124
                     V++ E       I +V E + G   +D I   G    +    RK+  Q+ 
Sbjct: 70  TTDPNSTFRCVQMLEWFEHHGHICIVFE-LLGLSTYDFIKENGFLPFRLDHIRKMAYQIC 128

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGN-------------------IKISDFGLSALPQ 165
             V++ H+  + H DLK ENIL                         IK+ DFG SA   
Sbjct: 129 KSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-SATYD 187

Query: 166 HFRDDGLLHTTCGSPNYV------APEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
                   H+T      V      APEV+   G+     D+WS G IL     G+  F
Sbjct: 188 DEH-----HST-----LVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVF 234

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 63/238 (26%), Positives = 91/238 (38%), Gaps = 51/238 (21%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
            RYE+   LGEG FGKV    D   G    A+KI+ +N     K  +  + EI  LK +K
Sbjct: 19  ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII-RN---VGKYREAARLEINVLKKIK 74

Query: 73  HP------NVVRLHEVLASKSKIYMVLEYVTGGELFD--KIASKGRLQEAEGRKLFQQLI 124
                     V + +       + +  E + G   F+  K  +         R +  QL 
Sbjct: 75  EKDKENKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKENNFQPYPLPHVRHMAYQLC 133

Query: 125 DGVSYCHNKGVFHRDLKLENILLDS-------------------KGNIKISDFGLSALPQ 165
             + + H   + H DLK ENIL  +                     +I+++DFG SA   
Sbjct: 134 HALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SATFD 192

Query: 166 HFRDDGLLHTTCGSPNYV------APEVLANRGYDGATSDIWSCGVILYVILTGYLPF 217
           H       HTT      V       PEV+   G+     D+WS G IL+    G+  F
Sbjct: 193 HEH-----HTT-----IVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLF 239

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 92.3 bits (230), Expect = 2e-21
 Identities = 64/220 (29%), Positives = 100/220 (45%), Gaps = 34/220 (15%)

Query: 22  LGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE 81
           LG G FGKV   + L  G   AVK L++ R        Q + E+  + +  H N++RL  
Sbjct: 38  LGRGGFGKVYKGR-LADGTLVAVKRLKEER--TQGGELQFQTEVEMISMAVHRNLLRLRG 94

Query: 82  VLASKSKIYMVLEYVTGG----ELFDKIASKG------RLQEAEG--RKLFQQLIDGVSY 129
              + ++  +V  Y+  G     L ++  S+       R + A G  R        G++Y
Sbjct: 95  FCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR--------GLAY 146

Query: 130 CH---NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYV 183
            H   +  + HRD+K  NILLD +    + DFGL+ L     D    H T    G+  ++
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL----MDYKDTHVTTAVRGTIGHI 202

Query: 184 APEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA 223
           APE   + G     +D++  GV+L  ++TG   FD   LA
Sbjct: 203 APE-YLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLA 241

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 86.1 bits (213), Expect = 5e-19
 Identities = 81/371 (21%), Positives = 117/371 (31%), Gaps = 125/371 (33%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
           GRY + R LG G+F  V  + D+      A+K+++         T+    EI  LK ++ 
Sbjct: 37  GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRN 92

Query: 73  ----HPN---VVRLHEVLASKSK----IYMVLEYVTGGELFDKIAS--KGRLQEAEGRKL 119
                PN   VV+L +           I MV E V G  L   I       L     +K+
Sbjct: 93  SDPNDPNREMVVQLLDDFKISGVNGTHICMVFE-VLGHHLLKWIIKSNYQGLPLPCVKKI 151

Query: 120 FQQLIDGVSYCHNK-GVFHRDLKLENILL------------------------------- 147
            QQ++ G+ Y H K  + H D+K ENILL                               
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211

Query: 148 ------------------DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN-YVAPEVL 188
                               K  +KI+D G +             T       Y + EVL
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH------FTEDIQTRQYRSLEVL 265

Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY---------------------- 226
              GY+   +DIWS   + + + TG   F+  +                           
Sbjct: 266 IGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV 324

Query: 227 -----QKIF--RGDFKLPKWLSP-------------------GAQNLLRKILEPNPVKRI 260
                ++ F  +GD K    L P                   G  + L  +LE  P KR 
Sbjct: 325 AGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA 384

Query: 261 TIAGIKADEWF 271
           T A      W 
Sbjct: 385 TAAECLRHPWL 395

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 83.1 bits (205), Expect = 8e-18
 Identities = 52/223 (23%), Positives = 93/223 (41%), Gaps = 37/223 (16%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
            ++ LGR +G G+FG++    ++ +    A+K+ E  +  H     Q+  E    ++L+ 
Sbjct: 7   NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-ENVKTKH----PQLLYESKIYRILQG 61

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-------LQEAEGRKLFQQLID 125
              +  +           +V++ + G  L D      R       L  A+      Q+I+
Sbjct: 62  GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLAD------QMIN 114

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSAL------PQH--FRDDGLLH 174
            V + H+K   HRD+K +N L+        + I DFGL+         QH  +R++    
Sbjct: 115 RVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYREN---K 171

Query: 175 TTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP 216
              G+  Y +  V  + G +     D+ S G +L   L G LP
Sbjct: 172 NLTGTARYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLP 212

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 79.0 bits (195), Expect = 8e-17
 Identities = 60/242 (24%), Positives = 98/242 (40%), Gaps = 44/242 (18%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             + +G+ +G GNFG+++  ++L +    A+K LE  +        Q+  E    K L  
Sbjct: 9   PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK-LEPMKSRA----PQLHLEYRFYKQLGS 63

Query: 74  -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK--------LFQQLI 124
              + +++          MVLE   G  L D       L +   R         +  QLI
Sbjct: 64  GDGIPQVYYFGPCGKYNAMVLEL-LGPSLED-------LFDLCDRTFSLKTVLMIAIQLI 115

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGLS------ALPQH--FRDDG 171
             + Y H+K + +RD+K EN L+   GN     I I DF L+         +H  +R+  
Sbjct: 116 SRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175

Query: 172 LLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP---FDDRNLAVLYQ 227
            L    G+  Y++  +  + G +     D+ + G +    L G LP        L   YQ
Sbjct: 176 SL---TGTARYMS--INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQ 230

Query: 228 KI 229
           KI
Sbjct: 231 KI 232

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 75.9 bits (187), Expect = 8e-16
 Identities = 59/239 (24%), Positives = 95/239 (39%), Gaps = 40/239 (16%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            RY LGR +G G+FG +    D+ +G   A+K+ E  +  H     Q+  E    K+++ 
Sbjct: 9   NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-ECVKTKH----PQLHIESKIYKMMQG 63

Query: 74  -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-------LQEAEGRKLFQQLID 125
              +  +    A      MV+E + G  L D      R       L  A+      Q+I 
Sbjct: 64  GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLAD------QMIS 116

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFRDD-GLLHTT----- 176
            + Y H+K   HRD+K +N L+        + I DFGL+   + +RD     H       
Sbjct: 117 RIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA---KKYRDARTHQHIPYRENK 173

Query: 177 --CGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP---FDDRNLAVLYQKI 229
              G+  Y +  +  + G +     D+ S G +L     G LP            Y++I
Sbjct: 174 NLTGTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 74.7 bits (184), Expect = 2e-15
 Identities = 55/242 (22%), Positives = 95/242 (39%), Gaps = 44/242 (18%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             Y++GR +GEG+FG +    +L +    A+K  E  R        Q++ E  T KLL  
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-EPRRSDA----PQLRDEYRTYKLLAG 64

Query: 74  -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRK--------LFQQLI 124
              +  ++          +V++   G  L D       L +  GRK          +Q++
Sbjct: 65  CTGIPNVYYFGQEGLHNVLVIDL-LGPSLED-------LLDLCGRKFSVKTVAMAAKQML 116

Query: 125 DGVSYCHNKGVFHRDLKLENILL----DSKGN-IKISDFGLS------ALPQH--FRDDG 171
             V   H K + +RD+K +N L+        N I + DFG+          QH  +R+  
Sbjct: 117 ARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK- 175

Query: 172 LLHTTCGSPNYVAPEVLANRGYD-GATSDIWSCGVILYVILTGYLP---FDDRNLAVLYQ 227
                 G+  Y++  +  + G +     D+ + G +    L G LP            Y+
Sbjct: 176 --KNLSGTARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYE 231

Query: 228 KI 229
           +I
Sbjct: 232 RI 233

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 69.9 bits (170), Expect = 1e-13
 Identities = 38/192 (19%), Positives = 66/192 (34%), Gaps = 48/192 (25%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKIL-----EKNRIIHLKITDQIKREIATLK 69
           + +    +GEG FG+V F Q +    P A+KI+     +     H K  ++I  EI   K
Sbjct: 21  KLQRCEKIGEGVFGEV-F-QTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78

Query: 70  LL---------KHPNVVRLHEV------------------------------LASKSKIY 90
            L         +    + L+ V                                   +++
Sbjct: 79  ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138

Query: 91  MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDS 149
           +VLE+  GG   +++ +K     A  + +  QL   ++         HRDL   N+LL  
Sbjct: 139 IVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKK 197

Query: 150 KGNIKISDFGLS 161
               K+      
Sbjct: 198 TSLKKLHYTLNG 209

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 69.0 bits (169), Expect = 2e-13
 Identities = 31/179 (17%), Positives = 69/179 (38%), Gaps = 29/179 (16%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            ++ LG+ +G G FG +  A   +     A  +++     +      +  E+   + +  
Sbjct: 37  NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN----GPLFSELKFYQRVAK 92

Query: 74  PNVVRLHEVLASKSKI-------------------YMVLEYVTGGELFDKIASKGRLQEA 114
            + ++          +                   +MV+E + G +L       G  +++
Sbjct: 93  KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKS 151

Query: 115 EGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDG 171
              +L  +++D + Y H     H D+K  N+LL  K    + ++D+GLS     +  +G
Sbjct: 152 TVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS---YRYCPNG 207

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 65.2 bits (159), Expect = 6e-12
 Identities = 34/207 (16%), Positives = 74/207 (35%), Gaps = 55/207 (26%)

Query: 3   IAEKKQEGMRL-----GRYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRI 52
           +AE+   G  +       +++G  +G+G FG +  A     + + S  P  VK+   +  
Sbjct: 19  LAEQFAVGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD-- 76

Query: 53  IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI-------------------YMVL 93
                   +  E+   +    P  ++          +                   +M++
Sbjct: 77  -----NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIM 131

Query: 94  EYVTGGELFDKIASKGR-------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL 146
           +   G +L     +  +       LQ +       +++D + Y H     H D+K  N+L
Sbjct: 132 DRF-GSDLQKIYEANAKRFSRKTVLQLSL------RILDILEYIHEHEYVHGDIKASNLL 184

Query: 147 LDSK--GNIKISDFGLSALPQHFRDDG 171
           L+ K    + + D+GL+     +  +G
Sbjct: 185 LNYKNPDQVYLVDYGLA---YRYCPEG 208

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 63.6 bits (155), Expect = 1e-11
 Identities = 36/258 (13%), Positives = 84/258 (32%), Gaps = 58/258 (22%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGL--------PFAVKILEKNRIIHLKI-------- 57
            +++L       N G +  A    +           F++K+  K+  +  +         
Sbjct: 42  RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101

Query: 58  TDQIKREIATLKLLKHPNVVRLHEVLASKSKI-YMVLEYVTGGELFDKIASKGRLQEAEG 116
             Q+ +    L       +         + K  ++VL  + G  L           +   
Sbjct: 102 PLQVNKWK-KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-------ALDVSP 152

Query: 117 RKLF---------QQLIDGVSYCHNKGVFHRDLKLENILL--DSKGNIKISDFGLSALPQ 165
           + +           +L+D + + H     H ++  ENI +  + +  + ++ +G +    
Sbjct: 153 KHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFA---F 209

Query: 166 HFRDDG----------LLHTTCGSPNYVAPEVLANRGYDGA-TSDIWSCGVILYVILTGY 214
            +   G            H   G   +++  +  ++G   +  SD+ S G  +   L G+
Sbjct: 210 RYCPSGKHVAYVEGSRSPHE--GDLEFIS--MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265

Query: 215 LP---FDDRNLAVLYQKI 229
           LP          ++ QK 
Sbjct: 266 LPWTNCLPNTEDIMKQKQ 283

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 61.5 bits (149), Expect = 8e-11
 Identities = 37/108 (34%), Positives = 51/108 (47%), Gaps = 26/108 (24%)

Query: 122 QLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPN 181
           Q+  G+ +  ++   HRDL   NILL  K  +KI DFGL+      RD          P+
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA------RD------IYKDPD 248

Query: 182 YV------------APEVLANRGYDGATSDIWSCGVILYVILT-GYLP 216
           YV            APE + +R Y    SD+WS GV+L+ I + G  P
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASP 295

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 50.3 bits (120), Expect = 3e-07
 Identities = 32/171 (18%), Positives = 52/171 (30%), Gaps = 13/171 (7%)

Query: 17  ELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           +LG+ LG G FG+V  A         +    AVK+L             +  E+  L  +
Sbjct: 25  KLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKML--KEGATHSEHRALMSELKILIHI 82

Query: 72  -KHPNVVRLH-EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
             H NVV L          + +++E+   G L   +    R +  E      +       
Sbjct: 83  GHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----RSKRNEFVPYKTKGARFRQG 138

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
               G    DLK     + S  +   S F          ++          
Sbjct: 139 KDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF 189

>2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143

 Score = 46.2 bits (109), Expect = 2e-06
 Identities = 12/37 (32%), Positives = 22/37 (59%)

Query: 308 GSPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNCKF 344
             P ++NAF++I +S  L+LS  F++  +   R  +F
Sbjct: 2   EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQTRF 38

>2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123

 Score = 44.6 bits (105), Expect = 4e-06
 Identities = 9/34 (26%), Positives = 12/34 (35%)

Query: 309 SPPLINAFQLIGMSSCLDLSGFFEKEVNVKVRNC 342
               +NAF +I  S   +LSG F           
Sbjct: 2   GARRMNAFDIISGSPGFNLSGLFGDARKYDRVER 35

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 42.5 bits (99), Expect = 2e-04
 Identities = 53/346 (15%), Positives = 98/346 (28%), Gaps = 109/346 (31%)

Query: 2   VIAEKKQEGMRLGRYELGRTLGEGN--FGKV--KFAQDL----DSGLPFAVKILEKNRII 53
            ++      + L  + +  T  E      K      QDL     +  P  + I       
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI------- 332

Query: 54  HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQE 113
              I + I+  +AT    KH N  +L  ++ S       L                 L+ 
Sbjct: 333 ---IAESIRDGLATWDNWKHVNCDKLTTIIESS------LNV---------------LEP 368

Query: 114 AEGRKLFQQL--------I------------------DGVSYCHNKGVFHRDLK-----L 142
           AE RK+F +L        I                    V+  H   +  +  K     +
Sbjct: 369 AEYRKMFDRLSVFPPSAHIPTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISI 428

Query: 143 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG-ATSDIW 201
            +I L+ K                  ++  LH +    +Y  P     + +D       +
Sbjct: 429 PSIYLELK--------------VKLENEYALHRSIVD-HYNIP-----KTFDSDDLIPPY 468

Query: 202 SCGVILYVILTGY-LPFDDR-NLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKR 259
                   I  G+ L   +      L++ +F  DF   ++L    +  +R          
Sbjct: 469 LDQYFYSHI--GHHLKNIEHPERMTLFRMVFL-DF---RFL----EQKIRHD-STAWNAS 517

Query: 260 ITIAGIKADEWFEQDY-TPANPDDDE--EDI--FVDNEAFSMHEVP 300
            +I        F + Y    +P  +     I  F+     ++    
Sbjct: 518 GSILNTLQQLKFYKPYICDNDPKYERLVNAILDFLPKIEENLICSK 563

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282

 Score = 39.9 bits (93), Expect = 6e-04
 Identities = 28/166 (16%), Positives = 63/166 (37%), Gaps = 28/166 (16%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQI-------------- 61
             +G+ +GEG    V      +      VK  +       K+ ++               
Sbjct: 92  DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 150

Query: 62  -KREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
            + E   L+ L+   V +++          +++E +   EL+       R++  +  ++ 
Sbjct: 151 ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRV-----RVENPD--EVL 199

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH 166
             +++ V+  +++G+ H DL   N+L+  +  I I DF  S     
Sbjct: 200 DMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGE 244

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	344
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.96
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.95
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.89
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.83
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.53
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.4
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.31
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.23
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	99.02
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.88
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.83
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.7
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.56
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.56
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.3
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.3
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.15
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.14
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.12
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.03
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.78
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.71
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.7
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.64
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.63
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.61
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.52
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.29
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.19
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.13
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.73
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.73
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.84
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	87.67
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.3
3ls8_A	614	Phosphatidylinositol 3-kinase catalytic subunit ty	85.44
2x6h_A	696	GH13170P, VPS34, phosphotidylinositol 3 kinase 59F	84.54

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-70  Score=493.53  Aligned_cols=263  Identities=32%  Similarity=0.591  Sum_probs=244.0

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      ....++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+++|++++||||+++++++.+.+.+
T Consensus        28 ~~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~  107 (311)
T 4aw0_A           28 KKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKL  107 (311)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence            35567899999999999999999999999999999999876655555678899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      |+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.......
T Consensus       108 yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~  187 (311)
T 4aw0_A          108 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK  187 (311)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTT
T ss_pred             EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999986544334


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR  249 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~  249 (344)
                      .....+.+||+.|+|||++.+..+ +.++|||||||++|+|++|++||.+.+...+..++.++.+.+|..+++++++||.
T Consensus       188 ~~~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~  266 (311)
T 4aw0_A          188 QARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVE  266 (311)
T ss_dssp             CCCBCCCCSCGGGCCHHHHHHSCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHH
T ss_pred             cccccCcccCcccCCHHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHH
Confidence            445667899999999999988777 6899999999999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCcCCCCCHhh------hhcCccccc
Q 019216          250 KILEPNPVKRITIAG------IKADEWFEQ  273 (344)
Q Consensus       250 ~~L~~dP~~Rps~~e------il~~~~~~~  273 (344)
                      +||++||++|||++|      +++||||++
T Consensus       267 ~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~  296 (311)
T 4aw0_A          267 KLLVLDATKRLGCEEMEGYGPLKAHPFFES  296 (311)
T ss_dssp             HHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence            999999999999988      588999975

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.7e-70  Score=485.51  Aligned_cols=263  Identities=48%  Similarity=0.913  Sum_probs=224.2

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      ..|..+|+|++++.||+|+||+||+|.++.+|+.||+|++.+...........+.+|+.++++++||||+++++++.+.+
T Consensus         7 ~~G~~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~   86 (275)
T 3hyh_A            7 ADGAHIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKD   86 (275)
T ss_dssp             -------CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             CCCCEeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            46778999999999999999999999999999999999998776655566778999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+|+||||| +|+|.+++.+++++++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+|+.... 
T Consensus        87 ~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-  164 (275)
T 3hyh_A           87 EIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD-  164 (275)
T ss_dssp             EEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred             EEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC-
Confidence            999999999 779999999999999999999999999999999999999999999999999999999999999985432 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL  247 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (344)
                        .....+.+||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+...+...+..+.+.+|..+|+++++|
T Consensus       165 --~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  242 (275)
T 3hyh_A          165 --GNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGL  242 (275)
T ss_dssp             ------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHH
T ss_pred             --CCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence              333456799999999999998888778999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          248 LRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      |.+||+.||++|||++|+++||||+..
T Consensus       243 i~~~L~~dP~~R~s~~eil~hpw~k~~  269 (275)
T 3hyh_A          243 IKRMLIVNPLNRISIHEIMQDDWFKVD  269 (275)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred             HHHHccCChhHCcCHHHHHcCcccccC
Confidence            999999999999999999999999753

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=1.4e-68  Score=487.21  Aligned_cols=260  Identities=28%  Similarity=0.560  Sum_probs=228.9

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+.+.+|+.+|++++||||+++++++.+.+.+|+
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yi  100 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYI  100 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            35799999999999999999999999999999999987654 33457789999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           92 VLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      |||||+||+|.+++...  ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....  
T Consensus       101 VmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--  178 (350)
T 4b9d_A          101 VMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--  178 (350)
T ss_dssp             EEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--
T ss_pred             EEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--
Confidence            99999999999999754  35799999999999999999999999999999999999999999999999999864321  


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-CCCCCCCHHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKWLSPGAQNLL  248 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~li  248 (344)
                      .......+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.+...+..++..+.+ +.+..+|+++++||
T Consensus       179 ~~~~~~~~GT~~YmAPE~l~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li  257 (350)
T 4b9d_A          179 VELARACIGTPYYLSPEICENKPY-NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLV  257 (350)
T ss_dssp             HHHHHHHHSCCTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHH
T ss_pred             cccccccCCCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHH
Confidence            112345689999999999988777 6899999999999999999999999999999999988865 46778999999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          249 RKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      .+||++||++|||++|+|+||||.+..
T Consensus       258 ~~~L~~dP~~R~s~~e~l~hp~~~~~~  284 (350)
T 4b9d_A          258 SQLFKRNPRDRPSVNSILEKGFIAKRI  284 (350)
T ss_dssp             HHHTCSSGGGSCCHHHHHTSHHHHTTG
T ss_pred             HHHccCChhHCcCHHHHhcCHHhhcCC
Confidence            999999999999999999999997643

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.4e-67  Score=477.37  Aligned_cols=258  Identities=26%  Similarity=0.420  Sum_probs=230.9

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      ...+|+++++||+|+||.||+|.++.+|+.||||++.+.....   .+.+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus        72 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  148 (346)
T 4fih_A           72 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  148 (346)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            3467999999999999999999999999999999997654332   3567899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |||||+||+|.+++.+ +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....  ...
T Consensus       149 vmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~  225 (346)
T 4fih_A          149 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVP  225 (346)
T ss_dssp             EECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSC
T ss_pred             EEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCC
Confidence            9999999999998875 6799999999999999999999999999999999999999999999999999985432  223


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC---CCCCCCCHHHHHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQNLL  248 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~li  248 (344)
                      ...+.+||+.|+|||++.+..+ +.++|||||||++|||++|++||.+.+.......+.....   +.+..+|+++++||
T Consensus       226 ~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli  304 (346)
T 4fih_A          226 RRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL  304 (346)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHH
T ss_pred             cccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHH
Confidence            4567899999999999988777 6899999999999999999999999998888888877633   33456899999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          249 RKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      .+||+.||++|||++|+|+||||.+...
T Consensus       305 ~~~L~~dP~~R~ta~e~l~Hp~~~~~~~  332 (346)
T 4fih_A          305 DRLLVRDPAQRATAAELLKHPFLAKAGP  332 (346)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred             HHHcCCChhHCcCHHHHhcCHhhcCCCC
Confidence            9999999999999999999999987543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.1e-67  Score=471.85  Aligned_cols=259  Identities=34%  Similarity=0.622  Sum_probs=228.2

Q ss_pred             ccccCeEEeeeecccCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      ..-++|++++.||+|+||+||+|++.   .+++.||+|++.+...... ...++.+|+.+|++++||||+++++++.+++
T Consensus        21 ~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~   99 (304)
T 3ubd_A           21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEG   99 (304)
T ss_dssp             CCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred             CCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence            44578999999999999999999984   4678999999976543322 2346788999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... 
T Consensus       100 ~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~-  178 (304)
T 3ubd_A          100 KLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID-  178 (304)
T ss_dssp             EEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC----
T ss_pred             EEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999985322 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL  247 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (344)
                       ......+.+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.+...+..++.++.+.+|..+|+++++|
T Consensus       179 -~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  256 (304)
T 3ubd_A          179 -HEKKAYSFCGTVEYMAPEVVNRRGH-TQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSL  256 (304)
T ss_dssp             ---CCCCSCCCCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             -CCccccccccCcccCCHHHhccCCC-CCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHH
Confidence             2233456799999999999988777 58999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCcCCCCCH-----hhhhcCccccc
Q 019216          248 LRKILEPNPVKRITI-----AGIKADEWFEQ  273 (344)
Q Consensus       248 i~~~L~~dP~~Rps~-----~eil~~~~~~~  273 (344)
                      |++||++||++|||+     +|+++||||+.
T Consensus       257 i~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             HHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            999999999999984     79999999975

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.4e-65  Score=477.89  Aligned_cols=257  Identities=26%  Similarity=0.429  Sum_probs=231.1

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      ..++|+++++||+|+||.||+|.++.+|+.||||++.......   .+.+.+|+.+|+.++||||+++++++.+.+.+||
T Consensus       149 p~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~i  225 (423)
T 4fie_A          149 PRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWV  225 (423)
T ss_dssp             GGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEE
Confidence            4568999999999999999999999999999999997654322   3568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |||||+||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....  ...
T Consensus       226 VmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~  302 (423)
T 4fie_A          226 VMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVP  302 (423)
T ss_dssp             EEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCC
T ss_pred             EEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCc
Confidence            9999999999998865 5699999999999999999999999999999999999999999999999999985432  233


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC---CCCCCCCCHHHHHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQNLL  248 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~li  248 (344)
                      ...+.+||+.|||||++.+..| +.++|||||||++|||++|++||.+.+.......+....   ...+..+|+++++||
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y-~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli  381 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFL  381 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHH
T ss_pred             cccccccCcCcCCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHH
Confidence            4567899999999999988777 689999999999999999999999999888888887763   334566899999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          249 RKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      .+||+.||++|||++|+|+||||++..
T Consensus       382 ~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          382 DRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            999999999999999999999998753

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.8e-65  Score=455.72  Aligned_cols=255  Identities=25%  Similarity=0.478  Sum_probs=221.4

Q ss_pred             ccCe-EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee----CC
Q 019216           13 LGRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KS   87 (344)
Q Consensus        13 ~~~y-~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~   87 (344)
                      -|+| ++.++||+|+||+||+|.++.++..||+|++.+... .....+.+.+|+.++++++||||+++++++.+    ..
T Consensus        24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~  102 (290)
T 3fpq_A           24 DGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKK  102 (290)
T ss_dssp             TSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEE
T ss_pred             CCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCc
Confidence            3577 778899999999999999999999999999976543 33456789999999999999999999999865    35


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEEcc-CCCeEEeccccccCC
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDS-KGNIKISDFGLSALP  164 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--i~H~dikp~NILl~~-~~~vkl~Dfg~a~~~  164 (344)
                      .+|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+|||++. +|.+||+|||+|+..
T Consensus       103 ~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~  182 (290)
T 3fpq_A          103 CIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC
Confidence            68999999999999999999899999999999999999999999998  999999999999974 799999999999743


Q ss_pred             CcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc-cHHHHHHHHhhCCC--CCCCCCC
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDF--KLPKWLS  241 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~-~~~~~~~~i~~~~~--~~~~~~~  241 (344)
                          ......+.+||+.|+|||++.+ .+ +.++|||||||++|||+||+.||.+. +...+...+..+..  .++..++
T Consensus       183 ----~~~~~~~~~GTp~YmAPE~~~~-~y-~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~  256 (290)
T 3fpq_A          183 ----RASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAI  256 (290)
T ss_dssp             ----CTTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCC
T ss_pred             ----CCCccCCcccCccccCHHHcCC-CC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCC
Confidence                2334567799999999999865 45 68999999999999999999999764 45555666665533  3556789


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +++++||.+||+.||++|||++|+|+||||++.
T Consensus       257 ~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~  289 (290)
T 3fpq_A          257 PEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            999999999999999999999999999999863

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.5e-65  Score=462.08  Aligned_cols=257  Identities=25%  Similarity=0.363  Sum_probs=225.2

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .++.|++.++||+|+||.||+|+++.+|+.||||++++...        ..+|+.+++.++||||+++++++.+.+.+|+
T Consensus        56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~i  127 (336)
T 4g3f_A           56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNI  127 (336)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEE
T ss_pred             chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            45679999999999999999999999999999999976532        2369999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC-CeEEeccccccCCCcccCC
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~-~vkl~Dfg~a~~~~~~~~~  170 (344)
                      |||||+||+|.+++.+.+++++..++.++.||+.||+|||++||+||||||+|||++.+| ++||+|||+|+........
T Consensus       128 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          128 FMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            999999999999999989999999999999999999999999999999999999999998 6999999999865332111


Q ss_pred             ---CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC---CCCCCCCHHH
Q 019216          171 ---GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGA  244 (344)
Q Consensus       171 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~  244 (344)
                         ......+||+.|+|||++.+..+ +.++|||||||++|||++|++||.+.+...+..++.....   .+|..+++.+
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~  286 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPC-DAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT  286 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHH
T ss_pred             cceecCCccccCccccCHHHHCCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHH
Confidence               12234689999999999998777 6899999999999999999999998877777777877764   3677899999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhh-------------hcCccccccCCC
Q 019216          245 QNLLRKILEPNPVKRITIAGI-------------KADEWFEQDYTP  277 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~ei-------------l~~~~~~~~~~~  277 (344)
                      .+||.+||++||++|||+.|+             |+|||+.+...|
T Consensus       287 ~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          287 AQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             HHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence            999999999999999999997             578998765443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.8e-63  Score=459.12  Aligned_cols=261  Identities=26%  Similarity=0.355  Sum_probs=225.8

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee------CC
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------KS   87 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~~   87 (344)
                      ++|++++.||+|+||+||+|.++.+|+.||||++++.. ......+.+.+|+.+|+.++||||+++++++..      ..
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            47999999999999999999999999999999996543 233456788899999999999999999998753      36


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+|+|||||. |+|.+++.+.+++++..++.+++||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~  211 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS  211 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC---
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccC
Confidence            7899999995 689999998899999999999999999999999999999999999999999999999999999854321


Q ss_pred             --cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCC---------
Q 019216          168 --RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL---------  236 (344)
Q Consensus       168 --~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~---------  236 (344)
                        .......+.+||+.|+|||++.+..+++.++||||+||++|||++|++||.+.+.......|.......         
T Consensus       212 ~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~  291 (398)
T 4b99_A          212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVG  291 (398)
T ss_dssp             ----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC---
T ss_pred             ccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhh
Confidence              123344567999999999999887777899999999999999999999999998888877775421110         


Q ss_pred             ----------------------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          237 ----------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       237 ----------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                                            ...+++++.+||.+||+.||++|||++|+|+||||++...
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          292 AERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             --CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred             hhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence                                  1236899999999999999999999999999999987543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5e-62  Score=473.63  Aligned_cols=262  Identities=27%  Similarity=0.443  Sum_probs=232.0

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHH---HHHHHHHhCCCCCccceeeEEe
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLLKHPNVVRLHEVLA   84 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~   84 (344)
                      +..+++++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.   .++.+++.++||||++++++|.
T Consensus       183 ~~~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~  262 (689)
T 3v5w_A          183 NIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH  262 (689)
T ss_dssp             TCCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEE
T ss_pred             CCCCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEE
Confidence            3578899999999999999999999999999999999999875543323233333   4466777889999999999999


Q ss_pred             eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                      +.+.+|+|||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+..
T Consensus       263 ~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          263 TPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999854


Q ss_pred             CcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc---cHHHHHHHHhhCCCCCCCCCC
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGDFKLPKWLS  241 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~---~~~~~~~~i~~~~~~~~~~~~  241 (344)
                      ..    ....+.+||+.|+|||++.....++.++|||||||++|||++|++||.+.   +...+...+......+|..+|
T Consensus       343 ~~----~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S  418 (689)
T 3v5w_A          343 SK----KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFS  418 (689)
T ss_dssp             SS----CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSC
T ss_pred             CC----CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCC
Confidence            32    23456799999999999976544478999999999999999999999764   345667788888999999999


Q ss_pred             HHHHHHHHHhcCCCcCCCCC-----HhhhhcCccccc
Q 019216          242 PGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps-----~~eil~~~~~~~  273 (344)
                      +++++||.+||++||++|++     ++|+++||||+.
T Consensus       419 ~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          419 PELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             HHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             HHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            99999999999999999998     799999999974

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.2e-61  Score=435.15  Aligned_cols=259  Identities=27%  Similarity=0.392  Sum_probs=224.0

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEE
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL   83 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~   83 (344)
                      ..+..++|.+.+.||+|+||+||+|.+.     .++..||||+++..   .....+.+.+|+++|++++||||+++++++
T Consensus         8 ~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~   84 (299)
T 4asz_A            8 QHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVC   84 (299)
T ss_dssp             CBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            3456688999999999999999999875     35789999999643   344567899999999999999999999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIASK-------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK  150 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~~~-------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~  150 (344)
                      .+.+.+|+|||||++|+|.+++.+.             ..+++..+..++.||+.||+|||+++|+||||||+|||++.+
T Consensus        85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~  164 (299)
T 4asz_A           85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN  164 (299)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence            9999999999999999999999764             369999999999999999999999999999999999999999


Q ss_pred             CCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHH
Q 019216          151 GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI  229 (344)
Q Consensus       151 ~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i  229 (344)
                      +.+||+|||+|+..............+||+.|+|||++.+..+ +.++|||||||++|||+| |+.||.+.+..++...+
T Consensus       165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKF-TTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            9999999999975333222222334578999999999988777 689999999999999998 99999999888888888


Q ss_pred             hhCC-CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          230 FRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       230 ~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      ..+. .+.|..+|+++.+|+.+||+.||++|||+.++.  +|+++
T Consensus       244 ~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~  286 (299)
T 4asz_A          244 TQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQN  286 (299)
T ss_dssp             HHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred             HcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHH
Confidence            8775 567889999999999999999999999999994  56654

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.9e-61  Score=437.34  Aligned_cols=256  Identities=27%  Similarity=0.395  Sum_probs=217.4

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEE
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL   83 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~   83 (344)
                      ..+...+|.+.++||+|+||.||+|.+.     .+++.||||+++..   .....+.+.+|+++|++++||||+++++++
T Consensus        36 ~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~  112 (329)
T 4aoj_A           36 HHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVC  112 (329)
T ss_dssp             CBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            3456678999999999999999999865     36889999999643   344567899999999999999999999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEc
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIASK---------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD  148 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~~~---------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~  148 (344)
                      .+...+|+|||||++|+|.+++.+.               +++++.++..++.|++.||+|||+++|+||||||+|||++
T Consensus       113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~  192 (329)
T 4aoj_A          113 TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG  192 (329)
T ss_dssp             CSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEEC
Confidence            9999999999999999999999753               3589999999999999999999999999999999999999


Q ss_pred             cCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHH
Q 019216          149 SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQ  227 (344)
Q Consensus       149 ~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~  227 (344)
                      .++.+||+|||+|+..............+||+.|+|||++.+..+ +.++|||||||++|||+| |+.||.+.+......
T Consensus       193 ~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~-~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          193 QGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKF-TTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             TTTEEEECCCC----------------CCCCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCC-CccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            999999999999986543322333345689999999999988777 689999999999999999 999999988888888


Q ss_pred             HHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          228 KIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       228 ~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+..+ .++.|..+++++.+|+.+||+.||++|||+.|++++
T Consensus       272 ~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          272 CITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             HHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            88776 567888999999999999999999999999999864

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3e-61  Score=434.19  Aligned_cols=257  Identities=25%  Similarity=0.375  Sum_probs=224.9

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEE
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL   83 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~   83 (344)
                      ..+.+++++++++||+|+||+||+|...     .+++.||||+++...  .....+.+.+|+.++++++||||+++++++
T Consensus        21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~   98 (308)
T 4gt4_A           21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVV   98 (308)
T ss_dssp             CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence            3477889999999999999999999853     467899999986432  234467899999999999999999999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL  147 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl  147 (344)
                      ...+.+++|||||++|+|.+++...                ..+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus        99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl  178 (308)
T 4gt4_A           99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV  178 (308)
T ss_dssp             CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence            9999999999999999999999643                358999999999999999999999999999999999999


Q ss_pred             ccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHH
Q 019216          148 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLY  226 (344)
Q Consensus       148 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~  226 (344)
                      ++++.+||+|||+|+..............+||+.|+|||++.+..+ +.++|||||||++|||+| |+.||.+.+...+.
T Consensus       179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~-s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~  257 (308)
T 4gt4_A          179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKF-SIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVV  257 (308)
T ss_dssp             CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHH
T ss_pred             CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCC-CccchhhhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999985543333333455789999999999988776 689999999999999998 89999999988888


Q ss_pred             HHHhhCC-CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          227 QKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       227 ~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ..+..+. .+.|..+++.+.+|+.+||+.||++|||+.||+++
T Consensus       258 ~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          258 EMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8887764 56788899999999999999999999999999875

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=7.1e-62  Score=437.02  Aligned_cols=256  Identities=25%  Similarity=0.422  Sum_probs=204.0

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC-----
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----   87 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----   87 (344)
                      +++|++++.||+|+||.||+|+++.+|+.||||++....  .....+.+.+|+.+|++++||||+++++++...+     
T Consensus         4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-----
T ss_pred             chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccc
Confidence            567999999999999999999999999999999997543  3344578899999999999999999999986543     


Q ss_pred             -------eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEec
Q 019216           88 -------KIYMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD  157 (344)
Q Consensus        88 -------~~~iv~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~D  157 (344)
                             .+|+|||||+||+|.+++...+.   .++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence                   47999999999999999987654   34567899999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccCC----------CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH-HHHH
Q 019216          158 FGLSALPQHFRDD----------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLY  226 (344)
Q Consensus       158 fg~a~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~-~~~~  226 (344)
                      ||+|+........          ......+||+.|+|||++.+..+ +.++|||||||++|||++   ||.+... ....
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y-~~~~DiwSlGvilyell~---Pf~~~~~~~~~~  237 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSY-SHKVDIFSLGLILFELLY---PFSTQMERVRTL  237 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHS---CCSSHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCC-CCHHHHHHHHHHHHHHcc---CCCCccHHHHHH
Confidence            9999865432111          12234689999999999988776 689999999999999995   8866432 2333


Q ss_pred             HHHhhCCCC-CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          227 QKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       227 ~~i~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ..+.....+ .+...++.+.+||++||+.||++|||+.|+++||||++.
T Consensus       238 ~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~  286 (299)
T 4g31_A          238 TDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL  286 (299)
T ss_dssp             HHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred             HHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence            344433322 223356788999999999999999999999999999864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.2e-60  Score=437.20  Aligned_cols=253  Identities=25%  Similarity=0.401  Sum_probs=208.6

Q ss_pred             ccCeEEeeeecccCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCe
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSK   88 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~   88 (344)
                      -++|+++++||+|+||+||+|+++   .+++.||+|.+.+..     ...++.+|+++|+.+ .||||+++++++.+.+.
T Consensus        20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~   94 (361)
T 4f9c_A           20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH   94 (361)
T ss_dssp             GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTE
T ss_pred             cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCE
Confidence            368999999999999999999875   467899999886543     235678999999998 59999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC-CCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~-~~vkl~Dfg~a~~~~~~  167 (344)
                      +|+|||||+|++|.+++.   .+++.+++.+++||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus        95 ~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~  171 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT  171 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred             EEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence            999999999999999884   59999999999999999999999999999999999999877 79999999999743221


Q ss_pred             c--------------------------CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC-c
Q 019216          168 R--------------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-R  220 (344)
Q Consensus       168 ~--------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~-~  220 (344)
                      .                          ......+.+||+.|+|||++.+...++.++||||+||++|+|++|+.||.. .
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence            1                          011234568999999999998877668899999999999999999999954 3


Q ss_pred             cHHHHHHHHhh--------------------------------------CC----------------CCCCCCCCHHHHH
Q 019216          221 NLAVLYQKIFR--------------------------------------GD----------------FKLPKWLSPGAQN  246 (344)
Q Consensus       221 ~~~~~~~~i~~--------------------------------------~~----------------~~~~~~~~~~~~~  246 (344)
                      +.......+..                                      ..                .+....+|+++++
T Consensus       252 ~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~D  331 (361)
T 4f9c_A          252 DDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYD  331 (361)
T ss_dssp             SHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHH
T ss_pred             CHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHH
Confidence            33333332211                                      00                0112347899999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          247 LLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      ||++||+.||++|+|++|+|+||||++
T Consensus       332 Ll~~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          332 LLDKLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHHHHCcCChhHCcCHHHHhcCcccCC
Confidence            999999999999999999999999986

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.9e-60  Score=427.59  Aligned_cols=254  Identities=24%  Similarity=0.376  Sum_probs=208.0

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..+++++.++||+|+||+||+|++..   .||||+++... ...+..+.+.+|+.++++++||||+++++++.. +.++
T Consensus        33 i~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~  107 (307)
T 3omv_A           33 IEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLA  107 (307)
T ss_dssp             CCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             EcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEE
Confidence            456789999999999999999998543   59999986543 344567889999999999999999999998865 5689


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +|||||+||+|.+++.. .+++++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+|||+|+.......
T Consensus       108 iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          108 IVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             EEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            99999999999999975 45799999999999999999999999999999999999999999999999999986554333


Q ss_pred             CCccccccCCCcccchhhhccC--CCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC------CCCCCCC
Q 019216          170 DGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------KLPKWLS  241 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~------~~~~~~~  241 (344)
                      .......+||+.|+|||++.+.  ..++.++|||||||++|||+||+.||.+.+.......+.....      ..+..++
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  267 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCP  267 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccch
Confidence            4445567999999999998643  2347899999999999999999999988665444433333221      2456689


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcCc
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKADE  269 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~~  269 (344)
                      +.+.+|+.+||+.||++|||+.|++++.
T Consensus       268 ~~l~~li~~cl~~dP~~RPs~~ei~~~L  295 (307)
T 3omv_A          268 KAMKRLVADCVKKVKEERPLFPQILSSI  295 (307)
T ss_dssp             HHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence            9999999999999999999999987653

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.2e-59  Score=457.88  Aligned_cols=261  Identities=30%  Similarity=0.590  Sum_probs=235.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      ..+++|++++.||+|+||.||+|.++.+|+.||+|++.+..   ....+.+.+|+.+|+.++||||+++++++.+...+|
T Consensus       154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~  230 (573)
T 3uto_A          154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV  230 (573)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred             cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            45789999999999999999999999999999999997543   334567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC--CCeEEeccccccCCCcc
Q 019216           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHF  167 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~--~~vkl~Dfg~a~~~~~~  167 (344)
                      +|||||+||+|.+++.. .+.+++.+++.+++||+.||.|||++||+||||||+|||++.+  +.+||+|||+|+...  
T Consensus       231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~--  308 (573)
T 3uto_A          231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD--  308 (573)
T ss_dssp             EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC--
T ss_pred             EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc--
Confidence            99999999999999864 4679999999999999999999999999999999999999854  899999999998543  


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCCCHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG  243 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~  243 (344)
                       ........+||+.|+|||++.+..+ +.++|||||||++|+|++|++||.+.+......++....+.++    ..+|++
T Consensus       309 -~~~~~~~~~GT~~y~APEv~~~~~y-~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  386 (573)
T 3uto_A          309 -PKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED  386 (573)
T ss_dssp             -TTSEEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred             -CCCceeeeEECccccCHHHhCCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence             2334556799999999999998877 6899999999999999999999999999999999988876655    458999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCccccccCCCC
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA  278 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~~  278 (344)
                      +++||.+||+.||++|||+.|+|+||||+....+.
T Consensus       387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~  421 (573)
T 3uto_A          387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG  421 (573)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence            99999999999999999999999999998765543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=4.3e-58  Score=419.07  Aligned_cols=265  Identities=42%  Similarity=0.828  Sum_probs=242.6

Q ss_pred             hccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216            7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus         7 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      ..+...+++|++++.||+|+||.||+|.+..+|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++...
T Consensus         8 ~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~   86 (328)
T 3fe3_A            8 ADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETE   86 (328)
T ss_dssp             ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             cccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC
Confidence            3456778999999999999999999999999999999999976543 344567889999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ...|+||||++|++|.+++...+++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.... 
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~-  165 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT-  165 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGS-
T ss_pred             CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecC-
Confidence            9999999999999999999988999999999999999999999999999999999999999999999999999987432 


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN  246 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  246 (344)
                        ........+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+.......+..+...+|..+++++.+
T Consensus       166 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  243 (328)
T 3fe3_A          166 --VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCEN  243 (328)
T ss_dssp             --SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             --CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence              233456678999999999999888777899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          247 LLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      ||++||+.||.+|||++|+++||||+...
T Consensus       244 li~~~L~~dP~~R~t~~eil~h~~~~~~~  272 (328)
T 3fe3_A          244 LLKRFLVLNPIKRGTLEQIMKDRWINAGH  272 (328)
T ss_dssp             HHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred             HHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence            99999999999999999999999998654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1e-58  Score=424.78  Aligned_cols=255  Identities=26%  Similarity=0.376  Sum_probs=217.7

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCC-----CceEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCccceeeEEe
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLA   84 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~   84 (344)
                      +..++|++++.||+|+||.||+|.+...     ++.||+|.+....  .....+.+.+|+.+|.+++| |||++++++|.
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~  138 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT  138 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence            4567999999999999999999997654     3679999986543  23446789999999999975 89999999986


Q ss_pred             e-CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE
Q 019216           85 S-KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL  147 (344)
Q Consensus        85 ~-~~~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl  147 (344)
                      . ...+++|||||++|+|.+++++.                ..+++..+..++.||+.||+|||+++|+||||||+|||+
T Consensus       139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl  218 (353)
T 4ase_A          139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  218 (353)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred             ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence            5 45789999999999999999752                348999999999999999999999999999999999999


Q ss_pred             ccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCcc-HHHH
Q 019216          148 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRN-LAVL  225 (344)
Q Consensus       148 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~-~~~~  225 (344)
                      +.++.+||+|||+|+..............+||+.|+|||++.+..+ +.++|||||||++|||+| |+.||.+.+ ....
T Consensus       219 ~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y-~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~  297 (353)
T 4ase_A          219 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  297 (353)
T ss_dssp             CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH
T ss_pred             CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC-CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999986543322233445689999999999988776 689999999999999998 999998865 3444


Q ss_pred             HHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          226 YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       226 ~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ...+..+ .++.|..+++++.+|+.+||+.||++|||+.++++|
T Consensus       298 ~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          298 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            4555554 567888999999999999999999999999999987

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=4.3e-57  Score=413.80  Aligned_cols=260  Identities=32%  Similarity=0.630  Sum_probs=238.6

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +.+++|++++.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.....+|
T Consensus         2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~   81 (337)
T 1o6l_A            2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence            56899999999999999999999999999999999997654434445678889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      +||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....  ..
T Consensus        82 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~  159 (337)
T 1o6l_A           82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG  159 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CC
Confidence            9999999999999999888999999999999999999999999999999999999999999999999999974221  22


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK  250 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~  250 (344)
                      ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..+++++.+||.+
T Consensus       160 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  238 (337)
T 1o6l_A          160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             CcccccccChhhCChhhhcCCCC-CchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            33456789999999999988776 68999999999999999999999999999999999999999999999999999999


Q ss_pred             hcCCCcCCCC-----CHhhhhcCccccc
Q 019216          251 ILEPNPVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       251 ~L~~dP~~Rp-----s~~eil~~~~~~~  273 (344)
                      ||+.||++||     +++++++||||..
T Consensus       239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            9999999999     8999999999974

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.6e-57  Score=419.28  Aligned_cols=262  Identities=33%  Similarity=0.633  Sum_probs=232.8

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCC
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS   87 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~   87 (344)
                      ..+.+++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|..+++.+ +||||+++++++....
T Consensus        18 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~   97 (353)
T 3txo_A           18 NRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPD   97 (353)
T ss_dssp             -----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCC
Confidence            457789999999999999999999999999999999999876544455667788999999988 6999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.... 
T Consensus        98 ~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-  176 (353)
T 3txo_A           98 RLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-  176 (353)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence            9999999999999999999889999999999999999999999999999999999999999999999999999974221 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL  247 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (344)
                       ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+..++..+...+|..+++.+.+|
T Consensus       177 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  254 (353)
T 3txo_A          177 -NGVTTATFCGTPDYIAPEILQEMLY-GPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGI  254 (353)
T ss_dssp             ----------CCGGGCCHHHHHHHHC-TTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHH
T ss_pred             -CCccccccCCCcCeEChhhcCCCCc-CCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence             2233456789999999999987776 68999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCcCCCCCH------hhhhcCccccc
Q 019216          248 LRKILEPNPVKRITI------AGIKADEWFEQ  273 (344)
Q Consensus       248 i~~~L~~dP~~Rps~------~eil~~~~~~~  273 (344)
                      |++||+.||.+||++      +++++||||++
T Consensus       255 i~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          255 LKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             HHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             HHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            999999999999998      89999999975

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-56  Score=407.19  Aligned_cols=258  Identities=32%  Similarity=0.686  Sum_probs=237.7

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      .+.+++|++++.||+|+||.||+|.++.+|+.||+|++.+.........+.+.+|..+++.++||||+++++++.+...+
T Consensus         2 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~   81 (318)
T 1fot_A            2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQI   81 (318)
T ss_dssp             -CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEE
T ss_pred             CCChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEE
Confidence            46789999999999999999999999999999999999765443444567788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      |+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....   
T Consensus        82 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~---  158 (318)
T 1fot_A           82 FMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---  158 (318)
T ss_dssp             EEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred             EEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence            99999999999999999888999999999999999999999999999999999999999999999999999974322   


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR  249 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~  249 (344)
                        .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......++......+|..+++++.+||.
T Consensus       159 --~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~  235 (318)
T 1fot_A          159 --VTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLS  235 (318)
T ss_dssp             --CBCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred             --ccccccCCccccCHhHhcCCCC-CcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence              2345789999999999988776 6899999999999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCcCCCC-----CHhhhhcCccccc
Q 019216          250 KILEPNPVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       250 ~~L~~dP~~Rp-----s~~eil~~~~~~~  273 (344)
                      +||+.||++||     +++++++||||+.
T Consensus       236 ~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          236 RLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            99999999999     8999999999974

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=9.4e-57  Score=412.72  Aligned_cols=263  Identities=33%  Similarity=0.600  Sum_probs=236.2

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK   86 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~   86 (344)
                      ...+.+++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+..|..++..+ +||||+++++++.+.
T Consensus        11 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~   90 (345)
T 1xjd_A           11 QIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK   90 (345)
T ss_dssp             -----CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             cCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC
Confidence            3568899999999999999999999999999999999999765433334466788899999876 899999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ..+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus        91 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  170 (345)
T 1xjd_A           91 ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML  170 (345)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc
Confidence            99999999999999999999888999999999999999999999999999999999999999999999999999974321


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN  246 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  246 (344)
                        ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+...+......+|..+++.+.+
T Consensus       171 --~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  247 (345)
T 1xjd_A          171 --GDAKTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD  247 (345)
T ss_dssp             --TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             --CCCcccCCCCCcccCChhhhcCCCC-CChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHH
Confidence              2223456789999999999988776 6899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCcCCCCCHh-hhhcCccccc
Q 019216          247 LLRKILEPNPVKRITIA-GIKADEWFEQ  273 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~-eil~~~~~~~  273 (344)
                      ||.+||+.||++||++. ++++||||+.
T Consensus       248 li~~lL~~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          248 LLVKLFVREPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             HHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             HHHHHhcCCHhHcCCChHHHHcCccccC
Confidence            99999999999999998 9999999975

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.1e-56  Score=416.96  Aligned_cols=263  Identities=30%  Similarity=0.608  Sum_probs=232.7

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK   86 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~   86 (344)
                      ...+.+++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|..+++++ +||||+++++++.+.
T Consensus        46 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~  125 (396)
T 4dc2_A           46 SSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE  125 (396)
T ss_dssp             ---CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC
Confidence            4567889999999999999999999999999999999999876655555566788999999877 799999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ..+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++... 
T Consensus       126 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~-  204 (396)
T 4dc2_A          126 SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL-  204 (396)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC-
T ss_pred             CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc-
Confidence            9999999999999999999988899999999999999999999999999999999999999999999999999997422 


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC---------ccHHHHHHHHhhCCCCCC
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---------RNLAVLYQKIFRGDFKLP  237 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~---------~~~~~~~~~i~~~~~~~~  237 (344)
                       .........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..         .......+.+......+|
T Consensus       205 -~~~~~~~~~~gt~~Y~aPE~l~~~~~-~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p  282 (396)
T 4dc2_A          205 -RPGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP  282 (396)
T ss_dssp             -CTTCCBCCCCBCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC
T ss_pred             -cCCCccccccCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC
Confidence             12334556799999999999988776 6899999999999999999999963         234557788888899999


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCH------hhhhcCccccc
Q 019216          238 KWLSPGAQNLLRKILEPNPVKRITI------AGIKADEWFEQ  273 (344)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~------~eil~~~~~~~  273 (344)
                      ..+++.+.+||++||+.||++||++      +|+++||||+.
T Consensus       283 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          283 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence            9999999999999999999999995      79999999974

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1e-55  Score=406.76  Aligned_cols=260  Identities=34%  Similarity=0.666  Sum_probs=240.1

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      .....+++|++++.||+|+||.||+|.++.+|+.||+|++.+.........+.+.+|+.+++.++||||+++++++.+..
T Consensus        35 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~  114 (350)
T 1rdq_E           35 QNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS  114 (350)
T ss_dssp             CCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             ccCCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCC
Confidence            34578899999999999999999999999999999999997665444455678899999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.... 
T Consensus       115 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~-  193 (350)
T 1rdq_E          115 NLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-  193 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred             EEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence            9999999999999999999888999999999999999999999999999999999999999999999999999975322 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL  247 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (344)
                          .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......++..+...+|..+++.+.+|
T Consensus       194 ----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~l  268 (350)
T 1rdq_E          194 ----RTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL  268 (350)
T ss_dssp             ----CBCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHH
T ss_pred             ----CcccccCCccccCHHHhcCCCC-CCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence                2345689999999999988776 68999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCcCCCCC-----HhhhhcCccccc
Q 019216          248 LRKILEPNPVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       248 i~~~L~~dP~~Rps-----~~eil~~~~~~~  273 (344)
                      |.+||+.||.+||+     ++++++||||..
T Consensus       269 i~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          269 LRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            99999999999998     999999999974

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.1e-55  Score=405.82  Aligned_cols=262  Identities=31%  Similarity=0.606  Sum_probs=236.6

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCC
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS   87 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~   87 (344)
                      ..+.+++|++++.||+|+||.||+|+++.+++.||+|++.+.........+.+.+|..+++++ +||||+++++++....
T Consensus         4 ~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~   83 (345)
T 3a8x_A            4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES   83 (345)
T ss_dssp             CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             CCCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCC
Confidence            457789999999999999999999999999999999999877666666778899999999988 8999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.... 
T Consensus        84 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~-  162 (345)
T 3a8x_A           84 RLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-  162 (345)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC-
T ss_pred             EEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC-
Confidence            9999999999999999999888999999999999999999999999999999999999999999999999999974221 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC---------ccHHHHHHHHhhCCCCCCC
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---------RNLAVLYQKIFRGDFKLPK  238 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~---------~~~~~~~~~i~~~~~~~~~  238 (344)
                       ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||..         .........+......+|.
T Consensus       163 -~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~  240 (345)
T 3a8x_A          163 -PGDTTSTFCGTPNYIAPEILRGEDY-GFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR  240 (345)
T ss_dssp             -TTCCBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT
T ss_pred             -CCCcccccCCCccccCccccCCCCC-ChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC
Confidence             2233456789999999999988776 6899999999999999999999975         3445667788888889999


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCH------hhhhcCccccc
Q 019216          239 WLSPGAQNLLRKILEPNPVKRITI------AGIKADEWFEQ  273 (344)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~------~eil~~~~~~~  273 (344)
                      .+++.+.+||.+||+.||.+||++      +++++||||..
T Consensus       241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence            999999999999999999999996      79999999974

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.6e-56  Score=410.10  Aligned_cols=263  Identities=34%  Similarity=0.614  Sum_probs=236.4

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK   86 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~   86 (344)
                      ...+.+++|++++.||+|+||.||+|.++.+|+.||+|++.+.........+.+.+|..++..+ .||||+++++++...
T Consensus        14 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~   93 (353)
T 2i0e_A           14 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM   93 (353)
T ss_dssp             -----CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS
T ss_pred             cCCCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC
Confidence            4568899999999999999999999999999999999999875443444567788999999988 799999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ..+|+||||++||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus        94 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           94 DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            99999999999999999999888999999999999999999999999999999999999999999999999999974321


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN  246 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  246 (344)
                        ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+..++......+|..+++++.+
T Consensus       174 --~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~  250 (353)
T 2i0e_A          174 --DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVA  250 (353)
T ss_dssp             --TTCCBCCCCSCGGGCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred             --CCcccccccCCccccChhhhcCCCc-CCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence              2233456789999999999988776 6899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCcCCCCC-----HhhhhcCccccc
Q 019216          247 LLRKILEPNPVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       247 li~~~L~~dP~~Rps-----~~eil~~~~~~~  273 (344)
                      ||.+||+.||.+||+     ++++++||||+.
T Consensus       251 li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          251 ICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            999999999999995     699999999974

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.1e-57  Score=415.51  Aligned_cols=263  Identities=45%  Similarity=0.873  Sum_probs=235.0

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      .+..+|+|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.....
T Consensus         4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~   83 (336)
T 3h4j_B            4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD   83 (336)
T ss_dssp             CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence            35678999999999999999999999999999999999976543333345678999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      .++||||+ +|+|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....   
T Consensus        84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~---  159 (336)
T 3h4j_B           84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT---  159 (336)
T ss_dssp             EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT---
T ss_pred             EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc---
Confidence            99999999 78999999888899999999999999999999999999999999999999999999999999997543   


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL  248 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  248 (344)
                      ........+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.........+..+...+|..+++.+.+||
T Consensus       160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li  239 (336)
T 3h4j_B          160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI  239 (336)
T ss_dssp             TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHH
T ss_pred             CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence            23334567899999999999887776789999999999999999999998876655555566666778888999999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          249 RKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      ++||+.||.+|||++|+++||||+...
T Consensus       240 ~~~L~~dP~~Rpt~~eil~hp~~~~~~  266 (336)
T 3h4j_B          240 RRMIVADPMQRITIQEIRRDPWFNVNL  266 (336)
T ss_dssp             HTTSCSSGGGSCCHHHHTTCHHHHTTC
T ss_pred             HHHcCCChhHCcCHHHHHhChhhccCC
Confidence            999999999999999999999998653

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=3.8e-55  Score=404.40  Aligned_cols=261  Identities=34%  Similarity=0.590  Sum_probs=233.8

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      ....-++|++++.||+|+||.||+|.++.+|+.||+|++.+......   ...+.+.+|+.+++.++||||+++++++.+
T Consensus         7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~   86 (361)
T 2yab_A            7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN   86 (361)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence            34456789999999999999999999999999999999976543221   235678999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC----CeEEeccccc
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLS  161 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~----~vkl~Dfg~a  161 (344)
                      ...+++||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++    .+||+|||++
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            999999999999999999998888999999999999999999999999999999999999998877    7999999999


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----  237 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----  237 (344)
                      .....   .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++    
T Consensus       167 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  242 (361)
T 2yab_A          167 HEIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF  242 (361)
T ss_dssp             EECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred             eEcCC---CCccccCCCCccEECchHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence            75432   223456789999999999987766 6899999999999999999999999999999999988877665    


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      ..+++.+++||.+||..||.+|||+.|+++||||..
T Consensus       243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            568999999999999999999999999999999974

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=9.2e-56  Score=421.74  Aligned_cols=265  Identities=51%  Similarity=0.921  Sum_probs=243.1

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      ...+.+++|++++.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++....
T Consensus        10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~   89 (476)
T 2y94_A           10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS   89 (476)
T ss_dssp             CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred             CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence            35578999999999999999999999999999999999997654434445678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....  
T Consensus        90 ~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~--  167 (476)
T 2y94_A           90 DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS--  167 (476)
T ss_dssp             EEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC--
T ss_pred             EEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc--
Confidence            999999999999999999888899999999999999999999999999999999999999999999999999997543  


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL  247 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (344)
                       ........+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.+......++..+....|..+++.+.+|
T Consensus       168 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~L  246 (476)
T 2y94_A          168 -DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVISL  246 (476)
T ss_dssp             -TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHHH
T ss_pred             -ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHHH
Confidence             2334456789999999999988777678999999999999999999999999888899999999888999999999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          248 LRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      |++||+.||++|||+.++++||||.+..
T Consensus       247 i~~~L~~dP~~Rpt~~eil~hp~~~~~~  274 (476)
T 2y94_A          247 LKHMLQVDPMKRATIKDIREHEWFKQDL  274 (476)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred             HHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence            9999999999999999999999998754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.1e-55  Score=392.11  Aligned_cols=267  Identities=31%  Similarity=0.647  Sum_probs=238.6

Q ss_pred             hccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216            7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus         7 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      +...+.+++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.++++++||||+++++++...
T Consensus         2 k~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   81 (279)
T 3fdn_A            2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA   81 (279)
T ss_dssp             --CCCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred             CcceeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC
Confidence            45678999999999999999999999999999999999999765544444567789999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ...++||||+++++|.+.+.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus        82 ~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~  161 (279)
T 3fdn_A           82 TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS  161 (279)
T ss_dssp             SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--
T ss_pred             CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc
Confidence            99999999999999999999888999999999999999999999999999999999999999999999999999864322


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN  246 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  246 (344)
                          .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+.......+......+|..+++.+.+
T Consensus       162 ----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (279)
T 3fdn_A          162 ----SRRTDLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD  236 (279)
T ss_dssp             ----------CCCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHH
T ss_pred             ----ccccccCCCCCccCHhHhccCCC-CccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHH
Confidence                22345678999999999887665 6899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhcCccccccCCCC
Q 019216          247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPA  278 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~~~~~~~~~~~~  278 (344)
                      ||.+||+.||++|||+.|+++||||+......
T Consensus       237 li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~~  268 (279)
T 3fdn_A          237 LISRLLKHNPSQRPMLREVLEHPWITANSSKP  268 (279)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHHCHHHHHHCSSC
T ss_pred             HHHHHhccChhhCCCHHHHhhCccccCCccCc
Confidence            99999999999999999999999998765443

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.8e-55  Score=406.90  Aligned_cols=263  Identities=35%  Similarity=0.598  Sum_probs=229.3

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHH-HHhCCCCCccceeeEEeeC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT-LKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~-l~~l~h~niv~l~~~~~~~   86 (344)
                      ...+..++|++++.||+|+||.||+|+++.+++.||+|++.+...........+.+|..+ ++.++||||+++++++...
T Consensus        32 ~~~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~  111 (373)
T 2r5t_A           32 NPHAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA  111 (373)
T ss_dssp             CTTCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS
T ss_pred             CCCCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC
Confidence            345788999999999999999999999999999999999987765555555667778776 5778999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      +.+|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++... 
T Consensus       112 ~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~-  190 (373)
T 2r5t_A          112 DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENI-  190 (373)
T ss_dssp             SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGB-
T ss_pred             CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccc-
Confidence            9999999999999999999988899999999999999999999999999999999999999999999999999987421 


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN  246 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  246 (344)
                       .........+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.+...+..++......++..+++.+.+
T Consensus       191 -~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  268 (373)
T 2r5t_A          191 -EHNSTTSTFCGTPEYLAPEVLHKQPY-DRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARH  268 (373)
T ss_dssp             -CCCCCCCSBSCCCCCCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHH
T ss_pred             -cCCCccccccCCccccCHHHhCCCCC-CchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHH
Confidence             12234456789999999999988776 6899999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhcCCCcCCCCCH----hhhhcCccccc
Q 019216          247 LLRKILEPNPVKRITI----AGIKADEWFEQ  273 (344)
Q Consensus       247 li~~~L~~dP~~Rps~----~eil~~~~~~~  273 (344)
                      ||.+||+.||.+||++    .++++||||..
T Consensus       269 li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          269 LLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            9999999999999997    68999999974

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=4.3e-55  Score=406.67  Aligned_cols=263  Identities=27%  Similarity=0.505  Sum_probs=236.2

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      ...+.+++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+..
T Consensus         9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~   88 (384)
T 4fr4_A            9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE   88 (384)
T ss_dssp             CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred             CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence            35678999999999999999999999999999999999997765444455678999999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+|+||||+.|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....  
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~--  166 (384)
T 4fr4_A           89 DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--  166 (384)
T ss_dssp             EEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc--
Confidence            999999999999999999988899999999999999999999999999999999999999999999999999997543  


Q ss_pred             cCCCccccccCCCcccchhhhccC--CCCCccchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhhCCCCCCCCCCH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKLPKWLSP  242 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~ll~ell~g~~pf~~---~~~~~~~~~i~~~~~~~~~~~~~  242 (344)
                       ........+||+.|+|||++...  ..++.++|||||||++|+|++|+.||..   .........+......+|..+++
T Consensus       167 -~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~  245 (384)
T 4fr4_A          167 -RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ  245 (384)
T ss_dssp             -TTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             -CCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCH
Confidence             23345567899999999998642  2236899999999999999999999974   44566677777888889999999


Q ss_pred             HHHHHHHHhcCCCcCCCCC-HhhhhcCccccc
Q 019216          243 GAQNLLRKILEPNPVKRIT-IAGIKADEWFEQ  273 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps-~~eil~~~~~~~  273 (344)
                      .+.+||.+||+.||.+||+ ++++++||||..
T Consensus       246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             HHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence            9999999999999999998 899999999974

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=4.9e-55  Score=415.29  Aligned_cols=261  Identities=33%  Similarity=0.629  Sum_probs=227.9

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      .+.+++|++++.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++...+.+
T Consensus       144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~  223 (446)
T 4ejn_A          144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRL  223 (446)
T ss_dssp             CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEE
T ss_pred             CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEE
Confidence            46778999999999999999999999999999999999765444445566788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ++||||++|++|.+++.+.+.+++..++.++.||+.||+|||+ .||+||||||+|||++.++.+||+|||+++....  
T Consensus       224 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--  301 (446)
T 4ejn_A          224 CFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--  301 (446)
T ss_dssp             EEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC--
T ss_pred             EEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--
Confidence            9999999999999999988899999999999999999999998 8999999999999999999999999999974322  


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL  248 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  248 (344)
                      ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......+|..+++.+.+||
T Consensus       302 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li  380 (446)
T 4ejn_A          302 DGATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLL  380 (446)
T ss_dssp             -----CCSSSCGGGCCHHHHHTSCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             CCcccccccCCccccCHhhcCCCCC-CCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence            2233456789999999999988776 689999999999999999999999999999999999999999999999999999


Q ss_pred             HHhcCCCcCCCC-----CHhhhhcCccccc
Q 019216          249 RKILEPNPVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       249 ~~~L~~dP~~Rp-----s~~eil~~~~~~~  273 (344)
                      .+||+.||.+||     |++++++||||..
T Consensus       381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             HHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence            999999999999     9999999999975

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.3e-54  Score=389.31  Aligned_cols=259  Identities=26%  Similarity=0.456  Sum_probs=227.5

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      .+-..++|++++.||+|+||+||+|.+..+|+.||+|++......   ..+.+.+|+.+++.++||||+++++++...+.
T Consensus        15 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   91 (297)
T 3fxz_A           15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (297)
T ss_dssp             SSCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             cCChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeeccccc---HHHHHHHHHHHHhcCCCCCCCeEeEEEEECCE
Confidence            455678999999999999999999999999999999998754432   24678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      .++||||++|++|.+++.+ ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....  
T Consensus        92 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--  168 (297)
T 3fxz_A           92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--  168 (297)
T ss_dssp             EEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--
T ss_pred             EEEEEECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC--
Confidence            9999999999999999876 4699999999999999999999999999999999999999999999999999875432  


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC---CCCCCCCCCHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQ  245 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~  245 (344)
                      .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+...   ....+..+++.+.
T Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (297)
T 3fxz_A          169 EQSKRSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR  247 (297)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHCSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHH
T ss_pred             cccccCCccCCcCccChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHH
Confidence            2223445689999999999988776 68999999999999999999999988766655555433   3445677899999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          246 NLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +||.+||+.||++|||+.|+++||||+..
T Consensus       248 ~li~~~l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          248 DFLNRCLEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHHHHccCChhHCcCHHHHhhChhhccc
Confidence            99999999999999999999999999864

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=2.4e-54  Score=409.14  Aligned_cols=260  Identities=37%  Similarity=0.698  Sum_probs=231.6

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      ...++|++++.||+|+||.||+|.++.+|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEE
Confidence            345789999999999999999999999999999999976543 3344677899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEc---cCCCeEEeccccccCCCcc
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~---~~~~vkl~Dfg~a~~~~~~  167 (344)
                      +|||||.|++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..... 
T Consensus        87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~-  165 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-  165 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT-
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC-
Confidence            9999999999999999989999999999999999999999999999999999999998   457899999999975432 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCC----CCCHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPG  243 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~  243 (344)
                       ........+||+.|+|||++.+..+ +.++|||||||++|+|++|.+||.+.+.......+..+...++.    .+++.
T Consensus       166 -~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  243 (444)
T 3soa_A          166 -EQQAWFGFAGTPGYLSPEVLRKDPY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPE  243 (444)
T ss_dssp             -TCCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHH
T ss_pred             -CCceeecccCCcccCCHHHhcCCCC-CCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHH
Confidence             2223345789999999999988776 68999999999999999999999999999999999888776653    58999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +.+||.+||+.||++|||+.|+|+||||...
T Consensus       244 ~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          244 AKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            9999999999999999999999999999754

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=2.1e-54  Score=394.70  Aligned_cols=262  Identities=36%  Similarity=0.636  Sum_probs=225.5

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhCCCCCccceeeEEe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKHPNVVRLHEVLA   84 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~   84 (344)
                      ..+..++|++++.||+|+||.||+|.+.   .+|+.||+|++.+.... .......+.+|+.+++.++||||+++++++.
T Consensus        12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   91 (327)
T 3a62_A           12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ   91 (327)
T ss_dssp             -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence            4578899999999999999999999985   68999999999765432 2234566788999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                      ..+.+|+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++..
T Consensus        92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~  171 (327)
T 3a62_A           92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES  171 (327)
T ss_dssp             CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence            99999999999999999999998889999999999999999999999999999999999999999999999999998743


Q ss_pred             CcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHH
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGA  244 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  244 (344)
                      ..  ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......++......+|..+++.+
T Consensus       172 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~  248 (327)
T 3a62_A          172 IH--DGTVTHTFCGTIEYMAPEILMRSGH-NRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA  248 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred             cc--CCccccccCCCcCccCHhhCcCCCC-CCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence            22  2223345689999999999987766 68999999999999999999999999988899999999999999999999


Q ss_pred             HHHHHHhcCCCcCCCC-----CHhhhhcCccccc
Q 019216          245 QNLLRKILEPNPVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rp-----s~~eil~~~~~~~  273 (344)
                      .+||.+||+.||++||     ++.++++||||+.
T Consensus       249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             HHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             HHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            9999999999999999     8899999999974

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=4.2e-54  Score=386.34  Aligned_cols=259  Identities=29%  Similarity=0.471  Sum_probs=219.4

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +++|++++.||+|+||+||+|.++.+++.||+|++..... .......+.+|+.++++++||||+++++++......++|
T Consensus         1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   79 (292)
T 3o0g_A            1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence            5799999999999999999999999999999999976543 334567788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~-~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |||+.+ ++.+.+. ..+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.....  ...
T Consensus        80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~  156 (292)
T 3o0g_A           80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVR  156 (292)
T ss_dssp             EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCS
T ss_pred             EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--ccc
Confidence            999976 5555554 467899999999999999999999999999999999999999999999999999975432  222


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCC-CCCccHHHHHHHHhhCC-----------------
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGD-----------------  233 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~p-f~~~~~~~~~~~i~~~~-----------------  233 (344)
                      ......||+.|+|||++.+....+.++|||||||++|+|++|..| |.+.+.......+....                 
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            334568899999999998777567899999999999999987776 66666666665554310                 


Q ss_pred             ------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          234 ------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       234 ------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                                  ......+++.+++||.+||+.||++|||++|+++||||++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence                        011234789999999999999999999999999999998643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3e-54  Score=385.61  Aligned_cols=270  Identities=31%  Similarity=0.668  Sum_probs=239.6

Q ss_pred             hhhhccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEE
Q 019216            4 AEKKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL   83 (344)
Q Consensus         4 ~~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~   83 (344)
                      ++-......+++|++.+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++
T Consensus         4 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   83 (284)
T 2vgo_A            4 AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF   83 (284)
T ss_dssp             ------CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhCCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence            44455678899999999999999999999999999999999999765433334457789999999999999999999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      ......++||||+++++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++..
T Consensus        84 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~  163 (284)
T 2vgo_A           84 HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH  163 (284)
T ss_dssp             ECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence            99999999999999999999999888899999999999999999999999999999999999999999999999999864


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHH
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG  243 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  243 (344)
                      ...    .......|++.|+|||++.+..+ +.++||||||+++|+|++|+.||...+.......+......+|..+++.
T Consensus       164 ~~~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 2vgo_A          164 APS----LRRRTMCGTLDYLPPEMIEGKTH-DEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDG  238 (284)
T ss_dssp             CSS----SCBCCCCSCGGGCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHH
T ss_pred             Ccc----cccccccCCCCcCCHHHhccCCC-CcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHH
Confidence            322    22345679999999999987766 6899999999999999999999999888888888888888899999999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCccccccCCCC
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA  278 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~~  278 (344)
                      +.++|.+||+.||.+|||+.++++||||+......
T Consensus       239 ~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~  273 (284)
T 2vgo_A          239 SKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRV  273 (284)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCC
T ss_pred             HHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcccc
Confidence            99999999999999999999999999998765443

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.1e-54  Score=405.42  Aligned_cols=263  Identities=30%  Similarity=0.508  Sum_probs=229.4

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..+..++|++++.||+|+||.||+|.++.+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~  143 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY  143 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            45678899999999999999999999999999999999976443333334457889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +|+|||||+||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..... 
T Consensus       144 ~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~-  221 (410)
T 3v8s_A          144 LYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-  221 (410)
T ss_dssp             EEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-
T ss_pred             EEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC-
Confidence            9999999999999998875 56999999999999999999999999999999999999999999999999999743321 


Q ss_pred             CCCccccccCCCcccchhhhccCCC---CCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--CCCC--CCCC
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGY---DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKLP--KWLS  241 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--~~~~--~~~~  241 (344)
                      ........+||+.|+|||++.+...   ++.++|||||||++|+|++|+.||.+.+......++....  ..+|  ..++
T Consensus       222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s  301 (410)
T 3v8s_A          222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDIS  301 (410)
T ss_dssp             SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCC
T ss_pred             CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCccccc
Confidence            1112346789999999999976541   3689999999999999999999999999888888887642  3444  4699


Q ss_pred             HHHHHHHHHhcCCCcCC--CCCHhhhhcCccccc
Q 019216          242 PGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ  273 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~--Rps~~eil~~~~~~~  273 (344)
                      +.+++||++||+.+|.+  ||+++|+++||||+.
T Consensus       302 ~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~  335 (410)
T 3v8s_A          302 KEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKN  335 (410)
T ss_dssp             HHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCC
T ss_pred             HHHHHHHHHHccChhhhCCCCCHHHHhcCccccC
Confidence            99999999999999998  999999999999985

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.4e-54  Score=397.86  Aligned_cols=257  Identities=37%  Similarity=0.715  Sum_probs=230.9

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++......|+|
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv  106 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV  106 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence            4589999999999999999999999999999999976543 334567889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC---CeEEeccccccCCCcccC
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRD  169 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~---~vkl~Dfg~a~~~~~~~~  169 (344)
                      |||+.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++.....   
T Consensus       107 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~---  183 (362)
T 2bdw_A          107 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---  183 (362)
T ss_dssp             ECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT---
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC---
Confidence            99999999999998888899999999999999999999999999999999999998654   599999999975432   


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCC----CCCHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQ  245 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~  245 (344)
                      .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+..+...+|.    .+++.+.
T Consensus       184 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  262 (362)
T 2bdw_A          184 SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  262 (362)
T ss_dssp             CCSCCCSCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred             CcccccCCCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            223345689999999999987766 68999999999999999999999999988888888888776653    4799999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          246 NLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +||.+||+.||++|||+.++|+||||...
T Consensus       263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          263 SLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-54  Score=393.26  Aligned_cols=256  Identities=25%  Similarity=0.479  Sum_probs=229.9

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      .++|++.+.||+|+||.||+|.++.+++.||+|++....    .....+.+|+.+++.++||||+++++++.+...+++|
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv   79 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMI   79 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence            579999999999999999999999999999999986432    3346688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc--CCCeEEeccccccCCCcccC
Q 019216           93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~--~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      ||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++....   .
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~---~  156 (321)
T 1tki_A           80 FEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---P  156 (321)
T ss_dssp             ECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---T
T ss_pred             EEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC---C
Confidence            9999999999999765 47999999999999999999999999999999999999987  7899999999997543   2


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCCCHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQ  245 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~  245 (344)
                      ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++    ..+++++.
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          157 GDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             TCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             CCccccccCChhhcCcHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence            233455689999999999987665 6899999999999999999999999998888899988877765    46899999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          246 NLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      +||.+||+.||.+|||+.|+|+||||++...
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~  266 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQHPWLKQKIE  266 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred             HHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence            9999999999999999999999999987543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.7e-54  Score=397.59  Aligned_cols=259  Identities=40%  Similarity=0.772  Sum_probs=218.0

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      ...++|++++.||+|+||.||+|.++.+++.||+|++.+....    .+.+.+|+.+++.++||||+++++++......+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI----DENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS----CHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc----cHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            4568999999999999999999999999999999999764432    256789999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC--eEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~--vkl~Dfg~a~~~~~~~  168 (344)
                      +||||++|++|.+++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.  +||+|||+++...   
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~---  169 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV---  169 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc---
Confidence            99999999999999988889999999999999999999999999999999999999987765  9999999987322   


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc----HHHHHHHHhhCCCCCCC--CCCH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPK--WLSP  242 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~--~~~~  242 (344)
                      ........+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+..    .......+......+|.  .+++
T Consensus       170 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  249 (361)
T 3uc3_A          170 LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISP  249 (361)
T ss_dssp             -----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCH
T ss_pred             ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCH
Confidence            22233456799999999999888876666999999999999999999998743    34555666666666655  5899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      .+.+||.+||+.||++|||+.|+++||||.....
T Consensus       250 ~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~  283 (361)
T 3uc3_A          250 ECCHLISRIFVADPATRISIPEIKTHSWFLKNLP  283 (361)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence            9999999999999999999999999999976543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.2e-54  Score=391.01  Aligned_cols=259  Identities=35%  Similarity=0.610  Sum_probs=230.4

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      .-++|++.+.||+|+||.||+|.++.+|+.||+|++.+......   ...+.+.+|+.+++.++||||+++++++.....
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   88 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD   88 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence            44689999999999999999999999999999999976543211   135778999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC----CeEEeccccccCC
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALP  164 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~----~vkl~Dfg~a~~~  164 (344)
                      .++||||++|++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++    .+||+|||++...
T Consensus        89 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  168 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI  168 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence            999999999999999998888899999999999999999999999999999999999999887    7999999999754


Q ss_pred             CcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCC
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWL  240 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~  240 (344)
                      ..   .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++    ..+
T Consensus       169 ~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (326)
T 2y0a_A          169 DF---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  244 (326)
T ss_dssp             CT---TSCCCCCCSCTTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTS
T ss_pred             CC---CCccccccCCcCcCCceeecCCCC-CcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccC
Confidence            32   223345689999999999987666 6899999999999999999999999888888888877766654    468


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ++.+.+||.+||+.||++|||+.++++||||...
T Consensus       245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            9999999999999999999999999999999753

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.9e-54  Score=394.43  Aligned_cols=263  Identities=38%  Similarity=0.667  Sum_probs=223.4

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      -+++|++++.||+|+||.||+|.+..+++.||+|++......  ...+.+.+|+.+++.++||||+++++++......|+
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence            468999999999999999999999999999999998654322  234668899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      ||||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999997543322233


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHHhhCCCCC--CCCCCHHHHHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKL--PKWLSPGAQNLL  248 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~-~~~~~i~~~~~~~--~~~~~~~~~~li  248 (344)
                      .....+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.+.... .............  ...+++.+.+||
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  242 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALL  242 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHH
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHH
Confidence            3446789999999999988777678899999999999999999999875543 2222333332222  245899999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          249 RKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      .+||+.||++|||+.|+++||||++...
T Consensus       243 ~~~L~~dP~~R~t~~eil~h~~~~~~~~  270 (323)
T 3tki_A          243 HKILVENPSARITIPDIKKDRWYNKPLK  270 (323)
T ss_dssp             HHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHHccCChhhCcCHHHHhhChhhccccc
Confidence            9999999999999999999999986543

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=2.1e-54  Score=408.41  Aligned_cols=264  Identities=27%  Similarity=0.493  Sum_probs=228.9

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..+..++|+++++||+|+||.||+|+++.+++.||+|++.+...........+.+|..++..++||||+++++++.+...
T Consensus        69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  148 (437)
T 4aw2_A           69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN  148 (437)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence            34667899999999999999999999999999999999976443333334458889999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      +|+|||||+||+|.+++.+ .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~  228 (437)
T 4aw2_A          149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED  228 (437)
T ss_dssp             EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence            9999999999999999987 578999999999999999999999999999999999999999999999999999743221


Q ss_pred             cCCCccccccCCCcccchhhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CCCCCC---
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLPK---  238 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~~---  238 (344)
                       ........+||+.|+|||++..    ...++.++|||||||++|||++|+.||.+.+......++...  .+.+|.   
T Consensus       229 -~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  307 (437)
T 4aw2_A          229 -GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT  307 (437)
T ss_dssp             -SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred             -CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence             1112334689999999999872    333478999999999999999999999999988888888653  344454   


Q ss_pred             CCCHHHHHHHHHhcCCCcCC--CCCHhhhhcCccccc
Q 019216          239 WLSPGAQNLLRKILEPNPVK--RITIAGIKADEWFEQ  273 (344)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~--Rps~~eil~~~~~~~  273 (344)
                      .+++++++||++||..+|++  |++++|+++||||+.
T Consensus       308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence            48999999999999999988  999999999999974

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4.4e-54  Score=382.75  Aligned_cols=264  Identities=49%  Similarity=0.911  Sum_probs=230.7

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..+..++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.++||||+++++++.....
T Consensus         6 g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (276)
T 2h6d_A            6 GRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTD   85 (276)
T ss_dssp             -CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCe
Confidence            45778999999999999999999999999999999999976544344456788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      .++||||+++++|.+++...+.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....  
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~--  163 (276)
T 2h6d_A           86 FFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--  163 (276)
T ss_dssp             EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred             EEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC--
Confidence            999999999999999999888899999999999999999999999999999999999999999999999999875432  


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLL  248 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li  248 (344)
                       ........||+.|+|||.+.+..+.+.++||||||+++|+|++|+.||...+.......+..+....|..+++.+.++|
T Consensus       164 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  242 (276)
T 2h6d_A          164 -GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVATLL  242 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred             -CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHHHH
Confidence             2223456789999999999877665689999999999999999999999988888888888888888999999999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          249 RKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      .+||+.||++|||+.++++||||++..
T Consensus       243 ~~~l~~~p~~Rps~~~~l~h~~~~~~~  269 (276)
T 2h6d_A          243 MHMLQVDPLKRATIKDIREHEWFKQDL  269 (276)
T ss_dssp             HHHTCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHccCChhhCCCHHHHHhChhhccCc
Confidence            999999999999999999999998753

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3e-53  Score=381.05  Aligned_cols=266  Identities=35%  Similarity=0.607  Sum_probs=241.5

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++...+..
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~   90 (294)
T 2rku_A           11 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV   90 (294)
T ss_dssp             TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             CCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEE
Confidence            45678999999999999999999999999999999999876655566678899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      ++||||+++++|.+++...+.+++..++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.....  .
T Consensus        91 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~--~  168 (294)
T 2rku_A           91 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--D  168 (294)
T ss_dssp             EEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS--T
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceeccc--C
Confidence            99999999999999998888999999999999999999999999999999999999999999999999999875432  1


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR  249 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~  249 (344)
                      ........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+......+|..+++.+.++|.
T Consensus       169 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  247 (294)
T 2rku_A          169 GERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ  247 (294)
T ss_dssp             TCCBCCCCSCCSSCCHHHHTTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHH
T ss_pred             ccccccccCCCCcCCcchhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHHHHHHHH
Confidence            222345678999999999987666 6899999999999999999999999888888888888888899999999999999


Q ss_pred             HhcCCCcCCCCCHhhhhcCccccccCCCC
Q 019216          250 KILEPNPVKRITIAGIKADEWFEQDYTPA  278 (344)
Q Consensus       250 ~~L~~dP~~Rps~~eil~~~~~~~~~~~~  278 (344)
                      +||+.||++|||++++++||||.+...+.
T Consensus       248 ~~l~~~p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          248 KMLQTDPTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             HHcccChhhCcCHHHHhhChheecCCcCC
Confidence            99999999999999999999998765543

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.1e-54  Score=391.71  Aligned_cols=248  Identities=24%  Similarity=0.318  Sum_probs=193.0

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC----eE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI   89 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~   89 (344)
                      .+|.+.++||+|+||+||+|++  +|+.||||++....    ........|+..+.+++||||+++++++...+    .+
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~----~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~   76 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence            4689999999999999999997  58899999986432    11222345666677889999999999997643    68


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeecCCCCcEEEccCCCeEEeccccc
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~--------~i~H~dikp~NILl~~~~~vkl~Dfg~a  161 (344)
                      |+|||||++|+|.+++.+ .++++..+..++.|++.||+|||++        +|+||||||+|||++.++++||+|||+|
T Consensus        77 ~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            999999999999999976 5689999999999999999999987        9999999999999999999999999999


Q ss_pred             cCCCcccC--CCccccccCCCcccchhhhccCC-----CCCccchhhhhhHHHHHHHhCCCCCCCc--------------
Q 019216          162 ALPQHFRD--DGLLHTTCGSPNYVAPEVLANRG-----YDGATSDIWSCGVILYVILTGYLPFDDR--------------  220 (344)
Q Consensus       162 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~DvwslG~ll~ell~g~~pf~~~--------------  220 (344)
                      +.......  .......+||+.|+|||++.+..     .++.++|||||||++|||+||.+||...              
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            75432211  11223468999999999987542     1256899999999999999997765321              


Q ss_pred             -cHHHHHHHHhhCC--CCCCCC-----CCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          221 -NLAVLYQKIFRGD--FKLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       221 -~~~~~~~~i~~~~--~~~~~~-----~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                       ........+....  +.+|..     .+..+.+|+.+||+.||++|||+.|+++.
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence             2233444444332  233432     23468899999999999999999999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=4.1e-53  Score=387.46  Aligned_cols=265  Identities=35%  Similarity=0.612  Sum_probs=241.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++...+..+
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  117 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVF  117 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEE
Confidence            45679999999999999999999999999999999998766556667788999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      +||||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  ..
T Consensus       118 lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--~~  195 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DG  195 (335)
T ss_dssp             EEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS--TT
T ss_pred             EEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc--Cc
Confidence            9999999999999998888999999999999999999999999999999999999999999999999999875432  12


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK  250 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~  250 (344)
                      .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+......+|..+++.+.+||.+
T Consensus       196 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  274 (335)
T 2owb_A          196 ERKKVLCGTPNYIAPEVLSKKGH-SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK  274 (335)
T ss_dssp             CCBCCCCSCCSSCCHHHHHTSCB-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHH
T ss_pred             ccccccCCCccccCHHHhccCCC-CchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHHH
Confidence            23345679999999999987766 68999999999999999999999998888888888888888999999999999999


Q ss_pred             hcCCCcCCCCCHhhhhcCccccccCCCC
Q 019216          251 ILEPNPVKRITIAGIKADEWFEQDYTPA  278 (344)
Q Consensus       251 ~L~~dP~~Rps~~eil~~~~~~~~~~~~  278 (344)
                      ||+.||++|||+.++++|+||.....+.
T Consensus       275 ~l~~dp~~Rps~~ell~~~~~~~~~~~~  302 (335)
T 2owb_A          275 MLQTDPTARPTINELLNDEFFTSGYIPA  302 (335)
T ss_dssp             HTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             HccCChhHCcCHHHHhcCccccCCCccc
Confidence            9999999999999999999999876543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.4e-54  Score=387.29  Aligned_cols=262  Identities=36%  Similarity=0.647  Sum_probs=220.8

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc-----------------------hhHHHHHHHH
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-----------------------LKITDQIKRE   64 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-----------------------~~~~~~~~~E   64 (344)
                      ...+.+++|++.+.||+|+||.||+|.+..+++.||+|++.+.....                       ....+.+.+|
T Consensus         7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E   86 (298)
T 2zv2_A            7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE   86 (298)
T ss_dssp             ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred             CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence            34577899999999999999999999999999999999997643211                       1124568899


Q ss_pred             HHHHHhCCCCCccceeeEEee--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCC
Q 019216           65 IATLKLLKHPNVVRLHEVLAS--KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKL  142 (344)
Q Consensus        65 ~~~l~~l~h~niv~l~~~~~~--~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp  142 (344)
                      +.++++++||||+++++++..  ....++||||+++++|.+++ ..+++++..++.++.||+.||.|||++||+||||||
T Consensus        87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp  165 (298)
T 2zv2_A           87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKP  165 (298)
T ss_dssp             HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence            999999999999999999986  56899999999999998754 346799999999999999999999999999999999


Q ss_pred             CcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCC--CCccchhhhhhHHHHHHHhCCCCCCCc
Q 019216          143 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYVILTGYLPFDDR  220 (344)
Q Consensus       143 ~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslG~ll~ell~g~~pf~~~  220 (344)
                      +|||++.++.+||+|||++.....  .........||+.|+|||++.+...  .+.++|||||||++|+|++|+.||.+.
T Consensus       166 ~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          166 SNLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             GGEEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            999999999999999999875432  1222345689999999999876542  367899999999999999999999998


Q ss_pred             cHHHHHHHHhhCCCCCC--CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccc
Q 019216          221 NLAVLYQKIFRGDFKLP--KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE  272 (344)
Q Consensus       221 ~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~  272 (344)
                      +.......+......+|  ..+++.+.+||.+||+.||++|||+.|+++||||+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          244 RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             SHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             cHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            88877777777766555  46899999999999999999999999999999996

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.2e-54  Score=425.80  Aligned_cols=262  Identities=34%  Similarity=0.617  Sum_probs=237.5

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCC
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS   87 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~   87 (344)
                      ..+.+++|++++.||+|+||.||+|.++.+++.||||++.+.........+.+..|..++..+ .||+|+++++++.+.+
T Consensus       336 ~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~  415 (674)
T 3pfq_A          336 DRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMD  415 (674)
T ss_dssp             ----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSS
T ss_pred             ccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCC
Confidence            456789999999999999999999999999999999999865444444567788899999988 6999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.... 
T Consensus       416 ~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~-  494 (674)
T 3pfq_A          416 RLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-  494 (674)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC-
T ss_pred             EEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc-
Confidence            9999999999999999999888999999999999999999999999999999999999999999999999999974221 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL  247 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (344)
                       ........+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.+...+...+......+|..+++++.+|
T Consensus       495 -~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l  572 (674)
T 3pfq_A          495 -DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAI  572 (674)
T ss_dssp             -TTCCBCCCCSCSSSCCHHHHTCCCB-STHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHH
T ss_pred             -CCcccccccCCCcccCHhhhcCCCC-CccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHH
Confidence             2234556789999999999988777 68999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhcCCCcCCCCCH-----hhhhcCccccc
Q 019216          248 LRKILEPNPVKRITI-----AGIKADEWFEQ  273 (344)
Q Consensus       248 i~~~L~~dP~~Rps~-----~eil~~~~~~~  273 (344)
                      |++||+.||++||++     ++|++||||+.
T Consensus       573 i~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             HHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             HHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            999999999999998     99999999974

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=7.2e-54  Score=389.50  Aligned_cols=262  Identities=27%  Similarity=0.441  Sum_probs=208.0

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++.....  ......+.+|+.++++++||||+++++++...+..++
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   80 (317)
T 2pmi_A            3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTL   80 (317)
T ss_dssp             ----------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEE
T ss_pred             cccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEE
Confidence            45799999999999999999999999999999999975432  2234568899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           92 VLEYVTGGELFDKIASK------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      ||||++ ++|.+++...      ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        81 v~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  159 (317)
T 2pmi_A           81 VFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFG  159 (317)
T ss_dssp             EEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred             EEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence            999997 5999988753      358999999999999999999999999999999999999999999999999987543


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--C----------
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D----------  233 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~----------  233 (344)
                      .  .........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...  .          
T Consensus       160 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          160 I--PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             S--CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             C--CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            2  1222345678999999999987555578999999999999999999999998877766665431  0          


Q ss_pred             ----------------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCCC
Q 019216          234 ----------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA  278 (344)
Q Consensus       234 ----------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~~  278 (344)
                                            ...+..+++.+.+||.+||+.||++|||+.|+++||||.+.+.++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  304 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA  304 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence                                  001235788999999999999999999999999999999876554

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-54  Score=403.49  Aligned_cols=263  Identities=25%  Similarity=0.461  Sum_probs=227.4

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..+..++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|..++..++||||+++++++.+...
T Consensus        56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~  135 (412)
T 2vd5_A           56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY  135 (412)
T ss_dssp             HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred             ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence            45678999999999999999999999999999999999976543333445568899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      +|+||||++||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++.....
T Consensus       136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~  215 (412)
T 2vd5_A          136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD  215 (412)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence            999999999999999998754 7999999999999999999999999999999999999999999999999999754321


Q ss_pred             cCCCccccccCCCcccchhhhcc------CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CCCCC--
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLAN------RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP--  237 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~--  237 (344)
                       ........+||+.|+|||++..      ...++.++|||||||++|||++|+.||.+.+......++...  ...+|  
T Consensus       216 -~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  294 (412)
T 2vd5_A          216 -GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV  294 (412)
T ss_dssp             -SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred             -CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence             1112234689999999999873      223468999999999999999999999999888888887753  23333  


Q ss_pred             -CCCCHHHHHHHHHhcCCCcCCC---CCHhhhhcCccccc
Q 019216          238 -KWLSPGAQNLLRKILEPNPVKR---ITIAGIKADEWFEQ  273 (344)
Q Consensus       238 -~~~~~~~~~li~~~L~~dP~~R---ps~~eil~~~~~~~  273 (344)
                       ..+++++++||++||. +|.+|   |+++|+++||||..
T Consensus       295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~  333 (412)
T 2vd5_A          295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG  333 (412)
T ss_dssp             --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred             ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence             5799999999999999 99988   59999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.5e-54  Score=382.62  Aligned_cols=264  Identities=31%  Similarity=0.632  Sum_probs=209.3

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      .+..+++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.++++++||||+++++++.....
T Consensus         6 ~g~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   85 (278)
T 3cok_A            6 IGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNY   85 (278)
T ss_dssp             HCSSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSE
T ss_pred             cccccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCe
Confidence            46678999999999999999999999999999999999976544334446788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .++||||+++++|.+++... .++++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           86 VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999999999865 57999999999999999999999999999999999999999999999999998754321


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNL  247 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l  247 (344)
                        ........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+.......|..+++.+.+|
T Consensus       166 --~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  242 (278)
T 3cok_A          166 --HEKHYTLCGTPNYISPEIATRSAH-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDL  242 (278)
T ss_dssp             -----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHH
T ss_pred             --CCcceeccCCCCcCCcchhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHH
Confidence              122334678999999999877665 68999999999999999999999887766666666666677888899999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          248 LRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      |.+||+.||++|||+.++++||||.+..
T Consensus       243 i~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          243 IHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            9999999999999999999999998643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=1.9e-53  Score=392.17  Aligned_cols=259  Identities=32%  Similarity=0.646  Sum_probs=222.9

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      .-++|++.+.||+|+||.||+|.++.+|+.||+|++.......  ....+.+.+|+.+++.++||||+++++++.....+
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~  101 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGML  101 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence            3468999999999999999999999999999999986543211  11356789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC---eEEecccccc
Q 019216           90 YMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSA  162 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~---vkl~Dfg~a~  162 (344)
                      |+|||||+|++|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            9999999999998877542    35899999999999999999999999999999999999987654   9999999997


Q ss_pred             CCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----C
Q 019216          163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----K  238 (344)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~  238 (344)
                      ....  ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.. ......+..+....+    .
T Consensus       182 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~  257 (351)
T 3c0i_A          182 QLGE--SGLVAGGRVGTPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWS  257 (351)
T ss_dssp             ECCT--TSCBCCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHT
T ss_pred             EecC--CCeeecCCcCCcCccCHHHHcCCCC-CchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccccc
Confidence            5432  1222345689999999999988776 689999999999999999999998854 455666666666554    4


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .+++.+.+||.+||+.||++|||+.++++||||++.
T Consensus       258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            689999999999999999999999999999999863

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.6e-53  Score=412.35  Aligned_cols=261  Identities=30%  Similarity=0.444  Sum_probs=233.5

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..+..++|++++.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...
T Consensus       179 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  258 (576)
T 2acx_A          179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDA  258 (576)
T ss_dssp             SCCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             cCccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCE
Confidence            44778899999999999999999999999999999999976554444456678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           89 IYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      +|+||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus       259 l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~  338 (576)
T 2acx_A          259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE  338 (576)
T ss_dssp             EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc
Confidence            999999999999999998654  399999999999999999999999999999999999999999999999999975332


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc----cHHHHHHHHhhCCCCCCCCCCH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWLSP  242 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~~~  242 (344)
                         .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.    ....+...+......+|..+++
T Consensus       339 ---~~~~~~~~GT~~Y~APEvl~~~~~-~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~  414 (576)
T 2acx_A          339 ---GQTIKGRVGTVGYMAPEVVKNERY-TFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP  414 (576)
T ss_dssp             ---TCCEECCCSCGGGCCHHHHTTCEE-SSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             ---CccccccCCCccccCHHHHcCCCC-CccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCH
Confidence               223445689999999999988776 68999999999999999999999875    3466677777778888899999


Q ss_pred             HHHHHHHHhcCCCcCCCC-----CHhhhhcCccccc
Q 019216          243 GAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rp-----s~~eil~~~~~~~  273 (344)
                      ++.+||.+||+.||.+||     +++|+++||||+.
T Consensus       415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             HHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            999999999999999999     7899999999985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.7e-52  Score=374.05  Aligned_cols=260  Identities=37%  Similarity=0.701  Sum_probs=232.0

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .-++|++.+.||+|+||.||+|.++.+|+.||+|++..... .....+.+.+|+.++++++||||+++++++......++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYL   82 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEE
Confidence            45799999999999999999999999999999999976543 33456788899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC---eEEeccccccCCCccc
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSALPQHFR  168 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~---vkl~Dfg~a~~~~~~~  168 (344)
                      ||||+++++|.+.+.....+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|||++.....  
T Consensus        83 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~--  160 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND--  160 (284)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS--
T ss_pred             EEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc--
Confidence            9999999999999988889999999999999999999999999999999999999987665   99999999874332  


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCCCHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA  244 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~  244 (344)
                       ........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+.......+..+....+    ..+++.+
T Consensus       161 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          161 -SEAWHGFAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             -SCBCCCSCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             -CccccCCCCCcCCcCchhhcCCCC-CcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence             223345679999999999988776 6899999999999999999999999988888888888766554    3589999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          245 QNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      .+||.+||+.||++|||+.|+++||||++...
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~  270 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITADQALKVPWICNRER  270 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred             HHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence            99999999999999999999999999987543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.1e-53  Score=409.04  Aligned_cols=262  Identities=27%  Similarity=0.441  Sum_probs=234.4

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      .++..++|++++.||+|+||.||+|+++.+|+.||+|++.+...........+.+|+.++++++||||+++++++.....
T Consensus       180 ~~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~  259 (543)
T 3c4z_A          180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTD  259 (543)
T ss_dssp             SCCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             ccCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCE
Confidence            56788999999999999999999999999999999999976654444456788899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           89 IYMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                      +|+||||++|++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++..
T Consensus       260 l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~  339 (543)
T 3c4z_A          260 LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVEL  339 (543)
T ss_dssp             EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeec
Confidence            99999999999999998763    36999999999999999999999999999999999999999999999999999754


Q ss_pred             CcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc----cHHHHHHHHhhCCCCCCCCC
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR----NLAVLYQKIFRGDFKLPKWL  240 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~----~~~~~~~~i~~~~~~~~~~~  240 (344)
                      ..  ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.    ....+...+......+|..+
T Consensus       340 ~~--~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~  416 (543)
T 3c4z_A          340 KA--GQTKTKGYAGTPGFMAPELLLGEEY-DFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKF  416 (543)
T ss_dssp             CT--TCCCBCCCCSCTTTSCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTS
T ss_pred             cC--CCcccccccCCccccChhhhcCCCC-ChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCccc
Confidence            32  1222345689999999999988776 68999999999999999999999875    45677788888888899999


Q ss_pred             CHHHHHHHHHhcCCCcCCCCC-----HhhhhcCccccc
Q 019216          241 SPGAQNLLRKILEPNPVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps-----~~eil~~~~~~~  273 (344)
                      ++.+.+||++||+.||++||+     ++++++||||+.
T Consensus       417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence            999999999999999999996     488999999985

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.9e-53  Score=395.31  Aligned_cols=265  Identities=21%  Similarity=0.348  Sum_probs=219.8

Q ss_pred             ccccCeEEeeeeccc--CceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216           11 MRLGRYELGRTLGEG--NFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G--~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ...++|++++.||+|  +||.||+|.++.+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++...+.
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  100 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNE  100 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCE
Confidence            467899999999999  999999999999999999999976543 34567788999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           89 IYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      +++|||||++++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+.....
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          101 LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            99999999999999999875  6799999999999999999999999999999999999999999999999998764321


Q ss_pred             cc-----CCCccccccCCCcccchhhhccC-CCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-------
Q 019216          167 FR-----DDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------  233 (344)
Q Consensus       167 ~~-----~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-------  233 (344)
                      ..     ........+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||.+.+.......+..+.       
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  260 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDT  260 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccc
Confidence            11     11122345789999999999873 233689999999999999999999998755433333222211       


Q ss_pred             ---------------------------------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          234 ---------------------------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       234 ---------------------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                                                             .+.+..+++.+.+||.+||+.||++|||+.|+|+||||++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~  340 (389)
T 3gni_B          261 STIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  340 (389)
T ss_dssp             ---------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC
T ss_pred             cccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHH
Confidence                                                   12345578999999999999999999999999999999875


Q ss_pred             CC
Q 019216          275 YT  276 (344)
Q Consensus       275 ~~  276 (344)
                      ..
T Consensus       341 ~~  342 (389)
T 3gni_B          341 KR  342 (389)
T ss_dssp             --
T ss_pred             hh
Confidence            43

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=2.1e-53  Score=385.39  Aligned_cols=260  Identities=29%  Similarity=0.409  Sum_probs=215.3

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      ....++|++++.||+|+||+||+|.+. +|+.||+|++.... ........+.+|+.++++++||||+++++++......
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   94 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCL   94 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEE
Confidence            356789999999999999999999985 58999999986543 2334457788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ++||||+++ +|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  
T Consensus        95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--  171 (311)
T 3niz_A           95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI--  171 (311)
T ss_dssp             EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTS--
T ss_pred             EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCC--
Confidence            999999975 888877654 4599999999999999999999999999999999999999999999999999975432  


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CC------------
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF------------  234 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~------------  234 (344)
                      .........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...  ..            
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  251 (311)
T 3niz_A          172 PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELP  251 (311)
T ss_dssp             CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSH
T ss_pred             CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccc
Confidence            1222344678999999999987655578999999999999999999999876655544444321  00            


Q ss_pred             ----------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          235 ----------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       235 ----------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                                      .....+++++.+||.+||+.||++|||++|+++||||++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          252 LWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             HHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             hhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence                            0113367899999999999999999999999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-53  Score=392.03  Aligned_cols=262  Identities=29%  Similarity=0.570  Sum_probs=230.4

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      .+...++|++++.||+|+||.||+|.++.+|+.||+|++....   ......+.+|+.+++.++||||+++++++.....
T Consensus        46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~  122 (387)
T 1kob_A           46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  122 (387)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence            4456789999999999999999999999999999999986543   2334578899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc--CCCeEEeccccccCCC
Q 019216           89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQ  165 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~--~~~vkl~Dfg~a~~~~  165 (344)
                      .++||||+.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++....
T Consensus       123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~  202 (387)
T 1kob_A          123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  202 (387)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence            99999999999999998754 37999999999999999999999999999999999999974  4689999999998543


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCCC
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS  241 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~  241 (344)
                      .   .......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++    ..++
T Consensus       203 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  278 (387)
T 1kob_A          203 P---DEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS  278 (387)
T ss_dssp             T---TSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred             C---CcceeeeccCCCccCchhccCCCC-CCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCC
Confidence            2   223445689999999999987766 6899999999999999999999999888888888887765543    4589


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      +++.+||.+||+.||++|||+.++++||||......
T Consensus       279 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  314 (387)
T 1kob_A          279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN  314 (387)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhhCccccCCccc
Confidence            999999999999999999999999999999875443

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.9e-53  Score=396.05  Aligned_cols=262  Identities=31%  Similarity=0.421  Sum_probs=211.7

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCC--
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKS--   87 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~--   87 (344)
                      ..+++|++++.||+|+||.||+|.++.+|+.||+|++.+. .........+.+|+.+++.+. ||||+++++++...+  
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~   84 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDR   84 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSS
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCC
Confidence            4568999999999999999999999999999999998643 334455677889999999997 999999999997544  


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+|+|||||. ++|.+++.. +.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           85 DVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             CEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred             EEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence            7899999996 589888876 57999999999999999999999999999999999999999999999999999753221


Q ss_pred             c-------------------CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHH
Q 019216          168 R-------------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK  228 (344)
Q Consensus       168 ~-------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~  228 (344)
                      .                   ........+||+.|+|||++.+...++.++|||||||++|+|++|++||.+.+.......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  242 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER  242 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            0                   112234468999999999998755557899999999999999999999999887776666


Q ss_pred             HhhCC-C----------------------------------------------CCCCCCCHHHHHHHHHhcCCCcCCCCC
Q 019216          229 IFRGD-F----------------------------------------------KLPKWLSPGAQNLLRKILEPNPVKRIT  261 (344)
Q Consensus       229 i~~~~-~----------------------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps  261 (344)
                      +.... .                                              ..+..+++++.+||.+||+.||++|||
T Consensus       243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t  322 (388)
T 3oz6_A          243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS  322 (388)
T ss_dssp             HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence            54210 0                                              011257899999999999999999999


Q ss_pred             HhhhhcCccccccC
Q 019216          262 IAGIKADEWFEQDY  275 (344)
Q Consensus       262 ~~eil~~~~~~~~~  275 (344)
                      ++|+|+||||....
T Consensus       323 ~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          323 ANDALKHPFVSIFH  336 (388)
T ss_dssp             HHHHTTSTTTTTTC
T ss_pred             HHHHhCCHHHHHhc
Confidence            99999999997643

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2e-53  Score=381.24  Aligned_cols=257  Identities=32%  Similarity=0.496  Sum_probs=214.8

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +++|++++.||+|+||.||+|.+ .+|+.||+|++..... .......+.+|+.++++++||||+++++++...+..++|
T Consensus         1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (288)
T 1ob3_A            1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (288)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence            57999999999999999999998 7789999999865432 223346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |||+++ +|.+++... +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....  ...
T Consensus        79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~  155 (288)
T 1ob3_A           79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVR  155 (288)
T ss_dssp             EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc--ccc
Confidence            999975 998888764 6799999999999999999999999999999999999999999999999999874321  112


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CC---------------
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF---------------  234 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~---------------  234 (344)
                      ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...  ..               
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD  235 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence            2334578999999999977655578999999999999999999999988776666555431  00               


Q ss_pred             ------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          235 ------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       235 ------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                                  .+...+++.+.+||.+||+.||++|||++|+++||||++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                        1123478999999999999999999999999999999863

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.8e-53  Score=381.20  Aligned_cols=260  Identities=28%  Similarity=0.427  Sum_probs=217.7

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.++++++||||+++++++......++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence            689999999999999999999999999999999986543 3344567788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....  ....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~  158 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSDY  158 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--cccc
Confidence            99999999999888888899999999999999999999999999999999999999999999999999975432  1222


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC-------------------C
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------------D  233 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~-------------------~  233 (344)
                      .....||+.|+|||++.+....+.++||||||+++|+|++|+.||.+.+.......+...                   .
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            345678999999999987555578999999999999999999999987766555443321                   0


Q ss_pred             CCCC------------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          234 FKLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       234 ~~~~------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      ...+            ..+++.+.+||.+||+.||++|||++|+++||||++..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence            0111            34788999999999999999999999999999998743

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.8e-53  Score=374.35  Aligned_cols=258  Identities=37%  Similarity=0.680  Sum_probs=231.4

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      +...++|++.+.||+|+||.||+|.+..++..||+|.+.+....   ..+.+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   81 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVE---DVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDI   81 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeE
Confidence            34567899999999999999999999999999999998765432   356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE---ccCCCeEEeccccccCCCc
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl---~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ++||||+++++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++.... 
T Consensus        82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~-  160 (277)
T 3f3z_A           82 YLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK-  160 (277)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC-
T ss_pred             EEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc-
Confidence            9999999999999999988899999999999999999999999999999999999999   778899999999987433 


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCC----CCCH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSP  242 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~  242 (344)
                        .........||+.|+|||++.+.  .+.++||||||+++|+|++|+.||.+.+.......+..+....|.    .+++
T Consensus       161 --~~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (277)
T 3f3z_A          161 --PGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSP  236 (277)
T ss_dssp             --TTSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCH
T ss_pred             --CccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCH
Confidence              22334556799999999998654  468999999999999999999999999888888888888877764    6899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      .+.+||.+||+.||++|||+.++++||||++..
T Consensus       237 ~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          237 QAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            999999999999999999999999999998643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.7e-53  Score=387.71  Aligned_cols=263  Identities=27%  Similarity=0.390  Sum_probs=213.3

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      ..+..+++|++++.||+|+||+||+|.+..+++.||+|++..... .......+.+|+.++++++||||+++++++....
T Consensus        28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (329)
T 3gbz_A           28 PSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNH  106 (329)
T ss_dssp             ----CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETT
T ss_pred             CcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCC
Confidence            466889999999999999999999999999999999999965432 3334566789999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEc-----cCCCeEEecccccc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-----SKGNIKISDFGLSA  162 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~-----~~~~vkl~Dfg~a~  162 (344)
                      ..++||||+.| +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++     .++.+||+|||++.
T Consensus       107 ~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~  185 (329)
T 3gbz_A          107 RLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR  185 (329)
T ss_dssp             EEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHH
T ss_pred             EEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCcc
Confidence            99999999975 9999999888999999999999999999999999999999999999995     44559999999987


Q ss_pred             CCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--CC-----
Q 019216          163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FK-----  235 (344)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--~~-----  235 (344)
                      ....  .........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....  ..     
T Consensus       186 ~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  263 (329)
T 3gbz_A          186 AFGI--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP  263 (329)
T ss_dssp             HHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccCC--cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhh
Confidence            4321  12223455789999999999876655789999999999999999999999888776666654321  00     


Q ss_pred             -----------C------------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          236 -----------L------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       236 -----------~------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                                 +            +..+++++.+||.+||+.||++|||++|+|+||||++.
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             TGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             hhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence                       0            01167899999999999999999999999999999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=1.5e-52  Score=404.12  Aligned_cols=264  Identities=35%  Similarity=0.647  Sum_probs=231.2

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch----------hHHHHHHHHHHHHHhCCCCCccc
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL----------KITDQIKREIATLKLLKHPNVVR   78 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~h~niv~   78 (344)
                      .+...++|+++++||+|+||+||+|.++.+++.||+|++.+......          ...+.+.+|+.++++++||||++
T Consensus        31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~  110 (504)
T 3q5i_A           31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK  110 (504)
T ss_dssp             CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred             CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence            44567899999999999999999999999999999999976543221          34567899999999999999999


Q ss_pred             eeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC---CeEE
Q 019216           79 LHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKI  155 (344)
Q Consensus        79 l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~---~vkl  155 (344)
                      +++++.....+|+|||||+|++|.+.+.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||
T Consensus       111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl  190 (504)
T 3q5i_A          111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI  190 (504)
T ss_dssp             EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred             EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence            9999999999999999999999999999888999999999999999999999999999999999999998876   6999


Q ss_pred             eccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC
Q 019216          156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK  235 (344)
Q Consensus       156 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~  235 (344)
                      +|||++.....   .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+..+...
T Consensus       191 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~  265 (504)
T 3q5i_A          191 VDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY  265 (504)
T ss_dssp             CCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred             EECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999975432   233456689999999999864 44 68999999999999999999999999999999999988776


Q ss_pred             CC----CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          236 LP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       236 ~~----~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      ++    ..+++.+++||++||+.||.+|||++++|+||||+.....
T Consensus       266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~  311 (504)
T 3q5i_A          266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN  311 (504)
T ss_dssp             CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred             CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence            65    5689999999999999999999999999999999875443

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.5e-52  Score=381.39  Aligned_cols=260  Identities=34%  Similarity=0.581  Sum_probs=231.1

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      ....++|++.+.||+|+||.||+|.++.+|+.||+|++........   ...+.+.+|+.+++.++||||+++++++...
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   87 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR   87 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence            3456789999999999999999999999999999999976543221   1357789999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC----CeEEecccccc
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSA  162 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~----~vkl~Dfg~a~  162 (344)
                      ...++||||+++++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||++.++    .+||+|||++.
T Consensus        88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            99999999999999999999888899999999999999999999999999999999999999888    79999999997


Q ss_pred             CCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----C
Q 019216          163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----K  238 (344)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~  238 (344)
                      ....   ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.......+......++    .
T Consensus       168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  243 (321)
T 2a2a_A          168 EIED---GVEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS  243 (321)
T ss_dssp             ECCT---TCCCCCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred             ecCc---cccccccCCCCCccCcccccCCCC-CCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence            5432   223345679999999999987666 6899999999999999999999999888888888887766654    5


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      .+++.+.+||.+||+.||++|||+.++++||||..
T Consensus       244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence            68999999999999999999999999999999975

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=3.2e-53  Score=406.84  Aligned_cols=261  Identities=37%  Similarity=0.654  Sum_probs=233.6

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      ...++|++.+.||+|+||.||+|.++.+|+.||+|++.+...........+.+|+.++++++||||+++++++.....++
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  102 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY  102 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            44578999999999999999999999999999999997765544455678999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE---ccCCCeEEeccccccCCCcc
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl---~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      +|||||.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....  
T Consensus       103 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~--  180 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE--  180 (484)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC--
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc--
Confidence            999999999999999988899999999999999999999999999999999999999   567899999999987432  


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCCCHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG  243 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~  243 (344)
                       ........+||+.|+|||++.+ .+ +.++|||||||++|+|++|++||.+.+.......+..+...++    ..+++.
T Consensus       181 -~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  257 (484)
T 3nyv_A          181 -ASKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES  257 (484)
T ss_dssp             -CCCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHH
T ss_pred             -cccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHH
Confidence             2233455689999999999876 44 6899999999999999999999999999888989888865543    358999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      +++||++||+.||++|||+.++|+||||+....
T Consensus       258 ~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~  290 (484)
T 3nyv_A          258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTK  290 (484)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred             HHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence            999999999999999999999999999986543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.4e-53  Score=384.61  Aligned_cols=254  Identities=38%  Similarity=0.730  Sum_probs=204.1

Q ss_pred             ccCeEEe---eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCe
Q 019216           13 LGRYELG---RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSK   88 (344)
Q Consensus        13 ~~~y~~~---~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~   88 (344)
                      ..+|++.   +.||+|+||.||+|.++.+++.||+|++.+.      ....+.+|+.+++.+. ||||+++++++.+...
T Consensus         7 ~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~   80 (325)
T 3kn6_A            7 YQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH   80 (325)
T ss_dssp             HHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             hhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE
Confidence            4578875   7899999999999999999999999998643      2456788999999997 9999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC---CeEEeccccccCCC
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQ  165 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~---~vkl~Dfg~a~~~~  165 (344)
                      .|+||||++|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~  160 (325)
T 3kn6_A           81 TFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP  160 (325)
T ss_dssp             EEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECC
T ss_pred             EEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecC
Confidence            999999999999999999988999999999999999999999999999999999999998766   79999999997433


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc-------HHHHHHHHhhCCCCCCC
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-------LAVLYQKIFRGDFKLPK  238 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~-------~~~~~~~i~~~~~~~~~  238 (344)
                      .  ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+       .......+..+...++.
T Consensus       161 ~--~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~  237 (325)
T 3kn6_A          161 P--DNQPLKTPCFTLHYAAPELLNQNGY-DESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEG  237 (325)
T ss_dssp             C------------------------CCC-CHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCS
T ss_pred             C--CCCcccccCCCcCccCHHHhcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCc
Confidence            2  2223445678999999999987776 689999999999999999999997643       35667777777766653


Q ss_pred             ----CCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          239 ----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       239 ----~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                          .+++++.+||.+||+.||++|||+.++++||||++..
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~  278 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS  278 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence                4899999999999999999999999999999998643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.8e-53  Score=389.46  Aligned_cols=253  Identities=37%  Similarity=0.639  Sum_probs=221.7

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~   90 (344)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++.+...       ...+|+.++.++ +||||+++++++.+....|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~   92 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVY   92 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEE
Confidence            35689999999999999999999999999999999976542       234688888777 7999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC-C---CeEEeccccccCCCc
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-G---NIKISDFGLSALPQH  166 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~-~---~vkl~Dfg~a~~~~~  166 (344)
                      +|||||+|++|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||+..+ +   .+||+|||++.....
T Consensus        93 lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           93 VVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             EEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            999999999999999988899999999999999999999999999999999999998543 3   599999999975432


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhhCCCCCC----CC
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKLP----KW  239 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~---~~~~~~~~~i~~~~~~~~----~~  239 (344)
                        ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+   .+...+...+..+.+.++    ..
T Consensus       173 --~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  249 (342)
T 2qr7_A          173 --ENGLLMTPCYTANFVAPEVLERQGY-DAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNS  249 (342)
T ss_dssp             --TTCCBCCSSCCSSCCCHHHHHHHHH-HHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTT
T ss_pred             --CCCceeccCCCccccCHHHhcCCCC-CCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccccc
Confidence              2233456789999999999987666 5899999999999999999999986   456777888888877655    45


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +++.+.+||++||+.||++|||+.++++||||.+.
T Consensus       250 ~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          250 VSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            89999999999999999999999999999999753

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.1e-53  Score=385.04  Aligned_cols=261  Identities=25%  Similarity=0.380  Sum_probs=213.9

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +++|++++.||+|+||.||+|.+..+++.||+|++......  .....+.+|+.+++.++||||+++++++......++|
T Consensus         1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   78 (324)
T 3mtl_A            1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV   78 (324)
T ss_dssp             CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence            57999999999999999999999999999999998643321  1112345799999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |||+. ++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....  ...
T Consensus        79 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~  155 (324)
T 3mtl_A           79 FEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTK  155 (324)
T ss_dssp             EECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred             ecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC--Ccc
Confidence            99996 5898888764 4599999999999999999999999999999999999999999999999999875432  122


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-----------------
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-----------------  234 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-----------------  234 (344)
                      ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.....                 
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            234557899999999998755557899999999999999999999999887776666544100                 


Q ss_pred             -------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCCC
Q 019216          235 -------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA  278 (344)
Q Consensus       235 -------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~~  278 (344)
                                   ..+..+++++.+||.+||+.||++|||++|+|+||||.+.....
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~  292 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI  292 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTT
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccc
Confidence                         01124688999999999999999999999999999998765543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.5e-52  Score=372.68  Aligned_cols=258  Identities=36%  Similarity=0.631  Sum_probs=221.7

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      +|...++|++.+.||+|+||.||+|.+..++..+|+|++.....  ....+.+.+|+.++++++||||+++++++.....
T Consensus        17 ~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   94 (285)
T 3is5_A           17 QGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHN   94 (285)
T ss_dssp             SSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             CCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHHheecCCe
Confidence            56667899999999999999999999999999999999876542  2235778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE---ccCCCeEEeccccc
Q 019216           89 IYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLS  161 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl---~~~~~vkl~Dfg~a  161 (344)
                      .++||||+++++|.+.+..    ...+++..++.++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a  174 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA  174 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecc
Confidence            9999999999999998854    3679999999999999999999999999999999999999   45578999999999


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC---C
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP---K  238 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~---~  238 (344)
                      .....   ........||+.|+|||++.. .+ +.++||||||+++|+|++|+.||.+.+.......+.......+   .
T Consensus       175 ~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  249 (285)
T 3is5_A          175 ELFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECR  249 (285)
T ss_dssp             CC-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--C
T ss_pred             eecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccC
Confidence            75432   223345679999999999864 34 6899999999999999999999999888877777766654443   3


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      .+++.+.+||.+||+.||++|||+.|+++||||++
T Consensus       250 ~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          250 PLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            47999999999999999999999999999999986

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.4e-52  Score=399.76  Aligned_cols=262  Identities=29%  Similarity=0.385  Sum_probs=201.8

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee-----CC
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-----KS   87 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----~~   87 (344)
                      -++|++++.||+|+||.||+|.++.+|+.||||++.+. .......+++.+|+.+|+.++||||+++++++..     ..
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~  130 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD  130 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence            47899999999999999999999999999999998653 3344556789999999999999999999999843     35


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+|+||||+ +++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus       131 ~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~  209 (458)
T 3rp9_A          131 ELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYP  209 (458)
T ss_dssp             CEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSC
T ss_pred             eEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCc
Confidence            799999998 6799999998888999999999999999999999999999999999999999999999999999865322


Q ss_pred             cCC-------------------------CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh----------
Q 019216          168 RDD-------------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT----------  212 (344)
Q Consensus       168 ~~~-------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~----------  212 (344)
                      ...                         ......+||++|+|||++.....++.++|||||||++|||++          
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~  289 (458)
T 3rp9_A          210 ENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHA  289 (458)
T ss_dssp             TTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGG
T ss_pred             cccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccc
Confidence            111                         123456889999999987655545789999999999999999          


Q ss_pred             -CCCCCCCccH--------------------HHHHHHHhh--C--------------------C---------CCCCCCC
Q 019216          213 -GYLPFDDRNL--------------------AVLYQKIFR--G--------------------D---------FKLPKWL  240 (344)
Q Consensus       213 -g~~pf~~~~~--------------------~~~~~~i~~--~--------------------~---------~~~~~~~  240 (344)
                       |+++|.+.+.                    ......+..  +                    .         ......+
T Consensus       290 ~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  369 (458)
T 3rp9_A          290 DRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPAS  369 (458)
T ss_dssp             GCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTS
T ss_pred             cccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCC
Confidence             7778866431                    111111110  0                    0         0011346


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      ++++.+||++||+.||++|||++|+|+||||++...
T Consensus       370 s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~  405 (458)
T 3rp9_A          370 SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI  405 (458)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred             CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence            899999999999999999999999999999987543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=9.8e-53  Score=400.78  Aligned_cols=257  Identities=28%  Similarity=0.428  Sum_probs=212.5

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC-----
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----   86 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----   86 (344)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++.+. .......+++.+|+.+++.++||||+++++++...     
T Consensus        60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~  138 (464)
T 3ttj_A           60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE  138 (464)
T ss_dssp             EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESG-GGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcc-ccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence            368999999999999999999999999999999999754 23445567889999999999999999999999654     


Q ss_pred             -CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 -~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                       ..+|+||||+.+ +|.+.+.  ..+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus       139 ~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          139 FQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             CCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             CCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence             467999999965 5666664  358999999999999999999999999999999999999999999999999998543


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-----------
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-----------  234 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-----------  234 (344)
                      .   .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......++.....           
T Consensus       216 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          216 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             ----CCCC----CCCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             C---CcccCCCcccccccCHHHHcCCCC-CHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            2   233456789999999999988776 6899999999999999999999999887776666543100           


Q ss_pred             ----------------CC----CCC-----------CCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          235 ----------------KL----PKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       235 ----------------~~----~~~-----------~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                                      .+    |..           .++++.+||.+||+.||++|||++|+|+||||+....
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~  364 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  364 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence                            00    000           1567999999999999999999999999999986543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-52  Score=377.91  Aligned_cols=259  Identities=31%  Similarity=0.411  Sum_probs=213.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhCC---CCCccceeeEEee
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLK---HPNVVRLHEVLAS   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~   85 (344)
                      +..++|++++.||+|+||+||+|.+..+++.||+|++......  .......+.+|+.+++.++   ||||+++++++..
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~   85 (308)
T 3g33_A            6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT   85 (308)
T ss_dssp             ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence            4568999999999999999999999999999999998743321  1112345667777777664   9999999999977


Q ss_pred             CC-----eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecc
Q 019216           86 KS-----KIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF  158 (344)
Q Consensus        86 ~~-----~~~iv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Df  158 (344)
                      ..     ..+++|||+. ++|.+++.....  +++..++.++.||+.||+|||++||+||||||+|||++.++.+||+||
T Consensus        86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df  164 (308)
T 3g33_A           86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF  164 (308)
T ss_dssp             CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred             cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence            55     5899999996 599999987554  999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--C--
Q 019216          159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--F--  234 (344)
Q Consensus       159 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--~--  234 (344)
                      |++.....   .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......++....  .  
T Consensus       165 g~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  240 (308)
T 3g33_A          165 GLARIYSY---QMALTPVVVTLWYRAPEVLLQSTY-ATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE  240 (308)
T ss_dssp             SCTTTSTT---CCCSGGGGCCCSSCCHHHHHTSCC-CSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             ccccccCC---CcccCCccccccccCchHHcCCCC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence            99975432   233456789999999999988776 689999999999999999999999988777776665321  0  


Q ss_pred             -C----------------------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          235 -K----------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       235 -~----------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                       .                      ....+++.+.+||.+||+.||++|||+.|+|+||||++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          241 DDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             TTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence             0                      113478999999999999999999999999999999864

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.2e-52  Score=402.90  Aligned_cols=263  Identities=37%  Similarity=0.647  Sum_probs=230.7

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      ..+...++|++++.||+|+||+||+|.++.+++.||+|++.+..... .....+.+|+.++++++||||+++++++....
T Consensus        16 ~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   94 (486)
T 3mwu_A           16 FQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSS   94 (486)
T ss_dssp             TCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred             ccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCC
Confidence            35567789999999999999999999999999999999997543222 23567889999999999999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEc---cCCCeEEeccccccCC
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALP  164 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~---~~~~vkl~Dfg~a~~~  164 (344)
                      .+|+|||||.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        95 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A           95 SFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            9999999999999999998888999999999999999999999999999999999999995   4567999999999753


Q ss_pred             CcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCC
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWL  240 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~  240 (344)
                      ..   .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+.+.......+..+...++    ..+
T Consensus       175 ~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  249 (486)
T 3mwu_A          175 QQ---NTKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI  249 (486)
T ss_dssp             CC---C----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGS
T ss_pred             CC---CCccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCC
Confidence            32   233455689999999999875 34 6899999999999999999999999999888888888765543    348


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      ++.+++||.+||+.||++|||+.++|+||||+....
T Consensus       250 s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~  285 (486)
T 3mwu_A          250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS  285 (486)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence            999999999999999999999999999999987543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.5e-52  Score=384.28  Aligned_cols=255  Identities=35%  Similarity=0.668  Sum_probs=209.1

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .-++|++.+.||+|+||.||+|.+..+++.||+|++....     ..+.+.+|+.++++++||||+++++++......++
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l  125 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL  125 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence            4467999999999999999999999999999999987542     23567889999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc---CCCeEEeccccccCCCccc
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~---~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.   ++.+||+|||++.....  
T Consensus       126 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~--  203 (349)
T 2w4o_A          126 VLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH--  203 (349)
T ss_dssp             EECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------
T ss_pred             EEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc--
Confidence            9999999999999988888999999999999999999999999999999999999975   78999999999875432  


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhhCCCCCC----CCCCHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKLP----KWLSPG  243 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~----~~~~~~  243 (344)
                       .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+... ......+.......+    ..+++.
T Consensus       204 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  281 (349)
T 2w4o_A          204 -QVLMKTVCGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN  281 (349)
T ss_dssp             ----------CGGGSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             -ccccccccCCCCccCHHHhcCCCC-CcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence             223345689999999999987766 6899999999999999999999976554 346666666654433    458999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      +.+||.+||+.||++|||+.++++||||....
T Consensus       282 ~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  313 (349)
T 2w4o_A          282 AKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA  313 (349)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            99999999999999999999999999998643

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=5.8e-52  Score=392.48  Aligned_cols=264  Identities=27%  Similarity=0.382  Sum_probs=213.2

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC-----
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----   86 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----   86 (344)
                      .-++|++++.||+|+||.||+|.++.+++.||||++.+. .......+++.+|+.+|+.++||||+++++++...     
T Consensus        24 i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  102 (432)
T 3n9x_A           24 VPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKF  102 (432)
T ss_dssp             CCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTC
T ss_pred             ecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcC
Confidence            457999999999999999999999999999999999653 33445567899999999999999999999998765     


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ..+|+||||+. ++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          103 DELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             CCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             CeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            57999999995 59999999888899999999999999999999999999999999999999999999999999985433


Q ss_pred             ccCC--------------------CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-----------CCC
Q 019216          167 FRDD--------------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-----------GYL  215 (344)
Q Consensus       167 ~~~~--------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-----------g~~  215 (344)
                      ....                    ......+||++|+|||++.....++.++|||||||++|||++           |++
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p  261 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP  261 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccc
Confidence            2111                    123567899999999997655555799999999999999998           455


Q ss_pred             CCCCcc-----------------HHHHHHHHh------------------------hCCCCC-------CCCCCHHHHHH
Q 019216          216 PFDDRN-----------------LAVLYQKIF------------------------RGDFKL-------PKWLSPGAQNL  247 (344)
Q Consensus       216 pf~~~~-----------------~~~~~~~i~------------------------~~~~~~-------~~~~~~~~~~l  247 (344)
                      +|.+.+                 .......+.                        ......       ...+++.+.+|
T Consensus       262 ~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dL  341 (432)
T 3n9x_A          262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINL  341 (432)
T ss_dssp             SCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHH
T ss_pred             cCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHH
Confidence            554432                 011111111                        111111       13479999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          248 LRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      |++||+.||++|||++|+|+||||++...+
T Consensus       342 l~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  371 (432)
T 3n9x_A          342 LESMLKFNPNKRITIDQALDHPYLKDVRKK  371 (432)
T ss_dssp             HHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred             HHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence            999999999999999999999999875443

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=4.6e-53  Score=387.13  Aligned_cols=256  Identities=30%  Similarity=0.514  Sum_probs=224.0

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCccceeeEEe
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----KITDQIKREIATLKLLKHPNVVRLHEVLA   84 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~   84 (344)
                      +...++|++++.||+|+||.||+|.++.+++.||+|++.+......     .....+.+|+.++++++||||+++++++.
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~   99 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE   99 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            4456799999999999999999999999999999999976543221     13345778999999999999999999999


Q ss_pred             eCCeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           85 SKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~-~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      .....++||||+.++ +|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY  179 (335)
T ss_dssp             CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence            999999999998666 9999999888999999999999999999999999999999999999999999999999999975


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHH
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPG  243 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  243 (344)
                      ...   .......+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.....      ........|..+++.
T Consensus       180 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~~~~~~~~~~  250 (335)
T 3dls_A          180 LER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAIHPPYLVSKE  250 (335)
T ss_dssp             CCT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCCCCSSCCCHH
T ss_pred             CCC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhccCCCcccCHH
Confidence            432   23344568999999999998887767899999999999999999999976432      233455667779999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +.+||.+||+.||++|||+.++++||||.+.
T Consensus       251 l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            9999999999999999999999999999763

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.6e-52  Score=401.43  Aligned_cols=257  Identities=35%  Similarity=0.660  Sum_probs=223.8

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      ...++|++++.||+|+||+||+|.++.++..||+|++.+..... .....+.+|+.+++.++||||+++++++.....+|
T Consensus        34 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  112 (494)
T 3lij_A           34 HLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYY  112 (494)
T ss_dssp             CHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred             chhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEE
Confidence            34457999999999999999999999999999999997654322 23567889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC---CCeEEeccccccCCCcc
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQHF  167 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~---~~vkl~Dfg~a~~~~~~  167 (344)
                      +|||||+|++|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++..... 
T Consensus       113 lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~-  191 (494)
T 3lij_A          113 LVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN-  191 (494)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT-
T ss_pred             EEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC-
Confidence            999999999999999888899999999999999999999999999999999999999764   4599999999975432 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCCCHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG  243 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~  243 (344)
                        .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+.+.......+..+...++    ..+++.
T Consensus       192 --~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  267 (494)
T 3lij_A          192 --QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEG  267 (494)
T ss_dssp             --TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHH
T ss_pred             --CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHH
Confidence              233456789999999999864 44 6899999999999999999999999999999999988876654    358999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      +.+||.+||+.||.+|||+.++|+||||++
T Consensus       268 ~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          268 AKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             HHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence            999999999999999999999999999975

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.8e-53  Score=382.94  Aligned_cols=265  Identities=26%  Similarity=0.410  Sum_probs=224.2

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC-
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-   87 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-   87 (344)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++.............+.+|+.++++++||||+++++++.... 
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   86 (311)
T 3ork_A            7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETP   86 (311)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEET
T ss_pred             cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCC
Confidence            4456789999999999999999999999999999999998765556666788999999999999999999999986543 


Q ss_pred             ---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           88 ---KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        88 ---~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                         ..|+||||++|++|.+++...+++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        87 ~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           87 AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             TEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             CCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence               35999999999999999998889999999999999999999999999999999999999999999999999999754


Q ss_pred             CcccC-CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCC----CCC
Q 019216          165 QHFRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL----PKW  239 (344)
Q Consensus       165 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~  239 (344)
                      ..... ........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+...............    +..
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  245 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence            33211 122334578999999999987766 689999999999999999999999988777776666655433    245


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +++++.++|.+||+.||.+||++.+++.|+|++..
T Consensus       246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            89999999999999999999999999999999753

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.6e-52  Score=384.30  Aligned_cols=265  Identities=26%  Similarity=0.386  Sum_probs=220.7

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee-----
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-----   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-----   85 (344)
                      -.+++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++..     
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   92 (351)
T 3mi9_A           14 DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPY   92 (351)
T ss_dssp             CBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC----
T ss_pred             ccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeecccccc
Confidence            467999999999999999999999999999999999865433 22334567889999999999999999999876     


Q ss_pred             ---CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccc
Q 019216           86 ---KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus        86 ---~~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a  161 (344)
                         .+..++||||+.+ +|.+.+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        93 ~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           93 NRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             ----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             ccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence               4568999999975 77777764 457999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCccc--CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCC
Q 019216          162 ALPQHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW  239 (344)
Q Consensus       162 ~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  239 (344)
                      .......  .........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.......+..
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            7543221  12233456789999999999876655789999999999999999999999988777666665421111111


Q ss_pred             --------------------------------CCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          240 --------------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       240 --------------------------------~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                                      .++.+.+||.+||+.||++|||++|+|+||||.....+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  321 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP  321 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence                                            26789999999999999999999999999999875444

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=9.8e-52  Score=376.11  Aligned_cols=255  Identities=25%  Similarity=0.445  Sum_probs=223.1

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      ..|+..+.||+|+||.||+|.++.+|+.||||++.....   ...+.+.+|+.++++++||||+++++++......++||
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~  121 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLM  121 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEE
Confidence            358889999999999999999999999999999875432   23567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      ||++|++|.+++.+ ..+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....  .....
T Consensus       122 e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~  198 (321)
T 2c30_A          122 EFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--DVPKR  198 (321)
T ss_dssp             CCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCB
T ss_pred             ecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeeccc--Ccccc
Confidence            99999999998764 5799999999999999999999999999999999999999999999999999875432  12223


Q ss_pred             ccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC---CCCCCCHHHHHHHHH
Q 019216          174 HTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSPGAQNLLRK  250 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~li~~  250 (344)
                      ....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+.......+.....+   .+..+++.+.++|.+
T Consensus       199 ~~~~gt~~y~aPE~~~~~~~-~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  277 (321)
T 2c30_A          199 KSLVGTPYWMAPEVISRSLY-ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLER  277 (321)
T ss_dssp             CCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHH
T ss_pred             ccccCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHH
Confidence            45689999999999987666 68999999999999999999999988877777776665332   234589999999999


Q ss_pred             hcCCCcCCCCCHhhhhcCccccccC
Q 019216          251 ILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       251 ~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      ||+.||++|||+.++++||||.+..
T Consensus       278 ~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          278 MLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HccCChhhCcCHHHHhcChhhccCC
Confidence            9999999999999999999998643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=3.1e-52  Score=376.07  Aligned_cols=265  Identities=37%  Similarity=0.673  Sum_probs=228.3

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCccceeeEEe--eCCe
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSK   88 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~   88 (344)
                      .+++|++.+.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++.  ....
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            4689999999999999999999999999999999997543221 234578899999999999999999999984  4567


Q ss_pred             EEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           89 IYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      .++||||+.++ |.+++..  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  161 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHP  161 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             EEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCc
Confidence            89999999775 7777765  45699999999999999999999999999999999999999999999999999975543


Q ss_pred             ccCCCccccccCCCcccchhhhccCC-CCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ  245 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  245 (344)
                      ...........||+.|+|||++.+.. ..+.++||||||+++|+|++|+.||.+.+.......+..+...++..+++.+.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l~  241 (305)
T 2wtk_C          162 FAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS  241 (305)
T ss_dssp             TCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHHH
T ss_pred             cccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHHH
Confidence            33333344567999999999987643 23578999999999999999999999999888888998998889999999999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          246 NLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      +||.+||+.||.+|||+.++++||||++...+
T Consensus       242 ~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~  273 (305)
T 2wtk_C          242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP  273 (305)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred             HHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence            99999999999999999999999999876544

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4e-52  Score=385.51  Aligned_cols=257  Identities=29%  Similarity=0.405  Sum_probs=214.2

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC------
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------   86 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------   86 (344)
                      .++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...      
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~  102 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF  102 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence            478999999999999999999999999999999986532 3445567889999999999999999999999765      


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ..+|+||||+ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       103 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          103 TDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            3469999999 8899998876 6799999999999999999999999999999999999999999999999999985322


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-------------
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------  233 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-------------  233 (344)
                           ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....             
T Consensus       181 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          181 -----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             -----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             -----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence                 23456889999999998874445789999999999999999999999887766665554310             


Q ss_pred             ------------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          234 ------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       234 ------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                        .......++.+.+||.+||+.||++|||++++|+||||++...+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence                              01224578999999999999999999999999999999875443

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=7.1e-52  Score=375.71  Aligned_cols=262  Identities=34%  Similarity=0.591  Sum_probs=219.0

Q ss_pred             cCccccCeEEe-eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeC
Q 019216            9 EGMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASK   86 (344)
Q Consensus         9 ~~~~~~~y~~~-~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~   86 (344)
                      ++.-.++|++. +.||+|+||.||+|.+..+++.||||++.+...   .....+.+|+.++.++ +||||+++++++...
T Consensus         7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~   83 (316)
T 2ac3_A            7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEE   83 (316)
T ss_dssp             CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred             CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence            44556789996 789999999999999999999999999975532   3356788999999885 799999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC---eEEeccccccC
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSAL  163 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~---vkl~Dfg~a~~  163 (344)
                      +.+++||||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.   +||+|||++..
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~  163 (316)
T 2ac3_A           84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG  163 (316)
T ss_dssp             TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred             CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence            999999999999999999998889999999999999999999999999999999999999988776   99999999875


Q ss_pred             CCcccC-----CCccccccCCCcccchhhhcc-----CCCCCccchhhhhhHHHHHHHhCCCCCCCcc------------
Q 019216          164 PQHFRD-----DGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRN------------  221 (344)
Q Consensus       164 ~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~ll~ell~g~~pf~~~~------------  221 (344)
                      ......     .......+||+.|+|||++..     ..+ +.++|||||||++|+|++|+.||.+..            
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  242 (316)
T 2ac3_A          164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC  242 (316)
T ss_dssp             ------------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred             cccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence            432111     112234579999999999875     233 688999999999999999999997653            


Q ss_pred             ---HHHHHHHHhhCCCCCC----CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          222 ---LAVLYQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       222 ---~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                         .......+..+...+|    ..+++.+.+||.+||+.||++|||+.|+++||||+..
T Consensus       243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence               2445667777777766    3589999999999999999999999999999999864

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2.2e-52  Score=371.62  Aligned_cols=262  Identities=38%  Similarity=0.664  Sum_probs=224.6

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +++|++++.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++......++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEE
Confidence            5789999999999999999999999999999999875432  23457889999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |||+++++|.+++.....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...........
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            99999999999998777899999999999999999999999999999999999999999999999999875432222223


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHHhhCCCC--CCCCCCHHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFK--LPKWLSPGAQNLLR  249 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~-~~~~~i~~~~~~--~~~~~~~~~~~li~  249 (344)
                      .....||+.|+|||++.+..+.+.++||||||+++|+|++|+.||.+.... .....+......  ....+++.+.+||.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  243 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHH
Confidence            445679999999999987776667899999999999999999999875532 223333333222  23458999999999


Q ss_pred             HhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          250 KILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       250 ~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      +||+.||++|||++++++||||++...
T Consensus       244 ~~l~~~p~~Rps~~~il~~~~~~~~~~  270 (276)
T 2yex_A          244 KILVENPSARITIPDIKKDRWYNKPLK  270 (276)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred             HHCCCCchhCCCHHHHhcCccccChhh
Confidence            999999999999999999999987544

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.1e-52  Score=380.88  Aligned_cols=261  Identities=29%  Similarity=0.427  Sum_probs=220.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      ..+++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++......+
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  100 (331)
T 4aaa_A           22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY  100 (331)
T ss_dssp             BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence            57899999999999999999999999999999999986543 33445667889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      +||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....  ..
T Consensus       101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~  178 (331)
T 4aaa_A          101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA--PG  178 (331)
T ss_dssp             EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC--Cc
Confidence            9999999999988877778899999999999999999999999999999999999999999999999999975432  12


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC------------------
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------  232 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~------------------  232 (344)
                      .......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...                  
T Consensus       179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (331)
T 4aaa_A          179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF  258 (331)
T ss_dssp             -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred             cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence            23345678999999999987655578999999999999999999999987766555444321                  


Q ss_pred             -CCCCC------------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          233 -DFKLP------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       233 -~~~~~------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                       ....+            ..+++.+.+||.+||+.||++|||+.|+|+||||+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence             01111            2478999999999999999999999999999999753

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.2e-51  Score=381.95  Aligned_cols=258  Identities=32%  Similarity=0.591  Sum_probs=226.9

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhC-CCCCccceeeEEeeC
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLL-KHPNVVRLHEVLASK   86 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~   86 (344)
                      .++|++.+.||+|+||.||+|.++.+|+.||||++......     .....+.+.+|+.+++++ +||||+++++++...
T Consensus        93 ~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~  172 (365)
T 2y7j_A           93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS  172 (365)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS
T ss_pred             hhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC
Confidence            36799999999999999999999999999999998754311     123356788999999999 799999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ...++||||++|++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus       173 ~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~  252 (365)
T 2y7j_A          173 SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP  252 (365)
T ss_dssp             SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred             CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence            99999999999999999999888899999999999999999999999999999999999999999999999999875432


Q ss_pred             ccCCCccccccCCCcccchhhhccC-----CCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANR-----GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----  237 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----  237 (344)
                         .......+||+.|+|||++.+.     ...+.++|||||||++|+|++|+.||.+.+.......+..+....+    
T Consensus       253 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  329 (365)
T 2y7j_A          253 ---GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW  329 (365)
T ss_dssp             ---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred             ---CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence               2234557899999999998642     2236789999999999999999999999888888888877766554    


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      ..+++.+.+||.+||+.||++|||+.++++||||+.
T Consensus       330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          330 DDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            458899999999999999999999999999999963

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.5e-51  Score=370.37  Aligned_cols=260  Identities=25%  Similarity=0.392  Sum_probs=221.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +.-++|++++.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++++++||||+++++++...+..+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~   87 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY   87 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence            44578999999999999999999999999999999997766666667788999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      +||||++|++|.+++.+.+++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus        88 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  166 (294)
T 4eqm_A           88 LVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET-SL  166 (294)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc-cc
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999854321 11


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC-----CCCCCCHHHH
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-----LPKWLSPGAQ  245 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~  245 (344)
                      ......+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+......+......+     .+..+++.+.
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  245 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS  245 (294)
T ss_dssp             --------CCSSCCHHHHHTCCC-CTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHH
T ss_pred             cccCccccCccccCHhHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHH
Confidence            22334679999999999988766 68999999999999999999999998877666555554432     3466899999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhcCcccc
Q 019216          246 NLLRKILEPNPVKRITIAGIKADEWFE  272 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~~~~~~  272 (344)
                      ++|.+||+.||++||+..+.+.+.|..
T Consensus       246 ~li~~~l~~dp~~R~~~~~~l~~~l~~  272 (294)
T 4eqm_A          246 NVILRATEKDKANRYKTIQEMKDDLSS  272 (294)
T ss_dssp             HHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred             HHHHHHhcCCHhHccccHHHHHHHHHH
Confidence            999999999999999666666666643

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.1e-51  Score=379.87  Aligned_cols=255  Identities=25%  Similarity=0.391  Sum_probs=223.0

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      .+|++++.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.++++++||||+++++++......++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            56999999999999999999999999999999997665555556678999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           94 EYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~-~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||+. |+|.+.+. ...++++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....      
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~------  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC------
Confidence            9996 58878775 456799999999999999999999999999999999999999999999999999975432      


Q ss_pred             cccccCCCcccchhhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC--CCCCCCHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNLL  248 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li  248 (344)
                      .....||+.|+|||++..  ....+.++|||||||++|+|++|+.||.+.+.......+.....+  .+..+++.+.+||
T Consensus       207 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  286 (348)
T 1u5q_A          207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFV  286 (348)
T ss_dssp             BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred             CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHH
Confidence            235679999999999852  233468999999999999999999999988776666666655432  2456899999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          249 RKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      .+||+.||++|||++++++||||....
T Consensus       287 ~~~l~~dP~~Rps~~~ll~h~~~~~~~  313 (348)
T 1u5q_A          287 DSCLQKIPQDRPTSEVLLKHRFVLRER  313 (348)
T ss_dssp             HHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHcccChhhCcCHHHHhhChhhhccC
Confidence            999999999999999999999997643

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.3e-51  Score=369.21  Aligned_cols=264  Identities=31%  Similarity=0.521  Sum_probs=229.2

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccc------cchhHHHHHHHHHHHHHhCC-CCCccceee
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI------IHLKITDQIKREIATLKLLK-HPNVVRLHE   81 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~------~~~~~~~~~~~E~~~l~~l~-h~niv~l~~   81 (344)
                      .....++|++.+.||+|+||.||+|.++.+|+.||+|++.....      ......+.+.+|+.+++++. ||||+++++
T Consensus        12 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~   91 (298)
T 1phk_A           12 THGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD   91 (298)
T ss_dssp             ---CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             CcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence            34567899999999999999999999999999999999975431      11234567889999999996 999999999


Q ss_pred             EEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccc
Q 019216           82 VLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus        82 ~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a  161 (344)
                      ++......++||||+++++|.+++.....+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~  171 (298)
T 1phk_A           92 TYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS  171 (298)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             eeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccch
Confidence            99999999999999999999999998889999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhcc-----CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCC
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL  236 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~  236 (344)
                      .....   ........||+.|+|||++..     ....+.++||||||+++|+|++|..||.+.+.......+..+....
T Consensus       172 ~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  248 (298)
T 1phk_A          172 CQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQF  248 (298)
T ss_dssp             EECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC
T ss_pred             hhcCC---CcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCccc
Confidence            75332   223445679999999999852     2233689999999999999999999999988888888887776554


Q ss_pred             C----CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          237 P----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       237 ~----~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      +    ..+++.+.+||.+||+.||.+|||+.++++||||++..
T Consensus       249 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             CcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence            4    34789999999999999999999999999999998643

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1e-51  Score=368.85  Aligned_cols=259  Identities=34%  Similarity=0.622  Sum_probs=226.4

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++........   ...+.+.+|+.++++++||||+++++++.....
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~   82 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD   82 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence            34689999999999999999999999999999999976543221   235778999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC----CeEEeccccccCC
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALP  164 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~----~vkl~Dfg~a~~~  164 (344)
                      .++||||+++++|.+++.+...+++..++.++.||+.||.|||+.|++||||||+||+++.++    .+||+|||++...
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            999999999999999998888899999999999999999999999999999999999998877    8999999998743


Q ss_pred             CcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCC
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWL  240 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~  240 (344)
                      ..   ........||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+.......+.......+    ..+
T Consensus       163 ~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T 3bhy_A          163 EA---GNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT  238 (283)
T ss_dssp             C-----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             cC---CCcccccCCCcCccCcceecCCCC-CcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence            32   222345578999999999887665 6899999999999999999999999888888887777665544    568


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ++.+.+||.+||+.||++|||+.++++||||+..
T Consensus       239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            9999999999999999999999999999999864

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=6.5e-52  Score=384.75  Aligned_cols=254  Identities=33%  Similarity=0.555  Sum_probs=218.5

Q ss_pred             cCeEE--eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           14 GRYEL--GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        14 ~~y~~--~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      +.|++  .+.||+|+||.||+|.+..+|+.||+|++.....   ...+.+.+|+.++++++||||+++++++......++
T Consensus        87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred             cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            44555  6789999999999999999999999999975432   345678999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE--ccCCCeEEeccccccCCCccc
Q 019216           92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL--DSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl--~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+  +.++.+||+|||++.....  
T Consensus       164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~--  241 (373)
T 2x4f_A          164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP--  241 (373)
T ss_dssp             EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT--
T ss_pred             EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC--
Confidence            99999999999988653 469999999999999999999999999999999999999  5567899999999985432  


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCCCHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA  244 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~  244 (344)
                       .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......++    ..+++.+
T Consensus       242 -~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  319 (373)
T 2x4f_A          242 -REKLKVNFGTPEFLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA  319 (373)
T ss_dssp             -TCBCCCCCSSCTTCCHHHHTTCBC-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHH
T ss_pred             -ccccccccCCCcEeChhhccCCCC-CcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHH
Confidence             223345679999999999877665 6899999999999999999999999998888888888766554    4589999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          245 QNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .+||.+||+.||.+|||+.|+++||||.+.
T Consensus       320 ~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          320 KEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            999999999999999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.8e-52  Score=382.97  Aligned_cols=264  Identities=33%  Similarity=0.526  Sum_probs=222.0

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc--chhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII--HLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      -++|++++.||+|+||.||+|.+..+++.||+|++.+....  .....+.+.+|+.++++++||||+++++++......+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            36899999999999999999999999999999999754321  2345678999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 019216           91 MVLEYVTGGELFDKIAS----------------------------------------KGRLQEAEGRKLFQQLIDGVSYC  130 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~----------------------------------------~~~~~~~~~~~i~~ql~~~L~~L  130 (344)
                      +||||++|++|.+++..                                        ...+++..++.++.||+.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999998842                                        11236788899999999999999


Q ss_pred             HhCCceeecCCCCcEEEccCC--CeEEeccccccCCCcccCC--CccccccCCCcccchhhhccC-CCCCccchhhhhhH
Q 019216          131 HNKGVFHRDLKLENILLDSKG--NIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGV  205 (344)
Q Consensus       131 H~~~i~H~dikp~NILl~~~~--~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~  205 (344)
                      |+.||+||||||+|||++.++  .+||+|||++.........  .......||+.|+|||++.+. ...+.++|||||||
T Consensus       185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~  264 (345)
T 3hko_A          185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV  264 (345)
T ss_dssp             HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred             HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence            999999999999999998776  8999999999743322111  123456799999999998752 34478999999999


Q ss_pred             HHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCC----CCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          206 ILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       206 ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      ++|+|++|+.||.+.+.......+......++.    .+++.+.+||.+||+.||.+|||+.++++||||++...
T Consensus       265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence            999999999999998888888888877655442    37999999999999999999999999999999987543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=5.3e-52  Score=388.85  Aligned_cols=256  Identities=31%  Similarity=0.590  Sum_probs=211.3

Q ss_pred             cCccccCeEEe-eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCccceeeEEee-
Q 019216            9 EGMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLAS-   85 (344)
Q Consensus         9 ~~~~~~~y~~~-~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~-   85 (344)
                      .+..+++|.+. +.||+|+||.||+|.++.+|+.||||++...        ..+.+|+.++ +..+||||+++++++.. 
T Consensus        56 ~~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~  127 (400)
T 1nxk_A           56 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL  127 (400)
T ss_dssp             CSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred             CCcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeec
Confidence            45677899987 7899999999999999999999999998632        3466788887 45589999999999875 


Q ss_pred             ---CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc---CCCeEEec
Q 019216           86 ---KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISD  157 (344)
Q Consensus        86 ---~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~---~~~vkl~D  157 (344)
                         ...+|+|||||+|++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|
T Consensus       128 ~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~D  207 (400)
T 1nxk_A          128 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD  207 (400)
T ss_dssp             ETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECC
T ss_pred             ccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEe
Confidence               567899999999999999998643  5999999999999999999999999999999999999988   78999999


Q ss_pred             cccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH----HHHHHHhhCC
Q 019216          158 FGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA----VLYQKIFRGD  233 (344)
Q Consensus       158 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~----~~~~~i~~~~  233 (344)
                      ||+++....   .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..    .....+..+.
T Consensus       208 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~  283 (400)
T 1nxk_A          208 FGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ  283 (400)
T ss_dssp             CTTCEECC--------------CTTCCGGGSCCCCS-SSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTC
T ss_pred             cccccccCC---CCccccCCCCCCccCHhhcCCCCC-CCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCc
Confidence            999974322   223456789999999999877766 68999999999999999999999765432    2445555666


Q ss_pred             CCCC----CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          234 FKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       234 ~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      ..++    ..+++++.+||++||+.||++|||+.++++||||.+...
T Consensus       284 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~  330 (400)
T 1nxk_A          284 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK  330 (400)
T ss_dssp             CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred             ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence            5554    458999999999999999999999999999999986543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.1e-51  Score=372.63  Aligned_cols=257  Identities=36%  Similarity=0.672  Sum_probs=226.2

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      ....++|++.+.||+|+||.||+|.+..+|+.||+|++.....   ...+.+.+|+.+++.++||||+++++++......
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (304)
T 2jam_A            5 TNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHY   81 (304)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             cchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEE
Confidence            3455799999999999999999999999999999999975432   2235688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE---ccCCCeEEeccccccCCCc
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl---~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ++||||+++++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||+   +.++.+||+|||++.... 
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~-  160 (304)
T 2jam_A           82 YLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ-  160 (304)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC-
T ss_pred             EEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC-
Confidence            9999999999999999888899999999999999999999999999999999999999   778899999999987432 


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCCCH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSP  242 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~  242 (344)
                         ........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+.......+..+...++    ..+++
T Consensus       161 ---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  236 (304)
T 2jam_A          161 ---NGIMSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISE  236 (304)
T ss_dssp             ---CBTTHHHHSCCCBCCTTTBSSCSC-CHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCH
T ss_pred             ---CCccccccCCCCccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCH
Confidence               222345679999999999887665 6899999999999999999999999888888888887755443    56899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .+.+||.+||+.||++|||+.++++||||...
T Consensus       237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          237 SAKDFICHLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence            99999999999999999999999999999864

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.6e-51  Score=380.32  Aligned_cols=251  Identities=26%  Similarity=0.415  Sum_probs=215.7

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCccceeeEEee
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----HPNVVRLHEVLAS   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~~~~~~   85 (344)
                      +.-++|+++++||+|+||.||+|.+..+++.||+|++...    ......+..|+.+++.+.     ||||+++++++..
T Consensus        32 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~  107 (360)
T 3llt_A           32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY  107 (360)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred             EecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence            3457999999999999999999999999999999998642    234566788999999986     9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc--------------
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--------------  149 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~--------------  149 (344)
                      .+..++||||+ +++|.+++....  .+++..++.++.||+.||+|||++||+||||||+|||++.              
T Consensus       108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence            99999999999 999999998654  5999999999999999999999999999999999999975              


Q ss_pred             -----------CCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCC
Q 019216          150 -----------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFD  218 (344)
Q Consensus       150 -----------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~  218 (344)
                                 ++.+||+|||++.....     ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~ell~g~~pf~  260 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGW-DVSSDMWSFGCVLAELYTGSLLFR  260 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSCC
T ss_pred             ccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCC-CCccchHHHHHHHHHHHHCCCCCC
Confidence                       78999999999974322     2345689999999999988776 689999999999999999999999


Q ss_pred             CccHHHHHHHHhhCCCCCCC----------------------------------------------CCCHHHHHHHHHhc
Q 019216          219 DRNLAVLYQKIFRGDFKLPK----------------------------------------------WLSPGAQNLLRKIL  252 (344)
Q Consensus       219 ~~~~~~~~~~i~~~~~~~~~----------------------------------------------~~~~~~~~li~~~L  252 (344)
                      +.+.......+.....+.|.                                              ..++.+.+||.+||
T Consensus       261 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L  340 (360)
T 3llt_A          261 THEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSIL  340 (360)
T ss_dssp             CSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHC
T ss_pred             CCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHh
Confidence            87766665555433222211                                              12477889999999


Q ss_pred             CCCcCCCCCHhhhhcCcccc
Q 019216          253 EPNPVKRITIAGIKADEWFE  272 (344)
Q Consensus       253 ~~dP~~Rps~~eil~~~~~~  272 (344)
                      +.||++|||+.|+|+||||+
T Consensus       341 ~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          341 QIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CSSGGGSCCHHHHTTSGGGC
T ss_pred             cCChhhCCCHHHHhcCcccC
Confidence            99999999999999999995

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-52  Score=381.27  Aligned_cols=267  Identities=27%  Similarity=0.356  Sum_probs=216.5

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      .+...++|++++.||+|+||.||+|.+..+|+.||+|++.......  ......+.+|+.+++.++||||+++++++...
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   84 (346)
T 1ua2_A            5 VKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK   84 (346)
T ss_dssp             --------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred             hHHHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC
Confidence            3456789999999999999999999999999999999986543221  12234678999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      ...++||||+.+ +|.+.+... ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        85 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (346)
T 1ua2_A           85 SNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFG  163 (346)
T ss_dssp             TCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTT
T ss_pred             CceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceecc
Confidence            999999999976 888888754 468999999999999999999999999999999999999999999999999998543


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CC---CC----
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DF---KL----  236 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~---~~----  236 (344)
                      .  ........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+......++...  ..   ..    
T Consensus       164 ~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          164 S--PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             S--CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             C--CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            2  2223345688999999999977665578999999999999999999999998877776666542  00   00    


Q ss_pred             -------------------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCCC
Q 019216          237 -------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA  278 (344)
Q Consensus       237 -------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~~  278 (344)
                                         ...+++.+.+||.+||+.||++|||+.|+++||||.+...+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~  302 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPT  302 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCC
Confidence                               134678999999999999999999999999999998765443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.4e-51  Score=378.84  Aligned_cols=260  Identities=29%  Similarity=0.449  Sum_probs=218.9

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC-----Ce
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK   88 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~   88 (344)
                      ++|++++.||+|+||.||+|.+..+++.||+|++....  .......+.+|+.++++++||||+++++++...     ..
T Consensus        27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            49999999999999999999999999999999986432  344567889999999999999999999998654     46


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      .|+||||+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       105 ~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  182 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  182 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCC
Confidence            899999996 599988865 569999999999999999999999999999999999999999999999999998554322


Q ss_pred             C-CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--C------------
Q 019216          169 D-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D------------  233 (344)
Q Consensus       169 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~------------  233 (344)
                      . .......+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...  .            
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  262 (364)
T 3qyz_A          183 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  262 (364)
T ss_dssp             CBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             CccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence            2 122345689999999999876665578999999999999999999999887655555444321  0            


Q ss_pred             ------------C-----CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          234 ------------F-----KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       234 ------------~-----~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                  .     .....+++++.+||.+||+.||++|||+.|+|+||||++...+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~  323 (364)
T 3qyz_A          263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  323 (364)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence                        0     0124478999999999999999999999999999999876443

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-51  Score=381.04  Aligned_cols=264  Identities=31%  Similarity=0.586  Sum_probs=226.3

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhC-CCCCccceeeEE
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLL-KHPNVVRLHEVL   83 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~   83 (344)
                      ..+.+++|++++.||+|+||.||+|.+.   .+++.||||++.+.... .....+.+.+|+.+++.+ .||||+++++++
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  128 (355)
T 1vzo_A           49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF  128 (355)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence            3456789999999999999999999984   58999999998654321 122334567899999999 699999999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      ......++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.
T Consensus       129 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~  208 (355)
T 1vzo_A          129 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  208 (355)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             eeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCee
Confidence            99999999999999999999999888999999999999999999999999999999999999999999999999999874


Q ss_pred             CCcccCCCccccccCCCcccchhhhccC-CCCCccchhhhhhHHHHHHHhCCCCCCC----ccHHHHHHHHhhCCCCCCC
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIFRGDFKLPK  238 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~ll~ell~g~~pf~~----~~~~~~~~~i~~~~~~~~~  238 (344)
                      .... ........+||+.|+|||++.+. ...+.++|||||||++|+|++|+.||..    .....+...+......+|.
T Consensus       209 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  287 (355)
T 1vzo_A          209 FVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ  287 (355)
T ss_dssp             CCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred             cccC-CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCc
Confidence            3221 12223456899999999998753 3346889999999999999999999964    3345566677777888889


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCC-----CHhhhhcCccccc
Q 019216          239 WLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rp-----s~~eil~~~~~~~  273 (344)
                      .+++.+.+||.+||+.||.+||     |++++++||||+.
T Consensus       288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            9999999999999999999999     9999999999975

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6.5e-51  Score=365.07  Aligned_cols=254  Identities=24%  Similarity=0.444  Sum_probs=218.0

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee----CCeE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSKI   89 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~~   89 (344)
                      ..|++.+.||+|+||.||+|.+..++..||+|++..... .....+.+.+|+.+++.++||||+++++++..    ...+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence            458999999999999999999999999999999975443 34456788999999999999999999998865    4568


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEEc-cCCCeEEeccccccCCCc
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLD-SKGNIKISDFGLSALPQH  166 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--i~H~dikp~NILl~-~~~~vkl~Dfg~a~~~~~  166 (344)
                      ++||||+++++|.+++...+.+++..++.++.||+.||.|||+.|  |+||||||+|||++ .++.+||+|||++.... 
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~-  183 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-  183 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-
T ss_pred             EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc-
Confidence            999999999999999998889999999999999999999999999  99999999999997 78899999999987432 


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc-HHHHHHHHhhCC--CCCCCCCCHH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRGD--FKLPKWLSPG  243 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~-~~~~~~~i~~~~--~~~~~~~~~~  243 (344)
                         ........||+.|+|||++.+ . .+.++|||||||++|+|++|+.||.+.. .......+..+.  ..++...++.
T Consensus       184 ---~~~~~~~~~t~~y~aPE~~~~-~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (290)
T 1t4h_A          184 ---ASFAKAVIGTPEFMAPEMYEE-K-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPE  258 (290)
T ss_dssp             ---TTSBEESCSSCCCCCGGGGGT-C-CCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHH
T ss_pred             ---ccccccccCCcCcCCHHHHhc-c-CCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHH
Confidence               223445679999999998764 3 4689999999999999999999998744 444444444432  2345667899


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +.+||.+||+.||++|||+.++++||||++.
T Consensus       259 l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          259 VKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             HHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             HHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            9999999999999999999999999999863

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=4.4e-51  Score=364.85  Aligned_cols=254  Identities=23%  Similarity=0.311  Sum_probs=215.7

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~   89 (344)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++...... ......+.+|+..+..+ +||||+++++++...+..
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~   86 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHM   86 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEE
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeE
Confidence            3457899999999999999999999999999999999764332 23456788899999999 899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC---------------
Q 019216           90 YMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---------------  150 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~---------------  150 (344)
                      ++||||+++++|.+++...    +.+++..++.++.||+.||.|||++||+||||||+|||++.+               
T Consensus        87 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           87 LIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-----------------
T ss_pred             EEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999999999764    679999999999999999999999999999999999999854               


Q ss_pred             ----CCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHH
Q 019216          151 ----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY  226 (344)
Q Consensus       151 ----~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~  226 (344)
                          ..+||+|||++.....      .....||+.|+|||++.+....+.++|||||||++|+|++|.+++.....   .
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~---~  237 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ---W  237 (289)
T ss_dssp             ---CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH---H
T ss_pred             cCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH---H
Confidence                4799999999874332      23346899999999998765556799999999999999999988765443   2


Q ss_pred             HHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          227 QKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       227 ~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ..+..+ ...+|..+++.+.+||.+||+.||++|||+.++++||||.+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          238 HEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            333333 345677899999999999999999999999999999999864

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.5e-51  Score=371.53  Aligned_cols=258  Identities=29%  Similarity=0.485  Sum_probs=215.8

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      .+..++|++.+.||+|+||+||+|.+  +|+.||+|++..... .....+.+.+|+.++++++||||+++++++......
T Consensus        33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~  109 (309)
T 3p86_A           33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL  109 (309)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred             cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence            46788999999999999999999987  678999999875543 345567889999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           90 YMVLEYVTGGELFDKIASKGR---LQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~---~~~~~~~~i~~ql~~~L~~LH~~~--i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                      ++||||+++++|.+++...+.   +++..++.++.|++.||+|||+.|  |+||||||+|||++.++.+||+|||+++..
T Consensus       110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  189 (309)
T 3p86_A          110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK  189 (309)
T ss_dssp             EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred             EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence            999999999999999986553   999999999999999999999999  999999999999999999999999999743


Q ss_pred             CcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh--hCCCCCCCCCCH
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIF--RGDFKLPKWLSP  242 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~--~~~~~~~~~~~~  242 (344)
                      ..  .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.  .....+|..+++
T Consensus       190 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (309)
T 3p86_A          190 AS--TFLSSKSAAGTPEWMAPEVLRDEPS-NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP  266 (309)
T ss_dssp             --------------CCTTSCHHHHTTCCC-CTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred             cc--cccccccCCCCccccChhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence            22  1122345689999999999988776 689999999999999999999999988777766663  345677888999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhc--Cccccc
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKA--DEWFEQ  273 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~--~~~~~~  273 (344)
                      .+.+||.+||+.||.+|||+.++++  +++++.
T Consensus       267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~  299 (309)
T 3p86_A          267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS  299 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            9999999999999999999999987  444443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-51  Score=373.41  Aligned_cols=251  Identities=25%  Similarity=0.357  Sum_probs=206.5

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCccceeeEEeeCCeEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .++|+++++||+|+||+||+|.++.+|+.||||++....... ........|+..+.. .+||||+++++++......++
T Consensus        56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l  134 (311)
T 3p1a_A           56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGP-KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL  134 (311)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccCh-HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence            378999999999999999999999999999999986543332 333444555555544 489999999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      ||||+ +++|.+.+... ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.....   .
T Consensus       135 v~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~---~  210 (311)
T 3p1a_A          135 QTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT---A  210 (311)
T ss_dssp             EEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred             EEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc---C
Confidence            99999 77998888754 4699999999999999999999999999999999999999999999999999875432   2


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC--CCCCCCCHHHHHHH
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--KLPKWLSPGAQNLL  248 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~li  248 (344)
                      .......||+.|+|||++.+ .+ +.++|||||||++|+|++|..|+.+...   ...+..+..  .++..+++.+.+||
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li  285 (311)
T 3p1a_A          211 GAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVL  285 (311)
T ss_dssp             ----CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHH
T ss_pred             CCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHH
Confidence            23345679999999999876 44 6899999999999999999777655432   223333322  23566899999999


Q ss_pred             HHhcCCCcCCCCCHhhhhcCccccc
Q 019216          249 RKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       249 ~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      .+||+.||++|||++++++||||++
T Consensus       286 ~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          286 VMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HHHcCCChhhCcCHHHHHhCccccC
Confidence            9999999999999999999999975

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.1e-51  Score=382.48  Aligned_cols=261  Identities=25%  Similarity=0.402  Sum_probs=216.9

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCCccceeeEEeeCCeEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~~~   90 (344)
                      -.+|++++.||+|+||.||+|.+.. ++.||||++..... .....+.+.+|+.+++.++  ||||+++++++.....+|
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~  132 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  132 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence            3469999999999999999999865 89999999976543 3455678999999999997  599999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      +||| +.+++|.+++.....+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||+++........
T Consensus       133 lv~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          133 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             EEEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             EEEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            9999 55889999999888999999999999999999999999999999999999995 689999999999865432222


Q ss_pred             CccccccCCCcccchhhhccC----------CCCCccchhhhhhHHHHHHHhCCCCCCCcc-HHHHHHHHhhC--CCCCC
Q 019216          171 GLLHTTCGSPNYVAPEVLANR----------GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFKLP  237 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslG~ll~ell~g~~pf~~~~-~~~~~~~i~~~--~~~~~  237 (344)
                      ......+||+.|+|||++.+.          ...+.++|||||||++|+|++|+.||.+.. .......+...  ...+|
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~  290 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP  290 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC
Confidence            234456899999999998652          234689999999999999999999998753 33444555544  34567


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      ...++.+.+||.+||+.||++|||+.++++||||+....+
T Consensus       291 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~  330 (390)
T 2zmd_A          291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  330 (390)
T ss_dssp             CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred             ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence            7889999999999999999999999999999999865443

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.2e-51  Score=376.07  Aligned_cols=263  Identities=25%  Similarity=0.418  Sum_probs=216.2

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCccceeeEEeeCCe
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSK   88 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~   88 (344)
                      +.-++|++++.||+|+||.||+|.+ .+++.||+|++..... .....+.+.+|+.+++.++|  |||+++++++.....
T Consensus         6 ~~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~   83 (343)
T 3dbq_A            6 VKGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY   83 (343)
T ss_dssp             SSSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred             eecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCE
Confidence            4456899999999999999999997 5689999999975432 34456788999999999986  999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      .++|||+ .+++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++.......
T Consensus        84 ~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~  161 (343)
T 3dbq_A           84 IYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  161 (343)
T ss_dssp             EEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC----
T ss_pred             EEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccc
Confidence            9999995 5889999999988999999999999999999999999999999999999996 6889999999998654332


Q ss_pred             CCCccccccCCCcccchhhhcc----------CCCCCccchhhhhhHHHHHHHhCCCCCCCcc-HHHHHHHHhhC--CCC
Q 019216          169 DDGLLHTTCGSPNYVAPEVLAN----------RGYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFK  235 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~~~DvwslG~ll~ell~g~~pf~~~~-~~~~~~~i~~~--~~~  235 (344)
                      ........+||+.|+|||++.+          ....+.++|||||||++|+|++|+.||.... .......+...  ...
T Consensus       162 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~  241 (343)
T 3dbq_A          162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  241 (343)
T ss_dssp             --------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence            2223445689999999999864          1334689999999999999999999998743 33333444332  456


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       236 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      +|...++.+.+||.+||+.||.+|||+.++++||||+....+
T Consensus       242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  283 (343)
T 3dbq_A          242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  283 (343)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence            777889999999999999999999999999999999865444

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.3e-51  Score=381.81  Aligned_cols=257  Identities=31%  Similarity=0.437  Sum_probs=202.9

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC------
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK------   86 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~------   86 (344)
                      -++|++++.||+|+||.||+|.+..+|+.||||++.... ......+.+.+|+.+++.++||||+++++++...      
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~  106 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF  106 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence            379999999999999999999999999999999986532 3344567888999999999999999999998653      


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ...|++||++ +++|.+++.. +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....
T Consensus       107 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~  184 (367)
T 2fst_X          107 NDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD  184 (367)
T ss_dssp             CCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---------
T ss_pred             CeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc
Confidence            5689999999 7899888865 6799999999999999999999999999999999999999999999999999975322


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--C-----------
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--D-----------  233 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~-----------  233 (344)
                           ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...  .           
T Consensus       185 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          185 -----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             -----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence                 2345689999999999987555578999999999999999999999998776665555431  0           


Q ss_pred             ----------CCC--------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          234 ----------FKL--------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       234 ----------~~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                ...        ....++.+.+||.+||+.||++|||+.++|+||||.+...+
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence                      001        12468899999999999999999999999999999875443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=2.9e-51  Score=373.90  Aligned_cols=256  Identities=35%  Similarity=0.555  Sum_probs=220.3

Q ss_pred             cCeEEe-eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEE
Q 019216           14 GRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        14 ~~y~~~-~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~i   91 (344)
                      ++|.+. +.||+|+||.||+|.++.+++.||+|++.+.... ......+.+|+.+++.+. ||||+++++++......++
T Consensus        28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l  106 (327)
T 3lm5_A           28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL  106 (327)
T ss_dssp             HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence            468887 8999999999999999999999999999765432 234567889999999995 6999999999999999999


Q ss_pred             EEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc---CCCeEEeccccccCCCc
Q 019216           92 VLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALPQH  166 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~---~~~vkl~Dfg~a~~~~~  166 (344)
                      ||||+.+++|.+++..  ...+++..++.++.||+.||+|||++||+||||||+|||++.   ++.+||+|||++.....
T Consensus       107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  186 (327)
T 3lm5_A          107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH  186 (327)
T ss_dssp             EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred             EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence            9999999999998854  367999999999999999999999999999999999999987   78999999999985432


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCCCH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSP  242 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~  242 (344)
                         ........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+.......+.......+    ..+++
T Consensus       187 ---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  262 (327)
T 3lm5_A          187 ---ACELREIMGTPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ  262 (327)
T ss_dssp             ----------CCCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             ---ccccccccCCcCccCCeeecCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence               222345679999999999987766 6899999999999999999999999888887777776654433    45899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .+.+||.+||+.||.+|||++++|+||||++.
T Consensus       263 ~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            99999999999999999999999999999864

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.2e-51  Score=381.64  Aligned_cols=252  Identities=27%  Similarity=0.401  Sum_probs=211.9

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee------
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------   85 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------   85 (344)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|++.....       ...+|+.+++.++||||+++++++..      
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~   77 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP   77 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence            45799999999999999999999999999999999865432       22369999999999999999999843      


Q ss_pred             --------------------------------CCeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Q 019216           86 --------------------------------KSKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSY  129 (344)
Q Consensus        86 --------------------------------~~~~~iv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~  129 (344)
                                                      ...+++||||+++ +|.+.+.    ....+++..++.++.||+.||.|
T Consensus        78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~  156 (383)
T 3eb0_A           78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF  156 (383)
T ss_dssp             --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence                                            3458899999975 7766654    45779999999999999999999


Q ss_pred             HHhCCceeecCCCCcEEEc-cCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHH
Q 019216          130 CHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILY  208 (344)
Q Consensus       130 LH~~~i~H~dikp~NILl~-~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~  208 (344)
                      ||+.||+||||||+|||++ .++.+||+|||+++....   ........+|+.|+|||++.+....+.++|||||||++|
T Consensus       157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (383)
T 3eb0_A          157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG  233 (383)
T ss_dssp             HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred             HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence            9999999999999999998 678999999999974322   223445678999999999887665578999999999999


Q ss_pred             HHHhCCCCCCCccHHHHHHHHhhC-----------------CCC------------CCCCCCHHHHHHHHHhcCCCcCCC
Q 019216          209 VILTGYLPFDDRNLAVLYQKIFRG-----------------DFK------------LPKWLSPGAQNLLRKILEPNPVKR  259 (344)
Q Consensus       209 ell~g~~pf~~~~~~~~~~~i~~~-----------------~~~------------~~~~~~~~~~~li~~~L~~dP~~R  259 (344)
                      +|++|+.||.+.+.......+...                 ...            ++..+++.+.+||.+||+.||++|
T Consensus       234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R  313 (383)
T 3eb0_A          234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR  313 (383)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence            999999999998777666655431                 001            345688999999999999999999


Q ss_pred             CCHhhhhcCcccccc
Q 019216          260 ITIAGIKADEWFEQD  274 (344)
Q Consensus       260 ps~~eil~~~~~~~~  274 (344)
                      ||+.|+++||||++.
T Consensus       314 ~t~~e~l~hp~f~~~  328 (383)
T 3eb0_A          314 INPYEAMAHPFFDHL  328 (383)
T ss_dssp             CCHHHHHTSGGGHHH
T ss_pred             CCHHHHhcCHHHHHH
Confidence            999999999999864

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.2e-51  Score=376.22  Aligned_cols=257  Identities=24%  Similarity=0.402  Sum_probs=209.9

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC----
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----   87 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----   87 (344)
                      -+++|++++.||+|+||.||+|.++.+|+.||||++....  .....+.+.+|+.++++++||||+++++++....    
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   81 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKW   81 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchh
Confidence            3578999999999999999999999999999999997543  2345678999999999999999999999885543    


Q ss_pred             -----------------------------------------------------eEEEEEeccCCCChHHHHHhcCC---C
Q 019216           88 -----------------------------------------------------KIYMVLEYVTGGELFDKIASKGR---L  111 (344)
Q Consensus        88 -----------------------------------------------------~~~iv~e~~~g~~L~~~l~~~~~---~  111 (344)
                                                                           ..++|||||+|++|.+++.....   .
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~  161 (332)
T 3qd2_B           82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDR  161 (332)
T ss_dssp             HHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGS
T ss_pred             hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccch
Confidence                                                                 38999999999999999987543   5


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC----------CCccccccCCCc
Q 019216          112 QEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD----------DGLLHTTCGSPN  181 (344)
Q Consensus       112 ~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~----------~~~~~~~~gt~~  181 (344)
                      ++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........          .......+||+.
T Consensus       162 ~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          162 EHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             hhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            5667899999999999999999999999999999999999999999999985443211          112234579999


Q ss_pred             ccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC-CCCCCCHHHHHHHHHhcCCCcCCCC
Q 019216          182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-LPKWLSPGAQNLLRKILEPNPVKRI  260 (344)
Q Consensus       182 y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rp  260 (344)
                      |+|||++.+..+ +.++|||||||++|+|++|..|+..  .......+.....+ .+...++.+.+||.+||+.||++||
T Consensus       242 y~aPE~~~~~~~-~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp  318 (332)
T 3qd2_B          242 YMSPEQIHGNNY-SHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP  318 (332)
T ss_dssp             GSCHHHHHCCCC-CTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGGSC
T ss_pred             ccChHHhcCCCC-cchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCcCC
Confidence            999999988776 6899999999999999999877532  22233333333222 1234678899999999999999999


Q ss_pred             CHhhhhcCccccc
Q 019216          261 TIAGIKADEWFEQ  273 (344)
Q Consensus       261 s~~eil~~~~~~~  273 (344)
                      |+.++++||||++
T Consensus       319 s~~~~l~~~~f~~  331 (332)
T 3qd2_B          319 EATDIIENAIFEN  331 (332)
T ss_dssp             CHHHHHHSTTCCC
T ss_pred             CHHHHhhchhhhc
Confidence            9999999999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.6e-51  Score=387.99  Aligned_cols=257  Identities=36%  Similarity=0.642  Sum_probs=209.2

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++.+....     .......+.+|+.++++++||||+++++++.. .
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~  212 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E  212 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence            57899999999999999999999999999999999765422     11223357899999999999999999999854 5


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC---CeEEeccccccCC
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALP  164 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~---~vkl~Dfg~a~~~  164 (344)
                      ..++||||+++++|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++   .+||+|||+++..
T Consensus       213 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~  292 (419)
T 3i6u_A          213 DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL  292 (419)
T ss_dssp             EEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSC
T ss_pred             ceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceec
Confidence            6899999999999999998888999999999999999999999999999999999999997654   5999999999864


Q ss_pred             CcccCCCccccccCCCcccchhhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhhCCCCCC----
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFKLP----  237 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~-~~~~~~i~~~~~~~~----  237 (344)
                      ..   .......+||+.|+|||++.+  ....+.++|||||||++|+|++|+.||.+... ......+..+....+    
T Consensus       293 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~  369 (419)
T 3i6u_A          293 GE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  369 (419)
T ss_dssp             C--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHH
T ss_pred             CC---CccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhh
Confidence            32   233456789999999999864  23336799999999999999999999976433 234445555554433    


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          238 KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      ..+++.+.+||.+||+.||++|||++++++||||++
T Consensus       370 ~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          370 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             cccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            458999999999999999999999999999999975

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.6e-51  Score=377.30  Aligned_cols=259  Identities=29%  Similarity=0.432  Sum_probs=221.5

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..+..++|++++.||+|+||.||+|.+..+++.||+|++....  .....+.+.+|+.+++.++||||+++++++...+.
T Consensus        28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  105 (360)
T 3eqc_A           28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGE  105 (360)
T ss_dssp             CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTE
T ss_pred             cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCE
Confidence            3467789999999999999999999999999999999987542  34456789999999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~-~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .++||||++|++|.+++.+.+.+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++..... 
T Consensus       106 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-  184 (360)
T 3eqc_A          106 ISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-  184 (360)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH-
T ss_pred             EEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCccccc-
Confidence            999999999999999999888999999999999999999999996 999999999999999999999999999863221 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHH--------------------
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ--------------------  227 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~--------------------  227 (344)
                         .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+......                    
T Consensus       185 ---~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (360)
T 3eqc_A          185 ---SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP  260 (360)
T ss_dssp             ---HC----CCCCTTCCHHHHTTCCC-SHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----------------
T ss_pred             ---ccccCCCCCCCeECHHHHcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccC
Confidence               12334579999999999988766 689999999999999999999998765443322                    


Q ss_pred             ----------------------HHhhCC-CCC-CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          228 ----------------------KIFRGD-FKL-PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       228 ----------------------~i~~~~-~~~-~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                                            .+.... ... +..+++++.+||.+||+.||++|||++++++||||+..
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~  331 (360)
T 3eqc_A          261 GRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  331 (360)
T ss_dssp             -------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             CCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcc
Confidence                                  122221 112 23478999999999999999999999999999999864

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=8e-51  Score=364.10  Aligned_cols=260  Identities=22%  Similarity=0.321  Sum_probs=205.0

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      .+..++|++++.||+|+||.||+|.+..+|+.||+|++..... .....+.+.++...++.++||||+++++++...+..
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            3567899999999999999999999999999999999865432 223344455566668888999999999999999999


Q ss_pred             EEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           90 YMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~LH~~-~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                      ++||||++| +|.+++.    ....+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus        82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  160 (290)
T 3fme_A           82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL  160 (290)
T ss_dssp             EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred             EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence            999999965 8877664    356799999999999999999999998 9999999999999999999999999998754


Q ss_pred             CcccCCCccccccCCCcccchhhhc---cCCCCCccchhhhhhHHHHHHHhCCCCCCC-ccH-HHHHHHHhhCCCCCC-C
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLA---NRGYDGATSDIWSCGVILYVILTGYLPFDD-RNL-AVLYQKIFRGDFKLP-K  238 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DvwslG~ll~ell~g~~pf~~-~~~-~~~~~~i~~~~~~~~-~  238 (344)
                      ..   ........||+.|+|||++.   .....+.++|||||||++|+|++|+.||.. ... ......+.......+ .
T Consensus       161 ~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  237 (290)
T 3fme_A          161 VD---DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD  237 (290)
T ss_dssp             ------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred             cc---cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence            32   22233457999999999973   333347899999999999999999999985 233 333333333333333 4


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          239 WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .+++.+.+||.+||+.||++|||+.++++||||+..
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~  273 (290)
T 3fme_A          238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH  273 (290)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence            689999999999999999999999999999999864

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=3.6e-51  Score=364.48  Aligned_cols=260  Identities=30%  Similarity=0.523  Sum_probs=225.9

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe--eCCeE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--SKSKI   89 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--~~~~~   89 (344)
                      ..++|++++.||+|+||.||+|.++.+++.||+|.+..... .....+.+.+|+.++++++||||+++++++.  .....
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   82 (279)
T 2w5a_A            4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   82 (279)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred             chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence            57899999999999999999999999999999999976543 3345678999999999999999999999874  36789


Q ss_pred             EEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeecCCCCcEEEccCCCeEEecccc
Q 019216           90 YMVLEYVTGGELFDKIASK----GRLQEAEGRKLFQQLIDGVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGL  160 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~~-----i~H~dikp~NILl~~~~~vkl~Dfg~  160 (344)
                      ++||||+++++|.+++...    ..+++..++.++.|++.||.|||+.|     |+||||||+|||++.++.+||+|||+
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~  162 (279)
T 2w5a_A           83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  162 (279)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred             EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence            9999999999999998753    34999999999999999999999999     99999999999999999999999999


Q ss_pred             ccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-CCCCC
Q 019216          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW  239 (344)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~  239 (344)
                      +.....  .........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+.......+..+.. .++..
T Consensus       163 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~  239 (279)
T 2w5a_A          163 ARILNH--DTSFAKTFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR  239 (279)
T ss_dssp             HHHC-----CHHHHHHHSCCTTCCHHHHHCC-C-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             heeecc--ccccccccCCCccccChHHhccCCC-CchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence            874322  1112234578999999999987765 6899999999999999999999999888877777777754 56778


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      +++.+.++|.+||+.||.+|||+.++++|+|+.+..
T Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            999999999999999999999999999999997653

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=4.2e-51  Score=379.22  Aligned_cols=256  Identities=27%  Similarity=0.407  Sum_probs=208.9

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC----
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----   87 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----   87 (344)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++....    
T Consensus        23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~  101 (371)
T 2xrw_A           23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE  101 (371)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred             hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence            4689999999999999999999999999999999997543 33455678889999999999999999999997654    


Q ss_pred             --eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           88 --KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        88 --~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                        ..|+||||+.+ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       102 ~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          102 FQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             CCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             ccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence              78999999965 7888775  458999999999999999999999999999999999999999999999999997533


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC----------
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK----------  235 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~----------  235 (344)
                      .   .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......          
T Consensus       179 ~---~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          179 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             --------------CTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             c---ccccCCceecCCccCHHHhcCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            2   223345689999999999988766 68999999999999999999999998877766666543110          


Q ss_pred             ------------C--------------CC------CCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          236 ------------L--------------PK------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       236 ------------~--------------~~------~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                                  +              |.      ..++.+.+||++||+.||++|||++|+|+||||+...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence                        0              00      0156789999999999999999999999999998643

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8e-51  Score=377.15  Aligned_cols=256  Identities=26%  Similarity=0.443  Sum_probs=221.3

Q ss_pred             CccccCeEEeeeecccCceEEEEEEEC-------CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceee
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE   81 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~   81 (344)
                      .+..++|++.+.||+|+||.||+|.+.       .++..||+|++....  .....+.+.+|+.+++++ +||||+++++
T Consensus        77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  154 (370)
T 2psq_A           77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  154 (370)
T ss_dssp             BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            356689999999999999999999974       345679999996542  344567899999999999 8999999999


Q ss_pred             EEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcE
Q 019216           82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI  145 (344)
Q Consensus        82 ~~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NI  145 (344)
                      ++...+.+|+||||+++++|.+++...+                .+++..+..++.||+.||.|||++||+||||||+||
T Consensus       155 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  234 (370)
T 2psq_A          155 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  234 (370)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             EEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhE
Confidence            9999999999999999999999998643                478999999999999999999999999999999999


Q ss_pred             EEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHH
Q 019216          146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV  224 (344)
Q Consensus       146 Ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~  224 (344)
                      |++.++.+||+|||+++...............+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.....
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~p~~~~~~~~  313 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  313 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            999999999999999985433222223334567889999999987766 689999999999999999 999999888777


Q ss_pred             HHHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          225 LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       225 ~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ....+..+ ....|..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       314 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          314 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            77766665 356778899999999999999999999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.2e-52  Score=390.55  Aligned_cols=249  Identities=19%  Similarity=0.217  Sum_probs=205.5

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH---HHHhCCCCCcccee-------eE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA---TLKLLKHPNVVRLH-------EV   82 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~---~l~~l~h~niv~l~-------~~   82 (344)
                      .++|++.+.||+|+||.||+|.++.+|+.||||++.+.........+.+.+|+.   +++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            578999999999999999999999999999999998665555566788999995   45555799999998       66


Q ss_pred             EeeCC-----------------eEEEEEeccCCCChHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCceee
Q 019216           83 LASKS-----------------KIYMVLEYVTGGELFDKIASKGRLQE-------AEGRKLFQQLIDGVSYCHNKGVFHR  138 (344)
Q Consensus        83 ~~~~~-----------------~~~iv~e~~~g~~L~~~l~~~~~~~~-------~~~~~i~~ql~~~L~~LH~~~i~H~  138 (344)
                      +...+                 ..|++|||+ +|+|.+++...+.+++       ..++.++.||+.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            65543                 288999999 6799999987655555       7888899999999999999999999


Q ss_pred             cCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccC-----------CCCCccchhhhhhHHH
Q 019216          139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-----------GYDGATSDIWSCGVIL  207 (344)
Q Consensus       139 dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~~DvwslG~ll  207 (344)
                      ||||+|||++.++.+||+|||+++..     .......+| +.|+|||++.+.           .+ +.++|||||||++
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~-----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il  303 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVI  303 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEET-----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheec-----CCcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHH
Confidence            99999999999999999999999842     223445677 999999999876           45 6899999999999


Q ss_pred             HHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          208 YVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       208 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      |+|++|+.||.+.+.......+.    ..+..+++.+.+||.+||+.||++|||+.++++||||++
T Consensus       304 ~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          304 YWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            99999999998765433332222    234568999999999999999999999999999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.1e-50  Score=363.11  Aligned_cols=260  Identities=38%  Similarity=0.647  Sum_probs=228.4

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ++...++|++++.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.++++++||||+++++++.....
T Consensus        17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   95 (287)
T 2wei_A           17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS   95 (287)
T ss_dssp             THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence            456678999999999999999999999999999999999754432 2345778899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC---CCeEEeccccccCCC
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFGLSALPQ  165 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~---~~vkl~Dfg~a~~~~  165 (344)
                      .++||||+++++|.+.+...+.+++..++.++.||+.||.|||++|++||||||+||+++.+   +.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~  175 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ  175 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred             EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence            99999999999999999888889999999999999999999999999999999999999764   469999999987533


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCCC
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS  241 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~  241 (344)
                      .   ........+|+.|+|||++.+.  .+.++||||||+++|+|++|+.||.+.+.......+..+....+    ..++
T Consensus       176 ~---~~~~~~~~~~~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (287)
T 2wei_A          176 Q---NTKMKDRIGTAYYIAPEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS  250 (287)
T ss_dssp             C---CSSCSCHHHHHTTCCHHHHTTC--CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSC
T ss_pred             C---CCccccccCcccccChHHhcCC--CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcC
Confidence            2   2223345688999999998764  46899999999999999999999999888888888877765443    4689


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +.+.++|.+||+.||++|||+.++++||||++.
T Consensus       251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            999999999999999999999999999999864

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8.4e-51  Score=384.07  Aligned_cols=254  Identities=28%  Similarity=0.396  Sum_probs=213.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC------CCCCccceeeEEe
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL------KHPNVVRLHEVLA   84 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l------~h~niv~l~~~~~   84 (344)
                      ...++|++++.||+|+||.||+|.+..+++.||||++...    ......+.+|+.+++.+      .|+||+++++++.
T Consensus        94 ~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~  169 (429)
T 3kvw_A           94 HVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFT  169 (429)
T ss_dssp             EETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEE
T ss_pred             cccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecc
Confidence            3456899999999999999999999999999999998643    23345677888888776      5779999999999


Q ss_pred             eCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC--eEEecccc
Q 019216           85 SKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--IKISDFGL  160 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~--vkl~Dfg~  160 (344)
                      ....+++||||+. ++|.+++....  .+++..++.++.||+.||+|||+.||+||||||+|||++.++.  +||+|||+
T Consensus       170 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~  248 (429)
T 3kvw_A          170 FRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGS  248 (429)
T ss_dssp             ETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             cCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccc
Confidence            9999999999995 69999987654  4999999999999999999999999999999999999999987  99999999


Q ss_pred             ccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC------
Q 019216          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------  234 (344)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~------  234 (344)
                      +....     ......+||+.|+|||++.+..+ +.++|||||||++|+|++|++||.+.+.......+.....      
T Consensus       249 a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~  322 (429)
T 3kvw_A          249 SCYEH-----QRVYTYIQSRFYRAPEVILGARY-GMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKL  322 (429)
T ss_dssp             CEETT-----CCCCSSCSCGGGCCHHHHHTBCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred             ceecC-----CcccccCCCCCccChHHHhCCCC-CchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHH
Confidence            86422     23345689999999999988776 6899999999999999999999998877666554432100      


Q ss_pred             -----------------------------------------------------CCCCCCCHHHHHHHHHhcCCCcCCCCC
Q 019216          235 -----------------------------------------------------KLPKWLSPGAQNLLRKILEPNPVKRIT  261 (344)
Q Consensus       235 -----------------------------------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps  261 (344)
                                                                           .++...++.+.+||.+||+.||++|||
T Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt  402 (429)
T 3kvw_A          323 LDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT  402 (429)
T ss_dssp             HHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC
Confidence                                                                 011224788999999999999999999


Q ss_pred             HhhhhcCccccccC
Q 019216          262 IAGIKADEWFEQDY  275 (344)
Q Consensus       262 ~~eil~~~~~~~~~  275 (344)
                      ++|+|+||||++..
T Consensus       403 a~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          403 PGQALRHPWLRRRL  416 (429)
T ss_dssp             HHHHHTSTTTC---
T ss_pred             HHHHhCChhhccCC
Confidence            99999999998753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.2e-51  Score=377.46  Aligned_cols=260  Identities=27%  Similarity=0.513  Sum_probs=226.6

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchh--------------HHHHHHHHHHHHHhCCCC
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--------------ITDQIKREIATLKLLKHP   74 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~--------------~~~~~~~E~~~l~~l~h~   74 (344)
                      .....++|++++.||+|+||.||+|.+  +|+.||+|++.........              ..+.+.+|+.++++++||
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~  103 (348)
T 2pml_X           26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE  103 (348)
T ss_dssp             SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred             cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence            346679999999999999999999998  8999999998754332211              127889999999999999


Q ss_pred             CccceeeEEeeCCeEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcE
Q 019216           75 NVVRLHEVLASKSKIYMVLEYVTGGELFDK------IAS--KGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENI  145 (344)
Q Consensus        75 niv~l~~~~~~~~~~~iv~e~~~g~~L~~~------l~~--~~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NI  145 (344)
                      ||+++++++...+..++||||+++++|.++      +..  ...+++..++.++.|++.||.|||+ .||+||||||+||
T Consensus       104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni  183 (348)
T 2pml_X          104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI  183 (348)
T ss_dssp             TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred             CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence            999999999999999999999999999988      655  5679999999999999999999999 9999999999999


Q ss_pred             EEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccC-CCCCccchhhhhhHHHHHHHhCCCCCCCccH-H
Q 019216          146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR-GYDGATSDIWSCGVILYVILTGYLPFDDRNL-A  223 (344)
Q Consensus       146 Ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DvwslG~ll~ell~g~~pf~~~~~-~  223 (344)
                      |++.++.+||+|||++.....    .......||+.|+|||++.+. .+.+.++|||||||++|+|++|+.||..... .
T Consensus       184 l~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          184 LMDKNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             EECTTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             EEcCCCcEEEecccccccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            999999999999999875322    134456799999999998876 4433389999999999999999999988766 7


Q ss_pred             HHHHHHhhCCCCCC-------------------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          224 VLYQKIFRGDFKLP-------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       224 ~~~~~i~~~~~~~~-------------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .....+..+...+|                   ..+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus       260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~  329 (348)
T 2pml_X          260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT  329 (348)
T ss_dssp             HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence            77778877777766                   5689999999999999999999999999999999763

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.6e-50  Score=369.03  Aligned_cols=252  Identities=25%  Similarity=0.420  Sum_probs=211.1

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEee--CC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS--KS   87 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~   87 (344)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++....      .+.+.+|+.++++++ ||||+++++++..  ..
T Consensus        33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~  106 (330)
T 3nsz_A           33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSR  106 (330)
T ss_dssp             EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTC
T ss_pred             cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCC
Confidence            34679999999999999999999999999999999986432      467889999999997 9999999999987  66


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC-CeEEeccccccCCCc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQH  166 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~-~vkl~Dfg~a~~~~~  166 (344)
                      ..++||||+.+++|.+++..   +++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus       107 ~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          107 TPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             CEEEEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             ceEEEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            78999999999999888753   89999999999999999999999999999999999999777 899999999975332


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc-cHHHHHHH-------------HhhC
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQK-------------IFRG  232 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~-~~~~~~~~-------------i~~~  232 (344)
                         ........||..|+|||++.+....+.++|||||||++|+|++|+.||... +.......             +...
T Consensus       184 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          184 ---GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             ---TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHT
T ss_pred             ---CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHh
Confidence               223445688999999999987555578999999999999999999999432 22221111             1111


Q ss_pred             CCCC------------------------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          233 DFKL------------------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       233 ~~~~------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ....                        +..+++.+.+||.+||+.||++|||++|+|+||||++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             TCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence            1111                        12279999999999999999999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.7e-50  Score=362.38  Aligned_cols=259  Identities=24%  Similarity=0.418  Sum_probs=226.8

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .-.+|++++.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.+++.++||||+++++++......++
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   97 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWI   97 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEE
Confidence            34679999999999999999999999999999999975542  2346788999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      ||||+++++|.+++.. +++++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++......  ..
T Consensus        98 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~~  174 (303)
T 3a7i_A           98 IMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--QI  174 (303)
T ss_dssp             EEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--BC
T ss_pred             EEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc--cc
Confidence            9999999999998865 67999999999999999999999999999999999999999999999999998754321  11


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-CCCCCCCCHHHHHHHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRK  250 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~  250 (344)
                      ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...........+.... ..++..+++.+.+||.+
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  253 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAY-DSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEA  253 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHHH
T ss_pred             ccCccCCCcCccCHHHHhcCCC-CchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHHH
Confidence            2345678999999999987766 589999999999999999999999887776666665543 44667799999999999


Q ss_pred             hcCCCcCCCCCHhhhhcCccccccCC
Q 019216          251 ILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       251 ~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      ||+.||++|||+.++++||||.....
T Consensus       254 ~l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          254 CLNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             HCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             HcCCChhhCcCHHHHhhChhhhcCCC
Confidence            99999999999999999999976543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.4e-50  Score=381.64  Aligned_cols=255  Identities=28%  Similarity=0.394  Sum_probs=210.2

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC-----
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----   86 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----   86 (344)
                      ...+|++++.||+|+||.||+|.+..+|+.||||++.....       ...+|+.+++.++||||+++++++...     
T Consensus        52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~  124 (420)
T 1j1b_A           52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD  124 (420)
T ss_dssp             EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred             ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence            34579999999999999999999999999999999865431       234699999999999999999988531     


Q ss_pred             -CeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC-CCeEEecccc
Q 019216           87 -SKIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGL  160 (344)
Q Consensus        87 -~~~~iv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~-~~vkl~Dfg~  160 (344)
                       ..+++||||+++ ++.+.+.    ....+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus       125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~  203 (420)
T 1j1b_A          125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS  203 (420)
T ss_dssp             EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence             246799999975 6666554    35679999999999999999999999999999999999999966 5689999999


Q ss_pred             ccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--------
Q 019216          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--------  232 (344)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--------  232 (344)
                      ++....   .......+||+.|+|||++.+...++.++|||||||++|||++|+.||.+.+......++...        
T Consensus       204 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~  280 (420)
T 1j1b_A          204 AKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ  280 (420)
T ss_dssp             CEECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             hhhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            985322   222345688999999999977654578999999999999999999999988766655554431        


Q ss_pred             ---------CCC------------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          233 ---------DFK------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       233 ---------~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                               .+.            ++..+++++.+||.+||+.||.+|||+.|+++||||.+...+
T Consensus       281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  346 (420)
T 1j1b_A          281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  346 (420)
T ss_dssp             HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence                     111            234568999999999999999999999999999999875443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.9e-50  Score=372.89  Aligned_cols=262  Identities=24%  Similarity=0.358  Sum_probs=206.5

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC-
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-   87 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-   87 (344)
                      ....+++|++.+.||+|+||.||+|.+..+|+.||||++......    .....+++..++.++||||+++++++.... 
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~   93 (360)
T 3e3p_A           18 SRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGE   93 (360)
T ss_dssp             HHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECS
T ss_pred             chhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccc
Confidence            346789999999999999999999999999999999998654322    235567888888899999999999986533 


Q ss_pred             ------eEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCceeecCCCCcEEEcc-CCCeE
Q 019216           88 ------KIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCH--NKGVFHRDLKLENILLDS-KGNIK  154 (344)
Q Consensus        88 ------~~~iv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~LH--~~~i~H~dikp~NILl~~-~~~vk  154 (344)
                            .+++||||+.+ +|.+.+.    ....+++..++.++.|++.||.|||  +.||+||||||+|||++. ++.+|
T Consensus        94 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~k  172 (360)
T 3e3p_A           94 RDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLK  172 (360)
T ss_dssp             SCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEE
T ss_pred             ccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEE
Confidence                  28899999976 5544433    4567899999999999999999999  999999999999999997 89999


Q ss_pred             EeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-
Q 019216          155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-  233 (344)
Q Consensus       155 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-  233 (344)
                      |+|||++.....   ........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+.+.. 
T Consensus       173 l~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  249 (360)
T 3e3p_A          173 LCDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG  249 (360)
T ss_dssp             ECCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred             EeeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence            999999985432   2233456789999999999776655789999999999999999999999988776666654310 


Q ss_pred             -------------------------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCCC
Q 019216          234 -------------------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA  278 (344)
Q Consensus       234 -------------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~~  278 (344)
                                                     ...+...++.+.+||.+||+.||.+|||+.|+|+||||++...+.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~  325 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDPA  325 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCTT
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCcc
Confidence                                           011222568999999999999999999999999999999865554

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=9.3e-51  Score=369.62  Aligned_cols=258  Identities=36%  Similarity=0.640  Sum_probs=213.2

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++......     .......+.+|+.+++.++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            346899999999999999999999999999999998654321     122344688999999999999999999998766


Q ss_pred             CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC---eEEeccccccC
Q 019216           87 SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKISDFGLSAL  163 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~---vkl~Dfg~a~~  163 (344)
                      . .++||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++..
T Consensus        88 ~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           88 D-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             S-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             c-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            5 8999999999999999988889999999999999999999999999999999999999987664   99999999875


Q ss_pred             CCcccCCCccccccCCCcccchhhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHHhhCCCCC----
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGDFKL----  236 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~-~~~~~i~~~~~~~----  236 (344)
                      ...   ........||+.|+|||++..  ....+.++|||||||++|+|++|..||...... .....+..+....    
T Consensus       167 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  243 (322)
T 2ycf_A          167 LGE---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  243 (322)
T ss_dssp             CCC---CHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHH
T ss_pred             ccc---ccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchh
Confidence            322   222345679999999999742  333468999999999999999999999764422 3334444454433    


Q ss_pred             CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       237 ~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      +..+++.+.+||.+||+.||++|||+.++++||||++
T Consensus       244 ~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          244 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             hhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            2458999999999999999999999999999999975

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=5.8e-50  Score=362.83  Aligned_cols=256  Identities=26%  Similarity=0.438  Sum_probs=217.1

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|.+....     ....+.+|+.+++.++||||+++++++......+
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~  100 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLW  100 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEE
Confidence            45678999999999999999999999999999999987543     2356889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           91 MVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~-~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +||||+++++|.+++. ....+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......  
T Consensus       101 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (314)
T 3com_A          101 IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT--  178 (314)
T ss_dssp             EEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT--
T ss_pred             EEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh--
Confidence            9999999999999987 4567999999999999999999999999999999999999999999999999998754321  


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC---CCCCCCCCHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQN  246 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~  246 (344)
                      ........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...+.......+....   ...+..+++.+.+
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  257 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIGY-NCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTD  257 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSCB-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHH
T ss_pred             ccccCccCCCCCccChhhcCCCCC-CccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHH
Confidence            122345678999999999987766 689999999999999999999998877665555544432   2345568999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          247 LLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ||.+||+.||.+|||+.++++||||...
T Consensus       258 li~~~l~~dp~~Rpt~~~ll~~~~~~~~  285 (314)
T 3com_A          258 FVKQCLVKSPEQRATATQLLQHPFVRSA  285 (314)
T ss_dssp             HHHHHTCSCTTTSCCHHHHTTSHHHHTC
T ss_pred             HHHHHccCChhhCcCHHHHHhCHHHhcC
Confidence            9999999999999999999999999864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.3e-50  Score=368.90  Aligned_cols=263  Identities=26%  Similarity=0.383  Sum_probs=217.2

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC----
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK----   86 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~----   86 (344)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++...  ........+.+|+.+++.++||||+++++++...    
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   85 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN   85 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTT
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCc
Confidence            3457999999999999999999999999999999998543  2344566788999999999999999999987654    


Q ss_pred             -CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 -SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 -~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                       ...++||||+. ++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        86 ~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           86 FNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             CCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             cceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence             67899999996 589888876 579999999999999999999999999999999999999999999999999997543


Q ss_pred             cccCC--------CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC-----
Q 019216          166 HFRDD--------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-----  232 (344)
Q Consensus       166 ~~~~~--------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~-----  232 (344)
                      .....        ......+||+.|+|||++......+.++|||||||++|+|++|+.||.+.+.......+...     
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            21111        11234578999999999876555578999999999999999999999987765544433210     


Q ss_pred             -------------------CCC--------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          233 -------------------DFK--------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       233 -------------------~~~--------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                         ...        .+..+++.+.+||.+||+.||++|||+.++++||||+....+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~  315 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP  315 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence                               000        113578999999999999999999999999999999875443

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=1.5e-50  Score=378.41  Aligned_cols=255  Identities=27%  Similarity=0.403  Sum_probs=209.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC---
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---   87 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---   87 (344)
                      ..-++|++++.||+|+||.||+|.+..+++ +|+|.+.....       ...+|+.+++.++||||+++++++....   
T Consensus        37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~  108 (394)
T 4e7w_A           37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKK  108 (394)
T ss_dssp             EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSS
T ss_pred             cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCC
Confidence            455789999999999999999999977666 88887754332       1236999999999999999999985433   


Q ss_pred             ---eEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEc-cCCCeEEeccc
Q 019216           88 ---KIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFG  159 (344)
Q Consensus        88 ---~~~iv~e~~~g~~L~~~l~----~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~-~~~~vkl~Dfg  159 (344)
                         .+++||||++++ +.+.+.    ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||
T Consensus       109 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG  187 (394)
T 4e7w_A          109 DEVFLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG  187 (394)
T ss_dssp             SCEEEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred             CceEEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence               388999999764 433332    356799999999999999999999999999999999999999 78999999999


Q ss_pred             cccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC-------
Q 019216          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------  232 (344)
Q Consensus       160 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~-------  232 (344)
                      +++....   ........+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+...       
T Consensus       188 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~  264 (394)
T 4e7w_A          188 SAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE  264 (394)
T ss_dssp             TCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             CcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            9975422   223345678999999999987665578999999999999999999999998776666555431       


Q ss_pred             ----------CCC------------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          233 ----------DFK------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       233 ----------~~~------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                ...            ++..+++++.+||.+||+.||++|||+.|+++||||++...+
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence                      011            234478999999999999999999999999999999875443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.5e-51  Score=369.08  Aligned_cols=255  Identities=26%  Similarity=0.417  Sum_probs=211.1

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC--e
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--K   88 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~   88 (344)
                      ..-++|++.+.||+|+||.||+|.+..+++.||+|++......  ...+.+.+|+.++++++||||+++++++....  .
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   83 (319)
T 4euu_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (319)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence            4567999999999999999999999999999999999754322  23567789999999999999999999987654  7


Q ss_pred             EEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE----ccCCCeEEeccccc
Q 019216           89 IYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLS  161 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl----~~~~~vkl~Dfg~a  161 (344)
                      .++||||+++++|.+++....   .+++..++.++.||+.||.|||+.||+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            899999999999999998643   39999999999999999999999999999999999999    77778999999999


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhcc-------CCCCCccchhhhhhHHHHHHHhCCCCCCC----ccHHHHHHHHh
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLAN-------RGYDGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIF  230 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~~DvwslG~ll~ell~g~~pf~~----~~~~~~~~~i~  230 (344)
                      +....   ........||+.|+|||++..       ....+.++|||||||++|+|++|+.||..    ........++.
T Consensus       164 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  240 (319)
T 4euu_A          164 RELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (319)
T ss_dssp             EECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHH
T ss_pred             eecCC---CCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHh
Confidence            75432   223345679999999999862       23346899999999999999999999963    23344444554


Q ss_pred             hCCC-------------------C------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcc
Q 019216          231 RGDF-------------------K------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW  270 (344)
Q Consensus       231 ~~~~-------------------~------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~  270 (344)
                      .+.+                   .      ++..+++.+.+||++||+.||++|||++|+|+||-
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             cCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            4332                   1      11224568899999999999999999999999974

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3.6e-50  Score=372.93  Aligned_cols=253  Identities=30%  Similarity=0.424  Sum_probs=213.3

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE----
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI----   89 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~----   89 (344)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++......    
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            69999999999999999999999999999999996543 3445567889999999999999999999999876654    


Q ss_pred             --EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           90 --YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        90 --~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                        ++||||+. ++|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... 
T Consensus       121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-  196 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-  196 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC------
T ss_pred             eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-
Confidence              99999996 58877763  4599999999999999999999999999999999999999999999999999974322 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--------------
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--------------  233 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--------------  233 (344)
                          ......||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+....              
T Consensus       197 ----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          197 ----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             ----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence                23456789999999999874555789999999999999999999999887666655553310              


Q ss_pred             ---------C--------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          234 ---------F--------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       234 ---------~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                               .        ..+..+++.+.+||.+||+.||++|||++|+|+||||+...
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence                     0        01234789999999999999999999999999999998643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7e-51  Score=377.17  Aligned_cols=262  Identities=23%  Similarity=0.306  Sum_probs=223.9

Q ss_pred             cCccccCeEEeeeecccCceEEEEEE-----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEE
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL   83 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~   83 (344)
                      ..+..++|++++.||+|+||.||+|.     +..+++.||+|++....  .......+.+|+.++++++||||+++++++
T Consensus        66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  143 (367)
T 3l9p_A           66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS  143 (367)
T ss_dssp             CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            34667899999999999999999999     44577899999986432  334456788999999999999999999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC---Ce
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG---NI  153 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~~~~-------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~---~v  153 (344)
                      ......++||||++|++|.+++...+       .+++..++.++.||+.||.|||++||+||||||+|||++.++   .+
T Consensus       144 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~  223 (367)
T 3l9p_A          144 LQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  223 (367)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             ecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceE
Confidence            99889999999999999999997643       489999999999999999999999999999999999999655   59


Q ss_pred             EEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC
Q 019216          154 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG  232 (344)
Q Consensus       154 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~  232 (344)
                      ||+|||+++...............||+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......+..+
T Consensus       224 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~  302 (367)
T 3l9p_A          224 KIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  302 (367)
T ss_dssp             EECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECCCccccccccccccccCCCcCCcccEECHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999874322222233345678999999999987776 689999999999999998 99999998888888877766


Q ss_pred             C-CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          233 D-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       233 ~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      . ...+..+++.+.+|+.+||+.||++|||+.+++++.++..
T Consensus       303 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~  344 (367)
T 3l9p_A          303 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  344 (367)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence            4 5567789999999999999999999999999999987653

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.1e-50  Score=380.59  Aligned_cols=260  Identities=32%  Similarity=0.444  Sum_probs=196.5

Q ss_pred             ccCeEE-eeeecccCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee--CC
Q 019216           13 LGRYEL-GRTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KS   87 (344)
Q Consensus        13 ~~~y~~-~~~Lg~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~   87 (344)
                      -+.|++ .++||+|+||.||+|.++  .+++.||+|++.....     ...+.+|+.++++++||||+++++++..  ..
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADR   93 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTT
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCC
Confidence            356887 458999999999999976  5789999999865432     2467889999999999999999999954  67


Q ss_pred             eEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE----ccCCCeE
Q 019216           88 KIYMVLEYVTGGELFDKIASK---------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIK  154 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~---------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl----~~~~~vk  154 (344)
                      .+++||||+. ++|.+++...         ..+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+|
T Consensus        94 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           94 KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            8999999995 5888877532         249999999999999999999999999999999999999    6778999


Q ss_pred             EeccccccCCCccc-CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH---------H
Q 019216          155 ISDFGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------V  224 (344)
Q Consensus       155 l~Dfg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~---------~  224 (344)
                      |+|||+++...... ........+||+.|+|||++.+...++.++|||||||++|+|++|++||.+....         .
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            99999998643321 1123345689999999999987665679999999999999999999999765431         2


Q ss_pred             HHHHHhhC--CCC------------------------------------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhh
Q 019216          225 LYQKIFRG--DFK------------------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIK  266 (344)
Q Consensus       225 ~~~~i~~~--~~~------------------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil  266 (344)
                      ....+...  ...                                    .....++.+.+||.+||+.||++|||++|+|
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            22222211  000                                    0011278899999999999999999999999


Q ss_pred             cCccccccCCCC
Q 019216          267 ADEWFEQDYTPA  278 (344)
Q Consensus       267 ~~~~~~~~~~~~  278 (344)
                      +||||.+...+.
T Consensus       333 ~hp~f~~~~~~~  344 (405)
T 3rgf_A          333 QDPYFLEDPLPT  344 (405)
T ss_dssp             TSGGGTSSSCCC
T ss_pred             cChhhccCCCCc
Confidence            999998765543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.3e-50  Score=364.88  Aligned_cols=259  Identities=26%  Similarity=0.407  Sum_probs=218.1

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      ...++|++++.||+|+||.||+|.+..+++.||+|++....   ....+.+.+|+.+++.++||||+++++++......+
T Consensus        16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   92 (302)
T 2j7t_A           16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW   92 (302)
T ss_dssp             CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred             CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence            44579999999999999999999999999999999986443   234577889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +||||+++++|.+++.. ...+++..++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.....  .
T Consensus        93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~  170 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLK--T  170 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHH--H
T ss_pred             EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccc--c
Confidence            99999999999998875 56799999999999999999999999999999999999999999999999998752111  1


Q ss_pred             CCccccccCCCcccchhhhc----cCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC---CCCCCCH
Q 019216          170 DGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK---LPKWLSP  242 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~---~~~~~~~  242 (344)
                      ........||+.|+|||++.    .....+.++||||||+++|+|++|+.||...+.......+.....+   .+..++.
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (302)
T 2j7t_A          171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSV  250 (302)
T ss_dssp             HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCH
T ss_pred             ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCH
Confidence            11123457899999999984    2333468999999999999999999999988877777666665432   3566899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .+.++|.+||+.||++|||+.++++||||...
T Consensus       251 ~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  282 (302)
T 2j7t_A          251 EFRDFLKIALDKNPETRPSAAQLLEHPFVSSI  282 (302)
T ss_dssp             HHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTC
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhcChHHhhh
Confidence            99999999999999999999999999999864

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-50  Score=363.89  Aligned_cols=258  Identities=26%  Similarity=0.390  Sum_probs=215.3

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEee----
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS----   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~----   85 (344)
                      ...++|++++.||+|+||.||+|.+..+|+.||+|++.....    ....+.+|+.+++++ +||||+++++++..    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   96 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP   96 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence            457899999999999999999999999999999999865432    235788999999998 79999999999976    


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccc
Q 019216           86 --KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus        86 --~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a  161 (344)
                        ....++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~  176 (326)
T 2x7f_A           97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS  176 (326)
T ss_dssp             CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred             cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence              56899999999999999999764  57999999999999999999999999999999999999999999999999998


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC--
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--  235 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~--  235 (344)
                      ......  ........||+.|+|||++..    ....+.++|||||||++|+|++|..||.+.+.......+.....+  
T Consensus       177 ~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~  254 (326)
T 2x7f_A          177 AQLDRT--VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL  254 (326)
T ss_dssp             C---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC
T ss_pred             eecCcC--ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC
Confidence            754321  122345578999999999863    233468999999999999999999999887776666665554332  


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       236 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .+..+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus       255 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~  293 (326)
T 2x7f_A          255 KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQ  293 (326)
T ss_dssp             SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCC
T ss_pred             CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhC
Confidence            245689999999999999999999999999999999864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=4.7e-50  Score=365.64  Aligned_cols=256  Identities=24%  Similarity=0.384  Sum_probs=219.9

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      .+..++|++.+.||+|+||.||+|.+..+++   .||||++....  .....+.+.+|+.+++.++||||+++++++...
T Consensus        45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  122 (325)
T 3kul_A           45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG  122 (325)
T ss_dssp             BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred             ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence            4667899999999999999999999986655   49999986432  334567889999999999999999999999998


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      ...++||||++|++|.+++... +.+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  202 (325)
T 3kul_A          123 RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLE  202 (325)
T ss_dssp             GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred             CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccc
Confidence            9999999999999999999754 579999999999999999999999999999999999999999999999999998543


Q ss_pred             cccCCC-ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCH
Q 019216          166 HFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP  242 (344)
Q Consensus       166 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~  242 (344)
                      ...... ......+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+ ..+.+..+++
T Consensus       203 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  281 (325)
T 3kul_A          203 DDPDAAYTTTGGKIPIRWTAPEAIAFRTF-SSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPH  281 (325)
T ss_dssp             ----CCEECC---CCGGGSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCH
T ss_pred             cCccceeeccCCCCcccccCHhHhcCCCC-CcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCH
Confidence            322111 1223456788999999987766 689999999999999999 99999998888877777765 4566778999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+.+||.+||+.||++|||+.++++.
T Consensus       282 ~l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          282 ALHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999863

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.7e-50  Score=364.48  Aligned_cols=260  Identities=28%  Similarity=0.397  Sum_probs=211.8

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe--------
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA--------   84 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~--------   84 (344)
                      -++|++++.||+|+||.||+|.+..+|+.||+|++...   +....+.+.+|+.++++++||||+++++++.        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            46999999999999999999999999999999998644   3455678899999999999999999999873        


Q ss_pred             ------eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEc-cCCCeEEec
Q 019216           85 ------SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISD  157 (344)
Q Consensus        85 ------~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~-~~~~vkl~D  157 (344)
                            .....++||||+. ++|.+++.+ +++++..++.++.|++.||+|||++||+||||||+|||++ .++.+||+|
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence                  4468899999997 599988864 6799999999999999999999999999999999999997 567999999


Q ss_pred             cccccCCCccc-CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC-
Q 019216          158 FGLSALPQHFR-DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-  235 (344)
Q Consensus       158 fg~a~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~-  235 (344)
                      ||++....... .........+|..|+|||.+.+....+.++|||||||++|+|++|+.||.+.+.......+...... 
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            99998643221 1222344577999999999876555578999999999999999999999988776666555432110 


Q ss_pred             -----------------------------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          236 -----------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       236 -----------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                                   .+..+++.+.+||.+||+.||++|||+.++++||||+....+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence                                         124589999999999999999999999999999999875444

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2e-50  Score=367.35  Aligned_cols=264  Identities=25%  Similarity=0.350  Sum_probs=202.8

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      .+..++|++++.||+|+||.||+|.+..++.   .||+|++..... .....+.+.+|+.++++++||||+++++++...
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   97 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRS   97 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeecc
Confidence            3566799999999999999999999877665   899999865432 234467899999999999999999999999776


Q ss_pred             CeE------EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeE
Q 019216           87 SKI------YMVLEYVTGGELFDKIASKG------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK  154 (344)
Q Consensus        87 ~~~------~iv~e~~~g~~L~~~l~~~~------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vk  154 (344)
                      ...      ++||||+.+++|.+++....      .+++..++.++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence            654      99999999999999986432      589999999999999999999999999999999999999999999


Q ss_pred             EeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-
Q 019216          155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-  232 (344)
Q Consensus       155 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-  232 (344)
                      |+|||++................+++.|+|||.+.+..+ +.++|||||||++|+|++ |+.||.+.+.......+..+ 
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~  256 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLY-TVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN  256 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCC-CCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC
Confidence            999999975433222222334456789999999988766 689999999999999999 99999988777777766655 


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCCcCCCCC-------HhhhhcCccccccC
Q 019216          233 DFKLPKWLSPGAQNLLRKILEPNPVKRIT-------IAGIKADEWFEQDY  275 (344)
Q Consensus       233 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps-------~~eil~~~~~~~~~  275 (344)
                      ....+..+++.+.+|+.+||+.||++|||       +++++.|+|+....
T Consensus       257 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~  306 (323)
T 3qup_A          257 RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS  306 (323)
T ss_dssp             CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred             CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence            45677889999999999999999999999       77889999987643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=9.6e-51  Score=369.38  Aligned_cols=257  Identities=33%  Similarity=0.582  Sum_probs=222.7

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCC--CCCccceeeEE
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLK--HPNVVRLHEVL   83 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~   83 (344)
                      .....++|++.+.||+|+||.||+|.+..+++.||+|++........   .....+.+|+.++++++  |+||+++++++
T Consensus        38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~  117 (320)
T 3a99_A           38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF  117 (320)
T ss_dssp             --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred             cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence            34567899999999999999999999999999999999976543221   11245667999999996  59999999999


Q ss_pred             eeCCeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEc-cCCCeEEeccccc
Q 019216           84 ASKSKIYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLS  161 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g-~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~-~~~~vkl~Dfg~a  161 (344)
                      ......++|||++.+ ++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++
T Consensus       118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~  197 (320)
T 3a99_A          118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG  197 (320)
T ss_dssp             ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred             ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence            999999999999976 89999999888999999999999999999999999999999999999999 6789999999998


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCC
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLS  241 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  241 (344)
                      .....    .......||+.|+|||++.+..+.+.++|||||||++|+|++|+.||....      .+......++..++
T Consensus       198 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~  267 (320)
T 3a99_A          198 ALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVS  267 (320)
T ss_dssp             EECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCC
T ss_pred             ccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCC
Confidence            75432    223456799999999999887776788999999999999999999997643      34456667788899


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      +.+.+||.+||+.||++|||++++++||||++..
T Consensus       268 ~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            9999999999999999999999999999998643

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-49  Score=360.80  Aligned_cols=260  Identities=25%  Similarity=0.384  Sum_probs=211.7

Q ss_pred             hhccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216            6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus         6 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      ....+..+++|++.+.||+|+||.||+|.+..+++.||+|++...........+.+.+|+.++++++||||+++++++..
T Consensus        26 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~  105 (309)
T 2h34_A           26 ESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI  105 (309)
T ss_dssp             --------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             ccCCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee
Confidence            44577889999999999999999999999999999999999976655555667889999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      .+..++||||++|++|.+++...+.+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus       106 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  185 (309)
T 2h34_A          106 DGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATT  185 (309)
T ss_dssp             TTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----
T ss_pred             CCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccc
Confidence            99999999999999999999988899999999999999999999999999999999999999999999999999987543


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC---CCCCCCCH
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSP  242 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~  242 (344)
                      .. .........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+.......+.....   ..+..+++
T Consensus       186 ~~-~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (309)
T 2h34_A          186 DE-KLTQLGNTVGTLYYMAPERFSESHA-TYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPV  263 (309)
T ss_dssp             ------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCT
T ss_pred             cc-ccccccccCCCcCccCHHHHcCCCC-CchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCH
Confidence            21 1122335578999999999887665 6899999999999999999999998876655544443322   34567899


Q ss_pred             HHHHHHHHhcCCCcCCCC-CHhhhhc
Q 019216          243 GAQNLLRKILEPNPVKRI-TIAGIKA  267 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rp-s~~eil~  267 (344)
                      .+.++|.+||+.||++|| |++++++
T Consensus       264 ~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          264 AFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            999999999999999999 7877765

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.7e-50  Score=371.42  Aligned_cols=262  Identities=25%  Similarity=0.373  Sum_probs=210.5

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccc--------cchhHHHHHHHHHHHHHhCCCCCccceeeE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI--------IHLKITDQIKREIATLKLLKHPNVVRLHEV   82 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~h~niv~l~~~   82 (344)
                      ...++|++++.||+|+||.||+|.+.. |+.||+|++.....        ......+.+.+|+.++++++||||++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   97 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDI   97 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeee
Confidence            345899999999999999999999855 99999999864322        123345789999999999999999999999


Q ss_pred             Eee-----CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEe
Q 019216           83 LAS-----KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKIS  156 (344)
Q Consensus        83 ~~~-----~~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~  156 (344)
                      +..     ...+|+||||+. ++|.+.+... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        98 ~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~  176 (362)
T 3pg1_A           98 FVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITIC  176 (362)
T ss_dssp             EEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred             EEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEE
Confidence            843     346899999996 5888877654 479999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC----
Q 019216          157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----  232 (344)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~----  232 (344)
                      |||++.....   ........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...    
T Consensus       177 Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~  253 (362)
T 3pg1_A          177 DFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP  253 (362)
T ss_dssp             CTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            9999974322   223345678999999999887555578999999999999999999999988766665555321    


Q ss_pred             --------------------CC--------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          233 --------------------DF--------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       233 --------------------~~--------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                          ..        ..+..+++.+.+||.+||+.||++|||+.++++||||+..+.+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             CHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             ChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence                                00        0123468899999999999999999999999999999876544

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7e-51  Score=366.59  Aligned_cols=264  Identities=26%  Similarity=0.446  Sum_probs=198.5

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      -.+..++|++.+.||+|+||.||+|.+..+++.||+|++.....  ....+.+.+|+.++++++||||+++++++...+.
T Consensus        10 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   87 (303)
T 2vwi_A           10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE   87 (303)
T ss_dssp             ---CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred             cccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence            44677899999999999999999999988999999998864432  2335678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecccc
Q 019216           89 IYMVLEYVTGGELFDKIAS--------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~--------~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~  160 (344)
                      .++||||+++++|.+++..        .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~  167 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV  167 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence            9999999999999999874        45689999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCccc---CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC---
Q 019216          161 SALPQHFR---DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---  234 (344)
Q Consensus       161 a~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~---  234 (344)
                      +.......   .........||+.|+|||++.+....+.++||||||+++|+|++|+.||.................   
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  247 (303)
T 2vwi_A          168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL  247 (303)
T ss_dssp             HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT
T ss_pred             hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc
Confidence            86433211   111223457999999999987633346899999999999999999999988665544444433321   


Q ss_pred             -------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          235 -------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       235 -------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                             .....+++.+.+||.+||+.||.+|||+.++++||||++.
T Consensus       248 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          248 ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence                   1234578999999999999999999999999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=370.06  Aligned_cols=256  Identities=27%  Similarity=0.451  Sum_probs=223.7

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceee
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE   81 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~   81 (344)
                      .+..++|++.+.||+|+||.||+|.+..       .+..||+|++....  .......+.+|+.+++++ +||||+++++
T Consensus        65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~  142 (382)
T 3tt0_A           65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG  142 (382)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence            4566899999999999999999999753       34579999986542  344567889999999999 8999999999


Q ss_pred             EEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcE
Q 019216           82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI  145 (344)
Q Consensus        82 ~~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NI  145 (344)
                      ++...+..++||||+++++|.+++....                .+++..++.++.||+.||.|||+.||+||||||+||
T Consensus       143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  222 (382)
T 3tt0_A          143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV  222 (382)
T ss_dssp             EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence            9999999999999999999999998653                489999999999999999999999999999999999


Q ss_pred             EEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHH
Q 019216          146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV  224 (344)
Q Consensus       146 Ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~  224 (344)
                      |++.++.+||+|||+++...............+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+...
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwslG~il~ellt~g~~p~~~~~~~~  301 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEE  301 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence            999999999999999986544332233444567889999999987665 689999999999999999 999999988888


Q ss_pred             HHHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          225 LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       225 ~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ....+..+ ....+..+++.+.+||.+||+.||++|||+.+++++
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            87777766 456678899999999999999999999999999886

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8e-50  Score=354.15  Aligned_cols=252  Identities=23%  Similarity=0.404  Sum_probs=219.5

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      .+..++|++++.||+|+||.||+|.+. +++.||+|++......    .+.+.+|+.++++++||||+++++++......
T Consensus         6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   80 (269)
T 4hcu_A            6 VIDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI   80 (269)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred             EeChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCce
Confidence            356689999999999999999999986 5778999999754432    35688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ++||||+++++|.+++.. .+.+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++.......
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  160 (269)
T 4hcu_A           81 CLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ  160 (269)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred             EEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence            999999999999999975 4468999999999999999999999999999999999999999999999999987432211


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                       ........+|+.|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.........+..+ ....|..+++.+.+
T Consensus       161 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (269)
T 4hcu_A          161 -YTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQ  238 (269)
T ss_dssp             -HHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             -cccccCcccccccCCHHHhcCCCC-CchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHH
Confidence             112233456788999999987776 689999999999999999 99999998888888877766 45567778999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhcC
Q 019216          247 LLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ++.+||+.||++|||+.+++++
T Consensus       239 li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          239 IMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHccCCcccCcCHHHHHHH
Confidence            9999999999999999999876

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=5e-50  Score=362.99  Aligned_cols=257  Identities=28%  Similarity=0.377  Sum_probs=221.4

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEE
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL   83 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~   83 (344)
                      -.+..++|++.+.||+|+||.||+|.+.     .+++.||+|++....  .....+.+.+|+.+++.++||||+++++++
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   95 (314)
T 2ivs_A           18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGAC   95 (314)
T ss_dssp             TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence            3466789999999999999999999983     456899999986443  345567899999999999999999999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCceeec
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIASKGR------------------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRD  139 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~~~~~------------------------~~~~~~~~i~~ql~~~L~~LH~~~i~H~d  139 (344)
                      ......++||||+++++|.+++.....                        +++..++.++.||+.||.|||++||+|||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d  175 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD  175 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence            999999999999999999999986543                        89999999999999999999999999999


Q ss_pred             CCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCC
Q 019216          140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFD  218 (344)
Q Consensus       140 ikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~  218 (344)
                      |||+|||++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.
T Consensus       176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~  254 (314)
T 2ivs_A          176 LAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIY-TTQSDVWSFGVLLWEIVTLGGNPYP  254 (314)
T ss_dssp             CSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             cchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCc-CchhhHHHHHHHHHHHHhCCCCCCC
Confidence            999999999999999999999875433222122234467889999999987665 689999999999999999 999999


Q ss_pred             CccHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          219 DRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       219 ~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +.........+..+ ....+..+++.+.++|.+||+.||++|||+.+++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          255 GIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             TCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            88777776666655 355677899999999999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=5.4e-50  Score=367.31  Aligned_cols=256  Identities=26%  Similarity=0.363  Sum_probs=222.0

Q ss_pred             CccccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA   84 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~   84 (344)
                      .+..++|++++.||+|+||.||+|.+.     .+++.||+|++....  .....+.+.+|+.++++++||||+++++++.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            567789999999999999999999987     355899999986543  3445678999999999999999999999999


Q ss_pred             eCCeEEEEEeccCCCChHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecC
Q 019216           85 SKSKIYMVLEYVTGGELFDKIASK------------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL  140 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~~------------------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~di  140 (344)
                      .....++||||+++++|.+++...                        ..+++..++.++.||+.||.|||++||+||||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl  200 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL  200 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            999999999999999999999763                        56899999999999999999999999999999


Q ss_pred             CCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCC
Q 019216          141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD  219 (344)
Q Consensus       141 kp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~  219 (344)
                      ||+|||++.++.+||+|||++................+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+
T Consensus       201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~  279 (343)
T 1luf_A          201 ATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYG  279 (343)
T ss_dssp             SGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred             CcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCc-CcccccHHHHHHHHHHHhcCCCcCCC
Confidence            99999999999999999999874332222222334567899999999987776 689999999999999999 9999999


Q ss_pred             ccHHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          220 RNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       220 ~~~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+.......+..+. ...|..+++.+.+++.+||+.||++|||+.+++++
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          280 MAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             SCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            88888877777665 35678899999999999999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.3e-49  Score=366.63  Aligned_cols=254  Identities=30%  Similarity=0.415  Sum_probs=213.0

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe----
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK----   88 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~----   88 (344)
                      -++|.+.+.||+|+||.||+|.++.+|+.||||++.... ......+.+.+|+.+++.++||||+++++++.....    
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  101 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF  101 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence            378999999999999999999999999999999986543 344456788999999999999999999999976643    


Q ss_pred             --EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           89 --IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        89 --~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                        +++||||+. ++|.+.+.  ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          102 YDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             eeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence              599999996 58877664  3589999999999999999999999999999999999999999999999999975322


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--------------
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--------------  232 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--------------  232 (344)
                           ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+.......+...              
T Consensus       179 -----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  253 (353)
T 3coi_A          179 -----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  253 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred             -----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence                 2334678999999999887555578999999999999999999999987766555444321              


Q ss_pred             -----------------CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          233 -----------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       233 -----------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                                       ....+..+++.+.+||.+||+.||++|||+.++++||||+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          254 KAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             HHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence                             0112345799999999999999999999999999999998643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.6e-50  Score=374.73  Aligned_cols=254  Identities=27%  Similarity=0.402  Sum_probs=218.2

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++.+.||+|+||.||+|.++.+++.||+|++....  .......+.+|+.++++++||||+++++++......+
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  188 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIY  188 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCE
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcE
Confidence            44578999999999999999999999999999999986432  3344567889999999999999999999999888999


Q ss_pred             EEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           91 MVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +||||+++++|.+++...+ .+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus       189 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~  268 (377)
T 3cbl_A          189 IVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY  268 (377)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce
Confidence            9999999999999997644 699999999999999999999999999999999999999999999999999874322111


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL  247 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~l  247 (344)
                      ........++..|+|||++.+..+ +.++|||||||++|||++ |..||.+.+.......+..+ ..+.|..+++.+.+|
T Consensus       269 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  347 (377)
T 3cbl_A          269 AASGGLRQVPVKWTAPEALNYGRY-SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRL  347 (377)
T ss_dssp             ECCSSCCEEEGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             eecCCCCCCCcCcCCHhHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence            111112234678999999987666 689999999999999998 99999998877776666654 456778899999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhc
Q 019216          248 LRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~  267 (344)
                      +.+||+.||++|||+.++++
T Consensus       348 i~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          348 MEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999876

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.5e-50  Score=371.93  Aligned_cols=256  Identities=26%  Similarity=0.389  Sum_probs=216.1

Q ss_pred             CccccCeEEeeeecccCceEEEEEE-----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL   83 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~   83 (344)
                      .+..++|++.+.||+|+||.||+|.     +..+++.||+|++....  .....+.+.+|+.+++++ +||||+++++++
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~   95 (359)
T 3vhe_A           18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC   95 (359)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence            3567899999999999999999999     55677899999996543  234457789999999999 799999999998


Q ss_pred             eeCC-eEEEEEeccCCCChHHHHHhcCC----------------------------------------------------
Q 019216           84 ASKS-KIYMVLEYVTGGELFDKIASKGR----------------------------------------------------  110 (344)
Q Consensus        84 ~~~~-~~~iv~e~~~g~~L~~~l~~~~~----------------------------------------------------  110 (344)
                      ...+ ..++|||||++++|.+++.....                                                    
T Consensus        96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (359)
T 3vhe_A           96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD  175 (359)
T ss_dssp             CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred             ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence            7754 48999999999999999976433                                                    


Q ss_pred             --------------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccc
Q 019216          111 --------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT  176 (344)
Q Consensus       111 --------------~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~  176 (344)
                                    +++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...............
T Consensus       176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  255 (359)
T 3vhe_A          176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA  255 (359)
T ss_dssp             --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred             hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence                          899999999999999999999999999999999999999999999999999855433333334456


Q ss_pred             cCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHH-HHHHHHhhC-CCCCCCCCCHHHHHHHHHhcC
Q 019216          177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLA-VLYQKIFRG-DFKLPKWLSPGAQNLLRKILE  253 (344)
Q Consensus       177 ~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~-~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~  253 (344)
                      .||+.|+|||++.+..+ +.++|||||||++|+|++ |+.||.+.... .....+..+ ....|..+++.+.+++.+||+
T Consensus       256 ~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  334 (359)
T 3vhe_A          256 RLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWH  334 (359)
T ss_dssp             EECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred             CCCceeEChhhhcCCCC-CchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcc
Confidence            78899999999987766 689999999999999998 99999886533 333333333 556778899999999999999


Q ss_pred             CCcCCCCCHhhhhcC
Q 019216          254 PNPVKRITIAGIKAD  268 (344)
Q Consensus       254 ~dP~~Rps~~eil~~  268 (344)
                      .||++|||+.++++|
T Consensus       335 ~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          335 GEPSQRPTFSELVEH  349 (359)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCCCHHHHHHH
Confidence            999999999999886

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=8.1e-50  Score=364.90  Aligned_cols=253  Identities=30%  Similarity=0.424  Sum_probs=212.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEE-CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC------CccceeeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQD-LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP------NVVRLHEVL   83 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~-~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~------niv~l~~~~   83 (344)
                      +..++|++++.||+|+||.||+|.+ ..+++.||+|++...    ....+.+.+|+.+++.++|+      +++++++++
T Consensus        11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~   86 (339)
T 1z57_A           11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWF   86 (339)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEE
T ss_pred             CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccc
Confidence            4457999999999999999999998 568899999998643    23456788899999888765      499999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc------------
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS------------  149 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~------------  149 (344)
                      ...+..++||||+ +++|.+++...+  ++++..++.++.||+.||+|||++||+||||||+|||++.            
T Consensus        87 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~  165 (339)
T 1z57_A           87 EHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIK  165 (339)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----
T ss_pred             ccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccc
Confidence            9999999999999 889999998765  6899999999999999999999999999999999999987            


Q ss_pred             -------CCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH
Q 019216          150 -------KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL  222 (344)
Q Consensus       150 -------~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~  222 (344)
                             ++.+||+|||++....     .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+.
T Consensus       166 ~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~  239 (339)
T 1z57_A          166 RDERTLINPDIKVVDFGSATYDD-----EHHSTLVSTRHYRAPEVILALGW-SQPCDVWSIGCILIEYYLGFTVFPTHDS  239 (339)
T ss_dssp             CEEEEESCCCEEECCCSSCEETT-----SCCCSSCSCGGGCCHHHHTTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCSCH
T ss_pred             cccccccCCCceEeeCcccccCc-----cccccccCCccccChHHhhCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCh
Confidence                   6689999999987432     22345678999999999987776 6899999999999999999999988776


Q ss_pred             HHHHHHHhhCCCCC--------------------------------------------CCCCCHHHHHHHHHhcCCCcCC
Q 019216          223 AVLYQKIFRGDFKL--------------------------------------------PKWLSPGAQNLLRKILEPNPVK  258 (344)
Q Consensus       223 ~~~~~~i~~~~~~~--------------------------------------------~~~~~~~~~~li~~~L~~dP~~  258 (344)
                      ......+......+                                            +...++.+.+||.+||+.||.+
T Consensus       240 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  319 (339)
T 1z57_A          240 KEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK  319 (339)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCccc
Confidence            55444332211111                                            1123567899999999999999


Q ss_pred             CCCHhhhhcCcccccc
Q 019216          259 RITIAGIKADEWFEQD  274 (344)
Q Consensus       259 Rps~~eil~~~~~~~~  274 (344)
                      |||+.|+++||||+..
T Consensus       320 Rpt~~ell~hp~f~~~  335 (339)
T 1z57_A          320 RITLREALKHPFFDLL  335 (339)
T ss_dssp             SCCHHHHTTSGGGGGG
T ss_pred             ccCHHHHhcCHHHHHH
Confidence            9999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.7e-50  Score=360.91  Aligned_cols=252  Identities=24%  Similarity=0.390  Sum_probs=212.4

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      .+..++|++.+.||+|+||+||+|.+..+++.||+|.+...   .....+.+.+|+.++++++||||+++++++......
T Consensus         6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~   82 (310)
T 3s95_A            6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL   82 (310)
T ss_dssp             EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred             eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence            35678999999999999999999999999999999988543   345567899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ++||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999999999987 5679999999999999999999999999999999999999999999999999997543221


Q ss_pred             CC------------CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHH-----HHHHHhh
Q 019216          169 DD------------GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV-----LYQKIFR  231 (344)
Q Consensus       169 ~~------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~-----~~~~i~~  231 (344)
                      ..            ......+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.......     ...... 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~-  240 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSY-DEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL-  240 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH-
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc-
Confidence            11            01124579999999999988766 689999999999999999999986522100     000111 


Q ss_pred             CCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          232 GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       232 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                       ....|..+++.+.+++.+||+.||++|||+.++++
T Consensus       241 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          241 -DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             -HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence             11246678999999999999999999999999986

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.9e-49  Score=351.44  Aligned_cols=252  Identities=25%  Similarity=0.420  Sum_probs=218.2

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      .+..++|++++.||+|+||.||+|.+. ++..||+|++......    .+.+.+|+.++++++||||+++++++......
T Consensus         4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   78 (268)
T 3sxs_A            4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI   78 (268)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence            356789999999999999999999875 5678999999754432    35688999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           90 YMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~  158 (268)
T 3sxs_A           79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ  158 (268)
T ss_dssp             EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred             EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence            99999999999999998654 59999999999999999999999999999999999999999999999999987433211


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC-CCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~  246 (344)
                       ........+|+.|+|||.+.+..+ +.++||||||+++|+|++ |+.||...+.......+..+. ...|..+++.+.+
T Consensus       159 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  236 (268)
T 3sxs_A          159 -YVSSVGTKFPVKWSAPEVFHYFKY-SSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQ  236 (268)
T ss_dssp             -EEECCSCCCCGGGCCHHHHHHSEE-ETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             -hhcccCCCcCcccCCHHHHhccCC-chhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHH
Confidence             111223456778999999987666 589999999999999999 999999988877777776664 4556778999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhcC
Q 019216          247 LLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ++.+||+.||++|||+.+++++
T Consensus       237 li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          237 IMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-50  Score=376.46  Aligned_cols=255  Identities=15%  Similarity=0.159  Sum_probs=195.3

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCcccee-------eEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--KHPNVVRLH-------EVL   83 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~-------~~~   83 (344)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            34599999999999999999999999999999999876654556667788885544444  699988755       444


Q ss_pred             eeC-----------------CeEEEEEeccCCCChHHHHHhc-CCCCHHHH------HHHHHHHHHHHHHHHhCCceeec
Q 019216           84 ASK-----------------SKIYMVLEYVTGGELFDKIASK-GRLQEAEG------RKLFQQLIDGVSYCHNKGVFHRD  139 (344)
Q Consensus        84 ~~~-----------------~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~------~~i~~ql~~~L~~LH~~~i~H~d  139 (344)
                      ...                 ..+|+||||++ ++|.+++... ..+++...      ..++.||+.||+|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            332                 34899999997 7999999863 33444455      57779999999999999999999


Q ss_pred             CCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhcc--CCCCCccchhhhhhHHHHHHHhCCCCC
Q 019216          140 LKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPF  217 (344)
Q Consensus       140 ikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~ll~ell~g~~pf  217 (344)
                      |||+|||++.++.+||+|||+++....     ......+|+.|+|||++.+  ..+ +.++|||||||++|+|++|+.||
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCST
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCC
Confidence            999999999999999999999984322     2224567799999999976  444 78999999999999999999999


Q ss_pred             CCccHHHH--HH-----HHhhCCCCC--CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          218 DDRNLAVL--YQ-----KIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       218 ~~~~~~~~--~~-----~i~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .+......  ..     ........+  +..+++.+.+||.+||+.||++|||+.++++||||++.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          294 GLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             TBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             CCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            87632210  00     000112222  34689999999999999999999999999999999863

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.5e-49  Score=356.03  Aligned_cols=254  Identities=29%  Similarity=0.479  Sum_probs=208.0

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee-------
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-------   85 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------   85 (344)
                      .++|++++.||+|+||.||+|.+..+|+.||+|++...    ....+.+.+|+.+++.++||||+++++++..       
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKP   80 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhh
Confidence            46899999999999999999999999999999998543    3446788999999999999999999998754       


Q ss_pred             ------CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecc
Q 019216           86 ------KSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF  158 (344)
Q Consensus        86 ------~~~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Df  158 (344)
                            ....++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus        81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df  160 (303)
T 1zy4_A           81 MTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF  160 (303)
T ss_dssp             -----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred             hcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence                  356899999999999999998544 5788999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccc------------CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC-ccHHHH
Q 019216          159 GLSALPQHFR------------DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVL  225 (344)
Q Consensus       159 g~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~-~~~~~~  225 (344)
                      |++.......            .........||+.|+|||++.+....+.++|||||||++|+|++   ||.. .+....
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~  237 (303)
T 1zy4_A          161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNI  237 (303)
T ss_dssp             CCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred             cchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHH
Confidence            9987543211            01123345789999999999876555789999999999999998   5543 344455


Q ss_pred             HHHHhhCCCCCC----CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          226 YQKIFRGDFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       226 ~~~i~~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      ...+......+|    ...++.+.++|.+||+.||.+|||+.++++||||..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (303)
T 1zy4_A          238 LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPV  289 (303)
T ss_dssp             HHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCC
T ss_pred             HHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCC
Confidence            555555544444    446678999999999999999999999999999975

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=3.5e-49  Score=354.28  Aligned_cols=261  Identities=28%  Similarity=0.453  Sum_probs=214.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      ..+++|.....||+|+||.||+|.+..+++.||+|.+....   ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus        19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   95 (295)
T 2clq_A           19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIK   95 (295)
T ss_dssp             ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEE
Confidence            44455555569999999999999999999999999986543   234577889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc-CCCeEEeccccccCCCc
Q 019216           91 MVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-KGNIKISDFGLSALPQH  166 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~-~~~vkl~Dfg~a~~~~~  166 (344)
                      +||||+++++|.+++....   .+++..++.++.|++.||.|||+.|++||||||+|||++. ++.+||+|||++.....
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~  175 (295)
T 2clq_A           96 IFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG  175 (295)
T ss_dssp             EEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred             EEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence            9999999999999997642   4678999999999999999999999999999999999988 89999999999875432


Q ss_pred             ccCCCccccccCCCcccchhhhccCC-CCCccchhhhhhHHHHHHHhCCCCCCCccHH--HHH-HHHhhCCCCCCCCCCH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRNLA--VLY-QKIFRGDFKLPKWLSP  242 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~ll~ell~g~~pf~~~~~~--~~~-~~i~~~~~~~~~~~~~  242 (344)
                      .  ........||+.|+|||++.+.. ..+.++||||||+++|+|++|+.||......  ... .........++..+++
T Consensus       176 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (295)
T 2clq_A          176 I--NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSA  253 (295)
T ss_dssp             -------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCH
T ss_pred             C--CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCH
Confidence            1  12234567899999999987643 2368999999999999999999999754322  122 2223345667888999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      .+.+||.+||+.||++|||+.++++||||+....
T Consensus       254 ~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  287 (295)
T 2clq_A          254 EAKAFILKCFEPDPDKRACANDLLVDEFLKVSSK  287 (295)
T ss_dssp             HHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred             HHHHHHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence            9999999999999999999999999999986543

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.4e-50  Score=373.68  Aligned_cols=251  Identities=29%  Similarity=0.438  Sum_probs=206.4

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC--------CCCccceeeEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--------HPNVVRLHEVL   83 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------h~niv~l~~~~   83 (344)
                      ..++|++++.||+|+||.||+|.+..+++.||+|++...    ....+.+.+|+.+++.++        |+||+++++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~  110 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF  110 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecce
Confidence            357899999999999999999999999999999998643    234567889999999885        78899999998


Q ss_pred             e----eCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEEccCC-----
Q 019216           84 A----SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKG-----  151 (344)
Q Consensus        84 ~----~~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~-~i~H~dikp~NILl~~~~-----  151 (344)
                      .    ....+++||||+ +++|.+.+...  +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++     
T Consensus       111 ~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~  189 (397)
T 1wak_A          111 KISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR  189 (397)
T ss_dssp             EEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred             eecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence            7    456899999999 66777776643  5699999999999999999999998 999999999999998775     


Q ss_pred             --------------------------------------------CeEEeccccccCCCcccCCCccccccCCCcccchhh
Q 019216          152 --------------------------------------------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV  187 (344)
Q Consensus       152 --------------------------------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~  187 (344)
                                                                  .+||+|||++.....     ......||+.|+|||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGGCCHHH
T ss_pred             hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcccCChh
Confidence                                                        799999999975332     2345679999999999


Q ss_pred             hccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc------HHHHHHHHhh--C---------------------------
Q 019216          188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRN------LAVLYQKIFR--G---------------------------  232 (344)
Q Consensus       188 ~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~------~~~~~~~i~~--~---------------------------  232 (344)
                      +.+..+ +.++|||||||++|+|++|+.||.+.+      .......+..  +                           
T Consensus       265 ~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  343 (397)
T 1wak_A          265 LIGSGY-NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHIT  343 (397)
T ss_dssp             HHTSCC-CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCC
T ss_pred             hcCCCC-CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCcccccccc
Confidence            988776 689999999999999999999997533      1222222211  0                           


Q ss_pred             -------------CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          233 -------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       233 -------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                                   ....+...++.+.+||.+||+.||++|||++|+|+||||++
T Consensus       344 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          344 KLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             CCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             ccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence                         01112233567899999999999999999999999999963

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-50  Score=363.68  Aligned_cols=255  Identities=33%  Similarity=0.608  Sum_probs=212.5

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhC----CCCCccceeeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLL----KHPNVVRLHEV   82 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~h~niv~l~~~   82 (344)
                      ....++|++.+.||+|+||.||+|.+..+++.||+|++........   .....+.+|+.+++++    +||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            3456789999999999999999999999999999999975543221   1223456789999888    89999999999


Q ss_pred             EeeCCeEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEc-cCCCeEEecccc
Q 019216           83 LASKSKIYMVLEY-VTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD-SKGNIKISDFGL  160 (344)
Q Consensus        83 ~~~~~~~~iv~e~-~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~-~~~~vkl~Dfg~  160 (344)
                      +...+..++|||+ +.+++|.+++.+.+.+++..++.++.||+.||.|||+.||+||||||+||+++ .++.+||+|||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            9988899999999 78999999999888899999999999999999999999999999999999999 789999999999


Q ss_pred             ccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCC
Q 019216          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL  240 (344)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  240 (344)
                      +.....    .......||..|+|||++.+..+.+.++||||||+++|+|++|+.||....      .+......++..+
T Consensus       187 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~  256 (312)
T 2iwi_A          187 GALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPAHV  256 (312)
T ss_dssp             CEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCTTS
T ss_pred             hhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcccC
Confidence            875432    223456789999999999877776668999999999999999999997643      3445667788889


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ++.+.+||.+||+.||++|||+.++++||||+..
T Consensus       257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence            9999999999999999999999999999999864

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.2e-49  Score=356.39  Aligned_cols=249  Identities=21%  Similarity=0.285  Sum_probs=214.2

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCC-------ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSG-------LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEV   82 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~   82 (344)
                      .+..++|++.+.||+|+||.||+|.+..++       ..||+|++....   ....+.+.+|+.++++++||||++++++
T Consensus         4 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~   80 (289)
T 4fvq_A            4 KIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGV   80 (289)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred             EechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence            466789999999999999999999988777       469999986543   3446789999999999999999999999


Q ss_pred             EeeCCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC--------e
Q 019216           83 LASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN--------I  153 (344)
Q Consensus        83 ~~~~~~~~iv~e~~~g~~L~~~l~~~~~-~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~--------v  153 (344)
                      +...+..++||||++|++|.+++...+. +++..++.++.||+.||.|||++||+||||||+|||++.++.        +
T Consensus        81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999999987554 999999999999999999999999999999999999999887        9


Q ss_pred             EEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhC-CCCCCCccHHHHHHHHhhC
Q 019216          154 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRG  232 (344)
Q Consensus       154 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g-~~pf~~~~~~~~~~~i~~~  232 (344)
                      ||+|||++.....      .....||+.|+|||++.+....+.++|||||||++|+|++| .+||....... .......
T Consensus       161 kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-~~~~~~~  233 (289)
T 4fvq_A          161 KLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-KLQFYED  233 (289)
T ss_dssp             EECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-HHHHHHT
T ss_pred             eeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-HHHHhhc
Confidence            9999999874321      23456789999999998745457899999999999999995 55565554443 3444556


Q ss_pred             CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          233 DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       233 ~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ....+...++.+.+|+.+||+.||++|||+.+++++
T Consensus       234 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          234 RHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             TCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            667777889999999999999999999999999986

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.9e-49  Score=353.02  Aligned_cols=251  Identities=23%  Similarity=0.399  Sum_probs=216.2

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++++.||+|+||.||+|.+. ++..||+|++......    .+.+.+|+.+++.++||||+++++++......+
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   95 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF   95 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence            55679999999999999999999875 6778999999755432    356889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-  174 (283)
T 3gen_A           96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-  174 (283)
T ss_dssp             EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred             EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence            99999999999999976 5679999999999999999999999999999999999999999999999999987432211 


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL  247 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~l  247 (344)
                      ........+|+.|+|||++.+..+ +.++||||||+++|+|++ |+.||...+.......+..+ ....|..+++.+.++
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  253 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI  253 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             cccccCCccCcccCCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHH
Confidence            111223456788999999987776 689999999999999998 99999998888887777766 345667789999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhcC
Q 019216          248 LRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~~  268 (344)
                      |.+||+.||++|||+.++++|
T Consensus       254 i~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          254 MYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCChhHCcCHHHHHHH
Confidence            999999999999999999886

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=6.3e-49  Score=357.73  Aligned_cols=258  Identities=31%  Similarity=0.422  Sum_probs=214.6

Q ss_pred             cccCeEEeeeecccCceEEEEEEEC-CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccceeeEEe---
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLA---   84 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~-~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~---   84 (344)
                      .-++|++++.||+|+||.||+|.+. .+|+.||+|++....... .....+.+|+.+++.+   .||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            3489999999999999999999995 678999999987543221 1123455677776665   8999999999986   


Q ss_pred             --eCCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecccc
Q 019216           85 --SKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (344)
Q Consensus        85 --~~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~  160 (344)
                        .....++||||+. ++|.+++....  .+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~  166 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL  166 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcc
Confidence              4567899999997 59999998643  489999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-------
Q 019216          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------  233 (344)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-------  233 (344)
                      +.....   ........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.+.......+....       
T Consensus       167 ~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (326)
T 1blx_A          167 ARIYSF---QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  242 (326)
T ss_dssp             CCCCCG---GGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             cccccC---CCCccccccccceeCHHHHhcCCC-CcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCccc
Confidence            975432   122345678999999999987765 689999999999999999999999888776666654310       


Q ss_pred             --------------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          234 --------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       234 --------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                                          ..++..+++.+.+||.+||+.||++|||+.++++||||++..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          243 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             CccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence                                012345789999999999999999999999999999998643

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.5e-49  Score=362.59  Aligned_cols=256  Identities=21%  Similarity=0.327  Sum_probs=210.0

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceE----EEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF----AVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA   84 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~   84 (344)
                      ..+..++|++++.||+|+||.||+|.+..+++.+    |+|.+....  .....+.+.+|+.++++++||||+++++++.
T Consensus        10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   87 (327)
T 3poz_A           10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICL   87 (327)
T ss_dssp             EECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEE
T ss_pred             hhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEe
Confidence            3466789999999999999999999998887765    666664322  2334578899999999999999999999998


Q ss_pred             eCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           85 SKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      ... .++++||+.+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        88 ~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             SSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             cCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeE
Confidence            765 7789999999999999976 45799999999999999999999999999999999999999999999999999875


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCC
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLS  241 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~  241 (344)
                      ..............+|..|+|||.+.+..+ +.++|||||||++|+|++ |+.||.+.+.......+..+ ..+.+..++
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT  245 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBC
T ss_pred             ccCCcccccccCCCccccccChHHhccCCC-CchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCC
Confidence            433222223334567889999999988776 689999999999999999 99999987776666666554 456677899


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ..+.+++.+||+.||++|||+.+++++
T Consensus       246 ~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          246 IDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999999876

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=3.5e-49  Score=354.72  Aligned_cols=259  Identities=25%  Similarity=0.384  Sum_probs=210.3

Q ss_pred             hhccCccccCeEEeeeecccCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceee
Q 019216            6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHE   81 (344)
Q Consensus         6 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~   81 (344)
                      +....+..++|++++.||+|+||.||+|.    +..+++.||+|++...   .....+.+.+|+.++++++||||+++++
T Consensus         2 s~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~   78 (295)
T 3ugc_A            2 SDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKG   78 (295)
T ss_dssp             ----CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CCcCcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            34567788999999999999999999998    5678999999998643   3445678899999999999999999999


Q ss_pred             EEee--CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecc
Q 019216           82 VLAS--KSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDF  158 (344)
Q Consensus        82 ~~~~--~~~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Df  158 (344)
                      ++..  ...+++||||+++++|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+||
T Consensus        79 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Df  158 (295)
T 3ugc_A           79 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF  158 (295)
T ss_dssp             EECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCC
T ss_pred             EEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccC
Confidence            9854  356899999999999999997644 5999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCcccCC-CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH--------------
Q 019216          159 GLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA--------------  223 (344)
Q Consensus       159 g~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~--------------  223 (344)
                      |++......... .......++..|+|||++.+..+ +.++||||||+++|+|++|..||......              
T Consensus       159 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~  237 (295)
T 3ugc_A          159 GLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI  237 (295)
T ss_dssp             CSCC-------------CTTCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHH
T ss_pred             cccccccCCcceeeeccCCCCccceeCcHHhcCCCC-ChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchh
Confidence            999864332111 12233456778999999988776 68999999999999999999998654322              


Q ss_pred             --HHHHHHh-hCCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          224 --VLYQKIF-RGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       224 --~~~~~i~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                        .....+. ....+.|..+++.+.+|+.+||+.||++|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~  285 (295)
T 3ugc_A          238 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR  285 (295)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence              1122222 23456678899999999999999999999999999763

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.7e-49  Score=349.34  Aligned_cols=250  Identities=27%  Similarity=0.446  Sum_probs=206.2

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc-hhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH-LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      +..++|++.+.||+|+||.||+|.+.  ++.||+|++....... ....+.+.+|+.+++.++||||+++++++......
T Consensus         4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~   81 (271)
T 3dtc_A            4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL   81 (271)
T ss_dssp             CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred             cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence            56789999999999999999999974  8899999987543322 23457788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeecCCCCcEEEcc--------CCCeEEecc
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG---VFHRDLKLENILLDS--------KGNIKISDF  158 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---i~H~dikp~NILl~~--------~~~vkl~Df  158 (344)
                      ++||||+++++|.+++. .+++++..++.++.|++.||.|||+.|   |+||||||+|||++.        ++.+||+||
T Consensus        82 ~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Df  160 (271)
T 3dtc_A           82 CLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDF  160 (271)
T ss_dssp             EEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCC
T ss_pred             EEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccC
Confidence            99999999999988875 467999999999999999999999999   999999999999986        678999999


Q ss_pred             ccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--CCC
Q 019216          159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--FKL  236 (344)
Q Consensus       159 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--~~~  236 (344)
                      |++.....    .......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||.+.+.......+....  .+.
T Consensus       161 g~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  235 (271)
T 3dtc_A          161 GLAREWHR----TTKMSAAGAYAWMAPEVIRASMF-SKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI  235 (271)
T ss_dssp             CC-----------------CCGGGSCHHHHHHCCC-SHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred             Cccccccc----ccccCCCCccceeCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence            99975332    12234578999999999987766 689999999999999999999999988777766666554  456


Q ss_pred             CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       237 ~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +..+++.+.+++.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          236 PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            67899999999999999999999999999875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=3.5e-49  Score=367.68  Aligned_cols=253  Identities=28%  Similarity=0.363  Sum_probs=211.1

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CC-----CccceeeEEe
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HP-----NVVRLHEVLA   84 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~-----niv~l~~~~~   84 (344)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++...    ......+.+|+.+++.++ |+     +|+++++++.
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~  126 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM  126 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEE
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeec
Confidence            3468999999999999999999999999999999998643    234566778888888875 54     4999999999


Q ss_pred             eCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCceeecCCCCcEEEc--cCCCeEEecc
Q 019216           85 SKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCH--NKGVFHRDLKLENILLD--SKGNIKISDF  158 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH--~~~i~H~dikp~NILl~--~~~~vkl~Df  158 (344)
                      .....++||||+. ++|.+++...  +.+++..++.++.|++.||.|||  +.||+||||||+|||++  .++.+||+||
T Consensus       127 ~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DF  205 (382)
T 2vx3_A          127 FRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF  205 (382)
T ss_dssp             ETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred             cCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence            9999999999995 5999999865  46999999999999999999999  57999999999999995  4678999999


Q ss_pred             ccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCC--
Q 019216          159 GLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--  236 (344)
Q Consensus       159 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~--  236 (344)
                      |++.....     ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+.......  
T Consensus       206 G~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~  279 (382)
T 2vx3_A          206 GSSCQLGQ-----RIYQYIQSRFYRSPEVLLGMPY-DLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPA  279 (382)
T ss_dssp             TTCEETTC-----CCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred             cCceeccc-----ccccccCCccccChHHHcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence            99975422     2345689999999999988776 689999999999999999999999888776666554321000  


Q ss_pred             ----------------CC-------------------C---------------------------CCHHHHHHHHHhcCC
Q 019216          237 ----------------PK-------------------W---------------------------LSPGAQNLLRKILEP  254 (344)
Q Consensus       237 ----------------~~-------------------~---------------------------~~~~~~~li~~~L~~  254 (344)
                                      |.                   .                           .++.+.+||.+||+.
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          280 HILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence                            00                   0                           013789999999999


Q ss_pred             CcCCCCCHhhhhcCcccccc
Q 019216          255 NPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       255 dP~~Rps~~eil~~~~~~~~  274 (344)
                      ||++|||++|+|+||||++.
T Consensus       360 dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          360 DPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             CTTTSCCHHHHTTSGGGCC-
T ss_pred             ChhhCCCHHHHhcCcccccC
Confidence            99999999999999999864

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=7.4e-49  Score=355.61  Aligned_cols=264  Identities=25%  Similarity=0.403  Sum_probs=213.2

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC--CCCccceeeEEeeCCe
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASKSK   88 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~   88 (344)
                      +.-++|++++.||+|+||.||+|.+. +++.||+|++..... .....+.+.+|+.++++++  ||||+++++++.....
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~  102 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY  102 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCE
Confidence            34467999999999999999999984 588999999975432 3445678899999999997  5999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      .++||| +.+++|.+++...+.+++..++.++.|++.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus       103 ~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~  180 (313)
T 3cek_A          103 IYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  180 (313)
T ss_dssp             EEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-----
T ss_pred             EEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcc
Confidence            999999 45889999999888999999999999999999999999999999999999995 5899999999998654322


Q ss_pred             CCCccccccCCCcccchhhhccC----------CCCCccchhhhhhHHHHHHHhCCCCCCCcc-HHHHHHHHhhC--CCC
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANR----------GYDGATSDIWSCGVILYVILTGYLPFDDRN-LAVLYQKIFRG--DFK  235 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~~~DvwslG~ll~ell~g~~pf~~~~-~~~~~~~i~~~--~~~  235 (344)
                      .........||+.|+|||++.+.          ...+.++||||||+++|+|++|+.||.... .......+...  ...
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  260 (313)
T 3cek_A          181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE  260 (313)
T ss_dssp             ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred             ccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccC
Confidence            22233456799999999998652          234689999999999999999999998653 33333344433  345


Q ss_pred             CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCCC
Q 019216          236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA  278 (344)
Q Consensus       236 ~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~~  278 (344)
                      ++...++.+.++|.+||+.||++|||+.++++||||+....+.
T Consensus       261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~~  303 (313)
T 3cek_A          261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPV  303 (313)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC----
T ss_pred             CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCch
Confidence            6777899999999999999999999999999999998765443

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-49  Score=363.57  Aligned_cols=258  Identities=24%  Similarity=0.367  Sum_probs=215.3

Q ss_pred             CccccCeEEeeeecccCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL   83 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~   83 (344)
                      .+..++|++.+.||+|+||.||+|.+     ..++..||+|++....  .....+.+.+|+.+++++ +||||+++++++
T Consensus        41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  118 (344)
T 1rjb_A           41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC  118 (344)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            35668999999999999999999997     3466789999996432  223457789999999999 899999999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecC
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIASKG-----------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDL  140 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~~~~-----------------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~di  140 (344)
                      ...+..++||||+++++|.+++....                       .+++..++.++.||+.||.|||+.||+||||
T Consensus       119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Di  198 (344)
T 1rjb_A          119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL  198 (344)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred             eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence            99999999999999999999997643                       3789999999999999999999999999999


Q ss_pred             CCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCC
Q 019216          141 KLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDD  219 (344)
Q Consensus       141 kp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~  219 (344)
                      ||+|||++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+
T Consensus       199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCC-ChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            99999999999999999999985433222222334567889999999887666 689999999999999998 9999988


Q ss_pred             ccHHHHHHHHhhC--CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcc
Q 019216          220 RNLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW  270 (344)
Q Consensus       220 ~~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~  270 (344)
                      .............  ....|..+++.+.+||.+||+.||.+|||+.+++++..
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence            6644444444433  34567779999999999999999999999999998643

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=8.7e-50  Score=363.80  Aligned_cols=256  Identities=22%  Similarity=0.347  Sum_probs=215.4

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCce----EEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP----FAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA   84 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~   84 (344)
                      ..+..++|++++.||+|+||.||+|.+..+++.    ||+|.+....  .......+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   85 (325)
T 3kex_A            8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP   85 (325)
T ss_dssp             CBCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hhcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence            346678999999999999999999999888876    6666654322  1122345678999999999999999999986


Q ss_pred             eCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           85 SKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      . ...++||||+.+++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus        86 ~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           86 G-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             B-SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             C-CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence            4 5688999999999999999764 5799999999999999999999999999999999999999999999999999986


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCC
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLS  241 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~  241 (344)
                      ..............+|..|+|||++.+..+ +.++|||||||++|+|++ |+.||.+.........+..+ ....|..++
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKY-THQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICT  243 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBC
T ss_pred             cCcccccccccCCCCcccccChHHhccCCC-ChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCc
Confidence            544333333445678889999999987776 689999999999999999 99999988777777666665 456677889


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +.+.+++.+||+.||.+|||+.+++++
T Consensus       244 ~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          244 IDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999999886

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.8e-49  Score=351.46  Aligned_cols=255  Identities=27%  Similarity=0.426  Sum_probs=208.0

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      -.+..++|++.+.||+|+||.||+|.+..+   +..||+|.+...  ......+.+.+|+.++++++||||+++++++. 
T Consensus        10 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-   86 (281)
T 1mp8_A           10 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-   86 (281)
T ss_dssp             CBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred             eEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-
Confidence            346678999999999999999999998654   457999988543  23445678999999999999999999999985 


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                      ++..++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           87 ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence            456889999999999999998654 6999999999999999999999999999999999999999999999999999754


Q ss_pred             CcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCH
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP  242 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~  242 (344)
                      .... ........+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.........+..+ ..+.+..+++
T Consensus       167 ~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  244 (281)
T 1mp8_A          167 EDST-YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPP  244 (281)
T ss_dssp             -------------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCH
T ss_pred             Cccc-ccccccCCCcccccChhhcccCCC-CCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCH
Confidence            3211 111233456789999999987666 689999999999999997 99999987776666666655 4567788999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+.+++.+||+.||++|||+.+++++
T Consensus       245 ~l~~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          245 TLYSLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999999874

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=6.7e-49  Score=359.21  Aligned_cols=256  Identities=26%  Similarity=0.445  Sum_probs=219.6

Q ss_pred             CccccCeEEeeeecccCceEEEEEEEC-------CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceee
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHE   81 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~-------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~   81 (344)
                      .+..++|++.+.||+|+||.||+|.+.       .++..||+|++....  .......+.+|+.+++++ +||||+++++
T Consensus        31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  108 (334)
T 2pvf_A           31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLG  108 (334)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence            356689999999999999999999986       457789999986543  334567889999999999 8999999999


Q ss_pred             EEeeCCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcE
Q 019216           82 VLASKSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI  145 (344)
Q Consensus        82 ~~~~~~~~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NI  145 (344)
                      ++...+..++||||+++++|.+++....                .+++..++.++.||+.||.|||+.||+||||||+||
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  188 (334)
T 2pvf_A          109 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNV  188 (334)
T ss_dssp             EECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             EEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceE
Confidence            9999999999999999999999998644                389999999999999999999999999999999999


Q ss_pred             EEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHH
Q 019216          146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV  224 (344)
Q Consensus       146 Ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~  224 (344)
                      |++.++.+||+|||++................+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.....
T Consensus       189 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~  267 (334)
T 2pvf_A          189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY-THQSDVWSFGVLMWEIFTLGGSPYPGIPVEE  267 (334)
T ss_dssp             EECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred             EEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc-ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH
Confidence            999999999999999975433221122234467889999999887665 689999999999999999 999999988877


Q ss_pred             HHHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          225 LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       225 ~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ....+..+ ....+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          268 LFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            77777665 356677899999999999999999999999999875

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=7.4e-49  Score=347.58  Aligned_cols=251  Identities=20%  Similarity=0.319  Sum_probs=218.2

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC-
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-   86 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-   86 (344)
                      ..++.+++|++.+.||+|+||.||+|.+.  ++.||+|++..... .....+.+.+|+.++++++||||+++++++... 
T Consensus         4 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   80 (271)
T 3kmu_A            4 HSGIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPP   80 (271)
T ss_dssp             CCCCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTT
T ss_pred             cCCCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCC
Confidence            46788999999999999999999999984  88999999975432 334567799999999999999999999999876 


Q ss_pred             -CeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEEccCCCeEEeccccc
Q 019216           87 -SKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus        87 -~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~--i~H~dikp~NILl~~~~~vkl~Dfg~a  161 (344)
                       ...++||||+++++|.+++....  .+++..++.++.|++.||.|||++|  ++||||||+|||++.++.++|+|||++
T Consensus        81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~  160 (271)
T 3kmu_A           81 APHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK  160 (271)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSC
T ss_pred             CCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccce
Confidence             78899999999999999998755  4899999999999999999999999  999999999999999999999999887


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhccCCCC--CccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC--CCCCC
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD--GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG--DFKLP  237 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~--~~~~~  237 (344)
                      ...       ......||+.|+|||++.+....  +.++|||||||++|+|++|+.||.+.+.......+...  ....|
T Consensus       161 ~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (271)
T 3kmu_A          161 FSF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP  233 (271)
T ss_dssp             CTT-------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred             eee-------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC
Confidence            532       12345789999999998875543  23799999999999999999999988877776666554  45667


Q ss_pred             CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          238 KWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       238 ~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ..+++.+.+++.+||+.||++|||+.++++.
T Consensus       234 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  264 (271)
T 3kmu_A          234 PGISPHVSKLMKICMNEDPAKRPKFDMIVPI  264 (271)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            8899999999999999999999999999863

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5e-49  Score=359.18  Aligned_cols=256  Identities=22%  Similarity=0.335  Sum_probs=210.9

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceE----EEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF----AVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA   84 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~v----aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~   84 (344)
                      ..+..++|++++.||+|+||.||+|.+..+++.+    |+|.+....  .....+.+.+|+.+++.++||||+++++++.
T Consensus        10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   87 (327)
T 3lzb_A           10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICL   87 (327)
T ss_dssp             EECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEE
T ss_pred             cccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEe
Confidence            3466789999999999999999999999888876    555543221  2334678899999999999999999999998


Q ss_pred             eCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           85 SKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      ... .+++++++.+++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        88 ~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           88 TST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             SSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             cCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence            765 7889999999999999976 45799999999999999999999999999999999999999999999999999986


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCC
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLS  241 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~  241 (344)
                      ..............+|+.|+|||++.+..+ +.++|||||||++|+|++ |+.||.+.........+..+ ..+.+..++
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICT  245 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBC
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCC-ChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCC
Confidence            543333333344567889999999988776 689999999999999999 99999988777666666655 456677899


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +.+.++|.+||+.||.+|||+.++++.
T Consensus       246 ~~l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          246 IDVYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999999999873

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.3e-49  Score=362.70  Aligned_cols=255  Identities=30%  Similarity=0.560  Sum_probs=185.7

Q ss_pred             CccccCeEEee-eecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee---
Q 019216           10 GMRLGRYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS---   85 (344)
Q Consensus        10 ~~~~~~y~~~~-~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~---   85 (344)
                      ....++|++++ .||+|+||.||+|.++.+|+.||+|++....       ....+....++.+.||||+++++++..   
T Consensus        24 ~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~   96 (336)
T 3fhr_A           24 YAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYENMHH   96 (336)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEEEET
T ss_pred             ccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhhccC
Confidence            35668999965 6999999999999999999999999986432       112223344677799999999999875   


Q ss_pred             -CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC---CCeEEeccc
Q 019216           86 -KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNIKISDFG  159 (344)
Q Consensus        86 -~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~---~~vkl~Dfg  159 (344)
                       ....++||||++|++|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||
T Consensus        97 ~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A           97 GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccc
Confidence             456899999999999999998654  69999999999999999999999999999999999999764   459999999


Q ss_pred             cccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHH----HHHHhhCCCC
Q 019216          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL----YQKIFRGDFK  235 (344)
Q Consensus       160 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~----~~~i~~~~~~  235 (344)
                      ++....    .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+......    ...+......
T Consensus       177 ~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  251 (336)
T 3fhr_A          177 FAKETT----QNALQTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYG  251 (336)
T ss_dssp             TCEEC--------------------------CHH-HHHHHHHHHHHHHHHHHHSSCCC---------------------C
T ss_pred             cceecc----ccccccCCCCcCccChhhhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccc
Confidence            987432    222345678999999999876665 5899999999999999999999977654433    2222223332


Q ss_pred             CC----CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          236 LP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       236 ~~----~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                      ++    ..+++.+.+||.+||+.||++|||+.++++||||++...
T Consensus       252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  296 (336)
T 3fhr_A          252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMV  296 (336)
T ss_dssp             CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGG
T ss_pred             cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccccc
Confidence            22    468999999999999999999999999999999987543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.9e-49  Score=362.15  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=210.6

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCC-ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC------ccceeeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN------VVRLHEVL   83 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~-~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n------iv~l~~~~   83 (344)
                      ...++|++++.||+|+||.||+|.+..++ +.||+|++...    ....+.+.+|+.+++.++|++      ++.+++++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~   91 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF   91 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEE
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeee
Confidence            44579999999999999999999998777 68999998643    234567888999999887665      89999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE--------------
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL--------------  147 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl--------------  147 (344)
                      ......++||||+ ++++.+.+...  ..+++..++.++.||+.||.|||++||+||||||+|||+              
T Consensus        92 ~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~  170 (355)
T 2eu9_A           92 NFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKS  170 (355)
T ss_dssp             EETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-C
T ss_pred             eeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccc
Confidence            9999999999999 67787777654  369999999999999999999999999999999999999              


Q ss_pred             -----ccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH
Q 019216          148 -----DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL  222 (344)
Q Consensus       148 -----~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~  222 (344)
                           +.++.+||+|||++....     .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.
T Consensus       171 ~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~  244 (355)
T 2eu9_A          171 CEEKSVKNTSIRVADFGSATFDH-----EHHTTIVATRHYRPPEVILELGW-AQPCDVWSIGCILFEYYRGFTLFQTHEN  244 (355)
T ss_dssp             CCEEEESCCCEEECCCTTCEETT-----SCCCSSCSCGGGCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccCCCcEEEeecCcccccc-----ccccCCcCCCcccCCeeeecCCC-CCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence                 567899999999997432     22345689999999999987776 6899999999999999999999998766


Q ss_pred             HHHHHHHhhCCCCCC--------------------------------------------CCCCHHHHHHHHHhcCCCcCC
Q 019216          223 AVLYQKIFRGDFKLP--------------------------------------------KWLSPGAQNLLRKILEPNPVK  258 (344)
Q Consensus       223 ~~~~~~i~~~~~~~~--------------------------------------------~~~~~~~~~li~~~L~~dP~~  258 (344)
                      ......+.......|                                            ...++.+.+||.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~  324 (355)
T 2eu9_A          245 REHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ  324 (355)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTT
T ss_pred             HHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhh
Confidence            554433322111111                                            112457889999999999999


Q ss_pred             CCCHhhhhcCcccccc
Q 019216          259 RITIAGIKADEWFEQD  274 (344)
Q Consensus       259 Rps~~eil~~~~~~~~  274 (344)
                      |||+.++++||||++.
T Consensus       325 Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          325 RITLAEALLHPFFAGL  340 (355)
T ss_dssp             SCCHHHHTTSGGGGGC
T ss_pred             CcCHHHHhcChhhcCC
Confidence            9999999999999863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.2e-49  Score=367.32  Aligned_cols=256  Identities=26%  Similarity=0.454  Sum_probs=209.0

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-----------CCCccce
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----------HPNVVRL   79 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l   79 (344)
                      +..++|++++.||+|+||.||+|.+..+++.||+|++....    .....+.+|+.++++++           ||||+++
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~   91 (373)
T 1q8y_A           16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL   91 (373)
T ss_dssp             ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred             ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence            45689999999999999999999999999999999986432    33567788999998876           8999999


Q ss_pred             eeEEeeCC----eEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEEccC--
Q 019216           80 HEVLASKS----KIYMVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSK--  150 (344)
Q Consensus        80 ~~~~~~~~----~~~iv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~-~i~H~dikp~NILl~~~--  150 (344)
                      ++++....    .++++||++ +++|.+++..  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+  
T Consensus        92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~  170 (373)
T 1q8y_A           92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS  170 (373)
T ss_dssp             CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred             HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence            99987644    789999999 8999999976  34599999999999999999999998 99999999999999543  


Q ss_pred             ----CCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH----
Q 019216          151 ----GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----  222 (344)
Q Consensus       151 ----~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~----  222 (344)
                          +.+||+|||++.....     ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.    
T Consensus       171 ~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          171 PENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             TTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             CcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCC-CchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence                3799999999975432     2344578999999999988776 6899999999999999999999986431    


Q ss_pred             --HHHHHHHh------------------------------------------hCCCCCCCCCCHHHHHHHHHhcCCCcCC
Q 019216          223 --AVLYQKIF------------------------------------------RGDFKLPKWLSPGAQNLLRKILEPNPVK  258 (344)
Q Consensus       223 --~~~~~~i~------------------------------------------~~~~~~~~~~~~~~~~li~~~L~~dP~~  258 (344)
                        ......+.                                          .....++..+++.+.+||.+||+.||++
T Consensus       245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence              11111111                                          1122334445678999999999999999


Q ss_pred             CCCHhhhhcCccccccCCC
Q 019216          259 RITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       259 Rps~~eil~~~~~~~~~~~  277 (344)
                      |||++|+++||||++....
T Consensus       325 Rpt~~ell~hp~f~~~~~~  343 (373)
T 1q8y_A          325 RADAGGLVNHPWLKDTLGM  343 (373)
T ss_dssp             CBCHHHHHTCGGGTTCTTC
T ss_pred             cCCHHHHhhChhhhcccCc
Confidence            9999999999999875443

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4e-49  Score=356.87  Aligned_cols=256  Identities=27%  Similarity=0.415  Sum_probs=216.8

Q ss_pred             CccccCeEEeeeecccCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL   83 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~   83 (344)
                      .+..++|++.+.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++++ +||||+++++++
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~   96 (313)
T 1t46_A           19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC   96 (313)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence            35668999999999999999999985     4577899999996543  234467889999999999 899999999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcE
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIASKG------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENI  145 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~~~~------------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NI  145 (344)
                      ...+..++||||+++++|.+++....                  .+++..++.++.||+.||.|||++||+||||||+||
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  176 (313)
T 1t46_A           97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI  176 (313)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence            99999999999999999999997644                  489999999999999999999999999999999999


Q ss_pred             EEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHH
Q 019216          146 LLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV  224 (344)
Q Consensus       146 Ll~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~  224 (344)
                      |++.++.+||+|||++................+|+.|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.....
T Consensus       177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~  255 (313)
T 1t46_A          177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDS  255 (313)
T ss_dssp             EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred             EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence            999999999999999986543322222334567889999999887665 689999999999999999 999998765433


Q ss_pred             HHHHHhhC--CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          225 LYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       225 ~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ........  ....+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            33333322  334467789999999999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=8.3e-49  Score=356.46  Aligned_cols=255  Identities=22%  Similarity=0.313  Sum_probs=220.1

Q ss_pred             ccccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      +..++|++.+.||+|+||.||+|.+.     .+++.||+|.+....  .......+.+|+.+++.++||||+++++++..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            55689999999999999999999876     357889999986433  33445678899999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEE
Q 019216           86 KSKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI  155 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~----------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl  155 (344)
                      ....++||||+++++|.+++...          ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl  179 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  179 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence            99999999999999999998752          45799999999999999999999999999999999999999999999


Q ss_pred             eccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC-
Q 019216          156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-  233 (344)
Q Consensus       156 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~-  233 (344)
                      +|||++................+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+..+. 
T Consensus       180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  258 (322)
T 1p4o_A          180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  258 (322)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             CcCccccccccccccccccCCCCCCCccChhhhccCCC-CchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence            99999875432221122234467889999999887666 689999999999999999 899999988877777776654 


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          234 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       234 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ...+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            45677899999999999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.4e-49  Score=358.27  Aligned_cols=254  Identities=27%  Similarity=0.416  Sum_probs=217.7

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceE--EEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEee
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPF--AVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS   85 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~v--aiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~   85 (344)
                      ..+.+++|++.+.||+|+||.||+|.+..++..+  |+|.+....  .....+.+.+|+.+++++ +||||+++++++..
T Consensus        20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~   97 (327)
T 1fvr_A           20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   97 (327)
T ss_dssp             SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             ccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence            4577899999999999999999999998888865  999886432  233456788999999999 89999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKG----------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS  149 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~----------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~  149 (344)
                      .+..++||||+++++|.+++...+                .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~  177 (327)
T 1fvr_A           98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  177 (327)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcC
Confidence            999999999999999999997654                6999999999999999999999999999999999999999


Q ss_pred             CCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHH
Q 019216          150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK  228 (344)
Q Consensus       150 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~  228 (344)
                      ++.+||+|||++......   .......+++.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.+.......
T Consensus       178 ~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~  253 (327)
T 1fvr_A          178 NYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  253 (327)
T ss_dssp             GGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             CCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccC-CchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHH
Confidence            999999999998743221   11233456889999999987665 689999999999999998 9999999888887777


Q ss_pred             HhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          229 IFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       229 i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +..+ ....+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          254 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7665 455677899999999999999999999999999886

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.2e-48  Score=348.95  Aligned_cols=256  Identities=30%  Similarity=0.485  Sum_probs=208.6

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      ...+++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.++++++||||+++++++......
T Consensus        28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~  107 (310)
T 2wqm_A           28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL  107 (310)
T ss_dssp             TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred             cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence            35788999999999999999999999999999999999765555566678899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           90 YMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      ++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus       108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~  187 (310)
T 2wqm_A          108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS  187 (310)
T ss_dssp             EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred             EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence            999999999999998864    4568999999999999999999999999999999999999999999999999987543


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc--cHHHHHHHHhhCCCC-C-CCCCC
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR--NLAVLYQKIFRGDFK-L-PKWLS  241 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~--~~~~~~~~i~~~~~~-~-~~~~~  241 (344)
                      ..  ........|++.|+|||++.+..+ +.++||||||+++|+|++|..||.+.  +.......+.....+ . +..++
T Consensus       188 ~~--~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (310)
T 2wqm_A          188 SK--TTAAHSLVGTPYYMSPERIHENGY-NFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS  264 (310)
T ss_dssp             -------------CCSSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSC
T ss_pred             CC--CccccccCCCeeEeChHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccC
Confidence            21  122334578999999999987666 68999999999999999999999764  333444555544332 2 25689


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +.+.+||.+||+.||++|||+.+++++
T Consensus       265 ~~l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          265 EELRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            999999999999999999999999874

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=8.5e-49  Score=350.74  Aligned_cols=253  Identities=27%  Similarity=0.401  Sum_probs=221.0

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      .+..++|++.+.||+|+||.||+|.+..++..||+|++....    ...+.+.+|+.++++++||||+++++++......
T Consensus         9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   84 (288)
T 3kfa_A            9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF   84 (288)
T ss_dssp             BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred             cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCE
Confidence            357789999999999999999999999999999999986432    2356788999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           90 YMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ++||||++|++|.+++...  ..+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus        85 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  164 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD  164 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred             EEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence            9999999999999999863  45899999999999999999999999999999999999999999999999999854321


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ  245 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~  245 (344)
                       .........+|+.|+|||++.+..+ +.++||||||+++|+|++ |..||.+.+.......+... ....+..+++.+.
T Consensus       165 -~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  242 (288)
T 3kfa_A          165 -TYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY  242 (288)
T ss_dssp             -SSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             -ccccccCCccccCcCChhhhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCCCCHHHH
Confidence             1122233456788999999987766 689999999999999999 99999987776666666555 4566788999999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhcC
Q 019216          246 NLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +|+.+||+.||.+|||+.++++.
T Consensus       243 ~li~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          243 ELMRACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhCCChhhCcCHHHHHHH
Confidence            99999999999999999999763

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=5.5e-49  Score=358.70  Aligned_cols=262  Identities=22%  Similarity=0.296  Sum_probs=218.3

Q ss_pred             cCccccCeEEeeeecccCceEEEEEE-----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEE
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQ-----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL   83 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~-----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~   83 (344)
                      ..+..++|++++.||+|+||.||+|.     +..++..||+|++....  .......+.+|+.++++++||||+++++++
T Consensus        25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (327)
T 2yfx_A           25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVS  102 (327)
T ss_dssp             CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence            45778999999999999999999999     55778899999986432  334456788999999999999999999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC---CCe
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIASKG-------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK---GNI  153 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~~~~-------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~---~~v  153 (344)
                      ......++||||+++++|.+++....       .+++..++.++.||+.||.|||+.||+||||||+|||++.+   ..+
T Consensus       103 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~  182 (327)
T 2yfx_A          103 LQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVA  182 (327)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCE
T ss_pred             cCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceE
Confidence            99889999999999999999998653       48999999999999999999999999999999999999854   469


Q ss_pred             EEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC
Q 019216          154 KISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG  232 (344)
Q Consensus       154 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~  232 (344)
                      ||+|||++................+|+.|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.+.......+..+
T Consensus       183 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~  261 (327)
T 2yfx_A          183 KIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIF-TSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSG  261 (327)
T ss_dssp             EECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred             EECccccccccccccccccCCCcCCCcceeCHhHhcCCCC-CchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcC
Confidence            9999999863322112222334567899999999987766 689999999999999998 99999988877777777665


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          233 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       233 -~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                       ....+..+++.+.++|.+||+.||.+|||+.+++++.|+..
T Consensus       262 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~  303 (327)
T 2yfx_A          262 GRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT  303 (327)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence             44567789999999999999999999999999999988753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.5e-48  Score=347.61  Aligned_cols=255  Identities=26%  Similarity=0.405  Sum_probs=212.6

Q ss_pred             hccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhH----HHHHHHHHHHHHhCCCCCccceeeE
Q 019216            7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKI----TDQIKREIATLKLLKHPNVVRLHEV   82 (344)
Q Consensus         7 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~----~~~~~~E~~~l~~l~h~niv~l~~~   82 (344)
                      ....+.-++|++.+.||+|+||.||+|.+..+++.||+|++..........    .+.+.+|+.++++++||||++++++
T Consensus        12 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   91 (287)
T 4f0f_A           12 RLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGL   91 (287)
T ss_dssp             CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhee
Confidence            335577889999999999999999999999999999999986544332221    2678999999999999999999999


Q ss_pred             EeeCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEEccCCC-----eE
Q 019216           83 LASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGN-----IK  154 (344)
Q Consensus        83 ~~~~~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~--i~H~dikp~NILl~~~~~-----vk  154 (344)
                      +....  ++||||+++++|.+.+... ..+++..++.++.|++.||+|||+.|  |+||||||+|||++.++.     +|
T Consensus        92 ~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~k  169 (287)
T 4f0f_A           92 MHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAK  169 (287)
T ss_dssp             ETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEE
T ss_pred             ecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEE
Confidence            87665  6899999999998888654 47999999999999999999999999  999999999999988876     99


Q ss_pred             EeccccccCCCcccCCCccccccCCCcccchhhhcc-CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHH--HHHHHhh
Q 019216          155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN-RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV--LYQKIFR  231 (344)
Q Consensus       155 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~--~~~~i~~  231 (344)
                      |+|||++....     .......||+.|+|||++.. ....+.++|||||||++|+|++|+.||.......  ....+..
T Consensus       170 l~Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~  244 (287)
T 4f0f_A          170 VADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE  244 (287)
T ss_dssp             ECCCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH
T ss_pred             eCCCCcccccc-----ccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc
Confidence            99999987422     23445679999999999843 2233689999999999999999999998654322  2333333


Q ss_pred             C--CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          232 G--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       232 ~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .  ....+..+++.+.++|.+||+.||.+|||+.++++.
T Consensus       245 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  283 (287)
T 4f0f_A          245 EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE  283 (287)
T ss_dssp             SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            3  445678899999999999999999999999999863

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.1e-48  Score=344.29  Aligned_cols=251  Identities=23%  Similarity=0.404  Sum_probs=218.1

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++.+.||+|+||.||+|.+. +++.||+|++......    .+.+.+|+.+++.++||||+++++++......+
T Consensus         5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   79 (267)
T 3t9t_A            5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC   79 (267)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred             EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence            45679999999999999999999985 6788999999755432    357889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           91 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++....... 
T Consensus        80 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-  158 (267)
T 3t9t_A           80 LVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-  158 (267)
T ss_dssp             EEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-
T ss_pred             EEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-
Confidence            999999999999999864 568999999999999999999999999999999999999999999999999987432211 


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNL  247 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~l  247 (344)
                      ........++..|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.+.......+..+ ....|..+++.+.++
T Consensus       159 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l  237 (267)
T 3t9t_A          159 YTSSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQI  237 (267)
T ss_dssp             HHSTTSTTCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred             ccccccccccccccChhhhcCCCc-cchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHH
Confidence            111223456788999999987666 689999999999999999 99999998888877777766 345567789999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhcC
Q 019216          248 LRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~~  268 (344)
                      +.+||+.||++|||+.+++++
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          238 MNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=3.7e-48  Score=351.26  Aligned_cols=260  Identities=23%  Similarity=0.357  Sum_probs=201.3

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      ...+++|++++.||+|+||.||+|.++.+|+.||+|++..... .....+.+.++..+++.++||||+++++++......
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~   99 (318)
T 2dyl_A           21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDV   99 (318)
T ss_dssp             ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcE
Confidence            3578899999999999999999999999999999999975532 222334455555678888999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~-~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ++||||+ ++.+..+... .+.+++..++.++.|++.||.|||+. |++||||||+|||++.++.+||+|||++..... 
T Consensus       100 ~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~-  177 (318)
T 2dyl_A          100 FIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-  177 (318)
T ss_dssp             EEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             EEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC-
Confidence            9999999 5566555543 56799999999999999999999995 999999999999999999999999999874322 


Q ss_pred             cCCCccccccCCCcccchhhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhhCCCC-CC--CC
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRGDFK-LP--KW  239 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~ll~ell~g~~pf~~-~~~~~~~~~i~~~~~~-~~--~~  239 (344)
                        ........||+.|+|||++..    ....+.++||||||+++|+|++|+.||.. .........+...... ++  ..
T Consensus       178 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (318)
T 2dyl_A          178 --DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG  255 (318)
T ss_dssp             -----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred             --CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence              222344578999999999852    23346899999999999999999999987 3445555555555432 33  35


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +++.+.+||.+||+.||.+|||++++++||||++.
T Consensus       256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (318)
T 2dyl_A          256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY  290 (318)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence            89999999999999999999999999999999864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=9.3e-49  Score=363.60  Aligned_cols=255  Identities=22%  Similarity=0.370  Sum_probs=208.1

Q ss_pred             CccccCeEEeeeecccCceEEEEEEEC---CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      .+..++|++.+.||+|+||.||+|.++   .++..||||++....  .....+.+.+|+.++++++||||+++++++...
T Consensus        41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~  118 (373)
T 2qol_A           41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS  118 (373)
T ss_dssp             BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence            456679999999999999999999976   467789999986542  344567899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 SKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      ...++||||+++++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++...
T Consensus       119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  198 (373)
T 2qol_A          119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE  198 (373)
T ss_dssp             SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence            99999999999999999998654 69999999999999999999999999999999999999999999999999998643


Q ss_pred             cccCCC-ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCH
Q 019216          166 HFRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSP  242 (344)
Q Consensus       166 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~  242 (344)
                      ...... ......++..|+|||++.+..+ +.++|||||||++|+|++ |+.||.+.+.......+..+ ..+.+..+++
T Consensus       199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~  277 (373)
T 2qol_A          199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKF-TSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPA  277 (373)
T ss_dssp             ---------------CTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBH
T ss_pred             cCCccceeccCCCcCCCccChhhhccCCc-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccH
Confidence            321111 1122345778999999987776 689999999999999998 99999988877777776655 3455667899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .+.+++.+||+.||++||++.++++
T Consensus       278 ~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          278 ALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHhCcChhhCcCHHHHHH
Confidence            9999999999999999999999876

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.5e-48  Score=348.56  Aligned_cols=254  Identities=23%  Similarity=0.328  Sum_probs=215.0

Q ss_pred             ccccCeEEee-eecccCceEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216           11 MRLGRYELGR-TLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus        11 ~~~~~y~~~~-~Lg~G~~g~Vy~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      +..++|++.+ .||+|+||.||+|.+  ..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++ ...
T Consensus        13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~   90 (291)
T 1xbb_A           13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAE   90 (291)
T ss_dssp             CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESS
T ss_pred             ecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCC
Confidence            4557899998 999999999999954  5678899999986543 2334567899999999999999999999999 566


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ..++||||+++++|.+++...+.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus        91 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  170 (291)
T 1xbb_A           91 SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD  170 (291)
T ss_dssp             SEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccC
Confidence            78999999999999999998888999999999999999999999999999999999999999999999999998754321


Q ss_pred             cCC-CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHH
Q 019216          168 RDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA  244 (344)
Q Consensus       168 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~  244 (344)
                      ... .......+++.|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.+.......+..+ ....|..+++.+
T Consensus       171 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  249 (291)
T 1xbb_A          171 ENYYKAQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREM  249 (291)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             CCcccccccCCCCceeeChHHhccCCC-ChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            111 11122356788999999987665 589999999999999999 99999998887777777665 355678899999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhc
Q 019216          245 QNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .++|.+||+.||++|||+.++++
T Consensus       250 ~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          250 YDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999876

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=7.8e-49  Score=357.59  Aligned_cols=261  Identities=23%  Similarity=0.358  Sum_probs=195.3

Q ss_pred             hccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHH-HHHhCCCCCccceeeEEee
Q 019216            7 KQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA-TLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus         7 ~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~-~l~~l~h~niv~l~~~~~~   85 (344)
                      ..-.+..++|++++.||+|+||.||+|.++.+|+.||+|++....  .......+.+|+. +++.++||||+++++++..
T Consensus        15 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~   92 (327)
T 3aln_A           15 QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR   92 (327)
T ss_dssp             EEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC
T ss_pred             HhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe
Confidence            345578899999999999999999999999999999999997543  2233445556665 7778899999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeecCCCCcEEEccCCCeEEeccc
Q 019216           86 KSKIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNIKISDFG  159 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~-~i~H~dikp~NILl~~~~~vkl~Dfg  159 (344)
                      .+..++||||+.+ +|.+++..     ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||
T Consensus        93 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg  171 (327)
T 3aln_A           93 EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFG  171 (327)
T ss_dssp             SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCS
T ss_pred             CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCC
Confidence            9999999999975 88777763     56799999999999999999999999 99999999999999999999999999


Q ss_pred             cccCCCcccCCCccccccCCCcccchhhhc----cCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH-HHHHHHhhCC-
Q 019216          160 LSALPQHFRDDGLLHTTCGSPNYVAPEVLA----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-VLYQKIFRGD-  233 (344)
Q Consensus       160 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~-~~~~~i~~~~-  233 (344)
                      ++.....   ........||+.|+|||++.    +..+ +.++|||||||++|+|++|+.||.+.... .....+..+. 
T Consensus       172 ~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  247 (327)
T 3aln_A          172 ISGQLVD---SIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDP  247 (327)
T ss_dssp             SSCC---------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCC
T ss_pred             Cceeccc---ccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCC
Confidence            9975432   22223447899999999984    3334 68999999999999999999999875421 2222222222 


Q ss_pred             CCCC----CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          234 FKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       234 ~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ..++    ..+++.+.+||.+||+.||++|||+.++++||||...
T Consensus       248 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~  292 (327)
T 3aln_A          248 PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMY  292 (327)
T ss_dssp             CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHh
Confidence            1122    3589999999999999999999999999999999764

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4e-48  Score=347.92  Aligned_cols=253  Identities=19%  Similarity=0.228  Sum_probs=212.0

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCC
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS   87 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~   87 (344)
                      ..+.-++|++.+.||+|+||.||+|.+..+|+.||+|++.....     ...+.+|+.+++.+ .|+|++++++++....
T Consensus         5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~   79 (298)
T 1csn_A            5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL   79 (298)
T ss_dssp             -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred             CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence            44566789999999999999999999999999999999864432     23577899999999 7999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC-----eEEeccccc
Q 019216           88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGLS  161 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~-----vkl~Dfg~a  161 (344)
                      ..++||||+ +++|.+++...+ ++++..++.++.||+.||.|||++||+||||||+|||++.++.     +||+|||++
T Consensus        80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~  158 (298)
T 1csn_A           80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV  158 (298)
T ss_dssp             EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred             eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence            999999999 999999998654 5999999999999999999999999999999999999987776     999999999


Q ss_pred             cCCCcccCC-----CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc---cHHHHHHHHhhCC
Q 019216          162 ALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---NLAVLYQKIFRGD  233 (344)
Q Consensus       162 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~---~~~~~~~~i~~~~  233 (344)
                      .........     .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+.   ........+....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  237 (298)
T 1csn_A          159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK  237 (298)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccccccCccCCCCCcccCCchhhcCCCC-ChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence            754332111     12345679999999999987776 68999999999999999999999873   3333333333221


Q ss_pred             -----CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          234 -----FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       234 -----~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                           ......+++.+.+++.+||+.||++|||+.++++.
T Consensus       238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence                 12235689999999999999999999999998764

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=3.1e-48  Score=368.77  Aligned_cols=244  Identities=26%  Similarity=0.479  Sum_probs=212.5

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC-eE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-KI   89 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-~~   89 (344)
                      +..++|++++.||+|+||.||+|.+.  |+.||||+++...     ..+.+.+|+.++++++||||+++++++.... ..
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~  262 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL  262 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCce
Confidence            56789999999999999999999974  7799999986543     3467889999999999999999999987654 79


Q ss_pred             EEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           90 YMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ++||||+++++|.+++...+.  +++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.... 
T Consensus       263 ~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-  341 (450)
T 1k9a_A          263 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-  341 (450)
T ss_dssp             EEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC--
T ss_pred             EEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc-
Confidence            999999999999999987553  79999999999999999999999999999999999999999999999999874321 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ  245 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~  245 (344)
                          ......++..|+|||++.+..+ +.++|||||||++|||++ |+.||.+.+.......+..+ ..+.|..+++.+.
T Consensus       342 ----~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~  416 (450)
T 1k9a_A          342 ----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY  416 (450)
T ss_dssp             ---------CCCTTTSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ----cccCCCCCcceeCHHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence                1223467889999999987776 689999999999999998 99999987766666666665 4667888999999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhc
Q 019216          246 NLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~  267 (344)
                      +||.+||+.||++|||+.++++
T Consensus       417 ~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          417 DVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999875

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=9.5e-49  Score=357.62  Aligned_cols=249  Identities=22%  Similarity=0.286  Sum_probs=209.3

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~   89 (344)
                      +.-++|++.+.||+|+||.||+|.+..+|+.||||++.....     ...+.+|+.+++.+ +||||+++++++......
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~   80 (330)
T 2izr_A            6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYN   80 (330)
T ss_dssp             EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEE
T ss_pred             EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCcc
Confidence            344689999999999999999999999999999999865432     23577899999999 899999999999999999


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC-----eEEeccccccC
Q 019216           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN-----IKISDFGLSAL  163 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~-----vkl~Dfg~a~~  163 (344)
                      ++||||+ +++|.+++.. .+.+++..++.++.|++.||+|||+.||+||||||+|||++.++.     +||+|||++..
T Consensus        81 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~  159 (330)
T 2izr_A           81 AMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKE  159 (330)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEE
T ss_pred             EEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEccccee
Confidence            9999999 9999999986 467999999999999999999999999999999999999998887     99999999985


Q ss_pred             CCcccCCC-----ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC---ccHHHHHHHHhhCCCC
Q 019216          164 PQHFRDDG-----LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFK  235 (344)
Q Consensus       164 ~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~---~~~~~~~~~i~~~~~~  235 (344)
                      ........     .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+   .........+......
T Consensus       160 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          160 YIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQ-SRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eecCCCCccccccccCCcCCCccccChHHHcCCCC-CchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            43221111     1245689999999999988776 6899999999999999999999987   3344445554433322


Q ss_pred             CC-----CCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          236 LP-----KWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       236 ~~-----~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .+     ..++ .+.+++.+||+.||.+||++.++++
T Consensus       239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            22     2244 9999999999999999999998876

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=8.6e-49  Score=355.15  Aligned_cols=256  Identities=26%  Similarity=0.388  Sum_probs=215.9

Q ss_pred             CccccCeEEeeeecccCceEEEEEEE-----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL   83 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~-----~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~   83 (344)
                      ....++|++.+.||+|+||.||+|.+     ..+++.||+|++....  .....+.+.+|+.+++++ +||||+++++++
T Consensus        23 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~  100 (316)
T 2xir_A           23 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC  100 (316)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEE
Confidence            35678999999999999999999985     4577899999996543  334456789999999999 699999999998


Q ss_pred             eeCC-eEEEEEeccCCCChHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEE
Q 019216           84 ASKS-KIYMVLEYVTGGELFDKIASKGR----------------LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL  146 (344)
Q Consensus        84 ~~~~-~~~iv~e~~~g~~L~~~l~~~~~----------------~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NIL  146 (344)
                      ...+ .+++||||+++++|.+++.....                +++..++.++.||+.||.|||+.||+||||||+|||
T Consensus       101 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil  180 (316)
T 2xir_A          101 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL  180 (316)
T ss_dssp             CCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             ecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence            7654 58999999999999999986543                899999999999999999999999999999999999


Q ss_pred             EccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccH-HH
Q 019216          147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNL-AV  224 (344)
Q Consensus       147 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~-~~  224 (344)
                      ++.++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+... ..
T Consensus       181 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  259 (316)
T 2xir_A          181 LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  259 (316)
T ss_dssp             ECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             ECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc-cchhHHHHHHHHHHHHHhCCCCCCcccchhHH
Confidence            99999999999999985443222223344567889999999987766 689999999999999998 9999987653 33


Q ss_pred             HHHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          225 LYQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       225 ~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ....+..+ ....+..+++.+.+++.+||+.||.+|||+.++++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          260 FCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            33334333 456678899999999999999999999999999986

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2.8e-48  Score=351.71  Aligned_cols=257  Identities=25%  Similarity=0.372  Sum_probs=208.7

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      .+..++|++.+.||+|+||.||+|.+..   ++..||+|.+..... .....+.+.+|+.++++++||||+++++++...
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~  108 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEM  108 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeec
Confidence            3566899999999999999999998765   456899999865432 334567889999999999999999999998765


Q ss_pred             C-----eEEEEEeccCCCChHHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEE
Q 019216           87 S-----KIYMVLEYVTGGELFDKIA------SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI  155 (344)
Q Consensus        87 ~-----~~~iv~e~~~g~~L~~~l~------~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl  155 (344)
                      .     ..++||||+++++|.+++.      ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence            4     3599999999999999984      2356999999999999999999999999999999999999999999999


Q ss_pred             eccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-C
Q 019216          156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-D  233 (344)
Q Consensus       156 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~  233 (344)
                      +|||++................+++.|+|||.+.+..+ +.++||||||+++|+|++ |..||.+.........+..+ .
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~  267 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVY-TSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR  267 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCc-cchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC
Confidence            99999975433222222334467889999999987666 689999999999999999 99999988777777666665 4


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          234 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       234 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ...+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       268 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          268 LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            56678899999999999999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.5e-48  Score=356.59  Aligned_cols=256  Identities=24%  Similarity=0.394  Sum_probs=215.8

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCc-----eEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGL-----PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVL   83 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~   83 (344)
                      .+..++|++.+.||+|+||.||+|.+..+++     .||+|.+....  .....+.+.+|+.+++.+ +||||+++++++
T Consensus        42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~  119 (333)
T 2i1m_A           42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC  119 (333)
T ss_dssp             BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence            3556899999999999999999999977664     79999986543  334567889999999999 899999999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIASK--------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS  149 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~~~--------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~  149 (344)
                      ......++||||+++++|.+++...              ..+++..++.++.||+.||.|||+.||+||||||+|||++.
T Consensus       120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~  199 (333)
T 2i1m_A          120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTN  199 (333)
T ss_dssp             CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEG
T ss_pred             ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECC
Confidence            9999999999999999999998752              35799999999999999999999999999999999999999


Q ss_pred             CCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHH
Q 019216          150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQK  228 (344)
Q Consensus       150 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~  228 (344)
                      ++.+||+|||++................+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........
T Consensus       200 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  278 (333)
T 2i1m_A          200 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY-TVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYK  278 (333)
T ss_dssp             GGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHH
T ss_pred             CCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCC-ChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHH
Confidence            99999999999985433222222334567889999999887766 689999999999999998 9999987654443333


Q ss_pred             HhhC--CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          229 IFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       229 i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +...  ....|..+++.+.+++.+||+.||.+|||+.+++++
T Consensus       279 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          279 LVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            3332  344567789999999999999999999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.4e-48  Score=355.46  Aligned_cols=251  Identities=22%  Similarity=0.276  Sum_probs=202.2

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC---
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS---   87 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~---   87 (344)
                      +..++|++++.||+|+||.||+|.+.  ++.||||++....    .......+|+.++++++||||+++++++....   
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   94 (322)
T 3soc_A           21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVD   94 (322)
T ss_dssp             ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSS
T ss_pred             cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCC
Confidence            56679999999999999999999974  7899999986432    23345667999999999999999999997643   


Q ss_pred             -eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeecCCCCcEEEccCCCeEEe
Q 019216           88 -KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK----------GVFHRDLKLENILLDSKGNIKIS  156 (344)
Q Consensus        88 -~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~----------~i~H~dikp~NILl~~~~~vkl~  156 (344)
                       .+++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.          ||+||||||+|||++.++.+||+
T Consensus        95 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~  173 (322)
T 3soc_A           95 VDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA  173 (322)
T ss_dssp             EEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEEC
T ss_pred             ceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEc
Confidence             47999999999999999976 5599999999999999999999999          99999999999999999999999


Q ss_pred             ccccccCCCcccCCCccccccCCCcccchhhhccCC----CCCccchhhhhhHHHHHHHhCCCCCCCcc-----------
Q 019216          157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG----YDGATSDIWSCGVILYVILTGYLPFDDRN-----------  221 (344)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~DvwslG~ll~ell~g~~pf~~~~-----------  221 (344)
                      |||+++...............||+.|+|||++.+..    ..+.++|||||||++|+|++|+.||.+..           
T Consensus       174 DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~  253 (322)
T 3soc_A          174 DFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI  253 (322)
T ss_dssp             CCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHH
T ss_pred             cCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhh
Confidence            999997543322333344568999999999987632    22467899999999999999999997532           


Q ss_pred             -----HHHHHHHHhhCCC--CCCCC-----CCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          222 -----LAVLYQKIFRGDF--KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       222 -----~~~~~~~i~~~~~--~~~~~-----~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                           .......+.....  .++..     .++.+.+||.+||+.||++|||+.++++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                 2222222322221  11111     23459999999999999999999999863

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-48  Score=346.24  Aligned_cols=256  Identities=25%  Similarity=0.362  Sum_probs=217.9

Q ss_pred             ccccCeEEee-eecccCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216           11 MRLGRYELGR-TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus        11 ~~~~~y~~~~-~Lg~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      +..++|.+.+ .||+|+||.||+|.+.  .++..||+|++....  .....+.+.+|+.+++.++||||+++++++ ..+
T Consensus         6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~   82 (287)
T 1u59_A            6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE   82 (287)
T ss_dssp             CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS
T ss_pred             ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC
Confidence            4567898887 9999999999999864  467889999996542  344567899999999999999999999999 455


Q ss_pred             eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           88 KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           83 ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             SEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             CcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            689999999999999998643 5699999999999999999999999999999999999999999999999999975432


Q ss_pred             ccC-CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC-CCCCCCCCHH
Q 019216          167 FRD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPG  243 (344)
Q Consensus       167 ~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~  243 (344)
                      ... ........+|+.|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.........+..+. ...|..+++.
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~  241 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPE  241 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHH
T ss_pred             CcceeeccccccccccccCHHHhccCCC-CchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHH
Confidence            111 111223456889999999987665 689999999999999998 999999888777777776653 5677889999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCcc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEW  270 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~  270 (344)
                      +.++|.+||+.||++|||+.+++++.+
T Consensus       242 l~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          242 LYALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             HHHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            999999999999999999999998744

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.5e-48  Score=351.90  Aligned_cols=256  Identities=23%  Similarity=0.357  Sum_probs=213.1

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      .+..++|++.+.||+|+||.||+|.+..++    ..||+|++....  .......+.+|+.+++.++||||+++++++..
T Consensus        40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  117 (333)
T 1mqb_A           40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK  117 (333)
T ss_dssp             BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred             cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence            356678999999999999999999986553    459999986443  33455678999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           86 KSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                      ....++||||+++++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus       118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  197 (333)
T 1mqb_A          118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL  197 (333)
T ss_dssp             SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred             CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence            99999999999999999999764 57999999999999999999999999999999999999999999999999999854


Q ss_pred             CcccCC-CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCC
Q 019216          165 QHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLS  241 (344)
Q Consensus       165 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~  241 (344)
                      ...... .......+|+.|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.+.......+..+ ..+.+..++
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  276 (333)
T 1mqb_A          198 EDDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCP  276 (333)
T ss_dssp             -------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCB
T ss_pred             ccccccccccCCCCccccccCchhcccCCC-CchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCC
Confidence            332111 11223356788999999987666 689999999999999999 99999988877777777665 456677899


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +.+.+++.+||+.||++||++.+++++
T Consensus       277 ~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          277 SAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999999875

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.2e-48  Score=343.35  Aligned_cols=256  Identities=24%  Similarity=0.348  Sum_probs=214.2

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECC---CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA   84 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~   84 (344)
                      +.++..++|++.+.||+|+||.||+|.+..   ++..||+|.+....  .....+.+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   83 (281)
T 3cc6_A            6 QYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE   83 (281)
T ss_dssp             CCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred             cceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence            456788999999999999999999998654   34469999986543  3345678999999999999999999999986


Q ss_pred             eCCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           85 SKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      .. ..++||||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence            54 568999999999999999764 4599999999999999999999999999999999999999999999999999875


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCC
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLS  241 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~  241 (344)
                      ..... ........+++.|+|||++.+..+ +.++||||||+++|+|++ |+.||...........+..+ ..+.+..++
T Consensus       163 ~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (281)
T 3cc6_A          163 IEDED-YYKASVTRLPIKWMSPESINFRRF-TTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCP  240 (281)
T ss_dssp             C----------CCCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCC
T ss_pred             ccccc-ccccccCCCCcceeCchhhccCCC-CchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCC
Confidence            43311 112234457889999999987666 689999999999999998 99999876655555555544 456677899


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +.+.++|.+||+.||++|||+.+++++
T Consensus       241 ~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          241 PVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            999999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.4e-48  Score=348.43  Aligned_cols=255  Identities=25%  Similarity=0.381  Sum_probs=209.5

Q ss_pred             CccccCeEEeeeecccCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      .....+|++++.||+|+||.||+|.    +..+++.||+|++....  .......+.+|+.+++.++||||+++++++..
T Consensus        17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   94 (302)
T 4e5w_A           17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTE   94 (302)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence            3556779999999999999999999    56789999999986543  22345778999999999999999999999977


Q ss_pred             C--CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecccccc
Q 019216           86 K--SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus        86 ~--~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      .  ..+++||||+++++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~  174 (302)
T 4e5w_A           95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK  174 (302)
T ss_dssp             ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred             CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence            6  678999999999999999954 4579999999999999999999999999999999999999999999999999997


Q ss_pred             CCCcccCC-CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc---------------cHHHHH
Q 019216          163 LPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR---------------NLAVLY  226 (344)
Q Consensus       163 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~---------------~~~~~~  226 (344)
                      ........ .......||..|+|||++.+..+ +.++||||||+++|+|++|..|+...               ......
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKF-YIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHH
T ss_pred             cccCCCcceeccCCCCCCccccCCeeecCCCC-CcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHH
Confidence            54332111 12334568888999999987776 58999999999999999999876432               112222


Q ss_pred             HHHhh-CCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          227 QKIFR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       227 ~~i~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ..+.. ...+.+..+++.+.+||.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            22222 245567789999999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2.4e-48  Score=373.58  Aligned_cols=251  Identities=27%  Similarity=0.407  Sum_probs=218.2

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +...+|++.+.||+|+||.||+|.++.++..||||++.....    ..+.+.+|+.++++++||||+++++++.....++
T Consensus       217 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~  292 (495)
T 1opk_A          217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY  292 (495)
T ss_dssp             CCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             cCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEE
Confidence            455789999999999999999999998899999999865432    2567899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +||||+++++|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       293 lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  372 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT  372 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC
T ss_pred             EEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc
Confidence            999999999999999863  458999999999999999999999999999999999999999999999999998543211


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                       ........++..|+|||++....+ +.++|||||||++|||++ |..||.+.+.......+..+ ....|..+++.+.+
T Consensus       373 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  450 (495)
T 1opk_A          373 -YTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE  450 (495)
T ss_dssp             -EECCTTCCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             -eeecCCCcCCcceeCHhHHhcCCC-CcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence             111223456788999999987766 689999999999999999 99999987776666666554 45667889999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhc
Q 019216          247 LLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~  267 (344)
                      ||.+||+.||++|||+.++++
T Consensus       451 li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          451 LMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCcChhHCcCHHHHHH
Confidence            999999999999999999976

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=4.8e-48  Score=346.42  Aligned_cols=254  Identities=24%  Similarity=0.422  Sum_probs=198.5

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      .+.-++|++.++||+|+||.||+|.+..   .||+|++.... ......+.+.+|+.++++++||||++++++. .....
T Consensus        20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~   94 (289)
T 3og7_A           20 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQL   94 (289)
T ss_dssp             BCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSC
T ss_pred             ccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCcc
Confidence            4667899999999999999999998543   59999986543 3445567899999999999999999999965 45568


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus        95 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           95 AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            999999999999999864 4569999999999999999999999999999999999999999999999999997554333


Q ss_pred             CCCccccccCCCcccchhhhcc--CCCCCccchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHhhCCCC-----CCCCC
Q 019216          169 DDGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIFRGDFK-----LPKWL  240 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~-~~~~~~i~~~~~~-----~~~~~  240 (344)
                      .........||+.|+|||++..  ....+.++||||||+++|+|++|+.||.+... ......+..+...     .+..+
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNC  254 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTS
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccC
Confidence            3334455679999999999862  22336799999999999999999999987543 3344444443322     23468


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ++.+.+||.+||+.||.+|||+.++++.
T Consensus       255 ~~~l~~li~~~l~~~p~~Rps~~ell~~  282 (289)
T 3og7_A          255 PKRMKRLMAECLKKKRDERPSFPRILAE  282 (289)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            8999999999999999999999999863

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.3e-48  Score=367.07  Aligned_cols=249  Identities=25%  Similarity=0.421  Sum_probs=214.5

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++.+.||+|+||.||+|.+. ++..||||+++....    ..+.+.+|+.++++++||||+++++++. ....+
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~  258 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIY  258 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCE
T ss_pred             echHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccE
Confidence            45678999999999999999999984 567899999975432    3567899999999999999999999986 56789


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +||||+++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       259 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~  338 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE  338 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc
Confidence            999999999999999753  368999999999999999999999999999999999999999999999999998532211


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                       ........++..|+|||++....+ +.++|||||||++|||++ |+.||.+.+.......+..+ ..+.|..+++.+.+
T Consensus       339 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  416 (454)
T 1qcf_A          339 -YTAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN  416 (454)
T ss_dssp             -HHTTCSSSSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHH
T ss_pred             -eeccCCCcccccccCHHHhccCCC-CcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence             011123346788999999987766 689999999999999999 99999998887777777665 45667889999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhc
Q 019216          247 LLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~  267 (344)
                      ||.+||+.||++|||+++++.
T Consensus       417 li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          417 IMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhHCcCHHHHHH
Confidence            999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1e-47  Score=342.73  Aligned_cols=246  Identities=26%  Similarity=0.428  Sum_probs=210.5

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee-------
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-------   85 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-------   85 (344)
                      .++|++++.||+|+||.||+|.+..+++.||+|.+....       ..+.+|+.+++.++||||+++++++..       
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (284)
T 2a19_B           10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPET   82 (284)
T ss_dssp             HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---
T ss_pred             ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccc
Confidence            368999999999999999999999999999999986543       246689999999999999999998854       


Q ss_pred             ---------CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeE
Q 019216           86 ---------KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIK  154 (344)
Q Consensus        86 ---------~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vk  154 (344)
                               ...+++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+|
T Consensus        83 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~k  162 (284)
T 2a19_B           83 SSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK  162 (284)
T ss_dssp             ------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEE
T ss_pred             ccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEE
Confidence                     44589999999999999999754  5799999999999999999999999999999999999999999999


Q ss_pred             EeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC
Q 019216          155 ISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF  234 (344)
Q Consensus       155 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~  234 (344)
                      |+|||++.....   ........||+.|+|||++.+..+ +.++||||||+++|+|++|..|+...  ......+...  
T Consensus       163 l~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~--  234 (284)
T 2a19_B          163 IGDFGLVTSLKN---DGKRTRSKGTLRYMSPEQISSQDY-GKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDG--  234 (284)
T ss_dssp             ECCCTTCEESSC---CSCCCCCCSCCTTSCHHHHHCSCC-CTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTT--
T ss_pred             ECcchhheeccc---cccccccCCcccccChhhhccCCC-cchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhcc--
Confidence            999999875432   222345679999999999987666 68999999999999999999987532  2223333332  


Q ss_pred             CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          235 KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       235 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      .++..+++.+.++|.+||+.||.+|||+.+++++.+.-.
T Consensus       235 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          235 IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            346778999999999999999999999999999987654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-47  Score=350.18  Aligned_cols=256  Identities=26%  Similarity=0.396  Sum_probs=214.5

Q ss_pred             cCccccCeEEeeeecccCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA   84 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~   84 (344)
                      .-+..++|++++.||+|+||.||+|.    +..+++.||+|++...   .....+.+.+|+.++++++||||+++++++.
T Consensus        18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   94 (327)
T 3lxl_A           18 TIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSY   94 (327)
T ss_dssp             CBCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence            44667899999999999999999999    5678999999998654   3345677899999999999999999999886


Q ss_pred             --eCCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccc
Q 019216           85 --SKSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus        85 --~~~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a  161 (344)
                        .....++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.||+||||||+|||++.++.+||+|||++
T Consensus        95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  174 (327)
T 3lxl_A           95 GPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA  174 (327)
T ss_dssp             CSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred             cCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence              45679999999999999999976 456999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCcccCC-CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH---------------HH
Q 019216          162 ALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------------VL  225 (344)
Q Consensus       162 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~---------------~~  225 (344)
                      ......... .......+|..|+|||++.+..+ +.++||||||+++|+|++|..||......               ..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          175 KLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF-SRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             EECCTTCSEEECSSCCCSCGGGSCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             eecccCCccceeeccCCccccccCHHHhccCCC-ChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            854322111 12233568888999999987766 68999999999999999999998664432               22


Q ss_pred             HHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          226 YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       226 ~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ...+..+ ..+.+..+++.+.+||.+||+.||++|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2222222 455677899999999999999999999999999765

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.3e-48  Score=342.81  Aligned_cols=245  Identities=25%  Similarity=0.475  Sum_probs=206.7

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC-Ce
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-SK   88 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-~~   88 (344)
                      .+..++|++.+.||+|+||.||+|.+  +|+.||+|++....     ..+.+.+|+.++++++||||+++++++... ..
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   89 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG   89 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred             cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence            36678999999999999999999987  48899999986432     356788999999999999999999987544 47


Q ss_pred             EEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           89 IYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~--~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      .++||||+++++|.+++.+.+.  +++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~  169 (278)
T 1byg_A           90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS  169 (278)
T ss_dssp             CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred             eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence            8999999999999999976543  89999999999999999999999999999999999999999999999999874322


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA  244 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~  244 (344)
                           ......+++.|+|||++.+..+ +.++||||||+++|+|++ |+.||...+.......+..+ ....+..+++.+
T Consensus       170 -----~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  243 (278)
T 1byg_A          170 -----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAV  243 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHH
T ss_pred             -----cccCCCccccccCHHHhCCCCC-CchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHH
Confidence                 1233467889999999987666 689999999999999998 99999987776666666555 456678899999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhc
Q 019216          245 QNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .++|.+||+.||++|||+.++++
T Consensus       244 ~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          244 YEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcCChhhCCCHHHHHH
Confidence            99999999999999999999876

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-47  Score=341.56  Aligned_cols=252  Identities=24%  Similarity=0.363  Sum_probs=211.4

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE-
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI-   89 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~-   89 (344)
                      -.|++.+.||+|+||+||+|.+..++.   .||+|.+...  ......+.+.+|+.+++.++||||+++++++...+.. 
T Consensus        21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   98 (298)
T 3pls_A           21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP   98 (298)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred             eEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence            356778999999999999999765544   7999998542  2345567889999999999999999999999766554 


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +++|||+.+++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A           99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            899999999999999976 4568999999999999999999999999999999999999999999999999997543221


Q ss_pred             --CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHH
Q 019216          169 --DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA  244 (344)
Q Consensus       169 --~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~  244 (344)
                        .........+|+.|+|||.+.+..+ +.++||||||+++|+|++ |.+||...+.......+... ....+..+++.+
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  257 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRF-TTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL  257 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccccccCcCCCCCccccChhhhccCCC-ChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence              1222334567889999999987766 689999999999999999 66667776666666666555 355677899999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          245 QNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+++.+||+.||.+|||+.++++.
T Consensus       258 ~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          258 YQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999998763

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.9e-47  Score=342.57  Aligned_cols=256  Identities=25%  Similarity=0.338  Sum_probs=212.1

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEE-ee
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-AS   85 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~   85 (344)
                      +....+|++.+.||+|+||.||+|.+..+   +..+|+|.+...  ......+.+.+|+.++++++||||+++++++ ..
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~   98 (298)
T 3f66_A           21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS   98 (298)
T ss_dssp             CGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCS
T ss_pred             CccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcC
Confidence            44566899999999999999999997543   346899988643  2345567899999999999999999999985 45


Q ss_pred             CCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           86 KSKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                      +...++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        99 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~  178 (298)
T 3f66_A           99 EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDM  178 (298)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCC
T ss_pred             CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccc
Confidence            6678999999999999999975 456899999999999999999999999999999999999999999999999999854


Q ss_pred             CcccC--CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC-CCCCCCC
Q 019216          165 QHFRD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWL  240 (344)
Q Consensus       165 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~  240 (344)
                      .....  ........+|+.|+|||.+.+..+ +.++||||||+++|+|++ |.+||.+.+.......+..+. ...|..+
T Consensus       179 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (298)
T 3f66_A          179 YDKEYYSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYC  257 (298)
T ss_dssp             SCGGGCBC-----CCBCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTC
T ss_pred             cccchhccccccCCCCCccccChHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccC
Confidence            33221  122334567889999999987776 689999999999999999 788888877666666666554 4456778


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ++.+.+++.+||+.||++|||+.++++.
T Consensus       258 ~~~l~~li~~~l~~~p~~Rps~~ell~~  285 (298)
T 3f66_A          258 PDPLYEVMLKCWHPKAEMRPSFSELVSR  285 (298)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999998863

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.2e-47  Score=340.15  Aligned_cols=249  Identities=27%  Similarity=0.412  Sum_probs=213.1

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++++.||+|+||.||+|.+. ++..||+|.+.....    ..+.+.+|+.+++.++||||+++++++.. +..+
T Consensus        10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~   83 (279)
T 1qpc_A           10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (279)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence            45689999999999999999999974 567899999865432    24678899999999999999999999864 4588


Q ss_pred             EEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +||||+++++|.+++....  .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            9999999999999987543  69999999999999999999999999999999999999999999999999987543211


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                       ........++..|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.+.......+..+ ....+..+++.+.+
T Consensus       164 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  241 (279)
T 1qpc_A          164 -YTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ  241 (279)
T ss_dssp             -EECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             -cccccCCCCccCccChhhhccCCC-CchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHH
Confidence             111223456788999999987665 689999999999999999 99999988877777777665 34566789999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhc
Q 019216          247 LLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~  267 (344)
                      ++.+||+.||++|||+.++++
T Consensus       242 li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          242 LMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhccChhhCCCHHHHHH
Confidence            999999999999999999876

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=7e-48  Score=354.12  Aligned_cols=256  Identities=18%  Similarity=0.201  Sum_probs=201.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECC---CCceEEEEEeecccccchh--------HHHHHHHHHHHHHhCCCCCccce
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLD---SGLPFAVKILEKNRIIHLK--------ITDQIKREIATLKLLKHPNVVRL   79 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~---~~~~vaiK~~~~~~~~~~~--------~~~~~~~E~~~l~~l~h~niv~l   79 (344)
                      ..-++|++.+.||+|+||.||+|.+..   ++..+|+|++.........        ....+.+|+..++.++||||+++
T Consensus        34 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~  113 (345)
T 2v62_A           34 MEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLF  113 (345)
T ss_dssp             TTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCE
T ss_pred             ccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCccee
Confidence            344689999999999999999999987   8899999998754321111        12246678899999999999999


Q ss_pred             eeEEee----CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC--Ce
Q 019216           80 HEVLAS----KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG--NI  153 (344)
Q Consensus        80 ~~~~~~----~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~--~v  153 (344)
                      ++++..    ....|+||||+ |++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|||++.++  .+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence            999987    77899999999 999999998877899999999999999999999999999999999999999887  99


Q ss_pred             EEeccccccCCCcccC-----CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc--cHHHHH
Q 019216          154 KISDFGLSALPQHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR--NLAVLY  226 (344)
Q Consensus       154 kl~Dfg~a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~--~~~~~~  226 (344)
                      ||+|||+++.......     ........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.  +.....
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~  271 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVAL-SRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQ  271 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHH
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCccccccccHHHH
Confidence            9999999975432211     111245689999999999987765 68999999999999999999999652  222222


Q ss_pred             HHHhhCCCCCC---------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          227 QKIFRGDFKLP---------KWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       227 ~~i~~~~~~~~---------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .........+|         ..+++.+.++|.+||+.||++|||++++++.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          272 TAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            11111111122         2689999999999999999999999999874

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.9e-49  Score=357.13  Aligned_cols=254  Identities=21%  Similarity=0.304  Sum_probs=208.6

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||+|.+....   ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  111 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI  111 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred             HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence            3568999999999999999999996 568999999886543   234677899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           91 MVLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      +||||+++++|.+++....    .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  191 (321)
T 2qkw_B          112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE  191 (321)
T ss_dssp             EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred             EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence            9999999999999886543    589999999999999999999999999999999999999999999999999875433


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHH------H-HHHHhhCCC-----
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV------L-YQKIFRGDF-----  234 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~------~-~~~i~~~~~-----  234 (344)
                      ...........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.....      . ......+..     
T Consensus       192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (321)
T 2qkw_B          192 LDQTHLSTVVKGTLGYIDPEYFIKGRL-TEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD  270 (321)
T ss_dssp             SSCCCCBCCCEEETTTCCHHHHHHCBC-CTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred             ccccccccccCCCccccCHHHhcCCCC-CcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence            223333344568999999999887766 689999999999999999999997643211      1 111111111     


Q ss_pred             -C----CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCc
Q 019216          235 -K----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADE  269 (344)
Q Consensus       235 -~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~  269 (344)
                       .    .+...+..+.+++.+||+.||++|||+.+++++.
T Consensus       271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence             1    1122456789999999999999999999999864

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7e-47  Score=341.95  Aligned_cols=243  Identities=28%  Similarity=0.445  Sum_probs=200.6

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++.+.||+|+||.||+|.+  .++.||+|.+...     ...+.+.+|+.++++++||||+++++++.+  ..+
T Consensus         5 i~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~   75 (307)
T 2eva_A            5 IDYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC   75 (307)
T ss_dssp             CCGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred             CCHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence            5678999999999999999999997  4788999998532     235678899999999999999999998863  478


Q ss_pred             EEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCceeecCCCCcEEEccCCC-eEEeccccccC
Q 019216           91 MVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHN---KGVFHRDLKLENILLDSKGN-IKISDFGLSAL  163 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~---~~i~H~dikp~NILl~~~~~-vkl~Dfg~a~~  163 (344)
                      +||||+++++|.+++....   .++...+..++.|++.||.|||+   +||+||||||+|||++.++. +||+|||++..
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            9999999999999998654   37899999999999999999999   89999999999999999887 79999999874


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc--HHHHHHHHhh-CCCCCCCCC
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN--LAVLYQKIFR-GDFKLPKWL  240 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~--~~~~~~~i~~-~~~~~~~~~  240 (344)
                      ...     ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....  .......+.. .....+..+
T Consensus       156 ~~~-----~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (307)
T 2eva_A          156 IQT-----HMTNNKGSAAWMAPEVFEGSNY-SEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNL  229 (307)
T ss_dssp             --------------CCTTSSCHHHHTCCCC-CTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTC
T ss_pred             ccc-----ccccCCCCCceEChhhhCCCCC-CcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCccccc
Confidence            322     1234568999999999987665 689999999999999999999997532  2223333333 345566789


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ++.+.+++.+||+.||++|||+.+++++
T Consensus       230 ~~~l~~li~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          230 PKPIESLMTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            9999999999999999999999999874

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=3.3e-47  Score=341.63  Aligned_cols=249  Identities=22%  Similarity=0.271  Sum_probs=205.2

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEE-eeCCeEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-ASKSKIY   90 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~   90 (344)
                      .-++|++.+.||+|+||.||+|.+..+|+.||+|++.....     ...+.+|+.+++.++|++++..+..+ ......+
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~   81 (296)
T 3uzp_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNV   81 (296)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEE
T ss_pred             eccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCCceE
Confidence            35789999999999999999999999999999999865432     23578899999999988876665554 6678889


Q ss_pred             EEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE---ccCCCeEEeccccccCCCc
Q 019216           91 MVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl---~~~~~vkl~Dfg~a~~~~~  166 (344)
                      +||||+ +++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||+   +.++.+||+|||++.....
T Consensus        82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  160 (296)
T 3uzp_A           82 MVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             EEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence            999999 9999999974 5579999999999999999999999999999999999999   4888999999999975433


Q ss_pred             ccCC-----CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHHhhCCCC---
Q 019216          167 FRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFK---  235 (344)
Q Consensus       167 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~---~~~~~~~i~~~~~~---  235 (344)
                      ....     .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+..   .......+......   
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 3uzp_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             cccccccccccccccccccccCChhhhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch
Confidence            2211     11245689999999999988775 689999999999999999999997632   22222222222222   


Q ss_pred             --CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          236 --LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       236 --~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                        .+..+++.+.+++.+||+.||++|||+.++++
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence              23678999999999999999999999999876

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.2e-47  Score=361.93  Aligned_cols=249  Identities=25%  Similarity=0.381  Sum_probs=210.5

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++.+.||+|+||.||+|.+.. +..||||++.....    ..+.+.+|+.++++++||||+++++++.. ...+
T Consensus       181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~  254 (452)
T 1fmk_A          181 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  254 (452)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence            456789999999999999999999864 46799999875432    24578999999999999999999999876 6789


Q ss_pred             EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +||||+++++|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            99999999999999974  3569999999999999999999999999999999999999999999999999998543211


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                       ........++..|+|||++....+ +.++||||||+++|+|++ |+.||.+.........+..+ ..+.|..+++.+.+
T Consensus       335 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  412 (452)
T 1fmk_A          335 -YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD  412 (452)
T ss_dssp             ---------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             -eecccCCcccccccCHhHHhcCCC-CccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence             111233456788999999987766 689999999999999999 99999998887777777665 45667889999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhc
Q 019216          247 LLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~  267 (344)
                      ||.+||+.||++|||++++++
T Consensus       413 li~~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          413 LMCQCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHccCChhhCcCHHHHHH
Confidence            999999999999999999876

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=9.4e-48  Score=344.33  Aligned_cols=257  Identities=27%  Similarity=0.388  Sum_probs=207.7

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECC-CCc--eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLD-SGL--PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~-~~~--~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      .+..++|++++.||+|+||.||+|.+.. +++  .||+|++...........+.+.+|+.++++++||||+++++++...
T Consensus        14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   93 (291)
T 1u46_A           14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP   93 (291)
T ss_dssp             ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred             ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence            3556799999999999999999998643 333  6899998765544556678899999999999999999999999776


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      . .++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus        94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~  172 (291)
T 1u46_A           94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  172 (291)
T ss_dssp             S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence            5 88999999999999998764 579999999999999999999999999999999999999999999999999987543


Q ss_pred             cccCC-CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC--CCCCCCCC
Q 019216          166 HFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLS  241 (344)
Q Consensus       166 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~  241 (344)
                      ..... .......+|..|+|||++.+..+ +.++||||||+++|+|++ |+.||.+.+.......+....  .+.+..++
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (291)
T 1u46_A          173 QNDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP  251 (291)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred             ccccchhhhccCCCCceeeCchhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence            22111 11223467888999999987665 689999999999999999 999999988888877776653  44556799


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +.+.++|.+||+.||.+|||+.+++++
T Consensus       252 ~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          252 QDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999999999873

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.1e-48  Score=363.02  Aligned_cols=252  Identities=27%  Similarity=0.421  Sum_probs=206.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC--e
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS--K   88 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~--~   88 (344)
                      ..-++|++.+.||+|+||.||+|.+..+|+.||+|++.....  ....+.+.+|+.++++++||||+++++++....  .
T Consensus         6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~   83 (396)
T 4eut_A            6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH   83 (396)
T ss_dssp             CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred             CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence            445799999999999999999999999999999999975432  223567789999999999999999999987654  7


Q ss_pred             EEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE----ccCCCeEEeccccc
Q 019216           89 IYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL----DSKGNIKISDFGLS  161 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl----~~~~~vkl~Dfg~a  161 (344)
                      .++||||+++++|.+++....   .+++..++.++.||+.||+|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            899999999999999997543   39999999999999999999999999999999999999    67778999999999


Q ss_pred             cCCCcccCCCccccccCCCcccchhhhccC-------CCCCccchhhhhhHHHHHHHhCCCCCCC----ccHHHHHHHHh
Q 019216          162 ALPQHFRDDGLLHTTCGSPNYVAPEVLANR-------GYDGATSDIWSCGVILYVILTGYLPFDD----RNLAVLYQKIF  230 (344)
Q Consensus       162 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DvwslG~ll~ell~g~~pf~~----~~~~~~~~~i~  230 (344)
                      +....   ........||+.|+|||++.+.       ...+.++|||||||++|+|++|+.||..    ........++.
T Consensus       164 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~  240 (396)
T 4eut_A          164 RELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII  240 (396)
T ss_dssp             EECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHH
T ss_pred             eEccC---CCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHh
Confidence            75432   2223456799999999998652       2235789999999999999999999964    23344455555


Q ss_pred             hCCCC-------------------------CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          231 RGDFK-------------------------LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       231 ~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .+.+.                         ++..+++.+.++|++||+.||++|||+.++++
T Consensus       241 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             cCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence            44321                         11224567899999999999999999998754

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=347.75  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=206.0

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe----eC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA----SK   86 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~----~~   86 (344)
                      +.-++|++++.||+|+||.||+|.+..+|+.||+|++...   .....+.+.+|+.+++.++||||+++++++.    ..
T Consensus        26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  102 (317)
T 2buj_A           26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAK  102 (317)
T ss_dssp             ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTE
T ss_pred             ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCC
Confidence            4457899999999999999999999999999999998653   3345678899999999999999999999986    23


Q ss_pred             CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecccccc
Q 019216           87 SKIYMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      ...++||||+.+++|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       103 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~  182 (317)
T 2buj_A          103 HEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMN  182 (317)
T ss_dssp             EEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCE
T ss_pred             ceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcch
Confidence            478999999999999998875    4679999999999999999999999999999999999999999999999999887


Q ss_pred             CCCcccCCC-------ccccccCCCcccchhhhccCCC--CCccchhhhhhHHHHHHHhCCCCCCCccH--HHHHHHHhh
Q 019216          163 LPQHFRDDG-------LLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYVILTGYLPFDDRNL--AVLYQKIFR  231 (344)
Q Consensus       163 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslG~ll~ell~g~~pf~~~~~--~~~~~~i~~  231 (344)
                      .........       ......||+.|+|||++.....  .+.++||||||+++|+|++|+.||.....  ......+..
T Consensus       183 ~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~  262 (317)
T 2buj_A          183 QACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN  262 (317)
T ss_dssp             ESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC
T ss_pred             hcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc
Confidence            432211110       0123457999999999865431  36799999999999999999999954211  011111111


Q ss_pred             -CCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          232 -GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       232 -~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                       ...+.+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       263 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          263 QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence             1233445689999999999999999999999999986

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.2e-47  Score=355.13  Aligned_cols=255  Identities=17%  Similarity=0.210  Sum_probs=200.5

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCC-----CceEEEEEeecccccchhH--------HHHHHHHHHHHHhCCCCCcc
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDS-----GLPFAVKILEKNRIIHLKI--------TDQIKREIATLKLLKHPNVV   77 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~-----~~~vaiK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~h~niv   77 (344)
                      ..-++|++++.||+|+||.||+|.+..+     ++.||+|++..........        .....+|+..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            3345999999999999999999998764     5889999987543211111        11244566677888999999


Q ss_pred             ceeeEEeeC----CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEc--cC
Q 019216           78 RLHEVLASK----SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD--SK  150 (344)
Q Consensus        78 ~l~~~~~~~----~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~--~~  150 (344)
                      ++++++...    ...++||||+ |++|.+++... +.+++..++.++.||+.||.|||+.||+||||||+|||++  .+
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCT
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCC
Confidence            999998764    5589999999 99999999875 6799999999999999999999999999999999999999  88


Q ss_pred             CCeEEeccccccCCCcccCC-----CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHH
Q 019216          151 GNIKISDFGLSALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL  225 (344)
Q Consensus       151 ~~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~  225 (344)
                      +.+||+|||+++........     ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+......
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~  269 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAP-SRRGDLEILGYCMIQWLTGHLPWEDNLKDPK  269 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCC-CchhhHHHHHHHHHHHHhCCCCccccccCHH
Confidence            99999999999754332211     11234569999999999988776 6899999999999999999999986322111


Q ss_pred             HHHHh----hCCC-------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          226 YQKIF----RGDF-------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       226 ~~~i~----~~~~-------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .....    ....       -.+..+++.+.+++..||+.||.+||++.++++
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          270 YVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            11110    0000       012567999999999999999999999999876

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.9e-47  Score=340.99  Aligned_cols=248  Identities=22%  Similarity=0.276  Sum_probs=201.5

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEE-eeCCeEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL-ASKSKIYM   91 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~-~~~~~~~i   91 (344)
                      -++|++.+.||+|+||.||+|.+..+++.||+|++.....     ...+.+|+.+++.++|++++..+..+ ......++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence            4689999999999999999999999999999998754432     23477899999999988877666555 67788999


Q ss_pred             EEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE---ccCCCeEEeccccccCCCcc
Q 019216           92 VLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl---~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      ||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++......
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~  161 (296)
T 4hgt_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             EEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCc
Confidence            99999 9999999974 4679999999999999999999999999999999999999   78899999999999854332


Q ss_pred             cCC-----CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH---HHHHHHHhhCCCC----
Q 019216          168 RDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL---AVLYQKIFRGDFK----  235 (344)
Q Consensus       168 ~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~---~~~~~~i~~~~~~----  235 (344)
                      ...     .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.   ......+......    
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 4hgt_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCGGGCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             ccCccCCCCcccccCCCccccchHHhcCCCC-CchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence            211     12335689999999999988776 6899999999999999999999976321   1222222222222    


Q ss_pred             -CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          236 -LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       236 -~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                       ....+++.+.+||.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          241 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence             23668999999999999999999999999876

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.1e-47  Score=350.72  Aligned_cols=245  Identities=16%  Similarity=0.213  Sum_probs=202.6

Q ss_pred             cCeEEeeeecccCceEEEEEEECC--------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccc-------
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLD--------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVR-------   78 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~-------   78 (344)
                      ++|++.+.||+|+||.||+|.+..        .++.||+|++...        +.+.+|+.++++++||||++       
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~  113 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS  113 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence            799999999999999999999987        4899999998654        35778999999999999887       


Q ss_pred             --------eeeEEee-CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE
Q 019216           79 --------LHEVLAS-KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL  147 (344)
Q Consensus        79 --------l~~~~~~-~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl  147 (344)
                              +++++.. ....++||||+ +++|.+++...  ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus       114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV  192 (352)
T ss_dssp             CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred             CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence                    5667765 77899999999 99999999875  789999999999999999999999999999999999999


Q ss_pred             ccCC--CeEEeccccccCCCcccCC-----CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc
Q 019216          148 DSKG--NIKISDFGLSALPQHFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR  220 (344)
Q Consensus       148 ~~~~--~vkl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~  220 (344)
                      +.++  .+||+|||+++........     .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~el~~g~~pf~~~  271 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGP-SRRSDLQSLGYCMLKWLYGFLPWTNC  271 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCC-CchhhHHHHHHHHHHHHhCCCCcccC
Confidence            9998  8999999999765432211     12234589999999999987765 68999999999999999999999875


Q ss_pred             c--HHHHHHH---HhhCCCCCC------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          221 N--LAVLYQK---IFRGDFKLP------KWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       221 ~--~~~~~~~---i~~~~~~~~------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .  .......   .......++      ..+++.+.+||.+||+.||++|||+.++++.
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          272 LPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             TTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             CcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            3  2222222   222222222      2468999999999999999999999998763

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.7e-47  Score=340.68  Aligned_cols=237  Identities=29%  Similarity=0.564  Sum_probs=197.1

Q ss_pred             ccCccccCeEEe-eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHH-HhCCCCCccceeeEEee
Q 019216            8 QEGMRLGRYELG-RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKHPNVVRLHEVLAS   85 (344)
Q Consensus         8 ~~~~~~~~y~~~-~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l-~~l~h~niv~l~~~~~~   85 (344)
                      ..+..+++|.++ +.||+|+||.||+|.++.+++.||+|++...        ..+.+|+.++ +.++||||+++++++..
T Consensus        11 ~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~   82 (299)
T 3m2w_A           11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN   82 (299)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             cccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence            467788999998 7899999999999999999999999998542        3566788887 66689999999999876


Q ss_pred             ----CCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc---CCCeEEe
Q 019216           86 ----KSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKIS  156 (344)
Q Consensus        86 ----~~~~~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~---~~~vkl~  156 (344)
                          ....++||||++|++|.+++....  .+++..++.++.|++.||.|||++||+||||||+|||++.   ++.+||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~  162 (299)
T 3m2w_A           83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  162 (299)
T ss_dssp             EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred             hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence                677899999999999999998754  6999999999999999999999999999999999999998   7889999


Q ss_pred             ccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHH----HhhC
Q 019216          157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK----IFRG  232 (344)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~----i~~~  232 (344)
                      |||++....                        +..+ +.++|||||||++|+|++|+.||.+.+.......    +...
T Consensus       163 Dfg~a~~~~------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~  217 (299)
T 3m2w_A          163 DFGFAKETT------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG  217 (299)
T ss_dssp             CCTTCEECT------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTT
T ss_pred             ccccccccc------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhc
Confidence            999986321                        1223 5789999999999999999999987654433211    1122


Q ss_pred             CCCCC----CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          233 DFKLP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       233 ~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      ...++    ..+++++.+||.+||+.||.+|||+.++++||||.+....
T Consensus       218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~  266 (299)
T 3m2w_A          218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV  266 (299)
T ss_dssp             CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGS
T ss_pred             cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccC
Confidence            23333    5689999999999999999999999999999999876543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.6e-47  Score=344.74  Aligned_cols=255  Identities=27%  Similarity=0.362  Sum_probs=208.9

Q ss_pred             cCccccCe-EEeeeecccCceEEEEEEE----CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEE
Q 019216            9 EGMRLGRY-ELGRTLGEGNFGKVKFAQD----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL   83 (344)
Q Consensus         9 ~~~~~~~y-~~~~~Lg~G~~g~Vy~a~~----~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~   83 (344)
                      ..+.-++| ++++.||+|+||.||++..    ..+++.||+|++....  .....+.+.+|+.++++++||||+++++++
T Consensus        25 ~~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (318)
T 3lxp_A           25 PTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCC  102 (318)
T ss_dssp             CCBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEE
Confidence            44455666 9999999999999988753    4578999999997542  344567899999999999999999999999


Q ss_pred             ee--CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccc
Q 019216           84 AS--KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus        84 ~~--~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a  161 (344)
                      ..  ...+++||||+++++|.+++.+. .+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a  181 (318)
T 3lxp_A          103 EDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA  181 (318)
T ss_dssp             EETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGC
T ss_pred             ecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccc
Confidence            87  46889999999999999998764 5999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCcccCC-CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH---------------HH
Q 019216          162 ALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA---------------VL  225 (344)
Q Consensus       162 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~---------------~~  225 (344)
                      ......... .......+|..|+|||++.+..+ +.++||||||+++|+|++|..||......               ..
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  260 (318)
T 3lxp_A          182 KAVPEGHEYYRVREDGDSPVFWYAPECLKEYKF-YYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRL  260 (318)
T ss_dssp             EECCTTCSEEEC---CCCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHH
T ss_pred             ccccccccccccccCCCCCceeeChHHhcCCCC-CcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHH
Confidence            854332111 12234567888999999987776 58999999999999999999999764322               11


Q ss_pred             HHHHhh-CCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          226 YQKIFR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       226 ~~~i~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ...+.. ...+.+..+++.+.+||.+||+.||++|||+.++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          261 TELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            122222 245567789999999999999999999999999985

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-47  Score=353.72  Aligned_cols=253  Identities=25%  Similarity=0.331  Sum_probs=202.7

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEe-eCCe
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLA-SKSK   88 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~-~~~~   88 (344)
                      ..+|++.+.||+|+||.||+|.+..+   +..||+|.+...  ......+.+.+|+.++++++||||+++++++. ..+.
T Consensus        88 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  165 (373)
T 3c1x_A           88 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGS  165 (373)
T ss_dssp             TEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSC
T ss_pred             hceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCC
Confidence            34688999999999999999997543   346899988643  23445678999999999999999999999864 4567


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .++||||+++++|.+++.+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       166 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~  245 (373)
T 3c1x_A          166 PLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK  245 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             eEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence            89999999999999999764 45889999999999999999999999999999999999999999999999999754321


Q ss_pred             cC--CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHH
Q 019216          168 RD--DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG  243 (344)
Q Consensus       168 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~  243 (344)
                      ..  ........+|+.|+|||++.+..+ +.++|||||||++|+|++ |.+||.+.+.......+..+ ....|..+++.
T Consensus       246 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~  324 (373)
T 3c1x_A          246 EFDSVHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDP  324 (373)
T ss_dssp             ------------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHH
T ss_pred             ccccccccCCCCCcccccChHHhcCCCC-CcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence            11  111233467789999999987766 689999999999999999 78899877665555555555 34557779999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +.+++.+||+.||++|||+.+++++
T Consensus       325 l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          325 LYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999875

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=1.1e-46  Score=371.54  Aligned_cols=249  Identities=24%  Similarity=0.344  Sum_probs=210.1

Q ss_pred             eEEe-eeecccCceEEEEEEE--CCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           16 YELG-RTLGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        16 y~~~-~~Lg~G~~g~Vy~a~~--~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +.+. +.||+|+||.||+|.+  +.+++.||||+++... ......+.+.+|+.++++++||||+++++++.. +..++|
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv  447 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLV  447 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEE
Confidence            4443 4899999999999954  4567899999986543 334456789999999999999999999999965 458899


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC-CC
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD-DG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~-~~  171 (344)
                      |||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus       448 ~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~  527 (635)
T 4fl3_A          448 MEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK  527 (635)
T ss_dssp             EECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------
T ss_pred             EEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccc
Confidence            99999999999999888899999999999999999999999999999999999999999999999999975432211 11


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR  249 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~  249 (344)
                      ......+|+.|+|||++.+..+ +.++|||||||++|||++ |+.||.+.+.......+..+ ....|..+++++.+||.
T Consensus       528 ~~~~~~~t~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  606 (635)
T 4fl3_A          528 AQTHGKWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMN  606 (635)
T ss_dssp             -------CGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             cccCCCCceeeeChhhhcCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence            2223456788999999987776 689999999999999998 99999998888887777766 45678889999999999


Q ss_pred             HhcCCCcCCCCCHhhhhc
Q 019216          250 KILEPNPVKRITIAGIKA  267 (344)
Q Consensus       250 ~~L~~dP~~Rps~~eil~  267 (344)
                      +||+.||++|||+.++++
T Consensus       607 ~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          607 LCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHTCSSTTTSCCHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHH
Confidence            999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.2e-47  Score=346.81  Aligned_cols=252  Identities=30%  Similarity=0.438  Sum_probs=188.9

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEe--------
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLA--------   84 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~--------   84 (344)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++...   .......+.+|+.+++++. ||||+++++++.        
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~  104 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT  104 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence            4899999999999999999999999999999998544   2344667889999999996 999999999983        


Q ss_pred             eCCeEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEEccCCCeEEeccc
Q 019216           85 SKSKIYMVLEYVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLDSKGNIKISDFG  159 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~--i~H~dikp~NILl~~~~~vkl~Dfg  159 (344)
                      ....++++|||+. |+|.+++..   .+++++..++.++.||+.||.|||+.|  |+||||||+|||++.++.+||+|||
T Consensus       105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg  183 (337)
T 3ll6_A          105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFG  183 (337)
T ss_dssp             SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCT
T ss_pred             CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCc
Confidence            3446899999995 689888864   567999999999999999999999999  9999999999999999999999999


Q ss_pred             cccCCCcccCCC----------ccccccCCCcccchhhhc--cCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHH
Q 019216          160 LSALPQHFRDDG----------LLHTTCGSPNYVAPEVLA--NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ  227 (344)
Q Consensus       160 ~a~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~--~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~  227 (344)
                      ++..........          ......||+.|+|||++.  .....+.++|||||||++|+|++|+.||.+........
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~  263 (337)
T 3ll6_A          184 SATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVN  263 (337)
T ss_dssp             TCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------
T ss_pred             cceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhc
Confidence            998654321110          112456899999999983  22333689999999999999999999998765443332


Q ss_pred             HHhhCCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          228 KIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       228 ~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      ..  ...+.+...++.+.+||.+||+.||.+|||+.+++++.+-
T Consensus       264 ~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  305 (337)
T 3ll6_A          264 GK--YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE  305 (337)
T ss_dssp             ----CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             Cc--ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            22  1233445678899999999999999999999999998543

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.2e-46  Score=364.97  Aligned_cols=249  Identities=25%  Similarity=0.381  Sum_probs=214.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++.++||+|+||.||+|.+.. +..||||++.....    ..+.+.+|+.+|++++||||+++++++.. ...+
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~  337 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY  337 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cchhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccce
Confidence            456789999999999999999999864 46799999975432    24578999999999999999999999876 6789


Q ss_pred             EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +||||+.+++|.+++..  ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       338 lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  417 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE  417 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH
T ss_pred             EeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc
Confidence            99999999999999974  3569999999999999999999999999999999999999999999999999998543211


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                       ........++..|+|||++....+ +.++|||||||++|||++ |+.||.+.........+..+ ..+.+..+++.+.+
T Consensus       418 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  495 (535)
T 2h8h_A          418 -YTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD  495 (535)
T ss_dssp             -HHTTCSTTSCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             -eecccCCcCcccccCHHHhccCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence             011223456788999999987766 689999999999999999 99999998887777777665 45667889999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhc
Q 019216          247 LLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~  267 (344)
                      ||.+||+.||++|||++++++
T Consensus       496 li~~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          496 LMCQCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999976

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=368.53  Aligned_cols=251  Identities=25%  Similarity=0.364  Sum_probs=209.1

Q ss_pred             ccCeEEee-eecccCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           13 LGRYELGR-TLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        13 ~~~y~~~~-~Lg~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      .+++.+.+ .||+|+||.||+|.++  .++..||||+++...  .....+.+.+|+.++++++||||+++++++.. +.+
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~  410 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EAL  410 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSE
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCe
Confidence            34566666 8999999999999875  356679999997542  23346789999999999999999999999976 568


Q ss_pred             EEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           90 YMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ++||||+.+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus       411 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~  490 (613)
T 2ozo_A          411 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD  490 (613)
T ss_dssp             EEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---
T ss_pred             EEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCC
Confidence            9999999999999998753 469999999999999999999999999999999999999999999999999998643221


Q ss_pred             CC-CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHH
Q 019216          169 DD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ  245 (344)
Q Consensus       169 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~  245 (344)
                      .. .......+++.|+|||++.+..+ +.++|||||||++|||++ |+.||.+.+.......+..+ ....|..+++.+.
T Consensus       491 ~~~~~~~~~~~~~~y~APE~~~~~~~-~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~  569 (613)
T 2ozo_A          491 SYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY  569 (613)
T ss_dssp             -----------CCTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred             ceeeeccCCCCccceeCHhhhcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHH
Confidence            11 11122345688999999987776 689999999999999998 99999998877777777766 4567788999999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhc
Q 019216          246 NLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~  267 (344)
                      +||.+||+.||++|||+.++++
T Consensus       570 ~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          570 ALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999754

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.7e-46  Score=342.19  Aligned_cols=259  Identities=25%  Similarity=0.391  Sum_probs=210.6

Q ss_pred             hhhccCccccCeEEeeeecccCceEEEEEE----ECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcccee
Q 019216            5 EKKQEGMRLGRYELGRTLGEGNFGKVKFAQ----DLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLH   80 (344)
Q Consensus         5 ~~~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~----~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~   80 (344)
                      .+....+..++|++++.||+|+||.||+|.    +..+++.||+|++...   .....+.+.+|+.++++++||||++++
T Consensus        32 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~  108 (326)
T 2w1i_A           32 DRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYK  108 (326)
T ss_dssp             -----CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEE
T ss_pred             ccCccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEE
Confidence            344566778899999999999999999998    4568999999998653   234567899999999999999999999


Q ss_pred             eEEeeCC--eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEec
Q 019216           81 EVLASKS--KIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISD  157 (344)
Q Consensus        81 ~~~~~~~--~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~D  157 (344)
                      +++....  ..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|
T Consensus       109 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~D  188 (326)
T 2w1i_A          109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGD  188 (326)
T ss_dssp             EEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECC
T ss_pred             EEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEec
Confidence            9986543  689999999999999999875 4699999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCcccCC-CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH-------------
Q 019216          158 FGLSALPQHFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA-------------  223 (344)
Q Consensus       158 fg~a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~-------------  223 (344)
                      ||++......... .......++..|+|||.+.+..+ +.++||||||+++|+|++|..||......             
T Consensus       189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~  267 (326)
T 2w1i_A          189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF-SVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM  267 (326)
T ss_dssp             CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHH
T ss_pred             CcchhhccccccccccccCCCCceeEECchhhcCCCC-CchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhh
Confidence            9999754332111 11223457788999999987766 68999999999999999999998653211             


Q ss_pred             ---HHHHHHhh-CCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          224 ---VLYQKIFR-GDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       224 ---~~~~~i~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                         .....+.. ...+.+..+++.+.++|.+||+.||++|||+.++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          268 IVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               11122222 245567789999999999999999999999999876

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6e-47  Score=357.70  Aligned_cols=255  Identities=25%  Similarity=0.348  Sum_probs=197.1

Q ss_pred             cccc--CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCC
Q 019216           11 MRLG--RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKS   87 (344)
Q Consensus        11 ~~~~--~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~   87 (344)
                      +.++  +|++.+.||+|+||+||. ....+|+.||||++......      .+.+|+.+++.+ +||||+++++++....
T Consensus        19 ~~i~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~   91 (432)
T 3p23_A           19 VIVGKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQ   91 (432)
T ss_dssp             EEETTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETT
T ss_pred             EEEccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence            4455  489999999999999764 33478899999998654322      245799999999 7999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc---CC--CeEEeccccc
Q 019216           88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KG--NIKISDFGLS  161 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~---~~--~vkl~Dfg~a  161 (344)
                      ..|+|||||. ++|.+++.... ..++..++.++.||+.||.|||++||+||||||+|||++.   ++  ++||+|||++
T Consensus        92 ~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           92 FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             EEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            9999999995 59999997644 4566677899999999999999999999999999999953   23  5789999999


Q ss_pred             cCCCcccC-CCccccccCCCcccchhhhcc--CCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCCCCC-
Q 019216          162 ALPQHFRD-DGLLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKL-  236 (344)
Q Consensus       162 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~-  236 (344)
                      +....... .......+||+.|+|||++.+  ....+.++|||||||++|+|++ |..||................... 
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~  250 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL  250 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc
Confidence            85433211 122345689999999999874  2233678999999999999999 999997655443333222222211 


Q ss_pred             --CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          237 --PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       237 --~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                        +...++.+.+||.+||+.||++|||+.++++||||..
T Consensus       251 ~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          251 HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence              2224567899999999999999999999999999964

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.1e-46  Score=337.18  Aligned_cols=250  Identities=24%  Similarity=0.346  Sum_probs=197.2

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCccceeeEEee--
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLAS--   85 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~--   85 (344)
                      ....++|++++.||+|+||+||+|.+  +++.||+|++....      ...+.+|.+++..  ++||||+++++++..  
T Consensus         4 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~   75 (301)
T 3q4u_A            4 RTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTSR   75 (301)
T ss_dssp             CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE
T ss_pred             ccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeecccc
Confidence            45678999999999999999999997  68899999985432      3455567777666  789999999998653  


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeecCCCCcEEEccCCCeEE
Q 019216           86 --KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH--------NKGVFHRDLKLENILLDSKGNIKI  155 (344)
Q Consensus        86 --~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH--------~~~i~H~dikp~NILl~~~~~vkl  155 (344)
                        ....++||||+++++|.++++. ..+++..++.++.|++.||+|||        +.||+||||||+|||++.++.+||
T Consensus        76 ~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl  154 (301)
T 3q4u_A           76 HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI  154 (301)
T ss_dssp             TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred             CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence              3468999999999999999954 57999999999999999999999        999999999999999999999999


Q ss_pred             eccccccCCCcccCC--CccccccCCCcccchhhhccCCCC-----CccchhhhhhHHHHHHHhC----------CCCCC
Q 019216          156 SDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYD-----GATSDIWSCGVILYVILTG----------YLPFD  218 (344)
Q Consensus       156 ~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DvwslG~ll~ell~g----------~~pf~  218 (344)
                      +|||++.........  .......||+.|+|||++.+....     +.++|||||||++|+|++|          +.||.
T Consensus       155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~  234 (301)
T 3q4u_A          155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY  234 (301)
T ss_dssp             CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred             eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence            999998643221111  112334799999999998765321     3689999999999999999          88885


Q ss_pred             Cc----cHHHHHHHHhhC---CCCCCC-----CCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          219 DR----NLAVLYQKIFRG---DFKLPK-----WLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       219 ~~----~~~~~~~~i~~~---~~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ..    ............   ....|.     .+++.+.+|+.+||+.||++|||+.++++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~  296 (301)
T 3q4u_A          235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT  296 (301)
T ss_dssp             TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            42    122222222222   122221     245789999999999999999999999863

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=4.6e-47  Score=351.23  Aligned_cols=246  Identities=15%  Similarity=0.197  Sum_probs=200.0

Q ss_pred             ccccCeEEeeeecccCceEEEEE-----EECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCccceeeE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFA-----QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEV   82 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a-----~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~   82 (344)
                      +.-++|++.+.||+|+||+||+|     .+..+++.||+|++....      ...+.+|+.+++.+.   |+||++++++
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~  135 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA  135 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence            34568999999999999999999     467889999999986542      346778888888887   9999999999


Q ss_pred             EeeCCeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc--------
Q 019216           83 LASKSKIYMVLEYVTGGELFDKIAS-----KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--------  149 (344)
Q Consensus        83 ~~~~~~~~iv~e~~~g~~L~~~l~~-----~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~--------  149 (344)
                      +...+..++|||||++|+|.+++..     ...+++..++.++.||+.||+|||++||+||||||+|||++.        
T Consensus       136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~  215 (365)
T 3e7e_A          136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE  215 (365)
T ss_dssp             EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred             eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence            9999999999999999999999973     457999999999999999999999999999999999999998        


Q ss_pred             ---CCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHH
Q 019216          150 ---KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY  226 (344)
Q Consensus       150 ---~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~  226 (344)
                         ++.+||+|||+++..............+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.........
T Consensus       216 ~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~pf~~~~~~~~~  294 (365)
T 3e7e_A          216 DDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPW-NYQIDYFGVAATVYCMLFGTYMKVKNEGGECK  294 (365)
T ss_dssp             ---CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCB-STHHHHHHHHHHHHHHHHSSCCCEEEETTEEE
T ss_pred             ccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCC-CccccHHHHHHHHHHHHhCCCccccCCCCcee
Confidence               89999999999975433333444556789999999999988776 68999999999999999999999654321000


Q ss_pred             HHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          227 QKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       227 ~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                         ...... ....++.+.+++..||+.+|.+|++..+.+.
T Consensus       295 ---~~~~~~-~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~  331 (365)
T 3e7e_A          295 ---PEGLFR-RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR  331 (365)
T ss_dssp             ---ECSCCT-TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred             ---echhcc-ccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence               001111 1134778999999999999999976544444

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.1e-46  Score=354.61  Aligned_cols=252  Identities=31%  Similarity=0.409  Sum_probs=194.8

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~   90 (344)
                      .-+.|.+.+.||+|+||+||.+. ..+|+.||||.+....      .+.+.+|+.+++++ +||||+++++++......|
T Consensus        13 l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~   85 (434)
T 2rio_A           13 LKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLY   85 (434)
T ss_dssp             CSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEE
T ss_pred             hhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEE
Confidence            33456677899999999998764 4679999999986432      35678899999876 8999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCC-------HHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC-------------
Q 019216           91 MVLEYVTGGELFDKIASKGRLQ-------EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-------------  150 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~-------~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~-------------  150 (344)
                      +|||||. ++|.+++.......       +..++.++.||+.||+|||++||+||||||+|||++.+             
T Consensus        86 lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~  164 (434)
T 2rio_A           86 IALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAEN  164 (434)
T ss_dssp             EEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCS
T ss_pred             EEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCc
Confidence            9999995 59999998654332       23457899999999999999999999999999999754             


Q ss_pred             CCeEEeccccccCCCcccCC--CccccccCCCcccchhhhcc------CCCCCccchhhhhhHHHHHHHh-CCCCCCCcc
Q 019216          151 GNIKISDFGLSALPQHFRDD--GLLHTTCGSPNYVAPEVLAN------RGYDGATSDIWSCGVILYVILT-GYLPFDDRN  221 (344)
Q Consensus       151 ~~vkl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~------~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~  221 (344)
                      +.+||+|||++.........  ......+||+.|+|||++.+      ....+.++|||||||++|+|++ |+.||.+..
T Consensus       165 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~  244 (434)
T 2rio_A          165 LRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY  244 (434)
T ss_dssp             CEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred             eEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence            47999999999854332111  12234689999999999875      2334789999999999999999 999997654


Q ss_pred             HHHHHHHHhhCCCCCCC-------CCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          222 LAVLYQKIFRGDFKLPK-------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       222 ~~~~~~~i~~~~~~~~~-------~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      ...  ..+..+....+.       .+++++.+||.+||+.||++|||+.++++||||..
T Consensus       245 ~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          245 SRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             THH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             hhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            333  234444333322       24578999999999999999999999999999964

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.6e-47  Score=345.62  Aligned_cols=255  Identities=23%  Similarity=0.338  Sum_probs=205.0

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||+|++.......  ....+.+|+.+++.++||||+++++++......+
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~  103 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERL  103 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCE
T ss_pred             HHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCceE
Confidence            4567999999999999999999985 468999999987543221  1236889999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           91 MVLEYVTGGELFDKIASKG----RLQEAEGRKLFQQLIDGVSYCHNK---GVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~----~~~~~~~~~i~~ql~~~L~~LH~~---~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      +||||+++++|.+++....    .+++..++.++.|++.||.|||+.   ||+||||||+|||++.++.+||+|||++..
T Consensus       104 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~  183 (326)
T 3uim_A          104 LVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKL  183 (326)
T ss_dssp             EEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEE
T ss_pred             EEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccc
Confidence            9999999999999997543    489999999999999999999999   999999999999999999999999999975


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH----HHHHHHHhhCCC-----
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL----AVLYQKIFRGDF-----  234 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~----~~~~~~i~~~~~-----  234 (344)
                      .... .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.....    ............     
T Consensus       184 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (326)
T 3uim_A          184 MDYK-DTHVTTAVRGTIGHIAPEYLSTGKS-SEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL  261 (326)
T ss_dssp             CCSS-SSCEECCCCSCGGGCCHHHHHHSEE-CHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS
T ss_pred             cCcc-cccccccccCCcCccCHHHhccCCC-CccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh
Confidence            4321 2223344569999999999987766 6899999999999999999999963110    000111111100     


Q ss_pred             ----------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcc
Q 019216          235 ----------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEW  270 (344)
Q Consensus       235 ----------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~  270 (344)
                                ..+...++.+.+++.+||+.||++|||+.++++|-.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          262 EALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             TTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             hhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence                      111113467999999999999999999999998754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=5.4e-47  Score=342.24  Aligned_cols=249  Identities=27%  Similarity=0.367  Sum_probs=203.4

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccc-cchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      |...+.||+|+||.||+|.+  +++.||+|++..... ......+.+.+|+.+++.++||||+++++++......++|||
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e  110 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV  110 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence            34458999999999999985  688999999865432 234456789999999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           95 YVTGGELFDKIAS---KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        95 ~~~g~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |+++++|.+++..   ..++++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..........
T Consensus       111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  190 (307)
T 2nru_A          111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV  190 (307)
T ss_dssp             CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred             ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence            9999999999873   3469999999999999999999999999999999999999999999999999987544332222


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH----HHHHHHhhCCC-----------CC
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA----VLYQKIFRGDF-----------KL  236 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~----~~~~~i~~~~~-----------~~  236 (344)
                      ......||+.|+|||++.+. + +.++||||||+++|+|++|..||......    .....+.....           ..
T Consensus       191 ~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (307)
T 2nru_A          191 MTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA  268 (307)
T ss_dssp             ECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred             cccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence            33446799999999998653 3 68999999999999999999999764422    22222222111           12


Q ss_pred             CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       237 ~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +...+..+.+++.+||+.||.+|||+.+++++
T Consensus       269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            22345778999999999999999999999874

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=343.84  Aligned_cols=260  Identities=22%  Similarity=0.344  Sum_probs=193.6

Q ss_pred             hhccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHH--HHhCCCCCccceeeEE
Q 019216            6 KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT--LKLLKHPNVVRLHEVL   83 (344)
Q Consensus         6 ~~~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~--l~~l~h~niv~l~~~~   83 (344)
                      ....++.+++|++++.||+|+||.||+|.+  +++.||+|++....      ...+..|..+  +..++||||+++++.+
T Consensus         5 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~   76 (336)
T 3g2f_A            5 ASEPSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGD   76 (336)
T ss_dssp             ----CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             ccCCCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecc
Confidence            345678999999999999999999999986  68899999986442      2333344444  4558999999999755


Q ss_pred             e-----eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeecCCCCcEEEcc
Q 019216           84 A-----SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---------GVFHRDLKLENILLDS  149 (344)
Q Consensus        84 ~-----~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---------~i~H~dikp~NILl~~  149 (344)
                      .     ....+++||||+++++|.+++... ..++..+..++.||+.||.|||+.         ||+||||||+|||++.
T Consensus        77 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~  155 (336)
T 3g2f_A           77 ERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKN  155 (336)
T ss_dssp             EEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECT
T ss_pred             cccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcC
Confidence            3     233678999999999999999764 458999999999999999999999         9999999999999999


Q ss_pred             CCCeEEeccccccCCCccc------CCCccccccCCCcccchhhhccC------CCCCccchhhhhhHHHHHHHhCCCCC
Q 019216          150 KGNIKISDFGLSALPQHFR------DDGLLHTTCGSPNYVAPEVLANR------GYDGATSDIWSCGVILYVILTGYLPF  217 (344)
Q Consensus       150 ~~~vkl~Dfg~a~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~~DvwslG~ll~ell~g~~pf  217 (344)
                      ++.+||+|||++.......      ........+||+.|+|||++.+.      ...+.++|||||||++|+|++|..||
T Consensus       156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~  235 (336)
T 3g2f_A          156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL  235 (336)
T ss_dssp             TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred             CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence            9999999999997543211      11222345799999999998762      12246899999999999999996665


Q ss_pred             C-Ccc-----------------HHHHHHHHhhC--CCCCCCC------CCHHHHHHHHHhcCCCcCCCCCHhhhhc----
Q 019216          218 D-DRN-----------------LAVLYQKIFRG--DFKLPKW------LSPGAQNLLRKILEPNPVKRITIAGIKA----  267 (344)
Q Consensus       218 ~-~~~-----------------~~~~~~~i~~~--~~~~~~~------~~~~~~~li~~~L~~dP~~Rps~~eil~----  267 (344)
                      . +..                 ...........  ...+|..      +++.+.+||.+||+.||++|||+.|+++    
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            2 211                 11111111111  2333333      3347999999999999999999999954    


Q ss_pred             --Ccccccc
Q 019216          268 --DEWFEQD  274 (344)
Q Consensus       268 --~~~~~~~  274 (344)
                        ++|-++.
T Consensus       316 ll~~~~~~~  324 (336)
T 3g2f_A          316 LMMIWERNK  324 (336)
T ss_dssp             HHHCCCC--
T ss_pred             HHHHHHhcc
Confidence              5555543

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7e-46  Score=339.00  Aligned_cols=249  Identities=23%  Similarity=0.369  Sum_probs=196.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhC--CCCCccceeeEEeeC--
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL--KHPNVVRLHEVLASK--   86 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l--~h~niv~l~~~~~~~--   86 (344)
                      ...++|++++.||+|+||.||+|.+.  ++.||+|++....      .....+|.+++..+  +||||+++++++...  
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~  105 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKGTG  105 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCG
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCC
Confidence            44579999999999999999999974  8899999985432      23445566666554  899999999999877  


Q ss_pred             --CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeecCCCCcEEEccCCCeEEe
Q 019216           87 --SKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK--------GVFHRDLKLENILLDSKGNIKIS  156 (344)
Q Consensus        87 --~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~--------~i~H~dikp~NILl~~~~~vkl~  156 (344)
                        ...++||||+++++|.+++.. ..+++..++.++.|++.||.|||+.        ||+||||||+|||++.++.+||+
T Consensus       106 ~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~  184 (337)
T 3mdy_A          106 SWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA  184 (337)
T ss_dssp             GGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred             CCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence              789999999999999999965 4699999999999999999999998        99999999999999999999999


Q ss_pred             ccccccCCCcccCCC--ccccccCCCcccchhhhccCCCCCc-----cchhhhhhHHHHHHHhC----------CCCCCC
Q 019216          157 DFGLSALPQHFRDDG--LLHTTCGSPNYVAPEVLANRGYDGA-----TSDIWSCGVILYVILTG----------YLPFDD  219 (344)
Q Consensus       157 Dfg~a~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~-----~~DvwslG~ll~ell~g----------~~pf~~  219 (344)
                      |||++..........  ......||+.|+|||++.+......     ++|||||||++|+|++|          ..||..
T Consensus       185 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~  264 (337)
T 3mdy_A          185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHD  264 (337)
T ss_dssp             CCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhh
Confidence            999997443221111  1234579999999999987655322     38999999999999999          777754


Q ss_pred             c-----cHHHHHHHHhhC--CCCCCC-----CCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          220 R-----NLAVLYQKIFRG--DFKLPK-----WLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       220 ~-----~~~~~~~~i~~~--~~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .     ........+...  ...+|.     .+++.+.+||.+||+.||++|||+.+++++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          265 LVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            2     122222222222  222332     355679999999999999999999999886

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.1e-47  Score=375.44  Aligned_cols=260  Identities=29%  Similarity=0.407  Sum_probs=206.7

Q ss_pred             ccCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee--
Q 019216            8 QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--   85 (344)
Q Consensus         8 ~~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--   85 (344)
                      ..+..+++|++.+.||+|+||.||+|.+..+|+.||+|++....  .....+.+.+|+.++++++||||+++++++..  
T Consensus         8 ~pg~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~   85 (676)
T 3qa8_A            8 LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQ   85 (676)
T ss_dssp             ---------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTC
T ss_pred             CCCCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccc
Confidence            45677899999999999999999999999999999999986532  34456788999999999999999999998755  


Q ss_pred             ----CCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC---eEE
Q 019216           86 ----KSKIYMVLEYVTGGELFDKIASKG---RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN---IKI  155 (344)
Q Consensus        86 ----~~~~~iv~e~~~g~~L~~~l~~~~---~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~---vkl  155 (344)
                          ....++||||++|++|.+++....   .+++..++.++.|++.||+|||+.||+||||||+|||++.++.   +||
T Consensus        86 ~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL  165 (676)
T 3qa8_A           86 KLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKI  165 (676)
T ss_dssp             CCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEE
T ss_pred             cccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEE
Confidence                667899999999999999998644   5899999999999999999999999999999999999998775   899


Q ss_pred             eccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHH-------
Q 019216          156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQK-------  228 (344)
Q Consensus       156 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~-------  228 (344)
                      +|||++.....   ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.........       
T Consensus       166 ~DFG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~-s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~  241 (676)
T 3qa8_A          166 IDLGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKY-TVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN  241 (676)
T ss_dssp             CSCCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCC-STTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC----
T ss_pred             ccccccccccc---ccccccccCCcccCChHHhccCCC-CchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccc
Confidence            99999985432   223345689999999999887766 6899999999999999999999976533221100       


Q ss_pred             --H-----hhCCC------C----CCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          229 --I-----FRGDF------K----LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       229 --i-----~~~~~------~----~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                        +     ..+..      +    ++..+++.+.+||.+||+.||++|||+.++++||||+.
T Consensus       242 ~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             --CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence              0     01111      1    11225688999999999999999999999999999974

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.7e-45  Score=364.28  Aligned_cols=253  Identities=26%  Similarity=0.432  Sum_probs=214.1

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCC---CceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~---~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      +..++|++.+.||+|+||.||+|.+..+   +..||+|.+...  ......+.+.+|+.++++++||||+++++++. ++
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~  463 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN  463 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence            4567899999999999999999998653   457999987543  23445678999999999999999999999985 45


Q ss_pred             eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           88 KIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ..++||||+++++|.+++...+ .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~  543 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  543 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred             ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence            6899999999999999998644 689999999999999999999999999999999999999999999999999985432


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA  244 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~  244 (344)
                      .. ........+|+.|+|||++.+..+ +.++|||||||++|+|++ |..||.+.........+..+ ..+.|..+++.+
T Consensus       544 ~~-~~~~~~~~~t~~y~aPE~~~~~~~-~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l  621 (656)
T 2j0j_A          544 ST-YYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL  621 (656)
T ss_dssp             -----------CCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred             Cc-ceeccCCCCCcceeCHHHhcCCCC-CchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence            11 111223456789999999987766 689999999999999997 99999998887777777665 456788899999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          245 QNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+||.+||+.||++|||+.++++.
T Consensus       622 ~~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          622 YSLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHHH
Confidence            999999999999999999999764

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=341.19  Aligned_cols=255  Identities=22%  Similarity=0.354  Sum_probs=210.6

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..+..++|++.+.||+|+||.||+|.+..   .+|+|++..... .....+.+.+|+.++++++||||+++++++.....
T Consensus        28 ~~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~  103 (319)
T 2y4i_B           28 WDIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPH  103 (319)
T ss_dssp             SSSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSC
T ss_pred             ccCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCc
Confidence            45778999999999999999999999854   499999865432 22233557789999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .++||||++|++|.+++...+ .+++..++.++.||+.||.|||++|++||||||+|||++ ++.+||+|||++......
T Consensus       104 ~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          104 LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             EEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             eEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            999999999999999997654 699999999999999999999999999999999999997 789999999998754321


Q ss_pred             c---CCCccccccCCCcccchhhhccC--------CCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCC
Q 019216          168 R---DDGLLHTTCGSPNYVAPEVLANR--------GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL  236 (344)
Q Consensus       168 ~---~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~  236 (344)
                      .   .........||+.|+|||++...        ...+.++||||||+++|+|++|+.||...........+..+..+.
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~  262 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPN  262 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCC
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCC
Confidence            1   12223345689999999998752        234688999999999999999999999988877777776654332


Q ss_pred             --CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          237 --PKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       237 --~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                        +..+++.+.+++.+||+.||++|||+.++++.
T Consensus       263 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          263 LSQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence              23588999999999999999999999999873

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.9e-45  Score=349.98  Aligned_cols=250  Identities=20%  Similarity=0.266  Sum_probs=205.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCccceeeEEeeCCeE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLASKSKI   89 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~   89 (344)
                      ...++|+++++||+|+||.||+|.+..+++.||||++......     ..+.+|+.+++.+.| +++..+..++......
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~   78 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYN   78 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEE
Confidence            3457999999999999999999999999999999988654322     347789999999986 5555666666788899


Q ss_pred             EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE---ccCCCeEEeccccccCCC
Q 019216           90 YMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL---DSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl---~~~~~vkl~Dfg~a~~~~  165 (344)
                      ++||||+ +++|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||+++...
T Consensus        79 ~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           79 VLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999999 9999999985 5679999999999999999999999999999999999999   688999999999998543


Q ss_pred             cccCC-----CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHHhhCC----
Q 019216          166 HFRDD-----GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGD----  233 (344)
Q Consensus       166 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~---~~~~~~~i~~~~----  233 (344)
                      .....     .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+..   ....+.++....    
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~-s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQ-SRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATS  236 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSC
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCC-ChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcccccc
Confidence            32211     11235689999999999988776 689999999999999999999998733   233333332221    


Q ss_pred             -CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          234 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       234 -~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                       ..++..+++++.+||.+||+.||++||++.++++
T Consensus       237 ~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          237 IEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence             1233668999999999999999999999988765

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.5e-46  Score=353.31  Aligned_cols=250  Identities=21%  Similarity=0.198  Sum_probs=196.0

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCccc---------ee--
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVR---------LH--   80 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~---------l~--   80 (344)
                      ...|.+.+.||+|+||.||+|.+..+|+.||||++...........+.+.+|+.+++.+.| +|...         ..  
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~  156 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  156 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence            3458899999999999999999999999999999875444444456788999999999987 32111         11  


Q ss_pred             ----------eEEee-----CCeEEEEEeccCCCChHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCceee
Q 019216           81 ----------EVLAS-----KSKIYMVLEYVTGGELFDKIAS-------KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHR  138 (344)
Q Consensus        81 ----------~~~~~-----~~~~~iv~e~~~g~~L~~~l~~-------~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~  138 (344)
                                .++..     ...++++|+++ +++|.++++.       ...+++..+..++.||+.||+|||++||+||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHr  235 (413)
T 3dzo_A          157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  235 (413)
T ss_dssp             EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence                      11111     22467788877 6799988852       2347788899999999999999999999999


Q ss_pred             cCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhc----------cCCCCCccchhhhhhHHHH
Q 019216          139 DLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA----------NRGYDGATSDIWSCGVILY  208 (344)
Q Consensus       139 dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----------~~~~~~~~~DvwslG~ll~  208 (344)
                      ||||+|||++.++.+||+|||+++....     .....+| +.|+|||++.          ...+ +.++|||||||++|
T Consensus       236 DiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~  308 (413)
T 3dzo_A          236 YLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIY  308 (413)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHH
T ss_pred             CcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHH
Confidence            9999999999999999999999875332     2445677 9999999983          3333 67999999999999


Q ss_pred             HHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          209 VILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       209 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +|++|+.||.+.+.......+..    ....+++.+.+||.+||+.||++|||+.++++||||++.
T Consensus       309 elltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          309 WIWCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HHHHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HHHHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            99999999988665443333322    224578999999999999999999999999999999753

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=6.9e-45  Score=333.22  Aligned_cols=247  Identities=25%  Similarity=0.348  Sum_probs=201.0

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh--CCCCCccceeeEEeeCC---
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL--LKHPNVVRLHEVLASKS---   87 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~--l~h~niv~l~~~~~~~~---   87 (344)
                      .++|++.+.||+|+||.||+|.+  +|+.||+|++...      ....+.+|.++++.  ++||||+++++++....   
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~  112 (342)
T 1b6c_B           41 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTW  112 (342)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred             cccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence            37899999999999999999997  5899999998543      23567788888887  68999999999998765   


Q ss_pred             -eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeecCCCCcEEEccCCCeEEecc
Q 019216           88 -KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH--------NKGVFHRDLKLENILLDSKGNIKISDF  158 (344)
Q Consensus        88 -~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH--------~~~i~H~dikp~NILl~~~~~vkl~Df  158 (344)
                       ..++||||+++++|.+++.+ ..+++..++.++.|++.||.|||        +.||+||||||+|||++.++++||+||
T Consensus       113 ~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          113 TQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             CCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCC
T ss_pred             ceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEEC
Confidence             79999999999999999976 56899999999999999999999        889999999999999999999999999


Q ss_pred             ccccCCCcccCC--CccccccCCCcccchhhhccCCCC-----CccchhhhhhHHHHHHHhC----------CCCCCCc-
Q 019216          159 GLSALPQHFRDD--GLLHTTCGSPNYVAPEVLANRGYD-----GATSDIWSCGVILYVILTG----------YLPFDDR-  220 (344)
Q Consensus       159 g~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~-----~~~~DvwslG~ll~ell~g----------~~pf~~~-  220 (344)
                      |++.........  .......||+.|+|||++.+....     +.++|||||||++|+|++|          ..||... 
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            998743221110  012345799999999998765322     2579999999999999999          7888653 


Q ss_pred             ----cHHHHHHHHhhCC--CCCCC-----CCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          221 ----NLAVLYQKIFRGD--FKLPK-----WLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       221 ----~~~~~~~~i~~~~--~~~~~-----~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                          ........+....  ..++.     ..++.+.+|+.+||+.||++|||+.+++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                2334444443332  22332     234578999999999999999999999876

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.1e-47  Score=346.05  Aligned_cols=245  Identities=22%  Similarity=0.309  Sum_probs=195.0

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc-----chhHHHHHHHHHHHHHhCC---------CCCc
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-----HLKITDQIKREIATLKLLK---------HPNV   76 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------h~ni   76 (344)
                      +..++|++++.||+|+||.||+|++  +|+.||||++......     .....+.+.+|+.+++.++         ||||
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni   94 (336)
T 2vuw_A           17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF   94 (336)
T ss_dssp             SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred             cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence            4568999999999999999999998  6899999999765321     2234577889999998886         6666


Q ss_pred             cceeeE-----------------Eee-------------CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHH
Q 019216           77 VRLHEV-----------------LAS-------------KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG  126 (344)
Q Consensus        77 v~l~~~-----------------~~~-------------~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~  126 (344)
                      +++.++                 +..             ...+|+|||||++|++.+.+.+ +.+++..++.++.||+.|
T Consensus        95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~a  173 (336)
T 2vuw_A           95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTAS  173 (336)
T ss_dssp             CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHH
T ss_pred             hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHH
Confidence            666554                 332             6789999999999977776644 678999999999999999


Q ss_pred             HHHHH-hCCceeecCCCCcEEEccCC--------------------CeEEeccccccCCCcccCCCccccccCCCcccch
Q 019216          127 VSYCH-NKGVFHRDLKLENILLDSKG--------------------NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP  185 (344)
Q Consensus       127 L~~LH-~~~i~H~dikp~NILl~~~~--------------------~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aP  185 (344)
                      |+||| ++||+||||||+|||++.++                    .+||+|||+|+....       ...+||+.|+||
T Consensus       174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aP  246 (336)
T 2vuw_A          174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCS
T ss_pred             HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccCh
Confidence            99999 99999999999999999987                    899999999984321       245899999999


Q ss_pred             hhhccCCCCCccchhhhhhHH-HHHHHhCCCCCCCccH-HHHHHHHhhC-CCC--C----CCCCCHHHHHHHHHhcCCCc
Q 019216          186 EVLANRGYDGATSDIWSCGVI-LYVILTGYLPFDDRNL-AVLYQKIFRG-DFK--L----PKWLSPGAQNLLRKILEPNP  256 (344)
Q Consensus       186 E~~~~~~~~~~~~DvwslG~l-l~ell~g~~pf~~~~~-~~~~~~i~~~-~~~--~----~~~~~~~~~~li~~~L~~dP  256 (344)
                      |++.+..  +.++||||||++ .+++++|..||.+... ......+... ...  .    +..+++++.+||++||+.| 
T Consensus       247 E~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-  323 (336)
T 2vuw_A          247 DLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-  323 (336)
T ss_dssp             GGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-
T ss_pred             hhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-
Confidence            9998655  589999998777 7789999999965322 2222333321 111  1    1236889999999999977 


Q ss_pred             CCCCCHhhhh-cCcccc
Q 019216          257 VKRITIAGIK-ADEWFE  272 (344)
Q Consensus       257 ~~Rps~~eil-~~~~~~  272 (344)
                          |++|+| +||||+
T Consensus       324 ----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          324 ----SATDLLCQHSLFK  336 (336)
T ss_dssp             ----SHHHHHHHCGGGC
T ss_pred             ----CHHHHHhcCCCcC
Confidence                999999 999995

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=9e-45  Score=324.87  Aligned_cols=224  Identities=15%  Similarity=0.170  Sum_probs=190.1

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .-++|++.+.||+|+||.||+|.+..+|+.||+|++...........+.+.+|+.++++++||||+++++++...+..|+
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~l  108 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLV  108 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEE
Confidence            33789999999999999999999999999999999987665556667889999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      ||||++|++|.+++.+ + .....+..++.|++.||.|||++||+||||||+|||++.+|.+||+++|.           
T Consensus       109 v~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~-----------  175 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT-----------  175 (286)
T ss_dssp             EEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC-----------
T ss_pred             EEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc-----------
Confidence            9999999999999854 3 46667899999999999999999999999999999999999999985542           


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHH---HHhhCCCC----CCCCCCHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQ---KIFRGDFK----LPKWLSPGA  244 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~---~i~~~~~~----~~~~~~~~~  244 (344)
                                 ++|        .+.++|||||||++|+|++|+.||.+.+......   +...+...    .+..+++.+
T Consensus       176 -----------~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (286)
T 3uqc_A          176 -----------MPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQI  236 (286)
T ss_dssp             -----------CTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHH
T ss_pred             -----------cCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHH
Confidence                       222        3689999999999999999999998754322110   11111111    235689999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          245 QNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .++|.+||+.||++| |+.++++.
T Consensus       237 ~~li~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          237 SAVAARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHHHHcccCCccC-CHHHHHHH
Confidence            999999999999999 99999874

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-44  Score=361.14  Aligned_cols=242  Identities=24%  Similarity=0.376  Sum_probs=199.9

Q ss_pred             cccCeEEeeeecccCceEEEEEEECC-CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe--
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLD-SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK--   88 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~--   88 (344)
                      ..++|++.+.||+|+||.||+|.+.. +|+.||||++....  .......+.+|+.++++++||||+++++++...+.  
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~  155 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG  155 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence            34899999999999999999999976 78999999986432  34456678899999999999999999999986554  


Q ss_pred             ---EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           89 ---IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        89 ---~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                         .|+||||++|++|.+.+..  .+++..++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||+++...
T Consensus       156 ~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~  232 (681)
T 2pzi_A          156 DPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN  232 (681)
T ss_dssp             CEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETT
T ss_pred             CceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcc
Confidence               7999999999999887654  79999999999999999999999999999999999999875 89999999997432


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHH
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ  245 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  245 (344)
                      .      .....||+.|+|||++.+..  +.++|||||||++|+|++|..||.+.......      ........++.+.
T Consensus       233 ~------~~~~~gt~~y~aPE~~~~~~--~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------~~~~~~~~~~~l~  298 (681)
T 2pzi_A          233 S------FGYLYGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------EDDPVLKTYDSYG  298 (681)
T ss_dssp             C------CSCCCCCTTTSCTTHHHHCS--CHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------TTCHHHHHCHHHH
T ss_pred             c------CCccCCCccccCHHHHcCCC--CCceehhhhHHHHHHHHhCCCCCccccccccc------ccccccccCHHHH
Confidence            2      24567999999999987643  68999999999999999999998763211000      0000011467899


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhcCcccc
Q 019216          246 NLLRKILEPNPVKRITIAGIKADEWFE  272 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~~~~~~  272 (344)
                      ++|.+||+.||++||+..+.+.|+|+.
T Consensus       299 ~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          299 RLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             HHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHhhhccCChhhCCCHHHHHHHHHHH
Confidence            999999999999999999999998875

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=6.7e-37  Score=297.75  Aligned_cols=190  Identities=15%  Similarity=0.136  Sum_probs=139.4

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeeccccc-------chhHHHHHHHHHHHHHhC-CCCCccceeeEEeeCCeEEE
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII-------HLKITDQIKREIATLKLL-KHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~-------~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~~~~~~i   91 (344)
                      ..++.|+.|.+..++....|+.||+|++.+....       .....+.+.+|+++|+++ .|+||++++++++++...||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            4567788888888887788999999999765321       123456799999999999 69999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      ||||++|++|.+++.+.+++++.   .|+.||+.||+|+|++||+||||||+|||++.+|++||+|||+|+....  ...
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--~~~  394 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--DCS  394 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----C
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC--CCc
Confidence            99999999999999998888765   4789999999999999999999999999999999999999999985433  233


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCC
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLP  216 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~p  216 (344)
                      ...+.+||+.|+|||++.+..  ..++|+||+|++++++.++..+
T Consensus       395 ~~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          395 WPTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             CSHHHHHHHHHHHHHHC-------------------CCCCTTHHH
T ss_pred             cccCceechhhccHHHhCCCC--CCcccccccccchhhhccccch
Confidence            455678999999999987643  4679999999999888766443

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.96  E-value=1.2e-30  Score=252.46  Aligned_cols=187  Identities=18%  Similarity=0.212  Sum_probs=143.5

Q ss_pred             EeeeecccCceEEEEEEECCCCceEEEEEeecccccch-----hHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL-----KITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        18 ~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      ..+.||+|+||.||+|.  ..+..+++|..........     ...+++.+|++++++++||||+++..++......|+|
T Consensus       340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV  417 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM  417 (540)
T ss_dssp             --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred             CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence            35689999999999994  5678899998654332211     2245689999999999999999555555566777999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC-
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG-  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~-  171 (344)
                      |||++|++|.+++..        +..++.|++.||.|||++||+||||||+|||++.  ++||+|||+++......... 
T Consensus       418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~  487 (540)
T 3en9_A          418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV  487 (540)
T ss_dssp             EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred             EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence            999999999998865        6789999999999999999999999999999998  99999999998654321111 


Q ss_pred             ----ccccccCCCcccchhhhcc--CCCCCccchhhhhhHHHHHHHhCCCCC
Q 019216          172 ----LLHTTCGSPNYVAPEVLAN--RGYDGATSDIWSCGVILYVILTGYLPF  217 (344)
Q Consensus       172 ----~~~~~~gt~~y~aPE~~~~--~~~~~~~~DvwslG~ll~ell~g~~pf  217 (344)
                          .....+||+.|+|||++..  ..| +..+|+|+..+-..+-+.++.+|
T Consensus       488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y-~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          488 DLIVFKKAVLSTHHEKFDEIWERFLEGY-KSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHCGGGHHHHHHHHHHHH-HHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             chhhhhhhhcCCCCcCCHHHHHHHHHHH-HHHHhHHHHHHHHHHHHHhcccc
Confidence                1235689999999999876  444 46789999988888887776665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.95  E-value=7.3e-28  Score=214.43  Aligned_cols=143  Identities=20%  Similarity=0.241  Sum_probs=116.1

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccch---------------hHHHHHHHHHHHHHhCCCCCccceeeEEe
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---------------KITDQIKREIATLKLLKHPNVVRLHEVLA   84 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~h~niv~l~~~~~   84 (344)
                      +.||+|+||.||+|.+ .+|+.||+|+++.......               .....+.+|+.++++++  | +++++++.
T Consensus        96 ~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~  171 (282)
T 1zar_A           96 KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYA  171 (282)
T ss_dssp             EEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEE
T ss_pred             CEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEe
Confidence            9999999999999999 8899999999864322111               23567889999999999  5 66666554


Q ss_pred             eCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCC
Q 019216           85 SKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALP  164 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~  164 (344)
                      . +..|+||||++|++|.+ +.      ......++.|++.||.|||+.||+||||||+|||++ ++.+||+|||+++. 
T Consensus       172 ~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~-  241 (282)
T 1zar_A          172 W-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE-  241 (282)
T ss_dssp             E-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE-
T ss_pred             c-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE-
Confidence            4 45699999999999987 32      234567999999999999999999999999999999 99999999999872 


Q ss_pred             CcccCCCccccccCCCcccchhhhcc
Q 019216          165 QHFRDDGLLHTTCGSPNYVAPEVLAN  190 (344)
Q Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~  190 (344)
                                    +..+.|||.+..
T Consensus       242 --------------~~~~~a~e~l~r  253 (282)
T 1zar_A          242 --------------VGEEGWREILER  253 (282)
T ss_dssp             --------------TTSTTHHHHHHH
T ss_pred             --------------CCCCCHHHHHHH
Confidence                          445789998753

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.89  E-value=2.3e-23  Score=183.05  Aligned_cols=139  Identities=21%  Similarity=0.280  Sum_probs=108.7

Q ss_pred             eEEeeeecccCceEEEEEEECCCCce--EEEEEeecccccc---------------------hhHHHHHHHHHHHHHhCC
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIH---------------------LKITDQIKREIATLKLLK   72 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~--vaiK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~   72 (344)
                      |++.+.||+|+||.||+|.+..+|+.  ||||+++......                     ......+.+|+.+++++.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            78899999999999999998778989  9999975432110                     011246789999999998


Q ss_pred             CCCc--cceeeEEeeCCeEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCceeecCCCCc
Q 019216           73 HPNV--VRLHEVLASKSKIYMVLEYVTG-G----ELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKLEN  144 (344)
Q Consensus        73 h~ni--v~l~~~~~~~~~~~iv~e~~~g-~----~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH-~~~i~H~dikp~N  144 (344)
                      |+++  ..+++.    ...++||||+.+ |    +|.+....   .++..+..++.|++.+|.+|| +.||+||||||+|
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N  201 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN  201 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence            8764  334432    246899999932 3    66665432   235578899999999999999 9999999999999


Q ss_pred             EEEccCCCeEEeccccccC
Q 019216          145 ILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus       145 ILl~~~~~vkl~Dfg~a~~  163 (344)
                      ||++.  .++|+|||+|..
T Consensus       202 ILl~~--~~~liDFG~a~~  218 (258)
T 1zth_A          202 IMYID--KVYFIDMGQAVT  218 (258)
T ss_dssp             EEESS--SEEECCCTTCEE
T ss_pred             EEEcC--cEEEEECccccc
Confidence            99988  999999999873

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.83  E-value=2.9e-21  Score=176.99  Aligned_cols=139  Identities=20%  Similarity=0.229  Sum_probs=101.0

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc---------------chh----HHHHHHHHHHHHHhCCCCCc
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---------------HLK----ITDQIKREIATLKLLKHPNV   76 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~---------------~~~----~~~~~~~E~~~l~~l~h~ni   76 (344)
                      |++.+.||+|++|.||+|.+ .+|+.||||+++.....               ...    ..-...+|...|.++.+.++
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            89999999999999999997 56999999998643211               000    01123456777777754443


Q ss_pred             cceeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCC----
Q 019216           77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGN----  152 (344)
Q Consensus        77 v~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~----  152 (344)
                      .-..-+...  ..++||||++|++|..+.      ....+..++.||+.+|.+||++||+||||||.|||++++|.    
T Consensus       176 ~vp~p~~~~--~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~  247 (397)
T 4gyi_A          176 PVPEPIAQS--RHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDP  247 (397)
T ss_dssp             SCCCEEEEE--TTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCT
T ss_pred             CCCeeeecc--CceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccc
Confidence            221111112  236999999998886432      22345678899999999999999999999999999988773    


Q ss_pred             ------eEEeccccccC
Q 019216          153 ------IKISDFGLSAL  163 (344)
Q Consensus       153 ------vkl~Dfg~a~~  163 (344)
                            +.|+||+.+..
T Consensus       248 ~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          248 SSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TSEEEEEEECCCTTCEE
T ss_pred             cccccceEEEEeCCccc
Confidence                  89999998863

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.53  E-value=5.4e-14  Score=123.23  Aligned_cols=141  Identities=15%  Similarity=0.112  Sum_probs=112.5

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~   90 (344)
                      .++.|++...++.|+.+.||++..  .+..+++|+........   ...+.+|+.+++.+. +..+.++++++...+..|
T Consensus        12 ~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~   86 (263)
T 3tm0_A           12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN   86 (263)
T ss_dssp             HHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred             HhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence            467899999999999999999984  36889999986422111   235788999999885 677888999998888999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN--------------------------------------  132 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~--------------------------------------  132 (344)
                      +|||+++|.+|.+.+.     +......++.+++.+|..||+                                      
T Consensus        87 lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (263)
T 3tm0_A           87 LLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED  161 (263)
T ss_dssp             EEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred             EEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence            9999999999876521     223345788999999999998                                      


Q ss_pred             ---------------------CCceeecCCCCcEEEccCCCeEEecccccc
Q 019216          133 ---------------------KGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       133 ---------------------~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                                           ..++|||++|.||++++++.+.|+||+.+.
T Consensus       162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                 448999999999999765556799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.40  E-value=2.6e-12  Score=111.99  Aligned_cols=136  Identities=19%  Similarity=0.193  Sum_probs=100.9

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccceeeEEeeCCeE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEVLASKSKI   89 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~~~~~~~~   89 (344)
                      .+..|.+....+.|..+.||++.. .+|..+++|+.....      ...+.+|+.+++.+.+.+  +.+++.+....+..
T Consensus        18 ~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~   90 (264)
T 1nd4_A           18 RLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRD   90 (264)
T ss_dssp             TTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCE
T ss_pred             hcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCC
Confidence            455677655555667799999964 567889999875431      235678999998886444  45688888777789


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG-----------------------------------  134 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~-----------------------------------  134 (344)
                      ++||||++|.+|.  .   ...+   ...++.+++..|..||+..                                   
T Consensus        91 ~~v~e~i~G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (264)
T 1nd4_A           91 WLLLGEVPGQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH  162 (264)
T ss_dssp             EEEEECCSSEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred             EEEEEecCCcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence            9999999998883  1   1122   2356777788888888643                                   


Q ss_pred             -----------------------ceeecCCCCcEEEccCCCeEEecccccc
Q 019216          135 -----------------------VFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       135 -----------------------i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                                             ++|||++|.||++++++.+.|+|||.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                   9999999999999876666799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.31  E-value=7.1e-12  Score=114.87  Aligned_cols=142  Identities=18%  Similarity=0.354  Sum_probs=106.1

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEee--cccccchhHHHHHHHHHHHHHhCC--CCCccceeeEEeeC---Ce
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILE--KNRIIHLKITDQIKREIATLKLLK--HPNVVRLHEVLASK---SK   88 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~---~~   88 (344)
                      ...++.|+.|.++.||++..  .+..+++|+..  ....  ......+.+|..+++.+.  +..+.+++.++.+.   +.
T Consensus        40 ~~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~  115 (359)
T 3dxp_A           40 PLSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGR  115 (359)
T ss_dssp             CCEEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSS
T ss_pred             CceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCC
Confidence            34578899999999999885  34678899764  2221  112346788999999887  45578888887665   44


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN------------------------------------  132 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~------------------------------------  132 (344)
                      .|+||||++|..+.+.  ....++......++.+++..|+.||+                                    
T Consensus       116 ~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (359)
T 3dxp_A          116 AFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETES  193 (359)
T ss_dssp             CEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSC
T ss_pred             eEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcC
Confidence            7899999999877431  12346788889999999999999997                                    


Q ss_pred             ----------------------CCceeecCCCCcEEEccCCC--eEEeccccccC
Q 019216          133 ----------------------KGVFHRDLKLENILLDSKGN--IKISDFGLSAL  163 (344)
Q Consensus       133 ----------------------~~i~H~dikp~NILl~~~~~--vkl~Dfg~a~~  163 (344)
                                            ..++|||+++.|||++.++.  +.|+||+.+..
T Consensus       194 ~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          194 IPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  35899999999999998763  58999998863

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.23  E-value=4e-12  Score=113.80  Aligned_cols=181  Identities=18%  Similarity=0.191  Sum_probs=120.5

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCC--ccceeeEEeeCC---eEEEE
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPN--VVRLHEVLASKS---KIYMV   92 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~n--iv~l~~~~~~~~---~~~iv   92 (344)
                      ++.++.|..+.||++.     ..+++|+....     .....+.+|..+++.+. +..  +.+++.......   ..|+|
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v   94 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG   94 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence            4569999999999764     46899985422     33567889999998874 333  344444433332   34789


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN----------------------------------------  132 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~----------------------------------------  132 (344)
                      |++++|.++.+...  ..++..+...++.|++..|+.||+                                        
T Consensus        95 m~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           95 FTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             EECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             EcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            99999988865432  346788888888999999988886                                        


Q ss_pred             ------------------CCceeecCCCCcEEEccC--CCeEEeccccccCCCcccCCCccccccCCCcc---cchhhh-
Q 019216          133 ------------------KGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNY---VAPEVL-  188 (344)
Q Consensus       133 ------------------~~i~H~dikp~NILl~~~--~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y---~aPE~~-  188 (344)
                                        ..++|+|++|.||+++++  +.+.|+||+.+..-....+      ......+   ..|+.. 
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D------l~~~~~~~~~~~~~~~~  246 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND------FISLMEDDEEYGMEFVS  246 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH------HHTTCCTTTSCCHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH------HHHHHhhccccCHHHHH
Confidence                              136999999999999984  5678999998763211100      0000011   222221 


Q ss_pred             ---ccCCCCC---------ccchhhhhhHHHHHHHhCCCCC
Q 019216          189 ---ANRGYDG---------ATSDIWSCGVILYVILTGYLPF  217 (344)
Q Consensus       189 ---~~~~~~~---------~~~DvwslG~ll~ell~g~~pf  217 (344)
                         ...+...         .-.+.|++|.++|.+.+|..+|
T Consensus       247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence               1111100         1258999999999999998775

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.88  E-value=3.7e-08  Score=86.20  Aligned_cols=132  Identities=15%  Similarity=0.223  Sum_probs=96.5

Q ss_pred             eecccCce-EEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEEEEeccCC
Q 019216           21 TLGEGNFG-KVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYMVLEYVTG   98 (344)
Q Consensus        21 ~Lg~G~~g-~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~iv~e~~~g   98 (344)
                      .+..|..+ .||+......+..+.+|+-...      ....+.+|...|+.+. +-.+.+++.++.+.+..++|||+++|
T Consensus        31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G  104 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG  104 (272)
T ss_dssp             EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred             EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence            44455554 6999887777888999986432      2456788999998875 33467888888888999999999999


Q ss_pred             CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 019216           99 GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK---------------------------------------------  133 (344)
Q Consensus        99 ~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~---------------------------------------------  133 (344)
                      .++.+.....    ......+..++...|..||..                                             
T Consensus       105 ~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          105 KTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             EEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             ccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            8887654431    222344556666666666631                                             


Q ss_pred             -------------CceeecCCCCcEEEccCCCeEEecccccc
Q 019216          134 -------------GVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       134 -------------~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                                   .++|+|+.+.||++++++.+-|+||+.+.
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                         15899999999999877767799999875

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.83  E-value=8.3e-08  Score=85.75  Aligned_cols=133  Identities=21%  Similarity=0.224  Sum_probs=94.8

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCC---CccceeeEEe-eCCeEEEEEe
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP---NVVRLHEVLA-SKSKIYMVLE   94 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~---niv~l~~~~~-~~~~~~iv~e   94 (344)
                      ++.++.|....||+.     |..+++|+...     ......+.+|..+|+.+.+.   .+.+++.+.. ..+..+++||
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e   93 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR   93 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence            466888999999988     56789998522     23456788999999998742   2456666653 3456789999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 019216           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK-----------------------------------------  133 (344)
Q Consensus        95 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~-----------------------------------------  133 (344)
                      +++|.++.+..-  ..++......++.++...|+.||+.                                         
T Consensus        94 ~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           94 KVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             CCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             ccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            999988865321  2345555566666666666666642                                         


Q ss_pred             -------------------CceeecCCCCcEEEcc---CCCe-EEeccccccC
Q 019216          134 -------------------GVFHRDLKLENILLDS---KGNI-KISDFGLSAL  163 (344)
Q Consensus       134 -------------------~i~H~dikp~NILl~~---~~~v-kl~Dfg~a~~  163 (344)
                                         .++|+|++|.||+++.   ++.+ .|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                               3599999999999987   4665 8999998764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.56  E-value=1.9e-07  Score=86.46  Aligned_cols=80  Identities=18%  Similarity=0.157  Sum_probs=50.0

Q ss_pred             EeeeecccCceEEEEEEECCCCceEEEEEeecccc-cc---hhHHHHHHHHHHHHHhCCC--CC-ccceeeEEeeCCeEE
Q 019216           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRI-IH---LKITDQIKREIATLKLLKH--PN-VVRLHEVLASKSKIY   90 (344)
Q Consensus        18 ~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~-~~---~~~~~~~~~E~~~l~~l~h--~n-iv~l~~~~~~~~~~~   90 (344)
                      ..+.||.|..+.||++....+++.+++|....... ..   .....++..|.++++.+..  +. +.+++.+  +....+
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~  111 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV  111 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence            46789999999999997656678899998643211 00   0123456778888887742  33 3455543  344467


Q ss_pred             EEEeccCCC
Q 019216           91 MVLEYVTGG   99 (344)
Q Consensus        91 iv~e~~~g~   99 (344)
                      +|||+++|.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999774

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.30  E-value=1.1e-05  Score=72.63  Aligned_cols=136  Identities=13%  Similarity=0.105  Sum_probs=76.9

Q ss_pred             EeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCcccee-e--EEeeCCeE
Q 019216           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----HPNVVRLH-E--VLASKSKI   89 (344)
Q Consensus        18 ~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~-~--~~~~~~~~   89 (344)
                      -++.|+.|..+.||++.. .+ ..+++|+....    .   ..+..|..+++.+.     .|.++... +  +....+..
T Consensus        36 ~~~~l~gG~~n~~~~v~~-~~-~~~vlk~~~~~----~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~  106 (346)
T 2q83_A           36 KIDVIQGNQMALVWKVHT-DS-GAVCLKRIHRP----E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL  106 (346)
T ss_dssp             EEEECC----CEEEEEEE-TT-EEEEEEEECSC----H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred             EeeeccccccCcEEEEEe-CC-CCEEEEecCCC----H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence            345677778899999885 33 35899988642    1   23334555554442     34333311 1  12346678


Q ss_pred             EEEEeccCCCChH--------------HHHHh-cCCC-------------CHHH--------------------------
Q 019216           90 YMVLEYVTGGELF--------------DKIAS-KGRL-------------QEAE--------------------------  115 (344)
Q Consensus        90 ~iv~e~~~g~~L~--------------~~l~~-~~~~-------------~~~~--------------------------  115 (344)
                      +++|+|++|.++.              ..+.. ...+             .+..                          
T Consensus       107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  186 (346)
T 2q83_A          107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ  186 (346)
T ss_dssp             EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred             EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence            9999999986431              11111 0101             1110                          


Q ss_pred             -----HHHHHHHHHHHHHHHHh-------------CCceeecCCCCcEEEccCCCeEEecccccc
Q 019216          116 -----GRKLFQQLIDGVSYCHN-------------KGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       116 -----~~~i~~ql~~~L~~LH~-------------~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                           +..+..++..++.+|++             ..++|||+++.|||++.++.+.|+||+.+.
T Consensus       187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence                 11111223345666652             479999999999999888899999999775

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.30  E-value=2.4e-06  Score=77.69  Aligned_cols=86  Identities=9%  Similarity=0.142  Sum_probs=55.1

Q ss_pred             eEEeeee-cccCceEEEEEEEC--C----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-C--CCccceeeEEee
Q 019216           16 YELGRTL-GEGNFGKVKFAQDL--D----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H--PNVVRLHEVLAS   85 (344)
Q Consensus        16 y~~~~~L-g~G~~g~Vy~a~~~--~----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~   85 (344)
                      ....+.| +.|..+.+|+....  .    ++..+++|+..............+.+|..+++.+. +  -.+.+++.+..+
T Consensus        22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~  101 (357)
T 3ats_A           22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT  101 (357)
T ss_dssp             EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred             eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence            3456788 88999999988753  1    26679999864332000000134667888888774 2  346677777655


Q ss_pred             C---CeEEEEEeccCCCCh
Q 019216           86 K---SKIYMVLEYVTGGEL  101 (344)
Q Consensus        86 ~---~~~~iv~e~~~g~~L  101 (344)
                      .   +..++|||+++|.++
T Consensus       102 ~~~~g~~~~v~e~l~G~~l  120 (357)
T 3ats_A          102 GDVLGTPFFLMDYVEGVVP  120 (357)
T ss_dssp             STTTSSCEEEEECCCCBCC
T ss_pred             CCccCCceEEEEecCCCCh
Confidence            4   346899999988654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.15  E-value=3.2e-05  Score=64.36  Aligned_cols=121  Identities=19%  Similarity=0.187  Sum_probs=81.2

Q ss_pred             CChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH-hCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccc
Q 019216           99 GELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCH-NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT  176 (344)
Q Consensus        99 ~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH-~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~  176 (344)
                      .+|.+.++. +.+++++++|.++.|.+.+|.-+- ...-..+=+.|..|++..+|.|.+.+ +.+.              
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------   97 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------   97 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------
Confidence            378898874 568999999999999999988762 22222344567899999999988764 2111              


Q ss_pred             cCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHhcCC
Q 019216          177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEP  254 (344)
Q Consensus       177 ~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~  254 (344)
                      .....+.|||...  ...+.+.=|||||+++|.-+- |-.+                  .-+..+|+.+.+||..|...
T Consensus        98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e------------------~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A           98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE------------------NEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ---------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT------------------TEEECCCHHHHHHHHHHTTC
T ss_pred             ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc------------------ccchhhCHHHHHHHHHHHhc
Confidence            1233467888653  233578899999999998874 2111                  22345899999999999866

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.14  E-value=1.3e-05  Score=74.75  Aligned_cols=80  Identities=13%  Similarity=0.047  Sum_probs=45.0

Q ss_pred             hCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCC--CCccchhhhhhHHHHH
Q 019216          132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY--DGATSDIWSCGVILYV  209 (344)
Q Consensus       132 ~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DvwslG~ll~e  209 (344)
                      ...++|||++|.|||++.++ ++++||+.+..-....+-...-. .-...|.+|+.......  .....++.++...+|+
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLG-NLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHH-HHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHH-HHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            45799999999999998876 99999998763211100000000 00123555554421110  0122445577777777


Q ss_pred             HHhC
Q 019216          210 ILTG  213 (344)
Q Consensus       210 ll~g  213 (344)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7653

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.12  E-value=3.4e-05  Score=68.83  Aligned_cols=77  Identities=21%  Similarity=0.238  Sum_probs=60.1

Q ss_pred             EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC---CCCccceeeEEeeCCeEEEEE
Q 019216           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK---HPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        17 ~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~---h~niv~l~~~~~~~~~~~iv~   93 (344)
                      .-.+.|+.|....+|+...  .+..+++|+....      ....+..|...|+.|.   ...+.+++.+....+..++||
T Consensus        39 ~~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm  110 (312)
T 3jr1_A           39 KHKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL  110 (312)
T ss_dssp             CEEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred             eeeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence            3467899999999999884  4678899987532      2456788988888874   356778888887778899999


Q ss_pred             eccCCCCh
Q 019216           94 EYVTGGEL  101 (344)
Q Consensus        94 e~~~g~~L  101 (344)
                      |+++|..+
T Consensus       111 e~l~G~~~  118 (312)
T 3jr1_A          111 EALNKSKN  118 (312)
T ss_dssp             ECCCCCCC
T ss_pred             EeccCCCC
Confidence            99998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.03  E-value=1.8e-05  Score=70.12  Aligned_cols=74  Identities=16%  Similarity=0.028  Sum_probs=46.2

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceeeEEeeCCeEEEEEe
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~iv~e   94 (344)
                      +.-++.|+.|....+|++      ..+++|+......   . .-...+|..+++.+...++ .+++...  ...-++++|
T Consensus        20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~---~-~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e   87 (301)
T 3dxq_A           20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTE---E-YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTR   87 (301)
T ss_dssp             CCSCEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEE
T ss_pred             ccceeEcCCcccccccee------eeEEEECCCCCcc---c-eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEe
Confidence            444788999999999998      5689998754211   0 1123457777777653233 4555543  333468999


Q ss_pred             cc-CCCCh
Q 019216           95 YV-TGGEL  101 (344)
Q Consensus        95 ~~-~g~~L  101 (344)
                      |+ +|.++
T Consensus        88 ~i~~g~~l   95 (301)
T 3dxq_A           88 YIAGAQTM   95 (301)
T ss_dssp             CCTTCEEC
T ss_pred             ecCCCccC
Confidence            99 66554

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.78  E-value=6.2e-05  Score=67.20  Aligned_cols=142  Identities=14%  Similarity=0.154  Sum_probs=78.7

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccceeeE------Eee
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEV------LAS   85 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~------~~~   85 (344)
                      ++..-++.|+.|....+|++... +| .+++|+.....  .   ...+..|..+++.+...+  +.+++..      ...
T Consensus        22 ~~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~---~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~   94 (322)
T 2ppq_A           22 GSLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL   94 (322)
T ss_dssp             CCEEEEEEECC---EEEEEEEES-SC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred             CcceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--C---HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE
Confidence            45555778888999999999853 33 68899886421  1   123455777766553111  2233211      123


Q ss_pred             CCeEEEEEeccCCCChH----H----------HHHhc-CC--------CCHHHHHH---------------HHHHHHHHH
Q 019216           86 KSKIYMVLEYVTGGELF----D----------KIASK-GR--------LQEAEGRK---------------LFQQLIDGV  127 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~----~----------~l~~~-~~--------~~~~~~~~---------------i~~ql~~~L  127 (344)
                      .+..+++|++++|..+.    .          .+... ..        .....-..               +...+...+
T Consensus        95 ~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~  174 (322)
T 2ppq_A           95 SGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEI  174 (322)
T ss_dssp             TTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHH
T ss_pred             CCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHH
Confidence            45678999999886431    0          11110 00        01110000               001133445


Q ss_pred             HHHHh-------CCceeecCCCCcEEEccCCCeEEecccccc
Q 019216          128 SYCHN-------KGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       128 ~~LH~-------~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      ..+.+       .+++|+|+.+.|||+++++.+.|+||+.+.
T Consensus       175 ~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          175 DYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            55542       369999999999999877656899999765

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.71  E-value=7.7e-05  Score=68.33  Aligned_cols=140  Identities=16%  Similarity=0.146  Sum_probs=84.0

Q ss_pred             cCeEEeeeecccCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEee
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS   85 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~   85 (344)
                      +..+ ++.|..|-...+|++....       +++.+++|+.... .   .....+.+|.++++.+. +.-..++++.+.+
T Consensus        51 ~~l~-v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~  125 (379)
T 3feg_A           51 EELR-VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFPE  125 (379)
T ss_dssp             GGCC-CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT
T ss_pred             CceE-EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC
Confidence            4444 4567778888999988642       3578999985321 1   12345668999998875 3333566666543


Q ss_pred             CCeEEEEEeccCCCChH--------------HHHH---hc-----CCCC--HHHHHHHHHHHHH----------------
Q 019216           86 KSKIYMVLEYVTGGELF--------------DKIA---SK-----GRLQ--EAEGRKLFQQLID----------------  125 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~--------------~~l~---~~-----~~~~--~~~~~~i~~ql~~----------------  125 (344)
                          .+||||++|.+|.              +.+.   ..     ....  ..++.++..++..                
T Consensus       126 ----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~  201 (379)
T 3feg_A          126 ----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYS  201 (379)
T ss_dssp             ----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTT
T ss_pred             ----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHH
Confidence                2899999885542              1111   11     1111  3456666655422                


Q ss_pred             ---HHHHHH----h----CCceeecCCCCcEEEccC----CCeEEecccccc
Q 019216          126 ---GVSYCH----N----KGVFHRDLKLENILLDSK----GNIKISDFGLSA  162 (344)
Q Consensus       126 ---~L~~LH----~----~~i~H~dikp~NILl~~~----~~vkl~Dfg~a~  162 (344)
                         .+..|.    .    ..++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       202 l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          202 LKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             HHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence               233332    2    248999999999999877    689999999876

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.70  E-value=0.00013  Score=67.99  Aligned_cols=74  Identities=9%  Similarity=0.103  Sum_probs=49.6

Q ss_pred             EeeeecccCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceeeEEeeCCeE
Q 019216           18 LGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKI   89 (344)
Q Consensus        18 ~~~~Lg~G~~g~Vy~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~   89 (344)
                      -++.|+.|....||++....       .+..+++|+.....  .   ...+.+|..+++.+...++ .++++.+.  +  
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFS--G--  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence            35678889899999998643       35789999874311  1   1345578888888753333 56666553  2  


Q ss_pred             EEEEeccCCCC
Q 019216           90 YMVLEYVTGGE  100 (344)
Q Consensus        90 ~iv~e~~~g~~  100 (344)
                      .+|+||++|.+
T Consensus       148 g~v~e~l~G~~  158 (429)
T 1nw1_A          148 GRLEEYIPSRP  158 (429)
T ss_dssp             EEEECCCCEEE
T ss_pred             CEEEEEeCCcc
Confidence            28899998744

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.64  E-value=0.0014  Score=57.51  Aligned_cols=80  Identities=15%  Similarity=0.123  Sum_probs=55.1

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-C--CCccceeeEEeeCCeEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H--PNVVRLHEVLASKSKIY   90 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--~niv~l~~~~~~~~~~~   90 (344)
                      .+..-++.+|.|..+.||++.. .+|+.|.+|+......   .....+..|...|+.|. .  -.+.+++.+  ..  -+
T Consensus        15 ~~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~   86 (288)
T 3f7w_A           15 REVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RT   86 (288)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TE
T ss_pred             CCeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ce
Confidence            3566788999999999999985 6789999998643322   12245678999888874 2  124455544  22  36


Q ss_pred             EEEeccCCCCh
Q 019216           91 MVLEYVTGGEL  101 (344)
Q Consensus        91 iv~e~~~g~~L  101 (344)
                      +|||+++++..
T Consensus        87 lv~e~l~~~~~   97 (288)
T 3f7w_A           87 LAMEWVDERPP   97 (288)
T ss_dssp             EEEECCCCCCC
T ss_pred             EEEEeecccCC
Confidence            88999977543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.63  E-value=0.00036  Score=62.34  Aligned_cols=75  Identities=24%  Similarity=0.216  Sum_probs=46.5

Q ss_pred             eeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC--ccceeeE-----EeeCCeEEEE
Q 019216           20 RTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN--VVRLHEV-----LASKSKIYMV   92 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n--iv~l~~~-----~~~~~~~~iv   92 (344)
                      ..|+ |....||++.. .+|+.+++|.......    ....+..|..+++.+...+  +.+++..     ....+..+++
T Consensus        32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l  105 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV  105 (328)
T ss_dssp             EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred             Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence            4566 88889998764 4566799999853321    1245666777777664212  3333332     2235567889


Q ss_pred             EeccCCCC
Q 019216           93 LEYVTGGE  100 (344)
Q Consensus        93 ~e~~~g~~  100 (344)
                      |++++|.+
T Consensus       106 ~~~i~G~~  113 (328)
T 1zyl_A          106 FPSVGGRQ  113 (328)
T ss_dssp             EECCCCEE
T ss_pred             EEecCCCC
Confidence            99998754

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.61  E-value=0.00014  Score=65.35  Aligned_cols=136  Identities=11%  Similarity=0.143  Sum_probs=70.1

Q ss_pred             eeeecccCceE-EEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCccceeeEEeeCCeEEEEEec
Q 019216           19 GRTLGEGNFGK-VKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKIYMVLEY   95 (344)
Q Consensus        19 ~~~Lg~G~~g~-Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~iv~e~   95 (344)
                      ++.|+.|+... +|+... .+|..+++|.......      ..+..|+.+++.+..  -.+.+++.+....+  +++||+
T Consensus        23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~------~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~   93 (333)
T 3csv_A           23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEG------GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED   93 (333)
T ss_dssp             ECC--------CCEEEEC-TTCCEEEEEECCTTTT------CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred             eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCCC------ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence            45676666555 666653 3366788876533210      223456666666642  23455666533333  689999


Q ss_pred             cCCCChHHHHHhc--------------------------CCCCHHHHH-------HHH-------------HHHHHHHHH
Q 019216           96 VTGGELFDKIASK--------------------------GRLQEAEGR-------KLF-------------QQLIDGVSY  129 (344)
Q Consensus        96 ~~g~~L~~~l~~~--------------------------~~~~~~~~~-------~i~-------------~ql~~~L~~  129 (344)
                      +.+..+.+.+...                          ..++.....       .+.             ..+...+..
T Consensus        94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~  173 (333)
T 3csv_A           94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ  173 (333)
T ss_dssp             CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred             CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence            9776665433210                          012221110       000             011122222


Q ss_pred             H------HhCCceeecCCCCcEEEccC----CCeEEeccccccC
Q 019216          130 C------HNKGVFHRDLKLENILLDSK----GNIKISDFGLSAL  163 (344)
Q Consensus       130 L------H~~~i~H~dikp~NILl~~~----~~vkl~Dfg~a~~  163 (344)
                      +      +...++|||+.+.||+++.+    +.+.|+||+.+..
T Consensus       174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3      12369999999999999875    6789999998763

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.52  E-value=0.00016  Score=65.91  Aligned_cols=74  Identities=11%  Similarity=0.017  Sum_probs=44.0

Q ss_pred             eeeecccCceEEEEEEECC--------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCC-ccceeeEEeeCCeE
Q 019216           19 GRTLGEGNFGKVKFAQDLD--------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN-VVRLHEVLASKSKI   89 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~--------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~n-iv~l~~~~~~~~~~   89 (344)
                      ++.|+.|....+|++....        .+..+++|+......    .......|..+++.+...+ +.++++..  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            5678888889999998643        136899998753211    1112356888887775333 34666544  22  


Q ss_pred             EEEEeccCCCC
Q 019216           90 YMVLEYVTGGE  100 (344)
Q Consensus        90 ~iv~e~~~g~~  100 (344)
                      ++||||++|.+
T Consensus       110 ~~v~e~i~G~~  120 (369)
T 3c5i_A          110 GRIEEWLYGDP  120 (369)
T ss_dssp             EEEEECCCSEE
T ss_pred             cEEEEEecCCc
Confidence            67999998754

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.29  E-value=0.0039  Score=56.01  Aligned_cols=29  Identities=24%  Similarity=0.392  Sum_probs=26.6

Q ss_pred             CceeecCCCCcEEEccCCCeEEecccccc
Q 019216          134 GVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       134 ~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      .++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~  235 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPM  235 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCe
Confidence            59999999999999988889999998775

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.19  E-value=0.0043  Score=58.21  Aligned_cols=76  Identities=13%  Similarity=0.168  Sum_probs=48.8

Q ss_pred             EeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-cceeeEEeeCCeEEEEEecc
Q 019216           18 LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-VRLHEVLASKSKIYMVLEYV   96 (344)
Q Consensus        18 ~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-v~l~~~~~~~~~~~iv~e~~   96 (344)
                      -++.|+.|-...+|++.....+..+++|+......   ... ...+|..+++.|...++ .++++.+.  +  ..||||+
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~---~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I  183 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD---EII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM  183 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC---SCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh---hhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence            35678889999999998754457899998743211   111 12578999988875444 56676663  2  2499999


Q ss_pred             CCCCh
Q 019216           97 TGGEL  101 (344)
Q Consensus        97 ~g~~L  101 (344)
                      +|.+|
T Consensus       184 ~G~~l  188 (458)
T 2qg7_A          184 DGYAL  188 (458)
T ss_dssp             CSEEC
T ss_pred             CCccC
Confidence            87543

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.73  E-value=0.0033  Score=58.29  Aligned_cols=76  Identities=13%  Similarity=0.078  Sum_probs=48.1

Q ss_pred             EeeeecccCceEEEEEEECCC-------CceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeE
Q 019216           18 LGRTLGEGNFGKVKFAQDLDS-------GLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKI   89 (344)
Q Consensus        18 ~~~~Lg~G~~g~Vy~a~~~~~-------~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~   89 (344)
                      -++.|..|-...+|++.....       +..+++|+.....   .. .-...+|..+++.+. +.-..++++.+  .+  
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--  145 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--  145 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence            356677788899999986521       5789999864321   11 112356888888775 33334556543  22  


Q ss_pred             EEEEeccCCCCh
Q 019216           90 YMVLEYVTGGEL  101 (344)
Q Consensus        90 ~iv~e~~~g~~L  101 (344)
                      +.||||++|.+|
T Consensus       146 ~~I~efI~G~~l  157 (424)
T 3mes_A          146 GRIEEFIDGEPL  157 (424)
T ss_dssp             EEEEECCCSEEC
T ss_pred             CEEEEEeCCccC
Confidence            678999998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.73  E-value=0.035  Score=50.99  Aligned_cols=29  Identities=34%  Similarity=0.441  Sum_probs=24.7

Q ss_pred             ceeecCCCCcEEEc------cCCCeEEeccccccC
Q 019216          135 VFHRDLKLENILLD------SKGNIKISDFGLSAL  163 (344)
Q Consensus       135 i~H~dikp~NILl~------~~~~vkl~Dfg~a~~  163 (344)
                      ++|+|+.+.|||+.      +++.+.++||.+|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            68999999999993      456799999998863

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.84  E-value=0.038  Score=51.78  Aligned_cols=63  Identities=10%  Similarity=0.154  Sum_probs=17.9

Q ss_pred             EEeeeecccCceEEEEEEECCCCceEEE------EEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEE
Q 019216           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAV------KILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVL   83 (344)
Q Consensus        17 ~~~~~Lg~G~~g~Vy~a~~~~~~~~vai------K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~   83 (344)
                      .+.+.||   ||.||++.......+||+      |..+... ...+....+.+|..+++.++|||+++.+.+.
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~-~~~e~~~~~~rea~l~~~~~H~niv~~h~f~  213 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDG-VSEKRLTSLVRRATLKENEQIPKYEKIHNFK  213 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCcccccccc-ccccccccccccccccccccccccCCCcceE
Confidence            3456676   999999998665568888      6553322 2223345677889999999999999988775

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=87.67  E-value=2.4  Score=34.99  Aligned_cols=115  Identities=11%  Similarity=0.151  Sum_probs=75.8

Q ss_pred             CCCCccceeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC
Q 019216           72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG  151 (344)
Q Consensus        72 ~h~niv~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~  151 (344)
                      .||+++.. .+-..++.+.+.++.-+.+.=+..+   ..++....++++.+|+....++  ..-+|--|+|+||+++.++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~~  116 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRDG  116 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTTS
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCCC
Confidence            58888876 5666677777776665432222223   3478888999999988876433  3346778999999999999


Q ss_pred             CeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCC
Q 019216          152 NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF  217 (344)
Q Consensus       152 ~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf  217 (344)
                      .+++.=-|+...                   ++|.     .. +...=.-.+=|++..+++++..|
T Consensus       117 ~p~i~~RGik~~-------------------l~P~-----~~-~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          117 LPIAKTRGLQNV-------------------VDPL-----PV-SEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             CEEESCCEETTT-------------------BSCC-----CC-CHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             CEEEEEccCccC-------------------CCCC-----CC-CHHHHHHHHHHHHHHHHcCCCCH
Confidence            999987775431                   1111     11 12222334678888888888876

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.30  E-value=3.1  Score=34.40  Aligned_cols=83  Identities=12%  Similarity=0.107  Sum_probs=60.1

Q ss_pred             CCCCccceeeEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCceeecCCCCcEEEccC
Q 019216           72 KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS-YCHNKGVFHRDLKLENILLDSK  150 (344)
Q Consensus        72 ~h~niv~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~-~LH~~~i~H~dikp~NILl~~~  150 (344)
                      .||++  -..+-.+++.+.+.++.-+++.=+..++   .++....++++.+|+.... ++  ..-+|--++|+||+++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            57777  4445567778777777665544445553   3788888888888877554 33  345677899999999999


Q ss_pred             CCeEEeccccc
Q 019216          151 GNIKISDFGLS  161 (344)
Q Consensus       151 ~~vkl~Dfg~a  161 (344)
                      +.+++.-.|+-
T Consensus       121 ~~p~i~hRGi~  131 (219)
T 4ano_A          121 LEPFFLHVGVK  131 (219)
T ss_dssp             CCEEESCCEET
T ss_pred             CcEEEEEcCCc
Confidence            99999877764

>3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A

Probab=85.44  E-value=25  Score=33.72  Aligned_cols=81  Identities=21%  Similarity=0.355  Sum_probs=51.5

Q ss_pred             cceeeEEeeCCeEEEEEeccCCCChHHHHHhcCC-----------------CCHHHHHHHHHHHHH--HHHHHHhCCcee
Q 019216           77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-----------------LQEAEGRKLFQQLID--GVSYCHNKGVFH  137 (344)
Q Consensus        77 v~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~-----------------~~~~~~~~i~~ql~~--~L~~LH~~~i~H  137 (344)
                      +..|.+........+ .|++++.++.+.+...+.                 ..+.....+++.+|-  .+.|+  .||  
T Consensus       402 i~~Y~Vipls~~~Gl-IE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YI--LGi--  476 (614)
T 3ls8_A          402 LTPYKVLATSTKHGF-MQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYI--LGV--  476 (614)
T ss_dssp             CCCCCEEESSSSEEE-EECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHH--HTC--
T ss_pred             eeccEEEEecCCCce-EEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhhee--eec--
Confidence            455666666655555 477776566555432211                 123445566665543  34444  343  


Q ss_pred             ecCCCCcEEEccCCCeEEecccccc
Q 019216          138 RDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       138 ~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      +|=.++|||++.+|++.=+|||.+.
T Consensus       477 gDRH~~NILld~tG~v~HIDFG~~f  501 (614)
T 3ls8_A          477 GDRHLDNLLLTKTGKLFHIDFGYIL  501 (614)
T ss_dssp             CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred             cCCCCcceeEcCCCCEeeeehHHhh
Confidence            5889999999999999999999875

>2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A*

Probab=84.54  E-value=22  Score=34.68  Aligned_cols=81  Identities=26%  Similarity=0.365  Sum_probs=49.8

Q ss_pred             cceeeEEeeCCeEEEEEeccCCCChHHHHHhcCC---------------C--CHHHHHHHHHHHH--HHHHHHHhCCcee
Q 019216           77 VRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR---------------L--QEAEGRKLFQQLI--DGVSYCHNKGVFH  137 (344)
Q Consensus        77 v~l~~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~---------------~--~~~~~~~i~~ql~--~~L~~LH~~~i~H  137 (344)
                      +..|.+........+| |++++.+|.+.+.+.+.               +  .......+++.+|  ..+.|+  .||  
T Consensus       476 i~~Y~Vipls~~~GLI-E~V~s~tl~~i~~~~~~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YI--LGl--  550 (696)
T 2x6h_A          476 LTPYKVLATSSKHGFL-QYVDSCTVAEVLAREGNIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYL--LGV--  550 (696)
T ss_dssp             CCCCCEEESSTTCEEE-ECCCCEEHHHHHHHSSSHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHH--HTC--
T ss_pred             EeccEEEeccCCCCee-eeCCCccHHHHHHhcChHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHH--ccC--
Confidence            3445555555444443 66666666665543221               1  1234455555554  234443  233  


Q ss_pred             ecCCCCcEEEccCCCeEEecccccc
Q 019216          138 RDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       138 ~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      +|-.++||||+.+|++.=+|||.+.
T Consensus       551 GDRH~~NILid~tG~v~HIDFG~~f  575 (696)
T 2x6h_A          551 GDRHLDNLLLTTNGKLFHIDFGYIL  575 (696)
T ss_dssp             CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred             CCCCCcceEEeCCCCEEEEeehhhh
Confidence            6889999999999999999999875

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	344
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-91
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-87
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-86
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-84
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-84
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	1e-81
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-81
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-80
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-80
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-80
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-78
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-77
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-77
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-76
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-75
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-75
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-75
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-74
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-74
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	3e-72
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	8e-72
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-71
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-70
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-69
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-66
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	8e-66
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-65
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-65
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-64
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	5e-64
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-63
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-63
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	4e-63
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-63
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-62
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-62
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	1e-62
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-62
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-62
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	9e-62
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-61
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-61
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-61
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-61
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-60
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-60
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-59
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-59
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	5e-59
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-58
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-58
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-57
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-56
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-56
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	9e-55
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	1e-54
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-54
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	8e-54
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	9e-52
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	2e-50
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-49
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	4e-42
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	6e-23

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  270 bits (691), Expect = 9e-91
 Identities = 85/262 (32%), Positives = 145/262 (55%), Gaps = 5/262 (1%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L  +E+GR LG+G FG V  A++  S    A+K+L K ++    +  Q++RE+     L+
Sbjct: 5   LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HPN++RL+      +++Y++LEY   G ++ ++    +  E        +L + +SYCH+
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           K V HRD+K EN+LL S G +KI+DFG S             T CG+ +Y+ PE++  R 
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSV----HAPSSRRTTLCGTLDYLPPEMIEGRM 180

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
           +D    D+WS GV+ Y  L G  PF+       Y++I R +F  P +++ GA++L+ ++L
Sbjct: 181 HDEK-VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239

Query: 253 EPNPVKRITIAGIKADEWFEQD 274
           + NP +R  +  +    W   +
Sbjct: 240 KHNPSQRPMLREVLEHPWITAN 261

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  262 bits (670), Expect = 2e-87
 Identities = 101/266 (37%), Positives = 150/266 (56%), Gaps = 5/266 (1%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  ++L +TLGEG +G+V+ A +  +    AVKI++  R +     + IK+EI   K+L 
Sbjct: 4   VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLN 61

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H NVV+ +      +  Y+ LEY +GGELFD+I     + E + ++ F QL+ GV Y H 
Sbjct: 62  HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
            G+ HRD+K EN+LLD + N+KISDFGL+ + ++   + LL+  CG+  YVAPE+L  R 
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 193 YDGATSDIWSCGVILYVILTGYLPFD-DRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLR 249
           +     D+WSCG++L  +L G LP+D   +    Y         L  W  +      LL 
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH 241

Query: 250 KILEPNPVKRITIAGIKADEWFEQDY 275
           KIL  NP  RITI  IK D W+ +  
Sbjct: 242 KILVENPSARITIPDIKKDRWYNKPL 267

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  260 bits (665), Expect = 2e-86
 Identities = 82/263 (31%), Positives = 135/263 (51%), Gaps = 1/263 (0%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
            R   ++ G+ LGEG+F  V  A++L +   +A+KILEK  II       + RE   +  
Sbjct: 5   KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 64

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
           L HP  V+L+       K+Y  L Y   GEL   I   G   E   R    +++  + Y 
Sbjct: 65  LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYL 124

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           H KG+ HRDLK ENILL+   +I+I+DFG + +          ++  G+  YV+PE+L  
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 184

Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK 250
           +    + SD+W+ G I+Y ++ G  PF   N  +++QKI + ++  P+   P A++L+ K
Sbjct: 185 KSACKS-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK 243

Query: 251 ILEPNPVKRITIAGIKADEWFEQ 273
           +L  +  KR+    ++     + 
Sbjct: 244 LLVLDATKRLGCEEMEGYGPLKA 266

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  257 bits (658), Expect = 2e-84
 Identities = 77/275 (28%), Positives = 143/275 (52%), Gaps = 14/275 (5%)

Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           ++G     Y++   LG G FG V    +  +G  F  K +     +       +K EI+ 
Sbjct: 23  KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY---TVKNEISI 79

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDG 126
           +  L HP ++ LH+    K ++ ++LE+++GGELFD+IA++  ++ EAE     +Q  +G
Sbjct: 80  MNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEG 139

Query: 127 VSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + + H   + H D+K ENI+ ++K   ++KI DFGL+        D ++  T  +  + A
Sbjct: 140 LKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAA 196

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WL 240
           PE++         +D+W+ GV+ YV+L+G  PF   +     Q + R D++  +     +
Sbjct: 197 PEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSV 255

Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
           SP A++ ++ +L+  P KR+T+       W + D+
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  256 bits (654), Expect = 5e-84
 Identities = 79/280 (28%), Positives = 137/280 (48%), Gaps = 14/280 (5%)

Query: 8   QEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           +    L  Y++   LG G FG V    +  +G  FA K +      H    + +++EI T
Sbjct: 20  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQT 76

Query: 68  LKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDG 126
           + +L+HP +V LH+     +++ M+ E+++GGELF+K+A +  ++ E E  +  +Q+  G
Sbjct: 77  MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136

Query: 127 VSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
           + + H     H DLK ENI+  +K    +K+ DFGL+A   H      +  T G+  + A
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAA 193

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWL 240
           PEV   +      +D+WS GV+ Y++L+G  PF   N     + +   D+ +       +
Sbjct: 194 PEVAEGKPVGYY-TDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252

Query: 241 SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           S   ++ +RK+L  +P  R+TI       W      P   
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRD 292

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  247 bits (633), Expect = 1e-81
 Identities = 73/269 (27%), Positives = 132/269 (49%), Gaps = 13/269 (4%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +E+   LG+G FGKV  AQ+ ++ +  A K+++      L+       EI  L    HP
Sbjct: 13  FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELE---DYMVEIDILASCDHP 69

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR-LQEAEGRKLFQQLIDGVSYCHNK 133
           N+V+L +    ++ +++++E+  GG +   +    R L E++ + + +Q +D ++Y H+ 
Sbjct: 70  NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
            + HRDLK  NIL    G+IK++DFG+SA  ++ R      +  G+P ++APEV+     
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETS 187

Query: 194 D----GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---FKLPKWLSPGAQN 246
                   +D+WS G+ L  +     P  + N   +  KI + +      P   S   ++
Sbjct: 188 KDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKD 247

Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDY 275
            L+K LE N   R T + +    +   D 
Sbjct: 248 FLKKCLEKNVDARWTTSQLLQHPFVTVDS 276

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  248 bits (634), Expect = 2e-81
 Identities = 64/272 (23%), Positives = 114/272 (41%), Gaps = 10/272 (3%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            +   R +G G+FG V FA+D+ +    A+K +  +     +    I +E+  L+ L+HP
Sbjct: 16  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N ++       +   ++V+EY  G         K  LQE E   +    + G++Y H+  
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRD+K  NILL   G +K+ DFG +            ++  G+P ++APEV+      
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGTPYWMAPEVILAMDEG 189

Query: 195 GAT--SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNLLRK 250
                 D+WS G+    +     P  + N       I + +    +    S   +N +  
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDS 249

Query: 251 ILEPNPVKRITIAGIKADEWFEQDYTPANPDD 282
            L+  P  R T   +    +  ++  P    D
Sbjct: 250 CLQKIPQDRPTSEVLLKHRFVLRERPPTVIMD 281

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  244 bits (625), Expect = 2e-80
 Identities = 64/261 (24%), Positives = 127/261 (48%), Gaps = 10/261 (3%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            +Y     +G+G  G V  A D+ +G   A++ +   +    +    I  EI  ++  K+
Sbjct: 20  KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKE---LIINEILVMRENKN 76

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           PN+V   +      ++++V+EY+ GG L D + ++  + E +   + ++ +  + + H+ 
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSN 135

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
            V HRD+K +NILL   G++K++DFG  A      +     T  G+P ++APEV+  + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSKRSTMVGTPYWMAPEVVTRKAY 193

Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLRK 250
                DIWS G++   ++ G  P+ + N       I      + + P+ LS   ++ L +
Sbjct: 194 GPK-VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNR 252

Query: 251 ILEPNPVKRITIAGIKADEWF 271
            L+ +  KR +   +   ++ 
Sbjct: 253 CLDMDVEKRGSAKELLQHQFL 273

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  244 bits (625), Expect = 3e-80
 Identities = 100/273 (36%), Positives = 148/273 (54%), Gaps = 13/273 (4%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y+    LG G F +V  A+D  +    A+K + K  +   +    ++ EIA L  +KHP
Sbjct: 10  IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKE--GSMENEIAVLHKIKHP 67

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+V L ++  S   +Y++++ V+GGELFD+I  KG   E +  +L  Q++D V Y H+ G
Sbjct: 68  NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127

Query: 135 VFHRDLKLENILL---DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
           + HRDLK EN+L    D    I ISDFGLS +        +L T CG+P YVAPEVLA +
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 184

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNL 247
            Y  A  D WS GVI Y++L GY PF D N A L+++I + +++        +S  A++ 
Sbjct: 185 PYSKA-VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243

Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           +R ++E +P KR T        W   D      
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAGDTALDKN 276

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  243 bits (621), Expect = 5e-80
 Identities = 84/275 (30%), Positives = 136/275 (49%), Gaps = 19/275 (6%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL------KITDQIKREIATL 68
            YE    LG G    V+      +   +AVKI++             ++ +   +E+  L
Sbjct: 4   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63

Query: 69  KLLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           + +  HPN+++L +   + +  ++V + +  GELFD +  K  L E E RK+ + L++ +
Sbjct: 64  RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 123

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
              H   + HRDLK ENILLD   NIK++DFG S           L   CG+P+Y+APE+
Sbjct: 124 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEI 180

Query: 188 LA-----NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL--PKW- 239
           +      N    G   D+WS GVI+Y +L G  PF  R   ++ + I  G+++   P+W 
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD 240

Query: 240 -LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
             S   ++L+ + L   P KR T     A  +F+Q
Sbjct: 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  241 bits (616), Expect = 1e-78
 Identities = 65/274 (23%), Positives = 126/274 (45%), Gaps = 15/274 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           +Y +   LG G FG V    +  S   +  K ++            +K+EI+ L + +H 
Sbjct: 6   KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHR 61

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNK 133
           N++ LHE   S  ++ M+ E+++G ++F++I +    L E E      Q+ + + + H+ 
Sbjct: 62  NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121

Query: 134 GVFHRDLKLENILLDSKGN--IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
            + H D++ ENI+  ++ +  IKI +FG +   +  +          +P Y APEV  + 
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVHQHD 178

Query: 192 GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQNL 247
               A +D+WS G ++YV+L+G  PF       + + I   ++       K +S  A + 
Sbjct: 179 VVSTA-TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDF 237

Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANPD 281
           + ++L      R+T +      W +Q     +  
Sbjct: 238 VDRLLVKERKSRMTASEALQHPWLKQKIERVSTK 271

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  238 bits (608), Expect = 2e-77
 Identities = 87/261 (33%), Positives = 145/261 (55%), Gaps = 5/261 (1%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKH 73
            + L + LG+G+FGKV  A+   +   FA+K L+K+ ++     +    E   L L  +H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           P +  +     +K  ++ V+EY+ GG+L   I S  +   +       ++I G+ + H+K
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
           G+ +RDLKL+NILLD  G+IKI+DFG+    ++   D   +T CG+P+Y+APE+L  + Y
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNTFCGTPDYIAPEILLGQKY 180

Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILE 253
           + +  D WS GV+LY +L G  PF  ++   L+  I   +   P+WL   A++LL K+  
Sbjct: 181 NHS-VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFV 239

Query: 254 PNPVKRITIAG-IKADEWFEQ 273
             P KR+ + G I+    F +
Sbjct: 240 REPEKRLGVRGDIRQHPLFRE 260

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (603), Expect = 3e-77
 Identities = 77/271 (28%), Positives = 127/271 (46%), Gaps = 16/271 (5%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
           R   YE+  T+G G++G+ +  +    G     K L+   +   +    +  E+  L+ L
Sbjct: 2   RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLREL 60

Query: 72  KHPNVVRLHEVLASKS--KIYMVLEYVTGGELFDKIA----SKGRLQEAEGRKLFQQLID 125
           KHPN+VR ++ +  ++   +Y+V+EY  GG+L   I      +  L E    ++  QL  
Sbjct: 61  KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120

Query: 126 GVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            +  CH +      V HRDLK  N+ LD K N+K+ DFGL+ +  H  D        G+P
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKAFVGTP 178

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW 239
            Y++PE +    Y+   SDIWS G +LY +     PF   +   L  KI  G F ++P  
Sbjct: 179 YYMSPEQMNRMSYNEK-SDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 237

Query: 240 LSPGAQNLLRKILEPNPVKRITIAGIKADEW 270
            S     ++ ++L      R ++  I  +  
Sbjct: 238 YSDELNEIITRMLNLKDYHRPSVEEILENPL 268

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (595), Expect = 4e-76
 Identities = 85/274 (31%), Positives = 131/274 (47%), Gaps = 17/274 (6%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---HLKITDQIKREIATLKL 70
            +Y++G  LG G FG V     +   LP A+K +EK+RI     L    ++  E+  LK 
Sbjct: 4   SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63

Query: 71  LK--HPNVVRLHEVLASKSKIYMVLEYVTGG-ELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +      V+RL +         ++LE      +LFD I  +G LQE   R  F Q+++ V
Sbjct: 64  VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123

Query: 128 SYCHNKGVFHRDLKLENILLD-SKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
            +CHN GV HRD+K ENIL+D ++G +K+ DFG          D +     G+  Y  PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG----ALLKDTVYTDFDGTRVYSPPE 179

Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN 246
            +    Y G ++ +WS G++LY ++ G +PF+         +I RG     + +S   Q+
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQH 233

Query: 247 LLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           L+R  L   P  R T   I+   W +    P   
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQET 267

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  233 bits (596), Expect = 1e-75
 Identities = 81/263 (30%), Positives = 147/263 (55%), Gaps = 11/263 (4%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
           +++ RTLG G+FG+V   +   +G  +A+K+L+K  ++ LK  +    E   L ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGV 135
           ++R+        +I+M+++Y+ GGELF  +    R      +    ++   + Y H+K +
Sbjct: 66  IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125

Query: 136 FHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDG 195
            +RDLK ENILLD  G+IKI+DFG +          + +T CG+P+Y+APEV++ + Y+ 
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPDYIAPEVVSTKPYNK 180

Query: 196 ATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKILEPN 255
           +  D WS G+++Y +L GY PF D N    Y+KI   + + P + +   ++LL +++  +
Sbjct: 181 S-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239

Query: 256 PVKRI-----TIAGIKADEWFEQ 273
             +R+         +K   WF++
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKE 262

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  233 bits (594), Expect = 3e-75
 Identities = 77/308 (25%), Positives = 125/308 (40%), Gaps = 52/308 (16%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           ++   +E    LG GN G V       SGL  A K++     I   I +QI RE+  L  
Sbjct: 3   LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHE 60

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYC 130
              P +V  +    S  +I + +E++ GG L   +   GR+ E    K+   +I G++Y 
Sbjct: 61  CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYL 120

Query: 131 HNK-GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
             K  + HRD+K  NIL++S+G IK+ DFG+S        D + ++  G+ +Y++PE L 
Sbjct: 121 REKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG----QLIDSMANSFVGTRSYMSPERLQ 176

Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPF---DDRNLAVLYQKIFRGDFKL---------- 236
              Y    SDIWS G+ L  +  G  P    D + L +++     GD             
Sbjct: 177 GTHYSVQ-SDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR 235

Query: 237 -------------------------------PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
                                              S   Q+ + K L  NP +R  +  +
Sbjct: 236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

Query: 266 KADEWFEQ 273
               + ++
Sbjct: 296 MVHAFIKR 303

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 4e-75
 Identities = 65/270 (24%), Positives = 125/270 (46%), Gaps = 18/270 (6%)

Query: 14  GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           GR+ +    +G G+F  V    D ++ +  A   L+  ++       + K E   LK L+
Sbjct: 8   GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQ 66

Query: 73  HPNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           HPN+VR ++   S  K    I +V E +T G L   +     ++    R   +Q++ G+ 
Sbjct: 67  HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126

Query: 129 YCHNKG--VFHRDLKLENILLDSK-GNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
           + H +   + HRDLK +NI +    G++KI D GL+      +         G+P ++AP
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT----LKRASFAKAVIGTPEFMAP 182

Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG--DFKLPKWLSP 242
           E+     YD +  D+++ G+ +  + T   P+ + +N A +Y+++  G       K   P
Sbjct: 183 EMY-EEKYDES-VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240

Query: 243 GAQNLLRKILEPNPVKRITIAGIKADEWFE 272
             + ++   +  N  +R +I  +    +F+
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (587), Expect = 1e-74
 Identities = 89/270 (32%), Positives = 141/270 (52%), Gaps = 15/270 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK---ITDQIKREIATLKLL 71
            Y+ G  LG G F  VK  ++  +GL +A K ++K R    +     + I+RE++ LK +
Sbjct: 11  YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           +HPNV+ LHEV  +K+ + ++LE V GGELFD +A K  L E E  +  +Q+++GV Y H
Sbjct: 71  QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH 130

Query: 132 NKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
           +  + H DLK ENI+L  +      IKI DFGL+                G+P +VAPE+
Sbjct: 131 SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFGTPEFVAPEI 187

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPG 243
           +         +D+WS GVI Y++L+G  PF           +   +++         S  
Sbjct: 188 VNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSAL 246

Query: 244 AQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
           A++ +R++L  +P KR+TI       W + 
Sbjct: 247 AKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  230 bits (588), Expect = 7e-74
 Identities = 85/336 (25%), Positives = 152/336 (45%), Gaps = 39/336 (11%)

Query: 11  MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL 70
           + +  + + R +G G FG+V   +  D+G  +A+K L+K RI   +       E   L L
Sbjct: 1   LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60

Query: 71  LK---HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGV 127
           +     P +V +     +  K+  +L+ + GG+L   ++  G   EA+ R    ++I G+
Sbjct: 61  VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGL 120

Query: 128 SYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEV 187
            + HN+ V +RDLK  NILLD  G+++ISD GL+            H + G+  Y+APEV
Sbjct: 121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLAC----DFSKKKPHASVGTHGYMAPEV 176

Query: 188 LANRGYDGATSDIWSCGVILYVILTGYLPFDD---RNLAVLYQKIFRGDFKLPKWLSPGA 244
           L       +++D +S G +L+ +L G+ PF     ++   + +       +LP   SP  
Sbjct: 177 LQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 236

Query: 245 QNLLRKILEPNPVKRITIAGIKADE-----WFEQDYTPANPDDDEEDIFVDNEAFSMHEV 299
           ++LL  +L+ +  +R+   G  A E     +F                 +D +   + + 
Sbjct: 237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS---------------LDWQMVFLQKY 281

Query: 300 PSDGGRTPGSPPLINAFQLIGMSSCLDLSGFFEKEV 335
           P         PPLI     +  +   D+  F E++ 
Sbjct: 282 P---------PPLIPPRGEVNAADAFDIGSFDEEDT 308

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  225 bits (575), Expect = 3e-72
 Identities = 86/264 (32%), Positives = 142/264 (53%), Gaps = 8/264 (3%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           +  ++  + LG+G FGKV   ++  +G  +A+KIL K  II          E   L+  +
Sbjct: 4   MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           HP +  L     +  ++  V+EY  GGELF  ++ +    E   R    +++  + Y H+
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           + V +RD+KLEN++LD  G+IKI+DFGL        D   + T CG+P Y+APEVL +  
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGTPEYLAPEVLEDND 181

Query: 193 YDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKIL 252
           Y  A  D W  GV++Y ++ G LPF +++   L++ I   + + P+ LSP A++LL  +L
Sbjct: 182 YGRA-VDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240

Query: 253 EPNPVKRITIAGIKADE-----WF 271
           + +P +R+      A E     +F
Sbjct: 241 KKDPKQRLGGGPSDAKEVMEHRFF 264

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 8e-72
 Identities = 59/261 (22%), Positives = 116/261 (44%), Gaps = 14/261 (5%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           G+  +G+ +G G+FG V   +        AVK+L        +     K E+  L+  +H
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRH 63

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI-ASKGRLQEAEGRKLFQQLIDGVSYCHN 132
            N++      ++  ++ +V ++  G  L+  +   + + +  +   + +Q   G+ Y H 
Sbjct: 64  VNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           K + HRDLK  NI L     +KI DFGL+ +   +          GS  ++APEV+  + 
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 193 YDGAT--SDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF------KLPKWLSPGA 244
            +  +  SD+++ G++LY ++TG LP+ + N       +    +      K+        
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242

Query: 245 QNLLRKILEPNPVKRITIAGI 265
           + L+ + L+    +R     I
Sbjct: 243 KRLMAECLKKKRDERPLFPQI 263

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  221 bits (565), Expect = 1e-71
 Identities = 70/266 (26%), Positives = 118/266 (44%), Gaps = 10/266 (3%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            RYELG  LG G   +V  A+DL      AVK+L  +         + +RE      L H
Sbjct: 7   DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66

Query: 74  PNVVRLHEVLASKSK----IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           P +V +++   +++      Y+V+EYV G  L D + ++G +      ++       +++
Sbjct: 67  PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVL 188
            H  G+ HRD+K  NI++ +   +K+ DFG++  +              G+  Y++PE  
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186

Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGA 244
                D   SD++S G +LY +LTG  PF   +   +  +  R D   P    + LS   
Sbjct: 187 RGDSVDAR-SDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADL 245

Query: 245 QNLLRKILEPNPVKRITIAGIKADEW 270
             ++ K L  NP  R   A     + 
Sbjct: 246 DAVVLKALAKNPENRYQTAAEMRADL 271

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  221 bits (564), Expect = 2e-70
 Identities = 89/272 (32%), Positives = 147/272 (54%), Gaps = 11/272 (4%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREI 65
             Q   +L +++  +TLG G+FG+V   +  +SG  +A+KIL+K +++ LK  +    E 
Sbjct: 33  PSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEK 92

Query: 66  ATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLID 125
             L+ +  P +V+L       S +YMV+EYV GGE+F  +   GR  E   R    Q++ 
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVL 152

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAP 185
              Y H+  + +RDLK EN+L+D +G I+++DFG +   +         T CG+P  +AP
Sbjct: 153 TFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT-----WTLCGTPEALAP 207

Query: 186 EVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQ 245
           E++ ++GY+ A  D W+ GV++Y +  GY PF       +Y+KI  G  + P   S   +
Sbjct: 208 EIILSKGYNKA-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266

Query: 246 NLLRKILEPNPVKRI-----TIAGIKADEWFE 272
           +LLR +L+ +  KR       +  IK  +WF 
Sbjct: 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  218 bits (555), Expect = 3e-69
 Identities = 79/301 (26%), Positives = 138/301 (45%), Gaps = 25/301 (8%)

Query: 8   QEGMRLGRYE-LGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIA 66
           ++   +  Y+   + LG G  GKV    +  +   FA+K+L+           + +RE+ 
Sbjct: 5   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVE 56

Query: 67  TL-KLLKHPNVVRLHEVL----ASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKL 119
              +  + P++VR+ +V     A +  + +V+E + GGELF +I  +G     E E  ++
Sbjct: 57  LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 116

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
            + + + + Y H+  + HRD+K EN+L  SK    I         +       L T C +
Sbjct: 117 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYT 176

Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFK 235
           P YVAPEVL    YD +  D+WS GVI+Y++L GY PF   +       +  +I  G ++
Sbjct: 177 PYYVAPEVLGPEKYDKS-CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYE 235

Query: 236 LP----KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEEDIFVDN 291
            P      +S   + L+R +L+  P +R+TI       W  Q             +  ++
Sbjct: 236 FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKED 295

Query: 292 E 292
           +
Sbjct: 296 K 296

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (533), Expect = 2e-66
 Identities = 68/311 (21%), Positives = 115/311 (36%), Gaps = 43/311 (13%)

Query: 12  RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
            + +YE    +G+G FG+V  A+   +G   A+K +               REI  L+LL
Sbjct: 8   EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLL 66

Query: 72  KHPNVVRLHEVLAS--------KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQL 123
           KH NVV L E+  +        K  IY+V ++              +   +E +++ Q L
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML 126

Query: 124 IDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL--PQHFRDDGLLHTTCGSPN 181
           ++G+ Y H   + HRD+K  N+L+   G +K++DFGL+                   +  
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 182 YVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--- 238
           Y  PE+L      G   D+W  G I+  + T                I +    +     
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 239 -----------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADE 269
                                           P A +L+ K+L  +P +RI        +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHD 306

Query: 270 WFEQDYTPANP 280
           +F  D  P++ 
Sbjct: 307 FFWSDPMPSDL 317

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (532), Expect = 8e-66
 Identities = 77/315 (24%), Positives = 127/315 (40%), Gaps = 39/315 (12%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            RY     +GEG +G V  A D  + +  A+K +      H     +  REI  L   +H
Sbjct: 8   PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65

Query: 74  PNVVRLHEVLASKS----KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            N++ +++++ + +    K   ++ ++ G +L+  +     L          Q++ G+ Y
Sbjct: 66  ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL-KTQHLSNDHICYFLYQILRGLKY 124

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT-CGSPNYVAPEVL 188
            H+  V HRDLK  N+LL++  ++KI DFGL+ +     D     T    +  Y APE++
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-------------- 234
            N      + DIWS G IL  +L+    F  ++       I                   
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 235 -----------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
                            +L       A +LL K+L  NP KRI +    A  + EQ Y P
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304

Query: 278 ANPDDDEEDIFVDNE 292
           ++    E     D E
Sbjct: 305 SDEPIAEAPFKFDME 319

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 1e-65
 Identities = 69/294 (23%), Positives = 109/294 (37%), Gaps = 32/294 (10%)

Query: 17  ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLK--ITDQIKREIATLKLLKHP 74
           E    LGEG F  V  A+D ++    A+K ++       K  I     REI  L+ L HP
Sbjct: 1   EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N++ L +    KS I +V +++          +   L  +  +      + G+ Y H   
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           + HRDLK  N+LLD  G +K++DFGL+        +        +  Y APE+L      
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAK--SFGSPNRAYTHQVVTRWYRAPELLFGARMY 178

Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR--GDFKLPKW------------- 239
           G   D+W+ G IL  +L         +      +IF   G     +W             
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238

Query: 240 -------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
                              +L++ +   NP  RIT       ++F     P   
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (525), Expect = 1e-65
 Identities = 64/257 (24%), Positives = 111/257 (43%), Gaps = 18/257 (7%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
             +L +T+G+G FG V        G   AVK ++ +             E + +  L+H 
Sbjct: 8   ELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHS 60

Query: 75  NVVRLHEVLA-SKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCH 131
           N+V+L  V+   K  +Y+V EY+  G L D + S+GR  L      K    + + + Y  
Sbjct: 61  NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120

Query: 132 NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANR 191
                HRDL   N+L+      K+SDFGL+      +D     T      + APE L  +
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALREK 175

Query: 192 GYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR 249
            +    SD+WS G++L+ I + G +P+    L  +  ++ +G     P    P    +++
Sbjct: 176 KFSTK-SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEVMK 234

Query: 250 KILEPNPVKRITIAGIK 266
                +   R +   ++
Sbjct: 235 NCWHLDAAMRPSFLQLR 251

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (516), Expect = 3e-64
 Identities = 64/259 (24%), Positives = 107/259 (41%), Gaps = 8/259 (3%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
              L   LG+G+FG V+  +        +  AVK L+ + +   +  D   RE+  +  L
Sbjct: 9   DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSL 68

Query: 72  KHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYC 130
            H N++RL+ V+ +   + MV E    G L D++    G        +   Q+ +G+ Y 
Sbjct: 69  DHRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127

Query: 131 HNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
            +K   HRDL   N+LL ++  +KI DFGL        D  ++      P          
Sbjct: 128 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLK 187

Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGDFKLPKW--LSPGAQNL 247
                  SD W  GV L+ + T G  P+   N + +  KI +   +LP+         N+
Sbjct: 188 TRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNV 247

Query: 248 LRKILEPNPVKRITIAGIK 266
           + +     P  R T   ++
Sbjct: 248 MVQCWAHKPEDRPTFVALR 266

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  202 bits (515), Expect = 5e-64
 Identities = 80/288 (27%), Positives = 131/288 (45%), Gaps = 33/288 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           +Y     +GEG +G V  AQ+ + G  FA+K +   +     I     REI+ LK LKH 
Sbjct: 3   KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHS 60

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           N+V+L++V+ +K ++ +V E++           +G L+    +    QL++G++YCH++ 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYD 194
           V HRDLK +N+L++ +G +KI+DFGL+                 +  Y AP+VL      
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLMGSKKY 178

Query: 195 GATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-------------------- 234
             T DIWS G I   ++ G   F   + A    +IFR                       
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238

Query: 235 ---------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ 273
                       K L     +LL K+L+ +P +RIT        +F++
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 2e-63
 Identities = 63/261 (24%), Positives = 106/261 (40%), Gaps = 10/261 (3%)

Query: 20  RTLGEGNFGKVKFA--QDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV 77
           + LG GNFG VK    Q        AVKIL KN      + D++  E   ++ L +P +V
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 78  RLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFH 137
           R+  +        +V+E    G L   +     +++    +L  Q+  G+ Y       H
Sbjct: 72  RMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130

Query: 138 RDLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGA 196
           RDL   N+LL ++   KISDFGLS AL                  + APE +    +   
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190

Query: 197 TSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEP 254
            SD+WS GV+++   + G  P+     + +   + +G+    P        +L+      
Sbjct: 191 -SDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249

Query: 255 NPVKRITIAGIKA--DEWFEQ 273
           +   R   A ++     ++  
Sbjct: 250 DVENRPGFAAVELRLRNYYYD 270

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 4e-63
 Identities = 72/302 (23%), Positives = 121/302 (40%), Gaps = 49/302 (16%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y   + +G G+FG V  A+  DSG   A+K + +++           RE+  ++ L H 
Sbjct: 21  SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHC 73

Query: 75  NVVRLHEVLASKSK------IYMVLEYVTGG---ELFDKIASKGRLQEAEGRKLFQQLID 125
           N+VRL     S  +      + +VL+YV             +K  L     +    QL  
Sbjct: 74  NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 133

Query: 126 GVSYCHNKGVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            ++Y H+ G+ HRD+K +N+LLD    + K+ DFG +   +         +   S  Y A
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA---KQLVRGEPNVSYICSRYYRA 190

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFR------------- 231
           PE++       ++ D+WS G +L  +L G   F   +      +I +             
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREM 250

Query: 232 ----GDFKLPKW------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY 275
                +FK P+               P A  L  ++LE  P  R+T     A  +F++  
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310

Query: 276 TP 277
            P
Sbjct: 311 DP 312

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 4e-63
 Identities = 60/253 (23%), Positives = 114/253 (45%), Gaps = 14/253 (5%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPN 75
               + LG G FG VK+ +        A+K++++  +      D+   E   +  L H  
Sbjct: 6   LTFLKELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60

Query: 76  VVRLHEVLASKSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKG 134
           +V+L+ V   +  I+++ EY+  G L + +   + R Q  +  ++ + + + + Y  +K 
Sbjct: 61  LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120

Query: 135 VFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEVLANRG 192
             HRDL   N L++ +G +K+SDFGLS   ++  DD    +        +  PEVL    
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLS---RYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177

Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250
           +    SDIW+ GV+++ I + G +P++    +   + I +G     P   S     ++  
Sbjct: 178 FSSK-SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236

Query: 251 ILEPNPVKRITIA 263
                  +R T  
Sbjct: 237 CWHEKADERPTFK 249

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 6e-63
 Identities = 73/296 (24%), Positives = 114/296 (38%), Gaps = 25/296 (8%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATL-KLLKH 73
             +    +GEGNFG+V  A+    GL     I                 E+  L KL  H
Sbjct: 11  DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHH 70

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----------------ASKGRLQEAEGR 117
           PN++ L      +  +Y+ +EY   G L D +                ++   L   +  
Sbjct: 71  PNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 118 KLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC 177
                +  G+ Y   K   HRDL   NIL+      KI+DFGLS   +            
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKTMGR 187

Query: 178 GSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFK 235
               ++A E L N       SD+WS GV+L+ I++ G  P+     A LY+K+ +G   +
Sbjct: 188 LPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE 246

Query: 236 LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDDEEDIFV 289
            P        +L+R+     P +R + A I    +   E+  T  N    E+  + 
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYA 302

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 1e-62
 Identities = 77/293 (26%), Positives = 133/293 (45%), Gaps = 33/293 (11%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            ++    +GEG +G V  A++  +G   A+K +  +      +     REI+ LK L HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETE-GVPSTAIREISLLKELNHP 61

Query: 75  NVVRLHEVLASKSKIYMVLEYV-TGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           N+V+L +V+ +++K+Y+V E++    + F   ++   +     +    QL+ G+++CH+ 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
            V HRDLK +N+L++++G IK++DFGL+                 +  Y APE+L    Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLA--RAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 194 DGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------------DFK 235
                DIWS G I   ++T    F   +      +IFR                      
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 236 LPKW-----------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
            PKW           L    ++LL ++L  +P KRI+     A  +F+    P
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (510), Expect = 1e-62
 Identities = 64/283 (22%), Positives = 111/283 (39%), Gaps = 35/283 (12%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSG-----LPFAVKILEKNRIIHLKITDQIKREIATL- 68
             E G+ LG G FGKV  A           +  AVK+L++         + +  E+  + 
Sbjct: 38  NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMT 95

Query: 69  KLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-------------------- 108
           +L  H N+V L         IY++ EY   G+L + + SK                    
Sbjct: 96  QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155

Query: 109 ---GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165
                L   +      Q+  G+ +   K   HRDL   N+L+     +KI DFGL+    
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215

Query: 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAV 224
              +  +         ++APE L    Y    SD+WS G++L+ I + G  P+    +  
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIK-SDVWSYGILLWEIFSLGVNPYPGIPVDA 274

Query: 225 LYQKIFRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            + K+ +  FK+  P + +     +++     +  KR +   +
Sbjct: 275 NFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNL 317

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 1e-62
 Identities = 80/282 (28%), Positives = 146/282 (51%), Gaps = 14/282 (4%)

Query: 6   KKQEGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRIIH-LKITDQI 61
              E + +  +EL + LG G +GKV   + +   D+G  +A+K+L+K  I+   K T+  
Sbjct: 16  GHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 75

Query: 62  KREIATLKLLKH-PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
           + E   L+ ++  P +V LH    +++K++++L+Y+ GGELF  ++ + R  E E +   
Sbjct: 76  RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 135

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
            +++  + + H  G+ +RD+KLENILLDS G++ ++DFGLS        +          
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKL 236
                 V           D WS GV++Y +LTG  PF         A + ++I + +   
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255

Query: 237 PKWLSPGAQNLLRKILEPNPVKRITIAGIKADE-----WFEQ 273
           P+ +S  A++L++++L  +P KR+      ADE     +F++
Sbjct: 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  199 bits (506), Expect = 1e-62
 Identities = 72/275 (26%), Positives = 123/275 (44%), Gaps = 12/275 (4%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
              +   LG G +G+V         L  AVK L+++ +      ++  +E A +K +KHP
Sbjct: 18  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHP 73

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHN 132
           N+V+L  V   +   Y++ E++T G L D +    R  +       +  Q+   + Y   
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           K   HRDL   N L+     +K++DFGLS L                  + APE LA   
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK 192

Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250
           +    SD+W+ GV+L+ I T G  P+   +L+ +Y+ + +    + P+        L+R 
Sbjct: 193 FSIK-SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRA 251

Query: 251 ILEPNPVKRITIAGIKADEWFEQDYTPANPDDDEE 285
             + NP  R + A I   + FE  +  ++  D+ E
Sbjct: 252 CWQWNPSDRPSFAEIH--QAFETMFQESSISDEVE 284

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 2e-62
 Identities = 77/303 (25%), Positives = 123/303 (40%), Gaps = 45/303 (14%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
            Y   + +G G +G V  A D  +G   A+K L +          +  RE+  LK ++H 
Sbjct: 19  VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSE-LFAKRAYRELRLLKHMRHE 77

Query: 75  NVVRLHEV------LASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           NV+ L +V      L   +  Y+V+ ++  G    K+    +L E   + L  Q++ G+ 
Sbjct: 78  NVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLR 135

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVL 188
           Y H  G+ HRDLK  N+ ++    +KI DFGL+        D  +     +  Y APEV+
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA-----DSEMTGYVVTRWYRAPEVI 190

Query: 189 ANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKW--------- 239
            N      T DIWS G I+  ++TG   F   +     ++I +     P           
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 240 ----------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
                                  SP A NLL K+L  +  +R+T     A  +FE  +  
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310

Query: 278 ANP 280
            + 
Sbjct: 311 EDE 313

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (500), Expect = 9e-62
 Identities = 75/295 (25%), Positives = 128/295 (43%), Gaps = 34/295 (11%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           + +YE    +GEG +G V  A++ ++    A+K +  +      +     REI  LK LK
Sbjct: 1   MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDE-GVPSSALREICLLKELK 59

Query: 73  HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
           H N+VRLH+VL S  K+ +V E+          +  G L     +    QL+ G+ +CH+
Sbjct: 60  HKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHS 119

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           + V HRDLK +N+L++  G +K+++FGL+                 +  Y  P+VL    
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 193 YDGATSDIWSCGVILYVILTGYLP-FDDRNLAVLYQKIFRGDF----------------- 234
               + D+WS G I   +     P F   ++    ++IFR                    
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237

Query: 235 ------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP 277
                        +   L+   ++LL+ +L+ NPV+RI+        +F  D+ P
Sbjct: 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF-SDFCP 291

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 1e-61
 Identities = 69/263 (26%), Positives = 120/263 (45%), Gaps = 14/263 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
             +L   LG G FG+V      +     AVK L++  +      D    E   +K L+H 
Sbjct: 14  TLKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQ 68

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHN 132
            +VRL+ V+ ++  IY++ EY+  G L D + +    +L   +   +  Q+ +G+++   
Sbjct: 69  RLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
           +   HRDL+  NIL+    + KI+DFGL+ L     +            + APE + N G
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPEAI-NYG 185

Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250
                SD+WS G++L  I+T G +P+       + Q + RG     P         L+R 
Sbjct: 186 TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLMRL 245

Query: 251 ILEPNPVKRITIAGIKA--DEWF 271
             +  P  R T   +++  +++F
Sbjct: 246 CWKERPEDRPTFDYLRSVLEDFF 268

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 2e-61
 Identities = 66/250 (26%), Positives = 103/250 (41%), Gaps = 10/250 (4%)

Query: 22  LGEGNFGKVKFAQD--LDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRL 79
           LG GNFG V+          +  A+K+L++        T+++ RE   +  L +P +VRL
Sbjct: 17  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRL 74

Query: 80  HEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHR 138
             V      + +V+E   GG L   +  K   +  +   +L  Q+  G+ Y   K   HR
Sbjct: 75  IGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133

Query: 139 DLKLENILLDSKGNIKISDFGLS-ALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGAT 197
           DL   N+LL ++   KISDFGLS AL                  + APE +  R +    
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR- 192

Query: 198 SDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPN 255
           SD+WS GV ++  L+ G  P+       +   I +G   + P    P    L+       
Sbjct: 193 SDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYALMSDCWIYK 252

Query: 256 PVKRITIAGI 265
              R     +
Sbjct: 253 WEDRPDFLTV 262

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 2e-61
 Identities = 65/275 (23%), Positives = 120/275 (43%), Gaps = 14/275 (5%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
              L   LG+G FG+V       +    A+K L+   +      +   +E   +K L+H 
Sbjct: 18  SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHE 72

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR--LQEAEGRKLFQQLIDGVSYCHN 132
            +V+L+ V+ S+  IY+V EY++ G L D +  +    L+  +   +  Q+  G++Y   
Sbjct: 73  KLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRG 192
               HRDL+  NIL+      K++DFGL+ L +   +            + APE      
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKWTAPEAALYGR 190

Query: 193 YDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRK 250
           +    SD+WS G++L  + T G +P+       +  ++ RG     P        +L+ +
Sbjct: 191 FTIK-SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQ 249

Query: 251 ILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDD 283
                P +R T   ++A  +++F        P ++
Sbjct: 250 CWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 5e-61
 Identities = 71/260 (27%), Positives = 120/260 (46%), Gaps = 11/260 (4%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLP-FAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
           R ELGR +GEG FG V     +    P  AV I          + ++  +E  T++   H
Sbjct: 8   RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDH 67

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHN 132
           P++V+L  V+ +++ +++++E  T GEL   +  +   L  A       QL   ++Y  +
Sbjct: 68  PHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126

Query: 133 KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTC--GSPNYVAPEVLAN 190
           K   HRD+   N+L+ S   +K+ DFGLS   ++  D      +       ++APE +  
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLS---RYMEDSTYYKASKGKLPIKWMAPESINF 183

Query: 191 RGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLL 248
           R +  A SD+W  GV ++ IL  G  PF       +  +I  G+   +P    P   +L+
Sbjct: 184 RRFTSA-SDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYSLM 242

Query: 249 RKILEPNPVKRITIAGIKAD 268
            K    +P +R     +KA 
Sbjct: 243 TKCWAYDPSRRPRFTELKAQ 262

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (490), Expect = 2e-60
 Identities = 57/252 (22%), Positives = 108/252 (42%), Gaps = 10/252 (3%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
                + +G G FG V     L+     A+K + +  +      +    E   +  L HP
Sbjct: 6   ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHP 60

Query: 75  NVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQ-EAEGRKLFQQLIDGVSYCHNK 133
            +V+L+ V   ++ I +V E++  G L D + ++  L        +   + +G++Y    
Sbjct: 61  KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
            V HRDL   N L+     IK+SDFG++              T     + +PEV +   Y
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRY 179

Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKI 251
               SD+WS GV+++ + + G +P+++R+ + + + I  G     P+  S     ++   
Sbjct: 180 SSK-SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHC 238

Query: 252 LEPNPVKRITIA 263
            +  P  R   +
Sbjct: 239 WKERPEDRPAFS 250

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 7e-60
 Identities = 78/295 (26%), Positives = 124/295 (42%), Gaps = 42/295 (14%)

Query: 15  RYELGRTLGEGNFGKVKFAQDL-DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK- 72
           +YE    +GEG +GKV  A+DL + G   A+K + + +     +     RE+A L+ L+ 
Sbjct: 8   QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLSTIREVAVLRHLET 66

Query: 73  --HPNVVRLHEVLAS-----KSKIYMVLEYVTGGEL-FDKIASKGRLQEAEGRKLFQQLI 124
             HPNVVRL +V        ++K+ +V E+V      +     +  +     + +  QL+
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 125 DGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVA 184
            G+ + H+  V HRDLK +NIL+ S G IK++DFGL+ +           +   +  Y A
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVTLWYRA 183

Query: 185 PEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG------------ 232
           PEVL    Y     D+WS G I   +      F   +      KI               
Sbjct: 184 PEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 233 ---------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFE 272
                            K    +    ++LL K L  NP KRI+     +  +F+
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 1e-59
 Identities = 80/321 (24%), Positives = 128/321 (39%), Gaps = 51/321 (15%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHP 74
           RY+    +G G +G V  A D  +GL  AVK L +     +    +  RE+  LK +KH 
Sbjct: 19  RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHE 77

Query: 75  NVVRLHEVLASKSKI-----YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
           NV+ L +V      +       ++ ++ G    + I    +L +   + L  Q++ G+ Y
Sbjct: 78  NVIGLLDVFTPARSLEEFNDVYLVTHLMGA-DLNNIVKCQKLTDDHVQFLIYQILRGLKY 136

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLA 189
            H+  + HRDLK  N+ ++    +KI DFGL+                 +  Y APE++ 
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM-----TGYVATRWYRAPEIML 191

Query: 190 NRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWL--------- 240
           N  +   T DIWS G I+  +LTG   F   +     + I R        L         
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 241 ----------------------SPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPA 278
                                 +P A +LL K+L  +  KRIT A   A  +F Q + P 
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD 311

Query: 279 --------NPDDDEEDIFVDN 291
                   +   +  D+ +D 
Sbjct: 312 DEPVADPYDQSFESRDLLIDE 332

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  190 bits (484), Expect = 3e-59
 Identities = 57/262 (21%), Positives = 106/262 (40%), Gaps = 12/262 (4%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLK 69
           +   ++ + +G G FG+V        G   +  A+K L+       K       E + + 
Sbjct: 25  ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMG 82

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVS 128
              HPNV+ L  V+   + + ++ E++  G L   +    G+    +   + + +  G+ 
Sbjct: 83  QFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 142

Query: 129 YCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT---CGSPNYVAP 185
           Y  +    HRDL   NIL++S    K+SDFGLS   +    D    +         + AP
Sbjct: 143 YLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAP 202

Query: 186 EVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPG 243
           E +  R +  A SD+WS G++++ +++ G  P+ D     +   I +      P      
Sbjct: 203 EAIQYRKFTSA-SDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA 261

Query: 244 AQNLLRKILEPNPVKRITIAGI 265
              L+    + +   R     I
Sbjct: 262 LHQLMLDCWQKDRNHRPKFGQI 283

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 5e-59
 Identities = 55/285 (19%), Positives = 111/285 (38%), Gaps = 6/285 (2%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEK--NRIIHLKITDQIKREIATLKLLKH 73
           ++  + LG G FG V     +  G    + +  K        K   +I  E   +  + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 74  PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNK 133
           P+V RL  +  + +   +      G  L      K  +          Q+  G++Y  ++
Sbjct: 71  PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130

Query: 134 GVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGY 193
            + HRDL   N+L+ +  ++KI+DFGL+ L      +           ++A E + +R Y
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIY 190

Query: 194 DGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQNLLRKI 251
               SD+WS GV ++ ++T G  P+D    + +   + +G+    P   +     ++ K 
Sbjct: 191 THQ-SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVKC 249

Query: 252 LEPNPVKRITIAGIKAD-EWFEQDYTPANPDDDEEDIFVDNEAFS 295
              +   R     +  +     +D         +E + + +   S
Sbjct: 250 WMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMHLPSPTDS 294

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  188 bits (477), Expect = 3e-58
 Identities = 65/282 (23%), Positives = 109/282 (38%), Gaps = 34/282 (12%)

Query: 15  RYELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
             E  R +GEG FG+V           +     AVK+L++     ++     +RE A + 
Sbjct: 14  NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQ--ADFQREAALMA 71

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR------------------- 110
              +PN+V+L  V A    + ++ EY+  G+L + + S                      
Sbjct: 72  EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 111 -----LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ 165
                L  AE   + +Q+  G++Y   +   HRDL   N L+     +KI+DFGLS    
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL-PFDDRNLAV 224
                           ++ PE +    Y    SD+W+ GV+L+ I +  L P+       
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTE-SDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 225 LYQKIFRGDF-KLPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
           +   +  G+    P+       NL+R      P  R +   I
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSI 292

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  187 bits (475), Expect = 8e-58
 Identities = 59/293 (20%), Positives = 100/293 (34%), Gaps = 27/293 (9%)

Query: 11  MRLG-RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           +R+G RY LGR +G G+FG +    D+ +G   A+K+             Q+  E    K
Sbjct: 3   LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYK 57

Query: 70  LLKHPN-VVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVS 128
           +++    +  +    A      MV+E +             +        L  Q+I  + 
Sbjct: 58  MMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE 117

Query: 129 YCHNKGVFHRDLKLENILLDSKG---NIKISDFGLSALPQHFRDDGLLH-----TTCGSP 180
           Y H+K   HRD+K +N L+        + I DFGL+   +  R    +         G+ 
Sbjct: 118 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK----- 235
            Y +              D+ S G +L     G LP+     A   QK  R   K     
Sbjct: 178 RYASINTHLGIEQSRR-DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP 236

Query: 236 ---LPKWLSPGAQNLLRKILEPNPVKRITIAGIKA---DEWFEQDYTPANPDD 282
              L K         L          +   + ++    + +  Q ++     D
Sbjct: 237 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSYDYVFD 289

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  186 bits (472), Expect = 5e-57
 Identities = 64/299 (21%), Positives = 122/299 (40%), Gaps = 54/299 (18%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-H 73
            Y+L R LG G + +V  A ++ +     VKIL+  +        +IKREI  L+ L+  
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGG 89

Query: 74  PNVVRLHEVLASKSK--IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCH 131
           PN++ L +++         +V E+V   +          L + + R    +++  + YCH
Sbjct: 90  PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCH 146

Query: 132 NKGVFHRDLKLENILLDSKGN-IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLAN 190
           + G+ HRD+K  N+++D +   +++ D+GL+   + +      +    S  +  PE+L +
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQEYNVRVASRYFKGPELLVD 203

Query: 191 RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAV--------------LYQKIFRGDFKL 236
                 + D+WS G +L  ++    PF   +                 LY  I + + +L
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263

Query: 237 PKW------------------------LSPGAQNLLRKILEPNPVKRITIAGIKADEWF 271
                                      +SP A + L K+L  +   R+T        +F
Sbjct: 264 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 322

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 1e-56
 Identities = 68/278 (24%), Positives = 117/278 (42%), Gaps = 30/278 (10%)

Query: 15  RYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           R   G+TLG G FGKV  A        D+ +  AVK+L+ +   HL   + +  E+  L 
Sbjct: 24  RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLS 81

Query: 70  LLK-HPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKG------------------R 110
            L  H N+V L           ++ EY   G+L + +  K                    
Sbjct: 82  YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141

Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+++  +K   HRDL   NILL      KI DFGL+   ++  + 
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201

Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 229
            +         ++APE + N       SD+WS G+ L+ + + G  P+    +   + K+
Sbjct: 202 VVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260

Query: 230 FRGDFKL--PKWLSPGAQNLLRKILEPNPVKRITIAGI 265
            +  F++  P+       ++++   + +P+KR T   I
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQI 298

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 8e-56
 Identities = 70/280 (25%), Positives = 118/280 (42%), Gaps = 29/280 (10%)

Query: 15  RYELGRTLGEGNFGKVKFAQDL-------DSGLPFAVKILEKNRIIHLKITDQIKREIAT 67
           R  LG+ LGEG FG+V  A+ +       +     AVK+L+ +     K    +  E+  
Sbjct: 14  RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEM 71

Query: 68  LK-LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKI----------------ASKGR 110
           +K + KH N++ L         +Y+++EY + G L + +                  + +
Sbjct: 72  MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 111 LQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD 170
           L   +      Q+  G+ Y  +K   HRDL   N+L+     +KI+DFGL+    H    
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKI 229
                      ++APE L +R Y    SD+WS GV+L+ I T G  P+    +  L++ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQ-SDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250

Query: 230 FRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD 268
             G     P   +     ++R      P +R T   +  D
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  179 bits (454), Expect = 9e-55
 Identities = 50/290 (17%), Positives = 93/290 (32%), Gaps = 27/290 (9%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
             Y++GR +GEG+FG +    +L +    A+K   +          Q++ E  T KLL  
Sbjct: 5   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAG 59

Query: 74  -PNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN 132
              +  ++          +V++ +             +          +Q++  V   H 
Sbjct: 60  CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119

Query: 133 KGVFHRDLKLENILLDSK-----GNIKISDFGLSALPQHFRDDGLLH-----TTCGSPNY 182
           K + +RD+K +N L+          I + DFG+    +       +         G+  Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179

Query: 183 VAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK------- 235
           ++      R       D+ + G +    L G LP+     A   QK  R   K       
Sbjct: 180 MSINTHLGREQSRR-DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238

Query: 236 -LPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTPANPDDDE 284
            L           +                ++    F +     N  +DE
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQ--GLFSKVLERLNTTEDE 286

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 1e-54
 Identities = 61/259 (23%), Positives = 107/259 (41%), Gaps = 11/259 (4%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKL 70
                + +G G FG+V       S     +P A+K L+       ++      E   +  
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQ 65

Query: 71  LKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSY 129
             H N++RL  V++    + ++ EY+  G L   +  K G     +   + + +  G+ Y
Sbjct: 66  FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSA-LPQHFRDDGLLHTTCGSPNYVAPEVL 188
             N    HRDL   NIL++S    K+SDFGLS  L                  + APE +
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 189 ANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN 246
           + R +  A SD+WS G++++ ++T G  P+ + +   + + I  G     P         
Sbjct: 186 SYRKFTSA-SDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQ 244

Query: 247 LLRKILEPNPVKRITIAGI 265
           L+ +  +    +R   A I
Sbjct: 245 LMMQCWQQERARRPKFADI 263

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 1e-54
 Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 18/281 (6%)

Query: 15  RYELGRTLGEGNFGKVKFAQDLDS---GLPFAVKILEKNRIIHLKITDQIKREIATLKLL 71
                  +G G+FG V     LD+    +  AVK L  NRI  +    Q   E   +K  
Sbjct: 28  IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEVSQFLTEGIIMKDF 85

Query: 72  KHPNVVRLHEV-LASKSKIYMVLEYVTGGELFD-KIASKGRLQEAEGRKLFQQLIDGVSY 129
            HPNV+ L  + L S+    +VL Y+  G+L +            +      Q+  G+ +
Sbjct: 86  SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF 145

Query: 130 CHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTT--CGSPNYVAPEV 187
             +K   HRDL   N +LD K  +K++DFGL+        D + + T       ++A E 
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205

Query: 188 LANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGAQ 245
           L  + +    SD+WS GV+L+ ++T G  P+ D N   +   + +G     P++      
Sbjct: 206 LQTQKFTTK-SDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY 264

Query: 246 NLLRKILEPNPVKRITIAGIKA------DEWFEQDYTPANP 280
            ++ K   P    R + + + +        +  + Y   N 
Sbjct: 265 EVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNA 305

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 8e-54
 Identities = 75/338 (22%), Positives = 129/338 (38%), Gaps = 59/338 (17%)

Query: 13  LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK 72
           L RY+  + +G G  G V  A D       A+K L +    +     +  RE+  +K + 
Sbjct: 16  LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKCVN 74

Query: 73  HPNVVRLHEVLASKSK------IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDG 126
           H N++ L  V   +        +Y+V+E +           +  L       L  Q++ G
Sbjct: 75  HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI---QMELDHERMSYLLYQMLCG 131

Query: 127 VSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPE 186
           + + H+ G+ HRDLK  NI++ S   +KI DFGL+   +      ++     +  Y APE
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPE 188

Query: 187 VLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------- 232
           V+   GY     DIWS G I+  ++   + F  R+    + K+                 
Sbjct: 189 VILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247

Query: 233 ----------------------------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAG 264
                                       D +  K  +  A++LL K+L  +P KRI++  
Sbjct: 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 307

Query: 265 IKADEWFEQDYTPANPDDDEEDIF---VDNEAFSMHEV 299
                +    Y PA  +     I+   +D    ++ E 
Sbjct: 308 ALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEW 345

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (435), Expect = 9e-52
 Identities = 59/291 (20%), Positives = 116/291 (39%), Gaps = 22/291 (7%)

Query: 15  RYELGRTLGEGNFGKV-----KFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           +  + R LG+G+FG V     K     +     A+K + +     ++   +   E + +K
Sbjct: 21  KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMK 78

Query: 70  LLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGR----------LQEAEGRKL 119
                +VVRL  V++      +++E +T G+L   + S                ++  ++
Sbjct: 79  EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 120 FQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGS 179
             ++ DG++Y +     HRDL   N ++     +KI DFG++                  
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 180 PNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGD-FKLP 237
             +++PE L +  +   + D+WS GV+L+ I T    P+   +   + + +  G     P
Sbjct: 199 VRWMSPESLKDGVFTTYS-DVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257

Query: 238 KWLSPGAQNLLRKILEPNPVKRITIAGIKA--DEWFEQDYTPANPDDDEED 286
                    L+R   + NP  R +   I +   E  E  +   +    EE+
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEEN 308

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (425), Expect = 2e-50
 Identities = 62/294 (21%), Positives = 111/294 (37%), Gaps = 48/294 (16%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
               L  ++G+G FG+V   +    G   AVKI               + EI    +L+H
Sbjct: 3   RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSW----FREAEIYQTVMLRH 56

Query: 74  PNVVRLHEVL----ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSY 129
            N++           + +++++V +Y   G LFD + ++  +      KL      G+++
Sbjct: 57  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAH 115

Query: 130 CH--------NKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--DGLLHTTCGS 179
            H           + HRDLK +NIL+   G   I+D GL+       D  D   +   G+
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGT 175

Query: 180 PNYVAPEVL-----ANRGYDGATSDIWSCGVILYVILTGYLPFD---------------D 219
             Y+APEVL              +DI++ G++ + I                       D
Sbjct: 176 KRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235

Query: 220 RNLAVLYQKIFRGDFKLP---KWLSPGA----QNLLRKILEPNPVKRITIAGIK 266
            ++  + + +     +     +W S  A      ++R+    N   R+T   IK
Sbjct: 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 289

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 2e-49
 Identities = 63/276 (22%), Positives = 107/276 (38%), Gaps = 27/276 (9%)

Query: 15  RYELGRTLGEGNFGKVKFAQD-----LDSGLPFAVKILEKNRIIHLKITDQIKREIATLK 69
           R +LG+ LG G FG+V  A         +    AVK+L++    H +    +      + 
Sbjct: 14  RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIH 72

Query: 70  LLKHPNVVRLHEVLASK-SKIYMVLEYVTGGELFDKIASKGR----------------LQ 112
           +  H NVV L          + +++E+   G L   + SK                  L 
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 113 EAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL 172
                    Q+  G+ +  ++   HRDL   NILL  K  +KI DFGL+       D   
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGY-LPFDDRNLAVLYQKIFR 231
                    ++APE + +R Y    SD+WS GV+L+ I +    P+    +   + +  +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK 251

Query: 232 GD--FKLPKWLSPGAQNLLRKILEPNPVKRITIAGI 265
                + P + +P     +       P +R T + +
Sbjct: 252 EGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 287

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  148 bits (373), Expect = 4e-42
 Identities = 58/333 (17%), Positives = 117/333 (35%), Gaps = 72/333 (21%)

Query: 14  GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH 73
            RY L R LG G+F  V  A+D+ +    A+KI+  +++     T+  + EI  L+ +  
Sbjct: 13  ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVND 68

Query: 74  PNVVRL-------------HEVLASKSKIYMVLEYVTGG---ELFDKIASKGRLQEAEGR 117
            +  +              H      + +++V+ +   G       K      +     +
Sbjct: 69  ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128

Query: 118 KLFQQLIDGVSYCHNK-GVFHRDLKLENILLDSKGNI-KISDFGLSALPQHFRDDGLLHT 175
           ++ +QL+ G+ Y H + G+ H D+K EN+L++   +   +    ++ L      D     
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188

Query: 176 TCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY--------- 226
           +  +  Y +PEVL    +    +DIWS   +++ ++TG   F+                 
Sbjct: 189 SIQTREYRSPEVLLGAPWGCG-ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247

Query: 227 ---------------------------------------QKIFRGDFKLPKWLSPGAQNL 247
                                                  + +    +K  K  +    + 
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

Query: 248 LRKILEPNPVKRITIAGIKADEWFEQDYTPANP 280
           L  +L+ +P KR    G+    W  +D      
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWL-KDTLGMEE 339

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 92.5 bits (229), Expect = 6e-23
 Identities = 35/210 (16%), Positives = 71/210 (33%), Gaps = 36/210 (17%)

Query: 16  YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITD---------------Q 60
             +G+ +GEG    V             VK  +       K+ +                
Sbjct: 2   DAIGKLMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60

Query: 61  IKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLF 120
            + E   L+ L+   V +++          +++E +   EL+         +     ++ 
Sbjct: 61  ARNEFRALQKLQGLAVPKVYAW----EGNAVLMELIDAKELYRV-------RVENPDEVL 109

Query: 121 QQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSP 180
             +++ V+  +++G+ H DL   N+L+  +G I I DF  S          +L     + 
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRNI 168

Query: 181 NYVAPEVLANRGYDGATSDIWSCGVILYVI 210
                    +R Y     DI S   I  ++
Sbjct: 169 IT-----YFSRTY-RTEKDINS--AIDRIL 190

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	344
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.94
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.79
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.44
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.33
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.66
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.61
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.12

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-68  Score=465.64  Aligned_cols=259  Identities=32%  Similarity=0.667  Sum_probs=240.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +.+++|++++.||+|+||+||+|+++.+|+.||+|++.+.........+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus         3 ~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~   82 (263)
T d2j4za1           3 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY   82 (263)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred             cchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEE
Confidence            56899999999999999999999999999999999998765555556778999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      +|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|....    .
T Consensus        83 ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----~  158 (263)
T d2j4za1          83 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----S  158 (263)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----C
T ss_pred             EEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC----C
Confidence            999999999999999988999999999999999999999999999999999999999999999999999997533    2


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK  250 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~  250 (344)
                      ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......++.+..+.+|+.+|+++++||.+
T Consensus       159 ~~~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  237 (263)
T d2j4za1         159 SRRTTLCGTLDYLPPEMIEGRMH-DEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISR  237 (263)
T ss_dssp             CCCEETTEEGGGCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHH
T ss_pred             CcccccCCCCcccCHHHHcCCCC-CchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            23456789999999999988776 68999999999999999999999999999999999999999999999999999999


Q ss_pred             hcCCCcCCCCCHhhhhcCcccccc
Q 019216          251 ILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       251 ~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ||+.||++|||++|+|+||||...
T Consensus       238 ~L~~dp~~R~t~~eil~hp~~~~~  261 (263)
T d2j4za1         238 LLKHNPSQRPMLREVLEHPWITAN  261 (263)
T ss_dssp             HTCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HccCCHhHCcCHHHHHcCcCcCCc
Confidence            999999999999999999999764

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-66  Score=462.83  Aligned_cols=262  Identities=33%  Similarity=0.595  Sum_probs=236.0

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      ..-++|++++.||+|+||.||+|.++.+|+.||||++.+.........+.+.+|+.++++++||||+++++++.+.+.+|
T Consensus         5 ~~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~   84 (288)
T d1uu3a_           5 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLY   84 (288)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEE
T ss_pred             CCCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEE
Confidence            44578999999999999999999999999999999998765544556678999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      +|||||+||+|.+++...+.+++..++.++.|++.||+|||++||+||||||+|||+++++.+||+|||+|+........
T Consensus        85 ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          85 FGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             EEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999865543344


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK  250 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~  250 (344)
                      ......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+..++.+..+.+|..+++++++||++
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~  243 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSA-CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEK  243 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHT
T ss_pred             cccccccCCccccCceeeccCCC-CcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            44556789999999999988776 68999999999999999999999999999999999999999999999999999999


Q ss_pred             hcCCCcCCCCCHhh------hhcCccccc
Q 019216          251 ILEPNPVKRITIAG------IKADEWFEQ  273 (344)
Q Consensus       251 ~L~~dP~~Rps~~e------il~~~~~~~  273 (344)
                      ||+.||++|||++|      +++||||+.
T Consensus       244 ~L~~dP~~R~t~~e~~~~~~i~~Hpff~~  272 (288)
T d1uu3a_         244 LLVLDATKRLGCEEMEGYGPLKAHPFFES  272 (288)
T ss_dssp             TSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             HccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence            99999999999988      578899864

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-66  Score=459.10  Aligned_cols=260  Identities=38%  Similarity=0.674  Sum_probs=223.8

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +++|++++.||+|+||+||+|.++.+|+.||||++.+....  +..+.+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEE
Confidence            57899999999999999999999999999999999765432  2346788999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||||+||+|.+++.+++.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+..........
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999999986543333334


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHH-HHHHhhCCCC--CCCCCCHHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL-YQKIFRGDFK--LPKWLSPGAQNLLR  249 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~-~~~i~~~~~~--~~~~~~~~~~~li~  249 (344)
                      ....+||+.|+|||++.+..+++.++|||||||++|+|++|++||...+.... ...+......  .+..+|+++.+||.
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  241 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLH  241 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHH
Confidence            45678999999999999888777889999999999999999999977554322 2233332222  23458999999999


Q ss_pred             HhcCCCcCCCCCHhhhhcCcccccc
Q 019216          250 KILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       250 ~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +||+.||++|||++|+|+||||++.
T Consensus       242 ~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         242 KILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             HHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHcCCChhHCcCHHHHhcCHhhCcC
Confidence            9999999999999999999999764

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-65  Score=463.34  Aligned_cols=260  Identities=32%  Similarity=0.628  Sum_probs=241.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +++++|++++.||+|+||.||+|+++.+|+.||||++.+.........+.+.+|+.+|++++||||+++++++.+...+|
T Consensus         2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~   81 (337)
T d1o6la_           2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC   81 (337)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred             CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence            57899999999999999999999999999999999998765545556788999999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           91 MVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      +|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....  ..
T Consensus        82 iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~  159 (337)
T d1o6la_          82 FVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DG  159 (337)
T ss_dssp             EEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TT
T ss_pred             cceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CC
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999985332  23


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHH
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRK  250 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~  250 (344)
                      ......+||+.|+|||++.+.++ +.++|||||||++|||++|++||.+.+...+...+..+.+.+|..+|+++++||++
T Consensus       160 ~~~~~~~GT~~Y~aPE~~~~~~y-~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~  238 (337)
T d1o6la_         160 ATMKTFCGTPEYLAPEVLEDNDY-GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAG  238 (337)
T ss_dssp             CCBCCCEECGGGCCGGGGSSSCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred             cccccceeCHHHhhhhhccCCCC-ChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHh
Confidence            34556799999999999998887 68999999999999999999999999999999999999999999999999999999


Q ss_pred             hcCCCcCCCCC-----HhhhhcCccccc
Q 019216          251 ILEPNPVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       251 ~L~~dP~~Rps-----~~eil~~~~~~~  273 (344)
                      ||++||++|++     ++|+++||||.+
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             hccCCchhhcccccccHHHHHcCccccc
Confidence            99999999995     899999999975

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-64  Score=449.94  Aligned_cols=254  Identities=26%  Similarity=0.463  Sum_probs=226.0

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      -++|++++.||+|+||+||+|.++.+|+.||||++......   ..+.+.+|+.++++++||||+++++++.+.+.+|+|
T Consensus        19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv   95 (293)
T d1yhwa1          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV   95 (293)
T ss_dssp             TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             ccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEE
Confidence            35899999999999999999999999999999999765432   246789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||||+||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....  ....
T Consensus        96 mEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~  172 (293)
T d1yhwa1          96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSK  172 (293)
T ss_dssp             EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCC
T ss_pred             EEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--cccc
Confidence            999999999988765 5799999999999999999999999999999999999999999999999999985432  2233


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC---CCCCCCCCCHHHHHHHH
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG---DFKLPKWLSPGAQNLLR  249 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~li~  249 (344)
                      ....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+...   .+..|..+++.+++||.
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  251 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAY-GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN  251 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred             ccccccCCCccChhhhcCCCC-CchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence            456789999999999988776 68999999999999999999999988876666655544   34456779999999999


Q ss_pred             HhcCCCcCCCCCHhhhhcCccccc
Q 019216          250 KILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       250 ~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      +||+.||++|||++|+|+||||+.
T Consensus       252 ~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         252 RCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             HHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             HHccCChhHCcCHHHHhcCHhhCC
Confidence            999999999999999999999974

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.1e-64  Score=452.72  Aligned_cols=256  Identities=32%  Similarity=0.693  Sum_probs=238.7

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.++++++||||+++++++.+.+.+|+
T Consensus         2 sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i   81 (316)
T d1fota_           2 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM   81 (316)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred             chhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeee
Confidence            57899999999999999999999999999999999987655455567889999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |||||+|++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....     
T Consensus        82 vmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----  156 (316)
T d1fota_          82 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----  156 (316)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----
T ss_pred             EeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----
Confidence            999999999999999999999999999999999999999999999999999999999999999999999985432     


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI  251 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  251 (344)
                      .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......++..+...+|..+++++.++|.+|
T Consensus       157 ~~~~~~Gt~~Y~APE~l~~~~y-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~  235 (316)
T d1fota_         157 VTYTLCGTPDYIAPEVVSTKPY-NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL  235 (316)
T ss_dssp             CBCCCCSCTTTCCHHHHTTCCB-CTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             ccccccCcccccCHHHHcCCCC-CchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence            2346789999999999988777 589999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCcCCCC-----CHhhhhcCccccc
Q 019216          252 LEPNPVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       252 L~~dP~~Rp-----s~~eil~~~~~~~  273 (344)
                      |++||.+|+     |++++++||||++
T Consensus       236 L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         236 ITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             TCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             hhhCHHhccccchhhHHHHHcCccccc
Confidence            999999996     8999999999975

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-63  Score=448.56  Aligned_cols=256  Identities=38%  Similarity=0.710  Sum_probs=214.9

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      -++|++++.||+|+||+||+|+++.+|+.||||++.+.....  ....+.+|+.+|++++||||+++++++.+++.+|+|
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv   85 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI   85 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence            467999999999999999999999999999999997654332  235688999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEc---cCCCeEEeccccccCCCcccC
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD---SKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~---~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+.   +++.+||+|||+|+....   
T Consensus        86 mE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~---  162 (307)
T d1a06a_          86 MQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---  162 (307)
T ss_dssp             ECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             EeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC---
Confidence            99999999999999988999999999999999999999999999999999999995   578999999999985432   


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCCCHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSPGAQ  245 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~  245 (344)
                      .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......++    ..+|+++.
T Consensus       163 ~~~~~~~~GT~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  241 (307)
T d1a06a_         163 GSVLSTACGTPGYVAPEVLAQKPY-SKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK  241 (307)
T ss_dssp             ----------CTTSCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHH
T ss_pred             CCeeeeeeeCccccCcHHHcCCCC-CcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHH
Confidence            333456789999999999988776 6899999999999999999999999998888899988766543    56899999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          246 NLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +||.+||+.||++|||++|+++||||++.
T Consensus       242 ~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         242 DFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999999999764

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-64  Score=441.43  Aligned_cols=256  Identities=30%  Similarity=0.536  Sum_probs=217.6

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee--CCeE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS--KSKI   89 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~--~~~~   89 (344)
                      +.++|++++.||+|+||.||+|+++.+|+.||+|++.+... .....+.+.+|++++++++||||+++++++.+  ...+
T Consensus         2 r~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~   80 (269)
T d2java1           2 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL   80 (269)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CE
T ss_pred             CchhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEE
Confidence            35789999999999999999999999999999999976654 33456789999999999999999999999854  4568


Q ss_pred             EEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeecCCCCcEEEccCCCeEEecccc
Q 019216           90 YMVLEYVTGGELFDKIAS----KGRLQEAEGRKLFQQLIDGVSYCHNKG-----VFHRDLKLENILLDSKGNIKISDFGL  160 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~~-----i~H~dikp~NILl~~~~~vkl~Dfg~  160 (344)
                      |+|||||+||+|.+++.+    .+.+++..++.++.||+.||.|||+.|     |+||||||+|||++.++.+||+|||+
T Consensus        81 ~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~  160 (269)
T d2java1          81 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL  160 (269)
T ss_dssp             EEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred             EEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccc
Confidence            999999999999998863    467999999999999999999999976     99999999999999999999999999


Q ss_pred             ccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC-CCCCC
Q 019216          161 SALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF-KLPKW  239 (344)
Q Consensus       161 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~-~~~~~  239 (344)
                      |+....  ........+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.+...+..++..+.. .+|..
T Consensus       161 a~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~-~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~  237 (269)
T d2java1         161 ARILNH--DTSFAKAFVGTPYYMSPEQMNRMSY-NEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR  237 (269)
T ss_dssp             HHHC-------------CCCSCCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred             eeeccc--CCCccccCCCCcccCCHHHHcCCCC-ChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence            985432  2233456789999999999988776 6899999999999999999999999998888888888765 46788


Q ss_pred             CCHHHHHHHHHhcCCCcCCCCCHhhhhcCccc
Q 019216          240 LSPGAQNLLRKILEPNPVKRITIAGIKADEWF  271 (344)
Q Consensus       240 ~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~  271 (344)
                      +|+++.+||.+||+.||++|||++|+++|||+
T Consensus       238 ~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         238 YSDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            99999999999999999999999999999995

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2e-63  Score=447.22  Aligned_cols=256  Identities=25%  Similarity=0.365  Sum_probs=229.6

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+.........+.+.+|+.++++++||||+++++++.+.+.+|+||
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~   94 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence            35999999999999999999999999999999998776666667788999999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCcc
Q 019216           94 EYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLL  173 (344)
Q Consensus        94 e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~  173 (344)
                      |||.+|+|..++...+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|.....      .
T Consensus        95 E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~  168 (309)
T d1u5ra_          95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------A  168 (309)
T ss_dssp             ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------B
T ss_pred             EecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------C
Confidence            9999999987777788999999999999999999999999999999999999999999999999999985322      3


Q ss_pred             ccccCCCcccchhhhccC--CCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC--CCCCCCHHHHHHHH
Q 019216          174 HTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK--LPKWLSPGAQNLLR  249 (344)
Q Consensus       174 ~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~--~~~~~~~~~~~li~  249 (344)
                      ...+||+.|+|||++.+.  ..++.++|||||||++|+|++|+.||.+.+......++..+..+  .+..+|+.+++||.
T Consensus       169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~  248 (309)
T d1u5ra_         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVD  248 (309)
T ss_dssp             CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHH
T ss_pred             CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence            456899999999998642  23468999999999999999999999998887777777766543  24558999999999


Q ss_pred             HhcCCCcCCCCCHhhhhcCccccccC
Q 019216          250 KILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       250 ~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      +||+.||++|||++|+|+||||....
T Consensus       249 ~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         249 SCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             HHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            99999999999999999999997643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.6e-63  Score=453.99  Aligned_cols=258  Identities=34%  Similarity=0.667  Sum_probs=239.7

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      ...+++|++++.||+|+||.||+|.++.+|+.||||++.+.........+.+.+|+.+|+.++||||+++++++.....+
T Consensus        37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~  116 (350)
T d1rdqe_          37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL  116 (350)
T ss_dssp             CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccc
Confidence            45689999999999999999999999999999999999766555555677899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      ++||||+.||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|+....   
T Consensus       117 ~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~---  193 (350)
T d1rdqe_         117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG---  193 (350)
T ss_dssp             EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred             ccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence            99999999999999999989999999999999999999999999999999999999999999999999999985432   


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLR  249 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~  249 (344)
                        .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......++..+.+.+|..+++++.+||+
T Consensus       194 --~~~~~~Gt~~Y~APE~~~~~~~-~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~  270 (350)
T d1rdqe_         194 --RTWTLCGTPEALAPEIILSKGY-NKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR  270 (350)
T ss_dssp             --CBCCCEECGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred             --ccccccCccccCCHHHHcCCCC-CccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence              2345789999999999988777 6899999999999999999999999999999999999999999999999999999


Q ss_pred             HhcCCCcCCCC-----CHhhhhcCccccc
Q 019216          250 KILEPNPVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       250 ~~L~~dP~~Rp-----s~~eil~~~~~~~  273 (344)
                      +||+.||.+|+     |++++++||||+.
T Consensus       271 ~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         271 NLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHhhhCHHhccccccccHHHHHcCccccC
Confidence            99999999995     9999999999975

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-63  Score=444.77  Aligned_cols=256  Identities=27%  Similarity=0.429  Sum_probs=225.4

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVL   93 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~   93 (344)
                      +.|++++.||+|+||.||+|+++.+|+.||+|++.+..   ....+.+.+|+++|++++||||+++++++.+.+.+|+||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence            47999999999999999999999999999999997643   233567889999999999999999999999999999999


Q ss_pred             eccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           94 EYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        94 e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      |||+||+|.+++.+ .+++++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|+.....  ...
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~--~~~  166 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQR  166 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH--HHH
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC--ccc
Confidence            99999999998765 457999999999999999999999999999999999999999999999999998743221  112


Q ss_pred             cccccCCCcccchhhhcc----CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC---CCCCCCCHHHH
Q 019216          173 LHTTCGSPNYVAPEVLAN----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF---KLPKWLSPGAQ  245 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~----~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~---~~~~~~~~~~~  245 (344)
                      ....+||+.|+|||++..    ...++.++|||||||++|+|++|+.||.+.+......++..+..   ..|..+|++++
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~  246 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFK  246 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHH
Confidence            345789999999999853    23346899999999999999999999999888888888877653   34567899999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          246 NLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      +||.+||+.||++|||++|+++||||+..
T Consensus       247 ~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         247 DFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.4e-62  Score=448.94  Aligned_cols=261  Identities=30%  Similarity=0.585  Sum_probs=233.6

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      +-.+++|++++.||+|+||.||+|.++.+|+.||||++.+..   ....+.+.+|+.+|++++||||+++++++.+.+.+
T Consensus        22 ~~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   98 (350)
T d1koaa2          22 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEM   98 (350)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEE
T ss_pred             CCCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            345789999999999999999999999999999999996543   23456789999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc--CCCeEEeccccccCCCc
Q 019216           90 YMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS--KGNIKISDFGLSALPQH  166 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~-~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~--~~~vkl~Dfg~a~~~~~  166 (344)
                      |+|||||+||+|.+++. ..+++++..++.++.||+.||.|||++||+||||||+|||++.  ++.+||+|||+++... 
T Consensus        99 ~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~-  177 (350)
T d1koaa2          99 VMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-  177 (350)
T ss_dssp             EEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC-
T ss_pred             EEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc-
Confidence            99999999999999985 4567999999999999999999999999999999999999964  5789999999998543 


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCCCH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLSP  242 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~  242 (344)
                        ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......++    ..+|+
T Consensus       178 --~~~~~~~~~gT~~Y~aPEv~~~~~~-~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  254 (350)
T d1koaa2         178 --PKQSVKVTTGTAEFAAPEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISE  254 (350)
T ss_dssp             --TTSCEEEECSCTTTCCHHHHHTCCB-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCH
T ss_pred             --cccccceecCcccccCHHHHcCCCC-ChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence              2334456789999999999988777 6899999999999999999999999999999999988876655    34899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      ++++||.+||+.||++|||++|+|+||||++...+
T Consensus       255 ~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         255 DGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             HHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             HHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            99999999999999999999999999999876544

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-62  Score=433.53  Aligned_cols=252  Identities=26%  Similarity=0.483  Sum_probs=219.4

Q ss_pred             cCe-EEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee----CCe
Q 019216           14 GRY-ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS----KSK   88 (344)
Q Consensus        14 ~~y-~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~----~~~   88 (344)
                      ||| ++.++||+|+||+||+|.++.+++.||+|.+..... .....+.+.+|+++|++++||||+++++++..    ...
T Consensus         8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~   86 (270)
T d1t4ha_           8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC   86 (270)
T ss_dssp             SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred             CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence            456 678899999999999999999999999999876543 33456789999999999999999999999864    456


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeecCCCCcEEEc-cCCCeEEeccccccCCC
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKG--VFHRDLKLENILLD-SKGNIKISDFGLSALPQ  165 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~--i~H~dikp~NILl~-~~~~vkl~Dfg~a~~~~  165 (344)
                      +|+|||||+||+|.+++.+.+.+++..++.++.||+.||+|||++|  |+||||||+|||++ +++.+||+|||+|+.. 
T Consensus        87 ~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~-  165 (270)
T d1t4ha_          87 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-  165 (270)
T ss_dssp             EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC-
T ss_pred             EEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceec-
Confidence            8999999999999999999899999999999999999999999998  99999999999996 5789999999999743 


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCc-cHHHHHHHHhhCCC--CCCCCCCH
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDR-NLAVLYQKIFRGDF--KLPKWLSP  242 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~-~~~~~~~~i~~~~~--~~~~~~~~  242 (344)
                         ........+||+.|+|||++.+ .+ +.++|||||||++|+|++|+.||.+. +...+...+..+..  .++..+++
T Consensus       166 ---~~~~~~~~~GT~~Y~aPE~~~~-~~-~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~  240 (270)
T d1t4ha_         166 ---RASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP  240 (270)
T ss_dssp             ---CTTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred             ---cCCccCCcccCccccCHHHhCC-CC-CCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCH
Confidence               2334456789999999999865 44 68999999999999999999999765 45555666665532  34566899


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhcCcccc
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKADEWFE  272 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~~~~~~  272 (344)
                      ++.+||.+||+.||++|||++|+|+||||+
T Consensus       241 ~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999999999999995

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-62  Score=444.96  Aligned_cols=258  Identities=33%  Similarity=0.600  Sum_probs=234.8

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHH-hCCCCCccceeeEEeeCCeEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLK-LLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      +++|++++.||+|+||+||+|+++.+|+.||||++++.........+.+..|..++. .++||||+++++++.+++.+|+
T Consensus         1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi   80 (320)
T d1xjda_           1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF   80 (320)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence            478999999999999999999999999999999998655444444566777777665 6899999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++++||+|||+++....  ...
T Consensus        81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~  158 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDA  158 (320)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTC
T ss_pred             EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--ccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999985432  223


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHHHHHHh
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQNLLRKI  251 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~  251 (344)
                      .....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+...+..++..+.+.+|+.+|+++.+||++|
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~  237 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKY-NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL  237 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCCC-CchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence            3455789999999999998887 589999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCcCCCCCHh-hhhcCccccc
Q 019216          252 LEPNPVKRITIA-GIKADEWFEQ  273 (344)
Q Consensus       252 L~~dP~~Rps~~-eil~~~~~~~  273 (344)
                      |+.||++|||+. ++++||||++
T Consensus       238 L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         238 FVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             cccCCCCCcCHHHHHHhCchhcc
Confidence            999999999996 8999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-62  Score=439.02  Aligned_cols=257  Identities=35%  Similarity=0.608  Sum_probs=232.2

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc---hhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH---LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKI   89 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~   89 (344)
                      -++|++++.||+|+||+||+|+++.+|+.||||++.+.....   ....+.+.+|+.+|++++||||+++++++.+...+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~   88 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV   88 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            367999999999999999999999999999999997654322   22467899999999999999999999999999999


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC----CeEEeccccccCCC
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG----NIKISDFGLSALPQ  165 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~----~vkl~Dfg~a~~~~  165 (344)
                      |+|||||+||+|.+++.+.+.+++..++.++.|++.||+|||++||+||||||+|||++.++    .+||+|||++....
T Consensus        89 ~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~  168 (293)
T d1jksa_          89 ILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID  168 (293)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred             EEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence            99999999999999999888999999999999999999999999999999999999998877    49999999997543


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCCC
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS  241 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~  241 (344)
                         .........||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+.......+......++    ..+|
T Consensus       169 ---~~~~~~~~~~t~~y~APE~~~~~~~-~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (293)
T d1jksa_         169 ---FGNEFKNIFGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  244 (293)
T ss_dssp             ---TSCBCSCCCCCGGGCCHHHHTTCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             ---CCccccccCCCCcccCHHHHcCCCC-CCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence               2333456789999999999987766 6899999999999999999999999999999999988876654    5689


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                      +.+++||++||+.||++|||++|+++||||+.
T Consensus       245 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  276 (293)
T d1jksa_         245 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  276 (293)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            99999999999999999999999999999975

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.9e-62  Score=448.35  Aligned_cols=262  Identities=29%  Similarity=0.568  Sum_probs=234.0

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      .+-.+++|++++.||+|+||.||+|.++.+|+.||||++.+...   .....+.+|+.+|++++||||+++++++.++..
T Consensus        24 ~~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~  100 (352)
T d1koba_          24 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE  100 (352)
T ss_dssp             CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred             CCCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcch---hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCE
Confidence            44567889999999999999999999999999999999875432   334678899999999999999999999999999


Q ss_pred             EEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEc--cCCCeEEeccccccCCC
Q 019216           89 IYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLD--SKGNIKISDFGLSALPQ  165 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~--~~~~vkl~Dfg~a~~~~  165 (344)
                      +|+|||||+||+|.+.+... .++++..++.++.||+.||.|||++||+||||||+|||++  .++.+||+|||+|....
T Consensus       101 ~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~  180 (352)
T d1koba_         101 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN  180 (352)
T ss_dssp             EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred             EEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC
Confidence            99999999999999887654 4699999999999999999999999999999999999997  56899999999998543


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCC----CCCC
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLP----KWLS  241 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~  241 (344)
                         ........+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+......++......++    ..+|
T Consensus       181 ---~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  256 (352)
T d1koba_         181 ---PDEIVKVTTATAEFAAPEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS  256 (352)
T ss_dssp             ---TTSCEEEECSSGGGCCHHHHTTCCB-CHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred             ---CCCceeeccCcccccCHHHHcCCCC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCC
Confidence               2334556789999999999988777 6899999999999999999999999999999999988876655    4589


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      +++.+||.+||+.||.+|||++|+|+||||+.....
T Consensus       257 ~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~  292 (352)
T d1koba_         257 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN  292 (352)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcch
Confidence            999999999999999999999999999999875443

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=7.3e-62  Score=430.63  Aligned_cols=258  Identities=31%  Similarity=0.548  Sum_probs=231.0

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccc------hhHHHHHHHHHHHHHhCC-CCCccceeeEEee
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH------LKITDQIKREIATLKLLK-HPNVVRLHEVLAS   85 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~   85 (344)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.....      ....+.+.+|+.++++++ ||||+++++++.+
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            478999999999999999999999999999999997654322      224457889999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      .+.+|+|||||+||+|.+++..++++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~  161 (277)
T d1phka_          82 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD  161 (277)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             CcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence            99999999999999999999998999999999999999999999999999999999999999999999999999998543


Q ss_pred             cccCCCccccccCCCcccchhhhcc-----CCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCC--
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLAN-----RGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK--  238 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--  238 (344)
                      .   .......+||+.|+|||++.+     ....+.++||||+||++|+|++|+.||.+.+.......+..+....+.  
T Consensus       162 ~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~  238 (277)
T d1phka_         162 P---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE  238 (277)
T ss_dssp             T---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred             C---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc
Confidence            2   223455789999999999864     223468899999999999999999999999999988888888765443  


Q ss_pred             --CCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          239 --WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       239 --~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                        .+|+++++||.+||+.||++|||++|+|+||||++
T Consensus       239 ~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             GGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             cccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence              58999999999999999999999999999999975

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.1e-62  Score=449.20  Aligned_cols=259  Identities=27%  Similarity=0.451  Sum_probs=226.0

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHH---HHHHHHHhCCCCCccceeeEEeeCC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIK---REIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~---~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      +++++|++++.||+|+||.||+|+++.+|+.||||++.+...........+.   +++.+++.++||||+++++++...+
T Consensus         1 lslddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~   80 (364)
T d1omwa3           1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD   80 (364)
T ss_dssp             CCSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred             CCHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECC
Confidence            4789999999999999999999999999999999999765443322223333   4577778888999999999999999


Q ss_pred             eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           88 KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      .+|+|||||+||+|.+++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.... 
T Consensus        81 ~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~-  159 (364)
T d1omwa3          81 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-  159 (364)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS-
T ss_pred             EEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC-
Confidence            9999999999999999999989999999999999999999999999999999999999999999999999999985432 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHHhhCCCCCCCCCCHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGDFKLPKWLSPGA  244 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~  244 (344)
                         ......+||+.|+|||++.....++.++|||||||++|+|++|+.||.+.+   .......+......+|..+|+++
T Consensus       160 ---~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  236 (364)
T d1omwa3         160 ---KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL  236 (364)
T ss_dssp             ---SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHH
T ss_pred             ---CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHH
Confidence               234557899999999999765555789999999999999999999998644   33444555566777888999999


Q ss_pred             HHHHHHhcCCCcCCCCC-----HhhhhcCccccc
Q 019216          245 QNLLRKILEPNPVKRIT-----IAGIKADEWFEQ  273 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps-----~~eil~~~~~~~  273 (344)
                      ++||.+||+.||++|||     ++|+++||||++
T Consensus       237 ~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         237 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             HHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             HHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            99999999999999999     799999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-63  Score=447.30  Aligned_cols=256  Identities=29%  Similarity=0.444  Sum_probs=218.0

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .-++|+++++||+|+||+||+|.++.+|+.||+|++++..  .......+.+|+.+|++++||||+++++++.+...+|+
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            4578999999999999999999999999999999997543  23445788999999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      |||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|+....    
T Consensus        82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~----  157 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----  157 (322)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC----
Confidence            99999999999999988899999999999999999999997 5999999999999999999999999999984322    


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHH------------------------
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLY------------------------  226 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~------------------------  226 (344)
                      ....+.+||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+.+.....                        
T Consensus       158 ~~~~~~~GT~~Y~APEvl~~~~y-~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         158 SMANSFVGTRSYMSPERLQGTHY-SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             HTC---CCSSCCCCHHHHHCSCC-CTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             CccccccCCccccCchHHcCCCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence            22345789999999999998776 68999999999999999999999765422110                        


Q ss_pred             ------------------HHHhhC-CCCCC-CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          227 ------------------QKIFRG-DFKLP-KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       227 ------------------~~i~~~-~~~~~-~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                                        ..+... ....+ ..+|+++.+||.+||+.||.+|||++|+|+||||++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~  304 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  304 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHH
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcC
Confidence                              011111 11122 2368899999999999999999999999999999863

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-61  Score=436.85  Aligned_cols=256  Identities=25%  Similarity=0.484  Sum_probs=230.6

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~i   91 (344)
                      .+++|++++.||+|+||+||+|.++.+|+.||+|++++...    ....+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~l   78 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVM   78 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEE
Confidence            36899999999999999999999999999999999976432    23567899999999999999999999999999999


Q ss_pred             EEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC--CCeEEeccccccCCCccc
Q 019216           92 VLEYVTGGELFDKIASKG-RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK--GNIKISDFGLSALPQHFR  168 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~-~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~--~~vkl~Dfg~a~~~~~~~  168 (344)
                      |||||+|++|.+++...+ ++++.+++.++.||+.||.|||++||+||||||+|||++.+  +.+||+|||+++...   
T Consensus        79 vmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~---  155 (321)
T d1tkia_          79 IFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK---  155 (321)
T ss_dssp             EECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC---
T ss_pred             EEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc---
Confidence            999999999999998655 79999999999999999999999999999999999999855  489999999997432   


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCC----CCCHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK----WLSPGA  244 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~  244 (344)
                      .........+|+.|+|||.+.+..+ +.++|||||||++|+|++|+.||.+.+......++.++...++.    .+|+++
T Consensus       156 ~~~~~~~~~~t~~y~ape~~~~~~~-~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  234 (321)
T d1tkia_         156 PGDNFRLLFTAPEYYAPEVHQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA  234 (321)
T ss_dssp             TTCEEEEEESCGGGSCHHHHTTCEE-CHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHH
T ss_pred             cCCcccccccccccccchhccCCCC-CchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHH
Confidence            2333456789999999999887776 68999999999999999999999999999999999998877763    689999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          245 QNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      ++||.+||+.||++|||++|+++||||++..
T Consensus       235 ~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  265 (321)
T d1tkia_         235 MDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHHHccCChhHCcCHHHHhcCHhhccCc
Confidence            9999999999999999999999999997643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-61  Score=428.70  Aligned_cols=251  Identities=34%  Similarity=0.604  Sum_probs=222.6

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccch---hHHHHHHHHHHHHHhCC--CCCccceeeEEeeCCe
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHL---KITDQIKREIATLKLLK--HPNVVRLHEVLASKSK   88 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--h~niv~l~~~~~~~~~   88 (344)
                      ++|++.+.||+|+||+||+|.++.+|+.||||++.+......   ....++.+|+.++++++  ||||+++++++.+.+.
T Consensus         4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~   83 (273)
T d1xwsa_           4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS   83 (273)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred             CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence            689999999999999999999999999999999976543321   12234668999999986  8999999999999999


Q ss_pred             EEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccC-CCeEEeccccccCCCc
Q 019216           89 IYMVLEYVTG-GELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSK-GNIKISDFGLSALPQH  166 (344)
Q Consensus        89 ~~iv~e~~~g-~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~-~~vkl~Dfg~a~~~~~  166 (344)
                      .|+||||+.+ +++.+++.+++.+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+... 
T Consensus        84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~-  162 (273)
T d1xwsa_          84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-  162 (273)
T ss_dssp             EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC-
T ss_pred             EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc-
Confidence            9999999976 6888888888999999999999999999999999999999999999999865 789999999997532 


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCCCCCHHHHH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPKWLSPGAQN  246 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  246 (344)
                         .......+||+.|+|||++.+..+++.++|||||||++|+|++|+.||.+.+      .+.++...++..+|+++++
T Consensus       163 ---~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~~~~  233 (273)
T d1xwsa_         163 ---DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQH  233 (273)
T ss_dssp             ---SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHHHHH
T ss_pred             ---cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHHHHH
Confidence               2334567899999999999888877788999999999999999999998743      4667788889999999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          247 LLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      ||++||+.||++|||++|+++||||++.
T Consensus       234 li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         234 LIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             HHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999999864

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-61  Score=431.71  Aligned_cols=259  Identities=25%  Similarity=0.328  Sum_probs=218.0

Q ss_pred             EEeeeecccCceEEEEEEECCCCceEEEEEeecccccc--hhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEe
Q 019216           17 ELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIH--LKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLE   94 (344)
Q Consensus        17 ~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e   94 (344)
                      +.+++||+|+||+||+|+++.+|+.||||+++......  ....+.+.+|+.++++++||||+++++++..++.+|+|||
T Consensus         1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence            35789999999999999999999999999987544322  1224568899999999999999999999999999999999


Q ss_pred             ccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCccc
Q 019216           95 YVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGLLH  174 (344)
Q Consensus        95 ~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~  174 (344)
                      ||.++++..+......+++..++.+++||+.||+|||++||+||||||+|||++.++.+||+|||+++....  ......
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~--~~~~~~  158 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYT  158 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--CCCCCC
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC--Cccccc
Confidence            999888877766677899999999999999999999999999999999999999999999999999975433  222344


Q ss_pred             cccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC--------------------
Q 019216          175 TTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF--------------------  234 (344)
Q Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~--------------------  234 (344)
                      ..+||+.|+|||++.....++.++|||||||++|+|++|++||.+.+..+...++.....                    
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK  238 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence            568999999999998776668999999999999999999999999888777776653100                    


Q ss_pred             CC--------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          235 KL--------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       235 ~~--------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                      ..        ...+++++.+||.+||+.||++|||++|+|+||||++...+
T Consensus       239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence            00        12468899999999999999999999999999999875544

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-59  Score=420.55  Aligned_cols=261  Identities=28%  Similarity=0.445  Sum_probs=219.4

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      +++|+++++||+|+||.||+|.++.+|+.||||++..... .....+.+.+|++++++++||||+++++++.+...+|+|
T Consensus         1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv   79 (298)
T d1gz8a_           1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV   79 (298)
T ss_dssp             CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence            5799999999999999999999999999999999965432 233456888999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC
Q 019216           93 LEYVTGGELFDKIA--SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD  170 (344)
Q Consensus        93 ~e~~~g~~L~~~l~--~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~  170 (344)
                      |||+.+ ++.+++.  ..+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....  ..
T Consensus        80 ~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~  156 (298)
T d1gz8a_          80 FEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PV  156 (298)
T ss_dssp             EECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CS
T ss_pred             EeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Cc
Confidence            999965 4445443  345699999999999999999999999999999999999999999999999999974322  22


Q ss_pred             CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCC----------------
Q 019216          171 GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDF----------------  234 (344)
Q Consensus       171 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~----------------  234 (344)
                      .......||+.|+|||.+....+.+.++|||||||++|+|++|+.||.+.+......++.....                
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            3344568999999999998888778999999999999999999999998887766665543100                


Q ss_pred             --CC-----------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          235 --KL-----------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       235 --~~-----------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                        ..           ...+++++.+||++||+.||++|||++|+|+||||++-..|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence              01           12367899999999999999999999999999999876554

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-59  Score=427.89  Aligned_cols=256  Identities=30%  Similarity=0.575  Sum_probs=215.9

Q ss_pred             ccCccccCeEEee-eecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHh-CCCCCccceeeEEee
Q 019216            8 QEGMRLGRYELGR-TLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKL-LKHPNVVRLHEVLAS   85 (344)
Q Consensus         8 ~~~~~~~~y~~~~-~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~-l~h~niv~l~~~~~~   85 (344)
                      +....+++|++++ .||+|+||.||+|.++.+|+.||||++++.        ..+.+|+.++.+ ++||||++++++|.+
T Consensus         5 ~~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~   76 (335)
T d2ozaa1           5 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN   76 (335)
T ss_dssp             BCSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred             CCCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEee
Confidence            3456689999985 599999999999999999999999998643        356789988654 589999999999865


Q ss_pred             ----CCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc---CCCeEEe
Q 019216           86 ----KSKIYMVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKIS  156 (344)
Q Consensus        86 ----~~~~~iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~---~~~vkl~  156 (344)
                          ...+|+|||||+||+|.+++.+.  .++++.+++.++.||+.||+|||++||+||||||+|||++.   ++.+||+
T Consensus        77 ~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~  156 (335)
T d2ozaa1          77 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT  156 (335)
T ss_dssp             EETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEEC
T ss_pred             cccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccc
Confidence                46789999999999999999864  36999999999999999999999999999999999999986   4579999


Q ss_pred             ccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHH----HHHHhhC
Q 019216          157 DFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVL----YQKIFRG  232 (344)
Q Consensus       157 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~----~~~i~~~  232 (344)
                      |||+|+....   .......+||+.|+|||++.+..+ +.++|||||||++|+|+||++||.+.+....    ...+..+
T Consensus       157 DFG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y-~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~  232 (335)
T d2ozaa1         157 DFGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG  232 (335)
T ss_dssp             CCTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGG-SHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSC
T ss_pred             ccceeeeccC---CCccccccCCcccCCcHHHcCCCC-CHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcC
Confidence            9999985432   333456789999999999988776 6899999999999999999999987654333    3334444


Q ss_pred             CCCCCC----CCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          233 DFKLPK----WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       233 ~~~~~~----~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                      ...+|.    .+|+++.+||++||+.||++|||+.|+++||||.+..
T Consensus       233 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  279 (335)
T d2ozaa1         233 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST  279 (335)
T ss_dssp             SSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred             CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence            555553    3799999999999999999999999999999997643

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.1e-59  Score=416.72  Aligned_cols=257  Identities=31%  Similarity=0.459  Sum_probs=218.8

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      ++||+++++||+|+||+||+|+++ +|+.||||++..... .....+.+.+|+.+|++++||||+++++++...+..+++
T Consensus         1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~   78 (286)
T d1ob3a_           1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV   78 (286)
T ss_dssp             CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred             CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence            579999999999999999999985 789999999966533 333457899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ||++.++.+..+....+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+||+|||.+.....  ....
T Consensus        79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~--~~~~  156 (286)
T d1ob3a_          79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRK  156 (286)
T ss_dssp             EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc--Cccc
Confidence            99998877777777778899999999999999999999999999999999999999999999999999874322  1222


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-------------------
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------------  233 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-------------------  233 (344)
                      .....+++.|+|||.+.+..+.+.++|||||||++|||++|+.||.+.+......++....                   
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T d1ob3a_         157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (286)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence            3445789999999999887777899999999999999999999999887776666654210                   


Q ss_pred             ----------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccc
Q 019216          234 ----------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQ  273 (344)
Q Consensus       234 ----------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~  273 (344)
                                ...+..+++.+.+||++||+.||++|||++|+|+||||++
T Consensus       237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence                      0123447899999999999999999999999999999975

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=8.6e-59  Score=411.85  Aligned_cols=259  Identities=27%  Similarity=0.420  Sum_probs=218.4

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC----e
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----K   88 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~   88 (344)
                      -++|++++.||+|+||.||+|.++.+|+.||||++.+....+......+.+|+.+++.++||||+++++++....    .
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            468999999999999999999999999999999998776666677788999999999999999999999987543    4


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +|+|||||+|++|.+++...+++++.+++.++.||+.||+|||++||+||||||+|||++.++.++|+|||.+.......
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~  165 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  165 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC---
T ss_pred             EEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcccc
Confidence            89999999999999999998999999999999999999999999999999999999999999999999999886433221


Q ss_pred             -CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCC----CCCCCHH
Q 019216          169 -DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKL----PKWLSPG  243 (344)
Q Consensus       169 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~----~~~~~~~  243 (344)
                       ........+||+.|+|||++.+..+ +.++|||||||++|+|+||++||.+.+......++.......    ...+|++
T Consensus       166 ~~~~~~~~~~Gt~~Y~aPE~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  244 (277)
T d1o6ya_         166 NSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSAD  244 (277)
T ss_dssp             -------------TTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHH
T ss_pred             ccccccccccCcccccCHHHHcCCCC-CcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHH
Confidence             2223445689999999999987766 689999999999999999999999998888887777765543    3568999


Q ss_pred             HHHHHHHhcCCCcCCCCCHhhhhcCcccc
Q 019216          244 AQNLLRKILEPNPVKRITIAGIKADEWFE  272 (344)
Q Consensus       244 ~~~li~~~L~~dP~~Rps~~eil~~~~~~  272 (344)
                      +.+||.+||++||++||+..+.+.|+|.+
T Consensus       245 l~~li~~~L~~dp~~R~~sa~~l~~~l~r  273 (277)
T d1o6ya_         245 LDAVVLKALAKNPENRYQTAAEMRADLVR  273 (277)
T ss_dssp             HHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             HHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence            99999999999999999544444566653

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.5e-58  Score=410.20  Aligned_cols=251  Identities=27%  Similarity=0.398  Sum_probs=217.6

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++.+.||+|+||+||+|.++.+|+.||||++++...    ..+.+.+|+.+|++++||||+++++++.+.+.++
T Consensus        14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (287)
T d1opja_          14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY   89 (287)
T ss_dssp             CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence            355789999999999999999999999999999999865432    2467899999999999999999999999999999


Q ss_pred             EEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIASK--GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +|||||++|+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+..... 
T Consensus        90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~-  168 (287)
T d1opja_          90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD-  168 (287)
T ss_dssp             EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS-
T ss_pred             EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCC-
Confidence            999999999999998754  56899999999999999999999999999999999999999999999999999864331 


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCC-CCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYL-PFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~-pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                      .........||+.|+|||++.+..+ +.++|||||||++|||++|.. ||.+.+.......+..+ .++.|..+++.+.+
T Consensus       169 ~~~~~~~~~g~~~y~aPE~~~~~~~-~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  247 (287)
T d1opja_         169 TYTAHAGAKFPIKWTAPESLAYNKF-SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYE  247 (287)
T ss_dssp             SSEEETTEEECGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             CceeeccccccccccChHHHcCCCC-CchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHH
Confidence            1112233468899999999988776 689999999999999999554 55666666666666554 46678889999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhc
Q 019216          247 LLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~  267 (344)
                      ||.+||+.||++|||++++++
T Consensus       248 li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         248 LMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHH
Confidence            999999999999999999976

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.3e-58  Score=409.99  Aligned_cols=256  Identities=22%  Similarity=0.352  Sum_probs=211.0

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCc---eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGL---PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~---~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      .+..++|++.++||+|+||+||+|.++.+++   .||||.+....  .....+.+.+|+.+|++++||||+++++++...
T Consensus        22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~   99 (299)
T d1jpaa_          22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKS   99 (299)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred             hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence            3567899999999999999999999987665   58888875432  344567899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 SKIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      +.+++|||||++|+|.+++.. .+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus       100 ~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  179 (299)
T d1jpaa_         100 TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE  179 (299)
T ss_dssp             SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred             CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEcc
Confidence            999999999999999998876 4579999999999999999999999999999999999999999999999999998654


Q ss_pred             cccCCC---ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCC
Q 019216          166 HFRDDG---LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWL  240 (344)
Q Consensus       166 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~  240 (344)
                      ......   ......||+.|+|||.+.+..+ +.++|||||||++|||+| |+.||.+.+...+...+..+ ..+.|..+
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  258 (299)
T d1jpaa_         180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKF-TSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDC  258 (299)
T ss_dssp             ----------------CGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTC
T ss_pred             CCCCcceeeecccccCCccccCHHHHhcCCC-CcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence            322211   1223467899999999987776 689999999999999998 89999998888888887765 45677889


Q ss_pred             CHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          241 SPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       241 ~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ++.+.+|+.+||+.||++|||+.|++++
T Consensus       259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         259 PSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999998875

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-58  Score=409.03  Aligned_cols=253  Identities=25%  Similarity=0.401  Sum_probs=207.9

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++++.||+|+||+||+|+..   ..||||+++.... .....+.+.+|+.++++++||||+++++++.. +.++
T Consensus         5 i~~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~   79 (276)
T d1uwha_           5 IPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLA   79 (276)
T ss_dssp             CCTTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCE
T ss_pred             cccccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEE
Confidence            45689999999999999999999853   3599999975543 33457789999999999999999999998754 5689


Q ss_pred             EEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC
Q 019216           91 MVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD  169 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~  169 (344)
                      +|||||+||+|.+++... .++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus        80 lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          80 IVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             EEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             EEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999999999754 5699999999999999999999999999999999999999999999999999986554434


Q ss_pred             CCccccccCCCcccchhhhccC--CCCCccchhhhhhHHHHHHHhCCCCCCCccHHH-HHHHHhhCCC-----CCCCCCC
Q 019216          170 DGLLHTTCGSPNYVAPEVLANR--GYDGATSDIWSCGVILYVILTGYLPFDDRNLAV-LYQKIFRGDF-----KLPKWLS  241 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~-~~~~i~~~~~-----~~~~~~~  241 (344)
                      ........||+.|+|||++.+.  ..++.++|||||||++|||+||+.||.+.+... ....+..+..     ..+..++
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  239 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCP  239 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCC
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccch
Confidence            4445567899999999998643  234789999999999999999999998865443 3334433321     2456789


Q ss_pred             HHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          242 PGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       242 ~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +.+.+|+.+||+.||++|||+++++++
T Consensus       240 ~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         240 KAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999999987

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-58  Score=418.41  Aligned_cols=255  Identities=24%  Similarity=0.377  Sum_probs=215.7

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCc-----eEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEe
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGL-----PFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA   84 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~-----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~   84 (344)
                      +..++|++++.||+|+||+||+|++...++     .||+|.+....  .......+.+|+.++.++ +||||+++++++.
T Consensus        34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~  111 (325)
T d1rjba_          34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT  111 (325)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence            345799999999999999999999876543     69999886433  223456788999999988 8999999999999


Q ss_pred             eCCeEEEEEeccCCCChHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCC
Q 019216           85 SKSKIYMVLEYVTGGELFDKIASK-----------------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLK  141 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~~-----------------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dik  141 (344)
                      +.+.+|+|||||++|+|.+++.+.                       ..+++..++.++.||+.||+|||++||+|||||
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK  191 (325)
T d1rjba_         112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA  191 (325)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred             eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence            999999999999999999999754                       248899999999999999999999999999999


Q ss_pred             CCcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCc
Q 019216          142 LENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDR  220 (344)
Q Consensus       142 p~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~  220 (344)
                      |+|||++.++.+||+|||+|+...............||+.|+|||++.+..+ +.++|||||||++|||+| |+.||.+.
T Consensus       192 p~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwS~Gvil~emlt~g~~Pf~~~  270 (325)
T d1rjba_         192 ARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIY-TIKSDVWSYGILLWEIFSLGVNPYPGI  270 (325)
T ss_dssp             GGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCC-CcceeccchhHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999986544333333345678999999999988776 689999999999999998 89999987


Q ss_pred             cHHHHHHHHhhC--CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          221 NLAVLYQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       221 ~~~~~~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +......++...  .++.|..+|+++.+||.+||+.||++|||++||++|
T Consensus       271 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            655555555554  456678899999999999999999999999999876

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-58  Score=403.35  Aligned_cols=249  Identities=23%  Similarity=0.410  Sum_probs=209.7

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      -++|++++.||+|+||+||+|.++ +++.||||++.+...    ..+.+.+|+.++++++||||+++++++...+..++|
T Consensus         4 p~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv   78 (263)
T d1sm2a_           4 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV   78 (263)
T ss_dssp             CSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             hHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence            368999999999999999999985 567899999875432    235789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      ||||++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++...... ..
T Consensus        79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~  157 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT  157 (263)
T ss_dssp             EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC-ce
Confidence            9999999999988754 568999999999999999999999999999999999999999999999999998543321 12


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR  249 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~  249 (344)
                      ......||+.|+|||++.+..+ +.++|||||||++|||+| |.+||...+...+...+..+ ....|..+++++.+|+.
T Consensus       158 ~~~~~~gt~~y~aPE~l~~~~~-~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  236 (263)
T d1sm2a_         158 SSTGTKFPVKWASPEVFSFSRY-SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN  236 (263)
T ss_dssp             -------CTTSCCHHHHTTCCC-CHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred             eecceecCcccCChHHhcCCCC-CchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHH
Confidence            2334678999999999988776 689999999999999999 68888888888888887776 45567889999999999


Q ss_pred             HhcCCCcCCCCCHhhhhcC
Q 019216          250 KILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       250 ~~L~~dP~~Rps~~eil~~  268 (344)
                      +||+.||++|||++++++|
T Consensus       237 ~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         237 HCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHH
Confidence            9999999999999999986

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-58  Score=413.99  Aligned_cols=264  Identities=25%  Similarity=0.352  Sum_probs=217.2

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee------
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------   85 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------   85 (344)
                      .+++|+++++||+|+||+||+|+++.+|+.||||++.+... .......+.+|+.+|++++||||+++++++..      
T Consensus         8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~   86 (318)
T d3blha1           8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN   86 (318)
T ss_dssp             BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred             ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence            47999999999999999999999999999999999865433 23345678899999999999999999998854      


Q ss_pred             --CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           86 --KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        86 --~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                        ...+|+||||+.++.+.........+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~  166 (318)
T d3blha1          87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA  166 (318)
T ss_dssp             ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence              346899999998777665555667899999999999999999999999999999999999999999999999999975


Q ss_pred             CCccc--CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCCCCC---
Q 019216          164 PQHFR--DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFKLPK---  238 (344)
Q Consensus       164 ~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~---  238 (344)
                      .....  ........+||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+.......+.   
T Consensus       167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  246 (318)
T d3blha1         167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  246 (318)
T ss_dssp             CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence            43221  1223344689999999999987765678999999999999999999999988877766655442111110   


Q ss_pred             -----------------------------CCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          239 -----------------------------WLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       239 -----------------------------~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                                                   ..++.+.+||.+||+.||++|||++|+|+||||+..+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~  313 (318)
T d3blha1         247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM  313 (318)
T ss_dssp             TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred             cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence                                         03678899999999999999999999999999986544

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-58  Score=408.00  Aligned_cols=249  Identities=23%  Similarity=0.350  Sum_probs=211.8

Q ss_pred             eeecccCceEEEEEEEC--CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEEEeccC
Q 019216           20 RTLGEGNFGKVKFAQDL--DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMVLEYVT   97 (344)
Q Consensus        20 ~~Lg~G~~g~Vy~a~~~--~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv~e~~~   97 (344)
                      ++||+|+||+||+|.+.  .+++.||||+++... .+....+.+.+|+.+|++++||||+++++++..+ ..++|||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence            47999999999999864  456789999986543 3445567899999999999999999999998654 5789999999


Q ss_pred             CCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCC-Cccccc
Q 019216           98 GGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDD-GLLHTT  176 (344)
Q Consensus        98 g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~-~~~~~~  176 (344)
                      +|+|.+++.+..++++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........ ......
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            9999999999899999999999999999999999999999999999999999999999999999854332211 122345


Q ss_pred             cCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHHHhcCC
Q 019216          177 CGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLRKILEP  254 (344)
Q Consensus       177 ~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~~~L~~  254 (344)
                      .||+.|+|||++.+..+ +.++|||||||++|||++ |+.||.+.+...+...+..+ .++.|..+|+++.+||.+||+.
T Consensus       171 ~gt~~y~APE~l~~~~~-~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~  249 (277)
T d1xbba_         171 KWPVKWYAPECINYYKF-SSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY  249 (277)
T ss_dssp             CCCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred             CCCceecCchhhcCCCC-CchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence            78999999999988776 689999999999999998 89999998888888877775 4677888999999999999999


Q ss_pred             CcCCCCCHhhh---hcCccc
Q 019216          255 NPVKRITIAGI---KADEWF  271 (344)
Q Consensus       255 dP~~Rps~~ei---l~~~~~  271 (344)
                      ||++|||++++   |+|+|+
T Consensus       250 dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         250 DVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             STTTSCCHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHhhCHHh
Confidence            99999999998   456554

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-57  Score=403.74  Aligned_cols=260  Identities=28%  Similarity=0.438  Sum_probs=224.2

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      ++||+++++||+|+||+||+|+++.+|+.||||+++... ........+.+|+.+++.++||||+++++++......+++
T Consensus         1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv   79 (292)
T d1unla_           1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV   79 (292)
T ss_dssp             CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence            579999999999999999999999999999999997654 3445678899999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCCc
Q 019216           93 LEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDGL  172 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~  172 (344)
                      ++++.++++..++...+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+.....  ....
T Consensus        80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~--~~~~  157 (292)
T d1unla_          80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRC  157 (292)
T ss_dssp             EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--CCSC
T ss_pred             eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC--CCcc
Confidence            99999999998888888999999999999999999999999999999999999999999999999999985432  2223


Q ss_pred             cccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCC-CCccHHHHHHHHhhC-------------------
Q 019216          173 LHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPF-DDRNLAVLYQKIFRG-------------------  232 (344)
Q Consensus       173 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf-~~~~~~~~~~~i~~~-------------------  232 (344)
                      .....+++.|+|||++....+.+.++|||||||++|+|++|+.|| .+.+......++...                   
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            334567889999999988776688999999999999999999885 555555555544321                   


Q ss_pred             ----------CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          233 ----------DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       233 ----------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                                ....+..+++.+.+||++||+.||++|||++|+|+||||++..
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                      0112234689999999999999999999999999999998643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-57  Score=398.18  Aligned_cols=249  Identities=23%  Similarity=0.405  Sum_probs=222.1

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIYMV   92 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~iv   92 (344)
                      -++|+++++||+|+||+||+|++ .+++.||||++++....    .+.+.+|+.++++++||||+++++++.+.+.+++|
T Consensus         3 ~~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv   77 (258)
T d1k2pa_           3 PKDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred             hHHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence            46899999999999999999998 47889999999865432    35789999999999999999999999999999999


Q ss_pred             EeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccCCC
Q 019216           93 LEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRDDG  171 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~~~  171 (344)
                      |||+++|+|.+++.. ...+++..+++++.|+++||+|||+.||+||||||+|||++.++.+||+|||+++..... ...
T Consensus        78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~-~~~  156 (258)
T d1k2pa_          78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD-EYT  156 (258)
T ss_dssp             EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSS-SCC
T ss_pred             EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCC-Cce
Confidence            999999999988764 567899999999999999999999999999999999999999999999999999865432 222


Q ss_pred             ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHHHHH
Q 019216          172 LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQNLLR  249 (344)
Q Consensus       172 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~li~  249 (344)
                      ......||+.|+|||++.+..+ +.++|||||||++|||+| |+.||.+.+..++..++..+ ....|..+++.+.+||.
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~-~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~  235 (258)
T d1k2pa_         157 SSVGSKFPVRWSPPEVLMYSKF-SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMY  235 (258)
T ss_dssp             CCCCSCCCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred             eecccCCCCCcCCcHHhcCCCC-CcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHH
Confidence            3344678999999999988777 689999999999999998 89999999988888888876 45678889999999999


Q ss_pred             HhcCCCcCCCCCHhhhhcC
Q 019216          250 KILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       250 ~~L~~dP~~Rps~~eil~~  268 (344)
                      +||+.||++|||++++++|
T Consensus       236 ~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         236 SCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HTTCSSGGGSCCHHHHHHH
T ss_pred             HHccCCHhHCcCHHHHHHH
Confidence            9999999999999999987

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-57  Score=405.13  Aligned_cols=257  Identities=25%  Similarity=0.362  Sum_probs=219.6

Q ss_pred             cccCeEEeee-ecccCceEEEEEEECC--CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCe
Q 019216           12 RLGRYELGRT-LGEGNFGKVKFAQDLD--SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSK   88 (344)
Q Consensus        12 ~~~~y~~~~~-Lg~G~~g~Vy~a~~~~--~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~   88 (344)
                      ..++|.+.+. ||+|+||+||+|.++.  ++..||||+++...  .....+.+.+|+++|++++||||+++++++..+ .
T Consensus         6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~   82 (285)
T d1u59a_           6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-A   82 (285)
T ss_dssp             CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred             cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-e
Confidence            3467888884 9999999999998764  45579999986542  344567899999999999999999999998654 5


Q ss_pred             EEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      +|+|||||++|+|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        83 ~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          83 LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            8899999999999998765 457999999999999999999999999999999999999999999999999999865432


Q ss_pred             cC-CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHH
Q 019216          168 RD-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGA  244 (344)
Q Consensus       168 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~  244 (344)
                      .. ........||+.|+|||++....+ +.++|||||||++|||+| |+.||.+.+..++...+..+ .++.|..+|+++
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l  241 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKF-SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPEL  241 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHH
T ss_pred             ccccccccccccCccccChHHHhCCCC-CccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHH
Confidence            21 122234578999999999987776 689999999999999998 99999998887888888776 467888999999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhh---hcCcccc
Q 019216          245 QNLLRKILEPNPVKRITIAGI---KADEWFE  272 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~ei---l~~~~~~  272 (344)
                      .+||.+||+.||++|||+.++   |+|+|+.
T Consensus       242 ~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~  272 (285)
T d1u59a_         242 YALMSDCWIYKWEDRPDFLTVEQRMRACYYS  272 (285)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            999999999999999999887   6677764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-57  Score=403.52  Aligned_cols=255  Identities=26%  Similarity=0.419  Sum_probs=218.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++++.||+|+||.||+|.++ +++.||||++.....    ..+.+.+|+.++++++||||+++++++.+ +..+
T Consensus        10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~   83 (272)
T d1qpca_          10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY   83 (272)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence            35589999999999999999999974 578899999965432    24578999999999999999999998755 4578


Q ss_pred             EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +|||||++|+|.+++..  ..++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... 
T Consensus        84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~-  162 (272)
T d1qpca_          84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN-  162 (272)
T ss_dssp             EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS-
T ss_pred             EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCC-
Confidence            99999999999987753  336999999999999999999999999999999999999999999999999999864321 


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                      .........||+.|+|||++.+..+ +.++|||||||++|||+| |.+||...+.......+..+ ....|..+++++.+
T Consensus       163 ~~~~~~~~~gt~~y~APE~~~~~~~-~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~  241 (272)
T d1qpca_         163 EYTAREGAKFPIKWTAPEAINYGTF-TIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQ  241 (272)
T ss_dssp             CEECCTTCCCCTTTSCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred             ccccccccCCcccccChHHHhCCCC-CchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHH
Confidence            1122334578999999999987766 689999999999999999 56777777777777777765 45678889999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhc--Cccccc
Q 019216          247 LLRKILEPNPVKRITIAGIKA--DEWFEQ  273 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~--~~~~~~  273 (344)
                      |+.+||+.||++|||++++++  ++||..
T Consensus       242 li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         242 LMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence            999999999999999999988  778753

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-57  Score=409.48  Aligned_cols=257  Identities=31%  Similarity=0.404  Sum_probs=212.4

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCC-CceEEEEEeecccccchhHHHHHHHHHHHHHhC---CCCCccceeeEEee---
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDS-GLPFAVKILEKNRIIHLKITDQIKREIATLKLL---KHPNVVRLHEVLAS---   85 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l---~h~niv~l~~~~~~---   85 (344)
                      -++|+++++||+|+||+||+|++..+ ++.||||+++...... .....+.+|+.+++.+   +||||+++++++..   
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            47999999999999999999999765 6679999987543221 2223455677776665   79999999999853   


Q ss_pred             --CCeEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecccccc
Q 019216           86 --KSKIYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus        86 --~~~~~iv~e~~~g~~L~~~l~-~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                        ....+++|||+.++++..... ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence              346899999998876654433 34569999999999999999999999999999999999999999999999999987


Q ss_pred             CCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC---------
Q 019216          163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD---------  233 (344)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~---------  233 (344)
                      ....   .......+||+.|+|||++.+..+ +.++|||||||++|||++|++||.+.+......++....         
T Consensus       165 ~~~~---~~~~~~~~gT~~Y~APE~~~~~~y-~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         165 IYSF---QMALTSVVVTLWYRAPEVLLQSSY-ATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             CCCG---GGGGCCCCCCCTTCCHHHHTTCCC-CTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhcc---cccCCCcccChhhcCcchhcCCCC-ChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            5432   233456789999999999988777 689999999999999999999999988877776664310         


Q ss_pred             ------------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          234 ------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       234 ------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                                        ..++..+++.+.+||.+||+.||++|||++|+|+||||++-
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                              01234578999999999999999999999999999999863

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.6e-57  Score=411.74  Aligned_cols=255  Identities=29%  Similarity=0.408  Sum_probs=213.1

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC-----
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----   87 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----   87 (344)
                      -++|+++++||+|+||+||+|.++.+|+.||||++.+.. ......+.+.+|+.+|+.++||||+++++++...+     
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~   95 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF   95 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence            479999999999999999999999999999999997543 34456778999999999999999999999997554     


Q ss_pred             -eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           88 -KIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        88 -~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                       .+|+||||| +.+|...++ .+++++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+|+... 
T Consensus        96 ~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~-  172 (346)
T d1cm8a_          96 TDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD-  172 (346)
T ss_dssp             CCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC-
Confidence             579999999 667766654 5679999999999999999999999999999999999999999999999999998533 


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC-------------
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD-------------  233 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~-------------  233 (344)
                          .......||+.|+|||++.+..+.+.++|||||||++|+|++|++||.+.+.......+....             
T Consensus       173 ----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (346)
T d1cm8a_         173 ----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  248 (346)
T ss_dssp             ----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             ----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcc
Confidence                234567899999999999877777899999999999999999999999877655544433210             


Q ss_pred             ------------------CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccC
Q 019216          234 ------------------FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDY  275 (344)
Q Consensus       234 ------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~  275 (344)
                                        ......+++.+.+||.+||+.||++|||++|+|+||||++..
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         249 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence                              012345789999999999999999999999999999998643

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-57  Score=412.18  Aligned_cols=255  Identities=28%  Similarity=0.370  Sum_probs=212.2

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee------C
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------K   86 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------~   86 (344)
                      --+|+.+++||+|+||+||+|+++.+|+.||||++.+...       ...+|+.+|++++||||+++++++..      .
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~   91 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE   91 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence            3479999999999999999999999999999999976432       23469999999999999999999853      3


Q ss_pred             CeEEEEEeccCCCChHHH---HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC-CeEEecccccc
Q 019216           87 SKIYMVLEYVTGGELFDK---IASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSA  162 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~---l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~-~vkl~Dfg~a~  162 (344)
                      .++|+|||||+++.+..+   ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus        92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~  171 (350)
T d1q5ka_          92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK  171 (350)
T ss_dssp             CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred             eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence            458999999976543332   23456799999999999999999999999999999999999999876 89999999987


Q ss_pred             CCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC----------
Q 019216          163 LPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG----------  232 (344)
Q Consensus       163 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~----------  232 (344)
                      ...   ........+||+.|+|||.+.+...++.++|||||||++|||++|++||.+.+.......+.+.          
T Consensus       172 ~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~  248 (350)
T d1q5ka_         172 QLV---RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR  248 (350)
T ss_dssp             ECC---TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             hcc---CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence            533   2333456789999999999887666679999999999999999999999988776666555421          


Q ss_pred             -------CCCC------------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          233 -------DFKL------------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       233 -------~~~~------------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                             ...+            ...+++++.+||.+||+.||++|||+.|+|+||||++...+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~  312 (350)
T d1q5ka_         249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP  312 (350)
T ss_dssp             HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred             hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccCC
Confidence                   0111            23478999999999999999999999999999999876443

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-57  Score=407.74  Aligned_cols=264  Identities=31%  Similarity=0.588  Sum_probs=227.4

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEEC---CCCceEEEEEeeccccc-chhHHHHHHHHHHHHHhCCC-CCccceeeEE
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDL---DSGLPFAVKILEKNRII-HLKITDQIKREIATLKLLKH-PNVVRLHEVL   83 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~---~~~~~vaiK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~   83 (344)
                      +.+.+++|++++.||+|+||+||+|.+.   .+|+.||||++.+.... +....+.+.+|+.++++++| |||+++++++
T Consensus        19 ~~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~   98 (322)
T d1vzoa_          19 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF   98 (322)
T ss_dssp             CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred             cccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeee
Confidence            4466899999999999999999999974   47899999998765432 22335668899999999976 8999999999


Q ss_pred             eeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccC
Q 019216           84 ASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSAL  163 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~  163 (344)
                      .+...++++|||+.+++|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.
T Consensus        99 ~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_          99 QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999975


Q ss_pred             CCcccCCCccccccCCCcccchhhhccCC-CCCccchhhhhhHHHHHHHhCCCCCCCcc----HHHHHHHHhhCCCCCCC
Q 019216          164 PQHFRDDGLLHTTCGSPNYVAPEVLANRG-YDGATSDIWSCGVILYVILTGYLPFDDRN----LAVLYQKIFRGDFKLPK  238 (344)
Q Consensus       164 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DvwslG~ll~ell~g~~pf~~~~----~~~~~~~i~~~~~~~~~  238 (344)
                      .... .........|++.|+|||.+.... ..+.++|||||||++|+|++|+.||.+.+    ...+.........++|.
T Consensus       179 ~~~~-~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~  257 (322)
T d1vzoa_         179 FVAD-ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ  257 (322)
T ss_dssp             CCGG-GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCT
T ss_pred             hccc-ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcc
Confidence            4332 222345678999999999987644 34678999999999999999999997744    34445555667788888


Q ss_pred             CCCHHHHHHHHHhcCCCcCCCC-----CHhhhhcCccccc
Q 019216          239 WLSPGAQNLLRKILEPNPVKRI-----TIAGIKADEWFEQ  273 (344)
Q Consensus       239 ~~~~~~~~li~~~L~~dP~~Rp-----s~~eil~~~~~~~  273 (344)
                      .+++++.+||.+||++||.+||     |++|+++||||++
T Consensus       258 ~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             cCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            9999999999999999999999     4899999999975

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-56  Score=396.07  Aligned_cols=256  Identities=25%  Similarity=0.399  Sum_probs=214.5

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCCeEE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKSKIY   90 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~   90 (344)
                      +..++|++.+.||+|+||.||+|+++.+ +.||||++.....    ..+.+.+|+.++++++||||+++++++.+ +.++
T Consensus        14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~   87 (285)
T d1fmka3          14 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY   87 (285)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             cCHHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeE
Confidence            5668999999999999999999998654 5799999965432    23678999999999999999999999854 5578


Q ss_pred             EEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           91 MVLEYVTGGELFDKIAS--KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        91 iv~e~~~g~~L~~~l~~--~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      +|||||++|+|.+++..  .+.+++.++..++.||+.||+|||++||+||||||+|||++.++++||+|||+++..... 
T Consensus        88 lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~-  166 (285)
T d1fmka3          88 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN-  166 (285)
T ss_dssp             EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             EEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC-
Confidence            99999999999888754  457999999999999999999999999999999999999999999999999999854321 


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHHH
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQN  246 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~  246 (344)
                      .........||+.|+|||++.+..+ +.++|||||||++|||++ |++|+.+.....+...+..+ ..+.+..+++++.+
T Consensus       167 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~  245 (285)
T d1fmka3         167 EYTARQGAKFPIKWTAPEAALYGRF-TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHD  245 (285)
T ss_dssp             ---------CCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHH
T ss_pred             CceeeccccccccccChHHHhCCCC-CcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHH
Confidence            1222334678999999999988776 689999999999999999 56667777777777777665 45788889999999


Q ss_pred             HHHHhcCCCcCCCCCHhhhhc--Ccccccc
Q 019216          247 LLRKILEPNPVKRITIAGIKA--DEWFEQD  274 (344)
Q Consensus       247 li~~~L~~dP~~Rps~~eil~--~~~~~~~  274 (344)
                      ||.+||+.||++|||++++++  ++||...
T Consensus       246 li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         246 LMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             HHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence            999999999999999999987  7777654

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-56  Score=406.85  Aligned_cols=260  Identities=29%  Similarity=0.460  Sum_probs=213.6

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC-----e
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS-----K   88 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~-----~   88 (344)
                      +||+++++||+|+||+||+|.++.+|+.||||++.+..  .....+.+.+|+.+|+.++||||+++++++....     .
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~   85 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD   85 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence            47999999999999999999999999999999997543  3445678899999999999999999999986543     3


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      ++++ +++.|++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        86 ~~l~-~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~  163 (345)
T d1pmea_          86 VYLV-THLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH  163 (345)
T ss_dssp             EEEE-EECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred             EEEE-EeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence            4555 55669999999975 569999999999999999999999999999999999999999999999999997543322


Q ss_pred             C-CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCC--------------
Q 019216          169 D-DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGD--------------  233 (344)
Q Consensus       169 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~--------------  233 (344)
                      . .......+||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+............              
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (345)
T d1pmea_         164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL  243 (345)
T ss_dssp             CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred             ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence            2 2234557899999999998776666789999999999999999999998876554443332110              


Q ss_pred             --------C---------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          234 --------F---------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       234 --------~---------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                              .         .....+++++++||.+||+.||++|||++|+|+||||++...+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence                    0         0123478899999999999999999999999999999865544

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-55  Score=392.53  Aligned_cols=254  Identities=23%  Similarity=0.352  Sum_probs=209.6

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCC----ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG----LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~----~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      +.-++|++.++||+|+||.||+|.++.++    ..||||.+....  .......+.+|+.++++++||||+++++++...
T Consensus         4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~   81 (283)
T d1mqba_           4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY   81 (283)
T ss_dssp             CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence            44578999999999999999999977654    469999986443  334456789999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           87 SKIYMVLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      ...++|||||.++++.+.+... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~  161 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE  161 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence            9999999999999998877654 579999999999999999999999999999999999999999999999999998654


Q ss_pred             cccCC-CccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhC-CCCCCCccHHHHHHHHhhC-CCCCCCCCCH
Q 019216          166 HFRDD-GLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRG-DFKLPKWLSP  242 (344)
Q Consensus       166 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g-~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~  242 (344)
                      ..... .......||+.|+|||++.+..+ +.++|||||||++|||++| .+|+.+.+...+...+..+ ..+.|..+++
T Consensus       162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~-~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~  240 (283)
T d1mqba_         162 DDPEATYTTSGGKIPIRWTAPEAISYRKF-TSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPS  240 (283)
T ss_dssp             ------------CCCGGGSCHHHHHSCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBH
T ss_pred             CCCccceEeccCCCCccccCHHHHccCCC-CCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHH
Confidence            32221 22334578999999999988776 6899999999999999994 6666667777777776665 4567788999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .+.+||.+||+.||++|||+.++++
T Consensus       241 ~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         241 AIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            9999999999999999999999987

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-56  Score=401.27  Aligned_cols=254  Identities=22%  Similarity=0.339  Sum_probs=211.8

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCc----eEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGL----PFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      .-.+|++++.||+|+||+||+|.+..+|+    .||+|.+....  ..+..+.+.+|+.++++++||||+++++++.++ 
T Consensus         7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-   83 (317)
T d1xkka_           7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   83 (317)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred             CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence            34679999999999999999999988876    47777775332  334567899999999999999999999999765 


Q ss_pred             eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ..++++|++.+++|.+.+.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+....
T Consensus        84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            56778899999999888775 45799999999999999999999999999999999999999999999999999986543


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC-CCCCCCCCHHH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGA  244 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~  244 (344)
                      ...........||+.|+|||++.+..+ +.++|||||||++|||+| |.+||.+.+...+...+..+. ++.|..+++.+
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~  242 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIY-THQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDV  242 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHH
T ss_pred             ccccccccccccCccccChHHHhcCCC-ChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHH
Confidence            333333344578999999999988776 689999999999999998 899999888777777777654 67788899999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcCc
Q 019216          245 QNLLRKILEPNPVKRITIAGIKADE  269 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~~  269 (344)
                      .+|+.+||+.||.+|||+.++++|.
T Consensus       243 ~~li~~cl~~dP~~RPs~~eil~~l  267 (317)
T d1xkka_         243 YMIMVKCWMIDADSRPKFRELIIEF  267 (317)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHhCCCChhhCcCHHHHHHHH
Confidence            9999999999999999999999873

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-56  Score=407.02  Aligned_cols=257  Identities=30%  Similarity=0.401  Sum_probs=216.0

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC-----Ce
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK-----SK   88 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~-----~~   88 (344)
                      +||+++++||+|+||+||+|+++.+|+.||||++.+.. .+....+++.+|+.+|++++|||++++++++...     ..
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            68999999999999999999999999999999997543 3344567789999999999999999999998532     33


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCccc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFR  168 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~  168 (344)
                      .+++|+++.|++|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||++....   
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~---  172 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---  172 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT---
T ss_pred             eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC---
Confidence            4566677779999998854 579999999999999999999999999999999999999999999999999987432   


Q ss_pred             CCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhCCCC-------------
Q 019216          169 DDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRGDFK-------------  235 (344)
Q Consensus       169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~~~~-------------  235 (344)
                        .......||+.|+|||++.+..+.+.++|||||||++|+|++|++||.+.+.......+......             
T Consensus       173 --~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  250 (348)
T d2gfsa1         173 --DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES  250 (348)
T ss_dssp             --GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHH
T ss_pred             --cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchh
Confidence              23445678999999999888777788999999999999999999999988877666665432111             


Q ss_pred             ----------C--------CCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCCC
Q 019216          236 ----------L--------PKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYTP  277 (344)
Q Consensus       236 ----------~--------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~~  277 (344)
                                .        ...+++++++||++||+.||++|||++|+|+||||++...+
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~  310 (348)
T d2gfsa1         251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  310 (348)
T ss_dssp             HHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             hhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence                      1        12478999999999999999999999999999999876543

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=390.86  Aligned_cols=253  Identities=27%  Similarity=0.433  Sum_probs=208.5

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      +..++|++++.||+|+||.||+|.+..++   ..||+|.++..  ......+.+.+|+.++++++||||+++++++. ++
T Consensus         4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~   80 (273)
T d1mp8a_           4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN   80 (273)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred             cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence            34579999999999999999999986543   46888887533  23455678999999999999999999999986 46


Q ss_pred             eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      .+|+|||||++|+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+|+....
T Consensus        81 ~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          81 PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             eEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            78999999999999988764 45799999999999999999999999999999999999999999999999999985433


Q ss_pred             ccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC-CCCCCCCCHHH
Q 019216          167 FRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD-FKLPKWLSPGA  244 (344)
Q Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~  244 (344)
                      . .........||+.|+|||++.+..+ +.++|||||||++|||++ |.+||.+.+......++..+. .+.|..+|+.+
T Consensus       161 ~-~~~~~~~~~gt~~y~apE~l~~~~~-~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  238 (273)
T d1mp8a_         161 S-TYYKASKGKLPIKWMAPESINFRRF-TSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL  238 (273)
T ss_dssp             -----------CCGGGCCHHHHHHCCC-SHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred             C-cceeccceecCcccchhhHhccCCC-CCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence            2 1222344578999999999988776 689999999999999998 899999988888888887764 67888899999


Q ss_pred             HHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          245 QNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       245 ~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      .+||.+||+.||++|||+.|++++
T Consensus       239 ~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         239 YSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999999876

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.6e-55  Score=398.74  Aligned_cols=251  Identities=24%  Similarity=0.412  Sum_probs=209.0

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEee--CCe
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLAS--KSK   88 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~--~~~   88 (344)
                      ..++|+++++||+|+||+||+|+++.+|+.||||++++..      .+++.+|+.+|+.++ ||||+++++++..  ...
T Consensus        33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~  106 (328)
T d3bqca1          33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT  106 (328)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred             CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence            4578999999999999999999999999999999986432      457889999999996 9999999999874  456


Q ss_pred             EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCC-CeEEeccccccCCCcc
Q 019216           89 IYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKG-NIKISDFGLSALPQHF  167 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~-~vkl~Dfg~a~~~~~~  167 (344)
                      +++|||||.+++|...   .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|+.... 
T Consensus       107 ~~~v~e~~~~~~L~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~-  182 (328)
T d3bqca1         107 PALVFEHVNNTDFKQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-  182 (328)
T ss_dssp             EEEEEECCCSCBGGGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT-
T ss_pred             eeEEEeecCCCcHHHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC-
Confidence            9999999999999765   35699999999999999999999999999999999999998765 599999999975432 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccH-HHHHHHHh-------------hCC
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNL-AVLYQKIF-------------RGD  233 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~-~~~~~~i~-------------~~~  233 (344)
                        .......++|+.|+|||.+.+...++.++||||+||++|+|++|+.||..... ......+.             ...
T Consensus       183 --~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         183 --GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             --TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             --CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcc
Confidence              23345678999999999988776667899999999999999999999975432 11111111             000


Q ss_pred             C------------------------CCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCcccccc
Q 019216          234 F------------------------KLPKWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQD  274 (344)
Q Consensus       234 ~------------------------~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~  274 (344)
                      .                        .....+++++.+||++||+.||++|||++|+|+||||++.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            0                        0112368999999999999999999999999999999763

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.2e-55  Score=394.24  Aligned_cols=253  Identities=26%  Similarity=0.362  Sum_probs=219.6

Q ss_pred             cccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeC
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASK   86 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~   86 (344)
                      ..++|++++.||+|+||+||+|+++     .+++.||||++....  .....+++.+|+.++++++||||+++++++...
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~   88 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVG   88 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccC
Confidence            4578999999999999999999975     356789999986433  344567899999999999999999999999999


Q ss_pred             CeEEEEEeccCCCChHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCC
Q 019216           87 SKIYMVLEYVTGGELFDKIASKG------------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKL  142 (344)
Q Consensus        87 ~~~~iv~e~~~g~~L~~~l~~~~------------------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp  142 (344)
                      ...+++|||+++|+|.+++....                        .+++..+..++.|++.||+|||++||+||||||
T Consensus        89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp  168 (301)
T d1lufa_          89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  168 (301)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcc
Confidence            99999999999999999986432                        378899999999999999999999999999999


Q ss_pred             CcEEEccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhC-CCCCCCcc
Q 019216          143 ENILLDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRN  221 (344)
Q Consensus       143 ~NILl~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g-~~pf~~~~  221 (344)
                      +|||++.++.+||+|||+|+..............+||+.|+|||.+.+..+ +.++|||||||++|||++| .+||.+.+
T Consensus       169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRY-TTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             cceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCC-ChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            999999999999999999975443333333445678999999999988776 6899999999999999998 57899999


Q ss_pred             HHHHHHHHhhCC-CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          222 LAVLYQKIFRGD-FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       222 ~~~~~~~i~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ..+....+..+. .+.|..+++++.+|+.+||+.||++|||+.|+++
T Consensus       248 ~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         248 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            888888888775 4567889999999999999999999999999965

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-55  Score=389.82  Aligned_cols=255  Identities=27%  Similarity=0.407  Sum_probs=207.8

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECC-CC--ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLD-SG--LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS   87 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~-~~--~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~   87 (344)
                      +..++|++++.||+|+||.||+|+... ++  ..||||++.+......+..+.+.+|+.++++++||||+++++++.++ 
T Consensus         5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-   83 (273)
T d1u46a_           5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-   83 (273)
T ss_dssp             CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-
T ss_pred             EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-
Confidence            345789999999999999999998643 33  46899998776655666678899999999999999999999999754 


Q ss_pred             eEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCc
Q 019216           88 KIYMVLEYVTGGELFDKIAS-KGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQH  166 (344)
Q Consensus        88 ~~~iv~e~~~g~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~  166 (344)
                      ..++|||||+++++.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus        84 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          84 PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhccc
Confidence            67899999999999987764 45799999999999999999999999999999999999999999999999999986533


Q ss_pred             ccCCC-ccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhCC--CCCCCCCCH
Q 019216          167 FRDDG-LLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRGD--FKLPKWLSP  242 (344)
Q Consensus       167 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~~--~~~~~~~~~  242 (344)
                      ..... ......|+..|+|||.+.+..+ +.++|||||||++|||+| |+.||.+.+......++.+..  ++.+..+|+
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~-~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  242 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTF-SHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ  242 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEE-EHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCH
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCC-CcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccH
Confidence            22221 2233467889999999988766 689999999999999998 899999999999888887764  455677999


Q ss_pred             HHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          243 GAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       243 ~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .+.+||.+||+.||++|||++++++
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999863

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=396.14  Aligned_cols=254  Identities=27%  Similarity=0.399  Sum_probs=217.8

Q ss_pred             cCccccCeEEeeeecccCceEEEEEEECCCCce--EEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEee
Q 019216            9 EGMRLGRYELGRTLGEGNFGKVKFAQDLDSGLP--FAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLAS   85 (344)
Q Consensus         9 ~~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~--vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~~   85 (344)
                      .-+.+++|++.++||+|+||+||+|.++.+|..  ||||.+....  ..+..+.+.+|+.+|+++ +||||+++++++..
T Consensus         5 ~~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~   82 (309)
T d1fvra_           5 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEH   82 (309)
T ss_dssp             SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred             CccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec
Confidence            456788999999999999999999999888775  6667664322  233456799999999998 69999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc
Q 019216           86 KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS  149 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~  149 (344)
                      .+.+++||||+++|+|.+++...                ..+++..+..++.||+.||.|||+.||+||||||+|||++.
T Consensus        83 ~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          83 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGE  162 (309)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECG
T ss_pred             CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcC
Confidence            99999999999999999999653                56899999999999999999999999999999999999999


Q ss_pred             CCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhC-CCCCCCccHHHHHHH
Q 019216          150 KGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQK  228 (344)
Q Consensus       150 ~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g-~~pf~~~~~~~~~~~  228 (344)
                      ++.+||+|||+++.....   .......||..|+|||.+.+..+ +.++|||||||++|||++| .+||.+.+...+...
T Consensus       163 ~~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~-~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~  238 (309)
T d1fvra_         163 NYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK  238 (309)
T ss_dssp             GGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEE-CHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred             CCceEEcccccccccccc---ccccceecCCcccchHHhccCCC-CccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            999999999999754332   12234578999999999988776 6899999999999999996 568999998888888


Q ss_pred             HhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          229 IFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       229 i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +..+ .++.|..+++++.+||.+||+.||++|||+.+++++
T Consensus       239 i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         239 LPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             GGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8765 567788899999999999999999999999999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-55  Score=386.28  Aligned_cols=245  Identities=25%  Similarity=0.470  Sum_probs=208.8

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee-CCeE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKI   89 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~   89 (344)
                      +.+++|++++.||+|+||.||+|.+  +|..||||++++..     ..+.+.+|+.++++++||||+++++++.+ .+.+
T Consensus         4 i~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~   76 (262)
T d1byga_           4 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL   76 (262)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred             cCHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence            4678999999999999999999997  47789999996542     34678899999999999999999998854 4568


Q ss_pred             EEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcc
Q 019216           90 YMVLEYVTGGELFDKIASKG--RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHF  167 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~--~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~  167 (344)
                      |+||||+++|+|.+++...+  .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.... 
T Consensus        77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~-  155 (262)
T d1byga_          77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-  155 (262)
T ss_dssp             EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred             EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-
Confidence            99999999999999997543  589999999999999999999999999999999999999999999999999985322 


Q ss_pred             cCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHHHHHHhhC-CCCCCCCCCHHHH
Q 019216          168 RDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVLYQKIFRG-DFKLPKWLSPGAQ  245 (344)
Q Consensus       168 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~~  245 (344)
                          ......+|..|+|||++.+..+ +.++|||||||++|||+| |++||...+...+...+..+ .+++|..+++.+.
T Consensus       156 ----~~~~~~~~~~y~aPE~l~~~~~-t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (262)
T d1byga_         156 ----TQDTGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY  230 (262)
T ss_dssp             ----------CCTTTSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred             ----CCccccccccCCChHHHhCCCC-ChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHH
Confidence                2344578899999999988776 799999999999999998 79999998888888887764 5678888999999


Q ss_pred             HHHHHhcCCCcCCCCCHhhhhcC
Q 019216          246 NLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       246 ~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      +||.+||+.||++|||+.+++++
T Consensus       231 ~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         231 EVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcccCHhHCcCHHHHHHH
Confidence            99999999999999999999874

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.9e-55  Score=390.17  Aligned_cols=254  Identities=27%  Similarity=0.451  Sum_probs=217.6

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECCCC-------ceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeE
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLDSG-------LPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEV   82 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~-------~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~   82 (344)
                      +..++|++++.||+|+||.||+|++..++       ..||||++++..  .......+.+|...+.++ +||||++++++
T Consensus        10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_          10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            45689999999999999999999976544       479999986543  334467788899888887 79999999999


Q ss_pred             EeeCCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEE
Q 019216           83 LASKSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL  146 (344)
Q Consensus        83 ~~~~~~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NIL  146 (344)
                      +.++...++|||||++|+|.+++...                ..+++..++.++.||+.||+|||+.||+||||||+|||
T Consensus        88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL  167 (299)
T d1fgka_          88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL  167 (299)
T ss_dssp             ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence            99999999999999999999999754                34899999999999999999999999999999999999


Q ss_pred             EccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHH
Q 019216          147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL  225 (344)
Q Consensus       147 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~  225 (344)
                      ++.++.+||+|||+++...............+|+.|+|||.+.+..+ +.++|||||||++|||++ |.+||.+.+...+
T Consensus       168 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y-~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~  246 (299)
T d1fgka_         168 VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY-THQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  246 (299)
T ss_dssp             ECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             ecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCC-CchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence            99999999999999986655444444556788999999999988776 699999999999999998 7999999888888


Q ss_pred             HHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          226 YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       226 ~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ...+..+ .++.|..+++++.+||.+||+.||++|||+.|+++
T Consensus       247 ~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         247 FKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            8777665 56778889999999999999999999999999987

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-55  Score=392.69  Aligned_cols=255  Identities=25%  Similarity=0.377  Sum_probs=205.0

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEe
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA   84 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~   84 (344)
                      +..++|+++++||+|+||.||+|.+..     +++.||||++....  .....+.+.+|..++.++ .|+||+.+++++.
T Consensus        10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~   87 (299)
T d1ywna1          10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT   87 (299)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence            456889999999999999999999754     45689999986433  233456677788877776 5899999999876


Q ss_pred             e-CCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEE
Q 019216           85 S-KSKIYMVLEYVTGGELFDKIASK----------------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILL  147 (344)
Q Consensus        85 ~-~~~~~iv~e~~~g~~L~~~l~~~----------------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl  147 (344)
                      . ...+++|||||++|+|.+++...                ..+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus        88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl  167 (299)
T d1ywna1          88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL  167 (299)
T ss_dssp             STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred             cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence            5 45689999999999999999753                248899999999999999999999999999999999999


Q ss_pred             ccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhC-CCCCCCccHH-HH
Q 019216          148 DSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLA-VL  225 (344)
Q Consensus       148 ~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g-~~pf~~~~~~-~~  225 (344)
                      +.++.+||+|||+|+...............||+.|+|||++.+..+ +.++|||||||++|||++| .+||.+.... ..
T Consensus       168 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~-~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~  246 (299)
T d1ywna1         168 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY-TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF  246 (299)
T ss_dssp             CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred             CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC-CcccceeehHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999986544333444456789999999999988776 6899999999999999986 6788776543 33


Q ss_pred             HHHHhhC-CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          226 YQKIFRG-DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       226 ~~~i~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ...+..+ .++.|..+++++.+|+.+||+.||++|||++|+++|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         247 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            3444443 566788899999999999999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-55  Score=401.62  Aligned_cols=257  Identities=28%  Similarity=0.423  Sum_probs=205.8

Q ss_pred             cccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee------
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS------   85 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~------   85 (344)
                      .+.+|+++++||+|+||+||+|.++.+|+.||||++.+... +.....++.+|+.++++++||||+++++++..      
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence            35789999999999999999999999999999999976543 44556789999999999999999999999953      


Q ss_pred             CCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCC
Q 019216           86 KSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQ  165 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~  165 (344)
                      ...+|+|||||.++ +.+.+  ...+++..++.+++||+.||.|||++||+||||||+|||++.++.+|++|||+++...
T Consensus        94 ~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          94 FQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             CCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence            36899999999664 44544  3568999999999999999999999999999999999999999999999999987533


Q ss_pred             cccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhhC-------------
Q 019216          166 HFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKIFRG-------------  232 (344)
Q Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i~~~-------------  232 (344)
                      .   .......++|+.|+|||++.+..+ +.++||||+||++|+|++|++||.+.+......++...             
T Consensus       171 ~---~~~~~~~~~t~~y~aPE~l~~~~~-~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         171 T---SFMMTPYVVTRYYRAPEVILGMGY-KENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             -------------CCTTCCHHHHTTCCC-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             c---ccccccccccccccChhhhcCCCC-CCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            2   333455689999999999988766 68999999999999999999999987766655544321             


Q ss_pred             ---------CCCCC--------------------CCCCHHHHHHHHHhcCCCcCCCCCHhhhhcCccccccCC
Q 019216          233 ---------DFKLP--------------------KWLSPGAQNLLRKILEPNPVKRITIAGIKADEWFEQDYT  276 (344)
Q Consensus       233 ---------~~~~~--------------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~~~~~~~~~~  276 (344)
                               .....                    ...++++.+||++||+.||++|||++|+|+||||+....
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~  319 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  319 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence                     11000                    013678899999999999999999999999999987543

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-54  Score=386.83  Aligned_cols=254  Identities=22%  Similarity=0.304  Sum_probs=221.8

Q ss_pred             ccccCeEEeeeecccCceEEEEEEECC-----CCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDLD-----SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS   85 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~~-----~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~   85 (344)
                      +..++|++++.||+|+||+||+|.++.     +++.||||++++..  .......+.+|+.++++++||||+++++++..
T Consensus        17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~   94 (308)
T d1p4oa_          17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   94 (308)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence            445899999999999999999998752     45789999986543  33455678999999999999999999999999


Q ss_pred             CCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEE
Q 019216           86 KSKIYMVLEYVTGGELFDKIASK----------GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKI  155 (344)
Q Consensus        86 ~~~~~iv~e~~~g~~L~~~l~~~----------~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl  155 (344)
                      ....++|||||++|+|.+++...          ..+++..+..++.|++.||.|||+++|+||||||+|||++.++++||
T Consensus        95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl  174 (308)
T d1p4oa_          95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI  174 (308)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred             CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence            99999999999999999988642          24688999999999999999999999999999999999999999999


Q ss_pred             eccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhC-CCCCCCccHHHHHHHHhhCC-
Q 019216          156 SDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTG-YLPFDDRNLAVLYQKIFRGD-  233 (344)
Q Consensus       156 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g-~~pf~~~~~~~~~~~i~~~~-  233 (344)
                      +|||+++...............||+.|+|||.+.+..+ +.++|||||||++|||+|| .+||.+.+.......+.++. 
T Consensus       175 ~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~-~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~  253 (308)
T d1p4oa_         175 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVF-TTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL  253 (308)
T ss_dssp             CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred             eecccceeccCCcceeeccceecccccCCHHHHccCCC-CcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCC
Confidence            99999986544333333444578999999999988776 5899999999999999998 68999999888888887764 


Q ss_pred             CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          234 FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       234 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      .+.|..+++.+.+||.+||+.||++|||+.++++
T Consensus       254 ~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         254 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            5567889999999999999999999999999988

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-53  Score=384.50  Aligned_cols=254  Identities=27%  Similarity=0.427  Sum_probs=217.4

Q ss_pred             ccccCeEEeeeecccCceEEEEEEEC-----CCCceEEEEEeecccccchhHHHHHHHHHHHHHhC-CCCCccceeeEEe
Q 019216           11 MRLGRYELGRTLGEGNFGKVKFAQDL-----DSGLPFAVKILEKNRIIHLKITDQIKREIATLKLL-KHPNVVRLHEVLA   84 (344)
Q Consensus        11 ~~~~~y~~~~~Lg~G~~g~Vy~a~~~-----~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l-~h~niv~l~~~~~   84 (344)
                      +.-++|++.++||+|+||.||+|++.     .+++.||||++++..  .......+.+|+.+++++ +||||+++++++.
T Consensus        20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~   97 (311)
T d1t46a_          20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (311)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence            34589999999999999999999863     567799999997543  334566789999999999 6999999999999


Q ss_pred             eCCeEEEEEeccCCCChHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEE
Q 019216           85 SKSKIYMVLEYVTGGELFDKIASKG------------------RLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENIL  146 (344)
Q Consensus        85 ~~~~~~iv~e~~~g~~L~~~l~~~~------------------~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NIL  146 (344)
                      .....++|||||++|+|.+++....                  .+++..+..++.||+.||+|||++|++||||||+|||
T Consensus        98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl  177 (311)
T d1t46a_          98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL  177 (311)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred             eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence            9999999999999999999987543                  5899999999999999999999999999999999999


Q ss_pred             EccCCCeEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHh-CCCCCCCccHHHH
Q 019216          147 LDSKGNIKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILT-GYLPFDDRNLAVL  225 (344)
Q Consensus       147 l~~~~~vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~-g~~pf~~~~~~~~  225 (344)
                      ++.++.+|++|||+++..............+||+.|+|||.+.+..+ +.++|||||||++|||+| |.+||.+.+....
T Consensus       178 ~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~  256 (311)
T d1t46a_         178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY-TFESDVWSYGIFLWELFSLGSSPYPGMPVDSK  256 (311)
T ss_dssp             EETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHH
T ss_pred             ccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCC-CCcccccchHHHHHHHHhCCCCCCCCCCHHHH
Confidence            99999999999999987654433334445689999999999987665 689999999999999998 7777877665554


Q ss_pred             HHHHhhC--CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          226 YQKIFRG--DFKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       226 ~~~i~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                      ..++...  ....|..+++.+.+||.+||+.||++|||++++++
T Consensus       257 ~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            4444433  34556779999999999999999999999999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-52  Score=371.60  Aligned_cols=249  Identities=24%  Similarity=0.315  Sum_probs=205.2

Q ss_pred             EEeeeecccCceEEEEEEECCCC---ceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEee-CCeEEEE
Q 019216           17 ELGRTLGEGNFGKVKFAQDLDSG---LPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLAS-KSKIYMV   92 (344)
Q Consensus        17 ~~~~~Lg~G~~g~Vy~a~~~~~~---~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~-~~~~~iv   92 (344)
                      .+.++||+|+||+||+|.+..++   ..||||.+++.  .+....+++.+|+++|++++||||+++++++.. +...++|
T Consensus        30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv  107 (311)
T d1r0pa_          30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  107 (311)
T ss_dssp             EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred             ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence            34689999999999999986543   36899998642  345567889999999999999999999999765 5689999


Q ss_pred             EeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEeccccccCCCcccC--
Q 019216           93 LEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGLSALPQHFRD--  169 (344)
Q Consensus        93 ~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~a~~~~~~~~--  169 (344)
                      ||||++++|.+++... ..+++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++.......  
T Consensus       108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~  187 (311)
T d1r0pa_         108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS  187 (311)
T ss_dssp             EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred             EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence            9999999999988754 3577889999999999999999999999999999999999999999999999986543221  


Q ss_pred             CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCC-ccHHHHHHHHhhC-CCCCCCCCCHHHHHH
Q 019216          170 DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDD-RNLAVLYQKIFRG-DFKLPKWLSPGAQNL  247 (344)
Q Consensus       170 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~-~~~~~~~~~i~~~-~~~~~~~~~~~~~~l  247 (344)
                      ........||+.|+|||.+....+ +.++||||||+++|||++|..||.. .+.......+..+ .+..|..+++.+.+|
T Consensus       188 ~~~~~~~~gt~~y~aPE~~~~~~~-~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l  266 (311)
T d1r0pa_         188 VHNKTGAKLPVKWMALESLQTQKF-TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV  266 (311)
T ss_dssp             TTCTTCSSCCGGGSCHHHHHHCCC-CHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred             ceecccccccccccChHHHhcCCC-CChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence            122234578999999999988776 6899999999999999997666654 4444455555555 455678899999999


Q ss_pred             HHHhcCCCcCCCCCHhhhhcC
Q 019216          248 LRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       248 i~~~L~~dP~~Rps~~eil~~  268 (344)
                      |.+||+.||++|||+.|++++
T Consensus       267 i~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         267 MLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHcCCCHhHCcCHHHHHHH
Confidence            999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.5e-51  Score=365.93  Aligned_cols=260  Identities=23%  Similarity=0.267  Sum_probs=204.5

Q ss_pred             cccc-CeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCcc-ceeeEEeeCCe
Q 019216           11 MRLG-RYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVV-RLHEVLASKSK   88 (344)
Q Consensus        11 ~~~~-~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv-~l~~~~~~~~~   88 (344)
                      +++| +|++++.||+|+||.||+|+++.+|+.||||++.....     ...+.+|+++++.++|+|++ .+.+++.....
T Consensus         3 ~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~   77 (299)
T d1ckia_           3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY   77 (299)
T ss_dssp             CEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred             CeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence            3454 79999999999999999999999999999999865432     13477899999999877655 55566678889


Q ss_pred             EEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc---CCCeEEeccccccCC
Q 019216           89 IYMVLEYVTGGELFDKIA-SKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS---KGNIKISDFGLSALP  164 (344)
Q Consensus        89 ~~iv~e~~~g~~L~~~l~-~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~---~~~vkl~Dfg~a~~~  164 (344)
                      .++||||+ ++++.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++.   +..+||+|||+|+..
T Consensus        78 ~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~  156 (299)
T d1ckia_          78 NVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  156 (299)
T ss_dssp             EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred             EEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence            99999999 567666654 4567999999999999999999999999999999999999854   457999999999865


Q ss_pred             CcccC-----CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH---hh----C
Q 019216          165 QHFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLAVLYQKI---FR----G  232 (344)
Q Consensus       165 ~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~~~~~~i---~~----~  232 (344)
                      .....     ........||+.|+|||++.+..+ +.++|||||||++|||++|+.||...........+   ..    .
T Consensus       157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ckia_         157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQ-SRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  235 (299)
T ss_dssp             BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCC-CHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred             cccccccceeccccCCcCCCccccCHHHHhCCCC-CChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence            43221     122345689999999999988776 68999999999999999999999875443322211   11    1


Q ss_pred             -CCCCCCCCCHHHHHHHHHhcCCCcCCCCCHhh---hhcCccccccCCC
Q 019216          233 -DFKLPKWLSPGAQNLLRKILEPNPVKRITIAG---IKADEWFEQDYTP  277 (344)
Q Consensus       233 -~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e---il~~~~~~~~~~~  277 (344)
                       ....+..+|+++.+++.+||+.||++||++.+   +|+|+|.++....
T Consensus       236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~~  284 (299)
T d1ckia_         236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY  284 (299)
T ss_dssp             CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCCC
T ss_pred             ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCCC
Confidence             11234668999999999999999999999874   5778776654443

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=6e-50  Score=357.33  Aligned_cols=248  Identities=19%  Similarity=0.220  Sum_probs=205.2

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC-CCccceeeEEeeCCeEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH-PNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-~niv~l~~~~~~~~~~~i   91 (344)
                      -++|++++.||+|+||+||+|+++.+|+.||||++.....     ...+.+|++.++.+.| +|++.+++++......++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            3699999999999999999999999999999999865432     2346788999999975 899999999999999999


Q ss_pred             EEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEcc-----CCCeEEeccccccCCC
Q 019216           92 VLEYVTGGELFDKIASK-GRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDS-----KGNIKISDFGLSALPQ  165 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~-----~~~vkl~Dfg~a~~~~  165 (344)
                      ||||+ +++|.+++... ..++...+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+|+...
T Consensus        79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~  157 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR  157 (293)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred             EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence            99999 78999988764 46999999999999999999999999999999999999974     5689999999998643


Q ss_pred             cccC-----CCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCcc---HHHHHHHHhhCC----
Q 019216          166 HFRD-----DGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRN---LAVLYQKIFRGD----  233 (344)
Q Consensus       166 ~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~---~~~~~~~i~~~~----  233 (344)
                      ....     .......+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+..   ......++....    
T Consensus       158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~-~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQ-SRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCC-CHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             cCccccceeecccCceEEchhhcCHHHhcCCCC-ChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            2211     122345689999999999988776 689999999999999999999997533   223333332211    


Q ss_pred             -CCCCCCCCHHHHHHHHHhcCCCcCCCCCHhhhhc
Q 019216          234 -FKLPKWLSPGAQNLLRKILEPNPVKRITIAGIKA  267 (344)
Q Consensus       234 -~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  267 (344)
                       ..++..+|+++.+++..|++.+|++||+++.+.+
T Consensus       237 ~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence             1234568999999999999999999999877644

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.4e-50  Score=358.18  Aligned_cols=248  Identities=24%  Similarity=0.324  Sum_probs=191.6

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCccceeeEEeeCC----eE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNVVRLHEVLASKS----KI   89 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~----~~   89 (344)
                      .+|.+.++||+|+||.||+|++  +|+.||||++....    ........|+..+..++||||+++++++....    .+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~----~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~   76 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL   76 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGG----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc----hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence            4789999999999999999986  68899999985432    11122334555556789999999999997543    68


Q ss_pred             EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeecCCCCcEEEccCCCeEEeccccc
Q 019216           90 YMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN--------KGVFHRDLKLENILLDSKGNIKISDFGLS  161 (344)
Q Consensus        90 ~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~--------~~i~H~dikp~NILl~~~~~vkl~Dfg~a  161 (344)
                      |+|||||++|+|.+++++ .++++.....++.|++.||+|||+        +||+||||||+|||++.++.+||+|||++
T Consensus        77 ~lv~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          77 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            999999999999999976 468999999999999999999996        59999999999999999999999999998


Q ss_pred             cCCCcccC--CCccccccCCCcccchhhhccCCC-----CCccchhhhhhHHHHHHHhCCCCCCC---------------
Q 019216          162 ALPQHFRD--DGLLHTTCGSPNYVAPEVLANRGY-----DGATSDIWSCGVILYVILTGYLPFDD---------------  219 (344)
Q Consensus       162 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~-----~~~~~DvwslG~ll~ell~g~~pf~~---------------  219 (344)
                      +.......  ........||+.|+|||++.+...     .+.++|||||||++|||+||..||..               
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            75432211  122345689999999999875431     25689999999999999999887632               


Q ss_pred             ccHHHHHHHHhhCCC--CCCCC-----CCHHHHHHHHHhcCCCcCCCCCHhhhhcC
Q 019216          220 RNLAVLYQKIFRGDF--KLPKW-----LSPGAQNLLRKILEPNPVKRITIAGIKAD  268 (344)
Q Consensus       220 ~~~~~~~~~i~~~~~--~~~~~-----~~~~~~~li~~~L~~dP~~Rps~~eil~~  268 (344)
                      ...............  .+|..     ....+.+|+.+||+.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            122333333333322  23322     22458899999999999999999999764

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-48  Score=358.73  Aligned_cols=251  Identities=25%  Similarity=0.436  Sum_probs=195.0

Q ss_pred             cCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-----------CCCccceeeE
Q 019216           14 GRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----------HPNVVRLHEV   82 (344)
Q Consensus        14 ~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------h~niv~l~~~   82 (344)
                      |||+++++||+|+||+||+|+++.+|+.||||++++..    ...+.+.+|+.+++.+.           |+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~----~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc----cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            57999999999999999999999999999999997543    23456778888888775           5789999988


Q ss_pred             Eee--CCeEEEEEeccCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHh-CCceeecCCCCcEEEccCCC----
Q 019216           83 LAS--KSKIYMVLEYVTGGELFDKI---ASKGRLQEAEGRKLFQQLIDGVSYCHN-KGVFHRDLKLENILLDSKGN----  152 (344)
Q Consensus        83 ~~~--~~~~~iv~e~~~g~~L~~~l---~~~~~~~~~~~~~i~~ql~~~L~~LH~-~~i~H~dikp~NILl~~~~~----  152 (344)
                      +..  ....+++|+++..+......   .....+++..++.++.|++.||+|||+ .||+||||||+|||++.++.    
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            753  45667777776554433322   234578999999999999999999998 89999999999999987653    


Q ss_pred             --eEEeccccccCCCcccCCCccccccCCCcccchhhhccCCCCCccchhhhhhHHHHHHHhCCCCCCCccHH------H
Q 019216          153 --IKISDFGLSALPQHFRDDGLLHTTCGSPNYVAPEVLANRGYDGATSDIWSCGVILYVILTGYLPFDDRNLA------V  224 (344)
Q Consensus       153 --vkl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslG~ll~ell~g~~pf~~~~~~------~  224 (344)
                        ++++|||.+....     ......+||+.|+|||++....+ +.++||||+||++++|++|+.||...+..      .
T Consensus       169 ~~~kl~dfg~s~~~~-----~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~  242 (362)
T d1q8ya_         169 IQIKIADLGNACWYD-----EHYTNSIQTREYRSPEVLLGAPW-GCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  242 (362)
T ss_dssp             EEEEECCCTTCEETT-----BCCCSCCSCGGGCCHHHHHTCCC-CTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             ceeeEeecccccccc-----cccccccccccccChhhccccCC-CccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence              9999999987432     23356789999999999988777 58999999999999999999999753321      1


Q ss_pred             HHHHHhh------------------------------------------CCCCCCCCCCHHHHHHHHHhcCCCcCCCCCH
Q 019216          225 LYQKIFR------------------------------------------GDFKLPKWLSPGAQNLLRKILEPNPVKRITI  262 (344)
Q Consensus       225 ~~~~i~~------------------------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~  262 (344)
                      .......                                          .....+...++.+.+||.+||+.||.+|||+
T Consensus       243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta  322 (362)
T d1q8ya_         243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  322 (362)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence            1111000                                          0011112246789999999999999999999


Q ss_pred             hhhhcCcccccc
Q 019216          263 AGIKADEWFEQD  274 (344)
Q Consensus       263 ~eil~~~~~~~~  274 (344)
                      +|+|+||||++.
T Consensus       323 ~e~L~Hp~f~~~  334 (362)
T d1q8ya_         323 GGLVNHPWLKDT  334 (362)
T ss_dssp             HHHHTCGGGTTC
T ss_pred             HHHhcCcccCCC
Confidence            999999999854

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.94  E-value=4.7e-27  Score=195.26  Aligned_cols=136  Identities=19%  Similarity=0.253  Sum_probs=107.7

Q ss_pred             eEEeeeecccCceEEEEEEECCCCceEEEEEeeccccc---------------chhHHHHHHHHHHHHHhCCCCCcccee
Q 019216           16 YELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII---------------HLKITDQIKREIATLKLLKHPNVVRLH   80 (344)
Q Consensus        16 y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~h~niv~l~   80 (344)
                      +.+.++||+|+||+||+|.+ .+|+.||||+++.....               .........+|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            46889999999999999998 47899999987532211               011223456789999999999999888


Q ss_pred             eEEeeCCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCceeecCCCCcEEEccCCCeEEecccc
Q 019216           81 EVLASKSKIYMVLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHNKGVFHRDLKLENILLDSKGNIKISDFGL  160 (344)
Q Consensus        81 ~~~~~~~~~~iv~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~i~H~dikp~NILl~~~~~vkl~Dfg~  160 (344)
                      ++.  .  .+++|||+++..+.+       ++...+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||+
T Consensus        81 ~~~--~--~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~  148 (191)
T d1zara2          81 AWE--G--NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ  148 (191)
T ss_dssp             EEE--T--TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred             Eec--C--CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence            653  2  268999998765532       4556678899999999999999999999999999999865 489999999


Q ss_pred             ccCC
Q 019216          161 SALP  164 (344)
Q Consensus       161 a~~~  164 (344)
                      |...
T Consensus       149 a~~~  152 (191)
T d1zara2         149 SVEV  152 (191)
T ss_dssp             CEET
T ss_pred             cccC
Confidence            8743

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.79  E-value=2.5e-08  Score=84.75  Aligned_cols=140  Identities=15%  Similarity=0.124  Sum_probs=94.1

Q ss_pred             ccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEEeeCCeEEE
Q 019216           13 LGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        13 ~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~i   91 (344)
                      +..|+..+..+.++.+.||+..  .+++.+.+|........   ....+.+|...++.+. +--+.+++.+...++..++
T Consensus        13 ~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~---~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~l   87 (263)
T d1j7la_          13 IEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL   87 (263)
T ss_dssp             HTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred             hhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCccc---chhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEE
Confidence            5678887776666668999886  45667888877543221   1234667888877764 3345677888888889999


Q ss_pred             EEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q 019216           92 VLEYVTGGELFDKIASKGRLQEAEGRKLFQQLIDGVSYCHN---------------------------------------  132 (344)
Q Consensus        92 v~e~~~g~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~---------------------------------------  132 (344)
                      ||++++|.++.+....     ......++.++...++.||+                                       
T Consensus        88 v~~~l~G~~~~~~~~~-----~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (263)
T d1j7la_          88 LMSEADGVLCSEEYED-----EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT  162 (263)
T ss_dssp             EEECCSSEEHHHHTTT-----CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTC
T ss_pred             EEEecccccccccccc-----cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccc
Confidence            9999998877543321     11122233344444444442                                       


Q ss_pred             --------------C------CceeecCCCCcEEEccCCCeEEecccccc
Q 019216          133 --------------K------GVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       133 --------------~------~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                                    .      .++|+|+.|.|||+++++.+-|.||+.+.
T Consensus       163 ~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             SCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                          1      26899999999999876666799999775

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.44  E-value=4.7e-07  Score=81.51  Aligned_cols=81  Identities=17%  Similarity=0.152  Sum_probs=49.7

Q ss_pred             eeeecccCceEEEEEEECCCCceEEEEEeeccccc----chhHHHHHHHHHHHHHhCC--CC-CccceeeEEeeCCeEEE
Q 019216           19 GRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRII----HLKITDQIKREIATLKLLK--HP-NVVRLHEVLASKSKIYM   91 (344)
Q Consensus        19 ~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~----~~~~~~~~~~E~~~l~~l~--h~-niv~l~~~~~~~~~~~i   91 (344)
                      .+.||.|....||++.+..+++.+++|.-......    -....++...|...|+.+.  .| .+.+++.+  +....++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            56799999999999998777889999964321100    0112345567888887663  23 35555544  3445578


Q ss_pred             EEeccCCCCh
Q 019216           92 VLEYVTGGEL  101 (344)
Q Consensus        92 v~e~~~g~~L  101 (344)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999977544

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.33  E-value=1.2e-06  Score=73.48  Aligned_cols=79  Identities=18%  Similarity=0.201  Sum_probs=53.1

Q ss_pred             CeEEeeeecccCc-eEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCC--CCccceeeEEeeCCeEEE
Q 019216           15 RYELGRTLGEGNF-GKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKH--PNVVRLHEVLASKSKIYM   91 (344)
Q Consensus        15 ~y~~~~~Lg~G~~-g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--~niv~l~~~~~~~~~~~i   91 (344)
                      .++. +.+..|.. +.||+... ..+..+++|.......      ..+..|...++.+..  -.+.+++.+..+.+..++
T Consensus        12 g~~~-~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~   83 (255)
T d1nd4a_          12 GYDW-AQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL   83 (255)
T ss_dssp             TCEE-EECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred             CCce-EEcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEE
Confidence            3443 34455543 68998884 5567789997654322      246677777776643  235677888778888999


Q ss_pred             EEeccCCCCh
Q 019216           92 VLEYVTGGEL  101 (344)
Q Consensus        92 v~e~~~g~~L  101 (344)
                      ||++++|.++
T Consensus        84 v~~~i~G~~~   93 (255)
T d1nd4a_          84 LLGEVPGQDL   93 (255)
T ss_dssp             EEECCSSEET
T ss_pred             EEEeeecccc
Confidence            9999988655

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.66  E-value=0.00011  Score=65.61  Aligned_cols=80  Identities=11%  Similarity=0.084  Sum_probs=52.7

Q ss_pred             cccCeEEeeeecccCceEEEEEEECC-------CCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-CCCccceeeEE
Q 019216           12 RLGRYELGRTLGEGNFGKVKFAQDLD-------SGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-HPNVVRLHEVL   83 (344)
Q Consensus        12 ~~~~y~~~~~Lg~G~~g~Vy~a~~~~-------~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~   83 (344)
                      ..+..+ ++.|+.|-.-.+|++....       ..+.|.+++.-..  ..   .-...+|..+++.+. +.-..++++++
T Consensus        41 ~~~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~---~idr~~E~~i~~~ls~~gl~Pkll~~~  114 (395)
T d1nw1a_          41 PLEHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIF  114 (395)
T ss_dssp             CGGGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred             CccceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch---hhHHHHHHHHHHHHHhCCCCCeEEEEc
Confidence            344555 4678889999999998653       3456788876421  11   234567898988885 43345777776


Q ss_pred             eeCCeEEEEEeccCCCCh
Q 019216           84 ASKSKIYMVLEYVTGGEL  101 (344)
Q Consensus        84 ~~~~~~~iv~e~~~g~~L  101 (344)
                      .+    .+|+||++|.++
T Consensus       115 ~~----g~I~efi~g~~l  128 (395)
T d1nw1a_         115 SG----GRLEEYIPSRPL  128 (395)
T ss_dssp             TT----EEEECCCCEEEC
T ss_pred             CC----ceEEEEeccccC
Confidence            42    578999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.61  E-value=0.00014  Score=63.02  Aligned_cols=70  Identities=26%  Similarity=0.262  Sum_probs=45.2

Q ss_pred             cCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCCCCCc-----cce--eeEEeeCCeEEEEEeccC
Q 019216           25 GNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLKHPNV-----VRL--HEVLASKSKIYMVLEYVT   97 (344)
Q Consensus        25 G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni-----v~l--~~~~~~~~~~~iv~e~~~   97 (344)
                      +--..||++.. .+|..|++|+.+.....    .+.+..|+..+..|...++     +..  -..+...+..+.+++++.
T Consensus        33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~s----~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~  107 (325)
T d1zyla1          33 SYENRVYQFQD-EDRRRFVVKFYRPERWT----ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG  107 (325)
T ss_dssp             CSSSEEEEECC-TTCCCEEEEEECTTTSC----HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred             cccceeEEEEc-CCCCEEEEEEeCCCCCC----HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence            33468999985 67889999998654322    3556778888777642221     111  122345677889999997


Q ss_pred             CC
Q 019216           98 GG   99 (344)
Q Consensus        98 g~   99 (344)
                      |.
T Consensus       108 G~  109 (325)
T d1zyla1         108 GR  109 (325)
T ss_dssp             CE
T ss_pred             Cc
Confidence            64

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.12  E-value=0.0026  Score=54.27  Aligned_cols=146  Identities=15%  Similarity=0.160  Sum_probs=77.7

Q ss_pred             CccccCeEEeeeecccCceEEEEEEECCCCceEEEEEeecccccchhHHHHHHHHHHHHHhCC-----CCCcccee---e
Q 019216           10 GMRLGRYELGRTLGEGNFGKVKFAQDLDSGLPFAVKILEKNRIIHLKITDQIKREIATLKLLK-----HPNVVRLH---E   81 (344)
Q Consensus        10 ~~~~~~y~~~~~Lg~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h~niv~l~---~   81 (344)
                      ...+|+..-.+.|..|--.+.|+... .+| .+++|++....  .   .+.+..|+.++..|.     .|..+...   .
T Consensus        14 ~Y~lg~~~~~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~--~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~   86 (316)
T d2ppqa1          14 QYDVGSLTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGEL   86 (316)
T ss_dssp             TBCCCCEEEEEEECC---EEEEEEEE-SSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCS
T ss_pred             hCCCCCceEeecCCCCcccCeEEEEE-CCC-cEEEEEcCCCC--C---HHHHHHHHHHHHhhhhccccccccceecCCCc
Confidence            35567777677788888899999885 334 58999985432  1   134445666666553     22222211   0


Q ss_pred             EEeeCCeEEEEEeccCCCChH--------------HHHHh---c------CCCCH------------------HHHHHHH
Q 019216           82 VLASKSKIYMVLEYVTGGELF--------------DKIAS---K------GRLQE------------------AEGRKLF  120 (344)
Q Consensus        82 ~~~~~~~~~iv~e~~~g~~L~--------------~~l~~---~------~~~~~------------------~~~~~i~  120 (344)
                      +..-......++.+..|....              ..+..   .      .....                  ......+
T Consensus        87 ~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  166 (316)
T d2ppqa1          87 LGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEI  166 (316)
T ss_dssp             CEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHH
T ss_pred             ceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHH
Confidence            112344566667766553220              00000   0      00001                  0111222


Q ss_pred             HHHHHHHHHHHh----CCceeecCCCCcEEEccCCCeEEecccccc
Q 019216          121 QQLIDGVSYCHN----KGVFHRDLKLENILLDSKGNIKISDFGLSA  162 (344)
Q Consensus       121 ~ql~~~L~~LH~----~~i~H~dikp~NILl~~~~~vkl~Dfg~a~  162 (344)
                      ..+...+...+.    .|+||+|+.++||+++.+...-|.||+.+.
T Consensus       167 ~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         167 RPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             HHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            223333333332    479999999999999988777899999775